PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhao, ZG; Wang, ZL; Li, QB; Li, WM; You, Y; Zou, P				Zhao, Zhigang; Wang, Zhenling; Li, Qiubai; Li, Weiming; You, Yong; Zou, Ping			The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; BONE-MARROW; IMMUNOSUPPRESSIVE THERAPY; DENDRITIC CELLS; RESPONSES; SUPPRESSION; EXPANSION; INHIBIT	Myelodysplastic syndrome (MDS) are a group of progressive, clonal, neoplastic bone marrow disorders characterized by hematopoietic stem cell dysregulation and abnormalities in the immune system. Mesenchymal stem cells (MSC) have gained further interests after the demonstration of an immunoregulatory role. Nevertheless, the immunoregulatory function of MDS bone marrow derived MSC (MDS-MSC) remains poorly defined. In addition, it is not clear whether there are differences in the regulatory functions between low-risk and high-risk MDS-MSC. In this study, we obtain and expand MSC from bone marrow of patients with MDS. Our results show that there are significant differences in the immunoregulatory functions between low-risk and high-risk MDS-MSC. Compare to low-risk MDS-MSC, high-risk MDS-MSC is associated with the presence of increased TGF-beta 1, higher apoptosis, higher immunosuppressive rate and a poor ability of hematopoietic support. In addition, our results find that there are great differences in the CD4+CD25+Foxp3+Tregs inducible rate between high-risk MDS-MSC and low-risk MDS-MSC. Compared to high-risk MDS-MSC, the inducible rate of CD4+CD25+Foxp3+Tregs of low-risk MDS-MSC is lower. At last, we find that MDS-MSC derived TGF-beta 1 is largely responsible for the increase in CD4+CD25+Foxp3+Tregs based on knockdown studies. These results elucidate the different immunoregulatory role of MSC in low-risk and high-risk MDS, which may be important for understand the pathogenesis of MDS and the development of novel immunomodulatory strategies for the treatment of MDS.	[Zhao, Zhigang; Wang, Zhenling] Tianjin Med Univ, Oncol Hosp, Dept Hematol, Tianjin, Peoples R China; [Li, Qiubai; Li, Weiming; You, Yong; Zou, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Hematol, Dept Hematol, Wuhan 430074, Peoples R China	Tianjin Medical University; Huazhong University of Science & Technology	Zhao, ZG (corresponding author), Tianjin Med Univ, Oncol Hosp, Dept Hematol, Tianjin, Peoples R China.	zhaodor001@gmail.com	Li, Qiubai/GWQ-9911-2022		National Natural Science Foundation [30801051, 81172833]; Tianjin Application Foundation; Advanced Technology Research Program [08JCYBJC06500, 09JCYBJC11000]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Application Foundation; Advanced Technology Research Program	This work is supported by grants from the National Natural Science Foundation (No. 30801051; No. 81172833) and the Tianjin Application Foundation and Advanced Technology Research Program (08JCYBJC06500; 09JCYBJC11000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aggarwal S, 2011, BRIT J HAEMATOL, V153, P568, DOI 10.1111/j.1365-2141.2011.08683.x; Asano Y, 2001, ANN HEMATOL, V80, P634; Bacigalupo A, 2005, EXP HEMATOL, V33, P819, DOI 10.1016/j.exphem.2005.05.006; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Chen Wanjun, 2002, Curr Dir Autoimmun, V5, P62; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Devine SM, 2000, CURR OPIN HEMATOL, V7, P358, DOI 10.1097/00062752-200011000-00007; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Guo H, 2003, EXP HEMATOL, V31, P650, DOI 10.1016/S0301-472X(03)00087-0; Han Q, 2007, LEUKEMIA RES, V31, P1369; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Klaus M, 2010, STEM CELLS DEV, V19, P1043, DOI 10.1089/scd.2009.0286; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Saunthararajah Y, 2003, BLOOD, V102, P3025, DOI 10.1182/blood-2002-11-3325; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wang J, 2005, INT J HEMATOL, V82, P152, DOI 10.1532/IJH97.A10505; Wlodarski MW, 2006, BLOOD, V108, P2632, DOI 10.1182/blood-2005-09-3902; Wlodarski MW, 2005, BLOOD, V106, P2769, DOI 10.1182/blood-2004-10-4045; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Zhao ZG, 2008, IMMUNOL INVEST, V37, P726, DOI 10.1080/08820130802349940; Zhi-Gang Z, 2008, LEUKEMIA LYMPHOMA, V49, P2187, DOI 10.1080/10428190802455875	32	100	103	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45675	10.1371/journal.pone.0045675	http://dx.doi.org/10.1371/journal.pone.0045675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029178	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800079
J	Roucher, C; Rogier, C; Dieye-Ba, F; Sokhna, C; Tall, A; Trape, JF				Roucher, Clementine; Rogier, Christophe; Dieye-Ba, Fambaye; Sokhna, Cheikh; Tall, Adama; Trape, Jean-Francois			Changing Malaria Epidemiology and Diagnostic Criteria for Plasmodium falciparum Clinical Malaria	PLOS ONE			English	Article							PYROGENIC THRESHOLD; HOLOENDEMIC AREA; CASE DEFINITIONS; AFRICA; TRANSMISSION; MORTALITY; CHILDREN; INTENSE; FEVER; PARASITEMIA	Background: In tropical Africa, where malaria is highly endemic, low grade infections are asymptomatic and the diagnosis of clinical malaria is usually based on parasite density. Here we investigate how changes in malaria control and endemicity modify diagnostic criteria of Plasmodium falciparum attacks. Methods and Findings: Parasitological and clinical data from the population of Dielmo, Senegal, monitored during 20 years, are analyzed in a random-effect logistic regression model to investigate the relationship between the level of parasitemia and risk of fever. Between 1990 and 2010, P. falciparum prevalence in asymptomatic persons declined from 85% to 1% in children 0-3 years and from 34% to 2% in adults >= 50 years. Thresholds levels of parasitemia for attributing fever episodes to malaria decreased by steps in relation to control policies. Using baseline threshold during following periods underestimated P. falciparum attacks by 9.8-20.2% in children and 18.9-40.2% in adults. Considering all fever episodes associated with malaria parasites as clinical attacks overestimated P. falciparum attacks by 42.2-68.5% in children and 45.9-211.7% in adults. Conclusions: Malaria control modifies in all age-groups the threshold levels of parasitemia to be used for the assessment of malaria morbidity and to guide therapeutic decisions. Even under declining levels of malaria endemicity, the parasite density method must remain the reference method for distinguishing malaria from other causes of fever and assessing trends in the burden of malaria.	[Roucher, Clementine; Dieye-Ba, Fambaye; Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, UMR 198, Dakar, Senegal; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo 101, Madagascar; [Rogier, Christophe; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol, UMR 198, BP 1386, Dakar, Senegal.	jean-francois.trape@ird.fr	ROGIER, Christophe/C-2550-2008		Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)	Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)(Ministry of Research, France)	The Dielmo project was funded by the Institut Pasteur of Paris, the Institut Pasteur of Dakar, the Institut de Recherche pour le Developpement (IRD, formerly ORSTOM) and received grants from the Ministry of Cooperation and the Ministry of Research (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], FOC SEN PROGR IMP SE; BASSETT MT, 1991, J TROP MED HYG, V94, P65; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; Ceesay SJ, 2008, LANCET, V373, P58; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Kitchen SF, 1949, MALARIOLOGY; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P479; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ogbonna A, 2008, T ROY SOC TROP MED H, V102, P621, DOI 10.1016/j.trstmh.2008.03.024; RICHARD A, 1988, ANN SOC BELG MED TR, V68, P317; Robert V., 2003, Bulletin de la Societe de Pathologie Exotique, V96, P6; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 2001, Med Trop (Mars), V61, P27; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Trape JF, 2012, J INFECT DIS, V205, P672, DOI 10.1093/infdis/jir805; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1987, AM J EPIDEMIOL, V126, P193, DOI 10.1093/aje/126.2.193; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25	34	50	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46188	10.1371/journal.pone.0046188	http://dx.doi.org/10.1371/journal.pone.0046188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029433	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900106
J	Tai, K; Quintino, L; Isaksson, C; Gussing, F; Lundberg, C				Tai, Khalid; Quintino, Luis; Isaksson, Christina; Gussing, Fredrik; Lundberg, Cecilia			Destabilizing Domains Mediate Reversible Transgene Expression in the Brain	PLOS ONE			English	Article							REGULATED GENE-EXPRESSION; NEUROTROPHIC FACTOR; LENTIVIRAL VECTORS; PARKINSONS-DISEASE; PROTEIN STABILITY; TETRACYCLINE; DELIVERY; THERAPY; SYSTEM; CELLS	Regulating transgene expression in vivo by delivering oral drugs has been a long-time goal for the gene therapy field. A novel gene regulating system based on targeted proteasomal degradation has been recently developed. The system is based on a destabilizing domain (DD) of the Escherichia coli dihydrofolate reductase (DHFR) that directs fused proteins to proteasomal destruction. Creating YFP proteins fused to destabilizing domains enabled TMP based induction of YFP expression in the brain, whereas omission of TMP resulted in loss of YFP expression. Moreover, induction of YFP expression was dose dependent and at higher TMP dosages, induced YFP reached levels comparable to expression of unregulated transgene., Transgene expression could be reversibly regulated using the DD system. Importantly, no adverse effects of TMP treatment or expression of DD-fusion proteins in the brain were observed. To show proof of concept that destabilizing domains derived from DHFR could be used with a biologically active molecule, DD were fused to GDNF, which is a potent neurotrophic factor of dopamine neurons. N-terminal placement of the DD resulted in TMP-regulated release of biologically active GDNF. Our findings suggest that TMP-regulated destabilizing domains can afford transgene regulation in the brain. The fact that GDNF could be regulated is very promising for developing future gene therapies (e.g. for Parkinson's disease) and should be further investigated.	[Tai, Khalid; Quintino, Luis; Isaksson, Christina; Gussing, Fredrik; Lundberg, Cecilia] Lund Univ, CNS Gene Therapy Unit, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Lund, Sweden	Lund University	Lundberg, C (corresponding author), Lund Univ, CNS Gene Therapy Unit, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Lund, Sweden.	Cecilia.Lundberg@med.lu.se	Quintino, Luis/D-3122-2014	Quintino, Luis/0000-0002-3040-6074; Lundberg, Cecilia/0000-0002-6959-2564	Swedish Research Council [2010-4496, 2007-8626]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grants #2010-4496 and #2007-8626, www.vr.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Anderson PO, 2001, HDB CLIN DRUG DATA; Arvidsson A, 2003, NEUROBIOL DIS, V14, P542, DOI 10.1016/j.nbd.2003.08.002; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BARLING RWA, 1978, J ANTIMICROB CHEMOTH, V4, P203, DOI 10.1093/jac/4.3.203; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Cress DE, 2008, EXP NEUROL, V209, P30, DOI 10.1016/j.expneurol.2007.08.015; Georgievska B, 2004, HUM GENE THER, V15, P934, DOI 10.1089/hum.2004.15.934; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guo ZS, 2008, TRENDS MOL MED, V14, P410, DOI 10.1016/j.molmed.2008.07.003; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kordower JH, 2008, EXP NEUROL, V209, P34, DOI 10.1016/j.expneurol.2007.08.001; Nielsen TT, 2009, J GENE MED, V11, P559, DOI 10.1002/jgm.1333; Pollock R, 2000, P NATL ACAD SCI USA, V97, P13221, DOI 10.1073/pnas.230446297; Rang H.P., 2003, PHARMACOLOGY; Regulier E, 2002, HUM GENE THER, V13, P1981, DOI 10.1089/10430340260355383; Rungoe C, 2010, PEDIATR BLOOD CANCER, V55, P304, DOI 10.1002/pbc.22423; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Suter DM, 2006, SWISS MED WKLY, V136, P413; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Vogel R, 2008, HUM GENE THER, V19, P167, DOI 10.1089/hum.2007.125; Xiao H, 2002, J NEUROCHEM, V82, P801, DOI 10.1046/j.1471-4159.2002.00993.x; Zywiel MG, 2011, INT ORTHOP, V35, P37, DOI 10.1007/s00264-010-0992-x	25	30	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46269	10.1371/journal.pone.0046269	http://dx.doi.org/10.1371/journal.pone.0046269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029456	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900120
J	Blenda, A; Fang, DD; Rami, JF; Garsmeur, O; Luo, F; Lacape, JM				Blenda, Anna; Fang, David D.; Rami, Jean-Francois; Garsmeur, Olivier; Luo, Feng; Lacape, Jean-Marc			A High Density Consensus Genetic Map of Tetraploid Cotton That Integrates Multiple Component Maps through Molecular Marker Redundancy Check	PLOS ONE			English	Article							X GOSSYPIUM-BARBADENSE; SIMPLE SEQUENCE REPEAT; LINKAGE MAP; GENOME STRUCTURE; RICH REGIONS; SSR MARKERS; HIRSUTUM; QTL; IDENTIFICATION; CONSTRUCTION	A consensus genetic map of tetraploid cotton was constructed using six high-density maps and after the integration of a sequence-based marker redundancy check. Public cotton SSR libraries (17,343 markers) were curated for sequence redundancy using 90% as a similarity cutoff. As a result, 20% of the markers (3,410) could be considered as redundant with some other markers. The marker redundancy information had been a crucial part of the map integration process, in which the six most informative interspecific Gossypium hirsutum xG. barbadense genetic maps were used for assembling a high density consensus (HDC) map for tetraploid cotton. With redundant markers being removed, the HDC map could be constructed thanks to the sufficient number of collinear non-redundant markers in common between the component maps. The HDC map consists of 8,254 loci, originating from 6,669 markers, and spans 4,070 cM, with an average of 2 loci per cM. The HDC map presents a high rate of locus duplications, as 1,292 markers among the 6,669 were mapped in more than one locus. Two thirds of the duplications are bridging homoeologous A(T) and D-T chromosomes constitutive of allopolyploid cotton genome, with an average of 64 duplications per A(T)/D-T chromosome pair. Sequences of 4,744 mapped markers were used for a mutual blast alignment (BBMH) with the 13 major scaffolds of the recently released Gossypium raimondii genome indicating high level of homology between the diploid D genome and the tetraploid cotton genetic map, with only a few minor possible structural rearrangements. Overall, the HDC map will serve as a valuable resource for trait QTL comparative mapping, map-based cloning of important genes, and better understanding of the genome structure and evolution of tetraploid cotton.	[Rami, Jean-Francois; Garsmeur, Olivier; Lacape, Jean-Marc] CIRAD, UMR AGAP, Montpellier, France; [Garsmeur, Olivier] Clemson Univ, Sch Comp, Clemson, SC USA; [Blenda, Anna] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Blenda, Anna] Erskine Coll, Dept Biol, Due West, SC USA; [Fang, David D.] ARS, Cotton Fiber Biosci Res Unit, USDA, SRRC, New Orleans, LA USA	CIRAD; Universite de Montpellier; Clemson University; Clemson University; United States Department of Agriculture (USDA)	Lacape, JM (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	marc.lacape@cirad.fr	Lacape, JM/Y-1806-2019; Lacape, Jean-Marc/B-4326-2008; FANG, DAVID/AAV-5774-2020; Blenda, Anna/J-9915-2019	Lacape, Jean-Marc/0000-0003-0891-8329; FANG, DAVID/0000-0003-0036-5459; Blenda, Anna/0000-0001-7669-3120				Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Lopez-Lavalle LAB, 2011, GENOME, V54, P779, DOI [10.1139/G11-037, 10.1139/g11-037]; BRUBAKER CL, 1994, AM J BOT, V81, P1309, DOI 10.2307/2445407; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Campbell BT, 2009, EUPHYTICA, V169, P285, DOI 10.1007/s10681-009-9917-4; Chen X, 2010, J COMPUT BIOL, V17, P1561, DOI 10.1089/cmb.2009.0268; Claverie M, 2012, THEOR APPL GENET, V124, P665, DOI 10.1007/s00122-011-1738-x; Cone KC, 2002, PLANT PHYSIOL, V130, P1598, DOI 10.1104/pp.012245; Desai A, 2006, GENOME, V49, P336, DOI 10.1139/G05-116; Gill KS, 1996, GENETICS, V144, P1883; Gill KS, 1996, GENETICS, V143, P1001; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Gutierrez OA, 2009, MOL BREEDING, V23, P693, DOI 10.1007/s11032-009-9266-y; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hinze LL, 2012, CROP SCI, V52, P222, DOI 10.2135/cropsci2011.04.0202; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Lagercrantz U, 1996, GENETICS, V144, P1903; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Lin ZX, 2009, EUPHYTICA, V166, P35, DOI 10.1007/s10681-008-9822-2; Luo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035261; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Nguyen TB, 2004, THEOR APPL GENET, V109, P167, DOI 10.1007/s00122-004-1612-1; Percival A. E., 1990, Advances in Agronomy, V44, P225, DOI 10.1016/S0065-2113(08)60823-8; REINISCH AJ, 1994, GENETICS, V138, P829; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; Shappley ZW, 1998, THEOR APPL GENET, V97, P756, DOI 10.1007/s001220050952; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stelly D. M., 1993, P BELTW COTT C NEW O, P1545; Truco MJ, 2007, THEOR APPL GENET, V115, P735, DOI 10.1007/s00122-007-0599-9; Ulloa M, 2002, THEOR APPL GENET, V104, P200, DOI 10.1007/s001220100739; Veyrieras JB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-49; Waghmare VN, 2005, THEOR APPL GENET, V111, P665, DOI 10.1007/s00122-005-2032-6; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XF, 2006, GENOME, V49, P1393, DOI 10.1139/G06-113; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Xiao J, 2009, J COTTON SCI, V13, P75; Yu J, 2010, GENOMICS, V95, P230, DOI 10.1016/j.ygeno.2010.02.001; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y	52	82	92	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45739	10.1371/journal.pone.0045739	http://dx.doi.org/10.1371/journal.pone.0045739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029214	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700064
J	Khan, AH; Lin, A; Smith, DJ				Khan, Arshad H.; Lin, Andy; Smith, Desmond J.			Discovery and Characterization of Human Exonic Transcriptional Regulatory Elements	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; CONSERVED ELEMENTS; CODING REGION; PPAR-ALPHA; ENHANCER; GENOME; IDENTIFICATION; CHROMATIN; PROMOTER; SPECIFICITY	We sought exonic transcriptional regulatory elements by shotgun cloning human cDNA fragments into luciferase reporter vectors and measuring the resulting expression levels in liver cells. We uncovered seven regulatory elements within coding regions and three within 3' untranslated regions (UTRs). Two of the putative regulatory elements were enhancers and eight were silencers. The regulatory elements were generally but not consistently evolutionarily conserved and also showed a trend toward decreased population diversity. Furthermore, the exonic regulatory elements were enriched in known transcription factor binding sites (TFBSs) and were associated with several histone modifications and transcriptionally relevant chromatin. Evidence was obtained for bidirectional cis-regulation of a coding region element within a tubulin gene, TUBA1B, by the transcription factors PPARA and RORA. We estimate that hundreds of exonic transcriptional regulatory elements exist, an unexpected finding that highlights a surprising multi-functionality of sequences in the human genome.	[Khan, Arshad H.; Lin, Andy; Smith, Desmond J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	DSmith@mednet.ucla.edu						Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barthel KKB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002184; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Chen HP, 2008, GENOMICS, V92, P292, DOI 10.1016/j.ygeno.2008.07.009; Chiquet M, 1998, EUR J BIOCHEM, V257, P362, DOI 10.1046/j.1432-1327.1998.2570362.x; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsu MH, 1998, J BIOL CHEM, V273, P27988, DOI 10.1074/jbc.273.43.27988; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLellan AS, 2006, AM J PHYSIOL-CELL PH, V291, pC300, DOI 10.1152/ajpcell.00345.2005; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ohoka N, 2009, MOL ENDOCRINOL, V23, P759, DOI 10.1210/me.2008-0277; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Raichur S, 2010, NUCLEIC ACIDS RES, V38, P4296, DOI 10.1093/nar/gkq180; SHACHTER NS, 1993, J LIPID RES, V34, P1699; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tzameli I, 1996, J BIOL CHEM, V271, P8402, DOI 10.1074/jbc.271.14.8402; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46098	10.1371/journal.pone.0046098	http://dx.doi.org/10.1371/journal.pone.0046098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029400	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700114
J	Li, J; Qu, XD; He, XY; Duan, L; Wu, GJ; Bi, DX; Deng, ZX; Liu, W; Ou, HY				Li, Jing; Qu, Xudong; He, Xinyi; Duan, Lian; Wu, Guojun; Bi, Dexi; Deng, Zixin; Liu, Wen; Ou, Hong-Yu			ThioFinder: A Web-Based Tool for the Identification of Thiopeptide Gene Clusters in DNA Sequences	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BIOSYNTHESIS; PEPTIDE; THIOSTREPTON; ALIGNMENT	Thiopeptides are a growing class of sulfur-rich, highly modified heterocyclic peptides that are mainly active against Gram-positive bacteria including various drug-resistant pathogens. Recent studies also reveal that many thiopeptides inhibit the proliferation of human cancer cells, further expanding their application potentials for clinical use. Thiopeptide biosynthesis shares a common paradigm, featuring a ribosomally synthesized precursor peptide and conserved posttranslational modifications, to afford a characteristic core system, but differs in tailoring to furnish individual members. Identification of new thiopeptide gene clusters, by taking advantage of increasing information of DNA sequences from bacteria, may facilitate new thiopeptide discovery and enrichment of the unique biosynthetic elements to produce novel drug leads by applying the principle of combinatorial biosynthesis. In this study, we have developed a web-based tool ThioFinder to rapidly identify thiopeptide biosynthetic gene cluster from DNA sequence using a profile Hidden Markov Model approach. Fifty-four new putative thiopeptide biosynthetic gene clusters were found in the sequenced bacterial genomes of previously unknown producing microorganisms. ThioFinder is fully supported by an open-access database ThioBase, which contains the sufficient information of the 99 known thiopeptides regarding the chemical structure, biological activity, producing organism, and biosynthetic gene (cluster) along with the associated genome if available. The ThioFinder website offers researchers a unique resource and great flexibility for sequence analysis of thiopeptide biosynthetic gene clusters. ThioFinder is freely available at http://db-mml.sjtu.edu.cn/ThioFinder/.	[Li, Jing; He, Xinyi; Wu, Guojun; Bi, Dexi; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Qu, Xudong; Duan, Lian; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Ou, HY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	wliu@mail.sioc.ac.cn; hyou@sjtu.edu.cn	Qu, Xudong/E-1778-2016; Wu, Guuojun/AHB-4249-2022; OU, Hong-Yu/O-5208-2019	Qu, Xudong/0000-0002-3301-8536; Wu, Guuojun/0000-0002-7910-2813; OU, Hong-Yu/0000-0001-9439-1660; Duan, Lian/0000-0002-8266-717X; Bi, Dexi/0000-0001-9325-8868	National Natural Science Foundation of China; Ministry of Science and Technology of China; Ministry of Education of China [NCET-10-0572]; Shanghai Jiaotong University; Shanghai Municipality	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Shanghai Jiaotong University; Shanghai Municipality	This study was supported in part by grants from the National Natural Science Foundation of China; the Ministry of Science and Technology of China (973 and 863 Programs); the Program for New Century Excellent Talents in University, Ministry of Education of China [NCET-10-0572]; the Chen Xing Young Scholars Program, Shanghai Jiaotong University; and Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt HD, 2009, ANGEW CHEM INT EDIT, V48, P6770, DOI 10.1002/anie.200901808; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumann S, 2010, J AM CHEM SOC, V132, P6973, DOI 10.1021/ja909317n; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Duan L, 2012, CHEM BIOL, V19, P443, DOI 10.1016/j.chembiol.2012.02.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hegde NS, 2011, NAT CHEM, V3, P829, DOI 10.1038/nchem.1162; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2011, J AM CHEM SOC, V133, P2852, DOI 10.1021/ja1111173; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; SMITH TM, 1993, J CHEM SOC CHEM COMM, P1612, DOI 10.1039/c39930001612; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108; Yu Y, 2010, J AM CHEM SOC, V132, P16324, DOI 10.1021/ja106571g; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	38	30	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45878	10.1371/journal.pone.0045878	http://dx.doi.org/10.1371/journal.pone.0045878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029291	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700083
J	Brisson, BK; Barton, ER				Brisson, Becky K.; Barton, Elisabeth R.			Insulin-Like Growth Factor-I E-Peptide Activity Is Dependent on the IGF-I Receptor	PLOS ONE			English	Article							SKELETAL-MUSCLE HYPERTROPHY; (IGF)-I E-PEPTIDES; TRANSGENIC MICE; SIGNALING PATHWAYS; GENE-EXPRESSION; E-DOMAIN; DIFFERENTIATION; CELLS; PROTEIN; REGENERATION	Insulin-like growth factor-I (IGF-I) is an essential growth factor that regulates the processes necessary for cell proliferation, differentiation, and survival. The Igf1 gene encodes mature IGF-I and a carboxy-terminal extension called the E-peptide. In rodents, alternative splicing and post-translational processing produce two E-peptides (EA and EB). EB has been studied extensively and has been reported to promote cell proliferation and migration independently of IGF-I and its receptor (IGF-IR), but the mechanism by which EB causes these actions has not been identified. Further, the properties of EA have not been evaluated. Therefore, the goals of this study were to determine if EA and EB possessed similar activity and if these actions were IGF-IR independent. We utilized synthetic peptides for EA, EB, and a scrambled control to examine cellular responses. Both E-peptides increased MAPK signaling, which was blocked by pharmacologic IGF-IR inhibition. Although the E-peptides did not directly induce IGF-IR phosphorylation, the presence of either E-peptide increased IGF-IR activation by IGF-I, and this was achieved through enhanced cell surface bioavailability of the receptor. To determine if E-peptide biological actions required the IGF-IR, we took advantage of the murine C2C12 cell line as a platform to examine the key steps of skeletal muscle proliferation, migration and differentiation. EB increased myoblast proliferation and migration while EA delayed differentiation. The proliferation and migration effects were inhibited by MAPK or IGF-IR signaling blockade. Thus, in contrast to previous studies, we find that E-peptide signaling, mitogenic, and motogenic effects are dependent upon IGF-IR. We propose that the E-peptides have little independent activity, but instead affect growth via modulating IGF-I signaling, thereby increasing the complexity of IGF-I biological activity.	[Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Barton, ER (corresponding author), Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.	erbarton@dental.upenn.edu			National Institutes of Health [AR057363, AR056480]; Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, PA [AR053461]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057363, R21AR056480, T32AR053461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, PA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants AR057363 and AR056480 to E.R. Barton. B.K. Brisson was supported by a fellowship from the Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, PA (AR053461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Adams GR, 1996, J APPL PHYSIOL, V81, P2509, DOI 10.1152/jappl.1996.81.6.2509; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bulayeva NN, 2004, STEROIDS, V69, P181, DOI 10.1016/j.steroids.2003.12.003; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CLEMMONS DR, 1986, J BIOL CHEM, V261, P293; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; CONOVER CA, 1993, REGUL PEPTIDES, V48, P1, DOI 10.1016/0167-0115(93)90330-B; CONOVER CA, 1989, J CLIN ENDOCR METAB, V69, P25, DOI 10.1210/jcem-69-1-25; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; DUGUAY SJ, 1995, J BIOL CHEM, V270, P17566, DOI 10.1074/jbc.270.29.17566; Duguay SJ, 1999, HORM METAB RES, V31, P43, DOI 10.1055/s-2007-978697; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Goldspink G, 2005, BRIT J SPORT MED, V39, P787, DOI 10.1136/bjsm.2004.015826; Hailey J, 2002, MOL CANCER THER, V1, P1349; Heidegger I, 2011, CANCER BIOL THER, V11, P701, DOI 10.4161/cbt.11.8.14689; JENNISCHE E, 1987, ACTA PHYSIOL SCAND, V130, P327, DOI 10.1111/j.1748-1716.1987.tb08144.x; JOHNSON SE, 1990, EXP CELL RES, V187, P250, DOI 10.1016/0014-4827(90)90088-R; Kandalla PK, 2011, MECH AGEING DEV, V132, P154, DOI 10.1016/j.mad.2011.02.007; Kuo YH, 2002, EXP CELL RES, V280, P75, DOI 10.1006/excr.2002.5628; Leloup L, 2007, INT J BIOCHEM CELL B, V39, P1177, DOI 10.1016/j.biocel.2007.03.003; Leloup L, 2006, INT J BIOCHEM CELL B, V38, P2049, DOI 10.1016/j.biocel.2006.04.012; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528; Lund PK, 1998, HDB PHYSL ENDOCRINE, P537; Lynch GS, 2001, NEUROMUSCULAR DISORD, V11, P260, DOI 10.1016/S0960-8966(00)00192-9; Matheny RW, 2011, ENDOCRINOLOGY, V152, P1923, DOI 10.1210/en.2010-1279; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Mills P, 2007, AM J TRANSPLANT, V7, P2247, DOI 10.1111/j.1600-6143.2007.01927.x; Mills P, 2007, EXP CELL RES, V313, P527, DOI 10.1016/j.yexcr.2006.10.032; Musaro A, 1999, MOL CELL BIOL, V19, P3115; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Pfeffer LA, 2009, MOL BIOL CELL, V20, P3810, DOI 10.1091/mbc.E08-12-1202; Philippou A, 2008, IN VIVO, V22, P27; Philippou A, 2009, IN VIVO, V23, P567; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Quinn LS, 1996, J CELL PHYSIOL, V168, P34, DOI 10.1002/(SICI)1097-4652(199607)168:1<34::AID-JCP5>3.0.CO;2-9; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; ROTWEIN P, 1986, P NATL ACAD SCI USA, V83, P77, DOI 10.1073/pnas.83.1.77; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; Schwarz AJ, 1996, J CLIN ENDOCR METAB, V81, P3492, DOI 10.1210/jc.81.10.3492; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shamblott Michael J., 1993, Molecular Marine Biology and Biotechnology, V2, P351; SHIMATSU A, 1987, J BIOL CHEM, V262, P7894; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Stavropoulou A, 2009, MOL MED, V15, P127, DOI 10.2119/molmed.2009.00012; Tian XC, 1999, ENDOCRINOLOGY, V140, P3387, DOI 10.1210/en.140.7.3387; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; Wilson HE, 2001, GROWTH HORM IGF RES, V11, P10, DOI 10.1054/ghir.2000.0182; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x; Wu NJ, 2002, MATRIX BIOL, V21, P149, DOI 10.1016/S0945-053X(01)00192-5; YANG H, 1997, J ANAT 4, V190, P613; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	76	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45588	10.1371/journal.pone.0045588	http://dx.doi.org/10.1371/journal.pone.0045588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029120	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800063
J	Kaler, P; Augenlicht, L; Klampfer, L				Kaler, Pawan; Augenlicht, Leonard; Klampfer, Lidija			Activating Mutations in beta-Catenin in Colon Cancer Cells Alter Their Interaction with Macrophages; the Role of Snail	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; WNT; GENE; TARGET; GROWTH; METASTASIS; EXPRESSION; PATHWAY; FAMILY	Background: Tumor cells become addicted to both activated oncogenes and to proliferative and pro-survival signals provided by the abnormal tumor microenvironment. Although numerous soluble factors have been identified that shape the crosstalk between tumor cells and stroma, it has not been established how oncogenic mutations in the tumor cells alter their interaction with normal cells in the tumor microenvironment. Principal Findings: We showed that the isogenic HCT116 and Hke-3 cells, which differ only by the presence of the mutant kRas allele, both stimulate macrophages to produce IL1 beta. In turn, macrophages enhanced Wnt signaling, proliferation and survival in both HCT116 and Hke-3 cells, demonstrating that signaling by oncogenic kRas in tumor cells does not impact their interaction with macrophages. HCT116 cells are heterozygous for beta-catenin (HCT116(WT/MT)), harboring one wild type (WT) and one mutant (MT) allele, but isogenic lines that carry only the WT (HCT116(WT)) or MT beta-catenin allele (HCT116(MT)) have been generated. We showed that macrophages promoted Wnt signaling in cells that carry the MT beta-catenin allele, but not in HCT116(WT) cells. Consistent with this observation, macrophages and IL1 beta failed to stabilize Snail in HCT116(WT) cells, and to protect these cells from TRAIL-induced apoptosis. Finally, we demonstrated that HCT116 cells expressing dominant negative TCF4 (dnTCF4) or HCT116 cells with silenced Snail failed to stimulate IL1 beta production in macrophages, demonstrating that tumor cells activate macrophages via a Wnt-dependent factor. Significance: Our data demonstrate that oncogenic beta-catenin mutations in tumor cells, and subsequent activation of Wnt signaling, not only trigger cell-intrinsic alterations, but also have a significant impact on the crosstalk of tumor cells with the tumor associated macrophages.	[Kaler, Pawan; Augenlicht, Leonard; Klampfer, Lidija] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Klampfer, L (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA.	lidija.klampfer@einstein.yu.edu			NCI (National Cancer Institute (U.S.)) [CA 111361, U54 CA 100926, P30-13330]; NATIONAL CANCER INSTITUTE [U54CA100926, R01CA111361] Funding Source: NIH RePORTER	NCI (National Cancer Institute (U.S.)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA 111361 (to LK), U54 CA 100926 (to LA) and P30-13330 from NCI (National Cancer Institute (U.S.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balkwill FR, SEMIN CANC BIOL, V22, P33; Bonecchi R, CANC CELL, V19, P434; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Cui L, PLOS ONE, V5; de Sousa EM, CLIN CANC RES, V17, P647; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Doubravska L, 2008, APOPTOSIS, V13, P573, DOI 10.1007/s10495-008-0191-z; Erreni M, CANC MICROENVIRON, V4, P141; Hwang WL, GASTROENTEROLOGY, V141, P279; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; KALER P, 2009, CANC MICROENVIRON; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Kanwar SS, MOL CANC, V9, P212; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Lyons JG, 2008, CANCER RES, V68, P4525, DOI 10.1158/1078-0432.CCR-07-6735; Malanchi I, NATURE, V481, P85; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Polakis P, 2000, GENE DEV, V14, P1837; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Qian BZ, NATURE, V475, P222; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Sparks AB, 1998, CANCER RES, V58, P1130; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Vermeulen L, NAT CELL BIOL, V12, P468; Vlantis K, J CLIN INVEST, V121, P2781; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	38	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45462	10.1371/journal.pone.0045462	http://dx.doi.org/10.1371/journal.pone.0045462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029025	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800051
J	Li, RW; Wan, B; Zhou, J; Wang, YL; Luo, T; Gu, XT; Chen, F; Yu, L				Li, Ruwei; Wan, Bo; Zhou, Jun; Wang, Yingli; Luo, Ting; Gu, Xiuting; Chen, Fang; Yu, Long			APC/C-Cdh1 Targets Brain-Specific Kinase 2 (BRSK2) for Degradation via the Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; ACTIVATED PROTEIN-KINASE; AMPK-RELATED KINASES; NEURONAL POLARIZATION; DIRECT BINDING; SAD-1 KINASE; CELL-CYCLE; KEN BOX; MITOSIS; YEAST	Studies of brain-specific kinase 2 (BRSK2), an AMP-activated protein kinase (AMPK)-related kinase, and its homologs suggest that they are multifunctional regulators of cell-cycle progression. BRSK2, which contains a ubiquitin-associated (UBA) domain, is polyubiquitinated in cells. However, the regulatory mechanisms and exact biological function of BRSK2 remain unclear. Herein, we show that BRSK2 co-localizes with the centrosomes during mitosis. We also demonstrate that BRSK2 protein levels fluctuate during the cell cycle, peaking during mitosis and declining in G1 phase. Furthermore, Cdh1, rather than Cdc20, promotes the degradation of BRSK2 in vivo. Consistent with this finding, knock-down of endogenous Cdh1 blocks BRSK2 degradation during the G1 phase. The conserved KEN box of BRSK2 is required for anaphase-promoting complex/cyclosome-Cdh1 (APC/C-Cdh1)-dependent degradation. Additionally, overexpression of either BRSK2(WT) or BRSK2(Delta KEN) increases the percentage of cells in G2/M. Thus, our results provide the first evidence that BRSK2 regulates cell-cycle progression controlled by APC/C-Cdh1 through the ubiquitin-proteasome pathway.	[Li, Ruwei; Wan, Bo; Zhou, Jun; Wang, Yingli; Luo, Ting; Gu, Xiuting; Chen, Fang; Yu, Long] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Yu, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Zhou, Jun/J-3035-2015; Wan, Bo/AAE-6352-2021; Chen, Fang/F-4325-2019	Chen, Fang/0000-0003-3108-8204	National Key Sci-Tech Special Project of China [2008ZX10002-020, 2008ZX10002-021]; National Natural Science Foundation of China [30872947]; National Natural Science Foundation for Young Scholar of China [81101810]	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scholar of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Key Sci-Tech Special Project of China (2008ZX10002-020, 2008ZX10002-021), http://www.nmp.gov.cn/, National Natural Science Foundation of China (30872947) and the National Natural Science Foundation for Young Scholar of China (grant no. 81101810), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Chen XY, 2012, J BIOL CHEM, V287, P30368, DOI 10.1074/jbc.M112.375618; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simpson-Lavy KJ, 2009, CELL CYCLE, V8, P3003; Stanchi F, 2001, YEAST, V18, P69, DOI 10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Vazquez-Martin A, 2011, CELL CYCLE, V10, P1295, DOI 10.4161/cc.10.8.15342; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhou J, 2012, BIOCHEM BIOPH RES CO, V422, P647, DOI 10.1016/j.bbrc.2012.05.045; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	37	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45932	10.1371/journal.pone.0045932	http://dx.doi.org/10.1371/journal.pone.0045932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029325	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800123
J	Engesaeter, B; Engebraaten, O; Florenes, VA; Maelandsmo, GM				Engesaeter, Birgit; Engebraaten, Olav; Florenes, Vivi Ann; Maelandsmo, Gunhild Mari			Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma	PLOS ONE			English	Article							NF-KAPPA-B; LIGAND-INDUCED APOPTOSIS; MONOCLONAL-ANTIBODY; PHASE-I; METASTATIC MELANOMA; MALIGNANT-MELANOMA; MEDIATED APOPTOSIS; DOWN-REGULATION; UP-REGULATION; NUDE-MICE	Mapatumumab and lexatumumab (targeting death receptor 4 (DR4) and 5 (DR5), respectively) are agonistic TRAIL receptor antibodies that induce apoptosis in a wide range of cancer cells. The potency of mapatumumab and lexatumumab was assessed in mono therapy protocols, and the ability to sensitize for dacarbazine (DTIC) treatment was explored in ten different melanoma cell lines. Our data indicated that melanoma cell lines tend to be resistant to mapatumumab, most likely due to low expression of DR4, while a dose dependent response to lexatumumab was observed. Combining DTIC and lexatumumab induced an additive or synergistic effect on cell death in the various melanoma cell lines. The synergistic effect observed in the FEMX-1 cell line was related to enhanced cleavage of Bid in parallel with elevated expression of the pro-apoptotic proteins Bim, Bax and Bak. Furthermore, the anti-apoptotic proteins Bcl-XL, cIAP-1, XIAP and livin were down regulated. Cleavage of Bid and down regulation of cIAP-2 and livin were observed in vivo. Altogether, these data suggest a change in the balance between pro-and anti-apoptotic proteins favoring induction of apoptosis. In the more therapy resistant cell line, HHMS, no changes in the pro-and anti-apoptotic proteins were observed. FEMX-1 xenografts treated with DTIC and lexatumumab showed reduced growth and increased level of apoptosis compared to the control groups, providing arguments for further evaluation of this combination in melanoma patients.	[Engesaeter, Birgit; Engebraaten, Olav; Maelandsmo, Gunhild Mari] Oslo Univ Hosp, Dept Tumor Biol, Oslo, Norway; [Engebraaten, Olav] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Engebraaten, Olav] Univ Oslo, Fac Med, Inst Clin Res, Oslo, Norway; [Florenes, Vivi Ann] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Maelandsmo, Gunhild Mari] Univ Tromso, Dept Pharm, Fac Hlth Sci, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Engesaeter, B (corresponding author), Oslo Univ Hosp, Dept Tumor Biol, Oslo, Norway.	birgite@rr-research.no	Mælandsmo, Gunhild Mari/AFV-4446-2022		Oslo University Hospital; Norwegian Ministry of Health	Oslo University Hospital; Norwegian Ministry of Health	Oslo University Hospital and Gene Therapy Funding from the Norwegian Ministry of Health supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2011, BIOCHEM PHARMACOL, V81, P71, DOI 10.1016/j.bcp.2010.09.010; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen N, 2009, HUM PATHOL, V40, P950, DOI 10.1016/j.humpath.2008.12.001; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Dai DL, 2008, J INVEST DERMATOL, V128, P403, DOI 10.1038/sj.jid.5700989; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Ding BY, 2011, INT J NANOMED, V6, P1991, DOI 10.2147/IJN.S24094; Duckett Colin S, 2005, Biochem J, V385, pe1; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; Engesaeter BO, 2011, CANCER BIOL THER, V12, P47, DOI 10.4161/cbt.12.1.15714; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; FODSTAD O, 1988, CANCER RES, V48, P4382; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Garbe C, 2007, MELANOMA RES, V17, P117, DOI 10.1097/CMR.0b013e328042bb36; Gong J, 2005, J CLIN PATHOL, V58, P1081, DOI 10.1136/jcp.2005.025817; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; HERLYN M, 1990, CANCER METAST REV, V9, P101, DOI 10.1007/BF00046337; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hornle M, 2011, ONCOGENE, V30, P575, DOI 10.1038/onc.2010.434; Ivanov VN, 2006, EXP CELL RES, V312, P4120, DOI 10.1016/j.yexcr.2006.09.019; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Leong S, 2009, J CLIN ONCOL, V27, P4413, DOI 10.1200/JCO.2008.21.7422; Lillehammer T, 2007, J GENE MED, V9, P440, DOI 10.1002/jgm.1036; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; Mom CH, 2009, CLIN CANCER RES, V15, P5584, DOI 10.1158/1078-0432.CCR-09-0996; Nachmias B, 2003, CANCER RES, V63, P6340; Nachmias B, 2007, EUR J IMMUNOL, V37, P3467, DOI 10.1002/eji.200636600; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Schneider-Jakob S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.66; Sloot AMvd, 2006, P NATL ACAD SCI USA, V103, P8634; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Zhang XD, 2001, CANCER RES, V61, P7339; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45492	10.1371/journal.pone.0045492	http://dx.doi.org/10.1371/journal.pone.0045492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029050	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900061
J	Nishimoto, T; Yamamoto, Y; Yoshida, K; Goto, N; Ohnami, S; Aoki, K				Nishimoto, Takeshi; Yamamoto, Yuki; Yoshida, Kimiko; Goto, Naoko; Ohnami, Shumpei; Aoki, Kazunori			Development of Peritoneal Tumor-Targeting Vector by In Vivo Screening with a Random Peptide-Displaying Adenovirus Library	PLOS ONE			English	Article							GENE-TRANSFER; FIBER KNOB; HI LOOP; THERAPY; CANCER; RECEPTOR; VIRUS; TROPISM; BINDING; MICE	The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in vector development. However, attempts to redirect adenovirus vectors to alternative receptors by engineering the capsid-coding region have shown limited success, because the proper targeting ligands on the cells of interest are generally unknown. To overcome this limitation, we have constructed a random peptide library displayed on the adenoviral fiber knob, and have successfully selected targeted vectors by screening the library on cancer cell lines in vitro. The infection of targeted vectors was considered to be mediated by specific receptors on target cells. However, the expression levels and kinds of cell surface receptors may be substantially different between in vitro culture and in vivo tumor tissue. Here, we screened the peptide display-adenovirus library in the peritoneal dissemination model of AsPC-1 pancreatic cancer cells. The vector displaying a selected peptide (PFWSGAV) showed higher infectivity in the AsPC-1 peritoneal tumors but not in organs and other peritoneal tumors as compared with a non-targeted vector. Furthermore, the infectivity of the PFWSGAV-displaying vector for AsPC-1 peritoneal tumors was significantly higher than that of a vector displaying a peptide selected by in vitro screening, indicating the usefulness of in vivo screening in exploring the targeting vectors. This vector-screening system can facilitate the development of targeted adenovirus vectors for a variety of applications in medicine.	[Nishimoto, Takeshi; Yamamoto, Yuki; Yoshida, Kimiko; Goto, Naoko; Aoki, Kazunori] Natl Canc Ctr, Res Inst, Div Gene & Immune Med, Chuo Ku, Tokyo 104, Japan; [Ohnami, Shumpei] Natl Canc Ctr, Res Inst, Cent Radioisotope Div, Chuo Ku, Tokyo 104, Japan; [Nishimoto, Takeshi] Hiroshima Univ, Dept Neurosurg, Grad Sch Med, Minami Ku, Hiroshima, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Hiroshima University	Aoki, K (corresponding author), Natl Canc Ctr, Res Inst, Div Gene & Immune Med, Chuo Ku, Tokyo 104, Japan.	kaoki@ncc.go.jp			Ministry of Health, Labour and Welfare of Japan; program for promotion of Foundation Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO); National Cancer Center Research and Development Fund [23-A-9]; Foundation (Japan) for the Promotion of Science	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); program for promotion of Foundation Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Foundation (Japan) for the Promotion of Science	This work was supported in part by a grant-in-aid for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan, grants-in-aid for Research from the Ministry of Health, Labour and Welfare of Japan, by the program for promotion of Foundation Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) and by the National Cancer Center Research and Development Fund (23-A-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; T Nishimoto is an awardee of a Research Resident Fellowship from the Foundation (Japan) for the Promotion of Science.	Aoki K, 2001, GENE THER, V8, P508, DOI 10.1038/sj.gt.3301435; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Eager RM, 2011, CANCER GENE THER, V18, P305, DOI 10.1038/cgt.2011.7; Hemminki A, 2001, CANCER RES, V61, P6377; Joung I, 2005, BIOCHEM BIOPH RES CO, V328, P1182, DOI 10.1016/j.bbrc.2005.01.080; Khare R, 2011, CURR GENE THER, V11, P241, DOI 10.2174/156652311796150363; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Lupold SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm914; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Miura Y, 2007, GENE THER, V14, P1448, DOI 10.1038/sj.gt.3303007; Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj.gt.3301701; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nicklin SA, 2004, J GENE MED, V6, P300, DOI 10.1002/jgm.526; Nicklin SA, 2001, MOL THER, V4, P534, DOI 10.1006/mthe.2001.0489; Nishimoto T, 2009, GENE THER, V16, P669, DOI 10.1038/gt.2009.1; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Sagawa T, 2004, MOL THER, V10, P1043, DOI 10.1016/j.ymthe.2004.08.023; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wu P, 2010, CANCER RES, V70, P9549, DOI 10.1158/0008-5472.CAN-10-1760; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; Yao XL, 2011, CURR CANCER DRUG TAR, V11, P810, DOI 10.2174/156800911796798896; Yoshida Y, 1998, HUM GENE THER, V9, P2503, DOI 10.1089/hum.1998.9.17-2503	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45550	10.1371/journal.pone.0045550	http://dx.doi.org/10.1371/journal.pone.0045550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029088	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900071
J	O'Flaherty, JT; Hu, YP; Wooten, RE; Horita, DA; Samuel, MP; Thomas, MJ; Sun, HG; Edwards, IJ				O'Flaherty, Joseph T.; Hu, Yungping; Wooten, Rhonda E.; Horita, David A.; Samuel, Michael P.; Thomas, Michael J.; Sun, Haiguo; Edwards, Iris J.			15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; POLYUNSATURATED FATTY-ACIDS; LIPID MEDIATORS; INTRAEPITHELIAL NEOPLASIA; ADENOCARCINOMA CELLS; GROWTH-FACTOR; TUMOR-GROWTH; EXPRESSION; RISK; CYCLOOXYGENASE-2	A 15-LOX, it is proposed, suppresses the growth of prostate cancer in part by converting arachidonic, eicosatrienoic, and/or eicosapentaenoic acids to n-6 hydroxy metabolites. These metabolites inhibit the proliferation of PC3, LNCaP, and DU145 prostate cancer cells but only at >= 1-10 mu M. We show here that the 15-LOX metabolites of docosahexaenoic acid (DHA), 17-hydroperoxy-, 17-hydroxy-, 10,17-dihydroxy-, and 7,17-dihydroxy-DHA inhibit the proliferation of these cells at >= 0.001, 0.01, 1, and 1 mM, respectively. By comparison, the corresponding 15-hydroperoxy, 15-hydroxy, 8,15-dihydroxy, and 5,15-dihydroxy metabolites of arachidonic acid as well as DHA itself require >= 10-100 mM to do this. Like DHA, the DHA metabolites a) induce PC3 cells to activate a peroxisome proliferator-activated receptor-gamma (PPAR gamma) reporter, express syndecan-1, and become apoptotic and b) are blocked from slowing cell proliferation by pharmacological inhibition or knockdown of PPAR gamma or syndecan-1. The DHA metabolites thus slow prostate cancer cell proliferation by engaging the PPAR gamma/syndecan-1 pathway of apoptosis and thereby may contribute to the prostate cancer-suppressing effects of not only 15-LOX but also dietary DHA.	[Hu, Yungping; Sun, Haiguo; Edwards, Iris J.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [O'Flaherty, Joseph T.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Wooten, Rhonda E.; Horita, David A.; Samuel, Michael P.; Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Edwards, IJ (corresponding author), Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.	iedwards@wakehealth.edu		Horita, David/0000-0002-9563-107X	NIH [PO1CA106742, RO1CA115958, RO1AI064609, NIH CA1207]; two Golfers' Against Cancer; National Science Foundation [BIR-9414018]; NATIONAL CANCER INSTITUTE [R01CA115958, P01CA106742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064609] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); two Golfers' Against Cancer; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants PO1CA106742 (J.T.O., Y.H. and I.J.E.), RO1CA115958 (I.J.E.), RO1AI064609 (D.A.H.) and Center Grant NIH CA1207 (M.J.T.) and two Golfers' Against Cancer grants (J.T.O.). National Science Foundation grant BIR-9414018 provided the funds to purchase the mass spectrometer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2008, CUAJ-CAN UROL ASSOC, V2, P510; Astorg P, 2005, B CANCER, V92, P670; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Berquin IM, 2011, CANCER METAST REV, V30, P295, DOI 10.1007/s10555-011-9299-7; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Brash AR, 1999, ADV EXP MED BIOL, V469, P83; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Butovich IA, 2006, J LIPID RES, V47, P854, DOI 10.1194/jlr.D500042-JLR200; Butovich IA, 2006, J LIPID RES, V47, P2462, DOI 10.1194/jlr.M600280-JLR200; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chen P, 2011, FASEB J, V25, P382, DOI 10.1096/fj.10-161836; Chung BH, 2001, CARCINOGENESIS, V22, P1201, DOI 10.1093/carcin/22.8.1201; Dangi B, 2009, J BIOL CHEM, V284, P14744, DOI 10.1074/jbc.M809014200; Edwards IJ, 2004, CLIN CANCER RES, V10, P8275, DOI 10.1158/1078-0432.CCR-04-1357; Edwards IJ, 2008, J BIOL CHEM, V283, P18441, DOI 10.1074/jbc.M802107200; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Freeman VL, 2004, CANCER-AM CANCER SOC, V101, P2744, DOI 10.1002/cncr.20676; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Gleissman H, 2010, FASEB J, V24, P906, DOI 10.1096/fj.09-137919; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hsi LC, 2002, J BIOL CHEM, V277, P40549, DOI 10.1074/jbc.M203522200; Hu YP, 2010, NEOPLASIA, V12, P826, DOI 10.1593/neo.10586; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; Kelavkar Uddhav, 2006, J Carcinog, V5, P9, DOI 10.1186/1477-3163-5-9; Kelavkar UP, 2006, NEOPLASIA, V8, P510, DOI 10.1593/neo.06202; Kelavkar UP, 2009, NEOPLASIA, V11, P692, DOI 10.1593/neo.09334; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; Kelavkar UP, 2004, NEOPLASIA, V6, P41, DOI 10.1016/S1476-5586(04)80052-6; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kobayashi N, 2006, CLIN CANCER RES, V12, P4662, DOI 10.1158/1078-0432.CCR-06-0459; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Mamalakis G, 2002, PROSTAG LEUKOTR ESS, V66, P467, DOI 10.1054/plef.2002.0384; Matsuyama M, 2008, BIOL-TARGETS THER, V2, P725; Norrish AE, 1999, BRIT J CANCER, V81, P1238, DOI 10.1038/sj.bjc.6690835; O'Flaherty JT, 2005, BBA-MOL CELL BIOL L, V1736, P228, DOI 10.1016/j.bbalip.2005.08.009; OFLAHERTY JT, 1985, PROSTA LEUKOTR MED, V17, P199, DOI 10.1016/0262-1746(85)90107-6; Pham H, 2003, CANCER LETT, V189, P17, DOI 10.1016/S0304-3835(02)00498-6; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Poulsen RC, 2008, AM J HEMATOL, V83, P437, DOI 10.1002/ajh.21170; ROSE DP, 1991, PROSTATE, V18, P243, DOI 10.1002/pros.2990180306; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shappell SB, 2001, NEOPLASIA, V3, P287, DOI 10.1038/sj.neo.7900166; Shappell SB, 2001, CANCER RES, V61, P497; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; Subbarayan V, 2006, ONCOGENE, V25, P6015, DOI 10.1038/sj.onc.1209617; Subbarayan V, 2004, CANCER EPIDEM BIOMAR, V13, P1710; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Sun HG, 2011, CARCINOGENESIS, V32, P1518, DOI 10.1093/carcin/bgr132; Suraneni MV, 2010, ONCOGENE, V29, P4261, DOI 10.1038/onc.2010.197; Tang DG, 2007, PROSTAG OTH LIPID M, V82, P135, DOI 10.1016/j.prostaglandins.2006.05.022; Terry P, 2001, LANCET, V357, P1764, DOI 10.1016/S0140-6736(00)04889-3; Vang K, 2005, PROSTAG LEUKOTR ESS, V72, P363, DOI 10.1016/j.plefa.2005.02.002; VANROLLINS M, 1984, J BIOL CHEM, V259, P5776; VANROLLINS M, 1984, J LIPID RES, V25, P507; Wecksler AT, 2008, BIOCHEMISTRY-US, V47, P7364, DOI 10.1021/bi800550n; Williams CD, 2011, NUTR RES, V31, P1, DOI 10.1016/j.nutres.2011.01.002; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3	61	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45480	10.1371/journal.pone.0045480	http://dx.doi.org/10.1371/journal.pone.0045480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029040	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900058
J	Eckrich, T; Varakina, K; Johnson, SL; Franz, C; Singer, W; Kuhn, S; Knipper, M; Holley, MC; Marcotti, W				Eckrich, Tobias; Varakina, Ksenya; Johnson, Stuart L.; Franz, Christoph; Singer, Wibke; Kuhn, Stephanie; Knipper, Marlies; Holley, Matthew C.; Marcotti, Walter			Development and Function of the Voltage-Gated Sodium Current in Immature Mammalian Cochlear Inner Hair Cells	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; ACTION-POTENTIALS; GENE-EXPRESSION; CENTRAL NEURONS; RIBBON SYNAPSE; IONIC CURRENTS; NA+ CHANNELS; RAT UTRICLE; DEPENDENCE; NERVE	Inner hair cells (IHCs), the primary sensory receptors of the mammalian cochlea, fire spontaneous Ca2+ action potentials before the onset of hearing. Although this firing activity is mainly sustained by a depolarizing L-type (Ca(V)1.3) Ca2+ current (I-Ca), IHCs also transiently express a large Na+ current (I-Na). We aimed to investigate the specific contribution of I-Na to the action potentials, the nature of the channels carrying the current and whether the biophysical properties of I-Na differ between low-and high-frequency IHCs. We show that I-Na is highly temperature-dependent and activates at around -60 mV, close to the action potential threshold. Its size was larger in apical than in basal IHCs and between 5% and 20% should be available at around the resting membrane potential (-55 mV/-60 mV). However, in vivo the availability of I-Na could potentially increase to >60% during inhibitory postsynaptic potential activity, which transiently hyperpolarize IHCs down to as far as -70 mV. When IHCs were held at -60 mV and I-Na elicited using a simulated action potential as a voltage command, we found that I-Na contributed to the subthreshold depolarization and upstroke of an action potential. We also found that I-Na is likely to be carried by the TTX-sensitive channel subunits Na(V)1.1 and Na(V)1.6 in both apical and basal IHCs. The results provide insight into how the biophysical properties of I-Na in mammalian cochlear IHCs could contribute to the spontaneous physiological activity during cochlear maturation in vivo.	[Eckrich, Tobias; Johnson, Stuart L.; Kuhn, Stephanie; Holley, Matthew C.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Varakina, Ksenya; Franz, Christoph; Singer, Wibke; Knipper, Marlies] Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, Tubingen, Germany	University of Sheffield; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Holley, MC (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.c.holley@sheffield.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478; Holley, Matthew/0000-0001-9547-1953	Wellcome Trust [088719, 091895]; Royal Society; Deutsche Forschungsgemeinschaft DFG [Kni 316-4-1]; Royal Society University Research Fellowship	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by The Wellcome Trust (088719 and 091895) and The Royal Society to W. M. and Deutsche Forschungsgemeinschaft DFG Kni 316-4-1 to M. K. W. M. and S.L.J. are supported by Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chabbert C, 2003, J PHYSIOL-LONDON, V553, P113, DOI 10.1113/jphysiol.2003.043034; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; EVANS MG, 1987, BIOPHYS J, V52, P649, DOI 10.1016/S0006-3495(87)83256-3; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Glowatzki E, 2008, CURR OPIN NEUROBIOL, V18, P389, DOI 10.1016/j.conb.2008.09.006; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Knipper M, 1998, DEVELOPMENT, V125, P3709; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Lennan GWT, 1999, PFLUG ARCH EUR J PHY, V438, P40, DOI 10.1007/s004240050877; Li GQ, 2010, AM J PHYSIOL-REG I, V298, pR351, DOI 10.1152/ajpregu.00460.2009; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Masetto S, 2003, J NEUROPHYSIOL, V90, P1266, DOI 10.1152/jn.01157.2002; Milburn T, 1995, RECEPTOR CHANNEL, V3, P201; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; MULLER M, 1991, HEARING RES, V56, P1, DOI 10.1016/0378-5955(91)90147-2; Nouvian R, 2007, J PHYSIOL-LONDON, V584, P535, DOI 10.1113/jphysiol.2007.139675; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Oliver D, 1997, PFLUG ARCH EUR J PHY, V434, P772, DOI 10.1007/s004240050464; Pineda RH, 2006, DEVELOPMENT, V133, P3827, DOI 10.1242/dev.02559; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Richardson PJ, 2000, J NEUROCHEM, V74, P839, DOI 10.1046/j.1471-4159.2000.740839.x; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; Vega-Saenz de Miera E, 1997, P NATL ACAD SCI USA, V94, P7059; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WITT CM, 1994, J NEUROPHYSIOL, V72, P1037, DOI 10.1152/jn.1994.72.2.1037; Wooltorton JRA, 2007, J NEUROPHYSIOL, V97, P1684, DOI 10.1152/jn.00649.2006; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	46	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45732	10.1371/journal.pone.0045732	http://dx.doi.org/10.1371/journal.pone.0045732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029208	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000309388400126
J	Maia, MF; Abonuusum, A; Lorenz, LM; Clausen, PH; Bauer, B; Garms, R; Kruppa, T				Maia, Marta Ferreira; Abonuusum, Ayimbire; Lorenz, Lena Maria; Clausen, Peter-Henning; Bauer, Burkhard; Garms, Rolf; Kruppa, Thomas			The Effect of Deltamethrin-treated Net Fencing around Cattle Enclosures on Outdoor-biting Mosquitoes in Kumasi, Ghana	PLOS ONE			English	Article							BLOOD-FEEDING BEHAVIOR; ANOPHELES-ARABIENSIS; PASSIVE ZOOPROPHYLAXIS; MALARIA VECTOR; PYRETHROID INSECTICIDES; BIOKO ISLAND; TSETSE-FLIES; GAMBIAE; TRANSMISSION; PREVENTION	Classic vector control strategies target mosquitoes indoors as the main transmitters of malaria are indoor-biting and resting mosquitoes. However, the intensive use of insecticide-treated bed-nets (ITNs) and indoor residual spraying have put selective pressure on mosquitoes to adapt in order to obtain human blood meals. Thus, early-evening and outdoor vector activity is becoming an increasing concern. This study assessed the effect of a deltamethrin-treated net (100 mg/m(2)) attached to a one-meter high fence around outdoor cattle enclosures on the number of mosquitoes landing on humans. Mosquitoes were collected from four cattle enclosures: Pen A - with cattle and no net; B - with cattle and protected by an untreated net; C - with cattle and protected by a deltamethrin-treated net; D - no cattle and no net. A total of 3217 culicines and 1017 anophelines were collected, of which 388 were Anopheles gambiae and 629 An. ziemanni. In the absence of cattle nearly 3 times more An. gambiae (p<0.0001) landed on humans. The deltamethrin-treated net significantly reduced (nearly three-fold, p<0.0001) culicine landings inside enclosures. The sporozoite rate of the zoophilic An. ziemanni, known to be a secondary malaria vector, was as high as that of the most competent vector An. gambiae; raising the potential of zoophilic species as secondary malaria vectors. After deployment of the ITNs a deltamethrin persistence of 9 months was observed despite exposure to African weather conditions. The outdoor use of ITNs resulted in a significant reduction of host-seeking culicines inside enclosures. Further studies investigating the effectiveness and spatial repellence of ITNs around other outdoor sites, such as bars and cooking areas, as well as their direct effect on vector-borne disease transmission are needed to evaluate its potential as an appropriate outdoor vector control tool for rural Africa.	[Maia, Marta Ferreira; Lorenz, Lena Maria] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Maia, Marta Ferreira] Ifakara Hlth Inst, Bagamoyo, Pwani Region, Tanzania; [Abonuusum, Ayimbire] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Garms, Rolf; Kruppa, Thomas] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Clausen, Peter-Henning; Bauer, Burkhard] Free Univ Berlin, Fac Vet Med, Inst Parasitol & Trop Vet Med, Berlin, Germany	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Free University of Berlin	Maia, MF (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Marta.Maia@lshtm.ac.uk	Maia, Marta/I-6003-2019	Maia, Marta/0000-0003-3302-5610; Lorenz, Lena/0000-0002-4724-1421	Vestergaard Frandsen Co.; Vestergaard Frandsen	Vestergaard Frandsen Co.; Vestergaard Frandsen	The study was funded by Vestergaard Frandsen Co. (www.vestergaard-frandsen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Flight expenses to Kumasi, construction of the animal enclosures and provision of the experimental nets was sponsored by the Vestergaard Frandsen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abonuusum A, 2011, PARASITOL RES, V108, P1465, DOI 10.1007/s00436-010-2195-1; Afrane YA, 2004, ACTA TROP, V89, P125, DOI 10.1016/j.actatropica.2003.06.001; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; ArredondoJimenez JI, 1997, MED VET ENTOMOL, V11, P87, DOI 10.1111/j.1365-2915.1997.tb00294.x; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUER B, 1992, TROP MED PARASITOL, V43, P41; Bauer B, 2006, TROP ANIM HEALTH PRO, V38, P29, DOI 10.1007/s11250-006-4343-2; BAUER B, 1995, TROP MED PARASITOL, V46, P183; Bauer B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001343; Bogh C, 2002, T ROY SOC TROP MED H, V96, P593, DOI 10.1016/S0035-9203(02)90320-2; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hill N, 2007, BMJ, V55; Hlatshwayo M, 2005, ONDERSTEPOORT J VET, V72, P245; Kawaguchi I, 2004, P ROY SOC B-BIOL SCI, V271, P301, DOI 10.1098/rspb.2003.2575; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Maia M, 2010, PARASITOL RES, V106, P1307, DOI 10.1007/s00436-010-1796-z; Manh CD, 2010, MAL J, V9; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; R Development Core Team website, 2011, R LANG ENV STAT COMP; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39	42	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45794	10.1371/journal.pone.0045794	http://dx.doi.org/10.1371/journal.pone.0045794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029245	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309388400130
J	Regier, N; Frey, B; Converse, B; Roden, E; Grosse-Honebrink, A; Bravo, AG; Cosio, C				Regier, Nicole; Frey, Beat; Converse, Brandon; Roden, Eric; Grosse-Honebrink, Alexander; Bravo, Andrea Garcia; Cosio, Claudia			Effect of Elodea nuttallii Roots on Bacterial Communities and MMHg Proportion in a Hg Polluted Sediment	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; SOIL MICROBIAL COMMUNITIES; MERCURY METHYLATION; PRINCIPAL METHYLATORS; WATER; METHYLMERCURY; CONTAMINATION; RHIZOSPHERE; RESERVOIR; QUALITY	The objective of this study was to assess the effect of a rooted macrophyte Elodea nuttallii on rhizosphere bacterial communities in Hg contaminated sediments. Specimens of E. nuttallii were exposed to sediments from the Hg contaminated Babeni reservoir (Olt River, Romania) in our microcosm. Plants were allowed to grow for two months until they occupied the entirety of the sediments. Total Hg and MMHg were analysed in sediments where an increased MMHg percentage of the total Hg in pore water of rhizosphere sediments was found. E. nuttallii roots also significantly changed the bacterial community structure in rhizosphere sediments compared to bulk sediments. Deltaproteobacteria dominated the rhizosphere bacterial community where members of Geobacteraceae within the Desulfuromonadales and Desulfobacteraceae were identified. Two bacterial operational taxonomic units (OTUs) which were phylogenetically related to sulfate-reducing bacteria (SRB) became abundant in the rhizosphere. We suggest that these phylotypes could be potentially methylating bacteria and might be responsible for the higher MMHg percentage of the total Hg in rhizosphere sediments. However, SRB were not significantly favoured in rhizosphere sediments as shown by qPCR. Our findings support the hypothesis that rooted macrophytes created a microenvironment favorable for Hg methylation. The presence of E. nuttallii in Hg contaminated sediments should therefore not be overlooked.	[Regier, Nicole; Grosse-Honebrink, Alexander; Bravo, Andrea Garcia; Cosio, Claudia] Univ Geneva, FA Forel Inst, Versoix, Switzerland; [Frey, Beat] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Converse, Brandon; Roden, Eric] Univ Wisconsin, Dept Geosci, Madison, WI USA	University of Geneva; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Wisconsin System; University of Wisconsin Madison	Cosio, C (corresponding author), Univ Geneva, FA Forel Inst, Versoix, Switzerland.	Claudia.Cosio@unige.ch	Frey, Beat/AAE-1745-2022; Bravo, Andrea G/L-8378-2014; Ungureanu, Gheorghe Viorel/J-4680-2012; BRAVO, ANDREA G/O-8687-2019	Frey, Beat/0000-0002-6391-3574; Bravo, Andrea G/0000-0002-8341-3462; Ungureanu, Gheorghe Viorel/0000-0002-4479-1735; BRAVO, ANDREA G/0000-0002-8341-3462; Cosio, Claudia/0000-0001-8570-2738; Grosse-Honebrink, Alexander/0000-0003-3893-7483; Garcia Bravo, Andrea/0000-0001-6673-1568	Secretariat d'Etat a l'education et a la recherche SER [IZLRZ3_128305]; Swiss National Found [205321_138254]; Schmidheiny Foundation; La Societe Academique de Geneve	Secretariat d'Etat a l'education et a la recherche SER; Swiss National Found; Schmidheiny Foundation; La Societe Academique de Geneve	This work was supported by the Secretariat d'Etat a l'education et a la recherche SER (contract IZLRZ3_128305), and by the Swiss National Found (contract no 205321_138254), by the Schmidheiny Foundation (grant to AGB) and by La Societe Academique de Geneve (grant to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha D, 2011, CHEMOSPHERE, V82, P911, DOI 10.1016/j.chemosphere.2010.10.050; Avramescu ML, 2011, SCI TOTAL ENVIRON, V409, P968, DOI 10.1016/j.scitotenv.2010.11.016; Ben-Dov E, 2007, MICROB ECOL, V54, P439, DOI 10.1007/s00248-007-9233-2; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; Boudou A, 2005, ENVIRON SCI TECHNOL, V39, P2448, DOI 10.1021/es049149r; BOUDOU A, 1991, WATER AIR SOIL POLL, V56, P807, DOI 10.1007/BF00342318; Bravo AG, MERCURY METHYLATION; Bravo AG, 2010, THESIS; Bravo AG, 2012, EMISSIONS MERC UNPUB; Bravo AG, 2010, ENVIRON SCI POLLUT R, V17, P1422, DOI 10.1007/s11356-010-0328-9; Bravo AG, 2009, ENVIRON SCI POLLUT R, V16, P66, DOI 10.1007/s11356-008-0057-5; Canario J, 2007, ENVIRON SCI TECHNOL, V41, P7376, DOI 10.1021/es071078j; Caslake LF, 2006, WATER AIR SOIL POLL, V174, P93, DOI 10.1007/s11270-005-9040-7; Chavan PV, 2007, J HAZARD MATER, V149, P543, DOI 10.1016/j.jhazmat.2007.06.077; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Cosio C, MERCURY BIOACCUMULAT; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Fleming EJ, 2006, APPL ENVIRON MICROB, V72, P457, DOI 10.1128/AEM.72.1.457-464.2006; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Frey B, 2008, ENVIRON MICROBIOL, V10, P1433, DOI 10.1111/j.1462-2920.2007.01556.x; Frey B, 2006, SOIL BIOL BIOCHEM, V38, P1745, DOI 10.1016/j.soilbio.2005.11.032; GILMOUR CC, 1991, ENVIRON POLLUT, V71, P131, DOI 10.1016/0269-7491(91)90031-Q; Guimaraes JRD, 2000, SCI TOTAL ENVIRON, V261, P99, DOI 10.1016/S0048-9697(00)00628-8; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; Hartmann M, 2005, J MICROBIOL METH, V61, P349, DOI 10.1016/j.mimet.2004.12.011; Hines ME, 1999, APPL ENVIRON MICROB, V65, P2209; Kerin EJ, 2006, APPL ENVIRON MICROB, V72, P7919, DOI 10.1128/AEM.01602-06; King JK, 2002, CHEMOSPHERE, V46, P859, DOI 10.1016/S0045-6535(01)00135-7; King JK, 2000, APPL ENVIRON MICROB, V66, P2430, DOI 10.1128/AEM.66.6.2430-2437.2000; Liu B, 2012, ENVIRON POLLUT, V160, P109, DOI 10.1016/j.envpol.2011.09.023; Maag J, 2002, MERCURY GLOBAL POLLU; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Merritt KA, 2009, EARTH-SCI REV, V96, P54, DOI 10.1016/j.earscirev.2009.06.002; Nielsen LB, 2001, ENVIRON MICROBIOL, V3, P63, DOI 10.1046/j.1462-2920.2001.00160.x; Noges T, 2010, AQUAT ECOL, V44, P83, DOI 10.1007/s10452-009-9249-4; Patty C, 2009, ENVIRON SCI TECHNOL, V43, P7397, DOI 10.1021/es901076q; Ranchou-Peyruse M, 2009, GEOMICROBIOL J, V26, P1, DOI 10.1080/01490450802599227; Regier N, 2012, CHEMOSPHERE UNPUB; Rumbold DG, 2006, ENVIRON MONIT ASSESS, V112, P115, DOI 10.1007/s10661-006-0767-4; Sohpal Vipan Kumar, 2010, Int J Bioinform Res Appl, V6, P230, DOI 10.1504/IJBRA.2010.034072; Stoichev T, 2004, TALANTA, V62, P433, DOI 10.1016/j.talanta.2003.08.006; Tian Ji-Lin, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P577; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; Vladar P, 2008, MICROB ECOL, V56, P64, DOI 10.1007/s00248-007-9324-0; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Widmer F, 2006, J MICROBIOL METH, V66, P512, DOI 10.1016/j.mimet.2006.02.007; Windham-Myers L, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000815; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007	49	23	23	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45565	10.1371/journal.pone.0045565	http://dx.doi.org/10.1371/journal.pone.0045565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23029102	Green Published, gold			2022-12-27	WOS:000309742800065
J	Liang, JL; Huang, W; Yu, XY; Ashraf, A; Wary, KK; Xu, MF; Millard, RW; Ashraf, M; Wang, YG				Liang, Jialiang; Huang, Wei; Yu, Xiyong; Ashraf, Atif; Wary, Kishore K.; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang			Suicide Gene Reveals the Myocardial Neovascularization Role of Mesenchymal Stem Cells Overexpressing CXCR4 (MSCCXCR4)	PLOS ONE			English	Article							MARROW-DERIVED CELLS; ETS-BINDING-SITES; CARDIAC-FUNCTION; PROGENITOR CELLS; INFARCTED MYOCARDIUM; ENDOTHELIAL-CELLS; IN-VITRO; HYPOXIA; EXPRESSION; REPAIR	Background: Our previous studies indicated that MSCCXCR4 improved cardiac function after myocardial infarction (MI). This study was aimed to investigate the specific role of MSCCXCR4 in neovascularization of infarcted myocardium using a suicide gene approach. Methods: MSCs were transduced with either lentivirus-null vector/GFP (MSCNull as control) or vector encoding for overexpressing CXCR4/GFP. The MSC derived-endothelial cell (EC) differentiation was assessed by a tube formation assay, Dil-ac-LDL uptake, EC marker expression, and VE-cadherin promoter activity assay. Gene expression was analyzed by quantitative RT-PCR or Western blot. The suicide gene approach was under the control of VE-cadherin promoter. In vivo studies: Cell patches containing MSCNull or MSCCXCR4 were transduced with suicide gene and implanted into the myocardium of MI rat. Rats received either ganciclovir (GCV) or vehicle after cell implantation. After one month, the cardiac functional changes and neovascularization were assessed by echocardiography, histological analysis, and micro-CT imaging. Results: The expression of VEGF-A and HIF-1 alpha was significantly higher in MSCCXCR4 as compared to MSCNull under hypoxia. Additionally, MSCCXCR4 enhanced new vessel formation and EC differentiation, as well as STAT3 phosphorylation under hypoxia. STAT3 participated in the transcription of VE-cadherin in MSCCXCR4 under hypoxia, which was inhibited by WP1066 (a STAT3 inhibitor). In addition, GCV specifically induced death of ECs with suicide gene activation. In vivo studies: MSCCXCR4 implantation promoted cardiac functional restoration, reduced infarct size, improved cardiac remodeling, and enhanced neovascularization in ischemic heart tissue. New vessels derived from MSCCXCR4 were observed at the injured heart margins and communicated with native coronary arteries. However, the derived vessel networks were reduced by GCV, reversing improvement of cardiac function. Conclusion: The transplanted MSCCXCR4 enhanced neovascularization after MI by boosting release of angiogenic factors and increasing the potential of endothelial differentiation.	[Liang, Jialiang; Huang, Wei; Ashraf, Atif; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang] Univ Cincinnati, Med Ctr, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Liang, Jialiang; Huang, Wei; Ashraf, Atif; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang] Univ Cincinnati, Med Ctr, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Liang, Jialiang; Yu, Xiyong] So Med Univ, Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Wary, Kishore K.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	yi-gang.wang@uc.edu	Ashraf, Muhammad/ABB-3463-2021; HUANG, WEI/A-4639-2013; LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Huang, Wei/0000-0003-3046-4220; Liang, Jialiang/0000-0002-1556-7195; Wary, Kishore/0000-0001-8851-8565	National Institutes of Health [HL081859, HL089824, HL110740, HL-080686, R37HL-074272]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081859, R01HL089824, R01HL110740, R01HL079356, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL081859, HL089824, and HL110740 (to YW); HL-080686 and R37HL-074272 (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shoshan J, 2008, STEM CELLS, V26, P2634, DOI 10.1634/stemcells.2008-0369; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Eun LY, 2010, BIOCHEM BIOPH RES CO, V402, P272, DOI 10.1016/j.bbrc.2010.10.013; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Huber P, 1996, GENOMICS, V32, P21, DOI 10.1006/geno.1996.0072; Iwakura T, 2011, J MOL CELL CARDIOL, V51, P207, DOI 10.1016/j.yjmcc.2011.04.013; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mavria G, 2001, GENE THER, V8, P913, DOI 10.1038/sj.gt.3301483; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MULLEN CA, 1994, PHARMACOL THERAPEUT, V63, P199, DOI 10.1016/0163-7258(94)90046-9; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Rivard A, 1998, MOL MED, V4, P429, DOI 10.1007/BF03401749; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shabbir A, 2010, AM J PHYSIOL-HEART C, V299, pH1428, DOI 10.1152/ajpheart.00488.2010; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Wang YG, 2010, AM J PHYSIOL-HEART C, V298, pH275, DOI 10.1152/ajpheart.00765.2009; Xu J, 2008, J CELL MOL MED, V12, P2395, DOI 10.1111/j.1582-4934.2008.00266.x; Yin LY, 2012, CIRC RES, V110, P241, DOI 10.1161/CIRCRESAHA.111.250126; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhang DS, 2010, AM J PHYSIOL-HEART C, V299, pH1339, DOI 10.1152/ajpheart.00592.2010; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	44	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46158	10.1371/journal.pone.0046158	http://dx.doi.org/10.1371/journal.pone.0046158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029422	Green Published, gold			2022-12-27	WOS:000309973900102
J	Zhang, LB; Wang, KZ; Zhao, FL; Hu, WP; Chen, JJ; Lanza, GM; Shen, BZ; Zhang, B				Zhang, Lingbo; Wang, Kezheng; Zhao, Falin; Hu, Weiping; Chen, Junjie; Lanza, Gregory M.; Shen, Baozhong; Zhang, Bin			Near Infrared Imaging of EGFR of Oral Squamous Cell Carcinoma in Mice Administered Arsenic Trioxide	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; INDUCED APOPTOSIS; CANCER CELLS; EXPRESSION; XENOGRAFTS; METASTASIS; ACTIVATION; RESISTANCE; INHIBITION	Background: The effectiveness of near-infrared imaging (NIR) interrogation of epidermal growth factor receptor (EGFR) expression as a sensitive biomarker of oral squamous cell carcinoma (OSCC) response to arsenic trioxide therapy was studied in mice. Material and Methods: A431 OSCC in vitro were exposed to 0 mu M, 0.5 mu M, 2.5 mu M, or 5 mu M of As2O3 for 0 h, 24 h, 48 h and 72 h. Confocal microscopy and flow cytometry confirmed EGFR expression and demonstrated a sensitivity dose-related signal decline with As2O3 treatment. Next, mice with pharynx-implanted A431 cells received As2O3 i.p. every 48 h at 0.0, 0.5, 2.5, or 5 mg/kg/day (n = 6/group) from day 0 to 10. An intravenous NIR probe, EGF-Cy5.5, was injected at baseline and on days 4, 8, and 12 for dynamic NIR imaging. Tumor volume and body weights were measured three times weekly. Results: In vitro, A431 EGFR expression was well appreciated in the controls and decreased (p<0.05) with increasing As2O3 dose and treatment duration. In vivo EGFR NIR tumor signal intensity decreased (p<0.05) in As2O3 treated groups versus controls from days 4 to 12, consistent with increasing dosage. Tumor volume diminished in a dose-related manner while body weight was unaffected. Immunohistochemical staining of excised tumors confirmed that EGFR expression was reduced by As2O3 treatment in a dose responsive pattern. Conclusion: This study demonstrates for the first time that OSCC can be interrogated in vivo by NIR molecular imaging of the EGFR and that this biomarker is effective for the longitudinal assessment of OSCC response to As2O3 treatment.	[Wang, Kezheng; Shen, Baozhong] Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Wang, Kezheng; Shen, Baozhong] Harbin Med Univ, Mol Imaging Ctr, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Zhang, Lingbo; Hu, Weiping; Zhang, Bin] Harbin Med Univ, Dept Stomatol, Inst Hard Tissue Dev & Regenerat, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhao, Falin] Hangzhou Normal Univ, Sch Hlth Management, Hangzhou, Zhejiang, Peoples R China; [Chen, Junjie; Lanza, Gregory M.] Washington Univ, Div Cardiol, Sch Med, St Louis, MO USA; [Chen, Junjie; Lanza, Gregory M.] Washington Univ, C TRAIN, Sch Med, St Louis, MO USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Hangzhou Normal University; Washington University (WUSTL); Washington University (WUSTL)	Shen, BZ (corresponding author), Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China.	baozhongshen@gmail.com; zhangbinhmu@gmail.com			National Natural Science Foundation of China [81170960, 81130028, 30970807, 30570527]; International Cooperation and Exchanges Program of the National Ministry of Science and Technology [2009DFB30040]; Foundation of Department of Science and Technology of Heilongjiang Province [GC12C303-2]; National Natural Science Foundation for Young Scholars of China [81101086]; China Postdoctoral Science Foundation [20100471020]; Medical Scientific Research Foundation of Heilongjiang Province Health Department [2010-156]; National Institutes of Health [CA119342, CA154737, HL094470, HL073646, HL078631, HL113392, AR056468, NS073457]; DOD [CA100623]; NATIONAL CANCER INSTITUTE [R01CA154737, R21CA100623, U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113392, R01HL078631, R01HL094470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073457] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Program of the National Ministry of Science and Technology; Foundation of Department of Science and Technology of Heilongjiang Province; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Scientific Research Foundation of Heilongjiang Province Health Department; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge grant support from the National Natural Science Foundation of China (81170960, 81130028, 30970807 and 30570527) (for BZ, BS), the International Cooperation and Exchanges Program of the National Ministry of Science and Technology (2009DFB30040) (for BS), Foundation of Department of Science and Technology of Heilongjiang Province (GC12C303-2) (for BZ), the National Natural Science Foundation for Young Scholars of China (81101086) (for KW), China Postdoctoral Science Foundation (20100471020) (for KW) and Medical Scientific Research Foundation of Heilongjiang Province Health Department (2010-156) (for KW), and the National Institutes of Health (CA119342, CA154737, HL094470, HL073646, HL078631, HL113392, AR056468, NS073457) and DOD (CA100623) (for GML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Science Foundation of China: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm; The International Cooperation and Exchanges Program of the National Ministry of Science and Technology http://www.most.gov.cn/eng/cooperation/; Foundation of Department of Science and Technology of Heilongjiang Province: http://210.76.36.142/kjt/tztg/200902/t20090210_98480.htm; National Natural Science Foundation for Young Scholars of China: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0106.htm; China Postdoctoral Science Foundation: http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx; Medical Scientific Research Foundation of Heilongjiang Province Health Department: www.hljwst.gov.cn/; NIH: http://www.nih.gov/; DOD: http://www.defense.gov/.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Atkins D, 2004, J HISTOCHEM CYTOCHEM, V52, P893, DOI 10.1369/jhc.3A6195.2004; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Chen X, 2009, ONCOL REP, V22, P73, DOI 10.3892/or_00000408; Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956; Chou YH, 2011, TOXICOL LETT, V203, P147, DOI 10.1016/j.toxlet.2011.03.017; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gleysteen JP, 2008, HEAD NECK-J SCI SPEC, V30, P782, DOI 10.1002/hed.20782; Huang HS, 2006, J BIOMED SCI, V13, P113, DOI 10.1007/s11373-005-9040-z; Jhala DD, 2008, FOOD CHEM TOXICOL, V46, P1138, DOI 10.1016/j.fct.2007.11.009; Ke S, 2003, CANCER RES, V63, P7870; Konkimalla VB, 2007, EXPERT REV ANTICANC, V7, P317, DOI 10.1586/14737140.7.3.317; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Laimer K, 2007, ORAL ONCOL, V43, P193, DOI 10.1016/j.oraloncology.2006.02.009; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Liu ZM, 2006, CELL SIGNAL, V18, P244, DOI 10.1016/j.cellsig.2005.04.006; Maeda H, 2001, CANCER RES, V61, P5432; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Nitin N, 2009, NEOPLASIA, V11, P542, DOI 10.1593/neo.09188; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Oyen WJG, 2009, NAT REV CLIN ONCOL, V6, P609, DOI 10.1038/nrclinonc.2009.139; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Rosenthal EL, 2006, LARYNGOSCOPE, V116, P1636, DOI 10.1097/01.mlg.0000232513.19873.da; Sarkis SA, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-13; SHIN DM, 1994, CANCER RES, V54, P3153; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tichauer K. M, 2011, MOL IMAGING BIOL; Tsai CW, 2010, ANTICANCER RES, V30, P3655; Vernhet L, 2001, BIOCHEM PHARMACOL, V61, P1387, DOI 10.1016/S0006-2952(01)00606-2; Wang KZ, 2009, ACTA RADIOL, V50, P1095, DOI 10.3109/02841850903008800; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Withrow KP, 2008, TECHNOL CANCER RES T, V7, P61, DOI 10.1177/153303460800700108; Yeh KY, 2011, HEAD NECK-J SCI SPEC, V33, P734, DOI 10.1002/hed.21535; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46255	10.1371/journal.pone.0046255	http://dx.doi.org/10.1371/journal.pone.0046255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029451	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900117
J	Caugant, DA; Kristiansen, PA; Wang, X; Mayer, LW; Taha, MK; Ouedraogo, R; Kandolo, D; Bougoudogo, F; Sow, S; Bonte, L				Caugant, Dominique A.; Kristiansen, Paul A.; Wang, Xin; Mayer, Leonard W.; Taha, Muhamed-Kheir; Ouedraogo, Rasmata; Kandolo, Denis; Bougoudogo, Flabou; Sow, Samba; Bonte, Laurence			Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; BURKINA-FASO; W135; DISEASE; EPIDEMIC; EMERGENCE; OUTBREAK; STRAIN; NIGER	Background: The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at risk of epidemics. To document the molecular characteristics of disease-causing meningococcal strains circulating in the meningitis belt of Africa before vaccine introduction, the World Health Organization Collaborating Centers on Meningococci in Europe and United States established a common strain collection of 773 isolates from cases of invasive meningococcal disease collected between 2004 and 2010 from 13 sub-Saharan countries. Methodology: All isolates were characterized by multilocus sequence typing, and 487 (62%) were also analyzed for genetic variation in the surface antigens PorA and FetA. Antibiotic susceptibility was tested for part of the collection. Principal Findings: Only 19 sequence types (STs) belonging to 6 clonal complexes were revealed. ST-5 clonal complex dominated with 578 (74.8%) isolates. All ST-5 complex isolates were remarkably homogeneous in their PorA (P1.20,9) and FetA (F3-1) and characterized the serogroup A strains which have been responsible for most epidemics during this time period. Sixty-eight (8.8%) of the 773 isolates belonged to the ST-11 clonal complex which was mainly represented by serogroup W135, while an additional 38 (4.9%) W135 isolates belonged to the ST-175 complex. Forty-eight (6.2%) serogroup X isolates from West Africa belonged to the ST-181 complex, while serogroup X cases in Kenya and Uganda were caused by an unrelated clone, ST-5403. Serogroup X, ST-181, emerged in Burkina Faso before vaccine introduction. Conclusions: In the seven years preceding introduction of a new serogroup A conjugate vaccine, serogroup A of the ST-5 clonal complex was identified as the predominant disease-causing strain.	[Caugant, Dominique A.; Kristiansen, Paul A.] Norwegian Inst Publ Hlth, WHO Collaborating Ctr Reference & Res Meningococc, Oslo, Norway; [Caugant, Dominique A.] Univ Oslo, Fac Med, Oslo, Norway; [Wang, Xin; Mayer, Leonard W.] Ctr Dis Control & Prevent, WHO Collaborating Ctr Prevent & Control Epidem Me, Atlanta, GA USA; [Taha, Muhamed-Kheir] Inst Pasteur, WHO Collaborating Ctr Reference & Res Meningococc, Paris, France; [Ouedraogo, Rasmata] Ctr Hosp Univ Pediat Charles de Gaulle, Lab Reference Meningite, Ouagadougou, Burkina Faso; [Kandolo, Denis] WHO Inter Country Support Team W Africa, Ouagadougou, Burkina Faso; [Bougoudogo, Flabou] INRSP, Bamako, Mali; [Sow, Samba] CVD, Bamako, Mali; [Bonte, Laurence] Med Sans Frontieres, Support Logist, Paris, France	Norwegian Institute of Public Health (NIPH); University of Oslo; Centers for Disease Control & Prevention - USA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders	Caugant, DA (corresponding author), Norwegian Inst Publ Hlth, WHO Collaborating Ctr Reference & Res Meningococc, Oslo, Norway.	dominique.caugant@fhi.no	, dcaugant/AAH-6843-2019	, dcaugant/0000-0003-2765-9844	Norwegian Institute of Public Health; Institute Pasteur; Centres for Disease Control and Prevention	Norwegian Institute of Public Health; Institute Pasteur; Centres for Disease Control and Prevention	The work was supported by the Norwegian Institute of Public Health, Institute Pasteur and Centres for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO GW, 1984, J CLIN MICROBIOL, V20, P55, DOI 10.1128/JCM.20.1.55-58.1984; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P306; Bai XL, 2010, EXPERT REV VACCINES, V9, P1203, DOI 10.1586/ERV.10.116; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; CRAVEN DE, 1978, J CLIN MICROBIOL, V7, P410; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; DENIS F, 1982, LANCET, V2, P1335; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Katz LS, 2009, NUCLEIC ACIDS RES, V37, pW606, DOI 10.1093/nar/gkp288; Koumare B, 2007, VACCINE, V25, pA37, DOI 10.1016/j.vaccine.2007.04.038; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Materu S, 2007, EMERG INFECT DIS, V13, P944, DOI 10.3201/eid1306.070042; Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; Nicolas P, 2006, Med Trop (Mars), V66, P494; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nicolas P, 1996, Med Trop (Mars), V56, P203; Ouedraogo-Traore R, 2002, SCAND J INFECT DIS, V34, P804, DOI 10.1080/0036554021000026949; Pollard A. J., 2003, EMERG INFECT DIS, V9, P1503; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; REINGOLD AL, 1985, LANCET, V2, P114; Riou J-Y, 1996, B WORLD HEALTH ORGAN, V74, P1996; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170	34	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46019	10.1371/journal.pone.0046019	http://dx.doi.org/10.1371/journal.pone.0046019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029368	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500056
J	Meng, RX; Sabelis, MW; Janssen, A				Meng, Rui-Xia; Sabelis, Maurice W.; Janssen, Arne			Limited Predator-Induced Dispersal in Whiteflies	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENTS; HOST-PLANT SELECTION; BEMISIA-TABACI; PHYTOSEIID PREDATORS; AMBLYSEIUS-SWIRSKII; PREY INTERACTIONS; ANTIPREDATOR BEHAVIOR; ACARI PHYTOSEIIDAE; ALTERNATIVE FOOD; DYNAMICS	Whereas prey are known to avoid habitats with their predators, it is less well established whether they are triggered to emigrate to new habitats when exposed to predators in their current habitat. We studied plant-to-plant dispersal of adult whiteflies in response to the presence of predatory mites on the plant on which the whiteflies were released. These predators attack whitefly eggs and crawlers, but not the adults, which can fly to other plants and can learn to avoid plants with predators. Being tiny and wingless, the predatory mites are slow dispersers compared to adult whiteflies. This offers the whiteflies the opportunity to escape from plants with predatory mites to plants without predators, thus avoiding predation of their offspring. To test for this escape response, a greenhouse experiment was carried out, where whiteflies were released on the first of a row of 5 cucumber plants, 0.6 m or 2 m apart, and predators either on the same plant, on the next plant, or nowhere (control). Adult whiteflies dispersed significantly faster from plants with predatory mites onto neighbouring plants when the plants were 0.6 m apart, but not when plants were 2 m apart. However, the final numbers of whiteflies that had successfully dispersed at the end of the experiments did not differ significantly for either of the two interplant distances. Overall, the proportion of whiteflies that did disperse was low, suggesting that adult whiteflies were apparently reluctant to disperse, even from plants with predators. Our results suggest that this reluctance increases with the distance between the plants, so most likely depends on the uncertainty to find a new plant. Thus, whiteflies do not always venture to fly even when they can easily bridge the distance to another plant.	[Sabelis, Maurice W.; Janssen, Arne] Univ Amsterdam, IBED, Amsterdam, Netherlands; [Meng, Rui-Xia] Inner Mongolia Agr Univ, Entomol Lab, Hohhot, Peoples R China; [Meng, Rui-Xia] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	University of Amsterdam; Inner Mongolia Agricultural University; China Agricultural University	Janssen, A (corresponding author), Univ Amsterdam, IBED, Amsterdam, Netherlands.	arne.janssen@uva.nl	Janssen, Arne/B-2657-2009	Janssen, Arne/0000-0001-5075-5303	Special Fund for Agro-scienfic Research in the Public Interest [200903032]; Project "973" of China [2002CB111407]	Special Fund for Agro-scienfic Research in the Public Interest; Project "973" of China(National Basic Research Program of China)	R-X Meng was sponsored by Special Fund for Agro-scienfic Research in the Public Interest (nr. 200903032) and Project "973" (nr. 2002CB111407) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1984, BEHAV ECOLOGY; Arthurs S, 2009, BIOL CONTROL, V49, P91, DOI 10.1016/j.biocontrol.2009.01.002; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Buitenhuis R, 2010, BIOL CONTROL, V52, P110, DOI 10.1016/j.biocontrol.2009.10.007; Byrne DN, 1996, OECOLOGIA, V105, P320, DOI 10.1007/BF00328734; Calvo FJ, 2011, BIOCONTROL, V56, P185, DOI 10.1007/s10526-010-9319-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Crawley M.J., 2007, R BOOK; Cronin JT, 2004, ECOLOGY, V85, P2134, DOI 10.1890/03-0591; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; FRANSEN JJ, 1994, PESTIC SCI, V42, P129, DOI 10.1002/ps.2780420210; Gerling D., 1996, BEMISIA 1995 TAXONOM; HANSKI I, 1997, METAPOPULATION BIOL; Holland MD, 2008, NATURE, V456, P792, DOI 10.1038/nature07395; JANSSEN A, 1995, OIKOS, V73, P356, DOI 10.2307/3545959; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kroon A, 2008, NATURWISSENSCHAFTEN, V95, P1195, DOI 10.1007/s00114-008-0442-4; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Magalhaes S, 2002, OECOLOGIA, V132, P143, DOI 10.1007/s00442-002-0950-4; McCauley SJ, 2010, BIOL LETTERS, V6, P449, DOI 10.1098/rsbl.2009.1082; Meng RX, 2006, EXP APPL ACAROL, V38, P113, DOI 10.1007/s10493-006-0010-6; Messelink GJ, 2008, BIOL CONTROL, V44, P372, DOI 10.1016/j.biocontrol.2007.10.017; Messelink GJ, 2006, BIOCONTROL, V51, P753, DOI 10.1007/s10526-006-9013-9; Nomikou M, 2005, EXP APPL ACAROL, V36, P263, DOI 10.1007/s10493-005-6650-0; Nomikou M, 2004, ENTOMOL EXP APPL, V110, P95, DOI 10.1111/j.0013-8703.2004.00114.x; Nomikou M, 2003, OECOLOGIA, V136, P484, DOI 10.1007/s00442-003-1289-1; Nomikou M, 2002, EXP APPL ACAROL, V27, P57, DOI 10.1023/A:1021559421344; Nomikou M, 2001, EXP APPL ACAROL, V25, P271, DOI 10.1023/A:1017976725685; Nomikou M, 2010, BIOCONTROL, V55, P253, DOI 10.1007/s10526-009-9233-x; Pallini A, 1997, OECOLOGIA, V110, P179, DOI 10.1007/s004420050147; Pallini A, 1999, EXP APPL ACAROL, V23, P803, DOI 10.1023/A:1006266232714; Park HH, 2010, J ECON ENTOMOL, V103, P563, DOI 10.1603/EC09161; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PERSSON L, 1990, ECOLOGY, V71, P1699, DOI 10.2307/1937579; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; Sabelis M.W., 1985, P141; SABELIS MW, 1994, EXP APPL ACAROL, V18, P711; SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Sih Andrew, 1998, P221; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; TINBERGEN JM, 1981, ARDEA, V69, P1; van Maanen R, 2012, ONE PREDATOR 2 PREY; van Maanen R, 2010, EXP APPL ACAROL, V52, P29, DOI 10.1007/s10493-010-9343-2; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760	53	3	4	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45487	10.1371/journal.pone.0045487	http://dx.doi.org/10.1371/journal.pone.0045487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029046	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500031
J	Arsic, B; Zhu, Y; Heinrichs, DE; McGavin, MJ				Arsic, Benjamin; Zhu, Yue; Heinrichs, David E.; McGavin, Martin J.			Induction of the Staphylococcal Proteolytic Cascade by Antimicrobial Fatty Acids in Community Acquired Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; GRAM-POSITIVE BACTERIA; PEPTIDE-SENSING SYSTEM; METALLOPROTEASE AUREOLYSIN; NASAL CARRIAGE; ANALYSIS REVEALS; SERINE-PROTEASE; GENOME SEQUENCE; IMMUNE EVASION; SKIN SURFACE	Community acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and the USA300 strain of CA-MRSA in particular, are known for their rapid community transmission, and propensity to cause aggressive skin and soft tissue infections. To assess factors that contribute to these hallmark traits of CA-MRSA, we evaluated how growth of USA300 and production of secreted virulence factors was influenced on exposure to physiologic levels of unsaturated free fatty acids that would be encountered on the skin or anterior nares, which represent the first sites of contact with healthy human hosts. There was a sharp threshold between sub-inhibitory and inhibitory concentrations, such that 100 mu M sapienic acid (C16:1) and linoleic acid (C18:1) were sufficient to prevent growth after 24 h incubation, while 25 mM allowed unrestricted growth, and 50 mM caused an approximate 10-12 h lag, followed by unimpeded exponential growth. Conversely, saturated palmitic or stearic acids did not affect growth at 100 mu M. Although growth was not affected by 25 mM sapienic or linoleic acid, these and other unsaturated C16 and C18 fatty acids, but not their saturated counterparts, promoted robust production of secreted proteases comprising the Staphylococcal proteolytic cascade. This trait was also manifested to varying degrees in other CA-MRSA, and in genetically diverse methicillin susceptible S. aureus strains. Therefore, induction of the Staphylococcal proteolytic cascade by unsaturated fatty acids is another feature that should now be evaluated as a potential contributing factor in the aggressive nature of skin and soft tissue infections caused by USA300, and as a general virulence mechanism of S. aureus.	[Arsic, Benjamin; Zhu, Yue; Heinrichs, David E.; McGavin, Martin J.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Heinrichs, David E.; McGavin, Martin J.] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	McGavin, MJ (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	martin.mcgavin@schulich.uwo.ca	Heinrichs, David/ABD-5702-2021	McGavin, Martin/0000-0001-5955-0689; Heinrichs, David/0000-0002-7217-2456	Natural Sciences and Engineering Research Council of Canada Discovery Grants; Western University Schulich School of Medicine and Dentistry internal award	Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Western University Schulich School of Medicine and Dentistry internal award	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grants (http://www.nserc-crsng.gc.ca) and Western University Schulich School of Medicine and Dentistry internal award (http://www.schulich.uwo.ca/research) to MJM and DEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; AYORA S, 1994, J BACTERIOL, V176, P3218, DOI 10.1128/jb.176.11.3218-3223.1994; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Elie-Turenne MC, 2010, INFECT CONT HOSP EP, V31, P574, DOI 10.1086/652525; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gonzalez DJ, 2012, J BIOL CHEM, V287, P13889, DOI 10.1074/jbc.M112.349860; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Holtfreter S, 2009, CLIN VACCINE IMMUNOL, V16, P1607, DOI 10.1128/CVI.00263-09; Howden BP, 2008, ANTIMICROB AGENTS CH, V52, P3755, DOI 10.1128/AAC.01613-07; Imamura T, 2005, J EXP MED, V201, P1669, DOI 10.1084/jem.20042041; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kies S, 2001, INFECT IMMUN, V69, P7933, DOI 10.1128/IAI.69.12.7933-7936.2001; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lai YP, 2007, MOL MICROBIOL, V63, P497, DOI 10.1111/j.1365-2958.2006.05540.x; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Massimi I, 2002, J BIOL CHEM, V277, P41770, DOI 10.1074/jbc.M207162200; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; McGavin MJ, 2012, FRONTIERS CELLULAR I, V2; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; MILLER SJ, 1988, ARCH DERMATOL, V124, P209, DOI 10.1001/archderm.124.2.209; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Moore PCL, 2002, J MED MICROBIOL, V51, P516, DOI 10.1099/0022-1317-51-6-516; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nickerson N, 2010, MOL MICROBIOL, V75, P161, DOI 10.1111/j.1365-2958.2009.06974.x; Nickerson NN, 2008, MOL MICROBIOL, V69, P1530, DOI 10.1111/j.1365-2958.2008.06384.x; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Ohbayashi T, 2011, MICROBIOL-SGM, V157, P786, DOI 10.1099/mic.0.044503-0; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Pynnonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002104; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; SHRYOCK TR, 1992, J MED MICROBIOL, V36, P288, DOI 10.1099/00222615-36-4-288; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sivaraman K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-433; Stefaniak AB, 2006, TOXICOL IN VITRO, V20, P1265, DOI 10.1016/j.tiv.2006.05.011; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Yeung M, 2011, MICROBES INFECT, V13, P189, DOI 10.1016/j.micinf.2010.10.023; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	85	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45952	10.1371/journal.pone.0045952	http://dx.doi.org/10.1371/journal.pone.0045952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029337	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700095
J	Gnjidic, D; Stanaway, FF; Cumming, R; Waite, L; Blyth, F; Naganathan, V; Handelsman, DJ; Le Couteur, DG				Gnjidic, Danijela; Stanaway, Fiona F.; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Handelsman, David J.; Le Couteur, David G.			Mild Cognitive Impairment Predicts Institutionalization among Older Men: A Population-Based Cohort Study	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; URINARY-INCONTINENCE; ALZHEIMERS-DISEASE; CARE HOMES; SHORT-FORM; DEMENTIA; ADMISSION; DIAGNOSIS; HEALTH; RELIABILITY	Background: There is a lack of evidence on the contribution of mild cognitive impairment (MCI) to institutionalization in older adults. This study aimed to evaluate a range of risk factors including MCI of institutionalization in older men. Methods: Men aged >= 70 years (n = 1705), participating in the Concord Health and Ageing in Men Project, Sydney, Australia were studied. Participants completed self-reported questionnaires and underwent comprehensive clinical assessments during 2005-2007. Institutionalization was defined as entry into a nursing home facility or hostel at any time over an average of 5 years of follow-up. Cox regression analysis was conducted to generate hazard ratios (HR) with 95% confidence intervals (CI). Results: A total of 125 (7.3%) participants were institutionalized. Piecewise Cox proportional models were generated and divided at 3.4 years (1250 days) of follow-up due to violation of the proportional hazards assumption for the association between MCI and institutionalization (chi(2) = 6.44, p = 0.01). Dementia, disability in Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL), poor grip strength, few social interactions, being a Non-English speaking immigrant and age were predictive of institutionalization during both time periods, whereas MCI (HR = 4.39, 95% CI 2.17-8.87) only predicted institutionalization in the period beyond 3.4 years of follow-up. Being married (HR = 0.42, 95% CI: 0.24-0.72) was protective only during the period after 3.4 years of follow-up. Discussion: In this study, the strongest predictors of institutionalization were dementia, MCI, ADL and IADL disability. MCI was not a predictor of early institutionalization but became a significant predictor beyond 3.4 years of follow-up.	[Gnjidic, Danijela] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Handelsman, David J.; Le Couteur, David G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gnjidic, Danijela; Stanaway, Fiona F.; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Le Couteur, David G.] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Handelsman, David J.; Le Couteur, David G.] Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Stanaway, Fiona F.; Cumming, Robert] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney	Gnjidic, D (corresponding author), Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia.	danijela.gnjidic@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; Handelsman, David/AAR-9580-2021	Handelsman, David/0000-0002-4200-7476; Naganathan, Vasikaran/0000-0001-7243-0796; Waite, Louise/0000-0001-9056-6996; Le Couteur, David/0000-0002-4227-5817	Australian National Health and Medical Research Council (NHMRC) [301916]; Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation; Geoff and Elaine Penney Ageing Research Unit	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation; Geoff and Elaine Penney Ageing Research Unit	The CHAMP study is funded by the Australian National Health and Medical Research Council (NHMRC Project Grant No. 301916), Sydney Medical School Foundation and Ageing and Alzheimer's Research Foundation. The authors gratefully acknowledge the funding support from the Geoff and Elaine Penney Ageing Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW) AIoHaW, 2011, DRUG STAT SER, V26; AIHW (Australian Institute of Health and Welfare), 2011, AG CAR STAT SER, V35; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Busse A, 2006, BRIT J PSYCHIAT, V189, P399, DOI 10.1192/bjp.bp.105.014779; Byrne LMT, 1998, J CLIN EXP NEUROPSYC, V20, P286, DOI 10.1076/jcen.20.2.286.1176; Chan DC, 2003, J GERONTOL A-BIOL, V58, P548; Chukwujama O, 2011, NEW ENGL J MED, V365, P1358, DOI 10.1056/NEJMc1108238; Cohen-Mansfield J, 2011, ARCH GERONTOL GERIAT, V53, P309, DOI 10.1016/j.archger.2010.12.009; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Dudas RB, 2005, AM J GERIAT PSYCHIAT, V13, P218, DOI 10.1176/appi.ajgp.13.3.218; Dunn J E, 1993, J Aging Health, V5, P194, DOI 10.1177/089826439300500203; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Gibson D., 2001, PROJECTIONS OLDER IM; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Grundy E, 2007, AGE AGEING, V36, P424, DOI 10.1093/ageing/afm067; Guo MX, 2012, J NEUROL SCI, V312, P39, DOI 10.1016/j.jns.2011.08.026; HE W, 2005, CURRENT POPULATION R, P23; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; LIEBERMAN MA, 1991, GERONTOLOGIST, V31, P371, DOI 10.1093/geront/31.3.371; Lord SR, 1996, ARCH PHYS MED REHAB, V77, P232, DOI 10.1016/S0003-9993(96)90103-3; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; McCallum J, 2005, AUSTRALAS J AGEING, V24, P169, DOI 10.1111/j.1741-6612.2005.00116.x; McCann M, 2011, AGE AGEING, V40, P358, DOI 10.1093/ageing/afr031; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rowland JT, 2004, INT PSYCHOGERIATR, V118, P111; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tuokko H, 2003, ARCH NEUROL-CHICAGO, V60, P577, DOI 10.1001/archneur.60.4.577; Turcotte Martin., 2007, PORTRAIT SENIORS CAN; Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wechsler D, 1987, WMS R WECHSLER MEMOR; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46061	10.1371/journal.pone.0046061	http://dx.doi.org/10.1371/journal.pone.0046061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029389	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700111
J	Lo, JC; Groeger, JA; Santhi, N; Arbon, EL; Lazar, AS; Hasan, S; von Schantz, M; Archer, SN; Dijk, DJ				Lo, June C.; Groeger, John A.; Santhi, Nayantara; Arbon, Emma L.; Lazar, Alpar S.; Hasan, Sibah; von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan			Effects of Partial and Acute Total Sleep Deprivation on Performance across Cognitive Domains, Individuals and Circadian Phase	PLOS ONE			English	Article							NEUROBEHAVIORAL FUNCTION; SUSTAINED ATTENTION; WORKING-MEMORY; TIME AWAKE; SHORT-FORM; ONE NIGHT; PER3; POLYMORPHISM; RESTRICTION; HEALTH	Background: Cognitive performance deteriorates during extended wakefulness and circadian phase misalignment, and some individuals are more affected than others. Whether performance is affected similarly across cognitive domains, or whether cognitive processes involving Executive Functions are more sensitive to sleep and circadian misalignment than Alertness and Sustained Attention, is a matter of debate. Methodology/Principal Findings: We conducted a 2 x 12-day laboratory protocol to characterize the interaction of repeated partial and acute total sleep deprivation and circadian phase on performance across seven cognitive domains in 36 individuals (18 males; mean +/- SD of age = 27.6 +/- 4.0 years). The sample was stratified for the rs57875989 polymorphism in PER3, which confers cognitive susceptibility to total sleep deprivation. We observed a deterioration of performance during both repeated partial and acute total sleep deprivation. Furthermore, prior partial sleep deprivation led to poorer cognitive performance in a subsequent total sleep deprivation period, but its effect was modulated by circadian phase such that it was virtually absent in the evening wake maintenance zone, and most prominent during early morning hours. A significant effect of PER3 genotype was observed for Subjective Alertness during partial sleep deprivation and on n-back tasks with a high executive load when assessed in the morning hours during total sleep deprivation after partial sleep loss. Overall, however, Subjective Alertness and Sustained Attention were more affected by both partial and total sleep deprivation than other cognitive domains and tasks including n-back tasks of Working Memory, even when implemented with a high executive load. Conclusions/Significance: Sleep loss has a primary effect on Sleepiness and Sustained Attention with much smaller effects on challenging Working Memory tasks. These findings have implications for understanding how sleep debt and circadian rhythmicity interact to determine waking performance across cognitive domains and individuals.	[Lo, June C.; Groeger, John A.; Santhi, Nayantara; Arbon, Emma L.; Lazar, Alpar S.; Hasan, Sibah; von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England; [Groeger, John A.] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Hull; University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England.	d.j.dijk@surrey.ac.uk	von Schantz, Malcolm/C-5962-2014; Groeger, John/AAK-2799-2020; Groeger, John/AAQ-8187-2021; Groeger, John/B-5671-2014	von Schantz, Malcolm/0000-0002-9911-9436; Groeger, John/0000-0002-3582-1058; Lazar, Alpar/0000-0003-3147-8229; Santhi, Nayantara/0000-0003-4568-1447	AFOSR [FA9550-08-1-0080]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was funded by AFOSR award FA9550-08-1-0080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ARTHUR W, 1994, EDUC PSYCHOL MEAS, V54, P394, DOI 10.1177/0013164494054002013; BABKOFF H, 1988, Q J EXP PSYCHOL-A, V40, P737, DOI 10.1080/14640748808402296; BADDELEY AD, 1968, PSYCHON SCI, V10, P341; Balkin TJ, 2004, J SLEEP RES, V13, P219, DOI 10.1111/j.1365-2869.2004.00407.x; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brown JW, 2009, ENCY NEUROSCIENCE, P93; Buysse D J, 1989, Psychiatry Res, V28, P193; Cain SW, 2011, BRAIN COGNITION, V76, P37, DOI 10.1016/j.bandc.2011.03.005; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czeisler CA, 1985, SLEEP RES, V14, P295; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 2005, SLEEP, V28, P1059; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; FRITH CD, 1973, Q J EXP PSYCHOL, V25, P253, DOI 10.1080/14640747308400345; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gonzalez MMC, 2006, SLEEP, V29, P1327, DOI 10.1093/sleep/29.10.1327; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; Groeger JA, 2008, SLEEP, V31, P1159; Groeger JA, 2011, BEHAV NEUROSCI, V125, P252, DOI 10.1037/a0022692; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Harrison Y, 2000, SLEEP, V23, P1067; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Harrison Y, 2007, NEUROPSYCHOLOGIA, V45, P1966, DOI 10.1016/j.neuropsychologia.2006.12.012; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Klerman EB, 2008, CURR BIOL, V18, P1118, DOI 10.1016/j.cub.2008.06.047; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Luckhaupt SE, 2010, SLEEP, V33, P149, DOI 10.1093/sleep/33.2.149; Macmillan NA, 1996, PSYCHON B REV, V3, P164, DOI 10.3758/BF03212415; Macmillan NA, 2005, DETECTION THEORY USE; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Miller E.K., 2009, ENCYCL NEUROSCI, V4, P99; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Pilcher JJ, 2007, AVIAT SPACE ENVIR MD, V78, pB15; POLLACK I, 1964, PSYCHON SCI, V1, P125, DOI 10.3758/BF03342823; Rechtschaffen A, 1968, NATL I HLTH PUBLICAT; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers NL, 2008, J SLEEP RES, V17, P406, DOI 10.1111/j.1365-2869.2008.00681.x; Rupp TL, 2012, SLEEP, V35, P1163, DOI 10.5665/sleep.2010; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; Van Dongen HPA, 2001, CHRONOBIOL INT, V18, P85, DOI 10.1081/CBI-100001178; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vandierendonck A, 1998, Q J EXP PSYCHOL-A, V51, P197, DOI 10.1080/713755748; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WYATT JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zhou X, 2011, SLEEP, V34, P931, DOI 10.5665/SLEEP.1130	85	207	209	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45987	10.1371/journal.pone.0045987	http://dx.doi.org/10.1371/journal.pone.0045987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029352	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700100
J	Beyer, M; Mallmann, MR; Xue, J; Staratschek-Jox, A; Vorholt, D; Krebs, W; Sommer, D; Sander, J; Mertens, C; Nino-Castro, A; Schmidt, SV; Schultze, JL				Beyer, Marc; Mallmann, Michael R.; Xue, Jia; Staratschek-Jox, Andrea; Vorholt, Daniela; Krebs, Wolfgang; Sommer, Daniel; Sander, Jil; Mertens, Christina; Nino-Castro, Andrea; Schmidt, Susanne V.; Schultze, Joachim L.			High-Resolution Transcriptome of Human Macrophages	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; DENDRITIC CELLS; HUMAN MONOCYTES; 2B4 CD244; DIFFERENTIATION; GENOME; POLARIZATION; ACTIVATION; MOLECULES	Macrophages are dynamic cells integrating signals from their microenvironment to develop specific functional responses. Although, microarray-based transcriptional profiling has established transcriptional reprogramming as an important mechanism for signal integration and cell function of macrophages, current knowledge on transcriptional regulation of human macrophages is far from complete. To discover novel marker genes, an area of great need particularly in human macrophage biology but also to generate a much more thorough transcriptome of human M1- and M1-like macrophages, we performed RNA sequencing (RNA-seq) of human macrophages. Using this approach we can now provide a high-resolution transcriptome profile of human macrophages under classical (M1-like) and alternative (M2-like) polarization conditions and demonstrate a dynamic range exceeding observations obtained by previous technologies, resulting in a more comprehensive understanding of the transcriptome of human macrophages. Using this approach, we identify important gene clusters so far not appreciated by standard microarray techniques. In addition, we were able to detect differential promoter usage, alternative transcription start sites, and different coding sequences for 57 gene loci in human macrophages. Moreover, this approach led to the identification of novel M1-associated (CD120b, TLR2, SLAMF7) as well as M2-associated (CD1a, CD1b, CD93, CD226) cell surface markers. Taken together, these data support that high-resolution transcriptome profiling of human macrophages by RNA-seq leads to a better understanding of macrophage function and will form the basis for a better characterization of macrophages in human health and disease.	[Beyer, Marc; Mallmann, Michael R.; Xue, Jia; Staratschek-Jox, Andrea; Vorholt, Daniela; Krebs, Wolfgang; Sommer, Daniel; Sander, Jil; Mertens, Christina; Nino-Castro, Andrea; Schmidt, Susanne V.; Schultze, Joachim L.] Univ Bonn, LIMES Inst, Bonn, Germany; [Mallmann, Michael R.] Univ Bonn, Dept Obstet & Gynecol, Bonn, Germany	University of Bonn; University of Bonn	Schultze, JL (corresponding author), Univ Bonn, LIMES Inst, Bonn, Germany.	j.schultze@uni-bonn.de	Schmidt, Susanne/AAU-6827-2021; Schultze, Joachim L./ABA-8176-2020; Beyer, Marc/ABE-1408-2021	Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Nino-Castro, Andrea/0000-0002-0895-3637	German Research Foundation [SFB 832, SFB 704, INST 217/575-1, INST 217/576-1, INST 217/577-1]; Wilhelm-Sander-Foundation; German Cancer Aid; German Jose-Carreras-Foundation; BMBF [NGFN2]; BONFOR grant of the University of Bonn; Becton Dickinson	German Research Foundation(German Research Foundation (DFG)); Wilhelm-Sander-Foundation; German Cancer Aid(Deutsche Krebshilfe); German Jose-Carreras-Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); BONFOR grant of the University of Bonn; Becton Dickinson	This work was supported by the German Research Foundation (SFB 832, SFB 704, INST 217/575-1, INST 217/576-1, INST 217/577-1), the Wilhelm-Sander-Foundation, the German Cancer Aid, the German Jose-Carreras-Foundation, the BMBF (NGFN2) (to J.L.S. and M.B.). M.R.M. has been supported by a BONFOR grant of the University of Bonn. This study was supported in part by research funding from Becton Dickinson to J.L.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashokkumar C, 2011, AM J PATHOL, V179, P1929, DOI 10.1016/j.ajpath.2011.06.040; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Camarata T, 2010, DEV BIOL, V337, P233, DOI 10.1016/j.ydbio.2009.10.039; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; Faria JC, 2010, BPCA BIPLOT MULTIVAR; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenlee-Wacker MC, 2011, CURR DRUG TARGETS; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jeon JW, 2010, J IMMUNOL, V185, P4921, DOI 10.4049/jimmunol.0904011; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; KASINRERK W, 1993, J IMMUNOL, V150, P579; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matas D, 2004, CELL DEATH DIFFER, V11, P458, DOI 10.1038/sj.cdd.4401379; McGreal EP, 2002, J IMMUNOL, V168, P5222, DOI 10.4049/jimmunol.168.10.5222; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy JJ, 2002, BIOCHEM J, V361, P431, DOI 10.1042/0264-6021:3610431; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakagawa N, 2000, BIOCHEM BIOPH RES CO, V272, P505, DOI 10.1006/bbrc.2000.2787; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sinha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021868; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waldo SW, 2008, AM J PATHOL, V172, P1112, DOI 10.2353/ajpath.2008.070513; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972	57	166	171	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45466	10.1371/journal.pone.0045466	http://dx.doi.org/10.1371/journal.pone.0045466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029029	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800052
J	Dutta, D; Williamson, CD; Cole, NB; Donaldson, JG				Dutta, Dipannita; Williamson, Chad D.; Cole, Nelson B.; Donaldson, Julie G.			Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; TERMINAL DOMAIN; SMALL MOLECULES; PATHWAY; PROTEINS; DYNAMIN; CARGO; CELLS; ENDOSOMES	Clathrin independent endocytosis (CIE) is a form of endocytosis present in all cells that mediates the entry of nutrients, macromolecules and membrane proteins into cells. When compared to clathrin-dependent endocytosis (CDE), however, much less is known about the machinery involved in forming CIE endosomes. One way to distinguish CIE from CDE has been to deplete cells of coat proteins involved in CDE such as clathrin or the dynamin GTPase, leading to a block of CDE but not CIE. A drawback of such genetic manipulations is that depletion of proteins important for mediating CDE over a period of days can have complex indirect effects on cellular function. The identification of chemical compounds that specifically and rapidly block CDE or CIE would facilitate the determination of whether a process involved CDE or CIE. To date, all of those compounds have targeted CDE. Dynasore and the dynoles specifically target and block dynamin activity thus inhibiting CDE but not most forms of CIE. Recently, a new compound called pitstop 2 was identified as an inhibitor of the interaction of amphiphysin with the amino terminal domain of clathrin, and shown to inhibit CDE in cells. Here we show that pitstop 2 is also a potent inhibitor of CIE. The effects of pitstop 2 are not restricted to inhibition of clathrin since knockdown of clathrin fails to rescue the inhibition of endocytosis of CIE proteins by the drug. Thus pitstop 2 has additional cellular targets besides the amino terminal domain of clathrin and thus cannot be used to distinguish CIE from CDE.	[Dutta, Dipannita; Williamson, Chad D.; Cole, Nelson B.; Donaldson, Julie G.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Donaldson, JG (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	donaldsonj@helix.nih.gov			Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) [HL006060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006130] Funding Source: NIH RePORTER	Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), HL006060. http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole NB, 2012, ACS CHEM BIOL, V7, P464, DOI 10.1021/cb2004252; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Zhao XH, 2001, J CELL SCI, V114, P353	27	126	130	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45799	10.1371/journal.pone.0045799	http://dx.doi.org/10.1371/journal.pone.0045799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029248	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800098
J	del Villar, LP; Burguillo, FJ; Lopez-Aban, J; Muro, A				Perez del Villar, Luis; Burguillo, Francisco J.; Lopez-Aban, Julio; Muro, Antonio			Systematic Review and Meta-Analysis of Artemisinin Based Therapies for the Treatment and Prevention of Schistosomiasis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MANSONI INFECTIONS; ANTISCHISTOSOMAL DRUGS; ORAL ARTEMETHER; PRAZIQUANTEL; ARTESUNATE; EFFICACY; HAEMATOBIUM; RESISTANCE	Background: Chemotherapy based on repeated doses of praziquantel is still the most effective control strategy against Schistosomiasis, however artemisinin derivatives emerged as a family of compounds with schistomicide activity. The aim of the present work is to compare the efficacy of artemisinin-based therapies in the treatment and prophylaxis of human schistosomiasis. The design of this work involved a quantitative systematic review and meta-analysis. Methodology/Principal Findings: Retrieval of published studies was carried out through an electronic search of the PubMed (MEDLINE), EMBASE, Cochrane Library and CINAHL databases. This included reports comparing the therapeutic efficacy of artesunate alone, artesunate plus sulfadoxine-pyrimethamine and a combination of artemisinin derivatives plus praziquantel against praziquantel alone on different types of schistosomiasis. Moreover, studies on artesunate and artemether used as preventive drugs were also analyzed against placebo. The primary outcome measure for schistosomiasis treatment was "parasitological cure'', whereas for the prophylaxis the outcome evaluated was "infection rate''. Our results show that patients treated with artesunate alone have significantly lower cure rates than those treated with praziquantel (OR = 0.27 (95% C.I. 0.13-0.53; p < 0.001)) and that the combined therapy of artesunate plus sulfadoxine-pyrimethamine is also significantly less effective than praziquantel treatment (OR = 0.14 (95% C. I. 0.02-0.92; p = 0.04)). However, the combination of an artemisinin derivatives plus praziquantel showed a higher cure rate than praziquantel monotherapy with OR = 2.07 (95% C.I. 1.27-3.36; p = 0.003). Finally, chemoprophylaxis with either artesunate (RR = 0.11 (95% C.I. 0.06-0.22; p < 0.001)) or artemether (RR = 0.25 (95% C.I. 0.16-0.40; p, 0.001)) was significantly better than a placebo in both cases. Conclusions/Significance: This meta-analysis confirms that artemisinin derivatives used in combination with praziquantel have the potential to increase the cure rates in schistosomiasis treatment, but not artesunate alone. It is also confirmed that repeated doses of artemisinin derivatives play a prophylactic role, significantly reducing the incidence of Schistosoma japonicum infections compared with placebo.	[Perez del Villar, Luis; Lopez-Aban, Julio; Muro, Antonio] Univ Salamanca, Fac Farm, IBSAL CIETUS, Lab Inmunol & Parasitol Mol, E-37007 Salamanca, Spain; [Burguillo, Francisco J.] Univ Salamanca, Fac Farm, Dept Quim Fis, E-37007 Salamanca, Spain	University of Salamanca; University of Salamanca	del Villar, LP (corresponding author), Univ Salamanca, Fac Farm, IBSAL CIETUS, Lab Inmunol & Parasitol Mol, E-37007 Salamanca, Spain.	luispmoro@usal.es	López-Abán, Julio/B-3557-2015	López-Abán, Julio/0000-0001-8509-0727; Muro, Antonio/0000-0003-0244-4740	Fundacion Ramon Areces; Junta de Castilla y Leon [Orden EDU/330/2008]	Fundacion Ramon Areces; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Fundacion Ramon Areces (2010-13) and Junta de Castilla y Leon (Orden EDU/330/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Borenstein M., 2009, INTRO METAANALYSIS; Borrmann S, 2001, J INFECT DIS, V184, P1363, DOI 10.1086/324004; Danso-Appiah A, 2009, PARASITOLOGY, V136, P1837, DOI 10.1017/S0031182009005939; Danso-Appiah A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000053.pub2; De Clercq D, 2000, TROP MED INT HEALTH, V5, P744, DOI 10.1046/j.1365-3156.2000.00628.x; De Clercq D, 2000, T ROY SOC TROP MED H, V94, P90, DOI 10.1016/S0035-9203(00)90453-X; De Clercq D, 2002, ACTA TROP, V82, P61, DOI 10.1016/S0001-706X(02)00003-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Gautam A, 2009, CURR DRUG METAB, V10, P289, DOI 10.2174/138920009787846323; GREER GJ, 1988, J PARASITOL, V74, P471, DOI 10.2307/3282058; Gryseels B, 2001, TROP MED INT HEALTH, V6, P864, DOI 10.1046/j.1365-3156.2001.00811.x; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Hou XY, 2008, B WORLD HEALTH ORGAN, V86, P788, DOI 10.2471/BLT.08.053041; Inyang-Etoh PC, 2009, T ROY SOC TROP MED H, V103, P38, DOI 10.1016/j.trstmh.2008.08.002; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keiser J, 2007, CURR OPIN INFECT DIS, V20, P605, DOI 10.1097/QCO.0b013e3282f19ec4; Keiser J, 2010, CLIN INFECT DIS, V50, P1205, DOI 10.1086/651682; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Li HY, 1999, CHIN J PARASIT DIS C, V12, P412; Li SW, 1996, CHINESE MED J-PEKING, V109, P848; Li YS, 2005, ACTA TROP, V96, P184, DOI 10.1016/j.actatropica.2005.07.013; Liu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-201; Lu GuangYi, 2000, Chinese Journal of Parasitic Disease Control, V13, P212; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Mohamed AA, 2009, T ROY SOC TROP MED H, V103, P1062, DOI 10.1016/j.trstmh.2009.01.026; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muth S, 2010, ADV PARASIT, V72, P179, DOI 10.1016/S0065-308X(10)72007-8; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; Obonyo CO, 2010, LANCET INFECT DIS, V10, P603, DOI 10.1016/S1473-3099(10)70161-4; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Scherrer AU, 2009, ACTA TROP, V109, P226, DOI 10.1016/j.actatropica.2008.11.015; Schwarzer G., 2012, META METAANALYSIS R; Sissoko MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006732; Song Y, 1998, CHINESE MED J-PEKING, V111, P123; Song Yu, 2006, Journal of Tropical Medicine (Guangzhou), V6, P1182; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tchuente LAT, 2003, TRENDS PARASITOL, V19, P389, DOI 10.1016/S1471-4922(03)00193-4; Tian ZiYing, 1997, Chinese Journal of Parasitology & Parasitic Diseases, V15, P208; Tian ZY, 2001, CHIN J SCHISTO CONT, V13, P299; Utzinger J, 2000, LANCET, V355, P1320, DOI 10.1016/S0140-6736(00)02114-0; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; Utzinger J, 2010, LANCET INFECT DIS, V10, P579, DOI 10.1016/S1473-3099(10)70169-9; Wang JiaLong, 1997, Chinese Journal of Parasitology & Parasitic Diseases, V15, P138; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Wu LingJuan, 1995, Chinese Journal of Schistosomiasis Control, V7, P323; Wu Tai-xiang, 2003, Zhonghua Yi Xue Za Zhi, V83, P1219; Xiao S, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P170; Xiao SH, 2005, ACTA TROP, V96, P153, DOI 10.1016/j.actatropica.2005.07.010; Xiao SH, 2000, PARASITOL TODAY, V16, P122, DOI 10.1016/S0169-4758(99)01601-4; Xiao SH, 2010, ADV PARASIT, V73, P231, DOI 10.1016/S0065-308X(10)73009-8; Xiao ShuHua, 1996, Chinese Journal of Parasitology & Parasitic Diseases, V14, P11; Xu M, 1999, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V17, P241; Xu MingSheng, 1997, Chinese Journal of Parasitology & Parasitic Diseases, V15, P212; Zhang SJ, 2000, MOD DIAGN TREAT, V11, P68	60	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45867	10.1371/journal.pone.0045867	http://dx.doi.org/10.1371/journal.pone.0045867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029285	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800111
J	Maiti, D; Sarkar, TS; Ghosh, S				Maiti, Debasis; Sarkar, Tuhin Subhra; Ghosh, Sanjay			Detection of S-Nitrosothiol and Nitrosylated Proteins in Arachis hypogaea Functional Nodule: Response of the Nitrogen Fixing Symbiont	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MEDICAGO-TRUNCATULA; NITROSOGLUTATHIONE REDUCTASE; FORMALDEHYDE DEHYDROGENASE; SUPEROXIDE-DISMUTASE; ARABIDOPSIS-THALIANA; NITROSATIVE STRESS; ROOT-NODULES; PLANT; PEANUT	To detect the presence of NO, ROS and RNS in nodules of crack entry legumes, we used Arachis hypogaea functional nodule. The response of two cognate partner rhizobia was compared towards NO and GSNO using S. meliloti and Bradyrhizobium sp NC921001. ROS, NO, nitrosothiol and bacteroids were detected by fluorescence microscopy. Redox enzymes and thiol pools were detected biochemically. Nitrosothiols were found to be present but ROS and NO were absent in A. hypogaea nodule. A number of S-nitrosylated proteins were also detected. The total thiol pool and most of the redox enzymes were low in nodule cytosolic extract but these were found to be high in the partner microorganisms indicating partner rhizobia could protect the nodule environment against the nitrosothiols. Both S. meliloti and Bradyrhizobium sp NC921001 were found to contain GSNO reductase. Interestingly, there was a marked difference in growth pattern between S. meliloti and Bradyrhizobium sp in presence of sodium nitroprusside (SNP) and S-nitrosoglutathione (GSNO). Bradyrhizobium sp was found to be much more tolerant to NO donor compounds than the S. meliloti. In contrast, S. meliloti showed resistance to GSNO but was sensitive to SNP. Together our data indicate that nodule environment of crack entry legumes is different than the nodules of infection mode entry in terms of NO, ROS and RNS. Based on our biochemical characterization, we propose that exchange of redox molecules and reactive chemical species is possible between the bacteroid and nodule compartment.	[Maiti, Debasis; Sarkar, Tuhin Subhra; Ghosh, Sanjay] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India	University of Calcutta	Ghosh, S (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India.	ghoshs71@hotmail.com		Ghosh, Sanjay/0000-0001-8624-1494	University Grants commission (UGC)-Centre for Advanced Studies (CAS); University with Potential for Excellence (UPE); DBT-IPLS programme; DST-FIST, Government of India; Centre for Research in Nanoscience and Nanotechnology (CRNN), University of Calcutta; University of Calcutta	University Grants commission (UGC)-Centre for Advanced Studies (CAS); University with Potential for Excellence (UPE); DBT-IPLS programme; DST-FIST, Government of India(Department of Science & Technology (India)); Centre for Research in Nanoscience and Nanotechnology (CRNN), University of Calcutta(University of Calcutta); University of Calcutta(University of Calcutta)	This work was supported by the University Grants commission (UGC)-Centre for Advanced Studies (CAS), University with Potential for Excellence (UPE) and DBT-IPLS programme, DST-FIST, Government of India and Centre for Research in Nanoscience and Nanotechnology (CRNN), University of Calcutta. The Senior Research fellowship of D. Maiti is supported by University Research Grant, University of Calcutta. T. Sarkar is Senior Research Fellow of University Grants Commission (UGC), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Akerboom T P, 1981, Methods Enzymol, V77, P373; Aleryani S, 1998, J BIOL CHEM, V273, P6041, DOI 10.1074/jbc.273.11.6041; ALLEN O. N., 1940, Botanical Gazette, V102, P121, DOI 10.1086/334940; Allen O. N., 1981, The Leguminosae. A source book of characteristics, uses and nodulation.; BAL AK, 1989, PROTOPLASMA, V150, P19, DOI 10.1007/BF01352917; Barroso JB, 2006, J EXP BOT, V57, P1785, DOI 10.1093/jxb/erj175; Baudouin E, 2006, MOL PLANT MICROBE IN, V19, P970, DOI 10.1094/MPMI-19-0970; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; BHUVANESWARI TV, 1981, PLANT PHYSIOL, V68, P1144, DOI 10.1104/pp.68.5.1144; Boogerd FC, 1997, FEMS MICROBIOL REV, V21, P5, DOI 10.1016/S0168-6445(97)00004-1; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chaki M, 2011, PLANT CELL ENVIRON, V34, P1803, DOI 10.1111/j.1365-3040.2011.02376.x; CHANDLER MR, 1978, J EXP BOT, V29, P749, DOI 10.1093/jxb/29.3.749; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; DALTON DA, 1991, PLANT PHYSIOL, V96, P812, DOI 10.1104/pp.96.3.812; DEFARIA SM, 1989, NEW PHYTOL, V111, P607, DOI 10.1111/j.1469-8137.1989.tb02354.x; del Giudice J, 2011, NEW PHYTOL, V191, P405, DOI 10.1111/j.1469-8137.2011.03693.x; Del Rio LA, 2004, PHYTOCHEMISTRY, V65, P783, DOI 10.1016/j.phytochem.2004.02.001; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Ferrarini A, 2008, MOL PLANT MICROBE IN, V21, P781, DOI 10.1094/MPMI-21-6-0781; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Haynes JG, 2004, NEW PHYTOL, V163, P661, DOI 10.1111/j.1469-8137.2004.01138.x; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Horchani F, 2011, PLANT PHYSIOL, V155, P1023, DOI 10.1104/pp.110.166140; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; KANAYAMA Y, 1990, PLANT CELL PHYSIOL, V31, P341; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Martinez MC, 1996, EUR J BIOCHEM, V241, P849, DOI 10.1111/j.1432-1033.1996.00849.x; Matamoros MA, 2003, MOL PLANT MICROBE IN, V16, P1039, DOI 10.1094/MPMI.2003.16.11.1039; Meilhoc E, 2011, PLANT SCI, V181, P573, DOI 10.1016/j.plantsci.2011.04.007; Meilhoc E, 2010, MOL PLANT MICROBE IN, V23, P748, DOI 10.1094/MPMI-23-6-0748; Melo PM, 2011, PLANT PHYSIOL, V157, P1505, DOI 10.1104/pp.111.186056; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Moreau M, 2010, PHYSIOL PLANTARUM, V138, P372, DOI 10.1111/j.1399-3054.2009.01308.x; Nagata M, 2008, CLIN TRANSPLANT, V22, P1, DOI 10.1111/j.1399-0012.2008.00859.x; NAMBIAR PTC, 1983, J EXP BOT, V34, P484, DOI 10.1093/jxb/34.4.484; Oehrle NW, 2008, PHYTOCHEMISTRY, V69, P2426, DOI 10.1016/j.phytochem.2008.07.004; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; PIETRAFORTE D, 1995, BIOCHEMISTRY-US, V34, P7177, DOI 10.1021/bi00021a032; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; PUPPO A, 1982, PLANTA, V156, P374, DOI 10.1007/BF00397477; Sarkar TS, 2011, PLANT SIGNAL BEHAV, V6, P501, DOI 10.4161/psb.6.4.13912; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; SEN D, 1986, J EXP BOT, V37, P356, DOI 10.1093/jxb/37.3.356; Serpa V, 2007, BIOCHEM BIOPH RES CO, V361, P1048, DOI 10.1016/j.bbrc.2007.07.133; Shimoda Y, 2005, PLANT CELL PHYSIOL, V46, P99, DOI 10.1093/pci/pci001; Staab CA, 2008, CELL MOL LIFE SCI, V65, P3950, DOI 10.1007/s00018-008-8592-2; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taurian T, 2008, ARCH MICROBIOL, V189, P345, DOI 10.1007/s00203-007-0325-7; Uheda E, 2001, CAN J BOT, V79, P733, DOI 10.1139/cjb-79-6-733; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valderrama R, 2007, FEBS LETT, V581, P453, DOI 10.1016/j.febslet.2007.01.006; Wendel A, 1981, Methods Enzymol, V77, P325; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Yu MD, 2012, CURR OPIN PLANT BIOL, V15, P424, DOI 10.1016/j.pbi.2012.03.005; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008	64	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45526	10.1371/journal.pone.0045526	http://dx.doi.org/10.1371/journal.pone.0045526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029073	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400097
J	Tochigi, M; Nishida, A; Shimodera, S; Oshima, N; Inoue, K; Okazaki, Y; Sasaki, T				Tochigi, Mamoru; Nishida, Atsushi; Shimodera, Shinji; Oshima, Norihito; Inoue, Ken; Okazaki, Yuji; Sasaki, Tsukasa			Irregular Bedtime and Nocturnal Cellular Phone Usage as Risk Factors for Being Involved in Bullying: A Cross-Sectional Survey of Japanese Adolescents	PLOS ONE			English	Article							PEER-VICTIMIZATION; ELEMENTARY-SCHOOL; CHILDHOOD; ASSOCIATION; POPULATION; SCHEDULES; PRESCHOOL; SYMPTOMS; CHILDREN; BEHAVIOR	Purpose: A number of studies have tried to identify risk factors for being involved in bullying in order to help developing preventive measures; however, to our knowledge, no study has investigated the effect of nocturnal lifestyle behavior such as sleep pattern or cellular phone usage. In the present study, we aimed to investigate the relationship between school bullying and sleep pattern or nocturnal cellular phone usage in adolescents. The effect of school size on school bullying was also examined. Methods: Data from the cross-sectional survey of psychopathologies conducted for 19,436 Japanese students from 45 public junior high schools (7th-9th grade) and 28 senior high schools (10th-12th grade) were analyzed. Results: Bullying status was significantly associated with irregular bedtime (OR = 1.23 and 1.41 for pure bullies and bully-victims, respectively) and e-mail exchange or calling after lights-out (OR = 1.53 and 1.31 for pure bullies and bully-victims, respectively) after controlling domestic violence and substance usage. In addition, school size was significantly associated with the increased risk of bullying in junior high school students (OR = 1.13 for bully-victims). Conclusions: The present results suggested that sleep pattern and nocturnal cellular phone usage might be risk factors for being involved in school bullying in adolescents. Although further accumulation of data is needed, progressive trend towards nocturnal lifestyle and increasing usage of cellular phone might impair the well-being of adolescents. School-based interventions for lifestyle including sleep pattern and cellular phone usage may be encouraged to reduce school bullying.	[Shimodera, Shinji] Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan; [Tochigi, Mamoru] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan; [Nishida, Atsushi] Tokyo Inst Psychiat, Dept Schizophrenia Res, Tokyo, Japan; [Oshima, Norihito; Sasaki, Tsukasa] Univ Tokyo, Off Mental Hlth Support, Tokyo, Japan; [Inoue, Ken] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Dept Hlth Educ, Grad Sch Educ, Tokyo, Japan	Kochi University; University of Tokyo; Tokyo Institute of Psychiatry; University of Tokyo; Fujita Health University; University of Tokyo	Shimodera, S (corresponding author), Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan.	shimodes@kochi-u.ac.jp	Andoh, Akira/AAB-9303-2022		Ministry of Health, Labor and Welfare of Japan [H19-kokoro-ippan-012]; Grants-in-Aid for Scientific Research [22791158] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant from the Ministry of Health, Labor and Welfare of Japan (#H19-kokoro-ippan-012) and the Grant-in-aid from the Research Group for Schizophrenia in Japan (AN). AN also acknowledges the support from the Research Group for Schizophrenia in Japan, Award for Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; DAHL R, 1995, PRINCIPLES PRACTICE, V2, P19; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61; Harada T, 2004, SLEEP BIOL RHYTHMS, V2, P97; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hodges EVE, 1997, DEV PSYCHOL, V33, P1032, DOI 10.1037//0012-1649.33.6.1032; Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426, DOI 10.4088/JCP.v68n0916; Kumpulainen K, 2000, CHILD ABUSE NEGLECT, V24, P1567, DOI 10.1016/S0145-2134(00)00210-6; Ladd GW, 2003, CHILD DEV, V74, P1344, DOI 10.1111/1467-8624.00611; National Institute for Educational Policy Research, 2010, FOLL UP SURV BULL 20; Olweus D., 1999, NATURE SCH BULLYING, P7; Sasazawa Y, 1991, JPN J SCH HLTH S, V41, P638; Sasazawa Y, 2001, JPN J SCH HLTH S, V42, P23; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Schwartz D, 2000, DEV PSYCHOL, V36, P646, DOI 10.1037//0012-1649.36.5.646; Shields A, 2001, J CLIN CHILD PSYCHOL, V30, P349, DOI 10.1207/S15374424JCCP3003_7; Snyder J, 2003, CHILD DEV, V74, P1881, DOI 10.1046/j.1467-8624.2003.00644.x; Solbere ME, 2007, BRIT J EDUC PSYCHOL, V77, P441, DOI 10.1348/000709906X105689; Sourander A, 2000, CHILD ABUSE NEGLECT, V24, P873, DOI 10.1016/S0145-2134(00)00146-0; Takasu NN, 2012, SLEEP BIOL RHYTHMS, V10, P84, DOI 10.1111/j.1479-8425.2011.00524.x; Turagabeci AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001585; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Wever R.A., 1979, CIRCADIAN SYSTEM MAN; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yokomaku A, 2008, CHRONOBIOL INT, V25, P549, DOI 10.1080/07420520802261705	28	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45736	10.1371/journal.pone.0045736	http://dx.doi.org/10.1371/journal.pone.0045736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23029211	Green Published, gold			2022-12-27	WOS:000309388400127
J	Futami, I; Ishijima, M; Kaneko, H; Tsuji, K; Ichikawa-Tomikawa, N; Sadatsuki, R; Muneta, T; Arikawa-Hirasawa, E; Sekiya, I; Kaneko, K				Futami, Ippei; Ishijima, Muneaki; Kaneko, Haruka; Tsuji, Kunikazu; Ichikawa-Tomikawa, Naoki; Sadatsuki, Ryo; Muneta, Takeshi; Arikawa-Hirasawa, Eri; Sekiya, Ichiro; Kaneko, Kazuo			Isolation and Characterization of Multipotential Mesenchymal Cells from the Mouse Synovium	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; STEM-CELLS; ADIPOSE-TISSUE; MARROW; DIFFERENTIATION; REGENERATION; SYNOVECTOMY; EXPRESSION; OSTEOBLAST; CHONDROGENESIS	The human synovium contains mesenchymal stem cells (MSCs), which are multipotential non-hematopoietic progenitor cells that can differentiate into a variety of mesenchymal lineages and they may therefore be a candidate cell source for tissue repair. However, the molecular mechanisms by which this can occur are still largely unknown. Mouse primary cell culture enables us to investigate the molecular mechanisms underlying various phenomena because it allows for relatively easy gene manipulation, which is indispensable for the molecular analysis. However, mouse synovial mesenchymal cells (SMCs) have not been established, although rabbit, cow, and rat SMCs are available, in addition to human MSCs. The aim of this study was to establish methods to harvest the synovium and to isolate and culture primary SMCs from mice. As the mouse SMCs were not able to be harvested and isolated using the same protocol for human, rat and rabbit SMCs, the protocol for humans was modified for SMCs from the Balb/c mouse knee joint. The mouse SMCs obtained showed superior proliferative potential, growth kinetics and colony formation compared to cells derived from muscle and bone marrow. They expressed PDGFRa and Sca-1 detected by flow cytometry, and showed an osteogenic, adipogenic and chondrogenic potential similar or superior to the cells derived from muscle and bone marrow by demonstrating in vitro osteogenesis, adipogenesis and chondrogenesis. In conclusion, we established a primary mouse synovial cell culture method. The cells derived from the mouse synovium demonstrated both the ability to proliferate and multipotentiality similar or superior to the cells derived from muscle and bone marrow.	[Futami, Ippei; Ishijima, Muneaki; Kaneko, Haruka; Sadatsuki, Ryo; Kaneko, Kazuo] Juntendo Univ, Grad Sch Med, Dept Med Motor Organ, Tokyo, Japan; [Futami, Ippei; Ishijima, Muneaki; Kaneko, Haruka; Sadatsuki, Ryo; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthopaed, Tokyo 113, Japan; [Ishijima, Muneaki; Kaneko, Kazuo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Tsuji, Kunikazu; Muneta, Takeshi] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Ichikawa-Tomikawa, Naoki; Arikawa-Hirasawa, Eri] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Muneta, Takeshi] Tokyo Med & Dent Univ, Grad Sch, Sect Orthopaed Surg, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Grad Sch, Sect Cartilage Regenerat, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); Juntendo University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Ishijima, M (corresponding author), Juntendo Univ, Grad Sch Med, Dept Med Motor Organ, Tokyo, Japan.	ishijima@juntendo.ac.jp	Tsuji, Kunikazu/HDM-9242-2022; Ishijima, Muneaki/L-4816-2016	Tsuji, Kunikazu/0000-0002-1013-8359; Ishijima, Muneaki/0000-0002-0920-0805; Muneta, Takeshi/0000-0003-1018-2939	High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [19791047, 21791418]; Grants-in-Aid for Scientific Research [24790390, 22300223, 22570135] Funding Source: KAKEN	High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by a High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19791047 and 21791418 for M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahn AH, 2007, KNEE SURG SPORT TR A, V15, P242, DOI 10.1007/s00167-006-0177-8; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; BENTLEY G, 1975, J BONE JOINT SURG BR, V57, P454, DOI 10.1302/0301-620X.57B4.454; CAMPBELL WG, 1971, LAB INVEST, V24, P404; Chalaux E, 1998, J BIOL CHEM, V273, P537, DOI 10.1074/jbc.273.1.537; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dulos J, 2004, ARTHRITIS RHEUM-US, V50, P3346, DOI 10.1002/art.20509; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hashimoto S, 2002, OSTEOARTHR CARTILAGE, V10, P180, DOI 10.1053/joca.2001.0505; Horie M, 2012, J BONE JOINT SURG AM, V94A, P701, DOI 10.2106/JBJS.K.00176; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012; IWATA H, 1993, CLIN ORTHOP RELAT R, P295; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jones BA, 2012, TISSUE ENG B; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li P, 2000, J IMMUNOL, V164, P5990, DOI 10.4049/jimmunol.164.11.5990; Mahadevan V, 2008, GRAYS ANATOMY ANATOM, P1327; MITCHELL N, 1968, J BONE JOINT SURG AM, VA 50, P675, DOI 10.2106/00004623-196850040-00003; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sakamoto Y, 2010, J ORTHOP RES; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701; SIMMONS DJ, 1991, CALCIFIED TISSUE INT, V48, P326, DOI 10.1007/BF02556152; Feitosa MLT, 2010, ACTA CIR BRAS, V25, P416, DOI 10.1590/S0102-86502010000500006; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Vinardell T, 2012, TISSUE ENG A; Wada MR, 2002, DEVELOPMENT, V129, P2987; Waldburger JM, 2011, ARTHRITIS RHEUM-US, V63, P3354, DOI 10.1002/art.30522; WAYMOUTH C, 1974, IN VITRO CELL DEV B, V10, P97; Wu L, 2012, TISSUE ENG A; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	53	64	65	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45517	10.1371/journal.pone.0045517	http://dx.doi.org/10.1371/journal.pone.0045517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029067	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900152
J	Stempler, S; Ruppin, E				Stempler, Shiri; Ruppin, Eytan			Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer's Disease	PLOS ONE			English	Article							BRAIN; ASTROCYTES; PATHOLOGY	Alterations in gene expression resulting from Alzheimer's disease have received considerable attention in recent years. Although expression has been investigated separately in whole brain tissue, in astrocytes and in neurons, a rigorous comparative study quantifying the relative utility of these sources in predicting the progression of Alzheimer's disease has been lacking. Here we analyze gene expression from neurons, astrocytes and whole tissues across different brain regions, and compare their ability to predict Alzheimer's disease progression by building pertaining classification models based on gene expression sets annotated to different biological processes. Remarkably, we find that predictions based on neuronal gene expression are significantly more accurate than those based on astrocyte or whole tissue expression. The findings explicate the central role of neurons, particularly as compared to glial cells, in the pathogenesis of Alzheimer's disease, and emphasize the importance of measuring gene expression in the most relevant (pathogenically 'proximal') single cell types.	[Stempler, Shiri; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Stempler, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	shirist2@post.tau.ac.il; ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Israeli Science Foundation; Tel Aviv University	Israeli Science Foundation(Israel Science Foundation); Tel Aviv University	This work was supported by a grant from the Israeli Science Foundation to E.R. S.S gratefully acknowledges the support of the Josef Sagol fellowship for brain research at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Galvin JE, 2004, NEUROCHEM RES, V29, P1041, DOI 10.1023/B:NERE.0000023592.53769.4d; Ginsberg SD, 2011, NEUROBIOL DIS; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Simpson JE, 2011, NEUROBIOL AGING; Stahlberg A, 2011, EXPERT REV MOL DIAGN, V11, P735, DOI [10.1586/erm.11.60, 10.1586/ERM.11.60]; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Stempler S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.003; van der Flier WM, 2011, LANCET NEUROL, V10, P280, DOI 10.1016/S1474-4422(10)70306-9; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45879	10.1371/journal.pone.0045879	http://dx.doi.org/10.1371/journal.pone.0045879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029292	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900060
J	Auerswald, K; Wittmer, MHOM; Tungalag, R; Bai, YF; Schnyder, H				Auerswald, Karl; Wittmer, Max H. O. M.; Tungalag, Radnaakhand; Bai, Yongfei; Schnyder, Hans			Sheep Wool delta C-13 Reveals No Effect of Grazing on the C-3/C-4 Ratio of Vegetation in the Inner Mongolia-Mongolia Border Region Grasslands	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; C-4 GRASSES; LONG-TERM; DIVERSITY; NITROGEN; GRADIENT; STEPPE; SOIL	We tested whether the abundance of C-4 vegetation in grasslands of the Mongolian plateau is influenced by grazing conditions. The analysis exploited the politically originated contrast that exists between Mongolia (low stocking rate, transhumant system) and the district of Inner Mongolia, China (high stocking rate, sedentary system). We estimated the proportion of C-4 carbon (P-C4) in grazed vegetation from the relative carbon isotope ratio (delta C-13) of sheep wool sampled from 298 annual shearings originating from 1996 to 2007. Annual stocking rates varying over time and between the districts of both countries were taken from regional statistics. The P-C4 pattern within the 0.7 million km(2) sampling area was geostatistically analyzed and related to stocking rates and temperature gradients. For similar climatic conditions, P-C4 was the same in both countries. Further, a unique relationship was found between P-C4 and July temperature on both sides of the border, which explained 71% of the pattern. Stocking rate and grazing system had no significant influences on present-day C-3/C-4 abundance ratio. This finding suggests that recent changes in the C-3/C-4 ratio of these grasslands are mainly a consequence of regional warming, not overgrazing.	[Auerswald, Karl; Wittmer, Max H. O. M.; Schnyder, Hans] Tech Univ Munich, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany; [Tungalag, Radnaakhand] Natl Univ Mongolia, Ulaanbaatar, Mongolia; [Bai, Yongfei] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Technical University of Munich; National University of Mongolia; Chinese Academy of Sciences; Institute of Botany, CAS	Auerswald, K (corresponding author), Tech Univ Munich, Lehrstuhl Grunlandlehre, Alte Akad 12, Freising Weihenstephan, Germany.	auerswald@wzw.tum.de	Schnyder, Hans/B-7089-2011; Auerswald, Karl/C-5186-2008	Schnyder, Hans/0000-0002-0139-7535; Auerswald, Karl/0000-0001-5275-4320	Deutsche Forschungsgemeinschaft; National Natural Science Foundation of China [30825008, 30770370]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the Deutsche Forschungsgemeinschaft for funding this research, which was also partly supported by the National Natural Science Foundation of China (30825008 and 30770370). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allen VG, 2011, GRASS FORAGE SCI, V66, P2, DOI 10.1111/j.1365-2494.2010.00780.x; [Anonymous], 2008, STAT YB INNER MONGOL; Auerswald K, 2009, BIOGEOSCIENCES, V6, P795, DOI 10.5194/bg-6-795-2009; Auerswald K, 2012, BASIC APPL ECOL, V13, P67, DOI 10.1016/j.baae.2011.11.004; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Chen SH, 2001, ROOTS GRASSLAND PLAN; Chinese Academy of Sciences Integrative Expedition Team to Inner Mongolia and Ningxia, 1985, VEGETATION INNER MON; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; Derner JD, 2006, PLANT SOIL, V280, P77, DOI 10.1007/s11104-005-2554-3; Fernandez-Gimenez ME, 2006, RANGELANDS CENTRAL A, P30; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Hickman KR, 2004, J RANGE MANAGE, V57, P58, DOI 10.2307/4003955; Hilbig W., 1995, VEGETATION MONGOLIA; Humphrey C, 1995, PASTORAL DEV NETWORK, V39, P2; Kubasek J, 2007, PHOTOSYNTH RES, V91, P47, DOI 10.1007/s11120-007-9136-6; Lewin-Koh NJ, 2008, MAPTOOLS TOOLS READI; Li SG, 2000, AGR FOREST METEOROL, V102, P125, DOI 10.1016/S0168-1923(00)00101-5; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Monson R.K., 1999, C4 PLANT BIOL, P339; National Statistical Office of Mongolia, 2004, STAT YB MONG; National Statistical Office of Mongolia, 2007, STAT YB; National Statistical Office of Mongolia, 2003, STAT YB MONG; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pyankov VI, 2000, OECOLOGIA, V123, P15, DOI 10.1007/s004420050985; R Core Team, 2020, R LANG ENV STAT COMP; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Suttie JM, 2000, COUNTRY PASTURE FORA; Wang RZ, 2002, PHOTOSYNTHETICA, V40, P57, DOI 10.1023/A:1020185906183; [汪诗平 Wang Shiping], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P337; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Wittmer MHOM, 2010, BASIC APPL ECOL, V11, P83, DOI 10.1016/j.baae.2009.10.007; Wittmer MHOM, 2011, PLANT SOIL, V340, P25, DOI 10.1007/s11104-010-0411-5; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Yang H, 2011, J EXP BOT, V62, P4143, DOI 10.1093/jxb/err102; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; [No title captured]	39	4	4	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45552	10.1371/journal.pone.0045552	http://dx.doi.org/10.1371/journal.pone.0045552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029090	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500032
J	Constantino, FC; Pinggera, L; Paranamana, S; Kashino, M; Chait, M				Constantino, Francisco Cervantes; Pinggera, Leyla; Paranamana, Supathum; Kashino, Makio; Chait, Maria			Detection of Appearing and Disappearing Objects in Complex Acoustic Scenes	PLOS ONE			English	Article							AUDITORY-CORTEX; AUDIOVISUAL LINKS; CHANGE-BLINDNESS; ONSET RESPONSES; CHANGE DEAFNESS; FREQUENCY; ASYMMETRIES; INCREMENTS; PERCEPTION; DECREMENTS	The ability to detect sudden changes in the environment is critical for survival. Hearing is hypothesized to play a major role in this process by serving as an "early warning device," rapidly directing attention to new events. Here, we investigate listeners' sensitivity to changes in complex acoustic scenes-what makes certain events "pop-out" and grab attention while others remain unnoticed? We use artificial "scenes" populated by multiple pure-tone components, each with a unique frequency and amplitude modulation rate. Importantly, these scenes lack semantic attributes, which may have confounded previous studies, thus allowing us to probe low-level processes involved in auditory change perception. Our results reveal a striking difference between "appear" and "disappear" events. Listeners are remarkably tuned to object appearance: change detection and identification performance are at ceiling; response times are short, with little effect of scene-size, suggesting a pop-out process. In contrast, listeners have difficulty detecting disappearing objects, even in small scenes: performance rapidly deteriorates with growing scene-size; response times are slow, and even when change is detected, the changed component is rarely successfully identified. We also measured change detection performance when a noise or silent gap was inserted at the time of change or when the scene was interrupted by a distractor that occurred at the time of change but did not mask any scene elements. Gaps adversely affected the processing of item appearance but not disappearance. However, distractors reduced both appearance and disappearance detection. Together, our results suggest a role for neural adaptation and sensitivity to transients in the process of auditory change detection, similar to what has been demonstrated for visual change detection. Importantly, listeners consistently performed better for item addition (relative to deletion) across all scene interruptions used, suggesting a robust perceptual representation of item appearance.	[Constantino, Francisco Cervantes; Pinggera, Leyla; Paranamana, Supathum; Chait, Maria] Univ London Imperial Coll Sci Technol & Med, Ear Inst, London, England; [Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Imperial College London; Nippon Telegraph & Telephone Corporation	Chait, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ear Inst, London, England.	m.chait@ucl.ac.uk	Cervantes Constantino, Francisco/AAA-1200-2020	Cervantes Constantino, Francisco/0000-0002-7393-3579; Chait, Maria/0000-0002-7808-3593	Deafness Research United Kingdom; Wellcome Trust [093292/Z/10/Z]	Deafness Research United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by a Deafness Research United Kingdom (http://www.deafnessresearch.org.uk/) fellowship, and a Wellcome Trust project grant (093292/Z/10/Z) to MC. MK is employed by NTT Communication Science Laboratories, NTT Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREGMAN AS, 1994, J ACOUST SOC AM, V96, P2694, DOI 10.1121/1.411277; Chait M, 2008, BRAIN RES, V1213, P78, DOI 10.1016/j.brainres.2008.03.050; Cole GG, 2010, Q J EXP PSYCHOL, V63, P147, DOI 10.1080/17470210902853522; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Demany L, 2008, PSYCHOL SCI, V19, P85, DOI 10.1111/j.1467-9280.2008.02050.x; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Eramudugolla R, 2005, CURR BIOL, V15, P1108, DOI 10.1016/j.cub.2005.05.051; Erviti M, 2011, J ACOUST SOC AM, V129, P3837, DOI 10.1121/1.3589257; Fishman YI, 2009, HEARING RES, V254, P64, DOI 10.1016/j.heares.2009.04.010; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gregg MK, 2008, J EXP PSYCHOL HUMAN, V34, P974, DOI 10.1037/0096-1523.34.4.974; Gregg MK, 2012, NEUROIMAGE, V62, P113, DOI 10.1016/j.neuroimage.2012.04.057; Hartmann WM, 2006, J ACOUST SOC AM, V120, P2142, DOI 10.1121/1.2228476; Kubovy M., 1981, PERCEPTUAL ORG; Macmillan NA, 2005, DETECTION THEORY USE; Mazza V, 2007, NEUROPSYCHOLOGIA, V45, P514, DOI 10.1016/j.neuropsychologia.2006.02.010; McAnally KI, 2010, J EXP PSYCHOL HUMAN, V36, P994, DOI 10.1037/a0016895; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Moore BCJ, 1997, J ACOUST SOC AM, V102, P2954, DOI 10.1121/1.420350; Moore BCJ, 1999, J ACOUST SOC AM, V106, P3539, DOI 10.1121/1.428207; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Pavani F, 2008, PERCEPT PSYCHOPHYS, V70, P619, DOI 10.3758/PP.70.4.619; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; Phillips DP, 2002, HEARING RES, V167, P192, DOI 10.1016/S0378-5955(02)00393-3; PLACK CJ, 1990, J ACOUST SOC AM, V87, P2178, DOI 10.1121/1.399185; Qin L, 2007, J NEUROPHYSIOL, V97, P3421, DOI 10.1152/jn.00184.2007; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Simons DJ, 2002, CONSCIOUS COGN, V11, P78, DOI 10.1006/ccog.2001.0533; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; SUMMERFIELD Q, 1987, J ACOUST SOC AM, V81, P700, DOI 10.1121/1.394838; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406; Yamashiro K, 2009, EUR J NEUROSCI, V30, P125, DOI 10.1111/j.1460-9568.2009.06790.x; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	41	34	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46167	10.1371/journal.pone.0046167	http://dx.doi.org/10.1371/journal.pone.0046167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23029426	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500069
J	Zhang, R; Yao, FY; Gao, F; Abou-Samra, AB				Zhang, Ren; Yao, Fayi; Gao, Feng; Abou-Samra, Abdul B.			Nrac, a Novel Nutritionally-Regulated Adipose and Cardiac-Enriched Gene	PLOS ONE			English	Article							UNITED-STATES; OBESITY; ENDOCRINE; TISSUE; PREVALENCE; OVERWEIGHT; ADIPOCYTE; CHILDREN; TRENDS; CHINA	Obesity increases the risk of multiple diseases, such as type 2 diabetes and coronary heart diseases, and therefore the current obesity epidemic poses a major public health issue. Therapeutic approaches are urgently needed to treat obesity as well as its complications. Plasma-membrane proteins with restricted tissue distributions are attractive drug targets, because of their accessibility to various drug delivery mechanisms and potentially alleviated side effects. To identify genes involved in metabolism, we performed RNA-Seq on fat in mice treated with a high-fat diet or fasting. Here we show that the gene A530016L24Rik (human ortholog C14orf180), named Nrac, is a novel nutritionally-regulated adipose and cardiac-enriched gene. Nrac is expressed specifically and abundantly in fat and the heart. Both fasting and obesity reduced Nrac expression in white adipose tissue, and fasting reduced its expression in brown fat. Nrac is localized to the plasma membrane, and highly induced during adipocyte differentiation. Nrac is therefore a novel adipocyte marker and has potential functions in metabolism.	[Zhang, Ren; Yao, Fayi; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Ctr Mol Med, Detroit, MI 48202 USA; [Zhang, Ren; Yao, Fayi; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Genet & Endocrine Div, Detroit, MI USA; [Gao, Feng] Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China	Wayne State University; Wayne State University; Tianjin University	Zhang, R (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med, Detroit, MI 48202 USA.	rzhang@med.wayne.edu	Abou-Samra, Abdul/ABE-8723-2020; Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841; Abou-Samra, Abdul/0000-0001-8735-1142	Wayne State University [176412]; National Natural Science Foundation of China [90408028, 31171238, 30800642, 10747150]	Wayne State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported in part by a fund (176412) from Wayne State University to R.Z. and by the National Natural Science Foundation of China (Grant Nos. 90408028, 31171238, 30800642 and 10747150) to F.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Gupta RK, 2011, CELL METAB, V14, P739, DOI 10.1016/j.cmet.2011.11.007; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Virtanen KA, 2009, NEW ENGL J MED, V361, P1123; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46254	10.1371/journal.pone.0046254	http://dx.doi.org/10.1371/journal.pone.0046254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029450	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500077
J	Kothari, H; Rao, LVM; Vankayalapati, R; Pendurthi, UR				Kothari, Hema; Rao, L. Vijaya Mohan; Vankayalapati, Ramakrishna; Pendurthi, Usha R.			Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROTEASE-ACTIVATED RECEPTORS; PROCOAGULANT ACTIVITY; COAGULATION; FIBRINOLYSIS; MONOCYTES; GROWTH; GENES; INFLAMMATION; HEMOSTASIS	A number of earlier studies reported the occurrence of thrombotic complications, particularly disseminated intravascular coagulation and deep vein thrombosis, in tuberculosis (TB) patients. The aberrant expression of tissue factor (TF), the primary activator of coagulation cascade, is known to be responsible for thrombotic disorders in many diseases including bacterial infections. Further, expression of TF by cells of the monocyte/macrophage lineage is also shown to contribute to the development and progression of local and systemic inflammatory reactions. In the present study, we have investigated whether Mycobacterium tuberculosis (Mtb) infection induces TF expression in macrophages, and various host and pathogenic factors responsible for TF expression. We have tested the effect of live virulent Mtb H37Rv, gamma-irradiated Mtb H37Rv (gamma-Mtb) and various components derived from Mtb H37Rv on TF expression in macrophages. The data presented in the manuscript show that both live virulent Mtb and gamma-Mtb treatments markedly increased TF activity in macrophages, predominantly in the CD14(+) macrophages. Detailed studies using gamma-Mtb showed that the increased TF activity in macrophages following Mtb treatment is the result of TF transcriptional activation. The signaling pathways of TF induction by Mtb appears to be distinct from that of LPS-induced TF expression. Mtb-mediated TF expression is dependent on cooperation of CD14/TLR2/TLR4 and probably yet another unknown receptor/cofactor. Mtb cell wall core components, mycolyl arabinogalactan peptidoglycan (mAGP), phosphatidylinositol mannoside-6 (PIM6) and lipomannan (LM) were identified as factors responsible for induction of TF in the order of mAGP > PIM6 > LM. A direct contact between bacteria and macrophage and not Mtb-released soluble factors is critical for TF induction by Mtb. In summary, our data show that Mtb induces TF expression in macrophages and Mtb signaling pathways that elicit TF induction require cooperation of multiple receptors, co-receptors/co-factors including Toll-like receptors. The importance of TF in granuloma formation and containment of Mtb is discussed.	[Kothari, Hema; Rao, L. Vijaya Mohan; Pendurthi, Usha R.] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Vankayalapati, Ramakrishna] Univ Texas Hlth Ctr Tyler, Ctr Pulm & Infect Dis Control, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Kothari, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA.	Hema.Kothari@uthct.edu			American Heart Association, Texas; NIH/NHLBI [HL58869, HL65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058869, R01HL065500] Funding Source: NIH RePORTER	American Heart Association, Texas(American Heart Association); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was primarily supported by a post-doctoral fellowship award from American Heart Association, Texas affiliate to Hema Kothari. L.V.M.R and U.R.P. are partly supported by NIH/NHLBI grants HL58869 and HL65500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Ameixa C, 2002, INFECT IMMUN, V70, P4743, DOI 10.1128/IAI.70.8.4743-4746.2002; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; BEHLING CA, 1993, ANN CLIN LAB SCI, V23, P256; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Carraway MS, 2003, AM J RESP CRIT CARE, V167, P1200, DOI 10.1164/rccm.200204-287OC; Chu AJ, 2005, ARCH BIOCHEM BIOPHYS, V440, P123, DOI 10.1016/j.abb.2005.06.005; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; DELPRETE G, 1995, BLOOD, V86, P250, DOI 10.1182/blood.V86.1.250.bloodjournal861250; Dhiman R, 2011, J IMMUNOL; DRAKE TA, 1989, J CELL BIOL, V109, P389, DOI 10.1083/jcb.109.1.389; DRAKE TA, 1993, AM J PATHOL, V142, P1458; El Fekih Leila, 2009, Tunis Med, V87, P328; Garcia-Perez BE, 2011, IMMUNOBIOLOGY, V216, P925, DOI 10.1016/j.imbio.2011.01.004; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Franco RF, 2000, BLOOD, V96, P554; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Garcia-Perez BE, 1970, UNDERSTANDING TUBERC; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Jung YJ, 2002, J EXP MED, V196, P991, DOI 10.1084/jem.20021186; Lang IM, 1996, HUM PATHOL, V27, P423, DOI 10.1016/S0046-8177(96)90118-5; LEATHAM EW, 1995, BRIT HEART J, V73, P10; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; LYBERG T, 1982, INFECT IMMUN, V38, P855, DOI 10.1128/IAI.38.3.855-859.1982; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Mehta PK, 2006, MICROB PATHOGENESIS, V41, P119, DOI 10.1016/j.micpath.2006.05.002; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; Moller ASW, 2001, THROMB RES, V102, P273, DOI 10.1016/S0049-3848(01)00248-1; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Osterud B, 1995, HYPERCOAG STS, P1; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P940, DOI 10.1161/01.ATV.17.5.940; Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RICKLES FR, 1973, J CLIN INVEST, V52, P1427, DOI 10.1172/JCI107316; Rindi L, 1999, BIOCHEM BIOPH RES CO, V258, P94, DOI 10.1006/bbrc.1999.0591; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; SCHEIBENBOGEN C, 1992, HAEMOSTASIS, V22, P173; SCHWAGER I, 1994, BLOOD, V83, P152, DOI 10.1182/blood.V83.1.152.bloodjournal831152; SELVARAJ P, 1994, EUR RESPIR J, V7, P1227, DOI 10.1183/09031936.94.07071227; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; STEIN DS, 1990, SOUTHERN MED J, V83, P60, DOI 10.1097/00007611-199001000-00019; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TANNENBAUM SH, 1986, J IMMUNOL, V137, P1532; Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200; Taylor F B Jr, 1994, New Horiz, V2, P555; Taylor FB, 1998, BLOOD, V91, P1609, DOI 10.1182/blood.V91.5.1609.1609_1609_1615; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; Turken O, 2002, INT J TUBERC LUNG D, V6, P927; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Wang JY, 2005, THROMB HAEMOSTASIS, V93, P729, DOI 10.1160/TH04-09-0562; Welty-wolf KE, 2000, AM J RESP CRIT CARE, V161, pA517; Williams Julie C, 2012, Front Biosci (Elite Ed), V4, P358; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	79	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45700	10.1371/journal.pone.0045700	http://dx.doi.org/10.1371/journal.pone.0045700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029190	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700059
J	Huff, DD; Lindley, ST; Wells, BK; Chai, F				Huff, David D.; Lindley, Steven T.; Wells, Brian K.; Chai, Fei			Green Sturgeon Distribution in the Pacific Ocean Estimated from Modeled Oceanographic Features and Migration Behavior	PLOS ONE			English	Article							ACIPENSER-MEDIROSTRIS; SPECIES DISTRIBUTIONS; TROPHIC DYNAMICS; PREDICTION; VARIABILITY; CALIFORNIA; HOTSPOTS; SYSTEM; RIVER; FIELD	The green sturgeon (Acipenser medirostris), which is found in the eastern Pacific Ocean from Baja California to the Bering Sea, tends to be highly migratory, moving long distances among estuaries, spawning rivers, and distant coastal regions. Factors that determine the oceanic distribution of green sturgeon are unclear, but broad-scale physical conditions interacting with migration behavior may play an important role. We estimated the distribution of green sturgeon by modeling species-environment relationships using oceanographic and migration behavior covariates with maximum entropy modeling (MaxEnt) of species geographic distributions. The primary concentration of green sturgeon was estimated from approximately 41-51.5 degrees N latitude in the coastal waters of Washington, Oregon, and Vancouver Island and in the vicinity of San Francisco and Monterey Bays from 36-37 degrees N latitude. Unsuitably cold water temperatures in the far north and energetic efficiencies associated with prevailing water currents may provide the best explanation for the range-wide marine distribution of green sturgeon. Independent trawl records, fisheries observer records, and tagging studies corroborated our findings. However, our model also delineated patchily distributed habitat south of Monterey Bay, though there are few records of green sturgeon from this region. Green sturgeon are likely influenced by countervailing pressures governing their dispersal. They are behaviorally directed to revisit natal freshwater spawning rivers and persistent overwintering grounds in coastal marine habitats, yet they are likely physiologically bounded by abiotic and biotic environmental features. Impacts of human activities on green sturgeon or their habitat in coastal waters, such as bottom-disturbing trawl fisheries, may be minimized through marine spatial planning that makes use of high-quality species distribution information.	[Huff, David D.; Lindley, Steven T.; Wells, Brian K.] Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA; [Huff, David D.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Chai, Fei] Univ Maine, Sch Marine Sci, Orono, ME USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; University of Maine System; University of Maine Orono	Huff, DD (corresponding author), Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA.	david.huff@noaa.gov	Lindley, Steven T/G-3997-2014; Huff, David/A-8166-2008	Lindley, Steven T/0000-0001-9556-0411; Huff, David/0000-0001-9061-7685	National Oceanic and Atmospheric Administration; California Current Integrated Ecosystem Assessment Program; Species of Concern Program; NASA Grant [NNX09AU39G]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); California Current Integrated Ecosystem Assessment Program; Species of Concern Program; NASA Grant(National Aeronautics & Space Administration (NASA))	The authors' research was supported by funds from the National Oceanic and Atmospheric Administration, California Current Integrated Ecosystem Assessment Program (http://www.st.nmfs.noaa.gov/iea/index.html), a Species of Concern Program (http://www.nmfs.noaa.gov/pr/species/concern/grant.htm) grant to S.T.L. and by NASA Grant number NNX09AU39G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Al-Humaidhi A. W., 2012, OBSERVED ESTIMATED T; Auad G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001987; Bellman M.A., 2010, OBSERVED ESTIMATED T; Bidigare RR, 2009, J PLANKTON RES, V31, P1131, DOI 10.1093/plankt/fbp064; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; BRINK KH, 1991, J GEOPHYS RES-OCEANS, V96, P14637, DOI 10.1029/91JC01206; BRINKHURST RO, 1991, CONT SHELF RES, V11, P737, DOI 10.1016/0278-4343(91)90077-J; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; Chai F, 2009, J OCEANOGR, V65, P703, DOI 10.1007/s10872-009-0061-5; Colway Christa, 2007, Northwestern Naturalist, V88, P188, DOI 10.1898/1051-1733(2007)88[188:CROTGS]2.0.CO;2; Commerce Do, 2008, END THREAT WILDL PLA, P52084; CRAWFORD WR, 1991, CONT SHELF RES, V11, P669, DOI 10.1016/0278-4343(91)90073-F; Cross Jeffrey N., 1993, P459; Dewees CM, 1984, CALIFORNIA COOPERATI, V25, P68; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Erickson DL, 2007, AM FISH S S, V56, P197; Erickson DL, 2007, ENVIRON BIOL FISH, V79, P255, DOI 10.1007/s10641-006-9072-x; Erickson DL, 2011, COMMUNICATION; Favorite F., 1976, INT N PACIFIC FISHER, V187; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hastie T., 2009, SPRINGER SERIES STAT, Vxxii; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; Huff DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025156; Huff DD, 2005, N AM J FISH MANAGE, V25, P346, DOI 10.1577/M03-231.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly JT, 2012, ENVIRON BIOL FISH, V93, P151, DOI 10.1007/s10641-011-9898-8; Klimley AP, 1985, BIOL WHITE SHARK, P15; Krige DG, 1967, J S AFR I MIN METALL, V67, P21; LARGE WG, 1982, J PHYS OCEANOGR, V12, P464, DOI 10.1175/1520-0485(1982)012<0464:SALHFM>2.0.CO;2; Levings C. D., 1980, FJORD OCEANOGRAPHY, P515; Lindley ST, 2008, T AM FISH SOC, V137, P182, DOI 10.1577/T07-055.1; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu G, 2009, ICES J MAR SCI, V66, P420, DOI 10.1093/icesjms/fsn219; Lucas B.G, 2007, ECOSYSTEM OVERVIEW P; Mayfield RB, 2004, T AM FISH SOC, V133, P961, DOI 10.1577/T02-144.1; McLain D.R., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P165; MCNAB BK, 2002, PHYSL ECOLOGY VERTEB, V27; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Mora EA, 2009, J APPL ICHTHYOL, V25, P39, DOI 10.1111/j.1439-0426.2009.01297.x; [National Oceanic and Atmospheric Administration Commerce Do], 2010, ENV ASS PROP APPL PR, V101; [National Oceanic and Atmospheric Administration Commerce Do], 2007, NOAA FISH NAM PAN EX; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Polovina JJ, 2008, PROG OCEANOGR, V77, P217, DOI 10.1016/j.pocean.2008.03.011; Ranasinghe JA, 2011, HABITAT RELATED BENT; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Rosales-Casian JA, 2009, CAL COOP OCEAN FISH, V50, P169; Scott JM, 2002, PREDICTING SPECIES O, Vxvii; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Stabeno PJ, 2001, FISH OCEANOGR, V10, P81, DOI 10.1046/j.1365-2419.2001.00157.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P519, DOI 10.1046/j.1439-0426.2002.00413.x; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Thomson R.E., 1981, CANADIAN SPECIAL PUB, P291; Ware D.M., 1989, CAN SPEC PUBL FISH A, V108, P359; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Xiu P., 2011, J GEOPHYS RES OCEANS, V116; Xiu P, 2012, DEEP-SEA RES PT I, V63, P102, DOI 10.1016/j.dsr.2012.01.006; Xiu P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005657; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang HM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027086	71	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45852	10.1371/journal.pone.0045852	http://dx.doi.org/10.1371/journal.pone.0045852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029274	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800105
J	Jacobson, D; Parker, A; Spetzler, C; de Bruin, WB; Hollenbeck, K; Heckerman, D; Fischhoff, B				Jacobson, David; Parker, Andrew; Spetzler, Chris; de Bruin, Wandi Bruine; Hollenbeck, Keith; Heckerman, David; Fischhoff, Baruch			Improved Learning in US History and Decision Competence with Decision-Focused Curriculum	PLOS ONE			English	Article							MAKING COMPETENCE; INDIVIDUAL-DIFFERENCES	Decision making is rarely taught in high school, even though improved decision skills could benefit young people facing life-shaping decisions. While decision competence has been shown to correlate with better life outcomes, few interventions designed to improve decision skills have been evaluated with rigorous quantitative measures. A randomized study showed that integrating decision making into U.S. history instruction improved students' history knowledge and decision-making competence, compared to traditional history instruction. Thus, integrating decision training enhanced academic performance and improved an important, general life skill associated with improved life outcomes.	[Spetzler, Chris; Heckerman, David] Decis Educ Fdn, Palo Alto, CA USA; [Jacobson, David] Springfield Sch Dist, Springfield, OR USA; [Parker, Andrew] RAND Corp, Pittsburgh, PA USA; [de Bruin, Wandi Bruine] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Hollenbeck, Keith] Univ Oregon, Coll Educ, Eugene, OR 97403 USA; [Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Fischhoff, Baruch] Carnegie Mellon Univ, Dept Engn & Publ Policy, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	RAND Corporation; Carnegie Mellon University; University of Oregon; Microsoft; Carnegie Mellon University	Heckerman, D (corresponding author), Decis Educ Fdn, Palo Alto, CA USA.	heckerma@microsoft.com	Bruine de Bruin, Wandi/N-8588-2018; Parker, Andrew M/B-2466-2009; Fischhoff, Baruch/I-9859-2014	Bruine de Bruin, Wandi/0000-0002-1601-789X; Parker, Andrew M/0000-0001-7511-0894; Fischhoff, Baruch/0000-0002-3030-6874	Decision Education	Decision Education	This study was conducted mostly through volunteer efforts. The exception was that one of the authors, CS, received salary from the Decision Education to work, in part, on this study. CS helped to design the study and helped to write the paper. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON J, 1991, TEACHING DECISION MA; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Deslauriers L, 2011, SCIENCE, V332, P862, DOI 10.1126/science.1201783; Fischhoff B, 2008, DEV REV, V28, P12, DOI 10.1016/j.dr.2007.08.001; Keelin T, 2008, DECISION QUALITY FUN; Parker AM, 2005, J BEHAV DECIS MAKING, V18, P1, DOI 10.1002/bdm.481; U.S. Department of Education, 2009, 2009 HIGH SCH TRANSC	7	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45775	10.1371/journal.pone.0045775	http://dx.doi.org/10.1371/journal.pone.0045775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029237	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800096
J	Pan, JC; Bahar, AA; Syed, H; Ren, DC				Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng			Reverting Antibiotic Tolerance of Pseudomonas aeruginosa PAO1 Persister Cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; INHIBITION; RESISTANCE; BACTERIA; ELEMENTS; TOXINS; GROWTH; RIDDLE; RNAS	Background: Bacteria are well known to form dormant persister cells that are tolerant to most antibiotics. Such intrinsic tolerance also facilitates the development of multidrug resistance through acquired mechanisms. Thus persister cells are a promising target for developing more effective methods to control chronic infections and help prevent the development of multidrug-resistant bacteria. However, control of persister cells is still an unmet challenge. Methodology/Principal Findings: We show in this report that (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one (BF8) can restore the antibiotic susceptibility of Pseudomonas aeruginosa PAO1 persister cells at growth non-inhibitory concentrations. Persister control by BF8 was found to be effective against both planktonic and biofilm cells of P. aeruginosa PAO1. Interestingly, although BF8 is an inhibitor of quorum sensing (QS) in Gram-negative bacteria, the data in this study suggest that the activities of BF8 to revert antibiotic tolerance of P. aeruginosa PAO1 persister cells is not through QS inhibition and may involve other targets. Conclusion: BF8 can sensitize P. aeruginosa persister cells to antibiotics.	[Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA; [Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY USA; [Ren, Dacheng] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Ren, Dacheng] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University; Syracuse University; Syracuse University; Syracuse University	Ren, DC (corresponding author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.	dren@syr.edu			U.S. National Science Foundation [CAREER-1055644, EFRI-1137186]	U.S. National Science Foundation(National Science Foundation (NSF))	The studies described in this work were supported by the U.S. National Science Foundation (CAREER-1055644 and EFRI-1137186, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Brazas MD, 2005, ANTIMICROB AGENTS CH, V49, P3222, DOI 10.1128/AAC.49.8.3222-3227.2005; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Duo M, 2010, APPL MICROBIOL BIOT, V85, P1551, DOI 10.1007/s00253-009-2174-6; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goodrich AF, 1999, RNA, V5, P972, DOI 10.1017/S1355838299990398; Han Y, 2008, BIOORG MED CHEM LETT, V18, P1006, DOI 10.1016/j.bmcl.2007.12.032; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hou S, 2009, INHIBITING MICROBIAL, P6; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Niepa THR, 2012, BIOMATERIALS, V33, P7356, DOI 10.1016/j.biomaterials.2012.06.092; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Pabdee AB, 1959, J MOL BIOL, V1, P156; Pan JC, 2009, EXPERT OPIN THER PAT, V19, P1581, DOI 10.1517/13543770903222293; Pearson H, 2002, NATURE, V418, P469, DOI 10.1038/418469b; Ren DC, 2001, ENVIRON MICROBIOL, V3, P731, DOI 10.1046/j.1462-2920.2001.00249.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; TAYLOR PC, 1983, ANTIMICROB AGENTS CH, V23, P142, DOI 10.1128/AAC.23.1.142; Wang R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00144	43	50	51	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45778	10.1371/journal.pone.0045778	http://dx.doi.org/10.1371/journal.pone.0045778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029239	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900099
J	Wang, O; Wang, CY; Nie, M; Cui, QC; Guan, H; Jiang, Y; Li, M; Xia, WB; Meng, XW; Xing, XP				Wang, Ou; Wang, Chunyan; Nie, Min; Cui, Quancai; Guan, Heng; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping			Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas	PLOS ONE			English	Article							JAW TUMOR SYNDROME; HRPT2 GENE; HUMAN PAF1; HPT-JT; HYPERPARATHYROIDISM; DIAGNOSIS; ADENOMAS; PROTEIN; CANCER	Objective: It is widely recognized that the diagnosis of parathyroid carcinoma (PC) is often difficult because of the overlap of characteristics between malignant and benign parathyroid tumors, especially at an early stage. Based on the identification of tumor suppressor gene HRPT2/CDC73 and its association with hereditary and sporadic PC, screening of gene mutations and detection of parafibromin immunoreactivity have been suggested as diagnostic instruments of PC in Whites. There is little information about HRPT2/CDC73 mutations and its corresponding protein expression in patients with sporadic PC in Chinese population, and the long-term follow-up data is scarce. Methods: Paraffin-embedded tissues were obtained from 13 patients with PC, 13 patients with parathyroid adenoma (PA) and 7 patients with parathyroid hyperplasia(PH), and 6 normal parathyroid (NP) tissues as controls. Peripheral blood from 11 patients with PC was collected. PCR products using Genomic DNA extracted from tumor tissues or blood as template was sequenced for HRPT2/CDC73 gene. Expression of parafibromin in tumor tissues was evaluated by immunohistochemical analysis. Results: Six mutations in 6 of 13 patients with PC were identified, with three being novel. Four of them were germ-line mutations. Patients with mutations were susceptible to recurrence of the PC. Complete (8/13, 61.5%) or partial (5/13, 38.5%) loss of parafibromin expression was observed in PC tissues. All of tissue samples from normal parathyroid or benign parathyroid tumors displayed positive immunostaining of parafibromin except one adenoma. Conclusions: The present study supplies information on the mutations and protein expression of HRPT2/CDC73 gene and phenotypes of parathyroid carcinoma in Chinese population. And the expanded mutation database of this gene may benefit patients in the diagnosis and treatment of this disease.	[Wang, Ou; Wang, Chunyan; Nie, Min; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China; [Cui, Quancai] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Guan, Heng] Chinese Acad Med Sci, Dept Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xing, XP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrinol,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China.	xingxp2006@126.com			Project of National Natural Science Foundation of China [81100559]; Department of Pathology and Surgery	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Pathology and Surgery	This study was partially supported by grants from the Project of National Natural Science Foundation of China (81100559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We thank all subjects for their participation in the research. We are grateful to the support from the Department of Pathology and Surgery.	Bringhurst F, 2003, WILLIAMS TXB ENDOCRI, V10th, P1303; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Cetani F, 2007, EUR J ENDOCRINOL, V156, P547, DOI 10.1530/EJE-06-0720; DeLellis RA, 2005, ADV ANAT PATHOL, V12, P53, DOI 10.1097/01.pap.0000151319.42376.d4; Favia G, 1998, WORLD J SURG, V22, P1225, DOI 10.1007/s002689900549; Fernandez-Ranvier GG, 2009, CANCER-AM CANCER SOC, V115, P334, DOI 10.1002/cncr.24037; Frank-Raue K, 2011, EUR J ENDOCRINOL, V165, P477, DOI 10.1530/EJE-11-0003; Gill AJ, 2006, AM J SURG PATHOL, V30, P1140; Guarnieri V, 2006, J CLIN ENDOCR METAB, V91, P2827, DOI 10.1210/jc.2005-1239; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Hewitt KM, 2007, ANN OTO RHINOL LARYN, V116, P928, DOI 10.1177/000348940711601210; Howell VM, 2003, J MED GENET, V40, P657, DOI 10.1136/jmg.40.9.657; Juhlin CC, 2007, ENDOCR-RELAT CANCER, V14, P501, DOI 10.1677/ERC-07-0021; Juhlin CC, 2011, VIRCHOWS ARCH, V459, P47, DOI 10.1007/s00428-010-1032-3; Juhlin CC, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/324964; Krebs LJ, 2005, J CLIN ENDOCR METAB, V90, P5015, DOI 10.1210/jc.2005-0717; Marx SJ, 2002, J BONE MINER RES, V17, pN37; Newey PJ, 2010, HUM MUTAT, V31, P295, DOI 10.1002/humu.21188; Rodgers SE, 2006, CURR OPIN ONCOL, V18, P16, DOI 10.1097/01.cco.0000198019.53606.2b; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Sharretts JM, 2010, SEMIN ONCOL, V37, P580, DOI 10.1053/j.seminoncol.2010.10.013; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; [王鸥 Wang Ou], 2006, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V26, P1798; Witteveen JE, 2011, MODERN PATHOL, V24, P688, DOI 10.1038/modpathol.2010.236; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005	28	36	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45567	10.1371/journal.pone.0045567	http://dx.doi.org/10.1371/journal.pone.0045567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029104	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900076
J	Roberts, IN; Lam, XT; Miranda, H; Kieselbach, T; Funk, C				Roberts, Irma N.; Lam, Xuan Tam; Miranda, Helder; Kieselbach, Thomas; Funk, Christiane			Degradation of PsbO by the Deg Protease HhoA Is Thioredoxin Dependent	PLOS ONE			English	Article							MANGANESE-STABILIZING PROTEIN; SYNECHOCYSTIS-SP PCC-6803; OXYGEN-EVOLVING COMPLEX; II REACTION-CENTER; CHLOROPLAST THYLAKOID LUMEN; SP STRAIN PCC-6803; PHOTOSYSTEM-II; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; DISULFIDE BOND	The widely distributed members of the Deg/HtrA protease family play an important role in the proteolysis of misfolded and damaged proteins. Here we show that the Deg protease rHhoA is able to degrade PsbO, the extrinsic protein of the Photosystem II (PSII) oxygenq-evolving complex in Synechocystis sp. PCC 6803 and in spinach. PsbO is known to be stable in its oxidized form, but after reduction by thioredoxin it became a substrate for recombinant HhoA (rHhoA). rHhoA cleaved reduced eukaryotic (specifically, spinach) PsbO at defined sites and created distinct PsbO fragments that were not further degraded. As for the corresponding prokaryotic substrate (reduced PsbO of Synechocystis sp. PCC 6803), no PsbO fragments were observed. Assembly to PSII protected PsbO from degradation. For Synechocystis sp. PCC 6803, our results show that HhoA, HhoB, and HtrA are localized in the periplasma and/or at the thylakoid membrane. In agreement with the idea that PsbO could be a physiological substrate for Deg proteases, part of the cellular fraction of the three Deg proteases of Synechocystis sp. PCC 6803 (HhoA, HhoB, and HtrA) was detected in the PSIIq-enriched membrane fraction.	[Funk, Christiane] Umea Univ, Dept Chem, Umea, Sweden; Umea Univ, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Funk, C (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	Christiane.Funk@chem.umu.se	Kieselbach, Thomas/O-6023-2015; Funk, Christiane/AAO-6041-2021	Kieselbach, Thomas/0000-0001-5577-2938; Funk, Christiane/0000-0002-7897-4038; Roberts, Irma/0000-0003-4896-7782	Swedish Energy Agency [2009-000928]; Royal Swedish Academy of Sciences [312-3820-06]; Lawsky Foundation; Umea University	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Royal Swedish Academy of Sciences; Lawsky Foundation; Umea University	This work was supported by grants of the Swedish Energy Agency (2009-000928 to CF), the Royal Swedish Academy of Sciences (312-3820-06 to CF), the Lawsky Foundation (to XTL) and Umea University (to CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLANO JB, 1994, PHYSIOL PLANTARUM, V91, P369, DOI 10.1111/j.1399-3054.1994.tb02962.x; Balmer Y, 2006, ANTIOXID REDOX SIGN, V8, P1829, DOI 10.1089/ars.2006.8.1829; Barker M, 2006, J BIOL CHEM, V281, P30347, DOI 10.1074/jbc.M601064200; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betts SD, 1996, BBA-BIOENERGETICS, V1274, P135, DOI 10.1016/0005-2728(96)00023-0; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BURNAP RL, 1994, BIOCHEMISTRY-US, V33, P13712, DOI 10.1021/bi00250a023; Chassin Y, 2002, PLANT PHYSIOL, V130, P857, DOI 10.1104/pp.007922; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; De Las Rivas J, 2004, PHOTOSYNTH RES, V81, P329, DOI 10.1023/B:PRES.0000036889.44048.e4; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; ETTINGER WF, 1991, J CELL BIOL, V115, P321, DOI 10.1083/jcb.115.2.321; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Funk C, 2001, FAMILY DEG HTR PROTE, pS8; GORLACH J, 1993, PLANT CELL PHYSIOL, V34, P497; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hall M, 2010, PROTEOMICS, V10, P987, DOI 10.1002/pmic.200900654; Hashimoto A, 1996, FEBS LETT, V391, P29; Hauske P, 2009, MOL BIOSYST, V5, P980, DOI 10.1039/b902089f; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2007, J BACTERIOL, V189, P6611, DOI 10.1128/JB.00883-07; Huesgen PF, 2011, BIOCHEM J, V435, P733, DOI 10.1042/BJ20102131; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; IRRGANG KD, 1995, J BIOL CHEM, V270, P17588, DOI 10.1074/jbc.270.29.17588; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Kaneko T, 1996, DNA Res, V3, P109; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kieselbach T, 2003, PHYSIOL PLANTARUM, V119, P337, DOI 10.1034/j.1399-3054.2003.00199.x; Kieselbach T, 1998, J BIOL CHEM, V273, P6710, DOI 10.1074/jbc.273.12.6710; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2010, CHINESE SCI BULL, V55, P3145, DOI 10.1007/s11434-010-4042-2; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; Lu YK, 2005, PLANT CELL PHYSIOL, V46, P1944, DOI 10.1093/pcp/pci209; Lundin B, 2007, BBA-BIOENERGETICS, V1767, P500, DOI 10.1016/j.bbabio.2006.10.009; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P404, DOI 10.1021/bi981847z; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Marchand C, 2006, PROTEOMICS, V6, P6528, DOI 10.1002/pmic.200600443; Mata-Cabana A, 2007, PROTEOMICS, V7, P3953, DOI 10.1002/pmic.200700410; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; Nikitina J, 2008, PHOTOSYNTH RES, V98, P391, DOI 10.1007/s11120-008-9327-9; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk M, 2004, PHYS CHEM CHEM PHYS, V6, P4878, DOI 10.1039/b407316a; PALOMARES R, 1993, EUR J BIOCHEM, V217, P345, DOI 10.1111/j.1432-1033.1993.tb18252.x; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Popelkova H, 2003, PHOTOSYNTH RES, V77, P21, DOI 10.1023/A:1024970926655; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Shutova T, 2005, BIOCHEMISTRY-US, V44, P15182, DOI 10.1021/bi0512750; Silva P, 2002, PHILOS T R SOC B, V357, P1461, DOI 10.1098/rstb.2002.1146; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Spence E, 2003, MOL MICROBIOL, V48, P1481, DOI 10.1046/j.1365-2958.2003.03519.x; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Stroher E, 2008, PHYSIOL PLANTARUM, V133, P566, DOI 10.1111/j.1399-3054.2008.01103.x; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Sun XW, 2010, PLANT PHYSIOL, V152, P1263, DOI 10.1104/pp.109.150722; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; TANAKA S, 1989, BIOCHEMISTRY-US, V28, P7188, DOI 10.1021/bi00444a009; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; WALES R, 1989, PLANT MOL BIOL, V12, P439, DOI 10.1007/BF00017583; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wong JH, 2004, PHYTOCHEMISTRY, V65, P1629, DOI 10.1016/j.phytochem.2004.05.010; Wyman AJ, 2005, PHOTOSYNTH RES, V85, P359, DOI 10.1007/s11120-005-7385-9; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	81	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45713	10.1371/journal.pone.0045713	http://dx.doi.org/10.1371/journal.pone.0045713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029195	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400123
J	Chen, HM; Zheng, CX; Gao, Q; Ge, YC; Liu, ZH				Chen, Hui-Mei; Zheng, Chun-Xia; Gao, Qing; Ge, Yong-Chun; Liu, Zhi-Hong			Heart-Type Fatty Acid Binding Protein Is Associated with Proteinuria in Obesity	PLOS ONE			English	Article							RENAL LIPID-METABOLISM; DIABETIC-NEPHROPATHY; GLOMERULOPATHY; INSIGHTS; INJURY; MICE; GLOMERULOSCLEROSIS; HYPERTENSION; ALBUMINURIA; DAMAGE	Rationale: Lipid metabolism contributes to the formation of obesity-related glomerulopathy (ORG). Heart-type fatty acid binding protein (H-FABP or FABP3) is involved in lipid metabolism and was predicted to relate to renal lesions in obesity. Methods: A total of 28 patients with ORG were investigated, and renal tissue from 7 kidney donors served as controls. Db/db mice with albuminuria were treated with Simvastatin for 12 weeks. Results: Immunohistochemistry demonstrated the H-FABP staining in glomerular and tubular areas of patients with ORG, and the percentage of H-FABP in the glomerular area was significantly higher than in controls (15.8 +/- 1.62 versus 4.51 +/- 0.56%, P<0.001). Moreover, H-FABP expression correlated with proteinuria, high-density lipoprotein (HDL) cholesterol, waist circumference and the homeostatic model assessment-insulin resistance (HOMA-IR) among patients with ORG. Enhanced expression of H-FABP was also detected in the db/db mice, and expression increased from 8 to 20 weeks of age and was weakly related to increased albuminuria (r = 0.433; P = 0.020). Furthermore, H-FABP was co-localized with synaptopodin and demonstrated a podocyte pattern distribution. After Simvastation treatment, the urine albumin levels decreased with lipid levels and H-FABP expression in the glomeruli. The expression of H-FABP was related to Simvastatin treatment, albuminuria and triglycerides, while it was only linked with triglycerides and albuminuria (r = 0.643, P = 0.036). Conclusions: This study confirmed an association of H-FABP with the pathogenesis of clinical and experimental ORG, and suggests that such a process might be related to podocytes and lipid dysmetabolism.	[Chen, Hui-Mei; Zheng, Chun-Xia; Gao, Qing; Ge, Yong-Chun; Liu, Zhi-Hong] Nanjing Univ, Res Inst Nephrol, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing University	Chen, HM (corresponding author), Nanjing Univ, Res Inst Nephrol, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	chenhuimei@nju.edu.cn; zhihong-liu@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726; Chen, Huimei/0000-0001-7788-1334	National Natural Science Foundation of China [30800546, 81070579]; Doctoral Foundation of Education Ministry of China [200802841008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Education Ministry of China	This work was supported by the National Natural Science Foundation of China (grant number: 30800546, 81070579) and the Doctoral Foundation of Education Ministry of China (grant number: 200802841008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco S, 2005, AM J HYPERTENS, V18, P557, DOI 10.1016/j.amjhyper.2004.10.034; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; Chen HM, 2011, J RENAL NUTR, V21, P309, DOI 10.1053/j.jrn.2010.06.019; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kimura H, 1999, KIDNEY INT, V56, pS159; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Mayrhofer C, 2009, AM J PATHOL, V174, P1191, DOI 10.2353/ajpath.2009.080654; Negishi K, 2007, KIDNEY INT, V72, P348, DOI 10.1038/sj.ki.5002304; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Praga M, 2001, NEPHROL DIAL TRANSPL, V16, P1790, DOI 10.1093/ndt/16.9.1790; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Raz I, 2011, DIABETES CARE, V34, pS99, DOI 10.2337/dc11-s201; Sharma K, 2009, KIDNEY INT, V76, P145, DOI 10.1038/ki.2009.137; Sheridan AM, 1996, KIDNEY INT, V49, P88, DOI 10.1038/ki.1996.12; Stieger N, 2011, DIABETES-METAB RES, V27, P207, DOI 10.1002/dmrr.1164; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Tran HA, 2004, J CLIN ENDOCR METAB, V89, P6358, DOI 10.1210/jc.2004-1174; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	28	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45691	10.1371/journal.pone.0045691	http://dx.doi.org/10.1371/journal.pone.0045691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029183	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900168
J	Janvilisri, T; Scaria, J; Teng, CH; McDonough, SP; Gleed, RD; Fubini, SL; Zhang, S; Akey, B; Chang, YF				Janvilisri, Tavan; Scaria, Joy; Teng, Ching-Hao; McDonough, Sean P.; Gleed, Robin D.; Fubini, Susan L.; Zhang, Sheng; Akey, Bruce; Chang, Yung-Fu			Temporal Differential Proteomes of Clostridium difficile in the Pig Ileal-Ligated Loop Model	PLOS ONE			English	Article							INTESTINAL SMOOTH-MUSCLE; GRAM-POSITIVE BACTERIA; TOXIN GENE-EXPRESSION; STATIONARY-PHASE; PROTEINS; INFECTION; VIRULENCE; STRAINS; GENOME; METABOLISM	The impact of Clostridium difficile infection (CDI) on healthcare is becoming increasingly recognized as it represents a major cause of nosocomial diarrhea. A rising number of CDI cases and outbreaks have been reported worldwide. Here, we developed the pig ileal-ligated loop model for semi-quantitative analysis comparing temporal differential proteomes in C. difficile following in vivo incubation with in vitro growth using isobaric tags for relative and absolute quantification (iTRAQ). Proteins retrieved from the in vitro cultures and the loop contents after 4, 8, and 12 h in vivo incubation were subjected to in-solution digestion, iTRAQ labeling, two-dimensional liquid chromatography/tandem mass spectrometry and statistical analyses. From a total of 1152 distinct proteins identified in this study, 705 proteins were available for quantitative measures at all time points in both biological and technical replicates; 109 proteins were found to be differentially expressed. With analysis of clusters of orthologous group and protein-protein network interactions, we identified the proteins that might play roles in adaptive responses to the host environment, hence enhancing pathogenicity during CDI. This report represents the quantitative proteomic analysis of C. difficile that demonstrates time-dependent protein expression changes under conditions that mimic in vivo infection and identifies potential candidates for diagnostic or therapeutic measures.	[Janvilisri, Tavan; Scaria, Joy; Akey, Bruce; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Janvilisri, Tavan] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Teng, Ching-Hao] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Gleed, Robin D.; Fubini, Susan L.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Zhang, Sheng] Cornell Univ, Prote & Mass Spectrometry Core Facil, Ithaca, NY 14853 USA	Cornell University; Mahidol University; National Cheng Kung University; Cornell University; Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu	Janvilisri, Tavan/C-8391-2015; Janvilisri, Tavan/O-6679-2019	Janvilisri, Tavan/0000-0002-6376-5575; Janvilisri, Tavan/0000-0002-6376-5575; Scaria, Joy/0000-0002-5299-8074	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30054, ZC005-06, ZC008-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030054] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract, N01-AI-30054, Project No. ZC005-06 and ZC008-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Gerding DN, 2009, INT J ANTIMICROB AG, V33, pS2, DOI 10.1016/S0924-8579(09)70008-1; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; GILBERT RJ, 1989, AM J PHYSIOL, V256, pG759, DOI 10.1152/ajpgi.1989.256.4.G759; GILBERT RJ, 1989, AM J PHYSIOL, V256, pG767, DOI 10.1152/ajpgi.1989.256.4.G767; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; Kelly CP, 1998, ANNU REV MED, V49, P375; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lindahl M, 2011, ANTIOXID REDOX SIGN, V14, P2581, DOI 10.1089/ars.2010.3551; Lopez JL, 2007, J CHROMATOGR B, V849, P190, DOI 10.1016/j.jchromb.2006.11.049; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Melanson JE, 2006, PROTEOMICS, V6, P4466, DOI 10.1002/pmic.200600112; Moliere N, 2009, RES MICROBIOL, V160, P637, DOI 10.1016/j.resmic.2009.08.020; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; ODOM JM, 1984, ANNU REV MICROBIOL, V38, P551, DOI 10.1146/annurev.mi.38.100184.003003; Phillips CI, 2005, CELL MICROBIOL, V7, P1061, DOI 10.1111/j.1462-5822.2005.00554.x; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Scaria J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015147; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TRIADAFILOPOULOS G, 1987, GASTROENTEROLOGY, V93, P273, DOI 10.1016/0016-5085(87)91014-6; Vollmer AC, 2004, ADV MICROB PHYSIOL, V49, P131, DOI 10.1016/S0065-2911(04)49003-1; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	48	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45608	10.1371/journal.pone.0045608	http://dx.doi.org/10.1371/journal.pone.0045608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029131	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900162
J	Yang, FY; Wang, HE; Liu, RS; Teng, MC; Li, JJ; Lu, M; Wei, MC; Wong, TT				Yang, Feng-Yi; Wang, Hsin-Ell; Liu, Ren-Shyan; Teng, Ming-Che; Li, Jia-Je; Lu, Maggie; Wei, Ming-Cheng; Wong, Tai-Tong			Pharmacokinetic Analysis of In-111-Labeled Liposomal Doxorubicin in Murine Glioblastoma after Blood-Brain Barrier Disruption by Focused Ultrasound	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; INTERLEUKIN-4 IL-4 RECEPTORS; ANTIBACTERIAL ACTIVITY; THERAPEUTIC-EFFICACY; CANCER; MODEL; CARCINOMA; XENOGRAFT; DELIVERY; INVITRO	The goal of this study was to evaluate the pharmacokinetics of targeted and untargeted In-111-doxorubicin liposomes after these have been intravenously administrated to tumor-bearing mice in the presence of blood-brain barrier disruption (BBB-D) induced by focused ultrasound (FUS). An intracranial brain tumor model in NOD-scid mice using human brain glioblastoma multiforme (GBM) 8401 cells was developed in this study. In-111-labeled human atherosclerotic plaque-specific peptide-1 (AP-1)-conjugated liposomes containing doxorubicin (Lipo-Dox; AP-1 Lipo-Dox) were used as a microSPECT probe for radioactivity measurements in the GBM-bearing mice. Compared to the control tumors treated with an injection of In-111-AP-1 Lipo-Dox or In-111-Lipo-Dox, the animals receiving the drugs followed by FUS exhibited enhanced accumulation of the drug in the brain tumors (p<0.05). Combining sonication with drugs significantly increased the tumor-to-normal brain doxorubicin ratio of the target tumors compared to the control tumors. The tumor-to-normal brain ratio was highest after the injection of In-111-AP-1 Lipo-Dox with sonication. The In-111-liposomes micro-SPECT/CT should be able to provide important information about the optimum therapeutic window for the chemotherapy of brain tumors using sonication.	[Yang, Feng-Yi; Wang, Hsin-Ell; Teng, Ming-Che; Li, Jia-Je] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Liu, Ren-Shyan] Natl Yang Ming Univ, Sch Med, Taipei Vet Gen Hosp, Dept Nucl Med, Taipei 112, Taiwan; [Lu, Maggie; Wei, Ming-Cheng] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Drug Delivery Lab, Hsinchu, Taiwan; [Wong, Tai-Tong] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Industrial Technology Research Institute - Taiwan; Taipei Veterans General Hospital	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw		Wong, Tai-Tong/0000-0003-4075-6227	National Science Council of Taiwan [NSC 100-2321-B-010-010, NSC 99-2321-B-010-017]; Department of Health of Taiwan [DOH101-TD-PB-111-TM012, DOH101-TD-C-111-007]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST100-G1-3-3]; Yen Tjing Ling Medical Foundation [CI-100-17]; Cheng Hsin General Hospital Foundation [100F117CY25]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health of Taiwan; Veterans General Hospitals University System of Taiwan Joint Research Program; Yen Tjing Ling Medical Foundation; Cheng Hsin General Hospital Foundation	This study was supported by grants from the National Science Council of Taiwan (no. NSC 100-2321-B-010-010 and NSC 99-2321-B-010-017), Department of Health of Taiwan (DOH101-TD-PB-111-TM012 and DOH101-TD-C-111-007), Veterans General Hospitals University System of Taiwan Joint Research Program (# VGHUST100-G1-3-3), Yen Tjing Ling Medical Foundation (grant CI-100-17), and Cheng Hsin General Hospital Foundation (no. 100F117CY25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKERWOUDENBERG IAJM, 1989, J PHARMACOL EXP THER, V251, P321; Black Keith L, 2004, Cancer Control, V11, P165; BOERMAN OC, 1995, J NUCL MED, V36, P1639; Chow TH, 2008, NUCL MED BIOL, V35, P623, DOI 10.1016/j.nucmedbio.2008.04.001; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; DEEN DF, 1993, J NEURO-ONCOL, V16, P243, DOI 10.1007/BF01057041; FARBER E, 1991, CANCER RES, V51, P2751; Frenkel V, 2000, ULTRASOUND MED BIOL, V26, P473, DOI 10.1016/S0301-5629(99)00164-7; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Husain SR, 1998, CANCER RES, V58, P3649; Joshi BH, 2001, CANCER RES, V61, P8058; LEE WH, 1988, J SURG ONCOL, V38, P173, DOI 10.1002/jso.2930380309; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Messerer CL, 2004, CLIN CANCER RES, V10, P6638, DOI 10.1158/1078-0432.CCR-04-0221; NACUCCHIO MC, 1988, J MICROENCAPSUL, V5, P303, DOI 10.3109/02652048809036726; OLSON RD, 1990, FASEB J, V4, P3076, DOI 10.1096/fasebj.4.13.2210154; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Pardridge William M, 2005, NeuroRx, V2, P3; PURI RK, 1994, INT J CANCER, V58, P574, DOI 10.1002/ijc.2910580421; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; van Rooy I, 2011, J CONTROL RELEASE, V150, P30, DOI 10.1016/j.jconrel.2010.11.014; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2010, J MAGN RESON IMAGING, V32, P593, DOI 10.1002/jmri.22297; Yang FY, 2009, J ACOUST SOC AM, V126, P3344, DOI 10.1121/1.3242376; Yuh EL, 2005, RADIOLOGY, V234, P431, DOI 10.1148/radiol.2342030889	28	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45468	10.1371/journal.pone.0045468	http://dx.doi.org/10.1371/journal.pone.0045468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029030	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900141
J	Hayashi, T; Yao, SY; Crain, B; Chan, M; Tawatao, RI; Gray, C; Vuong, L; Lao, F; Cottam, HB; Carson, DA; Corr, M				Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Chan, Michael; Tawatao, Rommel I.; Gray, Christine; Vuong, Linda; Lao, Fitzgerald; Cottam, Howard B.; Carson, Dennis A.; Corr, Maripat			Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN DENDRITIC CELLS; MULTIPLE-SCLEROSIS; AGONIST 852A; IFN-GAMMA; T-CELLS; RESPONSES; ENCEPHALOMYELITIS; PROLIFERATION; DEMYELINATION	The Toll-like receptors (TLR) have been advocated as attractive therapeutic targets because TLR signaling plays dual roles in initiating adaptive immune responses and perpetuating inflammation. Paradoxically, repeated stimulation of bone marrow mononuclear cells with a synthetic TLR7 ligand 9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (called 1V136) leads to subsequent TLR hyporesponsiveness. Further studies on the mechanism of action of this pharmacologic agent demonstrated that the TLR7 ligand treatment depressed dendritic cell activation, but did not directly affect T cell function. To verify this mechanism, we utilized experimental allergic encephalitis (EAE) as an in vivo T cell dependent autoimmune model. Drug treated SJL/J mice immunized with proteolipid protein (PLP)(139-151) peptide had attenuated disease severity, reduced accumulation of mononuclear cells in the central nervous system (CNS), and limited demyelination, without any apparent systemic toxicity. Splenic T cells from treated mice produced less cytokines upon antigenic rechallenge. In the spinal cords of 1V136-treated EAE mice, the expression of chemoattractants was also reduced, suggesting innate immune cell hyposensitization in the CNS. Indeed, systemic 1V136 did penetrate the CNS. These experiments indicated that repeated doses of a TLR7 ligand may desensitize dendritic cells in lymphoid organs, leading to diminished T cell responses. This treatment strategy might be a new modality to treat T cell mediated autoimmune diseases.	[Corr, Maripat] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Chan, Michael; Tawatao, Rommel I.; Gray, Christine; Vuong, Linda; Lao, Fitzgerald; Cottam, Howard B.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Corr, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mcorr@ucsd.edu		Vuong, Linda/0000-0001-5253-3712	Telormedix (Bioggio, Switzerland); Arthritis Foundation; United States National Institutes of Health [CA23100, HHSN272200900034C]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER	Telormedix (Bioggio, Switzerland); Arthritis Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from Telormedix (Bioggio, Switzerland), the Arthritis Foundation (MC) and by CA23100 and HHSN272200900034C (DAC) from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chan M, 2011, BIOCONJUGATE CHEM, V22, P445, DOI 10.1021/bc1004813; Chan M, 2009, BIOCONJUGATE CHEM, V20, P1194, DOI 10.1021/bc900054q; Chang YC, 2005, SOUTH MED J, V98, P914, DOI 10.1097/01.SMJ.0000176712.01491.98; Craft N, 2005, J IMMUNOL, V175, P1983, DOI 10.4049/jimmunol.175.3.1983; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; Dumitru CD, 2009, CANCER IMMUNOL IMMUN, V58, P575, DOI 10.1007/s00262-008-0581-7; Dummer R, 2008, CLIN CANCER RES, V14, P856, DOI 10.1158/1078-0432.CCR-07-1938; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fleming CJ, 2004, BRIT J DERMATOL, V151, P485, DOI 10.1111/j.1365-2133.2004.05983.x; Forward NA, 2010, J LEUKOCYTE BIOL, V87, P117, DOI 10.1189/jlb.0908559; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; Hayashi T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/262394; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; Inglefield JR, 2008, J INTERF CYTOK RES, V28, P253, DOI 10.1089/jir.2007.0097; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Merson TD, 2010, NEUROMOL MED, V12, P99, DOI 10.1007/s12017-010-8112-z; Milo R, 2011, J NEUROIMMUNOL, V231, P23, DOI 10.1016/j.jneuroim.2010.10.021; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Purdon CH, 2004, CRIT REV THER DRUG, V21, P97, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i2.20; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	47	18	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45860	10.1371/journal.pone.0045860	http://dx.doi.org/10.1371/journal.pone.0045860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029281	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900059
J	Mitra, A; Fay, PA; Morgan, JK; Vendura, KW; Versaggi, SL; Riordan, JT				Mitra, Avishek; Fay, Pamela A.; Morgan, Jason K.; Vendura, Khoury W.; Versaggi, Salvatore L.; Riordan, James T.			Sigma Factor N, Liaison to an ntrC and rpoS Dependent Regulatory Pathway Controlling Acid Resistance and the LEE in Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT LEE; O-ANTIGEN-EXPRESSION; RNA-POLYMERASE; PROTEIN SECRETION; SALMONELLA-TYPHIMURIUM; PATHOGENICITY ISLAND; BORRELIA-BURGDORFERI; INTRACELLULAR LEVELS; 2-COMPONENT SYSTEM; SUBUNIT SYNTHESIS	Enterohemorrhagic Escherichia coli (EHEC) is dependent on acid resistance for gastric passage and low oral infectious dose, and the locus of enterocyte effacement (LEE) for intestinal colonization. Mutation of rpoN, encoding sigma factor N (sigma(N)), dramatically alters the growth-phase dependent regulation of both acid resistance and the LEE. This study reports on the determinants of sigma(N)-directed acid resistance and LEE expression, and the underlying mechanism attributable to this phenotype. Glutamate-dependent acid resistance (GDAR) in TW14359 Delta rpoN correlated with increased expression of the gadX-gadW regulatory circuit during exponential growth, whereas upregulation of arginine-dependent acid resistance (ADAR) genes adiA and adiC in TW14359 Delta rpoN did not confer acid resistance by the ADAR mechanism. LEE regulatory (ler), structural (espA and cesT) and effector (tir) genes were downregulated in TW14359 Delta rpoN, and mutation of rpoS encoding sigma factor 38 (sigma(S)) in TW14359 Delta rpoN restored acid resistance and LEE genes to WT levels. Stability, but not the absolute level, of sigma(S) was increased in TW14359 Delta rpoN; however, increased stability was not solely attributable to the GDAR and LEE expression phenotype. Complementation of TW14359 Delta rpoN with a sigma(N) allele that binds RNA polymerase (RNAP) but not DNA, did not restore WT levels of S-sigma stability, gadE, ler or GDAR, indicating a dependence on transcription from a sigma(N) promoter(s) and not RNAP competition for the phenotype. Among a library of sigma(N) enhancer binding protein mutants, only TW14359 Delta ntrC, inactivated for nitrogen regulatory protein NtrC, phenocopied TW14359 Delta rpoN for sigma(S) stability, GDAR and ler expression. The results of this study suggest that during exponential growth, NtrC-sigma(N) regulate GDAR and LEE expression through downregulation of s S at the post-translational level; likely by altering sigma(S) stability or activity. The regulatory interplay between NtrC, other EBPs, and sigma(N)-sigma(S), represents a mechanism by which EHEC can coordinate GDAR, LEE expression and other cellular functions, with nitrogen availability and physiologic stimuli.	[Mitra, Avishek; Fay, Pamela A.; Morgan, Jason K.; Vendura, Khoury W.; Versaggi, Salvatore L.; Riordan, James T.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Riordan, JT (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA.	jtriordan@usf.edu	Mitra, Avishek/AAA-5628-2021	Mitra, Avishek/0000-0003-0243-2045	University of South Florida	University of South Florida	This research was supported by intramural start-up funds from the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe P, 1997, INFECT IMMUN, V65, P3547, DOI 10.1128/IAI.65.9.3547-3555.1997; Baik HS, 1996, MICROBIOL-SGM, V142, P3195, DOI 10.1099/13500872-142-11-3195; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Belik A S, 2008, Mol Gen Mikrobiol Virusol, P3; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bittner M, 2004, MICROB PATHOGENESIS, V36, P19, DOI 10.1016/j.micpath.2003.08.003; Bittner M, 2002, MICROBIOL-SGM, V148, P3789, DOI 10.1099/00221287-148-12-3789; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; BOHANNON DE, 1991, J BACTERIOL, V173, P4482, DOI 10.1128/JB.173.14.4482-4492.1991; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chart H, 2000, J APPL MICROBIOL, V88, p12S, DOI 10.1111/j.1365-2672.2000.tb05328.x; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gong SM, 2004, MOL MICROBIOL, V54, P948, DOI 10.1111/j.1365-2958.2004.04312.x; Hartland EL, 1999, MOL MICROBIOL, V32, P151, DOI 10.1046/j.1365-2958.1999.01338.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; HENGGEARONIS R, 1992, MOL MICROBIOL, V6, P1877, DOI 10.1111/j.1365-2958.1992.tb01360.x; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Ishihama A, 1990, Adv Biophys, V26, P19, DOI 10.1016/0065-227X(90)90005-E; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Joslin SN, 2008, J BACTERIOL, V190, P2422, DOI 10.1128/JB.01827-07; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kwon YM, 1998, APPL ENVIRON MICROB, V64, P3458; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Mead P, 1998, INT C EM INF DIS ATL; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller JH., 1972, EXPT MOL GENETICS; MORTON HJ, 1970, IN VITRO CELL DEV B, V6, P89; Muffler A, 1996, J BACTERIOL, V178, P1607, DOI 10.1128/jb.178.6.1607-1613.1996; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Paesold G, 1999, J BACTERIOL, V181, P1264, DOI 10.1128/JB.181.4.1264-1268.1999; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; Price SB, 2000, APPL ENVIRON MICROB, V66, P632, DOI 10.1128/AEM.66.2.632-637.2000; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; Riordan JT, 2010, MICROBIOL-SGM, V156, P719, DOI 10.1099/mic.0.032631-0; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; SANKAR P, 1988, J BACTERIOL, V170, P5433, DOI 10.1128/jb.170.12.5433-5439.1988; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; Taylor M, 1996, MOL MICROBIOL, V22, P1045, DOI 10.1046/j.1365-2958.1996.01547.x; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Wang L, 2001, J BIOL CHEM, V276, P8979, DOI 10.1074/jbc.M009587200; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zgurskaya HI, 1997, MOL MICROBIOL, V24, P643, DOI 10.1046/j.1365-2958.1997.3961742.x; Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	99	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46288	10.1371/journal.pone.0046288	http://dx.doi.org/10.1371/journal.pone.0046288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029465	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500085
J	Gounder, SS; Kannan, S; Devadoss, D; Miller, CJ; Whitehead, KS; Odelberg, SJ; Firpo, MA; Paine, R; Hoidal, JR; Abel, ED; Rajasekaran, NS				Gounder, Sellamuthu S.; Kannan, Sankaranarayanan; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Firpo, Matthew A.; Paine, Robert, III; Hoidal, John R.; Abel, E. Dale; Rajasekaran, Namakkal S.			Impaired Transcriptional Activity of Nrf2 in Age-Related Myocardial Oxidative Stress Is Reversible by Moderate Exercise Training	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; CARDIOVASCULAR-DISEASE; REACTIVE OXYGEN; CELL-DEATH; ENHANCES SUSCEPTIBILITY; ENDOTHELIAL-CELLS; RECEPTOR FUNCTION; OLD RATS; IN-VIVO; ANTIOXIDANT	Aging promotes accumulation of reactive oxygen/nitrogen species (ROS/RNS) in cardiomyocytes, which leads to contractile dysfunction and cardiac abnormalities. These changes may contribute to increased cardiovascular disease in the elderly. Inducible antioxidant pathways are regulated by nuclear erythroid 2 p45-related factor 2 (Nrf2) through antioxidant response cis-elements (AREs) and are impaired in the aging heart. Whereas acute exercise stress (AES) activates Nrf2 signaling and promotes myocardial antioxidant function in young mice (similar to 2 months), aging mouse (> 23 months) hearts exhibit significant oxidative stress as compared to those of the young. The purpose of this study was to investigate agedependent regulation of Nrf2-antioxidant mechanisms and redox homeostasis in mouse hearts and the impact of exercise. Old mice were highly susceptible to oxidative stress following high endurance exercise stress (EES), but demonstrated increased adaptive redox homeostasis after moderate exercise training (MET; 10m/min, for 45 min/day) for similar to 6 weeks. Following EES, transcription and protein levels for most of the ARE-antioxidants were increased in young mice but their induction was blunted in aging mice. In contrast, 6-weeks of chronic MET promoted nuclear levels of Nrf2 along with its target antioxidants in the aging heart to near normal levels as seen in young mice. These observations suggest that enhancing Nrf2 function and endogenous cytoprotective mechanisms by MET, may combat age-induced ROS/RNS and protect the myocardium from oxidative stress diseases.	[Gounder, Sellamuthu S.; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Rajasekaran, Namakkal S.] Univ Utah, Dept Internal Med, Div Cardiol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Gounder, Sellamuthu S.; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Paine, Robert, III; Hoidal, John R.; Rajasekaran, Namakkal S.] Univ Utah, Dept Internal Med, Div Pulm, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Kannan, Sankaranarayanan] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Firpo, Matthew A.] Univ Utah, Dept Gen Surg, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Abel, E. Dale] Univ Utah, Dept Internal Med, Div Endocrinol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rajasekaran, NS (corresponding author), Univ Utah, Dept Internal Med, Div Cardiol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.	Raj.Soorappan@hsc.utah.edu	Devadoss, Dinesh/AAO-7983-2020	Devadoss, Dinesh/0000-0003-0069-1799; Abel, E. Dale/0000-0001-5290-0738	Center on Aging (CoA); Utah - Pilot Grant Program Award; AHA [086501F]; University of Utah Interdisciplinary Seed Grant; Divisions of Cardiology and Pulmonary; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042860] Funding Source: NIH RePORTER	Center on Aging (CoA); Utah - Pilot Grant Program Award; AHA(American Heart Association); University of Utah Interdisciplinary Seed Grant; Divisions of Cardiology and Pulmonary; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a Center on Aging (CoA), Utah - Pilot Grant Program Award, Beginning Grant-In-Aid from the AHA (086501F) and University of Utah Interdisciplinary Seed Grant to Namakkal S. Rajasekaran. Seed funding from the Divisions of Cardiology and Pulmonary also supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EUR HEART J; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Baker JM, 2011, FASEB J, V25, P4348, DOI 10.1096/fj.11-189043; Bean JF, 2004, ARCH PHYS MED REHAB, V85, pS31, DOI 10.1016/j.apmr.2004.03.010; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Chicco AJ, 2005, AM J PHYSIOL-REG I, V289, pR424, DOI 10.1152/ajpregu.00636.2004; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; George L, 2009, AM J PHYSIOL-RENAL, V297, pF1174, DOI 10.1152/ajprenal.00397.2009; GURWITZ JH, 1991, JAMA-J AM MED ASSOC, V265, P1720, DOI 10.1001/jama.265.13.1720; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hazzard William R., 1995, Am J Geriatr Cardiol, V4, P16; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Hirayama A, 2003, FREE RADICAL BIO MED, V34, P1236, DOI 10.1016/S0891-5849(03)00073-X; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Jennings JR, 1997, PSYCHOL AGING, V12, P225, DOI 10.1037/0882-7974.12.2.225; Jialal I, 2003, CIRCULATION, V107, P926, DOI 10.1161/01.CIR.0000048966.26216.4C; Junn E, 2001, J NEUROCHEM, V78, P374, DOI 10.1046/j.1471-4159.2001.00425.x; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P332, DOI 10.3109/10799893.2011.607171; Lakatta Edward, 1994, Am J Geriatr Cardiol, V3, P11; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li MY, 2006, J CELL PHYSIOL, V206, P518, DOI 10.1002/jcp.20496; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Muthusamy VR, 2012, FREE RADIC BIOL MED; Naumann P, 2011, INT J ONCOL, V39, P101, DOI 10.3892/ijo.2011.1025; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Newsholme P, 2010, CLIN SCI, V118, P341, DOI 10.1042/CS20090433; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Rajasekaran NS, 2005, BBA-MOL BASIS DIS, V1741, P103, DOI 10.1016/j.bbadis.2004.11.025; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Sharma S, 2011, EUR HEART J; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092; Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Varadharaj S, 2005, ANTIOXID REDOX SIGN, V7, P287, DOI 10.1089/ars.2005.7.287; Weinsaft J W, 2001, Am J Geriatr Cardiol, V10, P348, DOI 10.1111/j.1076-7460.2001.00833.x; Wissler RW, 1996, CIRCULATION, V93, P1608, DOI 10.1161/01.CIR.93.9.1608; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058	66	124	132	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45697	10.1371/journal.pone.0045697	http://dx.doi.org/10.1371/journal.pone.0045697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029187	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700058
J	Malt, AL; Cagliero, J; Legent, K; Silber, J; Zider, A; Flagiello, D				Malt, Andre Landin; Cagliero, Julie; Legent, Kevin; Silber, Joel; Zider, Alain; Flagiello, Domenico			Alteration of TEAD1 Expression Levels Confers Apoptotic Resistance through the Transcriptional Up-Regulation of Livin	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; CELL-PROLIFERATION; CONTACT INHIBITION; RNA INTERFERENCE; BANTAM MICRORNA; HIPPO PATHWAY; ORGAN SIZE; GENE; YAP; DROSOPHILA	Background: TEA domain (TEAD) proteins are highly conserved transcription factors involved in embryonic development and differentiation of various tissues. More recently, emerging evidences for a contribution of these proteins towards apoptosis and cell proliferation regulation have also been proposed. These effects appear to be mediated by the interaction between TEAD and its co-activator Yes-Associated Protein (YAP), the downstream effector of the Hippo tumour suppressor pathway. Methodology/Principal Findings: We further investigated the mechanisms underlying TEAD-mediated apoptosis regulation and showed that overexpression or RNAi-mediated silencing of the TEAD1 protein is sufficient to protect mammalian cell lines from induced apoptosis, suggesting a proapoptotic function for TEAD1 and a non physiological cytoprotective effect for overexpressed TEAD1. Moreover we show that the apoptotic resistance conferred by altered TEAD1 expression is mediated by the transcriptional up-regulation of Livin, a member of the Inhibitor of Apoptosis Protein (IAP) family. In addition, we show that overexpression of a repressive form of TEAD1 can induce Livin up-regulation, indicating that the effect of TEAD1 on Livin expression is indirect and favoring a model in which TEAD1 activates a repressor of Livin by interacting with a limiting cofactor that gets titrated upon TEAD1 up-regulation. Interestingly, we show that overexpression of a mutated form of TEAD1 (Y421H) implicated in Sveinsson's chorioretinal atrophy that strongly reduces its interaction with YAP as well as its activation, can induce Livin expression and protect cells from induced apoptosis, suggesting that YAP is not the cofactor involved in this process. Conclusions/Significance: Taken together our data reveal a new, Livin-dependent, apoptotic role for TEAD1 in mammals and provide mechanistic insight downstream of TEAD1 deregulation in cancers.	[Malt, Andre Landin; Cagliero, Julie; Legent, Kevin; Silber, Joel; Zider, Alain; Flagiello, Domenico] Univ Paris Diderot, Equipe Genet Mol Differenciat, IJM, CNRS,UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Zider, A (corresponding author), Univ Paris Diderot, Equipe Genet Mol Differenciat, IJM, CNRS,UMR 7592, Paris, France.	zider@ijm.univ-paris-diderot.fr; flagiello@ijm.univ-paris-diderot.fr	Malt, Andre Landin/AAO-2509-2021	LEGENT, Kevin/0000-0001-8547-0914; Landin Malt, Andre/0000-0002-6655-7333; , Domenico R/0000-0003-4185-2675	Groupement des Entreprises Francaises dans la Lutte contre le Cancer (G.E.F.L.U.C.); Association pour la Recherche sur le Cancer (A.R.C) [5119]; Region Ile-de-France [E539]	Groupement des Entreprises Francaises dans la Lutte contre le Cancer (G.E.F.L.U.C.); Association pour la Recherche sur le Cancer (A.R.C)(Fondation ARC pour la Recherche sur le Cancer); Region Ile-de-France(Region Ile-de-France)	This work was supported by grants from Groupement des Entreprises Francaises dans la Lutte contre le Cancer (G.E.F.L.U.C.) subvention 2007 and from Association pour la Recherche sur le Cancer (A.R.C), Grant no5119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge D. Vucic for the ML-IAP Pro4 plasmids and Cathrine Alcaide for the BUA cells. We thank Nicole Boggetto from the Flow Cytometry facility (ImagoSeine) at the Jacques Monod Institute (Paris, France) for precious help in FACS analyses (apparatus INFLUX 500, contract number E539, supported by Region Ile-de-France) and Anne-Lise Haenni for help with the English.	Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; Ashhab Y, 2001, FEBS LETT, V495, P56, DOI 10.1016/S0014-5793(01)02366-3; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Barbieri G, 2002, INT IMMUNOL, V14, P839, DOI 10.1093/intimm/dxf060; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CAMPBELL SD, 1991, GENETICS, V127, P367; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Cowell IG, 2000, EXP CELL RES, V255, P86, DOI 10.1006/excr.1999.4772; Crnkovic-Mertens I, 2006, J MOL MED, V84, P232, DOI 10.1007/s00109-005-0021-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Gluck S, BREAST CANC RES TREA; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Gunther S, 2004, NUCLEIC ACIDS RES, V32, P791, DOI 10.1093/nar/gkh248; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Jacquemin P, 1998, DEV DYNAM, V212, P423, DOI 10.1002/(SICI)1097-0177(199807)212:3<423::AID-AJA10>3.0.CO;2-1; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kessler DS, 1997, P NATL ACAD SCI USA, V94, P13017, DOI 10.1073/pnas.94.24.13017; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Legent K, 2006, CELL CYCLE, V5, P740, DOI 10.4161/cc.5.7.2613; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maeda T, 2002, BIOCHEM BIOPH RES CO, V294, P791, DOI 10.1016/S0006-291X(02)00556-9; Maeda T, 2002, J BIOL CHEM, V9, P9; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Richter B W, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.44.pe1; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Song Tao, 2008, Zhonghua Nan Ke Xue, V14, P30; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Stocker H, 2011, CURR BIOL, V21, pR37, DOI 10.1016/j.cub.2010.11.057; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Walker PR, 1999, ANN NY ACAD SCI, V887, P48, DOI 10.1111/j.1749-6632.1999.tb07921.x; Wu S, 2008, DEV CELL; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu XW, 2008, COMP BIOCHEM PHYS B, V150, P447, DOI 10.1016/j.cbpb.2008.05.003; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yan BA, 2010, J CELL BIOCHEM, V111, P1114, DOI 10.1002/jcb.22797; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Ye L, 2011, PROSTATE, V71, P42, DOI 10.1002/pros.21220; Yu LL, 2009, J HUAZHONG U SCI-MED, V29, P625, DOI 10.1007/s11596-009-0518-1; Zhang L, 2008, DEV CELL; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	69	22	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45498	10.1371/journal.pone.0045498	http://dx.doi.org/10.1371/journal.pone.0045498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029054	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700043
J	Saeed, M; Schwarze, F; Loidl, A; Meraner, J; Lechner, M; Loidl, P				Saeed, Muhammad; Schwarze, Florian; Loidl, Adele; Meraner, Joachim; Lechner, Markus; Loidl, Peter			In Vitro Phosphorylation and Acetylation of the Murine Pocket Protein Rb2/p130	PLOS ONE			English	Article							RETINOBLASTOMA GENE FAMILY; P130; P130/RBL2; CLONING; MEMBER	The retinoblastoma protein (pRb) and the related proteins Rb2/p130 and 107 represent the "pocket protein" family of cell cycle regulators. A key function of these proteins is the cell cycle dependent modulation of E2F-regulated genes. The biological activity of these proteins is controlled by acetylation and phosphorylation in a cell cycle dependent manner. In this study we attempted to investigate the interdependence of acetylation and phosphorylation of Rb2/p130 in vitro. After having identified the acetyltransferase p300 among several acetyltransferases to be associated with Rb2/p130 during S-phase in NIH3T3 cells in vivo, we used this enzyme and the CDK4 protein kinase for in vitro modification of a variety of full length Rb2/p130 and truncated versions with mutations in the acetylatable lysine residues 1079, 128 and 130. Mutation of these residues results in the complete loss of Rb2/p130 acetylation. Replacement of lysines by arginines strongly inhibits phosphorylation of Rb2/p130 by CDK4; the inhibitory effect of replacement by glutamines is less pronounced. Preacetylation of Rb2/p130 strongly enhances CDK4-catalyzed phosphorylation, whereas deacetylation completely abolishes in vitro phosphorylation. In contrast, phosphorylation completely inhibits acetylation of Rb2/p130 by p300. These results suggest a mutual interdependence of modifications in a way that acetylation primes Rb2/p130 for phosphorylation and only dephosphorylated Rb2/p130 can be subject to acetylation. Human papillomavirus 16-E7 protein, which increases acetylation of Rb2/p130 by p300 strongly reduces phosphorylation of this protein by CDK4. This suggests that the balance between phosphorylation and acetylation of Rb2/p130 is essential for its biological function in cell cycle control.	[Saeed, Muhammad; Schwarze, Florian; Loidl, Adele; Meraner, Joachim; Lechner, Markus; Loidl, Peter] Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria	Medical University of Innsbruck	Loidl, P (corresponding author), Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria.	Peter.Loidl@i-med.ac.at		Schwarze, Florian/0000-0002-1334-1301	Tyrolean Science Foundation (TWF) [TWF 34]	Tyrolean Science Foundation (TWF)	This work was supported by Tyrolean Science Foundation (TWF), TWF 34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Claudio PP, 1996, CANCER RES, V56, P2003; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fiorentino FP, 2009, CELL RES, V19, P1044, DOI 10.1038/cr.2009.96; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Hansen K, 1999, ELECTROPHORESIS, V20, P372, DOI 10.1002/(SICI)1522-2683(19990201)20:2<372::AID-ELPS372>3.0.CO;2-R; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; MAYOL X, 1993, ONCOGENE, V8, P2561; MAYOL X, 1995, ONCOGENE, V11, P801; Purev E, 2011, J CELL PHYSIOL, V226, P1027, DOI 10.1002/jcp.22418; Roman A, 2006, CELL CYCLE, V5, P567, DOI 10.4161/cc.5.6.2571; Schwarze F, 2010, ONCOGENE, V29, P5755, DOI 10.1038/onc.2010.311; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618	20	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46174	10.1371/journal.pone.0046174	http://dx.doi.org/10.1371/journal.pone.0046174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029429	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700120
J	Laghi, L; Beghelli, S; Spinelli, A; Bianchi, P; Basso, G; Di Caro, G; Brecht, A; Celesti, G; Turri, G; Bersani, S; Schumacher, G; Rocken, C; Grantzdorffer, I; Roncalli, M; Zerbi, A; Neuhaus, P; Bassi, C; Montorsi, M; Scarpa, A; Malesci, A				Laghi, Luigi; Beghelli, Stefania; Spinelli, Antonino; Bianchi, Paolo; Basso, Gianluca; Di Caro, Giuseppe; Brecht, Anna; Celesti, Giuseppe; Turri, Giona; Bersani, Samantha; Schumacher, Guido; Roecken, Christoph; Graentzdoerffer, Ilona; Roncalli, Massimo; Zerbi, Alessandro; Neuhaus, Peter; Bassi, Claudio; Montorsi, Marco; Scarpa, Aldo; Malesci, Alberto			Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR GENE; FAMILIAL PREDISPOSITION; INTERNATIONAL CRITERIA; MEDULLARY CARCINOMA; INSTITUTE WORKSHOP; CLINICAL-FEATURES; MUTATIONS; TUMORS; SURVIVAL	Background and Aims: Pancreatic cancer risk is increased in Lynch syndrome (LS) patients with mismatch repair gene defects predisposing to colonic and extracolonic cancers with microsatellite instability (MSI). However, the frequency of MSI pancreatic cancers has never been ascertained in consecutive, unselected clinical series, and their contribution to the sporadic and inherited burden of pancreatic cancer remains to be established. Aims of the study were to determine the prevalence of MSI in surgically resected pancreatic cancers in a multicentric, retrospective study, and to assess the occurrence of pancreatic cancer in LS. Methods: MS-status was screened by a panel of 5 mononucleotide repeats (Bat26, Bat25, NR-21, NR-24 and NR-27) in 338 consecutive pancreatic ductal adenocarcinoma (PDAC), resected at two Italian and one German referral centres. The personal history of pancreatic cancer was assessed in an independent set of 58 probands with LS and in 138 first degree relatives who had cancers. Results: Only one PDAC (0.3%) showed MSI. This was a medullary type cancer, with hMLH1-deficiency, and no identified germ-line mutation but methylation of hMLH1. Pancreatic cancer occurred in 5 (2.5%) LS patients. Histological sampling was available for 2 cases, revealing PDAC in one case and an ampullary cancer in the other one. Conclusions: MSI prevalence is negligible in sporadic, resected PDAC. Differently, the prevalence of pancreatic cancer is 2.5% in LS patients, and cancers other than PDAC may be encountered in this setting. Surveillance for pancreatic cancer should be advised in LS mutation carriers at referral centers.	[Laghi, Luigi; Bianchi, Paolo; Basso, Gianluca; Di Caro, Giuseppe; Celesti, Giuseppe] Humanitas Clin & Res Ctr, Lab Mol Gastroenterol, Milan, Italy; [Laghi, Luigi; Malesci, Alberto] Humanitas Clin & Res Ctr, Dept Gastroenterol, Milan, Italy; [Beghelli, Stefania; Scarpa, Aldo] Univ Verona, Ctr Appl Res Canc, ARC NET, I-37100 Verona, Italy; [Spinelli, Antonino; Zerbi, Alessandro; Montorsi, Marco] IRCCS Ist Clin Humanitas, Milan, Italy; [Basso, Gianluca] Univ Milan, Sch Mol Med, Milan, Italy; [Di Caro, Giuseppe] Univ Milan, Sch Expt Pathol & Neuropathol, Milan, Italy; [Brecht, Anna; Schumacher, Guido; Neuhaus, Peter] Univ Berlin, Charite Campus Virchow, Dept Gen Surg & Transplantat, Berlin, Germany; [Turri, Giona; Bersani, Samantha; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Roecken, Christoph; Graentzdoerffer, Ilona] Univ Berlin, Charite Campus Virchow, Dept Pathol, Berlin, Germany; [Roncalli, Massimo] Humanitas Clin & Res Ctr, Dept Pathol, Milan, Italy; [Roncalli, Massimo; Montorsi, Marco; Malesci, Alberto] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Bassi, Claudio] Univ Hosp Trust Verona, Dept Surg & Oncol, Verona, Italy	University of Verona; Humanitas University; IRCCS Humanitas Research Hospital; University of Milan; University of Milan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Verona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Milan; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Laghi, L (corresponding author), Humanitas Clin & Res Ctr, Lab Mol Gastroenterol, Milan, Italy.	luigi.laghi@humanitas.it; alberto.malesci@humanitas.it	Bianchi, Paolo/E-7592-2013; Laghi, Luigi/GZM-5831-2022; scarpa, aldo/K-6832-2016; Röcken, Christoph/A-9239-2010; Spinelli, Antonino/ABI-1441-2020; Montorsi, Marco/GYD-3896-2022	Bianchi, Paolo/0000-0001-5786-5644; Laghi, Luigi/0000-0003-4187-1059; scarpa, aldo/0000-0003-1678-739X; Röcken, Christoph/0000-0002-6989-8002; Spinelli, Antonino/0000-0002-1493-1768; Montorsi, Marco/0000-0002-3887-3451; zerbi, alessandro/0000-0002-9176-0448; Roncalli, Massimo/0000-0002-7901-8910; Basso, Gianluca/0000-0002-8430-4727; SALVIA, Roberto/0000-0002-3514-8473	Italian Minister of Health [58]	Italian Minister of Health	This research was funded by the Italian Minister of Health, grant "Tumor stroma interaction, as therapy target in pancreatic cancer'' (Ricerca Finalizzata 2005, no. 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGA, 1999, GASTROENTEROLOGY, V117, P1463; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; Banville N, 2006, HUM PATHOL, V37, P1498, DOI 10.1016/j.humpath.2006.06.024; Boland CR, 1998, CANCER RES, V58, P5248; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; DiMagno EP, 1999, GASTROENTEROLOGY, V117, P1464, DOI 10.1016/S0016-5085(99)70298-2; Furukawa H, 1996, CANCER, V78, P986, DOI 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A; Geary J, 2008, FAM CANCER, V7, P163, DOI 10.1007/s10689-007-9164-6; Ghimenti C, 1999, BRIT J CANCER, V80, P11, DOI 10.1038/sj.bjc.6690314; Goggins M, 1998, AM J PATHOL, V152, P1501; Grover S, 2010, GASTROENTEROLOGY, V139, P1076, DOI 10.1053/j.gastro.2010.08.012; Halling KC, 1999, AM J PATHOL, V155, P205, DOI 10.1016/S0002-9440(10)65114-0; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Immervoll H, 2006, VIRCHOWS ARCH, V448, P788, DOI 10.1007/s00428-006-0191-8; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Katz MHG, 2008, CA-CANCER J CLIN, V58, P111, DOI 10.3322/CA.2007.0012; Laghi L, 2008, ONCOGENE, V27, P6313, DOI 10.1038/onc.2008.217; Laghi L, 2002, LAB INVEST, V82, P265, DOI 10.1038/labinvest.3780420; Longnecker DS, 2000, PANCREAS, V21, P338, DOI 10.1097/00006676-200011000-00003; Malesci A, 2007, CLIN CANCER RES, V13, P3831, DOI 10.1158/1078-0432.CCR-07-0366; Maple JT, 2005, PANCREATOLOGY, V5, P220, DOI 10.1159/000085275; Miranda E, 2006, BRIT J CANCER, V95, P1101, DOI 10.1038/sj.bjc.6603337; Murphy MA, 2010, INT J CANC; NAGAKAWA T, 1991, INT J PANCREATOL, V9, P135; Nagakawa T, 1996, CANCER, V77, P640, DOI 10.1002/(SICI)1097-0142(19960215)77:4<640::AID-CNCR9>3.0.CO;2-K; Nakata B, 2002, CLIN CANCER RES, V8, P2536; Nardon E, 2010, DIAGN MOL PATHOL, V19, P236, DOI 10.1097/PDM.0b013e3181db67af; Onoyama H, 1992, Gan To Kagaku Ryoho, V19, P2304; Percesepe A, 1998, ONCOGENE, V17, P157, DOI 10.1038/sj.onc.1201944; Perucho M, 1999, CANCER RES, V59, P249; Real FX, 2005, PANCREATOLOGY, V5, P227; Ruemmele P, 2009, AM J SURG PATHOL, V33, P691, DOI 10.1097/PAS.0b013e3181983ef7; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Tomaszewska Romana, 2003, Polish Journal of Pathology, V54, P31; Wilentz RE, 2000, AM J PATHOL, V156, P1641, DOI 10.1016/S0002-9440(10)65035-3; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033; Yamamoto H, 2001, CANCER RES, V61, P3139; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893	40	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46002	10.1371/journal.pone.0046002	http://dx.doi.org/10.1371/journal.pone.0046002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029359	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800129
J	Lepinay, C; Rigaud, T; Salon, C; Lemanceau, P; Mougel, C				Lepinay, Clementine; Rigaud, Thierry; Salon, Christophe; Lemanceau, Philippe; Mougel, Christophe			Interaction between Medicago truncatula and Pseudomonas fluorescens: Evaluation of Costs and Benefits across an Elevated Atmospheric CO2	PLOS ONE			English	Article							MICROBIAL COMMUNITY; MYCORRHIZA DEVELOPMENT; CARBON-DIOXIDE; DYNAMICS; NITROGEN; RESPONSES; PLANTS; ROOTS; MODEL; SOIL	Soil microorganisms play a key role in both plants nutrition and health. Their relation with plant varies from mutualism to parasitism, according to the balance of costs and benefits for the two partners of the interaction. These interactions involved the liberation of plant organic compounds via rhizodeposition. Modification of atmospheric CO2 concentration may affect rhizodeposition and as a consequence trophic interactions that bind plants and microorganisms. Positive effect of elevated CO2 on plants are rather well known but consequences for micoorganisms and their interactions with plants are still poorly understood. A gnotobiotic system has been developed to study the interaction between Medicago truncatula Jemalong J5 and the mutualistic bacteria Pseudomonas fluorescens strain C7R12 under two atmospheric CO2 concentrations: ambient (365 ppm) versus enriched (750 ppm). Costs and benefits for each partner have been determined over time by measuring plant development and growth, the C and N contents of the various plant parts and the density of the bacteria in rhizosphere compartments. Following the increase in CO2, there was a beneficial effect of P. fluorescens C7R12 on development, vegetative growth, and C/N content of M. truncatula. Concerning plant reproduction, an early seed production was noticed in presence of the bacterial strain combined with increased atmospheric CO2 conditions. Paradoxically, this transient increase in seed production was correlated with a decrease in bacterial density in the rhizosphere soil, revealing a cost of increased CO2 for the bacterial strain. This shift of costs-benefits ratio disappeared later during the plant growth. In conclusion, the increase in CO2 concentration modifies transiently the cost-benefit balance in favor of the plant. These results may be explained either by a competition between the two partners or a change in bacterial physiology. The ecosystem functioning depends on the stability of many plant-microbe associations that abiotic factors can disrupt.	[Lepinay, Clementine; Salon, Christophe; Lemanceau, Philippe; Mougel, Christophe] INRA, UMR Agroecol 1347, F-21034 Dijon, France; [Rigaud, Thierry] Univ Bourgogne, UMR CNRS, CNRS, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Mougel, C (corresponding author), INRA, UMR Agroecol 1347, F-21034 Dijon, France.	christophe.mougel@dijon.inra.fr	Salon, Christophe/AAH-5285-2021; Mougel, Christophe/D-5118-2017; Rigaud, Thierry/ABE-2552-2020; Salon, Christophe/C-3460-2014; Rigaud, Thierry/T-4053-2017	Mougel, Christophe/0000-0001-8675-3115; Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Lepinay, Clementine/0000-0003-1330-1550	National Institute for Agricultural Research (INRA Plant Health and Environment division); Regional Council of Burgundy [AIB29000359, AIB 29000427, 29000594]	National Institute for Agricultural Research (INRA Plant Health and Environment division); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	C.L. was funded by a doctoral grant from National Institute for Agricultural Research (INRA Plant Health and Environment division) and the Regional Council of Burgundy (project no AIB29000359). Grants AIB 29000427 & 29000594 were obtained from the Regional Council of Burgundy for support to intregrated Agrale 6 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Arnone JA, 2000, NEW PHYTOL, V147, P73, DOI 10.1046/j.1469-8137.2000.00685.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Bakker PAHM, 2007, EUR J PLANT PATHOL, V119, P241, DOI 10.1007/s10658-007-9114-z; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; BARRAQUIO WL, 1983, CAN J MICROBIOL, V29, P867, DOI 10.1139/m83-141; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; Briat J.F., 2007, ADV BOT RES, V46, P137, DOI DOI 10.1016/S0065-2296(07)46004-9; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Colebatch G, 2002, NEW PHYTOL, V153, P37, DOI 10.1046/j.0028-646X.2001.00304.x; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Drigo B, 2008, BIOL FERT SOILS, V44, P667, DOI 10.1007/s00374-008-0277-3; EPARVIER A, 1991, FEMS MICROBIOL ECOL, V86, P177, DOI 10.1111/j.1574-6968.1991.tb04807.x; Finzi AC, 2006, ECOSYSTEMS, V9, P215, DOI 10.1007/s10021-005-0078-6; Huxman TE, 1999, FUNCT ECOL, V13, P769, DOI 10.1046/j.1365-2435.1999.00366.x; Johnstone RA, 2008, J EVOLUTION BIOL, V21, P879, DOI 10.1111/j.1420-9101.2008.01505.x; KING EO, 1954, J LAB CLIN MED, V44, P301; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Lambers H, 2009, PLANT SOIL, V321, P83, DOI 10.1007/s11104-009-0042-x; LEMANCEAU P, 1992, AGRONOMIE, V12, P413, DOI 10.1051/agro:19920601; LEMANCEAU P, 1988, AGRONOMIE, V8, P243, DOI 10.1051/agro:19880310; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Luo YQ, 1998, GLOBAL CHANGE BIOL, V4, P173, DOI 10.1046/j.1365-2486.1998.00116.x; Moreau D, 2007, PLANT CELL ENVIRON, V30, P213, DOI 10.1111/j.1365-3040.2006.01620.x; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Pivato B, 2008, FEMS MICROBIOL LETT, V289, P173, DOI 10.1111/j.1574-6968.2008.01391.x; Pivato B, 2009, MYCORRHIZA, V19, P81, DOI 10.1007/s00572-008-0205-2; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Salon C, 2001, AGRONOMIE, V21, P539, DOI 10.1051/agro:2001143; Sanchez L, 2004, NEW PHYTOL, V161, P855, DOI 10.1046/j.1469-8137.2004.00997.x; Sanhewe AJ, 1996, J EXP BOT, V47, P631, DOI 10.1093/jxb/47.5.631; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thoquet Philippe, 2002, BMC Plant Biology, V2, P1, DOI 10.1186/1471-2229-2-1; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE CP, 1991, ANNU REV PLANT PHYS, V42, P373, DOI 10.1146/annurev.pp.42.060191.002105; Vansuyt G, 2007, MOL PLANT MICROBE IN, V20, P441, DOI 10.1094/MPMI-20-4-0441; Voisin AS, 2003, ANN BOT-LONDON, V91, P539, DOI 10.1093/aob/mcg055; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Williams MA, 2000, PLANT SOIL, V227, P127, DOI 10.1023/A:1026590001307; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; Young ND, 2003, CURR OPIN PLANT BIOL, V6, P199, DOI 10.1016/S1369-5266(03)00006-2; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891; Ziska L.H., 2008, PLANT GROWTH CLIMATE, P17, DOI [10.1002/9780470988695, DOI 10.1002/9780470988695.CH2, DOI 10.1002/9780470988695]	53	4	4	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45740	10.1371/journal.pone.0045740	http://dx.doi.org/10.1371/journal.pone.0045740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029215	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800088
J	Rothenbacher, D; Kleiner, A; Koenig, W; Primatesta, P; Breitling, LP; Brenner, H				Rothenbacher, Dietrich; Kleiner, Andrea; Koenig, Wolfgang; Primatesta, Paola; Breitling, Lutz P.; Brenner, Hermann			Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK; HYPERURICEMIA; GOUT; METAANALYSIS; ASSOCIATION; BIOMARKERS; COHORT; STROKE	Background: So far it is unclear whether the association between serum uric acid (SUA), inflammatory cytokines and risk of atherosclerosis is causal or an epiphenomenon. The aim of the project is to investigate the independent prognostic relationship of inflammatory markers and SUA levels with adverse cardiovascular outcomes in a patient population with stable coronary heart disease (CHD). Methods: SUA, C-reactive protein (CRP) and interleukin (IL)-6 were measured at baseline in a cohort of 1,056 patients aged 30-70 years with CHD. Cox proportional hazards model was used to determine the prognostic value of these markers on a combined CVD endpoint during eight year follow-up after adjustment for covariates. Results: For 1,056 patients with stable coronary heart disease aged 30-70 years (mean age 58.9 years, SD 8.0) follow-up information and serum measurements were complete and n = 151 patients (incidence 21.1 per 1000 patients years) experienced a fatal or non-fatal CVD event during follow-up (p-value = 0.05 for quartiles of SUA, p = 0.002 for quartiles of CRP, p = 0.13 for quartiles of IL-6 in Kaplan-Meier analysis). After adjustment for age, gender and hospital site the hazard ratio (HR) for SUA increased from 1.37 to 1.65 and 2.27 in the second, third, and top quartile, when compared to the bottom one (p for trend <0.0005). The HR for CRP increased from 0.85 to 0.98 and 1.64 in the respective quartiles (p for trend 0.02). After further adjustment for covariates SUA still showed a clear statistically significant relationship with the outcome (p for trend 0.045), whereas CRP did not (p for trend 0.10). Conclusion: The data suggest that compared to inflammatory markers such as CRP and IL-6 serum uric acid levels may predict future CVD risk in patients with stable CHD with a risk increase even at levels considered normal.	[Rothenbacher, Dietrich; Kleiner, Andrea] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Primatesta, Paola] Novartis Pharma AG, Global Clin Epidemiol, Basel, Switzerland; [Breitling, Lutz P.; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany	Ulm University; Ulm University; Novartis; Helmholtz Association; German Cancer Research Center (DKFZ)	Rothenbacher, D (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.	dietrich.rothenbacher@uni-ulm.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Koenig, Wolfgang/0000-0002-2064-9603; Rothenbacher, Dietrich/0000-0002-3563-2791	German Federal Ministry of Education and Research [01GD9820/0]; Pitzer Foundation (Bad Nauheim, Germany); Novartis Pharma (Basel, Switzerland)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pitzer Foundation (Bad Nauheim, Germany); Novartis Pharma (Basel, Switzerland)	The study was supported in part by the German Federal Ministry of Education and Research (#01GD9820/0) and the Pitzer Foundation (Bad Nauheim, Germany). Part of this work was financed by Novartis Pharma (Basel, Switzerland) by an unrestricted grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Chen CC, 2011, AM J PHYSIOL-HEART C, V301, pH1107, DOI 10.1152/ajpheart.01071.2010; Chuang SY, 2012, INT J CARDIOL, V154, P316, DOI 10.1016/j.ijcard.2011.06.055; Cook NR, 2010, INT J CLIN PRACT, V64, P1723, DOI 10.1111/j.1742-1241.2010.02469.x; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Filippatos GS, 2011, EUR HEART J, V32, P712, DOI 10.1093/eurheartj/ehq473; Ito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027817; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin WJ, 2010, IMMUNOL CELL BIOL, V88, P15, DOI 10.1038/icb.2009.89; Neri L, 2011, AM J KIDNEY DIS, V58, P398, DOI 10.1053/j.ajkd.2011.04.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; SORIANO LC, 2011, ARTHRITIS RES THERAP, V0013; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang QL, 2010, ATHEROSCLEROSIS, V211, P342, DOI 10.1016/j.atherosclerosis.2010.02.028	24	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45907	10.1371/journal.pone.0045907	http://dx.doi.org/10.1371/journal.pone.0045907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029307	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800117
J	Wetter, M; Goulding, D; Pickard, D; Kowarik, M; Waechter, CJ; Dougan, G; Wacker, M				Wetter, Michael; Goulding, David; Pickard, Derek; Kowarik, Michael; Waechter, Charles J.; Dougan, Gordon; Wacker, Michael			Molecular Characterization of the viaB Locus Encoding the Biosynthetic Machinery for Vi Capsule Formation in Salmonella Typhi	PLOS ONE			English	Article							ESCHERICHIA-COLI K1; ATP-BINDING COMPONENT; POLYSIALIC ACID; NUCLEOTIDE-SEQUENCE; GENETIC-ANALYSIS; ABC-TRANSPORTER; ANTIGEN; POLYSACCHARIDE; EXPRESSION; MUTANTS	The Vi capsular polysaccharide (CPS) of Salmonella enterica serovar Typhi, the cause of human typhoid, is important for infectivity and virulence. The Vi biosynthetic machinery is encoded within the viaB locus composed of 10 genes involved in regulation of expression (tviA), polymer synthesis (tviB-tviE), and cell surface localization of the CPS (vexA-vexE). We cloned the viaB locus from S. Typhi and transposon insertion mutants of individual viaB genes were characterized in Escherichia coli DH5 alpha. Phenotype analysis of viaB mutants revealed that tviB, tviC, tviD and tviE are involved in Vi polymer synthesis. Furthermore, expression of tviB-tviE in E. coli DH5 alpha directed the synthesis of cytoplasmic Vi antigen. Mutants of the ABC transporter genes vexBC and the polysaccharide copolymerase gene vexD accumulated the Vi polymer within the cytoplasm and productivity in these mutants was greatly reduced. In contrast, de novo synthesis of Vi polymer in the export deficient vexA mutant was comparable to wild-type cells, with drastic effects on cell stability. VexE mutant cells exported the Vi, but the CPS was not retained at the cell surface. The secreted polymer of a vexE mutant had different physical characteristics compared to the wild-type Vi.	[Wetter, Michael; Kowarik, Michael; Wacker, Michael] GlycoVaxyn AG, Schlieren, Switzerland; [Goulding, David; Pickard, Derek; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Waechter, Charles J.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	Wellcome Trust Sanger Institute; University of Kentucky	Wacker, M (corresponding author), GlycoVaxyn AG, Schlieren, Switzerland.	michael.wacker@glycovaxyn.com			GlycoVaxyn AG	GlycoVaxyn AG	The work described here was funded by GlycoVaxyn AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNUNZIATO PW, 1995, J BACTERIOL, V177, P312, DOI 10.1128/jb.177.2.312-319.1995; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Arya SC, 2002, J INFECT DIS, V185, P845, DOI 10.1086/339191; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; BRANDIS H, 1956, Z HYG INFEKTIONSKR, V143, P50, DOI 10.1007/BF02152548; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; CRAIGIE J., 1938, Canadian Public Health Journal, V29, P448; Craigie J, 1937, T R SOC CAN, V5, P79; Craigle J, 1936, J PATHOL BACTERIOL, V43, P233, DOI 10.1002/path.1700430202; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Demil P, 2003, Patent No. [EP 1 107 787 B1, 11077871]; DESRANLEAU J. M., 1949, CANADIAN JOUR PUBL HEALTH, V40, P473; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Engels EA, 1998, BRIT MED J, V316, P110, DOI 10.1136/bmj.316.7125.110; FRIEDMAN AM, 1982, GENE, V18, P289, DOI 10.1016/0378-1119(82)90167-6; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; HASHIMOTO Y, 1991, FEMS MICROBIOL LETT, V90, P53, DOI 10.1016/0378-1097(91)90645-Q; HESTRIN S, 1949, J BIOL CHEM, V180, P249; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; HORNICK RB, 1970, NEW ENGL J MED, V283, P739, DOI 10.1056/NEJM197010012831406; HOUNG HSH, 1992, J BACTERIOL, V174, P5910, DOI 10.1128/jb.174.18.5910-5915.1992; Jansen AM, PLOS PATHOG, V7; JOHNSON EM, 1969, J BACTERIOL, V99, P358, DOI 10.1128/JB.99.1.358-359.1969; LOONEY RJ, 1986, J LAB CLIN MED, V108, P506; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; PAVELKA MS, 1994, J BIOL CHEM, V269, P20149; PICKARD D, 1994, INFECT IMMUN, V62, P3984, DOI 10.1128/IAI.62.9.3984-3993.1994; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; QADRI A, 1990, J IMMUNOASSAY, V11, P235, DOI 10.1080/01971529008053271; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; Sathiyamoorthy K, 2011, BIOCHEMISTRY-US, V50, P5465, DOI 10.1021/bi101869h; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; SZU SC, 1991, INFECT IMMUN, V59, P4555, DOI 10.1128/IAI.59.12.4555-4561.1991; Szu SSC, 2003, METHOD ENZYMOL, V363, P552; TAYLOR K, 1965, BIOCHEM BIOPH RES CO, V20, P752, DOI 10.1016/0006-291X(65)90081-1; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Virlogeux I, 1996, J BACTERIOL, V178, P1691, DOI 10.1128/jb.178.6.1691-1698.1996; Virlogeux I, 1995, MICROBIOL-SGM, V141, P3039, DOI 10.1099/13500872-141-12-3039; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WUNDER DE, 1994, J BACTERIOL, V176, P4025, DOI 10.1128/JB.176.13.4025-4033.1994; Zhang H, 2006, BIOCHEMISTRY-US, V45, P8163, DOI 10.1021/bi060446d	46	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45609	10.1371/journal.pone.0045609	http://dx.doi.org/10.1371/journal.pone.0045609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029132	Green Published, gold			2022-12-27	WOS:000309392800066
J	Xin, W; Wei, W; Li, XY				Xin, Wei; Wei, Wei; Li, Xiaoying			Effect of Fish Oil Supplementation on Fasting Vascular Endothelial Function in Humans: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; N-3 FATTY-ACIDS; BRACHIAL-ARTERY; CARDIOVASCULAR OUTCOMES; DISEASE; OMEGA-3-FATTY-ACIDS; VASODILATATION; PATHWAYS	Background: Effect of fish oil supplementation on flow-mediated dilation, an index of endothelial function in humans, remains controversial. We performed a meta-analysis to determine whether fish oil supplementation could improve endothelial function. Methods: Human intervention studies were identified by systematic searches of Medline, Embase, Cochrane's library and references of related reviews and studies. A random-effect model was applied to estimate the pooled results. Metaregression and subgroup analyses were performed to evaluate the impact of study characteristics on the effect of fish oil supplementation on flow-mediated dilation. Results: A total of sixteen records with 1,385 subjects were reviewed. The results of the pooled analysis showed that fish oil supplementation significantly improved flow-mediated dilation (weighed mean difference: 1.49%, 95% confidence interval 0.48% to 2.50%, p = 0.004). Meta-regression and subgroup analysis suggested that the quality of included studies were inversely related to the overall effect (regression coefficient = -1.60, p = 0.04), and the significance of the effect was mainly driven by the studies with relatively poor quality. Sensitivity analysis including only double-blind, placebo-controlled studies indicated fish oil supplementation has no significant effect on endothelial function (weighed mean difference: 0.54%, 95% confidence interval -0.25% to 1.33%, p = 0.18). Besides, normoglycemic subjects or participants with lower diastolic blood pressure seemed to be associated with remarkable improvement of endothelial function after fish oil supplementation. Conclusions: Although current evidence suggested a possible role of fish oil in improving endothelial function, large-scale and high-quality clinical trials are needed to evaluate these effects before we can come to a definite conclusion.	[Xin, Wei; Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China; [Wei, Wei] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Li, XY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China.	lixy301@163.com						Anderson JS, 2010, AM J CLIN NUTR, V92, P1204, DOI 10.3945/ajcn.2010.29494; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bots ML, 2005, EUR HEART J, V26, P363, DOI 10.1093/eurheartj/ehi017; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Di Minno MND, 2010, THROMB HAEMOSTASIS, V104, P664, DOI 10.1160/TH10-01-0008; Dyerberg J, 2004, EUR J CLIN NUTR, V58, P1062, DOI 10.1038/sj.ejcn.1601934; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engler MM, 2004, INT J CLIN PHARM TH, V42, P672; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Haberka M, 2011, CLIN NUTR, V30, P79, DOI 10.1016/j.clnu.2010.07.011; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hileman CO, 2011, AIDS RES HUM RETROVI; Hill AM, 2007, AM J CLIN NUTR, V85, P1267, DOI 10.1093/ajcn/85.5.1267; Hu FB, 2012, ARCH INTERN MED; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kwak SM, 2012, ARCH INTERN MED; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Masoura C, 2011, ATHEROSCLEROSIS, V214, P129, DOI 10.1016/j.atherosclerosis.2010.10.008; Mindrescu C, 2008, VASC HEALTH RISK MAN, V4, P1439, DOI 10.2147/VHRM.S4001; Moertl D, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2011.02.011; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Ponnuchamy B, 2009, AM J PHYSIOL-REG I, V296, pR1001, DOI 10.1152/ajpregu.90960.2008; Prabodh Shah A, 2007, J CARDIOVASCULAR P A, V12; Rizza S, 2009, ATHEROSCLEROSIS, V206, P569, DOI 10.1016/j.atherosclerosis.2009.03.006; Sanders TAB, 2011, AM J CLIN NUTR, V94, P973, DOI 10.3945/ajcn.111.018036; Schiano V, 2008, CLIN NUTR, V27, P241, DOI 10.1016/j.clnu.2007.11.007; Shahin Y, 2011, ATHEROSCLEROSIS, V216, P7, DOI 10.1016/j.atherosclerosis.2011.02.044; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Stirban A, 2010, AM J CLIN NUTR, V91, P808, DOI 10.3945/ajcn.2009.28374; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Woodman RJ, 2003, ATHEROSCLEROSIS, V166, P85, DOI 10.1016/S0021-9150(02)00307-6; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	44	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46028	10.1371/journal.pone.0046028	http://dx.doi.org/10.1371/journal.pone.0046028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029372	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800132
J	Luo, CY; Chen, Q; Huang, R; Chen, XP; Chen, K; Huang, XQ; Tang, HH; Gong, QY; Shang, HF				Luo, ChunYan; Chen, Qin; Huang, Rui; Chen, XuePing; Chen, Ke; Huang, XiaoQi; Tang, HeHan; Gong, QiYong; Shang, Hui-Fang			Patterns of Spontaneous Brain Activity in Amyotrophic Lateral Sclerosis: A Resting-State fMRI Study	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; FUNCTIONAL RATING-SCALE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; EVOKED-POTENTIALS; CORTICAL ATROPHY; DEFAULT-MODE; ALSFRS-R; MRI; ABNORMALITIES	By detecting spontaneous low-frequency fluctuations (LFF) of blood oxygen level-dependent (BOLD) signals, resting-state functional magnetic resonance imaging (rfMRI) measurements are believed to reflect spontaneous cerebral neural activity. Previous fMRI studies were focused on the examination of motor-related areas and little is known about the functional changes in the extra-motor areas in amyotrophic lateral sclerosis (ALS) patients. The aim of this study is to investigate functional cerebral abnormalities in ALS patients on a whole brain scale. Twenty ALS patients and twenty age- and sex-matched healthy volunteers were enrolled. Voxel-based analysis was used to characterize the alteration of amplitude of low frequency fluctuation (ALFF). Compared with the controls, the ALS patients showed significantly decreased ALFF in the visual cortex, fusiform gyri and right postcentral gyrus; and significantly increased ALFF in the left medial frontal gyrus, and in right inferior frontal areas after grey matter (GM) correction. Taking GM volume as covariates, the ALFF results were approximately consistent with those without GM correction. In addition, ALFF value in left medial frontal gyrus was negatively correlated with the rate of disease progression and duration. Decreased functional activity observed in the present study indicates the underlying deficits of the sensory processing system in ALS. Increased functional activity points to a compensatory mechanism. Our findings suggest that ALS is a multisystem disease other than merely motor dysfunction and provide evidence that alterations of ALFF in the frontal areas may be a special marker of ALS.	[Huang, XiaoQi; Tang, HeHan; Gong, QiYong] Sichuan Univ, Huaxi MR Res Ctr, Dept Radiol, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Luo, ChunYan; Chen, Qin; Huang, Rui; Chen, XuePing; Chen, Ke; Shang, Hui-Fang] Sichuan Univ, Dept Neurol, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Gong, QiYong] Univ Liverpool, Div Med Imaging, Fac Med, Liverpool L69 3BX, Merseyside, England	Sichuan University; Sichuan University; University of Liverpool	Gong, QY (corresponding author), Sichuan Univ, Huaxi MR Res Ctr, Dept Radiol, W China Hosp, Chengdu 610064, Sichuan, Peoples R China.	qiyonggong@hmrrc.org.cn; hfshang@yahoo.com	Huang, Xiaoqi/O-7904-2017; Gong, Qiyong/W-3052-2019; Luo, Chunyan/AAE-5287-2020; Chen, Qin/AAG-4358-2021; Chen, Qin/AAA-6635-2020	Huang, Xiaoqi/0000-0001-8686-5010; Gong, Qiyong/0000-0002-5912-4871; Chen, Qin/0000-0001-5528-8732; 	National Natural Science Foundation of China [30973149, 81100973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30973149, 81100973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, CEREB CORTEX, V21, P2291, DOI 10.1093/cercor/bhr002; Agosta F, 2012, NEUROBIOL AGING; [Anonymous], 1996, Arch Neurol, V53, P141; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avants B, 2009, ARCH NEUROL-CHICAGO, V66, P138, DOI 10.1001/archneurol.2008.542; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2012, NEUROLOGY, V78, P1085, DOI 10.1212/WNL.0b013e31824e8f53; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cosottini M, 2012, EXP NEUROL, V234, P169, DOI 10.1016/j.expneurol.2011.12.024; de Carvalho M, 2003, MUSCLE NERVE, V28, P630, DOI 10.1002/mus.10469; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868; Hammad M, 2007, NEUROLOGY, V69, P2236, DOI 10.1212/01.wnl.0000286948.99150.16; Han Jing, 2006, Chinese Medical Sciences Journal, V21, P228; HATAZAWA J, 1988, J COMPUT ASSIST TOMO, V12, P630, DOI 10.1097/00004728-198807000-00019; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Isaacs JD, 2007, J NEUROL NEUROSUR PS, V78, P750, DOI 10.1136/jnnp.2006.098798; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; Kaufmann P, 2007, AMYOTROPH LATERAL SC, V8, P42, DOI 10.1080/17482960600888156; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kollewe K, 2011, J NEUROL, V258, P804, DOI 10.1007/s00415-010-5842-7; Konrad C, 2006, EXP BRAIN RES, V172, P361, DOI 10.1007/s00221-006-0352-7; Konrad C, 2002, EXP BRAIN RES, V143, P51, DOI 10.1007/s00221-001-0981-9; LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Lule D, 2010, J NEUROL NEUROSUR PS, V81, P899, DOI 10.1136/jnnp.2009.192260; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mohammadi B, 2011, HUM BRAIN MAPP, V32, P750, DOI 10.1002/hbm.21064; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Mohammadi B, 2009, J NEUROL, V256, P1263, DOI 10.1007/s00415-009-5112-8; MONDELLI M, 1993, MUSCLE NERVE, V16, P166, DOI 10.1002/mus.880160208; MULDER DW, 1983, NEUROLOGY, V33, P1625, DOI 10.1212/WNL.33.12.1625; Munte TF, 1998, J NEUROL, V245, P206, DOI 10.1007/s004150050206; Munte TF, 1999, AMYOTROPH LATERAL SC, V1, P21; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; RADTKE RA, 1986, NEUROLOGY, V36, P796, DOI 10.1212/WNL.36.6.796; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; SHEFNER JM, 1991, MUSCLE NERVE, V14, P1242, DOI 10.1002/mus.880141218; Skidmore FM, 2011, NEUROIMAGE; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stanton BR, 2007, J NEUROL, V254, P1260, DOI 10.1007/s00415-006-0513-4; SUBRAMANIAM JS, 1990, ARCH NEUROL-CHICAGO, V47, P989, DOI 10.1001/archneur.1990.00530090063014; Tedeschi G, 2010, NEUROBIOL AGING; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Turner MR, 2007, AMYOTROPH LATERAL SC, V8, P343, DOI 10.1080/17482960701538734; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wicks P, 2008, AMYOTROPH LATERAL SC, V9, P43, DOI 10.1080/17482960701737716; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou B, 2010, MOVEMENT DISORD, V25, P1226, DOI 10.1002/mds.22967	75	41	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45470	10.1371/journal.pone.0045470	http://dx.doi.org/10.1371/journal.pone.0045470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029031	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900057
J	Ochala, J; Ravenscroft, G; Laing, NG; Nowak, KJ				Ochala, Julien; Ravenscroft, Gianina; Laing, Nigel G.; Nowak, Kristen J.			Nemaline Myopathy-Related Skeletal Muscle alpha-Actin (ACTA1) Mutation, Asp286Gly, Prevents Proper Strong Myosin Binding and Triggers Muscle Weakness	PLOS ONE			English	Article							BETA-TROPOMYOSIN MUTATION; CONTRACTILE FUNCTION; DEFECTIVE REGULATION; SARCOMERE LENGTH; RABBIT PSOAS; FIBERS; ACTIVATION; FORCE; GENE; KINETICS	Many mutations in the skeletal muscle alpha-actin gene (ACTA1) lead to muscle weakness and nemaline myopathy. Despite increasing clinical and scientific interest, the molecular and cellular pathogenesis of weakness remains unclear. Therefore, in the present study, we aimed at unraveling these mechanisms using muscles from a transgenic mouse model of nemaline myopathy expressing the ACTA1 Asp286Gly mutation. We recorded and analyzed the mechanics of membranepermeabilized single muscle fibers. We also performed molecular energy state computations in the presence or absence of Asp286Gly. Results demonstrated that during contraction, the Asp286Gly acts as a "poison-protein'' and according to the computational analysis it modifies the actin-actin interface. This phenomenon is likely to prevent proper myosin crossbridge binding, limiting the fraction of actomyosin interactions in the strong binding state. At the cell level, this decreases the force-generating capacity, and, overall, induces muscle weakness. To counterbalance such negative events, future potential therapeutic strategies may focus on the inappropriate actin-actin interface or myosin binding.	[Ochala, Julien] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Ravenscroft, Gianina; Laing, Nigel G.; Nowak, Kristen J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia	Uppsala University; University of Western Australia	Ochala, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	julien.ochala@neuro.uu.se	Ravenscroft, Gina/H-5695-2014; Ochala, Julien/K-4120-2017	Ravenscroft, Gina/0000-0003-3634-211X; Ochala, Julien/0000-0002-6358-2920; Laing, Nigel/0000-0001-5111-3732	Swedish Research Council [Dnr2009-2277]; Harald och Greta Jeanssons Stiftelse; Australian National Health and Medical Research Council [APP1035955, APP1002147]; Australian Research Council [FT100100734]; A Foundation Building Strength for Nemaline Myopathy	Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald och Greta Jeanssons Stiftelse; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); A Foundation Building Strength for Nemaline Myopathy	This study was supported by grants from the Swedish Research Council (Dnr2009-2277) and Harald och Greta Jeanssons Stiftelse to J.O., from the Australian National Health and Medical Research Council to G.R. (APP1035955) and N.G.L (APP1002147), the Australian Research Council to K.J.N. (FT100100734) and A Foundation Building Strength for Nemaline Myopathy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Lindqvist J, 2012, ACTA NEUROPATHOL, V123, P739, DOI 10.1007/s00401-012-0962-z; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Malik FI, 2011, J MOL CELL CARDIOL, V51, P454, DOI 10.1016/j.yjmcc.2011.05.006; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Ochala J., 2011, FASEB J; Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45923	10.1371/journal.pone.0045923	http://dx.doi.org/10.1371/journal.pone.0045923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029319	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900112
J	Jenkins, HE; Cox, DR; Delahay, RJ				Jenkins, Helen E.; Cox, D. R.; Delahay, Richard J.			Direction of Association between Bite Wounds and Mycobacterium bovis Infection in Badgers: Implications for Transmission	PLOS ONE			English	Article							MELES-MELES POPULATION; CATTLE TUBERCULOSIS; EURASIAN BADGERS; DISEASE; GLOUCESTERSHIRE; ORGANIZATION; PATHOLOGY; ENGLAND; TB	Background: Badgers are involved in the transmission to cattle of bovine tuberculosis (TB), a serious problem for the UK farming industry. Cross-sectional studies have shown an association between bite wounds and TB infection in badgers which may have implications for M. bovis transmission and control, although the sequence of these two events is unclear. Transmission during aggressive encounters could potentially reduce the effectiveness of policies which increase the average range of a badger and thus its opportunities for interaction with other social groups. Methods: Data were obtained on badgers captured during a long term study at Woodchester Park, UK (1998-2006). Many badgers had multiple observations. At each observation, the badger was assigned a "state'' depending on presence of bite wounds and/or TB infection. Hence each badger had a "transition'' from the previous state to the current state. We calculated the numbers of each type of transition and the time spent in each state. Transition rates were calculated for each transition category, dividing the number of such transitions by the total time at risk. We compared the rate of bite wound acquisition in infected badgers with that for uninfected badgers and the rate of positive M. bovis test results in bitten badgers with that in unbitten badgers. Results: The rate of bite wound acquisition in infected badgers (0.291 per year) was 2.09 (95% CI: 1.41, 3.08) times that in uninfected badgers (0.139 per year). The rate of positive M. bovis test results in bitten badgers (0.097 per year) was 2.45 (95% CI: 1.29, 4.65) times that in unbitten badgers (0.040 per year). Conclusions: We found strong evidence of both potential sequences of events consistent with transmission via bite wounds and distinctive behaviour in infected badgers. The complex relationship between behaviour and infection must be considered when planning TB control strategies.	[Jenkins, Helen E.] Univ London Imperial Coll Sci Technol & Med, Med Res Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Cox, D. R.] Univ Oxford, Dept Stat, Nuffield Coll, Oxford OX1 3TG, England; [Delahay, Richard J.] Food & Environm Res Agcy, Wildlife & Emerging Dis Programme, York, N Yorkshire, England	Imperial College London; University of Oxford; Food & Environment Research Agency	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Med Res Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	jenkins.helen@gmail.com	Delahay, Richard/GSI-4663-2022; Delahay, Richard/J-2261-2014	Jenkins, Helen/0000-0003-4749-1591	Food & Farming Group at Department for the Environment, Food and Rural Affairs (defra); defra; Department for the Environment, Food and Rural Affairs	Food & Farming Group at Department for the Environment, Food and Rural Affairs (defra); defra(Department for Environment, Food & Rural Affairs (DEFRA)); Department for the Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by funding from the Food & Farming Group at the Department for the Environment, Food and Rural Affairs (defra) with which data from the Woodchester Park study were collected. HEJ would like to thank defra for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HEJ has previously received consultancy fees from the Department for the Environment, Food and Rural Affairs for analyses of data from the Randomised Badger Culling Trial. DRC and RJD have no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bourne F., 2007, BOVINE TUBERCULOSIS; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Delahay RJ, 2006, ANIM BEHAV, V71, P1047, DOI 10.1016/j.anbehav.2005.07.018; DELAHAY RJ, 2000, J ANIM ECOL, V69, P1; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; Fagan J., 1993, P117; GALLAGHER J, 1976, VET REC, V98, P9, DOI 10.1136/vr.98.1.9; GALLAGHER J, 1979, VET REC, V105, P546; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Garnett BT, 2005, APPL ANIM BEHAV SCI, V94, P331, DOI 10.1016/j.applanim.2005.02.013; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; GOODGER J, 1994, VET REC, V135, P82, DOI 10.1136/vr.135.4.82; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Jenkins HE, 2007, EPIDEMIOL INFECT, P1; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; NOLAN A, 1994, VET MICROBIOL, V40, P179, DOI 10.1016/0378-1135(94)90054-X; PRITCHARD DG, 1986, J HYG-CAMBRIDGE, V97, P27, DOI 10.1017/S0022172400064329; Tuyttens FAM, 1999, J APPL ECOL, V36, P1051, DOI 10.1046/j.1365-2664.1999.00462.x; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; Wilkinson D, 2000, J ZOOL, V250, P389, DOI 10.1111/j.1469-7998.2000.tb00782.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103	28	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45584	10.1371/journal.pone.0045584	http://dx.doi.org/10.1371/journal.pone.0045584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029117	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400111
J	Layachi, S; Rogerieux, F; Robidel, F; Lacroix, G; Bayat, S				Layachi, Skander; Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam			Effet of Combined Nitrogen Dioxide and Carbon Nanoparticle Exposure on Lung Function During Ovalbumin Sensitization in Brown Norway Rat	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; METHACHOLINE-INDUCED BRONCHOCONSTRICTION; AIR-POLLUTION; INFLAMMATORY RESPONSES; ANTIGEN INHALATION; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; NO2-EXPOSED RATS; ALLERGIC-ASTHMA; MURINE MODEL	The interaction of particulate and gaseous pollutants in their effects on the severity of allergic inflammation and airway responsiveness are not well understood. We assessed the effect of exposure to NO2 in the presence or absence of repetitive treatment with carbon nanoparticle (CNP) during allergen sensitization and challenges in Borwn-Norway (BN) rat, in order to assess their interactions on lung function and airway responses (AR) to allergen and methacholine (MCH), end-expiratory lung volume (EELV), bronchoalveolar lavage fluid (BALF) cellular content, serum and BALF cytokine levels and histological changes. Animals were divided into the following groups (n = 6): Control; CNP (Degussa-FW2): 13 nm, 0.5 mg/kg instilled intratracheally x3 at 7-day intervals; OVA: ovalbumin-sensitised; OVA+CNP: both sensitized and exposed to CNP. Rats were divided into equal groups exposed either to air or to NO2, 10 ppm, 6 h/d, 5d/wk for 4 weeks. Exposure to NO2, significantly enhanced lung inflammation and airway reactivity, with a significantly larger effect in animals sensitized to allergen, which was related to a higher expression of TH1 and TH2-type cytokines. Conversely, exposure to NO2 in animals undergoing repeated tracheal instillation of CNP alone, increased BALF neutrophilia and enhanced the expression of TH1 cytokines: TNF-alpha and IFN-gamma, but did not show an additive effect on airway reactivity in comparison to NO2 alone. The exposure to NO2 combined with CNP treatment and allergen sensitization however, unexpectedly resulted in a significant decrease in both airway reactivity to allergen and to methacholine, and a reduction in TH2-type cytokines compared to allergen sensitization alone. EELV was significantly reduced with sensitization, CNP treatment or both. These data suggest an immunomodulatory effect of repeated tracheal instillation of CNP on the proinflammatory effects of NO2 exposure in sensitized BN rat. Furthermore, our findings suggest that NO2, CNP and OVA sensitization may significantly slow overall lung growth in parenchymally mature animals.	[Layachi, Skander; Bayat, Sam] Univ Picardie Jules Verne, EA4285, Lab Perinatal & Risques Tox, UMI01,INERIS, Amiens, France; [Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam] Amiens Univ Hosp, Paediat Lung Funct Lab, Dept Paediat Cardiol, Amiens, France; [Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam] Amiens Univ Hosp, Paediat Lung Funct Lab, Dept Resp Med, Amiens, France; Inst Natl Environm Ind & Risques INERIS, Verneuil En Halatte, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de l'Environnement Industriel et des Risques (INERIS)	Bayat, S (corresponding author), Univ Picardie Jules Verne, EA4285, Lab Perinatal & Risques Tox, UMI01,INERIS, Amiens, France.	bayat.sam@chu-amiens.fr	Lacroix, Ghislaine/Q-8005-2018	Lacroix, Ghislaine/0000-0002-3260-8526	European Regional Development Fund via a Picardie Regional Council grant [REG08009]	European Regional Development Fund via a Picardie Regional Council grant	This study was entirely funded by the European Regional Development Fund via a Picardie Regional Council grant #REG08009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Humadi NH, 2002, EXP LUNG RES, V28, P333, DOI 10.1080/01902140290091976; Alberg T, 2011, INHAL TOXICOL, V23, P268, DOI 10.3109/08958378.2011.566898; Alessandrini F, 2006, J ALLERGY CLIN IMMUN, V117, P824, DOI 10.1016/j.jaci.2005.11.046; BADIER M, 1988, J APPL PHYSIOL, V64, P323, DOI 10.1152/jappl.1988.64.1.323; Boland S, 2000, AM J PHYSIOL-LUNG C, V278, pL25, DOI 10.1152/ajplung.2000.278.1.L25; Bolle I, 2008, J APPL PHYSIOL, V104, P1167, DOI 10.1152/japplphysiol.00587.2007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan A. J., 1998, Reviews on Environmental Health, V13, P73; CHITANO P, 1995, EUR RESPIR J, V8, P1357, DOI 10.1183/09031936.95.08081357; Chow WK, 2003, BUILD ENVIRON, V38, P227, DOI 10.1016/S0360-1323(02)00120-8; de Haar C, 2006, CLIN EXP ALLERGY, V36, P1469, DOI 10.1111/j.1365-2222.2006.02586.x; Dong CC, 2005, TOXICOL SCI, V88, P202, DOI 10.1093/toxsci/kfi280; FOLKESSON HG, 1991, J APPL PHYSIOL, V71, P1106, DOI 10.1152/jappl.1991.71.3.1106; Garn H, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-4; Garn H, 2003, AM J RESP CELL MOL, V28, P386, DOI 10.1165/rcmb.4888; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gilmour MI, 1996, FUND APPL TOXICOL, V31, P65, DOI 10.1006/faat.1996.0076; Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Graham LeRoy M, 2004, Paediatr Respir Rev, V5 Suppl A, pS59, DOI 10.1016/S1526-0542(04)90012-7; Granum B, 2002, TOXICOL SCI, V65, P7, DOI 10.1093/toxsci/65.1.7; Habre W, 2001, ANESTHESIOLOGY, V94, P348, DOI 10.1097/00000542-200102000-00026; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HEDBERG K, 1989, JAMA-J AM MED ASSOC, V262, P3014; HOLT PG, 1987, IMMUNOLOGY, V60, P97; Hussain I, 2004, CHEST, V126, P198, DOI 10.1378/chest.126.1.198; Inoue K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-106; Janosi TZ, 2006, J APPL PHYSIOL, V101, P454, DOI 10.1152/japplphysiol.00011.2006; KAROL MH, 1994, EUR RESPIR J, V7, P555, DOI 10.1183/09031936.94.07030555; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; KIPS JC, 1992, AM REV RESPIR DIS, V145, P1306, DOI 10.1164/ajrccm/145.6.1306; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; Li XY, 1999, INHAL TOXICOL, V11, P709; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; MATSUMURA Y, 1970, AM REV RESPIR DIS, V102, P430; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Mosqueron L, 2002, OCCUP ENVIRON MED, V59, P550, DOI 10.1136/oem.59.8.550; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Oberdorster G, 2000, Res Rep Health Eff Inst, P5; Oberdorster G, 2000, RES REP HLTH EFF I, P75; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892; Pereira CEL, 2007, BRAZ J MED BIOL RES, V40, P1353, DOI 10.1590/S0100-879X2006005000164; Persinger RL, 2002, MOL CELL BIOCHEM, V234, P71, DOI 10.1023/A:1015973530559; Petak F, 1997, J APPL PHYSIOL, V82, P1479, DOI 10.1152/jappl.1997.82.5.1479; PIERSON WE, 1992, J ALLERGY CLIN IMMUN, V90, P557, DOI 10.1016/0091-6749(92)90128-O; Poynter ME, 2006, AM J PHYSIOL-LUNG C, V290, pL144, DOI 10.1152/ajplung.00131.2005; Proust B, 2002, MEDIAT INFLAMM, V11, P251, DOI 10.1080/096293502900000113; Samuelsen M, 2008, TOXICOLOGY, V246, P124, DOI 10.1016/j.tox.2008.01.001; Saric J, 2010, J PROTEOME RES, V9, P2255, DOI 10.1021/pr901019z; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sears BW, 2010, J INFLAMM RES, V3, P105, DOI 10.2147/JIR.S12853; Siddiqui S, 2010, J APPL PHYSIOL, V109, P1170, DOI 10.1152/japplphysiol.01168.2009; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; van de Woestijne KP, 1981, P 28 INT C PHYS SCI, P655, DOI DOI 10.1016/B978-0-08-026823-1.50083-1; van Zijverden M, 2000, TOXICOL APPL PHARM, V168, P131, DOI 10.1006/taap.2000.9013; Vanacker NJ, 2001, AM J RESP CRIT CARE, V163, P674, DOI 10.1164/ajrccm.163.3.2004160; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; Yamashita K, 2009, TOXICOLOGY, V261, P19, DOI 10.1016/j.tox.2009.04.034; Yanagisawa R, 2003, THORAX, V58, P605, DOI 10.1136/thorax.58.7.605	68	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45687	10.1371/journal.pone.0045687	http://dx.doi.org/10.1371/journal.pone.0045687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029182	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900052
J	Mao, QY; Dong, CH; Li, XL; Gao, Q; Guo, ZB; Yao, X; Wang, YP; Gao, F; Li, FX; Xu, M; Yin, WD; Li, QH; Shen, XL; Liang, ZL; Wang, JZ				Mao, Qunying; Dong, Chenghong; Li, Xiuling; Gao, Qiang; Guo, Zengbing; Yao, Xin; Wang, Yiping; Gao, Fan; Li, Fengxiang; Xu, Miao; Yin, Weidong; Li, Qihan; Shen, Xinliang; Liang, Zhenglun; Wang, Junzhi			Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; NEUTRALIZING ANTIBODY; MOUTH-DISEASE; LETHAL ENTEROVIRUS-71; EXPRESSING VP1; NEONATAL MICE; INFECTION; IMMUNIZATION; HAND; FOOT	Background: Enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD). Three inactivated EV71 whole-virus vaccines of different strains developed by different manufacturers in mainland China have recently entered clinical trials. Although several studies on these vaccines have been published, a study directly comparing the immunogenicity and protective effects among them has not been carried out, which makes evaluating their relative effectiveness difficult. Thus, properly comparing newly developed vaccines has become a priority, especially in China. Methods and Findings: This comparative immunogenicity study was carried out on vaccine strains (both live and inactivated), final container products (FCPs) without adjuvant, and corresponding FCPs containing adjuvant (FCP-As) produced by three manufacturers. These vaccines were evaluated by neutralizing antibody (NAb) responses induced by the same or different dosages at one or multiple time points post-immunization. The protective efficacy of the three vaccines was also determined in one-day-old ICR mice born to immunized female mice. Survival rates were observed in these suckling mice after challenge with 20 LD50 of EV71/048M3C2. Three FCP-As, in a dose of 200 U, generated nearly 100% NAb positivity rates and similar geometric mean titers (GMTs), especially at 14-21 days post-inoculation. However, the dynamic NAb responses were different among three vaccine strains or three FCPs. The FCP-As at the lowest dose used in clinical trials (162 U) showed good protective effects in suckling mice against lethal challenge (90-100% survival), while the ED50 of NAb responses and protective effects varied among three FCP-As. Conclusions: These studies establish a standard method for measuring the immunogenicity of EV71 vaccines in mice. The data generated from our mouse model study indicated a clear dose-response relationship, which is important for vaccine quality control and assessment, especially for predicting protective efficacy in humans when combined with future clinical trial results.	[Mao, Qunying; Yao, Xin; Wang, Yiping; Gao, Fan; Li, Fengxiang; Xu, Miao; Liang, Zhenglun; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Dong, Chenghong] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Li, Xiuling; Shen, Xinliang] Natl Vaccine & Serum Inst, Beijing, Peoples R China; [Gao, Qiang; Yin, Weidong] Sinovac Biotech Co Ltd, Beijing, Peoples R China; [Guo, Zengbing; Li, Qihan] Hualan Biol Engn Inc, Henan, Peoples R China	National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS	Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	lzlun@yahoo.com; wangjz@nicpbp.org.cn	li, xiu/GXV-1745-2022		Ministry of Science and Technology of the People's Republic of China [2008BAI69B01, 2009ZX10004-804]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The current study was sponsored by the National Science Project (No. 2008BAI69B01) and the National 11th Five Major Special Projects Funding Program (No. 2009ZX10004-804) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen HF, 2006, VACCINE, V24, P2944, DOI 10.1016/j.vaccine.2005.12.047; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Grandien M, 1995, DIAGNOSTIC PROCEDURE, P279; HAMILTON MA, 1979, J AM STAT ASSOC, V74, P344, DOI 10.2307/2286333; Jia Hui, 2010, Chinese Journal of Biologicals, V23, P87; Kim Kyung Hyo, 2010, Korean J Pediatr, V53, P616, DOI 10.3345/kjp.2010.53.5.616; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, J VIROL METHODS, V176, P60, DOI 10.1016/j.jviromet.2011.06.001; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Ma E, 2010, JPN J INFECT DIS, V63, P422; Mao Qun-ying, 2010, Chinese Journal of Biologicals, V23, P885; Mao Qun-ying, 2009, Chinese Journal of Biologicals, V22, P911; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; SHIRODKAR S, 1990, PHARMACEUT RES, V7, P1282, DOI 10.1023/A:1015994006859; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang Li-chun, 2010, Virologica Sinica, V25, P98, DOI 10.1007/s12250-010-3102-8; Wang SM, 2012, EUR J CLIN MICROBIOL, V31, P1219, DOI 10.1007/s10096-011-1432-6; White JL, 2000, PHYSICOCHEMICAL PROC, P217; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368	40	29	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46043	10.1371/journal.pone.0046043	http://dx.doi.org/10.1371/journal.pone.0046043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029378	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900077
J	Asan; Geng, CY; Chen, Y; Wu, K; Cai, QL; Wang, Y; Lang, YS; Cao, HZ; Yang, HM; Wang, J; Zhang, XQ				Asan; Geng, Chunyu; Chen, Yan; Wu, Kui; Cai, Qingle; Wang, Yu; Lang, Yongshan; Cao, Hongzhi; Yang, Huangming; Wang, Jian; Zhang, Xiuqing			Paired-End Sequencing of Long-Range DNA Fragments for De Novo Assembly of Large, Complex Mammalian Genomes by Direct Intra-Molecule Ligation	PLOS ONE			English	Article							SHORT-READ; STRUCTURAL VARIATION; STRATEGY; MAP; PET	Background: The relatively short read lengths from next generation sequencing (NGS) technologies still pose a challenge for de novo assembly of complex mammal genomes. One important solution is to use paired-end (PE) sequence information experimentally obtained from long-range DNA fragments (>1 kb). Here, we characterize and extend a long-range PE library construction method based on direct intra-molecule ligation (or molecular linker-free circularization) for NGS. Results: We found that the method performs stably for PE sequencing of 2- to 5- kb DNA fragments, and can be extended to 10-20 kb (and even in extremes, up to similar to 35 kb). We also characterized the impact of low quality input DNA on the method, and develop a whole-genome amplification (WGA) based protocol using limited input DNA (<1 mu g). Using this PE dataset, we accurately assembled the YanHuang (YH) genome, the first sequenced Asian genome, into a scaffold N50 size of >2 Mb, which is over100-times greater than the initial size produced with only small insert PE reads(17 kb). In addition, we mapped two 7- to 8- kb insertions in the YH genome using the larger insert sizes of the long-range PE data. Conclusions: In conclusion, we demonstrate here the effectiveness of this long-range PE sequencing method and its use for the de novo assembly of a large, complex genome using NGS short reads.	[Asan; Geng, Chunyu; Chen, Yan; Wu, Kui; Cai, Qingle; Wang, Yu; Lang, Yongshan; Cao, Hongzhi; Yang, Huangming; Wang, Jian; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Beijing Genomics Institute (BGI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	wangjian@genomics.org.cn; zhangxq@genomics.org.cn			National High Technology Research and Development Program of China [2006AA02A302, 2009AA022707]; National Natural Science Foundation of China [30811130531]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High Technology Research and Development Program of China (2006AA02A302, 2009AA022707), and National Natural Science Foundation of China (30811130531). Funding for open access charge: National High Technology Research and Development Program of China (2006AA02A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Donahue WF, 2007, CURR PROTOC HUM GENE; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Harris R. S., 2007, THESIS PENNSYLVANIA; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	27	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46211	10.1371/journal.pone.0046211	http://dx.doi.org/10.1371/journal.pone.0046211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029438	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500073
J	Wajnberg, E; Curty, C; Jervis, M				Wajnberg, Eric; Curty, Christine; Jervis, Mark			Intra-Population Genetic Variation in the Temporal Pattern of Egg Maturation in a Parasitoid Wasp	PLOS ONE			English	Article							TRICHOGRAMMA-MAIDIS PINTUREAU; LIFE-HISTORY EVOLUTION; BODY-SIZE; TRADE-OFFS; ALLOCATION; FECUNDITY; INSECTS; LOAD; TIME; CONSEQUENCES	Parasitoid wasps are taxonomically and biologically extremely diverse. A conceptual framework has recently been developed for understanding life-history evolution and diversification in these animals, and it has confirmed that each of two linked life-history traits - the mode of larval development and the temporal pattern of egg maturation - acts as an organiser of life-history. The framework has been predicated on the assumption that there exists sufficient genetic variation in the latter trait to allow it to be shaped by natural selection. Focusing on the parasitoid wasp Trichogramma brassicae, our aim was to test the validity of that assumption, using established quantitative genetic methods. We demonstrate the existence of a statistically significant degree of intra-population polygenic variation in the temporal pattern of egg production within the wasp population we studied. Furthermore, our results, together with published data on clinal variation in the egg maturation pattern of another species, suggest that intra-specific evolutionary shifts in the temporal pattern of egg maturation of parasitoid wasps can result from a change in allocation to egg production either before, or very shortly after adult emergence, without there being an accompanying change in lifetime fecundity. As well as opening new avenues of research into the reproductive strategies, behaviour, community organisation and biological control potential of parasitoid wasps, this discovery also has implications for studies of life-history evolution and diversification in insects generally.	[Wajnberg, Eric; Curty, Christine] INRA, Sophia Antipolis, France; [Jervis, Mark] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	INRAE; Cardiff University	Wajnberg, E (corresponding author), INRA, Sophia Antipolis, France.	wajnberg@sophia.inra.fr	Wajnberg, Eric/A-4862-2009	Wajnberg, Eric/0000-0002-6700-7114				Bernstein Carlos, 2008, P129, DOI 10.1002/9780470696200.ch7; BIGLER F, 1987, J APPL ENTOMOL, V104, P340, DOI 10.1111/j.1439-0418.1987.tb00535.x; BLACKBURN TM, 1991, FUNCT ECOL, V5, P65, DOI 10.2307/2389556; BLACKBURN TM, 1991, J ANIM ECOL, V60, P151, DOI 10.2307/5451; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; BRUINS EBAW, 1994, ENTOMOL EXP APPL, V72, P297, DOI 10.1007/BF02383818; Clausen C. P., 1940, ENTOMOPHAGOUS INSECT; Dieckhoff C, 2010, ENTOMOL EXP APPL, V136, P254, DOI 10.1111/j.1570-7458.2010.01024.x; Dixon AFG, 2002, ECOL ENTOMOL, V27, P433, DOI 10.1046/j.1365-2311.2002.00429.x; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2004, EVOL ECOL RES, V6, P993; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Falconer D. S., 1981, INTRO QUANTITATIVE G; Gauld I. D., 1988, HYMENOPTERA; Hajek A.E., 2004, NATURAL ENEMIES INTR; Hassell M.P., 2000, SPATIAL TEMPORAL DYN; Hawkins B. A., 1994, PATTERN PROCESS HOST; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Heimpel GE, 1997, OECOLOGIA, V110, P346, DOI 10.1007/s004420050168; HOFFMANN AA, 1988, GENET SEL EVOL, V20, P87, DOI 10.1186/1297-9686-20-1-87; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jervis M.A., 2005, P73, DOI 10.1007/1-4020-2625-0_2; JERVIS MA, 1994, J APPL ENTOMOL, V117, P72, DOI 10.1111/j.1439-0418.1994.tb00709.x; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; Jervis MA, 2004, OIKOS, V107, P449, DOI 10.1111/j.0030-1299.2004.13453.x; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis M, 2011, BIOL J LINN SOC, V104, P443, DOI 10.1111/j.1095-8312.2011.01719.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jervis MA, 2007, BIOL J LINN SOC, V90, P293, DOI 10.1111/j.1095-8312.2007.00721.x; Jones TS, 2009, OECOLOGIA, V159, P627, DOI 10.1007/s00442-008-1247-z; Kindlmann P, 2001, J EVOLUTION BIOL, V14, P835, DOI 10.1046/j.1420-9101.2001.00323.x; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Lasalle John, 1993, P1; Lewontin R. C., 1965, P77; Mayhew PJ, 1999, J ANIM ECOL, V68, P906, DOI 10.1046/j.1365-2656.1999.00338.x; Mills NJ, 2000, ECOL ENTOMOL, V25, P315, DOI 10.1046/j.1365-2311.2000.00260.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Parsons P.A., 1980, Evolutionary Biology (New York), V13, P175; PINTUREAU B, 1981, AGRONOMIE, V1, P315, DOI 10.1051/agro:19810409; Roff Derek, 2002, pi; Shuker DM, 2007, HEREDITY, V98, P69, DOI 10.1038/sj.hdy.6800897; Stearns S.C., 1992, pi; Thorne AD, 2006, P ROY SOC B-BIOL SCI, V273, P1099, DOI 10.1098/rspb.2005.3416; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WAJNBERG E, 1989, ENTOMOPHAGA, V34, P397, DOI 10.1007/BF02372479; Wajnberg E, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P19, DOI 10.1079/9780851997353.0019; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; WAJNBERG E, 1989, ENTOMOL EXP APPL, V53, P177, DOI 10.1007/BF00187999; Wajnberg E, 1999, J ANIM ECOL, V68, P121, DOI 10.1046/j.1365-2656.1999.00270.x; Wajnberg E, 1994, BIOL CONTROL EGG PAR	53	12	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45915	10.1371/journal.pone.0045915	http://dx.doi.org/10.1371/journal.pone.0045915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029312	Green Accepted, Green Published, gold			2022-12-27	WOS:000309517500046
J	Heide, J; Mann, SA; Vandenberg, JI				Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.			The Schizophrenia-Associated Kv11.1-3.1 Isoform Results in Reduced Current Accumulation during Repetitive Brief Depolarizations	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; MOLECULAR-BASIS; ACTIVATION; GENES; KCNH2	Recent genome wide association studies identified a brain and primate specific isoform of a voltage-gated potassium channel, referred to as Kv11.1-3.1, which is significantly associated with schizophrenia. The 3.1 isoform replaces the first 102 amino acids of the most abundant isoform (referred to as Kv11.1-1A) with six unique amino acids. Here we show that the Kv11.1-3.1 isoform has faster rates of channel deactivation but a slowing of the rates of inactivation compared to the Kv11.1-1A isoform. The Kv11.1-3.1 isoform also has a significant depolarizing shift in the voltage-dependence of steady-state inactivation. The consequence of the altered gating kinetics is that there is lower current accumulation for Kv11.1-3.1 expressing cells during repetitive action potential firing compared to Kv11.1-1A expressing cells, which in turn will result in longer lasting trains of action potentials. Increased expression of Kv11.1-3.1 channels in the brain of schizophrenia patients might therefore contribute to disorganized neuronal firing.	[Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Heide, Juliane; Vandenberg, Jamie I.] Schizophrenia Res Inst, Darlinghurst, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Mann, Stefan/H-3874-2011; Vandenberg, Jamie I/B-6608-2013	Mann, Stefan/0000-0003-4533-2300; Vandenberg, Jamie I/0000-0002-3859-3716; Heide, Juliane/0000-0001-9395-4724	Schizophrenia Research Institute; St. Vincent's Clinic Foundation; National Health and Medical Research Council [1019693]	Schizophrenia Research Institute; St. Vincent's Clinic Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Schizophrenia Research Institute (http://www.schizophreniaresearch.org.au/), St. Vincent's Clinic Foundation (http://www.clinic.stvincents.com.au/clinic-foundation), and National Health and Medical Research Council (1019693) (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2010, NATURE, V468, P158, DOI 10.1038/468158a; Atalar F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-27; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Hamilton SP, 2008, AM J PSYCHIAT, V165, P420, DOI 10.1176/appi.ajp.2008.08020218; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2011, WORLD J BIOL PSYCHIA, DOI [10.3109/15622975.15622011.15604350, DOI 10.3109/15622975.15622011.15604350)]; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmitt A, 2008, EUR ARCH PSY CLIN N, V258, P35, DOI 10.1007/s00406-008-5019-x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Shepard PD, 2007, SCHIZOPHRENIA BULL, V33, P1263, DOI 10.1093/schbul/sbm106; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan Hao-Yang, 2009, Cogn Neuropsychiatry, V14, P277, DOI 10.1080/13546800903091665; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Walker BD, 1999, BRIT J PHARMACOL, V128, P444, DOI 10.1038/sj.bjp.0702774; Wang DY, 2010, CURR DRUG TARGETS, V11, P1; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637	24	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45624	10.1371/journal.pone.0045624	http://dx.doi.org/10.1371/journal.pone.0045624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029143	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700054
J	Lopez-Rosas, I; Orozco, E; Marchat, LA; Garcia-Rivera, G; Guillen, N; Weber, C; Carrillo-Tapia, E; de la Cruz, OH; Perez-Plasencia, C; Lopez-Camarillo, C				Lopez-Rosas, Itzel; Orozco, Esther; Marchat, Laurence A.; Garcia-Rivera, Guillermina; Guillen, Nancy; Weber, Christian; Carrillo-Tapia, Eduardo; Hernandez de la Cruz, Olga; Perez-Plasencia, Carlos; Lopez-Camarillo, Cesar			mRNA Decay Proteins Are Targeted to poly(A)(+) RNA and dsRNA-Containing Cytoplasmic Foci That Resemble P-Bodies in Entamoeba histolytica	PLOS ONE			English	Article							PROCESSING BODIES; GENE-EXPRESSION; STRESS GRANULES; HUMAN-CELLS; SITES; INTERFERENCE; DEADENYLATION; TRYPANOSOMES; DEGRADATION; STABILITY	In higher eukaryotes, mRNA degradation and RNA-based gene silencing occur in cytoplasmic foci referred to as processing bodies (P-bodies). In protozoan parasites, the presence of P-bodies and their putative role in mRNA decay have yet to be comprehensively addressed. Identification of P-bodies might provide information on how mRNA degradation machineries evolved in lower eukaryotes. Here, we used immunofluorescence and confocal microscopy assays to investigate the cellular localization of mRNA degradation proteins in the human intestinal parasite Entamoeba histolytica and found evidence of the existence of P-bodies. Two mRNA decay factors, namely the EhXRN2 exoribonuclease and the EhDCP2 decapping enzyme, were localized in cytoplasmic foci in a pattern resembling P-body organization. Given that amoebic foci appear to be smaller and less rounded than those described in higher eukaryotes, we have named them "P-body-like structures''. These foci contain additional mRNA degradation factors, including the EhCAF1 deadenylase and the EhAGO2-2 protein involved in RNA interference. Biochemical analysis revealed that EhCAF1 co-immunoprecipitated with EhXRN2 but not with EhDCP2 or EhAGO2-2, thus linking deadenylation to 5'-to-3' mRNA decay. The number of EhCAF1-containing foci significantly decreased after inhibition of transcription and translation with actinomycin D and cycloheximide, respectively. Furthermore, results of RNA-FISH assays showed that (i) EhCAF1 colocalized with poly(A)(+) RNA and (ii) during silencing of the Ehpc4 gene by RNA interference, EhAGO2-2 colocalized with small interfering RNAs in cytoplasmic foci. Our observation of decapping, deadenylation and RNA interference proteins within P-body-like foci suggests that these structures have been conserved after originating in the early evolution of eukaryotic lineages. To the best of our knowledge, this is the first study to report on the localization of mRNA decay proteins within P-body-like structures in E. histolytica. Our findings should open up opportunities for deciphering the mechanisms of mRNA degradation and RNA-based gene silencing in this deep-branching eukaryote.	[Lopez-Rosas, Itzel; Orozco, Esther; Carrillo-Tapia, Eduardo; Hernandez de la Cruz, Olga; Lopez-Camarillo, Cesar] Univ Autonoma Ciudad Mexico, Programa Ciencias Genom, Mexico City, DF, Mexico; [Orozco, Esther; Garcia-Rivera, Guillermina] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico; [Marchat, Laurence A.] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Programa Inst Biomed Mol & Red Biotecnol, Mexico City, DF, Mexico; [Guillen, Nancy; Weber, Christian] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Guillen, Nancy; Weber, Christian] INSERM, U786, Paris, France; [Perez-Plasencia, Carlos] Inst Nacl Canc, Unidad Genom & Secuenciac Masiva, Mexico City, DF, Mexico; [Perez-Plasencia, Carlos] Univ Nacl Autonoma Mexico, Unidad Biomed, Fac Estudios Super Iztacala, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Lopez-Camarillo, C (corresponding author), Univ Autonoma Ciudad Mexico, Programa Ciencias Genom, Mexico City, DF, Mexico.	cesar.lopez@uacm.edu.mx	Perez-Plasencia, Carlos/P-2372-2019; López-Rosas, Itzel/GVU-8431-2022; Lopez-Camarillo, Cesar/I-1946-2019; Weber, Christian/AAW-2153-2020; Marchat, Laurence A./S-8418-2018	Perez-Plasencia, Carlos/0000-0002-8593-8211; Lopez-Camarillo, Cesar/0000-0002-9417-2609; Weber, Christian/0000-0003-4610-8714; Marchat, Laurence A./0000-0003-1615-8614; Hernandez, Olga Nohemi/0000-0003-2623-5329; Lopez-Rosas, Itzel/0000-0003-3864-260X	Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD) [M08-S02]; European community; Autonomous University of Mexico City	Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD); European community(European Commission); Autonomous University of Mexico City	This work was supported by Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD) grant M08-S02 and European community grants. The authors acknowledge Autonomous University of Mexico City for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2008, PRION, V2, P131, DOI 10.4161/pri.2.4.7773; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Camarillo C, 2003, J BIOL CHEM, V278, P11273, DOI 10.1074/jbc.M211757200; Lopez-Camarillo C, 2008, GENE, V414, P19, DOI 10.1016/j.gene.2008.01.024; Lopez-Casamichana M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-35; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Marchat LA, 2002, CELL MICROBIOL, V4, P725, DOI 10.1046/j.1462-5822.2002.00220.x; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Solis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008424; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45966	10.1371/journal.pone.0045966	http://dx.doi.org/10.1371/journal.pone.0045966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029343	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700098
J	Reed, JR; Stone, MD; Beadnell, TC; Ryu, Y; Griffin, TJ; Schwertfeger, KL				Reed, Johanna R.; Stone, Matthew D.; Beadnell, Thomas C.; Ryu, Yungil; Griffin, Timothy J.; Schwertfeger, Kathryn L.			Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; MOLECULAR CHARACTERIZATION; FRACTALKINE RECEPTOR; CHEMOKINE RECEPTORS; MOUSE MODEL; EXPRESSION; PROGRESSION; MIGRATION; INVOLVEMENT	Tumor formation is an extensive process requiring complex interactions that involve both tumor cell-intrinsic pathways and soluble mediators within the microenvironment. Tumor cells exploit the intrinsic functions of many soluble molecules, including chemokines and their receptors, to regulate pro-tumorigenic phenotypes that are required for growth and progression of the primary tumor. Previous studies have shown that activation of inducible FGFR1 (iFGFR1) in mammary epithelial cells resulted in increased proliferation, migration, and invasion in vitro and tumor formation in vivo. These studies also demonstrated that iFGFR1 activation stimulated recruitment of macrophages to the epithelium where macrophages contributed to iFGFR1-mediated epithelial cell proliferation and angiogenesis. The studies presented here further utilize this model to identify the mechanisms that regulate FGFR1-induced macrophage recruitment. Results from this study elucidate a novel role for the inflammatory chemokine CX3CL1 in FGFR1-induced macrophage migration. Specifically, we illustrate that activation of both the inducible FGFR1 construct in mouse mammary epithelial cells and endogenous FGFR in the triple negative breast cancer cell line, HS578T, leads to expression of the chemokine CX3CL1. Furthermore, we demonstrate that FGFR-induced CX3CL1 is sufficient to recruit CX3CR1-expressing macrophages in vitro. Finally, blocking CX3CR1 in vivo leads to decreased iFGFR1-induced macrophage recruitment, which correlates with decreased angiogenesis. While CX3CL1 is a known target of FGF signaling in the wound healing environment, these studies demonstrate that FGFR activation also leads to induction of CX3CL1 in a tumor setting. Furthermore, these results define a novel role for CX3CL1 in promoting macrophage recruitment during mammary tumor formation, suggesting that the CX3CL1/CX3CR1 axis may represent a potential therapeutic approach for targeting breast cancers associated with high levels of tumor-associated macrophages.	[Reed, Johanna R.; Schwertfeger, Kathryn L.] Univ Minnesota, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Ryu, Yungil; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Ryu, Yungil; Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schwertfeger, KL (corresponding author), Univ Minnesota, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA.	schwe251@umn.edu		Griffin, Timothy/0000-0001-6801-2559	Department of Defense (DOD) [BC100038]; National Institutes of Health/National Cancer Institute (NIH/NCI) [R01CA132837]; NATIONAL CANCER INSTITUTE [R01CA132827, T32CA009138] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was provided by a Department of Defense (DOD) pre-doctoral fellowship BC100038 to JRR and National Institutes of Health/National Cancer Institute (NIH/NCI) R01CA132837 to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Courjal F, 1997, CANCER RES, V57, P4360; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dickson C, 2000, BREAST CANCER RES, V2, P191, DOI 10.1186/bcr53; Ferretti E, 2011, LEUKEMIA, V25, P1268, DOI 10.1038/leu.2011.88; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gil-Bernabe A. M., 2012, BLOOD; Graham K, 2011, CLIN CANCER RES, V17, P236, DOI 10.1158/1078-0432.CCR-10-1369; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Koizumi K, 2009, J IMMUNOL, V183, P7825, DOI 10.4049/jimmunol.0803627; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nevo I, 2009, CANCER LETT, V273, P127, DOI 10.1016/j.canlet.2008.07.029; Park MH, 2012, J SURG ONCOL; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Presta M, 2009, EUR CYTOKINE NETW, V20, P39, DOI 10.1684/ecn.2009.0155; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tuck AB, 1997, ARCH PATHOL LAB MED, V121, P578; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; White GE, 2009, BLOOD, V113, P767, DOI 10.1182/blood-2008-11-189860; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812; Yuen T, 2002, METHOD ENZYMOL, V345, P556	60	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45877	10.1371/journal.pone.0045877	http://dx.doi.org/10.1371/journal.pone.0045877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029290	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700082
J	Saito, S; Murase, K				Saito, Shigeyoshi; Murase, Kenya			Detection and Early Phase Assessment of Radiation-Induced Lung Injury in Mice Using Micro-CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MOUSE LUNG; PULMONARY-FIBROSIS; THORACIC IRRADIATION; EMPHYSEMA; DAMAGE; MODEL; CHEMOTHERAPY; RADIOTHERAPY; PNEUMONITIS	Radiation therapy is an important therapeutic modality for thoracic malignancies. However, radiation-induced pulmonary injuries such as radiation pneumonitis and fibrosis are major dose-limiting factors. Previous research shows that micro-computed tomography (micro-CT) can detect radiation-induced lung injuries a few months following irradiation, but studies to assess the early response of lung tissue are lacking. The aim of this study was to determine if micro-CT could be used to detect and assess early-phase radiation-induced lung injury in mice. Twenty-one animals were divided into three groups: normal (n = 7), one day after x-ray exposure (n = 7), and at four days after x-ray exposure (n = 7). The x-ray-exposed groups received a single dose of 20 Gy, to the whole lung. Histology showed enlargements of the air space (Lm: mean chord length) following irradiation. 40.5 +/- 3.8 mu m and 60.0 +/- 6.9 mu m were observed after one and four days, respectively, compared to 26.5 +/- 3.1 mu m in normal mice. Three-dimensional micro-CT images were constructed and histograms of radiodensity Hounsfield Units (HU) - were used to assess changes in mouse lungs. Radiation-induced lung injury was observed in irradiated mice, by the use of two parameters which were defined as shifts in peak HU between -200 to -800 HU (Peak(HU)) and increase in the number of pixels at -1000 HU (Number(-1000)). These parameters were correlated with histological changes. The results demonstrate that micro-CT can be used for the early detection and assessment of structural and histopathological changes resulting from radiation-induced lung injury in mice. Micro-CT has the advantage, over traditional histological techniques, of allowing longitudinal studies of lung disease progression and assessment of the entire lung, while reducing the number of animals required for such studies.	[Saito, Shigeyoshi; Murase, Kenya] Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Osaka, Japan	Osaka University	Saito, S (corresponding author), Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Osaka, Japan.	saito@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [24791299]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (No. 24791299) for Scientific Research (Kakenhi) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; ADAMSON IYR, 1970, AM J PATHOL, V58, P481; Artaechevarria X, 2011, EUR RADIOL, V21, P954, DOI 10.1007/s00330-010-1982-5; Cha JH, 2009, AM J ROENTGENOL, V193, pW95, DOI [10.2214/AJR.08.1833, 10.2214/AJR.08.2298]; Chen YY, 2002, SEMIN RADIAT ONCOL, V12, P26, DOI 10.1053/srao.2002.31360; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; COGGLE JE, 1986, ENVIRON HEALTH PERSP, V70, P261, DOI 10.2307/3430363; Ding XA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-24; Downing L, 2010, RADIAT RES, V173, P536, DOI 10.1667/RR1712.1; FIELD SB, 1976, BRIT J RADIOL, V49, P700, DOI 10.1259/0007-1285-49-584-700; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Ford NL, 2009, PHYS MED BIOL, V54, P2121, DOI 10.1088/0031-9155/54/7/018; Froese AR, 2007, EUR RESPIR J, V30, P1082, DOI 10.1183/09031936.00000507; Grutters JPC, 2010, RADIOTHER ONCOL, V95, P32, DOI 10.1016/j.radonc.2009.08.003; Hind M, 2004, EUR RESPIR J, V23, P20, DOI 10.1183/09031936.03.00119103; Ibuki Y, 1997, FREE RADICAL BIO MED, V22, P1029, DOI 10.1016/S0891-5849(96)00500-X; Jackson IL, 2011, RADIAT RES, V175, P510, DOI 10.1667/RR2421.1; Jackson IL, 2010, RADIAT RES, V173, P10, DOI 10.1667/RR1911.1; Jorgensen SM, 1998, AM J PHYSIOL-HEART C, V275, pH1103, DOI 10.1152/ajpheart.1998.275.3.H1103; Kameoka S, 2010, DENTOMAXILLOFAC RAD, V39, P441, DOI 10.1259/dmfr/37174063; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; Kimura T, 2006, INT J RADIAT ONCOL, V66, P483, DOI 10.1016/j.ijrobp.2006.05.008; MAISIN JR, 1970, RADIAT RES, V44, P545, DOI 10.2307/3573214; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; MOOSAVI H, 1977, INT J RADIAT ONCOL, V2, P921, DOI 10.1016/0360-3016(77)90190-0; Nakaya Yoshihiro, 2002, Nihon Hoshasen Gijutsu Gakkai Zasshi, V58, P885; NICHOLAS D, 1985, RADIOTHER ONCOL, V4, P253, DOI 10.1016/S0167-8140(85)80090-6; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; PHILLIPS TL, 1975, CANCER, V35, P1678, DOI 10.1002/1097-0142(197506)35:6<1678::AID-CNCR2820350629>3.0.CO;2-K; Postnov AA, 2005, J MICROSC-OXFORD, V220, P70, DOI 10.1111/j.1365-2818.2005.01510.x; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Shofer S, 2008, J APPL PHYSIOL, V105, P669, DOI 10.1152/japplphysiol.00980.2007; STEEL GG, 1979, BRIT J RADIOL, V52, P741, DOI 10.1259/0007-1285-52-621-741; Toma Claudia Lucia, 2011, Pneumologia, V60, P40; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239	38	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45960	10.1371/journal.pone.0045960	http://dx.doi.org/10.1371/journal.pone.0045960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029340	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700097
J	Van, ATN; Choisy, M; Nguyen, DH; Thanh, HTT; Kim, LTP; Phuong, TTD; Philippe, J; Nguyen, TS; Ho, ML; Tran, SV; Banuls, AL; Dang, DA				Van Anh Thi Nguyen; Choisy, Marc; Duy Hung Nguyen; Thanh Hoa Thi Tran; Kim Lien Thi Pham; Phuong Thao Thi Dinh; Philippe, Jules; Thai Son Nguyen; Minh Ly Ho; Sang Van Tran; Banuls, Anne-Laure; Duc Anh Dang			High Prevalence of Beijing and EAI4-VNM Genotypes among M. tuberculosis Isolates in Northern Vietnam: Sampling Effect, Rural and Urban Disparities	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENETIC DIVERSITY; STRAINS; FAMILY; DATABASE; COMPLEX; MIRU; DISSEMINATION; DIAGNOSIS; UTILITY	A total of 221 isolates of M. tuberculosis were sampled from hospitals and the general population in the northern plain of Vietnam, one of the most populated region of the country. Genotypic composition and diversity were characterized, and we investigated how they are affected by sampling (hospital vs. general population), correcting for potential confounding effects (location, age and gender of the patients). Spoligotyping and 12 MIRU-VNTR typing were used as first line. Then 15 MIRU-VNTR standard set was used, making 21 MIRU-VNTR typing for the clustered isolates. Result showed that 8 lineages and 13 sub-lineages were circulating in the region. The most predominant lineages were Beijing (38.5%) and EAI (38.5%). Others appeared with small proportions H (1.4%), LAM (1.8%), T (8.1%), X (0.9%), MANU (2.3%), and Zero (0.4%). Higher clustering rate was found in the hospital samples (17.9% in urban and 19.2% in rural areas) compared to the population ones (0%). The typical Vietnamese EAI4-VNM sub-lineage of EAI lineage accounted for 67% of EAI strains and was associated with older ages. Beijing genotypes were associated with younger, urban population and were characterized by high clustering rates. These characteristics strongly suggest that Beijing strains are invading the population, replacing the local EAI-VNM4, thus predicting a more serious tuberculosis situation in the future in the absence of more effective control strategies.	[Van Anh Thi Nguyen; Thanh Hoa Thi Tran; Kim Lien Thi Pham; Phuong Thao Thi Dinh; Philippe, Jules; Minh Ly Ho; Duc Anh Dang] Natl Inst Hyg & Epidemiol, Dept Bacteriol, Hanoi, Vietnam; [Choisy, Marc; Banuls, Anne-Laure] Univ Montpellier 1 & 2, MIVEGEC, IRD 224, CNRS 5290,Ctr IRD, Montpellier, France; [Duy Hung Nguyen] Hung Yen Hlth Serv, Hung Yen, Vietnam; [Thai Son Nguyen] Mil Med Univ, Hosp 103, Dept Microbiol, Hanoi, Vietnam; [Sang Van Tran] Hanoi Med Univ, Dept TB, Hanoi, Vietnam	National Institute of Hygiene & Epidemiology (NIHE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Hanoi Medical University	Van, ATN (corresponding author), Natl Inst Hyg & Epidemiol, Dept Bacteriol, Hanoi, Vietnam.	vananhtdt@gmail.com	Choisy, Marc/J-7131-2016; Choisy, Marc/AAE-2557-2020	Choisy, Marc/0000-0002-5187-6390; Choisy, Marc/0000-0002-5187-6390; NGUYEN, THAI SON/0000-0002-5878-9150; Banuls, Anne-Laure/0000-0002-2106-8667	Ministry of Science and Technology of Vietnamese through the project "Molecular Epidemiology of Tuberculosis in Vietnam"; Le Centre national de la recherche scientifique through the project "Biodiversity and Infectious Diseases in Vietnam" (GDRI)	Ministry of Science and Technology of Vietnamese through the project "Molecular Epidemiology of Tuberculosis in Vietnam"; Le Centre national de la recherche scientifique through the project "Biodiversity and Infectious Diseases in Vietnam" (GDRI)	This study was supported by Ministry of Science and Technology of Vietnamese through the project "Molecular Epidemiology of Tuberculosis in Vietnam" and by Le Centre national de la recherche scientifique through the project called "Biodiversity and Infectious Diseases in Vietnam" (GDRI). Data used in this work were partly produced through the technical facilities of the "Centre Mediterraneen Environnement Biodiversite". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2009, EMERG INFECT DIS, V15, P1570, DOI 10.3201/eid1510.090170; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Farnia P, 2007, EPIDEMIOL INFECT, V135, P346, DOI 10.1017/S0950268806006790; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Friedman CR, 1997, J INFECT DIS, V176, P478, DOI 10.1086/514067; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Grant A, 2008, J MOL EVOL, V66, P565, DOI 10.1007/s00239-008-9104-6; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hung NV, 2011, J FRANCO VIETNAMIEN, V2, P62; Iwamoto T, 2007, FEMS MICROBIOL LETT; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kam KM, 2005, J CLIN MICROBIOL, V43, P306, DOI 10.1128/JCM.43.1.306-313.2005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang H, 2009, TUBERC RESPIR DIS, V67, P499, DOI 10.4046/trd.2009.67.6.499; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kubin M., 2003, Epidemiologie Mikrobiologie Imunologie, V52, P3; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Long NH, 1999, INT J TUBERC LUNG D, V3, P388; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Parwati I, 2008, J CLIN MICROBIOL, V46, P3639, DOI 10.1128/JCM.00605-08; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; SMALL PM, 1993, J CLIN MICROBIOL, V31, P1677, DOI 10.1128/JCM.31.7.1677-1682.1993; Sun JR, 2011, APMIS, V119, P581, DOI 10.1111/j.1600-0463.2011.02790.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; van Soolingen D, 2007, TUBERCULOSIS 2007 BA; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; *WHO, 2005, WHO REP 2005 GLOB TU; World Health Organization, 2010, WHO REP 2010 GLOB TU; Yorsangsukkamol J, 2009, TUBERCULOSIS, V89, P304, DOI 10.1016/j.tube.2009.05.001; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-42	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45553	10.1371/journal.pone.0045553	http://dx.doi.org/10.1371/journal.pone.0045553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029091	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700045
J	Bizzarro, V; Fontanella, B; Carratu, A; Belvedere, R; Marfella, R; Parente, L; Petrella, A				Bizzarro, Valentina; Fontanella, Bianca; Carratu, Anna; Belvedere, Raffaella; Marfella, Raffaele; Parente, Luca; Petrella, Antonello			Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions	PLOS ONE			English	Article							INDUCED APOPTOSIS; RECEPTOR; ACTIN	Deficient wound healing in diabetic patients is very frequent, but the cellular and molecular causes are poorly defined. In this study, we have evaluated whether Annexin A1 derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. Using normal human skin fibroblasts WS1 in low glucose (LG) or high glucose (HG) we observed the enrichment of Annexin A1 protein at cell movement structures like lamellipodial extrusions and interestingly, a significant decrease in levels of the protein in HG conditions. The analysis of the translocation of Annexin A1 to cell membrane showed lower levels of Annexin A1 in both membrane pool and supernatants of WS1 cells treated with HG. Wound-healing assays using cell line transfected with Annexin A1 siRNAs indicated a slowing down in migration speed of cells suggesting that Annexin A1 has a role in the migration of WS1 cells. In order to analyze the role of extracellular Annexin A1 in cell migration, we have performed wound-healing assays using Ac2-26 showing that peptide was able to increase fibroblast cell migration in HG conditions. Experiments on the mobilization of intracellular calcium and analysis of p-ERK expression confirmed the activity of the FPR1 following stimulation with the peptide Ac2-26. A wound-healing assay on WS1 cells in the presence of the FPR agonist fMLP, of the FPR antagonist CsH and in the presence of Ac2-26 indicated that Annexin A1 influences fibroblast cell migration under HG conditions acting through FPR receptors whose expression was slightly increased in HG. In conclusion, these data demonstrate that (i) Annexin A1 is involved in migration of WS1 cells, through interaction with FPRs; (ii) N-terminal peptide of Annexin A1 Ac2-26 is able to stimulate direct migration of WS1 cells in high glucose treatment possibly due to the increased receptor expression observed in hyperglycemia conditions.	[Bizzarro, Valentina; Carratu, Anna; Belvedere, Raffaella; Parente, Luca; Petrella, Antonello] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Fontanella, Bianca] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Marfella, Raffaele] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy	University of Salerno; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli	Petrella, A (corresponding author), Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy.	apetrella@unisa.it	Petrella, Antonello/E-7708-2012; Belvedere, Raffaella/ABF-7735-2020; Marfella, Raffaele/AAH-2595-2019	Marfella, Raffaele/0000-0003-3960-9270; PETRELLA, Antonello/0000-0002-6945-5295; BIZZARRO, VALENTINA/0000-0002-5222-0705	University of Salerno (FARB); BCC, Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania	University of Salerno (FARB); BCC, Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania(Regione Campania)	The work conducted in the authors' laboratory and referred to in this paper was funded by University of Salerno (FARB 2009, 2010, 2011), from BCC, Banca di Credito Cooperativo, Fisciano (Salerno), from Fondazione con il Sud, and from Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezMartinez MT, 1997, BBA-PROTEIN STRUCT M, V1339, P331, DOI 10.1016/S0167-4838(97)00018-6; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Festa M, 2009, INT J CANCER, V124, P2728, DOI 10.1002/ijc.24260; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Katanaev VL, 2001, BIOCHEMISTRY-MOSCOW+, V66, P351, DOI 10.1023/A:1010293809553; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Marfella R, 2012, J CLIN ENDOCR METAB, V97, P933, DOI 10.1210/jc.2011-2037; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morello S, 2008, CANCER BIOL THER, V7, P278, DOI 10.4161/cbt.7.2.5301; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62	29	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45639	10.1371/journal.pone.0045639	http://dx.doi.org/10.1371/journal.pone.0045639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029153	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800072
J	Ran, C; Carrias, A; Williams, MA; Capps, N; Dan, BCT; Newton, JC; Kloepper, JW; Ooi, EL; Browdy, CL; Terhune, JS; Liles, MR				Ran, Chao; Carrias, Abel; Williams, Malachi A.; Capps, Nancy; Dan, Bui C. T.; Newton, Joseph C.; Kloepper, Joseph W.; Ooi, Ei L.; Browdy, Craig L.; Terhune, Jeffery S.; Liles, Mark R.			Identification of Bacillus Strains for Biological Control of Catfish Pathogens	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; IMMUNE-RESPONSE; RAINBOW-TROUT; DIETARY SUPPLEMENTATION; CHANNEL CATFISH; PROBIOTICS; SUBTILIS; PARAMETERS; RESISTANCE; INFECTION	Bacillus strains isolated from soil or channel catfish intestine were screened for their antagonism against Edwardsiella ictaluri and Aeromonas hydrophila, the causative agents of enteric septicemia of catfish (ESC) and motile aeromonad septicaemia (MAS), respectively. Twenty one strains were selected and their antagonistic activity against other aquatic pathogens was also tested. Each of the top 21 strains expressed antagonistic activity against multiple aquatic bacterial pathogens including Edwardsiella tarda, Streptococcus iniae, Yersinia ruckeri, Flavobacterium columnare, and/or the oomycete Saprolegnia ferax. Survival of the 21 Bacillus strains in the intestine of catfish was determined as Bacillus CFU/g of intestinal tissue of catfish after feeding Bacillus spore-supplemented feed for seven days followed by normal feed for three days. Five Bacillus strains that showed good antimicrobial activity and intestinal survival were incorporated into feed in spore form at a dose of 8 x 10(7) CFU/g and fed to channel catfish for 14 days before they were challenged by E. ictaluri in replicate. Two Bacillus subtilis strains conferred significant benefit in reducing catfish mortality (P<0.05). A similar challenge experiment conducted in Vietnam with four of the five Bacillus strains also showed protective effects against E. ictaluri in striped catfish. Safety of the four strains exhibiting the strongest biological control in vivo was also investigated in terms of whether the strains contain plasmids or express resistance to clinically important antibiotics. The Bacillus strains identified from this study have good potential to mediate disease control as probiotic feed additives for catfish aquaculture.	[Ran, Chao; Carrias, Abel; Williams, Malachi A.; Capps, Nancy; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Dan, Bui C. T.; Ooi, Ei L.] Novus Int Inc, Novus Aqua Res Ctr, Ho Chi Minh City, Vietnam; [Newton, Joseph C.] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA; [Kloepper, Joseph W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Browdy, Craig L.] Novus Int Inc, Charleston, SC USA; [Terhune, Jeffery S.] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Liles, MR (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	lilesma@auburn.edu			National Science Foundation; Novus International Inc.	National Science Foundation(National Science Foundation (NSF)); Novus International Inc.	A patent has been submitted for the use of these strains in aquaculture (patent pending). The authors Liles, Terhune, Newton, and Kloepper have been awarded a National Science Foundation grant to support this research. Novus International Inc. has also funded this work at Auburn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture U. D. o., 2003, REF FING CATF HLTH 1; Ai QH, 2011, AQUACULTURE, V317, P155, DOI 10.1016/j.aquaculture.2011.04.036; Aly SM, 2008, FISH SHELLFISH IMMUN, V25, P128, DOI 10.1016/j.fsi.2008.03.013; AUSTIN B, 1995, J FISH DIS, V18, P93, DOI 10.1111/j.1365-2761.1995.tb01271.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Casula G, 2002, APPL ENVIRON MICROB, V68, P2344, DOI 10.1128/AEM.68.5.2344-2352.2002; De Silva SS, 2010, AMBIO, V39, P504, DOI 10.1007/s13280-010-0072-x; Farmer B.D., 2004, IMPROVED METHODS ISO; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gildberg A, 1998, AQUACULTURE, V167, P103, DOI 10.1016/S0044-8486(98)00296-8; Gournier-Chateau N., 1994, Les probiotiques en alimentation animale et humaine.; Harikrishnan R, 2003, AQUACULTURE, V221, P41, DOI 10.1016/S0044-8486(03)00023-1; Hawke JP, 2004, DEV AQUAC FISH SCI, V34, P387; HAWKE JP, 1979, J FISH RES BOARD CAN, V36, P1508, DOI 10.1139/f79-219; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hyronimus B, 2000, INT J FOOD MICROBIOL, V61, P193, DOI 10.1016/S0168-1605(00)00366-4; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Jack RW, 1996, APPL ENVIRON MICROB, V62, P2897, DOI 10.1128/AEM.62.8.2897-2903.1996; Joborn A, 1997, J FISH DIS, V20, P383, DOI 10.1046/j.1365-2761.1997.00316.x; Kenny D. S., 1981, Biological control in crop production.: Papers presented at the fifth Annual Symposium held at the Beltsville Agricultural Centre, Maryland, 18-21 May 1980. (Beltsville Symposia in Agricultural Research, 5)., P143; Kumar R, 2008, FISH SHELLFISH IMMUN, V24, P168, DOI 10.1016/j.fsi.2007.10.008; National Committee for Clinical Laboratory Standards, 2012, PERF STAND ANT DISK; Nayak SK, 2007, FISH SHELLFISH IMMUN, V23, P892, DOI 10.1016/j.fsi.2007.02.008; Newaj-Fyzul A, 2007, J APPL MICROBIOL, V103, P1699, DOI 10.1111/j.1365-2672.2007.03402.x; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Phuong NT, 2010, SUCCESS STORIES IN ASIAN AQUACULTURE, P131, DOI 10.1007/978-90-481-3087-0_7; Pridgeon JW, 2011, J APPL MICROBIOL, V111, P114, DOI 10.1111/j.1365-2672.2011.05030.x; Qiao JQ, 2011, PLASMID, V65, P141, DOI 10.1016/j.plasmid.2010.11.008; Queiroz JF, 1998, J WORLD AQUACULT SOC, V29, P67, DOI 10.1111/j.1749-7345.1998.tb00300.x; Robertson PAW, 2000, AQUACULTURE, V185, P235, DOI 10.1016/S0044-8486(99)00349-X; Salinas I, 2005, FISH SHELLFISH IMMUN, V19, P67, DOI 10.1016/j.fsi.2004.11.007; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Sorokulova I, 2008, CLIN INFECT DIS, V46, pS92, DOI 10.1086/523334; USDA, 2003, REF FOODS CATF HLT 2; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	38	88	97	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45793	10.1371/journal.pone.0045793	http://dx.doi.org/10.1371/journal.pone.0045793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029244	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800097
J	Gjerstorff, MF; Rosner, HI; Pedersen, CB; Greve, KBV; Schmidt, S; Wilson, KL; Mollenhauer, J; Besir, H; Poulsen, FM; Mollegaard, NE; Ditzel, HJ				Gjerstorff, Morten F.; Rosner, Heike I.; Pedersen, Christina B.; Greve, Katrine B. V.; Schmidt, Steffen; Wilson, Katherine L.; Mollenhauer, Jan; Besir, Hueseyin; Poulsen, Flemming M.; Mollegaard, Niels Erik; Ditzel, Henrik J.			GAGE Cancer-Germline Antigens Are Recruited to the Nuclear Envelope by Germ Cell-Less (GCL)	PLOS ONE			English	Article							TO-AUTOINTEGRATION FACTOR; EMERIN IN-VITRO; TRANSCRIPTION FACTOR; INTRINSIC DISORDER; BTB/POZ DOMAIN; PROTEIN FAMILY; EXPRESSION; DROSOPHILA; BINDING; GENE	GAGE proteins are highly similar, primate-specific molecules with unique primary structure and undefined cellular roles. They are restricted to cells of the germ line in adult healthy individuals, but are broadly expressed in a wide range of cancers. In a yeast two-hybrid screen we identified the metazoan transcriptional regulator, Germ cell-less (GCL), as an interaction partner of GAGE12I. GCL directly binds LEM-domain proteins (LAP2 beta, emerin, MAN1) at the nuclear envelope, and we found that GAGE proteins were recruited to the nuclear envelope inner membrane by GCL. Based on yeast two-hybrid analysis and pull-down experiments of GCL polypeptides, GCL residues 209-320 (which includes the BACK domain) were deduced sufficient for association with GAGE proteins. GAGE mRNAs and GCL mRNA were demonstrated in human testis and most types of cancers, and at the protein level GAGE members and GCL were co-expressed in cancer cell lines. Structural studies of GAGE proteins revealed no distinct secondary or tertiary structure, suggesting they are intrinsically disordered. Interestingly GAGE proteins formed stable complexes with dsDNA in vitro at physiological concentrations, and GAGE12I bound several different dsDNA fragments, suggesting sequence-nonspecific binding. Dual association of GAGE family members with GCL at the nuclear envelope inner membrane in cells, and with dsDNA in vitro, implicate GAGE proteins in chromatin regulation in germ cells and cancer cells.	[Gjerstorff, Morten F.; Pedersen, Christina B.; Greve, Katrine B. V.; Schmidt, Steffen; Mollenhauer, Jan; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Rosner, Heike I.; Poulsen, Flemming M.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wilson, Katherine L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Mollenhauer, Jan] Univ So Denmark, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark; [Besir, Hueseyin] EMBL Heidelberg, Prot Express & Purificat Core Facil, Heidelberg, Germany; [Mollegaard, Niels Erik] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Copenhagen; Johns Hopkins University; Lundbeckfonden; University of Southern Denmark; European Molecular Biology Laboratory (EMBL); University of Copenhagen; University of Southern Denmark; Odense University Hospital	Gjerstorff, MF (corresponding author), Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark.	mgjerstorff@health.sdu.dk	Mollenhauer, Jan/G-4452-2012; Wilson, Katherine/HII-8144-2022	gjerstorff, morten/0000-0002-0845-1952; Ditzel, Henrik J./0000-0003-3927-5135; Mollegaard, Niels Erik/0000-0002-8255-3711; Rosner, Heike Ilona/0000-0002-6201-3195; Besir, Huseyin/0000-0002-7249-4762	Danish Research Council; Danish Cancer Society; National Institutes of Health [RO1 GM48646]; Danish Cancer Research Foundation; Lundbeck Foundation; LeoPharma Research Foundation; Horslev Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048646] Funding Source: NIH RePORTER	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Cancer Society(Danish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); LeoPharma Research Foundation; Horslev Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Danish Research Council, the Danish Cancer Society, the National Institutes of Health (RO1 GM48646), the Danish Cancer Research Foundation, the Lundbeck Foundation, the LeoPharma Research Foundation, and the Horslev Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Artemenko KA, 2011, ANALYST, V136, P1971, DOI 10.1039/c0an00649a; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Burger HG, 1981, TESTIS; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; de la Luna S, 1999, EMBO J, V18, P212, DOI 10.1093/emboj/18.1.212; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMIDOV V, 1993, NUCLEIC ACIDS RES, V21, P2103, DOI 10.1093/nar/21.9.2103; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Gjerstorff MF, 2007, HUM REPROD, V22, P953, DOI 10.1093/humrep/del494; Gjerstorff MF, 2010, PROTEIN EXPRES PURIF, V73, P217, DOI 10.1016/j.pep.2010.05.010; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Holaska JM, 2006, ANAT REC PART A, V288A, P676, DOI 10.1002/ar.a.20334; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; JONGENS TA, 1992, CELL, V70, P569, DOI 10.1016/0092-8674(92)90427-E; JONGENS TA, 1994, GENE DEV, V8, P2123, DOI 10.1101/gad.8.18.2123; Killen MW, 2011, AM J TRANSL RES, V3, P234; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Kimura T, 1999, BIOCHEM BIOPH RES CO, V262, P223, DOI 10.1006/bbrc.1999.1160; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kular RK, 2009, J INTERF CYTOK RES, V29, P645, DOI 10.1089/jir.2008.0099; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Liu Y, 2007, GENETICA; Magae J, 1996, J CELL SCI, V109, P1717; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Montes de Oca R, 2011, NUCLEUS, V2; Moore J, 2009, MECH DEVELOP, V126, P503, DOI 10.1016/j.mod.2009.04.002; Nili E, 2001, J CELL SCI, V114, P3297; Prokocimer M, 2006, J STRUCT BIOL, V155, P351, DOI 10.1016/j.jsb.2006.02.016; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Robertson SE, 1999, DEV BIOL, V215, P288, DOI 10.1006/dbio.1999.9453; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; WU CL, 1995, MOL CELL BIOL, V15, P2536; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45819	10.1371/journal.pone.0045819	http://dx.doi.org/10.1371/journal.pone.0045819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029259	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900104
J	Sato, Y; Morimoto, K; Kubo, T; Yanagihara, K; Seyama, T				Sato, Yuichiro; Morimoto, Kinjiro; Kubo, Takanori; Yanagihara, Kazuyoshi; Seyama, Toshio			High Mannose-Binding Antiviral Lectin PFL from Pseudomonas fluorescens Pf0-1 Promotes Cell Death of Gastric Cancer Cell MKN28 via Interaction with alpha 2-Integrin	PLOS ONE			English	Article							IN-VITRO; INTEGRIN; GLYCOSYLATION; SPECIFICITY; ADHESION; GLYCANS	Novel anti-HIV lectin family which shows a strict binding specificity for high mannose glycans has been found in lower organisms. The bacterial orthologue has been identified in the genome of Pseudomonas fluorescens Pf0-1 and the gene coding a putative lectin was cloned, expressed in Escherichia coli and purified by one step gel filtration. Glycan array screening of the recombinant lectin, termed PFL, has revealed that PFL preferentially recognizes high mannose glycans with alpha 1-3 Man that was highly exposed at the D2 position. In contrast, masking of this alpha 1-3 Man with alpha 1-2 Man dramatically impaired lectin-carbohydrate interactions. Reducing terminal disaccharide, GlcNAc-GlcNAc of high mannose glycans was also essential for PFL-binding. PFL showed a potent anti-influenza virus activity by inhibiting the virus entry into cells at doses of low nanomolar concentration. At micromolar concentration or higher, PFL showed a cytotoxicity accompanying loss of the cell adhesion against human gastric cancer MKN28 cells. The cell surface molecule to which PFL bound was coprecipitated with biotin-labeled PFL and identified as integrin alpha 2 by peptide mass fingerprinting using MALDI-TOF mass spectrometry. Intriguingly, upon treatment with exogenous PFL, integrin alpha 2 on the cell surface underwent rapid internalization to the cytoplasm and accumulated to perinuclear region, together with the bound PFL. The resulting loss of cell adherence would trigger a signaling pathway that induced anoikis-like cell death. These events were effectively inhibited by pretreatment of PFL with mannnan, indicating the involvement of high mannose glycans on PFL-induced cell death that was triggered by PFL-integrin alpha 2 interactions.	[Sato, Yuichiro; Morimoto, Kinjiro] Yasuda Womens Univ, Fac Pharm, Dept Med Pharm, Hiroshima, Japan; [Kubo, Takanori; Yanagihara, Kazuyoshi; Seyama, Toshio] Yasuda Womens Univ, Fac Pharm, Dept Life Sci, Hiroshima, Japan		Sato, Y (corresponding author), Yasuda Womens Univ, Fac Pharm, Dept Med Pharm, Hiroshima, Japan.	sato-y@yasuda-u.ac.jp		Kubo, Takanori/0000-0002-7609-7094	Japan Society for the Promotion of Science (JSPS) [24790101]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (Grant number 24790101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Fukuda Y, 2006, ANTI-CANCER DRUG, V17, P943, DOI 10.1097/01.cad.0000224458.13651.b4; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Liao WR, 2003, J IND MICROBIOL BIOT, V30, P433, DOI 10.1007/s10295-003-0068-7; Litynska A, 2002, ACTA BIOCHIM POL, V49, P491; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; Petrossian K, 2007, ACTA HISTOCHEM, V109, P491, DOI 10.1016/j.acthis.2007.05.004; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Sato Y, 2011, J BIOL CHEM, V286, P19446, DOI 10.1074/jbc.M110.216655; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315	28	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45922	10.1371/journal.pone.0045922	http://dx.doi.org/10.1371/journal.pone.0045922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029318	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900111
J	Gilot-Fromont, E; Jego, M; Bonenfant, C; Gibert, P; Rannou, B; Klein, F; Gaillard, JM				Gilot-Fromont, Emmanuelle; Jego, Mael; Bonenfant, Christophe; Gibert, Philippe; Rannou, Benoit; Klein, Francois; Gaillard, Jean-Michel			Immune Phenotype and Body Condition in Roe Deer: Individuals with High Body Condition Have Different, Not Stronger Immunity	PLOS ONE			English	Article							LIFE-HISTORY; TRADE-OFFS; INFECTION; IMMUNOLOGY; DEFENSE; STRESS; INNATE; MICE; WILD; CARE	An efficient immunity is necessary for host survival, but entails energetic costs. When energy is limited, immunocompetence and body condition should co-vary positively among individuals and, depending on body condition, individuals should allocate more either in innate immunity or in adaptive response. We tested whether immune phenotype depends on body condition in large mammals, using data from two contrasted populations of roe deer Capreolus capreolus in France. Roe deer living at Chize, a forest with poor habitat quality, were expected to show lower values for body condition and immune parameters than roe deer at Trois Fontaines, a forest with high habitat quality. From 285 blood samples collected between December 2009 and March 2011, we measured seven metabolic parameters and ten immunological parameters. A Principal Component Analysis showed that all indicators of body condition co-varied positively and were lowest at Chize. Several immunological indicators correlated to body condition and differed between Trois Fontaines and Chize. However, high body condition was not associated to a high average level of immunocompetence, but instead to high levels of indicators of acute inflammatory innate response, while low body condition was associated to high levels of monocytes and lymphocytes, possibly reflecting adaptive immunity. Limited data suggest that the difference between populations was not related to the presence of specific parasite species, however parasite exposure and stress have to be investigated to gain a more complete understanding of the determinants of immunity.	[Gilot-Fromont, Emmanuelle; Jego, Mael; Bonenfant, Christophe; Gaillard, Jean-Michel] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Gilot-Fromont, Emmanuelle; Jego, Mael; Rannou, Benoit] Univ Lyon, VetAgro Sup, Marcy Letoile, France; [Gibert, Philippe; Klein, Francois] Off Natl Chasse & Faune Sauvage, Studies & Res Dept, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; VetAgro Sup	Gilot-Fromont, E (corresponding author), Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France.	emmanuelle.gilotfromont@vetagro-sup.fr	Bonenfant, Christophe/I-8645-2019	Bonenfant, Christophe/0000-0002-9924-419X; Gilot-Fromont, Emmanuelle/0000-0003-0011-7519	ONCFS Office National de la Chasse et de la Faune Sauvage; VetAgro-Sup under Demographie et pathologie dans les populations de chevreuils [convention 2010/6171/13]; VetAgro-Sup under Agents pathogenes et dynamique des populations des ongules sauvages [convention 2011/18/6171]	ONCFS Office National de la Chasse et de la Faune Sauvage; VetAgro-Sup under Demographie et pathologie dans les populations de chevreuils; VetAgro-Sup under Agents pathogenes et dynamique des populations des ongules sauvages	The study was funded by the ONCFS Office National de la Chasse et de la Faune Sauvage and VetAgro-Sup under the projects "Demographie et pathologie dans les populations de chevreuils'' (convention 2010/6171/13) and "Agents pathogenes et dynamique des populations des ongules sauvages'' (convention 2011/18/6171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Beldomenico PM, 2008, P ROY SOC B-BIOL SCI, V275, P1753, DOI 10.1098/rspb.2008.0147; Body G, 2011, OECOLOGIA, V167, P635, DOI 10.1007/s00442-011-2018-9; Bourgeon S, 2010, J EXP BIOL, V213, P3810, DOI 10.1242/jeb.045484; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Horrocks NPC, 2011, INTEGR COMP BIOL, V51, P563, DOI 10.1093/icb/icr011; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Krams I, 2011, J ORNITHOL, V152, P889, DOI 10.1007/s10336-011-0672-7; Ksiazek A, 2012, PHYSIOL BIOCHEM ZOOL, V85, P51, DOI 10.1086/663696; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martin LB, 2007, AM J PHYSIOL-REG I, V292, pR316, DOI 10.1152/ajpregu.00386.2006; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Masello JF, 2009, COMP BIOCHEM PHYS A, V152, P176, DOI 10.1016/j.cbpa.2008.09.018; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Moller AP, 2002, BEHAV ECOL, V13, P248, DOI 10.1093/beheco/13.2.248; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; R Core Team, 2020, R LANG ENV STAT COMP; Rahman MM, 2010, VET PARASITOL, V168, P293, DOI 10.1016/j.vetpar.2009.12.001; Roitt I., 2001, IMMUNOLOGY, V6th; Sams MG, 1998, J WILDLIFE DIS, V34, P110, DOI 10.7589/0090-3558-34.1.110; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Segonds-Pichon A, 2001, THESIS U LYON 1, P1; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2; URSACHE O, 1980, REV MED VET-TOULOUSE, V131, P547; Valderrabano J, 2006, VET PARASITOL, V141, P122, DOI 10.1016/j.vetpar.2006.04.029	33	38	38	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45576	10.1371/journal.pone.0045576	http://dx.doi.org/10.1371/journal.pone.0045576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029110	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400108
J	Walsh, CJ; Fletcher, TD; Burns, MJ				Walsh, Christopher J.; Fletcher, Tim D.; Burns, Matthew J.			Urban Stormwater Runoff: A New Class of Environmental Flow Problem	PLOS ONE			English	Article							HYDROLOGIC ALTERATION; STREAM ECOLOGY; LAND-COVER; WATER; CATCHMENT; MANAGEMENT; URBANIZATION; MECHANISM; BEHAVIOR; LESSONS	Environmental flow assessment frameworks have begun to consider changes to flow regimes resulting from land-use change. Urban stormwater runoff, which degrades streams through altered volume, pattern and quality of flow, presents a problem that challenges dominant approaches to stormwater and water resource management, and to environmental flow assessment. We used evidence of ecological response to different stormwater drainage systems to develop methods for input to environmental flow assessment. We identified the nature of hydrologic change resulting from conventional urban stormwater runoff, and the mechanisms by which such hydrologic change is prevented in streams where ecological condition has been protected. We also quantified the increase in total volume resulting from urban stormwater runoff, by comparing annual streamflow volumes from undeveloped catchments with the volumes that would run off impervious surfaces under the same rainfall regimes. In catchments with as little as 5-10% total imperviousness, conventional stormwater drainage, associated with poor in-stream ecological condition, reduces contributions to baseflows and increases the frequency and magnitude of storm flows, but in similarly impervious catchments in which streams retain good ecological condition, informal drainage to forested hillslopes, without a direct piped discharge to the stream, results in little such hydrologic change. In urbanized catchments, dispersed urban stormwater retention measures can potentially protect urban stream ecosystems by mimicking the hydrologic effects of informal drainage, if sufficient water is harvested and kept out of the stream, and if discharged water is treated to a suitable quality. Urban stormwater is a new class of environmental flow problem: one that requires reduction of a large excess volume of water to maintain riverine ecological integrity. It is the best type of problem, because solving it provides an opportunity to solve other problems such as the provision of water for human use.	[Walsh, Christopher J.; Fletcher, Tim D.] Univ Melbourne, Dept Resource Management & Geog, Parkville, Vic 3052, Australia; [Fletcher, Tim D.; Burns, Matthew J.] Monash Univ, Dept Civil Engn, Clayton, Vic 3800, Australia; [Fletcher, Tim D.; Burns, Matthew J.] Monash Univ, Monash Water Liveabil, Clayton, Vic 3800, Australia	University of Melbourne; Monash University; Monash University	Walsh, CJ (corresponding author), Univ Melbourne, Dept Resource Management & Geog, Parkville, Vic 3052, Australia.	cwalsh@unimelb.edu.au	Fletcher, Tim/AAB-8356-2019; Walsh, Christopher/B-2552-2009	Fletcher, Tim/0000-0001-8819-5567; Walsh, Christopher/0000-0002-4181-6722	Melbourne Water; Australian Research Council's; Linkage Projects scheme [LP0883610]; Council's Future Fellowship scheme	Melbourne Water; Australian Research Council's(Australian Research Council); Linkage Projects scheme; Council's Future Fellowship scheme	This work was supported by Melbourne Water (www.melbournewater.com.au) and the Australian Research Council's (www.arc.gov.au) Linkage Projects scheme (project number LP0883610) and TDF is supported by the Council's Future Fellowship scheme. The views expressed herein are those of the authors and not necessarily those of the funding bodies. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Other than the acknowledged hydrographic data used in the paper that were collected by Melbourne Water, the funders had no role in data collection.	[Anonymous], 2007, STORMWATER RECYCLING; [Anonymous], 2006, SUST WAT STRAT CENTR; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Australian Bureau of Statistics, 2010, POP GROWTH PRES FUT; BOYD MJ, 1993, HYDROLOG SCI J, V38, P463, DOI 10.1080/02626669309492699; Bratieres K, 2008, 11 INT C URB DRAIN I; Brown LR, 2009, J N AM BENTHOL SOC, V28, P1051, DOI 10.1899/08-153.1; Burns MJ, 2012, LANDSCAPE URBAN PLAN, V105, P230, DOI 10.1016/j.landurbplan.2011.12.012; Burns MJ, 2012, 7 INT C WAT SENS URB; Carlson TN, 2000, GLOBAL PLANET CHANGE, V25, P49, DOI 10.1016/S0921-8181(00)00021-7; CHESSMAN BC, 1995, AUST J ECOL, V20, P122, DOI 10.1111/j.1442-9993.1995.tb00526.x; Coutts AM, 2007, J APPL METEOROL CLIM, V46, P477, DOI 10.1175/JAM2462.1; Fletcher TD, 2008, J ENVIRON QUAL, V37, pS116, DOI 10.2134/jeq2007.0411; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Hamel P, 2011, 12 INT C URB DRAIN I; Harremoes P, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00180-7; Hatt BE, 2006, J ENVIRON MANAGE, V79, P102, DOI 10.1016/j.jenvman.2005.06.003; Hatt BE, 2004, ENVIRON MANAGE, V34, P112, DOI 10.1007/s00267-004-0221-8; Holman-Dodds JK, 2003, J AM WATER RESOUR AS, V39, P205, DOI 10.1111/j.1752-1688.2003.tb01572.x; Jolly ID, 1997, WATER SALT BALANCES; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Kennen JG, 2008, ECOL MODEL, V211, P57, DOI 10.1016/j.ecolmodel.2007.08.014; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; Kirchner JW, 2003, HYDROL PROCESS, V17, P871, DOI 10.1002/hyp.5108; Knights D., 2009, STORMW IND ASS NSW V; Konrad CP, 2005, AM FISH S S, V47, P157; Lenoir A., 1996, INT S, P29; Leopold L.B., 1968, HYDROLOGY URBAN LAND, V554; Li H, 2009, J HYDROL ENG, V14, P407, DOI 10.1061/(ASCE)1084-0699(2009)14:4(407); Melbourne Water, 2006, WAT SUPPL DEM STRAT; Mikkelsen PS, 1996, J HYDRAUL RES, V34, P827, DOI 10.1080/00221686.1996.10525034; Mitchell VG, 2008, ENVIRON MODELL SOFTW, V23, P782, DOI 10.1016/j.envsoft.2007.09.006; Mitchell VG, 2006, ENVIRON MANAGE, V37, P589, DOI 10.1007/s00267-004-0252-1; Mitchell VG, 2003, ENVIRON MANAGE, V32, P735, DOI 10.1007/s00267-003-2062-2; Newton D, 2009, 32 HYDR WAT RES S NE, P102; Pagotto C, 2000, WATER RES, V34, P4446, DOI 10.1016/S0043-1354(00)00221-9; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Price K, 2011, PROG PHYS GEOG, V35, P465, DOI 10.1177/0309133311402714; Ragab R, 2003, HYDROL PROCESS, V17, P2409, DOI 10.1002/hyp.1250; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Roy AH, 2008, ENVIRON MANAGE, V42, P344, DOI 10.1007/s00267-008-9119-1; Shuster WD, 2005, URBAN WATER J, V2, P263; TANAKA T, 1988, J HYDROL, V102, P139, DOI 10.1016/0022-1694(88)90095-9; Taylor SL, 2004, FRESHWATER BIOL, V49, P835, DOI 10.1111/j.1365-2427.2004.01225.x; Tourbier J, 2007, ADV URBAN FLOOD MANA, P13; Walsh CJ, 2009, J N AM BENTHOL SOC, V28, P977, DOI 10.1899/08-161.1; Walsh CJ, 2009, J HYDROL ENG, V14, P399, DOI 10.1061/(ASCE)1084-0699(2009)14:4(399); Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LZ, 2003, T AM FISH SOC, V132, P825, DOI 10.1577/T02-099; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang L., 1999, 9912 COOP RES CTR CA	53	217	226	4	231	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45814	10.1371/journal.pone.0045814	http://dx.doi.org/10.1371/journal.pone.0045814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029257	Green Published, gold			2022-12-27	WOS:000309388400133
J	Li, BQ; Cai, YD; Feng, KY; Zhao, GJ				Li, Bi-Qing; Cai, Yu-Dong; Feng, Kai-Yan; Zhao, Gui-Jun			Prediction of Protein Cleavage Site with Feature Selection by Random Forest	PLOS ONE			English	Article							PROPROTEIN CONVERTASE CLEAVAGE; PROTEASOME; GENERATION; RECEPTOR; MOTIFS; TOOL	Proteinases play critical roles in both intra and extracellular processes by binding and cleaving their protein substrates. The cleavage can either be non-specific as part of degradation during protein catabolism or highly specific as part of proteolytic cascades and signal transduction events. Identification of these targets is extremely challenging. Current computational approaches for predicting cleavage sites are very limited since they mainly represent the amino acid sequences as patterns or frequency matrices. In this work, we developed a novel predictor based on Random Forest algorithm (RF) using maximum relevance minimum redundancy (mRMR) method followed by incremental feature selection (IFS). The features of physicochemical/biochemical properties, sequence conservation, residual disorder, amino acid occurrence frequency, secondary structure and solvent accessibility were utilized to represent the peptides concerned. Here, we compared existing prediction tools which are available for predicting possible cleavage sites in candidate substrates with ours. It is shown that our method makes much more reliable predictions in terms of the overall prediction accuracy. In addition, this predictor allows the use of a wide range of proteinases.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Bi-Qing] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Feng, Kai-Yan] Beijing Genom Inst, Shenzhen, Peoples R China; [Zhao, Gui-Jun] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Gui-Jun] Shanghai Lab Embryo & Reprod Engn, Shanghai, Peoples R China; [Zhao, Gui-Jun] Minist Hlth, Key Lab Embryo Mol Biol, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; Holzhutter HG, 1999, J MOL BIOL, V286, P1251, DOI 10.1006/jmbi.1998.2530; Holzhutter HG, 2000, BIOPHYS J, V79, P1196, DOI 10.1016/S0006-3495(00)76374-0; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Raghunath M, 1999, J CELL SCI, V112, P1093; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Van Damme P, 2008, BIOL CHEM, V389, P371, DOI 10.1515/BC.2008.043; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Witten I.H., 2005, DATA MINING PRACTICA; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; You Liwen, 2006, Comput Syst Bioinformatics Conf, P249; Zhang N, 2012, MOL BIOSYSTEMS; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	43	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45854	10.1371/journal.pone.0045854	http://dx.doi.org/10.1371/journal.pone.0045854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029276	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900171
J	Murani, E; Reyer, H; Ponsuksili, S; Fritschka, S; Wimmers, K				Murani, Eduard; Reyer, Henry; Ponsuksili, Siriluck; Fritschka, Stephan; Wimmers, Klaus			A Substitution in the Ligand Binding Domain of the Porcine Glucocorticoid Receptor Affects Activity of the Adrenal Gland	PLOS ONE			English	Article							STRESS; GENE; DISSECTION; MUTATION; SYSTEM; BRAIN; MOUSE; AXIS	Glucocorticoids produced in the adrenal cortex under the control of the hypothalamic-pituitary axis play a vital role in the maintenance of basal and stress-related homeostasis and influence health and well-being. To identify loci affecting regulation of the hypothalamic-pituitary-adrenal (HPA) axis in the pig we performed a genome-wide association study for two parameters of acute and long-term adrenal activity: plasma cortisol level and adrenal weight. We detected a major quantitative trait locus at the position of the glucocorticoid receptor gene (NR3C1) - a key regulator of HPA axis activity. To determine the causal variant(s), we resequenced the coding region of NR3C1 and found three missense single nucleotide polymorphisms (SNPs). SNP c. 1829C>T, leading to a p.Ala610Val substitution in the ligand binding domain, showed large (about 0.6x and 1.2x phenotypic standard deviations for cortisol level and adrenal weight, respectively), and highly significant (2.1E-39 <= log10(1/p)<= 1.7E+0) negative effects on both traits. We were able to replicate the association in three commercial pig populations with different breed origins. We analyzed effects of the p.Ala610Val substitution on glucocorticoid-induced transcriptional activity of porcine glucocorticoid receptor (GR) in vitro and determined that the substitution introduced by SNP c. gain-offunction increased sensitivity of GR by about two-fold. Finally, we found that non-coding polymorphisms in linkage disequilibrium with SNP c. 1829C>T have only a minor effect on the expression of NR3C1 in tissues related to the HPA axis. Our findings provide compelling evidence that SNP c. 1829C>T. T in porcine NR3C1 is a gain-of-function mutation with a major effect on the activity of the adrenal gland. Pigs carrying this SNP could provide a new animal model to study neurobiological and physiological consequences of genetically based GR hypersensitivity and adrenal hypofunction.	[Murani, Eduard; Reyer, Henry; Fritschka, Stephan; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany; [Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Grp Funct Genome Anal, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany.	wimmers@fbn-dummertorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	Phanomics network of competence (Federal Ministry of Education and Research); Leibniz Institute for Farm Animal Biology	Phanomics network of competence (Federal Ministry of Education and Research); Leibniz Institute for Farm Animal Biology	work was part-funded by Phanomics network of competence (Federal Ministry of Education and Research) and by matched funding provided by the Leibniz Institute for Farm Animal Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bledsoe RK, 2004, VITAM HORM, V68, P49; Charmandari E, 2008, J CLIN ENDOCR METAB, V93, P4963, DOI 10.1210/jc.2008-0892; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Crowe ML, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-133; DeRijk RH, 2009, NEUROIMMUNOMODULAT, V16, P340, DOI 10.1159/000216192; Erdmann G, 2008, J NEUROENDOCRINOL, V20, P655, DOI 10.1111/j.1365-2826.2008.01717.x; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Johnson AK, 2011, GENETICS OF THE PIG, 2ND EDITION, P200, DOI 10.1079/9781845937560.0200; Karpac J, 2005, ENDOCRINOLOGY, V146, P2555, DOI 10.1210/en.2004-1290; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937560.0426; Merks JWM, 2012, ANIMAL, V6, P535, DOI 10.1017/S1751731111002266; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Murani E, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-74; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Redei EE, 2008, ANN MED, V40, P139, DOI 10.1080/07853890701724863; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Steckler T, 2001, BEHAV PHARMACOL, V12, P381, DOI 10.1097/00008877-200111000-00002; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102; Zhang JH, 2009, J BIOL CHEM, V284, P6249, DOI 10.1074/jbc.M807997200	29	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45518	10.1371/journal.pone.0045518	http://dx.doi.org/10.1371/journal.pone.0045518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029068	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900153
J	Brand, GD; Magalhaes, MTQ; Tinoco, MLP; Aragao, FJL; Nicoli, J; Kelly, SM; Cooper, A; Bloch, C				Brand, Guilherme D.; Magalhaes, Mariana T. Q.; Tinoco, Maria L. P.; Aragao, Francisco J. L.; Nicoli, Jacques; Kelly, Sharon M.; Cooper, Alan; Bloch, Carlos, Jr.			Probing Protein Sequences as Sources for Encrypted Antimicrobial Peptides	PLOS ONE			English	Article							CIRCULAR-DICHROISM; MODEL MEMBRANES; BIOACTIVE PEPTIDES; TRANSGENIC PLANTS; LIPID-BILAYER; WHEAT GLUTEN; RESISTANCE; PATHOGENS; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HYDROPHOBICITY	Starting from the premise that a wealth of potentially biologically active peptides may lurk within proteins, we describe here a methodology to identify putative antimicrobial peptides encrypted in protein sequences. Candidate peptides were identified using a new screening procedure based on physicochemical criteria to reveal matching peptides within protein databases. Fifteen such peptides, along with a range of natural antimicrobial peptides, were examined using DSC and CD to characterize their interaction with phospholipid membranes. Principal component analysis of DSC data shows that the investigated peptides group according to their effects on the main phase transition of phospholipid vesicles, and that these effects correlate both to antimicrobial activity and to the changes in peptide secondary structure. Consequently, we have been able to identify novel antimicrobial peptides from larger proteins not hitherto associated with such activity, mimicking endogenous and/or exogenous microorganism enzymatic processing of parent proteins to smaller bioactive molecules. A biotechnological application for this methodology is explored. Soybean (Glycine max) plants, transformed to include a putative antimicrobial protein fragment encoded in its own genome were tested for tolerance against Phakopsora pachyrhizi, the causative agent of the Asian soybean rust. This procedure may represent an inventive alternative to the transgenic technology, since the genetic material to be used belongs to the host organism and not to exogenous sources.	[Brand, Guilherme D.; Magalhaes, Mariana T. Q.; Bloch, Carlos, Jr.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Tinoco, Maria L. P.; Aragao, Francisco J. L.] Embrapa Recursos Genet & Biotecnol, Lab Transferencia & Expressao Genes, Brasilia, DF, Brazil; [Nicoli, Jacques] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Kelly, Sharon M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Brand, Guilherme D.; Cooper, Alan] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; University of Glasgow; University of Glasgow	Bloch, C (corresponding author), Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil.	bloch.carlos@gmail.com	Kelly, Sharon/K-4611-2013; Aragão, Francisco J.L./E-6962-2013; Brand, Guilherme/B-5603-2015; Cooper, Alan/F-7813-2011; Bloch, Carlos/S-8375-2019; Nicoli, Jacques R/K-4807-2015	Brand, Guilherme/0000-0002-1615-0009; Cooper, Alan/0000-0001-6709-7343; Nicoli, Jacques R/0000-0003-2390-2608; Torquato Quezado de Magalhaes, Mariana/0000-0003-4912-0233; Kelly, Sharon/0000-0002-3516-1387; Bloch Jr, Carlos/0000-0003-2799-6883	Brazilian National Counsel of Technological and Scientific Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do DF (FAPDF); UK Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [B20089] Funding Source: researchfish	Brazilian National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do DF (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Brazilian National Counsel of Technological and Scientific Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Pesquisa do DF (FAPDF). The biological microcalorimetry facilities in Glasgow were originally funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragao FJL, 2000, THEOR APPL GENET, V101, P1, DOI 10.1007/s001220051441; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cunha WG, 2010, PLANT PATHOL, V59, P654, DOI 10.1111/j.1365-3059.2010.02279.x; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Dores RM, 2002, MASS SPECTROM REV, V21, P220, DOI 10.1002/mas.10029; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; EPAND RM, 1981, BIOCHEMISTRY-US, V20, P4603, DOI 10.1021/bi00519a014; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; FRALEY C, 2006, 504 U WASH DEP STAT; FUKUDOME S, 1993, FEBS LETT, V316, P17, DOI 10.1016/0014-5793(93)81727-H; FUKUDOME S, 1992, FEBS LETT, V296, P107, DOI 10.1016/0014-5793(92)80414-C; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; JAIN MK, 1977, J MEMBRANE BIOL, V34, P157, DOI 10.1007/BF01870299; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladokhin AS, 2010, J MEMBRANE BIOL, V236, P247, DOI 10.1007/s00232-010-9291-0; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Lewis RNAH, 2005, BBA-BIOMEMBRANES, V1668, P203, DOI 10.1016/j.bbamem.2004.12.007; LEWIS RV, 1983, ANNU REV PHARMACOL, V23, P353, DOI 10.1146/annurev.pa.23.040183.002033; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; Meisel H, 1999, ANTON LEEUW INT J G, V76, P207, DOI 10.1023/A:1002063805780; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3; Phelan M, 2009, INT DAIRY J, V19, P643, DOI 10.1016/j.idairyj.2009.06.001; Ponti D, 2003, BIOCHEM J, V370, P121, DOI 10.1042/BJ20021444; Rech EL, 2008, NAT PROTOC, V3, P410, DOI 10.1038/nprot.2008.9; REGOLI D, 1980, PHARMACOL REV, V32, P1; Rivero M, 2012, J BIOTECHNOL, V157, P334, DOI 10.1016/j.jbiotec.2011.11.005; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seto GWJ, 2007, BBA-BIOMEMBRANES, V1768, P2787, DOI 10.1016/j.bbamem.2007.07.018; Shewry PR, 1997, ADV BOT RES, V26, P135, DOI 10.1016/S0065-2296(08)60120-2; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306; Zhao Q, 1997, BIOPOLYMERS, V43, P75; Zhu WL, 2009, CHEM BIOL DRUG DES, V73, P209, DOI 10.1111/j.1747-0285.2008.00769.x	54	35	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45848	10.1371/journal.pone.0045848	http://dx.doi.org/10.1371/journal.pone.0045848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029273	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309973900058
J	Doodhi, H; Jana, SC; Devan, P; Mazumdar, S; Ray, K				Doodhi, Harinath; Jana, Swadhin C.; Devan, Pavithra; Mazumdar, Shyamalava; Ray, Krishanu			Biochemical and Molecular Dynamic Simulation Analysis of a Weak Coiled Coil Association between Kinesin-II Stalks	PLOS ONE			English	Article							HETEROTRIMERIC KINESIN; MOTOR PROTEIN; NECK REGION; CHOLINE-ACETYLTRANSFERASE; INTRAFLAGELLAR TRANSPORT; HETERODIMER FORMATION; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; ACCESSORY SUBUNIT; CRYSTAL-STRUCTURE	Definition: Kinesin-2 refers to the family of motor proteins represented by conserved, heterotrimeric kinesin-II and homodimeric Osm3/Kif17 class of motors. Background: Kinesin-II, a microtubule-based anterograde motor, is composed of three different conserved subunits, named KLP64D, KLP68D and DmKAP in Drosophila. Although previous reports indicated that coiled coil interaction between the middle segments of two dissimilar motor subunits established the heterodimer, the molecular basis of the association is still unknown. Methodology/Principal Findings: Here, we present a detailed heterodimeric association model of the KLP64D/68D stalk supported by extensive experimental analysis and molecular dynamic simulations. We find that KLP64D stalk is unstable, but forms a weak coiled coil heteroduplex with the KLP68D stalk when coexpressed in bacteria. Local instabilities, relative affinities between the C-terminal stalk segments, and dynamic long-range interactions along the stalks specify the heterodimerization. Thermal unfolding studies and independent simulations further suggest that interactions between the C-terminal stalk fragments are comparatively stable, whereas the N-terminal stalk reversibly unfolds at ambient temperature. Conclusions/Significance: Results obtained in this study suggest that coiled coil interaction between the C-terminal stalks of kinesin-II motor subunits is held together through a few hydrophobic and charged interactions. The N-terminal stalk segments are flexible and could uncoil reversibly during a motor walk. This supports the requirement for a flexible coiled coil association between the motor subunits, and its role in motor function needs to be elucidated.	[Doodhi, Harinath; Jana, Swadhin C.; Devan, Pavithra; Ray, Krishanu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Mazumdar, Shyamalava] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Ray, K (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	krishanu@tifr.res.in	Mazumdar, Shyamalava/B-5024-2012	Mazumdar, Shyamalava/0000-0002-7375-9267; Doodhi, Harinath/0000-0003-2978-4446; Ray, Krishanu/0000-0001-6406-3199; Jana, Swadhin/0000-0002-8311-3849	Department of Science and Technology (DST) [SR/SO/BB-59/2006]; Tata Institute of Fundamental Research (TIFR) intramural grant; DST Grant	Department of Science and Technology (DST)(Department of Science & Technology (India)); Tata Institute of Fundamental Research (TIFR) intramural grant; DST Grant	The project is jointly supported by a Department of Science and Technology (DST) grant SR/SO/BB-59/2006 to KR as well as a Tata Institute of Fundamental Research (TIFR) intramural grant to KR. PD was supported by a junior research fellowship from the DST Grant. HD and SJ were Research Scholars at TIFR during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Brown JH, 1996, PROTEINS, V26, P134; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Chana M, 2002, J STRUCT BIOL, V137, P206, DOI 10.1006/jsbi.2002.4446; Chana MS, 2005, J PEPT RES, V65, P209, DOI 10.1111/j.1399-3011.2005.00210.x; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; De Marco V, 2003, EMBO REP, V4, P717, DOI 10.1038/sj.embor.embor884; De Marco V, 2001, EMBO J, V20, P3370, DOI 10.1093/emboj/20.13.3370; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gratkowski H, 2002, BIOPHYS J, V83, P1613, DOI 10.1016/S0006-3495(02)73930-1; Henson JH, 1997, CELL MOTIL CYTOSKEL, V38, P29, DOI 10.1002/(SICI)1097-0169(1997)38:1<29::AID-CM4>3.0.CO;2-C; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Houston ME, 2002, J PEPT RES, V59, P34, DOI 10.1046/j.1397-002x.2001.10928.x; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; LEHRER SS, 1989, SCIENCE, V246, P926, DOI 10.1126/science.2814515; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Makino T, 2007, BIOCHEMISTRY-US, V46, P9523, DOI 10.1021/bi700291a; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Missimer JH, 2010, PROTEIN SCI, V19, P2462, DOI 10.1002/pro.528; Morii H, 1997, BIOCHEMISTRY-US, V36, P1933, DOI 10.1021/bi962392l; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Olufsen M, 2007, J MOL GRAPH MODEL, V26, P124, DOI 10.1016/j.jmgm.2006.10.003; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Ray K, 2006, PHYSICA A, V372, P52, DOI 10.1016/j.physa.2006.05.007; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Shimizu Y, 2005, BIOCHEM BIOPH RES CO, V337, P868, DOI 10.1016/j.bbrc.2005.09.126; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tripet B, 1997, J BIOL CHEM, V272, P8946; van der Spoel D., 2005, GROMACS USER MANUAL; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vukajlovic M, 2011, MOL BIOL CELL, V22, P4279, DOI 10.1091/mbc.E11-02-0112; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Whitby FG, 2000, PROTEINS, V38, P49; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	63	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45981	10.1371/journal.pone.0045981	http://dx.doi.org/10.1371/journal.pone.0045981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029351	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900070
J	Vermeij, A; van Beek, AHEA; Rikkert, MGMO; Claassen, JAHR; Kessels, RPC				Vermeij, Anouk; van Beek, Arenda H. E. A.; Rikkert, Marcel G. M. Olde; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.			Effects of Aging on Cerebral Oxygenation during Working-Memory Performance: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; PREFRONTAL CORTEX; HEMOGLOBIN OXYGENATION; BLOOD-VOLUME; BRAIN ACTIVATION; TASK; NIRS; STIMULATION; DEPENDENCY; DECREASE	Working memory is sensitive to aging-related decline. Evidence exists that aging is accompanied by a reorganization of the working-memory circuitry, but the underlying neurocognitive mechanisms are unclear. In this study, we examined aging-related changes in prefrontal activation during working-memory performance using functional Near-Infrared Spectroscopy (fNIRS), a noninvasive neuroimaging technique. Seventeen healthy young (21-32 years) and 17 healthy older adults (64-81 years) performed a verbal working-memory task (n-back). Oxygenated and deoxygenated hemoglobin concentration changes were registered by two fNIRS channels located over the left and right prefrontal cortex. Increased working-memory load resulted in worse performance compared to the control condition in older adults, but not in young participants. In both young and older adults, prefrontal activation increased with rising working-memory load. Young adults showed slight right-hemispheric dominance at low levels of working-memory load, while no hemispheric differences were apparent in older adults. Analysis of the time-activation curve during the high working-memory load condition revealed a continuous increase of the hemodynamic response in the young. In contrast to that, a quadratic pattern of activation was found in the older participants. Based on these results it could be hypothesized that young adults were better able to keep the prefrontal cortex recruited over a prolonged period of time. To conclude, already at low levels of working-memory load do older adults recruit both hemispheres, possibly in an attempt to compensate for the observed aging-related decline in performance. Also, our study shows that aging effects on the time course of the hemodynamic response must be taken into account in the interpretation of the results of neuroimaging studies that rely on blood oxygen levels, such as fMRI.	[Vermeij, Anouk; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Vermeij, Anouk; van Beek, Arenda H. E. A.; Rikkert, Marcel G. M. Olde; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Alzheimer Ctr Nijmegen, Dept Geriatr Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vermeij, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.vermeij@ger.umcn.nl	Rikkert, M.G.M. Olde/H-8078-2014; Claassen, Jurgen A.H.R./A-9806-2008; Kessels, Roy P.C./D-1902-2010; Vermeij, Anouk/J-5934-2012; Rikkert, Marcel Olde/D-9773-2012	Rikkert, M.G.M. Olde/0000-0003-1397-1677; Claassen, Jurgen A.H.R./0000-0002-1778-8151; Kessels, Roy P.C./0000-0001-9500-9793; 	Donders TopTalent Grant; Netherlands Organisation for Scientific Research (NWO); Alzheimer Nederland [WE03-2010-03]; VIDI innovational grant from NWO [452-08-005]	Donders TopTalent Grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Alzheimer Nederland; VIDI innovational grant from NWO	This project was funded by a Donders TopTalent Grant supported by the Netherlands Organisation for Scientific Research (NWO), awarded to AV and a grant from Alzheimer Nederland (no. WE03-2010-03) awarded to JC. RK was funded by a VIDI innovational grant from the NWO (no. 452-08-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Butti M, 2009, MED PHYS, V36, P4103, DOI 10.1118/1.3190557; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Claassen JAHR, 2006, PHYSIOL MEAS, V27, P255, DOI 10.1088/0967-3334/27/3/004; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Heekeren HR, 1997, PHILOS T ROY SOC B, V352, P743, DOI 10.1098/rstb.1997.0057; Herrmann MJ, 2007, EUR J NEUROSCI, V26, P2713, DOI 10.1111/j.1460-9568.2007.05921.x; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hoshi Y, 2003, NEUROIMAGE, V20, P1493, DOI 10.1016/S1053-8119(03)00412-9; Jansma JM, 2000, NEUROIMAGE, V12, P688, DOI 10.1006/nimg.2000.0645; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Kwee IL, 2003, J NEUROL, V250, P525, DOI 10.1007/s00415-003-1028-x; Leon-Carrion J, 2007, NEUROSCI LETT, V422, P147, DOI 10.1016/j.neulet.2007.04.087; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; LIU H, 1995, MED PHYS, V22, P1209, DOI 10.1118/1.597520; LIU HL, 1995, PHYS MED BIOL, V40, P1983, DOI 10.1088/0031-9155/40/11/015; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Meulenbroek O, 2010, BRAIN RES, V1315, P100, DOI 10.1016/j.brainres.2009.12.011; Missonnier P, 2011, J NEURAL TRANSM, V118, P945, DOI 10.1007/s00702-011-0600-2; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Nyberg L, 2009, SCAND J PSYCHOL, V50, P41, DOI 10.1111/j.1467-9450.2008.00678.x; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Sakatani K, 2006, LIFE SCI, V78, P2734, DOI 10.1016/j.lfs.2005.10.045; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmand B., 1992, NEDERLANDSE LEESTEST; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Tsujii T, 2010, BEHAV BRAIN RES, V210, P178, DOI 10.1016/j.bbr.2010.02.027; van Beek AHEA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.016; Van de Ven MJT, 2001, J CEREBR BLOOD F MET, V21, P110, DOI 10.1097/00004647-200102000-00002; Verhage F., 1964, INTELLIGENTIE LEEFTI; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6	64	69	71	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46210	10.1371/journal.pone.0046210	http://dx.doi.org/10.1371/journal.pone.0046210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029437	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900108
J	Wang, XH; Wu, T; Hu, Y; Marcinkiewicz, M; Qi, SJ; Valderrama-Carvajal, H; Luo, HY; Wu, JP				Wang, Xuehai; Wu, Tao; Hu, Yan; Marcinkiewicz, Martin; Qi, Shijie; Valderrama-Carvajal, Hector; Luo, Hongyu; Wu, Jiangping			Pno1 Tissue-Specific Expression and Its Functions Related to the Immune Responses and Proteasome Activities	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MICE; CELLS; OVEREXPRESSION; MATURATION; PROTEINS; 90S	Pno1 is a protein that plays a role in proteasome and ribosome neogenesis in yeast. So far, its functions in mammalian cells have not been investigated. To understand its function in mammals, we performed in situ hybridization analysis of Pno1 expression in different development stages and generated Pno1 gene knockout (KO) and transgenic (Tg) mice lineages. The results showed early lethality of homozygous Pno1 KO lineage caused, as demonstrated in parallel by ex vivo experiments, by arrest of embryo development before compaction stage. Though, heterozygous (HET) mice with 50% of normal Pno1 mRNA concentration were fertile and showed no obvious anomalies. The lymphoid organs of HET mice were normal in size, weight and cellularity, with normal T and B cell subpopulations. TCR-triggered activation and proliferation of HET T cells were normal. Proteasome activities in HET organs were uncompromised. Tg mice with actin promoter-driven Pno1 expression were also fertile, with no apparent anomalies, although they expressed 2-5-fold higher Pno1 mRNA levels. The lymphoid organs of Tg mice were of normal size, weight and cellularity with normal T and B cell sub-populations. TCR-triggered activation and proliferation of Tg T cells were normal. Tg organs and tissues presented normal proteasome activity as did their wild type counterparts. Tagged Pno1 over-expression in L cells and density gradient fractionation established that Pno1 existed in large complexes with sedimentation rates between 20S and 26S, bigger than mature 26S proteasomes. Pno1 in fractions did not coincide with 40S or 60S ribosome subunits. Our study indicates that Pno1 is essential for cellular functions, but only a small percentage of its normal level is sufficient, and excessive amounts are neither harmful nor useful. The nature of the large complexes it associates with remains to be identified, but it is certain that they are not mature proteasomes or ribosomes.	[Wang, Xuehai; Wu, Tao; Hu, Yan; Qi, Shijie; Valderrama-Carvajal, Hector; Luo, Hongyu; Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada; [Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Serv Nephrol, Montreal, PQ H2L 4K8, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Marcinkiewicz, Martin] Cytochem Inc, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Zhejiang University	Wu, JP (corresponding author), Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, MOP97829]; Heart and Stroke Foundation of Quebec; Jean-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Jean-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP57697 and MOP69089) and H. L. (MOP97829). It was also funded by grants from the Heart and Stroke Foundation of Quebec, the Jean-Louis Levesque Foundation to J.W. In addition, it was supported by a group grant from Fonds de la recherche en sante du Quebec (FRSQ) for Transfusional and Hemovigilance Medical Research to J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Han B, 2007, ARTHRITIS RHEUM-US, V56, P3748, DOI 10.1002/art.22978; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	21	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46093	10.1371/journal.pone.0046093	http://dx.doi.org/10.1371/journal.pone.0046093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029399	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900089
J	Merlini, E; Luzi, K; Suardi, E; Barassi, A; Cerrone, M; Martinez, JS; Bai, F; D'Eril, GVM; Monforte, AD; Marchetti, G				Merlini, Esther; Luzi, Kety; Suardi, Elisa; Barassi, Alessandra; Cerrone, Maddalena; Martinez, Javier Sanchez; Bai, Francesca; D'Eril, Gian Vico Melzi; Monforte, Antonella D'Arminio; Marchetti, Giulia			T-Cell Phenotypes, Apoptosis and Inflammation in HIV plus Patients on Virologically Effective cART with Early Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INDIVIDUAL ANTIRETROVIRAL DRUGS; CAROTID-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION; INFECTED PATIENTS; MICROBIAL TRANSLOCATION; HIV-1-INFECTED PATIENTS; REPLICATIVE SENESCENCE	Objective: We investigated the potential relationship between T-cell phenotype, inflammation, endotoxemia, and atherosclerosis evaluated by carotid intima-media thickness (IMT) in a cohort of HIV-positive patients undergoing long-term virologically suppressive combination antiretroviral therapy (cART). Design: We studied 163 patients receiving virologically suppressive cART. Methods: We measured IMT (carotid ultrasound); CD4+/CD8+ T-cell activation (CD38, CD45R0), differentiation (CD127), apoptosis (CD95), and senescence (CD28, CD57) (flow cytometry); plasma sCD14, IL-6, TNF-alpha, sVCAM-1, hs-CRP, anti-CMV IgG (ELISA); LPS (LAL). The results were compared by Mann-Whitney, Kruskal-Wallis or Chi-square tests, and factors associated with IMT were evaluated by multivariable logistic regression. Results: Of 163 patients, 112 demonstrated normal IMT (nIMT), whereas 51 (31.3%) had pathological IMT (pIMT: >= 1 mm). Of the patients with pIMT, 22 demonstrated an increased IMT (iIMT), and 29 were shown to have plaques. These patient groups had comparable nadir and current CD4+, VLs and total length of time on cART. Despite similar proportions of CD38-expressing CD8+ cells (p = .95), pIMT patients exhibited higher activated memory CD8+CD38+CD45R0+ cells (p = .038) and apoptotic CD4+CD95+ (p = .01) and CD8+CD95+ cells (p = .003). In comparison to nIMT patients, iIMT patients tended to have lower numbers of early differentiated CD28+CD57- memory CD4+ (p = .048) and CD28-CD57-CD8+ cells (p = .006), both of which are associated with a higher proliferative potential. Despite no differences in plasma LPS levels, pIMT patients showed significantly higher circulating levels of sCD14 than did nIMT patients (p = .046). No differences in anti-CMV IgG was shown. Although circulating levels of sCD14 seemed to be associated with a risk of ATS in an unadjusted analysis, this effect was lost after adjusting for classical cardiovascular predictors. Conclusions: Despite the provision of full viral suppression by cART, a hyperactivated, pro-apoptotic T-cell profile characterizes HIV-infected patients with early vascular damage, for whom the potential contribution of subclinical endotoxemia and anti-CMV immunity should be investigated further.	[Merlini, Esther; Luzi, Kety; Suardi, Elisa; Cerrone, Maddalena; Martinez, Javier Sanchez; Bai, Francesca; Monforte, Antonella D'Arminio; Marchetti, Giulia] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis & Trop Med, Milan, Italy; [Barassi, Alessandra; D'Eril, Gian Vico Melzi] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Lab Clin Analyses, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan	Marchetti, G (corresponding author), Univ Milan, San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis & Trop Med, Milan, Italy.	giulia.marchetti@unimi.it	Cerrone, Maddalena/AAH-9742-2021; Gori, Andrea/AAC-6078-2022; Cerrone, Maddalena/AAH-1559-2020; Bai, Francesca/K-4823-2018; Marchetti, Giulia/GPX-7655-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	Cerrone, Maddalena/0000-0002-6900-6086; barassi, alessandra/0000-0002-0404-8357; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828				Aiello AE, 2012, J INFECT DIS, V205, P1772, DOI 10.1093/infdis/jis288; Amar J, 2006, J HYPERTENS, V24, P1083, DOI 10.1097/01.hjh.0000226198.44181.0c; Bandres E, 2000, CLIN IMMUNOL, V96, P230, DOI 10.1006/clim.2000.4894; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Nadareishvili ZG, 2004, NEUROLOGY, V63, P1446; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rossi R, 2009, JAIDS-J ACQ IMM DEF, V52, P303, DOI 10.1097/QAI.0b013e3181b18c19; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; SalazarGonzalez JF, 1997, CLIN IMMUNOL IMMUNOP, V84, P36, DOI 10.1006/clin.1997.4364; SALONEN JT, 1993, CIRCULATION, V87, P56; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Sze DMY, 2001, BLOOD, V98, P2817, DOI 10.1182/blood.V98.9.2817; Vamvakopoulos J, 2003, TRANSPLANTATION, V75, P742, DOI 10.1097/01.TP.0000054929.87347.59; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	53	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46073	10.1371/journal.pone.0046073	http://dx.doi.org/10.1371/journal.pone.0046073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029393	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500061
J	Zou, XX; Suppanz, I; Raman, H; Hou, JN; Wang, J; Long, Y; Jung, C; Meng, JL				Zou, Xiaoxiao; Suppanz, Ida; Raman, Harsh; Hou, Jinna; Wang, Jing; Long, Yan; Jung, Christian; Meng, Jinling			Comparative Analysis of FLC Homologues in Brassicaceae Provides Insight into Their Role in the Evolution of Oilseed Rape	PLOS ONE			English	Article							FLOWERING-LOCUS-C; LINKAGE MAP; COMPARATIVE GENOMICS; TIME-VARIATION; QTL ANALYSIS; GENE; ARABIDOPSIS; NAPUS; VERNALIZATION; FRIGIDA	We identified nine FLOWERING LOCUS C homologues (BnFLC) in Brassica napus and found that the coding sequences of all BnFLCs were relatively conserved but the intronic and promoter regions were more divergent. The BnFLC homologues were mapped to six of 19 chromosomes. All of the BnFLC homologues were located in the collinear region of FLC in the Arabidopsis genome except BnFLC.A3b and BnFLC.C3b, which were mapped to noncollinear regions of chromosome A3 and C3, respectively. Four of the homologues were associated significantly with quantitative trait loci for flowering time in two mapping populations. The BnFLC homologues showed distinct expression patterns in vegetative and reproductive organs, and at different developmental stages. BnFLC.A3b was differentially expressed between the winter-type and semi-winter-type cultivars. Microsynteny analysis indicated that BnFLC.A3b might have been translocated to the present segment in a cluster with other flowering-time regulators, such as a homologue of FRIGIDA in Arabidopsis. This cluster of flowering-time genes might have conferred a selective advantage to Brassica species in terms of increased adaptability to diverse environments during their evolution and domestication process.	[Zou, Xiaoxiao; Hou, Jinna; Wang, Jing; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Suppanz, Ida; Jung, Christian] Univ Kiel, Plant Breeding Inst, Kiel, Germany; [Raman, Harsh] Wagga Wagga Agr Inst, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia	Huazhong Agricultural University; University of Kiel	Meng, JL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	jmeng@mail.hzau.edu.cn	RAMAN, HARSH/N-8891-2016	RAMAN, HARSH/0000-0001-9761-1518	National Basic Research and Development Programme [2006CB101600]; National Natural Science Foundation of China [30900788]; China Scholarship Council; German Academic Exchange Service [2008-3070]; New South Wales Agricultural Genomics Centre under the BioFirst Initiative of New South Wales Government, Australia	National Basic Research and Development Programme(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); New South Wales Agricultural Genomics Centre under the BioFirst Initiative of New South Wales Government, Australia	This work was supported by the National Basic Research and Development Programme (No. 2006CB101600) and National Natural Science Foundation of China (No. 30900788), Project Based Personnel Exchange Program with China Scholarship Council and German Academic Exchange Service (No. 2008-3070), and New South Wales Agricultural Genomics Centre funded under the BioFirst Initiative of New South Wales Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000953; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Cho K, 2010, PLANT J, V61, P591, DOI 10.1111/j.1365-313X.2009.04084.x; Choi J, 2009, PLANT J, V57, P918, DOI 10.1111/j.1365-313X.2008.03776.x; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Irwin JA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-21; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang CC, 2011, THEOR APPL GENET, V123, P927, DOI 10.1007/s00122-011-1637-1; Kawabe A, 2006, GENET RES, V88, P45, DOI 10.1017/S0016672306008287; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin SI, 2005, PLANT PHYSIOL, V137, P1037, DOI 10.1104/pp.104.058974; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Meier U., 2001, BBCH MONOGRAPH, V2nd ed., P1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2004, P NATL ACAD SCI USA, V101, P3281, DOI 10.1073/pnas.0306778101; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Mun JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r94; Okazaki K, 2007, THEOR APPL GENET, V114, P595, DOI 10.1007/s00122-006-0460-6; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Osborn TC, 1997, GENETICS, V146, P1123; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Raman H, 2012, DNA RES, V19, P51, DOI 10.1093/dnares/dsr041; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Razi H, 2008, THEOR APPL GENET, V116, P179, DOI 10.1007/s00122-007-0657-3; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tadege M, 2001, PLANT J, V28, P545, DOI 10.1046/j.1365-313X.2001.01182.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-539; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Yuan YX, 2009, J EXP BOT, V60, P1299, DOI 10.1093/jxb/erp010; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao JJ, 2010, J EXP BOT, V61, P1817, DOI 10.1093/jxb/erq048	67	51	58	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45751	10.1371/journal.pone.0045751	http://dx.doi.org/10.1371/journal.pone.0045751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029223	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500041
J	Pattani, KM; Soudry, E; Glazer, CA; Ochs, MF; Wang, H; Schussel, J; Sun, WY; Hennessey, P; Mydlarz, W; Loyo, M; Demokan, S; Smith, IM; Califano, JA				Pattani, Kavita M.; Soudry, Ethan; Glazer, Chad A.; Ochs, Michael F.; Wang, Hao; Schussel, Juliana; Sun, Wenyue; Hennessey, Patrick; Mydlarz, Wojciech; Loyo, Myriam; Demokan, Semra; Smith, Ian M.; Califano, Joseph A.			MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; CANCER-TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; SALIVARY RINSES; METHYLATION; HYPERMETHYLATION; LUNG; CARCINOGENESIS; TRANSCRIPTION; INACTIVATION	Purpose: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. Experimental Design: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. Results: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. Conclusion: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC.	[Pattani, Kavita M.; Soudry, Ethan; Glazer, Chad A.; Schussel, Juliana; Sun, Wenyue; Hennessey, Patrick; Mydlarz, Wojciech; Loyo, Myriam; Demokan, Semra; Smith, Ian M.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Demokan, Semra] Istanbul Univ, Inst Oncol, Dept Basic Oncol, Istanbul, Turkey; [Ochs, Michael F.; Wang, Hao] Johns Hopkins Med Inst, Dept Oncol Biostat, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Istanbul University; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Califano, JA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu	J, Schussel/A-5935-2013; Demokan, Semra/AAC-5943-2020	J, Schussel/0000-0001-5204-0782; Sun, Wenyue/0000-0003-1673-0895	NCI [P50 DE 019032]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support by NCI P50 DE 019032 Head and Neck Cancer SPORE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Brieger J, 2010, ORAL ONCOL, V46, P678, DOI 10.1016/j.oraloncology.2010.06.016; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Calmon MF, 2007, CANCER GENET CYTOGEN, V173, P31, DOI 10.1016/j.cancergencyto.2006.09.008; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Carvalho AL, 2006, CANCER RES, V66, P9401, DOI 10.1158/0008-5472.CAN-06-1073; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chen KM, 2007, ARCH OTOLARYNGOL, V133, P1131, DOI 10.1001/archotol.133.11.1131; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Dong SM, 2003, CLIN CANCER RES, V9, P3635; Glazer CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008189; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Jang SJ, 2001, CANCER RES, V61, P7959; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Loyo M, 2011, INT J CANC; Lurquin C, 1997, GENOMICS, V46, P397, DOI 10.1006/geno.1997.5052; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nagashima H, 2001, JPN J CANCER RES, V92, P167, DOI 10.1111/j.1349-7006.2001.tb01079.x; Paluszczak J, 2011, TOXICOL IN VITRO, V25, P213, DOI 10.1016/j.tiv.2010.11.003; Pattani KM, 2010, CANCER PREV RES, V3, P1093, DOI 10.1158/1940-6207.CAPR-10-0115; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027; Sharma R, 2010, ORAL DIS, V16, P668, DOI 10.1111/j.1601-0825.2010.01676.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Yalniz Z, 2011, DNA CELL BIOL, V30, P17, DOI 10.1089/dna.2010.1090; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	33	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45534	10.1371/journal.pone.0045534	http://dx.doi.org/10.1371/journal.pone.0045534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029077	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700044
J	Wang, XX; Sharp, AR; Miller, RD				Wang, Xinxin; Sharp, Alana R.; Miller, Robert D.			Early Postnatal B Cell Ontogeny and Antibody Repertoire Maturation in the Opossum, Monodelphis domestica	PLOS ONE			English	Article							SHORT-TAILED OPOSSUM; WALLABY MACROPUS-EUGENII; MARSUPIAL LIGHT-CHAINS; BONE-MARROW; FETAL LIVER; POUCH YOUNG; TRICHOSURUS-VULPECULA; JUNCTIONAL DIVERSITY; NEONATAL PIGLETS; LYMPHOID-TISSUES	Marsupials are a lineage of mammals noted for giving birth to highly altricial young, which complete much of their "fetal" development externally attached to a teat. Postnatal B cell ontogeny and diversity was investigated in a model marsupial species, the gray short-tailed opossum, Monodelphis domestica. The results support the initiation of B cell development late in gestation and progressing into the first two weeks of postnatal life. Transcription of CD79a and CD79b was detected in embryonic tissue prior to birth, while immunoglobulin heavy chain locus transcription was not detected until the first postnatal 24 hours. Transcription of the Ig light chains was not detected until postnatal day 7 at the earliest. The predicted timing of the earliest appearance of mature B cells and completion of gene rearrangements is consistent with previous analyses on the timing of endogenous antibody responses in newborn marsupials. The diversity of early B cell IgH chains is limited, as has been seen in fetal humans and mice, but lacks bias in the gene segments used to encode the variable domains. Newborn light chain diversity is, from the start, comparable to that of the adult, consistent with an earlier hypothesis that light chains contribute extensively to antibody diversity in this species.	[Wang, Xinxin; Sharp, Alana R.; Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	University of New Mexico	Miller, RD (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.	rdmiller@unm.edu	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Miller, Robert/0000-0002-8479-8819	National Institutes of Health from the Institutional Development Award program [P20 GM103452-09]; National Science Foundation [IOS-0641382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452] Funding Source: NIH RePORTER	National Institutes of Health from the Institutional Development Award program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part the National Institutes of Health grant no. P20 GM103452-09 from the Institutional Development Award program and a National Science Foundation award IOS-0641382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1999, J IMMUNOL, V162, P6009; Aveskogh M, 1998, EUR J IMMUNOL, V28, P2738, DOI 10.1002/(SICI)1521-4141(199809)28:09<2738::AID-IMMU2738>3.0.CO;2-I; Baker ML, 2005, J IMMUNOL, V174, P5665, DOI 10.4049/jimmunol.174.9.5665; Belov K, 2002, DEV COMP IMMUNOL, V26, P599, DOI 10.1016/S0145-305X(02)00015-0; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Butler JE, 2006, VET RES, V37, P417, DOI 10.1051/vetres:2006009; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Butler JE, 2001, J IMMUNOL, V167, P3239, DOI 10.4049/jimmunol.167.6.3239; Butler JE, 2000, J IMMUNOL, V165, P6999, DOI 10.4049/jimmunol.165.12.6999; DEANE EM, 1984, DEV COMP IMMUNOL, V8, P863, DOI 10.1016/0145-305X(84)90069-7; DECKER DJ, 1991, J IMMUNOL, V146, P350; del Blanco B, 2011, GENET RES, V2011, P1; DERRICKSON EM, 1992, FUNCT ECOL, V6, P57, DOI 10.2307/2389771; Duncan L, 2010, VET IMMUNOL IMMUNOP, V136, P235, DOI 10.1016/j.vetimm.2010.03.013; FADEM BH, 1985, BIOL REPROD, V33, P112, DOI 10.1095/biolreprod33.1.112; FEENEY AJ, 1992, J IMMUNOL, V149, P222; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; ISHINO S, 1991, J VET MED SCI, V53, P877, DOI 10.1292/jvms.53.877; KALMUTZ SE, 1962, NATURE, V193, P851, DOI 10.1038/193851a0; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; LAPLANTE ES, 1969, TRANSPLANTATION, V7, P67, DOI 10.1097/00007890-196901000-00006; LAVIA MF, 1963, SCIENCE, V140, P1219, DOI 10.1126/science.140.3572.1219; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Lucero JE, 1998, J IMMUNOL, V161, P6724; LYNE A. G., 1959, NATURE, V183, P622, DOI 10.1038/183622b0; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MILILI M, 1991, MOL IMMUNOL, V28, P753, DOI 10.1016/0161-5890(91)90118-4; Miller RD, 1999, IMMUNOGENETICS, V50, P329, DOI 10.1007/s002510050609; Miller RD, 1998, J IMMUNOL, V160, P259; Old JM, 2003, J ANAT, V203, P123, DOI 10.1046/j.1469-7580.2003.00207.x; Old JM, 2000, DEV COMP IMMUNOL, V24, P445, DOI 10.1016/S0145-305X(00)00008-2; PALACIOS R, 1992, MOL CELL BIOL, V12, P518, DOI 10.1128/MCB.12.2.518; Parra ZE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-111; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; ROWLANDS DT, 1972, J IMMUNOL, V108, P941; Samollow PB, 2006, AUST J ZOOL, V54, P173, DOI 10.1071/ZO05059; Samples K, 1986, AM J REPROD IMMUNOL, V11, P94; Schelonka RL, 2011, IMMUNOGENETICS, V63, P599, DOI 10.1007/s00251-011-0543-7; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; STANLEY NF, 1972, AUST J EXP BIOL MED, V50, P689, DOI 10.1038/icb.1972.62; Tonnelle C, 1995, ANN NY ACAD SCI, V764, P231; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang XX, 2012, IMMUNOGENETICS, V64, P713, DOI 10.1007/s00251-012-0627-z; Wang XX, 2012, IMMUNOGENETICS, V64, P647, DOI 10.1007/s00251-012-0626-0; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Yadav M, 1971, AUST J EXP BIOL MED, V49, P322; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45931	10.1371/journal.pone.0045931	http://dx.doi.org/10.1371/journal.pone.0045931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029324	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700089
J	Yao, J; Zhao, Q; Yuan, Y; Zhang, L; Liu, XM; Yung, WKA; Weinstein, JN				Yao, Jun; Zhao, Qi; Yuan, Ying; Zhang, Li; Liu, Xiaoming; Yung, W. K. Alfred; Weinstein, John N.			Identification of Common Prognostic Gene Expression Signatures with Biological Meanings from Microarray Gene Expression Datasets	PLOS ONE			English	Article							BREAST-CANCER; LUNG-CANCER; PREDICTION; SURVIVAL	Numerous prognostic gene expression signatures for breast cancer were generated previously with few overlap and limited insight into the biology of the disease. Here we introduce a novel algorithm named SCoR (Survival analysis using Cox proportional hazard regression and Random resampling) to apply random resampling and clustering methods in identifying gene features correlated with time to event data. This is shown to reduce overfitting noises involved in microarray data analysis and discover functional gene sets linked to patient survival. SCoR independently identified a common poor prognostic signature composed of cell proliferation genes from six out of eight breast cancer datasets. Furthermore, a sequential SCoR analysis on highly proliferative breast cancers repeatedly identified T/B cell markers as favorable prognosis factors. In glioblastoma, SCoR identified a common good prognostic signature of chromosome 10 genes from two gene expression datasets (TCGA and REMBRANDT), recapitulating the fact that loss of one copy of chromosome 10 (which harbors the tumor suppressor PTEN) is linked to poor survival in glioblastoma patients. SCoR also identified prognostic genes on sex chromosomes in lung adenocarcinomas, suggesting patient gender might be used to predict outcome in this disease. These results demonstrate the power of SCoR to identify common and biologically meaningful prognostic gene expression signatures.	[Yao, Jun; Yung, W. K. Alfred] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Yuan, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Zhang, Li; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Xiaoming] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; [Zhao, Qi] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Johns Hopkins University	Yao, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	jyao1@mdanderson.org	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528; Zhang, Li/0000-0003-0517-7860; Weinstein, John/0000-0001-9401-6908	National Institutes of Health (NIH) SPORE [5P50127001]; NIH [U24 CA143883]; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE [U24CA143883, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH) SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health (NIH) SPORE grant 5P50127001 and NIH grant U24 CA143883, and by Ben and Catherine Ivy Foundation (http://www.ivyfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Eisen Andrea, 1998, Current Opinion in Oncology, V10, P486, DOI 10.1097/00001622-199811000-00002; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Novello S, 2008, FUTURE ONCOL, V4, P705, DOI 10.2217/14796694.4.5.705; Paggi MG, 2010, CANCER LETT, V298, P1, DOI 10.1016/j.canlet.2010.08.009; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Robinson BM, 2011, J THORAC ONCOL, V6, P1691, DOI 10.1097/JTO.0b013e31822647fd; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorner AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013073; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	25	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45894	10.1371/journal.pone.0045894	http://dx.doi.org/10.1371/journal.pone.0045894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029298	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800113
J	Martin, D; Allagnat, F; Gesina, E; Caille, D; Gjinovci, A; Waeber, G; Meda, P; Haefliger, JA				Martin, David; Allagnat, Florent; Gesina, Emilie; Caille, Dorothee; Gjinovci, Asllan; Waeber, Gerard; Meda, Paolo; Haefliger, Jacques-Antoine			Specific Silencing of the REST Target Genes in Insulin-Secreting Cells Uncovers Their Participation in Beta Cell Survival	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURON-RESTRICTIVE SILENCER; CYTOKINE-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; UP-REGULATION; REPRESSOR; PHOSPHORYLATION; PROTEIN; BCL-2; CDK5	The absence of the transcriptional repressor RE-1 Silencing Transcription Factor (REST) in insulin-secreting beta cells is a major cue for the specific expression of a large number of genes. These REST target genes were largely ascribed to a function of neurotransmission in a neuronal context, whereas their role in pancreatic beta cells has been poorly explored. To identify their functional significance, we have generated transgenic mice expressing REST in beta cells (RIP-REST mice), and previously discovered that REST target genes are essential to insulin exocytosis. Herein we characterized a novel line of RIP-REST mice featuring diabetes. In diabetic RIP-REST mice, high levels of REST were associated with postnatal beta cell apoptosis, which resulted in gradual beta cell loss and sustained hyperglycemia in adults. Moreover, adenoviral REST transduction in INS-1E cells led to increased cell death under control conditions, and sensitized cells to death induced by cytokines. Screening for REST target genes identified several anti-apoptotic genes bearing the binding motif RE-1 that were downregulated upon REST expression in INS-1E cells, including Gjd2, Mapk8ip1, Irs2, Ptprn, and Cdk5r2. Decreased levels of Cdk5r2 in beta cells of RIP-REST mice further confirmed that it is controlled by REST, in vivo. Using siRNA-mediated knockdown in INS-1E cells, we showed that Cdk5r2 protects beta cells against cytokines and palmitate-induced apoptosis. Together, these data document that a set of REST target genes, including Cdk5r2, is important for beta cell survival.	[Martin, David; Allagnat, Florent; Waeber, Gerard; Haefliger, Jacques-Antoine] CHU Vaudois, Serv Internal Med, Lausanne, Switzerland; [Gesina, Emilie] Ecole Polytech Fed Lausanne, Fac Sci Vie, Lausanne, Switzerland; [Caille, Dorothee; Gjinovci, Asllan; Meda, Paolo] Univ Med Ctr, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Haefliger, JA (corresponding author), CHU Vaudois, Serv Internal Med, Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Allagnat, Florent/AAY-7188-2021; Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017	Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [31003A_138528/1, 310000-109402]; Juvenile Diabetes Research Foundation [1-2007-158]; European Union [BETAIMAGE 222980, IMIDIA, C2008-T7]; National Institutes of Health [HL64232]; Novartis; Octav; Marcella Botnar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064232] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Octav; Marcella Botnar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from The Swiss National Science Foundation [31003A_138528/1; 310000-109402], the Juvenile Diabetes Research Foundation [1-2007-158], the European Union [BETAIMAGE 222980; IMIDIA, C2008-T7], the National Institutes of Health HL64232, the Novartis and the Octav and the Marcella Botnar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allison J, 2000, INT IMMUNOL, V12, P9, DOI 10.1093/intimm/12.1.9; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Daval M, 2011, DIABETES, V60, P1186, DOI 10.2337/db10-1048; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Endo R, 2009, J BIOL CHEM, V284, P26029, DOI 10.1074/jbc.M109.026443; Haefliger JA, 2003, J CELL SCI, V116, P1463, DOI 10.1242/jcs.00356; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Klee P, CX36 PROTECTS UNPUB; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Martin Daniel, 2008, P51; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Mziaut H, 2008, P NATL ACAD SCI US; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Richardson SJ, 2009, DIABETOLOGIA, V52, P1686, DOI 10.1007/s00125-009-1410-z; Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/en.141.6.2003; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schuit Frans, 2005, Diabetologia, V48, pR93; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Takahashi S, 2010, AM J PATHOL, V176, P320, DOI 10.2353/ajpath.2010.081158; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TRIMBLE ER, 1985, ENDOCRINOLOGY, V117, P1246, DOI 10.1210/endo-117-3-1246; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631	49	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45844	10.1371/journal.pone.0045844	http://dx.doi.org/10.1371/journal.pone.0045844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029270	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900106
J	Ramadas, RA; Ewart, SL; Iwakura, Y; Medoff, BD; LeVine, AM				Ramadas, Ravisankar A.; Ewart, Susan L.; Iwakura, Yoichiro; Medoff, Benjamin D.; LeVine, Ann Marie			IL-36 alpha Exerts Pro-Inflammatory Effects in the Lungs of Mice	PLOS ONE			English	Article							NF-KAPPA-B; IL-1 RECEPTOR ANTAGONIST; EPITHELIAL-CELLS; MURINE MODEL; PSEUDOMONAS-AERUGINOSA; MECHANICAL VENTILATION; PULMONARY INFLAMMATION; IL-1-BETA SECRETION; PATTERN-RECOGNITION; INFLUENZA-VIRUS	Interleukin (IL-) 36 cytokines (previously designated as novel IL-1 family member cytokines; IL-1F5-IL-1F10) constitute a novel cluster of cytokines structurally and functionally similar to members of the IL-1 cytokine cluster. The effects of IL-36 cytokines in inflammatory lung disorders remains poorly understood. The current study sought to investigate the effects of IL-36 alpha (IL-1F6) and test the hypothesis that IL-36 alpha acts as a pro-inflammatory cytokine in the lung in vivo. Intratracheal instillation of recombinant mouse IL-36 alpha induced neutrophil influx in the lungs of wild-type C57BL/6 mice and IL-1 alpha beta(-/-) mice in vivo. IL-36 alpha induced neutrophil influx was also associated with increased mRNA expression of neutrophil-specific chemokines CXCL1 and CXCL2 in the lungs of C57BL/6 and IL-1 alpha beta(-/-) mice in vivo. In addition, intratracheal instillation of IL-36 alpha enhanced mRNA expression of its receptor IL-36R in the lungs of C57BL/6 as well as IL-1 alpha beta(-/-) mice in vivo. Furthermore, in vitro incubation of CD11c(+) cells with IL-36 alpha resulted in the generation of neutrophil-specific chemokines CXCL1, CXCL2 as well as TNF alpha. IL-36 alpha increased the expression of the co-stimulatory molecule CD40 and enhanced the ability of CD11c(+) cells to induce CD4(+) T cell proliferation in vitro. Furthermore, stimulation with IL-36 alpha activated NF-kappa B in a mouse macrophage cell line. These results demonstrate that IL-36 alpha acts as a pro-inflammatory cytokine in the lung without the contribution of IL-1 alpha and IL-1 beta. The current study describes the pro-inflammatory effects of IL-36 alpha in the lung, demonstrates the functional redundancy of IL-36 alpha with other agonist cytokines in the IL-1 and IL-36 cytokine cluster, and suggests that therapeutic targeting of IL-36 cytokines could be beneficial in inflammatory lung diseases.	[Ramadas, Ravisankar A.; Medoff, Benjamin D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Ramadas, Ravisankar A.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Ewart, Susan L.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Tokyo, Japan; [LeVine, Ann Marie] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Michigan State University; University of Tokyo; University of Michigan System; University of Michigan	Ramadas, RA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA.	rramadas@partners.org; anlevine@med.umich.edu	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Medoff, Benjamin/0000-0002-2558-0449	National Institute of Allergy and Infectious Diseases [1R03AI101366]; National Heart, Lung & Blood Institute [5T32HL007874]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI101366] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research work was supported by Grants from the National Institute of Allergy and Infectious Diseases 1R03AI101366 (R.A.R) and the National Heart, Lung & Blood Institute 5T32HL007874 (B.D.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; BORISH L, 1992, J IMMUNOL, V149, P3078; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Bry K, 2007, AM J RESP CELL MOL, V36, P32, DOI 10.1165/rcmb.2006-0116OC; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Choi IW, 2004, INT IMMUNOPHARMACOL, V4, P1817, DOI 10.1016/j.intimp.2004.07.030; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Desmet C, 2004, J IMMUNOL, V173, P5766, DOI 10.4049/jimmunol.173.9.5766; DeVoti JA, 2008, MOL MED, V14, P608, DOI 10.2119/2008-00060.DeVoti; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1977, P NATL ACAD SCI USA, V74, P4624, DOI 10.1073/pnas.74.10.4624; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Heiman AS, 2005, J INTERF CYTOK RES, V25, P82, DOI 10.1089/jir.2005.25.82; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jedrzkiewicz S, 2000, AM J PHYSIOL-LUNG C, V279, pL1058, DOI 10.1152/ajplung.2000.279.6.L1058; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kugathasan K, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-48; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LEFF JA, 1994, AM J PHYSIOL, V266, pL2, DOI 10.1152/ajplung.1994.266.1.L2; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin U, 2009, J IMMUNOL, V183, P4021, DOI 10.4049/jimmunol.0803301; McLellan AD, 1996, EUR J IMMUNOL, V26, P1204, DOI 10.1002/eji.1830260603; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ramadas RA, 2006, IMMUNOGENETICS, V58, P851, DOI 10.1007/s00251-006-0146-x; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Tonnel AB, 2001, INT ARCH ALLERGY IMM, V124, P267, DOI 10.1159/000053729; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; ULICH TR, 1991, AM J PATHOL, V138, P521; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Vigne S, 2011, BLOOD; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wang CC, 2006, GENE THER, V13, P1414, DOI 10.1038/sj.gt.3302798; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; ZHANG Y, 1993, J IMMUNOL, V150, P4188; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	76	68	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45784	10.1371/journal.pone.0045784	http://dx.doi.org/10.1371/journal.pone.0045784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029241	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900100
J	Vaughan, VC; Sullivan-Gunn, M; Hinch, E; Martin, P; Lewandowski, PA				Vaughan, Vanessa C.; Sullivan-Gunn, Melanie; Hinch, Edward; Martin, Peter; Lewandowski, Paul A.			Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia	PLOS ONE			English	Article							XANTHINE-OXIDASE INHIBITORS; PROTEOLYSIS-INDUCING FACTOR; N-3 FATTY-ACIDS; PROTEIN-DEGRADATION; OXIDATIVE STRESS; EXPRESSION; ALLOPURINOL; CATABOLISM; INDEXES; PATHWAY	Cancer cachexia is a wasting condition, driven by systemic inflammation and oxidative stress. This study investigated eicosapentaenoic acid (EPA) in combination with oxypurinol as a treatment in a mouse model of cancer cachexia. Mice with cancer cachexia were randomized into 4 treatment groups (EPA (0.4 g/kg/day), oxypurinol (1 mmol/L ad-lib), combination, or control), and euthanized after 29 days. Analysis of oxidative damage to DNA, mRNA analysis of pro-oxidant, antioxidant and proteolytic pathway components, along with enzyme activity of pro- and antioxidants were completed on gastrocnemius muscle. The control group displayed earlier onset of tumor compared to EPA and oxypurinol groups (P<0.001). The EPA group maintained body weight for an extended duration (20 days) compared to the oxypurinol (5 days) and combination (8 days) groups (P<0.05). EPA (18.2 +/- 3.2 pg/ml) and combination (18.4 +/- 3.7 pg/ml) groups had significantly higher 8-OH-dG levels than the control group (12.9 +/- 1.4 pg/ml, P <= 0.05) indicating increased oxidative damage to DNA. mRNA levels of GPx1, MURF1 and MAFbx were higher following EPA treatment compared to control (P <= 0.05). Whereas oxypurinol was associated with higher GPx1, MnSOD, CAT, XDH, MURF1, MAFbx and UbB mRNA compared to control (P <= 0.05). Activity of total SOD was higher in the oxypurinol group (32.2 +/- 1.5 U/ml) compared to control (27.0 +/- 1.3 U/ml, P<0.01), GPx activity was lower in the EPA group (8.76 +/- 2.0 U/ml) compared to control (14.0 +/- 1.9 U/ml, P<0.05), and catalase activity was lower in the combination group (14.4 +/- 2.8 U/ml) compared to control (20.9 +/- 2.0 U/ml, P<0.01). There was no change in XO activity. The increased rate of weight decline in mice treated with oxypurinol indicates that XO may play a protective role during the progression of cancer cachexia, and its inhibition is detrimental to outcomes. In combination with EPA, there was little significant improvement from control, indicating oxypurinol is unlikely to be a viable treatment compound in cancer cachexia.	[Vaughan, Vanessa C.; Hinch, Edward; Martin, Peter; Lewandowski, Paul A.] Deakin Univ, Sch Med, Waurn Ponds, Australia; [Sullivan-Gunn, Melanie] Victoria Univ, Sch Biomed & Hlth Sci, Melbourne, Vic 8001, Australia	Deakin University; Victoria University	Lewandowski, PA (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Australia.	paul.lewandowski@deakin.edu.au	Sullivan-Gunn, Melanie/U-4785-2019; Vaughan, Vanessa/AAB-6176-2019; Martin, Peter/R-6302-2017	Vaughan, Vanessa/0000-0003-3879-2448; Martin, Peter/0000-0002-1214-5149; SULLIVAN-GUNN, MELANIE/0000-0003-4099-5439	Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency; State Government of Victoria, Australia; Bellberry Support Scholarship through Bellberry Ltd.	Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency; State Government of Victoria, Australia; Bellberry Support Scholarship through Bellberry Ltd.	VV is the recipient of the Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency funded by the State Government of Victoria, Australia, and the Bellberry Support Scholarship through Bellberry Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Barber MD, 2001, NUTRITION, V17, P751, DOI 10.1016/S0899-9007(01)00631-1; Barreiro E, 2005, FEBS LETT, V579, P1646, DOI 10.1016/j.febslet.2005.02.017; BECK SA, 1991, CANCER RES, V51, P6089; Biondo PD, 2008, J NUTR BIOCHEM, V19, P787, DOI 10.1016/j.jnutbio.2008.02.003; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; de Palma L, 2008, JOINT BONE SPINE, V75, P53, DOI 10.1016/j.jbspin.2007.04.019; DEBY C, 1981, BIOCHEM PHARMACOL, V30, P2243, DOI 10.1016/0006-2952(81)90094-0; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Fearon KCH, 2006, J CLIN ONCOL, V24, P3401, DOI 10.1200/JCO.2005.04.5724; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardman WE, 2004, J NUTR, V134, p3427S, DOI 10.1093/jn/134.12.3427S; Hashimoto M, 1999, LIPIDS, V34, P1297, DOI 10.1007/s11745-999-0481-6; Kaynar H, 2005, CANCER LETT, V227, P133, DOI 10.1016/j.canlet.2004.12.005; Khal J, 2005, BRIT J CANCER, V93, P774, DOI 10.1038/sj.bjc.6602780; Li M, 2011, ENVIRON TOXICOL, V26, P217, DOI 10.1002/tox.20546; Mantovani G, 2003, J MOL MED-JMM, V81, P664, DOI 10.1007/s00109-003-0476-1; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Penna F, 2011, J CACHEXIA SARCOPENI, V2, P95, DOI 10.1007/s13539-011-0028-4; Russell ST, 2007, CELL SIGNAL, V19, P1797, DOI 10.1016/j.cellsig.2007.04.003; Russell ST, 2005, PROSTAG LEUKOTR ESS, V72, P409, DOI 10.1016/j.plefa.2005.03.002; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Skipworth RJE, 2007, CLIN NUTR, V26, P667, DOI 10.1016/j.clnu.2007.03.011; Springer J, 2009, J CARD FAIL, V15, pS22, DOI 10.1016/j.cardfail.2009.06.381; Stehr SN, 2006, CLIN CHIM ACTA, V373, P1, DOI 10.1016/j.cca.2006.04.024; Sullivan-Gunn M, 2011, BRIT J CANCER, V104, P1055, DOI 10.1038/bjc.2011.35; Sullivan-Gunn MJ, 2011, J CACHEXIA SARCOPENI, V2, P181, DOI 10.1007/s13539-011-0037-3; TATE GA, 1988, ARTHRITIS RHEUM, V31, P1543, DOI 10.1002/art.1780311211; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; Tijerina Amanda J, 2004, Dimens Crit Care Nurs, V23, P237, DOI 10.1097/00003465-200411000-00001; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van Norren K, 2009, BRIT J CANCER, V100, P713, DOI 10.1038/sj.bjc.6604905; Whitehouse AS, 2001, CANCER RES, V61, P3604; Wyke SM, 2005, BRIT J CANCER, V92, P711, DOI 10.1038/sj.bjc.6602402	36	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45900	10.1371/journal.pone.0045900	http://dx.doi.org/10.1371/journal.pone.0045900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029301	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900109
J	Yang, YW; Wang, Z; Ren, LL; Wang, W; Vernet, G; Paranhos-Baccala, G; Jin, Q; Wang, JW				Yang, Yaowu; Wang, Zhong; Ren, Lili; Wang, Wei; Vernet, Guy; Paranhos-Baccala, Glaucia; Jin, Qi; Wang, Jianwei			Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections, Beijing, 2009-2010	PLOS ONE			English	Article							A H1N1 VIRUS; CLINICAL CHARACTERISTICS; TRACT INFECTION; ADULTS; EPIDEMIOLOGY; RHINOVIRUSES; CIRCULATION; PREVALENCE; CHINA	To determine the role of the pandemic influenza A/H1N1 2009 (A/H1N1 2009pdm) in acute respiratory tract infections (ARTIs) and its impact on the epidemic of seasonal influenza viruses and other common respiratory viruses, nasal and throat swabs taken from 7,776 patients with suspected viral ARTIs from 2006 through 2010 in Beijing, China were screened by real-time PCR for influenza virus typing and subtyping and by multiplex or single PCR tests for other common respiratory viruses. We observed a distinctive dual peak pattern of influenza epidemic during the A/H1N1 2009pdm in Beijing, China, which was formed by the A/H1N1 2009pdm, and a subsequent influenza B epidemic in year 2009/2010. Our analysis also shows a small peak formed by a seasonal H3N2 epidemic prior to the A/H1N1 2009pdm peak. Parallel detection of multiple respiratory viruses shows that the epidemic of common respiratory viruses, except human rhinovirus, was delayed during the pandemic of the A/H1N1 2009pdm. The H1N1 2009pdm mainly caused upper respiratory tract infections in the sampled patients; patients infected with H1N1 2009pdm had a higher percentage of cough than those infected with seasonal influenza or other respiratory viruses. Our findings indicate that A/H1N1 2009pdm and other respiratory viruses except human rhinovirus could interfere with each other during their transmission between human beings. Understanding the mechanisms and effects of such interference is needed for effective control of future influenza epidemics.	[Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, CAMS Fondat Merieux, Beijing 100730, Peoples R China; [Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, Christophe Merieux Lab, CAMS Fondat Merieux, Beijing 100730, Peoples R China; [Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Vernet, Guy; Paranhos-Baccala, Glaucia] Fondat Merieux, Lyon, France; [Wang, Zhong] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Yang, Yaowu] China Natl Accreditat Serv Conform Assessment CNA, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, CAMS Fondat Merieux, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; wangjw28@163.com	Wang, Jianwei/AAW-9499-2020; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; 	National Basic Research Program (973 Program) of China [2010CB534003]; National Key Technologies RD Program; National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China [2009ZX10004-206]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program); National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China	This work was supported by the National Basic Research Program (973 Program) of China (2010CB534003), the National Key Technologies R&D Program, the National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China (2009ZX10004-206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Casalegno JS, 2010, EURO SURVEILL, V15; Centers for Disease Control and Prevention, 2009, FLU ACT SURV 2008 20; Centers for Disease Control and Prevention, 2010, FLU ACT SURV 2009 20; Centers for Disease Control and Prevention, 2009, 2007 08 US INFLUENZA; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dai XQ, 2012, BIOMED ENVIRON SCI, V25, P61, DOI 10.3967/0895-3988.2012.01.009; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; del Rio C, 2010, T AM CLIN CLIMAT ASS, V121, P138; del Rio Carlos, 2010, Trans Am Clin Climatol Assoc, V121, P128; Deng LH, 2012, J ZHEJIANG UNIV-SC B, V13, P49, DOI 10.1631/jzus.B1100168; European Centre for Disease Prevention and Control, 2010, WEEKL INFL SURV OV A; European Centre for Disease Prevention and Control, 2010, INFL SURV EUR 2008 0; European Centre for Disease Prevention and Control, 2009, WEEKL INFL SURV OV M; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Jacobson J, 2010, AM J NURS, V110, P22, DOI 10.1097/01.NAJ.0000389664.17370.d9; Li JG, 2012, J INFECTION, V64, P96, DOI 10.1016/j.jinf.2011.10.011; Mak GC, 2012, INFLUENZA OTHER RESP, V6, pe6, DOI 10.1111/j.1750-2659.2011.00323.x; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Patel M, 2010, BRIT J ANAESTH, V104, P128, DOI 10.1093/bja/aep375; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Raoult D, 2011, SCIENCE, V331, P144, DOI 10.1126/science.331.6014.144-c; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; WHO, 2010, GLOB AL RESP GAR PAN; World Health Organization, 2011, SUMM REV 2010 2011 N; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xiang ZC, 2010, J INFECTION, V61, P289, DOI 10.1016/j.jinf.2010.07.001; Yang YW, 2010, J VIROL METHODS, V167, P37, DOI 10.1016/j.jviromet.2010.03.007; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208	40	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45807	10.1371/journal.pone.0045807	http://dx.doi.org/10.1371/journal.pone.0045807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029253	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900102
J	Khoontawad, J; Laothong, U; Roytrakul, S; Pinlaor, P; Mulvenna, J; Wongkham, C; Yongvanit, P; Pairojkul, C; Mairiang, E; Sithithaworn, P; Pinlaor, S				Khoontawad, Jarinya; Laothong, Umawadee; Roytrakul, Sittiruk; Pinlaor, Porntip; Mulvenna, Jason; Wongkham, Chaisiri; Yongvanit, Puangrat; Pairojkul, Chawalit; Mairiang, Eimorn; Sithithaworn, Paiboon; Pinlaor, Somchai			Proteomic Identification of Plasma Protein Tyrosine Phosphatase Alpha and Fibronectin Associated with Liver Fluke, Opisthorchis viverrini, Infection	PLOS ONE			English	Article							NITRATIVE DNA-DAMAGE; BREAST-CANCER; DISCOVERY; LOCALIZATION; BIOMARKERS; FIBROSIS; COLLAGEN; DISEASE; TARGETS; PHASE	Opisthorchiasis caused by Opisthorchis viverrini induces periductal fibrosis via host immune/inflammatory responses. Plasma protein alteration during host-parasite interaction-mediated inflammation may provide potential diagnostic and/or prognostic biomarkers. To search for target protein changes in O. viverrini-infected hamsters, a 1-D PAGE gel band was trypsin-digested and analyzed by a LC-MS/MS-based proteomics approach in the plasma profile of infected hamsters, and applied to humans. Sixty seven proteins were selected for further analysis based on at least two unique tryptic peptides with protein ID score >10 and increased expression at least two times across time points. These proteins have not been previously identified in O. viverrini-associated infection. Among those, proteins involved in structural (19%), immune response (13%), cell cycle (10%) and transcription (10%) were highly expressed. Western blots revealed an expression level of protein tyrosine phosphatase alpha (PTP alpha) which reached a peak at 1 month and subsequently tended to decrease. Fibronectin significantly increased at 1 month and tended to increase with time, supporting proteomic analysis. PTPa was expressed in the cytoplasm of inflammatory cells, while fibronectin was observed mainly in the cytoplasm of fibroblasts and the extracellular matrix at periductal fibrosis areas. In addition, these protein levels significantly increased in the plasma of O. viverrini-infected patients compared to healthy individuals, and significantly decreased at 2-months post-treatment, indicating their potential as disease markers. In conclusion, our results suggest that plasma PTP alpha and fibronectin may be associated with opisthorchiasis and the hamster model provides the basis for development of novel diagnostic markers in the future.	[Khoontawad, Jarinya; Laothong, Umawadee; Sithithaworn, Paiboon; Pinlaor, Somchai] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand; [Roytrakul, Sittiruk] Genome Inst Biotechnol, Prote Res Lab, Pathum Thani, Thailand; [Pinlaor, Porntip] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev Med Diagnost Lab, Khon Kaen, Thailand; [Wongkham, Chaisiri; Yongvanit, Puangrat] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Pairojkul, Chawalit] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Mairiang, Eimorn] Khon Kaen Univ, Fac Med, Dept Radiol, Khon Kaen, Thailand; [Khoontawad, Jarinya; Laothong, Umawadee; Wongkham, Chaisiri; Yongvanit, Puangrat; Pairojkul, Chawalit; Sithithaworn, Paiboon; Pinlaor, Somchai] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Mulvenna, Jason] Queensland Inst Med Res, Fac Computat Biol, Dept Infect Dis & Canc, Brisbane, Qld 4006, Australia	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; QIMR Berghofer Medical Research Institute	Pinlaor, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand.	psomec@kku.ac.th	Sithithaworn, Paiboon/E-4378-2019; Mulvenna, Jason/H-7110-2014	Sithithaworn, Paiboon/0000-0002-9480-1778; Mulvenna, Jason/0000-0003-3521-8061; Pinlaor, Somchai/0000-0002-8187-7247	Thailand Research Fund through Royal Golden Jubilee Ph.D. Program; Thailand Research Fund [RMU5380016]; BIOTEC-NSTDA, Thailand; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand	Thailand Research Fund through Royal Golden Jubilee Ph.D. Program; Thailand Research Fund(Thailand Research Fund (TRF)); BIOTEC-NSTDA, Thailand; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand	This work was supported by Thailand Research Fund through Royal Golden Jubilee Ph.D. Program (to JK and SP); Thailand Research Fund (RMU5380016); Research Team Strengthening Grant from BIOTEC-NSTDA, Thailand; The Higher Education Research Promotion and National Research University Project of Thailand; and Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADNANI MS, 1985, J PATHOL, V147, P77, DOI 10.1002/path.1711470202; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021; Charoensuk L, 2011, INT J PARASITOL, V41, P615, DOI 10.1016/j.ijpara.2010.12.011; Cooper B, 2011, J PROTEOME RES, V10, P1432, DOI 10.1021/pr101003r; de Roos B, 2008, J PROTEOME RES, V7, P2280, DOI 10.1021/pr700714x; Dechakhamphu S, 2008, CANCER EPIDEM BIOMAR, V17, P1658, DOI 10.1158/1055-9965.EPI-08-0191; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; Greggio E, 2007, EXPERT REV PROTEOMIC, V4, P783, DOI 10.1586/14789450.4.6.783; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; HASWELLELKINS MR, 1994, INT J CANCER, V59, P505, DOI 10.1002/ijc.2910590412; Hondermarck H, 2001, PROTEOMICS, V1, P1216, DOI 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kaspar M, 2006, INT J CANCER, V118, P1331, DOI 10.1002/IJC.21677; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Khoontawad J, 2010, PARASITE IMMUNOL, V32, P314, DOI 10.1111/j.1365-3024.2009.01189.x; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucena Sara, 2007, Invest. clín, V48, P249; Mairiang Eimorn, 2006, Asian Pac J Cancer Prev, V7, P431; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; Ndao M, 2010, J CLIN MICROBIOL, V48, P1139, DOI 10.1128/JCM.02207-09; NORBERG R, 1979, EUR J BIOCHEM, V100, P575, DOI 10.1111/j.1432-1033.1979.tb04204.x; OHSHIMA H, 1994, CARCINOGENESIS, V15, P271, DOI 10.1093/carcin/15.2.271; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Pinlaor S, 2004, NITRIC OXIDE-BIOL CH, V11, P175, DOI 10.1016/j.niox.2004.08.004; Prakobwong S, 2010, INT J CANCER, V127, P2576, DOI 10.1002/ijc.25266; Prakobwong S, 2009, INT J PARASITOL, V39, P825, DOI 10.1016/j.ijpara.2008.12.002; Ruiz-Garcia E, 2010, BRIT J CANCER, V102, P462, DOI 10.1038/sj.bjc.6605511; Shao C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010975; Simon K, 1994, Wiad Lek, V47, P854; Sripa B, 2000, INT J PARASITOL, V30, P735, DOI 10.1016/S0020-7519(00)00054-0; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Sripa B, 2009, HEPATOLOGY, V50, P1273, DOI 10.1002/hep.23134; Srivastava G, 2010, EXPERT REV PROTEOMIC, V7, P127, DOI 10.1586/EPR.09.91; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Thanan R, 2008, CANCER EPIDEM BIOMAR, V17, P518, DOI 10.1158/1055-9965.EPI-07-2717; Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898; Tiberti N, 2010, MOL CELL PROTEOMICS, V9, P2783, DOI 10.1074/mcp.M110.001008; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; Zhao QX, 2009, BIOCHEM BIOPH RES CO, V384, P277, DOI 10.1016/j.bbrc.2009.04.088	48	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45460	10.1371/journal.pone.0045460	http://dx.doi.org/10.1371/journal.pone.0045460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029023	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900139
J	Suo, HC; Ma, QB; Ye, KX; Yang, CY; Tang, YJ; Hao, J; Zhang, ZYJ; Chen, ML; Feng, YQ; Nian, H				Suo, Haicui; Ma, Qibin; Ye, Kaixin; Yang, Cunyi; Tang, Yujuan; Hao, Juan; Zhang, Zhanyuan J.; Chen, Mingluan; Feng, Yuqi; Nian, Hai			Overexpression of AtDREB1A Causes a Severe Dwarf Phenotype by Decreasing Endogenous Gibberellin Levels in Soybean [Glycine max (L.) Merr.]	PLOS ONE			English	Article							MOLECULAR-CLONING; LOW-TEMPERATURE; TRANSCRIPTIONAL ACTIVATOR; STRESS TOLERANCE; GENE; EXPRESSION; DROUGHT; ELEMENT; BINDING; CBF1	Gibberellic acids (GAs) are plant hormones that play fundamental roles in plant growth and developmental processes. Previous studies have demonstrated that three key enzymes of GA20ox, GA3ox, and GA2ox are involved in GA biosynthesis. In this study, the Arabidopsis DREB1A gene driven by the CaMV 35S promoter was introduced into soybean plants by Agrobacterium-mediated transformation. The results showed that the transgenic soybean plants exhibited a typical phenotype of GA-deficient mutants, such as severe dwarfism, small and dark-green leaves, and late flowering compared to those of the non-transgenic plants. The dwarfism phenotype was rescued by the application of exogenous GA(3) once a week for three weeks with the concentrations of 144 mu M or three times in one week with the concentrations of 60 mu M. Quantitative RT-PCR analysis revealed that the transcription levels of the GA synthase genes were higher in the transgenic soybean plants than those in controls, whereas GA-deactivated genes except GmGA2ox4 showed lower levels of expression. The transcript level of GmGA2ox4 encoding the only deactivation enzyme using C-20-GAs as the substrates in soybean was dramatically enhanced in transgenic plants compared to that of wide type. Furthermore, the contents of endogenous bioactive GAs were significantly decreased in transgenic plants than those of wide type. The results suggested that AtDREB1A could cause dwarfism mediated by GA biosynthesis pathway in soybean.	[Suo, Haicui; Ma, Qibin; Ye, Kaixin; Yang, Cunyi; Tang, Yujuan; Hao, Juan; Nian, Hai] S China Agr Univ, Coll Agr, State Key Lab Agr & Biol Resources Protect & Util, Guangdong Subctr Natl Ctr Soybean Improvement, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhanyuan J.] Univ Missouri, Plant Transformat Core Facil, Columbia, MO USA; [Chen, Mingluan; Feng, Yuqi] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China	South China Agricultural University; University of Missouri System; University of Missouri Columbia; Wuhan University	Nian, H (corresponding author), S China Agr Univ, Coll Agr, State Key Lab Agr & Biol Resources Protect & Util, Guangdong Subctr Natl Ctr Soybean Improvement, Guangzhou, Guangdong, Peoples R China.	hnian@scau.edu.cn	Feng, Yu-Qi/H-1479-2011; ma, qibin/HDO-2133-2022	Feng, Yu-Qi/0000-0003-1107-5385; 	Major Projects of New Varieties Cultivation of Genetically Modified Organisms [2011ZX08004-002, 2008ZX08004-002, 2009ZX08004-007]; Project of New Transgenic Lines Cultivation of Soybean Resistant to Stresses Adapting to the Southern China Region [2009A020102004]; Special Fund for Agro-Scientific Research in the Public Benefit [200903002]; Science and Technology Projects of Guangdong Province [2011A020102010]; Special Fund in the Public Benefit, the Ministry of Agriculture [nyhyzx07-004-11]; Combination Project of Production-Study-Research in Guangdong Province, the Ministry of Education [2011B090400328]; National Nature Science Foundation [91017013, 31070327]	Major Projects of New Varieties Cultivation of Genetically Modified Organisms; Project of New Transgenic Lines Cultivation of Soybean Resistant to Stresses Adapting to the Southern China Region; Special Fund for Agro-Scientific Research in the Public Benefit; Science and Technology Projects of Guangdong Province; Special Fund in the Public Benefit, the Ministry of Agriculture; Combination Project of Production-Study-Research in Guangdong Province, the Ministry of Education; National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Projects of New Varieties Cultivation of Genetically Modified Organisms (2011ZX08004-002, 2008ZX08004-002 and 2009ZX08004-007); the Project of New Transgenic Lines Cultivation of Soybean Resistant to Stresses Adapting to the Southern China Region (2009A020102004); the Special Fund for Agro-Scientific Research in the Public Benefit (200903002); the Science and Technology Projects of Guangdong Province (2011A020102010); the Special Fund in the Public Benefit, the Ministry of Agriculture (nyhyzx07-004-11); the Combination Project of Production-Study-Research in Guangdong Province, the Ministry of Education (2011B090400328); and the National Nature Science Foundation (No. 91017013; No. 31070327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; An G, 1988, BINARY VECTORS, P1; Chen ML, 2011, J CHROMATOGR B, V879, P938, DOI 10.1016/j.jchromb.2011.03.003; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Cong L, 2008, PLANT SCI, V174, P156, DOI 10.1016/j.plantsci.2007.11.002; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Di R, 1996, PLANT CELL REP, V15, P746, DOI 10.1007/BF00232220; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Han FM, 2011, GENE, V473, P23, DOI 10.1016/j.gene.2010.10.010; Hao DY, 2002, BIOCHEMISTRY-US, V41, P4202, DOI 10.1021/bi015979v; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hong B, 2006, SCI CHINA SER C, V49, P436, DOI 10.1007/s11427-006-2014-1; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Huang JG, 2009, PLANT CELL ENVIRON, V32, P1132, DOI 10.1111/j.1365-3040.2009.01995.x; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lee DJ, 2005, PLANT PHYSIOL, V138, P243, DOI 10.1104/pp.104.056499; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu Y, 2006, FEBS LETT, V580, P1303, DOI 10.1016/j.febslet.2006.01.048; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Wei G, 2005, J BIOCHEM MOL BIOL, V38, P440; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Zeng P, 2004, PLANT CELL REP, V22, P478, DOI 10.1007/s00299-003-0712-8; Zhou ML, 2010, AFR J BIOTECHNOL, V9, P9255	34	41	51	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45568	10.1371/journal.pone.0045568	http://dx.doi.org/10.1371/journal.pone.0045568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029105	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900159
J	May, M; Mand, P; Biertz, F; Hummers-Pradier, E; Kruschinski, C				May, Marcus; Mand, Peter; Biertz, Frank; Hummers-Pradier, Eva; Kruschinski, Carsten			A Survey to Assess Family Physicians' Motivation to Teach Undergraduates in Their Practices	PLOS ONE			English	Article							MEDICAL-STUDENTS; GENERAL-PRACTITIONERS; COMMUNITY PRECEPTORS; PRIMARY-CARE; FACULTY; REWARDS; SATISFACTION; RECRUITMENT; INCENTIVES; RELIABILITY	Background: In Germany, family physicians (FPs) are increasingly needed to participate in undergraduate medical education. Knowledge of FPs' motivation to teach medical students in their practices is lacking. Purpose: To describe a novel questionnaire that assesses the motivation of FPs to teach undergraduates in their practices and to show the results of a subsequent survey using this instrument. Methods: The questionnaire was developed based on a review of the literature. Previously used empirical instruments assessing occupational values and motivation were included. A preliminary version was pretested in a pilot study. The resulting 68-item questionnaire was sent to 691 FPs involved in undergraduate medical education. Reliability was assessed and subgroups were analyzed with regard to differences in motivation. Results: A total of 523 physicians in n = 458 teaching practices participated (response rate 75.7%). 'Helping others' and 'interest' were revealed as the predominant motives. Responses showed a predominantly intrinsic motivation of the participating FPs. Their main incentives were an ambition to work as a medical preceptor, to generally improve undergraduate education and to share knowledge. Material compensation was of minor importance. Time restraints were indicated as a barrier by some FPs, but were not a general concern. Conclusion: German FPs involved in medical education have altruistic attitudes towards teaching medical students in their practices. Motivational features give an important insight for the recruitment of FP preceptors as well as for their training in instructional methods.	[May, Marcus] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; [Mand, Peter; Kruschinski, Carsten] Hannover Med Sch, Inst Gen Practice, D-3000 Hannover, Germany; [Biertz, Frank] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Hummers-Pradier, Eva] Univ Gottingen, Dept Gen Practice Family Med, Gottingen, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Gottingen	May, M (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	may.marcus@mh-hannover.de	May, Marcus/A-1456-2017	May, Marcus/0000-0002-7513-4244; Hummers, Eva/0000-0003-2707-6067	Hannover Medical School; Deutsche Forschungsgemeinschaft	Hannover Medical School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Hannover Medical School. Support was also received from the support Program 'open access publication' of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldor RA, 2001, MED EDUC, V35, P789, DOI 10.1046/j.1365-2923.2001.00980.x; Barnett RC, 1998, ACAD MED, V73, P180, DOI 10.1097/00001888-199802000-00017; Breipohl W, 2000, Folia Med (Plovdiv), V42, P5; Buddeberg-Fischer B, 2007, PRIMARY CARE, V42-43, P639; Chenot Jean-Francois, 2009, Ger Med Sci, V7, pDoc02, DOI 10.3205/000061; Clade H, 2004, DTSCH ARZTEBL, V101, pA; CSIKSZENTMIHALYI M, 1989, J PERS SOC PSYCHOL, V56, P815, DOI 10.1037/0022-3514.56.5.815; Dahlstrom Jane, 2005, BMC Med Educ, V5, P27, DOI 10.1186/1472-6920-5-27; Dodson MC, 1998, OBSTET GYNECOL, V92, P628, DOI 10.1016/S0029-7844(98)00261-0; Friedl R, 2006, ANN THORAC SURG, V82, P1790, DOI 10.1016/j.athoracsur.2006.05.118; Fulkerson P K, 1997, Fam Med, V29, P105; Gerrity MS, 1997, J GEN INTERN MED, V12, pS90, DOI 10.1046/j.1525-1497.12.s2.13.x; Grayson MS, 1998, J GEN INTERN MED, V13, P485, DOI 10.1046/j.1525-1497.1998.00139.x; Greving B., 2009, METHODIK EMPIRISCHEN, P65; Hartley S, 1999, BRIT MED J, V319, P1168, DOI 10.1136/bmj.319.7218.1168; Hill N, 1999, J Allied Health, V28, P86; Hoban JD, 1996, ACAD MED, V71, P106, DOI 10.1097/00001888-199602000-00003; Isler R, 2009, SWISS MED WKLY, V139, P161, DOI smw-12438; JONAS HS, 1993, JAMA-J AM MED ASSOC, V270, P1061, DOI 10.1001/jama.270.9.1061; Korzilius H., 2008, DTSCH ARZTEBL, V105, P373; Kumar A, 2002, TEACH LEARN MED, V14, P119, DOI 10.1207/S15328015TLM1402_09; Kumar A, 1999, J GEN INTERN MED, V14, P370, DOI 10.1046/j.1525-1497.1999.00341.x; Langlois J P, 1995, Fam Med, V27, P641; Latessa R, 2008, FAM MED, V40, P96; Latessa R, 2007, ACAD MED, V82, P698, DOI 10.1097/ACM.0b013e318067483c; Levy BT, 1997, ACAD MED, V72, P382, DOI 10.1097/00001888-199705000-00018; MacDougall J, 2005, MED EDUC, V39, P1213, DOI 10.1111/j.1365-2929.2005.02335.x; MARTINI CJM, 1994, JAMA-J AM MED ASSOC, V272, P661, DOI 10.1001/jama.272.9.661; Mook D, 1995, MOTIVATION ORG ACTIO; Murray E, 1997, MED EDUC, V31, P369, DOI 10.1046/j.1365-2923.1997.00678.x; Natanzon I, 2010, DEUT MED WOCHENSCHR, V135, P1011, DOI 10.1055/s-0030-1253690; Nikendei C, 2009, MED TEACH, V31, P591, DOI 10.1080/01421590902833010; PERKOFF GT, 1986, NEW ENGL J MED, V314, P27, DOI 10.1056/NEJM198601023140105; Raupach T, 2009, MED KLIN, V104, P841, DOI 10.1007/s00063-009-1180-x; Rheinberg F, 2001, DIAGNOSTICA, V47, P57, DOI 10.1026//0012-1924.47.2.57; Rheinberg F, 2004, MOTIVATIONSDIAGNOSTI; Ricer R E, 1995, Fam Med, V27, P360; Rosenberg M, 1957, OCCUPATIONS VALUES; Rutter H, 2002, MED EDUC, V36, P543, DOI 10.1046/j.1365-2923.2002.01229.x; Scott I, 2006, MED TEACH, V28, P563, DOI 10.1080/01421590600627375; Single P B, 1999, Fam Med, V31, P114; Starr S, 2006, TEACH LEARN MED, V18, P117, DOI 10.1207/s15328015tlm1802_5; Starr S, 2003, ACAD MED, V78, P820, DOI 10.1097/00001888-200308000-00017; Tartas M, 2011, MED TEACH, V33, pe163, DOI 10.3109/0142159X.2011.544795; Ullian JA, 2001, ACAD MED, V76, pS78, DOI 10.1097/00001888-200104001-00015; van Saane N, 2003, OCCUP MED-OXFORD, V53, P191, DOI 10.1093/occmed/kqg038; Vath BE, 2001, WESTERN J MED, V174, P242, DOI 10.1136/ewjm.174.4.242; VINSON DC, 1994, ACAD MED, V69, P237, DOI 10.1097/00001888-199403000-00020; Vollmeyer R, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P541; Vollmeyer R, 2006, EDUC PSYCHOL REV, V18, P239, DOI 10.1007/s10648-006-9017-0; Williams GC, 1999, ACAD MED, V74, P992, DOI 10.1097/00001888-199909000-00010; Wright SM, 2004, MAYO CLIN PROC, V79, P1145; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	53	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45846	10.1371/journal.pone.0045846	http://dx.doi.org/10.1371/journal.pone.0045846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029272	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900057
J	Orenstein, Y; Linhart, C; Shamir, R				Orenstein, Yaron; Linhart, Chaim; Shamir, Ron			Assessment of Algorithms for Inferring Positional Weight Matrix Motifs of Transcription Factor Binding Sites Using Protein Binding Microarray Data	PLOS ONE			English	Article							SIMPLE-MODELS; DISCOVERY; SIMILARITY	The new technology of protein binding microarrays (PBMs) allows simultaneous measurement of the binding intensities of a transcription factor to tens of thousands of synthetic double-stranded DNA probes, covering all possible 10-mers. A key computational challenge is inferring the binding motif from these data. We present a systematic comparison of four methods developed specifically for reconstructing a binding site motif represented as a positional weight matrix from PBM data. The reconstructed motifs were evaluated in terms of three criteria: concordance with reference motifs from the literature and ability to predict in vivo and in vitro bindings. The evaluation encompassed over 200 transcription factors and some 300 assays. The results show a tradeoff between how the methods perform according to the different criteria, and a dichotomy of method types. Algorithms that construct motifs with low information content predict PBM probe ranking more faithfully, while methods that produce highly informative motifs match reference motifs better. Interestingly, in predicting high-affinity binding, all methods give far poorer results for in vivo assays compared to in vitro assays.	[Orenstein, Yaron; Linhart, Chaim; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870; Orenstein, Yaron/0000-0002-3583-3112	European Community [HEALTH-F4-2009-223575]; Israel Science Foundation [802/08]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	European Community(European Commission); Israel Science Foundation(Israel Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University	This study was supported in part by the European Community's Seventh Framework grant [HEALTH-F4-2009-223575] for the TRIREME project; and by the Israel Science Foundation (grant no. 802/08). YO was supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Gordan R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r125; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Li N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Sandve GK, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-11; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Tanaka E, 2011, BIOINFORMATICS, V27, P1603, DOI 10.1093/bioinformatics/btr257; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46145	10.1371/journal.pone.0046145	http://dx.doi.org/10.1371/journal.pone.0046145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029415	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900096
J	Thiele, I; Fleming, RMT; Que, R; Bordbar, A; Diep, D; Palsson, BO				Thiele, Ines; Fleming, Ronan M. T.; Que, Richard; Bordbar, Aarash; Diep, Dinh; Palsson, Bernhard O.			Multiscale Modeling of Metabolism and Macromolecular Synthesis in E. coli and Its Application to the Evolution of Codon Usage	PLOS ONE			English	Article							IN-SILICO MODELS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; HIGH-THROUGHPUT; TRANSFER-RNAS; RECONSTRUCTION; NETWORK; EXPRESSION; GENOMES; CONSEQUENCES	Biological systems are inherently hierarchal and multiscale in time and space. A major challenge of systems biology is to describe biological systems as a computational model, which can be used to derive novel hypothesis and drive experiments leading to new knowledge. The constraint-based reconstruction and analysis approach has been successfully applied to metabolism and to the macromolecular synthesis machinery assembly. Here, we present the first integrated stoichiometric multiscale model of metabolism and macromolecular synthesis for Escherichia coli K12 MG1655, which describes the sequence-specific synthesis and function of almost 2000 gene products at molecular detail. We added linear constraints, which couple enzyme synthesis and catalysis reactions. Comparison with experimental data showed improvement of growth phenotype prediction with the multiscale model over E. coli's metabolic model alone. Many of the genes covered by this integrated model are well conserved across enterobacters and other, less related bacteria. We addressed the question of whether the bias in synonymous codon usage could affect the growth phenotype and environmental niches that an organism can occupy. We created two classes of in silico strains, one with more biased codon usage and one with more equilibrated codon usage than the wildtype. The reduced growth phenotype in biased strains was caused by tRNA supply shortage, indicating that expansion of tRNA gene content or tRNA codon recognition allow E. coli to respond to changes in codon usage bias. Our analysis suggests that in order to maximize growth and to adapt to new environmental niches, codon usage and tRNA content must co-evolve. These results provide further evidence for the mutation-selection-drift balance theory of codon usage bias. This integrated multiscale reconstruction successfully demonstrates that the constraint-based modeling approach is well suited to whole-cell modeling endeavors.	[Thiele, Ines; Fleming, Ronan M. T.] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland; [Thiele, Ines; Que, Richard; Bordbar, Aarash; Diep, Dinh; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Fleming, Ronan M. T.] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Reykjavik, Iceland	University of Iceland; University of Iceland; University of California System; University of California San Diego; University of Iceland	Thiele, I (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ines.thiele@gmail.com	Thiele, Ines/A-7629-2014; Fleming, Ronan MT/ABC-4093-2021; /AAG-5264-2021	Thiele, Ines/0000-0002-8071-7110; Fleming, Ronan MT/0000-0001-5346-9812; /0000-0001-6460-6771; Que, Richard/0000-0003-1076-4357; Palsson, Bernhard/0000-0003-2357-6785	Department of Energy [DE-SC0002009]; National Institutes of Health [R0157089]; Marie Curie International Reintegration Grant within the 7th European Community Framework Program [249261]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102098] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Reintegration Grant within the 7th European Community Framework Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Department of Energy (Grant No. DE-SC0002009), and by a grant from the National Institutes of Health (R0157089). IT was funded, in part, by a Marie Curie International Reintegration Grant (Nr. 249261) within the 7th European Community Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baumler DJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-182; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bragg JG, 2009, TRENDS GENET, V25, P5, DOI 10.1016/j.tig.2008.10.007; Bremer H., 1996, ESCHERICHIA COLI SAL; BULMER M, 1991, GENETICS, V129, P897; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Danchin A, 2009, FEMS MICROBIOL REV, V33, P3, DOI 10.1111/j.1574-6976.2008.00137.x; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holden C, 2002, SCIENCE, V297; Joyce AR, 2006, J BACTERIOLOGY, V188; Joyce AR, 2006, NATURE REV MOL CELL, V7; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KANG C, 1985, J MOL BIOL, V181, P241, DOI 10.1016/0022-2836(85)90088-9; Karp PD, 2004, ASM NEWS, V70, P25; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Liao YC, 2011, J BACTERIOL, V193, P1710, DOI 10.1128/JB.01218-10; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Riley M, 2006, NUCL ACIDS RES, V34; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Sigurdsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034337; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Sun Y, 2012, AN ALGORITHM FOR FLU; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thiele I, 2010, BIOPHYS J, V98, P2072, DOI 10.1016/j.bpj.2010.01.060; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Willenbrock H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r114; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zeeberg B, 2002, GENOME RES, V12, P944, DOI 10.1101/gr.213402; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	67	73	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45635	10.1371/journal.pone.0045635	http://dx.doi.org/10.1371/journal.pone.0045635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029152	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900047
J	Yao, F; Ariyaratne, PN; Hillmer, AM; Lee, WH; Li, GL; Teo, ASM; Woo, XY; Zhang, ZS; Chen, JQP; Poh, WT; Zawack, KFB; Chan, CS; Leong, ST; Neo, SC; Choi, PSD; Gao, S; Nagarajan, N; Thoreau, H; Shahab, A; Ruan, XA; Cacheux-Rataboul, V; Wei, CL; Bourque, G; Sung, WK; Liu, ET; Ruan, YJ				Yao, Fei; Ariyaratne, Pramila N.; Hillmer, Axel M.; Lee, Wah Heng; Li, Guoliang; Teo, Audrey S. M.; Woo, Xing Yi; Zhang, Zhenshui; Chen, Jieqi P.; Poh, Wan Ting; Zawack, Kelson F. B.; Chan, Chee Seng; Leong, See Ting; Neo, Say Chuan; Choi, Poh Sum D.; Gao, Song; Nagarajan, Niranjan; Thoreau, Herve; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Wei, Chia-Lin; Bourque, Guillaume; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun			Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons	PLOS ONE			English	Article							SHORT-READ; REARRANGEMENT; COMPLEXITY	Structural variations (SVs) contribute significantly to the variability of the human genome and extensive genomic rearrangements are a hallmark of cancer. While genomic DNA paired-end-tag (DNA-PET) sequencing is an attractive approach to identify genomic SVs, the current application of PET sequencing with short insert size DNA can be insufficient for the comprehensive mapping of SVs in low complexity and repeat-rich genomic regions. We employed a recently developed procedure to generate PET sequencing data using large DNA inserts of 10-20 kb and compared their characteristics with short insert (1 kb) libraries for their ability to identify SVs. Our results suggest that although short insert libraries bear an advantage in identifying small deletions, they do not provide significantly better breakpoint resolution. In contrast, large inserts are superior to short inserts in providing higher physical genome coverage for the same sequencing cost and achieve greater sensitivity, in practice, for the identification of several classes of SVs, such as copy number neutral and complex events. Furthermore, our results confirm that large insert libraries allow for the identification of SVs within repetitive sequences, which cannot be spanned by short inserts. This provides a key advantage in studying rearrangements in cancer, and we show how it can be used in a fusion-point-guided-concatenation algorithm to study focally amplified regions in cancer.	[Yao, Fei; Ariyaratne, Pramila N.; Hillmer, Axel M.; Lee, Wah Heng; Li, Guoliang; Teo, Audrey S. M.; Woo, Xing Yi; Zhang, Zhenshui; Chen, Jieqi P.; Poh, Wan Ting; Zawack, Kelson F. B.; Chan, Chee Seng; Leong, See Ting; Neo, Say Chuan; Choi, Poh Sum D.; Nagarajan, Niranjan; Thoreau, Herve; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Wei, Chia-Lin; Bourque, Guillaume; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Yao, Fei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Gao, Song] Natl Univ Singapore, Ctr Life Sci, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Ruan, Yijun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore	Ruan, YJ (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.	ruanyj@gis.a-star.edu.sg	Hillmer, Axel M/N-2927-2014; Hillmer, Axel M/B-7485-2015; Li, Guoliang/D-8014-2012; Bourque, Guillaume/AFR-2927-2022	Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Li, Guoliang/0000-0003-1601-6640; Bourque, Guillaume/0000-0002-3933-9656; Sung, Wing-Kin/0000-0001-7806-7086; Nagarajan, Niranjan/0000-0003-0850-5604; THOREAU, HERVE/0000-0001-6643-167X	Agency for Science Technology and Research (A*STAR), Singapore; National Cancer Institute (USA) [NCI: 5 R33 CA126996-02]	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Agency for Science Technology and Research (A*STAR), Singapore, and from a grant from the National Cancer Institute (USA) NCI: 5 R33 CA126996-02 (Pair-end-ditag technologies for the complete annotation of fusion genes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dunn JJ, 2002, GENOME RES, V12, P1756, DOI 10.1101/gr.306102; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wetzel J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-95	33	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46152	10.1371/journal.pone.0046152	http://dx.doi.org/10.1371/journal.pone.0046152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029419	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900099
J	Bhatt, JP; Manish, K; Pandit, MK				Bhatt, Jay P.; Manish, Kumar; Pandit, Maharaj K.			Elevational Gradients in Fish Diversity in the Himalaya: Water Discharge Is the Key Driver of Distribution Patterns	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; HABITAT HETEROGENEITY; ALTITUDINAL RANGE; EASTERN HIMALAYA; BIODIVERSITY; ENERGY; ARALIACEAE; ENDEMISM	Background: Studying diversity and distribution patterns of species along elevational gradients and understanding drivers behind these patterns is central to macroecology and conservation biology. A number of studies on biogeographic gradients are available for terrestrial ecosystems, but freshwater ecosystems remain largely neglected. In particular, we know very little about the species richness gradients and their drivers in the Himalaya, a global biodiversity hotspot. Methodology/Principal Findings: We collated taxonomic and distribution data of fish species from 16 freshwater Himalayan rivers and carried out empirical studies on environmental drivers and fish diversity and distribution in the Teesta river (Eastern Himalaya). We examined patterns of fish species richness along the Himalayan elevational gradients (50-3800 m) and sought to understand the drivers behind the emerging patterns. We used generalized linear models (GLM) and generalized additive models (GAM) to examine the richness patterns; GLM was used to investigate relationship between fish species richness and various environmental variables. Regression modelling involved stepwise procedures, including elimination of collinear variables, best model selection, based on the least Akaike's information criterion (AIC) and the highest percentage of deviance explained (D-2). This maiden study on the Himalayan fishes revealed that total and non-endemic fish species richness monotonously decrease with increasing elevation, while endemics peaked around mid elevations (700-1500 m). The best explanatory model (synthetic model) indicated that water discharge is the best predictor of fish species richness patterns in the Himalayan rivers. Conclusions/Significance: This study, carried out along one of the longest bioclimatic elevation gradients of the world, lends support to Rapoport's elevational rule as opposed to mid domain effect hypothesis. We propose a species-discharge model and contradict species-area model in predicting fish species richness. We suggest that drivers of richness gradients in terrestrial and aquatic ecosystems are likely to be different. These studies are crucial in context of the impacts of unprecedented on-going river regulation on fish diversity and distribution in the Himalaya.	[Bhatt, Jay P.; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India; [Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India	University of Delhi; University of Delhi	Pandit, MK (corresponding author), Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India.	rajkpandit@gmail.com	Manish, Kumar/M-5034-2019; Pandit, Maharaj K/A-4065-2014	Manish, Kumar/0000-0002-0373-0426; Pandit, Maharaj K/0000-0001-6611-560X	Ministry of Environment, Forests & Wildlife, Government of India; NHPC India [J.12011/11/99-IA.I]	Ministry of Environment, Forests & Wildlife, Government of India; NHPC India	The financial support for this study was provided by the Ministry of Environment, Forests & Wildlife, Government of India & NHPC India vide grant No. J.12011/11/99-IA.I sanctioned to MKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya BK, 2011, ACTA OECOL, V37, P329, DOI 10.1016/j.actao.2011.03.005; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Benke M, 2011, J BIOGEOGR, V38, P2021, DOI 10.1111/j.1365-2699.2011.02527.x; Bhatt J. P., 2005, Aquatic Ecosystem Health & Management, V8, P259, DOI 10.1080/14634980500218274; Bhatt JP, 2010, CURR SCI INDIA, V99, P196; Bhatt JP, 2001, CURR SCI INDIA, V81, P1332; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Chettri B, 2010, ACTA OECOL, V36, P16, DOI 10.1016/j.actao.2009.09.004; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Crawley M.J., 1993, GLIM ECOLOGISTS; Crawley M. J, 2002, STAT COMPUTING INTRO; Dahanukar N, 2004, J BIOGEOGR, V31, P123, DOI 10.1046/j.0305-0270.2003.01016.x; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fu CZ, 2004, GLOBAL ECOL BIOGEOGR, V13, P543, DOI 10.1111/j.1466-822X.2004.00122.x; Gordon ND, 2005, STREAM HYDROLOGY INT, P429; Griffiths D, 1997, J ANIM ECOL, V66, P49, DOI 10.2307/5963; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hack J.T., 1973, J RES US GEOL SURV, V1, P421; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCullagh P, 1989, GEN LINEAR MODELS; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2009, CONSERV BIOL, V23, P1346, DOI 10.1111/j.1523-1739.2009.01359.x; Pandit MK, 2012, CONSERV BIO IN PRESS; PENNAK RW, 1953, FRESHWATER INVERTEBR; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAINA HS, 1999, FISH FISHERIES HIGHE, P304; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Schwarz M, 2005, REMOTE SENS ENVIRON, V95, P428, DOI 10.1016/j.rse.2004.12.010; SEEBER L, 1983, TECTONOPHYSICS, V92, P335, DOI 10.1016/0040-1951(83)90201-9; Sharma SK, 2011, PLANT SYST EVOL, V297, P87, DOI 10.1007/s00606-011-0501-8; Sharma SK, 2010, PLANT SYST EVOL, V287, P29, DOI 10.1007/s00606-010-0286-1; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Venables W., 2013, MODERN APPL STAT S, V53, P86; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Welch PS, 1952, LIMNOLOGICAL METHODS; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wohlgemuth T, 2008, J BIOGEOGR, V35, P1226, DOI 10.1111/j.1365-2699.2008.01884.x; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; YOUNG A., 1974, SLOPE DEV	57	55	57	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46237	10.1371/journal.pone.0046237	http://dx.doi.org/10.1371/journal.pone.0046237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029444	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500074
J	Bloos, F; Sachse, S; Kortgen, A; Pletz, MW; Lehmann, M; Straube, E; Riedemann, NC; Reinhart, K; Bauer, M				Bloos, Frank; Sachse, Svea; Kortgen, Andreas; Pletz, Mathias W.; Lehmann, Marc; Straube, Eberhard; Riedemann, Niels C.; Reinhart, Konrad; Bauer, Michael			Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational Study	PLOS ONE			English	Article							REAL-TIME PCR; BLOOD-STREAM PATHOGENS; SEVERE SEPSIS; ANTIMICROBIAL THERAPY; MULTIPLEX PCR; CARE-UNIT; INFECTIONS; MORTALITY; INITIATION; DIAGNOSIS	Background: Treatment of septic shock relies on appropriate antimicrobial therapy. Current culture based methods deliver final results after days, which may delay potentially lifesaving adjustments in antimicrobial therapy. This study was undertaken to compare PCR with blood culture results under routine conditions regarding 1. impact on antimicrobial therapy, and 2. time to result, in patients with presumed sepsis. Methodology/Principal Findings: This was an observational study in a 50 beds ICU of a university hospital. In 245 patients with suspected sepsis, 311 concomitant blood cultures and blood for multiplex PCR (VYOO (R)) were obtained. 45 of 311 blood cultures (14.5%) and 94 of 311 PCRs (30.1%) were positive. However, blood culture or microbiological sampling from the presumed site of infection rarely confirmed PCR results and vice versa. Median time to positivity and interquartile range were 24.2 (18.0, 27.5) hours for the PCR and 68 (52.2, 88.5) hours for BC (p<0.01). PCR median time to result was dependent on technician availability (53.5 hours on Saturdays, 7.2 hours under optimal logistic conditions). PCR results showed good correlation with procalcitonin (p<0.001). In 34% of patients with positive PCRs antimicrobial therapy was considered inadequate according to assessment of clinical arbitrators including 5 patients with vancomycin-resistant enterococci (VRE), 3 cases with multiresistant staphylococci, and 4 patients with fungi. Conclusions: The results of this observational study support the hypothesis that PCR results are available faster, are more frequently positive, and may result in earlier adjustment of antimicrobial therapy. However, shorter time to result can only be fully exploited when the laboratory is adequately staffed for a 24 hour/7 day service, or when point of care/automated assay systems become available.	[Bloos, Frank; Kortgen, Andreas; Riedemann, Niels C.; Reinhart, Konrad; Bauer, Michael] Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany; [Bloos, Frank; Kortgen, Andreas; Reinhart, Konrad; Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Sachse, Svea; Straube, Eberhard] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany; [Pletz, Mathias W.] Jena Univ Hosp, Div Gastroenterol Hepatol & Infect Dis, Jena, Germany; [Lehmann, Marc] SIRS Lab GmbH, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Bauer, M (corresponding author), Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany.	Michael.Bauer@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019; Bloos, Frank/AAY-8265-2020	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Bloos, Frank/0000-0002-0767-7941; Bauer, Michael/0000-0002-1521-3514	Thuringian Ministry of Education (ProExzellenz-Initiative) [PR 108-2]; Thuringian Foundation for Technology, Innovation, and Research STIFT; German Sepsis Society; SIRS-Lab GmbH	Thuringian Ministry of Education (ProExzellenz-Initiative); Thuringian Foundation for Technology, Innovation, and Research STIFT; German Sepsis Society; SIRS-Lab GmbH	The study was financially supported by the Thuringian Ministry of Education (ProExzellenz-Initiative: PR 108-2, http://www.thueringen.de/de/tmbwk/wissenschaft/zukunftsinitiative/proexzellenz/), the Thuringian Foundation for Technology, Innovation, and Research STIFT (www.stift-thueringen.de), and the German Sepsis Society (www.sepsis-gesellschaft.de). SIRS-Lab GmbH has supplied the VYOO (R)-Kits and personnel to run the PCR. SIRS-Lab GmbH has also financed a prospective study which took place after this study was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, study goals and feasibility issues have been discussed with SIRS-Lab GmbH during the preparation phase of the study.	Bloos F, 2010, INTENS CARE MED, V36, P241, DOI 10.1007/s00134-009-1705-z; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Dupont H, 2011, J ANTIMICROB CHEMOTH, V66, P2379, DOI 10.1093/jac/dkr308; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Hebart H, 2009, BONE MARROW TRANSPL, V43, P553, DOI 10.1038/bmt.2008.355; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2010, CRIT CARE, V14, DOI 10.1186/cc9294; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Lerma FA, 2003, MED CLIN-BARCELONA, V121, P281, DOI 10.1157/13050710; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; MacArthur RD, 2004, CLIN INFECT DIS, V38, P284, DOI 10.1086/379825; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; Mauch H, 1999, MIQ QUALITATSSTANDAR; Micek ST, 2005, PHARMACOTHERAPY, V25, P26, DOI 10.1592/phco.25.1.26.55615; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; R Core Team, 2021, R LANGUAGE ENV STAT; Sachse S, 2009, J CLIN MICROBIOL, V47, P1050, DOI 10.1128/JCM.02242-08; Sandiumenge A, 2003, INTENS CARE MED, V29, P876, DOI 10.1007/s00134-003-1715-1; Shafazand S, 2002, CHEST, V122, P1727, DOI 10.1378/chest.122.5.1727; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Wellinghausen N, 2009, J MED MICROBIOL, V58, P1106, DOI 10.1099/jmm.0.007906-0; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x	33	63	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46003	10.1371/journal.pone.0046003	http://dx.doi.org/10.1371/journal.pone.0046003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029360	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500054
J	Chen, C; Yang, G; Geng, XR; Wang, XP; Liu, ZJ; Yang, PC				Chen, Chi; Yang, Gui; Geng, Xiao-Rui; Wang, Xingpeng; Liu, Zhanju; Yang, Ping-Chang			TNFAIP3 Facilitates Degradation of Microbial Antigen SEB in Enterocytes	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; BARRIER ABNORMALITIES; DENDRITIC CELLS; A20 DEFICIENCY; IMMUNE CELLS; TRANSPORT; IGE; SENSITIZATION; PERMEABILITY; ACTIVATION	Background and Aims: The enterocytes have the potential to absorb noxious substances, such as microbial products, from the gut lumen. How the enterocytes process the substances to harmless materials is not fully understood. This study aims to elucidate the role of ubiquitin E3 ligase TNFAIP3 (TNFAIP3) in facilitating the degradation of endocytic microbial products in enterocytes. Methods: Human intestinal epithelial cell line, HT-29 cells, was cultured to monolayers using as an in vitro model to observe the endocytosis and degradation of microbial products, Staphylococcal enterotoxin B (SEB) in epithelial cells. The RNA interference was employed to knock down the TNFAIP3 gene in HT-29 cells to observe the role of TNFAIP3 in the degradation of endocytic SEB. The role of TNFAIP3 in facilitating the endosome/lysosome fusion was observed by immunocytochemistry. Results: Upon the absorption of SEB, the expression of TNFAIP3 was increased in HT-29 cells. Silencing the TNFAIP3 gene in HT-29 cells resulted in a large quantity of SEB to be transported across the HT-29 monolayers to the transwell basal chambers; the transportation was via the intracellular pathway. TNFAIP3 was required in the fusion of SEB-carrying endosomes and lysosomes. Conclusions: TNFAIP3 plays a critical role in the degradation of endocytic SEB in enterocytes.	[Chen, Chi; Wang, Xingpeng; Liu, Zhanju] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Tongji University; McMaster University	Liu, ZJ (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	liuzhanju88@126.com; yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019		Canadian Institutes of Health Research [191063, 220058, 177843]; Natural Sciences, Engineering Research Council of Canada (NSERC) [371268]; National Natural Science Foundation of China [30971358, 81061120521]; Shanghai Science and Technology Commission [12XD1404000]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences, Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from the Canadian Institutes of Health Research (#191063, #220058 and #177843), Natural Sciences, Engineering Research Council of Canada (NSERC, #371268), the National Natural Science Foundation of China (No. 30971358; No. 81061120521), and Shanghai Science and Technology Commission (No. 12XD1404000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen X, 2010, N AM J MED SCI, V2, P241, DOI 10.4297/najms.2010.2241; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Forbes-Blom E, 2012, CLIN EXP ALLERGY, V42, P305, DOI 10.1111/j.1365-2222.2011.03861.x; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Hasilik A, 2009, INT J CLIN PHARM TH, V47, pS18; Hauri H P, 1991, Semin Cell Biol, V2, P355; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; Krakauer T, 2010, MIL MED, V175, P917, DOI 10.7205/MILMED-D-10-00148; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Lu J, 1998, J PHARMACOL EXP THER, V287, P128; Luzio JP, 2009, BIOCHEM SOC T, V37, P21; McKay DM, 1997, J IMMUNOL, V159, P2382; Miyazaki D, 2010, JPN J OPHTHALMOL, V54, P476, DOI 10.1007/s10384-010-0837-6; Moreto M, 2009, J ANIM SCI, V87, pE92, DOI 10.2527/jas.2008-1381; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Perez-Bosque A, 2010, P NUTR SOC, V69, P447, DOI 10.1017/S0029665110001849; Sluyter R, 2002, INT IMMUNOL, V14, P1415, DOI 10.1093/intimm/dxf111; Tu YH, 2009, N AM J MED SCI, V1, P24; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Yang PC, 1999, J IMMUNOL, V163, P2769; Yang PC, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-28; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	32	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45941	10.1371/journal.pone.0045941	http://dx.doi.org/10.1371/journal.pone.0045941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029332	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700093
J	Liu, QJ; Wu, HW; Wu, LZ; Xie, X; Kong, JL; Ye, XF; Liu, LP				Liu, Quanjun; Wu, Hongwen; Wu, Lingzhi; Xie, Xiao; Kong, Jinglin; Ye, Xiaofeng; Liu, Liping			Voltage-Driven Translocation of DNA through a High Throughput Conical Solid-State Nanopore	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; TRANSPORT; MOLECULES; FABRICATION; NANOTUBES; PROTEINS	Nanopores have become an important tool for molecule detection at single molecular level. With the development of fabrication technology, synthesized solid-state membranes are promising candidate substrates in respect of their exceptional robustness and controllable size and shape. Here, a 30-60 (tip-base) nm conical nanopore fabricated in 100 nm thick silicon nitride (Si3N4) membrane by focused ion beam (FIB) has been employed for the analysis of lambda-DNA translocations at different voltage biases from 200 to 450 mV. The distributions of translocation time and current blockage, as well as the events frequencies as a function of voltage are investigated. Similar to previously published work, the presence and configurations of lambda-DNA molecules are characterized, also, we find that greater applied voltages markedly increase the events rate, and stretch the coiled lambda-DNA molecules into linear form. However, compared to 6-30 nm ultrathin solid-state nanopores, a threshold voltage of 181 mV is found to be necessary to drive DNA molecules through the nanopore due to conical shape and length of the pore. The speed is slowed down similar to 5 times, while the capture radius is similar to 2 fold larger. The results show that the large nanopore in thick membrane with an improved stability and throughput also has the ability to detect the molecules at a single molecular level, as well as slows down the velocity of molecules passing through the pore. This work will provide more motivations for the development of nanopores as a Multi-functional sensor for a wide range of biopolymers and nano materials.	[Liu, Quanjun; Wu, Hongwen; Wu, Lingzhi; Kong, Jinglin; Ye, Xiaofeng; Liu, Liping] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Wu, Lingzhi] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Jiangsu, Peoples R China; [Xie, Xiao] Southeast Univ, SEU FEI Nanopico Ctr, Key Lab MEMS, Minist Educ, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing University of Posts & Telecommunications; Southeast University - China	Liu, QJ (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	lqj@seu.edu.cn	liu, li/HGC-0900-2022	Kong, Jinglin/0000-0003-4549-0720	National Natural Science Foundation of China [61071050]; Ministry of Science and Technology of China [2009 DFA32750]; Ministry of Education [200967]; State Key Laboratory of Bioelectronics of Southeast University [2011E14]; China Postdoctoral Science Foundation [20110491339]; Chinese Postdoctoral Fund [2011M500081]; Natural Science Foundation of China [61101056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; State Key Laboratory of Bioelectronics of Southeast University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Postdoctoral Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for financial support from National Natural Science Foundation of China (61071050); international cooperation project from the Ministry of Science and Technology of China (2009 DFA32750); the Ministry of Education major project(200967); the Open Project of State Key Laboratory of Bioelectronics of Southeast University (2011E14); the China Postdoctoral Science Foundation (20110491339); Chinese Postdoctoral Fund (No. 2011M500081); Natural Science Foundation of China (61101056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2001, ELECTROCHEMICAL METH, P66; Astier Y, 2011, SMALL, V7, P455, DOI 10.1002/smll.201002113; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; Chen P, 2004, NANO LETT, V4, P1333, DOI 10.1021/nl0494001; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Deamer DW, 2000, TRENDS BIOTECHNOL, V18, P147, DOI 10.1016/S0167-7799(00)01426-8; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fan R, 2005, NANO LETT, V5, P1633, DOI 10.1021/nl0509677; Fologea D, 2005, NANO LETT, V5, P1905, DOI 10.1021/nl051199m; Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o; Fologea D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767206; Fologea D, 2007, ELECTROPHORESIS, V28, P3186, DOI 10.1002/elps.200700047; Gershow M, 2007, NAT NANOTECHNOL, V2, P775, DOI 10.1038/nnano.2007.381; Hall AR, 2011, NANO LETT, V11, P2446, DOI 10.1021/nl200873w; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI [10.1038/nnano.2010.237, 10.1038/NNANO.2010.237]; Harrell CC, 2006, LANGMUIR, V22, P10837, DOI 10.1021/la061234k; He YH, 2011, ACS NANO, V5, P8391, DOI 10.1021/nn203186c; Heng JB, 2005, NANO LETT, V5, P1883, DOI 10.1021/nl0510816; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Kowalczyk SW, 2012, NANO LETT, V12, P1038, DOI 10.1021/nl204273h; Kowalczyk SW, 2010, NANO LETT, V10, P1414, DOI 10.1021/nl100271c; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Lan WJ, 2011, ANAL CHEM, V83, P3840, DOI 10.1021/ac200312n; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Li JL, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454129; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Mirsaidov U, 2010, NANOTECHNOLOGY, P21; Muthukumar M, 2007, ANNU REV BIOPH BIOM, V36, P435, DOI 10.1146/annurev.biophys.36.040306.132622; Niedzwiecki DJ, 2010, J AM CHEM SOC, V132, P10816, DOI 10.1021/ja1026858; Nkodo AE, 2001, ELECTROPHORESIS, V22, P2424, DOI 10.1002/1522-2683(200107)22:12<2424::AID-ELPS2424>3.0.CO;2-1; Oukhaled A, 2011, ACS NANO, V5, P3628, DOI 10.1021/nn1034795; Pedone D, 2009, ANAL CHEM, V81, P9689, DOI 10.1021/ac901877z; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sen YH, 2009, ANAL BIOANAL CHEM, V394, P437, DOI 10.1007/s00216-008-2529-3; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Singer A, 2010, NANO LETT, V10, P738, DOI 10.1021/nl100058y; Siwy Z, 2004, J AM CHEM SOC, V126, P10850, DOI 10.1021/ja047675c; Siwy ZS, 2006, ADV FUNCT MATER, V16, P735, DOI 10.1002/adfm.200500471; Skinner GM, 2009, NANO LETT, V9, P2953, DOI 10.1021/nl901370w; Smeets RMM, 2009, NANO LETT, V9, P3089, DOI 10.1021/nl803189k; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Stein DM, 2004, REV SCI INSTRUM, V75, P900, DOI 10.1063/1.1666986; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Wei RS, 2012, NAT NANOTECHNOL, V7, P257, DOI [10.1038/nnano.2012.24, 10.1038/NNANO.2012.24]; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12; Zhang JS, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021906; Zhao Q, 2008, NUCLEIC ACIDS RES, V36, P1532, DOI 10.1093/nar/gkm1017	64	42	45	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46014	10.1371/journal.pone.0046014	http://dx.doi.org/10.1371/journal.pone.0046014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029365	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700106
J	Weng, Y; Lu, LQ; Yuan, GR; Guo, J; Zhang, ZZ; Xie, XY; Chen, GD; Zhang, J				Weng, Yu; Lu, Liqin; Yuan, Guorong; Guo, Jing; Zhang, Zhizhong; Xie, Xinyou; Chen, Guangdi; Zhang, Jun			p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MDM2 SNP309; MYELOGENOUS LEUKEMIA; DNA-REPAIR; GENE; ASSOCIATION; SUSCEPTIBILITY; VARIANTS	Background: Previous studies on the association of p53 codon 72 (Arg72Pro) polymorphism with hematological malignancies risk have produced conflicting results. The purpose of this meta-analysis is to define the effect of p53 Arg72Pro polymorphism on hematological malignancies risk. Methodology/Principal Findings: Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH terms and keywords: "p53", "codon 72" "polymorphism" and "leukemia", or "lymphoma", or "myeloma", thirteen were identified as eligible articles in this meta-analysis for p53 Arg72Pro polymorphism (2,731 cases and 7, 356 controls), including nine studies on leukemia (1,266 cases and 4, 474 controls), three studies on lymphoma (1,359 cases and 2,652 controls), and one study on myeloma. The overall results suggested that p53 Arg72Pro polymorphism was not associated with hematological malignancies risk. In stratified analyses, significantly increased non-Hodgkin lymphomas risk was found in p53 Arg72Pro polymorphism heterozygote model (Arg/Pro vs. Arg/Arg: OR = 1.18, 95%CI: 1.02-1.35) and dominant model (Arg/Pro+Pro/Pro vs. Arg/Arg: OR = 1.18, 95%CI: 1.03-1.34), but no significant association was found between leukemia risk and p53 Arg72Pro polymorphism. Further studies showed no association between leukemia risk and p53 Arg72Pro polymorphism when stratified in subtypes of leukemias, ethnicities and sources of controls. Conclusions/Significance: This meta-analysis indicates that the p53 Arg72Pro polymorphism may contribute to susceptibility to non-Hodgkin lymphomas.	[Guo, Jing; Chen, Guangdi] Zhejiang Univ, Sch Med, Inst Environm Hlth, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhizhong] Nanjing Univ, Dept Neurol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Lu, Liqin; Yuan, Guorong] Zhejiang Prov Peoples Hosp, Dept Oncol, Hangzhou, Peoples R China; [Weng, Yu; Xie, Xinyou; Zhang, Jun] Zhejiang Univ, Sch Med, Dept Clin Lab, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Nanjing University; Zhejiang Provincial People's Hospital; Zhejiang University	Chen, GD (corresponding author), Zhejiang Univ, Sch Med, Inst Environm Hlth, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	chenguangdi@gmail.edu.cn			Zhejiang Provincial Natural Science Foundation of China [Y12H160154]; Health Bureau of Zhejiang Province [2011KYB012]; Zhejiang Provincial Administration of Traditional Chinese Medicine [2011ZA010]; Fundamental Research Funds for the Central Universities [2011QNA7018, 2012QNA7019]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Health Bureau of Zhejiang Province; Zhejiang Provincial Administration of Traditional Chinese Medicine; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the grants from Zhejiang Provincial Natural Science Foundation of China (Y12H160154), Health Bureau of Zhejiang Province (2011KYB012), Zhejiang Provincial Administration of Traditional Chinese Medicine (2011ZA010) and the Fundamental Research Funds for the Central Universities (2011QNA7018, 2012QNA7019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi G, 2004, HAEMATOLOGICA, V89, P868; Bittenbring J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-116; Chauhan PS, 2011, DNA CELL BIOL, V30, P39, DOI 10.1089/dna.2010.1092; Descatha A, 2005, CANCER CAUSE CONTROL, V16, P939, DOI 10.1007/s10552-005-2301-3; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Ellis NA, 2008, BLOOD, V112, P741, DOI 10.1182/blood-2007-11-126508; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Francisco G, 2011, INT J CANCER, V129, P920, DOI 10.1002/ijc.25710; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Hainaut P, 2009, LANCET ONCOL, V10, P913, DOI 10.1016/S1470-2045(09)70198-6; Havranek O, 2011, LEUKEMIA RES, V35, P1117, DOI 10.1016/j.leukres.2011.04.001; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Hishida A, 2004, LEUKEMIA LYMPHOMA, V45, P957, DOI 10.1080/10428190310001638878; Hrstka R, 2009, J CELL MOL MED, V13, P440, DOI 10.1111/j.1582-4934.2008.00634.x; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Irigaray P, 2007, BIOMED PHARMACOTHER, V61, P640, DOI 10.1016/j.biopha.2007.10.006; Ito A, 2011, J RADIAT RES, V52, P342, DOI 10.1269/jrr.10151; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kim HN, 2010, AM J HEMATOL, V85, P822, DOI 10.1002/ajh.21834; Kochethu G, 2006, LEUKEMIA RES, V30, P1113, DOI 10.1016/j.leukres.2005.12.014; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Majid A, 2011, BRIT J HAEMATOL, V153, P533, DOI 10.1111/j.1365-2141.2010.08484.x; MIWA H, 1992, LEUKEMIA RES, V16, P1105, DOI 10.1016/0145-2126(92)90049-D; Nakano Y, 2000, LEUKEMIA RES, V24, P349, DOI 10.1016/S0145-2126(99)00187-3; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Ortega MM, 2007, ANN HEMATOL, V86, P815, DOI 10.1007/s00277-007-0347-x; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Phang BH, 2008, EUR J CANCER, V44, P760, DOI 10.1016/j.ejca.2008.02.007; Phang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015320; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Pospelova TI, 2010, HAEMATOLOGY TRANSFUS, V1; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sturm I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-105; Takeuchi S, 2005, BRIT J HAEMATOL, V131, P552, DOI 10.1111/j.1365-2141.2005.05798.x; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xi B, 2011, BREAST CANCER RES TR, V130, P561, DOI [10.1007/s10549-011-1583-2, 10.1007/s10549-011-1602-3, 10.1007/s10549-011-1615-y]; Xiong XJ, 2009, LEUKEMIA RES, V33, P1454, DOI 10.1016/j.leukres.2009.04.007; Yamaguchi H, 2001, LEUKEMIA, V15, P1729, DOI 10.1038/sj.leu.2402265; ZHANG W, 1992, GENE, V117, P271, DOI 10.1016/0378-1119(92)90738-B; Zhang ZZ, 2010, BREAST CANCER RES TR, V120, P509, DOI 10.1007/s10549-009-0480-4; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	46	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45820	10.1371/journal.pone.0045820	http://dx.doi.org/10.1371/journal.pone.0045820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029260	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700076
J	Kac, G; Schlussel, MM; Perez-Escamilla, R; Velasquez-Melendez, G; da Silva, AAM				Kac, Gilberto; Schluessel, Michael M.; Perez-Escamilla, Rafael; Velasquez-Melendez, Gustavo; Moura da Silva, Antonio Augusto			Household Food Insecurity Is Not Associated with BMI for Age or Weight for Height among Brazilian Children Aged 0-60 Months	PLOS ONE			English	Article							OVERWEIGHT STATUS; SCHOOL-CHILDREN; US CHILDREN; OBESITY; INCOME; UNDERWEIGHT; COLOMBIA; FAMILIES	We examined the association between Household Food Insecurity (HFI), weight for height z-score (WHZ) and Body Mass Index for age z-score (BMI-Z) in a representative sample of children 0-60 months of age (n = 3,433) in five Brazilian geographical regions. Data were derived from the 2006-07 Brazilian Demographic and Health Survey. HFI was measured with the Brazilian Food Insecurity Scale. Associations were estimated using multiple linear regression models (beta coefficients and 95% CI) taking into account the complex sampling design. Interaction terms between HFI and geographical region and HFI and child sex and child age were assessed. The weighted prevalence of any level of HFI was 48.6%. Severe food insecurity was more prevalent among children from the North region (16.8%), born from mothers with <4 years of schooling (15.9%) and those from families with >= 3 children (18.8%). The interaction between HFI and geographical region was non-significant for BMI-Z (P = 0.119) and WHZ (P = 0.198). Unadjusted results indicated that HFI was negatively associated with BMI-Z (moderate to severe HFI: beta = -0.19, 95% CI: -0.35 - -0.03, P = 0.047), and WHZ (moderate to severe HFI: beta = -0.26, 95% CI: -0.42 - -0.09, P = 0.009). Estimates lost significance after adjustments for key confounders such as mothers' skin color, mothers' years of schooling, place of household, household income quartiles, mothers' smoking habit, mothers' marital status, number of children 0-60 months in the household, and birth order. HFI is unrelated to weight outcomes among Brazilian children 0-60 months.	[Kac, Gilberto; Schluessel, Michael M.] Univ Fed Rio de Janeiro, Observ Epidemiol Nutr, Inst Nutr Josue Castro, Rio De Janeiro, RJ, Brazil; [Perez-Escamilla, Rafael] Yale Sch Publ Hlth, New Haven, CT USA; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Dept Enfermagem Materno Infantil Saude Publ, Belo Horizonte, MG, Brazil; [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Maranhao, Brazil	Universidade Federal do Rio de Janeiro; Yale University; Universidade Federal de Minas Gerais; Universidade Federal do Maranhao	Kac, G (corresponding author), Univ Fed Rio de Janeiro, Observ Epidemiol Nutr, Inst Nutr Josue Castro, Rio De Janeiro, RJ, Brazil.	gilberto.kac@gmail.com	Kac, Gilberto/H-6862-2012; Silva, Antonio A M/B-5410-2009	Kac, Gilberto/0000-0001-8603-9077; Silva, Antonio A M/0000-0003-4968-5138	Rio de Janeiro State (FAPERJ)	Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	G. Kac, G. Velasquez-Melendez and A. A. M. Silva are research fellows from the Brazilian National Council for Scientific and Technological Development (CNPq). M. M. Schlussel is research fellow from Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo K, 2001, ARCH PEDIAT ADOL MED, V155, P1161, DOI 10.1001/archpedi.155.10.1161; Alvarado Beatriz Eugenia, 2005, Cad. Saúde Pública, V21, P724, DOI 10.1590/S0102-311X2005000300006; Baig-Ansari N, 2006, FOOD NUTR BULL, V27, P114, DOI 10.1177/156482650602700203; Bhargava A, 2008, BRIT J NUTR, V100, P438, DOI 10.1017/S0007114508894366; Casey PH, 2006, PEDIATRICS, V118, pE1406, DOI 10.1542/peds.2006-0097; dos Santos JV, 2010, CAD SAUDE PUBLICA, V26, P41, DOI 10.1590/S0102-311X2010000100005; Dubois L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-199; Eisenmann JC, 2011, OBES REV, V12, pe73, DOI 10.1111/j.1467-789X.2010.00820.x; Gundersen C, 2009, J NUTR, V139, P1173, DOI 10.3945/jn.109.105361; Hackett M, 2009, REV PANAM SALUD PUBL, V25, P506, DOI 10.1590/S1020-49892009000600006; Institute of Medicine, 2011, HUNG OB UND FOOD INS; Isanaka S, 2007, J NUTR, V137, P2747, DOI 10.1093/jn/137.12.2747; Jones SJ, 2003, ARCH PEDIAT ADOL MED, V157, P780, DOI 10.1001/archpedi.157.8.780; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; Kac G, 2012, PUBLIC HEALTH NUTR, P1; Kac Gilberto, 2003, Cad. Saúde Pública, V19, pS4, DOI 10.1590/S0102-311X2003000700001; Larson NI, 2011, AM J PREV MED, V40, P166, DOI 10.1016/j.amepre.2010.10.028; Antunes MML, 2010, CAD SAUDE PUBLICA, V26, P1642, DOI 10.1590/S0102-311X2010000800017; Metallinos-Katsaras E, 2009, J AM DIET ASSOC, V109, P1790, DOI 10.1016/j.jada.2009.07.007; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; Oh SY, 2003, EUR J CLIN NUTR, V57, P1598, DOI 10.1038/sj.ejcn.1601877; Oliveira Juliana Souza, 2010, Rev. Bras. Saude Mater. Infant., V10, P237, DOI 10.1590/S1519-38292010000200011; Ortiz-Hernandez L, 2007, REV INVEST CLIN, V59, P32; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Perez-Escamilla R, 2012, MODERN NUTR HLTH DIS; Perez-Escamilla R, 2008, REV NUTR, V21, P15; Reis M, 2012, HEALTH ECON, V21, P405, DOI 10.1002/hec.1722; Rose D, 2006, PEDIATRICS, V117, P464, DOI 10.1542/peds.2005-0582; Velasquez-Melendez G, 2011, J NUTR, V141, P898, DOI 10.3945/jn.110.135046; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 1995, PHYS STAT US INT ANT	31	22	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45747	10.1371/journal.pone.0045747	http://dx.doi.org/10.1371/journal.pone.0045747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029220	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800091
J	Vandergaast, R; Fredericksen, BL				Vandergaast, Rianna; Fredericksen, Brenda L.			West Nile Virus (WNV) Replication Is Independent of Autophagy in Mammalian Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; UNFOLDED PROTEIN RESPONSE; INFECTION; ACTIVATION; MACHINERY; DEGRADATION; INDUCTION; MARKER	Autophagy is a homeostatic process responsible for recycling cytosolic proteins and organelles. Moreover, this pathway contributes to the cell's intrinsic innate defenses. While many viruses have evolved mechanisms to antagonize the antiviral effects of the autophagy pathway, others subvert autophagy to facilitate replication. Here, we have investigated the role of autophagy in West Nile virus (WNV) replication. Experiments in cell lines derived from a variety of sources, including the kidney, liver, skin, and brain, indicated that WNV replication does not upregulate the autophagy pathway. Furthermore, WNV infection did not inhibit rapamycin-induced autophagy, suggesting that WNV does not disrupt the authophagy signaling cascade. Perturbation of the autophagy pathway by depletion of the major autophagy factors Atg5 or Atg7 had no effect on WNV infectious particle production, indicating that WNV does not require a functional autophagy pathway for replication. Taken together, the results of our study provide evidence that WNV, unlike several other viruses of the family Flaviviridae, does not significantly interact with the conventional autophagy pathway in mammalian cells.	[Vandergaast, Rianna; Fredericksen, Brenda L.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Vandergaast, Rianna; Fredericksen, Brenda L.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fredericksen, BL (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	bfreder@umd.edu			Public Health Service from the National Institute of Allergy and Infectious Diseases [AI083397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083397] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI083397 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982; Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Estrabaud E, 2011, J HEPATOL, V55, P1150, DOI 10.1016/j.jhep.2011.04.025; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Lin LT, 2010, VIROLOGY, V402, P1, DOI 10.1016/j.virol.2010.03.026; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; Sejvar JJ, 2006, REV MED VIROL, V16, P209, DOI 10.1002/rmv.501; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Shrivastava S, 2012, J VIROL; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	47	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45800	10.1371/journal.pone.0045800	http://dx.doi.org/10.1371/journal.pone.0045800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029249	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800099
J	Zhang, JZ; An, Y; Gao, JW; Han, J; Pan, XY; Pan, Y; Tie, L; Li, XJ				Zhang, Jianzhao; An, Yu; Gao, Junwei; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun			Aquaporin-1 Translocation and Degradation Mediates the Water Transportation Mechanism of Acetazolamide	PLOS ONE			English	Article							DOWN-REGULATION; CONCENTRATING ABILITY; MAPK PATHWAYS; CHANNELS; EXPRESSION; PERMEABILITY; PROTEIN; AQP1; TRAFFICKING; MEMBRANE	Background: Diuretic agents are widely used on the treatment of water retention related diseases, among which acetazolamide (AZA) acts originally as a carbonic anhydrase (CA) inhibitor. Aquaporin-1 (AQP1) being located in renal proximal tubules is required for urine concentration. Previously our lab has reported AZA putatively modulated AQP1. Aim of this study is to testify our hypothesis that regulating AQP1 may mediate diuretic effect of AZA. Methodology/Principal Findings: For in vivo study, we utilized Sprague Dawley rats, as well as AQP1 knock-out (AQP1(-/-)) mice to examine urine volume, and human kidney-2 (HK-2) cell line was used for in vitro mechanism study. In our present study we found that AZA decreased CAs activity initially but the activity gradually recovered. Contrarily, diuretic effect was consistently significant. AQP1 protein expression was significantly decreased on day 7 and 14. By utilizing AQP1(-/-) mice, we found diuretic effect of AZA was cancelled on day 14, while urine volume continuously increased in wild-type mice. Surface plasmon resonance (SPR) results indicated AQP1 was physiologically bound by myosin heavy chain (MHC), immunoprecipitation and immunofluorescence results confirmed this protein interaction. In vitro study results proved AZA facilitated AQP1 translocation onto cell membrane by promoting interaction with MHC, dependent on ERK/ myosin light chain kinase (MLCK) pathway activation. MHC inhibitor BDM and ERK inhibitor U0126 both abolished above effect of AZA. Eventually AZA induced AQP1 ubiquitination, while proteasome inhibitor MG132 reversed AZA's down-regulating effect upon AQP1. Conclusions/Significance: Our results identified AZA exerted diuretic effect through an innovative mechanism by regulating AQP1 and verified its inhibitory mechanism was via promoting MHC-dependent translocation onto cell membrane and then ubiquitin mediated degradation, implicating a novel mechanism and target for diuretic agent discovering.	[Zhang, Jianzhao; An, Yu; Gao, Junwei; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhang, Jianzhao; An, Yu; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China	Peking University; Peking University	Li, XJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	lixj@bjmu.edu.cn	An, Yu/O-2966-2013; Pan, Xueyang/Y-1641-2019	An, Yu/0000-0002-9678-3382; Pan, Xueyang/0000-0003-4453-4971	National Natural Science Foundation of China [81020108031, 30572202, 30973558, 30772571, 30901815, 30901803]; Ministry of Science and Technology in China [2009ZX09103-144]; Ministry of Education of China [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology in China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81020108031, 30572202, 30973558, 30772571, 30901815, 30901803), the Major Specialized Research Fund from the Ministry of Science and Technology in China (No. 2009ZX09103-144) and Research Fund from Ministry of Education of China (111 Projects No. B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF463; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; Amlal H, 2001, KIDNEY INT, V60, P1824, DOI 10.1046/j.1523-1755.2001.00995.x; BANKS DA, 1986, EPILEPSIA, V27, P510, DOI 10.1111/j.1528-1157.1986.tb03576.x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bin K, 2011, HEPATO-GASTROENTEROL, V58, P1502, DOI 10.5754/hge11154; BRION LP, 1988, ANAL BIOCHEM, V175, P289, DOI 10.1016/0003-2697(88)90391-0; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Dantzler WH, 2011, ACTA PHYSIOL, V202, P361, DOI 10.1111/j.1748-1716.2010.02214.x; Gao JW, 2006, ANAL BIOCHEM, V350, P165, DOI 10.1016/j.ab.2006.01.003; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Jiang Q, 2009, INT J MOL MED, V23, P771, DOI 10.3892/ijmm_00000191; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Lee J, 2006, KIDNEY BLOOD PRESS R, V29, P18, DOI 10.1159/000092483; Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498; LI XJ, 1994, BIOCHEM MOL BIOL INT, V32, P371; Liu LH, 2011, LUNG, V189, P331, DOI 10.1007/s00408-011-9288-1; Ma B, 2004, ACTA PHARMACOL SIN, V25, P90; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; MA TH, 1993, J BIOL CHEM, V268, P22756; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Mubarakshina Borisova MM, 2012, BIOCH BIOPHYS ACTA; Navratilova I, 2011, FUTURE MED CHEM, V3, P1809, DOI [10.4155/fmc.11.128, 10.4155/FMC.11.128]; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nielsen S, 1996, Perit Dial Int, V16 Suppl 1, pS25; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Noda Y, 2004, J PHARMACOL SCI, V96, P249, DOI 10.1254/jphs.FMJ04004X2; PRESTON GM, 1993, J BIOL CHEM, V268, P17; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Ran X, 2010, HEART VESSELS, V25, P237, DOI 10.1007/s00380-009-1179-5; Sakurada Tsutomu, 2004, Adv Perit Dial, V20, P37; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tang S, 2001, AM J KIDNEY DIS, V38, P317, DOI 10.1053/ajkd.2001.26097; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Tietz PS, 2006, BIOL CELL, V98, P43, DOI 10.1042/BC20040089; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Verkman AS, 1998, AM J MED SCI, V316, P310, DOI 10.1097/00000441-199811000-00004; Xiang Y, 2004, ACTA PHARMACOL SIN, V25, P812; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yool Andrea J, 2002, BMC Physiol, V2, P4, DOI 10.1186/1472-6793-2-4; Yool AJ, 2010, CLIN EXP PHARMACOL P, V37, P403, DOI 10.1111/j.1440-1681.2009.05244.x; Zhao D, 2006, AM J PHYSIOL-RENAL, V291, pF429, DOI 10.1152/ajprenal.00011.2006	52	27	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45976	10.1371/journal.pone.0045976	http://dx.doi.org/10.1371/journal.pone.0045976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029347	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800127
J	Hale, LP; Kant, EP; Greer, PK; Foster, WM				Hale, Laura P.; Kant, Erin Potts; Greer, Paula K.; Foster, W. Michael			RETRACTED: Iron Supplementation Decreases Severity of Allergic Inflammation in Murine Lung (Retracted article. See vol. 11, e0155387, 2016)	PLOS ONE			English	Article; Retracted Publication							PERITONEAL MAST-CELLS; HISTAMINE-RELEASE; ASTHMA PHENOTYPE; MEDICAL PROGRESS; MODEL; DESFERRIOXAMINE; INHIBITION; EXPRESSION	The incidence and severity of allergic asthma have increased over the last century, particularly in the United States and other developed countries. This time frame was characterized by marked environmental changes, including enhanced hygiene, decreased pathogen exposure, increased exposure to inhaled pollutants, and changes in diet. Although iron is well-known to participate in critical biologic processes such as oxygen transport, energy generation, and host defense, iron deficiency remains common in the United States and world-wide. The purpose of these studies was to determine how dietary iron supplementation affected the severity of allergic inflammation in the lungs, using a classic model of IgE-mediated allergy in mice. Results showed that mice fed an iron-supplemented diet had markedly decreased allergen-induced airway hyperreactivity, eosinophil infiltration, and production of pro-inflammatory cytokines, compared with control mice on an unsupplemented diet that generated mild iron deficiency but not anemia. In vitro, iron supplementation decreased mast cell granule content, IgE-triggered degranulation, and production of pro-inflammatory cytokines post-degranulation. Taken together, these studies show that iron supplementation can decrease the severity of allergic inflammation in the lung, potentially via multiple mechanisms that affect mast cell activity. Further studies are indicated to determine the potential of iron supplementation to modulate the clinical severity of allergic diseases in humans.	[Hale, Laura P.; Greer, Paula K.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Kant, Erin Potts; Foster, W. Michael] Duke Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA	Duke University; Duke University; Duke University	Hale, LP (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	laura.hale@duke.edu			NIH [ES 016347, AI 081672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grants ES 016347 and AI 081672 to WMF and by additional funds paid out of LPH's "discretionary account" rather than from existing grants. The funds in the discretionary account are derived from payments to LPH for services that she renders and are personal funds, diverted for use in the laboratory, rather than being taken as income. The National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Beasley R, 2002, J ALLERGY CLIN IMMUN, V109, pS482, DOI 10.1067/mai.2002.122716; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897; Chichlowski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012220; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Clark SF, 2008, NUTR CLIN PRACT, V23, P128, DOI 10.1177/0884533608314536; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gaga M, 2005, CLIN EXP ALLERGY, V35, P954, DOI 10.1111/j.1365-2222.2005.02281.x; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; GROSSWEEGE W, 1986, AGENTS ACTIONS, V19, P10; Hale LP, 2006, INT IMMUNOPHARMACOL, V6, P2038, DOI 10.1016/j.intimp.2006.08.007; Institute for Laboratory Animal Research (ILAR), 1995, NUTR REQ LAB AN, P80; Jeong HJ, 2003, BIOCHEM BIOPH RES CO, V306, P805, DOI 10.1016/S0006-291X(03)01073-8; Jin C, 2011, J CLIN INVEST, V121, P941, DOI 10.1172/JCI43584; Karman J, 2010, INT IMMUNOL, V22, P593, DOI 10.1093/intimm/dxq044; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lombardo T, 1996, AM J HEMATOL, V51, P90, DOI 10.1002/(SICI)1096-8652(199601)51:1<90::AID-AJH15>3.0.CO;2-F; Maazi H, 2011, CLIN EXP IMMUNOL, V166, P80, DOI 10.1111/j.1365-2249.2011.04448.x; MAGRO AM, 1983, IMMUNOLOGY, V49, P1; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Moorman JE., 2007, MMWR-MORBID MORTAL W, V56, P1; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Reuter S, 2010, INT ARCH ALLERGY IMM, V151, P214, DOI 10.1159/000242359; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; SHALIT M, 1991, J ALLERGY CLIN IMMUN, V88, P854, DOI 10.1016/0091-6749(91)90241-F; Shin JS, 2006, J IMMUNOL, V177, P5791, DOI 10.4049/jimmunol.177.9.5791; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Song KS, 2009, AM J RESP CELL MOL, V41, P40, DOI 10.1165/rcmb.2008-0280OC; Torrace JD, 1980, TISSUE IRON STORES; Vanderford DA, 2010, EXP DERMATOL, V19, P518, DOI 10.1111/j.1600-0625.2009.01032.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x	39	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45667	10.1371/journal.pone.0045667	http://dx.doi.org/10.1371/journal.pone.0045667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029172	Green Published, gold			2022-12-27	WOS:000309388900089
J	Buraschi, S; Neill, T; Owens, RT; Iniguez, LA; Purkins, G; Vadigepalli, R; Evans, B; Schaefer, L; Peiper, SC; Wang, ZX; Iozzo, RV				Buraschi, Simone; Neill, Thomas; Owens, Rick T.; Iniguez, Leonardo A.; Purkins, George; Vadigepalli, Rajanikanth; Evans, Barry; Schaefer, Liliana; Peiper, Stephen C.; Wang, Zi-Xuan; Iozzo, Renato V.			Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; DOWN-REGULATION; IN-VIVO; CANCER GROWTH; SUPPRESSION; INHIBITION; PROMOTER; CELLS	Decorin, a member of the small leucine-rich proteoglycan gene family, exists and functions wholly within the tumor microenvironment to suppress tumorigenesis by directly targeting and antagonizing multiple receptor tyrosine kinases, such as the EGFR and Met. This leads to potent and sustained signal attenuation, growth arrest, and angiostasis. We thus sought to evaluate the tumoricidal benefits of systemic decorin on a triple-negative orthotopic breast carcinoma xenograft model. To this end, we employed a novel high-density mixed expression array capable of differentiating and simultaneously measuring gene signatures of both Mus musculus (stromal) and Homo sapiens (epithelial) tissue origins. We found that decorin protein core modulated the differential expression of 374 genes within the stromal compartment of the tumor xenograft. Further, our top gene ontology classes strongly suggests an unexpected and preferential role for decorin protein core to inhibit genes necessary for immunomodulatory responses while simultaneously inducing expression of those possessing cellular adhesion and tumor suppressive gene properties. Rigorous verification of the top scoring candidates led to the discovery of three genes heretofore unlinked to malignant breast cancer that were reproducibly found to be induced in several models of tumor stroma. Collectively, our data provide highly novel and unexpected stromal gene signatures as a direct function of systemic administration of decorin protein core and reveals a fundamental basis of action for decorin to modulate the tumor stroma as a biological mechanism for the ascribed anti-tumorigenic properties.	[Buraschi, Simone; Neill, Thomas; Purkins, George; Vadigepalli, Rajanikanth; Evans, Barry; Peiper, Stephen C.; Wang, Zi-Xuan; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Buraschi, Simone; Neill, Thomas; Purkins, George; Vadigepalli, Rajanikanth; Evans, Barry; Peiper, Stephen C.; Wang, Zi-Xuan; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ USA; [Iniguez, Leonardo A.] Roche NimbleGen Inc, Res & Dev, Madison, WI USA; [Schaefer, Liliana] Goethe Univ Frankfurt, Dept Pharmacol, Frankfurt, Germany	Jefferson University; Jefferson University; Roche Holding; Goethe University Frankfurt	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org	Iozzo, Renato/AAS-1980-2020	Vadigepalli, Rajanikanth/0000-0002-8405-1037; Schaefer, Liliana/0000-0002-3318-3005; Iozzo, Renato/0000-0002-5908-5112; Buraschi, Simone/0000-0002-4233-7627	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA120975, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was in part supported by the National Institutes of Health grants RO1 CA39481, RO1 CA47282 and RO1 CA120975 (to RVI), and training grant T32 AA07463 (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADANY R, 1991, BIOCHEM J, V276, P301, DOI 10.1042/bj2760301; ADANY R, 1990, BIOCHEM BIOPH RES CO, V171, P1402, DOI 10.1016/0006-291X(90)90841-A; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen B, 2003, MOL ENDOCRINOL, V17, P2340, DOI 10.1210/me.2003-0207; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; COHEN IR, 1994, CANCER RES, V54, P5771; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dharajiya N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008172; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Heller G, 2007, BREAST CANCER RES TR, V103, P283, DOI 10.1007/s10549-006-9377-7; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Howell A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2435; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; IOZZO RV, 1995, LAB INVEST, V73, P157; IOZZO RV, 1988, CANCER METAST REV, V7, P39, DOI 10.1007/BF00048277; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kearns AE, 2001, J BIOL CHEM, V276, P42213, DOI 10.1074/jbc.M106163200; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kolettas E, 1998, EUR J BIOCHEM, V254, P266, DOI 10.1046/j.1432-1327.1998.2540266.x; LEE CGL, 1995, IMMUNOGENETICS, V41, P263, DOI 10.1007/BF00172150; Leygue E, 2000, J PATHOL, V192, P313; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liang QL, 2011, CANCER INVEST, V29, P107, DOI 10.3109/07357907.2010.543211; Liu HP, 2009, J CLIN LAB ANAL, V23, P362, DOI 10.1002/jcla.20344; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Maller O, 2010, J MAMMARY GLAND BIOL, V15, P301, DOI 10.1007/s10911-010-9189-6; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Mauviel A, 1996, J BIOL CHEM, V271, P24824, DOI 10.1074/jbc.271.40.24824; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Moon TR, 2004, NAT REV GENET, V5, P689; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nikitovic D, 2008, CONNECT TISSUE RES, V49, P235, DOI 10.1080/03008200802147589; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Rong BX, 2011, INT J BIOL MARKER, V26, P9, DOI 10.5301/JBM.2011.6372; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; SANTRA M, 1994, J BIOL CHEM, V269, P579; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; Schedin P, 2007, J MAMMARY GLAND BIOL, V12, P71, DOI 10.1007/s10911-007-9039-3; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Stander M, 1998, GENE THER, V5, P1187, DOI 10.1038/sj.gt.3300709; Sugerman PB, 2004, AM J PATHOL, V164, P2189, DOI 10.1016/S0002-9440(10)63776-5; Tamini Y, 2004, INVEST OPHTH VIS SCI, V45, P3904, DOI 10.1167/iovs.04-0628; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Troup S, 2003, CLIN CANCER RES, V9, P207; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	114	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45559	10.1371/journal.pone.0045559	http://dx.doi.org/10.1371/journal.pone.0045559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029096	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400104
J	Rossaint, J; Berger, C; Van Aken, H; Scheld, HH; Zahn, PK; Rukosujew, A; Zarbock, A				Rossaint, Jan; Berger, Christian; Van Aken, Hugo; Scheld, Hans H.; Zahn, Peter K.; Rukosujew, Andreas; Zarbock, Alexander			Cardiopulmonary Bypass during Cardiac Surgery Modulates Systemic Inflammation by Affecting Different Steps of the Leukocyte Recruitment Cascade	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOLUBLE ADHESION MOLECULES; E-SELECTIN; NEUTROPHIL ADHESION; INTEGRIN ACTIVATION; SURFACE EXPRESSION; P-SELECTIN; ISCHEMIA-REPERFUSION; RECEPTOR EXPRESSION; CD11B/CD18 MAC-1	Background: It is known that the use of a cardiopulmonary bypass (CPB) during cardiac surgery leads to leukocyte activation and may, among other causes, induce organ dysfunction due to increased leukocyte recruitment into different organs. Leukocyte extravasation occurs in a cascade-like fashion, including capturing, rolling, adhesion, and transmigration. However, the molecular mechanisms of increased leukocyte recruitment caused by CPB are not known. This clinical study was undertaken in order to investigate which steps of the leukocyte recruitment cascade are affected by the systemic inflammation during CPB. Methods: We investigated the effects of CPB on the different steps of the leukocyte recruitment cascade in whole blood from healthy volunteers (n = 9) and patients undergoing cardiac surgery with the use of cardiopulmonary bypass (n = 7) or in off-pump coronary artery bypass-technique (OPCAB, n = 9) by using flow chamber experiments, transmigration assays, and biochemical analysis. Results: CPB abrogated selectin-induced slow leukocyte rolling on E-selectin/ICAM-1 and P-selectin/ICAM-1. In contrast, chemokine-induced arrest and transmigration was significantly increased by CPB. Mechanistically, the abolishment of slow leukocyte rolling was due to disturbances in intracellular signaling with reduced phosphorylation of phospholipase C (PLC) gamma 2, Akt, and p38 MAP kinase. Furthermore, CPB induced an elevated transmigration which was caused by upregulation of Mac-1 on neutrophils. Conclusion: These data suggest that CPB abrogates selectin-mediated slow leukocyte rolling by disturbing intracellular signaling, but that the clinically observed increased leukocyte recruitment caused by CPB is due to increased chemokine-induced arrest and transmigration. A better understanding of the underlying molecular mechanisms causing systemic inflammation after CPB may aid in the development of new therapeutic approaches.	[Rossaint, Jan; Berger, Christian; Van Aken, Hugo; Zarbock, Alexander] Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Scheld, Hans H.; Rukosujew, Andreas] Univ Hosp Munster, Dept Thorac & Cardiovasc Surg, Munster, Germany; [Zahn, Peter K.] Univ Hosp Bergmannsheil Bochum, Dept Anesthesiol Intens Care Med Palliat Care Med, Bochum, Germany	University of Munster; University of Munster; Ruhr University Bochum	Zarbock, A (corresponding author), Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany.	zarbock@uni-muenster.de	Berger, Christian/AAI-6750-2021; Zahn, Peter/AAB-9377-2021	Berger, Christian/0000-0002-9087-7732; Rukosujew, Andreas/0000-0002-0869-1630	DFG ("Deutsche Forschungsgemeinschaft")	DFG ("Deutsche Forschungsgemeinschaft")(German Research Foundation (DFG))	This study was funded by the DFG ("Deutsche Forschungsgemeinschaft"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman U, 2007, J INFLAMM LOND, V4, P21, DOI DOI 10.1186/1476-9255-4-21; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9; Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2; Asimakopoulos G, 2001, PERFUSION-UK, V16, P353, DOI 10.1177/026765910101600505; Ben-Abraham R, 2003, PAEDIATR ANAESTH, V13, P655, DOI 10.1046/j.1460-9592.2003.01069.x; Block H, 2012, J EXP MED, V209, P407, DOI 10.1084/jem.20111493; BRAUDE S, 1986, AM REV RESPIR DIS, V134, P867, DOI 10.1164/arrd.1986.134.5.867; Cameron D, 1996, J CARDIOVASC PHARM, V27, pS1; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Diacovo TG, 1996, BLOOD, V88, P146; DREYER WJ, 1991, CIRCULATION, V84, P400, DOI 10.1161/01.CIR.84.1.400; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; ELLIOTT MJ, 1993, ANN THORAC SURG, V56, P1503, DOI 10.1016/0003-4975(93)90741-Y; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; FORSYTH KD, 1990, J IMMUNOL METHODS, V128, P159, DOI 10.1016/0022-1759(90)90206-B; FREYER DR, 1988, J IMMUNOL, V141, P580; GILLINOV AM, 1994, ANN THORAC SURG, V57, P126, DOI 10.1016/0003-4975(94)90380-8; GLASSER L, 1990, AM J CLIN PATHOL, V93, P662, DOI 10.1093/ajcp/93.5.662; Hambsch J, 2002, ANESTHESIOLOGY, V96, P1078, DOI 10.1097/00000542-200205000-00009; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HIND CRK, 1988, CARDIOVASC RES, V22, P37, DOI 10.1093/cvr/22.1.37; Inoue T, 2003, CIRCULATION, V107, P1757, DOI 10.1161/01.CIR.0000060487.15126.56; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KUIJPERS TW, 1991, BLOOD, V78, P1105; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Landis Clive, 2007, J Extra Corpor Technol, V39, P291; Landis RC, 2009, SEMIN CARDIOTHORAC V, V13, P87, DOI 10.1177/1089253209337743; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Lewis SM, 2009, AM J RESP CELL MOL, V40, P724, DOI 10.1165/rcmb.2008-0252OC; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liangos O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013658; Lo Presti R, 2004, CLIN HEMORHEOL MICRO, V30, P53; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marsik C, 2004, J CLIN IMMUNOL, V24, P62, DOI 10.1023/B:JOCI.0000018064.13793.83; May AE, 2002, BLOOD, V100, P3611, DOI 10.1182/blood-2002-03-0778; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Murphy GJ, 2004, J CARDIAC SURG, V19, P481, DOI 10.1111/j.0886-0440.2004.04101.x; Orr Y, 2007, J LEUKOCYTE BIOL, V82, P1115, DOI 10.1189/jlb.0906545; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Raja SG, 2007, J CARDIAC SURG, V22, P445, DOI 10.1111/j.1540-8191.2007.00447.x; RINDER CS, 1992, BLOOD, V79, P1201; Rinder CS, 2003, ANN THORAC SURG, V75, P899, DOI 10.1016/S0003-4975(02)04490-9; Rosenbloom AJ, 1999, J LEUKOCYTE BIOL, V66, P83, DOI 10.1002/jlb.66.1.83; ROSENBLOOM AJ, 1995, JAMA-J AM MED ASSOC, V274, P58, DOI 10.1001/jama.274.1.58; Rossaint J, 2011, KIDNEY INT, V80, P493, DOI 10.1038/ki.2011.125; SCHLEIFFENBAUM B, 1989, J IMMUNOL, V142, P3537; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Simon DI, 1997, ARTERIOSCL THROM VAS, V17, P528, DOI 10.1161/01.ATV.17.3.528; Sniecinski RM, 2011, ANESTH ANALG, V113, P1319, DOI 10.1213/ANE.0b013e3182354b7e; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; TELLADO JM, 1993, SURGERY, V113, P624; Urner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033403; VEDDER NB, 1988, J CLIN INVEST, V81, P676, DOI 10.1172/JCI113372; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Wei MX, 2003, WORLD J SURG, V27, P140, DOI 10.1007/s00268-002-6595-y; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zarbock A, 2012, J MOL MED, V90, P353, DOI 10.1007/s00109-011-0835-2; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zarbock A, 2009, J LEUKOCYTE BIOL, V86, P1119, DOI 10.1189/jlb.0209117; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104	75	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45738	10.1371/journal.pone.0045738	http://dx.doi.org/10.1371/journal.pone.0045738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029213	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400128
J	Yeo, ZX; Chan, M; Yap, YS; Ang, P; Rozen, S; Lee, ASG				Yeo, Zhen Xuan; Chan, Maurice; Yap, Yoon Sim; Ang, Peter; Rozen, Steve; Lee, Ann Siew Gek			Improving Indel Detection Specificity of the Ion Torrent PGM Benchtop Sequencer	PLOS ONE			English	Article							COPY-NUMBER; MUTATION; GENOME	The emergence of benchtop sequencers has made clinical genetic testing using next-generation sequencing more feasible. Ion Torrent's PGM (TM) is one such benchtop sequencer that shows clinical promise in detecting single nucleotide variations (SNVs) and microindel variations (indels). However, the large number of false positive indels caused by the high frequency of homopolymer sequencing errors has impeded PGM (TM)'s usage for clinical genetic testing. An extensive analysis of PGM (TM) data from the sequencing reads of the well-characterized genome of the Escherichia coli DH10B strain and sequences of the BRCA1 and BRCA2 genes from six germline samples was done. Three commonly used variant detection tools, SAMtools, Dindel, and GATK's Unified Genotyper, all had substantial false positive rates for indels. By incorporating filters on two major measures we could dramatically improve false positive rates without sacrificing sensitivity. The two measures were: B-Allele Frequency (BAF) and VARiation of the Width of gaps and inserts (VARW) per indel position. A BAF threshold applied to indels detected by UnifiedGenotyper removed similar to 99% of the indel errors detected in both the DH10B and BRCA sequences. The optimum BAF threshold for BRCA sequences was determined by requiring 100% detection sensitivity and minimum false discovery rate, using variants detected from Sanger sequencing as reference. This resulted in 15 indel errors remaining, of which 7 indel errors were removed by selecting a VARW threshold of zero. VARW specific errors increased in frequency with higher read depth in the BRCA datasets, suggesting that homopolymer-associated indel errors cannot be reduced by increasing the depth of coverage. Thus, using a VARW threshold is likely to be important in reducing indel errors from data with higher coverage. In conclusion, BAF and VARW thresholds provide simple and effective filtering criteria that can improve the specificity of indel detection in PGM (TM) data without compromising sensitivity.	[Yeo, Zhen Xuan; Chan, Maurice; Lee, Ann Siew Gek] Natl Canc Ctr Singapore, Div Med Sci, Singapore, Singapore; [Yap, Yoon Sim; Ang, Peter] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Ang, Peter] Gleneagles Med Ctr, Oncocare Canc Ctr, Singapore, Singapore; [Rozen, Steve] Duke NUS Grad Med Sch, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	; Rozen, Steven G./J-5939-2013	Ang, Peter/0000-0002-0482-3069; Rozen, Steven G./0000-0002-4288-0056	SingHealth Foundation [SHF/FG482S/2010]; National Medical Research Council of Singapore [NMRC/1194/2008]	SingHealth Foundation(SingHealth); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a SingHealth Foundation grant (SHF/FG482S/2010) awarded to MC and a grant from the National Medical Research Council of Singapore (NMRC/1194/2008) awarded to ASGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Losada L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019054; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Samarakoon U, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-116; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45798	10.1371/journal.pone.0045798	http://dx.doi.org/10.1371/journal.pone.0045798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029247	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400132
J	Vilaca, R; Mendes, V; Mendes, MV; Carreto, L; Amorim, MA; de Freitas, V; Moradas-Ferreira, P; Mateus, N; Costa, V				Vilaca, Rita; Mendes, Vanda; Mendes, Marta Vaz; Carreto, Laura; Amorim, Maria Amelia; de Freitas, Victor; Moradas-Ferreira, Pedro; Mateus, Nuno; Costa, Vitor			Quercetin Protects Saccharomyces cerevisiae against Oxidative Stress by Inducing Trehalose Biosynthesis and the Cell Wall Integrity Pathway	PLOS ONE			English	Article							COLON-CANCER CELLS; GLYCOGEN-PHOSPHORYLASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; GLUCOSE-UPTAKE; MAP KINASE; LIFE-SPAN; YEAST; GROWTH; TRANSCRIPTION	Background: Quercetin is a naturally occurring flavonol with antioxidant, anticancer and anti-ageing properties. In this study we aimed to identify genes differentially expressed in yeast cells treated with quercetin and its role in oxidative stress protection. Methods: A microarray analysis was performed to characterize changes in the transcriptome and the expression of selected genes was validated by RT-qPCR. Biological processes significantly affected were identified by using the FUNSPEC software and their relevance in H2O2 resistance induced by quercetin was assessed. Results: Genes associated with RNA metabolism and ribosome biogenesis were down regulated in cells treated with quercetin, whereas genes associated with carbohydrate metabolism, endocytosis and vacuolar proteolysis were up regulated. The induction of genes related to the metabolism of energy reserves, leading to the accumulation of the stress protectant disaccharide trehalose, and the activation of the cell wall integrity pathway play a key role in oxidative stress resistance induced by quercetin. Conclusions: These results suggest that quercetin may act as a modulator of cell signaling pathways related to carbohydrate metabolism and cell integrity to exert its protective effects against oxidative stress.	[Vilaca, Rita; Mendes, Vanda; Mendes, Marta Vaz; Amorim, Maria Amelia; Moradas-Ferreira, Pedro; Costa, Vitor] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Vilaca, Rita; Amorim, Maria Amelia; Moradas-Ferreira, Pedro; Costa, Vitor] Univ Porto, Inst Ciencias Biomed Abel Salazar, Dept Biol Mol, P-4100 Oporto, Portugal; [Mendes, Vanda; de Freitas, Victor; Mateus, Nuno] Univ Porto, Fac Ciencias, Ctr Invest Quim, P-4100 Oporto, Portugal; [Carreto, Laura] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Carreto, Laura] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro	Costa, V (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	vcosta@ibmc.up.pt	de Freitas, Victor A. P./H-7789-2013; MORADAS-FERREIRA, PEDRO/E-6357-2012; Vilaça, Rita Pereira/X-9033-2019; Costa, Vítor/A-2647-2008; Mateus, Nuno/F-3019-2013; Mendes, Marta Vaz/A-8541-2008	MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Vilaça, Rita Pereira/0000-0002-9961-0479; Costa, Vítor/0000-0002-7868-4663; Mateus, Nuno/0000-0002-9318-9732; Mendes, Marta Vaz/0000-0002-6105-522X; Freitas, Victor/0000-0003-0586-2278	FEDER (Fundo Europeu de Desenvolvimento Regional); FCT (Fundacao, paro a Ciencia e Tecnologia) [FCOMP-01-0124-FEDER-007422-PTDC/QUI/65501/2006, FCT/FEDER/PTDC/BIA-BCM/64745/2006, PTDC/QUI/65501/2006]; iBeSa (Instituto de Bebidas e Saude); POPH (Programa Operacional Potencial Humano); European Social Fund; Portuguese national funds from the MCTES (Ministerio da Ciencia, Tecnologia e Ensino Superior); Fundação para a Ciência e a Tecnologia [PTDC/QUI/65501/2006, PTDC/BIA-BCM/64745/2006] Funding Source: FCT	FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); FCT (Fundacao, paro a Ciencia e Tecnologia); iBeSa (Instituto de Bebidas e Saude); POPH (Programa Operacional Potencial Humano); European Social Fund(European Social Fund (ESF)); Portuguese national funds from the MCTES (Ministerio da Ciencia, Tecnologia e Ensino Superior); Fundação para a Ciência e a Tecnologia	This work was financially supported by FEDER (Fundo Europeu de Desenvolvimento Regional) through the program "Programa Operacional Factores de Competitividade-COMPETE'' and by FCT (Fundacao, paro a Ciencia e Tecnologia) through the projects FCOMP-01-0124-FEDER-007422-PTDC/QUI/65501/2006 and FCT/FEDER/PTDC/BIA-BCM/64745/2006. R.V. was supported by iBeSa (Instituto de Bebidas e Saude) and V.M. by FCT (fellowship PTDC/QUI/65501/2006). M.V.M. was supported by "Programa Ciencia 2007'' sponsored by POPH (Programa Operacional Potencial Humano) QREN (Quadro de Referencia Estrategico Nacional) Tipologia 4.2 Promocao do Emprego Cientifico program and co-financed by the European Social Fund and Portuguese national funds from the MCTES (Ministerio da Ciencia, Tecnologia e Ensino Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Alameddine Fadi M F, 2002, Congest Heart Fail, V8, P157, DOI 10.1111/j.1527-5299.2002.00719.x; Alameddine FM, 2002, CONGEST HEART FAIL, V8, P172; Amari F, 2008, J AGR FOOD CHEM, V56, P11740, DOI 10.1021/jf802829r; de la Torre-Ruiz MA, 2010, CURR PROTEIN PEPT SC, V11, P669; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bednarska S, 2008, BIOCHIMIE, V90, P1476, DOI 10.1016/j.biochi.2008.05.013; Belinha I, 2007, J AGR FOOD CHEM, V55, P2446, DOI 10.1021/jf063302e; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; BREWSTER NK, 1994, ARCH BIOCHEM BIOPHYS, V311, P62, DOI 10.1006/abbi.1994.1209; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; COHEN R, 1987, MOL CELL BIOL, V7, P2753, DOI 10.1128/MCB.7.8.2753; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Dani C, 2008, J AGR FOOD CHEM, V56, P4268, DOI 10.1021/jf800752s; DONNELLY SFH, 1993, MOL MICROBIOL, V10, P585, DOI 10.1111/j.1365-2958.1993.tb00930.x; Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gasparin FRS, 2003, XENOBIOTICA, V33, P587, DOI 10.1080/0049825031000089100; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Hwang EI, 2001, PLANTA MED, V67, P501, DOI 10.1055/s-2001-16487; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; Jimenez A, 2010, FEMS YEAST RES, V10, P858, DOI 10.1111/j.1567-1364.2010.00679.x; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Kim HJ, 2010, J AGR FOOD CHEM, V58, P8643, DOI 10.1021/jf101510z; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Lee EJ, 2010, INFLAMM RES, V59, P847, DOI 10.1007/s00011-010-0196-2; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martorell P, 2011, J AGR FOOD CHEM, V59, P2077, DOI 10.1021/jf104217g; MEGGIO F, 1986, EUR J BIOCHEM, V159, P31, DOI 10.1111/j.1432-1033.1986.tb09829.x; Meyers KJ, 2008, J AGR FOOD CHEM, V56, P830, DOI 10.1021/jf072358l; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; NI HT, 1995, MOL MICROBIOL, V16, P1197, DOI 10.1111/j.1365-2958.1995.tb02342.x; Nomura M, 2008, BIOL PHARM BULL, V31, P1403, DOI 10.1248/bpb.31.1403; Noubhani A, 2000, EUR J BIOCHEM, V267, P4566, DOI 10.1046/j.1432-1327.2000.01511.x; NWAKA S, 1995, J BIOL CHEM, V270, P10193, DOI 10.1074/jbc.270.17.10193; OH D, 1990, MOL CELL BIOL, V10, P1415, DOI 10.1128/MCB.10.4.1415; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Park HK, 2010, LIFE SCI, V87, P181, DOI 10.1016/j.lfs.2010.06.011; Parrou JL, 1999, YEAST, V15, P1471, DOI 10.1002/(SICI)1097-0061(199910)15:14&lt;1471::AID-YEA474&gt;3.0.CO;2-Q; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Prior RL, 2003, AM J CLIN NUTR, V78, p570S, DOI 10.1093/ajcn/78.3.570S; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Shoskes DA, 1999, UROLOGY, V54, P960, DOI 10.1016/S0090-4295(99)00358-1; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Sunnarborg SW, 2001, YEAST, V18, P1505; Teste MA, 2000, FEMS MICROBIOL LETT, V193, P105, DOI 10.1111/j.1574-6968.2000.tb09410.x; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Erk MJ, 2005, EUR J NUTR, V44, P143, DOI 10.1007/s00394-004-0503-1; Vargas AJ, 2010, NUTR REV, V68, P418, DOI 10.1111/j.1753-4887.2010.00301.x; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Weng CJ, 2011, NEW BIOTECHNOL, V28, P767, DOI 10.1016/j.nbt.2011.05.003; Winderickx J, 1996, MOL GEN GENET, V252, P470, DOI 10.1007/s004380050252; Wu MJ, 2011, FEMS YEAST RES, V11, P379, DOI 10.1111/j.1567-1364.2011.00726.x; Zahringer H, 1997, FEBS LETT, V412, P615, DOI 10.1016/S0014-5793(97)00868-5; Zhou W, 2010, INT J ONCOL, V37, P551, DOI 10.3892/ijo_00000704	79	24	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45494	10.1371/journal.pone.0045494	http://dx.doi.org/10.1371/journal.pone.0045494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029052	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900148
J	Wagner, GJ; Aunon, FM; Kaplan, RL; Rana, Y; Khouri, D; Tohme, J; Mokhbat, J				Wagner, Glenn J.; Aunon, Frances M.; Kaplan, Rachel L.; Rana, Yashodhara; Khouri, Danielle; Tohme, Johnny; Mokhbat, Jacques			A Qualitative Exploration of Sexual Risk and HIV Testing Behaviors among Men Who Have Sex with Men in Beirut, Lebanon	PLOS ONE			English	Article							BISEXUAL MEN; CONDOM USE; SAFER-SEX; PARTNERS; GAY; PREVENTION; HIV/AIDS; PREDICTORS; ATTITUDES; INTERNET	Men who have sex with men (MSM) may account for most new HIV infections in Lebanon, yet little is known about the factors that influence sexual risk behavior and HIV testing in this population. Qualitative interviews were conducted with 31 MSM living in Beirut, and content analysis was used to identify emergent themes. Mean age of the participants was 28.4 years, and all identified as either gay (77%) or bisexual (23%). Half reported not using condoms consistently and one quarter had not been HIV-tested. Many described not using condoms with a regular partner in the context of a meaningful relationship, mutual HIV testing, and a desire to not use condoms, suggesting that trust, commitment and intimacy play a role in condom use decisions. Condoms were more likely to be used with casual partners, partners believed to be HIV-positive, and with partners met online where men found it easier to candidly discuss HIV risk. Fear of infection motivated many to get HIV tested and use condoms, but such affect also led some to avoid HIV testing in fear of disease and social stigma if found to be infected. Respondents who were very comfortable with their sexual orientation and who had disclosed their sexuality to family and parents tended to be more likely to use condoms consistently and be tested for HIV. These findings indicate that similar factors influence the condom use and HIV testing of MSM in Beirut as those observed in studies elsewhere of MSM; hence, prevention efforts in Lebanon can likely benefit from lessons learned and interventions developed in other regions, particularly for younger, gay-identified men. Further research is needed to determine how prevention efforts may need to be tailored to address the needs of men who are less integrated into or do not identify with the gay community.	[Wagner, Glenn J.; Aunon, Frances M.; Rana, Yashodhara] RAND Corp, Santa Monica, CA 90401 USA; [Kaplan, Rachel L.] Univ Calif Berkeley, Sch Social Welf, Mack Ctr Mental Hlth & Social Conflict, Berkeley, CA 94720 USA; [Khouri, Danielle; Tohme, Johnny; Mokhbat, Jacques] Lebanese AIDS Soc, Beirut, Lebanon; [Tohme, Johnny] Sexual Hlth Ctr, Beirut, Lebanon; [Mokhbat, Jacques] Univ Med Ctr Rizk Hosp, Div Infect Dis, Beirut, Lebanon	RAND Corporation; University of California System; University of California Berkeley; Lebanese American University	Wagner, GJ (corresponding author), RAND Corp, Santa Monica, CA 90401 USA.	gwagner@rand.org			National Institute of Mental Health [5R21MH093204-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093204] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institute of Mental Health (Grant No. 5R21MH093204-02; PI: G. Wagner) funded the study but had no other role in the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi R, 2008, MISHWAR INTEGRATED B; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bernard H. H. R., 2009, ANAL QUALITATIVE DAT; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Crawford I, 2002, J SEX RES, V39, P179, DOI 10.1080/00224490209552140; Davidovich U, 2004, AIDS EDUC PREV, V16, P304, DOI 10.1521/aeap.16.4.304.40398; El-Sayyed N., 2008, Eastern Mediterranean Health Journal, V14, P905; Elrasheid S., 2006, 16 INT AIDS C TOR CA; FHI/MOH Egypt, 2006, HIV AIDS BIOL BEH SU; Glick SN, 2012, JAIDS-J ACQ IMM DEF, V60, P83, DOI 10.1097/QAI.0b013e318247925e; Gomez AM, 2012, AIDS BEHAV, V16, P1584, DOI 10.1007/s10461-011-0074-0; Hensel DJ, 2012, SEX TRANSM DIS, V39, P550, DOI 10.1097/OLQ.0b013e31824f1da4; Kahhaleh J. G., 2009, Eastern Mediterranean Health Journal, V15, P920; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Mahfoud Z, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000386733.02425.98; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Menza TW, 2011, AIDS BEHAV, V15, P319, DOI 10.1007/s10461-009-9626-y; Mor Z, 2011, SEX TRANSM INFECT, V87, P532, DOI 10.1136/sextrans-2011-050048; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Nakib M. E., 2002, 14 INT AIDS C AIDS 2; Neville S, 2009, CONTEMP NURSE, V33, P130, DOI 10.5172/conu.2009.33.2.130; Newcomb ME, 2011, ARCH SEX BEHAV, V40, P189, DOI 10.1007/s10508-009-9573-8; O'Leary A, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000167353.02289.b9; Obermeyer CM, 2006, BMJ-BRIT MED J, V333, P851, DOI 10.1136/bmj.38994.400370.7C; Parsons JT, 2012, AIDS BEHAV; Prestage G, 2012, AIDS BEHAV, V16, P664, DOI 10.1007/s10461-011-9952-8; Remien RH, 2009, JAIDS-J ACQ IMM DEF, V51, pS106, DOI 10.1097/QAI.0b013e3181aafd66; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Rouwenhorst E, 2012, AIDS BEHAV, V16, P1589, DOI 10.1007/s10461-011-0092-y; Shoptaw S, 2009, J URBAN HEALTH, V86, pS77, DOI 10.1007/s11524-009-9372-5; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; UNAIDS, 2011, LEB AIDS INF DAT; WHO UNICEF and World Bank, 2011, GLOB HIV AIDS RESP E	35	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45566	10.1371/journal.pone.0045566	http://dx.doi.org/10.1371/journal.pone.0045566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23029103	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900158
J	Cosson, P; Marchetti, A; Ravazzola, M; Orci, L				Cosson, Pierre; Marchetti, Anna; Ravazzola, Mariella; Orci, Lelio			Mitofusin-2 Independent Juxtaposition of Endoplasmic Reticulum and Mitochondria: An Ultrastructural Study	PLOS ONE			English	Article							ELECTRON TOMOGRAPHY; COLOCALIZATION; ORGANIZATION; MICROSCOPY; CHANNELS; FUSION; LINE; ER	Besides its role in controlling the morphology of mitochondria, mitofusin-2 has been proposed to tether mitochondria to the endoplasmic reticulum (ER), based largely on light microscopic analysis. In this study we have examined by electron microscopy the organization of ER and mitochondria in cells expressing or not mitofusin-2. Contrary to previous studies, we observed that loss of mitofusin-2 increased ER-mitochondria juxtaposition. These results suggest that mitofusin-2 does not play a critical role in the juxtapostion of ER and mitochondria, and highlight the essential role of ultrastructural analysis to visualize and measure contact between two intracellular compartments.	[Cosson, Pierre; Marchetti, Anna; Ravazzola, Mariella; Orci, Lelio] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland	University of Geneva	Cosson, P (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland.	Pierre.Cosson@unige.ch			Swiss National Science Foundation [31003A_135789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) to PC (31003A_135789). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; FIORI MG, 1981, NEUROSCIENCE, V6, P461, DOI 10.1016/0306-4522(81)90138-X; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Santel A, 2001, J CELL SCI, V114, P867; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	23	169	171	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46293	10.1371/journal.pone.0046293	http://dx.doi.org/10.1371/journal.pone.0046293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029466	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900125
J	Gao, L; Jiang, T; Guo, J; Liu, Y; Cui, GY; Gu, LZ; Su, LY; Zhang, YD				Gao, Li; Jiang, Teng; Guo, Jun; Liu, Yi; Cui, Guiyun; Gu, Lize; Su, Lingying; Zhang, Yingdong			Inhibition of Autophagy Contributes to Ischemic Postconditioning-Induced Neuroprotection against Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; HYPOXIA-ISCHEMIA; INFARCT SIZE; NEURON DEATH; CELL-DEATH; IN-VIVO; PATHWAYS; STROKE; MODEL; BRAIN	Background: Ischemic postconditioning (IPOC), or relief of ischemia in a stuttered manner, has emerged as an innovative treatment strategy to reduce programmed cell death, attenuate ischemic injuries, and improve neurological outcomes. However, the mechanisms involved have not been completely elucidated. Recent studies indicate that autophagy is a type of programmed cell death that plays elusive roles in controlling neuronal damage and metabolic homeostasis. This study aims to determine the role of autophagy in IPOC-induced neuroprotection against focal cerebral ischemia in rats. Methodology/Principal Findings: A focal cerebral ischemic model with permanent middle cerebral artery (MCA) occlusion plus transient common carotid artery (CCA) occlusion was established. The autophagosomes and the expressions of LC3/Beclin 1/p62 were evaluated for their contribution to the activation of autophagy. We found that autophagy was markedly induced with the upregulation of LC3/Beclin 1 and downregulation of p62 in the penumbra at various time intervals following ischemia. IPOC, performed at the onset of reperfusion, reduced infarct size, mitigated brain edema, inhibited the induction of LC3/Beclin 1 and reversed the reduction of p62 simultaneously. Rapamycin, an inducer of autophagy, partially reversed all the aforementioned effects induced by IPOC. Conversely, autophagy inhibitor 3-methyladenine (3-MA) attenuated the ischemic insults, inhibited the activation of autophagy, and elevated the expression of anti-apoptotic protein Bcl-2, to an extent comparable to IPOC. Conclusions/Significance: The present study suggests that inhibition of the autophagic pathway plays a key role in IPOC-induced neuroprotection against focal cerebral ischemia. Thus, pharmacological inhibition of autophagy may provide a novel therapeutic strategy for the treatment of stroke.	[Gao, Li; Jiang, Teng; Zhang, Yingdong] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Guo, Jun; Gu, Lize] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Liu, Yi; Su, Lingying] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Cui, Guiyun] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University	Zhang, YD (corresponding author), Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	zhangyingdong@yahoo.com.cn			Medical Science and Technology Development Foundation, Nanjing Department of Health [ZKX09036]	Medical Science and Technology Development Foundation, Nanjing Department of Health	This study was supported by Key Project of Medical Science and Technology Development Foundation, Nanjing Department of Health (NO. ZKX09036, http://www.njh.gov.cn/html/list_83.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Cui DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035324; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Ivanes F, 2011, ANTIOXID REDOX SIGN, V14, P811, DOI 10.1089/ars.2010.3354; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Krolikowski JG, 2006, CAN J ANAESTH, V53, P174, DOI 10.1007/BF03021824; Labrande C, 2006, NEUROSCIENCE, V137, P231, DOI 10.1016/j.neuroscience.2005.08.080; Lajoie C, 2009, CAN J PHYSIOL PHARM, V87, P460, DOI [10.1139/Y09-031, 10.1139/y09-031]; Leconte C, 2009, STROKE, V40, P3349, DOI 10.1161/STROKEAHA.109.557314; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Tian FF, 2010, AUTOPHAGY, V6, P1107, DOI 10.4161/auto.6.8.13427; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Victor ED, 2006, PATHOPHYSIOL, V13, P119; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; Wagner C, 2010, MOL CELL BIOCHEM, V339, P135, DOI 10.1007/s11010-009-0377-x; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	44	121	138	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46092	10.1371/journal.pone.0046092	http://dx.doi.org/10.1371/journal.pone.0046092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029398	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900088
J	Nicolau, I; Tian, LL; Menzies, D; Ostiguy, G; Pai, M				Nicolau, Ioana; Tian, Lulu; Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar			Point-of-Care Urine Tests for Smoking Status and Isoniazid Treatment Monitoring in Adult Patients	PLOS ONE			English	Article							ARKANSAS METHOD; DIPSTICK METHOD; ADHERENCE; TUBERCULOSIS; METAANALYSIS; COTININE; TOBACCO	Background: Poor adherence to isoniazid (INH) preventive therapy (IPT) is an impediment to effective control of latent tuberculosis (TB) infection. TB patients who smoke are at higher risk of latent TB infection, active disease, and TB mortality, and may have lower adherence to their TB medications. The objective of our study was to validate IsoScreen and SmokeScreen (GFC Diagnostics, UK), two point-of-care tests for monitoring INH intake and determining smoking status. The tests could be used together in the same individual to help identify patients with a high-risk profile and provide a tailored treatment plan that includes medication management, adherence interventions, and smoking cessation programs. Methodology/Principal Findings: 200 adult outpatients attending the TB and/or the smoking cessation clinic were recruited at the Montreal Chest Institute. Sensitivity and specificity were measured for each test against the corresponding composite reference standard. Test reliability was measured using kappa statistic for intra-rater and inter-rater agreement. Univariate and multivariate logistic regression models were used to explore possible covariates that might be related to false-positive and false-negative test results. IsoScreen had a sensitivity of 93.2% (95% confidence interval [CI] 80.3, 98.2) and specificity of 98.7% (94.8, 99.8). IsoScreen had intra-rater agreement (kappa) of 0.75 (0.48, 0.94) and inter-rater agreement of 0.61 (0.27, 0.90). SmokeScreen had a sensitivity of 69.2% (56.4, 79.8), specificity of 81.6% (73.0, 88.0), intra-rater agreement of 0.77 (0.56, 0.94), and inter-rater agreement of 0.66 (0.42, 0.88). False-positive SmokeScreen tests were strongly associated with INH treatment. Conclusions: IsoScreen had high validity and reliability, whereas SmokeScreen had modest validity and reliability. SmokeScreen tests did not perform well in a population receiving INH due to the association between INH treatment and false-positive SmokeScreen test results. Development of the next generation SmokeScreen assay should account for this potential interference.	[Nicolau, Ioana; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Tian, Lulu] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar] Montreal Chest Inst, Montreal, PQ, Canada	McGill University; Emory University; Rollins School Public Health; McGill University; McGill University	Pai, M (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research [MOP-89918]; European and Developing Countries Clinical Trials Partnership; CIHR; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European and Developing Countries Clinical Trials Partnership; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR grant MOP-89918) and the European and Developing Countries Clinical Trials Partnership (TB-NEAT grant). MP received a New Investigator Award from CIHR, and a salary award from Fonds de recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bernert JT, 2005, J ANAL TOXICOL, V29, P814, DOI 10.1093/jat/29.8.814; Chambers KL, 2001, BRIT J BIOMED SCI, V58, P61; Cope G, 1996, CLIN CHIM ACTA, V256, P135, DOI 10.1016/S0009-8981(96)06417-0; ELLARD GA, 1977, J CLIN PATHOL, V30, P84, DOI 10.1136/jcp.30.1.84; Fitzpatrick J, 1999, NICOMETER DETECTS NI; Gariti P, 2002, CANCER EPIDEM BIOMAR, V11, P1123; Guerra RL, 2010, RESP MED, V104, P754, DOI 10.1016/j.rmed.2010.02.001; Hanifa Y, 2007, INT J TUBERC LUNG D, V11, P1232; Hobbs SD, 2005, J VASC SURG, V41, P451, DOI 10.1016/j.jvs.2004.12.039; KILBURN JO, 1972, AM REV RESPIR DIS, V106, P923, DOI 10.1164/arrd.1972.106.6.923; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Meissner PE, 2002, INT J TUBERC LUNG D, V6, P903; Montalto NJ, 2007, CANCER EPIDEM BIOMAR, V16, P1858, DOI 10.1158/1055-9965.EPI-07-0189; Parker Donna R, 2002, Nicotine Tob Res, V4, P305, DOI 10.1080/14622200210142715; Payne CE, 2006, J PLAST RECONSTR AES, V59, P1156, DOI 10.1016/j.bjps.2005.12.053; Schmitz KE, 2010, CLIN NURS RES, V19, P131, DOI 10.1177/1054773810363473; SCHRAUFNAGEL DE, 1990, CHEST, V98, P314, DOI 10.1378/chest.98.2.314; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; StataCorp, 2021, STATA STAT SOFTWARE; Whitfield R, 2004, ANN CLIN BIOCHEM, V41, P411, DOI 10.1258/0004563041731637; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2008, WHO REP GLOB TOB EP	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45913	10.1371/journal.pone.0045913	http://dx.doi.org/10.1371/journal.pone.0045913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029310	Green Published, gold			2022-12-27	WOS:000309973900064
J	Soh, PN; Witkowski, B; Gales, A; Huyghe, E; Berry, A; Pipy, B; Benoit-Vical, F				Soh, Patrice Njomnang; Witkowski, Benoit; Gales, Amandine; Huyghe, Eric; Berry, Antoine; Pipy, Bernard; Benoit-Vical, Francoise			Implication of Glutathione in the In Vitro Antiplasmodial Mechanism of Action of Ellagic Acid	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTION; MALARIA; CHLOROQUINE; IDENTIFICATION; POTENTIATION; ANTIOXIDANT; EXTRACTS; DRUGS	The search for new antimalarial chemotherapy has become increasingly urgent due to parasite resistance to current drugs. Ellagic acid (EA) is a polyphenol, recently found in various plant products, that has effective antimalarial activity in vitro and in vivo without toxicity. To further understand the antimalarial mechanism of action of EA in vitro, we evaluated the effects of EA, ascorbic acid and N-acetyl-L-cysteine (NAC), alone and/or in combination on the production of reactive oxygen species (ROS) during the trophozoite and schizonte stages of the erythrocytic cycle of P. falciparum. The parasitized erythrocytes were pre-labelled with DCFDA (dichlorofluorescein diacetate). We showed that NAC had no effect on ROS production, contrary to ascorbic acid and EA, which considerably reduced ROS production. Surprisingly, EA reduced the production of the ROS with concentrations (6.6 x 10(-9) - 6.6x10(-6) M) ten-fold lower than ascorbic acid (113x10(-6) M). Additionally, the in vitro drug sensitivity of EA with antioxidants showed that antiplasmodial activity is independent of the ROS production inside parasites, which was confirmed by the additive activity of EA and desferrioxamine. Finally, EA could act by reducing the glutathione content inside the Plasmodium parasite. This was consolidated by the decrease in the antiplasmodial efficacy of EA in the murine model Plasmodium yoelii-high GSH strain, known for its high glutathione content. Given its low toxicity and now known mechanism of action, EA appears as a promising antiplasmodial compound.	[Soh, Patrice Njomnang; Witkowski, Benoit; Benoit-Vical, Francoise] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Benoit-Vical, Francoise] Univ Toulouse 3, UPS, INPT, LCC, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Berry, Antoine; Benoit-Vical, Francoise] Univ Toulouse 3, Ctr Hosp Univ Toulouse, Serv Parasitol Mycol, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Berry, Antoine; Benoit-Vical, Francoise] Univ Toulouse 3, Fac Med Rangueil, F-31062 Toulouse, France; [Gales, Amandine; Berry, Antoine; Pipy, Bernard] Univ Toulouse 3, UMR IRD UPS 152, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Huyghe, Eric] Ctr Hosp Univ Toulouse, Dept Urol & Androl, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Soh, PN (corresponding author), CNRS, Chim Coordinat Lab, 205 Route Narbonne, F-31077 Toulouse, France.	sohnjomnang@yahoo.fr	Galès, Amandine/M-9066-2014; Benoit-Vical, Francoise/E-3938-2016; Witkowski, Benoit/T-1118-2019; Berry, Antoine/J-9352-2014	Benoit-Vical, Francoise/0000-0002-9468-4823; Berry, Antoine/0000-0002-6626-7766; Pipy, Bernard/0000-0001-8060-7029; Huyghe, Eric/0000-0001-9445-4385	French National Research Agency (ANR) [ANR-06-RIB-020]	French National Research Agency (ANR)(French National Research Agency (ANR))	The French National Research Agency (ANR) is acknowledged for financial support (ANR-06-RIB-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banzouzi JT, 2002, J ETHNOPHARMACOL, V81, P399, DOI 10.1016/S0378-8741(02)00121-6; Benoit-Vical F, 2005, IDRUGS, V8, P45; Benoit-Vical F, 2000, ANTIMICROB AGENTS CH, V44, P2836, DOI 10.1128/AAC.44.10.2836-2841.2000; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; Fu Y, 2010, CYTOM PART A, V77A, P253, DOI 10.1002/cyto.a.20856; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Hayeshi R, 2007, FOOD CHEM TOXICOL, V45, P286, DOI 10.1016/j.fct.2006.07.027; KATO M, 1987, J PARASITOL, V73, P1058, DOI 10.2307/3282537; Labieniec M, 2006, CELL BIOL INT, V30, P761, DOI 10.1016/j.cellbi.2006.05.013; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Mohamed AF, 2005, MED SCI MONITOR, V11, pBR426; Pradines B, 1996, ANTIMICROB AGENTS CH, V40, P2094, DOI 10.1128/AAC.40.9.2094; Reddy MK, 2007, PLANTA MED, V73, P461, DOI 10.1055/s-2007-967167; Soh PN, 2009, ANTIMICROB AGENTS CH, V53, P1100, DOI 10.1128/AAC.01175-08; Srivastava P, 1999, TROP MED INT HEALTH, V4, P251, DOI 10.1046/j.1365-3156.1999.00387.x; Sturm N, 2009, ANTIMICROB AGENTS CH, V53, P622, DOI 10.1128/AAC.00544-08; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Verotta L, 2001, J NAT PROD, V64, P603, DOI 10.1021/np000306j; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P135; Witkowski B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032620; World Health Organization, 2010, WORLD MAL REP 2010	26	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45906	10.1371/journal.pone.0045906	http://dx.doi.org/10.1371/journal.pone.0045906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029306	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900062
J	Traven, A; Janicke, A; Harrison, P; Swaminathan, A; Seemann, T; Beilharz, TH				Traven, Ana; Jaenicke, Amrei; Harrison, Paul; Swaminathan, Angavai; Seemann, Torsten; Beilharz, Traude H.			Transcriptional Profiling of a Yeast Colony Provides New Insight into the Heterogeneity of Multicellular Fungal Communities	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANDIDA-ALBICANS BIOFILMS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID HOMEOSTASIS; BIDIRECTIONAL PROMOTERS; CATABOLITE DEGRADATION; DRUG-RESISTANCE; RNA; MITOCHONDRIA	Understanding multicellular fungal structures is important for designing better strategies against human fungal pathogens. For example, the ability to form multicellular biofilms is a key virulence property of the yeast Candida albicans. C. albicans biofilms form on indwelling medical devices and are drug resistant, causing serious infections in hospital settings. Multicellular fungal communities are heterogeneous, consisting of cells experiencing different environments. Heterogeneity is likely important for the phenotypic characteristics of communities, yet it is poorly understood. Here we used colonies of the yeast Saccharomyces cerevisiae as a model fungal multicellular structure. We fractionated the outside colony layers from the cells in the center by FACS, using a Cit1-GFP marker expressed exclusively on the outside. Transcriptomics analysis of the two subpopulations revealed that the outside colony layers are actively growing by fermentative metabolism, while the cells residing on the inside are in a resting state and experience changes to mitochondrial activity. Our data shows several parallels with C. albicans biofilms providing insight into the contributions of heterogeneity to biofilm phenotypes. Hallmarks of C. albicans biofilms - the expression of ribosome and translation functions and activation of glycolysis and ergosterol biosynthesis occur on the outside of colonies, while expression of genes associates with sulfur assimilation is observed in the colony center. Cell wall restructuring occurs in biofilms, and cell wall functions are enriched in both fractions: the outside cells display enrichment of cell wall biosynthesis enzymes and cell wall proteins, while the inside cells express cell wall degrading enzymes. Our study also suggests that noncoding transcription and posttranscriptional mRNA regulation play important roles during growth of yeast in colonies, setting the scene for investigating these pathways in the development of multicellular fungal communities.	[Traven, Ana; Jaenicke, Amrei; Swaminathan, Angavai; Beilharz, Traude H.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Harrison, Paul; Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia	Monash University; Monash University	Traven, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	ana.traven@monash.edu; traude.beilharz@monash.edu	Traven, Ana/H-8174-2017; Beilharz, Traude/O-5457-2019; Harrison, Paul/V-6978-2019; Beilharz, Traude/I-1438-2014; Seemann, Torsten/B-2318-2010	Traven, Ana/0000-0001-6252-3104; Beilharz, Traude/0000-0002-8942-9502; Harrison, Paul/0000-0002-3980-268X; Beilharz, Traude/0000-0002-8942-9502; Seemann, Torsten/0000-0001-6046-610X	Monash University funds	Monash University funds	This work was funded by Monash University funds. T. H. B. is an Australian Research Council fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batova M, 2008, CURR GENET, V53, P313, DOI 10.1007/s00294-008-0187-9; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Cap M, 2012, MOL CELL, V46, P436, DOI 10.1016/j.molcel.2012.04.001; Chang YW, 2001, GENETICS, V157, P17; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Khot PD, 2006, ANTIMICROB AGENTS CH, V50, P3708, DOI 10.1128/AAC.00997-06; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Minarikova L, 2001, EXP CELL RES, V271, P296, DOI 10.1006/excr.2001.5379; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Puig S, 2000, YEAST, V16, P139, DOI 10.1002/(SICI)1097-0061(20000130)16:2<139::AID-YEA512>3.3.CO;2-A; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Singh-Babak SD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002718; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Vachova L, 2004, J BIOL CHEM, V279, P37973, DOI 10.1074/jbc.M404594200; Vachova L, 2009, ENVIRON MICROBIOL, V11, P1866, DOI 10.1111/j.1462-2920.2009.01911.x; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808	46	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46243	10.1371/journal.pone.0046243	http://dx.doi.org/10.1371/journal.pone.0046243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029448	Green Published, gold			2022-12-27	WOS:000309973900116
J	Dambach, J; Thatje, S; Rodder, D; Basher, Z; Raupach, MJ				Dambach, Johannes; Thatje, Sven; Roedder, Dennis; Basher, Zeenatul; Raupach, Michael J.			Effects of Late-Cenozoic Glaciation on Habitat Availability in Antarctic Benthic Shrimps (Crustacea: Decapoda: Caridea)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EASTERN WEDDELL SEA; SOUTHERN-OCEAN; CHORISMUS ANTARCTICUS; CLIMATE-CHANGE; POLAR FRONT; ICE; TEMPERATURE; DISPERSAL; MAXIMUM	Marine invertebrates inhabiting the high Antarctic continental shelves are challenged by disturbance of the seafloor by grounded ice, low but stable water temperatures and variable food availability in response to seasonal sea-ice cover. Though a high diversity of life has successfully adapted to such conditions, it is generally agreed that during the Last Glacial Maximum (LGM) the large-scale cover of the Southern Ocean by multi-annual sea ice and the advance of the continental ice sheets across the shelf faced life with conditions, exceeding those seen today by an order of magnitude. Conditions prevailing at the LGM may have therefore acted as a bottleneck event to both the ecology as well as genetic diversity of today's fauna. Here, we use for the first time specific Species Distribution Models (SDMs) for marine arthropods of the Southern Ocean to assess effects of habitat contraction during the LGM on the three most common benthic caridean shrimp species that exhibit a strong depth zonation on the Antarctic continental shelf. While the shallow-water species Chorismus antarcticus and Notocrangon antarcticus were limited to a drastically reduced habitat during the LGM, the deep-water shrimp Nematocarcinus lanceopes found refuge in the Southern Ocean deep sea. The modeling results are in accordance with genetic diversity patterns available for C. antarcticus and N. lanceopes and support the hypothesis that habitat contraction at the LGM resulted in a loss of genetic diversity in shallow water benthos.	[Dambach, Johannes; Roedder, Dennis] Zool Forschungsmuseum Alexander Koenig, Bonn, Germany; [Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Basher, Zeenatul] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; [Raupach, Michael J.] Deutsch Zentrum Marine Biodiversitatsforsch, Wilhelmshaven, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); NERC National Oceanography Centre; University of Southampton; University of Auckland	Dambach, J (corresponding author), Zool Forschungsmuseum Alexander Koenig, Bonn, Germany.	j.dambach.zfmk@uni-bonn.de	Raupach, Michael J./AAF-7566-2020; Rödder, Dennis/AAT-8644-2021; Raupach, Michael/G-7072-2012	Raupach, Michael J./0000-0001-8299-6697; Rödder, Dennis/0000-0002-6108-1639; Basher, Zeenatul/0000-0002-6439-8324	German Research Foundation (DFG) [RA-1688-2]; New Zealand Government	German Research Foundation (DFG)(German Research Foundation (DFG)); New Zealand Government	This study was funded by the German Research Foundation (DFG, RA-1688-2). The Ross Sea specimens data collected by the cruise TAN0802 (IPY-CAML Voyage), made available through the New Zealand International Polar Year-Census of Antarctic Marine Life Project (Phase 1: So001IPY; Phase 2: IPY2007-01) was funded by the New Zealand Government. The authors gratefully acknowledge project governance by the Ministry of Fisheries Science Team and the Ocean Survey 20/20 CAML Advisory Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Ainley DG, 2012, POLAR BIOL, P1; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Arntz WE, 2006, POLAR BIOL, V29, P83, DOI 10.1007/s00300-005-0047-8; ARNTZ WE, 1991, POLAR BIOL, V11, P169; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; BARNARD K. H., 1950, ANN S AFRICAN MUS, V38, P1; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; BATE CS, 1888, ZOOLOGY, V24, P1, DOI DOI 10.5962/BHL.TITLE.6513; Bauer RT., 2004, REMARKABLE SHRIMPS A; Bigg GR, 2008, P ROY SOC B-BIOL SCI, V275, P163, DOI 10.1098/rspb.2007.1153; Bluhm BA, 2002, CRUSTACEANA, V75, P61, DOI 10.1163/156854002317373528; Bluhm BA, 2001, MAR BIOL, V138, P247, DOI 10.1007/s002270000458; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; BOWMAN AW, 2005, SM SMOOTHING METHODS; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; BUSBY J R, 1991, Plant Protection Quarterly, V6, P8; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WWL, 2008, 163 U BRIT COL FISH, V16; CLARKE A, 1982, INT J INVER REP DEV, V5, P71; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; CLARKE A, 1979, MAR BIOL, V55, P111, DOI 10.1007/BF00397306; CLARKE A, 1993, J EXP MAR BIOL ECOL, V168, P189, DOI 10.1016/0022-0981(93)90259-Q; CLARKE A, 1977, J EXP MAR BIOL ECOL, V27, P93, DOI 10.1016/0022-0981(77)90056-9; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; DITTRICH B, 1990, NATURWISSENSCHAFTEN, V77, P491, DOI 10.1007/BF01135930; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fraser CI, 2012, TRENDS ECOL EVOL, V1543, P10; Gaines SD, 2003, ECOL APPL, V13, pS32; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Gorny M, 1999, SCI MAR, V63, P367, DOI 10.3989/scimar.1999.63s1367; GORNY M, 1992, POLAR BIOL, V12, P111; Gorny M, 1997, POLAR BIOL, V17, P191, DOI 10.1007/s003000050122; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; GUTT J, 1991, ANTARCT SCI, V3, P363, DOI 10.1017/S0954102091000469; Gutt J, 2012, POLAR RES IN PRESS; Guzmán Guillermo, 2005, Gayana (Concepc.), V69, P285; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; KIRKWOOD JM, 1984, ANARE RES NOTES, V11, P1; Komai T, 1996, DEEP SEA SHRIMP CRUS, P179; Lardies MA, 2011, POLAR BIOL, V34, P707, DOI 10.1007/s00300-010-0926-5; Ledoyer M., 1989, Mesogee, V49, P67; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lovrich GA, 2005, SCI MAR, V69, P183, DOI 10.3989/scimar.2005.69s2183; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; Lumpkin R, 2005, J ATMOS OCEAN TECH, V22, P1403, DOI 10.1175/JTECH1793.1; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mascetti P, 1997, POLAR BIOL, V17, P384, DOI 10.1007/PL00013380; Maxwell J.G.H., 1985, P397; Page TJ, 2002, POLAR BIOL, V25, P818, DOI 10.1007/s00300-002-0414-7; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; Pfeffer G, 1886, JB HAMBURGISCHEN WIS, V4, P44; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POSSINGHAM HP, 1990, ECOLOGY, V71, P973, DOI 10.2307/1937366; Praca E, 2008, OCEAN SCI, V4, P49, DOI 10.5194/os-4-49-2008; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; Raupach MJ, 2006, POLAR BIOL, V29, P439, DOI 10.1007/s00300-005-0069-2; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Smith WO, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004251; Storch V, 2001, POLAR BIOL, V24, P604, DOI 10.1007/s003000100261; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Team R, 2010, R LANG ENV STAT COMP; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2005, POLAR BIOL, V28, P290, DOI 10.1007/s00300-004-0687-0; Thatje S, 2004, POLAR BIOL, V27, P195, DOI 10.1007/s00300-003-0583-z; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; TIEFENBACHER L, 1990, Spixiana, V13, P117; TIEFENBACHER L, 1990, Spixiana, V13, P229; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Wittmann A, 2010, POLAR BIOL, V33, P919, DOI 10.1007/s00300-010-0768-1; Yaldwyn J. C., 1965, Monographiae Biologicae, V15, P324; Zarenkov N.A., 1968, BIOL REP SOV ANTARCT, V4, P153	103	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46283	10.1371/journal.pone.0046283	http://dx.doi.org/10.1371/journal.pone.0046283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029463	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000309517500083
J	Fisher, DJ; Fernandez, RE; Adams, NE; Maurelli, AT				Fisher, Derek J.; Fernandez, Reinaldo E.; Adams, Nancy E.; Maurelli, Anthony T.			Uptake of Biotin by Chlamydia Spp. through the Use of a Bacterial Transporter (BioY) and a Host-Cell Transporter (SMVT)	PLOS ONE			English	Article							TRACHOMATIS SEROVAR L2; CHLAMYDOPHILA-ABORTUS; DEVELOPMENTAL CYCLE; MEMBRANE-PROTEINS; PROTEOME ANALYSIS; NICHE ADAPTATION; GENOME SEQUENCE; III SECRETION; COLI; LIGASE	Chlamydia spp. are obligate intracellular Gram-negative bacterial pathogens that cause disease in humans and animals. Minor variations in metabolic capacity between species have been causally linked to host and tissue tropisms. Analysis of the highly conserved genomes of Chlamydia spp. reveals divergence in the metabolism of the essential vitamin biotin with genes for either synthesis (bioF_2ADB) and/or transport (bioY). Streptavidin blotting confirmed the presence of a single biotinylated protein in Chlamydia. As a first step in unraveling the need for divergent biotin acquisition strategies, we examined BioY (CTL0613) from C. trachomatis 434/Bu which is annotated as an S component of the type II energy coupling-factor transporters (ECF). Type II ECFs are typically composed of a transport specific component (S) and a chromosomally unlinked energy module (AT). Intriguingly, Chlamydia lack recognizable AT modules. Using H-3-biotin and recombinant E. coli expressing CTL0613, we demonstrated that biotin was transported with high affinity (a property of Type II ECFs previously shown to require an AT module) and capacity (apparent K(m) of 3.35 nM and V(max) of 55.1 pmol x min(-1) x mg(-1)). Since Chlamydia reside in a host derived membrane vacuole, termed an inclusion, we also sought a mechanism for transport of biotin from the cell cytoplasm into the inclusion vacuole. Immunofluorescence microscopy revealed that the mammalian sodium multivitamin transporter (SMVT), which transports lipoic acid, biotin, and pantothenic acid into cells, localizes to the inclusion. Since Chlamydia also are auxotrophic for lipoic and pantothenic acids, SMVT may be subverted by Chlamydia to move multiple essential compounds into the inclusion where BioY and another transporter(s) would be present to facilitate transport into the bacterium. Collectively, our data validates the first BioY from a pathogenic organism and describes a two-step mechanism by which Chlamydia transport biotin from the host cell into the bacterial cytoplasm.	[Fernandez, Reinaldo E.; Adams, Nancy E.; Maurelli, Anthony T.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Fisher, Derek J.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Uniformed Services University of the Health Sciences - USA; Southern Illinois University System; Southern Illinois University	Maurelli, AT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.	anthony.maurelli@usuhs.edu		Maurelli, Anthony/0000-0002-4788-6166; Adams, Nancy/0000-0002-0781-0896; Fisher, Derek/0000-0002-1663-8389	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI044033, F32 AI078655-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI078655, R01AI044033] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI044033 (ATM) and F32 AI078655-01 (DJF) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Baneke A, 2012, TRAVEL MED INFECT DI; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; Berntsson RP, 2012, P NATL ACAD SCI US; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; DAKSHINAMURTI K, 1963, J BIOL CHEM, V238, P294; Delli-Bovi TA, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-73; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Elwell CA, 2012, CELL MICROBIOL; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Entcheva P, 2002, APPL ENVIRON MICROB, V68, P2843, DOI 10.1128/AEM.68.6.2843-2848.2002; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Giles TN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-166; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Guillen-Navarro K, 2005, FEMS MICROBIOL LETT, V250, P209, DOI 10.1016/j.femsle.2005.07.020; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; McClarty G, 2007, CURR OPIN MICROBIOL, V10, P47, DOI 10.1016/j.mib.2006.12.003; McCoy AJ, 2005, MOL MICROBIOL, V57, P41, DOI 10.1111/j.1365-2958.2005.04661.x; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1411; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Mock DM, 2005, J NUTR BIOCHEM, V16, P435, DOI 10.1016/j.jnutbio.2005.03.022; Neubauer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029087; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; PRAKASH O, 1974, J BACTERIOL, V120, P785, DOI 10.1128/JB.120.2.785-791.1974; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Purushothaman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016850; Ramaswamy AV, 2010, J BACTERIOL, V192, P6172, DOI 10.1128/JB.00717-10; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Said Hamid M, 2012, Subcell Biochem, V56, P1, DOI 10.1007/978-94-007-2199-9_1; Said HM, 1998, AM J PHYSIOL-CELL PH, V275, pC1365, DOI 10.1152/ajpcell.1998.275.5.C1365; Sait M, 2011, J BACTERIOL, V193, P4276, DOI 10.1128/JB.05290-11; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schneider J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-6; Shaw AC, 2002, PROTEOMICS, V2, P164, DOI 10.1002/1615-9861(200202)2:2<164::AID-PROT164>3.0.CO;2-U; Soriano A, 2006, ANAL BIOCHEM, V349, P268, DOI 10.1016/j.ab.2005.10.044; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Sullivan JT, 2001, MICROBIOL-SGM, V147, P1315, DOI 10.1099/00221287-147-5-1315; Taniguchi Ayumi, 2008, Congenital Anomalies, V48, P57, DOI 10.1111/j.1741-4520.2008.00179.x; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vandahl BB, 2002, METHOD ENZYMOL, V358, P277; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; WALLER JR, 1965, J BACTERIOL, V90, P853, DOI 10.1128/JB.90.4.853-856.1965; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724; Zempleni Janos, 2008, Expert Rev Endocrinol Metab, V3, P715, DOI 10.1586/17446651.3.6.715; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	76	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46052	10.1371/journal.pone.0046052	http://dx.doi.org/10.1371/journal.pone.0046052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029384	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500059
J	Ai, D; Desjardins-Proulx, P; Chu, CJ; Wang, G				Ai, Dexiecuo; Desjardins-Proulx, Philippe; Chu, Chengjin; Wang, Gang			Immigration, Local Dispersal Limitation, and the Repeatability of Community Composition under Neutral and Niche Dynamics	PLOS ONE			English	Article							BETA-DIVERSITY; SPECIES POOL; COMPETITION; ABUNDANCE; PATTERNS; INVASION; MODEL; PREDICTABILITY; DISSIMILARITY; CONSEQUENCES	Repeatability of community composition has been a critical aspect for community structure, which is closely associated with community stability, predictability, conservation biology and ecological restoration. It has been shown that both immigration and local dispersal limitation can affect the community composition in both neutral and niche model. Hence, we use a spatially explicit individual-based model to investigate the potential influence of immigration rate and strength of local dispersal limitation on repeatability in both neutral and niche models. Similarity measures are used to quantify repeatability. We examine the repeatability of community composition among replicate communities (which means the same community repeats many times), and between niche and neutral replicate communities. We find the correlation between repeatability and immigration rate is positive in the neutral model and an inverted unimodal in the niche model. The correlation between repeatability and local dispersal distance is positive in the niche model and negative in the neutral model. High repeatability between niche communities and neutral communities is observed with high immigration rates or when high local dispersal distance appears in the niche model or low local dispersal distance in the neutral model. Our results show that repeatability of community composition is not only dependent on the types of community models (niche vs. neutrality) but also strongly determined by immigration rates and local dispersal limitation.	[Ai, Dexiecuo; Chu, Chengjin; Wang, Gang] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Desjardins-Proulx, Philippe] Univ Quebec Rimouski, Theoret Ecosyst Ecol Lab, Rimouski, PQ, Canada; [Desjardins-Proulx, Philippe] McGill Univ, Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Desjardins-Proulx, Philippe] Univ Illinois, Coll Engn, Chicago, IL USA	Lanzhou University; University of Quebec; Universite du Quebec a Rimouski; McGill University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, G (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	wgmg36@lzu.edu.cn	Chu, Chu/T-6038-2019	Chu, Chengjin/0000-0002-0606-449X	National Natural Science Foundation of China [30970465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 30970465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Brudvig LA, 2008, RESTOR ECOL, V16, P290, DOI 10.1111/j.1526-100X.2007.00317.x; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Davies KF, 2001, ECOLOGY, V82, P1830, DOI 10.1890/0012-9658(2001)082[1830:EOWABP]2.0.CO;2; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez MT, 2005, INT J PARASITOL, V35, P1369, DOI 10.1016/j.ijpara.2005.07.016; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Holyoak M, 2006, ECOLOGY, V87, P1370, DOI 10.1890/0012-9658(2006)87[1370:REEWNC]2.0.CO;2; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; Irigoien X, 2011, J PLANKTON RES, V0, P1; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Laird RA, 2008, ECOLOGY, V89, P237, DOI 10.1890/07-0117.1; LAWTON JH, 1989, J ANIM ECOL, V58, P1021, DOI 10.2307/5139; Lechowicz M.J., 2001, INTEGRATING ECOLOGY, P117; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; PARRISH JAD, 1976, ECOLOGY, V57, P1281, DOI 10.2307/1935052; Poulin R, 2002, INT J PARASITOL, V32, P1235, DOI 10.1016/S0020-7519(02)00109-1; R Core Team, 2020, R LANG ENV STAT COMP; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; SHARIK TL, 1989, AM MIDL NAT, V122, P133, DOI 10.2307/2425690; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Volkov I, 2004, NATURE, V427, P696, DOI 10.1038/427696a; Zhou SR, 2008, ECOLOGY, V89, P248, DOI 10.1890/06-1817.1; Zobel M, 1998, APPL VEG SCI, V1, P55, DOI 10.2307/1479085	56	14	14	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46164	10.1371/journal.pone.0046164	http://dx.doi.org/10.1371/journal.pone.0046164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029424	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700118
J	Tucha, L; Aschenbrenner, S; Koerts, J; Lange, KW				Tucha, Lara; Aschenbrenner, Steffen; Koerts, Janneke; Lange, Klaus W.			The Five-Point Test: Reliability, Validity and Normative Data for Children and Adults	PLOS ONE			English	Article							FIGURAL FLUENCY; EXECUTIVE FUNCTIONS; VERBAL FLUENCY; NEUROPSYCHOLOGICAL TESTS; INTERRATER RELIABILITY; COGNITIVE DEFICITS; AGE; PERFORMANCE	The present study provides normative data from a sample of 257 healthy children and 608 adults on a modified version of the Five-Point Test (5PT). The 5PT is a structured and standardized test measuring figural fluency functions. Interrater reliability, test-retest-reliability and construct validity of this measure were analyzed. The sensitivity of the task for cognitive disturbances of patients with neurological diseases was proven by analyzing the test performance in the 5PT of patients with Parkinson's disease. Finally, normative data stratified by age and corrected for education level is provided. The results of the present study confirm the value of the 5PT in the measurement of figural fluency functions in clinical examination and neuropsychological research.	[Tucha, Lara; Koerts, Janneke] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Aschenbrenner, Steffen] Univ Heidelberg Hosp, Dept Psychosomat & Gen Internal Med, Ctr Psychosocial Med, Heidelberg, Germany; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, Regensburg, Germany	University of Groningen; Ruprecht Karls University Heidelberg; University of Regensburg	Tucha, L (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	l.i.tucha@rug.nl						Albert D, 2010, CHILD NEUROPSYCHOL, V16, P32, DOI 10.1080/09297040903049061; Beblo T, 2006, PSYCHIAT RES, V145, P127, DOI 10.1016/j.psychres.2006.01.017; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; Brummelman P, 2011, CLIN ENDOCRINOL, V74, P481, DOI 10.1111/j.1365-2265.2010.03947.x; Carter SL, 1998, CLIN NEUROPSYCHOL, V12, P531, DOI 10.1076/clin.12.4.531.7239; Cattelani R, 2011, NEUROL SCI, V32, P595, DOI 10.1007/s10072-011-0489-4; Chan T. T., 2005, P 27 ANN C COGN SCI, P412, DOI DOI 10.1038/NATURE09144; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; DESROSIERS G, 1987, INT J CLIN NEUROPSYC, V9, P162; EVANS RW, 1985, PERCEPT MOTOR SKILL, V61, P699, DOI 10.2466/pms.1985.61.3.699; Fenger MM, 2005, NORD J PSYCHIAT, V59, P39, DOI 10.1080/08039480510018814; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gelziniene G, 2011, MEDICINA-LITHUANIA, V47, P313, DOI 10.3390/medicina47060044; Goebel S, 2009, CLIN NEUROPSYCHOL, V23, P675, DOI 10.1080/13854040802389185; Hanks RA, 1996, ASSESSMENT, V3, P459; Hart RP, 2006, AGING NEUROPSYCHOL C, V13, P281, DOI 10.1080/13825580490904246; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027415; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; JOANETTE Y, 1988, BRAIN LANG, V34, P54, DOI 10.1016/0093-934X(88)90124-1; Fernandez-Serrano MJ, 2010, EUR J PHARMACOL, V626, P104, DOI 10.1016/j.ejphar.2009.10.019; Khalil MS, 2010, J CLIN EXP NEUROPSYC, V32, P1028, DOI 10.1080/13803391003672305; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; LINDENBERGER U, 1995, Z PSYCHOL, V203, P283; Lord F. M., 1968, STAT THEORIES MENTAL; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Mitrushina MN, 1999, HDB NORMATIVE DATA N, DOI DOI 10.1016/S1474-4422(06)70630-5; Mondal S, 2007, Indian J Physiol Pharmacol, V51, P69; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ruff R. M., 1988, RUFF FIGURAL FLUENCY; RUFF RM, 1994, ARCH CLIN NEUROPSYCH, V9, P41, DOI 10.1016/0887-6177(94)90013-2; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Tucha O, 1999, J CLIN EXP NEUROPSYC, V21, P229, DOI 10.1076/jcen.21.2.229.928; Tucha O, 2003, J NEUROSURG, V98, P21, DOI 10.3171/jns.2003.98.1.0021; Tucha Oliver, 2005, Cogn Neuropsychiatry, V10, P231, DOI 10.1080/13546800444000047; VIK P, 1988, DEV NEUROPSYCHOL, V4, P63, DOI 10.1080/87565648809540391; Wechsler D, 1987, WMS R WECHSLER MEMOR; WIEDERHOLT WC, 1993, J AM GERIATR SOC, V41, P639, DOI 10.1111/j.1532-5415.1993.tb06738.x; Woodard JL, 1992, NEUROPSYCHOLOGY, V6, P173, DOI DOI 10.1037/0894-4105.6.2.173	56	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46080	10.1371/journal.pone.0046080	http://dx.doi.org/10.1371/journal.pone.0046080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029395	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700113
J	Mamik, MK; Ghorpade, A				Mamik, Manmeet K.; Ghorpade, Anuja			Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase (SHP) 2 and p38 Regulate the Expression of Chemokine CXCL8 in Human Astrocytes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EPIDERMAL-GROWTH-FACTOR; INTERLEUKIN-8 SECRETION; SIGNALING MECHANISMS; TISSUE INHIBITOR; GENE-EXPRESSION; MAP KINASE; KAPPA-B; ACTIVATION; BRAIN	CXCL8, one of the first chemokines found in the brain, is upregulated in the brains and cerebrospinal fluid of HIV-1 infected individuals suggesting its potential role in human immune deficiency virus (HIV)-associated neuroinflammation. Astrocytes are known to be the major contributors to the CXCL8 pool. Interleukin (IL)-1 beta activated astrocytes exhibit significant upregulation of CXCL8. In order to determine the signaling pathways involved in CXCL8 regulation in astrocytes, we employed pharmacological inhibitors for non-receptor Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and mitogen-activated protein kinases (MAPK) pathway and observed reduced expression of CXCL8 following IL-1 beta stimulation. Overexpression of SHP2 and p38 enzymes in astrocytes led to elevated CXCL8 expression; however, inactivating SHP2 and p38 with dominant negative mutants abrogated CXCL8 induction. Furthermore, SHP2 overexpression resulted in higher SHP2 and p38 enzyme activity whereas p38 overexpression resulted in higher p38 but not SHP2 enzyme activity. Phosphorylation of SHP2 was important for phosphorylation of p38, which in turn was critical for phosphorylation of extracellular signal regulated kinase (ERK). Thus, our findings suggest an important role for SHP2 in CXCL8 expression in astrocytes during inflammation, as SHP2, directly or indirectly, modulates p38 and ERK MAPK in the signaling cascade leading to CXCL8 production. This study provides detailed understanding of the mechanisms involved in CXCL8 production during neuroinflammation.	[Mamik, Manmeet K.; Ghorpade, Anuja] Univ N Texas Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Ghorpade, A (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX 76107 USA.	anuja.ghorpade@unthsc.edu	Mamik, Manmeet/E-2534-2016	Mamik, Manmeet/0000-0002-7212-5430	NIMH [R01MH087345]; JES Edwards Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087345, U01MH083545] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JES Edwards Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by R01MH087345 from NIMH to A. Ghorpade and the JES Edwards Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95; ALOISI F, 1992, J IMMUNOL, V149, P2358; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Ashutosh, 2011, BIOCHEM BIOPH RES CO, V412, P565, DOI 10.1016/j.bbrc.2011.07.127; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Banerjee S, 2008, J NEUROIMMUNE PHARM, V3, P154, DOI 10.1007/s11481-008-9105-7; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Carrol ED, 2007, JAIDS-J ACQ IMM DEF, V44, P443, DOI 10.1097/QAI.0b013e31802f8390; Chadderton T, 1997, CELL MOL BIOL, V43, P1227; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Cota M, 2000, J NEUROVIROL, V6, P75, DOI 10.3109/13550280009006384; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; D'Aversa TG, 2008, J NEUROSCI RES, V86, P630, DOI 10.1002/jnr.21525; Depino A, 2005, J NEUROIMMUNOL, V168, P96, DOI 10.1016/j.jneuroim.2005.07.009; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dunn SL, 2002, GLIA, V37, P31, DOI 10.1002/glia.10010; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hoffmann KF, 2002, ADV PARASIT, V52, P265, DOI 10.1016/S0065-308X(02)52014-5; Jehs T, 2011, APMIS, V119, P551, DOI 10.1111/j.1600-0463.2011.02773.x; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kostulas N, 1998, STROKE, V29, P462, DOI 10.1161/01.STR.29.2.462; Kou W, 2009, J NEUROSCI RES, V87, P2326, DOI 10.1002/jnr.22060; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Liu J, 1996, J IMMUNOL, V157, P3569; Lu W, 2005, DEV BRAIN RES, V155, P127, DOI 10.1016/j.devbrainres.2005.01.004; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Mamik MK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-145; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Robins S, 2011, AM J RESP CELL MOL, V45, P984, DOI 10.1165/rcmb.2010-0450OC; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Subileau EA, 2009, J NEUROPATH EXP NEUR, V68, P227, DOI 10.1097/NEN.0b013e318197eca7; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Tichauer J, 2007, NEUROIMMUNOMODULAT, V14, P168, DOI 10.1159/000110642; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; Wu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004914; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xiong HG, 2003, J NEUROSCI RES, V71, P600, DOI 10.1002/jnr.10503; Yang CS, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-27; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015	57	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45596	10.1371/journal.pone.0045596	http://dx.doi.org/10.1371/journal.pone.0045596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029125	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800064
J	Quadt, KA; Barfod, L; Andersen, D; Bruun, J; Gyan, B; Hassenkam, T; Ofori, MF; Hviid, L				Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Gyan, Ben; Hassenkam, Tue; Ofori, Michael F.; Hviid, Lars			The Density of Knobs on Plasmodium falciparum-Infected Erythrocytes Depends on Developmental Age and Varies among Isolates	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; ATOMIC-FORCE MICROSCOPE; FAMILY EXPRESSION; VARIANT ANTIGENS; KNOBLESS CLONE; FINE-STRUCTURE; CELL-LINE; SURFACE; CYTOADHERENCE; BLOOD	Background: The virulence of Plasmodium falciparum malaria is related to the parasite's ability to evade host immunity through clonal antigenic variation and tissue-specific adhesion of infected erythrocytes (IEs). The P. falciparum erythrocyte membrane protein 1 (PfEMP1) family expressed on dome-shaped protrusions called knobs on the IE surface is central to both. Differences in receptor specificity and affinity of expressed PfEMP1 are important for IE adhesiveness, but it is not known whether differences in the number and size of the knobs on which the PfEMP1 proteins are expressed also play a role. Therefore, the aim of this study was to provide detailed information on isolate-and time-dependent differences in knob size and density. Methodology/Principal Findings: We used atomic force microscopy to characterize knobs on the surface of P. falciparum-infected erythrocytes. Fourteen ex vivo isolates from Ghanaian children with malaria and 10 P. falciparum isolates selected in vitro for expression of a particular PfEMP1 protein (VAR2CSA) were examined. Knob density increased from similar to 20 h to similar to 35 h post-invasion, with significant variation among isolates. The knob density ex vivo, which was about five-fold higher than following long-term in vitro culture, started to decline within a few months of culture. Although knob diameter and height varied among isolates, we did not observe significant time-dependent variation in these dimensions. Conclusions/Significance: The density of knobs on the P. falciparum-IE surface depends on time since invasion, but is also determined by the infecting isolate in a time-independent manner. This is the first study to quantitatively evaluate knob densities and dimensions on different P. falciparum isolates, to examine ex vivo isolates from humans, and to compare ex vivo and long-term in vitro-cultured isolates. Our findings contribute to the understanding of the interaction between P. falciparum parasites and the infected host.	[Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Hviid, Lars] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol I, Copenhagen, Denmark; [Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Hviid, Lars] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Gyan, Ben; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Ghana; [Hassenkam, Tue] Univ Copenhagen, Dept Chem, Fac Sci, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Ghana; University of Copenhagen	Hviid, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol I, Copenhagen, Denmark.	lhviid@sund.ku.dk	Hviid, Lars/G-3705-2012; Hassenkam, Tue/B-8391-2015; Bruun, Jonas/B-3821-2015; Ofori, Michael F/H-9072-2013	Hviid, Lars/0000-0002-1698-4927; Ofori, Michael F/0000-0003-2341-7514; Barfod, Lea/0000-0001-6510-495X	Danish Medical Research Council [271-07-0301]; Danish Consultative Research Committee for Development Research (FFU) [104.Dan.8 I/306]; European Community [242095]; Rigshospitalet Grant [9615.05330]; University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Consultative Research Committee for Development Research (FFU); European Community(European Commission); Rigshospitalet Grant; University of Copenhagen	The research leading to these results was funded by Danish Medical Research Council Grant 271-07-0301, Danish Consultative Research Committee for Development Research (FFU) Grant 104.Dan.8 I/306, European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095, Rigshospitalet Grant 9615.05330, and the University of Copenhagen Program of Excellence in membrane topology and quaternary structure of key membrane proteins involved in P. falciparum malaria pathogenesis and immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Armitage P., 1987, STAT METHODS MED RES; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; BARNWELL JW, 1982, J IMMUNOL, V128, P224; BIGGS BA, 1989, EXP PARASITOL, V69, P189, DOI 10.1016/0014-4894(89)90187-2; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; COATNEY GR, 1971, PRIMATE MALARIAS; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; GRUENBERG J, 1983, J CELL BIOL, V97, P795, DOI 10.1083/jcb.97.3.795; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; HO M, 1992, INFECT IMMUN, V60, P2225, DOI 10.1128/IAI.60.6.2225-2228.1992; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Hutchings CL, 2007, MOL MICROBIOL, V65, P1092, DOI 10.1111/j.1365-2958.2007.05850.x; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; LANGRETH SG, 1979, EXP PARASITOL, V48, P213, DOI 10.1016/0014-4894(79)90101-2; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Li Ang, 2010, Br J Haematol, V151, P1, DOI 10.1111/j.1365-2141.2010.08261.x; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACKENSTEDT U, 1989, PARASITOL RES, V75, P528, DOI 10.1007/BF00931161; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; MILLER L H, 1969, American Journal of Tropical Medicine and Hygiene, V18, P860; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; Nagao E, 2008, J STRUCT BIOL, V162, P460, DOI 10.1016/j.jsb.2008.03.005; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; PATTILLO RA, 1968, CANCER RES, V28, P1231; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TRAGER W, 1966, B WORLD HEALTH ORGAN, V35, P883; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 2011, WORLD MALARIA REPORT 2011, P1	45	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45658	10.1371/journal.pone.0045658	http://dx.doi.org/10.1371/journal.pone.0045658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029166	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900088
J	Guo, W; Luo, C; Wang, C; Zhu, Y; Wang, X; Gao, XD; Yao, WB				Guo, Wei; Luo, Cheng; Wang, Chen; Zhu, Yue; Wang, Xin; Gao, Xiangdong; Yao, Wenbing			Protection against Th17 Cells Differentiation by an Interleukin-23 Receptor Cytokine-Binding Homology Region	PLOS ONE			English	Article							ROR-GAMMA-T; AUTOIMMUNE INFLAMMATION; IL-17 PRODUCTION; IL-23; EXPRESSION; DISTINCT; ANTAGONIST; ACTIVATION; ARTHRITIS; PROMOTES	Th17 cells have been reported to produce proinflammatory cytokines like Interleukin-17, IL-22, and regarded as important players in various inflammatory diseases. One of the IL-12 cytokine family cytokines, IL-23, composed of p19 and p40 subunit, is known for its potential to promote Th17 development and IL-17 producing, and the IL-23/IL-17 pathway is considered to be potential therapeutic target for autoimmune inflammation responses. Knockout mice deficient in either IL-23 or IL-17 related genes can suppress the allergic responses. Several IL-23 or IL-17 neutralizing agents are being evaluated in vitro or in vivo to disrupt the IL-23/IL-17 axis. Herein, we report that prokaryotically expressed soluble IL-23 receptor cytokine-binding homology region as an endogenous extracellular receptor analogue could be a natural antagonist against IL-23/IL-17 axis. We provide evidence that IL23R-CHR can bind to IL-23 in a dose-dependent manner in vitro, and block IL-23 signal by IL23R-CHR reducing the ROR gamma t expression, which in turn lowers the expression of IL-17/IL-22, thus protecting naive CD4+ T cells against Th17 development. Together, this study indicates the importance of IL-23 pathway in Th17 development and the negative regulation of Th17 development by IL23R-CHR, and highlights the important roles of the soluble receptor extracellular region in the therapeutic strategy of neutralizing IL-23.	[Guo, Wei; Luo, Cheng; Wang, Chen; Zhu, Yue; Wang, Xin; Gao, Xiangdong; Yao, Wenbing] China Pharmaceut Univ, State Key Lab Nat Med, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Gao, XD (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xiangdong_gao@yahoo.com.cn; wbyao@cpu.edu.cn	Gao, Xiang/HDO-3543-2022; wang, chen/GWM-9481-2022					Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cornelissen F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2893; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nikoopour Enayat, 2008, Inflammation & Allergy Drug Targets, V7, P203, DOI 10.2174/187152808785748155; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Serhan C.N., 2010, FUNDAMENTALS INFLAMM, V1st ed, DOI [10.1017/CBO9781139195737, DOI 10.1017/CBO9781139195737]; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Suen KF, 2010, PROTEIN EXPRES PURIF, V71, P96, DOI 10.1016/j.pep.2009.12.015; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, SEMIN IMMUNOL, V19, P351, DOI 10.1016/j.smim.2008.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	37	13	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45625	10.1371/journal.pone.0045625	http://dx.doi.org/10.1371/journal.pone.0045625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029144	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388400113
J	Hajihashemi, MR; Grobmyer, SR; Al-Quran, SZ; Jiang, HB				Hajihashemi, Mohammad Reza; Grobmyer, Stephen R.; Al-Quran, Samer Z.; Jiang, Huabei			Noninvasive Evaluation of Nuclear Morphometry in Breast Lesions Using Multispectral Diffuse Optical Tomography	PLOS ONE			English	Article							MORPHOLOGY; CELLS; SPECTROSCOPY	Breast cancer is the most prevalent cancer and the main cause of cancer-related death in women worldwide. There are limitations associated with the existing clinical tools for breast cancer detection and alternative modalities for early detection and classification of breast cancer are urgently needed. Here we describe an optical imaging technique, called multispectral diffuse optical tomography (DOT), and demonstrate its ability of non-invasively evaluating nuclear morphometry for differentiating benign from malignant lesions. Photon densities along the surface of the breast were measured to allow for the extraction of three statistical parameters including the size, elongation and density of nuclei inside the breast tissue. The results from 14 patients (4 malignant and 10 benign lesions) show that there exist significant contrasts between the diseased and surrounding normal nuclei and that the recovered nuclear morphological parameters agree well the pathological findings. We found that the nuclei of cancer cells were less-spherical compared with those of surrounding normal cells, while the nuclear density or volume fraction provided the highest contrast among the three statistical parameters recovered. This pilot study demonstrates the potential of multispectral DOT as a cellular imaging method for accurate determination of breast cancer.	[Hajihashemi, Mohammad Reza; Jiang, Huabei] Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA; [Grobmyer, Stephen R.] Univ Florida, Dept Surg, Gainesville, FL USA; [Al-Quran, Samer Z.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jiang, HB (corresponding author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA.	hjiang@bme.ufl.edu			National Institutes of Health [5 R01 NS069848-02]; Bankhead Coley Florida Cancer Research Program; J. Crayton Pruitt Family Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead Coley Florida Cancer Research Program; J. Crayton Pruitt Family Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health, grant number: 5 R01 NS069848-02. This research was supported in part by the Bankhead Coley Florida Cancer Research Program and by the J. Crayton Pruitt Family Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArtachoPerula E, 1997, J MICROSC-OXFORD, V186, P133, DOI 10.1046/j.1365-2818.1997.1260680.x; Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325; Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Bartlett M, 2004, APPL OPTICS, V43, P1296, DOI 10.1364/AO.43.001296; Deacu M, 2011, ROM J MORPHOL EMBRYO, V52, P303; El Sharkarvy SL, 2008, APPL IMMUNOHISTO M M, V16, P108, DOI 10.1097/PAI.0b013e31806d9b88; Graf RN, 2005, OPT EXPRESS, V13, P4693, DOI 10.1364/OPEX.13.004693; Hajihashemi MR, 2011, APPL OPTICS, V50, P3896, DOI 10.1364/AO.50.003896; Hajihashemi MR, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3650313; Jiang H., 2010, DIFFUSE OPTICAL TOMO; Kalhan S, 2010, J CYTOL, V27, P16, DOI 10.4103/0970-9371.66694; Li CQ, 2008, MED PHYS, V35, P2493, DOI 10.1118/1.2921129; Li CQ, 2006, MED PHYS, V33, P627, DOI 10.1118/1.2171508; Mishchenko M.I., 2002, SCATTERING ABSORPTIO; Mishchenko MI, 1998, J QUANT SPECTROSC RA, V60, P309, DOI 10.1016/S0022-4073(98)00008-9; Mourant JR, 2002, J BIOMED OPT, V7, P378, DOI 10.1117/1.1483317; Nyirenda N, 2011, BREAST CANCER RES TR, V126, P345, DOI 10.1007/s10549-010-0914-z; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Suhane S, 2011, BIOCHEM BIOPH RES CO, V412, P590, DOI 10.1016/j.bbrc.2011.08.003; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; TUAN VD, 2003, BIOMEDICAL PHOTONICS; Yasokawa T, 2007, OPT REV, V14, P161, DOI 10.1007/s10043-007-0161-7; Yu CC, 2006, OPT LETT, V31, P3119, DOI 10.1364/OL.31.003119; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	24	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45714	10.1371/journal.pone.0045714	http://dx.doi.org/10.1371/journal.pone.0045714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029196	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400124
J	Rauschert, ESJ; Shea, K				Rauschert, Emily S. J.; Shea, Katriona			Influence of Microsite Disturbance on the Establishment of Two Congeneric Invasive Thistles	PLOS ONE			English	Article							SEEDLING EMERGENCE; PLANT-COMMUNITIES; CARDUUS-NUTANS; GAP SIZE; COMPETITION; SURVIVAL; REGENERATION; PERFORMANCE; MECHANISMS; GROWTH	The successful establishment of invasive species has been shown to depend on aspects of the invaded community, such as gap characteristics. Biotic resistance may be particularly critical for stopping invaders at early life history stages, but new species can often invade following disturbances, which may create microsites with very different characteristics than are usually present. We examine the response of two invasive thistle species, Carduus nutans L. and C. acanthoides L., to three different microsite characteristics: disturbance type, size, and water availability. The two species initially responded differently to the type of disturbance: C. acanthoides had higher emergence and survival in plots with both above- and belowground disturbance, whereas C. nutans had better early performance in large microsites with above-ground disturbance only. Later in their life cycle, C. nutans performed better in plots that had been disturbed both above- and belowground, whereas C. acanthoides was largely unaffected by disturbance type. Increased emergence and survival, larger size and a higher proportion flowering were observed in larger gaps for both species throughout the life cycle. Watering had a negative impact on C. nutans emergence and fall survival and on C. acanthoides survival to the following summer. Overall, these results suggest that disturbance-generated microsite characteristics (disturbance type and size) may have large impacts on establishment of these two Carduus species, which in turn may persist well beyond the initial stages of growth. Studying invader responses to disturbance can help us to understand under what circumstances they are likely to establish and create persistent problems; avoiding or ameliorating such situations will have significant management benefits.	[Rauschert, Emily S. J.] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA; [Rauschert, Emily S. J.; Shea, Katriona] Penn State Univ, Dept Biol, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Rauschert, Emily S. J.] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rauschert, ESJ (corresponding author), St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA.	erauschert@smcm.edu	Shea, Katriona/B-7954-2008	Shea, Katriona/0000-0002-7607-8248	United States Department of Agriculture Cooperative State Research, Education, and Extension Service (USDA-CSREES); Biology of Weedy and Invasive Plants National Research Initiative (NRI) [2002-35320-1228]; National Science Foundation (NSF) [DEB-0815373]; NASA Space Grant Fellowship; Direct For Biological Sciences [0815373] Funding Source: National Science Foundation	United States Department of Agriculture Cooperative State Research, Education, and Extension Service (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biology of Weedy and Invasive Plants National Research Initiative (NRI); National Science Foundation (NSF)(National Science Foundation (NSF)); NASA Space Grant Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by United States Department of Agriculture Cooperative State Research, Education, and Extension Service (USDA-CSREES) Biology of Weedy and Invasive Plants National Research Initiative (NRI) grant #2002-35320-1228 (http://usda.gov) and by National Science Foundation (NSF) grant #DEB-0815373 (http://nsf.gov) to KS, and by a NASA Space Grant Fellowship (http://pa.spacegrant.org/psgc-fellowship-program) to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker B, 2008, ECOLOGICAL MODELS DA; Cahill JF, 2002, OIKOS, V99, P101, DOI 10.1034/j.1600-0706.2002.990111.x; Cahill JF, 2003, PLANT ECOL, V164, P29, DOI 10.1023/A:1021228204599; Chen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024535; Crawley M. J, 2002, STAT COMPUTING INTRO; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; DESROCHERS AM, 1988, CAN J PLANT SCI, V68, P1053, DOI 10.4141/cjps88-126; DOING H, 1969, Vegetatio, V17, P313, DOI 10.1007/BF01965915; FELDMAN SR, 1994, WEED RES, V34, P265, DOI 10.1111/j.1365-3180.1994.tb01994.x; Gassmann A, 2002, MUSK THISTLE NODDING, P220; GOLDBERG DE, 1988, ECOLOGY, V69, P1677, DOI 10.2307/1941146; GROSS KL, 1982, ECOLOGY, V63, P921, DOI 10.2307/1937232; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HAMRICK JL, 1987, AM J BOT, V74, P451, DOI 10.2307/2443821; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Holm LG, 1979, GEOGRAPHICAL ATLAW; Huston MA, 2004, DIVERS DISTRIB, V10, P167, DOI 10.1111/j.1366-9516.2004.00083.x; Kelly D., 1988, Proceedings, New Zealand Weed and Pest Control Conference., P207; Kok LT, 2002, PLUMELESS THISTLE CU, P220; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Marchetto KM, 2010, OIKOS, V119, P1462, DOI 10.1111/j.1600-0706.2010.18329.x; Mason TJ, 2012, J VEG SCI, V23, P657, DOI 10.1111/j.1654-1103.2012.01393.x; McCarty MK, 1969, GERMINATION EARLY SE, P1; MCCONNAUGHAY KDM, 1987, ECOLOGY, V68, P411, DOI 10.2307/1939272; MCCONNAUGHAY KDM, 1990, ECOLOGY, V71, P1941, DOI 10.2307/1937602; PANETTA FD, 1992, AUST J ECOL, V17, P169, DOI 10.1111/j.1442-9993.1992.tb00795.x; Peterson-Smith J, 2010, J TORREY BOT SOC, V137, P287, DOI 10.3159/09-RA-070R1.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauschert ESJ, 2012, ECOL APPL, V22, P1413, DOI 10.1890/11-2107.1; Roxburgh SH, 2004, ECOLOGY, V85, P359, DOI 10.1890/03-0266; Ruggiero DC, 2011, NORTHEAST NAT, V18, P197, DOI 10.1656/045.018.0206; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Shea K, 2005, ECOLOGY, V86, P3174, DOI 10.1890/05-0195; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; WARDLE DA, 1995, J APPL ECOL, V32, P225, DOI 10.2307/2404431; Yang SA, 2011, AM NAT, V177, P110, DOI 10.1086/657433; Zhang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021725	44	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45490	10.1371/journal.pone.0045490	http://dx.doi.org/10.1371/journal.pone.0045490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029048	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900147
J	Arora, S; Korn, RL; Lenkiewicz, E; Cherni, I; Beach, TG; Hostetter, G; Barrett, MT; Weiss, GJ				Arora, Shilpi; Korn, Ronald L.; Lenkiewicz, Elizabeth; Cherni, Irene; Beach, Thomas G.; Hostetter, Galen; Barrett, Michael T.; Weiss, Glen J.			Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma	PLOS ONE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; COPY NUMBER; TUMORS; PROGRESSION; ESOPHAGUS; MUTATIONS; EXPOSURE; GENE	Background: Maxillary sinus carcinoma (MSC) is a rare cancer of the head and neck region. Patients are treated with surgery, radiation therapy, and chemotherapy and the treatment regimen is based on patient's age, general health condition, disease stage, and its extent of spread. There is very little information available on the genetics of this disease. DNA content based flow sorting of tumor cells followed by array comparative genomic hybridization allows for high definition global assessment of distinct clonal changes within tumor populations. Methods: We applied this technique to primary and metastatic samples collected from a patient with radio-and chemotherapy refractory maxillary sinus carcinoma to gauge the progression of this disease. Results: A clonal KIT amplicon was present in aneuploid populations sorted from the primary tumor and in divergent subclones arising in metastatic foci found in the brain, lung, and jejunum. The evolution of these subclones was associated with distinct genetic aberrations and DNA ploidies. Conclusion: The information presented here paves the path to understanding the development and progression of this disease.	[Arora, Shilpi; Lenkiewicz, Elizabeth; Cherni, Irene; Hostetter, Galen; Barrett, Michael T.; Weiss, Glen J.] Translat Genom Res Inst, Phoenix, AZ USA; [Korn, Ronald L.] Scottsdale Med Imaging LLC, Scottsdale, AZ USA; [Beach, Thomas G.] Banner Healthcare, Sun Hlth Res Inst, Phoenix, AZ USA; [Weiss, Glen J.] Scottsdale Healthcare, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA	Translational Genomics Research Institute; Banner Research; Banner Health; Scottsdale Healthcare Osborn	Weiss, GJ (corresponding author), Translat Genom Res Inst, Phoenix, AZ USA.	gweiss@tgen.org			IBIS Foundation of Arizona; Scottsdale Healthcare Foundation	IBIS Foundation of Arizona; Scottsdale Healthcare Foundation	IBIS Foundation of Arizona and Scottsdale Healthcare Foundation provided the funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; FUKUDA K, 1990, CANCER CAUSE CONTROL, V1, P165, DOI 10.1007/BF00053168; GIRI SPG, 1992, CANCER, V69, P657, DOI 10.1002/1097-0142(19920201)69:3<657::AID-CNCR2820690310>3.0.CO;2-7; Graham PH, 2010, INT J RADIAT ONCOL, V77, P648, DOI 10.1016/j.ijrobp.2009.05.032; Holmila R, 2010, INT J CANCER, V127, P578, DOI 10.1002/ijc.25064; Holmila R, 2010, MUTAT RES-FUND MOL M, V686, P9, DOI 10.1016/j.mrfmmm.2009.12.003; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Le QT, 1999, CANCER, V86, P1700, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1700::AID-CNCR11>3.3.CO;2-W; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lopez F, 2011, HEAD NECK-J SCI SPEC, V33, P145, DOI 10.1002/hed.21417; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Nishino H, 2000, CANCER, V89, P1925, DOI 10.1002/1097-0142(20001101)89:9<1925::AID-CNCR8>3.3.CO;2-8; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Weiss Glen J, 2010, Rare Tumors, V2, pe50, DOI 10.4081/rt.2010.e50; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; ZHENG W, 1993, AM J EPIDEMIOL, V138, P965, DOI 10.1093/oxfordjournals.aje.a116816	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45614	10.1371/journal.pone.0045614	http://dx.doi.org/10.1371/journal.pone.0045614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029135	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900046
J	Lee, YP; Wong, CH; Chan, KS; Lai, SK; Koh, CG; Li, HY				Lee, Yoke-Peng; Wong, Chi-Hang; Chan, Kheng-Sze; Lai, Soak-Kuan; Koh, Cheng-Gee; Li, Hoi-Yeung			In Vivo FRET Imaging Revealed a Regulatory Role of RanGTP in Kinetochore-Microtubule Attachments via Aurora B Kinase	PLOS ONE			English	Article							CHROMOSOME ALIGNMENT; SPINDLE CHECKPOINT; MITOTIC-SPINDLE; MAMMALIAN-CELLS; PROTEIN-KINASE; SOMATIC-CELLS; GTPASE RAN; CENP-E; ANAPHASE; GRADIENT	Under the fluctuating circumstances provided by the innate dynamics of microtubules and opposing tensions resulted from microtubule-associated motors, it is vital to ensure stable kinetochore-microtubule attachments for accurate segregation. However, a comprehensive understanding of how this regulation is mechanistically achieved remains elusive. Using our newly designed live cell FRET time-lapse imaging, we found that post-metaphase RanGTP is crucial in the maintenance of stable kinetochore-microtubule attachments by regulating Aurora B kinase via the NES-bearing Mst1. More importantly, our study demonstrates that by ensuring stable alignment of metaphase chromosomes prior to segregation, RanGTP is indispensible in governing the genomic integrity and the fidelity of cell cycle progression. Our findings suggest an additional role of RanGTP beyond its known function in mitotic spindle assembly during the prometaphase-metaphase transition.	[Lee, Yoke-Peng; Wong, Chi-Hang; Chan, Kheng-Sze; Lai, Soak-Kuan; Koh, Cheng-Gee; Li, Hoi-Yeung] Nanyang Technol Univ, Div Mol & Cell Biol, Sch Biol Sci, Coll Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Koh, CG (corresponding author), Nanyang Technol Univ, Div Mol & Cell Biol, Sch Biol Sci, Coll Sci, Singapore, Singapore.	cgkoh@ntu.edu.sg; hyli@ntu.edu.sg	Wong, Chi Hang/C-6909-2015; Koh, Cheng Gee/A-2215-2011; Wong, Chi Hang/ABE-8673-2021	Wong, Chi Hang/0000-0003-4157-6287; Koh, Cheng Gee/0000-0003-1905-8010; Wong, Chi Hang/0000-0003-4157-6287; Li, Hoi Yeung/0000-0002-8603-1953	Academic Research Council; Ministry of Education, Singapore [RG37/08]; A*STAR, Biomedical Research Council [08/1/22/19/568]	Academic Research Council; Ministry of Education, Singapore(Ministry of Education, Singapore); A*STAR, Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Council, Ministry of Education, Singapore (Academic Research Fund AcRF Tier 1, RG37/08) and A*STAR, Biomedical Research Council (BMRC grant 08/1/22/19/568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Maia AF, 2010, CHROMOSOMA, V119, P405, DOI 10.1007/s00412-010-0265-x; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Malkusch W, 2004, BIOSCIENCE TECHNOLOG, P32; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; NISHITANI H, 1990, J BIOCHEM-TOKYO, V107, P228, DOI 10.1093/oxfordjournals.jbchem.a123031; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Silverman-Gavrila RV, 2006, MOL BIOL CELL, V17, P2069, DOI 10.1091/mbc.E05-10-0991; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Tatsuka M, 1998, CANCER RES, V58, P4811; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000	39	57	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45836	10.1371/journal.pone.0045836	http://dx.doi.org/10.1371/journal.pone.0045836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029267	gold, Green Published			2022-12-27	WOS:000309973900056
J	Zhang, YQ; Pei, XW; Zhang, C; Lu, ZF; Wang, ZX; Jia, SR; Li, WM				Zhang, Yongqiang; Pei, Xinwu; Zhang, Chao; Lu, Zifeng; Wang, Zhixing; Jia, Shirong; Li, Weimin			De Novo Foliar Transcriptome of Chenopodium amaranticolor and Analysis of Its Gene Expression During Virus-Induced Hypersensitive Response	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RNA-SEQ; DISEASE-RESISTANCE; MOSAIC-VIRUS; ARABIDOPSIS-THALIANA; PLANT IMMUNITY; DEFENSE; CELL; TOOL; IDENTIFICATION	Background: The hypersensitive response (HR) system of Chenopodium spp. confers broad-spectrum virus resistance. However, little knowledge exists at the genomic level for Chenopodium, thus impeding the advanced molecular research of this attractive feature. Hence, we took advantage of RNA-seq to survey the foliar transcriptome of C. amaranticolor, a Chenopodium species widely used as laboratory indicator for pathogenic viruses, in order to facilitate the characterization of the HR-type of virus resistance. Methodology and Principal Findings: Using Illumina HiSeq (TM) 2000 platform, we obtained 39,868,984 reads with 3,588,208,560 bp, which were assembled into 112,452 unigenes (3,847 clusters and 108,605 singletons). BlastX search against the NCBI NR database identified 61,698 sequences with a cut-off E-value above 10(-5). Assembled sequences were annotated with gene descriptions, GO, COG and KEGG terms, respectively. A total number of 738 resistance gene analogs (RGAs) and homology sequences of 6 key signaling proteins within the R proteins-directed signaling pathway were identified. Based on this transcriptome data, we investigated the gene expression profiles over the stage of HR induced by Tobacco mosaic virus and Cucumber mosaic virus by using digital gene expression analysis. Numerous candidate genes specifically or commonly regulated by these two distinct viruses at early and late stages of the HR were identified, and the dynamic changes of the differently expressed genes enriched in the pathway of plant-pathogen interaction were particularly emphasized. Conclusions: To our knowledge, this study is the first description of the genetic makeup of C. amaranticolor, providing deep insight into the comprehensive gene expression information at transcriptional level in this species. The 738 RGAs as well as the differentially regulated genes, particularly the common genes regulated by both TMV and CMV, are suitable candidates which merit further functional characterization to dissect the molecular mechanisms and regulatory pathways of the HR-type of virus resistance in Chenopodium.	[Zhang, Yongqiang; Pei, Xinwu; Zhang, Chao; Wang, Zhixing; Jia, Shirong; Li, Weimin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Lu, Zifeng] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Lanzhou University	Li, WM (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	liwm518@hotmail.com	Pei, Xinwu/AAI-1736-2019; Jia, Shirong/L-8788-2019; pei, xinwu/O-7083-2019	Pei, Xinwu/0000-0001-7828-3037; 	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2011ZX08001-002, 2011ZX08004-004]; Special Fund for Agro-scientific Research in the Public Interest [201103026-2]	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (grant nos. 2011ZX08001-002 and 2011ZX08004-004), and the Special Fund for Agro-scientific Research in the Public Interest (grant no. 201103026-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Caldwell KS, 2009, GENETICS, V181, P671, DOI 10.1534/genetics.108.097279; Canto T, 1999, VIROLOGY, V265, P74, DOI 10.1006/viro.1999.0028; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; CMI/AAB, 1984, DESCR PLANT VIR JUL; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper B, 2001, PLANT J, V26, P339, DOI 10.1046/j.1365-313X.2001.01030.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DAWSON WO, 1986, P NATL ACAD SCI USA, V83, P1832, DOI 10.1073/pnas.83.6.1832; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hou WN, 2011, MOL PLANT PATHOL, V12, P595, DOI 10.1111/J.1364-3703.2010.00696.X; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pitzschke A., 2009, CURR OPIN PLANT BIOL, V12, P1; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Schmitz I, 1996, VIROLOGY, V226, P281, DOI 10.1006/viro.1996.0656; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Sun Q, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-53; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VISEDO G, 1990, PHYSIOL PLANTARUM, V78, P218; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zheng ZY, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-2; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	69	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45953	10.1371/journal.pone.0045953	http://dx.doi.org/10.1371/journal.pone.0045953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029338	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900067
J	Nagaishi, M; Nobusawa, S; Tanaka, Y; Ikota, H; Yokoo, H; Nakazato, Y				Nagaishi, Masaya; Nobusawa, Sumihito; Tanaka, Yuko; Ikota, Hayato; Yokoo, Hideaki; Nakazato, Yoichi			Slug, Twist, and E-Cadherin as Immunohistochemical Biomarkers in Meningeal Tumors	PLOS ONE			English	Article							SOLITARY FIBROUS TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS SNAIL; CENTRAL-NERVOUS-SYSTEM; CELL-CELL ADHESION; N-CADHERIN; EXPRESSION; CANCER; HEMANGIOPERICYTOMA; MENINGIOMA	The overexpression of Twist and Slug and subsequent down-regulation of E-cadherin facilitate the acquirement of invasive growth properties in cancer cells. It is unclear which of these molecules are expressed in mesenchymal tumors in the central nervous system. Here, we investigated 10 cases each of hemangiopericytoma, solitary fibrous tumor, meningothelial, fibrous, angiomatous, and atypical meningiomas, and 5 cases of anaplastic meningioma for Slug, Twist, E-cadherin, and N-cadherin immunoexpression. Nuclear Slug expression was observed in 9/10 (90%) hemangiopericytomas and 5/10 (50%) solitary fibrous tumors, but not in any meningiomas, except for 1 case. Similarly, nuclear Twist expression was more extensive in hemangiopericytomas and solitary fibrous tumors than meningiomas. In contrast to Slug and Twist, the positive expression of E-cadherin was observed in 39/45 (87%) meningiomas, but not in any hemangiopericytomas or solitary fibrous tumors (P < 0.0001). The fraction of tumor cells expressing E-cadherin in meningeal tumors was negatively correlated to those of Twist (P = 0.004) and Slug (P < 0.0001). The overexpression of Slug and Twist with down-regulation of E-cadherin was characteristic findings in hemangiopericytomas and solitary fibrous tumors, but not in meningiomas. The immunohistochemical profiles of the two tumor groups may be useful as diagnostic markers in cases that present a differential diagnosis challenge.	[Nagaishi, Masaya; Nobusawa, Sumihito; Tanaka, Yuko; Ikota, Hayato; Yokoo, Hideaki; Nakazato, Yoichi] Gunma Univ, Grad Sch Med, Dept Human Pathol, Gunma, Japan	Gunma University	Nakazato, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Human Pathol, Gunma, Japan.	nagaishi-nsu@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [21500335]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (No. 21500335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aamodt R, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/616023; Bisceglia M, 2011, ADV ANAT PATHOL, V18, P356, DOI 10.1097/PAP.0b013e318229c004; Borg M F, 1995, Australas Radiol, V39, P36, DOI 10.1111/j.1440-1673.1995.tb00229.x; Carneiro SS, 1996, AM J CLIN PATHOL, V106, P217, DOI 10.1093/ajcp/106.2.217; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chan JKC, 1997, HISTOPATHOLOGY, V31, P568, DOI 10.1046/j.1365-2559.1997.2400897.x; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Drummond KJ, 2000, J CLIN NEUROSCI, V7, P69, DOI 10.1054/jocn.1998.0153; Fletcher CDMUK, 2002, BONE; GUTHRIE BL, 1989, NEUROSURGERY, V25, P514, DOI 10.1227/00006123-198910000-00003; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; MENA H, 1991, HUM PATHOL, V22, P84, DOI 10.1016/0046-8177(91)90067-Y; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Nagaishi M, 2012, BRAIN PATHOL IN PRES; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nikas DC, 1999, ACTA NEUROCHIR, V141, P307, DOI 10.1007/s007010050302; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Pecina-Slaus N, 2010, J CANCER RES CLIN, V136, P695, DOI 10.1007/s00432-009-0708-z; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perry A, 1997, AM J SURG PATHOL, V21, P1354, DOI 10.1097/00000478-199711000-00010; Rajaram V, 2004, HUM PATHOL, V35, P1413, DOI 10.1016/j.humpath.2004.07.017; Richmond PJM, 1997, CANCER RES, V57, P3189; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Schreider C, 2002, J CELL SCI, V115, P543; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Taylor KM, 2007, CURR OPIN GENET DEV, V17, P326, DOI 10.1016/j.gde.2007.05.012; The WHO, 2020, CLASSIFICATION TUMOU; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Zhou KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011231	36	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46053	10.1371/journal.pone.0046053	http://dx.doi.org/10.1371/journal.pone.0046053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029385	gold, Green Published			2022-12-27	WOS:000309554700110
J	Boudreau, E; Labib, S; Bertrand, AT; Decostre, V; Bolongo, PM; Sylvius, N; Bonne, G; Tesson, F				Boudreau, Emilie; Labib, Sarah; Bertrand, Anne T.; Decostre, Valerie; Bolongo, Pierrette M.; Sylvius, Nicolas; Bonne, Gisele; Tesson, Frederique			Lamin A/C Mutants Disturb Sumo1 Localization and Sumoylation in Vitro and in Vivo	PLOS ONE			English	Article							NUCLEAR-ENVELOPE ALTERATIONS; SPATIAL-ORGANIZATION; MUSCULAR-DYSTROPHY; GENE; SMAD4; CARDIOMYOPATHY; TRANSCRIPTION; ACCUMULATION; FIBROBLASTS; MUTATIONS	A-type lamins A and C are nuclear intermediate filament proteins in which mutations have been implicated in multiple disease phenotypes commonly known as laminopathies. A few studies have implicated sumoylation in the regulation of A-type lamins. Sumoylation is a post-translational protein modification that regulates a wide range of cellular processes through the attachment of small ubiquitin-related modifier (sumo) to various substrates. Here we showed that laminopathy mutants result in the mislocalization of sumo1 both in vitro (C2C12 cells overexpressing mutant lamins A and C) and in vivo (primary myoblasts and myopathic muscle tissue from the Lmna(H222P/H222P) mouse model). In C2C12 cells, we showed that the trapping of sumo1 in p.Asp192Gly, p.Gln353Lys, and p.Arg386Lys aggregates of lamin A/C correlated with an increased steady-state level of sumoylation. However, lamin A and C did not appear to be modified by sumo1. Our results suggest that mutant lamin A/C alters the dynamics of sumo1 and thus misregulation of sumoylation may be contributing to disease progression in laminopathies.	[Boudreau, Emilie; Labib, Sarah; Bolongo, Pierrette M.; Sylvius, Nicolas; Tesson, Frederique] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Bertrand, Anne T.; Decostre, Valerie; Bonne, Gisele] INSERM, UMRS 974, Paris, France; [Bertrand, Anne T.; Decostre, Valerie; Bonne, Gisele] Univ Paris 06, Inst Myol, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, UF Cardiogenet & Myogenet, F-75634 Paris, France	University of Ottawa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Tesson, F (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	FTesson@uottawa.ca	Bertrand, Anne/AAR-6751-2020; Tesson, Frederique/A-3218-2013; Bonne, Gisèle/G-3121-2013	Bonne, Gisèle/0000-0002-2516-3258; Bertrand, Anne/0000-0001-7153-848X; Sylvius, Nicolas/0000-0002-3470-3711	Heart and Stroke Foundation [NA 6628]; Canadian Institutes of Health Research [77685]; Foreign Affairs and International Trade Canada Scholarship; INSERM (Institut national de la sante et de la recherche medicale); Universite Pierre et Marie Curie - Paris 6; Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foreign Affairs and International Trade Canada Scholarship; INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie - Paris 6; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This research was supported by an operating grant (NA 6628) from the Heart and Stroke Foundation (http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.3581583/k.BE4C/Home.htm) awarded to F. Tesson, an operating grant (77685) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) awarded to F. Tesson, a Foreign Affairs and International Trade Canada Scholarship (http://www.scholarships-bourses.gc.ca/scholarships-bourses/index.aspx?view=d) awarded to E. Boudreau, and INSERM (Institut national de la sante et de la recherche medicale, http://www.inserm.fr/), Universite Pierre et Marie Curie - Paris 6 (http://www.upmc.fr/), the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/), and the Association Francaise contre les Myopathies (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; Brown SC, 2008, BIOCHEM SOC T, V36, P1335, DOI 10.1042/BST0361335; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dutour A, 2011, HUM MOL GENET; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hubner S, 2005, EXP CELL RES, V312, P171, DOI 10.1016/j.yexcr.2005.10.011; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pichler Andrea, 2008, V446, P131, DOI 10.1007/978-1-60327-084-7_9; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sylvius N, 2005, J MED GENET, V42, P639, DOI 10.1136/jmg.2004.023283; Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017; Sylvius N, 2006, CURR OPIN CARDIOL, V21, P159, DOI 10.1097/01.hco.0000221575.33501.58; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; Yasugi T, 1996, NUCLEIC ACIDS RES, V24, P2005, DOI 10.1093/nar/24.11.2005; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124; Zhong N, 2005, BIOCHEM BIOPH RES CO, V338, P855, DOI 10.1016/j.bbrc.2005.10.020	43	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45918	10.1371/journal.pone.0045918	http://dx.doi.org/10.1371/journal.pone.0045918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029315	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800120
J	Rohrman, BA; Leautaud, V; Molyneux, E; Richards-Kortum, RR				Rohrman, Brittany A.; Leautaud, Veronica; Molyneux, Elizabeth; Richards-Kortum, Rebecca R.			A Lateral Flow Assay for Quantitative Detection of Amplified HIV-1 RNA	PLOS ONE			English	Article							VIRAL LOAD ASSAY; AMPLIFICATION	Although the accessibility of HIV treatment in developing nations has increased dramatically over the past decade, viral load testing to monitor the response of patients receiving therapy is often unavailable. Existing viral load technologies are often too expensive or resource-intensive for poor settings, and there is no appropriate HIV viral load test currently available at the point-of-care in low resource settings. Here, we present a lateral flow assay that employs gold nanoparticle probes and gold enhancement solution to detect amplified HIV RNA quantitatively. Preliminary results show that, when coupled with nucleic acid sequence based amplification (NASBA), this assay can detect concentrations of HIV RNA that match the clinically relevant range of viral loads found in HIV patients. The lateral flow test is inexpensive, simple and rapid to perform, and requires few resources. Our results suggest that the lateral flow assay may be integrated with amplification and sample preparation technologies to serve as an HIV viral load test for low-resource settings.	[Rohrman, Brittany A.; Leautaud, Veronica; Richards-Kortum, Rebecca R.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Molyneux, Elizabeth] Queen Elizabeth Cent Hosp, Coll Med, Dept Paediat, Blantyre, Malawi	Rice University; University of Malawi	Richards-Kortum, RR (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467	National Institute of Allergy and Infectious Diseases [R21AI087104]; Nanobiology Interdisciplinary Graduate Training Program (NIH) [T32 EB009379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009379] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nanobiology Interdisciplinary Graduate Training Program (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The project described was supported by Award Number R21AI087104 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This work was also funded in part by the Nanobiology Interdisciplinary Graduate Training Program (NIH Grant No. T32 EB009379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID US ANT AG HIV 1; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Carter DJ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm269; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; *DEP HLTH HUM SERV, 2006, GUID US ANT AG HIV 1; Dimov IK, 2008, LAB CHIP, V8, P2071, DOI 10.1039/b812515e; Ellerbee AK, 2009, ANAL CHEM, V81, P8447, DOI 10.1021/ac901307q; Fields B. N., 2007, FIELDS VIROLOGY; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g; Fu E, 2010, SENSOR ACTUAT B-CHEM, V149, P325, DOI 10.1016/j.snb.2010.06.024; Fu E, 2010, LAB CHIP, V10, P918, DOI 10.1039/b919614e; Gupta S, 2007, ANAL CHEM, V79, P3810, DOI 10.1021/ac062341m; He YQ, 2011, BIOSENS BIOELECTRON, V26, P2018, DOI 10.1016/j.bios.2010.08.079; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Lee HH, 2010, J INFECT DIS, V201, pS65, DOI 10.1086/650385; Lee SH, 2008, LAB CHIP, V8, P2121, DOI 10.1039/b811131f; Li X, 2010, ANAL BIOANAL CHEM, V396, P495, DOI 10.1007/s00216-009-3195-9; Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b; Martinez AW, 2010, LAB CHIP, V10, P2499, DOI [10.1039/c01c00021c, 10.1039/c0lc00021c]; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Parpia ZA, 2010, JAIDS-J ACQ IMM DEF, V55, P413, DOI 10.1097/QAI.0b013e3181f1afbc; Respess RA, 2005, J CLIN MICROBIOL, V43, P506, DOI 10.1128/JCM.43.1.506-508.2005; Stewart P, 2010, J CLIN VIROL, V49, P198, DOI 10.1016/j.jcv.2010.07.022; Tang SX, 2007, JAIDS-J ACQ IMM DEF, V46, P231, DOI 10.1097/QAI.0b013e31814a554b; Thaxton CS, 2006, CLIN CHIM ACTA, V363, P120, DOI 10.1016/j.cccn.2005.05.042; UNAIDS, 2010, GLOB REP UNAIDS REP; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Yu JH, 2011, LAB CHIP, V11, P1286, DOI 10.1039/c0lc00524j; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	34	115	127	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45611	10.1371/journal.pone.0045611	http://dx.doi.org/10.1371/journal.pone.0045611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029134	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800068
J	Trapp, S; Lepsien, J; Sehm, B; Villringer, A; Ragert, P				Trapp, Sabrina; Lepsien, Joeran; Sehm, Bernhard; Villringer, Arno; Ragert, Patrick			Changes of Hand Switching Costs during Bimanual Sequential Learning	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; INTERHEMISPHERIC INHIBITION; FINGER MOVEMENTS; SHORT-TERM; MECHANISMS; EXCITABILITY; SEQUENCES; NETWORKS; PREMOTOR	Many tasks in our daily life demand not only the use of different fingers of one hand in a serial fashion, but also to alternate from one hand to the other. Here, we investigated performance in a bimanual serial reaction time task (SRTT) with particular emphasis on learning-related changes in reaction time (RT) for consecutive button presses for homologous index- and middle fingers. The bimanual SRTT consisted of sequential button presses either with the left or right index-and middle-finger to a series of visual letters displayed on a computer screen. Each letter was assigned a specific button press with one of four fingers. Two outcome measures were investigated: (a) global sequence learning as defined by the time needed to complete a 15-letter SRTT sequence and (b) changes in hand switch costs across learning. We found that bimanual SRTT resulted in a global decrease in RT during the time course of learning that persisted for at least two weeks. Furthermore, RT to a button press showed an increase when the previous button press was associated with another hand as opposed to the same hand. This increase in RT was defined as switch costs. Hand switch costs significantly decreased during the time course of learning, and remained stable over a time of approximately two weeks. This study provides evidence for modulations of switch costs during bimanual sequence learning, a finding that might have important implications for theories of bimanual coordination and learning.	[Trapp, Sabrina; Lepsien, Joeran; Sehm, Bernhard; Villringer, Arno; Ragert, Patrick] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Villringer, Arno] Charite, Mind & Brain Inst, Berlin, Germany; [Villringer, Arno] Humboldt Univ, D-10099 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ragert, P (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	ragert@cbs.mpg.de	Ragert, Patrick/AAI-7290-2020	Villringer, Arno/0000-0003-2604-2404; Sehm, Bernhard/0000-0001-7195-0095				Avanzino L, 2008, EUR J NEUROSCI, V27, P1285, DOI 10.1111/j.1460-9568.2008.06086.x; Berner MP, 2008, PSYCHOL RES-PSYCH FO, V72, P138, DOI 10.1007/s00426-006-0097-8; Camus M, 2009, CLIN NEUROPHYSIOL, V120, P1859, DOI 10.1016/j.clinph.2009.08.013; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; FOX JG, 1964, ERGONOMICS, V7, P317, DOI 10.1080/00140136408930752; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; Harris-Love ML, 2011, NEUROREHAB NEURAL RE, V25, P398, DOI 10.1177/1545968310395600; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; KARNI A, 1995, NATURE, V377, P155; KAWASHIMA R, 1993, BRAIN RES, V623, P33, DOI 10.1016/0006-8993(93)90006-9; Koch G, 2007, J PHYSIOL-LONDON, V578, P551, DOI 10.1113/jphysiol.2006.123562; Kroeger J, 2010, EUR J NEUROSCI, V32, P1771, DOI 10.1111/j.1460-9568.2010.07442.x; LAROCHELLE S, 1984, ATTENTION PERFORM, V10, P43; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Rabbitt PM, 1975, ATTENTION PERFORMANC, pV; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P232, DOI 10.1080/14640746808400157; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; ROSENBAUM DA, 1982, ACTA PSYCHOL, V51, P223, DOI 10.1016/0001-6918(82)90036-1; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; SALTHOUSE TA, 1986, PSYCHOL BULL, V99, P303, DOI 10.1037/0033-2909.99.3.303; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387	29	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45857	10.1371/journal.pone.0045857	http://dx.doi.org/10.1371/journal.pone.0045857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029279	gold, Green Published			2022-12-27	WOS:000309392800107
J	Wang, XY; Tan, LX; Li, Y; Zhang, Y; Zhou, DY; Liu, TQ; Hao, W				Wang, Xuyi; Tan, Linxiang; Li, Yi; Zhang, Yao; Zhou, Dongyi; Liu, Tieqiao; Hao, Wei			HCV and HIV Infection among Heroin Addicts in Methadone Maintenance Treatment (MMT) and Not in MMT in Changsha and Wuhan, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; RISK; EPIDEMIOLOGY	Objective: To compare HCV and HIV infection among heroin addicts in MMT and not in MMT in two large cities in central China. Methods: A total of 541 heroin addicts were recruited from MMT clinics and voluntary detoxification centers in Changsha and Wuhan, China. Structured questionnaires collected data on their socio-demographics, clinical status, risk behaviors, and their knowledge of HIV. Their HIV serostatus and Hepatitis C virus (HCV) serostatus were determined by testing antibodies in blood serum. Results: We observed a higher prevalence of HCV infection among MMT heroin addicts (82.3%) than that in the non-MMT group (50.6%). However, our findings indicated that the heroin addicts in MMT had less drug or sexual HIV/HCV risk behaviors and more knowledge about HIV than non-MMT addicts. The heroin addicts in MMT had a significantly higher percentage of individuals who always used condoms (44.9%) compared with patients in the non-MMT group (14.6%, p = 0.039), and they had more knowledge about HIV than non-MMT individuals (p<.001). The percentage of HIV-positive addicts in the MMT group (0.7%) and non-MMT group (0.8%) were almost same. Conclusion: Our study indicated that the rate of HCV infection among heroin addicts among MMT or non-MMT settings in central China is very high. The non-MMT heroin addicts have higher risk of becoming infected with HCV in the future, while at present they have lower rates of HCV infection than MMT heroin addicts. Although rates of HIV infection among MMT and non-MMT heroin addicts are low now, they are all at great risk of becoming infected with HIV in the future, especially for non-MMT heroin addicts. We should use the MMT sites as a platform to improve the control of HCV and HIV infection in heroin addicts.	[Wang, Xuyi; Tan, Linxiang; Liu, Tieqiao; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Li, Yi; Zhang, Yao] Mental Hlth Ctr Wuhan, Wuhan, Hubei Province, Peoples R China; [Zhou, Dongyi] Psychiat Hosp Changsha, Changsha, Hunan, Peoples R China	Central South University	Hao, W (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China.	weiaho57@gmail.com	liu, tieqiao/GSE-2327-2022		State Key Program of National Natural Science of China [81130020]; National Key Technology R&D Program of China [2012BAI01B07]; National Key Basic Research and Development Program [2009CB522007]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Basic Research and Development Program(National Basic Research Program of China)	This work was supported by State Key Program of National Natural Science of China (grant no. 81130020), The National Key Technology R&D Program of China (grant no. 2012BAI01B07), and National Key Basic Research and Development Program (grant no. 2009CB522007) to Wei Hao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER A, 1995, ADDICTION, V90, P545, DOI 10.1111/j.1360-0443.1995.tb02189.x; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2012, AM J DRUG ALCOHOL AB, V38, P140, DOI 10.3109/00952990.2011.643984; Bravo MJ, 2012, INT J DRUG POLICY, VS0955-3959, P00016, DOI [10.1016/j.drugpo.2012.02.002, DOI 10.1016/J.DRUGP0.2012.02.002]; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Fletcher NF, 2012, J VIRAL HEPATITIS, V19, P301, DOI 10.1111/j.1365-2893.2012.01591.x; Gyarmathy VA, 2002, J ACQ IMMUN DEF SYND, V30, P448, DOI [10.1097/00042560-200208010-00011, 10.1097/01.QAI.0000018880.78058.98]; Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016; Joseph H, 2000, MT SINAI J MED, V67, P347; Li Ming-qiang, 2007, Harm Reduct J, V4, P8, DOI 10.1186/1477-7517-4-8; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Peles E, 2011, J ADDICT MED, V5, P214, DOI 10.1097/ADM.0b013e31820e13dd; Scheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tang YL, 2007, ADDICTION, V102, P1057, DOI 10.1111/j.1360-0443.2007.01849.x; Wang X, 2011, J NEUROIMMUNE PHARM, V6, P477, DOI 10.1007/s11481-011-9296-1; Willner-Reid J, 2008, J SUBST ABUSE TREAT, V35, P78, DOI 10.1016/j.jsat.2007.08.011; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210	23	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45632	10.1371/journal.pone.0045632	http://dx.doi.org/10.1371/journal.pone.0045632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029149	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800070
J	Hernandez, JF; Mantel-Teeuwisse, AK; van Thiel, GJMW; Belitser, SV; Warmerdam, J; de Valk, V; Raaijmakers, JAM; Pieters, T				Hernandez, Juan Francisco; Mantel-Teeuwisse, Aukje K.; van Thiel, Ghislaine J. M. W.; Belitser, Svetlana V.; Warmerdam, Jan; de Valk, Vincent; Raaijmakers, Jan A. M.; Pieters, Toine			A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK	PLOS ONE			English	Article							SUICIDE RATES; RISK; IMPACT; SALES; PRESCRIPTIONS; DEPRESSION; PAROXETINE; PUBLICITY; PATTERNS; CHILDREN	Background: In 2003-2004 and 2007-2008, the regulatory banning of SSRI use in pediatrics and young adults due to concerns regarding suicidality risk coincided with negative media coverage. SSRI use trends were analyzed from 2000-2010 in the Netherlands (NL) and the UK, and whether trend changes might be associated with media coverage of regulatory warnings. Methods: Monthly SSRIs sales were presented as DDDs/1000 inhabitants/day. SSRI-use trends were studied using time-series segmented regression analyses. Timing of trend changes was compared with two periods of media coverage of warnings. Annual Dutch SSRI prescription data were analyzed by age group. Results: Trend changes in SSRI use largely corroborated with the periods of media coverage of warnings. British SSRI use declined from 3.9 to 0.7 DDDs/month (95%CI 3.3;4.5 & 0.5;0.9, respectively) before the first warning period (2003-2004). A small decrease of -0.6 DDDs/month (-1.2; -0.05) was observed in Dutch SSRI use shortly after 2003-2004. From 20072008, British SSRI use stabilized, whilst Dutch SSRI use diminished to -0.04 DDDs/month (-0.4;0.3). Stratified analyses showed a rapid decrease of -1.2 DDDs/month (-2.1;-1.7) in UK paroxetine use before 2003-2004, but only a minimal change in Dutch paroxetine use (-0.3 DDDs/month -0.8;0.2). Other SSRI use, especially (es) citalopram, increased during 2003-2004 in both countries. Significant reductions in Dutch paroxetine use were observed in pediatrics, adolescents, and young adults after 2003-2004. Conclusion: Changes in SSRI use (NL & UK) were associated with the timing of the combined effect of media coverage and regulatory warnings. Our long-term assessment illustrates that changes in SSRI use were temporal, drug-specific and more pronounced in pediatrics and young adults. The twofold increase in SSRI use over one decade indicates that regulatory warnings and media coverage may come and go, but they do not have a significant impact on the overall upward trend of SSRI use as a class in both countries.	[Hernandez, Juan Francisco; Mantel-Teeuwisse, Aukje K.; Belitser, Svetlana V.; Raaijmakers, Jan A. M.; Pieters, Toine] Univ Utrecht, Utrecht Inst Pharmaceut Sci UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van Thiel, Ghislaine J. M. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Warmerdam, Jan] IMS Hlth, Capelle Aan Den Ijssel, Netherlands; [de Valk, Vincent] Healthcare Insurance Board CVZ, Genees En Hulpmiddelen Informatie Project GIP Dru, Diemen, Netherlands; [Raaijmakers, Jan A. M.] GlaxoSmithKline, External Sci Collaborat Europe, Zeist, Netherlands; [Pieters, Toine] Vrije Univ Amsterdam Med Ctr, EMGO, Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; GlaxoSmithKline; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Pieters, T (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	t.pieters@uu.nl	Van Thiel, Ghislaine/R-8977-2019; Mantel-Teeuwisse, Aukje/I-8902-2016	van Thiel, Ghislaine/0000-0003-1799-1894; Pieters, Toine/0000-0002-8156-8436	Dutch Top Institute Pharma [T6-202]; GlaxoSmithKline (GSK); Top Institute Pharma; Dutch Medicines Evaluation Board; Dutch Ministry of Health; Netherlands Organisation for Health Research and Development (ZonMW); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); private-public funded Top Institute Pharma; EU Innovative Medicines Initiative (IMI); EU 7th Framework Program (FP7); Dutch Ministry of Health and industry; Pfizer	Dutch Top Institute Pharma; GlaxoSmithKline (GSK)(GlaxoSmithKline); Top Institute Pharma; Dutch Medicines Evaluation Board; Dutch Ministry of Health; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); private-public funded Top Institute Pharma; EU Innovative Medicines Initiative (IMI); EU 7th Framework Program (FP7); Dutch Ministry of Health and industry; Pfizer(Pfizer)	This study was performed in the context of the Escher project (T6-202), a project of the Dutch Top Institute Pharma. The Division of Pharmacoepidemiology and Clinical Pharmacology, employing authors JFH, AKM, SVB, JAMR and TP, has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline (GSK), the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAMR is part-time professor at the Utrecht University and vice-president of external scientific collaborations for GSK in Europe, and holds stock in GSK. GSK was a co-funder for this study as part of the Dutch government-led research consortium TI-Pharma-Escher programme. The department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, has received unrestricted research funding from the Netherlands Organisation for Health Research and Development (ZonMW), the Dutch Health Care Insurance Board (CVZ), the Royal Dutch Pharmacists Association (KNMP), the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the EU Innovative Medicines Initiative (IMI), EU 7th Framework Program (FP7), the Dutch Medicines Evaluation Board, the Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer, and others). JW is director Healthcare Relations at IMS Health in the NL. VV is data manager at the GIP (Drug Information Project) in the NL. Paroxetine is a Glaxo Smith Kline product. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Archer DF, 2007, PHARMACOEPIDEM DR S, V16, P28, DOI 10.1002/pds.1342; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; BBC, 2001, ANT ADD WARN; BBC, 2002, PAN SECR SER; Boseley S, 2008, PROZAC USED 40M PEOP; Bramness JG, 2007, J AFFECT DISORDERS, V102, P1, DOI 10.1016/j.jad.2006.12.002; Brouneus F, 2005, EUR J CLIN PHARMACOL, V61, P285, DOI 10.1007/s00228-005-0914-9; CBO, 2010, RICHTL MULT RICHTL D; CBS, 2011, BEV; Check E, 2004, NATURE, V431, P122, DOI 10.1038/431122a; Check E, 2004, NATURE, V430, P954, DOI 10.1038/430954a; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; CVZ, 2012, GIPEILINGEN; EMA, 2008, CHMP ASS REP ANT; EMA, 2005, EUR MED AG FIN REV A; *FDA, 2007, ANT US CHILDR AD AD; FDA, 2004, SUIC CHILDR AD BEING; Gardarsdottir H, 2006, PHARMACOEPIDEM DR S, V15, P338, DOI 10.1002/pds.1223; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Guardian T, 2001, 4 PEOPL DEAD IS 4 TO; Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; Healy D, 2006, PLOS MED, V3, P1478, DOI 10.1371/journal.pmed.0030372; Hernandez JF, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000290; Isacsson G, 2009, ACTA PSYCHIAT SCAND, V120, P37, DOI 10.1111/j.1600-0447.2009.01344.x; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Korkeila J, 2007, J CLIN PSYCHIAT, V68, P505, DOI 10.4088/JCP.v68n0403; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Liem TBY, 2010, EUR J CLIN MICROBIOL, V29, P1301, DOI 10.1007/s10096-010-0990-3; Martin RM, 2006, BRIT J CLIN PHARMACO, V61, P224, DOI 10.1111/j.1365-2125.2005.02527.x; McRae F, 2008, ANTIDEPRESSANTS TAKE; Mebane FE, 2005, PHARMACOEPIDEM DR S, V14, P297, DOI 10.1002/pds.993; Meijer WEE, 2004, EUR J CLIN PHARMACOL, V60, P57, DOI 10.1007/s00228-004-0726-3; MHRA, 2004, REP CSM EXP WORK GRO; Milane MS, 2006, PLOS MED, V3, P816, DOI 10.1371/journal.pmed.0030190; Nemeroff CB, 2007, ARCH GEN PSYCHIAT, V64, P466, DOI 10.1001/archpsyc.64.4.466; NHG, 2009, M44 NHG STAND DEPR S; NICE, 2009, NAT CLIN PRACT GUID; Olfson M, 2008, ARCH GEN PSYCHIAT, V65, P94, DOI 10.1001/archgenpsychiatry.2007.5; R Foundation for Statistical Computing, R PROJECT STAT COMPU; Reid S, 2010, BRIT MED J, P340; Reseland S, 2006, BRIT J PSYCHIAT, V188, P354, DOI 10.1192/bjp.188.4.354; Stolk P, 2008, VALUE HEALTH, V11, P989, DOI 10.1111/j.1524-4733.2008.00331.x; Tonks A, 2002, BRIT MED J, V324, P260, DOI 10.1136/bmj.324.7332.260; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Volkers AC, 2007, PHARMACOEPIDEM DR S, V16, P1054, DOI 10.1002/pds.1430; Wadman M, 2004, NATURE, V429, P589, DOI 10.1038/429589a; Wheeler BW, 2008, BMJ-BRIT MED J, V336, P542, DOI 10.1136/bmj.39462.375613.BE; WHO, ATC DDD IND 2011; Wijlaars LPMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033181; Williams D, 2000, PHARMACOEPIDEM DR S, V9, P313, DOI 10.1002/1099-1557(200007/08)9:4<313::AID-PDS508>3.0.CO;2-F; World Health Organization (WHO), GUID ATC CLASS DDD A; Xianping G, 2002, SEGMENTAL SEMIMARKOV	55	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45515	10.1371/journal.pone.0045515	http://dx.doi.org/10.1371/journal.pone.0045515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029065	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900067
J	Lee, J; Friese, A; Mielich, M; Sigrist, M; Arber, S				Lee, Jun; Friese, Andreas; Mielich, Monika; Sigrist, Markus; Arber, Silvia			Scaling Proprioceptor Gene Transcription by Retrograde NT3 Signaling	PLOS ONE			English	Article							TARGET-DERIVED NEUROTROPHINS; MUSCLE SENSORY NEURONS; SPINAL-CORD; PRESYNAPTIC INHIBITION; MOTOR-NEURONS; PRIMARY AFFERENTS; NERVOUS-SYSTEM; DRG NEURONS; IN-VIVO; BRAIN	Cell-type specific intrinsic programs instruct neuronal subpopulations before target-derived factors influence later neuronal maturation. Retrograde neurotrophin signaling controls neuronal survival and maturation of dorsal root ganglion (DRG) sensory neurons, but how these potent signaling pathways intersect with transcriptional programs established at earlier developmental stages remains poorly understood. Here we determine the consequences of genetic alternation of NT3 signaling on genome-wide transcription programs in proprioceptors, an important sensory neuron subpopulation involved in motor reflex behavior. We find that the expression of many proprioceptor-enriched genes is dramatically altered by genetic NT3 elimination, independent of survival-related activities. Combinatorial analysis of gene expression profiles with proprioceptors isolated from mice expressing surplus muscular NT3 identifies an anticorrelated gene set with transcriptional levels scaled in opposite directions. Voluntary running experiments in adult mice further demonstrate the maintenance of transcriptional adjustability of genes expressed by DRG neurons, pointing to life-long gene expression plasticity in sensory neurons.	[Lee, Jun; Friese, Andreas; Mielich, Monika; Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland; [Lee, Jun; Friese, Andreas; Mielich, Monika; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.	silvia.arber@unibas.ch		Arber, Silvia/0000-0002-6261-250X	ERC Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	All authors were supported by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, EU Framework Program 7 and the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bautista W, 2012, J PHYSIOL-LONDON, V590, P3821, DOI 10.1113/jphysiol.2011.225987; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Brown AG, 1981, ORG SPINAL CORD; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; da Silva S, 2011, CURR OPIN NEUROBIOL, V21, P61, DOI 10.1016/j.conb.2010.07.007; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P237, DOI 10.1113/jphysiol.1962.sp006884; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FRANK K, 1957, FED PROC, V16, P39; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gaspard Nicolas, 2011, F1000 Biol Rep, V3, P6, DOI 10.3410/B3-6; Gong SC, 2010, NAT PROTOC, V5, P1678, DOI 10.1038/nprot.2010.131; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862; Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x; Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; Mendell LM, 1999, J NEUROSCI, V19, P3162; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MU XJ, 1993, J NEUROSCI, V13, P4029; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Oakley RA, 1997, J NEUROSCI, V17, P4262; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Scott SA, 1992, SENSORY NEURONS DIVE; Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang R, 2008, NAT NEUROSCI, V11, P488, DOI 10.1038/nn2069; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; Wu MR, 2010, FRONT BIOSCI-LANDMRK, V15, P957, DOI 10.2741/3656; Zelena J, 1994, NERVES MECHANORECEPT; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	58	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45551	10.1371/journal.pone.0045551	http://dx.doi.org/10.1371/journal.pone.0045551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029089	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400103
J	Felger, I; Maire, M; Bretscher, MT; Falk, N; Tiaden, A; Sama, W; Beck, HP; Owusu-Agyei, S; Smith, TA				Felger, Ingrid; Maire, Martin; Bretscher, Michael T.; Falk, Nicole; Tiaden, Andre; Sama, Wilson; Beck, Hans-Peter; Owusu-Agyei, Seth; Smith, Thomas A.			The Dynamics of Natural Plasmodium falciparum Infections	PLOS ONE			English	Article							MALARIA TRANSMISSION; SEASONAL-VARIATION; ACQUIRED-IMMUNITY; ANOPHELES-GAMBIAE; PROSPECTIVE RISK; RECOVERY RATES; DRY SEASON; CHILDREN; AGE; DETECTABILITY	Background: Natural immunity to Plasmodium falciparum has been widely studied, but its effects on parasite dynamics are understood. Acquisition and clearance rates of untreated infections are key elements of the dynamics of malaria, but estimating these parameters is challenging because of frequent super-infection and imperfect detectability of parasites. Consequently, information on effects of host immune status or age on infection dynamics is fragmentary. Methods: An age-stratified cohort of 347 individuals from Northern Ghana was sampled six times at 2 month intervals. High-throughput capillary electrophoresis was used to genotype the msp-2 locus of all P. falciparum infections detected by PCR. Force of infection (FOI) and duration were estimated for each age group using an immigration-death model that allows for imperfect detection of circulating parasites. Results: Allowing for imperfect detection substantially increased estimates of FOI and duration. Effects of naturally acquired immunity on the FOI and duration would be reflected in age dependence in these indices, but in our cohort data FOI tended to increase with age in children. Persistence of individual parasite clones was characteristic of all age-groups. Duration peaked in 5-9 year old children (average duration 319 days, 95% confidence interval 318; 320). Conclusions: The main age-dependence is on parasite densities, with only small age-variations in the FOI and persistence of infections. This supports the hypothesis that acquired immunity controls transmission mainly by limiting blood-stage parasite densities rather than changing rates of acquisition or clearance of infections.	[Felger, Ingrid; Maire, Martin; Bretscher, Michael T.; Falk, Nicole; Tiaden, Andre; Sama, Wilson; Beck, Hans-Peter; Owusu-Agyei, Seth; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Felger, Ingrid; Maire, Martin; Bretscher, Michael T.; Falk, Nicole; Tiaden, Andre; Sama, Wilson; Beck, Hans-Peter; Smith, Thomas A.] Univ Basel, Basel, Switzerland; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Kintampo Health Research Centre	Smith, TA (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Thomas-A.Smith@unibas.ch	Smith, Thomas/B-5569-2015	Smith, Thomas/0000-0002-3650-9381; Owusu-Agyei, Seth/0000-0002-0807-1781; Beck, Hans-Peter/0000-0001-8326-4834; Felger, Ingrid/0000-0003-1255-2606	Swiss National Science Foundation [3300C0-105994/1]; Bill & Melinda Gates Foundation [39777]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The study was supported by Swiss National Science Foundation (grant 3300C0-105994/1) and grant #39777 from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; ARON JL, 1983, MATH BIOSCI, V64, P249, DOI 10.1016/0025-5564(83)90007-X; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; CARNEVALE P, 1978, B WORLD HEALTH ORGAN, V56, P147; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Falk N, 2006, AM J TROP MED HYG, V74, P944, DOI 10.4269/ajtmh.2006.74.944; Felger I, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P3, DOI 10.1016/S0035-9203(99)90320-6; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Gilbert E, 2004, B MATH BIOL, V66, P1821, DOI 10.1016/j.bulm.2004.04.003; Khosravi A, 2011, PARASITE IMMUNOL, V33, P145, DOI 10.1111/j.1365-3024.2010.01260.x; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; Kobbe R, 2006, TROP MED INT HEALTH, V11, P613, DOI 10.1111/j.1365-3156.2006.01618.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Molineaux L, 1980, THE GARKI PROJECT; Muller DA, 2001, ACTA TROP, V78, P155, DOI 10.1016/S0001-706X(01)00067-5; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; PORT GR, 1980, B ENTOMOL RES, V70, P133, DOI 10.1017/S0007485300009834; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Sama W, 2006, T ROY SOC TROP MED H, V100, P811, DOI 10.1016/j.trstmh.2005.11.001; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sama W, 2005, STAT MED; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Smith T, 1999, T ROY SOC TROP MED H, V93, pS53, DOI 10.1016/S0035-9203(99)90328-0; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Smith T, 2012, TRENDS PARASITOL, V28, P3, DOI 10.1016/j.pt.2011.09.002; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4	44	73	73	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45542	10.1371/journal.pone.0045542	http://dx.doi.org/10.1371/journal.pone.0045542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029082	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000311313900154
J	Zou, L; Zhong, R; Lou, J; Lu, XZ; Wang, Q; Yang, Y; Xia, JH; Ke, JT; Zhang, T; Sun, Y; Liu, L; Cui, YP; Xiao, HB; Chang, L; Xia, D; Xu, H				Zou, Li; Zhong, Rong; Lou, Jiao; Lu, Xuzai; Wang, Qi; Yang, Yang; Xia, Jiahong; Ke, Juntao; Zhang, Ti; Sun, Yu; Liu, Li; Cui, Yongping; Xiao, Haibing; Chang, Lei; Xia, Ding; Xu, Hua			Replication Study in Chinese Population and Meta-Analysis Supports Association of the 11q23 Locus with Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; RISK; POLYMORPHISMS; SCAN; HETEROGENEITY; IMPACT	Background: A common single nucleotide polymorphism (SNP), rs3802842, located at 11q23, was identified by genome-wide association studies (GWAS) to be significantly associated with the risk of colorectal cancer (CRC); however, the results of following replication studies were not always concordant. Thus, a case-control study and a meta-analysis were performed to clearly discern the effect of this variant in CRC. Method and Findings: We determined the genotypes of rs3802842 in 641 unrelated Chinese patients with CRC and 1037 cancer-free controls. Additionally, a meta-analysis comprising current and previously published studies was conducted. In our case-control study, significant associations between the polymorphism and CRC risk were observed in all genetic models, with an additive OR being 1.45 (95% CI = 1.26-1.67). The meta-analysis of 38534 cases and 39446 controls further confirmed the significant associations in all genetic models but with obvious between-study heterogeneity. Nevertheless, ethnicity, study type and whether subjects affected by Lynch syndrome could synthetically accounted for the heterogeneity. Besides, the cumulative and sensitivity analyses indicated the robust stability of the results. Conclusion: The results from our case-control study and meta-analysis provided convincing evidence that rs3802842 significantly contributed to CRC risk.	[Zou, Li; Wang, Qi; Yang, Yang; Xiao, Haibing; Chang, Lei; Xia, Ding; Xu, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Lou, Jiao; Lu, Xuzai; Ke, Juntao; Zhang, Ti; Sun, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Lou, Jiao; Lu, Xuzai; Ke, Juntao; Zhang, Ti; Sun, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Xia, Jiahong] Huazhong Univ Sci & Technol, Union Hosp, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Cui, Yongping] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan, Shanxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Shanxi Medical University	Xu, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China.	xuhuawhu@163.com			National Natural Science Foundation of China [31072238, 31172441, 81170650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31072238, 31172441, 81170650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Chen WQ, 2012, CHINESE J CANCER RES, V24, P1, DOI 10.1007/s11670-012-0001-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lee ASG, 2000, BRIT J CANCER, V83, P750, DOI 10.1054/bjoc.2000.1366; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lubbe SJ, 2012, AM J EPIDEMIOL, V175, P1, DOI 10.1093/aje/kwr285; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marino C, 2011, BEHAV GENET, V41, P67, DOI 10.1007/s10519-010-9412-7; Mates IN, 2010, CHIRURGIA-BUCHAREST, V105, P749; Mates IN, 2012, J GASTROINTEST LIVER, V21, P45; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Mocellin S, 2012, J NATL CANC I; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Pardini B, 2012, MUTAGENESIS, V27, P161, DOI 10.1093/mutage/ger057; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Talseth-Palmer BA, 2011, J MED GENET, V48, P279, DOI 10.1136/jmg.2010.079962; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; US Cancer Statistics Working Group, 2010, US CANC STAT USCS 19; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wan De-Sen, 2009, Ai Zheng, V28, P897; Wijnen JT, 2009, GASTROENTEROLOGY, V136, P131, DOI 10.1053/j.gastro.2008.09.033; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	40	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45461	10.1371/journal.pone.0045461	http://dx.doi.org/10.1371/journal.pone.0045461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029024	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900140
J	Ma, L; Niknejad, N; Gorn-Hondermann, I; Dayekh, K; Dimitroulakos, J				Ma, Laurie; Niknejad, Nima; Gorn-Hondermann, Ivan; Dayekh, Khalil; Dimitroulakos, Jim			Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MEVALONATE PATHWAY; PROTEIN-KINASE; INDUCED APOPTOSIS; PHASE-I; CANCER; LKB1; TARGETS; PHOSPHORYLATION; SENSITIVITY	Background: Cellular stress responses trigger signaling cascades that inhibit proliferation and protein translation to help alleviate the stress or if the stress cannot be overcome induce apoptosis. In recent studies, we demonstrated the ability of lovastatin, an inhibitor of mevalonate synthesis, to induce the Integrated Stress Response as well as inhibiting epidermal growth factor receptor (EGFR) activation. Methodology/Principal Findings: In this study, we evaluated the effects of lovastatin on the activity of the LKB1/AMPK pathway that is activated upon cellular energy shortage and can interact with the above pathways. In the squamous cell carcinoma (SCC) cell lines SCC9 and SCC25, lovastatin treatment (1-25 mu M, 24 hrs) induced LKB1 and AMPK activation similar to metformin (1-10 mM, 24 hrs), a known inducer of this pathway. Lovastatin treatment impaired mitochondrial function and also decreased cellular ADP/ATP ratios, common triggers of LKB1/AMPK activation. The cytotoxic effects of lovastatin were attenuated in LKB1 null MEFs indicating a role for this pathway in regulating lovastatin-induced cytotoxicity. Of clinical relevance, lovastatin induces synergistic cytotoxicity in combination with the EGFR inhibitor gefitinib. In LKB1 deficient (A549, HeLa) and expressing (SCC9, SCC25) cell lines, metformin enhanced gefitinib cytotoxicity only in LKB1 expressing cell lines while both groups showed synergistic cytotoxic effects with lovastatin treatments. Furthermore, the combination of lovastatin with gefitinib induced a potent apoptotic response without significant induction of autophagy that is often induced during metabolic stress inhibiting cell death. Conclusion/Significance: Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.	[Ma, Laurie; Niknejad, Nima; Gorn-Hondermann, Ivan; Dayekh, Khalil; Dimitroulakos, Jim] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Dayekh, Khalil; Dimitroulakos, Jim] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Dayekh, Khalil; Dimitroulakos, Jim] Univ Ottawa, Dept Biochem, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Dimitroulakos, J (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	jdimitroulakos@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Canadian Institute of Health Research; Ottawa Regional Cancer Foundation; Prostate Cancer Fight Foundation (Motorcycle Ride for Dad)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation; Prostate Cancer Fight Foundation (Motorcycle Ride for Dad)	Research support from the Canadian Institute of Health Research (J.D.) and the Ottawa Regional Cancer Foundation and the Prostate Cancer Fight Foundation (Motorcycle Ride for Dad) (J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Boudeau J, 2003, FEBS LETT, V546, P159, DOI 10.1016/S0014-5793(03)00642-2; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chan KKW, 2003, CLIN CANCER RES, V9, P10; CHIACCHIERA F, 2010, CELL CYCLE IN PRESS, P9; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2001, CLIN CANCER RES, V7, P158; Dimitroulakos J, 1996, NAT MED, V2, P326, DOI 10.1038/nm0396-326; Dimitroulakos J, 2006, CLIN CANCER RES, V12, p4426S, DOI 10.1158/1078-0432.CCR-06-0089; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Herbst RS, 2003, SEMIN ONCOL, V30, P34, DOI 10.1016/S0093-7754(03)00184-2; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Korade Z, 2010, J LIPID RES, V51, P3259, DOI 10.1194/jlr.M009365; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Lian J, 2008, MOL NUTR FOOD RES, V52, P393, DOI 10.1002/mnfr.200700005; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Murtola TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039445; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; Sinthupibulyakit C, 2010, INT J ONCOL, V37, P1575, DOI 10.3892/ijo_00000811; Thibault A, 1996, CLIN CANCER RES, V2, P483; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219	52	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46055	10.1371/journal.pone.0046055	http://dx.doi.org/10.1371/journal.pone.0046055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029387	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900082
J	Sordelli, MS; Beltrame, JS; Cella, M; Gervasi, MG; Martinez, SP; Burdet, J; Zotta, E; Franchi, AM; Ribeiro, ML				Sordelli, Micaela S.; Beltrame, Jimena S.; Cella, Maximiliano; Gracia Gervasi, Maria; Perez Martinez, Silvina; Burdet, Juliana; Zotta, Elsa; Franchi, Ana M.; Laura Ribeiro, Maria			Interaction between Lysophosphatidic Acid, Prostaglandins and the Endocannabinoid System during the Window of Implantation in the Rat Uterus	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO IMPLANTATION; LYSOPHOSPHOLIPASE-D; CANNABINOID RECEPTOR; NITRIC-OXIDE; DIFFERENTIAL EXPRESSION; PERIIMPLANTATION PERIOD; MOUSE UTERUS; UTERINE; PREGNANCY	Bioactive lipid molecules as lysophosphatidic acid (LPA), prostaglandins (PG) and endocannabinoids are important mediators of embryo implantation. Based on previous published data we became interested in studying the interaction between these three groups of lipid derivatives in the rat uterus during the window of implantation. Thus, we adopted a pharmacological approach in vitro using LPA, DGPP (a selective antagonist of LPA3, an LPA receptor), endocannabinoids' receptor selective antagonists (AM251 and AM630) and non selective (indomethacin) and selective (NS-398) inhibitors of cyclooxygenase-1 and 2 enzymes. Cyclooxygenase isoforms participate in prostaglandins' synthesis. The incubation of the uterus from rats pregnant on day 5 of gestation (implantation window) with LPA augmented the activity and the expression of fatty acid amide hydrolase, the main enzyme involved in the degradation of endocannabinoids in the rodent uteri, suggesting that LPA decreased endocannabinoids' levels during embryo implantation. It has been reported that high endocannabinoids are deleterious for implantation. Also, LPA increased PGE2 production and cyclooxygenase-2 expression. The incubation of LPA with indomethacin or NS-398 reversed the increment in PGE2 production, suggesting that cyclooxygenase-2 was the isoform involved in LPA effect. PGs are important mediators of decidualization and vascularization at the implantation sites. All these effects were mediated by LPA3, as the incubation with DGPP completely reversed LPA stimulatory actions. Besides, we also observed that endocannabinoids mediated the stimulatory effect of LPA on cyclooxygenase-2 derived PGE2 production, as the incubation of LPA with AM251 or AM630 completely reversed LPA effect. Also, LPA augmented via LPA3 decidualization and vascularization markers. Overall, the results presented here demonstrate the participation of LPA3 in the process of implantation through the interaction with other groups of lipid molecules, prostaglandins and endocannabinoids, which prepare the uterine milieu for embryo invasion during the window of implantation.	[Sordelli, Micaela S.; Beltrame, Jimena S.; Laura Ribeiro, Maria] UBA, Fac Med, CONICET, Lab Fisiol & Farmacol Reprod,CEFYBO, Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] UBA, Fac Med, CONICET, Lab Fisiopatol Prenez & Parto,CEFYBO, Buenos Aires, DF, Argentina; [Gracia Gervasi, Maria; Perez Martinez, Silvina] UBA, Fac Med, CONICET, Lab Biol Reprod Mamiferos,CEFYBO, Buenos Aires, DF, Argentina; [Burdet, Juliana; Zotta, Elsa] UBA, Fac Farm & Bioquim, Dept Cs Biol, Catedra Fisiopatol,Lab Fisiopatol Mol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Ribeiro, ML (corresponding author), UBA, Fac Med, CONICET, Lab Fisiol & Farmacol Reprod,CEFYBO, Buenos Aires, DF, Argentina.	marialribeiro@yahoo.com.ar		zotta, elsa/0000-0002-8763-5046; Ribeiro, Maria Laura/0000-0002-3679-0193; Gervasi, Maria Gracia/0000-0002-5468-2700	Proyecto de Investigacion Plurianual (CONICET); Proyecto de Investigacion en Ciencia y Tecnologia (FONCYT)	Proyecto de Investigacion Plurianual (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Proyecto de Investigacion en Ciencia y Tecnologia (FONCYT)	This work was funded by Proyecto de Investigacion Plurianual 2008 (CONICET) and Proyecto de Investigacion en Ciencia y Tecnologia 2006 (FONCYT) to AMF; Proyecto de Investigacion Cientifica y Tecnologica 2010 (FONCYT) to MLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Achache H, 2010, FERTIL STERIL, V94, P1271, DOI 10.1016/j.fertnstert.2009.07.1668; Alexander JS, 1998, AM J PHYSIOL-HEART C, V274, pH115, DOI 10.1152/ajpheart.1998.274.1.H115; BANY BM, 1995, BIOL REPROD, V53, P126, DOI 10.1095/biolreprod53.1.126; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callegari EA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-3; CAMPBELL WB, 1987, METHOD ENZYMOL, V141, P323, DOI 10.1016/0076-6879(87)41080-X; Cong J, 2006, REPRODUCTION, V131, P139, DOI 10.1530/rep.1.00861; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Gainor JP, 2001, AM J PHYSIOL-HEART C, V281, P1992; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Iwasawa Y, 2009, AM J REPROD IMMUNOL, V62, P90, DOI 10.1111/j.1600-0897.2009.00715.x; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lim HJ, 2002, VITAM HORM, V64, P43, DOI 10.1016/S0083-6729(02)64002-6; Liszewska E, 2009, ENDOCRINOLOGY, V150, P422, DOI 10.1210/en.2008-0749; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Moore F, 2000, BIOCHEM BIOPH RES CO, V269, P322, DOI 10.1006/bbrc.2000.2290; Motta AB, 1997, PROSTAG LEUKOTR ESS, V56, P265, DOI 10.1016/S0952-3278(97)90569-X; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Ribeiro ML, 2005, P NATL ACAD SCI USA, V102, P8048, DOI 10.1073/pnas.0502899102; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Sordelli MS, 2012, EUR J PHARMACOL, V685, P174, DOI 10.1016/j.ejphar.2012.04.034; Sordelli MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018368; Stocco CO, 1998, J ENDOCRINOL, V156, P253, DOI 10.1677/joe.0.1560253; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x; Tokumura A, 1999, BIOL REPROD, V61, P195, DOI 10.1095/biolreprod61.1.195; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; TOKUMURA A, 1986, BIOCHIM BIOPHYS ACTA, V875, P31; TOKUMURA A, 1980, ARCH INT PHARMACOD T, V245, P74; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Wang HB, 2007, PROSTAG OTH LIPID M, V83, P62, DOI 10.1016/j.prostaglandins.2006.09.009; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121; Wodawek-Potocka I, 2009, REPRODUCTION, V137, P95, DOI 10.1530/REP-08-0209; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	54	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46059	10.1371/journal.pone.0046059	http://dx.doi.org/10.1371/journal.pone.0046059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029388	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900083
J	Stanley, R; Snelgrove, PVR; deYoung, B; Gregory, RS				Stanley, Ryan; Snelgrove, Paul V. R.; deYoung, Brad; Gregory, Robert S.			Dispersal Patterns, Active Behaviour, and Flow Environment during Early Life History of Coastal Cold Water Fishes	PLOS ONE			English	Article							COD GADUS-MORHUA; SHANNY ULVARIA-SUBBIFURCATA; CORAL-REEF FISHES; ATLANTIC COD; LARVAL FISH; SPATIAL-PATTERN; LOCOMOTOR MORPHOLOGY; SWIMMING PERFORMANCE; MARINE POPULATIONS; PELAGIC STAGES	During the pelagic larval phase, fish dispersal may be influenced passively by surface currents or actively determined by swimming behaviour. In situ observations of larval swimming are few given the constraints of field sampling. Active behaviour is therefore often inferred from spatial patterns in the field, laboratory studies, or hydrodynamic theory, but rarely are these approaches considered in concert. Ichthyoplankton survey data collected during 2004 and 2006 from coastal Newfoundland show that changes in spatial heterogeneity for multiple species do not conform to predictions based on passive transport. We evaluated the interaction of individual larvae with their environment by calculating Reynolds number as a function of ontogeny. Typically, larvae hatch into a viscous environment in which swimming is inefficient, and later grow into more efficient intermediate and inertial swimming environments. Swimming is therefore closely related to length, not only because of swimming capacity but also in how larvae experience viscosity. Six of eight species sampled demonstrated consistent changes in spatial patchiness and concomitant increases in spatial heterogeneity as they transitioned into more favourable hydrodynamic swimming environments, suggesting an active behavioural element to dispersal. We propose the tandem assessment of spatial heterogeneity and hydrodynamic environment as a potential approach to understand and predict the onset of ecologically significant swimming behaviour of larval fishes in the field.	[Stanley, Ryan; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada; [Stanley, Ryan; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Snelgrove, Paul V. R.] Mem Univ Newfoundland, Canada Res Chair Boreal & Cold Ocean Syst, St John, NF, Canada; [deYoung, Brad] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ecol Sci Sect, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ctr Expertise Aquat Habitat Res, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Stanley, R (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada.	rstanley@mun.ca			Natural Sciences and Engieering research Council of Canada; major federal government granting agency for natural sciences in Canada	Natural Sciences and Engieering research Council of Canada; major federal government granting agency for natural sciences in Canada	This study was funded by the Natural Sciences and Engieering research Council of Canada (www.nserc.ca), the major federal government granting agency for natural sciences in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Baumann H, 2003, ICES J MAR SCI, V60, P243, DOI 10.1016/S1054-3139(03)00019-5; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Bochdansky AB, 2008, MAR ECOL PROG SER, V367, P239, DOI 10.3354/meps07590; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bradbury IR, 2008, FISH RES, V91, P299, DOI 10.1016/j.fishres.2007.12.006; Bradbury IR, 2003, MAR ECOL PROG SER, V257, P233, DOI 10.3354/meps257233; Bradbury IR, 2001, FISH OCEANOGR, V10, P342, DOI 10.1046/j.1365-2419.2001.00179.x; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Bradbury IR, 2000, CAN J FISH AQUAT SCI, V57, P1761, DOI 10.1139/cjfas-57-9-1761; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crowder LB, 2000, B MAR SCI, V66, P799; DAVIDSON FJM, 1995, FISH OCEANOGR, V4, P33, DOI 10.1111/j.1365-2419.1995.tb00059.x; Davidson FJM, 2001, J GEOPHYS RES-OCEANS, V106, P7001, DOI 10.1029/2000JC900052; DEYOUNG B, 1995, ATMOS OCEAN, V33, P135, DOI 10.1080/07055900.1995.9649528; DEYOUNG B, 1993, CAN J FISH AQUAT SCI, V50, P2729, DOI 10.1139/f93-298; Fahay M.P., 2007, EARLY STAGES FISHES; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; FRANK KT, 1982, CAN J FISH AQUAT SCI, V39, P991, DOI 10.1139/f82-134; Fuiman LA, 1997, J EXP BIOL, V200, P1745; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gillis GB, 2003, J EXP BIOL, V206, P1768, DOI 10.1242/jeb.00297; Guan L, 2008, J EXP MAR BIOL ECOL, V360, P31, DOI 10.1016/j.jembe.2008.03.006; Harden Jones F.R., 1968, FISH MIGRATION; Hastings A, 2003, ECOL APPL, V13, pS65; HEWITT R, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P229; Hjort J., 1914, ICES, V20, P1; Kingsford MJ, 2002, B MAR SCI, V70, P309; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2007, MAR ECOL PROG SER, V349, P255, DOI 10.3354/meps07107; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2009, MAR FRESHWATER RES, V60, P211, DOI 10.1071/MF08186; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2010, FISH LOCOMOTION ECOE, P333; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; MATSUURA Y, 1995, FISH B-NOAA, V93, P172; Maynou F, 2006, FISH OCEANOGR, V15, P390, DOI 10.1111/j.1365-2419.2005.00398.x; MCGURK MD, 1987, ENVIRON BIOL FISH, V20, P81, DOI 10.1007/BF00005288; McHenry MJ, 2006, J MORPHOL, V267, P1099, DOI 10.1002/jmor.10462; Methven DA, 2003, ICES J MAR SCI, V60, P38, DOI 10.1006/jmsc.2002.1315; Muller UK, 1996, REV FISH BIOL FISHER, V6, P353, DOI 10.1007/BF00122586; Papritz A, 1999, SPATIAL STAT REMOTE, P83, DOI [DOI 10.1007/0-306-47647-9_6, 10.1007/0-306-47647-9_6]; Pepin P, 2000, MAR ECOL PROG SER, V204, P199, DOI 10.3354/meps204199; Pepin P, 1997, CAN J FISH AQUAT SCI, V54, P765, DOI 10.1139/cjfas-54-4-765; Pepin P, 2003, FISH OCEANOGR, V12, P19, DOI 10.1046/j.1365-2419.2003.00221.x; Pepin P, 2002, CAN J FISH AQUAT SCI, V59, P105, DOI 10.1139/F01-198; Rose G, 1996, NAFO SCI COUNCIL STU, V96; Schillinger DJ, 2000, PHYS BIOL 2 YO DATA; Snelgrove PVR, 2008, CAN J FISH AQUAT SCI, V65, P159, DOI 10.1139/F07-148; St Germain C, 2007, ZOOPLANKTON SPATIAL, P57; Stabeno PJ, 1996, FISH OCEANOGR, V5, P81, DOI 10.1111/j.1365-2419.1996.tb00084.x; Stanley RRE, 2009, BIOPHYSICAL STUDY CO; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TANAKA M, 1985, T AM FISH SOC, V114, P471, DOI 10.1577/1548-8659(1985)114<471:FATIMO>2.0.CO;2; TEMPLEMAN W, 1981, Journal of Northwest Atlantic Fishery Science, V2, P21; Tittensor D. P., 2002, ANAL PHYS OCEANOGRAP; Tittensor DP, 2001, ANAL PHYS OCEANOGRAP, P90; von Herbing IH, 2002, J FISH BIOL, V61, P865, DOI 10.1006/jfbi.2002.2118; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Williams PJ, 1996, CAN J FISH AQUAT SCI, V53, P1246, DOI 10.1139/cjfas-53-6-1246; Wroblewski J, 2005, COAST MANAGE, V33, P411, DOI 10.1080/08920750500217930; Yao T, 1986, ATMOS OCEAN, V24, P235, DOI 10.1080/07055900.1986.9649249	69	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46266	10.1371/journal.pone.0046266	http://dx.doi.org/10.1371/journal.pone.0046266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029455	Green Published, Green Accepted, gold			2022-12-27	WOS:000309973900119
J	Xu, Y; Huang, LZ; Fu, S; Wu, JX; Zhou, XP				Xu, Yi; Huang, Lingzhe; Fu, Shuai; Wu, Jianxiang; Zhou, Xueping			Population Diversity of Rice Stripe Virus-Derived siRNAs in Three Different Hosts and RNAi-Based Antiviral Immunity in Laodelphgax striatellus	PLOS ONE			English	Article							ARABIDOPSIS; INTERFERENCE; DEFENSE; POLYMERASE; AMPLIFICATION; COMPLEXES; BIOLOGY; STRAND	Background: Small RNA-mediated gene silencing plays evolutionarily conserved roles in gene regulation and defense against invasive nucleic acids. Virus-derived small interfering RNAs (vsiRNAs) are one of the key elements involved in RNA silencing-based antiviral activities in plant and insect. vsiRNAs produced after viruses infecting hosts from a single kingdom (i.e., plant or animal) are well described. In contrast, vsiRNAs derived from viruses capable of infecting both plants and their insect vectors have not been characterized. Methodology/Principal Findings: We examined Rice stripe virus (RSV)-derived small interfering RNAs in three different hosts, Oryza sativa, Nicotiana benthamiana and a natural RSV transmitting vector Laodelphgax striatellus, through deep sequencing. Our results show that large amounts of vsiRNAs generated in these hosts after RSV infection. The vsiRNAs from N. benthamiana and L. striatellus mapped equally to the genomic-and antigenomic-strand of RSV RNAs. They showed, however, a significant bias in those from O. sativa. Furthermore, our results demonstrate that the number and size distributions of vsiRNAs in the three hosts were very different. In O. sativa and N. benthamiana, most vsiRNAs were mapped to the discrete regions in the RSV genome sequence, and most of the vsiRNAs from these two hosts were generated from RSV genomic RNAs 3 and 4. In contrast, the vsiRNAs identified in L. striatellus distributed uniformly along the whole genome of RSV. We have also shown that silencing Agronaute 2 in L. striatellus enhanced RSV accumulation in this host. Conclusions/Significance: Our study demonstrates that the core RNA-induced gene silencing (RNAi) machinery is present in L. striatellus. We also provide evidence that the RNAi-mediated immunity against RSV is present in L. striatellus. We propose that a common small RNA-mediated virus defense mechanism exists in both helipterum insects and plants, but the vsiRNAs are generated differentially in different hosts.	[Xu, Yi; Huang, Lingzhe; Fu, Shuai; Wu, Jianxiang; Zhou, Xueping] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xueping] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, JX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	wujx@zju.edu.cn; zzhou@zju.edu.cn		Fu, Shuai/0000-0002-8338-0074	Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; National High Technology Research and Development Program of China (863 Program) [2012AA101505]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (IRT0943) and the National High Technology Research and Development Program of China (863 Program) (2012AA101505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; FALK BW, 1989, VIROLOGY, V173, P338, DOI 10.1016/0042-6822(89)90253-5; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hohn T, 2007, P NATL ACAD SCI USA, V104, P17905, DOI 10.1073/pnas.0709178104; Jiang L, 2012, VIRUS RES, V163, P512, DOI 10.1016/j.virusres.2011.11.016; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SY, 2011, PLOS ONE, V6; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sun F, 2011, J PHYTOPATHOL, V159, P767, DOI 10.1111/j.1439-0434.2011.01840.x; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xiong RY, 2008, J VIROL, V82, P12304, DOI 10.1128/JVI.01696-08; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303	47	29	29	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46238	10.1371/journal.pone.0046238	http://dx.doi.org/10.1371/journal.pone.0046238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029445	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900114
J	Zarrabi, N; Prosperi, M; Belleman, RG; Colafigli, M; De Luca, A; Sloot, PMA				Zarrabi, Narges; Prosperi, Mattia; Belleman, Robert G.; Colafigli, Manuela; De Luca, Andrea; Sloot, Peter M. A.			Combining Epidemiological and Genetic Networks Signifies the Importance of Early Treatment in HIV-1 Transmission	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ANTIRETROVIRAL THERAPY; EVOLUTIONARY DYNAMICS; RECONSTRUCTION; EPIDEMICS; EVENTS; SEX	Inferring disease transmission networks is important in epidemiology in order to understand and prevent the spread of infectious diseases. Reconstruction of the infection transmission networks requires insight into viral genome data as well as social interactions. For the HIV-1 epidemic, current research either uses genetic information of patients' virus to infer the past infection events or uses statistics of sexual interactions to model the network structure of viral spreading. Methods for a reliable reconstruction of HIV-1 transmission dynamics, taking into account both molecular and societal data are still lacking. The aim of this study is to combine information from both genetic and epidemiological scales to characterize and analyse a transmission network of the HIV-1 epidemic in central Italy. We introduce a novel filter-reduction method to build a network of HIV infected patients based on their social and treatment information. The network is then combined with a genetic network, to infer a hypothetical infection transmission network. We apply this method to a cohort study of HIV-1 infected patients in central Italy and find that patients who are highly connected in the network have longer untreated infection periods. We also find that the network structures for homosexual males and heterosexual populations are heterogeneous, consisting of a majority of 'peripheral nodes' that have only a few sexual interactions and a minority of 'hub nodes' that have many sexual interactions. Inferring HIV-1 transmission networks using this novel combined approach reveals remarkable correlations between high out-degree individuals and longer untreated infection periods. These findings signify the importance of early treatment and support the potential benefit of wide population screening, management of early diagnoses and anticipated antiretroviral treatment to prevent viral transmission and spread. The approach presented here for reconstructing HIV-1 transmission networks can have important repercussions in the design of intervention strategies for disease control.	[Zarrabi, Narges; Belleman, Robert G.; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Prosperi, Mattia] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Emerging Pathogens Inst, Gainesville, FL USA; [Prosperi, Mattia; Colafigli, Manuela; De Luca, Andrea] Univ Cattolica Sacro Cuore, Clin Infect Dis, I-00168 Rome, Italy; [De Luca, Andrea] Siena Univ Hosp, Infect Dis Unit, Siena, Italy; [Sloot, Peter M. A.] Natl Res Univ ITMO, St Petersburg, Russia; [Sloot, Peter M. A.] Nanyang Technol Univ, Singapore, Singapore	University of Amsterdam; State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; ITMO University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zarrabi, N (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	N.Zarrabi@uva.nl	De Luca, Andrea/G-8810-2011; Colafigli, Manuela/K-5167-2018; Sloot, Peter/B-3078-2014	De Luca, Andrea/0000-0002-9561-9193; Colafigli, Manuela/0000-0003-1610-6347; Sloot, Peter/0000-0002-3848-5395	DynaNets project; European Union [233847]; 'Leading Scientist Program' of the Government of the Russian Federation [11.G34.31.0019]	DynaNets project; European Union(European Commission); 'Leading Scientist Program' of the Government of the Russian Federation	This research was partly sponsored by the DynaNets project (www.dynanets.org), European Union grant agreement number 233847, and a grant from the 'Leading Scientist Program' of the Government of the Russian Federation, under contract 11.G34.31.0019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barcherini S, 1999, INT J EPIDEMIOL, V28, P122, DOI 10.1093/ije/28.1.122; Brancato G, 1997, INT J EPIDEMIOL, V26, P1107, DOI 10.1093/ije/26.5.1107; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown A.L., 2010, 17 C RETR OPP INF; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Castellano C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00371; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen MS, 2011, NEW ENGL J MED, V365, P1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DeGruttola V, 2011, CLIN INFECT DIS, V52, P1050, DOI 10.1093/cid/cir094; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2004, INFERRING PHYLOGENIE, V266, P418; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Fleischer NL, 2008, J EPIDEMIOL COMMUN H, V62, P842, DOI 10.1136/jech.2007.067371; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Giuliani M, 2005, AIDS, V19, P1429, DOI 10.1097/01.aids.0000180808.27298.af; Glymour M.M., 2006, METHODS SOCIAL EPIDE, P393; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Huson DH, 2010, PHYLOGENETIC NETWORK; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Lemey P, 2006, AIDS REV, V8, P125; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mei S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-118; Metzger VT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002015; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Phillips KD, 1992, J ASSOC NURSE AIDS C, V7, P57; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; REZZA G, 1994, J ACQ IMMUN DEF SYND, V7, P500; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Sloot PMA, 2008, INT J COMPUT MATH, V85, P1175, DOI 10.1080/00207160701750583; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Steel M., 2010, BIOMETRICS, V66, P324, DOI DOI 10.1111/J.1541-0420.2010.01388.X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thulasiraman K., 1992, GRAPHS THEORY ALGORI, P118; Van de Vijver D, 2006, REVIEWS, V2007, P17; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130	55	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46156	10.1371/journal.pone.0046156	http://dx.doi.org/10.1371/journal.pone.0046156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029421	Green Published, gold			2022-12-27	WOS:000309973900101
J	Beck, ET; He, J; Nelson, MI; Bose, ME; Fan, J; Kumar, S; Henrickson, KJ				Beck, Eric T.; He, Jie; Nelson, Martha I.; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.			Genome Sequencing and Phylogenetic Analysis of 39 Human Parainfluenza Virus Type 1 Strains Isolated from 1997-2010	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; RESPIRATORY SYNCYTIAL VIRUS; POLYMERASE-CHAIN-REACTION; NEWCASTLE-DISEASE VIRUS; SENDAI-VIRUS; RECOMBINANT SEQUENCES; MOLECULAR EVOLUTION; YOUNG-CHILDREN; GENE; IDENTIFICATION	Thirty-nine human parainfluenza type 1 (HPIV-1) genomes were sequenced from samples collected in Milwaukee, Wisconsin from 1997-2010. Following sequencing, phylogenetic analyses of these sequences plus any publicly available HPIV-1 sequences (from GenBank) were performed. Phylogenetic analysis of the whole genomes, as well as individual genes, revealed that the current HPIV-1 viruses group into three different clades. Previous evolutionary studies of HPIV-1 in Milwaukee revealed that there were two genotypes of HPIV-1 co-circulating in 1991 (previously described as HPIV-1 genotypes C and D). The current study reveals that there are still two different HPIV-1 viruses co-circulating in Milwaukee; however, both groups of HPIV-1 viruses are derived from genotype C indicating that genotype D may no longer be in circulation in Milwaukee. Analyses of genetic diversity indicate that while most of the genome is under purifying selection some regions of the genome are more tolerant of mutation. In the 40 HPIV-1 genomes sequenced in this study, the nucleotide sequence of the L gene is the most conserved while the sequence of the P gene is the most variable. Over the entire protein coding region of the genome, 81 variable amino acid residues were observed and as with nucleotide diversity, the P protein seemed to be the most tolerant of mutation (and contains the greatest proportion of non-synonymous to synonymous substitutions) while the M protein appears to be the least tolerant of amino acid substitution.	[Beck, Eric T.; He, Jie; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, Milwaukee, WI 53226 USA; [Beck, Eric T.; He, Jie; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Medical College of Wisconsin; Children's Hospital of Wisconsin; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Henrickson, KJ (corresponding author), Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Khenrick@mcw.edu			National Institutes of Health [NIAID U01-AI077988, NIAID U01-AI070428]; Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070428, U01AI077988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin(General Electric); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health (NIAID U01-AI077988 and NIAID U01-AI070428) with additional funding provided by the Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE MR, 1995, J INFECT DIS, V171, P851, DOI 10.1093/infdis/171.4.851; BOUSSE T, 1995, VIROLOGY, V209, P654, DOI 10.1006/viro.1995.1299; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Chong YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000872; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; CURRAN J, 1993, J VIROL, V67, P4358, DOI 10.1128/JVI.67.7.4358-4364.1993; Dave VP, 1997, VIRUS GENES, V14, P153; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FALSEY AR, 1991, INFECT CONT HOSP EP, V12, P602; Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Henrickson KJ, 1997, J INFECT DIS, V176, P867, DOI 10.1086/516533; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; Henrickson KJ, 1996, J CLIN MICROBIOL, V34, P695, DOI 10.1128/JCM.34.3.695-700.1996; HENRICKSON KJ, 1992, J INFECT DIS, V166, P995, DOI 10.1093/infdis/166.5.995; HETHERINGTON SV, 1994, J INFECT DIS, V169, P248, DOI 10.1093/infdis/169.2.248; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYN D, 1991, J GEN VIROL, V72, P983, DOI 10.1099/0022-1317-72-4-983; LYN D, 1991, J GEN VIROL, V72, P817, DOI 10.1099/0022-1317-72-4-817; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MATSUOKA Y, 1991, VIROLOGY, V181, P403, DOI 10.1016/0042-6822(91)90514-C; McAuliffe JM, 2004, J VIROL, V78, P2029, DOI 10.1128/JVI.78.4.2029-2036.2004; Mizuta K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-533; Newman JT, 2002, VIRUS GENES, V24, P77, DOI 10.1023/A:1014042221888; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Rassa JC, 1998, VIROLOGY, V247, P274, DOI 10.1006/viro.1998.9266; SMITH JM, 1992, J MOL EVOL, V34, P126; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; THOMPSON SD, 1987, VIROLOGY, V160, P1, DOI 10.1016/0042-6822(87)90037-7; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46048	10.1371/journal.pone.0046048	http://dx.doi.org/10.1371/journal.pone.0046048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029382	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500058
J	Casanova, CM; Sehr, P; Putzker, K; Hentze, MW; Neumann, B; Duncan, KE; Thoma, C				Casanova, Claudia M.; Sehr, Peter; Putzker, Kerstin; Hentze, Matthias W.; Neumann, Beate; Duncan, Kent E.; Thoma, Christian			Automated High-Throughput RNAi Screening in Human Cells Combined with Reporter mRNA Transfection to Identify Novel Regulators of Translation	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INTERNAL RIBOSOME ENTRY; TARGETING TRANSLATION; INITIATION; CANCER; EXPRESSION; VEGF; PHOSPHORYLATION; MECHANISMS; HYPOXIA	Proteins that promote angiogenesis, such as vascular endothelial growth factor (VEGF), are major targets for cancer therapy. Accordingly, proteins that specifically activate expression of factors like VEGF are potential alternative therapeutic targets and may help to combat evasive resistance to angiogenesis inhibitors. VEGF mRNA contains two internal ribosome entry sites (IRESs) that enable selective activation of VEGF protein synthesis under hypoxic conditions that trigger angiogenesis. To identify novel regulators of VEGF IRES-driven translation in human cells, we have developed a high-throughput screening approach that combines siRNA treatment with transfection of a VEGF-IRES reporter mRNA. We identified the kinase MAPK3 as a novel positive regulator of VEGF IRES-driven translation and have validated its regulatory effect on endogenous VEGF. Our automated method is scalable and readily adapted for use with other mRNA regulatory elements. Consequently, it should be a generally useful approach for high-throughput identification of novel regulators of mRNA translation.	[Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany; [Casanova, Claudia M.; Thoma, Christian] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany; [Casanova, Claudia M.; Sehr, Peter; Putzker, Kerstin; Hentze, Matthias W.; Neumann, Beate; Thoma, Christian] EMBL, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; European Molecular Biology Laboratory (EMBL)	Duncan, KE (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany.	kent.duncan@zmnh.uni-hamburg.de; christian.thoma@uniklinik-freiburg.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876; Sehr, Peter/0000-0002-4348-5066; Neumann, Beate/0000-0002-6899-502X; Duncan, Kent/0000-0003-4290-2670; Putzker, Kerstin/0000-0001-8375-5908	Deutsche Forschungsgemeinschaft [TH788/3-1, TH788/2-1, TH788/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to C. T. (TH788/3-1). C. T. is a recipient of a Heisenberg-Fellowship from the Deutsche Forschungsgemeinschaft (TH788/2-1 and TH788/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Ding L, 2012, STEM CELL REV REP, V8, P32, DOI 10.1007/s12015-011-9269-z; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gingras AC, 2001, GENE DEV, V15, P2852; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Malina A, 2011, ONCOTARGET, V2, P76; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Puri Nitin, 2008, Nucleic Acids Symp Ser (Oxf), P25, DOI 10.1093/nass/nrn013; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45943	10.1371/journal.pone.0045943	http://dx.doi.org/10.1371/journal.pone.0045943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029333	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500048
J	Feng, YY; Zhang, M; Zhang, LL; Zhang, T; Ding, JF; Zhuang, YP; Wang, XN; Yang, Z				Feng, Yanye; Zhang, Ming; Zhang, Linlin; Zhang, Ting; Ding, Jianfeng; Zhuang, Yingping; Wang, Xiaoning; Yang, Zhong			An Automatic Refolding Apparatus for Preparative-Scale Protein Production	PLOS ONE			English	Article							GROWTH-FACTOR-I; STRUCTURAL PROTEOMICS; CRYSTAL-STRUCTURE; ARTEMIN; EXPRESSION; STRATEGIES; BINDING; VITRO	Protein refolding is an important process to recover active recombinant proteins from inclusion bodies. Refolding by simple dilution, dialysis and on-column refolding methods are the most common techniques reported in the literature. However, the refolding process is time-consuming and laborious due to the variability of the behavior of each protein and requires a great deal of trial-and-error to achieve success. Hence, there is a need for automation to make the whole process as convenient as possible. In this study, we invented an automatic apparatus that integrated three refolding techniques: varying dilution, dialysis and on-column refolding. We demonstrated the effectiveness of this technology by varying the flow rates of the dilution buffer into the denatured protein and testing different refolding methods. We carried out different refolding methods on this apparatus: a combination of dilution and dialysis for human stromal cell-derived factor 1 (SDF-1/CXCL12) and thioredoxin fused-human artemin protein (Trx-ARTN); dilution refolding for thioredoxin fused-human insulin-like growth factor I protein (Trx-IGF1) and enhanced fluorescent protein (EGFP); and on-column refolding for bovine serum albumin (BSA). The protein refolding processes of these five proteins were preliminarily optimized using the slowly descending denaturants (or additives) method. Using this strategy of decreasing denaturants concentration, the efficiency of protein refolding was found to produce higher quantities of native protein. The standard refolding apparatus configuration can support different operations for different applications; it is not limited to simple dilution, dialysis and on-column refolding techniques. Refolding by slowly decreasing denaturants concentration, followed by concentration or purification on-column, may be a useful strategy for rapid and efficient recovery of active proteins from inclusion bodies. An automatic refolding apparatus employing this flexible strategy may provide a powerful tool for preparative scale protein production.	[Feng, Yanye; Zhang, Ming; Zhang, Ting; Zhuang, Yingping; Wang, Xiaoning] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Biotechnol, Shanghai 200237, Peoples R China; [Feng, Yanye; Zhang, Linlin; Yang, Zhong] Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China; [Ding, Jianfeng] Novoprotein Sci Inc, Dept R&D, Shanghai, Peoples R China	East China University of Science & Technology; Fudan University	Wang, XN (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Biotechnol, Shanghai 200237, Peoples R China.	xnwang88@gmail.com; zhongyang_fudan@163.com			National Basic Research Program of China [2009CB918600]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2009CB918600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Basu A, 2011, APPL MICROBIOL BIOT, V92, P241, DOI 10.1007/s00253-011-3513-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruinzeel W, 2011, APPL BIOCHEM BIOTECH, V165, P1379, DOI 10.1007/s12010-011-9354-4; Bruinzeel W, 2012, PROTEIN EXPRES PURIF, V81, P25, DOI 10.1016/j.pep.2011.08.028; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Buckle AM, 2005, NAT METHODS, V2, P3, DOI 10.1038/nmeth0105-3; Christendat D, 2000, PROG BIOPHYS MOL BIO, V73, P339, DOI 10.1016/S0079-6107(00)00010-9; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; Cowieson NP, 2006, PROTEOMICS, V6, P1750, DOI 10.1002/pmic.200500056; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Jones H, 2006, ORG BIOMOL CHEM, V4, P1223, DOI 10.1039/b517879g; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lange C, 2005, PROTEIN FOLDING HANDBOOK, P1245, DOI 10.1002/9783527619498.ch71; Langenhof M, 2005, J CHROMATOGR A, V1069, P195, DOI 10.1016/j.chroma.2005.01.063; Leland P, 2006, INNOVATION, P1; Li M, 2004, PROTEIN EXPRES PURIF, V33, P1, DOI 10.1016/j.pep.2003.08.023; Luo W X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P578; Mannall GJ, 2009, BIOTECHNOL BIOENG, V103, P329, DOI 10.1002/bit.22245; Peterson MJ, 2011, J CHEM EDUC, V88, P986, DOI 10.1021/ed100594h; Read EK, 2010, BIOTECHNOL BIOENG, V105, P276, DOI 10.1002/bit.22528; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V31, P149, DOI 10.1016/S1046-5928(03)00133-5; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Tsumoto K, 2010, CURR PHARM BIOTECHNO, V11, P285, DOI 10.2174/138920110791111979; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981; Yee A, 2003, ACCOUNTS CHEM RES, V36, P183, DOI 10.1021/ar010126g; Zhang L, 2012, ACTA CHIM SINICA, V70, P6	36	4	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45891	10.1371/journal.pone.0045891	http://dx.doi.org/10.1371/journal.pone.0045891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029296	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500044
J	Fukuda, H; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Fukuda, Hisashi; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			A Single Nucleotide Polymorphism within DUSP9 Is Associated with Susceptibility to Type 2 Diabetes in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; GENETIC-VARIATION; RISK LOCI; REPLICATION; VARIANTS; HOMEOSTASIS; OBESITY; STORAGE	Aims: The DUSP9 locus on chromosome X was identified as a susceptibility locus for type 2 diabetes in a meta-analysis of European genome-wide association studies (GWAS), and GWAS in South Asian populations identified 6 additional single nucleotide polymorphism (SNP) loci for type 2 diabetes. However, the association of these loci with type 2 diabetes have not been examined in the Japanese. We performed a replication study to investigate the association of these 7 susceptibility loci with type 2 diabetes in the Japanese population. Methods: We genotyped 11,319 Japanese participants (8,318 with type 2 diabetes and 3,001 controls) for each of the 7 SNPs-rs5945326 near DUSP9, rs3923113 near GRB14, rs16861329 in ST6GAL1, rs1802295 in VPS26A, rs7178572 in HMG20A, rs2028299 near AP3S2, and rs4812829 in HNF4A-and examined the association of each of these 7 SNPs with type 2 diabetes by using logistic regression analysis. Results: All SNPs had the same direction of effect (odds ratio [OR]>1.0) as in the original reports. One SNP, rs5945326 near DUSP9, was significantly associated with type 2 diabetes at a genome-wide significance level (p = 2.21x10(-8); OR 1.39, 95% confidence interval [CI]: 1.24-1.56). The 6 SNPs derived from South Asian GWAS were not significantly associated with type 2 diabetes in the Japanese population by themselves (p >= 0.007). However, a genetic risk score constructed from 6 South Asian GWAS derived SNPs was significantly associated with Japanese type 2 diabetes (p = 8.69x10(-4), OR = 1.06. 95% CI; 1.03-1.10). Conclusions/interpretation: These results indicate that the DUSP9 locus is a common susceptibility locus for type 2 diabetes across different ethnicities, and 6 loci identified in South Asian GWAS also have significant effect on susceptibility to Japanese type 2 diabetes.	[Fukuda, Hisashi; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Hisashi; Tanaka, Yasushi] St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Dept Internal Med, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Watada, Hirotaka] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Bunkyo Ku, Tokyo 1138421, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan	RIKEN; Saint Marianna University; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University	Maeda, S (corresponding author), RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan.	smaeda@src.riken.jp	Hirose, Hiroshi/F-8556-2014; Kashiwagi, Atsunori/H-8712-2019	Watada, Hirotaka/0000-0001-5961-1816; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2012, HUM MOL GENET, V10, P1093; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; International Diabetes Federation, 2011, DIABETES ATLAS, V6th; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46263	10.1371/journal.pone.0046263	http://dx.doi.org/10.1371/journal.pone.0046263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029454	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500079
J	Guo, HL; Topham, DJ				Guo, Hailong; Topham, David J.			Multiple Distinct Forms of CD8+T Cell Cross-Reactivity and Specificities Revealed after 2009 H1N1 Influenza A Virus Infection in Mice	PLOS ONE			English	Article							CYTOTOXIC LYMPHOCYTES-T; IMMUNITY; PROTECTION; EPITOPES; MEMORY; IDENTIFICATION; NUCLEOPROTEIN; RECOGNITION; VACCINATION; PROMINENT	Influenza primed mice are protected against lethal infection with H1N1 A/CA/04/E3/09 virus, and T depletion and serum transfer studies suggest a T-dependent mechanism. We therefore set out to investigate the quality of the cross-reactive T cell response to CA/E3/09 in mice primed with H3N2 influenza A/Hong Kong/X31 virus. Sequences of the immunodominant nucleoprotein (NP) NP366-374 and acid polymerase (PA) PA224-233 CD8 epitopes from X31 each differ from the CA/E3/09 virus by one amino acid: an M371V substitution at position 6 of the NP peptide, and an S224P substitution at position 1 of the PA peptide, raising questions about the role of these epitopes in protection. PA224-233 peptides from either virus could elicit IFN-gamma spot forming cells from mice infected with X31, indicating cross-reactivity of these two peptides. However, no T cell responses to either PA224-233 peptide were detectable after primary CA/E3/09 infection, suggesting it is cryptic in this virus. In contrast, primary responses to the NP366 peptides were detectable after infection with either virus, but did not cross-react in vitro. Similarly, H2-D-b tetramers of each NP epitope stained CD8+ T cells from each respective virus infection, but did not obviously cross-react. Early after lethal CA/E3/09 challenge, X31 primed mice had enhanced IFN-gamma responses toward both NP366 peptides, as well as recall responses to a set of subdominant NP and PA peptides not detectable after primary X31 infection alone. Furthermore, dual-tetramer staining revealed an expanded population of CD8 T cells reactive to both NP366 variant peptides also not seen after the priming infection alone. These observations demonstrate unusual CD8+ T cell cross-reactivity and specificity are elicited after primary and secondary CA/E3/09 influenza virus infections.	[Guo, Hailong] Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Vaccine Immunol, Rochester, NY 14621 USA; [Topham, David J.] Univ Rochester, Dept Microbiol & Immunol, New York Influenza Ctr Excellence, Rochester, NY USA; [Topham, David J.] Univ Rochester, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA	Rochester General Hospital; University of Rochester; University of Rochester	Guo, HL (corresponding author), Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Vaccine Immunol, Rochester, NY 14621 USA.	jackguo1234@yahoo.com; david_topham@urmc.rochester.edu		Guo, Hailong/0000-0003-2619-335X	NIH [N01-AI50020, HHSN266200700008C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant N01-AI50020 and NIH grant HHSN266200700008C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreansky S, 2004, INT CONGR SER, V1263, P141, DOI 10.1016/j.ics.2004.01.046; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; BENNINK J, 1978, IMMUNOLOGY, V35, P503; BENNINK JR, 1987, J VIROL, V61, P1098, DOI 10.1128/JVI.61.4.1098-1102.1987; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Doherty PC, 2009, CLIN PHARMACOL THER, V85, P665, DOI 10.1038/clpt.2009.52; Ellebedy AH, 2010, CLIN VACCINE IMMUNOL, V17, P1998, DOI 10.1128/CVI.00247-10; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Kedzierska K, 2006, IMMUNOL REV, V211, P133, DOI 10.1111/j.0105-2896.2006.00386.x; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Skountzou I, 2010, J IMMUNOL; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Vitiello A, 1996, J IMMUNOL, V157, P5555; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	36	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46166	10.1371/journal.pone.0046166	http://dx.doi.org/10.1371/journal.pone.0046166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029425	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500068
J	Hansson, ML; Behmer, S; Ceder, R; Mohammadi, S; Preta, G; Grafstrom, RC; Fadeel, B; Wallberg, AE				Hansson, Magnus L.; Behmer, Stefanie; Ceder, Rebecca; Mohammadi, Sadollah; Preta, Giulio; Grafstrom, Roland C.; Fadeel, Bengt; Wallberg, Annika E.			MAML1 Acts Cooperatively with EGR1 to Activate EGR1-Regulated Promoters: Implications for Nephrogenesis and the Development of Renal Cancer	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR MAML1; DROSOPHILA MASTERMIND; NOTCH COACTIVATOR; P300; COMPLEX; GROWTH; ACETYLATION; REGULATOR; CARCINOMA; APOPTOSIS	Mastermind-like 1 (MAML1) is a transcriptional coregulator of activators in various signaling pathways, such as Notch, p53, myocyte enhancer factor 2C (MEF2C) and beta-catenin. In earlier studies, we demonstrated that MAML1 enhanced p300 acetyltransferase activity, which increased the acetylation of Notch by p300. In this study, we show that MAML1 strongly induced acetylation of the transcription factor early growth response-1 (EGR1) by p300, and increased EGR1 protein expression in embryonic kidney cells. EGR1 mRNA transcripts were also upregulated in the presence of MAML1. We show that MAML1 physically interacted with, and acted cooperatively with EGR1 to increase transcriptional activity of the EGR1 and p300 promoters, which both contain EGR1 binding sites. Bioinformatics assessment revealed a correlation between p300, EGR1 and MAML1 copy number and mRNA alterations in renal clear cell carcinoma and p300, EGR1 and MAML1 gene alterations were associated with increased overall survival. Our findings suggest MAML1 may be a component of the transcriptional networks which regulate EGR1 target genes during nephrogenesis and could also have implications for the development of renal cell carcinoma.	[Hansson, Magnus L.; Behmer, Stefanie; Ceder, Rebecca; Mohammadi, Sadollah; Preta, Giulio; Grafstrom, Roland C.; Fadeel, Bengt; Wallberg, Annika E.] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden	Karolinska Institutet	Wallberg, AE (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden.	Annika.Wallberg@ki.se	Preta, Giulio/AAW-6182-2021; Grafström, Roland C/N-7217-2016; Preta, Giulio/N-7141-2016	Preta, Giulio/0000-0002-8318-4698	Swedish Research Council; Swedish Cancer Society; Swedish Children's Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation	The authors received support from the Swedish Research Council, Swedish Cancer Society and the Swedish Children's Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Hansson ML, 2009, NUCLEIC ACIDS RES, V37, P2996, DOI 10.1093/nar/gkp163; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lindberg MJ, 2010, FASEB J, V24, P2396, DOI 10.1096/fj.09-149401; Liu CT, 1998, CANCER GENE THER, V5, P3; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Pode-Shakked N, 2011, PEDIATR NEPHROL, V26, P1535, DOI 10.1007/s00467-011-1858-1; Popko-Scibor AE, 2011, BIOCHEM BIOPH RES CO, V416, P300, DOI 10.1016/j.bbrc.2011.11.030; RACKLEY RR, 1995, J UROLOGY, V154, P700, DOI 10.1016/S0022-5347(01)67136-2; Ribeiro MSJ, 2009, CURR PROTEIN PEPT SC, V10, P570; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Scharnhorst V, 2000, ONCOGENE, V19, P791, DOI 10.1038/sj.onc.1203390; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Strefford JC, 2005, CANCER GENET CYTOGEN, V159, P1, DOI 10.1016/j.cancergencyto.2004.09.020; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	27	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46001	10.1371/journal.pone.0046001	http://dx.doi.org/10.1371/journal.pone.0046001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029358	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500053
J	Kirchhoff, NT; Leef, MJ; Valdenegro, V; Hayward, CJ; Nowak, BF				Kirchhoff, Nicole T.; Leef, Melanie J.; Valdenegro, Victoria; Hayward, Craig J.; Nowak, Barbara F.			Correlation of Humoral Immune Response in Southern Bluefin Tuna, T. maccoyii, with Infection Stage of the Blood Fluke, Cardicola forsteri	PLOS ONE			English	Article							THUNNUS-MACCOYII; SCHISTOSOMA-MANSONI; SANGUINICOLIDAE; DIGENEA; TREMATODA; CASTELNAU; HEALTH	The blood fluke, Cardicola forsteri, is a prevalent infection in ranched southern bluefin tuna. This project aimed to define the timing and intensity of the various developmental stages of C. forsteri within southern bluefin tuna as well as to relate infection to host pathology and immune response. Archival samples from several cohorts of T. maccoyii sampled from 2008 to 2010 were used in this study. The prevalence and intensity of C. forsteri infection was described using heart flushes and histological examination. Humoral immune response, i.e. C. forsteri specific antibody, lysozyme activity, and alternative complement activity, was also described. Based on the validated and detailed C. forsteri infection timeline, relationships between infection events, physiological response, and diagnosis were proposed. Immune response developed concurrently with C. forsteri infection, with the majority of physiological response coinciding with commencing egg production. Further research is needed to confirm the origin of C. forsteri antigen which is responsible for immune response development and how T. maccoyii immune response works against infection. To aide this research, further diagnostic methods for confirmation of infection need to be developed.	[Kirchhoff, Nicole T.; Leef, Melanie J.; Valdenegro, Victoria; Hayward, Craig J.; Nowak, Barbara F.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia; [Hayward, Craig J.] Lincoln Marine Sci Ctr, SARDI Aquat Sci, Port Lincoln, SA, Australia	University of Tasmania	Kirchhoff, NT (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia.	Nicole.Kirchhoff@utas.edu.au	Nowak, Barbara/J-7261-2014; Leef, Melanie/C-6655-2013	Nowak, Barbara/0000-0002-0347-643X; Valdenegro Vega, Victoria/0000-0003-1708-9593	Fisheries Research and Development Corporation, a Australian Government organization	Fisheries Research and Development Corporation, a Australian Government organization	Funding for this project was provided by the Fisheries Research and Development Corporation, a Australian Government organization. This manuscript, its data and conclusions, have been approved by the Australian Southern Bluefin Tuna Industry Association (ASBTIA) research council for publication. No funding was provided by the ASBTIA. Please see www.frdc.com.au for more information about the funders of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken HM, 2006, AQUACULTURE, V254, P40, DOI 10.1016/j.aquaculture.2005.10.013; Aiken H, 2009, AQUACULTURE, V293, P204, DOI 10.1016/j.aquaculture.2009.04.034; Aiken HM, 2007, FISH FISH, V8, P167, DOI 10.1111/j.1467-2679.2007.00248.x; Aiken HM, 2008, FISH SHELLFISH IMMUN, V25, P66, DOI 10.1016/j.fsi.2007.12.010; Arkoosh M.R., 1990, Fish Immunology Technical Communications, P15; Bullard SA, 2004, J PARASITOL, V90, P128, DOI 10.1645/GE-106R; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carrington AC, 2007, FISH SHELLFISH IMMUN, V23, P781, DOI 10.1016/j.fsi.2007.02.006; Colquitt SE, 2001, J FISH DIS, V24, P225, DOI 10.1046/j.1365-2761.2001.00289.x; Colquittt SE, 1999, THESIS U TASMANIA LA; Cox FEG, 1997, INT J PARASITOL, V27, P1147, DOI 10.1016/S0020-7519(97)00112-4; Cribb TH, 2000, T ROY SOC SOUTH AUST, V124, P117; Cribb TH, 2011, INT J PARASITOL, V41, P861, DOI 10.1016/j.ijpara.2011.03.011; Dennis MM, 2011, VET PATHOL, V48, P846, DOI 10.1177/0300985810388524; Deveney MR, 2005, J FISH DIS, V28, P279, DOI 10.1111/j.1365-2761.2005.00629.x; Hayward CJ, 2010, VET PARASITOL, V173, P107, DOI 10.1016/j.vetpar.2010.06.007; HERBERT BW, 1995, INT J PARASITOL, V25, P3, DOI 10.1016/0020-7519(94)00071-U; Kirchhoff NT, 2011, J FISH BIOL, V79, P331, DOI 10.1111/j.1095-8649.2011.03019.x; Kirchhoff NT, 2011, AQUACULTURE, V315, P207, DOI 10.1016/j.aquaculture.2011.02.036; Kirchhoff NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023705; Leef MJ, 2012, AQUACULTURE UNPUB; MCLAREN DJ, 1978, PARASITOLOGY, V77, P313, DOI 10.1017/S0031182000050277; Mladineo I, 2004, B EUR ASSOC FISH PAT, V24, P144; Munday BL, 2003, J FISH DIS, V26, P187, DOI 10.1046/j.1365-2761.2003.00454.x; Nowak B, 2006, B EUR ASSOC FISH PAT, V26, P38; Roberts ML, 2005, PARASITOLOGY, V131, P261, DOI 10.1017/S0031182005007651; Rough K. M., 2000, ILLUSTRATED GUIDE PA; Shirakashi S, 2012, PARASITOLOG IN PRESS; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2; van Ede F, 2007, THESIS U TASMANIA LA, P107; Watts M, 2002, J FISH DIS, V25, P191, DOI 10.1046/j.1365-2761.2002.00342.x; Yano T., 1992, TECHNIQUES FISH IMMU, P131; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6	34	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45742	10.1371/journal.pone.0045742	http://dx.doi.org/10.1371/journal.pone.0045742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029217	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500038
J	Villar, D; Ortiz-Barahona, A; Gomez-Maldonado, L; Pescador, N; Sanchez-Cabo, F; Hackl, H; Rodriguez, BAT; Trajanoski, Z; Dopazo, A; Huang, THM; Yan, PS; del Peso, L				Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; Sanchez-Cabo, Fatima; Hackl, Hubert; Rodriguez, Benjamin A. T.; Trajanoski, Zlatko; Dopazo, Ana; Huang, Tim H. M.; Yan, Pearlly S.; del Peso, Luis			Cooperativity of Stress-Responsive Transcription Factors in Core Hypoxia-Inducible Factor Binding Regions	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR-I; DNA-BINDING; CHROMATIN IMMUNOPRECIPITATION; TRANSACTIVATION DOMAIN; MOLECULAR REGULATION; SIGNALING PATHWAYS; FACTOR 1-ALPHA; PROTEIN-ALPHA; UP-REGULATION	The transcriptional response driven by Hypoxia-inducible factor (HIF) is central to the adaptation to oxygen restriction. Despite recent characterization of genome-wide HIF DNA binding locations and hypoxia-regulated transcripts in different cell types, the molecular bases of HIF target selection remain unresolved. Herein, we combined multi-level experimental data and computational predictions to identify sequence motifs that may contribute to HIF target selectivity. We obtained a core set of bona fide HIF binding regions by integrating multiple HIF1 DNA binding and hypoxia expression profiling datasets. This core set exhibits evolutionarily conserved binding regions and is enriched in functional responses to hypoxia. Computational prediction of enriched transcription factor binding sites identified sequence motifs corresponding to several stress-responsive transcription factors, such as activator protein 1 (AP1), cAMP response element-binding (CREB), or CCAAT-enhancer binding protein (CEBP). Experimental validations on HIF-regulated promoters suggest a functional role of the identified motifs in modulating HIF-mediated transcription. Accordingly, transcriptional targets of these factors are overrepresented in a sorted list of hypoxia-regulated genes. Altogether, our results implicate cooperativity among stress-responsive transcription factors in fine-tuning the HIF transcriptional response.	[Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; del Peso, Luis] Univ Autonoma Madrid, Dept Biochem, Madrid, Spain; [Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; del Peso, Luis] Inst Invest Biomed Alberto Sols, Madrid, Spain; CNIC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Villar, D (corresponding author), Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Cambridge, England.	dvillar@iib.uam.es	Dopazo, Ana/N-1159-2014; Villar, Diego/K-8595-2017; Trajanoski, Zlatko/AAT-6703-2021; Hackl, Hubert/B-3168-2018; Sanchez-Cabo, Fatima/N-5030-2014; del Peso, Luis/K-9391-2014; Sanchez-Cabo, Fatima/AAC-5563-2020	Dopazo, Ana/0000-0002-4910-1684; Villar, Diego/0000-0002-8614-6232; Hackl, Hubert/0000-0003-4055-3841; Sanchez-Cabo, Fatima/0000-0003-1881-1664; del Peso, Luis/0000-0003-4014-5688; Sanchez-Cabo, Fatima/0000-0003-1881-1664	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) [SAF2008-03147]; Comunidad Autonoma de Madrid [S-SAL-0311_2006]; 7th Research Framework Programme of the European Union [METOXIA project ref. HEALTH-F2-2009-222741]; Spanish Ministry of Science and Innovation [FPU programme]; European Molecular Biology Organization [Short-Term Fellowships]	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN); Comunidad Autonoma de Madrid(Comunidad de Madrid); 7th Research Framework Programme of the European Union; Spanish Ministry of Science and Innovation [FPU programme](Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Organization [Short-Term Fellowships]	This work was supported by Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) [grant number SAF2008-03147 to L. del P.], Comunidad Autonoma de Madrid [grant number S-SAL-0311_2006 to L. del P.] and the 7th Research Framework Programme of the European Union [grant number METOXIA project ref. HEALTH-F2-2009-222741] to L. del P. D.V. was a recipient of PhD funding from the Spanish Ministry of Science and Innovation [FPU programme] and the European Molecular Biology Organization [Short-Term Fellowships]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Hemberg M, 2011, NUCLEIC ACIDS RES, V39, P7092, DOI 10.1093/nar/gkr404; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaplan T, 2012, METHOD CELL BIOL, V110, P263, DOI 10.1016/B978-0-12-388403-9.00011-4; Katada K, 2006, DIGESTION, V73, P89, DOI 10.1159/000094039; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Koslowski M, 2011, ONCOGENE, V30, P876, DOI 10.1038/onc.2010.481; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Liu QY, 2011, MOL CANCER THER, V10, P1113, DOI 10.1158/1535-7163.MCT-10-1010; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung FL, 2007, CANCER LETT, V253, P74, DOI 10.1016/j.canlet.2007.01.012; Tacchini L, 2002, BIOCHEM PHARMACOL, V63, P139, DOI 10.1016/S0006-2952(01)00836-X; Tavor S, 2003, J BIOL CHEM, V278, P52651, DOI 10.1074/jbc.M307077200; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Toedling J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000227; Tomancak P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-115; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Vengellur A, 2003, GENE EXPRESSION, V11, P181, DOI 10.3727/000000003108749062; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Zhang W, 1999, J HUM GENET, V44, P293, DOI 10.1007/s100380050163; Zhao XY, 2011, J BIOL CHEM, V286, P36808, DOI 10.1074/jbc.M111.247262	92	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45708	10.1371/journal.pone.0045708	http://dx.doi.org/10.1371/journal.pone.0045708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029193	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700061
J	Yang, S; Li, Q; Zeng, QL; Zhang, JB; Yu, ZI; Liu, ZD				Yang, Sen; Li, Qing; Zeng, Qinglan; Zhang, Jibin; Yu, Ziniu; Liu, Ziduo			Conversion of Solid Organic Wastes into Oil via Boettcherisca peregrine (Diptera: Sarcophagidae) Larvae and Optimization of Parameters for Biodiesel Production	PLOS ONE			English	Article							DEPENDENCE	The feedstocks for biodiesel production are predominantly from edible oils and the high cost of the feedstocks prevents its large scale application. In this study, we evaluated the oil extracted from Boettcherisca peregrine larvae (BPL) grown on solid organic wastes for biodiesel production. The oil contents detected in the BPL converted from swine manure, fermentation residue and the degreased food waste, were 21.7%, 19.5% and 31.1%, respectively. The acid value of the oil is 19.02 mg KOH/g requiring a two-step transesterification process. The optimized process of 12:1 methanol/oil (mol/mol) with 1.5% H2SO4 reacted at 70 degrees C for 120 min resulted in a 90.8% conversion rate of free fatty acid (FFA) by esterification, and a 92.3% conversion rate of triglycerides into esters by alkaline transesterification. Properties of the BPL oil-based biodiesel are within the specifications of ASTM D6751, suggesting that the solid organic waste-grown BPL could be a feasible non-food feedstock for biodiesel production.	[Yang, Sen; Li, Qing; Zhang, Jibin; Yu, Ziniu; Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Li, Qing] Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China; [Zeng, Qinglan] Xianning Vocat Tech Coll, Dept Biol Engn, Xianning, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	lzd@mail.hzau.edu.cn			open project of State Key Laboratory of Huazhong Agricultural University [ALM0810]; China National Natural Sciences Foundation [u1170303]; Genetically Modified Organisms Breeding Major Projects of China [2011ZX08001-001]	open project of State Key Laboratory of Huazhong Agricultural University; China National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China	This study was supported by grants from the open project of State Key Laboratory of Huazhong Agricultural University (ALM0810), the China National Natural Sciences Foundation (u1170303), and the Genetically Modified Organisms Breeding Major Projects of China (2011ZX08001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, EN14103; Banks JE, 2008, BIOL CONTROL, V47, P141, DOI 10.1016/j.biocontrol.2008.08.006; Chang KJL, 2011, PHYTOCHEMISTRY, V72, P1460, DOI 10.1016/j.phytochem.2011.04.001; Demirbas A, 2003, ENERG CONVERS MANAGE, V44, P2093, DOI 10.1016/S0196-8904(02)00234-0; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Gan S, 2010, BIORESOURCE TECHNOL, V101, P7338, DOI 10.1016/j.biortech.2010.04.028; GOFF ML, 1991, J FORENSIC SCI, V36, P537; Gui MM, 2008, ENERGY, V33, P1646, DOI 10.1016/j.energy.2008.06.002; Kafuku G, 2010, FUEL, V89, P2556, DOI 10.1016/j.fuel.2010.03.039; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Li Q, 2011, J PET ENV BIOTECHN S, VS2; Li Q, 2011, FUEL, V90, P1545, DOI 10.1016/j.fuel.2010.11.016; Li ZX, 2012, APPL ENERG, V94, P349, DOI 10.1016/j.apenergy.2012.01.068; Liu WC, 2007, THEOR POPUL BIOL, V72, P86, DOI 10.1016/j.tpb.2007.01.002; Martindale W, 2008, NAT BIOTECHNOL, V26, P1068, DOI 10.1038/nbt1008-1068; Min X. U., 1999, LUBRICATING OIL, P56; Mongobay, 2006, WHY OIL PALM REPLACI; Neves L, 2008, WASTE MANAGE, V28, P965, DOI 10.1016/j.wasman.2007.03.031; Rezanka T, 2009, PROG LIPID RES, V48, P206, DOI 10.1016/j.plipres.2009.03.003; Rodrigues C, 2011, CRIT REV BIOTECHNOL, P1; Schroeder Hilke, 2003, Leg Med (Tokyo), V5 Suppl 1, pS372; Sharma YC, 2010, FUEL, V89, P1470, DOI 10.1016/j.fuel.2009.10.013; Thoenes P., 2007, BIOFUELS COMMODITY M; Wang Hai-Yang, 2010, Huanjing Kunchong Xuebao, V32, P166; Wu Guo-Xing, 2006, Acta Entomologica Sinica, V49, P22; Zheng L, 2011, RENEW ENERG, V44, P1	27	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45940	10.1371/journal.pone.0045940	http://dx.doi.org/10.1371/journal.pone.0045940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029331	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700092
J	Kusuhara, S; Fukushima, Y; Fukuhara, S; Jakt, LM; Okada, M; Shimizu, Y; Hata, M; Nishida, K; Negi, A; Hirashima, M; Mochizuki, N; Nishikawa, SI; Uemura, A				Kusuhara, Sentaro; Fukushima, Yoko; Fukuhara, Shigetomo; Jakt, Lars Martin; Okada, Mitsuhiro; Shimizu, Yuri; Hata, Masayuki; Nishida, Kohji; Negi, Akira; Hirashima, Masanori; Mochizuki, Naoki; Nishikawa, Shin-Ichi; Uemura, Akiyoshi			Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR; MACULAR DEGENERATION; GENE-EXPRESSION; IDENTIFICATION; SURVIVAL; RANIBIZUMAB; BEVACIZUMAB; MICROARRAYS; RECEPTOR; REVEALS	Background: Drugs inhibiting vascular endothelial growth factor (VEGF) signaling are globally administered to suppress deregulated angiogenesis in a variety of eye diseases. However, anti-VEGF therapy potentially affects the normal functions of retinal neurons and glias which constitutively express VEGF receptor 2. Thus, it is desirable to identify novel drug targets which are exclusively expressed in endothelial cells (ECs). Here we attempted to identify an EC-specific Rho guanine nucleotide exchange factor (GEF) and evaluate its role in retinal angiogenesis. Methodology/Principal Findings: By exploiting fluorescence-activated cell sorting and microarray analyses in conjunction with in silico bioinformatics analyses, we comprehensively identified endothelial genes in angiogenic retinal vessels of postnatal mice. Of 9 RhoGEFs which were highly expressed in retinal ECs, we show that Arhgef15 acted as an EC-specific GEF to mediate VEGF-induced Cdc42 activation and potentiated RhoJ inactivation, thereby promoting actin polymerization and cell motility. Disruption of the Arhgef15 gene led to delayed extension of vascular networks and subsequent reduction of total vessel areas in postnatal mouse retinas. Conclusions/Significance: Our study provides information useful to the development of new means of selectively manipulating angiogenesis without affecting homeostasis in un-targeted tissues; not only in eyes but also in various disease settings such as cancer.	[Kusuhara, Sentaro; Fukushima, Yoko; Jakt, Lars Martin; Okada, Mitsuhiro; Shimizu, Yuri; Nishikawa, Shin-Ichi; Uemura, Akiyoshi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan; [Kusuhara, Sentaro; Negi, Akira; Uemura, Akiyoshi] Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan; [Fukushima, Yoko; Hata, Masayuki; Hirashima, Masanori; Uemura, Akiyoshi] Kobe Univ, Div Vasc Biol, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Fukushima, Yoko; Nishida, Kohji] Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Osaka, Japan	RIKEN; Kobe University; Kobe University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Uemura, A (corresponding author), RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan.	auemura@med.kobe-u.ac.jp	Hirashima, Masanori/ABC-9204-2021; Uemura, Akiyoshi/I-7510-2017	Hirashima, Masanori/0000-0002-0190-4381; Uemura, Akiyoshi/0000-0001-5574-5470; Kusuhara, Sentaro/0000-0002-6458-539X; Jakt, Lars Martin/0000-0002-3787-8138; Nishida, Kohji/0000-0001-9069-3610	Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation; Ministry of Education, Culture, Sports, Science and Technology, Japan [22689046]; Japan Science and Technology Agency [AS231Z03014G]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Inamori Foundation; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Mishima Saiichi Commemoration Ophthalmology Study Research Foundation; Grants-in-Aid for Scientific Research [22390040, 22113009, 22689046] Funding Source: KAKEN	Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Inamori Foundation; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Mishima Saiichi Commemoration Ophthalmology Study Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the 'Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation' and 'Grants-in-Aid for Young Scientists' (22689046) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and 'Exploratory Research, Feasibility Study Stage, A-STEP' (AS231Z03014G) from the Japan Science and Technology Agency. AU is supported by the Takeda Science Foundation, Mitsubishi Pharma Research Foundation, Inamori Foundation, Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder, and Mishima Saiichi Commemoration Ophthalmology Study Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Jakt LM, 2008, CANCER SCI, V99, P829, DOI 10.1111/j.1349-7006.2008.00767.x; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Mills JC, 2001, NAT CELL BIOL, V3, pE175, DOI 10.1038/35087108; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yang XJ, 1996, J NEUROSCI, V16, P6089	36	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45858	10.1371/journal.pone.0045858	http://dx.doi.org/10.1371/journal.pone.0045858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029280	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800108
J	Qiu, N; Xiao, ZS; Cao, L; David, V; Quarles, LD				Qiu, Ni; Xiao, Zhousheng; Cao, Li; David, Valentin; Quarles, Leigh Darryl			Conditional Mesenchymal Disruption of Pkd1 Results in Osteopenia and Polycystic Kidney Disease	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; EXTRARENAL MANIFESTATIONS; INTRACRANIAL ANEURYSMS; EPITHELIAL-CELLS; CRE RECOMBINASE; CYST FORMATION; BONE-FORMATION; STEM-CELLS; MICE; EXPRESSION	Conditional deletion of Pkd1 in osteoblasts using either Osteocalcin(Oc)-Cre or Dmp1-Cre results in defective osteoblast-mediated postnatal bone formation and osteopenia. Pkd1 is also expressed in undifferentiated mesenchyme that gives rise to the osteoblast lineage. To examine the effects of Pkd1 on prenatal osteoblast development, we crossed Pkd1(flox/flox) and Col1a1(3.6)-Cre mice, which has been used to achieve selective inactivation of Pkd1 earlier in the osteoblast lineage. Control Pkd1(flox/flox) and Pkd1(flox/+), heterozygous Col1a1(3.6)-Cre;Pkd1(flox/+) and Pkd1(flox/null), and homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) and Col1a1(3.6)-Cre;Pkd1(flox/null) mice were analyzed at ages ranging from E14.5 to 8-weeks-old. Newborn Col1a1(3.6)Cre;Pkd1(flox/null) mice exhibited defective skeletogenesis in association with a greater reduction in Pkd1 expression in bone. Conditional Col1a1(3.6)-Cre;Pkd1(flox/+) and Col1a1(3.6)-Cre;Pkd1(flox/flox) mice displayed a gene dose-dependent decrease in bone formation and increase in marrow fat at 6 weeks of age. Bone marrow stromal cell and primary osteoblast cultures from homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) mice showed increased proliferation, impaired osteoblast development and enhanced adipogenesis ex vivo. Unexpectedly, we found evidence for Col1a1(3.6)-Cre mediated deletion of Pkd1 in extraskeletal tissues in Col1a1(3.6)-Cre;Pkd1(flox/flox) mice. Deletion of Pkd1 in mesenchymal precursors resulted in pancreatic and renal, but not hepatic, cyst formation. The non-lethality of Col1a1(3.6)-Cre;Pkd1(flox/flox) mice establishes a new model to study abnormalities in bone development and cyst formation in pancreas and kidney caused by Pkd1 gene inactivation.	[Qiu, Ni; Xiao, Zhousheng; Cao, Li; David, Valentin; Quarles, Leigh Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institute of Diabetes and Digestive and Kidney Diseases [P50-DK057301, R01-DK083303]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21-AR056794]; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R01DK083303] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants P50-DK057301 (National Institute of Diabetes and Digestive and Kidney Diseases) to James P. Calvet, R21-AR056794 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) to Zhousheng Xiao, and R01-DK083303 (National Institute of Diabetes and Digestive and Kidney Diseases) to L. Darryl Quarles from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari G, 2012, J MOL MED BERL; Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; CHAUVEAU D, 1994, KIDNEY INT, V45, P1140, DOI 10.1038/ki.1994.151; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Chea SW, 2009, YONSEI MED J, V50, P105, DOI 10.3349/ymj.2009.50.1.105; Deal C, 2009, CURR OPIN RHEUMATOL, V21, P380, DOI 10.1097/BOR.0b013e32832cbc2a; Driscoll JA, 2008, CHEST, V133, P1181, DOI 10.1378/chest.07-2147; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Garcia-Gonzalez MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012821; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Guillaume R, 1999, DEV DYNAM, V214, P337, DOI 10.1002/(SICI)1097-0177(199904)214:4<337::AID-AJA6>3.0.CO;2-O; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; Hick AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-66; Horster M, 1997, PFLUG ARCH EUR J PHY, V434, P647, DOI 10.1007/s004240050448; Horster MF, 1999, PHYSIOL REV, V79, P1157, DOI 10.1152/physrev.1999.79.4.1157; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; Housset C, 2005, GASTROEN CLIN BIOL, V29, P861, DOI 10.1016/S0399-8320(05)86361-4; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; KAEHNY WD, 1991, SEMIN NEPHROL, V11, P661; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Leuenroth SJ, 2008, J AM SOC NEPHROL, V19, P1659, DOI 10.1681/ASN.2008030259; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Malka D, 1998, GUT, V42, P131, DOI 10.1136/gut.42.1.131; Martin ADV, 2012, MOL ENDOCRI IN PRESS; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; OWEN M, 1988, J CELL SCI, P63; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Peczkowska M, 2004, BLOOD PRESSURE, V13, P283, DOI 10.1080/08037050410016492; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Rickard DJ, 1996, J BONE MINER RES, V11, P312; SCHIEVINK WI, 1992, J AM SOC NEPHROL, V3, P88; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Skala I, 1985, Vnitr Lek, V31, P677; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Togawa H, 2011, AM J PHYSIOL-RENAL, V300, pF511, DOI 10.1152/ajprenal.00038.2010; Torra R, 1997, CLIN NEPHROL, V47, P19; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tulachan SS, 2006, DEV GROWTH DIFFER, V48, P65, DOI 10.1111/j.1440-169x.2006.00846.x; van Gulick JJM, 2011, NETH J MED, V69, P367; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xiao Y, 2009, MOL CELL BIOCH; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xu H, 2001, DNA SEQUENCE, V12, P361, DOI 10.3109/10425170109084460; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; ZEIER M, 1992, KIDNEY INT, V42, P1259, DOI 10.1038/ki.1992.413; Zha LB, 2008, J GENET GENOMICS, V35, P525, DOI 10.1016/S1673-8527(08)60072-7; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020	74	13	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46038	10.1371/journal.pone.0046038	http://dx.doi.org/10.1371/journal.pone.0046038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029375	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800133
J	Qu, ST; Yao, YL; Shang, C; Xue, YX; Ma, J; Li, Z; Liu, YH				Qu, Shengtao; Yao, Yilong; Shang, Chao; Xue, Yixue; Ma, Jun; Li, Zhen; Liu, Yunhui			MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene	PLOS ONE			English	Article							DOWN-REGULATION; CANCER-CELLS; EGF RECEPTOR; EXPRESSION; CARCINOMA; GROWTH; METHYLATION; PATHWAY; DISEASE; PROTEIN	MicroRNAs have recently emerged as key regulators of cancers. This study was therefore conducted to investigate the role of miR-330 in biological behaviors of human glioblastoma U87 and U251 cell lines and its molecular mechanism. SH3GL2 gene was identified as the target of miR-330. MiR-330 overexpression was established by transfecting miR-330 precursor into U87 and U251 cells, and its effects on proliferation, migration, invasion, cell cycle and apoptosis were studied. Overexpression of miR-330 can enhance cellular proliferation, promote migration and invasion, activate cell cycle and also inhibit apoptosis in U87 and U251 cells. Collectively, these above-mentioned results suggest that miRNA-330 plays an oncogenic role in human glioblastoma by regulating SH3GL2 gene and might be a new therapeutic target of human glioblastoma.	[Qu, Shengtao; Yao, Yilong; Li, Zhen; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China; [Shang, Chao; Xue, Yixue; Ma, Jun] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Peoples R China; [Shang, Chao; Xue, Yixue; Ma, Jun] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China.	liuyh62@gmail.com			Natural Science Foundation of China [81171131, 81172197, 30973079, 81072056]; special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities [20092104110015, 20102104110009]; Natural Science Foundation of Liaoning Province in China [201102300]; Science and Technology Plan Projects of Liaoning Province in China [2011225020]; Shenyang Science and Technology Plan Projects [F-10-205-1-22, F-10-205-1-37]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities; Natural Science Foundation of Liaoning Province in China(Natural Science Foundation of Liaoning Province); Science and Technology Plan Projects of Liaoning Province in China; Shenyang Science and Technology Plan Projects	This work is supported by grants from Natural Science Foundation of China (Nos. 81171131, 81172197, 30973079, 81072056), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities, (Nos. 20092104110015, 20102104110009), Natural Science Foundation of Liaoning Province in China (No. 201102300), Science and Technology Plan Projects of Liaoning Province in China (No. 2011225020) and Shenyang Science and Technology Plan Projects (Nos. F-10-205-1-22, F-10-205-1-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Hodzic J, 2011, NUCLEOS NUCLEOT NUCL, V30, P1214, DOI 10.1080/15257770.2011.629271; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li CS, 2009, AAPS J, V11, P747, DOI 10.1208/s12248-009-9145-9; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Osterberg L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-368; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Reutens AT, 2002, INT J BIOCHEM CELL B, V34, P1173, DOI 10.1016/S1357-2725(02)00063-8; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Shang C, 2010, PROGR ANATOMICAL SCI, V16, P128; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Sinha S, 2008, ANN SURG ONCOL, V15, P1070, DOI 10.1245/s10434-007-9790-0; Song JY, 2009, CANCER LETT, V283, P135, DOI 10.1016/j.canlet.2009.03.034; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Zhong Xiaomin, 2012, Methods Mol Biol, V822, P295, DOI 10.1007/978-1-61779-427-8_21	35	51	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46010	10.1371/journal.pone.0046010	http://dx.doi.org/10.1371/journal.pone.0046010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029364	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800130
J	Gerber, YN; Sabourin, JC; Hugnot, JP; Perrin, FE				Gerber, Yannick N.; Sabourin, Jean-Charles; Hugnot, Jean-Philippe; Perrin, Florence E.			Unlike Physical Exercise, Modified Environment Increases the Lifespan of SOD1(G93A) Mice However Both Conditions Induce Cellular Changes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; ENRICHED-ENVIRONMENT; DISEASE PROGRESSION; NEUROTROPHIC FACTOR; REGULAR EXERCISE; GROWTH-FACTOR; SPINAL-CORD; MICROGLIA; ALS	Background: Amyotrophic lateral sclerosis (ALS) is characterized by a gradual muscular paralysis resulting from progressive motoneurons death. ALS etiology remains unknown although it has been demonstrated to be a multifactorial disease involving several cellular partners. There is currently no effective treatment. Even if the effect of exercise is under investigation for many years, whether physical exercise is beneficial or harmful is still under debate. Methods and Findings: We investigated the effect of three different intensities of running exercises on the survival of SOD1(G93A) mice. At the early-symptomatic stage (P60), males were isolated and randomly assigned to 5 conditions: 2 sedentary groups ("sedentary" and "sedentary treadmill" placed on the inert treadmill), and 3 different training intensity groups (5 cm/s, 10 cm/s and 21 cm/s; 15 min/day, 5days/week). We first demonstrated that an appropriate "control" of the environment is of the utmost importance since comparison of the two sedentary groups evidenced an 11.6% increase in survival in the "sedentary treadmill" group. Moreover, we showed by immunohistochemistry that this increased lifespan is accompanied with motoneurons survival and increased glial reactivity in the spinal cord. In a second step, we showed that when compared with the proper control, all three running-based training did not modify lifespan of the animals, but result in motoneurons preservation and changes in glial cells activation. Conclusions/Significance: We demonstrate that increase in survival induced by a slight daily modification of the environment is associated with motoneurons preservation and strong glial modifications in the lumbar spinal cord of SOD1(G93A). Using the appropriate control, we then demonstrate that all running intensities have no effect on the survival of ALS mice but induce cellular modifications. Our results highlight the critical importance of the control of the environment in ALS studies and may explain discrepancy in the literature regarding the effect of exercise in ALS.	[Gerber, Yannick N.; Hugnot, Jean-Philippe; Perrin, Florence E.] St Eloi Hosp, INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France; [Gerber, Yannick N.; Perrin, Florence E.] IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Sabourin, Jean-Charles; Perrin, Florence E.] Univ Basque Country UPV EHU, Integrat Biol Neurodegenerat Neurosci Dept, Bilbao, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Basque Foundation for Science; University of Basque Country	Perrin, FE (corresponding author), St Eloi Hosp, INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France.	f.perrin@ikerbasque.org	PERRIN, Florence/AAY-6815-2021	PERRIN, Florence/0000-0002-7630-0515	Fondation de l'Avenir [ET7-456]; Spanish Government; Plan Nacional de I+D+I; ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion [PI10/00709]; Basque Government; Fondo Comun de Cooperacion Aquitania-Euskadi; Proyectos de Investigacion Sanitaria; Association Demain Debout Aquitaine; Swiss National Science Foundation	Fondation de l'Avenir; Spanish Government(Spanish GovernmentEuropean Commission); Plan Nacional de I+D+I; ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion; Basque Government(Basque Government); Fondo Comun de Cooperacion Aquitania-Euskadi; Proyectos de Investigacion Sanitaria; Association Demain Debout Aquitaine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Fondation de l'Avenir [ET7-456 to FEP], the Spanish Government, Plan Nacional de I+D+I 2008-2011 and ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion [PI10/00709 to FEP], the Basque Government, Fondo Comun de Cooperacion Aquitania-Euskadi and Proyectos de Investigacion Sanitaria [to FEP], the Association Demain Debout Aquitaine [to YNG] and the Swiss National Science Foundation [to ACK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; da Cunha MJ, 2012, INT J DEV NEUROSCI, V30, P69, DOI 10.1016/j.ijdevneu.2012.01.001; Deforges S, 2009, J PHYSIOL-LONDON, V587, P3561, DOI 10.1113/jphysiol.2009.169748; Diniz DG, 2010, EUR J NEUROSCI, V32, P509, DOI 10.1111/j.1460-9568.2010.07296.x; Ehninger D, 2011, CELL TISSUE RES, V345, P69, DOI 10.1007/s00441-011-1200-z; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Ferrer-Alcon M, 2008, NEUROSCIENCE, V152, P291, DOI 10.1016/j.neuroscience.2007.11.058; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Grondard C, 2005, J NEUROSCI, V25, P7615, DOI 10.1523/JNEUROSCI.1245-05.2005; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Li H, 2005, NEUROSCI LETT, V386, P160, DOI 10.1016/j.neulet.2005.06.009; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Liebetanz D, 2004, EUR J NEUROSCI, V20, P3115, DOI 10.1111/j.1460-9568.2004.03769.x; de Almeida JPL, 2012, NEUROL SCI, V33, P9, DOI 10.1007/s10072-011-0921-9; Lutz C., 2009, WORKING ALS MICE GUI; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sargsyan SA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-91; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Stam NC, 2008, EUR J NEUROSCI, V28, P717, DOI 10.1111/j.1460-9568.2008.06374.x; SZELIGO F, 1977, J COMP NEUROL, V172, P247, DOI 10.1002/cne.901720205; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Williamson LL, 2012, BRAIN BEHAV IMMUN	41	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45503	10.1371/journal.pone.0045503	http://dx.doi.org/10.1371/journal.pone.0045503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029057	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900063
J	Gupta, SK; Shen, CY; Moe, SM; Kamendulis, LM; Goldman, M; Dube, MP				Gupta, Samir K.; Shen, Changyu; Moe, Sharon M.; Kamendulis, Lisa M.; Goldman, Mitchell; Dube, Michael P.			Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; VITAMIN-D; DYSFUNCTION; ASSOCIATION; RISK; HYPERPARATHYROIDISM	Objective: Changes in endothelial function, measured as flow-mediated dilation (FMD) of the brachial artery, has not been systematically assessed beyond 6 months of initiation of antiretroviral therapy (ART) when drug-related effects might offset initial improvements with virologic control. Design: We assessed 6 and 12 month changes in FMD [presented as median (quartile 1, quartile 3)] and circulating HIV and cardiovascular biomarkers in 23 subjects initiating ART. Results: There were no significant changes in FMD at 6 or 12 months overall despite significant increases in CD4 cell count and HDL-C and reductions in HIV RNA level, MCP-1, IP-10, sVCAM-1, sTNFR2, and sCD14. However, there were significant differences (P = 0.04) in the changes in FMD between those receiving efavirenz [N = 12; -3.50% (-4.90%, 0.68%)] vs. protease inhibitors at 12 months [N = 11; 1.50% (-0.86%, 4.56%)]. The differences in changes in FMD between those receiving and not receiving emtricitabine/tenofovir/efavirenz were more pronounced and were significantly different at both 6 and 12 months (P < 0.02 for both). Additional studies showed no significant differences in changes in 25-(OH)-vitamin D, PTH, FGF-23, of F2-isoprostane levels between efavirenz and PI use or between those receiving and not receiving emtricitabine/tenofovir/efavirenz. Conclusion: Efavirenz use was associated with reduced FMD at 12 months compared to PI-based regimens while emtricitabine/tenofovir/efavirenz was associated with reduced FMD at both 6 and 12 months compared to those not receiving this combination. Long-term effects of antiretrovirals on endothelial function may play an important role in the risk of cardiovascular disease in HIV-infected patients.	[Gupta, Samir K.; Goldman, Mitchell] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA; [Shen, Changyu] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Moe, Sharon M.] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN USA; [Kamendulis, Lisa M.] Indiana Univ, Dept Environm Hlth, Bloomington, IN USA; [Dube, Michael P.] Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Southern California	Gupta, SK (corresponding author), Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA.	sgupta1@iupui.edu	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [R01 HL72711, R01 HL095149]; Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources [RR025761]; Gilead Sciences, Inc.; Merck Co.; Janssen (Tibotec) Therapeutics; Bristol-Myers Squibb; ViiV Healthcare/GlaxoSmithKline; Serono; Genzyme; Shire; Amgen; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072711, R01HL095149] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources; Gilead Sciences, Inc.(Gilead Sciences); Merck Co.(Merck & Company); Janssen (Tibotec) Therapeutics(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare/GlaxoSmithKline; Serono; Genzyme(Sanofi-AventisGenzyme Corporation); Shire; Amgen(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [R01 HL72711 and R01 HL095149] and by a Project Development Team within the Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources [RR025761]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.K.G. reports having received unrestricted research grant support from Gilead Sciences, Inc., Merck & Co., and Janssen (Tibotec) Therapeutics and receives consultant fees from Bristol-Myers Squibb. M.P.D. reports research grant support from ViiV Healthcare/GlaxoSmithKline and has received consultant fees from Serono. S.M.M. reports research grants and consulting fees from Genzyme, Shire, and Amgen. All other authors report no conflicts. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bastani NE, 2009, RAPID COMMUN MASS SP, V23, P2885, DOI 10.1002/rcm.4197; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Dekker D, 2011, ARTERIOSCL THROM VAS, V31, P458, DOI 10.1161/ATVBAHA.110.211789; Delaney JAC, 2010, AIDS, V24, P2201, DOI 10.1097/QAD.0b013e32833d2132; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Egashira K, 2002, CIRC J, V66, P529, DOI 10.1253/circj.66.529; Ekmekci A, 2009, J ENDOCRINOL INVEST, V32, P611, DOI [10.3275/6400, 10.1007/BF03346518]; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grubb JR, 2006, J INFECT DIS, V193, P1516, DOI 10.1086/503807; Gupta SK, 2007, JAIDS-J ACQ IMM DEF, V45, P596, DOI 10.1097/QAI.0b013e318061d2fa; Gupta SK, 2009, J INFECT DIS, V200, P614, DOI 10.1086/600890; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Jamaluddin MS, 2010, ATHEROSCLEROSIS, V208, P104, DOI 10.1016/j.atherosclerosis.2009.07.029; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Redhage LA, 2009, HIV CLIN TRIALS, V10, P181, DOI 10.1310/hct1003-181; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Suessenbacher A, 2006, VASC MED, V11, P239, DOI 10.1177/1358863x06075006; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Valgimigli M, 2003, ARCH BIOCHEM BIOPHYS, V420, P255, DOI 10.1016/j.abb.2003.07.006; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478	27	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45716	10.1371/journal.pone.0045716	http://dx.doi.org/10.1371/journal.pone.0045716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029197	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900092
J	Werkmeister, RM; Palkovits, S; Told, R; Groschl, M; Leitgeb, RA; Garhofer, G; Schmetterer, L				Werkmeister, Rene M.; Palkovits, Stefan; Told, Reinhard; Groeschl, Martin; Leitgeb, Rainer A.; Garhoefer, Gerhard; Schmetterer, Leopold			Response of Retinal Blood Flow to Systemic Hyperoxia as Measured with Dual-Beam Bidirectional Doppler Fourier-Domain Optical Coherence Tomography	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; FLICKER STIMULATION; VESSEL ANALYZER; VELOCITY; GLAUCOMA; VELOCIMETRY; MECHANISM; HUMANS; CELLS; NERVE	Purpose: There is a long-standing interest in the study of retinal blood flow in humans. In the recent years techniques have been established to measure retinal perfusion based on optical coherence tomography (OCT). In the present study we used a technique called dual-beam bidirectional Doppler Fourier-domain optical coherence tomography (FD-OCT) to characterize the effects of 100% oxygen breathing on retinal blood flow. These data were compared to data obtained with a laser Doppler velocimeter (LDV). Methods: 10 healthy subjects were studied on 2 study days. On one study day the effect of 100% oxygen breathing on retinal blood velocities was studied using dual-beam bidirectional Doppler FD-OCT. On the second study day the effect of 100% oxygen breathing on retinal blood velocities was assessed by laser Doppler velocimetry (LDV). Retinal vessel diameters were measured on both study days using a commercially available Dynamic Vessel Analyzer. Retinal blood flow was calculated based on retinal vessel diameters and red blood cell velocity. Results: As expected, breathing of pure oxygen induced a pronounced reduction in retinal vessel diameters, retinal blood velocities and retinal blood flow on both study days (p<0.001). Blood velocity data correlated well between the two methods applied under both baseline as well as under hyperoxic conditions (r=0.98 and r=0.75, respectively). Data as obtained with OCT were, however, slightly higher. Conclusion: A good correlation was found between red blood cell velocity as measured with dual-beam bidirectional Doppler FD-OCT and red blood cell velocity assessed by the laser Doppler method. Dual-beam bidirectional Doppler FD-OCT is a promising approach for studying retinal blood velocities in vivo.	[Werkmeister, Rene M.; Told, Reinhard; Leitgeb, Rainer A.; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Palkovits, Stefan; Told, Reinhard; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Groeschl, Martin] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Technische Universitat Wien	Schmetterer, L (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	leopold.schmetterer@meduniwien.ac.at		Leitgeb, Rainer/0000-0002-0131-4111; Schmetterer, Leopold/0000-0002-7189-1707; Told, Reinhard/0000-0003-2046-7081	Austrian Science Foundation [APP21570FW]; Austrian Research Promotion Agency (FFG) [FA 607A0502]; Christian Doppler Laboratory for Laser Development and their Application in Medicine; Austrian Science Fund (FWF) [P 21570] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG); Christian Doppler Laboratory for Laser Development and their Application in Medicine; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Foundation, project no. APP21570FW, http://www.fwf.ac.at/; Austrian Research Promotion Agency (FFG), project no. FA 607A0502, http://www.ffg.at/en; and Christian Doppler Laboratory for Laser Development and their Application in Medicine, http://www.cdg.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute American National Standard for Safe Use of Lasers, 2000, Z136122000 ANSI LAS; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bachmann AH, 2007, OPT EXPRESS, V15, P408, DOI 10.1364/OE.15.000408; Baumann B, 2011, BIOMED OPT EXPRESS, V2, P1539, DOI 10.1364/BOE.2.001539; Bower BA, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772877; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; FEKE GT, 1994, INVEST OPHTH VIS SCI, V35, P2968; FEKE GT, 1989, INVEST OPHTH VIS SCI, V30, P58; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garcia JPS, 2002, OPHTHALMIC RES, V34, P295, DOI 10.1159/000065600; Garhofer G, 2004, BRIT J OPHTHALMOL, V88, P887, DOI 10.1136/bjo.2003.033548; Garhofer G, 2012, INVEST OPHTH VIS SCI, V53, P698, DOI 10.1167/iovs.11-8624; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Gilmore ED, 2007, INVEST OPHTH VIS SCI, V48, P1744, DOI 10.1167/iovs.06-1016; GRUNWALD JE, 1992, INVEST OPHTH VIS SCI, V33, P356; Grunwald JE, 1996, BRIT J OPHTHALMOL, V80, P327, DOI 10.1136/bjo.80.4.327; Gullstrand A., 1924, HELMHOLTZS TREATISE, V1, P351; Iftimia NV, 2008, OPT EXPRESS, V16, P13624, DOI 10.1364/OE.16.013624; Kiss B, 2002, MICROVASC RES, V64, P75, DOI 10.1006/mvre.2002.2402; Leitgeb RA, 2004, OPT LETT, V29, P171, DOI 10.1364/OL.29.000171; Leitgeb RA, 2003, OPT EXPRESS, V11, P3116, DOI 10.1364/OE.11.003116; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; Logean E, 2000, APPL OPTICS, V39, P2858, DOI 10.1364/AO.39.002858; Logean E, 2003, LASER PHYS, V13, P45; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Michaely R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2771553; Mozaffarieh M, 2007, SURV OPHTHALMOL, V52, pS174, DOI 10.1016/j.survophthal.2007.08.013; Nagaoka Taiji, 2006, Nippon Ganka Gakkai Zasshi, V110, P872; Nguyen TT, 2009, INVEST OPHTH VIS SCI, V50, P5609, DOI 10.1167/iovs.09-3442; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Pedersen CJ, 2007, OPT LETT, V32, P506, DOI 10.1364/OL.32.000506; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Pemp B, 2010, DIABETES CARE, V33, P2038, DOI 10.2337/dc10-0502; Pemp B, 2010, INVEST OPHTH VIS SCI, V51, P2, DOI 10.1167/iovs.09-3888; Pemp B, 2009, INVEST OPHTH VIS SCI, V50, P4029, DOI 10.1167/iovs.08-3260; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Polska E, 2001, AM J PHYSIOL-HEART C, V280, pH1442, DOI 10.1152/ajpheart.2001.280.4.H1442; Resch H, 2009, ACTA OPHTHALMOL, V87, P4, DOI 10.1111/j.1755-3768.2007.01167.x; RIVA C, 1972, INVEST OPHTH VISUAL, V11, P936; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; RIVA CE, 1981, APPL OPTICS, V20, P117, DOI 10.1364/AO.20.000117; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; RIVA CE, 1983, INVEST OPHTH VIS SCI, V24, P47; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Schmetterer L, 1999, DIABETOLOGIA, V42, P387, DOI 10.1007/s001250051171; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Schmoll T, 2011, BIOMED OPT EXPRESS, V2, P1159, DOI 10.1364/BOE2.001159; Schmoll T, 2009, OPT EXPRESS, V17, P4166, DOI 10.1364/OE.17.004166; Singh ASG, 2010, BIOMED OPT EXPRESS, V1, P1047, DOI 10.1364/BOE.1.001047; Singh ASG, 2011, BIOMED OPT EXPRESS, V2, P1328, DOI 10.1364/BOE.2.001328; Stalmans I, 2011, ACTA OPHTHALMOL, V89, pe609, DOI 10.1111/j.1755-3768.2011.02178.x; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Szkulmowska A, 2008, OPT LETT, V33, P1425, DOI 10.1364/OL.33.001425; Tao YK, 2009, OPT EXPRESS, V17, P4177, DOI 10.1364/OE.17.004177; Tuchin V. V, 2006, OPTICAL CLEARING TIS; Wang Y, 2009, BRIT J OPHTHALMOL, V93, P634, DOI 10.1136/bjo.2008.150276; Wang YM, 2011, BIOMED OPT EXPRESS, V2, P1852, DOI 10.1364/BOE.001852; Wang YM, 2011, INVEST OPHTH VIS SCI, V52, P840, DOI 10.1167/iovs.10-5985; Werkmeister RM, 2008, OPT LETT, V33, P2967, DOI 10.1364/OL.33.002967; Yazdanfar S, 2003, ARCH OPHTHALMOL-CHIC, V121, P235; Yoshida A, 2003, AM J OPHTHALMOL, V135, P356, DOI 10.1016/S0002-9394(02)01949-9; Zhong ZY, 2011, INVEST OPHTH VIS SCI, V52, P4151, DOI 10.1167/iovs.10-6940; Zotter S, 2011, OPT EXPRESS, V19, P1217, DOI 10.1364/OE.19.001217	65	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45876	10.1371/journal.pone.0045876	http://dx.doi.org/10.1371/journal.pone.0045876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029289	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900172
J	Shimizu, T; Kasamatsu, A; Yamamoto, A; Koike, K; Ishige, S; Takatori, H; Sakamoto, Y; Ogawara, K; Shiiba, M; Tanzawa, H; Uzawa, K				Shimizu, Toshihiro; Kasamatsu, Atsushi; Yamamoto, Ayumi; Koike, Kazuyuki; Ishige, Shunsaku; Takatori, Hiroaki; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Annexin A10 in Human Oral Cancer: Biomarker for Tumoral Growth via G1/S Transition by Targeting MAPK Signaling Pathways	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ACUTE PROMYELOCYTIC LEUKEMIA; CYCLIN D1 EXPRESSION; HEPATOCELLULAR-CARCINOMA; KINASE ACTIVATION; PANCREATIC-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; PROTEIN; PROLIFERATION	Background: Annexins are calcium and phospholipid binding proteins that form an evolutionary conserved multigene family. Considerable evidence indicates that annexin A10 (ANXA10) is involved in tumoral progression, although little is known about its role in human oral carcinogenesis. In this study, we investigated the involvement of ANXA10 in oral squamous cell carcinoma (OSCC). Methodology/Principal Findings: ANXA10 mRNA and protein expressions were assessed by quantitative reverse transcriptase polymerase chain reaction and immunoblotting, and we conducted a proliferation assay and cell-cycle analysis in ANXA10 knockdown cells in vitro. We evaluated the correlation between the ANXA10 expression status in 100 primary OSCCs and the clinicopathological features by immunohistochemistry. ANXA10 mRNA and protein expression levels were up-regulated in all cellular lines examined (n = 7, p < 0.05). ANXA10 knockdown cells showed that cellular proliferation decreased by inactivation of extracellular regulated kinase (ERK) (p < 0.05), and cell-cycle arrest at the G1 phase resulted from up-regulation of cyclin-dependent kinase inhibitors. ANXA10 protein expression in primary OSCCs was also significantly greater than in normal counterparts (p < 0.05), and higher expression was correlated with tumoral size (p = 0.027). Conclusions/Significance: Our results proposed for the first time that ANXA10 is an indicator of cellular proliferation in OSCCs. Our results suggested that ANXA10 expression might indicate cellular proliferation and ANXA10 might be a potential therapeutic target for the development of new treatments for OSCCs.	[Shimizu, Toshihiro; Kasamatsu, Atsushi; Yamamoto, Ayumi; Koike, Kazuyuki; Ishige, Shunsaku; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan; [Kasamatsu, Atsushi; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba, Japan; [Takatori, Hiroaki] Chiba Univ, Dept Mol Genet, Grad Sch Med, Chuo Ku, Chiba, Japan	Chiba University; Chiba University	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Grants-in-Aid for Scientific Research [24790989] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; CHANG KS, 1992, BLOOD, V79, P1802; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Francia G, 1996, CANCER RES, V56, P3855; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Han EKH, 2000, BRIT J CANCER, V83, P83; Harada M., 1993, JAPANESE J ORAL MAXI, V39, P965, DOI [10.5794/jjoms.39.965, DOI 10.5794/JJOMS.39.965]; Iseki Y, 2009, LEUKEMIA RES, V33, P1658, DOI 10.1016/j.leukres.2009.04.010; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kataoka TR, 2000, JPN J CANCER RES, V91, P75, DOI 10.1111/j.1349-7006.2000.tb00862.x; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Kim JK, 2010, ONCOL REP, V24, P607, DOI 10.3892/or_00000898; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Koike H, 2005, CONNECT TISSUE RES, V46, P117, DOI 10.1080/03008200591008437; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Le Gall M, 1998, ONCOGENE, V17, P1271, DOI 10.1038/sj.onc.1202057; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Liu SH, 2002, AM J PATHOL, V160, P1831, DOI 10.1016/S0002-9440(10)61129-7; Lombardi DP, 1999, CANCER RES, V59, P5724; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; McCubrey JA, 2007, ADV ENZYME REGUL, V47, P64, DOI 10.1016/j.advenzreg.2006.12.013; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Mukherjee S, 2011, BIOCHEM J, V440, P115, DOI 10.1042/BJ20110240; Munksgaard PP, 2011, BRIT J CANCER, V105, P1379, DOI 10.1038/bjc.2011.404; Nah SS, 2009, J PINEAL RES, V47, P70, DOI 10.1111/j.1600-079X.2009.00689.x; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Pencil SD, 1998, CLIN EXP METASTAS, V16, P113, DOI 10.1023/A:1021917017109; Perisanidis C, 2012, J ORAL PATHOL MED, V41, P40, DOI 10.1111/j.1600-0714.2011.01071.x; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; SARKAR A, 1994, BLOOD, V84, P279; Sauter ER, 2002, CANCER RES, V62, P3200; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; THEOBALD J, 1995, BRIT J CANCER, V71, P786, DOI 10.1038/bjc.1995.152; Van Baal JWPM, 2005, GASTROENTEROLOGY, V129, P1274, DOI 10.1053/j.gastro.2005.07.026; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yue H, 2005, WORLD J GASTROENTERO, V11, P5057, DOI 10.3748/wjg.v11.i32.5057	56	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45510	10.1371/journal.pone.0045510	http://dx.doi.org/10.1371/journal.pone.0045510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23029062	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800064
J	Liu, L; Cui, J; Song, CJ; Bian, JS; Sparatore, A; Del Soldato, P; Wang, XY; Yan, CD				Liu, Lei; Cui, Jie; Song, Cheng-Jie; Bian, Jin-Song; Sparatore, Anna; Del Soldato, Piero; Wang, Xin-Yu; Yan, Chang-Dong			H(2)S-Releasing Aspirin Protects against Aspirin-Induced Gastric Injury via Reducing Oxidative Stress	PLOS ONE			English	Article							HYDROGEN-SULFIDE PROTECTS; INHIBITS SUPEROXIDE FORMATION; CYSTATHIONINE GAMMA-LYASE; LOW-DOSE ASPIRIN; GASTROINTESTINAL COMPLICATIONS; SILDENAFIL ACS6; INDUCED DAMAGE; NADPH OXIDASE; RAT; CELLS	The aim of this study was to examine the effect of ACS14, a hydrogen sulfide (H2S)-releasing derivative of aspirin (Asp), on Asp-induced gastric injury. Gastric hemorrhagic lesions were induced by intragastric administration of Asp (200 mg/kg, suspended in 0.5% carboxymethyl cellulose solutions) in a volume of 1 ml/100 g body weight. ACS14 (1, 5 or 10 mg/kg) was given 30 min before the Asp administration. The total area of gastric erosions, H2S concentration and oxidative stress in gastric tissues were measured three hours after administration of Asp. Treatment with Asp (200 mg/kg), but not ACS14 (430 mg/kg, at equimolar doses to 200 mg/kg Asp), for 3 h significantly increased gastric mucosal injury. The damage caused by Asp was reversed by ACS14 at 1-10 mg/kg in a concentration-dependent manner. ACS14 abrogated Asp-induced upregulation of COX-2 expression, but had no effect on the reduced PGE(2) level. ACS14 reversed the decreased H2S concentrations and blood flow in the gastric tissue in Asp-treated rats. Moreover, ACS14 attenuated Asp-suppressed superoxide dismutase-1 (SOD-1) expression and GSH activity, suggesting that ACS14 may stimulate antioxidants in the gastric tissue. ACS14 also obviously inhibited Asp-induced upregulation of protein expression of oxidases including XOD, p47(phox) and p67(phox). In conclusion, ACS14 protects Asp induced gastric mucosal injury by inhibiting oxidative stress in the gastric tissue.	[Wang, Xin-Yu] Shenzhen Second Peoples Hosp, Dept Endocrinol, Shenzhen, Guangdong, Peoples R China; [Liu, Lei; Cui, Jie; Song, Cheng-Jie; Yan, Chang-Dong] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China; [Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, Milan, Italy; [Del Soldato, Piero] CTG Pharma, Milan, Italy	Second People's Hospital of Shenzhen; Xuzhou Medical University; National University of Singapore; University of Milan	Wang, XY (corresponding author), Shenzhen Second Peoples Hosp, Dept Endocrinol, Shenzhen, Guangdong, Peoples R China.	wangxy926@yahoo.com; yancd55@163.com	Sparatore, Anna/J-8634-2015	Sparatore, Anna/0000-0003-2135-2649; Bian, Jinsong/0000-0002-7741-598X	China National Science Fund in Jiangsu Province [BK2009088]; National Natural Science Foundation of China [30873055]	China National Science Fund in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from China National Science Fund in Jiangsu Province (BK2009088) and National Natural Science Foundation of China (30873055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2004, BRIT J CLIN PHARMACO, V58, P587, DOI 10.1111/j.1365-2125.2004.02198.x; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Blandizzi C, 2008, DRUG AGING, V25, P197, DOI 10.2165/00002512-200825030-00003; Blandizzi C, 2009, PHARMACOL RES, V59, P90, DOI 10.1016/j.phrs.2008.11.004; Brandes RP, 2008, CURR OPIN LIPIDOL, V19, P513, DOI 10.1097/MOL.0b013e32830c91e3; Brzozowski T, 2000, J PHYSIOL PHARMACOL, V51, P751; D'Argenio G, 2008, BRIT J NUTR, V100, P1228, DOI 10.1017/S0007114508988747; Davies NM, 1997, ALIMENT PHARM THERAP, V11, P1101, DOI 10.1046/j.1365-2036.1997.00247.x; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Devai I, 2002, ENVIRON TECHNOL, V23, P319, DOI 10.1080/09593332508618412; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Erdmann K, 2008, BIOCHEM BIOPH RES CO, V368, P937, DOI 10.1016/j.bbrc.2008.02.009; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hatazawa R, 2007, AM J PHYSIOL-GASTR L, V293, pG788, DOI 10.1152/ajpgi.00131.2007; Hu LF, 2008, PFLUG ARCH EUR J PHY, V455, P971, DOI 10.1007/s00424-007-0346-8; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Kimura H, 2010, AMINO ACIDS; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Konturek PC, 2008, J PHYSIOL PHARMACOL, V59, P67; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Metwally NS, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-8; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P984, DOI 10.1038/bjp.2008.326; Muzaffar S, 2008, J VASC RES, V45, P521, DOI 10.1159/000129686; Naesdall J, 2006, DRUG SAFETY, V29, P119; Osborne NN, 2010, INVEST OPHTH VIS SCI, V51, P284, DOI 10.1167/iovs.09-3999; Osborne NN, 2012, NEUROCHEM INT; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Pohle T, 2001, ALIMENT PHARM THER, V15, P677, DOI 10.1046/j.1365-2036.2001.00975.x; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rossoni G, 2010, EUR J PHARMACOL, V648, P139, DOI 10.1016/j.ejphar.2010.08.039; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Shukla N, 2009, BJU INT, V103, P1522, DOI 10.1111/j.1464-410X.2009.08415.x; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Sparatore A, 2009, FREE RADICAL BIO MED, V46, P586, DOI 10.1016/j.freeradbiomed.2008.11.013; Suzuki T, 2008, J PHARMACOL SCI, V106, P469, DOI 10.1254/jphs.FP0071422; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Vacek TP, 2010, AMINO ACIDS, V39, P1161, DOI 10.1007/s00726-010-0550-2; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wallace JL, 2007, BRIT J PHARMACOL, V152, P421, DOI 10.1038/sj.bjp.0707396; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhang QY, 2004, BIOCHEM BIOPH RES CO, V317, P30, DOI 10.1016/j.bbrc.2004.02.176	61	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46301	10.1371/journal.pone.0046301	http://dx.doi.org/10.1371/journal.pone.0046301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029468	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900127
J	Ferreira, SM; Botha, JM; Emmett, MC				Ferreira, Sam M.; Botha, Judith M.; Emmett, Megan C.			Anthropogenic Influences on Conservation Values of White Rhinoceros	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; ELEPHANT POPULATION; MANAGEMENT; EVOLUTION; SIZE; HERBIVORES; SELECTION; DENSITY; SCIENCE; AFRICA	White rhinoceros (rhinos) is a keystone conservation species and also provides revenue for protection agencies. Restoring or mimicking the outcomes of impeded ecological processes allows reconciliation of biodiversity and financial objectives. We evaluate the consequences of white rhino management removal, and in recent times, poaching, on population persistence, regional conservation outcomes and opportunities for revenue generation. In Kruger National Park, white rhinos increased from 1998 to 2008. Since then the population may vary non-directionally. In 2010, we estimated 10,621 (95% CI: 8,767-12,682) white rhinos using three different population estimation methods. The desired management effect of a varying population was detectable after 2008. Age and sex structures in sink areas (focal rhino capture areas) were different from elsewhere. This comes from relatively more sub-adults being removed by managers than what the standing age distribution defined. Poachers in turn focused on more adults in 2011. Although the effect of poaching was not detectable at the population level given the confidence intervals of estimates, managers accommodated expected poaching annually and adapted management removals. The present poaching trend predicts that 432 white rhinos may be poached in Kruger during 2012. The white rhino management model mimicking outcomes of impeded ecological processes predicts 397 rhino management removals are required. At present poachers may be doing "management removals," but conservationists have no opportunity left to contribute to regional rhino conservation strategies or generate revenue through white rhino sales. In addition, continued trends in poaching predict detectable white rhino declines in Kruger National Park by 2016. Our results suggest that conservationists need innovative approaches that reduce financial incentives to curb the threats that poaching poses to several conservation values of natural resources such as white rhinos.	[Ferreira, Sam M.; Botha, Judith M.] S African Natl Pk, Sci Serv, Skukuza, South Africa; [Ferreira, Sam M.; Emmett, Megan C.] Rhino Act Grp Effort, Johannesburg, South Africa		Ferreira, SM (corresponding author), S African Natl Pk, Sci Serv, Skukuza, South Africa.	sam.ferreira@sanparks.org			SANParks; RAGE's mission; USFWS	SANParks; RAGE's mission; USFWS(US Fish & Wildlife Service)	Primary funding forms part of the annual budget of SANParks, the primary implementing agency that has management authority over the study area, Kruger National Park. Managers of SANParks that provided the funding through budget decisions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Rhino Action Group Effort is a Civil Action Group that originated from public outcry against rhino poaching in South Africa. SMF is chairman of the Committee and ME is a member representing visual media. RAGE's mission is to facilitate a range of support from the private sector to government institutions by coordination of information, funding and expertise complimenting the National Wildlife Crime Reaction Unit and associated agencies' curbing of rhino poaching in South Africa, and change attitudes to the use of rhino horn through information and awareness campaigns. Membership of the committee is voluntary and carries no financial gains. Committee members carry all cost associated with traveling for meetings against their own accounts. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; SANParks funded all surveys for white rhinos and captures from the annual budget. The Park Development Fund provided additional financial support for the age- and sex-structure surveys, while the USFWS funded the black rhino survey of 2009.	Aleper D, 2006, AFR J ECOL, V44, P157, DOI 10.1111/j.1365-2028.2006.00599.x; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 2011, ORYX, V45, P463; [Anonymous], 1982, ESTIMATION ANIMAL AB; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Biggs H., 2003, KRUGER EXPERIENCE EC; Borchers DL, 1998, BIOMETRICS, V54, P1207, DOI 10.2307/2533651; Brooks P.M., 1997, CONSERVATION PLAN BL; Buckland S., 2004, ADV DISTANCE SAMPLIN; Carruthers Jane, 2008, Transactions of the Royal Society of South Africa, V63, P160; CAUGHLEY G, 1974, J WILDLIFE MANAGE, V38, P921, DOI 10.2307/3800067; Caughley G., 1977, ANAL VERTEBRATE POPU; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Dobson A, 2008, TRENDS ECOL EVOL, V23, P177, DOI 10.1016/j.tree.2007.08.019; EDWARDS AWF, 1972, LIKELIHOOD; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; Emslie R., 1999, AFRICAN RHINO STATUS; Emslie RH, 1995, FINE TUNING RHINO MA; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Ferreira SM, 2011, S AFR J WILDL RES, V41, P192, DOI 10.3957/056.041.0206; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Ferreira SM, 2009, S AFR J WILDL RES, V39, P181, DOI 10.3957/056.039.0205; Gertenbach W.P.D., 1984, Koedoe, V26, P9; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Gray J, 2010, TRAFFIC B, V23, P13; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Knight M. H., 2009, Africa Insight, V39, P70; Knight M, 2011, PACHYDERM, P7; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; Lever C, 2004, ORYX, V38, P13; Lindeque M, 1998, RHINO CONSERVATION M; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Messer KD, 2010, ECOL ECON, V69, P2334, DOI 10.1016/j.ecolecon.2010.06.017; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Olivier PI, 2009, AFR J ECOL, V47, P202, DOI 10.1111/j.1365-2028.2008.00983.x; Owen-Smith N, 2006, S AFR J SCI, V102, P389; OWENSMITH N, 1973, THESIS U WISCONSIN W; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Redfern JV, 2002, S AFR J SCI, V98, P455; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Schutte I. C., 1986, KOEDOE, V29, P13, DOI DOI 10.4102/K0ED0E.V29I1.517; Sherriffs P, 2007, PACHYDERM, P116; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Thomas R., 2010, TRAFFIC BULL, V23, P3; Thompson S.K., 2012, SAMPLING, V2nd; TURTON C, 2009, REV TRADE RHINOCEROS; Ueno M, 2010, J WILDLIFE MANAGE, V74, P1472, DOI 10.2193/2009-339; van Aarde RJ, 2006, S AFR J SCI, V102, P385; van Aarde R, 1999, ANIM CONSERV, V2, P287, DOI 10.1017/S1367943099000621; Venter F. J., 1990, THESIS U S AFRICA PR; Venter FJ, 2008, ECOSYSTEMS, V11, P173, DOI 10.1007/s10021-007-9116-x; Walsh PD, 2001, J APPL ECOL, V38, P217, DOI 10.1046/j.1365-2664.2001.00578.x; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; Whyte Ian J., 1998, Pachyderm, V25, P45; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x	63	25	25	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45989	10.1371/journal.pone.0045989	http://dx.doi.org/10.1371/journal.pone.0045989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029354	gold, Green Published			2022-12-27	WOS:000309517500052
J	Khan, JA; Bellance, C; Guiochon-Mantel, A; Lombes, M; Loosfelt, H				Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues			Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; A-ISOFORM; HB-EGF; EXPRESSION; PHOSPHORYLATION; ESTROGEN; AMPHIREGULIN; TRANSCRIPTION; ALPHA	Progesterone receptor isoforms (PRA and PRB) are expressed at equal levels in normal mammary cells. However, alteration in PRA/PRB expression is often observed in aggressive breast cancer suggesting differential contribution of PR isoforms in carcinogenesis. The mechanisms underlying such processes remain to be established mainly due to paucity of appropriate cellular models. To investigate the role of PR isoforms and the impact of imbalanced PRA/PRB ratio in transcriptional regulation, we have generated an original human breast cancer cell line conditionally expressing PRA and/or PRB in dose-dependence of non-steroid inducers. We first focused on PR-dependent transcriptional regulation of the paracrine growth factor gene amphiregulin (AREG) playing important role in cancer. Interestingly, unliganded PRA increases AREG expression, independently of estrogen receptor, yet inhibitable by antiprogestins. We show that functional outcome of epidermal growth factor (EGF) on such regulation is highly dependent on PRA/PRB ratio. Using this valuable model, genome-wide transcriptomic studies allowed us to determine the differential effects of PRA and PRB as a function of hormonal status. We identified a large number of novel PR-regulated genes notably implicated in breast cancer and metastasis and demonstrated that imbalanced PRA/PRB ratio strongly impact their expression predicting poor outcome in breast cancer. In sum, our unique cell-based system strongly suggests that PRA/PRB ratio is a critical determinant of PR target gene selectivity and responses to hormonal/growth factor stimuli. These findings provide molecular support for the aggressive phenotype of breast cancers with impaired expression of PRA or PRB.	[Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Guiochon-Mantel, Anne] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Khan, Junaid A.] Univ Agr Faisalabad, Dept Physiol & Pharmacol, Faisalabad, Pakistan	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Agriculture Faisalabad	Loosfelt, H (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	hugues.loosfelt@u-psud.fr	Khan, Junaid Ali/ABG-6129-2020; Khan, Junaid Ali/ABG-2756-2020; Khan, Junaid/AAE-3522-2019; Lombes, Marc/L-5933-2018; Guiochon-Mantel, Anne S/S-8408-2018	Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; Guiochon-Mantel, Anne S/0000-0003-1737-1409	Institut National de la Sante et de la Recherche Medicale (INSERM) France; Association de la Recherche contre le Cancer (ARC), France; Higher Education Commission, Islamabad, Pakistan; La Ligue Contre le Cancer, France; Conseil Regional de la Martinique	Institut National de la Sante et de la Recherche Medicale (INSERM) France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association de la Recherche contre le Cancer (ARC), France; Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan); La Ligue Contre le Cancer, France; Conseil Regional de la Martinique	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) France (http://www.inserm.fr/), the Association de la Recherche contre le Cancer (ARC), France (http://www.arc-cancer.net). Junaid A. Khan was on study leave from the Department of Physiology and Pharmacology, University of Agriculture, Faisalabad and is a recipient of doctoral scholarship from Higher Education Commission, Islamabad, Pakistan, and a fellowship from La Ligue Contre le Cancer, France (http://www.ligue-cancer.net/). Catherine Bellance got a fellowship from the Conseil Regional de la Martinique (http://www.crmartinique.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Afhuppe W, 2009, J STEROID BIOCHEM, V113, P105, DOI 10.1016/j.jsbmb.2008.11.015; Amazit L, 2011, MOL ENDOCRINOL, V25, P394, DOI 10.1210/me.2010-0458; Arnett-Mansfield RL, 2001, CANCER RES, V61, P4576; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; CHAUCHEREAU A, 1991, J BIOL CHEM, V266, P18280; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Clarke RB, 1997, CANCER RES, V57, P4987; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Desruisseau S, 2004, INT J CANCER, V111, P733, DOI 10.1002/ijc.20312; Faivre E, 2005, STEROIDS, V70, P418, DOI 10.1016/j.steroids.2005.02.012; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Graham JD, 1995, J BIOL CHEM, V270, P30693, DOI 10.1074/jbc.270.51.30693; GRAHAM JD, 1995, CANCER RES, V55, P5063; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hagan CR, 2011, MOL CELL BIOL, V31, P2439, DOI 10.1128/MCB.01246-10; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; HORWITZ KB, 1992, ENDOCR REV, V13, P146, DOI 10.1210/er.13.2.146; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Jacobsen BM, 2003, J MAMMARY GLAND BIOL, V8, P257, DOI 10.1023/B:JOMG.0000010028.48159.84; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan JA, 2011, MOL ENDOCRINOL, V25, P394; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Leo JCL, 2005, INT J CANCER, V117, P561, DOI 10.1002/ijc.21186; Leonhardt SA, 1998, MOL ENDOCRINOL, V12, P1914, DOI 10.1210/me.12.12.1914; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Lin VCL, 1999, CLIN CANCER RES, V5, P395; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; Mani SK, 1996, MOL ENDOCRINOL, V10, P1728, DOI 10.1210/me.10.12.1728; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; McGowan EM, 2004, BREAST CANCER RES TR, V83, P211, DOI 10.1023/B:BREA.0000014041.58977.80; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Mote PA, 2004, GENE CHROMOSOME CANC, V39, P236, DOI 10.1002/gcc.10321; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; MUSGROVE EA, 1991, MOL CELL BIOL, V11, P5032, DOI 10.1128/MCB.11.10.5032; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Palli SR, 2003, EUR J BIOCHEM, V270, P1308, DOI 10.1046/j.1432-1033.2003.03501.x; Peng J, 2010, INT J ONCOL, V36, P451, DOI 10.3892/ijo_00000519; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Punglia RS, 2006, CANCER-AM CANCER SOC, V106, P2576, DOI 10.1002/cncr.21919; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Smid-Koopman E, 2005, J SOC GYNECOL INVEST, V12, P285, DOI 10.1016/j.jsgi.2005.01.003; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wargon V, 2011, BREAST CANCER RES TR, V126, P319, DOI 10.1007/s10549-010-0908-x; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; ZHANG ZM, 1994, ENDOCRINOLOGY, V134, P1089, DOI 10.1210/en.134.3.1089	82	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45993	10.1371/journal.pone.0045993	http://dx.doi.org/10.1371/journal.pone.0045993			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029355	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700102
J	Machida, T; Ishibashi, A; Kirino, A; Sato, J; Kawasaki, S; Niimura, Y; Honjoh, K; Miyamoto, T				Machida, Takeshi; Ishibashi, Akiko; Kirino, Ai; Sato, Jun-ichi; Kawasaki, Shinji; Niimura, Youichi; Honjoh, Ken-ichi; Miyamoto, Takahisa			Chloroplast NADPH-Dependent Thioredoxin Reductase from Chlorella vulgaris Alleviates Environmental Stresses in Yeast Together with 2-Cys Peroxiredoxin	PLOS ONE			English	Article							REACTION-MECHANISM; OXIDATIVE STRESS; REDOX SYSTEM; EXPRESSION; CELLS; PROTECTION; PROTEINS; NTRC	Chloroplast NADPH-dependent thioredoxin reductase (NTRC) catalyzes the reduction of 2-Cys peroxiredoxin (2-Cys Prx) and, thus, probably functions as an antioxidant system. The functions of the enzyme in oxidative and salt stresses have been reported previously. We have previously identified and characterized NTRC in Chlorella vulgaris. In the present study, we isolated a full-length cDNA clone encoding 2-Cys Prx from C. vulgaris and investigated the involvement of Chlorella NTRC/2-Cys Prx system in several environmental stress tolerances by using yeast as a eukaryotic model. Deduced Chlorella 2-Cys Prx was homologous to those of chloroplast 2-Cys Prxs from plants, and two conserved cysteine residues were found in the deduced sequence. Enzyme assay showed that recombinant mature C. vulgaris NTRC (mCvNTRC) transferred electrons from NADPH to recombinant mature C. vulgaris 2-Cys Prx (mCvPrx), and mCvPrx decomposed hydrogen peroxide, tert-butyl hydroperoxide, and peroxynitrite by cooperating with mCvNTRC. Based on the results, the mCvNTRC/mCvPrx antioxidant system was identified in Chlorella. The antioxidant system genes were expressed in yeast separately or coordinately. Stress tolerances of yeast against freezing, heat, and menadione-induced oxidative stresses were significantly improved by expression of mCvNTRC, and the elevated tolerances were more significant when both mCvNTRC and mCvPrx were co-expressed. Our results reveal a novel feature of NTRC: it functions as an antioxidant system with 2-Cys Prx in freezing and heat stress tolerances.	[Machida, Takeshi; Honjoh, Ken-ichi; Miyamoto, Takahisa] Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Machida, Takeshi] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan; [Ishibashi, Akiko; Kirino, Ai] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Sato, Jun-ichi; Kawasaki, Shinji; Niimura, Youichi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan	Kyushu University; Fukushima Medical University; Kyushu University; Tokyo University of Agriculture	Honjoh, K (corresponding author), Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	honjoh@agr.kyushu-u.ac.jp		Kawasaki, Shinji/0000-0001-8225-4431	Japan Society for the Promotion of Science (JSPS) [20580135, 08J02023]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (no. 20580135) from the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/e-grants/index.html). T. Machida was supported by a Grant-in-Aid for JSPS Fellows (no. 08J02023) from JSPS. JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for financial support.	Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; FLORENCIO FJ, 1988, ARCH BIOCHEM BIOPHYS, V266, P496, DOI 10.1016/0003-9861(88)90282-2; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; HUPPE HC, 1990, PLANTA, V180, P341, DOI 10.1007/BF01160389; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kim KH, 2010, BIOTECHNOL LETT, V32, P571, DOI 10.1007/s10529-009-0185-0; Kim MD, 2011, PLANT PHYSIOL BIOCH, V49, P891, DOI 10.1016/j.plaphy.2011.04.001; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machida T, 2008, PLANT SCI, V175, P238, DOI 10.1016/j.plantsci.2008.04.002; Machida T, 2009, BIOSCI BIOTECH BIOCH, V73, P695, DOI 10.1271/bbb.80761; Perez-Ruiz JM, 2009, FEBS LETT, V583, P1399, DOI 10.1016/j.febslet.2009.03.067; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Pulido P, 2009, PLANT J, V57, P132, DOI 10.1111/j.1365-313X.2008.03675.x; Rouhanizadeh M, 2008, METHOD ENZYMOL, V441, P111, DOI 10.1016/S0076-6879(08)01207-X; Sakamoto A, 2003, PLANT J, V33, P841, DOI 10.1046/j.1365-313X.2003.01669.x; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Takeda K, 2004, BIOSCI BIOTECH BIOCH, V68, P20, DOI 10.1271/bbb.68.20; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	29	7	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45988	10.1371/journal.pone.0045988	http://dx.doi.org/10.1371/journal.pone.0045988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029353	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700101
J	Yanashima, R; Garcia, AA; Aldridge, J; Weiss, N; Hayes, MA; Andrews, JH				Yanashima, Ryan; Garcia, Antonio A.; Aldridge, James; Weiss, Noah; Hayes, Mark A.; Andrews, James H.			Cutting a Drop of Water Pinned by Wire Loops Using a Superhydrophobic Surface and Knife	PLOS ONE			English	Article							LIQUID; ACTUATION; BREAKUP	A water drop on a superhydrophobic surface that is pinned by wire loops can be reproducibly cut without formation of satellite droplets. Drops placed on low-density polyethylene surfaces and Teflon-coated glass slides were cut with superhydrophobic knives of low-density polyethylene and treated copper or zinc sheets, respectively. Distortion of drop shape by the superhydrophobic knife enables a clean break. The driving force for droplet formation arises from the lower surface free energy for two separate drops, and it is modeled as a 2-D system. An estimate of the free energy change serves to guide when droplets will form based on the variation of drop volume, loop spacing and knife depth. Combining the cutting process with an electrofocusing driving force could enable a reproducible biomolecular separation without troubling satellite drop formation.	[Garcia, Antonio A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Yanashima, Ryan; Weiss, Noah; Hayes, Mark A.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Aldridge, James; Andrews, James H.] Youngstown State Univ, Dept Phys & Astron, Youngstown, OH 44555 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Ohio; Youngstown State University	Garcia, AA (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	tony.garcia@asu.edu			National Science Foundation [CBET 0925100]; National Institutes of Health [1R03AI094193-01, 1R03AI099740-01, 5R21EB010191-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI099740, R03AI094193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB010191] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Science Foundation grant CBET 0925100, and National Institutes of Health grants 1R03AI094193-01, 1R03AI099740-01, and 5R21EB010191-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormashenko E, 2011, LANGMUIR, V27, P3266, DOI 10.1021/la200258u; BOYS CV, 1959, SOAP BUBBLES THEIR C; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Chuech SG, 2006, INT J NUMER METH FL, V52, P1159, DOI 10.1002/fld.1226; Darhuber AA, 2005, ANNU REV FLUID MECH, V37, P425, DOI 10.1146/annurev.fluid.36.050802.122052; Das TK, 1997, ATOMIZATION SPRAY, V7, P549, DOI 10.1615/AtomizSpr.v7.i5.70; Egatz-Gomez A, 2007, APPL SURF SCI, V254, P330, DOI 10.1016/j.apsusc.2007.07.121; Larmour IA, 2007, ANGEW CHEM INT EDIT, V46, P1710, DOI 10.1002/anie.200604596; Nakajima A, 2011, NPG ASIA MATER, V3, P49, DOI 10.1038/asiamat.2011.55; PAPAGEORGIOU DT, 1995, PHYS FLUIDS, V7, P1529, DOI 10.1063/1.868540; Rayleigh L., 1892, DUBLIN PHILOS MAG J, V34, P145, DOI DOI 10.1080/14786449208620301; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; SCHULKES RMSM, 1994, J FLUID MECH, V278, P83, DOI 10.1017/S0022112094003629; Shapiro B, 2003, J APPL PHYS, V93, P5794, DOI 10.1063/1.1563828; TJAHJADI M, 1992, J FLUID MECH, V243, P297, DOI 10.1017/S0022112092002738; Tomotika S, 1936, PROC R SOC LON SER-A, V153, P0302, DOI 10.1098/rspa.1936.0003; Weiss NG, 2011, LANGMUIR, V27, P494, DOI 10.1021/la104085t; Xue CH, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/3/033002	18	19	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45893	10.1371/journal.pone.0045893	http://dx.doi.org/10.1371/journal.pone.0045893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029297	gold, Green Published			2022-12-27	WOS:000309554700086
J	Arendt, JFB; Nexo, E				Arendt, Johan F. B.; Nexo, Ebba			Cobalamin Related Parameters and Disease Patterns in Patients with Increased Serum Cobalamin Levels	PLOS ONE			English	Article							TRANSCOBALAMIN LEVELS; HOLO-TRANSCOBALAMIN; TRANSPORT PROTEINS; VITAMIN-B12; PLASMA; HAPTOCORRIN; FOLATE; QUANTIFICATION; ASSOCIATION; CELLS	Background: Measurement of serum cobalamin levels is routinely used to diagnose cobalamin deficiency. Surprisingly, approximately 15% of patients have high cobalamin levels and no consensus exists regarding the clinical implications. Methods: Hospital-treated patients above 18 years of age referred for serum cobalamin measurement were included in groups of patients [percentage cobalamin supplemented] with low (<200 pmol/L, n = 200 [6%]), normal (200-600, n = 202 [6%]) high (601-1000, n = 217 [27%]) and very high (>1000, n = 199 [53%]) cobalamin levels. Total and cobalamin-saturated (holo) transcobalamin, total haptocorrin, soluble TC receptor, sCD320, and methylmalonic acid were analyzed. Data on diagnoses and medical prescriptions was obtained through medical files and the Aarhus University Prescription Database. Results: Among patients not cobalamin supplemented median total haptocorrin and holo transcobalamin levels were markedly higher in the groups with high/very high cobalamin levels compared to groups with low/normal cobalamin levels. Median total transcobalamin and sCD320 levels were similar across the groups. A number of diagnoses were significantly associated to very high Cbl levels (odds ratio (95% confidence interval)): alcoholism (5.74 (2.76-11.96)), liver disease (8.53 (3.59-20.23)), and cancer (5.48 (2.85-10.55)). Elevated haptocorrin levels were seen in patients with alcoholism, cancer, liver-, renal-, autoimmune-, and bronchopulmonary disease. No clinical associations to sCD320 and total and holo transcobalamin levels were found. Conclusion: In non-supplemented patients, high cobalamin levels were associated to high haptocorrin levels, and several diagnoses, including alcoholism, liver disease and cancer. Our study emphasizes that clinicians should take high serum cobalamin levels into consideration in the diagnostic process.	[Arendt, Johan F. B.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Aarhus University	Arendt, JFB (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	johan.frederik.berg.arendt@sun.au.dk		Arendt, Johan Frederik Hakonsen/0000-0003-4423-4813; Nexo, Ebba/0000-0001-9406-9081	Faculty of Health, Aarhus University; Danish Medical Research Council; Lundbeck Foundation	Faculty of Health, Aarhus University; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by: the Faculty of Health, Aarhus University (www.health.au.dk); Danish Medical Research Council (www.fi.dk/raad-og-udvalg/det-frie-forskningsraad/om-dff/faglige-raad/sundhed-og-sygdom) and the Lundbeck Foundation (www.lundbeckfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGASAKI T, 1990, BLOOD, V76, P1380; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; ARNALICH F, 1990, BRIT J RHEUMATOL, V29, P171; ARNALICH F, 1990, J MED, V21, P277; Baker H, 1998, J AM COLL NUTR, V17, P235, DOI 10.1080/07315724.1998.10718752; Boisson F, 1999, CANCER DETECT PREV, V23, P89, DOI 10.1046/j.1525-1500.1999.09914.x; BOUDES P, 1990, LANCET, V335, P1401, DOI 10.1016/0140-6736(90)91279-J; CARMEL R, 1977, CANCER-AM CANCER SOC, V40, P1348, DOI 10.1002/1097-0142(197709)40:3<1348::AID-CNCR2820400352>3.0.CO;2-Q; Carmel R, 2001, CLIN LAB HAEMATOL, V23, P365, DOI 10.1046/j.1365-2257.2001.00134.x; Chiche L, 2008, REV MED INTERNE, V29, P187, DOI 10.1016/j.revmed.2007.07.007; Collin SM, 2010, CANCER EPIDEM BIOMAR, V19, P1632, DOI 10.1158/1055-9965.EPI-10-0180; COLTMAN C A JR, 1975, Medical and Pediatric Oncology, V1, P185, DOI 10.1002/mpo.2950010302; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ermens AAM, 2003, CLIN BIOCHEM, V36, P585, DOI 10.1016/j.clinbiochem.2003.08.004; FREMONT S, 1991, TUMOR BIOL, V12, P353, DOI 10.1159/000217736; GIMSING P, 1995, LEUKEMIA, V9, P1604; GIMSING P, 1995, BRIT J HAEMATOL, V89, P812; HALL CA, 1984, J LAB CLIN MED, V103, P70; HALL CA, 1964, NATURE, V204, P1207, DOI 10.1038/2041207a0; HALL CA, 1969, J LAB CLIN MED, V73, P60; Hvas AM, 2006, HAEMATOLOGICA, V91, P1506; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lildballe DL, 2011, CLIN CHEM, V57, P1436, DOI 10.1373/clinchem.2011.165944; Lildballe DL, 2009, CLIN CHEM LAB MED, V47, P182, DOI 10.1515/CCLM.2009.047; Lin CY, 2010, NUTR CANCER, V62, P190, DOI 10.1080/01635580903305334; LINDEMANS J, 1989, EXP CELL RES, V184, P449, DOI 10.1016/0014-4827(89)90343-1; Malik ZA, 2009, AIDS, V23, P403, DOI 10.1097/QAD.0b013e32831ef4f7; Morkbak AL, 2005, CLIN CHIM ACTA, V356, P184, DOI 10.1016/j.cccn.2005.01.013; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Nexo E, 2000, CLIN CHEM, V46, P1643; Nexo E, 2002, CLIN CHEM, V48, P561; REMACHA AF, 1993, HAEMATOLOGICA, V78, P84; RULE SAJ, 1994, AM J HEMATOL, V47, P167, DOI 10.1002/ajh.2830470304; VREUGDENHIL G, 1992, J INTERN MED, V231, P547, DOI 10.1111/j.1365-2796.1992.tb00972.x	35	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45979	10.1371/journal.pone.0045979	http://dx.doi.org/10.1371/journal.pone.0045979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029349	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800128
J	Bergman, I; Bishop, K; Tu, Q; Frech, W; Akerblom, S; Nilsson, M				Bergman, Inger; Bishop, Kevin; Tu, Qiang; Frech, Wolfgang; Akerblom, Staffan; Nilsson, Mats			The Influence of Sulphate Deposition on the Seasonal Variation of Peat Pore Water Methyl Hg in a Boreal Mire	PLOS ONE			English	Article							ATOMIC-ABSORPTION-SPECTROMETRY; NET METHYLMERCURY PRODUCTION; AQUEOUS-PHASE ETHYLATION; MERCURY METHYLATION; ACID-RAIN; GAS-CHROMATOGRAPHY; ANAEROBIC-BACTERIA; MARINE-SEDIMENTS; AQUATIC SYSTEMS; SURFACE-WATER	In this paper we investigate the hypothesis that long-term sulphate (SO42-) deposition has made peatlands a larger source of methyl mercury (MeHg) to remote boreal lakes. This was done on experimental plots at a boreal, low sedge mire where the effect of long-term addition of SO42- on peat pore water MeHg concentrations was observed weekly throughout the snow-free portion of 1999. The additions of SO42- started in 1995. The seasonal mean of the pore water MeHg concentrations on the plots with 17 kg ha(-1) yr(-1) of sulphur (S) addition (1.3 +/- 0.08 ng L-1, SE; n=44) was significantly (p<0.0001) higher than the mean MeHg concentration on the plots with 3 kg ha(-1) yr(-1) of ambient S deposition (0.6 +/- 0.02 ng L-1, SE; n=44). The temporal variation in pore water MeHg concentrations during the snow free season was larger in the S-addition plots, with an amplitude of >2 ng L-1 compared to +/-0.5 ng L-1 in the ambient S deposition plots. The concentrations of pore water MeHg in the S-addition plots were positively correlated (r(2)=0.21; p=0.001) to the groundwater level, with the lowest concentrations of MeHg during the period with the lowest groundwater levels. The pore water MeHg concentrations were not correlated to total Hg, DOC concentration or pH. The results from this study indicate that the persistently higher pore water concentrations of MeHg in the S-addition plots are caused by the long-term additions of SO42- to the mire surface. Since these waters are an important source of runoff, the results support the hypothesis that SO42- deposition has increased the contribution of peatlands to MeHg in downstream aquatic systems. This would mean that the increased deposition of SO42- in acid rain has contributed to the modern increase in the MeHg burdens of remote lakes hydrologically connected to peatlands.	[Bergman, Inger; Nilsson, Mats] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Bishop, Kevin; Akerblom, Staffan] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-90183 Umea, Sweden; [Bishop, Kevin] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Tu, Qiang; Frech, Wolfgang] Umea Univ, Dept Analyt Chem, S-90187 Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Umea University	Nilsson, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden.	Mats.B.Nilsson@slu.se	Åkerblom, Staffan/L-5421-2018; Bishop, Kevin H/C-7816-2012	Åkerblom, Staffan/0000-0001-7607-9518; Bishop, Kevin H/0000-0002-8057-1051	Swedish Foundation for Strategic Environmental Research; Department of Environmental Assessment at the Swedish University of Agricultural Sciences	Swedish Foundation for Strategic Environmental Research(Swedish Foundation for Strategic Research); Department of Environmental Assessment at the Swedish University of Agricultural Sciences	Funding for this research was provided by the Swedish Foundation for Strategic Environmental Research and the Department of Environmental Assessment at the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom S, 2012, CHEMOSPHERE, V86, P439, DOI 10.1016/j.chemosphere.2011.09.037; Alewell C, 2008, SCI TOTAL ENVIRON, V404, P335, DOI 10.1016/j.scitotenv.2007.11.001; Alewell C, 2006, ENVIRON SCI TECHNOL, V40, P7609, DOI 10.1021/es061018y; BISHOP K, 1995, WATER AIR SOIL POLL, V80, P435, DOI 10.1007/BF01189693; BLOOM N, 1989, CAN J FISH AQUAT SCI, V46, P1131, DOI 10.1139/f89-147; Branfireun BA, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003219; Branfireun BA, 1999, GLOBAL BIOGEOCHEM CY, V13, P743, DOI 10.1029/1999GB900033; Branfireun BA, 2001, GEOPHYS RES LETT, V28, P1227, DOI 10.1029/2000GL011867; Branfireun BA, 1998, BIOGEOCHEMISTRY, V41, P277, DOI 10.1023/A:1005964603828; Burns DA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001812; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Chen CW, 2010, J ENVIRON ENG-ASCE, V136, P354, DOI 10.1061/(ASCE)EE.1943-7870.0000176; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Conaway CH, 2010, ATMOS ENVIRON, V44, P1788, DOI 10.1016/j.atmosenv.2010.01.021; Demers JD, 2010, WATER RESOUR RES, V46, DOI 10.1029/2008WR007021; Deppe M, 2010, ENVIRON SCI TECHNOL, V44, P80, DOI 10.1021/es901669z; Devito KJ, 1997, HYDROL PROCESS, V11, P485, DOI 10.1002/(SICI)1099-1085(199704)11:5&lt;485::AID-HYP455&gt;3.0.CO;2-F; Downs SG, 1998, WATER AIR SOIL POLL, V108, P149, DOI 10.1023/A:1005023916816; Drevnick PE, 2007, ENVIRON SCI TECHNOL, V41, P7266, DOI 10.1021/es0712322; Drott A, 2007, ENVIRON SCI TECHNOL, V41, P2270, DOI 10.1021/es061724z; Emteborg H, 1996, SPECTROCHIM ACTA B, V51, P829, DOI 10.1016/0584-8547(96)01482-6; Eriksson T, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001285; Gauci V, 2006, SOIL BIOL BIOCHEM, V38, P3506, DOI 10.1016/j.soilbio.2006.05.011; GILMOUR CC, 1991, ENVIRON POLLUT, V71, P131, DOI 10.1016/0269-7491(91)90031-Q; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Granberg G, 1999, WATER RESOUR RES, V35, P3771, DOI 10.1029/1999WR900216; Granberg G, 2001, ECOLOGY, V82, P1982, DOI 10.1890/0012-9658(2001)082[1982:EOTANA]2.0.CO;2; Grigal D. F., 2002, Environmental Reviews, V10, P1, DOI 10.1139/a01-013; Grigal DF, 2003, J ENVIRON QUAL, V32, P393, DOI 10.2134/jeq2003.0393; Harmon SM, 2007, ARCH ENVIRON CON TOX, V52, P326, DOI 10.1007/s00244-006-0071-x; Jeremiason JD, 2006, ENVIRON SCI TECHNOL, V40, P3800, DOI 10.1021/es0524144; Judson H, 2004, GROUND WATER, V42, P1090, DOI [10.1111/j.1745-6584.2004.tb02646.x, DOI 10.1111/J.1745-6584.2004.TB02646.X]; Kaiser H., 1965, FRESEN Z ANAL CHEM, V209, P1; Kamman NC, 2005, ECOTOXICOLOGY, V14, P163, DOI 10.1007/s10646-004-6267-9; KELLY CA, 1995, WATER AIR SOIL POLL, V80, P715, DOI 10.1007/BF01189723; King JK, 1999, ENVIRON TOXICOL CHEM, V18, P1362, DOI 10.1002/etc.5620180704; Lahde E, 1967, ACTA FOR FENN, V81, P1; Lambertsson L, 2006, ENVIRON SCI TECHNOL, V40, P1822, DOI 10.1021/es051785h; Lambertsson L, 2004, ANAL BIOANAL CHEM, V380, P871, DOI 10.1007/s00216-004-2863-z; Lambertsson L, 2001, J ANAL ATOM SPECTROM, V16, P1296, DOI 10.1039/b106878b; Lee YH, 1998, BIOGEOCHEMISTRY, V40, P125, DOI 10.1023/A:1005926321337; LIANG L, 1994, TALANTA, V41, P371, DOI 10.1016/0039-9140(94)80141-X; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; MEILI M, 1991, WATER AIR SOIL POLL, V56, P439, DOI 10.1007/BF00342290; Meili M, 1997, MET IONS BIOL SYST, V34, P21; Mitchell CPJ, 2008, ENVIRON SCI TECHNOL, V42, P1010, DOI 10.1021/es0704986; Mitchell CPJ, 2008, APPL GEOCHEM, V23, P503, DOI 10.1016/j.apgeochem.2007.12.020; Mitchell CPJ, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006832; NEDWELL DB, 1995, SOIL BIOL BIOCHEM, V27, P893, DOI 10.1016/0038-0717(95)00018-A; P Ingram H A, 1981, WATER MOVEMENT MIREL; Qian J, 2000, FRESEN J ANAL CHEM, V367, P467, DOI 10.1007/s002160000364; Qvarnstrom J, 2000, ANALYST, V125, P1193, DOI 10.1039/b000933o; Ranchou-Peyruse M, 2009, GEOMICROBIOL J, V26, P1, DOI 10.1080/01490450802599227; Richardson MC, 2007, J HYDROL, V342, P97, DOI 10.1016/j.jhydrol.2007.05.016; RUDD JWM, 1995, WATER AIR SOIL POLL, V80, P697, DOI 10.1007/BF01189722; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; Schuster PF, 2008, WATER AIR SOIL POLL, V187, P89, DOI 10.1007/s11270-007-9500-3; Schwesig D, 2001, BIOGEOCHEMISTRY, V53, P181, DOI 10.1023/A:1010600600099; Selvendiran P, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000739; Skyllberg U, 2009, ENVIRON SCI TECHNOL, V43, P8535, DOI 10.1021/es900996z; Snodgrass JW, 2000, CAN J FISH AQUAT SCI, V57, P171, DOI 10.1139/cjfas-57-1-171; St Louis VL, 2004, ENVIRON SCI TECHNOL, V38, P1348, DOI 10.1021/es034424f; Steinmann P, 1997, GEOCHIM COSMOCHIM AC, V61, P1143, DOI 10.1016/S0016-7037(96)00401-2; Steinnes E, 2003, SCI TOTAL ENVIRON, V304, P215, DOI 10.1016/S0048-9697(02)00570-3; SUNDH I, 1994, MICROBIAL ECOL, V27, P253, DOI 10.1007/BF00182409; Tjerngren I, 2012, BIOGEOCHEMISTRY, V108, P335, DOI 10.1007/s10533-011-9603-1; Tjerngren I, 2012, ENVIRON SCI TECHNOL, V46, P8052, DOI 10.1021/es300845x; Travnikov O, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P571, DOI 10.1007/978-0-387-93958-2_20; Tyler G., 2001, WATER AIR SOIL POLL, V3, P279, DOI DOI 10.1023/A:1017528826641; Ward DM, 2010, ANN NY ACAD SCI, V1195, P62, DOI 10.1111/j.1749-6632.2010.05456.x; Watras CJ, 2008, CAN J FISH AQUAT SCI, V65, P100, DOI 10.1139/F07-159; Watras C. J., 1994, P153; Weston NB, 2005, P NATL ACAD SCI USA, V102, P17036, DOI 10.1073/pnas.0508798102; Wiedermann MM, 2007, ECOLOGY, V88, P454, DOI 10.1890/05-1823	74	18	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45547	10.1371/journal.pone.0045547	http://dx.doi.org/10.1371/journal.pone.0045547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029086	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800059
J	Lee, YL; Peng, Q; Fong, SW; Chen, ACH; Lee, KF; Ng, EHY; Nagy, A; Yeung, WSB				Lee, Yin Lau; Peng, Qian; Fong, Sze Wan; Chen, Andy C. H.; Lee, Kai Fai; Ng, Ernest H. Y.; Nagy, Andras; Yeung, William S. B.			Sirtuin 1 Facilitates Generation of Induced Pluripotent Stem Cells from Mouse Embryonic Fibroblasts through the miR-34a and p53 Pathways	PLOS ONE			English	Article							REGULATES APOPTOSIS; DNA-DAMAGE; DIFFERENTIATION; EXPRESSION; RESVERATROL; INDUCTION; TROPHOBLAST; DEACETYLASE; ACTIVATION; INHIBITION	Forced-expression of transcription factors can reprogram somatic cells into induced pluripotent stem cells (iPSC). Recent studies show that the reprogramming efficiency can be improved by inclusion of small molecules that regulate chromatin modifying enzymes. We report here that sirtuin 1 (SIRT1), a member of the sirtuin family of NAD(+)-dependent protein deacetylases, is involved in iPSC formation. By using an efficient mouse secondary fibroblast reprogramming system with doxycycline (DOX) inducible Yamanaka's transcription factors delivered by piggyBac (PB) transposition (2 degrees F/1B MEF), we show that SIRT1 knockdown decreased while resveratrol (RSV) increased the efficiency of iPSC formation. The treatments were associated with altered acetylated p53 and its downstream Nanog but not p21 expression. The stimulatory effect was also confirmed by SIRT1 over-expression, which stimulated the formation of colonies with induced Nanog and reduced p21 expression. Furthermore, the effects of RSV and SIRT1 knockdown on reprogramming were most pronounced during the initiation phase of reprogramming. MicroRNA-34a is a known regulator of SIRT1. Its inhibitor increased, while its mimics reduced iPSC formation. The stimulatory effect of SIRT1 during reprogramming was also confirmed in the primary MEF. RSV increased while tenovin-6, a small molecule that activates p53 through SIRT1 inhibition, suppressed reprogramming. In conclusion, SIRT1 enhances iPSC generation, in part, through deacetylation of p53, inhibition of p21 and enhancement of Nanog expression.	[Lee, Yin Lau; Peng, Qian; Fong, Sze Wan; Chen, Andy C. H.; Lee, Kai Fai; Ng, Ernest H. Y.; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Hong Kong; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Yeung, WSB (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hkucc.hku.hk	Nagy, Andras/G-6465-2013; Lee, Calvin Kai Fai/C-4328-2009; Lee, Yin Lau/C-4639-2009	Nagy, Andras/0000-0003-4311-0413; Ng, Ernest/0000-0002-7688-4557; Lee, Calvin Kai Fai/0000-0001-5957-439X; Lee, Yin Lau/0000-0003-0559-4381	General Research Fund from the Research Grant Council, Hong Kong [HKU775711M]; Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong	General Research Fund from the Research Grant Council, Hong Kong; Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong	This work was supported by the General Research Fund (HKU775711M) from the Research Grant Council, Hong Kong (http://www.ugc.edu.hk/cgi-bin/ugc/search_project.pl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kristina Nagy and Peter Tonge for their input on the study. We also thank the support from the Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong.	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brooks CL, 2008, CANCER CELL, V13, P377, DOI 10.1016/j.ccr.2008.04.009; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Camins A, 2010, BIOCH BIOPHYS ACTA; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Golos TG, 2006, SEMIN REPROD MED, V24, P314, DOI 10.1055/s-2006-952154; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honda A, 2010, J BIOL CHEM; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	56	38	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45633	10.1371/journal.pone.0045633	http://dx.doi.org/10.1371/journal.pone.0045633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029150	Green Published, gold			2022-12-27	WOS:000309392800071
J	Wang, SJ; Cao, CH; Chen, ZM; Bankaitis, V; Tzima, E; Sheibani, N; Burridge, K				Wang, Shijun; Cao, Canhong; Chen, Zhongming; Bankaitis, Vytas; Tzima, Eleni; Sheibani, Nader; Burridge, Keith			Pericytes Regulate Vascular Basement Membrane Remodeling and Govern Neutrophil Extravasation during Inflammation	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; LEUKOCYTE MIGRATION; VENULAR WALLS; ADHESION; PHOSPHORYLATION; INTEGRINS; PECAM-1; BINDING; RECEPTORS; PLATELET	During inflammation polymorphonuclear neutrophils (PMNs) traverse venular walls, composed of the endothelium, pericyte sheath and vascular basement membrane. Compared to PMN transendothelial migration, little is known about how PMNs penetrate the latter barriers. Using mouse models and intravital microscopy, we show that migrating PMNs expand and use the low expression regions (LERs) of matrix proteins in the vascular basement membrane (BM) for their transmigration. Importantly, we demonstrate that this remodeling of LERs is accompanied by the opening of gaps between pericytes, a response that depends on PMN engagement with pericytes. Exploring how PMNs modulate pericyte behavior, we discovered that direct PMN-pericyte contacts induce relaxation rather than contraction of pericyte cytoskeletons, an unexpected response that is mediated by inhibition of the RhoA/ROCK signaling pathway in pericytes. Taking our in vitro results back into mouse models, we present evidence that pericyte relaxation contributes to the opening of the gaps between pericytes and to the enlargement of the LERs in the vascular BM, facilitating PMN extravasation. Our study demonstrates that pericytes can regulate PMN extravasation by controlling the size of pericyte gaps and thickness of LERs in venular walls. This raises the possibility that pericytes may be targeted in therapies aimed at regulating inflammation.	[Wang, Shijun; Bankaitis, Vytas; Burridge, Keith] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27515 USA; [Wang, Shijun; Cao, Canhong; Bankaitis, Vytas; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Chen, Zhongming; Tzima, Eleni] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Tzima, Eleni; Burridge, Keith] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Wang, SJ (corresponding author), Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27515 USA.	shijun_wang@med.unc.edu	Tzima, Ellie/L-9256-2017; Sheibani, Nader/AAG-2379-2020	Tzima, Ellie/0000-0002-3437-0902; Sheibani, Nader/0000-0003-2723-9217; Chen, Zhongming/0000-0001-9271-1384	NIH [P01 HL080166, R56 NS37723, NIH EY16995, HL088632]; American Diabetes Association [1-10-BS-160]; Retina Research Foundation; NATIONAL EYE INSTITUTE [RC4EY021357, P30EY016665] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088632, P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from NIH grants P01 HL080166 (KB), R56 NS37723 (VB), NIH EY16995 (NS) and HL088632 (ET), and awards from American Diabetes Association (1-10-BS-160) (NS) and Retina Research Foundation (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; ALTIERI DC, 1991, J IMMUNOL, V147, P1891; AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; Cavaillon JM, 1999, CYTOKINE NETWORK IMM, VTheze, J., P251; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; FADOK VA, 1992, J IMMUNOL, V149, P4029; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; HORLEY KJ, 1989, EMBO J, V8, P2889, DOI 10.1002/j.1460-2075.1989.tb08437.x; HURLEY JV, 1963, AUST J EXP BIOL MED, V41, P171, DOI 10.1038/icb.1963.17; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Kim YJ, 2004, BIOCHEM BIOPH RES CO, V318, P579, DOI 10.1016/j.bbrc.2004.04.068; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; McMurdo L, 1998, J PHARMACOL EXP THER, V285, P1255; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nakamura K, 1997, BIOCHEM BIOPH RES CO, V235, P524, DOI 10.1006/bbrc.1997.6825; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Pearse D, 2010, CURR OPIN INVEST DR, V11, P1207; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Saito H, 1998, J IMMUNOL, V161, P1533; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Voisin MB, 2009, ARTERIOSCL THROM VAS, V29, P1193, DOI 10.1161/ATVBAHA.109.187450; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Wang SJ, 2005, J CELL SCI, V118, P2067, DOI 10.1242/jcs.02340; WARD RM, 1984, CLIN PERINATOL, V11, P703, DOI 10.1016/S0095-5108(18)30912-6; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Yadav R, 2003, THROMB HAEMOSTASIS, V90, P598, DOI 10.1160/TH03-04-0220	54	66	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45499	10.1371/journal.pone.0045499	http://dx.doi.org/10.1371/journal.pone.0045499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029055	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800055
J	Amini, P; Wadden, D; Cahill, F; Randell, E; Vasdev, S; Chen, XH; Gulliver, W; Zhang, WZ; Zhang, HW; Yi, YQ; Sun, G				Amini, Peyvand; Wadden, Danny; Cahill, Farrell; Randell, Edward; Vasdev, Sudesh; Chen, Xihua; Gulliver, Wayne; Zhang, Weizhen; Zhang, Hongwei; Yi, Yanqing; Sun, Guang			Serum Acylated Ghrelin Is Negatively Correlated with the Insulin Resistance In the CODING study	PLOS ONE			English	Article							PLASMA GHRELIN; CIRCULATING GHRELIN; METABOLIC SYNDROME; DIABETES-MELLITUS; HUMANS; GLUCOSE; SENSITIVITY; SECRETION; HOMEOSTASIS; PREVALENCE	Objective: Ghrelin is a 28-amino acid orexigenic peptide synthesized mainly in the stomach. Acute administration of ghrelin has been found to decrease insulin secretion. However, little data is available regarding whether ghrelin contributes to the long-term regulation of insulin resistance at the population level. The aim of this study is to investigate the association between circulating ghrelin and insulin resistance in a large population based study. Design: A total of 2082 CODING study (Complex Diseases in the Newfoundland population: Environment and Genetics) subjects were assessed. Subjects were of at least third generation Newfoundland descent, between the ages of 20 and 79 years, and had no serious metabolic, cardiovascular, or endocrine diseases. Ghrelin was measured with an Enzyme Immunoassay method. Insulin and fasting glucose were measured by Immulite 2500 autoanalyzer and Lx20 clinical chemistry analyzer, respectively. Homeostatic Model Assessment of beta cell function (HOMA-beta) and Insulin Resistance (HOMA-IR) and Quantitative Insulin-sensitivity Check Index (QUICKI) were used for measurement of insulin resistance. Results: Partial correlation analyses showed a significant negative correlation between circulating ghrelin and insulin level and insulin resistance in the entire cohort and also in men and women separately. The aforementioned correlation was independent of age, percentage of trunk fat and HDL-cholesterol. According to menopausal status, only pre-menopausal women revealed negative correlations. Conclusion: Our results suggest that except for postmenopausal women, high circulating ghrelin level is associated with lower insulin resistance in the general population.	[Amini, Peyvand; Wadden, Danny; Cahill, Farrell; Vasdev, Sudesh; Gulliver, Wayne; Zhang, Hongwei; Yi, Yanqing; Sun, Guang] Mem Univ Newfoundland, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada; [Chen, Xihua] Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada; [Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Peking University	Sun, G (corresponding author), Mem Univ Newfoundland, Div Med, St John, NF, Canada.	gsun@mun.ca	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798	Canadian Institutes for Health Research (CIHR) [MOP192552]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (CIHR) grant number MOP192552 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Beaumont NJ, 2003, J BIOL CHEM, V278, P8877, DOI 10.1074/jbc.C200575200; Bennett NR, 2009, CLIN ENDOCRINOL, V70, P408, DOI 10.1111/j.1365-2265.2008.03344.x; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Cano SC, 2012, CNS DRUGS, V26, P281, DOI 10.2165/11599890-000000000-00000; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Chacko SK, 2012, AM J PHYSL ENDOCRINO; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; International Diabetes Federation (IDF), 2011, GLOB BURD; Kalish GM, 2003, J CLIN ENDOCR METAB, V88, P1646, DOI 10.1210/jc.2002-021375; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Laferrere B, 2011, INT J OBESITY, V35, pS22, DOI 10.1038/ijo.2011.143; Longo KA, 2011, J PHARMACOL EXP THER, V339, P115, DOI 10.1124/jpet.111.183764; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ozgen IT, 2010, J PEDIATR ADOL GYNEC, V23, P285, DOI 10.1016/j.jpag.2010.02.011; Paik KH, 2004, J CLIN ENDOCR METAB, V89, P3885, DOI 10.1210/jc.2003-032137; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Purnell JQ, 2003, J CLIN ENDOCR METAB, V88, P5747, DOI 10.1210/jc.2003-030513; Qader SS, 2005, REGUL PEPTIDES, V128, P51, DOI 10.1016/j.regpep.2004.12.018; Schofield CJ, 2012, DIABET MED; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Soni AC, 2011, MENOPAUSE, V18, P296, DOI 10.1097/gme.0b013e3181f2e611; Sun YX, 2007, NEUROENDOCRINOLOGY, V86, P215, DOI 10.1159/000109094; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Toshinai Koji, 2007, Clin Calcium, V17, P1392; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Vartiainen J, 2010, J ENDOCRINOL INVEST, V33, P496, DOI [10.1007/BF03346631, 10.3275/6861]; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Wells T, 2009, PROG LIPID RES, V48, P257, DOI 10.1016/j.plipres.2009.04.002; WHO, 2006, DEF DIGN DIAB MELL I	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45657	10.1371/journal.pone.0045657	http://dx.doi.org/10.1371/journal.pone.0045657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029165	Green Accepted, Green Published, gold			2022-12-27	WOS:000309388900087
J	Verges, A; Bennett, S; Bellwood, DR				Verges, Adriana; Bennett, Scott; Bellwood, David R.			Diversity among Macroalgae-Consuming Fishes on Coral Reefs: A Transcontinental Comparison	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HERBIVOROUS FISHES; FEEDING PREFERENCES; COMMUNITY STRUCTURE; CHEMICAL DEFENSES; TROPHIC STATUS; PHASE-SHIFTS; SHELF; RESILIENCE; NINGALOO	Despite high diversity and abundance of nominally herbivorous fishes on coral reefs, recent studies indicate that only a small subset of taxa are capable of removing dominant macroalgae once these become established. This limited functional redundancy highlights the potential vulnerability of coral reefs to disturbance and stresses the need to assess the functional role of individual species of herbivores. However, our knowledge of species-specific patterns in macroalgal consumption is limited geographically, and there is a need to determine the extent to which patterns observed in specific reefs can be generalised at larger spatial scales. In this study, video cameras were used to quantify rates of macroalgae consumption by fishes in two coral reefs located at a similar latitude in opposite sides of Australia: the Keppel Islands in the Great Barrier Reef (eastern coast) and Ningaloo Reef (western coast). The community of nominally herbivorous fish was also characterised in both systems to determine whether potential differences in the species observed feeding on macroalgae were related to spatial dissimilarities in herbivore community composition. The total number of species observed biting on the dominant brown alga Sargassum myriocystum differed dramatically among the two systems, with 23 species feeding in Ningaloo, compared with just 8 in the Keppel Islands. Strong differences were also found in the species composition and total biomass of nominally herbivorous fish, which was an order of magnitude higher in Ningaloo. However, despite such marked differences in the diversity, biomass, and community composition of resident herbivorous fishes, Sargassum consumption was dominated by only four species in both systems, with Naso unicornis and Kyphosus vaigiensis consistently emerging as dominant feeders of macroalgae.	[Verges, Adriana] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Verges, Adriana] Sydney Inst Marine Sci, Mosman, WA, Australia; [Verges, Adriana] Edith Cowan Univ, Sch Nat Sci, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Bennett, Scott] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Bennett, Scott] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of New South Wales Sydney; Sydney Institute of Marine Science; Edith Cowan University; University of Western Australia; University of Western Australia; James Cook University	Verges, A (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	a.verges@unsw.edu.au	Bennett, Scott/A-8747-2016; Verges, Adriana/B-8288-2013	Bennett, Scott/0000-0003-2969-7430; Verges, Adriana/0000-0002-3507-1234	Western Australia Marine Science Institute under the Ningaloo Research Program; Australian Government's Marine and Tropical Sciences Research Facility; Australian Research Council	Western Australia Marine Science Institute under the Ningaloo Research Program; Australian Government's Marine and Tropical Sciences Research Facility(Australian Government); Australian Research Council(Australian Research Council)	This study was funded by the Western Australia Marine Science Institute under the Ningaloo Research Program (AV), the Australian Government's Marine and Tropical Sciences Research Facility (DRB) and the Australian Research Council (DRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PERMANOVA PRIMER; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bennett S, 2011, MAR ECOL PROG SER, V426, P241, DOI 10.3354/meps09016; Bennett S, 2010, CORAL REEFS, V29, P471, DOI 10.1007/s00338-010-0594-5; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheal AJ, 2010, CORAL REEFS; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Fox RJ, CORAL REEFS IN PRESS; FROESE R, 2005, FISHBASE WORLD WIDE; Gorley RN, 2006, PRIMER V6; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Lefevre CD, 2011, MAR ECOL PROG SER, V422, P239, DOI 10.3354/meps08916; Lefevre CD, 2010, MAR BIOL, V157, P955, DOI 10.1007/s00227-009-1376-x; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; McCook LJ, 1997, MAR BIOL, V129, P713, DOI 10.1007/s002270050214; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Michael PJ, 2009, THESIS E COWAN U; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; PAUL VJ, 1990, MAR ECOL PROG SER, V60, P23, DOI 10.3354/meps060023; R Core Team, 2020, R LANG ENV STAT COMP; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; TARGETT TE, 1990, MAR ECOL PROG SER, V66, P13, DOI 10.3354/meps066013; Underwood A.J., 1998, GEN MODEL ANAL VARIA; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; WYLIE CR, 1988, MAR ECOL PROG SER, V45, P23, DOI 10.3354/meps045023	54	38	39	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45543	10.1371/journal.pone.0045543	http://dx.doi.org/10.1371/journal.pone.0045543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029083	Green Accepted, Green Published, gold			2022-12-27	WOS:000309388900070
J	Gautam, R; Chandrasekar, B; Deobagkar-Lele, M; Rakshit, S; Kumar, BNV; Umapathy, S; Nandi, D				Gautam, Rekha; Chandrasekar, Bhagawat; Deobagkar-Lele, Mukta; Rakshit, Srabanti; Kumar, Vinay B. N.; Umapathy, Siva; Nandi, Dipankar			Identification of Early Biomarkers during Acetaminophen-Induced Hepatotoxicity by Fourier Transform Infrared Microspectroscopy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED LIVER-INJURY; CARBON-TETRACHLORIDE; SPECTROSCOPY; MICE; TOXICITY; CELLS; INTERLEUKIN-10; INFLAMMATION; DEPLETION	Acetaminophen is a widely prescribed drug used to relieve pain and fever; however, it is a leading cause of drug-induced liver injury and a burden on public healthcare. In this study, hepatotoxicity in mice post oral dosing of acetaminophen was investigated using liver and sera samples with Fourier Transform Infrared microspectroscopy. The infrared spectra of acetaminophen treated livers in BALB/ mice show decrease in glycogen, increase in amounts of cholesteryl esters and DNA respectively. Rescue experiments using L-methionine demonstrate that depletion in glycogen and increase in DNA are abrogated with pre-treatment, but not post-treatment, with L-methionine. This indicates that changes in glycogen and DNA are more sensitive to the rapid depletion of glutathione. Importantly, analysis of sera identified lowering of glycogen and increase in DNA and chlolesteryl esters earlier than increase in alanine aminotransferase, which is routinely used to diagnose liver damage. In addition, these changes are also observed in C57BL/6 and Nos2(-/-) mice. There is no difference in the kinetics of expression of these three molecules in both strains of mice, the extent of damage is similar and corroborated with ALT and histological analysis. Quantification of cytokines in sera showed increase upon APAP treatment. Although the levels of Tnf alpha and Ifn gamma in sera are not significantly affected, Nos2(-/-) mice display lower Il6 but higher Il10 levels during this acute model of hepatotoxicity. Overall, this study reinforces the growing potential of Fourier Transform Infrared microspectroscopy as a fast, highly sensitive and label-free technique for non-invasive diagnosis of liver damage. The combination of Fourier Transform Infrared microspectroscopy and cytokine analysis is a powerful tool to identify multiple biomarkers, understand differential host responses and evaluate therapeutic regimens during liver damage and, possibly, other diseases.	[Gautam, Rekha; Kumar, Vinay B. N.; Umapathy, Siva] Indian Inst Sci, Dept Inorgan & Phys Chem, Bangalore 560012, Karnataka, India; [Chandrasekar, Bhagawat; Deobagkar-Lele, Mukta; Rakshit, Srabanti; Nandi, Dipankar] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Umapathy, S (corresponding author), Indian Inst Sci, Dept Inorgan & Phys Chem, Bangalore 560012, Karnataka, India.	umapathy@ipc.iisc.ernet.in; nandi@biochem.iisc.ernet.in	Gautam, Rekha/O-9597-2015; Nandi, Dipankar/A-9194-2009; Nandi, Dipankar/O-1363-2019	Gautam, Rekha/0000-0002-1176-8491; Nandi, Dipankar/0000-0002-5221-9712; Deobagkar, Mukta/0000-0002-8543-6801; Bangalore Narayana, Vinay Kumar/0000-0001-8102-5936	Department of Biotechnology, Government of India; DST; CSIR; DBT	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	This study is funded by Program support from the Department of Biotechnology, Government of India. SU acknowledges the J C Bose fellowship from DST. RG and BC are supported by student fellowships from CSIR and DBT respectively. MD is supported by SPM fellowship from CSIR. SR is thankful for a postdoctoral fellowship from DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameredes BT, 2001, J LEUKOCYTE BIOL, V70, P730; Aydin HM, 2011, ANALYST, V136, P775, DOI 10.1039/c0an00530d; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Braun L, 1996, FEBS LETT, V388, P173, DOI 10.1016/0014-5793(96)00548-0; Braun L, 1997, ARCH BIOCHEM BIOPHYS, V348, P169, DOI 10.1006/abbi.1997.0379; Brown AT, 2012, MAGN RESON IMAGING, V30, P283, DOI 10.1016/j.mri.2011.09.023; Chan JW, 2009, J BIOPHOTONICS, V2, P656, DOI 10.1002/jbio.200910041; Chiriboga L, 2000, APPL SPECTROSC, V54, P1, DOI 10.1366/0003702001948204; Dong HJ, 2000, DRUG METAB DISPOS, V28, P1397; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Espina R, 2009, CHEM RES TOXICOL, V22, P299, DOI 10.1021/tx800251p; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Fontana RJ, 2008, SEMIN LIVER DIS, V28, P175, DOI 10.1055/s-2008-1073117; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Gardner CR, 2002, TOXICOL APPL PHARM, V184, P27, DOI 10.1006/taap.2002.9474; Griffiths P.R., 2007, CHEM ANAL-WARSAW, V2nd ed.; Grypioti AD, 2006, LIVER INT, V26, P97, DOI 10.1111/j.1478-3231.2005.01186.x; Harstad EB, 2002, TOXICOLOGY, V175, P83, DOI 10.1016/S0300-483X(02)00068-9; Henczova M, 2006, ANAL BIOANAL CHEM, V385, P652, DOI 10.1007/s00216-006-0429-y; HINSON JA, 1983, BIOCHEM PHARMACOL, V32, P1979, DOI 10.1016/0006-2952(83)90415-X; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; James LP, 2003, BIOCHEM BIOPH RES CO, V309, P857, DOI 10.1016/j.bbrc.2003.08.085; Kamanaka Y, 2003, LIFE SCI, V74, P793, DOI 10.1016/j.lfs.2003.09.036; Kasahara H, 1988, Nihon Geka Gakkai Zasshi, V89, P365; KATYARE SS, 1989, BRIT J PHARMACOL, V96, P51, DOI 10.1111/j.1476-5381.1989.tb11783.x; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kidder LH, 1997, NAT MED, V3, P235, DOI 10.1038/nm0297-235; Kim JH, 2011, NEUROSCIENCE, V185, P125, DOI 10.1016/j.neuroscience.2011.04.018; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lavoie S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022875; LOCKARD VG, 1983, EXP MOL PATHOL, V39, P230, DOI 10.1016/0014-4800(83)90054-0; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Masubuchi Y, 2009, CHEM-BIOL INTERACT, V179, P273, DOI 10.1016/j.cbi.2008.10.028; Melin AM, 2000, BIOPOLYMERS, V57, P160, DOI 10.1002/(SICI)1097-0282(2000)57:3<160::AID-BIP4>3.0.CO;2-1; Michael SL, 2001, NITRIC OXIDE-BIOL CH, V5, P432, DOI 10.1006/niox.2001.0385; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Saha B, 2009, HEPATOLOGY, V50, P1547, DOI 10.1002/hep.23180; Sahu R K, 2005, Future Oncol, V1, P635, DOI 10.2217/14796694.1.5.635; Schoonen WGEJ, 2007, TOXICOL SCI, V98, P271, DOI 10.1093/toxsci/kfm076; Sener G, 2006, HEPATOL RES, V35, P62, DOI 10.1016/j.hepres.2006.02.005; Shanley TP, 2002, CRIT CARE MED, V30, P1960, DOI 10.1097/00003246-200209000-00003; STADLER J, 1993, J LEUKOCYTE BIOL, V53, P165, DOI 10.1002/jlb.53.2.165; Sun Jinchun, 2009, Drug Metab Lett, V3, P130; Szalay G, 2006, AM J PATHOL, V169, P2085, DOI 10.2353/ajpath.2006.060350; Tarasow E, 2004, ACTA RADIOL, V45, P803, DOI 10.1080/02841850410008711; Tosi MR, 2005, CLIN CHIM ACTA, V359, P27, DOI 10.1016/j.cccn.2005.04.003; Toyran N, 2006, BIOCHEM J, V397, P427, DOI 10.1042/BJ20060171; Tran TT, 2008, BIOMARKERS, V13, P184, DOI 10.1080/13547500701791719 ; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	55	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45521	10.1371/journal.pone.0045521	http://dx.doi.org/10.1371/journal.pone.0045521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029070	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400096
J	Jeon, CY; Furuya, EY; Berman, MF; Larson, EL				Jeon, Christie Y.; Furuya, E. Yoko; Berman, Mitchell F.; Larson, Elaine L.			The Role of Pre-Operative and Post-Operative Glucose Control in Surgical-Site Infections and Mortality	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; CLINICAL-PRACTICE GUIDELINE; PERIOPERATIVE HYPERGLYCEMIA; GLYCEMIC CONTROL; ASSOCIATION; MANAGEMENT; SURGERY; RISK; SOCIETY; SERIES	Background and Objective: The impact of glucose control on surgical-site infection (SSI) and death remains unclear. We examined how pre- and post-operative glucose levels and their variability are associated with the risk of SSI or in-hospital death. Methods: This retrospective cohort study employed data on 13,800 hospitalized patients who underwent a surgical procedure at a large referral hospital in New York between 2006 and 2008. Over 20 different sources of electronic data were used to analyze how thirty-day risk of SSI and in-hospital death varies by glucose levels and variability. Maximum pre- and post-operative glucose levels were determined for 72 hours before and after the operation and glucose variability was defined as the coefficient of variation of the glucose measurements. We employed logistic regression to model the risk of SSI or death against glucose variables and the following potential confounders: age, sex, body mass index, duration of operation, diabetes status, procedure classification, physical status, emergency status, and blood transfusion. Results: While association of pre- and post-operative hyperglycemia with SSI were apparent in the crude analysis, multivariate results showed that SSI risk did not vary significantly with glucose levels. On the other hand, in-hospital deaths were associated with pre-operative hypoglycemia (OR = 5.09, 95% CI (1.80, 14.4)) and glucose variability (OR = 1.14, 95% CI (1.03, 1.27) for 10% increase in coefficient of variation). Conclusion: In-hospital deaths occurred more often among those with pre-operative hypoglycemia and higher glucose variability. These findings warrant further investigation to determine whether stabilization of glucose and prevention of hypoglycemia could reduce post-operative deaths.	[Jeon, Christie Y.; Larson, Elaine L.] Columbia Univ, Sch Nursing, New York, NY 10027 USA; [Jeon, Christie Y.] Univ Calif Los Angeles, Ctr Canc Prevent & Control Res, Los Angeles, CA USA; [Furuya, E. Yoko] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY USA; [Berman, Mitchell F.] Columbia Univ, Med Ctr, Dept Anesthesiol, New York, NY USA	Columbia University; University of California System; University of California Los Angeles; Columbia University; Columbia University	Jeon, CY (corresponding author), Columbia Univ, Sch Nursing, New York, NY 10027 USA.	christie.jeon@gmail.com			National Institute of Nursing Research [5R01NR010822]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010822] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by grant from National Institute of Nursing Research, 5R01NR010822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Apte MLT, 2011, SURG INFECT IN PRESS; Ata A, 2010, ARCH SURG-CHICAGO, V145, P858, DOI 10.1001/archsurg.2010.179; Brealey David, 2009, J Diabetes Sci Technol, V3, P1250; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Dungan KM, 2011, DIABETES-METAB RES, V27, P85, DOI 10.1002/dmrr.1155; Estrada CA, 2003, ANN THORAC SURG, V75, P1392, DOI 10.1016/S0003-4975(02)04997-4; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kagansky N, 2003, ARCH INTERN MED, V163, P1825, DOI 10.1001/archinte.163.15.1825; Kao LS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006806.pub2; Khaodhiar L, 1999, Curr Opin Clin Nutr Metab Care, V2, P79, DOI 10.1097/00075197-199901000-00013; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Latham R, 2001, INFECT CONT HOSP EP, V22, P607, DOI 10.1086/501830; Lazar HL, 2009, ANN THORAC SURG, V87, P663, DOI 10.1016/j.athoracsur.2008.11.011; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Pili-Floury S, 2009, DIABETES METAB, V35, P43, DOI 10.1016/j.diabet.2008.06.007; Qaseem A, 2011, ANN INTERN MED, V154, P260, DOI 10.7326/0003-4819-154-4-201102150-00007; Ramos M, 2008, ANN SURG, V248, P585, DOI 10.1097/SLA.0b013e31818990d1; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Sehgal R, 2011, J AM COLL SURGEONS, V212, P29, DOI 10.1016/j.jamcollsurg.2010.09.011; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; The Joint Commission, 2011, SENTINEL EVENT ALERT, P1; Trick WE, 2000, J THORAC CARDIOV SUR, V119, P108, DOI 10.1016/S0022-5223(00)70224-8; Zerr KJ, 1997, ANN THORAC SURG, V63, P356	29	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45616	10.1371/journal.pone.0045616	http://dx.doi.org/10.1371/journal.pone.0045616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029136	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400112
J	Sakai, H; Takahara, M; Honjo, NF; Doi, S; Sadato, N; Uchiyama, Y				Sakai, Hiroyuki; Takahara, Miwa; Honjo, Naomi F.; Doi, Shun'ichi; Sadato, Norihiro; Uchiyama, Yuji			Regional Frontal Gray Matter Volume Associated with Executive Function Capacity as a Risk Factor for Vehicle Crashes in Normal Aging Adults	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER-ADULTS; INDIVIDUAL-DIFFERENCES; ATTENTIONAL NETWORKS; ACCIDENT INVOLVEMENT; RESPONSE-INHIBITION; ACTION SELECTION; GO/NO-GO; MEMORY; MRI	Although low executive functioning is a risk factor for vehicle crashes among elderly drivers, the neural basis of individual differences in this cognitive ability remains largely unknown. Here we aimed to examine regional frontal gray matter volume associated with executive functioning in normal aging individuals, using voxel-based morphometry (VBM). To this end, 39 community-dwelling elderly volunteers who drove a car on a daily basis participated in structural magnetic resonance imaging, and completed two questionnaires concerning executive functioning and risky driving tendencies in daily living. Consequently, we found that participants with low executive function capacity were prone to risky driving. Furthermore, VBM analysis revealed that lower executive function capacity was associated with smaller gray matter volume in the supplementary motor area (SMA). Thus, the current data suggest that SMA volume is a reliable predictor of individual differences in executive function capacity as a risk factor for vehicle crashes among elderly persons. The implication of our results is that regional frontal gray matter volume might underlie the variation in driving tendencies among elderly drivers. Therefore, detailed driving behavior assessments might be able to detect early neurodegenerative changes in the frontal lobe in normal aging adults.	[Sakai, Hiroyuki; Uchiyama, Yuji] Toyota Cent Res & Dev Labs Inc, Informat & Elect Res Div, Nagakute, Aichi 48011, Japan; [Takahara, Miwa] Aichi Shukutoku Univ, Dept Human Informat, Nagakute, Aichi, Japan; [Honjo, Naomi F.] Osaka Neurosurg Hosp, Dept Radiol, Takamatsu, Kagawa, Japan; [Doi, Shun'ichi] Kagawa Univ, Div Intelligent Mech Syst Engn, Takamatsu, Kagawa 760, Japan; [Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan	Toyota Central R&D Labs Inc; Aichi Shukutoku University; Kagawa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Sakai, H (corresponding author), Toyota Cent Res & Dev Labs Inc, Informat & Elect Res Div, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	sakai@mosk.tytlabs.co.jp	Uchiyama, Yuji/GVS-0186-2022	Uchiyama, Yuji/0000-0003-1581-8668; Sadato, Norihiro/0000-0002-9786-3907	Toyota Central Research and Development Laboratories, Inc.	Toyota Central Research and Development Laboratories, Inc.	This work was carried out under the financial support of Toyota Central Research and Development Laboratories, Inc., which is funded by its stockholding companies (http://www.tytlabs.co.jp/english/comp/outline02.html). The funders had no role in the study design, data collection and analysis, and the decision to publish.	Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ball K, 1993, J Am Optom Assoc, V64, P71; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; de Toledo-Morrell L, 2000, HIPPOCAMPUS, V10, P136, DOI 10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Duarte A, 2006, NEUROSCI LETT, V406, P60, DOI 10.1016/j.neulet.2006.07.029; Elderkin-Thompson V, 2008, NEUROPSYCHOLOGY, V22, P626, DOI 10.1037/0894-4105.22.5.626; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Kanai R, 2011, NAT REV NEUROSCI, V31, P6620; Kanai R, 2011, CURR BIOL, V21, pR106, DOI [10.1016/j.cub.2010.12.009, 10.1016/j.cub.2011.03.017]; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Komada Y, 2009, IATSS REV, V34, P106; Kopelman MD, 2001, J NEUROL NEUROSUR PS, V71, P23, DOI 10.1136/jnnp.71.1.23; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; Lucidi F, 2010, ACCIDENT ANAL PREV, V42, P1689, DOI 10.1016/j.aap.2010.04.008; Mesken J, 2002, ERGONOMICS, V45, P469, DOI 10.1080/00140130210129682; Mungas D, 2002, NEUROLOGY, V59, P867, DOI 10.1212/WNL.59.6.867; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; OWSLEY C, 1994, OPTOMETRY VISION SCI, V71, P727, DOI 10.1097/00006324-199412000-00002; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Ozkan T, 2006, ACCIDENT ANAL PREV, V38, P386, DOI 10.1016/j.aap.2005.10.012; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Schwebel DC, 2007, J SAFETY RES, V38, P501, DOI 10.1016/j.jsr.2007.04.005; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P382, DOI 10.1162/jocn.2010.21444; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1313, DOI 10.1016/j.neuropsychologia.2004.02.009; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yamagata S, 2005, TWIN RES HUM GENET, V8, P300, DOI 10.1375/1832427054936790	52	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45920	10.1371/journal.pone.0045920	http://dx.doi.org/10.1371/journal.pone.0045920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029316	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400136
J	Cesaro, A; Anceriz, N; Plante, A; Page, N; Tardif, MR; Tessier, PA				Cesaro, Annabelle; Anceriz, Nadia; Plante, Audrey; Page, Nathalie; Tardif, Melanie R.; Tessier, Philippe A.			An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis	PLOS ONE			English	Article							URATE MONOHYDRATE CRYSTALS; BETA(2) INTEGRIN MAC-1; FACTOR-KAPPA-B; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; JOINT INFLAMMATION; HUMAN NEUTROPHILS; PROTEIN MRP-14; DISEASE; CELLS	Objective: The S100A9 and S100A8 proteins are highly expressed by neutrophils and monocytes and are part of a group of damage-associated molecular pattern molecules that trigger inflammatory responses. Sera and synovial fluids of patients with rheumatoid arthritis (RA) contain high concentrations of S100A8/A9 that correlate with disease activity. Methods: In this study, we investigated the importance of S100A9 in RA by using neutralizing antibodies in a murine lipopolysaccharide-synchronized collagen-induced arthritis model. We also used an in vitro model of stimulation of human immune cells to decipher the role played by S100A9 in leukocyte migration and pro-inflammatory cytokine secretion. Results: Treatment with anti-S100A9 antibodies improved the clinical score by 50%, diminished immune cell infiltration, reduced inflammatory cytokines, both in serum and in the joints, and preserved bone/collagen integrity. Stimulation of neutrophils with S100A9 protein led to the enhancement of neutrophil transendothelial migration. S100A9 protein also induced the secretion by monocytes of proinflammatory cytokines like TNF alpha, IL-1 beta and IL-6, and of chemokines like MIP-1 alpha and MCP-1. Conclusion: The effects of anti-S100A9 treatment are likely direct consequences of inhibiting the S100A9-mediated promotion of neutrophil transmigration and secretion of pro-inflammatory cytokines from monocytes. Collectively, our results show that treatment with anti-S100A9 may inhibit amplification of the immune response and help preserve tissue integrity. Therefore, S100A9 is a promising potential therapeutic target for inflammatory diseases like rheumatoid arthritis for which alternative therapeutic strategies are needed.	[Tessier, Philippe A.] Ctr Hosp Univ Quebec, Ctr Rech, Ctr Rech Infectiol, Quebec City, PQ, Canada; Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Tessier, PA (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech, Ctr Rech Infectiol, Quebec City, PQ, Canada.	philippe.tessier@crchul.ulaval.ca	Cesaro, Annabelle/AAX-3177-2020	Tessier, Philippe/0000-0001-7177-7763	Canadian Institutes of Health Research [84226]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants to P.A.T. from the Canadian Institutes of Health Research (grant number 84226). P.A.T. holds a scholarship from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AguiarPasseti T, 1997, J LEUKOCYTE BIOL, V62, P852, DOI 10.1002/jlb.62.6.852; Alves JD, 2011, INT J CLIN PRACT, V65, P508, DOI 10.1111/j.1742-1241.2010.02612.x; Baillet A, 2010, RHEUMATOLOGY, V49, P671, DOI 10.1093/rheumatology/kep452; BERNTZEN HB, 1991, SCAND J RHEUMATOL, V20, P74, DOI 10.3109/03009749109165280; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Eue I, 2000, INT IMMUNOL, V12, P1593, DOI 10.1093/intimm/12.11.1593; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; HOGG N, 1989, EUR J IMMUNOL, V19, P1053, DOI 10.1002/eji.1830190615; HOLMDAHL R, 1990, IMMUNOL REV, V118, P193, DOI 10.1111/j.1600-065X.1990.tb00817.x; Kido J, 2004, ORAL MICROBIOL IMMUN, V19, P182, DOI 10.1111/j.0902-0055.2004.00139.x; Klugewitz K, 1997, J CELL SCI, V110, P985; Koenders MI, 2011, ARTHRITIS RHEUM; Konttinen YT, 2000, ARTHRITIS RES, V2, P348, DOI 10.1186/ar111; LEIRISALOREPO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb01988.x; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Marie I, 2010, REV MED INTERNE, V31, P353, DOI 10.1016/j.revmed.2009.04.010; MarinovaMutafchieva L, 1997, CLIN EXP IMMUNOL, V107, P507, DOI 10.1046/j.1365-2249.1997.2901181.x; Miller EA, 2009, J CLIN INVEST, V119, P1079, DOI 10.1172/JCI39143; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Newton RA, 1998, J IMMUNOL, V160, P1427; Nishimoto N, 2000, INT IMMUNOL, V12, P187, DOI 10.1093/intimm/12.2.187; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Peter L., 2010, ANN SCI M ATL GEPRG; Prinz JC, 2011, NAT REV RHEUMATOL; Rampersad RR, 2009, SCAND J RHEUMATOL, V38, P445, DOI 10.3109/03009740902895743; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Rouleau P, 2003, CLIN IMMUNOL, V107, P46, DOI 10.1016/S1521-6616(02)00043-8; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schrier DJ, 1998, J LEUKOCYTE BIOL, V63, P359, DOI 10.1002/jlb.63.3.359; Shibata F, 2005, BIOL PHARM BULL, V28, P2312, DOI 10.1248/bpb.28.2312; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Youssef P, 1999, J RHEUMATOL, V26, P2523; Yu T, 2010, AM J PHYSIOL-CELL PH, V299, pC399, DOI 10.1152/ajpcell.00039.2009	51	76	80	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45478	10.1371/journal.pone.0045478	http://dx.doi.org/10.1371/journal.pone.0045478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029038	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900145
J	Cox, N; Pilling, D; Gomer, RH				Cox, Nehemiah; Pilling, Darrell; Gomer, Richard H.			NaCl Potentiates Human Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM AMYLOID-P; COLONY-STIMULATING FACTORS; DIETARY-SODIUM INTAKE; AMINO-ACID-TRANSPORT; HYPERTONIC SALINE; SALT INTAKE; MONOCYTE DIFFERENTIATION; CIRCULATING FIBROCYTES; PULMONARY-FIBROSIS; CHLORIDE CHANNELS	Excessive NaCl intake is associated with a variety of fibrosing diseases such as renal and cardiac fibrosis. This association has been attributed to increased blood pressure as the result of high NaCl intake. However, studies in patients with high NaCl intake and fibrosis reveal a connection between NaCl intake and fibrosis that is independent of blood pressure. We find that increasing the extracellular concentration of NaCl to levels that may occur in human blood after high-salt intake can potentiate, in serum-free culture conditions, the differentiation of freshly-isolated human monocytes into fibroblast-like cells called fibrocytes. NaCl affects the monocytes directly during their adhesion. Potassium chloride and sodium nitrate also potentiate fibrocyte differentiation. The plasma protein Serum Amyloid P (SAP) inhibits fibrocyte differentiation. High levels of extracellular NaCl change the SAP Hill coefficient from 1.7 to 0.8, and cause a four-fold increase in the concentration of SAP needed to inhibit fibrocyte differentiation by 95%. Together, our data suggest that NaCl potentiates fibrocyte differentiation. NaCl-increased fibrocyte differentiation may thus contribute to NaCl-increased renal and cardiac fibrosis.	[Cox, Nehemiah; Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Cox, Nehemiah/0000-0002-2369-4741; Pilling, Darrell/0000-0002-7413-2773	Texas AM University; NICHD	Texas AM University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by Texas A&M University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody M-38 developed by McDonald, J.A was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We thank Sarah Herlihy and Jonathan Phillips for their critical review of the manuscript and the staff at Beutel student health center for drawing blood from volunteers.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; ARCANGELI A, 1993, P NATL ACAD SCI USA, V90, P5858, DOI 10.1073/pnas.90.12.5858; ASHTON N, 1991, J PHYSIOL-LONDON, V435, P533, DOI 10.1113/jphysiol.1991.sp018523; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balgoma D, 2010, J IMMUNOL, V184, P3857, DOI 10.4049/jimmunol.0902883; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Colden-Stanfield M, 1998, AM J PHYSIOL-CELL PH, V275, pC267, DOI 10.1152/ajpcell.1998.275.1.C267; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Farquhar WB, 2005, J APPL PHYSIOL, V99, P1545, DOI 10.1152/japplphysiol.00262.2005; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; FROHLICH ED, 1993, AM J PHYSIOL, V264, pR30, DOI 10.1152/ajpregu.1993.264.1.R30; GILL GV, 1985, J ROY SOC MED, V78, P1009, DOI 10.1177/014107688507801206; Gomer RH, 2009, WOUND REPAIR REGEN, V17, P397, DOI 10.1111/j.1524-475X.2009.00482.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HAMILTON JA, 1980, J CELL PHYSIOL, V103, P435, DOI 10.1002/jcp.1041030309; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2011, EUR HEART J, V32, P3073, DOI 10.1093/eurheartj/ehr194; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kagiyama S, 2007, HYPERTENS RES, V30, P979, DOI 10.1291/hypres.30.979; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; LINDINGER MI, 1992, AM J PHYSIOL, V262, pR126, DOI 10.1152/ajpregu.1992.262.1.R126; Mantovani A, 1998, INT J CLIN LAB RES, V28, P77, DOI 10.1007/s005990050023; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNCK LK, 1995, GUT, V36, P215, DOI 10.1136/gut.36.2.215; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Reuter S, 2009, CURR HYPERTENS REP, V11, P91, DOI 10.1007/s11906-009-0018-5; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2; Susic D, 2012, CURR OPIN LIPIDOL, V23, P11, DOI 10.1097/MOL.0b013e32834d9c52; TOBIAS JW, 1987, BLOOD, V69, P1265; Wang HA, 2010, J CELL BIOCHEM, V111, P49, DOI 10.1002/jcb.22658; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621; YUAN BX, 1991, AM J PHYSIOL, V261, pH1397, DOI 10.1152/ajpheart.1991.261.5.H1397	68	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45674	10.1371/journal.pone.0045674	http://dx.doi.org/10.1371/journal.pone.0045674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029177	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900166
J	Ichibangase, T; Sugawara, Y; Yamabe, A; Koshiyama, A; Yoshimura, A; Enomoto, T; Imai, K				Ichibangase, Tomoko; Sugawara, Yasuhiro; Yamabe, Akio; Koshiyama, Akiyo; Yoshimura, Akari; Enomoto, Takemi; Imai, Kazuhiro			An FD-LC-MS/MS Proteomic Strategy for Revealing Cellular Protein Networks: A Conditional Superoxide Dismutase 1 Knockout Cells	PLOS ONE			English	Article								Systems biology aims to understand biological phenomena in terms of complex biological and molecular interactions, and thus proteomics plays an important role in elucidating protein networks. However, many proteomic methods have suffered from their high variability, resulting in only showing altered protein names. Here, we propose a strategy for elucidating cellular protein networks based on an FD-LC-MS/MS proteomic method. The strategy permits reproducible relative quantitation of differences in protein levels between different cell populations and allows for integration of the data with those obtained through other methods. We demonstrate the validity of the approach through a comparison of differential protein expression in normal and conditional superoxide dismutase 1 gene knockout cells and believe that beginning with an FD-LC-MS/MS proteomic approach will enable researchers to elucidate protein networks more easily and comprehensively.	[Ichibangase, Tomoko; Sugawara, Yasuhiro; Yamabe, Akio; Koshiyama, Akiyo; Yoshimura, Akari; Enomoto, Takemi; Imai, Kazuhiro] Musashino Univ, Pharmaceut Sci Res Inst, Tokyo, Japan		Imai, K (corresponding author), Musashino Univ, Pharmaceut Sci Res Inst, Tokyo, Japan.	k-imai@musashino-u.ac.jp	Yoshimura, Akari/ABE-5626-2020; Ichibangase, Tomoko/GQO-7772-2022	Yoshimura, Akari/0000-0003-4883-8497; 				Chen RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-235; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Ichibangase T, 2007, J PROTEOME RES, V6, P2841, DOI 10.1021/pr070094c; Imai K, 2011, BIOMED CHROMATOGR, V25, P59, DOI 10.1002/bmc.1541; Imai K, 2008, BIOMED CHROMATOGR, V22, P1304, DOI 10.1002/bmc.1102; Inoue E, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/795946; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	8	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45483	10.1371/journal.pone.0045483	http://dx.doi.org/10.1371/journal.pone.0045483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029042	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900146
J	Undem, C; Rios, EJ; Maylor, J; Shimoda, LA				Undem, Clark; Rios, Eon J.; Maylor, Julie; Shimoda, Larissa A.			Endothelin-1 Augments Na+/H+ Exchange Activity in Murine Pulmonary Arterial Smooth Muscle Cells via Rho Kinase	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; INTRACELLULAR PH; GROWTH-FACTORS; H+ EXCHANGE; HYPERTENSION; ACTIVATION; PROLIFERATION; MECHANISMS; ANTAGONIST; PREVENTS	Excessive production of endothelin-1 (ET-1), a potent vasoconstrictor, occurs with several forms of pulmonary hypertension. In addition to modulating vasomotor tone, ET-1 can potentiate pulmonary arterial smooth muscle cell (PASMC) growth and migration, both of which contribute to the vascular remodeling that occurs during the development of pulmonary hypertension. It is well established that changes in cell proliferation and migration in PASMCs are associated with alkalinization of intracellular pH (pH(i)), typically due to activation of Na+/H+ exchange (NHE). In the systemic vasculature, ET-1 increases pH(i), Na+/H+ exchange activity and stimulates cell growth via a mechanism dependent on protein kinase C (PKC). These results, coupled with data describing elevated levels of ET-1 in hypertensive animals/humans, suggest that ET-1 may play an important role in modulating pH(i) and smooth muscle growth in the lung; however, the effect of ET-1 on basal pH(i) and NHE activity has yet to be examined in PASMCs. Thus, we used fluorescent microscopy in transiently (3-5 days) cultured rat PASMCs and the pH-sensitive dye, BCECF-AM, to measure changes in basal pH(i) and NHE activity induced by increasing concentrations of ET-1 (10(-10) to 10(-8) M). We found that application of exogenous ET-1 increased pH(i) and NHE activity in PASMCs and that the ET-1-induced augmentation of NHE was prevented in PASMCs pretreated with an inhibitor of Rho kinase, but not inhibitors of PKC. Moreover, direct activation of PKC had no effect on pH(i) or NHE activity in PASMCs. Our results indicate that ET-1 can modulate pH homeostasis in PASMCs via a signaling pathway that includes Rho kinase and that, in contrast to systemic vascular smooth muscle, activation of PKC does not appear to be an important regulator of PASMC pH(i).	[Undem, Clark; Rios, Eon J.; Maylor, Julie; Shimoda, Larissa A.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Shimoda, LA (corresponding author), Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21218 USA.	shimodal@welch.jhu.edu			National Institutes of Health [HL-67919, HL-73859, HL-07963]; American Heart Association [AHA9930255N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073859, K02HL067919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-67919, HL-73859 and HL-07963) and by a Scientist Development Grant from the American Heart Association (AHA9930255N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1988, J PHYSIOL-LONDON, V402, P391, DOI 10.1113/jphysiol.1988.sp017211; Aalkjaer C, 1997, ACTA PHYSIOL SCAND, V161, P557, DOI 10.1046/j.1365-201X.1997.00263.x; Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Aversa CR, 1997, AM J PHYSIOL-LUNG C, V273, pL848, DOI 10.1152/ajplung.1997.273.4.L848; BERK BC, 1990, J BIOL CHEM, V265, P17334; Bialecki RA, 1999, PULM PHARMACOL THER, V12, P303, DOI 10.1006/pupt.1999.0211; Biswas P, 2005, AM J PHYSIOL-RENAL, V288, pF8, DOI 10.1152/ajprenal.00435.2003; BOBIK A, 1991, AM J PHYSIOL, V260, pC581, DOI 10.1152/ajpcell.1991.260.3.C581; BONVALLET ST, 1994, AM J PHYSIOL, V266, pH1327, DOI 10.1152/ajpheart.1994.266.4.H1327; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Chen SJ, 1997, J CARDIOVASC PHARM, V29, P713, DOI 10.1097/00005344-199706000-00003; CODY RJ, 1992, CIRCULATION, V85, P504, DOI 10.1161/01.CIR.85.2.504; DANTHULURI NR, 1990, J PHARMACOL EXP THER, V254, P393; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; DICARLO VS, 1995, AM J PHYSIOL-LUNG C, V269, pL690, DOI 10.1152/ajplung.1995.269.5.L690; Ebata S, 1999, KIDNEY INT, V56, P1400, DOI 10.1046/j.1523-1755.1999.00674.x; EDDAHIBI S, 1995, AM J PHYSIOL-HEART C, V268, pH828, DOI 10.1152/ajpheart.1995.268.2.H828; ELTON TS, 1992, AM J PHYSIOL, V263, pR1260, DOI 10.1152/ajpregu.1992.263.6.R1260; Frasch HF, 1999, AM J PHYSIOL-LUNG C, V276, pL304, DOI 10.1152/ajplung.1999.276.2.L304; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; GRIENDLING KK, 1989, J BIOL CHEM, V264, P8237; GUNTUPALLI J, 1994, AM J PHYSIOL, V266, pF658, DOI 10.1152/ajprenal.1994.266.4.F658; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Homma N, 2007, J CARDIOVASC PHARM, V50, P697, DOI 10.1097/FJC.0b013e3181593774; HUBEL CA, 1995, BIOCHEM J, V310, P1013, DOI 10.1042/bj3101013; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; JANAKIDEVI K, 1992, AM J PHYSIOL, V263, pC1295, DOI 10.1152/ajpcell.1992.263.6.C1295; Kawanabe Y, 2002, J CARDIOVASC PHARM, V40, P307, DOI 10.1097/00005344-200208000-00016; Koliakos G, 2007, ANN NY ACAD SCI, V1095, P274, DOI 10.1196/annals.1397.031; LAPOINTE MS, 1994, AM J MED SCI, V307, pS9; LI H, 1994, AM J PHYSIOL, V266, pL553, DOI 10.1152/ajplung.1994.266.5.L553; LI HB, 1994, J APPL PHYSIOL, V77, P1451, DOI 10.1152/jappl.1994.77.3.1451; LONCHAMPT MO, 1991, AM J HYPERTENS, V4, P776, DOI 10.1093/ajh/4.9.776; LUCCHESI PA, 1995, CARDIOVASC RES, V29, P172, DOI 10.1016/0008-6363(96)88566-X; Luke T, 2012, AM J PHYSIOL-LUNG C, V302, pL1128, DOI 10.1152/ajplung.00396.2011; LUSCHER TF, 1992, AM REV RESPIR DIS, V146, pS56; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Madden JA, 2001, AM J PHYSIOL-LUNG C, V280, pL264, DOI 10.1152/ajplung.2001.280.2.L264; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MITSUKA M, 1993, CIRC RES, V73, P269, DOI 10.1161/01.RES.73.2.269; MITSUKA M, 1991, AM J PHYSIOL, V260, pC562, DOI 10.1152/ajpcell.1991.260.3.C562; Mukherjee R, 2006, CIRCULATION, V114, pI308, DOI 10.1161/CIRCULATIONAHA.105.001388; Muto S, 2000, KIDNEY INT, V57, P2319, DOI 10.1046/j.1523-1755.2000.00092.x; Nakanishi K, 1999, LAB INVEST, V79, P1347; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; Quinn DA, 1996, AM J RESP CELL MOL, V14, P139, DOI 10.1165/ajrcmb.14.2.8630263; QUINN DA, 1991, AM J RESP CELL MOL, V5, P586, DOI 10.1165/ajrcmb/5.6.586; Quinn DA, 1998, AM J RESP CRIT CARE, V157, P1263, DOI 10.1164/ajrccm.157.4.9704106; Raymond MN, 2006, ENDOCRINOLOGY, V147, P5873, DOI 10.1210/en.2006-0291; Rios EJ, 2005, AM J PHYSIOL-LUNG C, V289, pL867, DOI 10.1152/ajplung.00455.2004; Rodriguez-Vita J, 2005, CIRC RES, V97, P125, DOI 10.1161/01.RES.0000174614.74469.83; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Shimoda L, 1998, AM J PHYSIOL-LUNG C, V274, pL842, DOI 10.1152/ajplung.1998.274.5.L842; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL1115, DOI 10.1152/ajplung.2001.281.5.L1115; STELZNER TJ, 1992, AM J PHYSIOL, V262, pL614, DOI 10.1152/ajplung.1992.262.5.L614; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Touyz RM, 1997, HYPERTENSION, V30, P1440, DOI 10.1161/01.HYP.30.6.1440; WALTER R, 1995, PFLUG ARCH EUR J PHY, V430, P137, DOI 10.1007/BF00373849; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL1058, DOI 10.1152/ajplung.2001.281.5.L1058; Weigand L, 2006, AM J PHYSIOL-LUNG C, V290, pL284, DOI 10.1152/ajplung.00449.2004; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yang XJ, 2007, AM J PHYSIOL-RENAL, V293, pF1054, DOI 10.1152/ajprenal.00295.2007; Yu LY, 2008, AM J RESP CRIT CARE, V177, P1276, DOI 10.1164/rccm.200710-1522OC	70	29	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46303	10.1371/journal.pone.0046303	http://dx.doi.org/10.1371/journal.pone.0046303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029469	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900128
J	Bennett, RL; Carruthers, AL; Hui, T; Kerney, KR; Liu, XF; May, WS				Bennett, Richard L.; Carruthers, Aubrey L.; Hui, Teng; Kerney, Krystal R.; Liu, Xiangfei; May, W. Stratford, Jr.			Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR FUNCTION; UP-REGULATION; RNA; INTERFERON; GENE; CELLS; P53; LEUKEMIA; STRESS	It has been reported that the expression and activity of the interferon-inducible, dsRNA-dependent protein kinase, PKR, is increased in mammary carcinoma cell lines and primary tumor samples. To extend these findings and determine how PKR signaling may affect breast cancer cell sensitivity to chemotherapy, we measured PKR expression by immunohistochemical staining of 538 cases of primary breast cancer and normal tissues. Significantly, PKR expression was elevated in ductal, lobular and squamous cell carcinomas or lymph node metastases but not in either benign tumor specimens or cases of inflammation compared to normal tissues. Furthermore, PKR expression was increased in precancerous stages of mammary cell hyperplasia and dysplasia compared to normal tissues, indicating that PKR expression may be upregulated by the process of tumorigenesis. To test the function of PKR in breast cancer, we generated MCF7, T-47D and MDA-MB-231 breast cancer cell lines with significantly reduced PKR expression by siRNA knockdown. Importantly, while knockdown of PKR expression had no effect on cell proliferation under normal growth conditions, MCF7, T-47D or MDA-MB-231 cells with reduced PKR expression or treated with a small molecule PKR inhibitor were significantly less sensitive to doxorubicin or H2O2-induced toxicity compared to control cells. In addition, the rate of eIF2 alpha phosphorylation following treatment with doxorubicin was delayed in breast cancer cell lines with decreased PKR expression. Significantly, treatment of breast cancer lines with reduced PKR expression with either interferon-alpha, which increases PKR expression, or salubrinal, which increases eIF2 alpha phosphorylation, restored doxorubicin sensitivity to normal levels. Taken together these results indicate that increased PKR expression in primary breast cancer tissues may serve as a biomarker for response to doxorubicin-containing chemotherapy and that future therapeutic approaches to promote PKR expression/activation and eIF2 alpha phosphorylation may be beneficial for the treatment of breast cancer.	[May, W. Stratford, Jr.] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32611 USA; Univ Florida, Univ Florida Shands Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	May, WS (corresponding author), Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32611 USA.	smay@ufl.edu	Liu, Xiangfei/F-3708-2017; Bennett, Richard/ABF-9211-2021	Bennett, Richard/0000-0002-0243-2443; Kerney, Krystal/0000-0003-4134-0020	NIH/NHLBI [R01-HL054083]; University of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054083] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Florida(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant NIH/NHLBI R01-HL054083. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ann Fu and the University of Florida's molecular pathology core for excellent technical assistance. In addition, K. K. was a participant in the University Scholar's Program, and T. H. was a participant in the HHMI-UF Science for Life Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Garcia MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023887; BARBER GN, 1993, GENOMICS, V16, P765, DOI 10.1006/geno.1993.1262; Basu S, 1997, CANCER RES, V57, P943; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bennett RL, 2012, CELL CYCLE, V11, P407, DOI 10.4161/cc.11.2.18999; Beretta L, 1996, ONCOGENE, V12, P1593; BERGER R, 1987, CANCER GENET CYTOGEN, V29, P9, DOI 10.1016/0165-4608(87)90026-4; BERGER R, 1988, CANCER GENET CYTOGEN, V34, P11, DOI 10.1016/0165-4608(88)90161-6; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Deb A, 2001, EMBO J, V20, P2487, DOI 10.1093/emboj/20.10.2487; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Gil J, 2001, ONCOGENE, V20, P385, DOI 10.1038/sj.onc.1204109; Haines GK, 1998, TUMOR BIOL, V19, P52, DOI 10.1159/000029974; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Ishii T, 2001, ONCOGENE, V20, P1900, DOI 10.1038/sj.onc.1204267; ITO T, 1994, P NATL ACAD SCI USA, V91, P7455, DOI 10.1073/pnas.91.16.7455; Kim SH, 2002, ONCOGENE, V21, P8741, DOI 10.1038/sj.onc.1205987; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; KIRCHHOFF S, 1995, ONCOGENE, V11, P439; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Kuyama M, 2003, J DERMATOL, V30, P579, DOI 10.1111/j.1346-8138.2003.tb00439.x; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Nussbaum JM, 2003, CANCER LETT, V196, P207, DOI 10.1016/S0304-3835(03)00276-3; Pataer A, 2010, CLIN CANCER RES, V16, P5522, DOI 10.1158/1078-0432.CCR-10-0753; Peidis P, 2010, CELL DEATH DIFFER, P1; Shir A, 2002, NAT BIOTECHNOL, V20, P895, DOI 10.1038/nbt730; SQUIRE J, 1993, GENOMICS, V16, P768, DOI 10.1006/geno.1993.1263; Tam NWN, 1999, EUR J BIOCHEM, V262, P149, DOI 10.1046/j.1432-1327.1999.00360.x; TANAKA H, 1995, GENE, V153, P283, DOI 10.1016/0378-1119(94)00821-9; Tanaka H, 2000, GENE, V246, P373, DOI 10.1016/S0378-1119(00)00080-9; TANAKA H, 1994, P NATL ACAD SCI USA, V91, P7995, DOI 10.1073/pnas.91.17.7995; Watanabe MAE, 2003, EUR J PHARMACOL, V465, P205, DOI 10.1016/S0014-2999(03)01480-8; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	41	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46040	10.1371/journal.pone.0046040	http://dx.doi.org/10.1371/journal.pone.0046040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029376	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700109
J	Coltri, PP; Oliveira, CC				Coltri, Patricia P.; Oliveira, Carla C.			Cwc24p Is a General Saccharomyces cerevisiae Splicing Factor Required for the Stable U2 snRNP Binding to Primary Transcripts	PLOS ONE			English	Article							PRE-MESSENGER-RNA; DEPENDENT ATPASE; RIBOSOMAL-RNA; PRP2 PROTEIN; BRANCH SITE; 19 COMPLEX; SPLICEOSOME; YEAST; STEP; CORE	Splicing of primary transcripts is an essential process for the control of gene expression. Specific conserved sequences in premature transcripts are important to recruit the spliceosome machinery. The Saccharomyces cerevisiae catalytic spliceosome is composed of about 60 proteins and 5 snRNAs (U1, U2, U4/U6 and U5). Among these proteins, there are core components and regulatory factors, which might stabilize or facilitate splicing of specific substrates. Assembly of a catalytic complex depends on the dynamics of interactions between these proteins and RNAs. Cwc24p is an essential S. cerevisiae protein, originally identified as a component of the NTC complex, and later shown to affect splicing in vivo. In this work, we show that Cwc24p also affects splicing in vitro. We show that Cwc24p is important for the U2 snRNP binding to primary transcripts, co-migrates with spliceosomes, and that it interacts with Brr2p. Additionally, we show that Cwc24p is important for the stable binding of Prp19p to the spliceosome. We propose a model in which Cwc24p is required for stabilizing the U2 association with primary transcripts, and therefore, especially important for splicing of RNAs containing non- consensus branchpoint sequences.	[Coltri, Patricia P.; Oliveira, Carla C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011; Coltri, Patricia P./E-6294-2014	Oliveira, Carla C/0000-0002-1098-9241; Coltri, Patricia P./0000-0001-8447-7516	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [09/52826-4]; FAPESP fellowship [09/52176-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (09/52826-4 to C.C.O.). P.P.C. was recipient of a FAPESP fellowship (09/52176-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Goldfeder MB, 2008, J BIOL CHEM, V283, P2644, DOI 10.1074/jbc.M707885200; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khanna M, 2009, RNA, V15, P2174, DOI 10.1261/rna.1790509; KING DS, 1990, NUCLEIC ACIDS RES, V18, P6559, DOI 10.1093/nar/18.22.6559; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McGrail JC, 2009, NUCLEIC ACIDS RES, V37, P4205, DOI 10.1093/nar/gkp341; Meyer Markus, 2009, Briefings in Functional Genomics & Proteomics, V8, P60, DOI 10.1093/bfgp/elp002; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; Munding EM, 2010, GENE DEV, V24, P2693, DOI 10.1101/gad.1977410; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Qiu ZCR, 2011, NUCLEIC ACIDS RES, V39, P3427, DOI 10.1093/nar/gkq1328; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Saha D, 2012, J BIOL CHEM, V287, P5390, DOI 10.1074/jbc.M111.298547; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Stevens SW, 2002, METHOD ENZYMOL, V351, P200; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; Vincenti S, 2007, RNA, V13, P138, DOI 10.1261/rna.251907; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Will CL, 2010, COLD SPRING HARB PER; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Yeh TC, 2011, MOL CELL BIOL, V31, P43, DOI 10.1128/MCB.00801-10; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	50	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45678	10.1371/journal.pone.0045678	http://dx.doi.org/10.1371/journal.pone.0045678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029180	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700057
J	Chadwick, AC; Sahoo, D				Chadwick, Alexandra C.; Sahoo, Daisy			Functional Characterization of Newly-Discovered Mutations in Human SR-BI	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; CELLULAR CHOLESTEROL EFFLUX; TERMINAL TRANSMEMBRANE DOMAIN; SELECTIVE LIPID UPTAKE; TRANSPORT IN-VIVO; SCAVENGER RECEPTOR; HDL CHOLESTEROL; PLASMA HDL; EXTRACELLULAR DOMAIN	In rodents, SR-BI has been firmly established as a physiologically relevant HDL receptor that mediates removal of HDL-cholesteryl esters (CE). However, its role in human lipoprotein metabolism is less defined. Recently, two unique point mutations in human SR-BI - S112F or T175A - were identified in subjects with high HDL-cholesterol (HDL-C) levels. We hypothesized that mutation of these conserved residues would compromise the cholesterol-transport functions of SR-BI. To test this hypothesis, S112F- and T175A-SR-BI were generated by site-directed mutagenesis. Cell surface expression was confirmed for both mutant receptors in COS-7 cells upon transient transfection, albeit at lower levels for T175A-SR-BI. Both mutant receptors displayed defective HDL binding, selective uptake of HDL-CE and release of free cholesterol (FC) from cells to HDL. Mutant receptors were also unable to re-organize plasma membrane pools of FC. While these impaired functions were independent of receptor oligomerization, inability of T175A-SR-BI to mediate cholesterol-transport functions could be related to altered N-linked glycosylation status. In conclusion, high HDL-C levels observed in carriers of S112F- or T175A-SRBI mutant receptors are consistent with the inability of these SR-BI receptors to mediate efficient selective uptake of HDL-CE, and suggest that increased plasma HDL concentrations in these settings may not be associated with lower risk of cardiovascular disease.	[Chadwick, Alexandra C.; Sahoo, Daisy] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	dsahoo@mcw.edu			National Institutes of Health [NIHR01HL58012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health NIHR01HL58012. http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Ashida A, 2007, PEDIATR NEPHROL, V22, P670, DOI 10.1007/s00467-006-0388-8; Athyros VG, 2012, J CARDIOVASC MED, V13, P254, DOI 10.2459/JCM.0b013e3283522422; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brunham LR, 2011, CLIN GENET, V79, P575, DOI 10.1111/j.1399-0004.2011.01682.x; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Connelly MA, 2003, J BIOL CHEM, V278, P25773, DOI 10.1074/jbc.M302820200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; Feys HB, 2009, BLOOD, V114, P4749, DOI 10.1182/blood-2009-07-230615; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GLASS C, 1985, J BIOL CHEM, V260, P744; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo L, 2011, J LIPID RES, V52, P2272, DOI 10.1194/jlr.M019091; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; Hewing B, 2012, CURR OPIN LIPIDOL; Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Imjeti NS, 2011, MOL BIOL CELL, V22, P4621, DOI 10.1091/mbc.E11-04-0320; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jang DS, 2004, BIOCHEM J, V382, P967, DOI 10.1042/BJ20031871; Ji AL, 2011, ATHEROSCLEROSIS, V217, P106, DOI 10.1016/j.atherosclerosis.2011.03.017; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Oram JF, 1996, J LIPID RES, V37, P2473; Papale GA, 2011, BIOCHEMISTRY-US, V50, P6245, DOI 10.1021/bi2005625; Papale GA, 2010, ARCH BIOCHEM BIOPHYS, V496, P132, DOI 10.1016/j.abb.2010.02.011; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; Stylianou IM, 2012, CIRC RES, V110, P337, DOI 10.1161/CIRCRESAHA.110.230854; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; Trigatti BL, 2000, BBA-MOL CELL BIOL L, V1529, P276, DOI 10.1016/S1388-1981(00)00154-2; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wild S, 2008, HEART, V94, P692, DOI 10.1136/hrt.2007.126326; Yancey PG, 2007, J LIPID RES, V48, P1140, DOI 10.1194/jlr.M600539-JLR200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yvan-Charvet L, 2008, J LIPID RES, V49, P107, DOI 10.1194/jlr.M700200-JLR200; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	70	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45660	10.1371/journal.pone.0045660	http://dx.doi.org/10.1371/journal.pone.0045660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029167	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800073
J	Greliche, N; Zeller, T; Wild, PS; Rotival, M; Schillert, A; Ziegler, A; Deloukas, P; Erdmann, J; Hengstenberg, C; Ouwehand, WH; Samani, NJ; Schunkert, H; Munzel, T; Lackner, KJ; Cambien, F; Goodall, AH; Tiret, L; Blankenberg, S; Tregouet, DA				Greliche, Nicolas; Zeller, Tanja; Wild, Philipp S.; Rotival, Maxime; Schillert, Arne; Ziegler, Andreas; Deloukas, Panos; Erdmann, Jeanette; Hengstenberg, Christian; Ouwehand, Willem H.; Samani, Nilesh J.; Schunkert, Heribert; Munzel, Thomas; Lackner, Karl J.; Cambien, Francois; Goodall, Alison H.; Tiret, Laurence; Blankenberg, Stefan; Tregouet, David-Alexandre		Cardiogenics Consortium	Comprehensive Exploration of the Effects of miRNA SNPs on Monocyte Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HISTONE DEACETYLASE 6; MICRORNA TARGETS; LUNG-CANCER; DISEASES; SUSCEPTIBILITY; BINDING; LOCUS; IDENTIFICATION; PREDICTION	We aimed to assess whether pri-miRNA SNPs (miSNPs) could influence monocyte gene expression, either through marginal association or by interacting with polymorphisms located in 3'UTR regions (3utrSNPs). We then conducted a genome-wide search for marginal miSNPs effects and pairwise miSNPs x 3utrSNPs interactions in a sample of 1,467 individuals for which genome-wide monocyte expression and genotype data were available. Statistical associations that survived multiple testing correction were tested for replication in an independent sample of 758 individuals with both monocyte gene expression and genotype data. In both studies, the hsa-mir-1279 rs1463335 was found to modulate in cis the expression of LYZ and in trans the expression of CNTN6, CTRC, COPZ2, KRT9, LRRFIP1, NOD1, PCDHA6, ST5 and TRAF3IP2 genes, supporting the role of hsa-mir-1279 as a regulator of several genes in monocytes. In addition, we identified two robust miSNPs x 3utrSNPs interactions, one involving HLA-DPB1 rs1042448 and hsa-mir-219-1 rs107822, the second the H1F0 rs1894644 and hsa-mir-659 rs5750504, modulating the expression of the associated genes. As some of the aforementioned genes have previously been reported to reside at disease-associated loci, our findings provide novel arguments supporting the hypothesis that the genetic variability of miRNAs could also contribute to the susceptibility to human diseases.	[Greliche, Nicolas; Rotival, Maxime; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 937, Paris, France; [Greliche, Nicolas] Univ Paris 11, Paris, France; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Munzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Schillert, Arne; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Hinxton, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Gen Hosp, Natl Inst Hlth Res Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Dept Clin Chem, Univ Med Ctr, Mainz, Germany; [Tregouet, David-Alexandre] Univ Paris 06, ICAN, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of Lubeck; Wellcome Trust Sanger Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Regensburg; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Johannes Gutenberg University of Mainz; UDICE-French Research Universities; Sorbonne Universite	Tregouet, DA (corresponding author), Univ Paris 06, INSERM, UMR S 937, Paris, France.	david.tregouet@upmc.fr	Wild, Philipp S./M-2106-2019; Trégouët, David-Alexandre/P-9210-2019; Greliche, Nicolas/P-4180-2015; Munzel, Thomas/A-2912-2014; Deloukas, Panos/B-2922-2013; Tregouet, David-Alexandre/E-3961-2016; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Greliche, Nicolas/0000-0003-0683-2257; Munzel, Thomas/0000-0001-5503-4150; Deloukas, Panos/0000-0001-9251-070X; Erdmann, Jeanette/0000-0002-4486-6231; Ziegler, Andreas/0000-0002-8386-5397; Maouche, Seraya/0000-0001-8186-1635; Matvienko-Sikar, Karen/0000-0003-2777-6581; Nelson, Christopher/0000-0001-8025-2897; Wild, Philipp/0000-0003-4413-9752; Goodall, Alison/0000-0002-7883-9645; Rendon, Augusto/0000-0001-8994-0039; Ouwehand, Willem/0000-0002-7744-1790; Wallace, Chris/0000-0001-9755-1703; Rotival, Maxime/0000-0003-2519-8044; Zeller, Tanja/0000-0003-3379-2641	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'') [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; National Genome Network "NGFNplus'' [A3 01GS0833, 01GS0831]; Federal Ministry of Education and Research, Germany [BMBF 01KU0908A]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; European Union [LSHM-CT-2006-037593]; British Heart Foundation; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; NIHR Cambridge Biomedical Research Centre; Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM); Genomic Network of the Pierre and Marie Curie University (Paris 06); British Heart Foundation [RG/09/012/28096] Funding Source: researchfish	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation''); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; National Genome Network "NGFNplus''; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Union(European Commission); British Heart Foundation(British Heart Foundation); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM)(Region Ile-de-France); Genomic Network of the Pierre and Marie Curie University (Paris 06); British Heart Foundation(British Heart Foundation)	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'', contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft'' and "Schwerpunkt Vaskulare Pravention'' of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. The present study was supported by the National Genome Network "NGFNplus'' (contract A3 01GS0833 and 01GS0831) and by a joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A) and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01) for the project CARDomics. CARDIOGENICS was funded by the European Union FP6 program (LSHM-CT-2006-037593). NJ Samani holds a Chair supported by the British Heart Foundation. Work described in this paper is part of the research portfolio supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. Collection of the Cardiogenics controls was part supported through the Cambridge Bioresource, which is funded by the NIHR Cambridge Biomedical Research Centre. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM) and the Genomic Network of the Pierre and Marie Curie University (Paris 06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castagne R, 2011, GENOMICS, V98, P320, DOI 10.1016/j.ygeno.2011.06.009; Castagne R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023956; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dalmasso C, 2008, GENETICS, V180, P697, DOI 10.1534/genetics.108.089839; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hughes AE, 2011, AM J HUM GENET; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inaoka H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-112; Inaoka H, 2007, P NATL ACAD SCI USA, V104, P5020, DOI 10.1073/pnas.0611078104; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kominami S, 2009, J HUM GENET, V54, P108, DOI 10.1038/jhg.2008.15; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leeper NJ, 2011, CIRCULATION, V123, P236, DOI 10.1161/CIRCULATIONAHA.110.003855; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shah S, 2011, CIRC CARDIOVASC GENE; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Slaby O, 2011, J CELL MOL MED; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Verhelst H, 2011, EUR J PAEDIATR NEURO, V15, P163, DOI 10.1016/j.ejpn.2010.07.004; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; ZAMANI MG, 1994, AM J MED GENET, V54, P372, DOI 10.1002/ajmg.1320540417; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982	62	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45863	10.1371/journal.pone.0045863	http://dx.doi.org/10.1371/journal.pone.0045863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029284	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309392800110
J	Gunetti, M; Tomasi, S; Giammo, A; Boido, M; Rustichelli, D; Mareschi, K; Errichiello, E; Parola, M; Ferrero, I; Fagioli, F; Vercelli, A; Carone, R				Gunetti, Monica; Tomasi, Simone; Giammo, Alessandro; Boido, Marina; Rustichelli, Deborah; Mareschi, Katia; Errichiello, Edoardo; Parola, Maurizio; Ferrero, Ivana; Fagioli, Franca; Vercelli, Alessandro; Carone, Roberto			Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence	PLOS ONE			English	Article							SKELETAL MYOBLASTS; CA2+ OSCILLATIONS; STROMAL CELLS; THERAPY; DIFFERENTIATION; TRANSPLANTATION; COMPLICATIONS; REGENERATION; COCULTURE; INJECTION	Urinary incontinence, defined as the complaint of any involuntary loss of urine, is a pathological condition, which affects 30% females and 15% males over 60, often following a progressive decrease of rhabdosphincter cells due to increasing age or secondary to damage to the pelvic floor musculature, connective tissue and/or nerves. Recently, stem cell therapy has been proposed as a source for cell replacement and for trophic support to the sphincter. To develop new therapeutic strategies for urinary incontinence, we studied the interaction between mesenchymal stem cells (MSCs) and muscle cells in vitro; thereafter, aiming at a clinical usage, we analyzed the supporting role of MSCs for muscle cells in vitro and in in vivo xenotransplantation. MSCs can express markers of the myogenic cell lineages and give rise, under specific cell culture conditions, to myotube-like structures. Nevertheless, we failed to obtain mixed myotubes both in vitro and in vivo. For in vivo transplantation, we tested a new protocol to collect human MSCs from whole bone marrow, to get larger numbers of cells. MSCs, when transplanted into the pelvic muscles close to the external urethral sphincter, survived for a long time in absence of immunosuppression, and migrated into the muscle among fibers, and towards neuromuscular endplates. Moreover, they showed low levels of cycling cells, and did not infiltrate blood vessels. We never observed formation of cell masses suggestive of tumorigenesis. Those which remained close to the injection site showed an immature phenotype, whereas those in the muscle had more elongated morphologies. Therefore, MSCs are safe and can be easily transplanted without risk of side effects in the pelvic muscles. Further studies are needed to elucidate their integration into muscle fibers, and to promote their muscular transdifferentiation either before or after transplantation.	[Gunetti, Monica; Rustichelli, Deborah; Mareschi, Katia; Errichiello, Edoardo; Ferrero, Ivana; Fagioli, Franca] Regina Margherita Childrens Hosp, Paediat Onco Haematol Stem Cell Transplantat & Ce, Turin, Italy; [Tomasi, Simone; Boido, Marina; Vercelli, Alessandro] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Tomasi, Simone; Boido, Marina; Vercelli, Alessandro] Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [Giammo, Alessandro; Carone, Roberto] CTO Maria Adelaide Hosp, Dept Neuro Urol, Turin, Italy; [Mareschi, Katia; Ferrero, Ivana] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Parola, Maurizio] Univ Turin, Interuniv Ctr Hepat Pathophysiol, Dept Expt Med & Oncol, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Turin	Gunetti, M (corresponding author), Regina Margherita Childrens Hosp, Paediat Onco Haematol Stem Cell Transplantat & Ce, Turin, Italy.	monica.gunetti@unito.it	Fagioli, Franca/AAC-2181-2022; Mareschi, katia/J-9659-2018; Ferrero, Ivana/AAC-2302-2022; Errichiello, Edoardo/K-8360-2019; Tomasi, Simone/D-8427-2011; Gunetti, Monica/AAA-7815-2020; Vercelli, Alessandro/A-1926-2012	Mareschi, katia/0000-0003-2889-0394; Gunetti, Monica/0000-0002-7466-4972; Parola, Maurizio/0000-0001-7720-5141; Errichiello, Edoardo/0000-0001-6346-1988; FERRERO, Ivana/0000-0002-4364-8021; Vercelli, Alessandro/0000-0002-5909-2128; Boido, Marina/0000-0003-1211-1552; FAGIOLI, FRANCA/0000-0002-9257-900X	Italian University, Research and Education Ministry (MIUR); Italian Ministry of Health; Italian Foundation for Continence; Oncology Network of Piedmont and Valle d'Aosta; Compagnia di San Paolo Foundation, Turin	Italian University, Research and Education Ministry (MIUR); Italian Ministry of Health(Ministry of Health, Italy); Italian Foundation for Continence; Oncology Network of Piedmont and Valle d'Aosta; Compagnia di San Paolo Foundation, Turin(Compagnia di San Paolo)	This work was supported by the Italian University, Research and Education Ministry (MIUR); the Italian Ministry of Health; the Italian Foundation for Continence; the Oncology Network of Piedmont and Valle d'Aosta; and the Compagnia di San Paolo Foundation, Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Appell RA, 2006, BJU INT, V98, P27, DOI 10.1111/j.1464-410X.2006.06305.x; Barry ELR, 2000, CALCIFIED TISSUE INT, V66, P145, DOI 10.1007/s002230010029; Beier JP, 2011, CELL BIOL INT, V35, P397, DOI 10.1042/CBI20100417; Boido M, 2009, EUR J NEUROSCI, V30, P833, DOI 10.1111/j.1460-9568.2009.06879.x; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Canzi L, 2012, MOL MED, V18, P401, DOI 10.2119/molmed.2011.00123; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Carvalho KAT, 2006, TRANSPL P, V38, P1596, DOI 10.1016/j.transproceed.2006.03.023; Carvalho KAT, 2004, TRANSPL P, V36, P991, DOI 10.1016/j.transproceed.2004.03.056; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corcos J, 2011, NEUROUROL URODYNAM, V30, P447, DOI 10.1002/nau.20998; DeLancey JOL, 2008, J UROLOGY, V179, P2286, DOI 10.1016/j.juro.2008.01.098; Deng DY, 2007, NEUROUROL URODYNAM, V26, P46, DOI 10.1002/nau.20357; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drost AC, 2009, ANN NY ACAD SCI, V1176, P135, DOI 10.1111/j.1749-6632.2009.04610.x; Garbossa D, 2012, NEUROSURG REV, V35, P293, DOI 10.1007/s10143-012-0385-2; Gawronska-Kozak B, 2007, J CELL BIOCHEM, V102, P122, DOI 10.1002/jcb.21286; Hanada M, 2010, J UROLOGY, V183, P2445, DOI 10.1016/j.juro.2010.01.063; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Heidler S, 2011, CURR OPIN UROL, V21, P488, DOI 10.1097/MOU.0b013e32834b1317; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hubner WA, 2005, BJU INT, V96, P587, DOI 10.1111/j.1464-410X.2005.05689.x; Karaoz E, 2011, J CELL PHYSIOL, V226, P1367, DOI 10.1002/jcp.22468; Kawano S, 2003, CELL CALCIUM, V34, P145, DOI 10.1016/S0143-4160(03)00069-1; Kinebuchi Y, 2010, INT J UROL, V17, P359, DOI 10.1111/j.1442-2042.2010.02471.x; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008; Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; LI H, 1993, NUCLEIC ACIDS RES, V21, P335, DOI 10.1093/nar/21.2.335; Lin GT, 2010, CYTOTHERAPY, V12, P88, DOI 10.3109/14653240903350265; Liu LH, 2006, STEM CELLS DEV, V15, P349, DOI 10.1089/scd.2006.15.349; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Mareschi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/920581; Mareschi K, 2009, CYTOTHERAPY, V11, P534, DOI 10.1080/14653240902974024; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Mitterberger M, 2008, J UROLOGY, V179, P226, DOI 10.1016/j.juro.2007.08.154; Nikolavsky D, 2010, NEUROUROL URODYNAM, V29, pS36, DOI 10.1002/nau.20833; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Shabbir A, 2009, TRANSPLANTATION, V87, P1275, DOI 10.1097/TP.0b013e3181a1719b; Sherman LS, 2011, CTS-CLIN TRANSL SCI, V4, P380, DOI 10.1111/j.1752-8062.2011.00283.x; Shokeir AA, 2010, INT J UROL, V17, P964, DOI 10.1111/j.1442-2042.2010.02643.x; Strasser H, 2000, J UROLOGY, V164, P1781, DOI 10.1016/S0022-5347(05)67106-6; Sweat SD, 1999, J UROLOGY, V161, P93, DOI 10.1016/S0022-5347(01)62074-3; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Ye B, 2010, PHYSIOL RES, V59, P323, DOI 10.33549/physiolres.931734; Zhao WM, 2011, EUR UROL, V59, P155, DOI 10.1016/j.eururo.2010.10.038	55	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45538	10.1371/journal.pone.0045538	http://dx.doi.org/10.1371/journal.pone.0045538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029081	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800058
J	Harrison, WJ; Mattingley, JB; Remington, RW				Harrison, William J.; Mattingley, Jason B.; Remington, Roger W.			Pre-Saccadic Shifts of Visual Attention	PLOS ONE			English	Article							EYE-MOVEMENTS; CORTEX; TARGET; SPACE; FIELD; MODEL	The locations of visual objects to which we attend are initially mapped in a retinotopic frame of reference. Because each saccade results in a shift of images on the retina, however, the retinotopic mapping of spatial attention must be updated around the time of each eye movement. Mathot and Theeuwes [1] recently demonstrated that a visual cue draws attention not only to the cue's current retinotopic location, but also to a location shifted in the direction of the saccade, the "future-field". Here we asked whether retinotopic and future-field locations have special status, or whether cue-related attention benefits exist between these locations. We measured responses to targets that appeared either at the retinotopic or future-field location of a brief, non-predictive visual cue, or at various intermediate locations between them. Attentional cues facilitated performance at both the retinotopic and future-field locations for cued relative to uncued targets, as expected. Critically, this cueing effect also occurred at intermediate locations. Our results, and those reported previously [1], imply a systematic bias of attention in the direction of the saccade, independent of any predictive remapping of attention that compensates for retinal displacements of objects across saccades [2].	[Harrison, William J.; Mattingley, Jason B.; Remington, Roger W.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Harrison, WJ (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	willjharri@gmail.com	Mattingley, Jason/J-1537-2014; Harrison, William/C-7131-2018	Mattingley, Jason/0000-0003-0929-9216; Harrison, William/0000-0002-6408-0359	Australian Research Council [DP0666772]; Australia Research Council Laureate Fellowship	Australian Research Council(Australian Research Council); Australia Research Council Laureate Fellowship(Australian Research Council)	This research was funded by an Australian Research Council grant to RWR (DP0666772) and an Australia Research Council Laureate Fellowship to JBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Golomb JD, 2011, ATTEN PERCEPT PSYCHO, V73, P7, DOI 10.3758/s13414-010-0016-3; Golomb JD, 2010, J NEUROSCI, V30, P10493, DOI 10.1523/JNEUROSCI.1546-10.2010; Golomb JD, 2010, J VISION, V10, DOI 10.1167/10.3.19; HUGHES HC, 1987, NEUROPSYCHOLOGIA, V25, P5, DOI 10.1016/0028-3932(87)90039-X; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mathot S, 2011, PHILOS T R SOC B, V366, P516, DOI 10.1098/rstb.2010.0187; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rizzolatti G, 1987, NEUROPSYCHOLOGIA; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHULMAN GL, 1979, J EXP PSYCHOL HUMAN, V5, P522, DOI 10.1037/0096-1523.5.3.522; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Szinte M, 2011, J VISION, V11, DOI 10.1167/11.2.4; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Zirnsak M, 2011, J NEUROSCI, V31, P17887, DOI 10.1523/JNEUROSCI.2465-11.2011; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	24	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45670	10.1371/journal.pone.0045670	http://dx.doi.org/10.1371/journal.pone.0045670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029175	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800077
J	Li, H; Duan, ZW; Xie, P; Liu, YR; Wang, WC; Dou, SX; Wang, PY				Li, Hui; Duan, Zhao-Wen; Xie, Ping; Liu, Yu-Ru; Wang, Wei-Chi; Dou, Shuo-Xing; Wang, Peng-Ye			Effects of Paclitaxel on EGFR Endocytic Trafficking Revealed Using Quantum Dot Tracking in Single Cells	PLOS ONE			English	Article							EPIDERMAL GROWTH-FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; RECEPTOR TYROSINE KINASES; LIVING CELLS; LIVE CELLS; INTERMEDIATE-FILAMENTS; AXONAL-TRANSPORT; ERBB RECEPTORS; A431 CELLS; TAXOL	Paclitaxel (PTX), a chemotherapeutic drug, affects microtubule dynamics and influences endocytic trafficking. However, the mechanism and the dynamics of altered endocytic trafficking by paclitaxel treatment in single living cells still remain elusive. By labeling quantum dots (QDs) to the epidermal growth factor (EGF), we continuously tracked the endocytosis and post-endocytic trafficking of EGF receptors (EGFRs) in A549 cells for a long time interval. A single-cell analysis method was introduced to quantitatively study the dynamics of endocytic trafficking. Compared with the control cells, the velocity of directed motion was reduced by 30% due to the suppression of high speed movements of EGF-QDs along the microtubules in PTX-treated cells. The endocytic trafficking in PTX-treated cells was mainly via super-diffusive mode of motion, whereas in control cells, it was mostly via sub-diffusive mode of motion. Moreover, PTX shortened endosomal trafficking and prevented EGF-QDs from moving to the perinuclear area via the rapid delivery of EGF-QDs into the peripheral lysosomes. The present study may shed light on the mechanism of the effect of PTX on the treatment of lung cancer.	[Li, Hui; Duan, Zhao-Wen; Xie, Ping; Liu, Yu-Ru; Wang, Wei-Chi; Dou, Shuo-Xing; Wang, Peng-Ye] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS	Wang, PY (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing Natl Lab Condensed Matter Phys, POB 603, Beijing 100080, Peoples R China.	pywang@aphy.iphy.ac.cn	Li, Hui/L-2704-2019; Duan, Zhaowen/AHE-6206-2022; Li, Hui/C-7251-2019	Li, Hui/0000-0003-0551-9912; Wang, Peng-Ye/0000-0002-9765-0610; Dou, Shuo-Xing/0000-0002-7201-2081; Multhoff, Gabriele/0000-0002-2616-3137	National Natural Science Foundation of China [10834014]; National Basic Research Program of China (973 Program) [2009CB930704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant 10834014) and the National Basic Research Program of China (973 Program) (Grant 2009CB930704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bridges AJ, 1996, CURR MED CHEM, V3, P167; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COLLOT M, 1984, P NATL ACAD SCI-BIOL, V81, P788, DOI 10.1073/pnas.81.3.788; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; FAUCHEUX LP, 1994, PHYS REV E, V49, P5158, DOI 10.1103/PhysRevE.49.5158; Flores-Rodriguez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024479; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; HAMMALVAREZ SF, 1994, P NATL ACAD SCI USA, V91, P7812, DOI 10.1073/pnas.91.16.7812; HammAlvarez SF, 1996, PHARMACEUT RES, V13, P1647, DOI 10.1023/A:1016432505275; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Holzbaur ELF, 2010, CURR OPIN CELL BIOL, V22, P4, DOI 10.1016/j.ceb.2009.12.014; Hornick JE, 2008, CELL MOTIL CYTOSKEL, V65, P595, DOI 10.1002/cm.20283; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Novikoff PM, 1996, J CELL SCI, V109, P21; Okano J, 2001, J BIOL CHEM, V276, P19555, DOI 10.1074/jbc.M011164200; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rajan SS, 2008, ACS NANO, V2, P1153, DOI 10.1021/nn700399e; Rajas F, 1996, J BIOL CHEM, V271, P29882, DOI 10.1074/jbc.271.47.29882; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Torres K, 1998, CANCER RES, V58, P3620; Vilalta PM, 1998, J CELL SCI, V111, P1841; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Xie P, 2006, BIOPHYS CHEM, V123, P58, DOI 10.1016/j.bpc.2006.04.003; Xie P, 2010, INT J BIOL SCI, V6, P665, DOI 10.7150/ijbs.6.665; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	66	39	40	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45465	10.1371/journal.pone.0045465	http://dx.doi.org/10.1371/journal.pone.0045465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029028	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900056
J	Beer, M; Liu, CQ				Beer, Michael; Liu, Chun-Qiang			Panning of a Phage Display Library against a Synthetic Capsule for Peptide Ligands That Bind to the Native Capsule of Bacillus anthracis	PLOS ONE			English	Article							POLY-GAMMA-GLUTAMATE; PROTECTIVE ANTIGEN; ANTIMICROBIAL PEPTIDES; HIGH-AFFINITY; ANTIBODIES; INHIBITORS; SPORES; THREAT; TOXIN; ACID	Bacillus anthracis is the causative agent of anthrax with the ability to not only produce a tripartite toxin, but also an enveloping capsule comprised primarily of gamma-D-glutamic acid residues. The purpose of this study was to isolate peptide ligands capable of binding to the native capsule of B. anthracis from a commercial phage display peptide library using a synthetic form of the capsule consisting of 12 gamma-D-glutamic acid residues. Following four rounds of selection, 80 clones were selected randomly and analysed by DNA sequencing. Four clones, each containing a unique consensus sequence, were identified by sequence alignment analysis. Phage particles were prepared and their derived 12-mer peptides were also chemically synthesized and conjugated to BSA. Both the phage particles and free peptide-BSA conjugates were evaluated by ELISA for binding to encapsulated cells of B. anthracis as well as a B. anthracis capsule extract. All the phage particles tested except one were able to bind to both the encapsulated cells and the capsule extract. However, the peptide-BSA conjugates could only bind to the encapsulated cells. One of the peptide-BSA conjugates, with the sequence DSSRIPMQWHPQ (termed G1), was fluorescently labelled and its binding to the encapsulated cells was further confirmed by confocal microscopy. The results demonstrated that the synthetic capsule was effective in isolating phage-displayed peptides with binding affinity for the native capsule of B. anthracis.	[Beer, Michael; Liu, Chun-Qiang] Def Sci & Technol Org, Human Protect & Performance Div, Fishermans Bend, Vic, Australia	Defence Science & Technology	Liu, CQ (corresponding author), Def Sci & Technol Org, Human Protect & Performance Div, Fishermans Bend, Vic, Australia.	chun.liu@dsto.defence.gov.au			Australian Government Department of Defence	Australian Government Department of Defence(Australian Government)	All funding for this research was provided by the Australian Government Department of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuCoin DP, 2009, DIAGN MICR INFEC DIS, V64, P229, DOI 10.1016/j.diagmicrobio.2009.02.001; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; Brigati J, 2004, CLIN CHEM, V50, P1899, DOI 10.1373/clinchem.2004.038018; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Dawson RM, 2008, CRIT REV MICROBIOL, V34, P89, DOI [10.1080/10408410802143808, 10.1080/10408410802143808 ]; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P3833, DOI 10.1128/AAC.00509-06; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gujraty K, 2005, MOL PHARMACEUT, V2, P367, DOI 10.1021/mp050040f; Joyce J, 2006, J BIOL CHEM, V281, P4831, DOI 10.1074/jbc.M509432200; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Lee DY, 2009, FEMS IMMUNOL MED MIC, V57, P165, DOI 10.1111/j.1574-695X.2009.00595.x; McGillivray SM, 2009, J INNATE IMMUN, V1, P494, DOI 10.1159/000225955; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Schneerson R, 2003, P NATL ACAD SCI USA, V100, P8945, DOI 10.1073/pnas.1633512100; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Scorpio A, 2010, MICROBIOL-SGM, V156, P1459, DOI 10.1099/mic.0.035857-0; Turnbough CL, 2003, J MICROBIOL METH, V53, P263, DOI 10.1016/S0167-7012(03)00030-7; Wang TT, 2004, INFECT IMMUN, V72, P5460, DOI 10.1128/IAI.72.9.5460-5463.2004; Zhou B, 2002, P NATL ACAD SCI USA, V99, P5241, DOI 10.1073/pnas.082121599	27	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45472	10.1371/journal.pone.0045472	http://dx.doi.org/10.1371/journal.pone.0045472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029033	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400091
J	Gleiss, S; Kayser, C				Gleiss, Stephanie; Kayser, Christoph			Audio-Visual Detection Benefits in the Rat	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; RHESUS-MONKEYS; VISUAL-PERCEPTION; AUDITORY-STIMULI; LOOMING SIGNALS; REACTION-TIME; SOUND; ENHANCEMENT; INFORMATION; CORTEX	Human psychophysical studies have described multisensory perceptual benefits such as enhanced detection rates and faster reaction times in great detail. However, the neural circuits and mechanism underlying multisensory integration remain difficult to study in the primate brain. While rodents offer the advantage of a range of experimental methodologies to study the neural basis of multisensory processing, rodent studies are still limited due to the small number of available multisensory protocols. We here demonstrate the feasibility of an audio-visual stimulus detection task for rats, in which the animals detect lateralized uni- and multi-sensory stimuli in a two-response forced choice paradigm. We show that animals reliably learn and perform this task. Reaction times were significantly faster and behavioral performance levels higher in multisensory compared to unisensory conditions. This benefit was strongest for dim visual targets, in agreement with classical patterns of multisensory integration, and was specific to task-informative sounds, while uninformative sounds speeded reaction times with little costs for detection performance. Importantly, multisensory benefits for stimulus detection and reaction times appeared at different levels of task proficiency and training experience, suggesting distinct mechanisms inducing these two multisensory benefits. Our results demonstrate behavioral multisensory enhancement in rats in analogy to behavioral patterns known from other species, such as humans. In addition, our paradigm enriches the set of behavioral tasks on which future studies can rely, for example to combine behavioral measurements with imaging or pharmacological studies in the behaving animal or to study changes of integration properties in disease models.	[Gleiss, Stephanie; Kayser, Christoph] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Kayser, Christoph] Bernstein Ctr Computat Neurosci, Tubingen, Germany	Max Planck Society	Kayser, C (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	christoph.kayser@tuebingen.mpg.de	Kayser, Christoph/A-3203-2012	Kayser, Christoph/0000-0001-7362-5704; Kayser, Stephanie/0000-0002-1577-6288	Max Planck Society; Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]	Max Planck Society(Max Planck Society); Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Max Planck Society and the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Caclin A, 2011, BRAIN RES, V1396, P35, DOI 10.1016/j.brainres.2011.04.016; Calvert G., 2004, HDB MULTISENSORY PRO; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; David N, 2011, AUTISM RES, V4, P383, DOI 10.1002/aur.210; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Doyle MC, 2001, PERCEPTION, V30, P795, DOI 10.1068/p3126; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Hirokawa J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025283; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jeffery KJ, 2007, BEHAV BRAIN RES, V183, P213, DOI 10.1016/j.bbr.2007.06.017; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Mahoney JR, 2011, BRAIN RES, V1426, P43, DOI 10.1016/j.brainres.2011.09.017; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Meier P, 2011, J VIS, V11, P22; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Nelson WT, 1998, HUM FACTORS, V40, P452, DOI 10.1518/001872098779591304; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Peiffer AM, 2007, NEUROREPORT, V18, P1077, DOI 10.1097/WNR.0b013e3281e72ae7; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sakata S, 2004, EXP BRAIN RES, V159, P409, DOI 10.1007/s00221-004-1962-6; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Schroeder C. E., 2004, COGN PROCESS, V5, P140; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; STEIN BE, 1978, J NEUROPHYSIOL, V41, P55, DOI 10.1152/jn.1978.41.1.55; Stein BE., 1993, MERGING SENSES; Stevenson RA, 2012, EXP BRAIN RES, V219, P121, DOI 10.1007/s00221-012-3072-1; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383	55	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45677	10.1371/journal.pone.0045677	http://dx.doi.org/10.1371/journal.pone.0045677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029179	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000311313900167
J	Tao, R; Zhang, JQ; Dai, YM; You, ZL; Fan, Y; Cui, JG; Wang, J				Tao, Ran; Zhang, Jiuquan; Dai, Yongming; You, Zhonglan; Fan, Yi; Cui, Jinguo; Wang, Jian			An In Vitro and In Vivo Analysis of the Correlation between Susceptibility-Weighted Imaging Phase Values and R2*in Cirrhotic Livers	PLOS ONE			English	Article							HEPATIC IRON CONCENTRATION; MAGNETIC-RESONANCE; 3 TESLA; DISEASE; BRAIN; MRI; DEPOSITION; DIAGNOSIS; OVERLOAD; QUANTIFICATION	Objective: To establish a baseline of susceptibility-weighted imaging (SWI) phase value as a means of detecting iron abnormalities in cirrhotic liver and to analyze its relationship with R2*. Materials and Methods: Sixteen MnCl2 phantoms, thirty-seven healthy individuals and 87 cirrhotic patients were performed SWI and multi-echo T2*-weighted imaging, and the signal processing in NMR (SPIN) software was used to measure the radian on SWI phase images and the R2* on T2* maps. The mean minus two times standard deviation (SD) of Siemens Phase Unit (SPU) in healthy individuals was designated as a threshold to separate the regions of interest (ROIs) into high-and lowiron areas in healthy participants and cirrhotic patients. The SWI phase values of high-iron areas were calculated. The R2* values was measured in the same ROI in both healthy participants and patients. Results: SWI phase values correlated linearly with R2* values in cases of MnCl2 concentrations lower than 2.3 mM in vitro (r = -0.996, P<0.001). The mean value and SD of 37 healthy participants were 2003 and 15 (SPU), respectively. A threshold of 1973 SPU (-0.115 radians) was determined. The SWI phase value and R2* values had a negative correlation in the cirrhotic patients (r = -0.742, P<0.001). However, no similar relationship was found in the healthy individuals (r = 0.096, P = 0.576). Both SWI phase values and R2* values were found to have significant correlations with serum ferritin concentrations in 42 patients with blood samples (r = -0.512, P= 0.001 and r = 0.641, P<0.001, respectively). Conclusion: SWI phase values had significant correlations with R2* after the establishment of a baseline on the phase image. SWI phase images may be used for non-invasive quantitative measurement of mild and moderate iron deposition in hepatic cirrhosis in vivo.	[Tao, Ran; Cui, Jinguo] Bethune Int Peace Hosp Peoples Liberty Army, Dept Radiol, Shijiazhuang, Hebei Province, Peoples R China; [Tao, Ran; Zhang, Jiuquan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Dai, Yongming] Siemens Healthcare, MR Collaborat NE Asia, Shanghai, Peoples R China; [You, Zhonglan; Fan, Yi] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China	Army Medical University; Siemens AG; Army Medical University	Cui, JG (corresponding author), Bethune Int Peace Hosp Peoples Liberty Army, Dept Radiol, Shijiazhuang, Hebei Province, Peoples R China.	cuijinguo2005@163.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019					Alustiza JM, 2004, RADIOLOGY, V230, P479, DOI 10.1148/radiol.2302020820; Beinker NK, 1996, J HEPATOL, V25, P633, DOI 10.1016/S0168-8278(96)80231-5; Chandarana H, 2009, AM J ROENTGENOL, V193, P1261, DOI 10.2214/AJR.08.1996; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Deistung A, 2009, J MAGN RESON IMAGING, V29, P1478, DOI 10.1002/jmri.21673; Du YPP, 2009, J MAGN RESON IMAGING, V30, P449, DOI 10.1002/jmri.21833; Emond MJ, 1999, CLIN CHEM, V45, P340; Fenzi A, 2001, J MAGN RESON IMAGING, V13, P392, DOI 10.1002/jmri.1056; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke E. M., 2011, SUSCEPTIBILITY WEIGH, P10; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HARBIN WP, 1980, RADIOLOGY, V135, P273, DOI 10.1148/radiology.135.2.7367613; Ito K, 2004, INTERVIROLOGY, V47, P134, DOI 10.1159/000078465; Ito K, 2002, MAGN RESON IMAGING C, V10, pvi; Ito Katsuyoshi, 2002, Magn Reson Imaging Clin N Am, V10, P75, DOI 10.1016/S1064-9689(03)00050-3; Kim MJ, 2001, ABDOM IMAGING, V26, P149, DOI 10.1007/s002610000121; Kordesch KV, 2006, CLIN MAGNETIC RESONA, P23; McCarville MB, 2010, PEDIATR RADIOL, V40, P1360, DOI 10.1007/s00247-010-1596-8; McCrea RPE, 2008, EUR J RADIOL, V68, pS109, DOI 10.1016/j.ejrad.2008.04.048; Metwally MA, 2004, AM J GASTROENTEROL, V99, P286, DOI 10.1111/j.1572-0241.2004.04049.x; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; Olthof AW, 2007, MAGN RESON IMAGING, V25, P228, DOI 10.1016/j.mri.2006.09.019; Rauscher A, 2003, J MAGN RESON IMAGING, V18, P175, DOI 10.1002/jmri.10346; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Szurowska E, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-13; Ulmer JL, 1996, AM J NEURORADIOL, V17, P805; Villeneuve JP, 1996, J HEPATOL, V25, P172, DOI 10.1016/S0168-8278(96)80070-5; Virtanen JM, 2008, MAGN RESON IMAGING, V26, P1175, DOI 10.1016/j.mri.2008.01.028; Vymazal J, 1996, MAGN RESON MED, V36, P61, DOI 10.1002/mrm.1910360111; Wang Y, 2000, J MAGN RESON IMAGING, V12, P661, DOI 10.1002/1522-2586(200011)12:5<661::AID-JMRI2>3.3.CO;2-C; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982	36	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45477	10.1371/journal.pone.0045477	http://dx.doi.org/10.1371/journal.pone.0045477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029037	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900144
J	Wyss, L; Schafer, J; Liebner, S; Mittelbronn, M; Deutsch, U; Enzmann, G; Adams, RH; Aurrand-Lions, M; Plate, KH; Imhof, BA; Engelhardt, B				Wyss, Lena; Schaefer, Julia; Liebner, Stefan; Mittelbronn, Michel; Deutsch, Urban; Enzmann, Gaby; Adams, Ralf H.; Aurrand-Lions, Michel; Plate, Karl H.; Imhof, Beat A.; Engelhardt, Britta			Junctional Adhesion Molecule (JAM)-C Deficient C57BL/6 Mice Develop a Severe Hydrocephalus	PLOS ONE			English	Article							JAM FAMILY-MEMBERS; TRANSENDOTHELIAL MIGRATION; PERIPHERAL-NERVES; CHOROID-PLEXUS; CELL POLARITY; IN-VIVO; EXPRESSION; BRAIN; CILIA; PERMEABILITY	The junctional adhesion molecule (JAM)-C is a widely expressed adhesion molecule regulating cell adhesion, cell polarity and inflammation. JAM-C expression and function in the central nervous system (CNS) has been poorly characterized to date. Here we show that JAM-C-/- mice backcrossed onto the C57BL/6 genetic background developed a severe hydrocephalus. An in depth immunohistochemical study revealed specific immunostaining for JAM-C in vascular endothelial cells in the CNS parenchyma, the meninges and in the choroid plexus of healthy C57BL/6 mice. Additional JAM-C immunostaining was detected on ependymal cells lining the ventricles and on choroid plexus epithelial cells. Despite the presence of hemorrhages in the brains of JAM-C-/- mice, our study demonstrates that development of the hydrocephalus was not due to a vascular function of JAM-C as endothelial re-expression of JAM-C failed to rescue the hydrocephalus phenotype of JAM-C-/- C57BL/6 mice. Evaluation of cerebrospinal fluid (CSF) circulation within the ventricular system of JAM-C-/- mice excluded occlusion of the cerebral aqueduct as the cause of hydrocephalus development but showed the acquisition of a block or reduction of CSF drainage from the lateral to the 3rd ventricle in JAM-C-/- C57BL/6 mice. Taken together, our study suggests that JAM-C-/- C57BL/6 mice model the important role for JAM-C in brain development and CSF homeostasis as recently observed in humans with a loss-of-function mutation in JAM-C.	[Wyss, Lena; Schaefer, Julia; Deutsch, Urban; Enzmann, Gaby; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Liebner, Stefan; Mittelbronn, Michel; Plate, Karl H.] Goethe Univ Frankfurt, Edinger Inst, Sch Med, Frankfurt, Germany; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, Munster, Germany; [Aurrand-Lions, Michel] INSERM, Ctr Rech Cancerol Marseille, Inst J Paoli I Calmettes, F-13258 Marseille, France; [Imhof, Beat A.] Univ Geneva, Dept Pathol & Immunol, CMU, Geneva, Switzerland	University of Bern; Goethe University Frankfurt; Max Planck Society; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Geneva	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Bern, Switzerland.	bengel@tki.unibe.ch	Engelhardt, Britta/K-7267-2014; Aurrand-Lions, Michel/O-9953-2016; Adams, Ralf H/AAE-9274-2019	Engelhardt, Britta/0000-0003-3059-9846; Aurrand-Lions, Michel/0000-0002-8361-3034; Mittelbronn, Michel/0000-0002-2998-052X; Deutsch, Urban/0000-0003-4265-6262	Swiss National Science Foundation [31003A_118390, 31003A_1330922]; European Union [201024, 202213]; JUSTBRAIN [241861]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); JUSTBRAIN	This work was supported by the Swiss National Science Foundation (grant numbers 31003A_118390 and 31003A_1330922) and European Union's Seventh Framework Programme grant agreements no201024 and no202213 (European Stroke Network) and JUSTBRAIN (grant No 241861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; BRYAN JHD, 1983, VIRCHOWS ARCH A, V399, P265, DOI 10.1007/BF00612944; CATHCART RS, 1964, J NEUROPATH EXP NEUR, V23, P609, DOI 10.1097/00005072-196410000-00002; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Colom B, 2012, FASEB J, V26, P1064, DOI 10.1096/fj.11-196220; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Famulski JK, 2010, SCIENCE; Fujimoto Y, 2004, PEDIATR NEUROSURG, V40, P32, DOI 10.1159/000076575; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; GREENSTONE MA, 1984, ARCH DIS CHILD, V59, P481, DOI 10.1136/adc.59.5.481; Greitz D, 1997, ACTA PAEDIATR, V86, P125, DOI 10.1111/j.1651-2227.1997.tb08850.x; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Keiper T, 2005, FASEB J, V19, P2078, DOI 10.1096/fj.05-4196fje; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li XC, 2009, ARTERIOSCL THROM VAS, V29, P1200, DOI 10.1161/ATVBAHA.109.189217; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026; Morris AP, 2006, CELL COMMUN ADHES, V13, P233, DOI 10.1080/15419060600877978; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Perez-Figares JM, 2001, MICROSC RES TECHNIQ, V52, P591, DOI 10.1002/1097-0029(20010301)52:5<591::AID-JEMT1043>3.0.CO;2-7; Praetor A, 2009, BLOOD, V113, P1919, DOI 10.1182/blood-2008-06-159574; Raimondi A J, 1973, Surg Neurol, V1, P50; Rickert CH, 2001, MICROSC RES TECHNIQ, V52, P104; Rolf B, 2001, BRAIN RES, V891, P247, DOI 10.1016/S0006-8993(00)03219-4; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; SHIMIZU A, 1992, CHILD NERV SYST, V8, P25, DOI 10.1007/BF00316558; Stelzer S, 2012, STEM CELLS DEV, V21, P757, DOI 10.1089/scd.2011.0274; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Tenan M, 2010, GLIA, V58, P524, DOI 10.1002/glia.20941; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; WILDE DB, 1983, J IMMUNOL, V131, P2178; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; WORTHINGTON WC, 1963, SCIENCE, V139, P221, DOI 10.1126/science.139.3551.221; YAMADORI T, 1979, Scanning Electron Microscopy, P335; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006; Zimmerli C, 2009, J IMMUNOL, V182, P4728, DOI 10.4049/jimmunol.0803892	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45619	10.1371/journal.pone.0045619	http://dx.doi.org/10.1371/journal.pone.0045619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029139	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900163
J	Paweska, JT; van Vuren, PJ; Masumu, J; Leman, PA; Grobbelaar, AA; Birkhead, M; Clift, S; Swanepoel, R; Kemp, A				Paweska, Janusz T.; van Vuren, Petrus Jansen; Masumu, Justin; Leman, Patricia A.; Grobbelaar, Antoinette A.; Birkhead, Monica; Clift, Sarah; Swanepoel, Robert; Kemp, Alan			Virological and Serological Findings in Rousettus aegyptiacus Experimentally Inoculated with Vero Cells-Adapted Hogan Strain of Marburg Virus	PLOS ONE			English	Article							EBOLA HEMORRHAGIC-FEVER; EXPERIMENTAL-INFECTION; DENDRITIC CELLS; RESERVOIR HOSTS; RHESUS-MONKEYS; CONGO; PATHOGENESIS; DISEASE; OUTBREAK; KIKWIT	The Egyptian fruit bat, Rousettus aegyptiacus, is currently regarded as a potential reservoir host for Marburg virus (MARV). However, the modes of transmission, the level of viral replication, tissue tropism and viral shedding pattern remains to be described. Captive-bred R. aegyptiacus, including adult males, females and pups were exposed to MARV by different inoculation routes. Blood, tissues, feces and urine from 9 bats inoculated by combination of nasal and oral routes were all negative for the virus and ELISA IgG antibody could not be demonstrated for up to 21 days post inoculation (p.i.). In 21 bats inoculated by a combination of intraperitoneal/subcutaneous route, viremia and the presence of MARV in different tissues was detected on days 2-9 p.i., and IgG antibody on days 9-21 p.i. In 3 bats inoculated subcutaneously, viremia was detected on days 5 and 8 (termination of experiment), with virus isolation from different organs. MARV could not be detected in urine, feces or oral swabs in any of the 3 experimental groups. However, it was detected in tissues which might contribute to horizontal or vertical transmission, e. g. lung, intestines, kidney, bladder, salivary glands, and female reproductive tract. Viremia lasting at least 5 days could also facilitate MARV mechanical transmission by blood sucking arthropods and infections of susceptible vertebrate hosts by direct contact with infected blood. All bats were clinically normal and no gross pathology was identified on post mortem examination. This work confirms the susceptibility of R. aegyptiacus to infection with MARV irrespective of sex and age and contributes to establishing a bat-filovirus experimental model. Further studies are required to uncover the mode of MARV transmission, and to investigate the putative role of R. aegyptiacus as a reservoir host.	[Paweska, Janusz T.; van Vuren, Petrus Jansen; Leman, Patricia A.; Grobbelaar, Antoinette A.; Birkhead, Monica; Kemp, Alan] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging & Zoonot Dis, Johannesburg, South Africa; [Paweska, Janusz T.] Univ Witwatersrand, Sch Pathol, Div Virol & Communicable Dis Surveillance, Johannesburg, South Africa; [Masumu, Justin] So African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Clift, Sarah; Swanepoel, Robert] Univ Pretoria, ZA-0002 Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Pretoria	Paweska, JT (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging & Zoonot Dis, Johannesburg, South Africa.	januszp@nicd.ac.za	Jansen van Vuren, Petrus/AAW-6963-2020; Clift, Sarah J/P-9497-2016	Jansen van Vuren, Petrus/0000-0003-2862-7983; Clift, Sarah J/0000-0003-1368-1215; /0000-0002-2051-467X	Wellcome Trust under African Institutions Initiative [WT087546MA]	Wellcome Trust under African Institutions Initiative(Wellcome Trust)	Justin Masumu is a Southern African Centre for Infectious Disease Surveillance postdoctoral research fellow at the University of Kinshasa and the National Institute for Biomedical Research, Kinshasa, who is supported by the Wellcome Trust grant WT087546MA under its African Institutions Initiative (http://www.wellcome.ac.uk/Funding/International/WTX055734.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASKERVILLE A, 1985, J PATHOL, V147, P199, DOI 10.1002/path.1711470308; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; BOWEN ETW, 1978, T ROY SOC TROP MED H, V72, P188, DOI 10.1016/0035-9203(78)90058-5; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Breman JG, 1999, J INFECT DIS, V179, pS139, DOI 10.1086/514278; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; CONRAD JL, 1978, AM J TROP MED HYG, V27, P1210, DOI 10.4269/ajtmh.1978.27.1210; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; ELLIS DS, 1978, J CLIN PATHOL, V31, P201, DOI 10.1136/jcp.31.3.201; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; FUKUNAGA Y, 1993, VET MICROBIOL, V36, P379, DOI 10.1016/0378-1135(93)90104-F; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Grard G, 2011, J INFECT DIS, V204, pS776, DOI 10.1093/infdis/jir364; Grolla A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001183; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; Johnson ED, 1999, ARCH VIROL, V11, P101; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; KUNZ C, 1968, ZBL BAKT PARASIT, V208, P347; Kuzmin IV, 2010, EMERG INFECT DIS, V16, P352, DOI 10.3201/eid1602.091269; Leirs H, 1999, J INFECT DIS, V179, pS155, DOI 10.1086/514299; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; MALHERBE H, 1968, LANCET, V1, P1434; MARTINI GA, 1973, POSTGRAD MED J, V49, P542, DOI 10.1136/pgmj.49.574.542; MARTINI GA, 1969, T ROY SOC TROP MED H, V63, P295, DOI 10.1016/0035-9203(69)90001-7; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; MURPHY FA, 1971, LAB INVEST, V24, P279; MUYEMBE T, 1995, LANCET, V345, P1448, DOI 10.1016/S0140-6736(95)92640-2; Olejnik J, 2011, VIRUSES-BASEL, V3, P1501, DOI 10.3390/v3081501; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Reiter P, 1999, J INFECT DIS, V179, pS148, DOI 10.1086/514304; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Ryabchikova E, 1996, ARCH VIROL, V141, P2177, DOI 10.1007/BF01718224; Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293; SMITH DH, 1982, LANCET, V1, P816; Steele KE, 2009, IMMUNOTHERAPY-UK, V1, P187, DOI 10.2217/1750743X.1.2.187; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090015, 10.3201/eid1508.090051]; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Turell MJ, 1996, AM J TROP MED HYG, V55, P89, DOI 10.4269/ajtmh.1996.55.89; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wulff H, 1977, HUMAN RELATED VIRU B, P3; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	60	55	57	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45479	10.1371/journal.pone.0045479	http://dx.doi.org/10.1371/journal.pone.0045479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23029039	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800063
J	Arora, G; Mezencev, R; McDonald, JF				Arora, Gaurav; Mezencev, Roman; McDonald, John F.			Human Cells Display Reduced Apoptotic Function Relative to Chimpanzee Cells	PLOS ONE			English	Article							MITOMYCIN-C; NONHUMAN; MITOCHONDRIAL; GENOME; TUMORS	Previously published gene expression analyses suggested that apoptotic function may be reduced in humans relative to chimpanzees and led to the hypothesis that this difference may contribute to the relatively larger size of the human brain and the increased propensity of humans to develop cancer. In this study, we sought to further test the hypothesis that humans maintain a reduced apoptotic function relative to chimpanzees by conducting a series of apoptotic function assays on human, chimpanzee and macaque primary fibroblastic cells. Human cells consistently displayed significantly reduced apoptotic function relative to the chimpanzee and macaque cells. These results are consistent with earlier findings indicating that apoptotic function is reduced in humans relative to chimpanzees.	[McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McDonald, JF (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu	Mezencev, Roman/O-8489-2019; Mezencev, Roman/A-8573-2009	Mezencev, Roman/0000-0003-4361-7628; McDonald, John F/0000-0002-4263-8155	Georgia Tech Foundation	Georgia Tech Foundation	This work was carried out with the financial support of the Georgia Tech Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora G, 2009, MED HYPOTHESES, V73, P453, DOI 10.1016/j.mehy.2009.03.035; BENIASHVILI DS, 1989, J MED PRIMATOL, V18, P423; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; de Sousa A., 2007, P291; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Goodman M, 1996, MOL PHYLOGENET EVOL, V5, P269, DOI 10.1006/mpev.1996.0021; Karaman MW, 2003, GENOME RES, V13, P1619, DOI 10.1101/gr.1289803; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; Mezencev R, 2011, J NAT MED-TOKYO, V65, P488, DOI 10.1007/s11418-011-0526-x; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Seong GJ, 2005, INVEST OPHTH VIS SCI, V46, P3545, DOI 10.1167/iovs.04-1358; SZYBALSKI W, 1964, FED PROC, V23, P946; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Vallender EJ, 2006, HUM MOL GENET, V15, P3034, DOI 10.1093/hmg/ddl245; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Waters DJ, 1998, PROSTATE, V36, P64; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	28	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46182	10.1371/journal.pone.0046182	http://dx.doi.org/10.1371/journal.pone.0046182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029431	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900104
J	Butler, JA; Mishur, RJ; Bokov, AF; Hakala, KW; Weintraub, ST; Rea, SL				Butler, Jeffrey A.; Mishur, Robert J.; Bokov, Alex F.; Hakala, Kevin W.; Weintraub, Susan T.; Rea, Shane L.			Profiling the Anaerobic Response of C. elegans Using GC-MS	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MASS SPECTROMETRY; METABOLISM; EXTRACTION; NEMATODE; YEAST; LIFE; KEGG; RHODOQUINONE; MITOCHONDRIA	The nematode Caenorhabditis elegans is a model organism that has seen extensive use over the last four decades in multiple areas of investigation. In this study we explore the response of the nematode Caenorhabditis elegans to acute anoxia using gas-chromatography mass-spectrometry (GC-MS). We focus on the readily-accessible worm exometabolome to show that C. elegans are mixed acid fermenters that utilize several metabolic pathways in unconventional ways to remove reducing equivalents - including partial reversal of branched-chain amino acid catabolism and a potentially novel use of the glyoxylate pathway. In doing so, we provide detailed methods for the collection and analysis of excreted metabolites that, with minimal adjustment, should be applicable to many other species. We also describe a procedure for collecting highly volatile compounds from C. elegans. We are distributing our mass spectral library in an effort to facilitate wider use of metabolomics.	[Butler, Jeffrey A.; Mishur, Robert J.; Bokov, Alex F.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Butler, Jeffrey A.; Mishur, Robert J.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Hakala, Kevin W.; Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	reas3@uthscsa.edu	Rea, Shane/F-4073-2014; Bokov, Alex/O-9952-2014	Bokov, Alex/0000-0002-0511-9815	National Institute on Aging; Ellison Medical Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation)	Financial support was provided by the National Institute on Aging and the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broeckling CD, 2006, ANAL CHEM, V78, P4334, DOI 10.1021/ac0521596; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; COOPER AF, 1971, J NEMATOL, V3, P205; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14; Geier FM, 2011, ANAL CHEM, V83, P3730, DOI 10.1021/ac2001109; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Li HL, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-49; MA YC, 1993, J BIOL CHEM, V268, P20360; Martin FPJ, 2011, J PROTEOME RES, V10, P990, DOI 10.1021/pr100703a; Mas S, 2007, BIOTECHNOL BIOENG, V96, P1014, DOI 10.1002/bit.21194; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Morrison DJ, 2004, RAPID COMMUN MASS SP, V18, P2593, DOI 10.1002/rcm.1662; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Paik MJ, 2008, BIOMED CHROMATOGR, V22, P450, DOI 10.1002/bmc.966; Paik MJ, 2004, J CHROMATOGR A, V1034, P13, DOI 10.1016/j.chroma.2004.02.032; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO J, 2012, R DEV CORE TEAM NLME; Pope GA, 2007, YEAST, V24, P667, DOI 10.1002/yea.1499; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Shepherd T, 2007, METABOLOMICS, V3, P475, DOI 10.1007/s11306-007-0058-2; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Takamiya S, 1999, ARCH BIOCHEM BIOPHYS, V371, P284, DOI 10.1006/abbi.1999.1465; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wylie T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-525; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	40	24	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46140	10.1371/journal.pone.0046140	http://dx.doi.org/10.1371/journal.pone.0046140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029411	gold, Green Published			2022-12-27	WOS:000309517500064
J	Crosby, K; Smith, DR				Crosby, Kate; Smith, David Roy			Does the Mode of Plastid Inheritance Influence Plastid Genome Architecture?	PLOS ONE			English	Article							MATERNAL INHERITANCE; CHLOROPLAST-DNA; PATERNAL INHERITANCE; CYTOPLASMIC INHERITANCE; CELL-CYCLE; NDH GENES; MITOCHONDRIAL; TRANSMISSION; EVOLUTION; ORGANELLAR	Plastid genomes show an impressive array of sizes and compactnesses, but the forces responsible for this variation are unknown. It has been argued that species with small effective genetic population sizes are less efficient at purging excess DNA from their genomes than those with large effective population sizes. If true, one may expect the primary mode of plastid inheritance to influence plastid DNA (ptDNA) architecture. All else being equal, biparentally inherited ptDNAs should have a two-fold greater effective population size than those that are uniparentally inherited, and thus should also be more compact. Here, we explore the relationship between plastid inheritance pattern and ptDNA architecture, and consider the role of phylogeny in shaping our observations. Contrary to our expectations, we found no significant difference in plastid genome size or compactness between ptDNAs that are biparentally inherited relative to those that are uniparentally inherited. However, we also found that there was significant phylogenetic signal for the trait of mode of plastid inheritance. We also found that paternally inherited ptDNAs are significantly smaller (n = 19, p = 0.000001) than those that are maternally, uniparentally (when isogamous), or biparentally inherited. Potential explanations for this observation are discussed.	[Crosby, Kate] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Smith, David Roy] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada	Dalhousie University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia	Crosby, K (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	crosbyk@dal.ca	Smith, David Roy/AAR-1529-2020; Smith, David/L-7910-2015	Smith, David Roy/0000-0001-9560-5210; Smith, David/0000-0001-9560-5210; Crosby, Kate/0000-0003-1860-8367	Natural Sciences and Engineering Research Council of Canada; Izaak Walton Killam Trusts	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Izaak Walton Killam Trusts	DRS is supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada and the Izaak Walton Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Amane M, 1999, THEOR APPL GENET, V99, P133, DOI 10.1007/s001220051217; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Azhagiri AK, 2007, PLANT J, V52, P817, DOI 10.1111/j.1365-313X.2007.03278.x; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Baur E., 1909, Z VEREBUNGSL, V1, P330, DOI DOI 10.1007/BF01990603; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BOBLENZ K, 1990, MOL GEN GENET, V220, P489, DOI 10.1007/BF00391760; Bogdanova VS, 2012, THEOR APPL GENET, V124, P1503, DOI 10.1007/s00122-012-1804-z; Bogdanova VS, 2009, THEOR APPL GENET, V118, P801, DOI 10.1007/s00122-008-0940-y; Bouzon Z, 2000, CRYPTOGAMIE ALGOL, V21; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; BRAWLEY SH, 1976, J CELL SCI, V20, P255; Carmichael JS, 1995, PLANT CELL, V7, P1975, DOI 10.1105/tpc.7.12.1975; Chen J, 2002, THEOR APPL GENET, V104, P1307, DOI 10.1007/s00122-002-0893-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CONDE MF, 1979, J HERED, V70, P2, DOI 10.1093/oxfordjournals.jhered.a109182; CORRIVEAU JL, 1990, CURR GENET, V17, P327, DOI 10.1007/BF00314880; CORRIVEAU JL, 1989, CURR GENET, V16, P47, DOI 10.1007/BF00411083; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Davis TM, 2010, ACTA HORTIC, V859, P221; DONG J, 1992, J HERED, V83, P419, DOI 10.1093/oxfordjournals.jhered.a111244; Drummond A., 2011, GENEIOUS V5 5; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferguson DJP, 2007, INT J PARASITOL, V37, P33, DOI 10.1016/j.ijpara.2006.10.003; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gregory TR, 2008, GENOME, V51, P309, DOI 10.1139/G08-003; Guo FL, 2005, PROTOPLASMA, V225, P5, DOI 10.1007/s00709-005-0088-4; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Havey MJ, 1998, THEOR APPL GENET, V97, P122, DOI 10.1007/s001220050875; Hu Z-M, 1995, ACTA BOT SIN, P1; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumari M, 2011, PLANT SCI, V180, P628, DOI 10.1016/j.plantsci.2011.01.003; KUROIWA T, 1986, PROTOPLASMA, V133, P85, DOI 10.1007/BF01293191; Latta RG, 1997, GENETICS, V146, P1153; LEE C. L., 1955, BOT GAZ, V117, P79, DOI 10.1086/335894; LEE RW, 1973, MOL GEN GENET, V121, P99, DOI 10.1007/BF00277524; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Lynch M, 2007, ORIGINS GENOME ARCHI; Martinez-Reyna JM, 2001, CROP SCI, V41, P1579, DOI 10.2135/cropsci2001.4151579x; Matsushima R, 2008, PLANT CELL PHYSIOL, V49, P81, DOI 10.1093/pcp/pcm170; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; MEJNARTOWICZ M, 1991, THEOR APPL GENET, V82, P477, DOI 10.1007/BF00588602; Miyamura S, 2010, J PLANT RES, V123, P171, DOI 10.1007/s10265-010-0309-6; MOGENSEN HL, 1988, P NATL ACAD SCI USA, V85, P2594, DOI 10.1073/pnas.85.8.2594; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; MOGENSEN HL, 1985, PROTOPLASMA, V128, P1, DOI 10.1007/BF01273229; Motomura T, 2010, J PLANT RES, V123, P185, DOI 10.1007/s10265-010-0313-x; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; Neale DB, 1986, PATERNAL INHERITANCE; Niwa K, 2010, J PHYCOL, V46, P693, DOI 10.1111/j.1529-8817.2010.00853.x; OHBA K, 1971, Silvae Genetica, V20, P101; Olson MS, 2000, P ROY SOC B-BIOL SCI, V267, P1801, DOI 10.1098/rspb.2000.1213; Orme D, 2011, CAPER PACKAGE COMP A; PACINI E, 1992, ANN BOT-LONDON, V70, P179, DOI 10.1093/oxfordjournals.aob.a088455; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Peters AF, 2004, EUR J PHYCOL, V39, P235, DOI 10.1080/09670260410001683241; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Renzaglia KS, 1999, INT J PLANT SCI, V160, P14, DOI 10.1086/314103; Renzaglia KS, 2002, NEW PHYTOL, V154, P159, DOI 10.1046/j.1469-8137.2002.00355.x; Renzaglia KS, 2001, AM J BOT, V88, P1151, DOI 10.2307/3558326; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; SCHMIT V, 1993, THEOR APPL GENET, V87, P506, DOI 10.1007/BF00215097; Suda S, 2004, PHYCOL RES, V52, P273, DOI 10.1111/j.1440-183.2004.00346.x; SUN GH, 1988, PROTOPLASMA, V144, P185, DOI 10.1007/BF01637252; SUTTON BCS, 1991, THEOR APPL GENET, V82, P242, DOI 10.1007/BF00226220; SZMIDT AE, 1987, PLANT MOL BIOL, V9, P59, DOI 10.1007/BF00017987; Van Droogenbroeck B, 2005, EUPHYTICA, V143, P161, DOI 10.1007/s10681-005-3156-0; Vivek BS, 1999, THEOR APPL GENET, V98, P669, DOI 10.1007/s001220051119; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080; Whittle CA, 2003, P NATL ACAD SCI USA, V100, P4055, DOI 10.1073/pnas.0730639100; Whittle CA, 2002, MOL BIOL EVOL, V19, P938, DOI 10.1093/oxfordjournals.molbev.a004151; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Wills DM, 2005, THEOR APPL GENET, V110, P941, DOI 10.1007/s00122-004-1914-3; Zanmin H, 1996, ACTA BOT SIN, V38; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170; Zhong ZR, 2011, MOL GENET GENOMICS, V286, P411, DOI 10.1007/s00438-011-0653-9; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	93	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46260	10.1371/journal.pone.0046260	http://dx.doi.org/10.1371/journal.pone.0046260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029453	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500078
J	Huang, KT; Pavlides, SC; Lecanda, J; Blank, SV; Mittal, KR; Gold, LI				Huang, Kuang-Tzu; Pavlides, Savvas C.; Lecanda, Jon; Blank, Stephanie V.; Mittal, Khushbakhat R.; Gold, Leslie I.			Estrogen and Progesterone Regulate p27kip1 Levels via the Ubiquitin-Proteasome System: Pathogenic and Therapeutic Implications for Endometrial Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DEPENDENT KINASE INHIBITOR; CELL-CYCLE ARREST; SUBCELLULAR-LOCALIZATION; RECEPTOR-ALPHA; IN-VIVO; P27(KIP1); PHOSPHORYLATION; LIGASE; SKP2	The levels of proteins that control the cell cycle are regulated by ubiquitin-mediated degradation via the ubiquitin-proteasome system (UPS) by substrate-specific E3 ubiquitin ligases. The cyclin-dependent kinase inhibitor, p27kip1 (p27), that blocks the cell cycle in G1, is ubiquitylated by the E3 ligase SCF-Skp2/Cks1 for degradation by the UPS. In turn, Skp2 and Cks1 are ubiquitylated by the E3 ligase complex APC/Cdh1 for destruction thereby maintaining abundant levels of nuclear p27. We previously showed that perpetual proteasomal degradation of p27 is an early event in Type I endometrial carcinogenesis (ECA), an estrogen (E2)-induced cancer. The present studies demonstrate that E2 stimulates growth of ECA cell lines and normal primary endometrial epithelial cells (EECs) and induces MAPK-ERK1/2-dependent phosphorylation of p27 on Thr187, a prerequisite for p27 ubiquitylation by nuclear SCF-Skp2/Cks1 and subsequent degradation. In addition, E2 decreases the E3 ligase [APC]Cdh1 leaving Skp2 and Cks1 intact to cause p27 degradation. Furthermore, knocking-down Skp2 prevents E2-induced p27 degradation and growth stimulation suggesting that the pathogenesis of E2-induced ECA is dependent on Skp2-mediated degradation of p27. Conversely, progesterone (Pg) as an inhibitor of endometrial proliferation increases nuclear p27 and Cdh1 in primary EECs and ECA cells. Pg, also increases Cdh1 binding to APC to form the active E3ligase. Knocking-down Cdh1 obviates Pg-induced stabilization of p27 and growth inhibition. Notably, neither E2 nor Pg affected transcription of Cdh1, Skp2, Cks1 nor p27. These studies provide new insights into hormone regulation of cell proliferation through the UPS. The data implicates that preventing nuclear p27 degradation by blocking Skp2/Cks1-mediated degradation of p27 or increasing Cdh1 to mediate degradation of Skp2-Cks1 are potential strategies for the prevention and treatment of ECA.	[Huang, Kuang-Tzu; Pavlides, Savvas C.; Lecanda, Jon; Gold, Leslie I.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Mittal, Khushbakhat R.; Gold, Leslie I.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Blank, Stephanie V.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Blank, Stephanie V.; Mittal, Khushbakhat R.; Gold, Leslie I.] NYU, Inst Canc, New York, NY USA	New York University; New York University; New York University; New York University	Gold, LI (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	leslie.gold@nyumc.org			National Institutes of Health, National Cancer Institute [R01 CA 89175]; New York University (NYU) Cancer Institute Pilot Project Grant; NATIONAL CANCER INSTITUTE [R01CA089175] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York University (NYU) Cancer Institute Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, R01 CA 89175 www.nih.gov (to LIG); and a New York University (NYU) Cancer Institute Pilot Project Grant (to LIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit A, 2011, OBSTET GYN CLIN N AM, V38, P1, DOI 10.1016/j.ogc.2011.02.001; An HJ, 2002, HISTOPATHOLOGY, V41, P437, DOI 10.1046/j.1365-2559.2002.01455.x; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; BRUNER KL, 1995, P NATL ACAD SCI USA, V92, P7362, DOI 10.1073/pnas.92.16.7362; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; Dellas A, 2009, CLIN CANCER RES, V15, P2456, DOI 10.1158/1078-0432.CCR-08-1732; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Fujita T, 2009, INT J CANCER, V125, P826, DOI 10.1002/ijc.24399; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hershko D, 2001, CANCER, V91, P1745, DOI 10.1002/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Koos RD, 2011, ENDOCRINOLOGY, V152, P4481, DOI 10.1210/en.2011-1449; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lacey JV, 2009, MATURITAS, V63, P39, DOI 10.1016/j.maturitas.2009.02.005; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Lecanda J, 2007, CANCER RES, V67, P1007, DOI 10.1158/0008-5472.CAN-06-0235; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; Li M, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-2; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Miyamoto T, 2010, GYNECOL ENDOCRINOL, V26, P220, DOI [10.1080/09513590903215482, 10.3109/09513590903215482]; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nigg EA, 1993, CURR OPIN CELL BIOL, V5, P187, DOI 10.1016/0955-0674(93)90101-U; Nycum LR, 2001, GYNECOL ONCOL, V81, P242, DOI 10.1006/gyno.2001.6144; Parekh TV, 2002, CANCER RES, V62, P2778; Park H, 2011, ARCH GYNECOL OBSTET; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Tang L, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-144; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Watanabe J, 2006, INT J GYNECOL CANCER, V16, P452, DOI 10.1111/j.1525-1438.2006.00418.x; Yu M, 2009, FERTIL STERIL, V92, P2122, DOI 10.1016/j.fertnstert.2009.06.013; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhou W, 2012, P AM ASS CANC RES, V103	61	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46072	10.1371/journal.pone.0046072	http://dx.doi.org/10.1371/journal.pone.0046072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029392	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500060
J	Song, ZJ; Song, YL; Yin, J; Shen, Y; Yao, CL; Sun, Z; Jiang, JJ; Zhu, DM; Zhang, Y; Shen, QJ; Gao, L; Tong, CY; Bai, CX				Song, Zhenju; Song, Yuanlin; Yin, Jun; Shen, Yao; Yao, Chenling; Sun, Zhan; Jiang, Jinjun; Zhu, Duming; Zhang, Yong; Shen, Qinjun; Gao, Lei; Tong, Chaoyang; Bai, Chunxue			Genetic Variation in the TNF Gene Is Associated with Susceptibility to Severe Sepsis, but Not with Mortality	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; TRAUMA PATIENTS; ALPHA; POLYMORPHISMS; RISK; MULTICENTER; LYMPHOTOXIN; INFECTION; HAPLOTYPE	Background: Tumor necrosis factor (TNF) and TNF receptor superfamily (TNFR)-mediated immune response play an essential role in the pathogenesis of severe sepsis. Studies examining associations of TNF and lymphotoxin-alpha (LTA) single nucleotide polymorphisms (SNPs) with severe sepsis have produced conflicting results. The objective of this study was to investigate whether genetic variation in TNF, LTA, TNFRSF1A and TNFRSF1B was associated with susceptibility to or death from severe sepsis in Chinese Han population. Methodology/Principal Findings: Ten SNPs in TNF, LTA, TNFRSF1A and TNFRSF1B were genotyped in samples of patients with severe sepsis (n = 432), sepsis (n = 384) and healthy controls (n = 624). Our results showed that rs1800629, a SNP in the promoter region of TNF, was significantly associated with risk for severe sepsis. The minor allele frequency of rs1800629 was significantly higher in severe sepsis patients than that in both healthy controls (P-adj = 0.00046, odds ratio (OR)(adj) = 1.92) and sepsis patients (P-adj = 0.002, ORadj = 1.56). Further, we investigated the correlation between rs1800629 genotypes and TNF-alpha concentrations in peripheral blood mononuclear cells (PBMCs) of healthy volunteers exposed to lipopolysaccharides (LPS) ex vivo, and the association between rs1800629 and TNF-alpha serum levels in severe sepsis patients. After exposure to LPS, the TNF-alpha concentration in culture supernatants of PBMCs was significantly higher in the subjects with AA+AG genotypes than that with GG genotype (P = 0.007). Moreover, in patients with severe sepsis, individuals with AA+AG genotypes had significantly higher TNF-alpha serum concentrations than those with GG genotype (P-adj = 0.02). However, there were no significant associations between SNPs in the four candidate genes and 30 day mortality for patients with severe sepsis. Conclusions/Significance: Our findings suggested that the functional TNF gene SNP rs1800629 was strongly associated with susceptibility to severe sepsis, but not with lethality in Chinese Han population.	[Song, Zhenju; Yin, Jun; Yao, Chenling; Sun, Zhan; Tong, Chaoyang] Fudan Univ, Zhongshan Hosp, Dept Emergency Med, Shanghai 200433, Peoples R China; [Song, Yuanlin; Shen, Yao; Jiang, Jinjun; Zhang, Yong; Shen, Qinjun; Gao, Lei; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Zhu, Duming] Fudan Univ, Zhongshan Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Tong, CY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Emergency Med, Shanghai 200433, Peoples R China.	tong.chaoyang@zs-hospital.sh.cn; bai.chunxue@zs-hospital.sh.cn	HASAN, AURANGZEB/B-8270-2010; Rasheed, Lubna/S-1841-2019	Rasheed, Lubna/0000-0002-5378-8079; Bai, Chunxue/0000-0001-5798-3130	National Natural Science Foundation of China [30930090, 81000023, 81171837]; Shanghai Committee of Science and Technology [09411960400]; Shanghai Public Health Fund for Distinguished Young Scholars [08GWQ026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Public Health Fund for Distinguished Young Scholars	This work was supported by grants from the Major Program of the National Natural Science Foundation of China (30930090), the National Natural Science Foundation of China (81000023 and 81171837), the Shanghai Committee of Science and Technology (09411960400) and the Shanghai Public Health Fund for Distinguished Young Scholars (08GWQ026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, CRIT CARE MED, V20, P864; Appoloni O, 2001, AM J MED, V110, P486, DOI 10.1016/S0002-9343(01)00656-8; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Calvano Jacqueline E, 2003, Surg Infect (Larchmt), V4, P163, DOI 10.1089/109629603766956951; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Constantin A, 2004, ARTHRITIS RHEUM-US, V50, P742, DOI 10.1002/art.20113; Dahmer Mary K, 2005, Pediatr Crit Care Med, V6, pS61, DOI 10.1097/01.PCC.0000161970.44470.C7; DEBETS JMH, 1989, CRIT CARE MED, V17, P489, DOI 10.1097/00003246-198906000-00001; Douni E, 1998, J EXP MED, V188, P1343, DOI 10.1084/jem.188.7.1343; Duan ZX, 2011, J TRAUMA, V70, P954, DOI 10.1097/TA.0b013e3181e88adf; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Garnacho-Montero J, 2006, CRIT CARE, V10, DOI 10.1186/cc4995; Gordon AC, 2004, GENES IMMUN, V5, P631, DOI 10.1038/sj.gene.6364136; Hamann L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-65; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; Horiuchi T, 2009, RHEUMATOLOGY, V48, P1045, DOI 10.1093/rheumatology/kep166; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Majetschak M, 1999, ANN SURG, V230, P207, DOI 10.1097/00000658-199908000-00011; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menges T, 2008, CRIT CARE MED, V36, P1456, DOI 10.1097/CCM.0B013E318170ABB6; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Moller M, 2010, AM J RESP CRIT CARE, V181, P388, DOI 10.1164/rccm.200905-0678OC; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reid CL, 2002, CRIT CARE MED, V30, P2216, DOI 10.1097/00003246-200210000-00007; Secher T, 2009, J IMMUNOL, V182, P7855, DOI 10.4049/jimmunol.0804008; Song Z, CRIT CARE, V15, pR12; Song ZhenJu, 2009, Chinese Journal of Emergency Medicine, V18, P956; Stuber F, 1995, J Inflamm, V46, P42; Tang GJ, 2000, CRIT CARE MED, V28, P2733, DOI 10.1097/00003246-200008000-00008; Teuffel O, 2010, CRIT CARE MED, V38, P276, DOI 10.1097/CCM.0b013e3181b42af0; Tiancha Huang, 2011, Scand J Infect Dis, V43, P436, DOI 10.3109/00365548.2011.562528; Toubiana J, 2010, CRIT CARE MED, V38, P2287, DOI 10.1097/CCM.0b013e3181f9f9c7; Wang SX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-27; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Zheng X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017987	44	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46113	10.1371/journal.pone.0046113	http://dx.doi.org/10.1371/journal.pone.0046113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029405	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500062
J	Zhao, JX; Zhao, JC; Perlman, S				Zhao, Jingxian; Zhao, Jincun; Perlman, Stanley			Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-gamma, IL-2 and IL-2R	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; IN-VIVO; DENDRITIC CELLS; TH1 DIFFERENTIATION; REGULATORY CELLS; FOXP3 EXPRESSION; INTERLEUKIN-2; RESPONSES; INFECTION	Complex interactions between effector T cells and Foxp3(+) regulatory T cells (Treg) contribute to clinical outcomes in cancer, and autoimmune and infectious diseases. Previous work showed that IL-12 reversed Treg-mediated suppression of CD4(+) Foxp3(-) T cell (Tconv) proliferation. We and others have also shown that Tregs express T-bet and IFN-gamma at sites of Th1 inflammation and that IL-12 induces IFN-gamma production by Tregs in vitro. To investigate whether loss of immunosuppression occurs when IFN-gamma is expressed by Tregs we treated mouse lymphocyte cultures with IL-12. IFN-gamma expression did not decrease the ability of Tregs to suppress Tconv proliferation. Rather, IL-12 treatment decreased Treg frequency and Foxp3 levels in Tregs. We further showed that IL-12 increased IL-2R expression on Tconv and CD8 T cells, diminished its expression on Tregs and decreased IL-2 production by Tconv and CD8 T cells. Together, these IL-12 mediated changes favored the outgrowth of non-Tregs. Additionally, we showed that treatment with a second cytokine, IL-27, decreased IL-2 expression without augmenting Tconv and CD8 T cell proliferation. Notably, IL-27 only slightly modified levels of IL-2R on non-Treg T cells. Together, these results show that IL-12 has multiple effects that modify the balance between Tregs and non-Tregs and support an important role for relative levels of IL-2R but not for IFN-gamma expression in IL-12-mediated reversal of Treg immunosuppression.	[Zhao, Jingxian; Zhao, Jincun; Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Zhao, Jingxian] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China	University of Iowa; Jinan University	Perlman, S (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	Stanley-Perlman@uiowa.edu	Zhao, Jincun/ABD-8679-2021	Zhao, Jincun/0000-0003-2515-5589; Perlman, Stanley/0000-0003-4213-2354	N.I.H. [RO1 NS36592]; National Multiple Sclerosis Society [RG 2864]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036592] Funding Source: NIH RePORTER	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the N.I.H. (RO1 NS36592) and the National Multiple Sclerosis Society (RG 2864, http://www.nationalmssociety.org/research/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Feng T, 2011, GASTROENTEROLOGY, V140, P2031, DOI 10.1053/j.gastro.2011.03.009; FLEMING JO, 1986, J VIROL, V58, P869, DOI 10.1128/JVI.58.3.869-875.1986; Kapil P, 2009, J VIROL, V83, P5978, DOI 10.1128/JVI.00315-09; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lazarski CA, 2008, IMMUNITY, V29, P511, DOI 10.1016/j.immuni.2008.09.012; Lemoine FM, 2009, INT J ONCOL, V35, P569, DOI 10.3892/ijo_00000368; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mach N, 2000, CANCER RES, V60, P3239; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Xing Z, 2001, CELL MOL BIOL, V47, P689; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	50	60	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46241	10.1371/journal.pone.0046241	http://dx.doi.org/10.1371/journal.pone.0046241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029447	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500075
J	Entling, MH; Schweiger, O; Bacher, S; Espadaler, X; Hickler, T; Kumschick, S; Woodcock, BA; Nentwig, W				Entling, Martin H.; Schweiger, Oliver; Bacher, Sven; Espadaler, Xavier; Hickler, Thomas; Kumschick, Sabrina; Woodcock, Ben A.; Nentwig, Wolfgang			Species Richness-Environment Relationships of European Arthropods at Two Spatial Grains: Habitats and Countries	PLOS ONE			English	Article							WOODY PLANT RICHNESS; METABOLIC THEORY; VEGETATION DYNAMICS; GLOBAL-MODELS; CLIMATE; DIVERSITY; SCALE; BIODIVERSITY; GRADIENTS; PATTERNS	We study how species richness of arthropods relates to theories concerning net primary productivity, ambient energy, water-energy dynamics and spatial environmental heterogeneity. We use two datasets of arthropod richness with similar spatial extents (Scandinavia to Mediterranean), but contrasting spatial grain (local habitat and country). Samples of ground-dwelling spiders, beetles, bugs and ants were collected from 32 paired habitats at 16 locations across Europe. Species richness of these taxonomic groups was also determined for 25 European countries based on the Fauna Europaea database. We tested effects of net primary productivity (NPP), annual mean temperature (T), annual rainfall (R) and potential evapotranspiration of the coldest month (PETmin) on species richness and turnover. Spatial environmental heterogeneity within countries was considered by including the ranges of NPP, T, R and PETmin. At the local habitat grain, relationships between species richness and environmental variables differed strongly between taxa and trophic groups. However, species turnover across locations was strongly correlated with differences in T. At the country grain, species richness was significantly correlated with environmental variables from all four theories. In particular, species richness within countries increased strongly with spatial heterogeneity in T. The importance of spatial heterogeneity in T for both species turnover across locations and for species richness within countries suggests that the temperature niche is an important determinant of arthropod diversity. We suggest that, unless climatic heterogeneity is constant across sampling units, coarse-grained studies should always account for environmental heterogeneity as a predictor of arthropod species richness, just as studies with variable area of sampling units routinely consider area.	[Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany; [Entling, Martin H.; Bacher, Sven; Kumschick, Sabrina; Nentwig, Wolfgang] Univ Bern, Bern, Switzerland; [Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Bacher, Sven] Univ Fribourg, Ecol & Evolut Unit, CH-1700 Fribourg, Switzerland; [Espadaler, Xavier] Autonomous Univ Barcelona, Anim Biodivers Grp, Ecol Unit, Bellaterra, Spain; [Espadaler, Xavier] Autonomous Univ Barcelona, CREAF, Bellaterra, Spain; [Hickler, Thomas] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Dept Phys Geog, Frankfurt, Germany; [Kumschick, Sabrina] Univ Stellenbosch, Ctr Excellence Invas Biol, Dept Bot & Zool, Matieland, South Africa; [Woodcock, Ben A.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England	University of Koblenz & Landau; University of Bern; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Fribourg; Autonomous University of Barcelona; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Stellenbosch University; UK Centre for Ecology & Hydrology (UKCEH)	Entling, MH (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany.	entling@uni-landau.de	Espadaler, Xavier/F-1898-2011; Entling, Martin H/C-6953-2008; Hickler, Thomas/S-6287-2016; Bacher, Sven/F-5431-2010; Nentwig, Wolfgang/A-6624-2011; Woodcock, Ben/F-9199-2010; Schweiger, Oliver/B-4909-2008	Espadaler, Xavier/0000-0002-7681-5957; Hickler, Thomas/0000-0002-4668-7552; Bacher, Sven/0000-0001-5147-7165; Woodcock, Ben/0000-0003-0300-9951; Schweiger, Oliver/0000-0001-8779-2335; Kumschick, Sabrina/0000-0001-8034-5831	EC FP6 ALARM Project [GOCE-CT-2003-506675]; FP7 SCALES Project [226 852]; MEC-FEDER [CGL2007-64080-C02-01]; Natural Environment Research Council [CEH010021] Funding Source: researchfish	EC FP6 ALARM Project(European Commission); FP7 SCALES Project; MEC-FEDER(Spanish GovernmentEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The sampling and the research of SB, TH, SK, WN and OS were supported by the EC FP6 ALARM Project (GOCE-CT-2003-506675) and the FP7 SCALES Project (grant 226 852). XE was supported by MEC-FEDER CGL2007-64080-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2004, 55 TYND CTR CLIM CHA; [Anonymous], 2010, R LANG ENV STAT COMP; Begon M., 2009, ECOLOGY INDIVIDUALS; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Cassemiro FAS, 2010, ECOLOGY, V91, P3729, DOI 10.1890/09-1434.1; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Ellenberg H, 2010, VETETATION MITTELEUR; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Entling W, 2010, J BIOGEOGR, V37, P477, DOI 10.1111/j.1365-2699.2009.02216.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Eyre MD, 2005, J BIOGEOGR, V32, P973, DOI 10.1111/j.1365-2699.2005.01258.x; Fauna Europaea Web Service, 2004, FAUN EUR VERS 1 1; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Hammen VC, 2010, ENVIRON MONIT ASSESS, V164, P337, DOI 10.1007/s10661-009-0896-7; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hawkins BA, 2007, ECOLOGY, V88, P255, DOI 10.1890/0012-9658(2007)88[255:GMFPWP]2.0.CO;2; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344; Hickler T, 2006, GLOBAL ECOL BIOGEOGR, V15, P567, DOI 10.1111/j.1466-8238.2006.00254.x; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hickler T, 2009, GLOBAL ECOL BIOGEOGR, V18, P304, DOI 10.1111/j.1466-8238.2009.00455.x; Hill MO, 2000, J APPL ECOL, V37, P3, DOI 10.1046/j.1365-2664.2000.00466.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaspari M, 2004, ECOLOGY, V85, P1800, DOI 10.1890/03-0682; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Koleff P, 2002, GLOBAL ECOL BIOGEOGR, V11, P363, DOI 10.1046/j.1466-822x.2002.00302.x; Kumschick S, 2009, ECOL ENTOMOL, V34, P748, DOI 10.1111/j.1365-2311.2009.01127.x; Lavers C, 2006, GLOBAL ECOL BIOGEOGR, V15, P213, DOI 10.1111/j.1466-822x.2006.00229.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenzweig Michael L., 1993, P52; Rotzer T, 2001, CLIM RES, V18, P249, DOI 10.3354/cr018249; Schoener T.W., 1989, P79; Schuldt A, 2010, BIOL CONSERV, V143, P2747, DOI 10.1016/j.biocon.2010.07.022; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Smith B, 2008, FOREST ECOL MANAG, V255, P3985, DOI 10.1016/j.foreco.2008.03.056; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3; [No title captured]	66	9	9	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45875	10.1371/journal.pone.0045875	http://dx.doi.org/10.1371/journal.pone.0045875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029288	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000309554700081
J	Kim, JH; Shim, KW; Yoon, YS; Lee, SY; Kim, SS; Oh, SW				Kim, Jung Hwan; Shim, Kyung Won; Yoon, Yeong Sook; Lee, Sang Yeoup; Kim, Sung Soo; Oh, Sang Woo			Cigarette Smoking Increases Abdominal and Visceral Obesity but Not Overall Fatness: An Observational Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREA NATIONAL-HEALTH; BODY-FAT DISTRIBUTION; METABOLIC SYNDROME; WEIGHT-GAIN; WOMEN; MEN; MASS; CONSUMPTION; CESSATION	Background: Cigarette smoking and obesity are leading public health concerns. Both increase the risk for cardiovascular disease, cancer, and metabolic abnormalities. This study was conducted to assess the association between cigarette smoking and different types of obesity. Methodology/Principal Findings: Two hundred eighty-three visitors to university hospitals located in four main provinces of South Korea were participated. All participants were classified as either current/past or never smokers and were divided into quartiles according to the total pack-years. Body mass index, waist circumference, total body fat percentage, and area of visceral and abdominal subcutaneous fat were measured. These results of each groups were compared. Waist circumference, and visceral fat area showed a J- or U-shaped association with total smoking amount during a lifetime. After restricting the analyses to past/current smokers, we found significant dose-dependent associations of smoking pack-years with abdominal and visceral obesity. Overall obesity measured by body mass index and total body fat percentage did not show such associations. Although current smokers clearly showed significant associations, we could not demonstrate these in past smokers, possibly because of the limited sample size. Conclusions/Significance: Although smokers did not show significant difference in mean body mass index than those who never smoked, they showed more metabolically adverse fat distributions with increasing smoking amounts. This finding suggests that smoking is not beneficial for weight control. Therefore, smoking cessation and avoidance of smoking commencement should be addressed as important public health issues in preventing obesity and related complications.	[Oh, Sang Woo] Dongguk Univ, Dept Family Med, Ctr Obes Metab & Clin Nutr, Int Hosp, Gyeonggi Do, South Korea; [Kim, Jung Hwan] Eulji Univ, Dept Family Med, Seoul Eulji Hosp, Seoul, South Korea; [Shim, Kyung Won] Ewha Womans Univ, Dept Family Med, Mokdong Hosp, Seoul, South Korea; [Yoon, Yeong Sook] Inje Univ, Dept Family Med, Ctr Hlth Promot, Ilsan Paik Hosp,Coll Med, Gyeonggi Do, South Korea; [Yoon, Yeong Sook] Inje Univ, Clin Res Ctr, Ilsan Paik Hosp, Coll Med, Gyeonggi Do, South Korea; [Lee, Sang Yeoup] Pusan Natl Univ, Dept Family Med, Coll Med, Pusan, South Korea; [Kim, Sung Soo] Chungnam Natl Univ Hosp, Dept Family Med, Taejon, South Korea	Dongguk University; Eulji University; Ewha Womans University; Inje University; Inje University; Pusan National University; Chungnam National University; Chungnam National University Hospital	Oh, SW (corresponding author), Dongguk Univ, Dept Family Med, Ctr Obes Metab & Clin Nutr, Int Hosp, Gyeonggi Do, South Korea.	osw6021@yahoo.co.kr	Lee, Sang Yeoup/AAV-2125-2020	Yoon, Yeong Sook/0000-0002-9249-2940; Lee, Sang Yeoup/0000-0002-3585-9910; Kim, JungHwan/0000-0001-8984-2914; Oh, Sang Woo/0000-0002-5623-6720	Korean Society for the Study of Obesity (KOSSO)	Korean Society for the Study of Obesity (KOSSO)	SWO was awarded a research grant named "MunSeok fund" by Korean Society for the Study of Obesity (KOSSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Bray G A, 1993, Obes Res, V1, P203; Calole C, 2011, BMC PUBLIC HEALTH, V11, P23; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Froom P, 1998, J FAM PRACTICE, V46, P460; Goldman J, 2001, Med Sci Monit, V7, P1280; Hideaki K, 2006, J EXP MED, V280, P123; Jee SH, 2002, OBES RES, V10, P891, DOI 10.1038/oby.2002.122; KHAW KT, 1988, NEW ENGL J MED, V318, P1705, DOI 10.1056/NEJM198806303182601; KOTANI K, 1994, INT J OBESITY, V18, P207; KVIST H, 1986, INT J OBESITY, V10, P53; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Okura T, 2005, INT J OBESITY, V29, P1259, DOI 10.1038/sj.ijo.0803013; Onat A, 2009, METABOLISM, V58, P963, DOI 10.1016/j.metabol.2009.02.029; Organization WH, 2000, ASIA PACIFIC PERSPEC; Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x; Pomerleau C S, 2001, Nicotine Tob Res, V3, P51, DOI 10.1080/14622200020032105; Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; SEIDELL JC, 1991, AM J EPIDEMIOL, V133, P257, DOI 10.1093/oxfordjournals.aje.a115870; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; STAMFORD BA, 1986, AM J CLIN NUTR, V43, P486, DOI 10.1093/ajcn/43.4.486; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Yumi M, 2011, OBESITY, V19, P647	28	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45815	10.1371/journal.pone.0045815	http://dx.doi.org/10.1371/journal.pone.0045815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029258	Green Published, gold			2022-12-27	WOS:000309554700075
J	Wu, N; Sulpice, E; Obeid, P; Benzina, S; Kermarrec, F; Combe, S; Gidrol, X				Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier			The miR-17 Family Links p63 Protein to MAPK Signaling to Promote the Onset of Human Keratinocyte Differentiation	PLOS ONE			English	Article							C-JUN; EPIDERMAL MORPHOGENESIS; MESSENGER-RNA; STEM-CELLS; SKIN; PROLIFERATION; EXPRESSION; MICRORNAS; REPRESSION; MIRNAS	The p63 protein plays a key role in regulating human keratinocyte proliferation and differentiation. Although some p63-regulating microRNAs (miRNAs) have been identified in the control of epidermal homeostasis, little is known about miRNAs acting downstream of p63. In this paper, we characterized multiple p63-regulated miRNAs (miR-17, miR-20b, miR-30a, miR-06a, miR-143 and miR-455-3p) and elucidated their roles in the onset of keratinocyte differentiation. We identified RB, p21 and multiple MAPKs as targets of these p63-controlled miRNAs. Upon inhibition of most of these miRNAs, we observed defects in commitment to differentiation that could be reversed by siRNA-mediated silencing of their targets. Furthermore, knockdown of MAPK8 and MAPK9 efficiently restored expression of the early differentiation markers keratin 1 and keratin 10 in p63-silenced primary human keratinocytes. These results highlight new mechanistic roles of multiple miRNAs, particularly the miR-17 family (miR-17, miR-20b and miR-106a), as regulatory intermediates for coordinating p63 with MAPK signaling in the commitment of human mature keratinocytes to early differentiation.	[Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] CEA, Lab Biol Grande Echelle, Grenoble, France; [Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] INSERM, U1038, Grenoble, France; [Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] Univ Grenoble 1, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gidrol, X (corresponding author), CEA, Lab Biol Grande Echelle, Grenoble, France.	xavier.gidrol@cea.fr		OBEID, Patricia/0000-0003-3144-0001; Gidrol, Xavier/0000-0002-4233-3749; Sulpice, Eric/0000-0001-7695-0561	CEA; FRM	CEA(French Atomic Energy Commission); FRM(Fondation pour la Recherche Medicale)	Funding provided by CEA (http://dirgre.cea.fr:8000/scripts/home/index.asp) and FRM (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2008, TRENDS BIOCHEM SCI, V33, P583, DOI 10.1016/j.tibs.2008.09.002; Alameda JP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.82; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antonini D, 2010, J INVEST DERMATOL, V130, P1249, DOI 10.1038/jid.2009.438; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hara T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.40; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MANNI I, 2009, FASEB J; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Scheel AHJ, 2009, CELL CYCLE, V8, P1426, DOI 10.4161/cc.8.9.8324; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	49	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45761	10.1371/journal.pone.0045761	http://dx.doi.org/10.1371/journal.pone.0045761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029228	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700066
J	Bro-Jorgensen, J				Bro-Jorgensen, Jakob			Longevity in Bovids Is Promoted by Sociality, But Reduced by Sexual Selection	PLOS ONE			English	Article							NATURAL-POPULATIONS; BODY-SIZE; RED DEER; SENESCENCE; EVOLUTION; DIMORPHISM; COSTS; AGE	Selection on intrinsic lifespan depends on both external factors affecting mortality and inherent tradeoffs in resource allocation between viability traits and other fitness-related traits. Longevity is therefore likely to vary between species in a sex-specific manner due to interspecific and intersexual differences in behavioural ecology. Here I focus on the bovid family to test two central hypotheses on longevity selection using the comparative method: firstly, that a reduction of extrinsic mortality in social species strengthens selection on intrinsic lifespan, and secondly, that mortality costs associated with intense sexual selection lead to shorter intrinsic lifespan. The results show that longevity (i) increases with sociality in both sexes and (ii) decreases with male-biased sexual size-dimorphism, but in males only. These discoveries suggest that sociality, a key ungulate strategy to reduce predation-related mortality, selects for inherently longer-lived organisms, and that strong sexual selection, which is known to compromise survival rates in the wild, can constrain also intrinsic lifespan. The contrasting results for males and females indicate that selection on longevity in the two sexes is partly uncoupled.	Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Dept Evolut Ecol & Behav,Mammalian Behav & Evolut, Liverpool L69 3BX, Neston, England	University of Liverpool	Bro-Jorgensen, J (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Dept Evolut Ecol & Behav,Mammalian Behav & Evolut, Liverpool L69 3BX, Neston, England.	bro@liv.ac.uk						[Anonymous], 2000, LONGEVITY RECORDS LI; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Bro-Jorgensen J, 2008, OIKOS, V117, P729, DOI 10.1111/j.0030-1299.2008.16069.x; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; Carranza J, 2007, AM NAT, V170, P370, DOI 10.1086/519852; Darwin C., 1874, DESCENT MAN SELECTIO; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harvey P.H., 1991, COMP METHOD EVOLUTIO; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jones M.L., 1982, Zoologische Garten, V53, P113; Jones Marvin L., 1993, International Zoo Yearbook, V32, P159; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; McClave J., 2003, STATISTICS; MEAD J I, 1989, Mammalian Species, P1, DOI 10.2307/3504167; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; Orme, 2011, CAPER COMP ANAL PHYL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; Polak J, 2009, BIOL J LINN SOC, V98, P872, DOI 10.1111/j.1095-8312.2009.01294.x; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Core Team, 2016, R FDN STAT COMP; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Shultz S, 2006, P ROY SOC B-BIOL SCI, V273, P207, DOI 10.1098/rspb.2005.3283; Stearns S.C., 1992, pi; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Weigl R., 2005, KL SENCKENBERG-REIHE; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008	43	12	14	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45769	10.1371/journal.pone.0045769	http://dx.doi.org/10.1371/journal.pone.0045769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029234	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800095
J	Kaushal, N; Ramesh, V; Gozal, D				Kaushal, Navita; Ramesh, Vijay; Gozal, David			TNF-alpha and Temporal Changes in Sleep Architecture in Mice Exposed to Sleep Fragmentation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; IMMUNE-RESPONSES; PLASMA-LEVELS; WAVE ACTIVITY; REM-SLEEP; DEPRIVATION; CYTOKINES; EEG; INTERLEUKIN-1	TNF-alpha plays critical roles in host-defense, sleep-wake regulation, and the pathogenesis of various disorders. Increases in the concentration of circulating TNF-alpha after either sleep deprivation or sleep fragmentation (SF) appear to underlie excessive daytime sleepiness in patients with sleep apnea (OSA). Following baseline recordings, mice were subjected to 15 days of SF (daily for 12 h/day from 07.00 h to 19.00 h), and sleep parameters were recorded on days1, 7 and 15. Sleep architecture and sleep propensity were assessed in both C57BL/6J and in TNF-alpha double receptor KO mice (TNFR KO). To further confirm the role of TNF-alpha, we also assessed the effect of treatment with a TNF-alpha neutralizing antibody in C57BL/6J mice. SF was not associated with major changes in global sleep architecture in C57BL/6J and TNFR KO mice. TNFR KO mice showed higher baseline SWS delta power. Further, following 15 days of SF, mice injected with TNF-alpha neutralizing antibody and TNFR KO mice showed increased EEG SWS activity. However, SWS latency, indicative of increased propensity to sleep, was only decreased in C57BL/6J, and was unaffected in TNFR KO mice as well as in C57BL/6J mice exposed to SF but treated with TNF-alpha neutralizing antibody. Taken together, our findings show that the excessive sleepiness incurred by recurrent arousals during sleep may be due to activation of TNF-alpha-dependent inflammatory pathways, despite the presence of preserved sleep duration and global sleep architecture.	[Kaushal, Navita; Ramesh, Vijay; Gozal, David] Univ Chicago, Dept Pediat, Sect Pediat Sleep Med, Chicago, IL 60637 USA	University of Chicago	Gozal, D (corresponding author), Univ Chicago, Dept Pediat, Sect Pediat Sleep Med, Chicago, IL 60637 USA.	dgozal@peds.bsd.uchicago.edu	Vijay, Ramesh/GNP-3175-2022; Gozal, David/ABH-3805-2020; Gozal, David/M-9492-2017; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health [HL-086662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grant HL-086662 to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; BORBELY AA, 1989, PHYSIOL REV, V69, P605, DOI 10.1152/physrev.1989.69.2.605; Bredow S, 1997, NEUROIMMUNOMODULAT, V4, P84, DOI 10.1159/000097325; BRINGMANN A, 1995, ARCH ITAL BIOL, V133, P1; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Darko DF, 1995, P NATL ACAD SCI USA, V92, P12080, DOI 10.1073/pnas.92.26.12080; Davis CJ, 2011, J CLIN SLEEP MED, V7, pS16, DOI 10.5664/JCSM.1346; Deboer T, 2002, J NEUROPHYSIOL, V88, P839, DOI 10.1152/jn.2002.88.2.839; DeSarro G, 1997, LIFE SCI, V60, P555, DOI 10.1016/S0024-3205(96)00692-3; Entzian P, 1996, AM J RESP CRIT CARE, V153, P1080, DOI 10.1164/ajrccm.153.3.8630548; Espana RA, 2007, SLEEP, V30, P1417, DOI 10.1093/sleep/30.11.1417; Fang JD, 1997, J NEUROSCI, V17, P5949; Floyd RA, 1997, NEUROREPORT, V8, P915, DOI 10.1097/00001756-199703030-00020; FRIEDMAN EM, 1995, AM J PRIMATOL, V35, P143, DOI 10.1002/ajp.1350350207; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Gozal D, 2010, SLEEP, V33, P319, DOI 10.1093/sleep/33.3.319; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Jhaveri KA, 2007, BRAIN BEHAV IMMUN, V21, P975, DOI 10.1016/j.bbi.2007.03.007; KAPAS L, 1992, AM J PHYSIOL, V263, pR708, DOI 10.1152/ajpregu.1992.263.3.R708; Kapas L, 2008, J APPL PHYSIOL, V105, P1187, DOI 10.1152/japplphysiol.90388.2008; Kapsimalis F, 2005, CURR OPIN PULM MED, V11, P481, DOI 10.1097/01.mcp.0000183062.98665.6b; Kaushal N, 2012, BRAIN RES, V1454, P65, DOI 10.1016/j.brainres.2012.03.019; Khalyfa A, 2011, J PEDIATR-US, V158, P81, DOI 10.1016/j.jpeds.2010.07.032; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Krueger JM, 2003, ANN NY ACAD SCI, V992, P9, DOI 10.1111/j.1749-6632.2003.tb03133.x; Kubota T, 2002, BRAIN RES, V932, P37, DOI 10.1016/S0006-8993(02)02262-X; Kubota T, 2001, AM J PHYSIOL-REG I, V280, pR1213, DOI 10.1152/ajpregu.2001.280.4.R1213; Li NF, 2010, CLIN EXP HYPERTENS, V32, P54, DOI 10.3109/10641960902993087; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Mills PJ, 2004, BRAIN BEHAV IMMUN, V18, P298, DOI 10.1016/j.bbi.2003.10.004; Mossner R, 1998, NEUROCHEM INT, V33, P251, DOI 10.1016/S0197-0186(98)00026-6; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; OPP MR, 1991, AM J PHYSIOL, V260, pR52, DOI 10.1152/ajpregu.1991.260.1.R52; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peschon JJ, 1998, J IMMUNOL, V160, P943; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ramesh V., 2009, SLEEP SCI, V2, P64; Ramesh V, 2007, J NEUROCHEM, V100, P1351, DOI 10.1111/j.1471-4159.2006.04314.x; Ramesh V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-91; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; SUSIC V, 1989, METAB BRAIN DIS, V4, P73, DOI 10.1007/BF00999497; Taishi P, 2007, BRAIN RES, V1156, P125, DOI 10.1016/j.brainres.2007.04.072; TAKAHASHI S, 1995, BRAIN RES, V690, P241, DOI 10.1016/0006-8993(95)00609-T; Takahashi S, 1996, J SLEEP RES, V5, P106, DOI 10.1046/j.1365-2869.1996.d01-63.x; Takahashi S, 1995, PFLUG ARCH EUR J PHY, V431, P155, DOI 10.1007/BF00410186; Terao A, 1998, NEUROREPORT, V9, P3791, DOI 10.1097/00001756-199812010-00005; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; UTHGENANNT D, 1995, PSYCHOSOM MED, V57, P97, DOI 10.1097/00006842-199503000-00001; Vgontzas AN, 1999, CLIN ENDOCRINOL, V51, P205, DOI 10.1046/j.1365-2265.1999.00763.x; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Vincendeau P, 2006, AN ACAD BRAS CIENC, V78, P645, DOI 10.1590/S0001-37652006000400004; Wang HL, 2008, J RHEUMATOL, V35, P1366; Yamada K, 2000, J NEUROIMMUNOL, V111, P131, DOI 10.1016/S0165-5728(00)00375-1; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Yoshida H, 2004, BRAIN RES, V1009, P129, DOI 10.1016/j.brainres.2004.02.055; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196	69	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45610	10.1371/journal.pone.0045610	http://dx.doi.org/10.1371/journal.pone.0045610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029133	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800067
J	Wojnarowicz, PM; Oros, KK; Quinn, MCJ; Arcand, SL; Gambaro, K; Madore, J; Birch, AH; de Ladurantaye, M; Rahimi, K; Provencher, DM; Mes-Masson, AM; Greenwood, CMT; Tonin, PN				Wojnarowicz, Paulina M.; Oros, Kathleen Klein; Quinn, Michael C. J.; Arcand, Suzanna L.; Gambaro, Karen; Madore, Jason; Birch, Ashley H.; de Ladurantaye, Manon; Rahimi, Kurosh; Provencher, Diane M.; Mes-Masson, Anne-Marie; Greenwood, Celia M. T.; Tonin, Patricia N.			The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ALLELE LOSS; PRIMARY CULTURES; CANCER; MUTATIONS; EXPRESSION; CHROMOSOME-17; GROWTH; HETEROZYGOSITY; OVEREXPRESSION	High-grade ovarian serous carcinomas (HGSC) are characterized by TP53 mutations and non-random patterns of chromosomal anomalies, where the nature of the TP53 mutation may correlate with clinical outcome. However, the frequency of common somatic genomic events occurring in HGSCs from demographically defined populations has not been explored. Whole genome SNP array, and TP53 mutation, gene and protein expression analyses were assessed in 87 confirmed HGSC samples with clinical correlates from French Canadians, a population exhibiting strong founder effects, and results were compared with independent reports describing similar analyses from unselected populations. TP53 mutations were identified in 91% of HGSCs. Anomalies observed in more than 50% of TP53 mutation-positive HGSCs involved gains of 3q, 8q and 20q, and losses of 4q, 5q, 6q, 8p, 13q, 16q, 17p, 17q, 22q and Xp. Nearly 400 regions of non-overlapping amplification or deletion were identified, where 178 amplifications and 98 deletions involved known genes. The subgroup expressing mutant p53 protein exhibited significantly prolonged overall and disease-free survival as compared with the p53 protein null subgroup. Interestingly, a comparative analysis of genomic landscapes revealed a significant enrichment of gains involving 1q, 8q, and 12p intervals in the subgroup expressing mutant p53 protein as compared with the p53 protein null subgroup. Although the findings show that the frequency of TP53 mutations and the genomic landscapes observed in French Canadian samples were similar to those reported for samples from unselected populations, there were differences in the magnitude of global gains/losses of specific chromosomal arms and in the spectrum of amplifications and deletions involving focal regions in individual samples. The findings from our comparative genomic analyses also support the notion that there may be biological differences between HGSCs that could be related to the nature of the TP53 mutation.	[Wojnarowicz, Paulina M.; Gambaro, Karen; Birch, Ashley H.; Tonin, Patricia N.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Oros, Kathleen Klein; Greenwood, Celia M. T.] McGill Univ, Jewish Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Oros, Kathleen Klein; Greenwood, Celia M. T.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Quinn, Michael C. J.; Madore, Jason; de Ladurantaye, Manon; Provencher, Diane M.; Mes-Masson, Anne-Marie] CRCHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Arcand, Suzanna L.; Tonin, Patricia N.] MUHC, Res Inst, Montreal, PQ, Canada; [Rahimi, Kurosh] CHUM, Dept Pathol, Montreal, PQ, Canada; [Provencher, Diane M.] Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University	Tonin, PN (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	patricia.tonin@mcgill.ca		Greenwood, Celia/0000-0002-2427-5696; Madore, Jason/0000-0002-3499-474X; Mes-Masson, Anne-Marie/0000-0002-6498-266X	Canadian Institutes of Health Research; Weekend to End Women's Cancer through the Lady Davis Institute for Medical Research at the Jewish General Hospital, Montreal, Canada; Fonds Recherche Quebec-Sante; The Terry Fox Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Weekend to End Women's Cancer through the Lady Davis Institute for Medical Research at the Jewish General Hospital, Montreal, Canada; Fonds Recherche Quebec-Sante; The Terry Fox Research Institute	PMW is a recipient of a doctoral research award from the Canadian Institutes of Health Research. CMTG is supported by funds from the Weekend to End Women's Cancer through the Lady Davis Institute for Medical Research at the Jewish General Hospital, Montreal, Canada. Research was performed at The Research Institute of the McGill University Health Centre and Centre de recherche du Centre hospitalier de l'Universite de Montreal which both received support from the Fonds Recherche Quebec-Sante. This research was supported by the Canadian Institutes of Health Research and The Terry Fox Research Institute to PNT, A-MM-M and DMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Al-Kuraya K, 2006, HUM PATHOL, V37, P453, DOI 10.1016/j.humpath.2005.12.004; Arcand SL, 2008, BREAST CANCER RES TR, V108, P399, DOI 10.1007/s10549-007-9608-6; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; Bernardini MQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-237; Bilyk O. O., 2011, Experimental Oncology, V33, P150; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; BOS JL, 1989, CANCER RES, V49, P4682; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bruening W, 1999, CANCER RES, V59, P4973; Calvo E, 2006, J CLIN ONCOL, V24, P2158, DOI 10.1200/JCO.2006.06.5961; Dimova I, 2009, TUMORI, V95, P357; Dion F, 2000, ONCOGENE, V19, P1466, DOI 10.1038/sj.onc.1203463; Dogan E, 2005, GYNECOL ONCOL, V97, P46, DOI 10.1016/j.ygyno.2004.12.053; ECCLES DM, 1992, BRIT J CANCER, V65, P40, DOI 10.1038/bjc.1992.8; Feng QH, 2008, GYNECOL ONCOL, V111, P320, DOI 10.1016/j.ygyno.2008.07.036; FOULKES WD, 1993, INT J CANCER, V54, P220, DOI 10.1002/ijc.2910540210; GODWIN AK, 1994, AM J HUM GENET, V55, P666; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; JACOBS IJ, 1993, CANCER RES, V53, P1218; Jacot W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3079; KIECHLESCHWARZ M, 1995, CANCER DETECT PREV, V19, P234; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Laframboise S, 2000, CANCER J, V6, P302; Lamy PJ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-13; Leidner RS, 2009, J CLIN ONCOL, V27, P5620, DOI 10.1200/JCO.2009.23.1431; LOUNIS H, 1994, EXP CELL RES, V215, P303, DOI 10.1006/excr.1994.1346; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; McManus DT, 1996, J PATHOL, V179, P177, DOI 10.1002/(SICI)1096-9896(199606)179:2<177::AID-PATH561>3.0.CO;2-2; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; Papp J, 1996, BRIT J CANCER, V74, P1592, DOI 10.1038/bjc.1996.594; Pergolizzi R, 1999, INT J CANCER, V81, P829; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pieretti M, 1995, INT J CANCER, V64, P434, DOI 10.1002/ijc.2910640614; Plisiecka-Halasa J, 2008, ANTICANCER RES, V28, P989; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; Presneau N, 2003, ONCOGENE, V22, P1568, DOI 10.1038/sj.onc.1206219; Quinn MCJ, 2009, MOL CARCINOGEN, V48, P648, DOI 10.1002/mc.20511; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Reles A, 1996, J CANCER RES CLIN, V122, P489, DOI 10.1007/BF01187161; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sangha N, 2008, NEOPLASIA, V10, P1362, DOI 10.1593/neo.08784; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Sood AK, 1999, CLIN CANCER RES, V5, P2485; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; TAVASSOLI M, 1993, GENE CHROMOSOME CANC, V8, P195, DOI 10.1002/gcc.2870080310; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wojnarowicz PM, 2012, INT J ONCOLOGY; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85	62	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45484	10.1371/journal.pone.0045484	http://dx.doi.org/10.1371/journal.pone.0045484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029043	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900059
J	Hamilton, JA; Lacey, DC; Turner, A; de Kok, B; Huynh, J; Scholz, GM				Hamilton, John A.; Lacey, Derek C.; Turner, Amanda; de Kok, Bernard; Huynh, Jennifer; Scholz, Glen M.			Hypoxia Enhances the Proliferative Response of Macrophages to CSF-1 and Their Pro-Survival Response to TNF	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC GROWTH-FACTORS; MARROW-DERIVED MACROPHAGES; RHEUMATOID-ARTHRITIS; KAPPA-B; DNA-SYNTHESIS; MONOCYTE/MACROPHAGE SURVIVAL; NEUTROPHIL SURVIVAL; MURINE MACROPHAGES	In chronic inflammatory lesions there are increased numbers of macrophages with a possible contribution of enhanced survival/proliferation due, for example, to cytokine action; such lesions are often hypoxic. Prior studies have found that culture in low oxygen can promote monocyte/macrophage survival. We show here, using pharmacologic inhibitors, that the hypoxia-induced pro-survival response of macrophages exhibits a dependence on PI3-kinase and mTOR activities but surprisingly is suppressed by Akt and p38 MAPK activities. It was also found that in hypoxia at CSF-1 concentrations, which under normoxic conditions are suboptimal for macrophage proliferation, macrophages can proliferate more strongly with no evidence for alteration in CSF-1 receptor degradation kinetics. TNF promoted macrophage survival in normoxic conditions with an additive effect in hypoxia. The enhanced hypoxia-dependent survival and/or proliferation of macrophages in the presence of CSF-1 or TNF may contribute to their elevated numbers at a site of chronic inflammation.	[Hamilton, John A.; Lacey, Derek C.; Turner, Amanda; de Kok, Bernard; Huynh, Jennifer; Scholz, Glen M.] Univ Melbourne, Dept Med, Royal Melbourne Hosp Parkville, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3010, Australia	Royal Melbourne Hospital; University of Melbourne	Hamilton, JA (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp Parkville, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3010, Australia.	jahami@unimelb.edu.au		Hamilton, John A/0000-0002-9493-9224; Scholz, Glen/0000-0003-2722-6344	National Health and Medical Research Council of Australia; Cooperative Research Centre for Chronic Inflammatory Diseases	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by grants from the National Health and Medical Research Council of Australia and the Cooperative Research Centre for Chronic Inflammatory Diseases, and by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia (to JAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Catrina AI, 2005, ARTHRITIS RHEUM-US, V52, P61, DOI 10.1002/art.20764; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003; Chang M, 2009, J LEUKOCYTE BIOL, V85, P947, DOI 10.1189/jlb.0908522; Choi HK, 2011, CELL SIGNAL, V23, P1633, DOI 10.1016/j.cellsig.2011.05.017; Comalada M, 2004, EUR J IMMUNOL, V34, P2257, DOI 10.1002/eji.200425110; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Degrossoli A, 2007, EXP BIOL MED, V232, P88; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Elsegood CL, 2009, ARTERIOSCL THROM VAS, V29, P1283, DOI 10.1161/ATVBAHA.108.180778; Fong CC, 2007, TOXICOLOGY, V235, P52, DOI 10.1016/j.tox.2007.03.006; Hamilton JA, 2000, J LEUKOCYTE BIOL, V67, P226, DOI 10.1002/jlb.67.2.226; Hamilton JA, 2003, J LEUKOCYTE BIOL, V73, P702, DOI 10.1189/jlb.0103037; Hamilton JA, 2001, BIOCHEM J, V354, P179, DOI 10.1042/0264-6021:3540179; Hamilton JA, 1998, INT J BIOCHEM CELL B, V30, P271, DOI 10.1016/S1357-2725(97)00111-8; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; HAMILTON JA, 1993, LANCET, V342, P536, DOI 10.1016/0140-6736(93)91653-4; HAMILTON JA, 1986, BIOCHEM BIOPH RES CO, V138, P445, DOI 10.1016/0006-291X(86)90301-3; HAMILTON JA, 1988, J CELL PHYSIOL, V134, P405, DOI 10.1002/jcp.1041340311; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; HANNAH S, 1995, FEBS LETT, V372, P233, DOI 10.1016/0014-5793(95)00986-J; HASLETT C, 1994, PHILOS T ROY SOC B, V345, P327, DOI 10.1098/rstb.1994.0113; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Kim HJ, 2008, CANCER LETT, V260, P88, DOI 10.1016/j.canlet.2007.10.030; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lo SZY, 2011, CANCER LETT, V307, P80, DOI 10.1016/j.canlet.2011.03.020; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Matsui T, 2009, J NUCL MED, V50, P920, DOI 10.2967/jnumed.108.060103; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; MESZAROS K, 1987, BIOCHEM BIOPH RES CO, V149, P1, DOI 10.1016/0006-291X(87)91596-8; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murray J, 2000, J CELL SCI, V113, P337; Murray JT, 2000, INFLAMM RES, V49, P610, DOI 10.1007/s000110050638; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Negus RPM, 1998, J LEUKOCYTE BIOL, V63, P758, DOI 10.1002/jlb.63.6.758; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; RYMSA B, 1990, RES COMMUN CHEM PATH, V68, P263; Sester DP, 2006, J IMMUNOL, V177, P4473, DOI 10.4049/jimmunol.177.7.4473; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; Walmsley SR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2632; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Xaus J, 2000, BLOOD, V95, P3823; Yun JK, 1997, P NATL ACAD SCI USA, V94, P13903, DOI 10.1073/pnas.94.25.13903	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45853	10.1371/journal.pone.0045853	http://dx.doi.org/10.1371/journal.pone.0045853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029275	Green Published, gold			2022-12-27	WOS:000309388400135
J	Crespo, I; Tao, H; Nieto, AB; Rebelo, O; Domingues, P; Vital, AL; Patino, MD; Barbosa, M; Lopes, MC; Oliveira, CR; Orfao, A; Tabernero, MD				Crespo, Ines; Tao, Herminio; Belen Nieto, Ana; Rebelo, Olinda; Domingues, Patricia; Vital, Ana Luisa; del Carmen Patino, Maria; Barbosa, Marcos; Lopes, Maria Celeste; Oliveira, Catarina Resende; Orfao, Alberto; Dolores Tabernero, Maria			Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; METHYLTHIOADENOSINE PHOSPHORYLASE; DEREGULATED EXPRESSION; EGFR AMPLIFICATION; MULTIFORME TUMORS; SPLICE VARIANTS; IN-SITU; AMPLICONS; ABERRATIONS; TARGET	Background: Glioblastoma multiforme (GBM) displays multiple amplicons and homozygous deletions that involve relevant pathogenic genes and other genes whose role remains unknown. Methodology: Single-nucleotide polymorphism (SNP)-arrays were used to determine the frequency of recurrent amplicons and homozygous deletions in GBM (n = 46), and to evaluate the impact of copy number alterations (CNA) on mRNA levels of the genes involved. Principal Findings: Recurrent amplicons were detected for chromosomes 7 (50%), 12 (22%), 1 (11%), 4 (9%), 11 (4%), and 17 (4%), whereas homozygous deletions involved chromosomes 9p21 (52%) and 10q (22%). Most genes that displayed a high correlation between DNA CNA and mRNA levels were coded in the amplified chromosomes. For some amplicons the impact of DNA CNA on mRNA expression was restricted to a single gene (e. g., EGFR at 7p11.2), while for others it involved multiple genes (e. g., 11 and 5 genes at 12q14.1-q15 and 4q12, respectively). Despite homozygous del(9p21) and del(10q23.31) included multiple genes, association between these DNA CNA and RNA expression was restricted to the MTAP gene. Conclusions: Overall, our results showed a high frequency of amplicons and homozygous deletions in GBM with variable impact on the expression of the genes involved, and they contributed to the identification of other potentially relevant genes.	[Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Dept Med, Ctr Canc Res CIC IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Crespo, Ines; Domingues, Patricia; Vital, Ana Luisa; Lopes, Maria Celeste; Oliveira, Catarina Resende] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Crespo, Ines; Domingues, Patricia; Vital, Ana Luisa; Lopes, Maria Celeste] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Tao, Herminio; Barbosa, Marcos] Univ Hosp Coimbra, Neurosurg Serv, Coimbra, Portugal; [Rebelo, Olinda] Univ Hosp Coimbra, Neurol Serv, Neuropathol Lab, Coimbra, Portugal; [del Carmen Patino, Maria] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain; [Barbosa, Marcos; Oliveira, Catarina Resende] Univ Coimbra, Fac Med, Coimbra, Portugal; [Dolores Tabernero, Maria] IECSCYL, Soria, Spain; [Orfao, Alberto; Dolores Tabernero, Maria] Univ Hosp Salamanca, Res Unit, Inst Biosanitario Salamanca IBSAL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Salamanca; Universidade de Coimbra	Tabernero, MD (corresponding author), Univ Salamanca, Dept Med, Ctr Canc Res CIC IBMCC CSIC USAL, E-37008 Salamanca, Spain.	taberner@usal.es	Orfao, Alberto/B-5801-2017; Lopes, Maria/GXF-7507-2022; Barbosa, Marcos/C-6884-2018	Barbosa, Marcos/0000-0003-3704-4499; Lopes, Maria/0000-0002-6469-0894; Oliveira, Catarina/0000-0001-6942-4328; Barbosa, Marcos/0000-0001-5225-6794; Nieto-Librero, Ana B./0000-0001-6643-247X	Fundacao para a Ciencia e a Tecnologia, Portugal [FCT PIC/IC/83108/2007, SFRH/BD/23086/2005, SFRH/BD/11820/2003]; Fundacion Mutua Madrilena, Madrid, Spain [AP87692011]; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain [RTICC RD06/0020/0035]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacion Mutua Madrilena, Madrid, Spain; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia, Portugal [FCT PIC/IC/83108/2007]; PhD fellowships from Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/23086/2005, SFRH/BD/11820/2003]; Fundacion Mutua Madrilena, Madrid, Spain [AP87692011]; and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain [RTICC RD06/0020/0035]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christopher SA, 2002, CANCER RES, V62, P6639; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Dahlback HSS, 2009, GENE CHROMOSOME CANC, V48, P908, DOI 10.1002/gcc.20690; Diesel B, 2005, CLIN CANCER RES, V11, P5370, DOI 10.1158/1078-0432.CCR-04-1968; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Filipski E, 2002, J NATL CANCER I, V94, P690; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Foulquier F, 2012, AM J HUM GENET; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gardina PJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-489; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; Houillier C, 2006, CANCER-AM CANCER SOC, V106, P2218, DOI 10.1002/cncr.21819; Hua H, 2007, CANCER GENE THER, V14, P815, DOI 10.1038/sj.cgt.7701061; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Hung KS, 2000, BIOCHEM BIOPH RES CO, V269, P718, DOI 10.1006/bbrc.2000.2339; Inda MD, 2003, MOL CARCINOGEN, V36, P6, DOI 10.1002/mc.10085; Kanu OO, 2009, CLIN MED INSIGHTS-ON, V3, P39; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Lo KC, 2007, GENE CHROMOSOME CANC, V46, P875, DOI 10.1002/gcc.20474; Lopez-Gines C, 2005, CLIN NEUROPATHOL, V24, P209; Lopez-Gines C, 2010, MODERN PATHOL, V23, P856, DOI 10.1038/modpathol.2010.62; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lymbouridou R, 2009, EUR J CANCER, V45, P1294, DOI 10.1016/j.ejca.2008.12.028; Maas RM, 2001, CLIN CANCER RES, V7, P868; NAVEILHAN P, 1994, J NEUROSCI RES, V37, P271, DOI 10.1002/jnr.490370212; NOBORI T, 1991, CANCER RES, V51, P3193; Nobusawa S, 2011, NEUROPATHOLOGY, V31, P583, DOI 10.1111/j.1440-1789.2011.01204.x; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ravenall SJ, 2002, EUR J NEUROSCI, V15, P281, DOI 10.1046/j.0953-816x.2001.01862.x; Reifenberger G, 1996, CANCER RES, V56, P5141; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sasaki S, 2003, ONCOGENE, V22, P3792, DOI 10.1038/sj.onc.1206589; Schlierf B, 2007, NEUROPATH APPL NEURO, V33, P621, DOI 10.1111/j.1365-2990.2007.00881.x; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Vital AL, 2010, NEURO-ONCOLOGY, V12, P991, DOI 10.1093/neuonc/noq050; Vital AL, 2010, NEUROGENETICS, V11, P227, DOI 10.1007/s10048-009-0217-x; Vranova V, 2007, ONCOL REP, V17, P457; Wikman H, 2005, GENE CHROMOSOME CANC, V42, P193, DOI 10.1002/gcc.20122; Xia HC, 2010, CAN J NEUROL SCI, V37, P365, DOI 10.1017/S031716710001026X; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yeh KT, 2005, J PATHOL, V206, P111, DOI 10.1002/path.1756; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	64	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46088	10.1371/journal.pone.0046088	http://dx.doi.org/10.1371/journal.pone.0046088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029397	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900087
J	Feng, YJ; Cronan, JE				Feng, Youjun; Cronan, John E.			Crosstalk of Escherichia coli FadR with Global Regulators in Expression of Fatty Acid Transport Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ACYL-COENZYME; RECEPTOR PROTEIN; DNA-BINDING; BIOSYNTHESIS; DEGRADATION; GROWTH; SYNTHETASE; REPRESSOR; EXCISION	Escherichia coli FadR plays two regulatory roles in fatty acid metabolism. FadR represses the fatty acid degradation (fad) system and activates the unsaturated fatty acid synthetic pathway. Cross-talk between E. coli FadR and the ArcA-ArcB oxygen-responsive two-component system was observed that resulted in diverse regulation of certain fad regulon beta-oxidation genes. We have extended such analyses to the fadL and fadD genes, the protein products of which are required for long chain fatty acid transport and have also studied the role of a third global regulator, the CRP-cAMP complex. The promoters of both the fadL and fadD genes contain two experimentally validated FadR-binding sites plus binding sites for ArcA and CRP-cAMP. Despite the presence of dual binding sites FadR only modestly regulates expression of these genes, indicating that the number of binding sites does not determine regulatory strength. We report complementary in vitro and in vivo studies indicating that the CRP-cAMP complex directly activates expression of fadL and fadD as well as the beta-oxidation gene, fadH. The physiological relevance of the fadL and fadD transcription data was validated by direct assays of long chain fatty acid transport.	[Feng, Youjun; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Feng, Youjun/I-4134-2012; Cronan, John/V-6626-2019		NIH from National Institute of Allergy and Infectious Diseases [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	NIH from National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI15650 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Clark D. P., 2005, ECOSAL ESCHERICHIA C; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2011, MOL MICROBIOL, V81, P1020, DOI 10.1111/j.1365-2958.2011.07748.x; Feng YJ, 2010, J BACTERIOL, V192, P4289, DOI 10.1128/JB.00516-10; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Feng Y, 2009, J BACTERIOL, V191, P6320, DOI 10.1128/JB.00835-09; FULDA M, 1994, MOL GEN GENET, V242, P241, DOI 10.1007/BF00280412; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; HIGASHITANI A, 1993, MOL GEN GENET, V240, P339, DOI 10.1007/BF00280384; Husnain SI, 2009, J BACTERIOL, V191, P6094, DOI 10.1128/JB.00672-09; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Iram SH, 2005, J BIOL CHEM, V280, P32148, DOI 10.1074/jbc.M504054200; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; PAULI G, 1974, J BACTERIOL, V117, P1178, DOI 10.1128/JB.117.3.1178-1183.1974; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Zhang Y, 1996, J BACTERIOL, V178, P3614, DOI 10.1128/jb.178.12.3614-3620.1996; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	41	80	81	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46275	10.1371/journal.pone.0046275	http://dx.doi.org/10.1371/journal.pone.0046275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029459	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900123
J	File, AL; Klironomos, J; Maherali, H; Dudley, SA				File, Amanda L.; Klironomos, John; Maherali, Hafiz; Dudley, Susan A.			Plant Kin Recognition Enhances Abundance of Symbiotic Microbial Partner	PLOS ONE			English	Article							MYCORRHIZAL FUNGAL DIVERSITY; COMMUNITY COMPOSITION; EVOLUTION; COOPERATION; SELECTION; TRADE; SPECIALIZATION; COLONIZATION; COMPETITION; MODEL	Background: The stability of cooperative interactions among different species can be compromised by cheating. In the plant-mycorrhizal fungi symbiosis, a single mycorrhizal network may interact with many plants, providing the opportunity for individual plants to cheat by obtaining nutrients from the fungi without donating carbon. Here we determine whether kin selection may favour plant investment in the mycorrhizal network, reducing the incentive to cheat when relatives interact with a single network. Methodology/Principal Findings: We show that mycorrhizal network size and root colonization were greater when Ambrosia artemisiifolia L. was grown with siblings compared to strangers. Soil fungal abundance was positively correlated with group leaf nitrogen, and increased root colonization was associated with a reduced number of pathogen-induced root lesions, indicating greater benefit to plants grown with siblings. Conclusions/Significance: Plants can benefit their relatives through investment in mycorrhizal fungi, and kin selection in plants could promote the persistence of the mycorrhizal symbiosis.	[File, Amanda L.; Dudley, Susan A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Klironomos, John] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	McMaster University; University of British Columbia; University of Guelph	File, AL (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	fileamanda@gmail.com			NSERC; Canada Foundation for Innovation; Ontario Innovation Trust	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	Funding for this work was supported by NSERC (http://www.nserccrsng.gc.ca/) to H. M, S. D., J.K.; Canada Foundation for Innovation (http://www.innovation.ca/) and Ontario Innovation Trust (http://www.mri.gov.on.ca/) to H. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Bingham MA, 2009, RANGELAND ECOL MANAG, V62, P60, DOI 10.2111/08-088; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; CHEPLICK GP, 1992, J ECOL, V80, P567, DOI 10.2307/2260699; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; de Mazancourt C, 2010, ECOL LETT, V13, P349, DOI 10.1111/j.1461-0248.2009.01431.x; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Denison RF, 2003, ECOLOGY, V84, P838, DOI 10.1890/0012-9658(2003)084[0838:CITRAT]2.0.CO;2; Donohue K, 2003, AM NAT, V162, P77, DOI 10.1086/375299; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Ferriere R, 2002, P ROY SOC B-BIOL SCI, V269, P773, DOI 10.1098/rspb.2001.1900; Fumanal B, 2006, MYCORRHIZA, V17, P25, DOI 10.1007/s00572-006-0078-1; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Grman E, 2012, AM NAT, V179, P567, DOI 10.1086/665006; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LAU TC, 1993, AM J BOT, V80, P763, DOI 10.2307/2445596; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MENGE JA, 1978, NEW PHYTOL, V80, P575, DOI 10.1111/j.1469-8137.1978.tb01589.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; MULLEN RB, 1993, OECOLOGIA, V94, P229, DOI 10.1007/BF00341321; Mummey DL, 2005, PLANT SOIL, V271, P83, DOI 10.1007/s11104-004-2066-6; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Omorusi VI, 2011, INT J AGRIC BIOL, V13, P391; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ronsheim ML, 2001, OECOLOGIA, V128, P77, DOI 10.1007/s004420000625; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.1890/0012-9658(1998)079[1029:SARTBM]2.0.CO;2; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Valentine AJ, 2001, SCI HORTIC-AMSTERDAM, V88, P177, DOI 10.1016/S0304-4238(00)00205-3; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Van Dyken JD, 2011, AM NAT, V177, P288, DOI 10.1086/658365; WADE MJ, 1980, BEHAV ECOL SOCIOBIOL, V7, P167, DOI 10.1007/BF00299360; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107	49	43	45	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45648	10.1371/journal.pone.0045648	http://dx.doi.org/10.1371/journal.pone.0045648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029158	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900050
J	Jin, ZD; Zong, CY; Jiang, BC; Zhou, Z; Tong, J; Cao, Y				Jin, Zongda; Zong, Chunyan; Jiang, Bingcheng; Zhou, Zhen; Tong, Jian; Cao, Yi			The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells	PLOS ONE			English	Article							MICROWAVE-RADIATION; APOPTOSIS; CALCIUM; CANCER; INDUCTION; DAMAGE; RATS	Human promyelocytic leukemia HL-60 cells were pre-exposed to non-ionizing 900 MHz radiofrequency fields (RF) at 12 mu W/cm(2) power density for 1 hour/day for 3 days and then treated with a chemotherapeutic drug, doxorubicin (DOX, 0.125 mg/L). Several end-points related to toxicity, viz., viability, apoptosis, mitochondrial membrane potential (MMP), intracellular free calcium (Ca2+) and Ca2+-Mg2+-ATPase activity were measured. The results obtained in un-exposed and sham-exposed control cells were compared with those exposed to RF alone, DOX alone and RF+DOX. The results indicated no significant differences between un-exposed, sham-exposed control cells and those exposed to RF alone while treatment with DOX alone showed a significant decrease in viability, increased apoptosis, decreased MMP, increased Ca2+ and decreased Ca2+-Mg2+-ATPase activity. When the latter results were compared with cells exposed RF+DOX, the data showed increased cell proliferation, decreased apoptosis, increased MMP, decreased Ca2+ and increased Ca2+-Mg2+-ATPase activity. Thus, RF preexposure appear to protect the HL-60 cells from the toxic effects of subsequent treatment with DOX. These observations were similar to our earlier data which suggested that pre-exposure of mice to 900 MHz RF at 120 mu W/cm(2) power density for 1 hours/day for 14 days had a protective effect in hematopoietic tissue damage induced by subsequent gamma-irradiation.	[Jin, Zongda; Zong, Chunyan; Jiang, Bingcheng; Zhou, Zhen; Tong, Jian; Cao, Yi] Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Cao, Y (corresponding author), Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China.	yicao@suda.edu.cn			Ministry of Science and Technology, China [2011CB503700]; National Natural Science Foundation [81020108028]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by a grant (973 project: 2011CB503700) from Ministry of Science and Technology, China (http://www.973.gov.cn/Default_3.aspx), a grant (81020108028) from National Natural Science Foundation (http://www.nsfc.gov.cn/Portal0/default106.htm), and The Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SECT CANC INF; [Anonymous], 2012, CANC FACTS 2012; Arcamone F., 1981, DOXORUBICIN ANTICANC; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Beer MH, 2006, MERCK MANUAL DIAGNOS; Burkhardt M, 1996, BIOELECTROMAGNETICS, V17, P483, DOI 10.1002/(SICI)1521-186X(1996)17:6<483::AID-BEM8>3.0.CO;2-#; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; CARTER SK, 1975, J NATL CANCER I, V55, P1265, DOI 10.1093/jnci/55.6.1265; Chakraborti S, 2007, MOL CELL BIOCHEM, V298, P1, DOI 10.1007/s11010-006-9355-8; Chen ZJ, 2010, MUTAT RES-GEN TOX EN, V695, P16, DOI 10.1016/j.mrgentox.2009.10.001; Comparisons F, 2010, DURG FACTS COMP; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Delgado-Coello B, 2006, MOL CELL BIOCHEM, V285, P1, DOI 10.1007/s11010-005-9060-z; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Drexler HG, 2005, DRUG DISCOV TODAY DI, V2, P51; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032040; KLUCK RM, 1994, BBA-MOL CELL RES, V1223, P247, DOI 10.1016/0167-4889(94)90233-X; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Mortazavi SMJ, 2011, IRAN J RADIAT RES, V9, P9; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Persson BRR, 1997, WIREL NETW, V3, P455, DOI 10.1023/A:1019150510840; Rezaei PF, 2011, CYTOTECHNOLOGY, V63, P503, DOI 10.1007/s10616-011-9373-6; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; Sannino A, 2011, INT J RADIAT BIOL, V87, P993, DOI 10.3109/09553002.2011.574779; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Xie SQ, 2008, TOXICOLOGY, V254, P68, DOI 10.1016/j.tox.2008.09.021; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	30	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46102	10.1371/journal.pone.0046102	http://dx.doi.org/10.1371/journal.pone.0046102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029402	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900091
J	Mohiman, N; Argentini, M; Batt, SM; Cornu, D; Masi, M; Eggeling, L; Besra, G; Bayan, N				Mohiman, Niloofar; Argentini, Manuela; Batt, Sarah M.; Cornu, David; Masi, Muriel; Eggeling, Lothar; Besra, Gurdyal; Bayan, Nicolas			The ppm Operon Is Essential for Acylation and Glycosylation of Lipoproteins in Corynebacterium glutamicum	PLOS ONE			English	Article							O-MANNOSYL GLYCANS; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; MONOPHOSPHOMANNOSE SYNTHASE; STREPTOMYCES-COELICOLOR; SORTING SIGNALS; IMMUNE-RESPONSE; MEMBRANE; PROTEIN; ANTIGEN	Background: Due to their contribution to bacterial virulence, lipoproteins and members of the lipoprotein biogenesis pathway represent potent drug targets. Following translocation across the inner membrane, lipoprotein precursors are acylated by lipoprotein diacylglycerol transferase (Lgt), cleaved off their signal peptides by lipoprotein signal peptidase (Lsp) and, in Gram-negative bacteria, further triacylated by lipoprotein N-acyl transferase (Lnt). The existence of an active apolipoprotein N-acyltransferase (Ms-Ppm2) involved in the N-acylation of LppX was recently reported in M. smegmatis. Ms-Ppm2 is part of the ppm operon in which Ppm1, a polyprenol-monophosphomannose synthase, has been shown to be essential in lipoglycans synthesis but whose function in lipoprotein biosynthesis is completely unknown. Results: In order to clarify the role of the ppm operon in lipoprotein biosynthesis, we investigated the post-translational modifications of two model lipoproteins (AmyE and LppX) in C. glutamicum Delta ppm1 and Delta ppm2 mutants. Our results show that both proteins are anchored into the membrane and that their N-termini are N-acylated by Cg-Ppm2. The acylated N-terminal peptide of LppX was also found to be modified by hexose moieties. This O-glycosylation is localized in the N-terminal peptide of LppX and disappeared in the Delta ppm1 mutant. While compromised in the absence of Cg-Ppm2, LppX O-glycosylation could be restored when Cg-Ppm1, Cg-Ppm2 or the homologous Mt-Ppm1 of M. tuberculosis was overexpressed. Conclusion: Together, these results show for the first time that Cg-Ppm1 (Ppm synthase) and Cg-Ppm2 (Lnt) operate in a common biosynthetic pathway in which lipoprotein N-acylation and glycosylation are tightly coupled.	[Mohiman, Niloofar; Masi, Muriel; Bayan, Nicolas] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Mohiman, Niloofar; Masi, Muriel; Bayan, Nicolas] CNRS, UMR 8619, F-91405 Orsay, France; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Gif Sur Yvette, France; [Batt, Sarah M.; Besra, Gurdyal] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Eggeling, Lothar] Forschungszentrum Julich, D-52425 Julich, Germany	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Helmholtz Association; Research Center Julich	Bayan, N (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.	nicolas.bayan@u-psud.fr	Bayan, Nicolas/AAI-5034-2020; Masi, Muriel/N-6758-2018	Masi, Muriel/0000-0002-1444-7511; Bayan, Nicolas/0000-0001-7760-0811; Besra, Gurdyal/0000-0002-5605-0395	Agence Nationale pour la Recherche [ANR-07-BLAN-0363]; CNRS; Universite of Paris Sud-XI	Agence Nationale pour la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite of Paris Sud-XI	This work has received financial support from the "Agence Nationale pour la Recherche" grant ANR-07-BLAN-0363, the CNRS and the Universite of Paris Sud-XI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brulle JK, BIOCH BIOPHYS RES CO, V391, P679; Chaban B, 2009, J BACTERIOL, V191, P187, DOI 10.1128/JB.00885-08; Cowlishaw DA, 2002, J BACTERIOL, V184, P6081, DOI 10.1128/JB.184.21.6081-6083.2002; Cui JM, 2011, ESSAYS BIOCHEM, V50, P85, DOI [10.1042/BSE0500085, 10.1042/bse0500085]; Denham EL, 2009, MICROBIOL-SGM, V155, P134, DOI 10.1099/mic.0.022061-0; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Endo T, 2004, GLYCOCONJUGATE J, V21, P3, DOI 10.1023/B:GLYC.0000043740.26062.2c; ESPITIA C, 1989, CLIN EXP IMMUNOL, V77, P378; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Hermann T, 2001, ELECTROPHORESIS, V22, P1712, DOI 10.1002/1522-2683(200105)22:9<1712::AID-ELPS1712>3.0.CO;2-G; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kurokawa K, 2012, J BIOL CHEM; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Sartain MJ, 2009, GLYCOBIOLOGY, V19, P38, DOI 10.1093/glycob/cwn102; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Serebryakova MV, 2011, J BIOL CHEM, V286, P22769, DOI 10.1074/jbc.M111.231316; Steyn AJC, 2003, MOL MICROBIOL, V47, P1074, DOI 10.1046/j.1365-2958.2003.03356.x; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Sutcliffe IC, 2012, PROTEIN CELL, V3, P163, DOI 10.1007/s13238-012-2023-8; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tjalsma H, 2005, PROTEOMICS, V5, P4472, DOI 10.1002/pmic.200402080; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Ujihara T, 2008, ANAL BIOCHEM, V374, P429, DOI 10.1016/j.ab.2007.11.014; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Wehmeier S, 2009, MOL MICROBIOL, V71, P421, DOI 10.1111/j.1365-2958.2008.06536.x; Wendisch VF, 1997, THESIS HEINRICH HEIN; Wilkinson KA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-93; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Wu HC, 1996, CELLULAR MOL BIOL	50	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46225	10.1371/journal.pone.0046225	http://dx.doi.org/10.1371/journal.pone.0046225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029442	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900112
J	Dibble, KL; Meyerson, LA				Dibble, Kimberly L.; Meyerson, Laura A.			Tidal Flushing Restores the Physiological Condition of Fish Residing in Degraded Salt Marshes	PLOS ONE			English	Article							MUMMICHOG FUNDULUS-HETEROCLITUS; PHRAGMITES-AUSTRALIS INVASION; STABLE-ISOTOPE; HABITAT-USE; PREDATION RISK; GUT CONTENTS; GROWTH; NEKTON; RESTORATION; RESPONSES	Roads, bridges, and dikes constructed across salt marshes can restrict tidal flow, degrade habitat quality for nekton, and facilitate invasion by non-native plants including Phragmites australis. Introduced P. australis contributes to marsh accretion and eliminates marsh surface pools thereby adversely affecting fish by reducing access to intertidal habitats essential for feeding, reproduction, and refuge. Our study assessed the condition of resident fish populations (Fundulus heteroclitus) at four tidally restricted and four tidally restored marshes in New England invaded by P. australis relative to adjacent reference salt marshes. We used physiological and morphological indicators of fish condition, including proximate body composition (% lipid, % lean dry, % water), recent daily growth rate, age class distributions, parasite prevalence, female gravidity status, length-weight regressions, and a common morphological indicator (Fulton's K) to assess impacts to fish health. We detected a significant increase in the quantity of parasites infecting fish in tidally restricted marshes but not in those where tidal flow was restored to reduce P. australis cover. Using fish length as a covariate, we found that unparasitized, non-gravid F. heteroclitus in tidally restricted marshes had significantly reduced lipid reserves and increased lean dry (structural) mass relative to fish residing in reference marshes. Fish in tidally restored marshes were equivalent across all metrics relative to those in reference marshes indicating that habitat quality was restored via increased tidal flushing. Reference marshes adjacent to tidally restored sites contained the highest abundance of young fish (ages 0-1) while tidally restricted marshes contained the lowest. Results indicate that F. heteroclitus residing in physically and hydrologically altered marshes are at a disadvantage relative to fish in reference marshes but the effects can be reversed through ecological restoration.	[Dibble, Kimberly L.; Meyerson, Laura A.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Meyerson, Laura A.] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic	University of Rhode Island; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Dibble, KL (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	klellisdibble@gmail.com	Meyerson, Laura/D-4487-2013; Meyerson, Laura A./S-2979-2019; Meyerson, Laura/K-9013-2012; Meyerson, Laura A./AAN-6688-2020	Meyerson, Laura A./0000-0002-1283-3865	Environmental Protection Agency [FP-91710001-0]; National Oceanic and Atmospheric Administration [NA09NOS4200041]; National Science Foundation [0504103]; Philanthropic Educational Organization [Lellis-Dib3158688]; Northeast Aquatic Plant Management Society; Rhode Island Natural History Survey; Nature Conservancy of Rhode Island [Lellis-Dibble 05-30-09]; University of Rhode Island Agricultural Experiment Station [RI00H-332, 311000-6044]; Direct For Biological Sciences [1050084] Funding Source: National Science Foundation; Division Of Environmental Biology [1049914] Funding Source: National Science Foundation	Environmental Protection Agency(United States Environmental Protection Agency); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Philanthropic Educational Organization; Northeast Aquatic Plant Management Society; Rhode Island Natural History Survey; Nature Conservancy of Rhode Island; University of Rhode Island Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the Environmental Protection Agency Science to Achieve Results Graduate Fellowship Program (FP-91710001-0), National Oceanic and Atmospheric Administration National Estuarine Research Reserve Graduate Fellowship Program (NA09NOS4200041), National Science Foundation Integrative Graduate Education and Research Traineeship Grant to the Coastal Institute at the University of Rhode Island (0504103), the Philanthropic Educational Organization Scholar Award (Lellis-Dib3158688), Northeast Aquatic Plant Management Society Graduate Scholarship Program, Rhode Island Natural History Survey and The Nature Conservancy of Rhode Island Wald Science Grant (Lellis-Dibble 05-30-09), and the University of Rhode Island Agricultural Experiment Station (RI00H-332, 311000-6044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2006, J EXP MAR BIOL ECOL, V335, P177, DOI 10.1016/j.jembe.2006.03.004; Able KW, 2003, ESTUARIES, V26, P484, DOI 10.1007/BF02823725; Adamowicz S.C., 2012, TIDAL MARSH RESTORAT; Adams S. M., 1999, ECOLOGICAL ROLE LIPI, P132; ALLEN EA, 1994, ESTUARIES, V17, P462, DOI 10.2307/1352676; Amara R, 2009, HYDROBIOLOGIA, V627, P87, DOI 10.1007/s10750-009-9717-9; Anisfeld SC, 1999, ESTUARIES, V22, P231, DOI 10.2307/1352980; Anisfeld SC, 1997, ENVIRON SCI TECHNOL, V31, P1650, DOI 10.1021/es960490o; Anisfeld SC, 2012, TIDAL MARSH RESTORAT, P39, DOI DOI 10.5822/978-1-61091-229-7_3; Arneri E, 2000, J FISH BIOL, V56, P1368, DOI 10.1006/jfbi.2000.1255; Balouskus RG, 2012, ESTUAR COAST, V35, P1100, DOI 10.1007/s12237-012-9495-x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; BOESCH DF, 1984, ESTUARIES, V7, P460, DOI 10.2307/1351627; Boumans RMJ, 2002, RESTOR ECOL, V10, P543, DOI 10.1046/j.1526-100X.2002.02032.x; Brawley AH, 1998, ENVIRON MANAGE, V22, P625, DOI 10.1007/s002679900134; Buchsbaum RN, 2006, WETLANDS, V26, P544, DOI 10.1672/0277-5212(2006)26[544:CISMVP]2.0.CO;2; Burdick D.M., 1997, Wetlands Ecology and Management, V4, P129, DOI 10.1007/BF01876233; Burdick D.M, 2012, TIDAL MARSH RESTORAT; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; Chambers RM, 2012, TIDAL MARSH RESTORAT, P81, DOI DOI 10.5822/978-1-61091-229-7_5; Childers DL, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P391; Darnell R. M., 1967, ESTUARIES, P376; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Eberhardt AL, 2011, RESTOR ECOL, V19, P776, DOI 10.1111/j.1526-100X.2010.00721.x; FRITZ ES, 1975, CAN J ZOOL, V53, P361, DOI 10.1139/z75-047; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fulton T. W., 1904, Report of the Fishery Board for Scotland, Vxxii, P141; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gilliers C, 2004, ENVIRON BIOL FISH, V71, P189, DOI 10.1007/s10641-004-0090-2; Golet F. C., 2012, TIDAL MARSH RESTORAT, P333; Goto D, 2010, CAN J FISH AQUAT SCI, V67, P1566, DOI 10.1139/F10-082; Halpin PM, 2000, MAR ECOL PROG SER, V198, P203, DOI 10.3354/meps198203; Harris CE, 2006, COMP PARASITOL, V73, P72, DOI 10.1654/41716.1; HASSAGER T K, 1991, Dana, V9, P39; Hunter KL, 2006, ESTUAR COAST, V29, P487, DOI 10.1007/BF02784996; Irlandi EA, 1997, OECOLOGIA, V110, P222, DOI 10.1007/s004420050154; James-Pirri MJ, 2001, ESTUAR COAST SHELF S, V53, P205, DOI 10.1006/ecss.2001.0807; Javonillo R, 1997, BIOL BULL, V193, P288, DOI 10.1086/BBLv193n2p288; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; Kelly CJ, 1999, ICES J MAR SCI, V56, P61, DOI 10.1006/jmsc.1998.0426; Kerambrun E, 2012, CHEMOSPHERE, V87, P692, DOI 10.1016/j.chemosphere.2011.12.059; Kneib Ronald T., 1997, Oceanography and Marine Biology an Annual Review, V35, P163; KNEIB RT, 1987, ECOLOGY, V68, P379, DOI 10.2307/1939269; KNEIB RT, 1994, MAR ECOL PROG SER, V106, P227, DOI 10.3354/meps106227; Lafferty KD, 2008, J FISH BIOL, V73, P2083, DOI 10.1111/j.1095-8649.2008.02059.x; Lloret J, 2003, MAR ECOL PROG SER, V248, P197, DOI 10.3354/meps248197; Madon SP, 2001, ECOL MODEL, V136, P149, DOI 10.1016/S0304-3800(00)00416-6; Marcogliese D. J., 2004, ECOHEALTH, V1, P151, DOI DOI 10.1007/S10393-004-0028-3; Marcogliese DJ, 2005, INT J PARASITOL, V35, P705, DOI 10.1016/j.ijpara.2005.01.015; MCIVOR CC, 1988, ECOLOGY, V69, P1341, DOI 10.2307/1941632; McMahon KW, 2005, ESTUARIES, V28, P966, DOI 10.1007/BF02696024; Meyerson L. A., 2000, Wetlands Ecology and Management, V8, P89, DOI 10.1023/A:1008432200133; Milone and MacBroom Inc, 1996, SYB CREEK SALT MARSH; Minello TJ, 2012, ESTUAR COAST, V35, P501, DOI 10.1007/s12237-011-9463-x; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; MUGIYA Y, 1987, NIPPON SUISAN GAKK, V53, P1979; National Oceanic and Atmospheric Administration, 2003, DRAK ISL MARSH REST; Neilson John D., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P115; Nixon S.W., 1980, ESTUAR WETL PROCESS, P437; Odum E.P., 1968, P 2 SEA GRANT C, P63; Osgood DT, 2003, ESTUARIES, V26, P522, DOI 10.1007/BF02823728; Otxotorena U, 2010, FISH RES, V106, P337, DOI 10.1016/j.fishres.2010.09.001; PARRISH DL, 1994, T AM FISH SOC, V123, P601, DOI 10.1577/1548-8659(1994)123<0601:NAAPOD>2.3.CO;2; Pineiro C, 2008, FISH RES, V93, P173, DOI 10.1016/j.fishres.2008.04.001; Portnoy JW, 1997, BIOGEOCHEMISTRY, V36, P275, DOI 10.1023/A:1005715520988; PORTNOY JW, 2003, PARK SCI, V22, P51; Post JR, 2001, ECOLOGY, V82, P1040, DOI 10.1890/0012-9658(2001)082[1040:EASIYF]2.0.CO;2; RADTKE RL, 1982, FISH B-NOAA, V80, P201; Raposa K, 2002, RESTOR ECOL, V10, P665, DOI 10.1046/j.1526-100X.2002.01047.x; Raposa K.B., 2012, TIDAL MARSH RESTORAT, P97; Raposa KB, 2003, ESTUARIES, V26, P98, DOI 10.1007/BF02691697; Raposa KB, 2003, ENVIRON MONIT ASSESS, V81, P239, DOI 10.1023/A:1021389327224; Raposa KB, 2001, WETLANDS, V21, P451, DOI 10.1672/0277-5212(2001)021[0451:SHUPON]2.0.CO;2; Raposa KB, 2008, J COASTAL RES, P180, DOI 10.2112/SI55-015; ROMAN CT, 1984, ENVIRON MANAGE, V8, P141, DOI 10.1007/BF01866935; Roman CT, 2002, RESTOR ECOL, V10, P450, DOI 10.1046/j.1526-100X.2002.01036.x; Rooth J. E., 2003, Estuaries, V26, P475, DOI 10.1007/BF02823724; ROUNTREE RA, 1992, T AM FISH SOC, V121, P765, DOI 10.1577/1548-8659(1992)121<0765:FHGATP>2.3.CO;2; Secor D. H., 1991, BW BARUCH I MAR BIOL; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Simpkins DG, 2003, CAN J ZOOL, V81, P1641, DOI [10.1139/z03-157, 10.1139/Z03-157]; SINICROPE TL, 1990, ESTUARIES, V13, P25, DOI 10.2307/1351429; Slason E, 2000, P 5 BIENN LONG ISL S; Smith SM, 2012, TIDAL MARSH RESTORAT, P59; Smith SM, 2009, RESTOR ECOL, V17, P606, DOI 10.1111/j.1526-100X.2008.00426.x; SPALDING MG, 1993, J WILDLIFE DIS, V29, P237, DOI 10.7589/0090-3558-29.2.237; TAYLOR MH, 1986, AM ZOOL, V26, P159; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Tomas J, 2000, FISH RES, V46, P131, DOI 10.1016/S0165-7836(00)00140-5; VALIELA I, 1977, MAR BIOL, V40, P135, DOI 10.1007/BF00396259; Warren RS, 2002, RESTOR ECOL, V10, P497, DOI 10.1046/j.1526-100X.2002.01031.x; Watzin M. C., 1992, FRAGILE FRINGE COAST; Weinstein MP, 2010, WETLANDS, V30, P1181, DOI 10.1007/s13157-010-0102-2; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Weis J.S., 2009, SALT MARSHES NATURAL; WEISBERG SB, 1981, MAR BIOL, V61, P243, DOI 10.1007/BF00386666; WEISBERG SB, 1982, MAR BIOL, V66, P307, DOI 10.1007/BF00397037; West JM, 2000, ESTUARIES, V23, P699, DOI 10.2307/1352896; Wozniak AS, 2006, ESTUAR COAST, V29, P568, DOI 10.1007/BF02784283	104	32	32	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46161	10.1371/journal.pone.0046161	http://dx.doi.org/10.1371/journal.pone.0046161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029423	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500067
J	Hua, Z				Hua, Zhu			Biogeographical Divergence of the Flora of Yunnan, Southwestern China Initiated by the Uplift of Himalaya and Extrusion of Indochina Block	PLOS ONE			English	Article							EVOLUTION	The floral composition of Yunnan is conspicuously linked to the biogeographical history of this extremely species-rich province in southwestern China. The floristic compositions of three representative regions in Yunnan were compared to reveal their variation with geography. From southern Yunnan, 4150 native species (including subspecies and varieties) from 1240 genera and 183 families of seed plants were recognized. From central Yunnan 3389 native species from 1095 genera and 167 families of seed plants were recognized. From northwestern Yunnan 6807 native species from 1296 genera and 166 families of seed plants were recognized. Although these three floras across Yunnan are similar in familial composition, similarities between the floras of southern and northwestern Yunnan are low at the generic and specific levels. The flora of northwestern Yunnan is dominated by families and genera with cosmopolitan and north temperate distributions, while the flora of southern Yunnan is dominated by tropical families and genera. Northwestern Yunnan is composed largely of temperate genera, of which the highest proportion has a north temperate distribution. In contrast, southern Yunnan has mainly tropical genera, of which most have a tropical Asian distribution. The flora of central Yunnan is a combination of southern and northwestern Yunnan. These three floras might be derived from a common Tertiary tropical or subtropical East Asian flora, but the geological history of each region has influenced its flora, and they have remained divergent since the late Tertiary. The flora of northwestern Yunnan has evolved with the uplift of the Himalayas and by gradual proliferation of mainly cosmopolitan and north temperate floristic elements, while the flora of southern Yunnan has evolved with extrusion of the Indochina block and the influence of mainly tropical Asian elements.	Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Hua, Z (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn			National Natural Science Foundation of China [41071040, 31170195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China (41071040, 31170195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Jin XC, 2002, J ASIAN EARTH SCI, V20, P633, DOI 10.1016/S1367-9120(01)00084-0; Jin ZZ, 1992, BRAUN BLANQUETIA, V8, P65; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; LI XW, 1986, J BIOGEOGR, V13, P367, DOI 10.2307/2844964; Mehrotra RC, 2005, REV PALAEOBOT PALYNO, V135, P145, DOI [10.1016/j.revpalbo.2005.03.004, 10.1016/j.revpalho.2005.03.004]; Metcalfe I, 2006, GONDWANA RES, V9, P24, DOI 10.1016/j.gr.2005.04.002; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Peng H, 1998, SEED PLANTS MT WULIA, P1; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Takhtajian Y, 1978, FLORISTIC REGION WOR, P50; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Wang Y, 2012, J ASIAN EARTH SCI, V44, P62, DOI 10.1016/j.jseaes.2011.05.020; WU CY, 1988, J JAPANESE BOT, V63, P1; Wu CY., 1996, P 1 INT S FLOR CHAR, P3, DOI DOI 10.1111/JSE.12037; Wu Z.Y., 1987, VEGETATION YUNNAN, P143; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Wu ZY, 1977, FLORA YUNNANICA, V1-16; Yan LC, 2009, J TROPICAL SUBTROPIC, V17, P283; Yang YQ, 2009, TECTONOPHYSICS, V465, P128, DOI 10.1016/j.tecto.2008.11.002; Yin A, 2010, TECTONOPHYSICS, V488, P293, DOI 10.1016/j.tecto.2009.06.002; Zhang DC, 2009, BIODIVERS CONSERV, V18, P699, DOI 10.1007/s10531-008-9534-x; Zhu H, 1997, J BIOGEOGR, V24, P647, DOI 10.1111/j.1365-2699.1997.tb00075.x; Zhu H, 2012, NATIVE SEED PLANTS X, P565; Zhu H, 2009, READ NATURE GEOLOGIC, P1; Zhu H, 2009, LIST SEED PLANTS AIL, P1; Zhu Hua, 2006, Guangxi Zhiwu / Guihaia, V26, P400; Zhu H, 2009, BOT STUD, V50, P467; Zhu H, 2008, ANN MO BOT GARD, V95, P661, DOI 10.3417/2006081; [朱华 ZHU Hua], 2008, [地球科学进展, Advance in Earth Sciences], V23, P830; [朱华 Zhu Hua], 2004, [广西植物, Guihaia], V24, P193	37	33	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45601	10.1371/journal.pone.0045601	http://dx.doi.org/10.1371/journal.pone.0045601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029127	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700049
J	Jia, ZF; Ding, YH; Tian, SY; Niu, JQ; Jiang, J				Jia, Zhifang; Ding, Yanhua; Tian, Suyan; Niu, Junqi; Jiang, Jing			Test of IL28B Polymorphisms in Chronic Hepatitis C Patients Treated with PegIFN and Ribavirin Depends on HCV Genotypes: Results from a Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; INTERFERON PLUS RIBAVIRIN; VIRUS-COINFECTED PATIENTS; EARLY VIRAL KINETICS; GENETIC-VARIATION; PEGYLATED INTERFERON; INTERLEUKIN 28B; PRETREATMENT PREDICTION; SPONTANEOUS CLEARANCE; VIROLOGICAL RESPONSE	Background: Many studies have been published on the association between single nucleotide polymorphisms (SNP) near the IL28B gene and response to the combined treatments of pegylated-interferon (PegIFN) and ribavirin (RBV) in chronic HCV-infected patients, but without identical conclusions. The aim of this study was to assess impact of the IL28B polymorphisms on the effect of HCV standard treatment using meta-analysis based method. Methods: Association studies between polymorphisms of rs12979860 or rs8099917 and response to PegIFN/RBV treatment in chronic HCV patients were retrieved from PubMed. Data of qualified studies on sustained virological response (SVR) in different genotypes were extracted and analyzed using meta-analysis method in Stata 10 software. Results: Thirty-four papers, containing 46 independent studies, were included in the analysis. In the HCV G1/4 patients without treatment history, individuals carrying rs12979860 CC genotype were more likely to achieve SVR (OR 3.97, 95% CI 3.29-4.80) compared to those carrying CT/TT genotypes. Similar results were observed in the HCV G1/4 patients with unsuccessful or unknown treatment history (OR 3.76, 95% CI 2.67-5.28) or in the patients co-infected with human immunodeficiency virus (OR 5.20, 95% CI 3.04-8.90). However, associations could not be observed in HCV G2/3 patients. For rs8099917, similar results were obtained for genotype TT compared to genotypes TG/GG, indicating that TT genotype was significantly associated with better treatment response in patients infected with genotype 1 or 4 HCV, but not genotype 2 or 3 HCV. Conclusion: Polymorphisms of rs12979860 and rs8099917 near IL28B only associate with the treatment response to PegIFN/RBV in patients infected with HCV genotype 1 or 4 but not with genotype 2 or 3, irrespective of the previous treatment history or HIV co-infected status. Therefore, identification of IL28B genotypes is necessary only in patients infected with relatively difficult-to-treat genotype 1 or 4 HCV.	[Jia, Zhifang; Tian, Suyan; Jiang, Jing] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Peoples R China; [Ding, Yanhua] Jilin Univ, Hosp 1, Dept Phase Clin Trials Med 1, Changchun 130023, Peoples R China; [Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Jiang, J (corresponding author), Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Peoples R China.	jiangjing19702000@yahoo.cn	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	National Natural Science Funds of China [81172726, 81072369]; Natural Science Fund of Jilin Province [201215035]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Jilin Province	This work was supported by the National Natural Science Funds of China (Grant No: 81172726 and 81072369,) and the Natural Science Fund of Jilin Province (Grant No: 201215035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Beinhardt S, 2012, HEPATOLOGY, V55, P30, DOI 10.1002/hep.24671; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; De Nicola S, 2012, HEPATOLOGY, V55, P336, DOI 10.1002/hep.24683; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Halfon P, 2011, EUR J GASTROEN HEPAT, V23, P931, DOI 10.1097/MEG.0b013e328349d0ef; Hayashi K, 2011, LIVER INT, V31, P1359, DOI 10.1111/j.1478-3231.2011.02571.x; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Howell CD, 2012, J HEPATOL, V56, P557, DOI 10.1016/j.jhep.2011.10.004; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Labarga P, 2011, AIDS, V25, P1131, DOI 10.1097/QAD.0b013e3283471d83; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Liao XW, 2011, ANTIVIR THER, V16, P141, DOI 10.3851/IMP1703; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Lunge VR, 2012, AIDS RES HUM RETROV, V28, P215, DOI 10.1089/aid.2011.0096; Lyoo K, 2011, J CLIN VIROL, V52, P363, DOI 10.1016/j.jcv.2011.08.006; Mangia A, 2011, HEPATOLOGY, V54, P772, DOI 10.1002/hep.24458; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Miyaaki H, 2011, HEPATOL RES, V41, P1216, DOI 10.1111/j.1872-034X.2011.00881.x; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; O'Brien TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020904; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2011, AIDS, V25, P1025, DOI 10.1097/QAD.0b013e3283471cae; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ridruejo E, 2011, ANN HEPATOL, V10, P452, DOI 10.1016/S1665-2681(19)31512-1; Rumi MG, 2010, GASTROENTEROLOGY, V138, P108, DOI [10.1053/j.gastro.2009.08.071, 10.1053/j.gastro.2010.04.037]; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Scherzer TM, 2011, HEPATOLOGY, V54, P1518, DOI 10.1002/hep.24546; Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Sinn DH, 2011, J GASTROEN HEPATOL, V26, P1374, DOI 10.1111/j.1440-1746.2011.06744.x; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139; Toyoda H, 2011, J MED VIROL, V83, P1203, DOI 10.1002/jmv.22092; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	54	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45698	10.1371/journal.pone.0045698	http://dx.doi.org/10.1371/journal.pone.0045698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029188	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800080
J	Lindhoud, S; Westphal, AH; Borst, JW; van Mierlo, CPM				Lindhoud, Simon; Westphal, Adrie H.; Borst, Jan Willem; van Mierlo, Carlo P. M.			Illuminating the Off-Pathway Nature of the Molten Globule Folding Intermediate of an alpha-beta Parallel Protein	PLOS ONE			English	Article							AZOTOBACTER-VINELANDII; REFRACTIVE-INDEX; FLUORESCENCE DEPOLARIZATION; HYDROGEN-EXCHANGE; ENERGY LANDSCAPE; APOFLAVODOXIN; STATE; AGGREGATION; MECHANISM; CUTINASE	Partially folded protein species transiently form during folding of most proteins. Often, these species are molten globules, which may be on-or off-pathway to the native state. Molten globules are ensembles of interconverting protein conformers that have a substantial amount of secondary structure, but lack virtually all tertiary side-chain packing characteristics of natively folded proteins. Due to solvent-exposed hydrophobic groups, molten globules are prone to aggregation, which can have detrimental effects on organisms. The molten globule observed during folding of the 179-residue apoflavodoxin from Azotobacter vinelandii is off-pathway, as it has to unfold before native protein can form. Here, we study folding of apoflavodoxin and characterize its molten globule using fluorescence spectroscopy and Forster Resonance Energy Transfer (FRET). Apoflavodoxin is site-specifically labeled with fluorescent donor and acceptor dyes, utilizing dye-inaccessibility of Cys69 in cofactor-bound protein. Donor (i.e., Alexa Fluor 488) is covalently attached to Cys69 in all apoflavodoxin variants used. Acceptor (i.e., Alexa Fluor 568) is coupled to Cys1, Cys131 and Cys178, respectively. Our FRET data show that apoflavodoxin's molten globule forms in a non-cooperative manner and that its N-terminal 69 residues fold last. In addition, striking conformational differences between molten globule and native protein are revealed, because the inter-label distances sampled in the 111-residue C-terminal segment of the molten globule are shorter than observed for native apoflavodoxin. Thus, FRET sheds light on the off-pathway nature of the molten globule during folding of an alpha-beta parallel protein.	[Lindhoud, Simon; Westphal, Adrie H.; Borst, Jan Willem; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [Westphal, Adrie H.; Borst, Jan Willem] Wageningen Univ, Microspect Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	Borst, Jan Willem/B-1259-2011; Westphal, Adrie Herman/L-3517-2019; vanMierlo, Carlo p/B-4491-2016	Westphal, Adrie Herman/0000-0003-4264-6267; vanMierlo, Carlo p/0000-0002-5358-8392	Netherlands Organization for Scientific Research (NWO) [700.56.002]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research (NWO) supported this work (grant number 700.56.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; AMIR D, 1992, PROTEINS, V13, P162, DOI 10.1002/prot.340130210; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fernandez-Recio J, 2001, BIOCHEMISTRY-US, V40, P15234, DOI 10.1021/bi010216t; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Haas E, 2005, CHEMPHYSCHEM, V6, P858, DOI 10.1002/cphc.200400617; Huang F, 2008, PROTEIN ENG DES SEL, V21, P131, DOI 10.1093/protein/gzm069; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Knox RS, 2002, J PHYS CHEM B, V106, P5289, DOI 10.1021/jp013927+; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laptenok SP, 2011, BIOCHEMISTRY-US, V50, P3441, DOI 10.1021/bi101965d; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; Melo EP, 2003, BIOCHEMISTRY-US, V42, P7611, DOI 10.1021/bi034267x; Nabuurs SM, 2010, EUR BIOPHYS J BIOPHY, V39, P689, DOI 10.1007/s00249-009-0556-4; Nabuurs SM, 2010, J BIOL CHEM, V285, P4165, DOI 10.1074/jbc.M109.087932; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nozaki Y., 1972, PREPARATION GUANIDIN; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Otzen DE, 2007, BBA-PROTEINS PROTEOM, V1774, P323, DOI 10.1016/j.bbapap.2006.11.012; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Ratner V, 2002, BIOCONJUGATE CHEM, V13, P1163, DOI 10.1021/bc025537b; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; SZABO A, 1984, J CHEM PHYS, V81, P150, DOI 10.1063/1.447378; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van den Berg PAW, 2004, BIOPHYS J, V87, P2577, DOI 10.1529/biophysj.104.040030; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Visser NV, 2008, BIOPHYS J, V95, P2462, DOI 10.1529/biophysj.108.132001; Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072	56	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45746	10.1371/journal.pone.0045746	http://dx.doi.org/10.1371/journal.pone.0045746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029219	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800090
J	Smith, SEP; Bida, AT; Davis, TR; Sicotte, H; Patterson, SE; Gil, D; Schrum, AG				Smith, Stephen E. P.; Bida, Anya T.; Davis, Tessa R.; Sicotte, Hugues; Patterson, Steven E.; Gil, Diana; Schrum, Adam G.			IP-FCM Measures Physiologic Protein-Protein Interactions Modulated by Signal Transduction and Small-Molecule Drug Inhibition	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; RECOGNITION; CELLS; IDENTIFICATION; SENSITIVITY; COMPLEX; CANCER; IL-2; SELF	Protein-protein interactions (PPI) mediate the formation of intermolecular networks that control biological signaling. For this reason, PPIs are of outstanding interest in pharmacology, as they display high specificity and may represent a vast pool of potentially druggable targets. However, the study of physiologic PPIs can be limited by conventional assays that often have large sample requirements and relatively low sensitivity. Here, we build on a novel method, immunoprecipitation detected by flow cytometry (IP-FCM), to assess PPI modulation during either signal transduction or pharmacologic inhibition by two different classes of small-molecule compounds. First, we showed that IP-FCM can detect statistically significant differences in samples possessing a defined PPI change as low as 10%. This sensitivity allowed IP-FCM to detect a PPI that increases transiently during T cell signaling, the antigen-inducible interaction between ZAP70 and the T cell antigen receptor (TCR)/CD3 complex. In contrast, IP-FCM detected no ZAP70 recruitment when T cells were stimulated with antigen in the presence of the src-family kinase inhibitor, PP2. Further, we tested whether IP-FCM possessed sufficient sensitivity to detect the effect of a second, rare class of compounds called SMIPPI (small-molecule inhibitor of PPI). We found that the first-generation non-optimized SMIPPI, Ro-26-4550, inhibited the IL-2:CD25 interaction detected by IP-FCM. This inhibition was detectable using either a recombinant CD25-Fc chimera or physiologic full-length CD25 captured from T cell lysates. Thus, we demonstrate that IP-FCM is a sensitive tool for measuring physiologic PPIs that are modulated by signal transduction and pharmacologic inhibition.	[Smith, Stephen E. P.; Bida, Anya T.; Davis, Tessa R.; Gil, Diana; Schrum, Adam G.] Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Sicotte, Hugues] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Patterson, Steven E.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Schrum, AG (corresponding author), Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA.	schrum.adam@mayo.edu		Schrum, Adam/0000-0001-9276-1859	National Institutes of Health [1R56AI084861]; Fraternal Order of Eagles Pilot Project grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Pilot Project grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant 1R56AI084861, a Fraternal Order of Eagles Pilot Project grant, a generous philanthropic gift for research directed toward Alopecia Areata by Mr. Bernard Fineman (AGS), and the Mayo Foundation (DG, AGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bida AT, 2012, METHODS, V56, P154, DOI 10.1016/j.ymeth.2011.09.005; Blazer LL, 2009, NEUROPSYCHOPHARMACOL, V34, P126, DOI 10.1038/npp.2008.151; Colas Pierre, 2008, Curr Drug Discov Technol, V5, P190, DOI 10.2174/157016308785739875; Davis TR, 2010, J VIS EXP; de la Cruz J, 2011, J IMMUNOL, V186, P2282, DOI 10.4049/jimmunol.1003225; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Gil D, 2008, J IMMUNOL, V180, P3900, DOI 10.4049/jimmunol.180.6.3900; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Kay BK, 1996, MOL DIVERS, V1, P139, DOI 10.1007/BF01721330; Laudet B, 2008, MOL CELL BIOCHEM, V316, P63, DOI 10.1007/s11010-008-9821-6; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Raimundo BC, 2004, J MED CHEM, V47, P3111, DOI 10.1021/jm049967u; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schrum A. G., 2007, SCI STKE, P12; Schrum Adam G, 2009, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0509s87; Schrum AG, 2011, J IMMUNOL, V187, P870, DOI 10.4049/jimmunol.1100538; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tilley JW, 1997, J AM CHEM SOC, V119, P7589, DOI 10.1021/ja970702x; Wilson CGM, 2011, CURR TOP MICROBIOL, V348, P25, DOI 10.1007/82_2010_93	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45722	10.1371/journal.pone.0045722	http://dx.doi.org/10.1371/journal.pone.0045722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029201	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800084
J	Tamura, Y; Ono, T; Kuwana, M; Inoue, K; Takei, M; Yamamoto, T; Kawakami, T; Fujita, J; Kataoka, M; Kimura, K; Sano, M; Daida, H; Satoh, T; Fukuda, K				Tamura, Yuichi; Ono, Tomohiko; Kuwana, Masataka; Inoue, Kenji; Takei, Makoto; Yamamoto, Tsunehisa; Kawakami, Takashi; Fujita, Jun; Kataoka, Masaharu; Kimura, Kensuke; Sano, Motoaki; Daida, Hiroyuki; Satoh, Toru; Fukuda, Keiichi			Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension	PLOS ONE			English	Article							RECOGNITION RECEPTOR PTX3; LONG PENTRAXIN; SYSTEMIC-SCLEROSIS; ALTERNATIVE ACTIVATION; VASCULAR INFLAMMATION; INNATE IMMUNITY; HEART-FAILURE; MARKER; EXPRESSION; OUTCOMES	Background: Although inflammation is an important feature of pulmonary arterial hypertension (PAH), the usefulness of local inflammatory markers as biomarkers for PAH is unknown. In this study, we tested whether plasma concentrations of human pentraxin 3 (PTX3), a local inflammatory marker, would be a useful biomarker for detecting PAH. Methods: Plasma PTX3 concentrations were evaluated in 50 PAH patients (27 with idiopathic PAH, 17 with PAH associated with connective tissue disease (CTD-PAH), and six with congenital heart disease), 100 age and sex-matched healthy controls, and 34 disease-matched CTD patients without PAH. Plasma concentrations of B-type natriuretic peptide (BNP) and C-reactive protein (CRP) were also determined. Results: Mean PTX3 levels were significantly higher in all PAH patients than in the healthy controls (4.40 +/- 0.37 vs. 1.94 +/- 0.09 ng/mL, respectively; P<0.001). Using a threshold level of 2.84 ng/mL, PTX3 yielded a sensitivity of 74.0% and a specificity of 84.0% for the detection of PAH. In CTD-PAH patients, mean PTX3 concentrations were significantly higher than in CTD patients without PAH (5.02 +/- 0.69 vs. 2.40 +/- 0.14 ng/mL, respectively; P<0.001). There was no significant correlation between plasma levels of PTX3 and BNP or CRP. Receiver operating characteristic (ROC) curves for screening PAH in patients with CTD revealed that PTX3 (area under the ROC curve 0.866) is superior to BNP. Using a PTX3 threshold of 2.85 ng/mL maximized true-positive and false-negative results (sensitivity 94.1%, specificity 73.5%). Conclusion: Plasma concentrations of PTX3 may be a better biomarker of PAH than BNP, especially in patients with CTD.	[Tamura, Yuichi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Kawakami, Takashi; Fujita, Jun; Kimura, Kensuke; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Rheumatol, Tokyo, Japan; [Inoue, Kenji] Juntendo Univ, Nerima Hosp, Dept Cardiol, Tokyo, Japan; [Kataoka, Masaharu; Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan	Keio University; Keio University; Juntendo University; Kyorin University; Juntendo University	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013; Yamamoto, Tsunehisa/O-2014-2013; Sano, Motoaki/L-3405-2013; Tamura, Yuichi/B-5991-2014; Kuwana, Masataka/L-2918-2013	Yamamoto, Tsunehisa/0000-0002-5241-9482; Tamura, Yuichi/0000-0002-4437-8019				Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Cavagna L, 2010, J RHEUMATOL, V37, P2064, DOI 10.3899/jrheum.090997; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Hinchcliff M, 2011, J RHEUMATOL, V38, P2172, DOI 10.3899/jrheum.101243; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Ishihara T, 2011, J AM COLL CARDIOL, V57, P1712, DOI 10.1016/j.jacc.2010.10.058; Launay D, 2007, J RHEUMATOL, V34, P1005; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsubara J, 2011, J AM COLL CARDIOL, V57, P861, DOI 10.1016/j.jacc.2010.10.018; Mukerjee D, 2004, RHEUMATOLOGY, V43, P461, DOI 10.1093/rheumatology/keh067; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Schreiber BE, 2011, ARTHRITIS RHEUM-US, V63, P3531, DOI 10.1002/art.30535; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Williams MH, 2006, EUR HEART J, V27, P1485, DOI 10.1093/eurheartj/ehi891; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	30	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45834	10.1371/journal.pone.0045834	http://dx.doi.org/10.1371/journal.pone.0045834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029266	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800103
J	Albrecht, M; Arnhold, M; Lingner, S; Mahapatra, S; Bruder, D; Hansen, G; Dittrich, AM				Albrecht, Melanie; Arnhold, Markus; Lingner, Sandra; Mahapatra, Subhashree; Bruder, Dunja; Hansen, Gesine; Dittrich, Anna-Maria			IL-4 Attenuates Pulmonary Epithelial Cell-Mediated Suppression of T Cell Priming	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GITR LIGAND; CYTOKINES; INDUCE; EXPRESSION; ACTIVATION; ANTIGEN; CHEMOKINES; CHILDREN; IMMUNITY	We have previously shown that Th2-polarized airway inflammation facilitates sensitization towards new, protein antigens. In this context, we could demonstrate that IL-4 needs to act on cells of the hematopoetic and the structural compartment in order to facilitate sensitization towards new antigens. We thus aimed to elucidate possible mechanisms of action of IL-4 on structural cells choosing to analyze pulmonary epithelial cells as an important part of the lung's structural system. We used a co-culture system of DC- or APC-dependent in vitro priming of T cells, co-cultivated on a layer of cells of a murine pulmonary epithelial cell line (LA-4) pretreated with or without IL-4. Effects on T cell priming were analyzed via CFSE-dilution and flow cytometric assessment of activation status. Pulmonary epithelial cells suppressed T cell proliferation in vitro but this effect was attenuated by pre-treatment of the epithelial cells with IL-4. Transwell experiments suggest that epithelial-mediated suppression of T cell activation is mostly cell-contact dependent and leads to attenuation in an early naive T cell phenotype. Secretion of soluble factors like TARC, TSLP, GM-CSF and CCL20 by epithelial cells did not change after IL-4 treatment. However, analysis of co-stimulatory expression on pulmonary epithelial cells revealed that pre-treatment of epithelial cells with IL-4 changed expression GITR-L, suggesting a possible mechanism for the effects observed. Our studies provide new insight into the role of IL-4 during the early phases of pulmonary sensitization: The inhibitory activity of pulmonary epithelial cells in homeostasis is reversed in the presence of IL-4, which is secreted in the context of Th2-dominated allergic airway inflammation. This mechanism might serve to explain facilitated sensitization in the clinical context of polysensitization where due to a pre-existing sensitization increased levels of IL-4 in the airways might facilitate T cell priming towards new antigens.	[Albrecht, Melanie; Arnhold, Markus; Lingner, Sandra; Mahapatra, Subhashree; Hansen, Gesine; Dittrich, Anna-Maria] Hannover Med Sch, D-3000 Hannover, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Bruder, Dunja] Univ Magdeburg, Dept Med Microbiol, Res Grp Infect Immunol, D-39106 Magdeburg, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University	Dittrich, AM (corresponding author), Hannover Med Sch, D-3000 Hannover, Germany.	dittrich.anna-maria@mh-hannover.de	Dittrich, Anna/GRY-6738-2022; Dittrich, Anna Maria/M-5640-2013		National Institutes of Health [RO1 HL54450-09]; Deutsche Forschungsgemeinschaft [DI 1224/1-1, SFB 587, N01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (grant RO1 HL54450-09, KB) and the Deutsche Forschungsgemeinschaft (DI 1224/1-1 and SFB 587, N01, AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne Aideen M, 2009, J Invest Dermatol, V129, P2784, DOI 10.1038/jid.2009.163; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Cunningham AC, 1997, IMMUNOLOGY, V91, P458, DOI 10.1046/j.1365-2567.1997.d01-2249.x; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Dittrich AM, 2008, J IMMUNOL, V181, P7307, DOI 10.4049/jimmunol.181.10.7307; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Mahesh SP, 2006, EUR J IMMUNOL, V36, P2128, DOI 10.1002/eji.200635893; Meyer-Hoffert U, 2003, INT ARCH ALLERGY IMM, V131, P264, DOI 10.1159/000072138; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Qiao JO, 2011, IMMUNOL CELL BIOL, V89, P231, DOI 10.1038/icb.2010.85; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; STONER GD, 1975, CANCER RES, V35, P2177; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Wang H, 2009, THORAX, V64, P283, DOI 10.1136/thx.2007.094870; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45916	10.1371/journal.pone.0045916	http://dx.doi.org/10.1371/journal.pone.0045916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029313	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900110
J	Wales, N; Romero-Navarro, JA; Cappellini, E; Gilbert, MTP				Wales, Nathan; Alberto Romero-Navarro, J.; Cappellini, Enrico; Gilbert, M. Thomas P.			Choosing the Best Plant for the Job: A Cost-Effective Assay to Prescreen Ancient Plant Remains Destined for Shotgun Sequencing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEANDERTHAL GENOME; LEAF DEVELOPMENT; DNA; MAIZE; PCR; CAPTURE; HISTORY; MAMMOTH; NUMBER	DNA extracted from ancient plant remains almost always contains a mixture of endogenous (that is, derived from the plant) and exogenous (derived from other sources) DNA. The exogenous 'contaminant' DNA, chiefly derived from microorganisms, presents significant problems for shotgun sequencing. In some samples, more than 90% of the recovered sequences are exogenous, providing limited data relevant to the sample. However, other samples have far less contamination and subsequently yield much more useful data via shotgun sequencing. Given the investment required for high-throughput sequencing, whenever multiple samples are available, it is most economical to sequence the least contaminated sample. We present an assay based on quantitative real-time PCR which estimates the relative amounts of fungal and bacterial DNA in a sample in comparison to the endogenous plant DNA. Given a collection of contextually-similar ancient plant samples, this low cost assay aids in selecting the best sample for shotgun sequencing.	[Wales, Nathan] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Wales, Nathan; Alberto Romero-Navarro, J.; Cappellini, Enrico; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Alberto Romero-Navarro, J.] Univ Nacl Autonoma Mexico, Undergrad Program Genom Sci, Cuernavaca 62191, Morelos, Mexico	University of Connecticut; Universidad Nacional Autonoma de Mexico	Wales, N (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT USA.	n_wales@hotmail.com	Wales, Nathan/B-4263-2015; Gilbert, Marcus TP/A-8936-2013; Cappellini, Enrico/F-9346-2013	Wales, Nathan/0000-0003-0359-8450; Gilbert, Marcus TP/0000-0002-5805-7195; Cappellini, Enrico/0000-0001-7885-7811	Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship [237227]; American-Scandinavian Foundation; University of Connecticut Open Access Author Fund; Department of Anthropology, University of Connecticut	Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship; American-Scandinavian Foundation; University of Connecticut Open Access Author Fund; Department of Anthropology, University of Connecticut	Funding came from the Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship [grant number 237227 allotted to E. C.]; and American-Scandinavian Foundation [dissertation fellowship for N.W.]. Funding for open access charge: University of Connecticut Open Access Author Fund and Department of Anthropology, University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby R.G., 1997, ANCIENT BIOMOLECULES, V1, P119; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown T. A., 1998, ANCIENT BIOMOLECULES, V2, P185; Bunning SL, 2012, J ARCHAEOL SCI, V39, P2780, DOI 10.1016/j.jas.2012.04.012; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cappellini E, 2010, NATURWISSENSCHAFTEN, V97, P205, DOI 10.1007/s00114-009-0629-3; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cooper A, 2000, SCIENCE, V289, P1139; Delseny M, 2010, PLANT SCI, V179, P407, DOI 10.1016/j.plantsci.2010.07.019; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Kudo N, 2001, SEX PLANT REPROD, V13, P279, DOI 10.1007/s004970100066; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutz KA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-54; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, J BIOL CHEM, V264, P9709; Palmer SA, 2012, MOL BIOL EVOL, V29, P2031, DOI 10.1093/molbev/mss070; Palmer SA, 2012, ANN ANAT, V194, P146, DOI 10.1016/j.aanat.2011.03.012; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; POSSINGH.JV, 1969, PLANTA, V86, P186, DOI 10.1007/BF00379826; Pyke K, 2009, PLASTID BIOLOGY, P1, DOI 10.1017/CBO9780511626715; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schlumbaum A, 2008, VEG HIST ARCHAEOBOT, V17, P233, DOI 10.1007/s00334-007-0125-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shaver JM, 2006, PLANTA, V224, P72, DOI 10.1007/s00425-005-0195-7; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Zoschke R, 2007, PLANT J, V50, P710, DOI 10.1111/j.1365-313X.2007.03084.x	50	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45644	10.1371/journal.pone.0045644	http://dx.doi.org/10.1371/journal.pone.0045644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029156	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900084
J	Gao, YX; Li, HY; Liu, J				Gao, Yunxia; Li, Haiyan; Liu, Jing			Direct Writing of Flexible Electronics through Room Temperature Liquid Metal Ink	PLOS ONE			English	Article							ORGANIC TRANSISTORS; LOW-COST; PAPER; CIRCUITS; POLYMER; SEMITRANSPARENT; PLATFORM; SENSOR; FILMS; THIN	Background: Conventional approaches of making a flexible circuit are generally complex, environment unfriendly, time and energy consuming, and thus expensive. Here, we describe for the first time the method of using high-performance GaIn10-based electrical ink, a significantly neglected room temperature liquid metal, as both electrical conductors and interconnects, for directly writing flexible electronics via a rather easy going and cost effective way. Methods: The new generation electric ink was made and its wettability with various materials was modified to be easily written on a group of either soft or rigid substrates such as epoxy resin board, glass, plastic, silica gel, paper, cotton, textiles, cloth and fiber etc. Conceptual experiments were performed to demonstrate and evaluate the capability of directly writing the electrical circuits via the invented metal ink. Mechanisms involved were interpreted through a series of fundamental measurements. Results: The electrical resistivity of the fluid like GaIn10-based material was measured as 34.5 mu Omega.cm at 297 K by four point probe method and increased with addition of the oxygen quantity, which indicates it as an excellent metal ink. The conductive line can be written with features that are approximately 10 mu m thick. Several functional devices such as a light emitting diode (LED) array showing designed lighting patterns and electrical fan were made to work by directly writing the liquid metal on the specific flexible substrates. And satisfactory performances were obtained. Conclusions: The present method opens the way to directly and quickly writing flexible electronics which can be as simple as signing a name or drawing a picture on the paper. The unique merit of the GaIn10-based liquid metal ink lies in its low melting temperature, well controlled wettability, high electrical conductivity and good biocompability. The new electronics writing strategy and basic principle has generalized purpose and can be extended to more industrial areas, even daily life.	[Gao, Yunxia; Li, Haiyan; Liu, Jing] Chinese Acad Sci, Key Lab Cryogen, Tech Inst Phys & Chem, Beijing, Peoples R China; [Liu, Jing] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Tsinghua University	Liu, J (corresponding author), Chinese Acad Sci, Key Lab Cryogen, Tech Inst Phys & Chem, Beijing, Peoples R China.	jliu@mail.ipc.ac.cn						Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI 10.1038/NNANO.2010.232; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Dragoman M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/37/375203; Fan ZY, 2009, ADV MATER, V21, P3730, DOI 10.1002/adma.200900860; Fan ZY, 2009, NAT MATER, V8, P648, DOI [10.1038/NMAT2493, 10.1038/nmat2493]; Gao YX, 2012, APPL PHYS A-MATER, V107, P701, DOI 10.1007/s00339-012-6887-5; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; Gates BD, 2009, SCIENCE, V323, P1566, DOI 10.1126/science.1171230; Hu LB, 2010, ACS NANO, V4, P5843, DOI 10.1021/nn1018158; Hu LB, 2009, P NATL ACAD SCI USA, V106, P21490, DOI 10.1073/pnas.0908858106; Ko SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345202; Li Y, 2005, SCIENCE, V308, P1419, DOI 10.1126/science.1110168; Liu J, 1999, CONDUCTIVE ADHESIVES; Ma Kunquan, 2007, Frontiers of Energy and Power Engineering in China, V1, P384, DOI 10.1007/s11708-007-0057-3; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Nikitin PV, 2004, IEEE ANTENNAS AND PROPAGATION SOCIETY SYMPOSIUM, VOLS 1-4 2004, DIGEST, P2035, DOI 10.1109/APS.2004.1330607; Park I, 2008, ADV MATER, V20, P489, DOI 10.1002/adma.200702326; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Pech D, 2010, J POWER SOURCES, V195, P1266, DOI 10.1016/j.jpowsour.2009.08.085; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Redinger D, 2004, IEEE T ELECTRON DEV, V51, P1978, DOI 10.1109/TED.2004.838451; Rida A, 2009, IEEE ANTENN PROPAG M, V51, P13, DOI 10.1109/MAP.2009.5251188; Russo A, 2011, ADV MATER, V23, P3426, DOI 10.1002/adma.201101328; Sekitani T, 2010, NAT MATER, V9, P1015, DOI 10.1038/NMAT2896; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Siegel AC, 2010, ADV FUNCT MATER, V20, P28, DOI 10.1002/adfm.200901363; SZYMANSKI D, 1979, J SOLID STATE CHEM, V30, P55, DOI 10.1016/0022-4596(79)90129-4; Taylor L. T., 1998, U.S. patent, Patent No. [5.792.236, 5792236, 5,792,236]; Wang Q, 2001, CHINESE SCI BULL, V46, P1431, DOI 10.1007/BF03187023; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287; Yu ZB, 2011, ADV MATER, V23, P4453, DOI 10.1002/adma.201101992; Zschieschang U, 2010, ADV MATER, V22, P982, DOI 10.1002/adma.200902740	40	123	129	7	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45485	10.1371/journal.pone.0045485	http://dx.doi.org/10.1371/journal.pone.0045485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029044	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400092
J	Le Mercier, M; Hastir, D; Lopez, XM; De Neve, N; Maris, C; Trepant, AL; Rorive, S; Decaestecker, C; Salmon, I				Le Mercier, Marie; Hastir, Delfyne; Lopez, Xavier Moles; De Neve, Nancy; Maris, Calliope; Trepant, Anne-Laure; Rorive, Sandrine; Decaestecker, Christine; Salmon, Isabelle			A Simplified Approach for the Molecular Classification of Glioblastomas	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; MALIGNANT GLIOMAS; IMAGE-ANALYSIS; COPY NUMBER; EXPRESSION; MUTATION; TISSUE; PROGNOSIS; PATHWAYS	Glioblastoma (GBM) is the most common malignant primary brain tumors in adults and exhibit striking aggressiveness. Although GBM constitute a single histological entity, they exhibit considerable variability in biological behavior, resulting in significant differences in terms of prognosis and response to treatment. In an attempt to better understand the biology of GBM, many groups have performed high-scale profiling studies based on gene or protein expression. These studies have revealed the existence of several GBM subtypes. Although there remains to be a clear consensus, two to four major subtypes have been identified. Interestingly, these different subtypes are associated with both differential prognoses and responses to therapy. In the present study, we investigated an alternative immunohistochemistry (IHC)-based approach to achieve a molecular classification for GBM. For this purpose, a cohort of 100 surgical GBM samples was retrospectively evaluated by immunohistochemical analysis of EGFR, PDGFRA and p53. The quantitative analysis of these immunostainings allowed us to identify the following two GBM subtypes: the "Classical-like" (CL) subtype, characterized by EGFR-positive and p53-and PDGFRA-negative staining and the "Proneural-like" (PNL) subtype, characterized by p53-and/or PDGFRA-positive staining. This classification represents an independent prognostic factor in terms of overall survival compared to age, extent of resection and adjuvant treatment, with a significantly longer survival associated with the PNL subtype. Moreover, these two GBM subtypes exhibited different responses to chemotherapy. The addition of temozolomide to conventional radiotherapy significantly improved the survival of patients belonging to the CL subtype, but it did not affect the survival of patients belonging to the PNL subtype. We have thus shown that it is possible to differentiate between different clinically relevant subtypes of GBM by using IHC-based profiling, a method that is advantageous in its ease of daily implementation and in large-scale clinical application.	[Le Mercier, Marie; Hastir, Delfyne; De Neve, Nancy; Maris, Calliope; Trepant, Anne-Laure; Rorive, Sandrine; Salmon, Isabelle] Univ Libre Brussels, Erasme Univ Hosp, Dept Pathol, Brussels, Belgium; [Lopez, Xavier Moles; Decaestecker, Christine] Univ Libre Brussels, Ecole Polytech Bruxelles, Brussels Sch Engn, LISA, Brussels, Belgium; [Lopez, Xavier Moles; Rorive, Sandrine; Decaestecker, Christine; Salmon, Isabelle] Acad Univ Wallonie Bruxelles, DIAPath Ctr Microscopy & Mol Imaging CMMI, Gosselies, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Salmon, I (corresponding author), Univ Libre Brussels, Erasme Univ Hosp, Dept Pathol, Brussels, Belgium.	Isabelle.Salmon@erasme.ulb.ac.be		Decaestecker, Christine/0000-0002-5495-1931	Televie, a program of the "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium); Fonds Yvonne Boel (Brussels, Belgium); European Regional Development Fund; Walloon Region	Televie, a program of the "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium); Fonds Yvonne Boel (Brussels, Belgium); European Regional Development Fund(European Commission); Walloon Region	Funding came from Televie, a program of the "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium), http://www2.frs-fnrs.be/, and Fonds Yvonne Boel (Brussels, Belgium), http://www.fondsyvonneboel.be/. The CMMI is supported by the European Regional Development Fund, http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm; and the Walloon Region, http://www.wallonie.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coulibaly B, 2010, HUM PATHOL, V41, P815, DOI 10.1016/j.humpath.2009.09.020; D'Haene N, 2005, INT J IMMUNOPATH PH, V18, P431, DOI 10.1177/039463200501800304; Decaestecker C, 2009, PROTEOMICS, V9, P4478, DOI 10.1002/pmic.200800936; Ducray F, 2009, CURR OPIN ONCOL, V21, P537, DOI 10.1097/CCO.0b013e32833065a7; Eguiluz C, 2006, PATHOL RES PRACT, V202, P561, DOI 10.1016/j.prp.2006.04.003; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Huse JT, 2011, GLIA; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kajdacsy-Balla A, 2007, J MOL HISTOL, V38, P113, DOI 10.1007/s10735-006-9054-5; Lopez-Gines C, 2010, MODERN PATHOL, V23, P856, DOI 10.1038/modpathol.2010.62; Marquez A, 2004, DIAGN MOL PATHOL, V13, P1, DOI 10.1097/00019606-200403000-00001; Martinho O, 2009, BRIT J CANCER, V101, P973, DOI 10.1038/sj.bjc.6605225; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1023, DOI 10.1093/jnci/dji193; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Metzger GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033520; Muris JJF, 2006, J PATHOL, V208, P714, DOI 10.1002/path.1924; NEWCOMB EW, 1993, BRAIN PATHOL, V3, P229, DOI 10.1111/j.1750-3639.1993.tb00749.x; Nikiforova MN, 2011, ARCH PATHOL LAB MED, V135, P558, DOI 10.1043/2010-0649-RAIR.1; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollack IF, 1997, CANCER RES, V57, P304; Rasheed A, 2002, CANCER-AM CANCER SOC, V94, P2688, DOI 10.1002/cncr.10544; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; The WHO, 2020, CLASSIFICATION TUMOU; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoon KS, 2001, J KOREAN MED SCI, V16, P481, DOI 10.3346/jkms.2001.16.4.481	37	46	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45475	10.1371/journal.pone.0045475	http://dx.doi.org/10.1371/journal.pone.0045475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029035	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900143
J	Moreau, R; Malu, DT; Dumais, M; Dalko, E; Gaudreault, V; Romero, H; Martineau, C; Kevorkova, O; Dardon, JS; Dodd, EL; Bohle, DS; Scorza, T				Moreau, Robert; Malu, Diane Tshikudi; Dumais, Mathieu; Dalko, Esther; Gaudreault, Veronique; Romero, Hugo; Martineau, Corine; Kevorkova, Olha; Dardon, Jaime Sanchez; Dodd, Erin Lynn; Bohle, David Scott; Scorza, Tatiana			Alterations in Bone and Erythropoiesis in Hemolytic Anemia: Comparative Study in Bled, Phenylhydrazine-Treated and Plasmodium-Infected Mice	PLOS ONE			English	Article							HEME OXYGENASE-1; MALARIAL ANEMIA; EXTRAMEDULLARY HEMATOPOIESIS; INEFFECTIVE ERYTHROPOIESIS; SUPPRESSION; MINERALIZATION; INDUCTION; HEMOPEXIN	Sustained erythropoiesis and concurrent bone marrow hyperplasia are proposed to be responsible for low bone mass density (BMD) in chronic hemolytic pathologies. As impaired erythropoiesis is also frequent in these conditions, we hypothesized that free heme may alter marrow and bone physiology in these disorders. Bone status and bone marrow erythropoiesis were studied in mice with hemolytic anemia (HA) induced by phenylhydrazine (PHZ) or Plasmodium infection and in bled mice. All treatments resulted in lower hemoglobin concentrations, enhanced erythropoiesis in the spleen and reticulocytosis. The anemia was severe in mice with acute hemolysis, which also had elevated levels of free heme and ROS. No major changes in cellularity and erythroid cell numbers occurred in the bone marrow of bled mice, which generated higher numbers of erythroid blast forming units (BFU-E) in response to erythropoietin. In contrast, low numbers of bone marrow erythroid precursors and BFU-E and low concentrations of bone remodelling markers were measured in mice with HA, which also had blunted osteoclastogenesis, in opposition to its enhancement in bled mice. The alterations in bone metabolism were accompanied by reduced trabecular bone volume, enhanced trabecular spacing and lower trabecular numbers in mice with HA. Taken together our data suggests that hemolysis exerts distinct effects to bleeding in the marrow and bone and may contribute to osteoporosis through a mechanism independent of the erythropoietic stress.	[Moreau, Robert; Malu, Diane Tshikudi; Dumais, Mathieu; Dalko, Esther; Gaudreault, Veronique; Romero, Hugo; Martineau, Corine; Kevorkova, Olha; Dardon, Jaime Sanchez; Scorza, Tatiana] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Dodd, Erin Lynn; Bohle, David Scott] McGill Univ, Dept Chem, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; McGill University	Scorza, T (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	scorza.tatiana@uqam.ca	Scorza, Tatiana/AAM-8992-2020	Dalko, Esther/0000-0001-7166-7417; Dodd, Erin/0000-0002-9870-2398; Martineau, Corine/0000-0002-1550-2420	Centre for Host Parasite Interactions (Fonds de Recherche Nature et Technologies, FQRNT, Quebec, Canada)	Centre for Host Parasite Interactions (Fonds de Recherche Nature et Technologies, FQRNT, Quebec, Canada)	The study was funded by a New Initiative grant from the Centre for Host Parasite Interactions (Fonds de Recherche Nature et Technologies, FQRNT, Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla J, 2000, BLOOD, V95, P3442, DOI 10.1182/blood.V95.11.3442.011k51_3442_3450; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Berger J., 2007, J APPL BIOMED, V5, P125, DOI [10.32725/jab.2007.017, DOI 10.32725/JAB.2007.017]; BOZZINI CE, 1970, AM J PHYSIOL, V219, P724, DOI 10.1152/ajplegacy.1970.219.3.724; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; Clemens M, 1984, BIOCH PHARM, V33; Crepaldi G, 2009, J Endocrinol Invest, V32, P2; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Faber TD, 2002, J DENT RES, V81, P214, DOI 10.1177/154405910208100314; Falk J, 1965, PORPHYRINS METALLOPO; Fasola F, 2007, J NATL MED ASSOC, V99, P891; Giuliani AL, 2007, EUR J HAEMATOL, V78, P72, DOI 10.1111/j.0902-4441.2006.t01-1-EJH3017.x; Gurevitch O, 2007, EXP HEMATOL, V35, P128, DOI 10.1016/j.exphem.2006.09.010; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Haidar R, 2011, BONE, V48, P425, DOI 10.1016/j.bone.2010.10.173; Haidar R, 2010, EUR SPINE J, V19, P871, DOI 10.1007/s00586-010-1357-2; Helleberg M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-56; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Ileri T, 2009, J PEDIAT HEMATOL ONC, V31, P681, DOI 10.1097/MPH.0b013e3181a71843; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kurtzhals JAL, 1997, BRIT J HAEMATOL, V97, P169, DOI 10.1046/j.1365-2141.1997.82654.x; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; Isidro ML, 2010, CURR DIABETES REV, V6, P144, DOI 10.2174/157339910791162970; Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2725(03)00107-9; MAINES MD, 1984, BIOCHEM J, V217, P409, DOI 10.1042/bj2170409; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; Melchiori Luca, 2010, Adv Hematol, V2010, P938640, DOI 10.1155/2010/938640; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nakamura M, 1999, BRIT J HAEMATOL, V107, P779, DOI 10.1046/j.1365-2141.1999.01774.x; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; Padate B, 2011, AM J HEMATOL, V86, P372, DOI 10.1002/ajh.21953; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Perisano C, 2012, ANEMIA, V2012, DOI 10.1155/2012/320737; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Phumala N, 2003, FREE RADICAL RES, V37, P129, DOI 10.1080/1071576031000060607; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Russell E. S., 1966, BIOL LAB MOUSE; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Skordis Nicos, 2011, Pediatr Endocrinol Rev, V8 Suppl 2, P300; Skorokhod OA, 2010, BLOOD, V116, P4328, DOI 10.1182/blood-2010-03-272781; Thongchote K, 2011, HISTOCHEM CELL BIOL, V136, P47, DOI 10.1007/s00418-011-0823-1; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Voskaridou E, 2001, BRIT J HAEMATOL, V112, P36, DOI 10.1046/j.1365-2141.2001.02549.x; Voskaridou E, 2006, HAEMATOLOGICA, V91, P813; Walkley CR, 2011, INT J HEMATOL, V93, P10, DOI 10.1007/s12185-010-0759-6; Wu CJ, 2005, BLOOD, V106, P3639, DOI 10.1182/blood-2005-04-1376; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	54	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46101	10.1371/journal.pone.0046101	http://dx.doi.org/10.1371/journal.pone.0046101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029401	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900090
J	Yin, L; Fristedt, R; Herdean, A; Solymosi, K; Bertrand, M; Andersson, MX; Mamedov, F; Vener, AV; Schoefs, B; Spetea, C				Yin, Lan; Fristedt, Rikard; Herdean, Andrei; Solymosi, Katalin; Bertrand, Martine; Andersson, Mats X.; Mamedov, Fikret; Vener, Alexander V.; Schoefs, Benoit; Spetea, Cornelia			Photosystem II Function and Dynamics in Three Widely Used Arabidopsis thaliana Accessions	PLOS ONE			English	Article							REVERSIBLE PROTEIN-PHOSPHORYLATION; PHOTOSYNTHETIC MEMBRANES; CHLOROPHYLL-A; HIGHER-PLANTS; FLUORESCENCE TRANSIENT; THYLAKOID MEMBRANES; PROTEOMIC APPROACH; XANTHOPHYLL CYCLE; COMPLEXES; PIGMENTS	Columbia-0 (Col-0), Wassilewskija-4 (Ws-4), and Landsberg erecta-0 (Ler-0) are used as background lines for many public Arabidopsis mutant collections, and for investigation in laboratory conditions of plant processes, including photosynthesis and response to high-intensity light (HL). The photosystem II (PSII) complex is sensitive to HL and requires repair to sustain its function. PSII repair is a multistep process controlled by numerous factors, including protein phosphorylation and thylakoid membrane stacking. Here we have characterized the function and dynamics of PSII complex under growth-light and HL conditions. Ws-4 displayed 30% more thylakoid lipids per chlorophyll and 40% less chlorophyll per carotenoid than Col-0 and Ler-0. There were no large differences in thylakoid stacking, photoprotection and relative levels of photosynthetic complexes among the three accessions. An increased efficiency of PSII closure was found in Ws-4 following illumination with saturation flashes or continuous light. Phosphorylation of the PSII D1/D2 proteins was reduced by 50% in Ws-4 as compared to Col-0 and Ler-0. An increase in abundance of the responsible STN8 kinase in response to HL treatment was found in all three accessions, but Ws-4 displayed 50% lower levels than Col-0 and Ler-0. Despite this, the HL treatment caused in Ws-4 the lagest extent of PSII inactivation, disassembly, D1 protein degradation, and the largest decrease in the size of stacked thylakoids. The dilution of chlorophyll-protein complexes with additional lipids and carotenoids in Ws-4 may represent a mechanism to facilitate lateral protein traffic in the membrane, thus compensating for the lack of a full complement of STN8 kinase. Nevertheless, additional PSII damage occurs in Ws-4, which exceeds the D1 protein synthesis capacity, thus leading to enhanced photoinhibition. Our findings are valuable for selection of appropriate background line for PSII characterization in Arabidopsis mutants, and also provide the first insights into natural variation of PSII protein phosphorylation.	[Yin, Lan; Herdean, Andrei; Andersson, Mats X.; Spetea, Cornelia] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fristedt, Rikard; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Solymosi, Katalin] Eotvos Lorand Univ, Dept Plant Anat, H-1088 Budapest, Hungary; [Bertrand, Martine] Natl Inst Marine Sci & Tech, Cnam, Cherbourg Octev, France; [Mamedov, Fikret] Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden; [Schoefs, Benoit] Univ Maine, EA2160, LUNAM Univ, F-72017 Le Mans, France	University of Gothenburg; Linkoping University; Eotvos Lorand University; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Uppsala University; Le Mans Universite	Spetea, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	cornelia.spetea.wiklund@bioenv.gu.se	Schoefs, Benoit/AAE-4010-2019; Mamedov, Fikret/A-1761-2016; Herdean, Andrei/C-6093-2018; Andersson, Mats/E-7958-2010; Wiklund, Cornelia Spetea/S-3635-2019	Schoefs, Benoit/0000-0002-7804-8130; Mamedov, Fikret/0000-0002-6218-3039; Herdean, Andrei/0000-0003-2143-0213; Andersson, Mats/0000-0003-4279-6572; Solymosi, Katalin/0000-0001-5246-2547	Swedish Research Council; Swedish Research Council for Environment, Agriculture and Space Planning (Formas); French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche; University of Le Mans	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Space Planning (Formas)(Swedish Research Council Formas); French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche; University of Le Mans	This work was supported by grants from the Swedish Research Council, the Swedish Research Council for Environment, Agriculture and Space Planning (Formas), the French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche, and University of Le Mans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Armbruster U, 2011, MOL PLANT, V4, P1, DOI 10.1093/mp/ssq060; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Darko E, 2000, J CHROMATOGR A, V876, P111, DOI 10.1016/S0021-9673(00)00141-2; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; Fristedt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024565; Fristedt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010963; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jung HS, 2009, PLANT PHYSIOL, V150, P977, DOI 10.1104/pp.109.137828; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; MCCOURT P, 1985, PLANT PHYSIOL, V78, P853, DOI 10.1104/pp.78.4.853; Moreau RA, 2008, LIPIDS, V43, P533, DOI 10.1007/s11745-008-3181-6; Moulin P., 2010, HDB PLANT CROP STRES, P407; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Noren H, 1999, BIOSCIENCE REP, V19, P499, DOI 10.1023/A:1020280710067; Pesaresi P, 2011, BBA-BIOENERGETICS, V1807, P887, DOI 10.1016/j.bbabio.2010.08.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Schoefs B, 2004, J CHROMATOGR A, V1054, P217, DOI 10.1016/j.chroma.2004.05.105; Schoefs B., 1996, AM BIOTECHNOL LAB, V14, P18; Schwarte S, 2011, MOL BIOL EVOL, V28, P1861, DOI 10.1093/molbev/msr008; Sirpio S, 2011, METHODS MOL BIOL, V775, P19, DOI 10.1007/978-1-61779-237-3_2; Solymosi K, 2012, PLANTA, V235, P1035, DOI 10.1007/s00425-011-1559-9; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; Tsimilli-Michael M, 2000, APPL SOIL ECOL, V15, P169, DOI 10.1016/S0929-1393(00)00093-7; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Willig A, 2011, PLANT PHYSIOL, V157, P2102, DOI 10.1104/pp.111.187328; Yin L, 2010, PLANT PHYSIOL, V153, P666, DOI 10.1104/pp.110.155804	51	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46206	10.1371/journal.pone.0046206	http://dx.doi.org/10.1371/journal.pone.0046206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029436	Green Published, gold			2022-12-27	WOS:000309973900107
J	Arefin, AS; Mathieson, L; Johnstone, D; Berretta, R; Moscato, P				Arefin, Ahmed Shamsul; Mathieson, Luke; Johnstone, Daniel; Berretta, Regina; Moscato, Pablo			Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer's Disease Progression	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; VISININ-LIKE PROTEIN-1; COMPLEMENT RECEPTOR 1; CA2+ SENSOR VILIP-1; GENE-EXPRESSION; AMYLOID-BETA; COGNITIVE IMPAIRMENT; TAU-PHOSPHORYLATION; MESSENGER-RNA; MITOCHONDRIAL DYNAMICS	Background: One primary goal of transcriptomic studies is identifying gene expression patterns correlating with disease progression. This is usually achieved by considering transcripts that independently pass an arbitrary threshold (e.g. p<0.05). In diseases involving severe perturbations of multiple molecular systems, such as Alzheimer's disease (AD), this univariate approach often results in a large list of seemingly unrelated transcripts. We utilised a powerful multivariate clustering approach to identify clusters of RNA biomarkers strongly associated with markers of AD progression. We discuss the value of considering pairs of transcripts which, in contrast to individual transcripts, helps avoid natural human transcriptome variation that can overshadow disease-related changes. Methodology/Principal Findings: We re-analysed a dataset of hippocampal transcript levels in nine controls and 22 patients with varying degrees of AD. A large-scale clustering approach determined groups of transcript probe sets that correlate strongly with measures of AD progression, including both clinical and neuropathological measures and quantifiers of the characteristic transcriptome shift from control to severe AD. This enabled identification of restricted groups of highly correlated probe sets from an initial list of 1,372 previously published by our group. We repeated this analysis on an expanded dataset that included all pair-wise combinations of the 1,372 probe sets. As clustering of this massive dataset is unfeasible using standard computational tools, we adapted and re-implemented a clustering algorithm that uses external memory algorithmic approach. This identified various pairs that strongly correlated with markers of AD progression and highlighted important biological pathways potentially involved in AD pathogenesis. Conclusions/Significance: Our analyses demonstrate that, although there exists a relatively large molecular signature of AD progression, only a small number of transcripts recurrently cluster with different markers of AD progression. Furthermore, considering the relationship between two transcripts can highlight important biological relationships that are missed when considering either transcript in isolation.	[Arefin, Ahmed Shamsul; Johnstone, Daniel; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Mathieson, Luke] Macquarie Univ, Fac Sci, Sydney, NSW 2109, Australia; [Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, Rankin Pk, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, Callaghan, NSW, Australia	University of Newcastle; Macquarie University; Hunter Medical Research Institute; University of Newcastle	Moscato, P (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	Johnstone, Daniel/E-9929-2013; MOSCATO, PABLO ALBERTO/G-7668-2013; Arefin, Ahmed Shamsul/G-8130-2013	Johnstone, Daniel/0000-0003-2876-3299; Arefin, Ahmed Shamsul/0000-0002-9290-3551; Moscato, Pablo/0000-0003-2570-5966; Mathieson, Luke/0000-0001-6470-2296; Berretta, Regina/0000-0002-4420-3446	ARC Centre of Excellence in Bioinformatics; University of Newcastle's through Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine	ARC Centre of Excellence in Bioinformatics(Australian Research Council); University of Newcastle's through Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine	The authors would like to thank the support of the ARC Centre of Excellence in Bioinformatics, and the University of Newcastle's through the funding of the Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; [Anonymous], 2001, BOOST GRAPH LIB USER; Arefin AS, 2011, LECT NOTES COMPUT SC, V7017, P375, DOI 10.1007/978-3-642-24669-2_36; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Bach-Holm D, 2011, ACTA OPHTHALMOL; Barner EL, 1998, ANN PHARMACOTHER, V32, P70, DOI 10.1345/aph.17150; Berretta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012262; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boissonneault V, 2009, M S-MED SCI, V25, P666, DOI 10.1051/medsci/2009258-9666; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bralten J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.017; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Brorsson AC, 2010, FRONT BIOSCI-LANDMRK, V15, P373; Burns JM., 2008, MILD COGNITIVE IMPAI; Cacabelos R, 2007, CURR ALZHEIMER RES, V4, P479, DOI 10.2174/156720507781788846; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; Carayol J, 2011, BIOL PSYCHIAT, V70, P880, DOI 10.1016/j.biopsych.2011.05.020; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cormen TH, 1998, PARALLEL COMPUT, V24, P5, DOI 10.1016/S0167-8191(97)00114-2; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Dementiev R, 2008, SOFTWARE PRACT EXPER, V38, P589, DOI 10.1002/spe.844; Dementiev R, 2004, INT FED INFO PROC, V155, P195; Desjardins P, 1998, NEUROSCI LETT, V244, P69, DOI 10.1016/S0304-3940(98)00138-4; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Emilsson L, 2006, SYNAPSE, V59, P173, DOI 10.1002/SYN.20226; Fabbro S, 2011, J NEUROCHEM, V118, P928, DOI 10.1111/j.1471-4159.2011.07359.x; Fabbro S, 2009, J NEUROCHEM, V109, P303, DOI 10.1111/j.1471-4159.2009.05894.x; FAYYAD UM, 1993, P 13 INT JOINT C ART, P1022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ge YS, 2009, CHINESE MED J-PEKING, V122, P716, DOI 10.3760/cma.j.issn.0366-6999.2009.06.024; George AJ, 2010, NEUROTOX RES, V17, P360, DOI 10.1007/s12640-009-9112-3; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Gonzalez-Barrios JM, 2003, STAT PROBABIL LETT, V62, P23, DOI 10.1016/S0167-7152(02)00421-2; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Hu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016616; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, P482; Inostroza-Ponta M, 2008, THESIS U NEWCASTLE N; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karelson E, 2002, ANN NY ACAD SCI, V973, P537, DOI 10.1111/j.1749-6632.2002.tb04696.x; Kerr F, 2006, FEBS LETT, V580, P3121, DOI 10.1016/j.febslet.2006.04.064; Kim SH, 2001, NEUROSCI LETT, V310, P77, DOI 10.1016/S0304-3940(01)02025-0; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Kusano S, 2011, BIOCHIMIE, V93, P1555, DOI 10.1016/j.biochi.2011.05.016; Laske C, 2010, CURR ALZHEIMER RES, V7, P409, DOI 10.2174/156720510791383813; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Leduc V, 2011, J NEUROSCI METH, V200, P14, DOI 10.1016/j.jneumeth.2011.05.026; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lian QY, 2001, EXP NEUROL, V167, P158, DOI 10.1006/exnr.2000.7534; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Magliulo L, 2011, EUR J CLIN PHARMACOL, V67, P47, DOI 10.1007/s00228-010-0883-5; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Marino S, 2002, DEVELOPMENT, V129, P3513; Marsagishvili LG, 2005, BIOFIZIKA+, V50, P803; Middle F, 2010, J ALZHEIMERS DIS, V20, P561, DOI 10.3233/JAD-2010-1405; Morimoto K, 2011, J ALZHEIMERS DIS, V25, P59, DOI 10.3233/JAD-2011-101815; Moscato P, 2005, LECT NOTES COMPUT SC, V3449, P84; Muma NA, 2003, SYNAPSE, V47, P58, DOI 10.1002/syn.10153; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Newington JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019191; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Penney KL, 2011, CARCINOGENESIS, V32, P853, DOI 10.1093/carcin/bgr050; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Rahman A, 2005, NEUROCHEM RES, V30, P277, DOI 10.1007/s11064-005-2483-9; Rentzos M, 2006, J GERIATR PSYCH NEUR, V19, P114, DOI 10.1177/0891988706286226; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rossner S, 2001, EUR J NEUROSCI, V13, P269, DOI 10.1046/j.1460-9568.2001.01388.x; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Schnurra I, 2001, NEUROBIOL DIS, V8, P900, DOI 10.1006/nbdi.2001.0432; Schultes D, 2004, EXTERNAL MEMORY SPAN; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; SHIMOHAMA S, 1995, ALZ DIS ASSOC DIS, V9, P15, DOI 10.1097/00002093-199501002-00004; Sibeyn JF, 2004, LECT NOTES COMPUT SC, V3111, P468; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; Sonoda Y, 2010, NEUROSCI LETT, V471, P20, DOI 10.1016/j.neulet.2009.12.078; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tschernatsch M, 2005, J NEUROL NEUROSUR PS, V76, P1702, DOI 10.1136/jnnp.2003.033225; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vitter JS, 2001, ACM COMPUTING SURVEY, V33; WALLACE MA, 1994, BBA-MOL BASIS DIS, V1227, P183, DOI 10.1016/0925-4439(94)90093-0; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wollmer MA, 2006, NEURODEGENER DIS, V3, P334, DOI 10.1159/000097302; Xu L, 2011, EXP ANIM TOKYO, V60, P71, DOI 10.1538/expanim.60.71; Yang GF, 2008, NEUROL RES, V30, P613, DOI 10.1179/174313208X284124; Yi-Jen Chiang, 1995, Proceedings of the Sixth Annual ACM-SIAM Symposium on Discrete Algorithms, P139; Youn HS, 2007, J ALZHEIMERS DIS, V11, P385; Zhang H, 2008, NEUROBIOL AGING, V29, P653, DOI 10.1016/j.neurobiolaging.2006.11.020; Zhang Q, 2010, BRAIN RES, V1348, P216, DOI 10.1016/j.brainres.2010.06.018; Zhang X, 2006, FASEB J, V20, P1272, DOI 10.1096/fj.06-5721fje; Zhao C, 2008, NEUROSCIENCE, V153, P1202, DOI 10.1016/j.neuroscience.2007.10.067; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z	122	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45535	10.1371/journal.pone.0045535	http://dx.doi.org/10.1371/journal.pone.0045535			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029078	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800056
J	Behrens, MD; Lafferty, KD				Behrens, Michael D.; Lafferty, Kevin D.			Geographic Variation in the Diet of Opaleye (Girella nigricans) with Respect to Temperature and Habitat	PLOS ONE			English	Article							MARINE HERBIVOROUS FISHES; STABLE-ISOTOPES; NITROGEN ISOTOPES; ONTOGENIC CHANGES; REEF COMMUNITIES; TROPHIC POSITION; STOMACH CONTENTS; FOOD SELECTION; ANIMALS; DELTA-N-15	We studied diet variation in an omnivorous fish across its range, which allowed us to test predictions about the effect of ocean temperature and habitat on herbivory. Throughout most of its geographic range, from Southern California to central Baja California, the opaleye (Girella nigricans) fed primarily on red and green algae, but there was significant variation in the amount of algal material in the diet among sites. The proportion of algal material in the diet was related to habitat, with algae making up a larger proportion of a fish's diet in algal-dominated habitats than in urchin barrens. Independent of habitat, the proportion of algal material in the diet increased with environmental temperature. Analyses of stable isotopes revealed similar changes in trophic position and confirmed that these associations with diet persisted over relatively long time scales. The shift to a more herbivorous diet at warmer temperatures is in agreement with past laboratory studies on this species that show a diet-dependent change in performance with temperature and can indicate a diet shift across the species' geographic range to meet its physiological demands. A possible plastic response to herbivory was a longer gut relative to body size. The results of this study are consistent with past findings that associate temperature with increases in the relative diversity of herbivorous fishes in tropical parts of the ocean.	[Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA; [Behrens, Michael D.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Lafferty, KD (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	kevin_lafferty@lifesci.ucsb.edu	Lafferty, Kevin D./B-3888-2009		United States Geological Survey; David and Lucille Packard Foundation; Andrew W. Mellon Foundation; UC MEXUS (The University of California Institute for Mexico and the United States); UC Marine Council; Fletcher Jones Foundation	United States Geological Survey(United States Geological Survey); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Andrew W. Mellon Foundation; UC MEXUS (The University of California Institute for Mexico and the United States); UC Marine Council; Fletcher Jones Foundation	This work was supported by the United States Geological Survey, the David and Lucille Packard Foundation, the Andrew W. Mellon Foundation, and UC MEXUS (The University of California Institute for Mexico and the United States). MDB was supported by UC Marine Council and Fletcher Jones Foundation Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BARRY JP, 1993, ENVIRON BIOL FISH, V37, P75, DOI 10.1007/BF00000715; Behrens M. D., 2005, THESIS U CALIFORNIA; Behrens MD, 2004, MAR ECOL PROG SER, V281, P307; Behrens MD, 2004, MAR ECOL PROG SER, V279, P129, DOI 10.3354/meps279129; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; BENAVIDES AG, 1994, FUNCT ECOL, V8, P46, DOI 10.2307/2390110; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; DEMARTINI EE, 1981, COPEIA, P785; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gonzalez-Bergonzoni I, 2012, ECOSYSTEMS, V15, P492, DOI 10.1007/s10021-012-9524-4; HALLACHER LE, 1985, ENVIRON BIOL FISH, V12, P91, DOI 10.1007/BF00002762; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; HORN MH, 1990, J FISH BIOL, V37, P237, DOI 10.1111/j.1095-8649.1990.tb05855.x; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Lin HJ, 2007, ESTUAR COAST SHELF S, V73, P527, DOI 10.1016/j.ecss.2007.02.013; LOBEL PS, 1981, J FISH BIOL, V19, P365, DOI 10.1111/j.1095-8649.1981.tb05842.x; Lobel PS., 1980, B MAR SCI, V30, P273; Love M, 1996, PROBABLY MORE YOU WA; MITCHELL DF, 1953, AM MIDL NAT, V49, P862, DOI 10.2307/2485213; Mountfort DO, 2002, APPL ENVIRON MICROB, V68, P1374, DOI 10.1128/AEM.68.3.1374-1380.2002; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Munoz AA, 2000, J FISH BIOL, V56, P986, DOI 10.1006/jfbi.1999.1224; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; ROBISON BH, 1984, MAR BIOL, V84, P119, DOI 10.1007/BF00392995; *SAS I INC, 2002, JMP STAT GRAPH GUID; Sotka EE, 2009, BIOL BULL-US, V216, P75; TARGETT TE, 1990, MAR ECOL PROG SER, V66, P13, DOI 10.3354/meps066013; Ventura M, 2008, FRESHWATER BIOL, V53, P1434, DOI 10.1111/j.1365-2427.2008.01975.x; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; WILLIAMS GEORGE C, 1955, CALIFORNIA FISH AND GAME, V41, P203; Wolesensky W, 2005, ECOL MODEL, V188, P358, DOI 10.1016/j.ecolmodel.2005.02.017; Zuanon JAS, 2007, COMP BIOCHEM PHYS A, V147, P761, DOI 10.1016/j.cbpa.2006.08.038	47	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45901	10.1371/journal.pone.0045901	http://dx.doi.org/10.1371/journal.pone.0045901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029302	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800115
J	Card, CM; Rutherford, WJ; Ramdahin, S; Yao, XJ; Kimani, M; Wachihi, C; Kimani, J; Plummer, FA; Ball, TB; Fowke, KR				Card, Catherine M.; Rutherford, W. John; Ramdahin, Suzie; Yao, Xiaojian; Kimani, Makobu; Wachihi, Charles; Kimani, Joshua; Plummer, Francis A.; Ball, T. Blake; Fowke, Keith R.			Reduced Cellular Susceptibility to In Vitro HIV Infection Is Associated with CD4+T Cell Quiescence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; IMMUNE ACTIVATION; SEX WORKERS; TRANSMISSION; REPLICATION; EXPRESSION; PROPAGATION; PROGRESSION; LYMPHOCYTES	Background: HIV preferentially establishes productive infection in activated T cells. Since proportions of activated CD4+ T cells vary between individuals, this study aimed to determine if individuals with a greater proportion of activated CD4+ T cells would be more susceptible to in vitro HIV infection. Methodology/Principal Findings: Unstimulated peripheral blood mononuclear cells (PBMC) from various donors were inoculated with HIVML1956 in vitro. HIV replication was evaluated by HIV p24 ELISA of culture supernatants and intracellular staining for HIV p24, which was detected by flow cytometry. Baseline T cell phenotypes and infected cell phenotypes were also evaluated by flow cytometry. Ex vivo phenotyping at the time of blood draw showed that elevated T cell activation and reduced Tregs were associated with increased cellular susceptibility to in vitro infection. Furthermore, the infected CD4+ T cell population was enriched for activated cells. Conclusion/Significance: These data suggest that CD4+ T cell quiescence provides an environment less conducive to the establishment of HIV infection by limiting the pool of activated target cells.	[Card, Catherine M.; Rutherford, W. John; Ramdahin, Suzie; Yao, Xiaojian; Plummer, Francis A.; Ball, T. Blake; Fowke, Keith R.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kimani, Makobu; Wachihi, Charles; Kimani, Joshua; Ball, T. Blake; Fowke, Keith R.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Fowke, Keith R.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Plummer, Francis A.; Ball, T. Blake] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Manitoba; University of Nairobi; University of Manitoba; Public Health Agency of Canada	Fowke, KR (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	fowkekr@cc.umanitoba.ca	Kimani, Makobu/V-6369-2019; Card, Catherine/AFK-2442-2022	Kimani, Makobu/0000-0001-9275-4018; Fowke, Keith/0000-0001-8227-6649; Card, Catherine/0000-0002-2561-9649; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [MOP-86721]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR; www.cihr-irsc.gc.ca), grant #MOP-86721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Banas B, 2001, FEBS LETT, V509, P207, DOI 10.1016/S0014-5793(01)03182-9; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Camara M, 2010, J INFECT DIS, V201, P835, DOI 10.1086/651000; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Land AM, 2008, AIDS RES HUM RETROV, V24, P865, DOI 10.1089/aid.2007.0200; Lane Jr, 1999, METH MOLEC MED, V17, P3, DOI 10.1385/0-89603-369-4:3; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Moreno-Fernandez ME, 2011, AIDS RES HUMAN RETRO; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; Sun Y, 2000, J IMMUNOL, V165, P1755, DOI 10.4049/jimmunol.165.4.1755; TANG SB, 1995, J VIROL, V69, P5659, DOI 10.1128/JVI.69.9.5659-5665.1995; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	39	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45911	10.1371/journal.pone.0045911	http://dx.doi.org/10.1371/journal.pone.0045911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029309	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800118
J	Kudryashova, E; Kalda, C; Kudryashov, DS				Kudryashova, Elena; Kalda, Caitlin; Kudryashov, Dmitri S.			Glutamyl Phosphate Is an Activated Intermediate in Actin Crosslinking by Actin Crosslinking Domain (ACD) Toxin	PLOS ONE			English	Article							CHOLERAE RTX TOXIN; VI-SECRETION-SYSTEM; ACCESSORY TOXINS; ELECTRON CRYOMICROSCOPY; EL-TOR; FILAMENTS; POLYMERIZATION; COLONIZATION; SYNTHETASES; NUCLEOTIDE	Actin Crosslinking Domain (ACD) is produced by several life-threatening Gram-negative pathogenic bacteria as part of larger toxins and delivered into the cytoplasm of eukaryotic host cells via Type I or Type VI secretion systems. Upon delivery, ACD disrupts the actin cytoskeleton by catalyzing intermolecular amide bond formation between E270 and K50 residues of actin, leading to the formation of polymerization-deficient actin oligomers. Ultimately, accumulation of the crosslinked oligomers results in structural and functional failure of the actin cytoskeleton in affected cells. In the present work, we advanced in our understanding of the ACD catalytic mechanism by discovering that the enzyme transfers the gamma-phosphoryl group of ATP to the E270 actin residue, resulting in the formation of an activated acyl phosphate intermediate. This intermediate is further hydrolyzed and the energy of hydrolysis is utilized for the formation of the amide bond between actin subunits. We also determined the pH optimum for the reaction and the kinetic parameters of ACD catalysis for its substrates, ATP and actin. ACD showed sigmoidal, non-Michaelis-Menten kinetics for actin (K-0.5 = 30 mu M) reflecting involvement of two actin molecules in a single crosslinking event. We established that ACD can also utilize Mg2+-GTP to support crosslinking, but the kinetic parameters (K-M = 8 mu M and 50 mu M for ATP and GTP, respectively) suggest that ATP is the primary substrate of ACD in vivo. The optimal pH for ACD activity was in the range of 7.0-9.0. The elucidated kinetic mechanism of ACD toxicity adds to understanding of complex network of host-pathogen interactions.	[Kudryashova, Elena; Kalda, Caitlin; Kudryashov, Dmitri S.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kudryashov, DS (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	kudryashov.1@osu.edu	Kudryashova, Elena/K-8223-2019; Kudryashova, Elena/ADL-6316-2022; Kudryashov, Dmitri/P-9004-2014	Kudryashova, Elena/0000-0002-1646-1229; Kudryashova, Elena/0000-0002-1646-1229; Kudryashov, Dmitri/0000-0003-1782-3305				Bisswanger H, 2004, PRACTICAL ENZYMOLOGY, Vxv; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; IYENGAR MR, 1964, BIOCHIM BIOPHYS ACTA, V86, P543, DOI 10.1016/0304-4165(64)90094-7; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; LIPMANN F, 1945, J BIOL CHEM, V161, P415; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007352; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; TSUDA Y, 1971, BIOCHEMISTRY-US, V10, P3186, DOI 10.1021/bi00793a004; WEDLER FC, 1972, J BIOL CHEM, V247, P993; WEINSTOCK JV, 1984, CELL IMMUNOL, V89, P46, DOI 10.1016/0008-8749(84)90196-5; WEISBROD RE, 1973, J BIOL CHEM, V248, P3997; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200	38	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45721	10.1371/journal.pone.0045721	http://dx.doi.org/10.1371/journal.pone.0045721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029200	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800083
J	Liu, JC; Wang, Y; Liu, FP				Liu, Jingchun; Wang, Yan; Liu, Fuping			Separation of Sensitized and Non-Sensitized RBCs: Sephadex-Based Cell-Affinity Adsorbents	PLOS ONE			English	Article							RED-CELLS; ELUTION METHODS; ANTIBODIES; TRANSFUSION; ERYTHROCYTES; BINDING; MATRIX; ACID; IGG	Introduction: In transfusion medicine, antibodies that cause RBCs positive DATs, may interfere with patients' phenotyping. Traditionally, these antibodies were removed using various antibody elution methodologies. However, the elution agents and conditions used have been only partially successful; and no one method is superior. The purpose of this study was to develop a general and efficient method to separate non-sensitized from sensitized RBCs using Sephadex-based cell-affinity adsorbents. Methods: First, we coupled Sephadex support with Staphylococcal Protein G (SpG) with or without NHS. Then we simulated clinical conditions by mixing differe Pi nt ratios of sensitized and non-sensitized RBCs in vitro. Sensitized cells were prepared by mixing antibody with corresponding antigen-positive RBCs. Finally, we checked the sensitization status of absorbed RBCs after absorption with modified Sephadex support. Results: The number of sensitized RBCs bound to Sephadex-based cell-affinity adsorbents is approximately 5 x 10(8) RBCs/mL support. Activated Sephadex could separate sensitized from non-sensitized RBCs. Conclusion Sephadex-based cell-affinity adsorbents with an NHS spacer arm have bigger capacity for binding RBCs than unmodified Sephadex. The Sephadex-based cell-affinity adsorbents readily separate non-sensitized RBCs from sensitized RBCs, thus providing a new strategy to type the blood for transfused patients.	[Liu, Jingchun; Liu, Fuping] Dongguan Blood Ctr, Blood Grp Reference Lab, Dongguan, Guangdong, Peoples R China; [Liu, Jingchun] Yale Univ, Sch Med, Dept Urol, New Haven, CT USA; [Wang, Yan] Dongguan Peoples Hosp, Dept Pediat, Dongguan, Guangdong, Peoples R China	Yale University	Liu, JC (corresponding author), Dongguan Blood Ctr, Blood Grp Reference Lab, Dongguan, Guangdong, Peoples R China.	jingchun21@yahoo.com			medical research fund of Guangdong Province in China [A2009744]	medical research fund of Guangdong Province in China	This study is supported by medical research fund of Guangdong Province in China: A2009744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BESSELINK GAJ, 1994, J BIOMAT SCI-POLYM E, V6, P675; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANCH DR, 1982, AM J CLIN PATHOL, V78, P161, DOI 10.1093/ajcp/78.2.161; BRANCH DR, 1983, AM J CLIN PATHOL, V80, P453, DOI 10.1093/ajcp/80.4.453; BRUN A, 1994, TRANSFUSION, V34, P162, DOI 10.1046/j.1537-2995.1994.34294143947.x; Caruccio L, 2002, VOX SANG, V83, P63, DOI 10.1046/j.1423-0410.2002.00181.x; CUATRECASAS P, 1972, BIOCHEMISTRY-US, V11, P2291, DOI 10.1021/bi00762a013; desRoziers NB, 1997, TRANSFUSION, V37, P497, DOI 10.1046/j.1537-2995.1997.37597293880.x; GRIFFIN GD, 1994, TRANSFUSION, V34, P233, DOI 10.1046/j.1537-2995.1994.34394196621.x; Kumar A, 2005, J MOL RECOGNIT, V18, P84, DOI 10.1002/jmr.693; Kumar A, 2007, CELL SEPARATION; Lee E, 2006, Immunohematology, V22, P161; MCCULLOUGH JS, 1993, TRANSFUSION, V33, P725, DOI 10.1046/j.1537-2995.1993.33994025021.x; PANZER S, 1984, VOX SANG, V46, P330, DOI 10.1111/j.1423-0410.1984.tb00094.x; Phillips TM, 2000, AFFINITY IMMUNOAFFIN; Randen I, 2008, HAEMATOLOGICA, V93, P627, DOI 10.3324/haematol.11356; REKVIG OP, 1977, VOX SANG, V33, P280, DOI 10.1111/j.1423-0410.1977.tb04476.x; Richa E, 2007, ANN CLIN LAB SCI, V37, P167; Rios M, 2000, ANN CLIN LAB SCI, V30, P379; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; TORLONI AS, 1994, VOX SANG, V66, P276, DOI 10.1111/j.1423-0410.1994.tb00329.x	21	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45583	10.1371/journal.pone.0045583	http://dx.doi.org/10.1371/journal.pone.0045583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029116	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800061
J	Piotrzkowski, N; Schillberg, S; Rasche, S				Piotrzkowski, Natalia; Schillberg, Stefan; Rasche, Stefan			Tackling Heterogeneity: A Leaf Disc-Based Assay for the High-Throughput Screening of Transient Gene Expression in Tobacco	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; PROTEIN-PRODUCTION; VIRULENCE GENES; OPTIMIZATION; SPECIFICITY; ATTACHMENT; SYSTEM; PLANTS; TRANSFORMATION; PURIFICATION	Transient Agrobacterium-mediated gene expression assays for Nicotiana tabacum (N. tabacum) are frequently used because they facilitate the comparison of multiple expression constructs regarding their capacity for maximum recombinant protein production. However, for three model proteins, we found that recombinant protein accumulation (rpa) was significantly influenced by leaf age and leaf position effects. The ratio between the highest and lowest amount of protein accumulation (max/min ratio) was found to be as high as 11. Therefore, construct-based impacts on the rpa level that are less than 11-fold will be masked by background noise. To address this problem, we developed a leaf disc-based screening assay and infiltration device that allows the rpa level in a whole tobacco plant to be reliably and reproducibly determined. The prototype of the leaf disc infiltration device allows 14 Agrobacterium-mediated infiltration events to be conducted in parallel. As shown for three model proteins, the average max/min rpa ratio was reduced to 1.4 using this method, which allows for a sensitive comparison of different genetic elements affecting recombinant protein expression.	[Piotrzkowski, Natalia; Schillberg, Stefan; Rasche, Stefan] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany	Fraunhofer Gesellschaft	Rasche, S (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	stefan.rasche@ime.fraunhofer.de	Schillberg, Stefan/I-5449-2013; Schillberg, Stefan/K-4211-2019	Schillberg, Stefan/0000-0002-1896-4575; Rasche, Stefan/0000-0002-3489-9881	founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" of the German Federal Ministry of Education and Research [PLANT-KBBE, FKZ0315456B]	founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" of the German Federal Ministry of Education and Research	This work was supported by the founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" (PLANT-KBBE, FKZ0315456B) of the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GC, 1993, PLANT CELL, V5, P603, DOI 10.1105/tpc.5.6.603; ANKENBAUER RG, 1990, J BACTERIOL, V172, P6442, DOI 10.1128/jb.172.11.6442-6446.1990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Chiera JM, 2008, TRANSGENIC RES, V17, P1143, DOI 10.1007/s11248-008-9192-5; Coelho PS, 2009, EUR J PLANT PATHOL, V125, P179, DOI 10.1007/s10658-009-9469-4; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; De Amicis F, 2007, TRANSGENIC RES, V16, P731, DOI 10.1007/s11248-006-9063-x; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Giddings G, 2001, CURR OPIN BIOTECH, V12, P450, DOI 10.1016/S0958-1669(00)00244-5; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Korban SS, 2002, IN VITRO CELL DEV-PL, V38, P231, DOI 10.1079/IVP2002292; LEPETIT M, 1991, PLANT CELL REP, V10, P401, DOI 10.1007/BF00232611; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Matoba N, 2011, METHODS MOL BIOL, V701, P199, DOI 10.1007/978-1-61737-957-4_11; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MELCHERS LS, 1989, MOL MICROBIOL, V3, P969, DOI 10.1111/j.1365-2958.1989.tb00246.x; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Molina A., 2009, Open Biotechnology Journal, V3, P67, DOI 10.2174/1874070700903010067; Petersen A, 1997, ELECTROPHORESIS, V18, P819, DOI 10.1002/elps.1150180528; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Rasche S., 2011, Open Biotechnology Journal, V5, P1; Raven N, 2011, SINGLE USE TECHNOLOG, P252; SANGWAN RS, 1992, PLANTA, V188, P439, DOI 10.1007/BF00192812; Sheludko YV, 2007, BIOTECHNOL BIOENG, V96, P608, DOI 10.1002/bit.21075; SPENCER PA, 1988, PHYTOCHEMISTRY, V27, P2781, DOI 10.1016/0031-9422(88)80663-0; Streatfield SJ, 2007, PLANT BIOTECHNOL J, V5, P2, DOI 10.1111/j.1467-7652.2006.00216.x; SWART S, 1994, PLANT MOL BIOL, V24, P171, DOI 10.1007/BF00040583; Teli NP, 2004, PLANT CELL TISS ORG, V79, P125, DOI 10.1007/s11240-004-0653-0; Villemont E, 1997, PLANTA, V201, P160, DOI 10.1007/BF01007700; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WAGNER VT, 1992, J BACTERIOL, V174, P5999, DOI 10.1128/jb.174.18.5999-6003.1992; Wong C, 2001, CANCER IMMUNOL IMMUN, V50, P93, DOI 10.1007/s002620100174; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zhou FY, 2006, APPL MICROBIOL BIOT, V72, P756, DOI 10.1007/s00253-005-0305-2	40	15	16	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45803	10.1371/journal.pone.0045803	http://dx.doi.org/10.1371/journal.pone.0045803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029251	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800100
J	Burgess, A; Lorca, T; Castro, A				Burgess, Andrew; Lorca, Thierry; Castro, Anna			Quantitative Live Imaging of Endogenous DNA Replication in Mammalian Cells	PLOS ONE			English	Article							FACTORIES; CHECKPOINT; DYNAMICS; PCNA	Historically, the analysis of DNA replication in mammalian tissue culture cells has been limited to static time points, and the use of nucleoside analogues to pulse-label replicating DNA. Here we characterize for the first time a novel Chromobody cell line that specifically labels endogenous PCNA. By combining this with high-resolution confocal time-lapse microscopy, and with a simplified analysis workflow, we were able to produce highly detailed, reproducible, quantitative 4D data on endogenous DNA replication. The increased resolution allowed accurate classification and segregation of S phase into early-, mid-, and late-stages based on the unique subcellular localization of endogenous PCNA. Surprisingly, this localization was slightly but significantly different from previous studies, which utilized over-expressed GFP tagged forms of PCNA. Finally, low dose exposure to Hydroxyurea caused the loss of mid- and late-S phase localization patterns of endogenous PCNA, despite cells eventually completing S phase. Taken together, these results indicate that this simplified method can be used to accurately identify and quantify DNA replication under multiple and various experimental conditions.	[Lorca, Thierry; Castro, Anna] Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France; [Lorca, Thierry; Castro, Anna] Univ Montpellier I, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France; [Burgess, Andrew] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Burgess, Andrew] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Program, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of New South Wales Sydney; Garvan Institute of Medical Research	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France.	a.burgess@garvan.org.au	Burgess, Andrew/C-7952-2009; Burgess, Andrew/H-3339-2019; CASTRO, ANNA/F-4350-2010	Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; CASTRO, ANNA/0000-0002-3655-1352; Lorca, Thierry/0000-0003-2007-8924	Ligue Nationale Contre le Cancer (Equipe Labellisee); Agence Nationale de la Recherche (ANR) [2010 BLAN 120701]; Cancer Institute NSW [10/FRL/3-02]	Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Cancer Institute NSW	This work was supported by the Ligue Nationale Contre le Cancer (Equipe Labellisee), and Agence Nationale de la Recherche (ANR) 2010 BLAN 120701, and a Cancer Institute NSW Future Research Leaders Fellowship [10/FRL/3-02][AB]. Funding for open access charge: [Cancer Institute NSW, 10/FRL/3-02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp901; Burgess A, 2008, ONCOGENE, V27, P5554, DOI 10.1038/onc.2008.167; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Ersoy I, 2009, LECT NOTES COMPUT SC, V5762, P617, DOI 10.1007/978-3-642-04271-3_75; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nakanishi M, 2010, CHROMOSOME RES, V18, P103, DOI 10.1007/s10577-009-9086-2; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sadoni N, 2004, J CELL SCI, V117, P5353, DOI 10.1242/jcs.01412; Schmidthals K, 2010, ANAL BIOANAL CHEM, V397, P3203, DOI 10.1007/s00216-010-3657-0; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; vonMikecz A., 2009, OPEN BIOL J, P193	25	48	49	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45726	10.1371/journal.pone.0045726	http://dx.doi.org/10.1371/journal.pone.0045726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029203	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900095
J	Choi, JS; Shin, YC; Jung, WH; Jang, JH; Kang, DH; Choi, CH; Choi, SW; Lee, JY; Hwang, JY; Kwon, JS				Choi, Jung-Seok; Shin, Young-Chul; Jung, Wi Hoon; Jang, Joon Hwan; Kang, Do-Hyung; Choi, Chi-Hoon; Choi, Sam-Wook; Lee, Jun-Young; Hwang, Jae Yeon; Kwon, Jun Soo			Altered Brain Activity during Reward Anticipation in Pathological Gambling and Obsessive-Compulsive Disorder	PLOS ONE			English	Article							HUMAN VENTRAL STRIATUM; EVENT-RELATED FMRI; DOPAMINE RELEASE; PREFRONTAL CORTEX; SEX-DIFFERENCES; AMPHETAMINE; ACTIVATION; ADDICTION; RESPONSES; SENSITIVITY	Background: Pathological gambling (PG) and obsessive-compulsive disorder (OCD) are conceptualized as a behavioral addiction, with a dependency on repetitive gambling behavior and rewarding effects following compulsive behavior, respectively. However, no neuroimaging studies to date have examined reward circuitry during the anticipation phase of reward in PG compared with in OCD while considering repetitive gambling and compulsion as addictive behaviors. Methods/Principal Findings: To elucidate the neural activities specific to the anticipation phase of reward, we performed event-related functional magnetic resonance imaging (fMRI) in young adults with PG and compared them with those in patients with OCD and healthy controls. Fifteen male patients with PG, 13 patients with OCD, and 15 healthy controls, group-matched for age, gender, and IQ, participated in a monetary incentive delay task during fMRI scanning. Neural activation in the ventromedial caudate nucleus during anticipation of both gain and loss decreased in patients with PG compared with that in patients with OCD and healthy controls. Additionally, reduced activation in the anterior insula during anticipation of loss was observed in patients with PG compared with that in patients with OCD which was intermediate between that in OCD and healthy controls (healthy controls < PG < OCD), and a significant positive correlation between activity in the anterior insula and South Oaks Gambling Screen score was found in patients with PG. Conclusions: Decreased neural activity in the ventromedial caudate nucleus during anticipation may be a specific neurobiological feature for the pathophysiology of PG, distinguishing it from OCD and healthy controls. Correlation of anterior insular activity during loss anticipation with PG symptoms suggests that patients with PG fit the features of OCD associated with harm avoidance as PG symptoms deteriorate. Our findings have identified functional disparities and similarities between patients with PG and OCD related to the neural responses associated with reward anticipation.	[Choi, Jung-Seok; Jang, Joon Hwan; Kang, Do-Hyung; Lee, Jun-Young; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok; Lee, Jun-Young; Hwang, Jae Yeon] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Shin, Young-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Psychiat, Seoul, South Korea; [Jung, Wi Hoon; Kwon, Jun Soo] SNU MRC, Inst Human Behav Med, Seoul, South Korea; [Choi, Chi-Hoon] Natl Med Ctr, Dept Radiol, Seoul, South Korea; [Choi, Sam-Wook] Eulji Univ, Dept Addict Rehabil & Social Welf, Songnam, South Korea; [Hwang, Jae Yeon; Kwon, Jun Soo] SNU, Coll Nat Sci, Brain & Cognit Sci WCU Program, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Eulji University; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019; Kang, Do-Hyung/J-5358-2012; Lee, Jun-Young/J-5604-2012; Kwon, Jun Soo/J-2734-2012; Lee, Jun-Young/N-5963-2019	Lee, Jun-Young/0000-0002-5893-3124; Lee, Jun-Young/0000-0002-5893-3124; Hwang, Jae Yeon/0000-0002-0616-9750; Jung, Wi Hoon/0000-0002-8697-9584	World Class University program through the Korea Science and Engineering Foundation; Ministry of Education, Science and Technology [R31-10089]	World Class University program through the Korea Science and Engineering Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by World Class University program through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (R31-10089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brody AL, 2004, AM J PSYCHIAT, V161, P1211, DOI 10.1176/appi.ajp.161.7.1211; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Denys D, 2004, J CLIN PSYCHIAT, V65, P11; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; First M.B., 2014, STRUCTURED CLIN INTE; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Holden C, 2001, SCIENCE, V294, P980, DOI 10.1126/science.294.5544.980; JOFFE RT, 1993, AM J PSYCHIAT, V150, P959; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OLDS ME, 1981, PHARMACOL BIOCHEM BE, V15, P167, DOI 10.1016/0091-3057(81)90172-6; Pallanti S, 2005, J GAMBL STUD, V21, P431, DOI 10.1007/s10899-005-5557-3; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pohjalainen T, 1998, AM J PSYCHIAT, V155, P768; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030	38	56	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45938	10.1371/journal.pone.0045938	http://dx.doi.org/10.1371/journal.pone.0045938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PT	23029329	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900114
J	Ling, X; Cao, SS; Cheng, QY; Keefe, JT; Rustum, YM; Li, FZ				Ling, Xiang; Cao, Shousong; Cheng, Qiuying; Keefe, James T.; Rustum, Youcef M.; Li, Fengzhi			A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity	PLOS ONE			English	Article							CANCER-CELLS; DOWN-REGULATION; INDUCED APOPTOSIS; TOPOISOMERASE-I; MEDIATED APOPTOSIS; DRUG-RESISTANCE; UP-REGULATION; STEM-CELLS; PHASE-II; EXPRESSION	Drug/radiation resistance to treatment and tumor relapse are major obstacles in identifying a cure for cancer. Development of novel agents that address these challenges would therefore be of the upmost importance in the fight against cancer. In this regard, studies show that the antiapoptotic protein survivin is a central molecule involved in both hurdles. Using cancer cell-based survivin-reporter systems (US 7,569,221 B2) via high throughput screening (HTS) of compound libraries, followed by in vitro and in vivo analyses of HTS-derived hit-lead compounds, we identified a novel anticancer compound (designated FL118). FL118 shows structural similarity to irinotecan. However, while the inhibition of DNA topoisomerase 1 activity by FL118 was no better than the active form of irinotecan, SN-38 at 1 mM, FL118 effectively inhibited cancer cell growth at less than nM levels in a p53 status-independent manner. Moreover, FL118 selectively inhibited survivin promoter activity and gene expression also in a p53 status-independent manner. Although the survivin promoter-reporter system was used for the identification of FL118, our studies revealed that FL118 not only inhibits survivin expression but also selectively and independently inhibits three additional cancer-associated survival genes (Mcl-1, XIAP and cIAP2) in a p53 status-independent manner, while showing no inhibitory effects on control genes. Genetic silencing or overexpression of FL118 targets demonstrated a role for these targets in FL118's effects. Follow-up in vivo studies revealed that FL118 exhibits superior antitumor efficacy in human tumor xenograft models in comparison with irinotecan, topotecan, doxorubicin, 5-FU, gemcitabine, docetaxel, oxaliplatin, cytoxan and cisplatin, and a majority of mice treated with FL118 showed tumor regression with a weekly x 4 schedule. FL118 induced favorable body-weight-loss profiles (temporary and reversible) and was able to eliminate large tumors. Together, the molecular targeting features of FL118 plus its superior antitumor activity warrant its further development toward clinical trials.	[Ling, Xiang; Cao, Shousong; Cheng, Qiuying; Keefe, James T.; Rustum, Youcef M.; Li, Fengzhi] Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA; [Ling, Xiang; Cao, Shousong; Cheng, Qiuying; Keefe, James T.; Rustum, Youcef M.; Li, Fengzhi] Roswell Pk Canc Inst, Dept Therapeut, Buffalo, NY 14263 USA; [Cao, Shousong] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Rustum, Youcef M.; Li, Fengzhi] Roswell Pk Canc Inst, NCI Supported Expt Therapeut Program, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roswell Park Cancer Institute	Li, FZ (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA.	fengzhi.li@roswellpark.org	Li, Fengzhi/GXF-0115-2022		National Institutes of Health (NIH) [CA109481, CA133241]; Mesothelioma Foundation (Alexandria, VA); NCI Cancer Center Core Support Grant [CA016056]; Mesothelioma Foundation; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA133241, R01CA109481] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mesothelioma Foundation (Alexandria, VA); NCI Cancer Center Core Support Grant; Mesothelioma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was sponsored in part by National Institutes of Health (NIH) R01 Grants (CA109481, CA133241) and the Mesothelioma Foundation (Alexandria, VA) grant to FL, and by shared resources supported by NCI Cancer Center Core Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) for providing chemical libraries and relevant hit analogs in the public domain they collected and/or synthesized as a major compound source during the process of our drug screening and characterization. We thank Mesothelioma Foundation for grant supporting. We would also like to thank Dr. Paul A. Spengler (University of Rochester) and Dr. Margot Ip (Roswell Park Cancer Institute - RPCI, Buffalo, NY) for critically reading and revising the manuscript, and Dr. Lili Tian (SUNY at Buffalo/RPCI) for acting as a statistics consultant, Dr. Bruce Dolnick (RPCI) for providing the DHFR antibody, Dr. Allen C. Gao (University of California, Davis), Dr. Daniel Chan (University of Colorado, Denver, CO) and Dr. Kunle Odunsi (RPCI) for providing several cancer cell lines, and Dr. Dario C. Altieri (Wistar Institute Cancer Center) for the pcDNA3-XIAP vector. We would also like to thank Mr. Andrew Haller (PhD student, RPCI) and Ms. Lileena Johnson (MS student, RPCI) for their involvement in testing gene expression and repeating some of the drug screening experiments. The author contribution to the studies is as follows: XL and FL were involved in designing the in vitro experiments. XL screened compound libraries and performed in vitro biochemical and cell-based studies. XL analyzed and organized the in vitro data. QC and JTK were involved in compound screening work. QC and XL did promoter-luciferase activity assays. SC, FL and YMR were involved in designing the animal model work. SC (major) and FL (minor) performed animal model work. SC analyzed and organized the in vivo data. YMR, SC and FL were involved in the regular three-person panel discussion for planning animal model work. FL initiated and overall supervised the project. FL was involved in compound formulation studies for animal model work and wrote the manuscript. All authors were involved in reading and revising the manuscript to reach the final version.	Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Barth SW, 2010, BIOTECHNOL J, V5, P321, DOI 10.1002/biot.200900174; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Cao SS, 2004, CLIN CANCER RES, V10, P2561, DOI 10.1158/1078-0432.CCR-03-0268; Cheng Qiuying, 2012, Int J Biochem Mol Biol, V3, P179; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Connolly K, 2009, CANCER CHEMOTH PHARM, V64, P307, DOI 10.1007/s00280-008-0872-x; Dai Y, 2008, INT J CANCER, V122, P2858, DOI 10.1002/ijc.23443; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Fengzhi Li, 2009, Patent, Patent No. [US7569221B2, 7569221, US7569221]; Friboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590; Fukuda S, 2011, J ONCOL, V2011, DOI 10.1155/2011/946936; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Gyurkocza B, 2006, J NATL CANCER I, V98, P1068, DOI 10.1093/jnci/djj300; Hansen JB, 2008, MOL CANCER THER, V7, P2736, DOI 10.1158/1535-7163.MCT-08-0161; Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Horisberger K, 2009, ANTI-CANCER DRUG, V20, P519, DOI 10.1097/CAD.0b013e32832b53ff; Hussain SRA, 2007, CLIN CANCER RES, V13, P2144, DOI 10.1158/1078-0432.CCR-06-2294; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P263, DOI 10.1016/j.bcp.2004.03.007; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kostopoulos I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-339; Lee M, 2008, APOPTOSIS, V13, P972, DOI 10.1007/s10495-008-0229-2; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2006, AM J PATHOL, V169, P1, DOI 10.2353/ajpath.2006.060121; Li FZ, 2010, AM J PATHOL, V176, P1629, DOI 10.2353/ajpath.2010.090414; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 2005, ONCOGENE, V24, P1385, DOI 10.1038/sj.onc.1208330; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Ling X, 2004, J BIOL CHEM, V279, P15196, DOI 10.1074/jbc.M310947200; Ling X, 2005, LUNG CANCER, V49, P353, DOI 10.1016/j.lungcan.2005.03.037; Ling X, 2009, AM J TRANSL RES, V1, P393; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mathijssen RHJ, 2002, CURR CANCER DRUG TAR, V2, P103, DOI 10.2174/1568009023333890; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; Miura K, 2009, EXPERT OPIN THER TAR, V13, P1333, DOI 10.1517/14728220903277256; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Qiao L, 2009, INT J COLORECTAL DIS, V24, P245, DOI 10.1007/s00384-008-0566-1; Rahman KMW, 2009, CANCER RES, V69, P4468, DOI 10.1158/0008-5472.CAN-08-4423; Raviv Z, 2011, BRIT J PHARMACOL, V164, P1433, DOI 10.1111/j.1476-5381.2011.01419.x; Reed JC, 1999, NAT CELL BIOL, V1, pE199, DOI 10.1038/70227; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Richter SN, 2009, CANCER CHEMOTH PHARM, V64, P199, DOI 10.1007/s00280-009-0971-3; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Rodel F, 2008, INT J RADIAT ONCOL, V71, P247, DOI 10.1016/j.ijrobp.2008.02.011; Ruckert F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-379; Rustum YM, 2010, J ONCOL, V2010, DOI 10.1155/2010/396286; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Tang L, 2012, BIOCHEM BIOPH RES CO, V421, P249, DOI 10.1016/j.bbrc.2012.03.147; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Trabulo S, 2011, MOL PHARMACEUT, V8, P1120, DOI 10.1021/mp100426e; Tu SP, 2010, CANCER-AM CANCER SOC, V116, P1252, DOI 10.1002/cncr.24814; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang S, 2010, ONCOGENE, V29, P4225, DOI 10.1038/onc.2010.180; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wu JG, 2005, J BIOL CHEM, V280, P9745, DOI 10.1074/jbc.M409350200; Wu JG, 2007, NUCLEIC ACIDS RES, V35, P2390, DOI 10.1093/nar/gkm149; Zhang M, 2006, J EXP CLIN CANC RES, V25, P391; Zhang T, 2001, CANCER RES, V61, P8664	82	88	90	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45571	10.1371/journal.pone.0045571	http://dx.doi.org/10.1371/journal.pone.0045571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029106	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400106
J	Matabos, M; Tunnicliffe, V; Juniper, SK; Dean, C				Matabos, Marjolaine; Tunnicliffe, Verena; Juniper, S. Kim; Dean, Courtney			A Year in Hypoxia: Epibenthic Community Responses to Severe Oxygen Deficit at a Subsea Observatory in a Coastal Inlet	PLOS ONE			English	Article							DEEP-WATER RENEWAL; SAANICH INLET; BRITISH-COLUMBIA; DISSOLVED-OXYGEN; ANOXIC FJORD; DYNAMICS; IMPACT; FISH; TOLERANCE; MORTALITY	Changes in ocean ventilation driven by climate change result in loss of oxygen in the open ocean that, in turn, affects coastal areas in upwelling zones such as the northeast Pacific. Saanich Inlet, on the west coast of Canada, is a natural seasonally hypoxic fjord where certain continental shelf species occur in extreme hypoxia. One study site on the VENUS cabled subsea network is located in the hypoxic zone at 104 m depth. Photographs of the same 5 m(2) area were taken with a remotely-controlled still camera every 2/3 days between October 6th 2009 and October 18th 2010 and examined for community composition, species behaviour and microbial mat features. Instruments located on a near-by platform provided high-resolution measurements of environmental variables. We applied multivariate ordination methods and a principal coordinate analysis of neighbour matrices to determine temporal structures in our dataset. Responses to seasonal hypoxia (0.1-1.27 ml/l) and its high variability on short time-scale (hours) varied among species, and their life stages. During extreme hypoxia, microbial mats developed then disappeared as a hippolytid shrimp, Spirontocaris sica, appeared in high densities (200 m(-2)) despite oxygen below 0.2 ml/l. The slender sole Lyopsetta exilis was abundant in severe hypoxia and diminished as oxygen increased in the summer. This planktivore may be responding to changes in the depth of the diurnal migration of zooplankton. While the squat lobster Munida quadrispina was common at all times, juveniles disappeared in fluctuating conditions. Despite low oxygen conditions, animal densities were high indicating that the risk from hypoxia is balanced by factors such as food availability and escape from less tolerant predators. As hypoxia increases on the continental shelf, we expect benthic communities to become dominated by low diversity, hypoxia-tolerant species of low commercial significance.	[Matabos, Marjolaine; Tunnicliffe, Verena; Juniper, S. Kim; Dean, Courtney] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Matabos, Marjolaine; Juniper, S. Kim] Univ Victoria, NEPTUNE Canada, Victoria, BC, Canada; [Tunnicliffe, Verena] Univ Victoria, VENUS, Victoria, BC, Canada	University of Victoria; University of Victoria; University of Victoria	Matabos, M (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.	mmatabos@uvic.ca	Tunnicliffe, Verena/D-1056-2014; Juniper, Kim/N-6769-2015	Juniper, Kim/0000-0002-7608-260X; Matabos, Marjolaine/0000-0003-1983-9896	NSERC Canada; Canada Foundation for Innovation (VENUS, University of Victoria); Canadian Healthy Ocean Network (CHONe)	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (VENUS, University of Victoria); Canadian Healthy Ocean Network (CHONe)	Funding was provided by NSERC Canada (http://www.nserc-crsng.gc.ca/; SK Juniper, V. Tunnicliffe) and the Canada Foundation for Innovation (http://www.innovation.ca/en; VENUS, University of Victoria). M. Matabos was a post-doctoral fellow funded by the Canadian Healthy Ocean Network (CHONe - http://chone.marinebiodiversity.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achberger C, 2011, B AM METEOROL SOC, V92, pS1, DOI 10.1175/1520-0477-92.6.S1; Alin SR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007511; ANDERSON J J, 1973, Estuarine and Coastal Marine Science, V1, P1, DOI 10.1016/0302-3524(73)90052-2; Andreev AG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003103; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Beveridge I, 2007, THESIS U VICTORIA; BlaisStevens A, 1997, CAN J EARTH SCI, V34, P1345, DOI 10.1139/e17-107; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; BURD BJ, 1988, CAN J ZOOL, V66, P2320, DOI 10.1139/z88-346; BURD BJ, 1984, J EXP MAR BIOL ECOL, V81, P1, DOI 10.1016/0022-0981(84)90221-1; Butler T, 1964, J FISHERIES BOARD CA, V21, P219; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Childress JJ, 1998, J EXP BIOL, V201, P1223; Crawford WR, 2010, STATE PHYS BIOL SELE, V2010, P137; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinning KM, 2013, MAR ECOL-EVOL PERSP, V34, P2, DOI 10.1111/j.1439-0485.2012.00517.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Freeland H, 1997, DEEP-SEA RES PT I, V44, P2117, DOI 10.1016/S0967-0637(97)00083-6; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; GALLARDO VA, 1994, J CRUSTACEAN BIOL, V14, P665, DOI 10.2307/1548860; Gargett AE, 2003, ESTUAR COAST SHELF S, V56, P1141, DOI 10.1016/S0272-7714(02)00319-0; Gooday AJ, 2009, DEEP-SEA RES PT II, V56, P488, DOI 10.1016/j.dsr2.2008.10.003; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Hansson D, 2011, J GEOPHYS RES, V116, P1; Haselmair A, 2010, MAR ECOL PROG SER, V414, P195, DOI 10.3354/meps08657; HERLINVEAUX RH, 1962, J FISH RES BOARD CAN, V19, P1, DOI 10.1139/f62-001; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; Hughes DJ, 2009, DEEP-SEA RES PT II, V56, P434, DOI 10.1016/j.dsr2.2008.05.030; Johannessen SC, 2009, CLIM RES, V40, P1, DOI 10.3354/cr00819; JORGENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1261; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; JUNIPER SK, 1986, MAR ECOL PROG SER, V33, P41, DOI 10.3354/meps033041; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Katz T, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003416; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keller AA, 2007, NMFSNSWFSC87 NOAA US; Keller AA, 2010, FISH OCEANOGR, V19, P76, DOI 10.1111/j.1365-2419.2009.00529.x; Kodama K, 2011, MAR POLLUT BULL, V63, P215, DOI 10.1016/j.marpolbul.2011.04.022; Kodama K, 2010, ECOTOXICOLOGY, V19, P479, DOI 10.1007/s10646-009-0438-7; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Legendre P., 1998, NUMERICAL ECOLOGY; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2009, DEEP-SEA RES PT II, V56, P449, DOI 10.1016/j.dsr2.2008.05.032; Manning CC, 2010, MAR CHEM, V122, P1, DOI 10.1016/j.marchem.2010.08.002; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Matabos M, 2011, J EXP MAR BIOL ECOL, V401, P89, DOI 10.1016/j.jembe.2011.02.041; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Ning X, 2011, J OCEANOGR, V67, P59, DOI 10.1007/s10872-011-0006-7; PEARCY WG, 1978, FISH B-NOAA, V76, P641; Pena MA, 2010, BIOGEOSCIENCES, V7, P933, DOI 10.5194/bg-7-933-2010; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Sturdivant SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034539; Timothy DA, 2001, MAR CHEM, V73, P37, DOI 10.1016/S0304-4203(00)00071-2; TUNNICLIFFE V, 1988, MAR ECOL PROG SER, V47, P117, DOI 10.3354/meps047117; Tunnicliffe V, 2000, LIMNOL OCEANOGR, V45, P1380, DOI 10.4319/lo.2000.45.6.1380; Tunnicliffe V, 1981, NATURE, V294, P354, DOI 10.1038/294354a0; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Vardaro MF, 2007, DEEP-SEA RES PT I, V54, P1231, DOI 10.1016/j.dsr.2007.05.004; VISMANN B, 1991, OPHELIA, V34, P1, DOI 10.1080/00785326.1991.10429703; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; WICKSTEN M K, 1989, Transactions of the San Diego Society of Natural History, V21, P291; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Yahel G, 2008, MAR ECOL PROG SER, V372, P195, DOI 10.3354/meps07688; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zimmermann M, 2006, CONT SHELF RES, V26, P1005, DOI 10.1016/j.csr.2006.02.013	76	38	39	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45626	10.1371/journal.pone.0045626	http://dx.doi.org/10.1371/journal.pone.0045626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029145	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400114
J	Alhasan, MK; Liu, L; Lewis, MA; Magnusson, J; Mason, RP				Alhasan, Mustafa K.; Liu, Li; Lewis, Matthew A.; Magnusson, Jennifer; Mason, Ralph P.			Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors	PLOS ONE			English	Article							ANTIVASCULAR THERAPY; TARGETING AGENTS; HIGH-THROUGHPUT; BREAST-CANCER; BLOOD-VESSELS; RADIATION; COMBINATION; BURDEN; GROWTH; MODEL	Small animal imaging provides diverse methods for evaluating tumor growth and acute response to therapy. This study compared the utility of non-invasive optical and ultrasound imaging to monitor growth of three diverse human tumor xenografts (brain U87-luc-mCherry, mammary MCF7-luc-mCherry, and prostate PC3-luc) growing in nude mice. Bioluminescence imaging (BLI), fluorescence imaging (FLI), and Power Doppler ultrasound (PD US) were then applied to examine acute vascular disruption following administration of arsenic trioxide (ATO). During initial tumor growth, strong correlations were found between manual caliper measured tumor volume and FLI intensity, BLI intensity following luciferin injection, and traditional B-mode US. Administration of ATO to established U87 tumors caused significant vascular shutdown within 2 hrs at all doses in the range 5 to 10 mg/kg in a dose dependant manner, as revealed by depressed bioluminescent light emission. At lower doses substantial recovery was seen within 4 hrs. At 8 mg/kg there was >85% reduction in tumor vascular perfusion, which remained depressed after 6 hrs, but showed some recovery after 24 hrs. Similar response was observed in MCF7 and PC3 tumors. Dynamic BLI and PD US each showed similar duration and percent reductions in tumor blood flow, but FLI showed no significant changes during the first 24 hrs. The results provide further evidence for comparable utility of optical and ultrasound imaging for monitoring tumor growth, More specifically, they confirm the utility of BLI and ultrasound imaging as facile assays of the vascular disruption in solid tumors based on ATO as a model agent.	[Alhasan, Mustafa K.; Liu, Li; Lewis, Matthew A.; Magnusson, Jennifer; Mason, Ralph P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Mason, RP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Ralph.Mason@UTSouthwestern.edu	Mason, Ralph/C-8472-2012; Liu, LI/B-6912-2013	Mason, Ralph/0000-0001-7517-3721; Liu, LI/0000-0002-9731-6145; Alhasan, Mustafa/0000-0002-6780-0059	Southwestern Small Animal Imaging Research Program (SW-SAIRP) [NIH U24 CA126608]; Live Cell Imaging Facility, Shared Resources of the Harold C. Simmons Cancer Center; National Cancer Institute Cancer Center [1P30 CA142543]; National Institutes of Health [S10RR024757]; Vevo770 [ARRA-1-S10RR025648]; NATIONAL CANCER INSTITUTE [P30CA142543, U24CA126608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025648, S10RR024757] Funding Source: NIH RePORTER	Southwestern Small Animal Imaging Research Program (SW-SAIRP); Live Cell Imaging Facility, Shared Resources of the Harold C. Simmons Cancer Center; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vevo770; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported in part by the Southwestern Small Animal Imaging Research Program (SW-SAIRP; NIH U24 CA126608) and Live Cell Imaging Facility, Shared Resources of the Harold C. Simmons Cancer Center, supported in part by an National Cancer Institute Cancer Center support grant, 1P30 CA142543. The IVIS Spectrum instrument was purchased with funds from National Institutes of Health Shared Instrumentation grant S10RR024757 and the Vevo770 from ARRA-1-S10RR025648 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RW, 2010, CLIN CANCER RES, V16, P3607, DOI 10.1158/1078-0432.CCR-10-0068; Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; Baj G, 2002, BREAST CANCER RES TR, V73, P61, DOI 10.1023/A:1015272401822; Bollinger R.A., 2006, EVALUATION LIGHT EMI; Caceres G, 2003, LUMINESCENCE, V18, P218, DOI 10.1002/bio.729; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178; Contero A, 2009, METHODS MOL BIOL, V574, P37, DOI 10.1007/978-1-60327-321-3_4; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; Gee MS, 2001, CANCER RES, V61, P2974; Goertz DE, 2002, CANCER RES, V62, P6371; Griffin RJ, 2005, INT J RADIAT ONCOL, V61, P1516, DOI 10.1016/j.ijrobp.2004.12.058; Griffin RJ, 2000, NEOPLASIA, V2, P555, DOI 10.1038/sj.neo.7900123; Griffin RJ, 2003, INT J HYPERTHER, V19, P575, DOI 10.1080/0265673031000124316; Hines-Peralta A, 2006, RADIOLOGY, V240, P82, DOI 10.1148/radiol.2401050788; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Kim JH, 2003, RADIAT RES, V160, P662, DOI 10.1667/RR3069; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Lew YS, 1999, CANCER RES, V59, P6033; Lew YS, 2002, CANCER RES, V62, P4202; LIU L, 2012, PLOS ONE IN PRESS; Maeda H, 2001, CANCER RES, V61, P5432; MAGNUSSON J, 2011, ASSESSMENT ANTIVASCU; Mason RP, 2011, INTEGR BIOL-UK, V3, P375, DOI 10.1039/c0ib00135j; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Murata R, 2001, RADIAT RES, V156, P503, DOI 10.1667/0033-7587(2001)156[0503:ITRBCR]2.0.CO;2; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Ning SC, 2006, INT J RADIAT ONCOL, V65, P493, DOI 10.1016/j.ijrobp.2005.12.015; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Park JH, 2011, EXPERT REV HEMATOL, V4, P427, DOI [10.1586/ehm.11.42, 10.1586/EHM.11.42]; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Pinter SZ, 2009, ULTRASOUND MED BIOL, V35, P1217, DOI 10.1016/j.ultrasmedbio.2009.01.010; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Sarraf-Yazdi S, 2004, J SURG RES, V120, P249, DOI 10.1016/j.jss.2004.03.013; SU X, 2009, ASSESSING VASCULAR T, P5018; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017926; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713	41	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46106	10.1371/journal.pone.0046106	http://dx.doi.org/10.1371/journal.pone.0046106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029403	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900092
J	Eischen, CM; Boyd, K				Eischen, Christine M.; Boyd, Kelli			Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53	PLOS ONE			English	Article							MYC-INDUCED LYMPHOMAGENESIS; MICE; SUPPRESSOR; P19(ARF); TUMORIGENESIS; APOPTOSIS; DEFICIENT; SPECTRUM; PATHWAY; CANCER	Inactivation of the Arf-Mdm2-p53 tumor suppressor pathway is a necessary event for tumorigenesis. Arf controls Mdm2, which in turn regulates p53, but Arf and Mdm2 also have p53-independent functions that affect tumor development. Moreover, inhibition of oncogene-induced tumorigenesis relies on Arf and p53, but the requirements of Arf and p53 in tumor development initiated in the absence of overt oncogene overexpression and the role of Mdm2 in this process remain unclear. In a series of genetic experiments in mice with defined deficiencies in Arf, Mdm2 and/or p53, we show Mdm2 haploinsufficiency significantly delayed tumorigenesis in mice deficient in Arf and p53. Mdm2 heterozygosity significantly inhibited tumor development in the absence of Arf, and in contrast to Myc oncogene-driven cancer, this delay in tumorigenesis could not be rescued with the presence of one allele of Arf. Notably, Mdm2 haploinsufficieny blocked the accelerated tumor development in Arf deficient mice caused by p53 heterozygosity. However, tumorigenesis was not inhibited in Mdm2 heterozygous mice lacking both alleles of p53 regardless of Arf status. Surprisingly, loss of Arf accelerated tumor development in p53-null mice. Tumor spectrum was largely dictated by Arf and p53 status with Mdm2 haploinsufficiency only modestly altering the tumor type in some of the genotypes and not the number of primary tumors that arose. Therefore, the significant effects of Mdm2 haploinsufficiency on tumor latency were independent of Arf and required at least one allele of p53, and an Mdm2 deficiency had minor effects on the types of tumors that developed. These data also demonstrate that decreased levels of Mdm2 are protective in the presence of multiple genetic events in Arf and p53 genes that normally accelerate tumorigenesis.	[Eischen, Christine M.; Boyd, Kelli] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA	Vanderbilt University	Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA.	christine.eischen@vanderbilt.edu			National Cancer Institute (NCI) [R01CA117935]; NCI cancer center [P30CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA117935] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant R01CA117935 and the Vanderbilt Translational Pathology Shared Resource supported by the NCI cancer center grant P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; O'Leary KA, 2004, MOL CELL BIOL, V24, P186, DOI 10.1128/MCB.24.1.186-191.2004; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	23	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46148	10.1371/journal.pone.0046148	http://dx.doi.org/10.1371/journal.pone.0046148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029416	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900097
J	Meijering, B; van Rijn, H; Taatgen, NA; Verbrugge, R				Meijering, Ben; van Rijn, Hedderik; Taatgen, Niels A.; Verbrugge, Rineke			What Eye Movements Can Tell about Theory of Mind in a Strategic Game	PLOS ONE			English	Article							DEPTH; ATTRIBUTION; ALLOCATION; CHIMPANZEE; BELIEFS	This study investigates strategies in reasoning about mental states of others, a process that requires theory of mind. It is a first step in studying the cognitive basis of such reasoning, as strategies affect tradeoffs between cognitive resources. Participants were presented with a two-player game that required reasoning about the mental states of the opponent. Game theory literature discerns two candidate strategies that participants could use in this game: either forward reasoning or backward reasoning. Forward reasoning proceeds from the first decision point to the last, whereas backward reasoning proceeds in the opposite direction. Backward reasoning is the only optimal strategy, because the optimal outcome is known at each decision point. Nevertheless, we argue that participants prefer forward reasoning because it is similar to causal reasoning. Causal reasoning, in turn, is prevalent in human reasoning. Eye movements were measured to discern between forward and backward progressions of fixations. The observed fixation sequences corresponded best with forward reasoning. Early in games, the probability of observing a forward progression of fixations is higher than the probability of observing a backward progression. Later in games, the probabilities of forward and backward progressions are similar, which seems to imply that participants were either applying backward reasoning or jumping back to previous decision points while applying forward reasoning. Thus, the game-theoretical favorite strategy, backward reasoning, does seem to exist in human reasoning. However, participants preferred the more familiar, practiced, and prevalent strategy: forward reasoning.	[Meijering, Ben; Taatgen, Niels A.; Verbrugge, Rineke] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands	University of Groningen; University of Groningen	Meijering, B (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	b.meijering@rug.nl	Verbrugge, Rineke/D-3781-2012; Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014	Verbrugge, Rineke/0000-0003-3829-0106; van Rijn, Hedderik/0000-0002-0461-9850; Taatgen, Niels/0000-0001-7286-3460	Netherlands Organization of Scientific Research (NWO) [227-80-001]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a Vici grant from the Netherlands Organization of Scientific Research (NWO; http://www.nwo.nl/) that was awarded to Rineke Verbrugge (grant 227-80-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly I. A., 2011, MINDREADERS COGNITIV; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Brassard G., 1996, FUNDAMENTALS ALGORIT; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Colman AM, 2003, TRENDS COGN SCI, V7, P2, DOI 10.1016/S1364-6613(02)00006-2; Flobbe L., 2008, J LOG LANG INF, V17, P417, DOI [10.1007/s10849-008-9064-7, DOI 10.1007/S10849-008-9064-7]; Fu WT, 2004, COGNITIVE SCI, V28, P901, DOI 10.1016/j.cogsci.2004.03.005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Ghosh S, 2010, P 3 LOG RES BOUND AG, P15; Ghosh S., 2011, CEUR WORKSHOP P, V751, P79; Goodie AS, 2012, J BEHAV DECIS MAKING, V25, P95, DOI 10.1002/bdm.717; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Hedden T, 2002, COGNITION, V85, P1, DOI 10.1016/S0010-0277(02)00054-9; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson EJ, 2002, J ECON THEORY, V104, P16, DOI 10.1006/jeth.2001.2850; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kong XH, 2010, COGNITIVE SCI, V34, P322, DOI 10.1111/j.1551-6709.2009.01075.x; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; Meijering B., 2011, P 33 ANN C COGN SCI, P2486; Meijering B, 2010, COGNITION IN FLUX, P1423; Nyamsuren E, COGNITIVE S IN PRESS; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Perea A., 2010, GAMES, V1, P168; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Todd PM, 2000, BEHAV BRAIN SCI, V23, P727, DOI 10.1017/S0140525X00003447; Weber R, 2001, ORGAN SCI, V12, P582, DOI 10.1287/orsc.12.5.582.10090; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zhang J, 2003, TRENDS COGN SCI, V7, P4, DOI 10.1016/S1364-6613(02)00007-4; Zhang J, 2012, COGNITIVE SCI, V36, P560, DOI 10.1111/j.1551-6709.2012.01238.x	39	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45961	10.1371/journal.pone.0045961	http://dx.doi.org/10.1371/journal.pone.0045961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029341	Green Published, gold			2022-12-27	WOS:000309973900068
J	Mochizuki, K; Tachibana, M; Saitou, M; Tokitake, Y; Matsui, Y				Mochizuki, Kentaro; Tachibana, Makoto; Saitou, Mitinori; Tokitake, Yuko; Matsui, Yasuhisa			Implication of DNA Demethylation and Bivalent Histone Modification for Selective Gene Regulation in Mouse Primordial Germ Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PREIMPLANTATION EMBRYOS; EPIGENETIC EVENTS; PATERNAL GENOME; NUCLEAR FACTOR; MICE; EXPRESSION; METHYLATION; SPECIFICATION; DIFFERENTIATION	Primordial germ cells (PGCs) sequentially induce specific genes required for their development. We focused on epigenetic changes that regulate PGC-specific gene expression. mil-1, Blimp1, and Stella are preferentially expressed in PGCs, and their expression is upregulated during PGC differentiation. Here, we first determined DNA methylation status of mil-1, Blimp1, and Stella regulatory regions in epiblast and in PGCs, and found that they were hypomethylated in differentiating PGCs after E9.0, in which those genes were highly expressed. We used siRNA to inhibit a maintenance DNA methyltransferase, Dnmt1, in embryonic stem (ES) cells and found that the flanking regions of all three genes became hypomethylated and that expression of each gene increased 1.5- to 3-fold. In addition, we also found 1.5- to 5-fold increase of the PGC genes in the PGCLCs (PGC-like cells) induced form ES cells by knockdown of Dnmt1. We also obtained evidence showing that methylation of the regulatory region of mil-1 resulted in 2.5-fold decrease in expression in a reporter assay. Together, these results suggested that DNA demethylation does not play a major role on initial activation of the PGC genes in the nascent PGCs but contributed to enhancement of their expression in PGCs after E9.0. However, we also found that repression of representative somatic genes, Hoxa1 and Hoxb1, and a tissue-specific gene, Gfap, in PGCs was not dependent on DNA methylation; their flanking regions were hypomethylated, but their expression was not observed in PGCs at E13.5. Their promoter regions showed the bivalent histone modification in PGCs, that may be involved in repression of their expression. Our results indicated that epigenetic status of PGC genes and of somatic genes in PGCs were distinct, and suggested contribution of epigenetic mechanisms in regulation of the expression of a specific gene set in PGCs.	[Mochizuki, Kentaro; Tokitake, Yuko; Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Tachibana, Makoto] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Kyoto 606, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Kyoto, Japan; [Saitou, Mitinori] CREST ERATO, JST, Kyoto, Japan	Tohoku University; Kyoto University; Kyoto University	Matsui, Y (corresponding author), Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ymatsui@idac.tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Japan Society for the Promotion of Science for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	K. Mochizuki was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li SSL, 2006, BIOCHEM BIOPH RES CO, V340, P48, DOI 10.1016/j.bbrc.2005.11.149; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mochizuki K, 2010, DEV GROWTH DIFFER, V52, P517, DOI 10.1111/j.1440-169X.2010.01190.x; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Okamura D, 2008, DEV BIOL, V317, P576, DOI 10.1016/j.ydbio.2008.03.002; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Tanaka SS, 2000, GENE DEV, V14, P841; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; WEBER J, 1994, CANCER RES, V54, P1766; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	63	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46036	10.1371/journal.pone.0046036	http://dx.doi.org/10.1371/journal.pone.0046036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029374	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900075
J	Minnicelli, C; Barros, MHM; Klumb, CE; Romano, SO; Zalcberg, IR; Hassan, R				Minnicelli, Carolina; Barros, Mario H. M.; Klumb, Claudete E.; Romano, Sergio O.; Zalcberg, Ilana R.; Hassan, Rocio			Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NON-HODGKINS-LYMPHOMA; GENOMIC ANCESTRY; GENE; SUSCEPTIBILITY; CHILDREN; DIFFERENTIATION; ASSOCIATION; EXPRESSION; INFECTION	Epstein-Barr virus (EBV) is an important environmental factor associated to the development of Burkitt lymphoma (BL) in endemic and intermediate risk regions. However, little is known about the contribution of genetic constitution to the development and clinical response of the disease. The aim of this work was to investigate the role of EBV and Interleukin 10 (IL10) single nucleotide polymorphisms (-1082A/G, -819C/T, -592C/A) and microsatellites (IL10.R and IL10.G) in susceptibility and clinical outcome in pediatric BL patients, in a region with intermediate EBV association frequency. The frequencies of IL10 promoter Single nucleotide polymorphisms -1082A/G, -819C/T, -592C/A, and IL10.R and IL10.G microsatellites were compared in 62 pediatric patients and 216 healthy donors. IL10 -1082GG and GCC/GCC genotypes were more frequent in patients than in controls, and associated to a higher risk of BL development (GG genotype OR 2.62, 95% CI, 1.25-5.51; P = 0.008; Pc = 0.024). EBV was detected in tumor samples by EBER-ISH in 54.1% of cases. EBV+ patients exhibited a better event free survival (EFS) (P = 0.019) than EBV- patients. Carriers of IL10 R3-GCC had worse EFS (P = 0.028). Our results suggest a risk effect and an independent prognostic value of IL10 polymorphisms and EBV in childhood BL patients.	[Minnicelli, Carolina; Barros, Mario H. M.; Zalcberg, Ilana R.; Hassan, Rocio] Inst Nacl Canc INCA, Bone Marrow Transplantat Ctr CEMO, Rio De Janeiro, Brazil; [Klumb, Claudete E.] Inst Nacl Canc INCA, Hematol Serv, Rio De Janeiro, Brazil; [Romano, Sergio O.] Inst Nacl Canc INCA, Pathol Dept DIPAT, Rio De Janeiro, Brazil	National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca)	Hassan, R (corresponding author), Inst Nacl Canc INCA, Bone Marrow Transplantat Ctr CEMO, Rio De Janeiro, Brazil.	rocio.hassan@pq.cnpq.br	Klumb, Claudete/L-2682-2015; Barros, Mario/G-1842-2014	Klumb, Claudete/0000-0002-7672-1088; Barros, Mario/0000-0001-6826-9565	Swissbridge Foundation (Switzerland); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq) (Brazil) [573806/2008-0]; Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (FAPERJ) (Brazil) [E26/170.026/2008]	Swissbridge Foundation (Switzerland); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq) (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (FAPERJ) (Brazil)	This work was supported by the Swissbridge Foundation (Switzerland), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio) and Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Grants Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq 573806/2008-0 and FAPERJ E26/170.026/2008) (Brazil). Sponsors had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.	[Anonymous], PHARMACOGENOMICS ADM; Araujo I, 1996, BLOOD, V87, P5279, DOI 10.1182/blood.V87.12.5279.bloodjournal87125279; Barros MH, 2011, INT J CANCER, V15, P3762; Berglund M, 2005, BLOOD, V105, P4894, DOI 10.1182/blood-2004-12-4814; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; Chan ATC, 2004, J CLIN ONCOL, V22, P1373, DOI 10.1200/JCO.2004.04.185; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Hassan R, 2008, HAEMATOLOGICA, V93, P780, DOI 10.3324/haematol.12424; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Helminen M, 1999, J INFECT DIS, V180, P496, DOI 10.1086/314883; Helminen ME, 2001, J INFECT DIS, V184, P777, DOI 10.1086/322987; HOLLAND G, 1993, CANCER INVEST, V11, P751, DOI 10.3109/07357909309046950; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kitagawa N, 2000, EMBO J, V19, P6742, DOI 10.1093/emboj/19.24.6742; Klumb CE, 2004, J PEDIAT HEMATOL ONC, V26, P462, DOI 10.1097/00043426-200407000-00014; Klumb CE, 2004, INT J CANCER, V108, P66, DOI 10.1002/ijc.11443; Kube D, 2003, GENES IMMUN, V4, P459, DOI 10.1038/sj.gene.6364003; Kube D, 2008, CLIN CANCER RES, V14, P3777, DOI 10.1158/1078-0432.CCR-07-5182; Labrecque LG, 1999, INT J CANCER, V81, P6, DOI 10.1002/(SICI)1097-0215(19990331)81:1&lt;6::AID-IJC2&gt;3.0.CO;2-2; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Magrath I, 1992, Semin Cancer Biol, V3, P285; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moraes MO, 2003, IMMUNOGENETICS, V54, P896, DOI 10.1007/s00251-003-0543-3; Mormann M, 2004, GENES IMMUN, V5, P246, DOI 10.1038/sj.gene.6364073; MURPHY SB, 1980, SEMIN ONCOL, V7, P332; Ogden CA, 2005, J IMMUNOL, V174, P3015, DOI 10.4049/jimmunol.174.5.3015; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patte C, 2002, BEST PRACT RES CL HA, V15, P695, DOI 10.1053/beha.2002.0231; Pizza M, 2008, HEMATOLOGY, V13, P114, DOI 10.1179/102453308X315942; Queiroga EM, 2008, AM J CLIN PATHOL, V130, P186, DOI 10.1309/2CNAWY6GAR0VQAXX; Reuss E, 2002, GENES IMMUN, V3, P407, DOI 10.1038/sj.gene.6363920; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Stefanoff CG, 2003, DIAGN MOL PATHOL, V12, P79, DOI 10.1097/00019606-200306000-00003; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Sumba PO, 2010, BRIT J CANCER, V103, P1736, DOI 10.1038/sj.bjc.6605947; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tang WH, 2010, CLIN CANCER RES, V16, P2055, DOI 10.1158/1078-0432.CCR-09-2424; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6	51	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46005	10.1371/journal.pone.0046005	http://dx.doi.org/10.1371/journal.pone.0046005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029361	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500055
J	Nagaraja, SB; Kumar, AMV; Sachdeva, KS; Ramachandran, R; Satyanarayana, S; Bansal, A; Parmar, M; Chadha, S; Nair, S; Kumar, A; Hinderaker, SG; Edginton, M; Dewan, PK				Nagaraja, Sharath Burugina; Kumar, Ajay M. V.; Sachdeva, Kuldeep Singh; Ramachandran, Ranjani; Satyanarayana, Srinath; Bansal, Avi; Parmar, Malik; Chadha, Sarabjit; Nair, Sreenivas; Kumar, Ashok; Hinderaker, Sven Gudmund; Edginton, Mary; Dewan, Puneet K.			Is One Sputum Specimen as Good as Two during Follow-Up Cultures for Monitoring Multi Drug Resistant Tuberculosis Patients in India?	PLOS ONE			English	Article								Background: In India, the Revised National Tuberculosis Control Programme (RNTCP) has adopted the strategy of examining two specimens during follow-up culture examinations to monitor the treatment response of multi-drug resistant tuberculosis (MDR-TB) patients. Objectives: To determine the incremental yield of the second sputum specimen during follow-up culture examinations among patients with MDR-TB and the effect on case management on changing from two to one specimen follow-up strategy. Methods: A cross sectional record review of MDR-TB patients registered during 2008-09 under RNTCP was undertaken in three MDR-TB treatment sites of India. Results: Of 1721 pairs of follow-up sputum culture examinations done among 220 MDR-TB patients, 451(26%) were positive with either of the two specimens; 29(1.7%) were culture positive only on the second specimen indicating the incremental yield. To detect one additional culture positive result on the second specimen, 59 specimens needed to be processed. If we had examined only one specimen, we would have missed 29 culture-positive results. By current RNTCP guidelines, however, a single specimen policy would have altered case management in only 3(0.2%) instances, where patients would have missed a one month extension of the intensive phase of MDR-TB treatment. There is no meaningful advantage in using two specimens for the monitoring of MDR-TB patients. A single specimen policy could be safely implemented with negligible clinical effect on MDR-TB patients and favourable resource implications for RNTCP.	[Nagaraja, Sharath Burugina; Ramachandran, Ranjani; Bansal, Avi; Parmar, Malik; Nair, Sreenivas; Dewan, Puneet K.] WHO, Off WHO Representat India, New Delhi, India; [Nagaraja, Sharath Burugina; Sachdeva, Kuldeep Singh; Bansal, Avi; Parmar, Malik; Kumar, Ashok] Minist Hlth & Family Welf, Cent TB Div, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath; Chadha, Sarabjit] Int Union TB & Lung Dis Union, New Delhi, India; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Edginton, Mary] Int Union TB & Lung Dis Union, Paris, France	World Health Organization; University of Bergen	Nagaraja, SB (corresponding author), WHO, Off WHO Representat India, New Delhi, India.	sharathb@rntcp.org	Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nair, Sreenivas/0000-0002-2586-6797; Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Centre for Operational Research, International Union against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels; Centre for International Health, University of Bergen	Centre for Operational Research, International Union against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels; Centre for International Health, University of Bergen	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union against Tuberculosis and Lung Disease, and the Operational Research Unit, Medecins sans Frontieres, Brussels. Additional support for running the course was provided by the Centre for International Health, University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2009, GLOB TUB CONTR; Book Abstract, 2009, 40 LUNG C INT UN S1, V13, P122; Central TB Division, 2012, TUB IND 2012 ANN REP; Central TB Division, 2009, STRAT DOC SUP MON RE; Central TB Division, 2012, GUID PROGR MAN DRUG; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; WHO, 1997, GUID MAN DRUG RES TU	8	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45554	10.1371/journal.pone.0045554	http://dx.doi.org/10.1371/journal.pone.0045554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029092	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500033
J	Robinson, H; Wray, S				Robinson, Hayley; Wray, Susan			A New Slow Releasing, H2S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; CYSTATHIONINE GAMMA-LYASE; HYDROGEN-SULFIDE; SARCOPLASMIC-RETICULUM; METABOLIC INHIBITION; IN-VITRO; INTRACELLULAR CALCIUM; FORCE PRODUCTION	Better tocolytics are required to help prevent preterm labour. The gaseotransmitter Hydrogen sulphide (H2S) has been shown to reduce myometrial contractility and thus is of potential interest. However previous studies used NaHS, which is toxic and releases H2S as a non-physiological bolus and thus alternative H2S donors are sought. GYY4137 has been developed to slowly release H2S and hence better reflect endogenous physiological release. We have examined its effects on spontaneous and oxytocin-stimulated contractility and compared them to NaHS, in human and rat myometrium, throughout gestation. The effects on contractility in response to GYY4137 (1 nM-1 mM) and NaHS (1 mM) were examined on myometrial strips from, biopsies of women undergoing elective caesarean section or hysterectomy, and from nonpregnant, 14, 18, 22 day (term) gestation or labouring rats. In pregnant rat and human myometrium dose-dependent and significant decreases in spontaneous contractions were seen with increasing concentrations of GYY4137, which also reduced underlying Ca transients. GYY4137 and NaHS significantly reduced oxytocin-stimulated and high-K depolarised contractions as well as spontaneous activity. Their inhibitory effects increased as gestation advanced, but were abruptly reversed in labour. Glibenclamide, an inhibitor of ATP-sensitive potassium (K-ATP) channels, abolished the inhibitory effect of GYY4137. These data suggest (i) H2S contributes to uterine quiescence from mid-gestation until labor, (ii) that H2S affects L-type calcium channels and K-ATP channels reducing Ca entry and thereby myometrial contractions, (iii) add to the evidence that H2S plays a physiological role in relaxing myometrium, and thus (iv) H2S is an attractive target for therapeutic manipulation of human myometrial contractility.	[Robinson, Hayley; Wray, Susan] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Wray, S (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	s.wray@liv.ac.uk	wray, susan/B-1197-2009	Wray, Susan/0000-0002-0086-1359	Wellcome Trust Prize Studentship [WT086736M]	Wellcome Trust Prize Studentship(Wellcome Trust)	H.R. was the recipient of a Wellcome Trust Prize Studentship (Ref. WT086736M, www.wellcome.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson PI, 2006, BRIT J PHARMACOL, V147, P815, DOI 10.1038/sj.bjp.0706644; Al-Magableh MR, 2011, N-S ARCH PHARMACOL, V383, P403, DOI 10.1007/s00210-011-0608-z; Bauer CC, 2010, ATHEROSCLEROSIS, V209, P374, DOI 10.1016/j.atherosclerosis.2009.10.004; BOYARSKY S, 1978, Urology, V12, P134, DOI 10.1016/0090-4295(78)90322-9; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Collins PL, 2000, BIOL REPROD, V63, P1262, DOI 10.1095/biolreprod63.5.1262; CRICHTON CA, 1993, J PHYSIOL-LONDON, V465, P629, DOI 10.1113/jphysiol.1993.sp019697; Curley M, 2002, MOL HUM REPROD, V8, P941, DOI 10.1093/molehr/8.10.941; Dawe GS, 2008, NEUROSCIENCE, V152, P169, DOI 10.1016/j.neuroscience.2007.12.008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Gallyas Jr F, 2012, BR J PHARM; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; HEATON RC, 1993, J PHYSIOL-LONDON, V465, P43, DOI 10.1113/jphysiol.1993.sp019665; Hu R, 2011, GYNECOL ENDOCRINOL, V27, P900, DOI 10.3109/09513590.2010.551563; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kubo S., 2007, Inflammopharmacology, V15, P288, DOI 10.1007/s10787-007-1590-4; Kubo S, 2007, J PHARMACOL SCI, V104, P392, DOI 10.1254/jphs.SC0070199; Kupittayanant S, 2002, BJOG-INT J OBSTET GY, V109, P289, DOI 10.1016/S1470-0328(02)01110-2; Kupittayanant S, 2001, PFLUG ARCH EUR J PHY, V443, P112, DOI 10.1007/s004240100668; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Lee SW, 2007, BIOCHEM BIOPH RES CO, V358, P1142, DOI 10.1016/j.bbrc.2007.05.063; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Liang GH, 2012, J PHYSL; Longo M, 2003, MOL HUM REPROD, V9, P159, DOI 10.1093/molehr/gag023; Luckas MJM, 2000, BRIT J OBSTET GYNAEC, V107, P1309, DOI 10.1111/j.1471-0528.2000.tb11626.x; Luckas MJM, 1999, AM J OBSTET GYNECOL, V181, P468, DOI 10.1016/S0002-9378(99)70580-6; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Noble K, 2006, J PHYSIOL-LONDON, V570, P29, DOI 10.1113/jphysiol.2005.098475; Olson KR, 2012, ANTIOXID REDOX SIGN, V17, P32, DOI 10.1089/ars.2011.4401; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shmigol AV, 2001, J PHYSIOL-LONDON, V531, P707, DOI 10.1111/j.1469-7793.2001.0707h.x; Sidhu R, 2001, PHARMACOL TOXICOL, V88, P198, DOI 10.1034/j.1600-0773.2001.d01-104.x; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; SZAL SE, 1994, AM J PHYSIOL, V267, pE77, DOI 10.1152/ajpendo.1994.267.1.E77; Taggart MJ, 1997, J PHYSIOL-LONDON, V499, P485, DOI 10.1113/jphysiol.1997.sp021943; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Tian XY, 2012, PHARMACOL RES, V65, P239, DOI 10.1016/j.phrs.2011.11.006; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Wray S, 2008, J NEUROENDOCRINOL, V20, P451, DOI 10.1111/j.1365-2826.2008.01665.x; Wray S, 2005, CELL CALCIUM, V38, P397, DOI 10.1016/j.ceca.2005.06.018; WRAY S, 1992, EXP PHYSIOL, V77, P307, DOI 10.1113/expphysiol.1992.sp003590; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Xu C, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-35; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Yu Fang, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P493; Zhang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037073; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	70	32	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46278	10.1371/journal.pone.0046278	http://dx.doi.org/10.1371/journal.pone.0046278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029460	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500081
J	Wadden, D; Cahill, F; Amini, P; Randell, E; Vasdev, S; Yi, YQ; Zhang, WZ; Sun, G				Wadden, Danny; Cahill, Farrell; Amini, Peyvand; Randell, Edward; Vasdev, Sudesh; Yi, Yanqing; Zhang, Weizhen; Sun, Guang			Serum Acylated Ghrelin Concentrations in Response to Short-Term Overfeeding in Normal Weight, Overweight, and Obese Men	PLOS ONE			English	Article							INCREASES FOOD-INTAKE; PLASMA GHRELIN; INSULIN-RESISTANCE; CIRCULATING GHRELIN; BODY-FAT; RELEASE; HYPERPHAGIA; SECRETION; DECREASE; HORMONES	Background: Ghrelin, an orexigenic gut hormone secreted primarily from the stomach, is involved in energy homeostasis. However, little data is available regarding its response to energy surplus and the development of human obesity. Objective: The present study investigated the response of circulating acylated ghrelin to a 7-day positive energy challenge. Design: A total of 68 healthy young men were overfed 70% more calories than required, for 1-week. Subjects were classified based on percent body fat (measured by dual-energy X-ray absorptiometry) as normal weight, overweight, and obese. Serum acylated ghrelin concentration was measured before and after the positive energy challenge. Additionally, the relationship between acylated ghrelin and obesity-related phenotypes including weight, body mass index, percent body fat, cholesterol, HDL-c, LDL-c, glucose, insulin and homeostasis model assessment of insulin resistance and beta-cell function at baseline and change due to overfeeding, were assessed. Results: Contrary to our expectations, serum acylated ghrelin was significantly increased in response to overfeeding and the increase was independent of obesity status. There was no significant difference in fasting acylated ghrelin between normal weight, overweight, and obese men at baseline. Acylated ghrelin was negatively correlated with weight and BMI for normal weight and with BMI in overweight men. Also ghrelin was correlated with change in weight and BMI in overweight (negative relationship) and obese (positive relationship) groups. Conclusion: Our results showed that circulating acylated ghrelin was increased after a 7-day positive energy challenge regardless of adiposity status. However, acylated ghrelin was correlated with change in weight and BMI in opposing directions, in overweight and obese subjects respectively, thus dependent on obesity status.	[Wadden, Danny; Cahill, Farrell; Amini, Peyvand; Vasdev, Sudesh; Yi, Yanqing; Sun, Guang] Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada; [Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Memorial University Newfoundland; Memorial University Newfoundland; Peking University	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada.	gsun@mun.ca	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798	Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation (CFI)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by the Canadian Institutes for Health Research (CIHR) and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; BRAY GA, 2003, HDB HLTH CARE; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; Callahan HS, 2004, J CLIN ENDOCR METAB, V89, P1319, DOI 10.1210/jc.2003-031267; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Druce MR, 2005, INT J OBESITY, V29, P1130, DOI 10.1038/sj.ijo.0803001; Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Hagobian TA, 2008, METABOLISM, V57, P393, DOI 10.1016/j.metabol.2007.10.016; Hansen TK, 2002, CLIN ENDOCRINOL, V56, P203, DOI 10.1046/j.0300-0664.2001.01456.x; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Hosoda H, 2003, J BIOL CHEM, V278, P64, DOI 10.1074/jbc.M205366200; Iwakura H, 2005, J BIOL CHEM, V280, P15247, DOI 10.1074/jbc.M411358200; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Konturek SJ, 2005, J PHYSIOL PHARMACOL, V56, P507; Korbonits M, 2004, EUR J ENDOCRINOL, V151, pS67, DOI 10.1530/eje.0.151S067; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Matsumoto M, 2001, BIOCHEM BIOPH RES CO, V287, P142, DOI 10.1006/bbrc.2001.5553; MAURIEGE P, 1992, INT J OBESITY, V16, P219; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE347, DOI 10.1152/ajpendo.00615.2004; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Natalucci G, 2005, EUR J ENDOCRINOL, V152, P845, DOI 10.1530/eje.1.01919; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Prince AC, 2009, AM J CLIN NUTR, V89, P755, DOI 10.3945/ajcn.2008.27056; Purnell JQ, 2003, J CLIN ENDOCR METAB, V88, P5747, DOI 10.1210/jc.2003-030513; Qader SS, 2005, REGUL PEPTIDES, V128, P51, DOI 10.1016/j.regpep.2004.12.018; Ravussin E, 2001, J CLIN ENDOCR METAB, V86, P4547, DOI 10.1210/jc.86.9.4547; Robertson MD, 2004, INT J OBESITY, V28, P727, DOI 10.1038/sj.ijo.0802637; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rosicka M, 2003, PHYSIOL RES, V52, P61; Shea J, 2007, AM J CLIN NUTR, V86, P1310, DOI 10.1093/ajcn/86.5.1310; Shea J, 2009, AM J CLIN NUTR, V89, P407, DOI 10.3945/ajcn.2008.25970; Stepien M, 2011, MED SCI MONITOR, V17, pPR13, DOI 10.12659/MSM.882030; Sun G, 2005, AM J CLIN NUTR, V81, P74; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Votruba SB, 2009, AM J CLIN NUTR, V89, P801, DOI 10.3945/ajcn.2008.27011; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zwirska-Korczala K, 2007, J PHYSIOL PHARMACOL, V58, P13	53	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45748	10.1371/journal.pone.0045748	http://dx.doi.org/10.1371/journal.pone.0045748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029221	Green Accepted, gold, Green Published			2022-12-27	WOS:000309517500040
J	Virgone, C; Cecchetto, G; Ferrari, A; Bisogno, G; Donofrio, V; Boldrini, R; Collini, P; Dall'Igna, P; Alaggio, R				Virgone, Calogero; Cecchetto, Giovanni; Ferrari, Andrea; Bisogno, Gianni; Donofrio, Vittoria; Boldrini, Renata; Collini, Paola; Dall'Igna, Patrizia; Alaggio, Rita			GATA-4 and FOG-2 Expression in Pediatric Ovarian Sex Cord-Stromal Tumors Replicates Embryonal Gonadal Phenotype: Results from the TREP Project	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; MULLERIAN-INHIBITING SUBSTANCE; GRANULOSA-CELL TUMORS; YOLK-SAC TUMORS; RARE TUMORS; PROMOTERS; APOPTOSIS; COFACTOR; FAMILY; CANCER	Aim: GATA proteins are a family of zinc finger transcription factors regulating gene expression, differentiation and proliferation in various tissues. The expression of GATA-4 and FOG-2, one of its modulators, was studied in pediatric Sex Cord-Stromal tumors of the ovary, in order to evaluate their potential role as diagnostic markers and prognostic factors. Materials and Methods: Clinical and histological data of 15 patients, enrolled into the TREP Project since 2000 were evaluated. When available, immunostaines for FOG-2, GATA-4, alpha-Inhibin, Vimentin and Pancytokeratin were also analyzed. Results: In our series there were 6 Juvenile Granulosa Cell Tumors (JGCT), 6 Sertoli-Leydig Cell Tumors (SLCT), 1 Cellular Fibroma, 1 Theca Cell Tumor and 1 Stromal Sclerosing Tumor (SST). Thirteen patients obtained a complete remission (CR), 1 reached a second CR after the removal of a metachronous tumor and 1 died of disease. Inhibin was detectable in 11/15, Vimentin in 13/15, Pancytokeratin in 6/15, GATA-4 in 5/13 and FOG-2 in 11/15. FOG-2 was highly expressed in 5/6 JGCT, while GATA-4 was weakly detectable only in 1 of the cases. SLCT expressed diffusely FOG-2 (4/6) and GATA-4 (3/5). GATA-4 and FOG-2 were detected in fibroma and thecoma but not in the SST. Conclusions: Pediatric granulosa tumors appear to express a FOG-2/GATA-4 phenotype in keeping with primordial ovarian follicles. High expression of GATA-4 does not correlate with aggressive behaviour as seen in adults, but it is probably involved in cell proliferation its absence can be associated with the better outcome of JGCT. SLCTs replicate the phenotype of Sertoli cells during embryogenesis in normal testis. In this group, the lack of expression of FOG-2 in tumors in advanced stages might reveal a hypothetical role in inhibiting GATA-4 cell proliferation pathway. In fibroma/thecoma group GATA-4 and FOG-2 point out the abnormal activation of GATA pathway and might be involved in the onset of these tumors.	[Virgone, Calogero; Cecchetto, Giovanni; Bisogno, Gianni; Dall'Igna, Patrizia] Univ Hosp, Dept Pediat, Padua, Italy; [Virgone, Calogero; Cecchetto, Giovanni; Bisogno, Gianni; Dall'Igna, Patrizia] Univ Hosp, Dept Gynaecol Obstet, Padua, Italy; [Ferrari, Andrea] Ist Nazl Tumori, Pediat Oncol Unit, I-20133 Milan, Italy; [Donofrio, Vittoria] Azienda Osped Rilievo Nazl Santobono Pausillipon, Serv Anat & Istol Patol, Naples, Italy; [Boldrini, Renata] Bambino Gesu Pediat Hosp, Pathol Unit, Rome, Italy; [Collini, Paola] Ist Nazl Tumori, Pathol Unit, I-20133 Milan, Italy; [Alaggio, Rita] Univ Padua, Dept Med & Diagnost Sci & Special Therapies, Pathol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Bambino Gesu; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua	Virgone, C (corresponding author), Univ Hosp, Dept Pediat, Padua, Italy.	calogero.virgone@unipd.it	alaggio, rita/AAC-2348-2019; Ferrari, Andrea/R-1028-2016; Virgone, Calogero/ABB-7432-2020; Collini, Paola/K-7354-2016; Bisogno, Gianni/K-9282-2016	alaggio, rita/0000-0003-3915-3816; Ferrari, Andrea/0000-0002-4724-0517; Collini, Paola/0000-0002-6158-210X; Dall'Igna, Patrizia/0000-0002-3822-3272; Bisogno, Gianni/0000-0003-4462-5523; Virgone, Calogero/0000-0002-3651-9416	Fondazione Cassa Di Risparmio Di Padova e Rovigo; "Fondazione Citta' della Speranza," Padua	Fondazione Cassa Di Risparmio Di Padova e Rovigo(Fondazione Cariparo); "Fondazione Citta' della Speranza," Padua	This paper is partially supported by a Grant from "Fondazione Cassa Di Risparmio Di Padova e Rovigo" and from the "Fondazione Citta' della Speranza," Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2005, J CLIN ENDOCR METAB, V90, P6529, DOI 10.1210/jc.2005-0921; Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Ball Allison, 2011, J Pediatr Adolesc Gynecol, V24, pe5, DOI 10.1016/j.jpag.2010.07.005; Cecchetto G, 2011, PEDIATR BLOOD CANCER, V56, P1062, DOI 10.1002/pbc.22918; Ferrari A, 2007, EUR J CANCER, V43, P654, DOI 10.1016/j.ejca.2006.08.028; Gwin K, 2008, PEDIAT DEV PATHOL, V12, P1; Ketola I, 2000, J CLIN ENDOCR METAB, V85, P3925, DOI 10.1210/jc.85.10.3925; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Kyronlahti A, 2010, ENDOCR-RELAT CANCER, V17, P709, DOI 10.1677/ERC-10-0041; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Mannisto S, 2005, TUMOR BIOL, V26, P265, DOI 10.1159/000087565; Masiakos PT, 1977, SEMIN PEDIATR SURG, V6, P147; Pastore G, 2009, PEDIATR BLOOD CANCER, V53, P152, DOI 10.1002/pbc.22049; Robert NM, 2002, ENDOCRINOLOGY, V143, P3963, DOI 10.1210/en.2002-220280; Robertson DM, 2004, SEMIN REPROD MED, V 22, P219, DOI 10.1055/s-2004-831897; Robertson DM, 2002, MOL CELL ENDOCRINOL, V191, P97, DOI 10.1016/S0303-7207(02)00060-6; Salonen J, 2010, EUR J ENDOCRINOL, V162, P625, DOI 10.1530/EJE-09-0734; SCULLY RE, 1996, ATLAS TUMOR PATHOLOG; Siltanen S, 1999, AM J PATHOL, V155, P1823, DOI 10.1016/S0002-9440(10)65500-9; Siltanen S, 2003, PEDIATR RES, V54, P542, DOI 10.1203/01.PDR.0000081295.56529.E9; Templeman Claire L, 2005, Semin Pediatr Surg, V14, P93; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; Viger RS, 2004, J ANDROL, V25, P441; Watanabe K, 2000, P NATL ACAD SCI USA, V97, P1624, DOI 10.1073/pnas.97.4.1624; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; YOUNG RH, 1984, AM J SURG PATHOL, V8, P575, DOI 10.1097/00000478-198408000-00002	29	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45914	10.1371/journal.pone.0045914	http://dx.doi.org/10.1371/journal.pone.0045914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029311	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700088
J	Sheng, XY; Wei, Q; Jiang, LP; Li, X; Gao, Y; Wang, L				Sheng, Xianyong; Wei, Qian; Jiang, Liping; Li, Xue; Gao, Yuan; Wang, Li			Different Degree in Proteasome Malfunction Has Various Effects on Root Growth Possibly through Preventing Cell Division and Promoting Autophagic Vacuolization	PLOS ONE			English	Article							INTRACELLULAR PROTEIN-DEGRADATION; UBIQUITIN/PROTEASOME PATHWAY; ARABIDOPSIS; UBIQUITIN; INHIBITION; INDUCTION; ROLES; DEATH; SIZE; OVEREXPRESSION	The ubiquitin/proteasome pathway plays a vital role in plant development. But the effects of proteasome malfunction on root growth, and the mechanism underlying this involvement remains unclear. In the present study, the effects of proteasome inhibitors on Arabidopsis root growth were studied through the analysis of the root length, and meristem size and cell length in maturation zone using FM4-64, and cell-division potential using GFP fusion cyclin B, and accumulation of ubiquitinated proteins using immunofluorescence labeling, and autophagy activity using LysoTracker and MDC. The results indicated that lower concentration of proteasome inhibitors promoted root growth, whereas higher concentration of inhibitors had the opposite effects. The accumulation of cyclin B was linked to MG132-induced decline in meristem size, indicating that proteasome malfunction prevented cell division. Besides, MG132-induced accumulation of the ubiquitinated proteins was associated with the increasing fluorescence signal of LysoTracker and MDC in the elongation zone, revealing a link between the activation of autophagy and proteasome malfunction. These results suggest that weak proteasome malfunction activates moderate autophagy and promotes cell elongation, which compensates the inhibitor-induced reduction of cell division, resulting in long roots. Whereas strong proteasome malfunction induces severe autophagy and disturbs cell elongation, resulting in short roots.	[Sheng, Xianyong; Wei, Qian; Jiang, Liping; Li, Xue; Gao, Yuan] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Sheng, Xianyong] Chinese Acad Sci, Inst Bot, Key Lab Mol Physiol, Beijing, Peoples R China; [Wang, Li] Cent S Univ, Sch Biol Sci & Technol, Changsha, Hunan, Peoples R China	Capital Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Central South University	Sheng, XY (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	xianyong.sheng@163.com			Natural Science Foundation of China [30700039, 30800088]; Scientific Research Project of Beijing Educational Committee [KM201210028017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Beijing Educational Committee	This work was supported by Natural Science Foundation of China (Grant No. 30700039; 30800088) and Scientific Research Project of Beijing Educational Committee (Grant No. KM201210028017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecconi F, 2007, AUTOPHAGY, V3, P506; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Criqui MC, 2000, PLANT J, V24, P763, DOI 10.1111/j.1365-313X.2000.t01-1-.x; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; Du YL, 2009, AUTOPHAGY, V5, P663, DOI 10.4161/auto.5.5.8377; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Ingvardsen C, 2001, PLANTA, V213, P333, DOI 10.1007/s004250000511; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Mitou G., 2009, INT J PLANT GENOMICS; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Negi S, 2010, MOL PLANT, V3, P854, DOI 10.1093/mp/ssq033; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Planchais S, 2004, PLANT J, V38, P616, DOI 10.1111/j.0960-7412.2004.02071.x; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sako K, 2010, J PLANT RES, V123, P701, DOI 10.1007/s10265-010-0321-x; Sheng XY, 2010, CELL BIOCHEM FUNCT, V28, P420, DOI 10.1002/cbf.1672; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Sheng XY, 2011, TREES-STRUCT FUNCT, V25, P407, DOI 10.1007/s00468-010-0515-9; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Takatsuka C, 2011, PLANT CELL PHYSIOL, V52, P2074, DOI 10.1093/pcp/pcr137; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wagenknecht B, 2000, J NEUROCHEM, V75, P2288, DOI 10.1046/j.1471-4159.2000.0752288.x; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031	46	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45673	10.1371/journal.pone.0045673	http://dx.doi.org/10.1371/journal.pone.0045673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029176	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800078
J	Liu, MC; Lin, SB; Chien, HF; Wang, WB; Yuan, YH; Hsueh, PR; Liaw, SJ				Liu, Ming-Che; Lin, Shwu-Bin; Chien, Hsiung-Fei; Wang, Won-Bo; Yuan, Yu-Han; Hsueh, Po-Ren; Liaw, Shwu-Jen			10 '(Z),13 '(E)-Heptadecadienylhydroquinone Inhibits Swarming and Virulence Factors and Increases Polymyxin B Susceptibility in Proteus mirabilis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; FACTOR EXPRESSION; CELL-DIFFERENTIATION; ESCHERICHIA-COLI; RESISTANCE; PHOSPHORELAY; MOTILITY; ZAPA; METALLOPROTEASE; IDENTIFICATION	In this study, we demonstrated that 10'(Z), 13'(E)-heptadecadienylhydroquinone (HQ17-2), isolated from the lacquer tree, could decrease swarming motility and hemolysin activity but increase polymyxin B (PB) susceptibilityof Proteus mirabilis which is intrinsically highly-resistant to PB. The increased PB susceptibility induced by HQ17-2 was also observed in clinical isolates and biofilm-grown cells. HQ17-2 could inhibit swarming in the wild-type and rppA mutant but not in the rcsB mutant, indicating that HQ17-2 inhibits swarming through the RcsB-dependent pathway, a two-component signaling pathway negatively regulating swarming and virulence factor expression. The inhibition of hemolysin activity by HQ17-2 is also mediated through the RcsB-dependent pathway, because HQ17-2 could not inhibit hemolysin activity in the rcsB mutant. Moreover, the finding that HQ17-2 inhibits the expression of flhDC gene in the wild-type and rcsB-complemented strain but not in the rcsB mutant supports the notion. By contrast, HQ17-2 could increase PB susceptibility in the wild-type and rcsB mutant but not in the rppA mutant, indicating that HQ17-2 increases PB susceptibility through the RppA-dependent pathway, a signaling pathway positively regulating PB resistance. In addition, HQ17-2 could inhibit the promoter activities of rppA and pmrI, a gene positively regulated by RppA and involved in PB resistance, in the wild-type but not in the rppA mutant. The inhibition of rppA and pmrI expression caused lipopolysaccharide purified from HQ17-2-treated cells to have higher affinity for PB. Altogether, this study uncovers new biological effects of HQ17-2 and provides evidence for the potential of HQ17-2 in clinical applications.	[Liu, Ming-Che; Lin, Shwu-Bin; Yuan, Yu-Han; Liaw, Shwu-Jen] Natl Taiwan Univ, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Wang, Won-Bo] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hsueh, Po-Ren; Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sjliaw@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC 97-2320-B-002-025-MY3]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC 97-2320-B-002-025-MY3) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON C, 1992, INFECT IMMUN, V60, P4740, DOI 10.1128/IAI.60.11.4740-4746.1992; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; Belas R, 1998, J BACTERIOL, V180, P6126; Chen YR, 2009, J AGR FOOD CHEM, V57, P2200, DOI 10.1021/jf802617a; Clemmer KM, 2007, RES MICROBIOL, V158, P295, DOI 10.1016/j.resmic.2006.11.010; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Pescaretti MD, 2010, MICROBIOL-SGM, V156, P3513, DOI 10.1099/mic.0.041319-0; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Fraser GM, 2002, MICROBIOL-SGM, V148, P2191, DOI 10.1099/00221287-148-7-2191; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Huang CP, 2008, TOXICOL APPL PHARM, V227, P331, DOI 10.1016/j.taap.2007.11.014; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P1564, DOI 10.1128/AAC.01219-09; Kim W, 2003, J BACTERIOL, V185, P3111, DOI 10.1128/JB.185.10.3111-3117.2003; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Liaw SJ, 2000, J MED MICROBIOL, V49, P725, DOI 10.1099/0022-1317-49-8-725; Liaw SJ, 2004, INFECT IMMUN, V72, P6836, DOI 10.1128/IAI.72.12.6836-6845.2004; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Liaw SJ, 2001, J MED MICROBIOL, V50, P1039, DOI 10.1099/0022-1317-50-12-1039; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Maresh J, 2007, BIOORG MED CHEM LETT, V17, P3281, DOI 10.1016/j.bmcl.2007.04.018; MOBLEY HLT, 1991, INFECT IMMUN, V59, P2036, DOI 10.1128/IAI.59.6.2036-2042.1991; Morgenstein RM, 2010, FEMS MICROBIOL REV, V34, P753, DOI 10.1111/j.1574-6976.2010.00229.x; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Nordlund JJ, 2006, J EUR ACAD DERMATOL, V20, P781, DOI 10.1111/j.1468-3083.2006.01670.x; Pandey DK, 2005, PESTIC BIOCHEM PHYS, V83, P82, DOI 10.1016/j.pestbp.2005.03.013; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Phan V, 2008, INFECT IMMUN, V76, P4859, DOI 10.1128/IAI.00122-08; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Takeda S, 2001, MOL MICROBIOL, V40, P440, DOI 10.1046/j.1365-2958.2001.02393.x; Walker KE, 1999, MOL MICROBIOL, V32, P825, DOI 10.1046/j.1365-2958.1999.01401.x; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Wang WB, 2008, INFECT IMMUN, V76, P2051, DOI 10.1128/IAI.01557-07; Wang WB, 2006, J MED MICROBIOL, V55, P1313, DOI 10.1099/jmm.0.46661-0; Wu PL, 2002, J NAT PROD, V65, P1719, DOI 10.1021/np0201467; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45563	10.1371/journal.pone.0045563	http://dx.doi.org/10.1371/journal.pone.0045563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029100	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900074
J	Quek, SI; Ho, ME; Loprieno, MA; Ellis, WJ; Elliott, N; Liu, AY				Quek, Sue-Ing; Ho, Melissa E.; Loprieno, Michelle A.; Ellis, William J.; Elliott, Nathan; Liu, Alvin Y.			A Multiplex Assay to Measure RNA Transcripts of Prostate Cancer in Urine	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; IDENTIFICATION; CELLS; MULTICENTER; SIGNATURE; DIAGNOSIS	The serum prostate-specific antigen (PSA) test has a high false positive rate. As a single marker, PSA provides limited diagnostic information. A multi-marker test capable of detecting not only tumors but also the potentially lethal ones provides an unmet clinical need. Using the nanoString nCounter gene expression system, a 20-gene multiplex test was developed based on digital gene counting of RNA transcripts in urine as a means to detect prostate cancer. In this test, voided urine is centrifuged to pellet cells and the purified RNA is amplified for hybridization to preselected probesets. Amplification of test cell line RNA appeared not to introduce significant bias, and the counts matched well with gene abundance levels as measured by DNA microarrays. For data analysis, the individual counts were compared to that of beta 2 microglobulin, a housekeeping gene. Urine samples of 5 pre-operative cases and 2 non-cancer were analyzed. Pathology information was then retrieved. Signals for a majority of the genes were low for non-cancer and low Gleason scores, and 6/6 known prostate cancer markers were positive in the cases. One case of Gleason 4+5 showed, in contrast, strong signals for all cancer-associated markers, including CD24. One non-cancer also showed signals for all 6 cancer markers, and this man might harbor an undiagnosed cancer. This multiplex test assaying a natural waste product can potentially be used for screening, early cancer detection and patient stratification. Diagnostic information is gained from the RNA signatures that are associated with cell types of prostate tumors.	[Quek, Sue-Ing; Ho, Melissa E.; Loprieno, Michelle A.; Ellis, William J.; Liu, Alvin Y.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Quek, Sue-Ing; Ho, Melissa E.; Loprieno, Michelle A.; Liu, Alvin Y.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Elliott, Nathan] NanoString Technol, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Quek, SI (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	sueq@u.washington.edu			National Cancer Institute - Early Detection Research Network (NCI EDRN) [CA111244]; NATIONAL CANCER INSTITUTE [U01CA111244] Funding Source: NIH RePORTER	National Cancer Institute - Early Detection Research Network (NCI EDRN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute - Early Detection Research Network (NCI EDRN) grant CA111244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2002, CANCER RES, V62, P3308; Bu HJ, 2011, PROSTATE, V71, P575, DOI 10.1002/pros.21273; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Durand X, 2012, BJU INT; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gorin MA, 2012, PROSTATE CANCER P D, V15, P177, DOI 10.1038/pcan.2011.57; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Hessels D, 2010, PROSTATE, V70, P10, DOI 10.1002/pros.21032; Jiang Z, 2003, HUM PATHOL, V34, P792, DOI 10.1016/S0046-8177(03)00268-5; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Liu AY, 2012, CELL TISSUE RES, V348, P589, DOI 10.1007/s00441-012-1383-y; Liu AY, 2004, AM J PATHOL, V165, P1543, DOI 10.1016/S0002-9440(10)63412-8; Magee JA, 2001, CANCER RES, V61, P5692; Newcomb LF, 2010, UROLOGY, V75, P407, DOI 10.1016/j.urology.2009.05.050; Oudes AJ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-86; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-452; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-317; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Sokoll LJ, 2008, CLIN CHIM ACTA, V389, P1, DOI 10.1016/j.cca.2007.11.003; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Udby L, 2005, J ANDROL, V26, P333, DOI 10.2164/jandrol.04132; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Poppel H, 2012, BJU INT, V109, P360, DOI 10.1111/j.1464-410X.2011.10377.x; Wayner EA, 2012, PROSTATE, V72, P1023, DOI 10.1002/pros.21508; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xu JC, 2000, CANCER RES, V60, P1677; Yuasa T, 1999, INT J UROL, V6, P286, DOI 10.1046/j.1442-2042.1999.00064.x; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188	34	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45656	10.1371/journal.pone.0045656	http://dx.doi.org/10.1371/journal.pone.0045656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029164	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900086
J	Lee, WC; Chiang, PH; Tain, YL; Wu, CC; Chuang, YC				Lee, Wei-Chia; Chiang, Po-Hui; Tain, You-Lin; Wu, Chia-Ching; Chuang, Yao-Chi			Sensory Dysfunction of Bladder Mucosa and Bladder Oversensitivity in a Rat Model of Metabolic Syndrome	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; URINARY-BLADDER; OVERACTIVE BLADDER; DETRUSOR OVERACTIVITY; RECEPTOR EXPRESSION; MICTURITION REFLEX; P2X(3) RECEPTOR; CONTRACTION; UROTHELIUM; PROTEIN	Purpose: To study the role of sensory dysfunction of bladder mucosa in bladder oversensitivity of rats with metabolic syndrome. Materials and Methods: Female Wistar rats were fed a fructose-rich diet (60%) or a normal diet for 3 months. Based on cystometry, the fructose-fed rats (FFRs) were divided into a group with normal detrusor function or detrusor overactivity (DO). Acidic adenosine triphosphate (ATP) solution (5mM, pH 3.3) was used to elicit reflex micturition. Cystometric parameters were evaluated before and after drug administration. Functional proteins of the bladder mucosa were assessed by western blotting. Results: Compared to the controls, intravesical acidic ATP solution instillation induced a significant increase in provoked phasic contractions in both FFR groups and a significant decrease in the mean functional bladder capacity of group DO. Pretreatment with capsaicin for C-fiber desentization, intravesical liposome for mucosal protection, or intravenous pyridoxal 5-phosphate 6-azophenyl-2',4'-disulfonic acid for antagonized purinergic receptors can interfere with the urodynamic effects of intravesical ATP in FFRs and controls. Over-expression of TRPV1, P2X(3), and iNOS proteins, and down-regulation of eNOS proteins were observed in the bladder mucosa of both fructose-fed groups. Conclusions: Alterations of sensory receptors and enzymes in the bladder mucosa, including over-expression of TRPV1, P2X(3), and iNOS proteins, can precipitate the emergence of bladder phasic contractions and oversensitivity through the activation of C-afferents during acidic ATP solution stimulation in FFRs. The down-regulation of eNOS protein in the bladder mucosa of FFRs may lead to a failure to suppress bladder oversensitivity and phasic contractions. Sensory dysfunction of bladder mucosa and DO causing by metabolic syndrome are easier to elicit bladder oversensitivity to certain urothelium stimuli.	[Lee, Wei-Chia; Chiang, Po-Hui; Chuang, Yao-Chi] Kaohsiung Chang Gung Mem Hosp, Div Urol, Kaohsiung, Taiwan; [Lee, Wei-Chia; Chiang, Po-Hui; Tain, You-Lin; Chuang, Yao-Chi] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Tain, You-Lin] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Wu, Chia-Ching] Cheng Shiu Univ, Dept Int Business, Coll Commerce & Management, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Cheng Shiu University	Chuang, YC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Urol, Kaohsiung, Taiwan.	chuang82@ms26.hinet.net	Tain, You-Lin/H-2827-2019	Tain, You-Lin/0000-0002-7059-6407; Chuang, Yao-Chi/0000-0002-1468-3792; Lee, Wei-Chia/0000-0003-0701-2285	National Science Council of the Republic of China [NSC 98-2314-B-182A-060-MY3]; Chang Gung Memorial Hospital [CMRPG890241]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work is supported by Grants: NSC 98-2314-B-182A-060-MY3 from the National Science Council of the Republic of China, and CMRPG890241 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2011, NEUROUROL URODYNAM, V30, P163, DOI 10.1002/nau.20940; Aizawa N, 2011, EUR UROL, V59, P264, DOI 10.1016/j.eururo.2010.10.035; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Apostolidis A, 2005, UROLOGY, V65, P400, DOI 10.1016/j.urology.2004.10.007; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Borysova L, 2011, CELL CALCIUM, V50, P393, DOI 10.1016/j.ceca.2011.07.003; Chien CT, 2000, NEUROSCIENCE, V96, P221, DOI 10.1016/S0306-4522(99)00508-4; Chuang YC, 2010, BJU INT, V106, P1782, DOI 10.1111/j.1464-410X.2010.09260.x; Chuang YC, 2009, J UROLOGY, V182, P1393, DOI 10.1016/j.juro.2009.06.024; Chung SD, 2011, NEUROUROL URODYNAM, V30, P1300, DOI 10.1002/nau.21057; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; DEGROAT WC, 1995, PARAPLEGIA, V33, P493, DOI 10.1038/sc.1995.109; Fraser MO, 2003, UROLOGY, V61, P656, DOI 10.1016/S0090-4295(02)02281-1; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Gillespie JI, 2009, BJU INT, V103, P1324, DOI 10.1111/j.1464-410X.2009.08377.x; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Kuo HC, 2006, J UROLOGY, V176, P641, DOI 10.1016/j.juro.2006.03.087; Lawrence JM, 2007, DIABETES CARE, V30, P2536, DOI 10.2337/dc07-0262; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Lee WC, 2011, J UROLOGY, V186, P318, DOI 10.1016/j.juro.2011.03.037; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; Morelli A, 2012, J STEROID BIOCHEM, V132, P80, DOI 10.1016/j.jsbmb.2012.02.007; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Munoz A, 2012, BJU INT, V110, pE409, DOI 10.1111/j.1464-410X.2012.11189.x; Munoz A, 2011, NEUROCHEM INT, V58, P295, DOI 10.1016/j.neuint.2010.12.002; Nishiguchi J, 2005, UROLOGY, V66, P1332, DOI 10.1016/j.urology.2005.06.099; O'Reilly BA, 2002, J UROLOGY, V167, P157, DOI 10.1016/S0022-5347(05)65403-1; Pandita RK, 2002, J UROLOGY, V168, P1230, DOI 10.1016/S0022-5347(05)64631-9; Qiao SL, 2004, NEUROCHEM RES, V29, P687, DOI 10.1023/B:NERE.0000018839.59457.5c; Streng T, 2006, BJU INT, V97, P1094, DOI 10.1111/j.1464-410X.2006.06137.x; Studeny S, 2005, AM J PHYSIOL-REG I, V289, pR1155, DOI 10.1152/ajpregu.00234.2005; Sun Y, 2004, J UROLOGY, V171, P448, DOI 10.1097/01.ju.0000099660.46774.3c; Tempest HV, 2004, BJU INT, V93, P1344, DOI 10.1111/j.1464-410X.2004.04858.x; Tong YC, 2007, J UROLOGY, V178, P1537, DOI 10.1016/j.juro.2007.05.114; Tong YC, 2006, NEUROSCI LETT, V406, P216, DOI 10.1016/j.neulet.2006.07.065; Wang TC, 2009, AM J PHYSIOL-RENAL, V297, pF1534, DOI 10.1152/ajprenal.00095.2009; Weng TI, 2009, INFECT IMMUN, V77, P3312, DOI 10.1128/IAI.00013-09; Wibberley A, 2003, BRIT J PHARMACOL, V138, P757, DOI 10.1038/sj.bjp.0705109; Yokoyama T, 2004, J UROLOGY, V172, P596, DOI 10.1097/01.ju.0000132769.71014.b5; Yoshida M, 2010, NEUROUROL URODYNAM, V29, P1350, DOI 10.1002/nau.20843; Yu YB, 2008, AM J PHYSIOL-RENAL, V294, pF1146, DOI 10.1152/ajprenal.00592.2007; Yuan XG, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.018	46	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45578	10.1371/journal.pone.0045578	http://dx.doi.org/10.1371/journal.pone.0045578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029112	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400109
J	Moen, SM; Celius, EG; Sandvik, L; Brustad, M; Nordsletten, L; Eriksen, EF; Holmoy, T				Moen, Stine Marit; Celius, Elisabeth Gulowsen; Sandvik, Leiv; Brustad, Magritt; Nordsletten, Lars; Eriksen, Erik Fink; Holmoy, Trygve			Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MINERAL DENSITY; 25-HYDROXYVITAMIN-D LEVELS; SERUM 25-HYDROXYVITAMIN-D; DOSE GLUCOCORTICOIDS; RISK; ASSOCIATION; WOMEN; HEALTH	Background: Low bone mass is prevalent in ambulatory multiple sclerosis (MS) patients even shortly after clinical onset. The mechanism is not known, but could involve shared etiological risk factors between MS and low bone mass such as hypovitaminosis D operating before disease onset, or increased bone loss after disease onset. The aim of this study was to explore the mechanism of the low bone mass in early-stage MS patients. Methodology/Principal Findings: We performed a population-based case-control study comparing bone turnover (crosslinked N-terminal telopeptide of type 1 collagen; NTX, bone alkaline phosphatase; bALP), metabolism (25-hydroxy-and 1, 25-dihydroxyvitamin D, calcium, phosphate, and parathyroid hormone), and relevant lifestyle factors in 99 patients newly diagnosed with clinically isolated syndrome (CIS) or MS, and in 159 age, sex, and ethnicity matched controls. After adjustment for possible confounders, there were no significant differences in NTX (mean 3.3; 95% CI -6.9, 13.5; p = 0.519), bALP (mean 1.6; 95% CI -0.2, 3.5; p = 0.081), or in any of the parameters related to bone metabolism in patients compared to controls. The markers of bone turnover and metabolism were not significantly correlated with bone mass density, or associated with the presence of osteoporosis or osteopenia within or between the patient and control groups. Intake of vitamin D and calcium, reported UV exposure, and physical activity did not differ significantly. Conclusions/Significance: Bone turnover and metabolism did not differ significantly in CIS and MS patients with prevalent low bone mass compared to controls. These findings indicate that the bone deficit in patients newly diagnosed with MS and CIS is not caused by recent acceleration of bone loss, and are compatible with shared etiological factors between MS and low bone mass.	[Moen, Stine Marit; Celius, Elisabeth Gulowsen] Univ Oslo, Ulleval Hosp, Dept Neurol, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Ulleval Hosp, Epidemiol & Biostat Sect, Oslo, Norway; [Brustad, Magritt] Univ Tromso, Dept Community Med, Tromso, Norway; [Nordsletten, Lars] Univ Oslo, Ulleval Hosp, Dept Orthoped, Oslo, Norway; [Eriksen, Erik Fink] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Holmoy, Trygve] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Moen, SM (corresponding author), Univ Oslo, Ulleval Hosp, Dept Neurol, Oslo, Norway.	s.m.moen@medisin.uio.no	Celius, Elisabeth Gulowsen/S-1387-2019; Eriksen, Erik Fink/AAF-5056-2020	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; 	South-Eastern Norway Regional Health Authority; Ulleval University Hospital; Odd Fellow Research Foundation for Multiple Sclerosis; Endowment of K. and K. H. Hemsen; Endowment of Fritz and Ingrid Nilsen	South-Eastern Norway Regional Health Authority; Ulleval University Hospital; Odd Fellow Research Foundation for Multiple Sclerosis; Endowment of K. and K. H. Hemsen; Endowment of Fritz and Ingrid Nilsen	Study funding: Supported by research grants from the South-Eastern Norway Regional Health Authority, Ulleval University Hospital, Odd Fellow Research Foundation for Multiple Sclerosis, the Endowment of K. and K. H. Hemsen, and the Endowment of Fritz and Ingrid Nilsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alver K, 2005, OSTEOPOROSIS INT, V16, P623, DOI 10.1007/s00198-004-1722-2; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barnes MS, 2007, MULT SCLER, V13, P670, DOI 10.1177/1352458506072666; Bazelier MT, 2012, MULT SCLER J, V18, P622, DOI 10.1177/1352458511426739; Bazelier MT, 2011, J BONE MINER RES, V26, P2271, DOI 10.1002/jbmr.418; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Brustad M, 2004, EUR J CLIN NUTR, V58, P128, DOI 10.1038/sj.ejcn.1601759; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cosman F, 1998, NEUROLOGY, V51, P1161, DOI 10.1212/WNL.51.4.1161; COSMAN F, 1994, J BONE MINER RES, V9, P1097; Czerny B, 2010, EUR J OBSTET GYN R B, V149, P82, DOI 10.1016/j.ejogrb.2009.12.010; Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164; Edvardsen K, 2009, INT J BIOMETEOROL, V53, P451, DOI 10.1007/s00484-009-0231-6; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Gibson JC, 2011, OSTEOPOROSIS INT, V22, P2935, DOI 10.1007/s00198-011-1644-8; Gilboe IM, 2000, ANN RHEUM DIS, V59, P110, DOI 10.1136/ard.59.2.110; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hearn AP, 2010, MULT SCLER J, V16, P1031, DOI 10.1177/1352458510368985; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; Lilleby V, 2005, ARTHRITIS RHEUM, V52, P2051, DOI 10.1002/art.21115; Lonergan R, 2011, J NEUROL NEUROSUR PS, V82, P317, DOI 10.1136/jnnp.2010.220988; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Minisola S, 2008, J Endocrinol Invest, V31, P28; Mirowska-Guzel D, 2011, J NEUROIMMUNOL, V236, P87, DOI 10.1016/j.jneuroim.2011.04.014; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Moen SM, 2011, NEUROLOGY, V77, P151, DOI 10.1212/WNL.0b013e3182242d34; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; NIEVES J, 1994, NEUROLOGY, V44, P1687, DOI 10.1212/WNL.44.9.1687; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Seibel MJ, 2003, ENDOCRIN METAB CLIN, V32, P83, DOI 10.1016/S0889-8529(02)00077-4; Shaygannejad V, 2010, INT J PREVENTIVE MED, V1, P195; Smestad C, 2008, J NEUROL, V255, P49, DOI 10.1007/s00415-007-0659-8; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Steffensen LH, 2010, J NEUROL, V257, P410, DOI 10.1007/s00415-009-5337-6; Stepan JJ, 2004, CLIN CHIM ACTA, V348, P147, DOI 10.1016/j.cccn.2004.05.012; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; Terzi T, 2010, J CLIN NEUROSCI, V17, P1260, DOI 10.1016/j.jocn.2010.01.044; Triantafyllou N, 2012, J NEUROL SCI, V313, P137, DOI 10.1016/j.jns.2011.09.002; Tuzun S, 2003, MULT SCLER, V9, P600, DOI 10.1191/1352458503ms966oa; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Zikan V, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/596294	54	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45703	10.1371/journal.pone.0045703	http://dx.doi.org/10.1371/journal.pone.0045703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029191	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400122
J	Schrader, M; Travis, J				Schrader, Matthew; Travis, Joseph			Embryonic IGF2 Expression Is Not Associated with Offspring Size among Populations of a Placental Fish	PLOS ONE			English	Article							VIVIPARITY-DRIVEN-CONFLICT; LIFE-HISTORY TRAITS; GROWTH-FACTOR-II; LEAST KILLIFISH; REPRODUCTIVE ISOLATION; HETERANDRIA-FORMOSA; LIVE-BEARING; EVOLUTION; POECILIOPSIS; INVESTMENT	In organisms that provision young between fertilization and birth, mothers and their developing embryos are expected to be in conflict over embryonic growth. In mammalian embryos, the expression of Insulin-like growth factor II (IGF2) plays a key role in maternal-fetal interactions and is thought to be a focus of maternal-fetal conflict. Recent studies have suggested that IGF2 is also a focus of maternal-fetal conflict in placental fish in the family Poeciliidae. However, whether the expression of IGF2 influences offspring size, the trait over which mothers and embryos are likely to be in conflict, has not been assessed in a poeciliid. We tested whether embryonic IGF2 expression varied among four populations of a placental poeciliid that display large and consistent differences in offspring size at birth. We found that IGF2 expression varied significantly among embryonic stages with expression being 50% higher in early stage embryos than late stage embryos. There were no significant differences among populations in IGF2 expression; small differences in expression between population pairs with different offspring sizes were comparable in magnitude to those between population pairs with the same offspring sizes. Our results indicate that variation in IGF2 transcript abundance does not contribute to differences in offspring size among H. formosa populations.	[Schrader, Matthew] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Schrader, Matthew; Travis, Joseph] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; Florida State University	Schrader, M (corresponding author), Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA.	schrader@bio.fsu.edu		Schrader, Matthew/0000-0001-5432-6696	US National Science Foundation [DEB 08-22547]	US National Science Foundation(National Science Foundation (NSF))	This work was funded by a grant by the US National Science Foundation (DEB 08-22547). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Lawton BR, 2005, DEV GENES EVOL, V215, P207, DOI 10.1007/s00427-004-0463-8; Leips J, 1999, J ANIM ECOL, V68, P595, DOI 10.1046/j.1365-2656.1999.00311.x; Leips J, 2000, ECOL MONOGR, V70, P289, DOI 10.1890/0012-9615(2000)070[0289:GIOEPD]2.0.CO;2; O'Neill MJ, 2007, P NATL ACAD SCI USA, V104, P12404, DOI 10.1073/pnas.0705048104; Panhuis TM, 2011, J HERED, V102, P352, DOI 10.1093/jhered/esr002; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Peterson BC, 2004, COMP BIOCHEM PHYS A, V139, P317, DOI 10.1016/j.cbpb.2004.09.015; Pires MN, 2007, J EXP ZOOL PART A, V307A, P113, DOI 10.1002/jez.a.356; Pires MN, 2011, VARIATION EVOLUTION; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Reznick D., 1989, REV LIFE HIST PATTER; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Schrader M, 2005, COPEIA, P649; Schrader M, 2012, ECOLOGY EVO IN PRESS; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; Schrader M, 2011, MOL ECOL, V20, P4140, DOI 10.1111/j.1365-294X.2011.05264.x; Schrader M, 2009, EVOLUTION, V63, P2805, DOI 10.1111/j.1558-5646.2009.00763.x; Schrader M, 2008, AM NAT, V172, P806, DOI 10.1086/592999; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V29, P307, DOI 10.1007/BF00163989; TRAVIS J, 1987, ECOLOGY, V68, P611, DOI 10.2307/1938466; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vrana PB, 2007, J MAMMAL, V88, P5, DOI 10.1644/06-MAMM-S-013R1.1; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9; Zeh JA, 2008, ANN NY ACAD SCI, V1133, P126, DOI 10.1196/annals.1438.006	30	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45463	10.1371/journal.pone.0045463	http://dx.doi.org/10.1371/journal.pone.0045463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029026	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400088
J	Gautam, P; Nair, SC; Gupta, MK; Sharma, R; Polisetty, RV; Uppin, MS; Sundaram, C; Puligopu, AK; Ankathi, P; Purohit, AK; Chandak, GR; Harsha, HC; Sirdeshmukh, R				Gautam, Poonam; Nair, Sudha C.; Gupta, Manoj Kumar; Sharma, Rakesh; Polisetty, Ravindra Varma; Uppin, Megha S.; Sundaram, Challa; Puligopu, Aneel K.; Ankathi, Praveen; Purohit, Aniruddh K.; Chandak, Giriraj R.; Harsha, H. C.; Sirdeshmukh, Ravi			Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SERUM CARNOSINASE; CHROMOGRANIN-A; EXPRESSION; BRAIN; FERRITIN; MARKERS; CELLS; DIFFERENTIATION; INFLAMMATION	Glioblastomas (GBMs) are the most common and lethal primary tumors of the central nervous system with high level of recurrence despite aggressive therapy. Tumor-associated proteins/peptides may appear in the plasma of these patients as a result of disruption of the blood-brain barrier in them, raising the scope for development of plasma-based tests for diagnosis and monitoring the disease. With this objective, we analyzed the levels of proteins present in the plasma from GBM patients using an iTRAQ based LC-MS/MS approach. Analysis with pooled plasma specimens from the patient and healthy control samples revealed high confidence identification of 296 proteins, of which 61 exhibited a fold-change >= 1.5 in the patient group. Forty-eight of them contained signal sequence. A majority have been reported in the differentially expressed transcript or protein profile of GBM tissues; 6 have been previously studied as plasma biomarkers for GBM and 16 for other types of cancers. Altered levels of three representative proteins-ferritin light chain (FTL), S100A9, and carnosinase 1 (CNDP1)-were verified by ELISA in a test set of ten individual plasma specimens. FTL is an inflammation marker also implicated in cancer, S100A9 is an important member of the Ca2+ signaling cascade reported to be altered in GBM tissue, and CNDP1 has been reported for its role in the regulation of the levels of carnosine, implicated as a potential drug for GBM. These and other proteins in the dataset may form useful starting points for further clinical investigations for the development of plasma-based biomarker panels for GBM.	[Sharma, Rakesh; Harsha, H. C.; Sirdeshmukh, Ravi] Inst Bioinformat, Bangalore, Karnataka, India; [Gautam, Poonam; Nair, Sudha C.; Gupta, Manoj Kumar; Polisetty, Ravindra Varma; Chandak, Giriraj R.; Sirdeshmukh, Ravi] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India; [Uppin, Megha S.; Sundaram, Challa; Puligopu, Aneel K.; Ankathi, Praveen; Purohit, Aniruddh K.] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences	Sirdeshmukh, R (corresponding author), Inst Bioinformat, Bangalore, Karnataka, India.	sirdesh@ibioinformatics.org	Gowda, Harsha/A-8526-2011	Gowda, Harsha/0000-0002-4118-6855; Gupta, Manoj Kumar/0000-0002-1432-9793; Chandak, Giriraj Ratan/0000-0002-3095-9453; Sharma, Rakesh/0000-0002-5306-3457	Council of Scientific and Industrial Research (CSIR), Government of India [NWP 0004, IAP 001]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work reported here was carried out under the Network Project NWP 0004 and IAP 001 supported by the Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belli Susana Haydee, 2009, Acta Gastroenterol Latinoam, V39, P184; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Deininger MH, 2003, ACTA NEUROPATHOL, V106, P271, DOI 10.1007/s00401-003-0727-9; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; GASQUE P, 1992, J IMMUNOL, V149, P1381; Gaunitz F, 2012, AMINO ACIDS, V43, P135, DOI 10.1007/s00726-012-1271-5; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Haapasalo J, 2007, NEURO-ONCOLOGY, V9, P308, DOI 10.1215/15228517-2007-001; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Iwamoto FM, 2011, NEURO-ONCOLOGY, V13, P1244, DOI 10.1093/neuonc/nor117; Jarvela S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-104; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Khwaja FW, 2006, PROTEOMICS, V6, P6277, DOI 10.1002/pmic.200600135; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P111, DOI 10.1016/j.ecl.2010.12.001; LENNEY JF, 1983, CLIN CHIM ACTA, V132, P157, DOI 10.1016/0009-8981(83)90243-7; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; MAXIM PE, 1986, CANCER, V57, P305, DOI 10.1002/1097-0142(19860115)57:2<305::AID-CNCR2820570219>3.0.CO;2-D; MCCOMB RD, 1982, J NEUROPATH EXP NEUR, V41, P479; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; MURAKAMI M, 1988, J CLIN INVEST, V82, P177, DOI 10.1172/JCI113568; Nemeth Julia, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P329; NOMURA A, 1992, CANCER EPIDEM BIOMAR, V1, P547; OZAWA H, 1994, PEDIATR NEUROL, V10, P44, DOI 10.1016/0887-8994(94)90066-3; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Quaranta M, 2007, TUMORI J, V93, P275; Rajcevic U, 2009, MOL CELL PROTEOMICS, V8, P2595, DOI 10.1074/mcp.M900124-MCP200; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Reynes G, 2011, J NEURO-ONCOL, V102, P35, DOI 10.1007/s11060-010-0290-x; ROTH J, 1993, BLOOD, V82, P1875; Salmaggi A, 1999, CANCER LETT, V146, P169, DOI 10.1016/S0304-3835(99)00255-4; Sato Y, 1998, J NEURO-ONCOL, V40, P47, DOI 10.1023/A:1006078521790; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Schoen P, 2003, CLIN CHEM, V49, P1930, DOI 10.1373/clinchem.2003.019398; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WASSIF WS, 1994, CLIN CHIM ACTA, V225, P57, DOI 10.1016/0009-8981(94)90027-2; WEINSTEIN PS, 1984, SCAND J IMMUNOL, V19, P193; Xu G, 2010, INDIAN J BIOCHEM BIO, V47, P211; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815	49	58	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46153	10.1371/journal.pone.0046153	http://dx.doi.org/10.1371/journal.pone.0046153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029420	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900100
J	Li, L; Ban, ZJ; Li, XH; Wu, MY; Wang, AL; Jiang, YQ; Jiang, YH				Li, Li; Ban, Zhao-Jun; Li, Xi-Hong; Wu, Mao-Yu; Wang, Ai-Li; Jiang, Yu-Qian; Jiang, Yun-Hong			Differential Expression of Anthocyanin Biosynthetic Genes and Transcription Factor PcMYB10 in Pears (Pyrus communis L.)	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; FLAVONOID BIOSYNTHESIS; CHALCONE SYNTHASE; COLOR DEVELOPMENT; PYRIFOLIA NAKAI; UV-B; RED; ACCUMULATION; APPLE; BIOCHEMISTRY	Anthocyanin biosynthesis in various plants is affected by environmental conditions and controlled by the transcription level of the corresponding genes. In pears (Pyrus communis cv. 'Wujiuxiang'), anthocyanin biosynthesis is significantly induced during low temperature storage compared with that at room temperature. We further examined the transcriptional levels of anthocyanin biosynthetic genes in 'Wujiuxiang' pears during developmental ripening and temperature-induced storage. The expression of genes that encode flavanone 3-hydroxylase, dihydroflavonol 4-reductase, anthocyanidin synthase, UDPglucose: flavonoid 3-O-glucosyltransferase, and R2R3 MYB transcription factor (PcMYB10) was strongly positively correlated with anthocyanin accumulation in 'Wujiuxiang' pears in response to both developmental and cold-temperature induction. Hierarchical clustering analysis revealed the expression patterns of the set of target genes, of which PcMYB10 and most anthocyanin biosynthetic genes were related to the same cluster. The present work may help explore the molecular mechanism that regulates anthocyanin biosynthesis and its response to abiotic stress at the transcriptional level in plants.	[Li, Li; Li, Xi-Hong; Wang, Ai-Li; Jiang, Yu-Qian] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China; [Ban, Zhao-Jun; Wu, Mao-Yu] All China Federat Supply & Mkt Cooperat, Jinan Fruit Res Inst, Jinan, Shandong, Peoples R China; [Ban, Zhao-Jun] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Xinjiang, Peoples R China; [Jiang, Yun-Hong] Univ Leeds, Sch Proc Environm & Mat Engn, Inst Particle Sci & Engn, Leeds, W Yorkshire, England	Tianjin University Science & Technology; Xinjiang Agricultural University; University of Leeds	Li, XH (corresponding author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China.	Jimmy.li1011@gmail.com	jiang, yu/HGU-0029-2022; jiang, yunhong/O-9673-2017	jiang, yunhong/0000-0003-3292-8164	Cultivation Foundation from Tianjin University of Science and Technology; Ministry of Education (MOE); Agriculture and Agri-Food Canada (AAFC)	Cultivation Foundation from Tianjin University of Science and Technology; Ministry of Education (MOE); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada)	The authors are grateful for the financial support provided by the Cultivation Foundation for the Excellent Ph.D. Dissertation from Tianjin University of Science and Technology, and the Ministry of Education (MOE) and Agriculture and Agri-Food Canada (AAFC) for the Ph.D. fellowship, granted for L. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Ban Y, 2009, PLANTA, V230, P871, DOI 10.1007/s00425-009-0993-4; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; CHRISTIE PJ, 1994, PLANTA, V194, P541, DOI 10.1007/BF00714468; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; DUSSI MC, 1995, J AM SOC HORTIC SCI, V120, P785, DOI 10.21273/JASHS.120.5.785; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V63, P175, DOI 10.1016/0304-4238(95)00807-6; Ju ZG, 1997, SCI HORTIC-AMSTERDAM, V70, P31, DOI 10.1016/S0304-4238(97)00040-X; Lancaster JE, 2000, J HORTIC SCI BIOTECH, V75, P142, DOI 10.1080/14620316.2000.11511213; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lister CE, 1996, J SCI FOOD AGR, V71, P313, DOI [10.1002/(SICI)1097-0010(199607)71:3<313::AID-JSFA586>3.0.CO;2-N, 10.1002/(SICI)1097-0010(199607)71:3&lt;313::AID-JSFA586&gt;3.0.CO;2-N]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Pierantoni L, 2010, PLANT PHYSIOL BIOCH, V48, P1020, DOI 10.1016/j.plaphy.2010.09.002; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Steyn WJ, 2005, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2005.671.9; Steyn WJ, 2004, J AM SOC HORTIC SCI, V129, P6, DOI 10.21273/JASHS.129.1.0006; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu J. W., 2012, TREE GENET GENOMES, P1; Yu B, 2012, SCI HORTIC-AMSTERDAM, V136, P29, DOI 10.1016/j.scienta.2011.12.026; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang D, 2012, SCI HORTIC-AMSTERDAM, V134, P53, DOI 10.1016/j.scienta.2011.10.025; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z	44	61	68	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46070	10.1371/journal.pone.0046070	http://dx.doi.org/10.1371/journal.pone.0046070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029391	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900084
J	Rodova, M; Fu, JS; Watkins, DN; Srivastava, RK; Shankar, S				Rodova, Mariana; Fu, Junsheng; Watkins, Dara Nall; Srivastava, Rakesh K.; Shankar, Sharmila			Sonic Hedgehog Signaling Inhibition Provides Opportunities for Targeted Therapy by Sulforaphane in Regulating Pancreatic Cancer Stem Cell Self-Renewal	PLOS ONE			English	Article							CHEMOPREVENTION; PREVENTION	Dysregulation of the sonic hedgehog (Shh) signaling pathway has been associated with cancer stem cells (CSC) and implicated in the initiation of pancreatic cancer. Pancreatic CSCs are rare tumor cells characterized by their ability to self-renew, and are responsible for tumor recurrence accompanied by resistance to current therapies. The lethality of these incurable, aggressive and invasive pancreatic tumors remains a daunting clinical challenge. Thus, the objective of this study was to investigate the role of Shh pathway in pancreatic cancer and to examine the molecular mechanisms by which sulforaphane (SFN), an active compound in cruciferous vegetables, inhibits self-renewal capacity of human pancreatic CSCs. Interestingly, we demonstrate here that Shh pathway is highly activated in pancreatic CSCs and plays important role in maintaining stemness by regulating the expression of stemness genes. Given the requirement for Hedgehog in pancreatic cancer, we investigated whether hedgehog blockade by SFN could target the stem cell population in pancreatic cancer. In an in vitro model, human pancreatic CSCs derived spheres were significantly inhibited on treatment with SFN, suggesting the clonogenic depletion of the CSCs. Interestingly, SFN inhibited the components of Shh pathway and Gli transcriptional activity. Interference of Shh-Gli signaling significantly blocked SFN-induced inhibitory effects demonstrating the requirement of an active pathway for the growth of pancreatic CSCs. SFN also inhibited downstream targets of Gli transcription by suppressing the expression of pluripotency maintaining factors (Nanog and Oct-4) as well as PDGFR alpha and Cyclin D1. Furthermore, SFN induced apoptosis by inhibition of BCL-2 and activation of caspases. Our data reveal the essential role of Shh-Gli signaling in controlling the characteristics of pancreatic CSCs. We propose that pancreatic cancer preventative effects of SFN may result from inhibition of the Shh pathway. Thus Sulforaphane potentially represents an inexpensive, safe and effective alternative for the management of pancreatic cancer.	[Rodova, Mariana; Fu, Junsheng; Watkins, Dara Nall; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Rodova, Mariana; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu			Veterans Affairs [I01BX001583] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs)		Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Dorado J, 2011, J GASTROENTEROL, V46, P966, DOI 10.1007/s00535-011-0422-x; Gills JJ, 2006, CANCER LETT, V236, P72, DOI 10.1016/j.canlet.2005.05.007; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Hunakova L, 2009, NEOPLASMA, V56, P548, DOI 10.4149/neo_2009_06_548; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kelleher FC, 2010, CARCINOGENESIS; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08013; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Li Y, 2012, CANC LETT; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Morton JP, 2007, CELL CYCLE, V6, P1553, DOI 10.4161/cc.6.13.4467; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Shankar S, 2008, CLIN CANCER RES, V14, P1; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Srivastava RK, 2010, FRONT BIOSC IN PRESS; Tanaka H, 2009, ANTICANCER RES, V29, P2147; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Ward JW, 2010, J FAM PRACTICE, V59, pS23; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	40	86	92	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46083	10.1371/journal.pone.0046083	http://dx.doi.org/10.1371/journal.pone.0046083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029396	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900086
J	Verant, ML; Boyles, JG; Waldrep, W; Wibbelt, G; Blehert, DS				Verant, Michelle L.; Boyles, Justin G.; Waldrep, William, Jr.; Wibbelt, Gudrun; Blehert, David S.			Temperature-Dependent Growth of Geomyces destructans, the Fungus That Causes Bat White-Nose Syndrome	PLOS ONE			English	Article							EMERGING DISEASE; MODEL; PHYSIOLOGY; SELECTION; PATHOGEN	White-nose syndrome (WNS) is an emergent disease estimated to have killed over five million North American bats. Caused by the psychrophilic fungus Geomyces destructans, WNS specifically affects bats during hibernation. We describe temperature-dependent growth performance and morphology for six independent isolates of G. destructans from North America and Europe. Thermal performance curves for all isolates displayed an intermediate peak with rapid decline in performance above the peak. Optimal temperatures for growth were between 12.5 and 15.8 degrees C, and the upper critical temperature for growth was between 19.0 and 19.8 degrees C. Growth rates varied across isolates, irrespective of geographic origin, and above 12 degrees C all isolates displayed atypical morphology that may have implications for proliferation of the fungus. This study demonstrates that small variations in temperature, consistent with those inherent of bat hibernacula, affect growth performance and physiology of G. destructans, which may influence temperature-dependent progression and severity of WNS in wild bats.	[Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Verant, Michelle L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Boyles, Justin G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Waldrep, William, Jr.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; University of Chicago; Leibniz Institut fur Zoo und Wildtierforschung	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.	dblehert@usgs.gov	Boyles, Justin G/A-5152-2010	Blehert, David/0000-0002-1065-9760; Verant, Michelle/0000-0001-6994-6257	US Geological Survey; US Fish and Wildlife Service; Bat Conservation International	US Geological Survey(United States Geological Survey); US Fish and Wildlife Service(US Fish & Wildlife Service); Bat Conservation International	Financial support for this project was provided by the US Geological Survey, the US Fish and Wildlife Service, and Bat Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brack V, 2007, ENVIRON MANAGE, V40, P739, DOI 10.1007/s00267-006-0274-y; Brasier C, 2003, MYCOL RES, V107, P258, DOI 10.1017/S0953756203227660; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Flory AR, 2012, J APPL ECOL; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HUEY RB, 1979, AM ZOOL, V19, P357; Kasuga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034728; Lin XR, 2005, EUKARYOT CELL, V4, P1746, DOI 10.1128/EC.4.10.1746-1754.2005; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Oksanen J, 1997, J VEG SCI, V8, P147, DOI 10.2307/3237252; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rashid A, 2001, Cutis, V67, P23; Robson GD, 2008, T BRIT MYCOL SOC, P129; Schuler MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020905; Shi PJ, 2010, J THERM BIOL, V35, P225, DOI 10.1016/j.jtherbio.2010.05.005; St-Germain G, 2011, IDENTIFYING FUNGI; TWENTE JW, 1955, ECOLOGY, V36, P706, DOI 10.2307/1931308; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Yazdanparast SA, 2006, J MED MICROBIOL, V55, P1577, DOI 10.1099/jmm.0.46474-0	34	171	173	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46280	10.1371/journal.pone.0046280	http://dx.doi.org/10.1371/journal.pone.0046280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029462	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900124
J	Williams, ED; Tillin, T; Whincup, P; Forouhi, NG; Chaturvedi, N				Williams, Emily D.; Tillin, Therese; Whincup, Peter; Forouhi, Nita G.; Chaturvedi, Nishi			Ethnic Differences in Disability Prevalence and Their Determinants Studied over a 20-Year Period: A Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VITAMIN-D DEFICIENCY; PHYSICAL-DISABILITY; BODY-COMPOSITION; UNITED-STATES; RISK-FACTORS; FOLLOW-UP; HEALTH; POPULATION; MEN	Background: To compare disability prevalence rates in the major ethnic groups in the UK and understand the risk factors contributing to differences identified. It was hypothesised that Indian Asian and African Caribbean people would experience higher rates of disability compared with Europeans. Methods: Data was collected from 888 European, 636 Indian Asian and 265 African Caribbean men and women, aged 5888 years at 20-year follow-up of community-based cohort study, based in West London. Disability was measured using a performance-based locomotor function test and self-reported questionnaires on functional limitation, and instrumental (IADL) and basic activities of daily living (ADL). Results: The mean (SD) age of participants at follow-up was 69.6 (6.2) years. Compared with Europeans, Indian Asian people were significantly more likely to experience all of the disability outcomes than Europeans; this persisted after adjustment for socioeconomic, behavioural, adiposity and chronic disease risk factors measured at baseline (locomotor dysfunction: adjusted odds ratio (OR) 2.20, 95% CI 1.56-3.11; functional limitation: OR 2.77, 2.01-3.81; IADL impairment: OR 3.12, 2.20-4.41; ADL impairment: OR 1.58, 1.11-2.24). In contrast, a modest excess risk of disability was observed in African Caribbeans, which was abolished after adjustment (e. g. locomotor dysfunction: OR 1.37, 0.90-1.91); indeed a reduced risk of ADL impairment appeared after multivariable adjustment (OR from 0.99, 0.68-1.45 to 0.59, 0.38-0.93), compared with Europeans. Conclusions: Substantially elevated risk of disability was observed among Indian Asian participants, unexplained by known factors. A greater understanding of determinants of disability and normative functional beliefs of healthy aging is required in this population to inform intervention efforts to prevent disability.	[Williams, Emily D.; Tillin, Therese; Chaturvedi, Nishi] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Whincup, Peter] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Forouhi, Nita G.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	Imperial College London; St Georges University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Williams, ED (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England.	e.williams@imperial.ac.uk		Tillin, Therese/0000-0003-1590-9826; Williams, Emily/0000-0002-9399-1960; Forouhi, Nita/0000-0002-5041-248X; Whincup, Peter/0000-0002-5589-4107	Wellcome Trust; British Heart Foundation (BHF); UK Medical Research Council; Diabetes UK [09/0003833]; MRC [MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_UP_A100_1003] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation (BHF)(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a joint programme grant from the Wellcome Trust and British Heart Foundation (BHF). The pilot follow-up study was supported by the BHF. The Southall Study was supported by the UK Medical Research Council, the British Diabetic Association (now Diabetes UK), the Wellcome Trust and the BHF. The Brent Study was supported by the UK Medical Research Council. E D Williams was funded by a Diabetes UK Fellowship (09/0003833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLDW PREV AN 1993; BAJEKAL M, 2003, HLTH SURVEY ENGLAND; Barnes LL, 2011, J GERONTOL B-PSYCHOL, V66, P354, DOI 10.1093/geronb/gbr016; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Bhan A, 2010, ENDOCRIN METAB CLIN, V39, P321, DOI 10.1016/j.ecl.2010.02.001; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Bowen ME, 2009, SOC SCI MED, V69, P433, DOI 10.1016/j.socscimed.2009.06.006; Chaturvedi N, 1996, BMJ-BRIT MED J, V313, P848; CRAIG R, 2006, HLTH SURVEY ENGLAND; de Leon CFM, 2005, J GERONTOL B-PSYCHOL, V60, pS263, DOI 10.1093/geronb/60.5.S263; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Dhillon PK, 1992, PSYCHOSOCIAL ASPECTS; Ebrahim S, 2000, INT J EPIDEMIOL, V29, P478, DOI 10.1093/ije/29.3.478; Falaschetti E, 2006, HLTH SURVEY ENGLAND, V1; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fuller-Thomson E, 2009, J AGING HEALTH, V21, P677, DOI 10.1177/0898264309338296; Grewal I, 2004, J ETHN MIGR STUD, V30, P737, DOI 10.1080/13691830410001699595; Haas S, 2010, SOC SCI MED, V70, P240, DOI 10.1016/j.socscimed.2009.10.003; Houston DK, 2011, J AM GERIATR SOC, V59, P1793, DOI 10.1111/j.1532-5415.2011.03601.x; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Kalavar JM, 2005, ACT ADAPT AGING, V29, P47, DOI 10.1300/J016v29n01_04; Karlsen S, 2010, ETHNIC HEALTH, V15, P549, DOI 10.1080/13557858.2010.497204; Kim MJ, 2010, GERIATR GERONTOL INT, V10, P302, DOI 10.1111/j.1447-0594.2010.00614.x; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; Kobayashi KM, 2008, ETHNIC HEALTH, V13, P129, DOI 10.1080/13557850701830299; Lindesay J, 1997, Ethn Health, V2, P59; Louie GH, 2011, AM J PUBLIC HEALTH, V101, P1322, DOI 10.2105/AJPH.2010.199455; Macfarlane GJ, 2005, ANN RHEUM DIS, V64, P1217, DOI 10.1136/ard.2004.032656; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Nazroo James Y., 2001, Ethnicity and Disease, V11, P401; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Ng TP, 2006, J AM GERIATR SOC, V54, P21, DOI 10.1111/j.1532-5415.2005.00533.x; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Niti M, 2007, J CLIN EPIDEMIOL, V60, P366, DOI 10.1016/j.jclinepi.2006.07.012; Office of Population Censuses and Surveys, 1980, CLASS OCC 1980; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Ostchega Y, 2000, J AM GERIATR SOC, V48, P1132, DOI 10.1111/j.1532-5415.2000.tb04791.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ramsay SE, 2006, AM J EPIDEMIOL, V164, P459, DOI 10.1093/aje/kwj217; Ramsay SE, 2008, ANN EPIDEMIOL, V18, P896, DOI 10.1016/j.annepidem.2008.09.006; Semba RD, 2000, AM J CLIN NUTR, V72, P1529; Sivakumar B, 2006, NUTRITION, V22, pS15, DOI 10.1016/j.nut.2005.07.012; Smaje C, 1998, SOC POLICY ADMIN, V32, P116, DOI 10.1111/1467-9515.00092; SOLANKI T, 1995, AGE AGEING, V24, P103, DOI 10.1093/ageing/24.2.103; Thorpe RJ, 2011, J GERONTOL A-BIOL, V66, P1114, DOI 10.1093/gerona/glr102; Tillin T, 2012, INT J EPIDEMIOL, V41, P33, DOI 10.1093/ije/dyq175; U.S. Department of Health and Human Services, 2011, HHS ACT PLAN RED RAC; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams ED, 2009, J EPIDEMIOL COMMUN H, V63, P986, DOI 10.1136/jech.2008.084186; Williams ED, 2011, HEART, V97, P655, DOI 10.1136/hrt.2010.201012; Williams ED, 2010, J PSYCHOSOM RES, V69, P379, DOI 10.1016/j.jpsychores.2010.03.015	57	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45602	10.1371/journal.pone.0045602	http://dx.doi.org/10.1371/journal.pone.0045602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029128	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000309973900045
J	Barbosa, CMG; Terra, M; de Albuquerque, ALP; Di Giorgi, D; Grupi, C; Negrao, CE; Rondon, MUPB; Martinez, DG; Marcourakis, T; dos Santos, FA; Braga, ALF; Zanetta, DMT; Santos, UD				Galvao Barbosa, Cristiane Maria; Terra-Filho, Mario; Pereira de Albuquerque, Andre Luis; Di Giorgi, Dante; Grupi, Cesar; Negrao, Carlos Eduardo; Pinto Brandao Rondon, Maria Urbana; Martinez, Daniel Godoy; Marcourakis, Tania; dos Santos, Fabiana Almeida; Ferreira Braga, Alfesio Luis; Trevisan Zanetta, Dirce Maria; Santos, Ubiratan de Paula			Burnt Sugarcane Harvesting - Cardiovascular Effects on a Group of Healthy Workers, Brazil	PLOS ONE			English	Article							AIR-POLLUTION; OXIDATIVE STRESS; BLOOD-PRESSURE; EXERCISE; EXPOSURE; HYPONATREMIA; POLLUTANTS; FAILURE; IMPACT; CITY	Background: Brazil is the world's largest producer of sugarcane. Harvest is predominantly manual, exposing workers to health risks: intense physical exertion, heat, pollutants from sugarcane burning. Design: Panel study to evaluate the effects of burnt sugarcane harvesting on blood markers and on cardiovascular system. Methods: Twenty-eight healthy male workers, living in the countryside of Brazil were submitted to blood markers, blood pressure, heart rate variability, cardiopulmonary exercise testing, sympathetic nerve activity evaluation and forearm blood flow measures (venous occlusion plethysmography) during burnt sugarcane harvesting and four months later while they performed other activities in sugar cane culture. Results: Mean participant age was 31 +/- 6.3 years, and had worked for 9.8 +/- 8.4 years on sugarcane work. Work during the harvest period was associated with higher serum levels of Creatine Kinase - 136.5 U/L (IQR: 108.5-216.0) vs. 104.5 U/L (IQR: 77.5-170.5), (p = 0.001); plasma Malondialdehyde-7.5 +/- 1.4 mu M/dl vs. 6.9 +/- 1.0 mu M/dl, (p = 0.058); Glutathione Peroxidase - 55.1 +/- 11.8 Ug/Hb vs. 39.5 +/- 9.5 Ug/Hb, (p < 0.001); Glutathione Transferase- 3.4 +/- 1.3 Ug/Hb vs. 3.0 +/- 1.3 Ug/Hb, (p = 0.001); and 24-hour systolic blood pressure - 120.1 +/- 10.3 mmHg vs. 117.0 +/- 10.0 mmHg, (p = 0.034). In cardiopulmonary exercise testing, rest-to-peak diastolic blood pressure increased by 11.12 mmHg and 5.13 mmHg in the harvest and non-harvest period, respectively. A 10 miliseconds reduction in rMSSD and a 10 burst/min increase in sympathetic nerve activity were associated to 2.2 and 1.8 mmHg rises in systolic arterial pressure, respectively. Conclusion: Work in burnt sugarcane harvesting was associated with changes in blood markers and higher blood pressure, which may be related to autonomic imbalance.	[Galvao Barbosa, Cristiane Maria; Terra-Filho, Mario; Pereira de Albuquerque, Andre Luis; Santos, Ubiratan de Paula] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil; [Galvao Barbosa, Cristiane Maria] FUNDACENTRO, Sao Paulo, Brazil; [Di Giorgi, Dante] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Hypertens Unit, Sao Paulo, Brazil; [Grupi, Cesar] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Electrocardiol Unit, Sao Paulo, Brazil; [Negrao, Carlos Eduardo; Pinto Brandao Rondon, Maria Urbana; Martinez, Daniel Godoy] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Unit Cardiovasc Rehabil & Exerci, Sao Paulo, Brazil; [Marcourakis, Tania; dos Santos, Fabiana Almeida] Univ Sao Paulo, Pharmacol Sci Sch, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis] Univ Sao Paulo, Fac Med, Dept Pathol, Lab Expt Air Pollut,Environm Epidemiol Study Grp, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis] Univ Catolica Santos, Environm Exposure & Risk Assessment Grp, Sao Paulo, Brazil; [Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Santos; Universidade de Sao Paulo	Santos, UD (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil.	pneubiratan@incor.usp.br	Zanetta, Dirce M T/G-4950-2013; Martinez, Daniel Godoy/D-9135-2015; Terra-Filho, Mario/H-5806-2012; Martinez, Daniel Godoy/O-6617-2019; Negrao, Carlos E/C-4281-2012; Rondon, Maria Urbana P B/G-5272-2012; Braga, Alfésio L. F./G-6920-2012; Santos, Ubiratan/H-7862-2012; Marcourakis, Tânia/D-6667-2012; Albuquerque, Andre/C-8835-2012	Martinez, Daniel Godoy/0000-0003-0034-7963; Terra-Filho, Mario/0000-0002-8642-5354; Martinez, Daniel Godoy/0000-0003-0034-7963; Rondon, Maria Urbana P B/0000-0002-4134-6126; Braga, Alfésio L. F./0000-0003-3254-3029; Santos, Ubiratan/0000-0003-4919-884X; Marcourakis, Tânia/0000-0002-0076-5017; Zanetta, Dirce Maria/0000-0002-7273-5087; Negrao, Carlos Eduardo/0000-0003-4652-1226; Albuquerque, Andre/0000-0003-3486-5240				ACGIH, 2022, THRESH LIM VAL TLVS; Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Alves Francisco, 2006, Saude soc., V15, P90; Anastasakis A, 2005, HEART, V91, P1477, DOI 10.1136/hrt.2004.055053; Anderson J, 2009, ATHEROSCLEROSIS, V10, P1; Arbex MA, 2010, J EPIDEMIOL COMMUN H, V64, P573, DOI 10.1136/jech.2009.094342; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Bankir L, 2007, CLIN J AM SOC NEPHRO, V2, P304, DOI 10.2215/CJN.03401006; Baumgartner J, 2011, ENV HLTH PERSPECT; Bosso RMV, 2006, SCI TOTAL ENVIRON, P382; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Brazilian Society of Cardiology. Brazilian Society of Cardiology. Department of Atherosclerosis Department of Pediatric Cardiology Brazilian Society of Pediatrics Department of Pediatric Endocrinology Department of Pediatric Endocrinology, 2005, ARQ BRAS CARDIOL, V85, P1; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; Cancado JE, 2006, ENVIRON HEALTH PERSP, V114, P725, DOI 10.1289/ehp.8485; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; Donde A, 2012, J OCCUP ENVIRON MED, V54, P466, DOI 10.1097/JOM.0b013e318246f1d4; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forbes LJL, 2009, EPIDEMIOLOGY, V20, P245, DOI 10.1097/EDE.0b013e318190ea3f; Fuks K, 2011, ENV HLTH PERSPECT; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; GLINER JA, 1975, J APPL PHYSIOL, V39, P628, DOI 10.1152/jappl.1975.39.4.628; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Goto DM, 2011, ENVIRON RES, V111, P664, DOI 10.1016/j.envres.2011.03.006; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Henderson SB, 2011, ENVIRON HEALTH PERSP, V119, P1266, DOI 10.1289/ehp.1002288; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; Hew-Butler T, 2010, SPORTS MED, V40, P459, DOI 10.2165/11532070-000000000-00000; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Laat EF, 2008, IMPACTOS IND CANAVIE, P36; Lakka TA, 2005, EUR HEART J, V26, P2018, DOI 10.1093/eurheartj/ehi394; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Liao DP, 2004, AM J EPIDEMIOL, V159, P768, DOI 10.1093/aje/kwh109; Marzatico F, 1997, J SPORT MED PHYS FIT, V37, P235; Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Negrao CE, 2001, AM J PHYSIOL-HEART C, V280, pH1286, DOI 10.1152/ajpheart.2001.280.3.H1286; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847; Ribeiro Helena, 2008, Rev. Saúde Pública, V42, P370, DOI 10.1590/S0034-89102008005000009; Romieu I, 2008, EUR RESPIR J, V31, P179, DOI 10.1183/09031936.00128106; Sangani RG, 2010, INHAL TOXICOL, V22, P621, DOI 10.3109/08958371003599037; Santos, 2006, J BRAS PNEUMOL, V32, pS5, DOI DOI 10.1590/S1806-37132006000800003; Santos UD, 2005, EUR HEART J, V26, P193, DOI 10.1093/eurheartj/ehi035; SHIEH SD, 1992, AM J NEPHROL, V12, P252, DOI 10.1159/000168454; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; SPURR GB, 1977, AM J CLIN NUTR, V30, P1740, DOI 10.1093/ajcn/30.10.1740; Tanskanen M, 2010, J SPORT SCI, V28, P309, DOI 10.1080/02640410903473844; Task Force of Eur Soc Cardiology North Am Society Eletrophysiology, 1996, CIRCULATION, V93, P1043; World Health Organization, 2006, WHO AIR QUAL GUID PA; Yin Z, 2009, AM J PHYSIOL-HEART C, V296, pH1540	57	32	36	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46142	10.1371/journal.pone.0046142	http://dx.doi.org/10.1371/journal.pone.0046142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029413	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500065
J	Sianglum, W; Srimanote, P; Taylor, PW; Rosado, H; Voravuthikunchai, SP				Sianglum, Wipawadee; Srimanote, Potjanee; Taylor, Peter W.; Rosado, Helena; Voravuthikunchai, Supayang P.			Transcriptome Analysis of Responses to Rhodomyrtone in Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							BACTERIAL-INFECTIONS; ANTIMICROBIAL AGENTS; TEICHOIC-ACID; PEPTIDOGLYCAN; BIOSYNTHESIS; TOMENTOSA; PRODUCTS; LYSINE; DRUG	Rhodomyrtone, purified from Rhodomyrtus tomentosa (Aiton) Hassk, exhibits a high degree of potency against methicillin-resistant Staphylococcus aureus (MRSA). We recently demonstrated that exposure of MRSA to a subinhibitory concentration (0.174 mu g/ml) of rhodomyrtone resulted in the alteration of expression of several functional classes of bacterial proteins. To provide further insight into the antibacterial mode of action of this compound, we determined the impact of exposure to rhodomyrtone on the gene transcriptional profile of MRSA using microarray analysis. Exposure of MRSA to subinhibitory concentrations (0.5MIC; 0.5 mu g/ml) of rhodomyrtone revealed significant modulation of gene expression, with induction of 64 genes and repression of 35 genes. Prominent changes in response to exposure to rhodomyrtone involved genes encoding proteins essential to metabolic pathways and processes such as amino acid metabolism, membrane function, ATP-binding cassette (ABC) transportation and lipoprotein and nucleotide metabolism. Genes involved in the synthesis of the aspartate family of amino acids, in particular proteins encoded by the dap operon were prominent. The diaminopimelate (DAP) biosynthetic pathway is the precursor of lysine synthesis and is essential for peptidoglycan biosynthesis. However, phenotypic analysis of the peptidoglycan amino acid content of rhodomyrtone-treated MRSA did not differ significantly from that extracted from control cells. Genes involved in the biosynthesis of amino acids and peptidoglycan, and a high affinity ATP-driven K ((+)) transport system, were investigated by quantitative reverse transcription-PCR (qRT-PCR) using EMRSA-16 1, 4, or 18 h after exposure to rhodomyrtone and in general the data concurred with that obtained by microarray, highlighting the relevance of the DAP biosynthetic pathway to the mode of action of rhodomyrtone.	[Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand; [Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Nat Prod Res Ctr, Fac Sci, Hat Yai, Thailand; [Srimanote, Potjanee] Thammasat Univ, Fac Allied Hlth Sci, Pathumtanee, Thailand; [Taylor, Peter W.; Rosado, Helena] UCL, Sch Pharm, London, England	Prince of Songkla University; Prince of Songkla University; Thammasat University; University of London; University College London; University of London School of Pharmacy	Voravuthikunchai, SP (corresponding author), Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand.	supayang.v@psu.ac.th	Srimanote, Potjanee/W-2221-2019		Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program [PHD/0053/2550]	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (http://www.nru.psu.ac.th/) and the Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program (http://rgj.trf.or.th/eng/rgje11.asp), grant no. PHD/0053/2550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy DY, 2008, CLIN MICROBIOL INFEC, V14, P411, DOI 10.1111/j.1469-0691.2007.01933.x; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Bradley JS, 2005, CURR OPIN PEDIATR, V17, P71, DOI 10.1097/01.mop.0000151555.17799.41; Brunskill EW, 1997, MICROBIOL-UK, V143, P2877, DOI 10.1099/00221287-143-9-2877; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173; Clinical and Laboratory Standards Institute, 2005, PERFORMANCE STANDARD, pM100; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Dachriyanus, 2002, AUST J CHEM, V55, P229, DOI 10.1071/CH01194; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Hiranrat A, 2008, TETRAHEDRON, V64, P11193, DOI 10.1016/j.tet.2008.09.054; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Limsuwan S, 2009, PHYTOMEDICINE, V16, P645, DOI 10.1016/j.phymed.2009.01.010; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Martin KW, 2003, J ANTIMICROB CHEMOTH, V51, P241, DOI 10.1093/jac/dkg087; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Saising J, 2008, J HEALTH SCI, V54, P589, DOI 10.1248/jhs.54.589; Samy RP, 2008, EVID-BASED COMPL ALT, P283; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Shakil S, 2008, J CHEMOTHERAPY, V20, P411, DOI 10.1179/joc.2008.20.4.411; Sianglum W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016628; Sorlozano A, 2010, EUR J CLIN MICROBIOL, V29, P73, DOI 10.1007/s10096-009-0823-4; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Wenzel RP, 2007, INT J ANTIMICROB AG, V30, P210, DOI 10.1016/j.ijantimicag.2007.04.003; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005	32	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45744	10.1371/journal.pone.0045744	http://dx.doi.org/10.1371/journal.pone.0045744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029218	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500039
J	Ceol, M; Tiralongo, E; Baelde, HJ; Vianello, D; Betto, G; Marangelli, A; Bonfante, L; Valente, M; Della Barbera, M; D'Angelo, A; Anglani, F; Del Prete, D				Ceol, Monica; Tiralongo, Emilia; Baelde, Hans J.; Vianello, Daniela; Betto, Giovanni; Marangelli, Annunziata; Bonfante, Luciana; Valente, Marialuisa; Della Barbera, Mila; D'Angelo, Angela; Anglani, Franca; Del Prete, Dorella			Involvement of the Tubular ClC-Type Exchanger ClC-5 in Glomeruli of Human Proteinuric Nephropathies	PLOS ONE			English	Article							ALBUMIN FILTRATION; PODOCYTE; RAT; EXPRESSION; MEMBRANE	Glomerular protein handling mechanisms have received much attention in studies of nephrotic syndrome. Histopathological findings in renal biopsies from severely proteinuric patients support the likelihood of protein endocytosis by podocytes. ClC-5 is involved in the endocytosis of albumin in the proximal tubule. Aim: To investigate whether ClC-5 is expressed in the glomerular compartment and whether it has a role in proteinuric nephropathies. ClC-5 expression was studied using Real-time PCR in manually-and laser-microdissected biopsies from patients with type 2 diabetes (n 37) and IgA nephropathy (n 10); in biopsies of membranous glomerulopathy (MG) (n 14) immunohistochemistry for ClC-5 (with morphometric analysis) and for WT1 was done. Controls: cortical tissue (n 23) obtained from unaffected parts of tumor-related nephrectomy specimens. Results: ClC-5 was expressed at glomerular level in all biopsies. Glomerular ClC-5 levels were significantly higher in diabetic nephropaty and MG at both mRNA and protein level (p<0.002; p<0.01). ClC-5 and WT1 double-staining analysis in MG showed that ClC-5 was localized in the podocytes. ClC-5 ultrastructural immunolocalization was demonstrated in podocytes foot processes. Our study is the first to demonstrate that ClC-5 is expressed in human podocytes. The ClC-5 overexpression found in biopsies of proteinuric patients suggests that proteinuria may play a part in its expression and that podocytes are likely to have a key role in albumin handling in proteinuric states.	[Ceol, Monica; Tiralongo, Emilia; Vianello, Daniela; Marangelli, Annunziata; Bonfante, Luciana; D'Angelo, Angela; Anglani, Franca; Del Prete, Dorella] Univ Padua, Dept Med, Nephrol Unit, Padua, Italy; [Ceol, Monica; Tiralongo, Emilia; Vianello, Daniela; Marangelli, Annunziata; Bonfante, Luciana; D'Angelo, Angela; Anglani, Franca; Del Prete, Dorella] Univ Padua, Kidney Histomorphol & Mol Biol Lab, Padua, Italy; [Baelde, Hans J.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Betto, Giovanni] S Antonio Hosp, Div Urol, Padua, Italy; [Valente, Marialuisa; Della Barbera, Mila] Univ Padua, Inst Pathol Anat, Dept Diagnost Med Sci & Special Therapies, Padua, Italy	University of Padua; University of Padua; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; ULSS 6 Euganea; Ospedale Sant'antonio Padova; University of Padua	Del Prete, D (corresponding author), Univ Padua, Dept Med, Nephrol Unit, Padua, Italy.	dorella.delprete@unipd.it	Baelde, Hans J/B-4092-2015; Anglani, Franca/F-9045-2017	Anglani, Franca/0000-0003-1534-4458; baelde, Hans/0000-0002-1214-500X; Valente, Marialuisa/0000-0002-3662-2878	University of Padova	University of Padova	This study was supported by Institutional funds for research of the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Del Prete D, 2003, KIDNEY INT, V64, P149, DOI 10.1046/j.1523-1755.2003.00065.x; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; GRAHAM RC, 1966, J EXP MED, V124, P1123, DOI 10.1084/jem.124.6.1123; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kinugasa S, 2010, MED MOL MORPHOL, V43, P218, DOI 10.1007/s00795-010-0500-9; Koop K, 2008, AM J PATHOL, V173, P315, DOI 10.2353/ajpath.2008.080063; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Tojo A, 2008, MED MOL MORPHOL, V41, P92, DOI 10.1007/s00795-008-0397-8; Wellhauser L, 2010, PFLUG ARCH EUR J PHY, V460, P543, DOI 10.1007/s00424-009-0769-5; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	17	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45605	10.1371/journal.pone.0045605	http://dx.doi.org/10.1371/journal.pone.0045605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029130	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700050
J	Chien, WC; Chung, CH; Jaakkola, JJK; Chu, CM; Kao, S; Su, SL; Lai, CH				Chien, Wu-Chien; Chung, Chi-Hsiang; Jaakkola, Jouni J. K.; Chu, Chi-Ming; Kao, Senyeong; Su, Sui-Lung; Lai, Ching-Huang			Risk and Prognostic Factors of Inpatient Mortality Associated with Unintentional Insecticide and Herbicide Poisonings: A Retrospective Cohort Study	PLOS ONE			English	Article							TAIWAN; EPIDEMIOLOGY	Introduction: Pesticide poisoning is an important public health problem worldwide. The study aimed to determine the risk of all-cause and cause-specific inpatient mortality and to identify prognostic factors for inpatient mortality associated with unintentional insecticide and herbicide pesticide poisonings. Methods: We performed a retrospective cohort study of 3,986 inpatients recruited at hospitalization between 1999 and 2008 in Taiwan. We used the International Classification of Disease, 9th ed., Clinical Modification external causes of injury codes to classify poisoning agents into accidental poisoning by insecticides and herbicides. Comparisons in mortality rates were made between insecticide poisoning patients and herbicide poisoning patients by using the Cox proportional hazards models to estimate multivariable-adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs). Results: There were 168 deaths during 21,583 person-days of follow-up evaluation (7.8 per 1,000 person-days). The major causes of mortality for insecticide poisonings were the toxic effect of organophosphate and coma, and the major causes of mortality for herbicide poisonings were the toxic effect of other pesticides and the toxic effect of organophosphate. The mortality for herbicide exposure was fourfold higher than that for insecticide exposure. The factors associated with inpatient mortality were herbicide poisonings (HR = 4.58, 95% CI 3.29 to 6.37) and receiving mechanical ventilation treatment (HR = 3.85, 95% CI 2.73 to 5.42). Conclusions: We demonstrated that herbicides stand out as the dominant agent for poisoning-related fatalities. The control of and limiting access to herbicide agents and developing appropriate therapeutic regimens, including emergency care, should be priorities.	[Chien, Wu-Chien; Chu, Chi-Ming; Kao, Senyeong; Su, Sui-Lung; Lai, Ching-Huang] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland	National Defense Medical Center; National Defense Medical Center; University of Oulu	Lai, CH (corresponding author), Natl Def Med Ctr, Dept Publ Hlth, 161,Sect 6, Taipei, Taiwan.	lgh@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Jaakkola, Jouni J.K./G-4314-2012; Lai, Ching-Huang/ABF-9274-2021	Su, Sui-Lung/0000-0003-3122-1116; Jaakkola, Jouni/0000-0003-4168-4683; Chu, Cordia/0000-0002-3683-5638; Kao, Senyeong/0000-0002-0209-240X	Academy of Finland [129419, 138691]	Academy of Finland(Academy of Finland)	JJ was supported by Academy of Finland (http://www.aka.fi/eng), grants no. 129419 (SALVE program) and 138691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon WA, 2005, JAMA-J AM MED ASSOC, V294, P455, DOI 10.1001/jama.294.4.455; Bradberry Sally M, 2004, Toxicol Rev, V23, P159, DOI 10.2165/00139709-200423030-00003; [Bureau of Animal and Plant Health Inspection Quarantine EY Taiwan (ROC)], 2012, PEST STAT AN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YH, 2011, LIVER INT, V31, P354, DOI 10.1111/j.1478-3231.2010.02350.x; Chen YJ, 2009, CLIN TOXICOL, V47, P670, DOI 10.1080/15563650903140399; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien, 2011, CHARACTERISTICS TREN; Chou P., 2003, VALIDATION COMORBIDI; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Gawarammana IB, 2011, BR J CLIN PHARM; Jaiprakash H, 2011, FOOD CHEM TOXICOL, V49, P248, DOI 10.1016/j.fct.2010.10.026; Lee CH, 2008, AM J EMERG MED, V26, P275, DOI 10.1016/j.ajem.2007.05.011; Lee HL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-7; Lien YC, 2009, ANN THORAC SURG, V88, P1124, DOI 10.1016/j.athoracsur.2009.06.002; Lin TJ, 2008, CLIN TOXICOL, V46, P794, DOI 10.1080/15563650801986695; Litchfield Melville H, 2005, Toxicol Rev, V24, P271, DOI 10.2165/00139709-200524040-00006; Liu Q, 2009, FORENSIC SCI INT, V193, P88, DOI 10.1016/j.forsciint.2009.09.013; National Health Research Institutes TR, 2011, NAT HLTH INS RES DAT; Senarathna L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-373; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; TOMINACK RL, 1991, J TOXICOL-CLIN TOXIC, V29, P91, DOI 10.3109/15563659109038601; WHO, 2020, WHO REC CLASS PEST H, V2019; Yang CC, 1996, J TOXICOL-CLIN TOXIC, V34, P651, DOI 10.3109/15563659609013825	24	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45627	10.1371/journal.pone.0045627	http://dx.doi.org/10.1371/journal.pone.0045627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029146	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800069
J	Conti, F; Ceccarelli, F; Perricone, C; Miranda, F; Truglia, S; Massaro, L; Pacucci, VA; Conti, V; Bartosiewicz, I; Spinelli, FR; Alessandri, C; Valesini, G				Conti, Fabrizio; Ceccarelli, Fulvia; Perricone, Carlo; Miranda, Francesca; Truglia, Simona; Massaro, Laura; Pacucci, Viviana Antonella; Conti, Virginia; Bartosiewicz, Izabella; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido			Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study	PLOS ONE			English	Article							RHEUMATOLOGY DAMAGE INDEX; COLLEGE; FREQUENCY; ECLAM	Objective: Several indices have been proposed to assess disease activity in patients with Systemic Lupus Erythematosus (SLE). Recent studies have showed a prevalence of flare between 28-35.3%, persistently active disease (PAD) between 46%-52% and serologically active clinically quiescent (SACQ) disease ranging from 6 to 15%. Our goal was to evaluate the flare, PAD and SACQ rate incidence in a cohort of SLE patients over a 2-year follow-up. Methods: We evaluated 394 SLE patients. Flare was defined as an increase in SLEDAI-2K score of >= 4 from the previous visit; PAD was defined as a SLEDAI-2K score of >= 4, on >2 consecutive visits; SACQ was defined as at least a 2-year period without clinical activity and with persistent serologic activity. Results: Among the 95 patients eligible for the analysis in 2009, 7 (7.3%) had >= 1 flare episode, whereas 9 (9.4%) had PAD. Similarly, among the 118 patients selected for the analysis in 2010, 6 (5%) had >= 1 flare episode, whereas 16 (13.5%) had PAD. Only 1/45 patient (2.2%) showed SACQ during the follow-up. Conclusion: We showed a low incidence of flare, PAD and SACQ in Italian SLE patients compared with previous studies which could be partly explained by ethnic differences.	[Conti, Fabrizio; Ceccarelli, Fulvia; Perricone, Carlo; Miranda, Francesca; Truglia, Simona; Massaro, Laura; Pacucci, Viviana Antonella; Conti, Virginia; Bartosiewicz, Izabella; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido] Univ Roma La Sapienza, Lupus Clin, Dipartimento Med Interna & Specialita Med, Rome, Italy	Sapienza University Rome	Perricone, C (corresponding author), Univ Roma La Sapienza, Lupus Clin, Dipartimento Med Interna & Specialita Med, Rome, Italy.	carlo.perricone@gmail.com	Spinelli, Francesca Romana/F-1475-2013; Spinelli, Francesca Romana/AAM-7061-2020	Spinelli, Francesca Romana/0000-0003-1969-2097; Alessandri, Cristiano/0000-0003-4149-5321; , simona/0000-0001-9515-2135; Perricone, Carlo/0000-0003-4771-6981				Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Conti F, 2010, ARTHRIT CARE RES, V62, P899, DOI 10.1002/acr.20145; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Gladman DD, 2002, J RHEUMATOL, V29, P288; GLADMAN DD, 1979, AM J MED, V66, P210, DOI 10.1016/0002-9343(79)90529-1; Gladman DD, 2000, J RHEUMATOL, V27, P377; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; LEBLANC BAEW, 1994, J RHEUMATOL, V21, P2239; Luijten KMAC, 2012, AUTOIMMUN REV, V11, P326, DOI 10.1016/j.autrev.2011.06.011; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Mosca M, 2010, ANN RHEUM DIS, V69, P1269, DOI 10.1136/ard.2009.117200; Nikpour M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1152, DOI 10.1002/art.24741; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Romero-Diaz J, 2011, ARTHRIT CARE RES, V63, pS37, DOI 10.1002/acr.20572; Sciascia S, 2012, AUTOIMMUNE REV  0401; Steiman AJ, 2010, J RHEUMATOL, V37, P1822, DOI 10.3899/jrheum.100007	18	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45934	10.1371/journal.pone.0045934	http://dx.doi.org/10.1371/journal.pone.0045934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029327	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800124
J	Luddington, IA; Kaczmarska, I; Lovejoy, C				Luddington, Ian A.; Kaczmarska, Irena; Lovejoy, Connie			Distance and Character-Based Evaluation of the V4 Region of the 18S rRNA Gene for the Identification of Diatoms (Bacillariophyceae)	PLOS ONE			English	Article							SKELETONEMA-COSTATUM; BARCODING DIATOMS; DNA; DIVERSITY; RDNA; TAXONOMY; UTILITY; MARINE; COX1; RBCL	DNA barcoding is a molecular tool that exploits a unique DNA sequence of a standardized gene or non-coding region for the species identification of unknown individuals. The investigation into a suitable barcode for diatoms is ongoing and there are several promising candidates including mitochondrial, plastidial and nuclear markers. We analyzed 272 sequences from 76 diatoms species in the orders Thalassiosirales, Lithodesmiales and Cymatosirales, using distance and character based approaches, to assess the applicability of a DNA barcode based on the hypervariable V4 region of the nuclear 18S rRNA gene. We show that the proposed V4 barcode separated ca. 97% of all centric diatom taxa tested using a threshold p-distance of 0.02 and that many problem pairs were further separated using a character based approach. The reliability of amplification, extensive reference library and variability seen in the V4 region make it the most promising candidate to date for a barcode marker for diatoms particularly when combined with DNA character analysis.	[Luddington, Ian A.; Kaczmarska, Irena] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Lovejoy, Connie] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada	Mount Allison University; Laval University; Laval University	Luddington, IA (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	ialuddington@mta.ca	Lovejoy, Connie/A-3756-2008	Lovejoy, Connie/0000-0001-8027-2281	NSERC discovery grant; Canadian Healthy Oceans Network	NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network	This work was supported by NSERC discovery grant (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.aspand) and Canadian Healthy Oceans Network (http://chone.marinebiodiversity.ca/), awarded to Irena Kaczmarska and Connie Lovejoy. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fryxell G, 1977, NOVA HEDWIGIA BEIH, V54, P67; Geospiza, GEOSP WEBS FINCH TV; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; HASLE G R, 1968, Journal of the Royal Microscopical Society, V88, P357; HASLE GR, 1980, NORW J BOT, V27, P167; HASLE GR, 1978, NORW J BOT, V25, P77; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoppenrath M, 2007, EUR J PHYCOL, V42, P271, DOI 10.1080/09670260701352288; Iwatani N, 2005, POLAR BIOSCIENCES, V18, P35; Kaczmarska I, 2006, J PHYCOL, V42, P121, DOI 10.1111/j.1529-8817.2006.00161.x; Kaczmarska I, 2007, P 1 CENTR EUR DIAT M, P69, DOI DOI 10.3372/CEDIATOM.114; Kaczmarska I, 2009, EUR J PHYCOL, V44, P461, DOI 10.1080/09670260902855873; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lang I, 2011, DIATOM RES, V26, P43, DOI 10.1080/0269249X.2011.573703; Lin SJ, 2006, J PHYCOL, V42, P646, DOI 10.1111/j.1529-8817.2006.00229.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; MacGillivary ML, 2012, BOTANY, V90, P205, DOI 10.1139/B11-101; MacGillivary ML, 2011, J EUKARYOT MICROBIOL, V58, P529, DOI 10.1111/j.1550-7408.2011.00585.x; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; MEDLIN LK, 1991, J PHYCOL, V27, P514, DOI 10.1111/j.0022-3646.1991.00514.x; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Sar EA, 2011, DIATOM RES, V26, P109, DOI 10.1080/0269249X.2011.573691; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Sarno D, 2007, J PHYCOL, V43, P156, DOI 10.1111/j.1529-8817.2006.00305.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Syvertsen E, 1977, NOVA HEDWIGIA S, V54, P99; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor H, 2012, MOL ECOL RES, V12, DOI [10.1111/j.1755-0998.2012.03119, DOI 10.1111/J.1755-0998.2012.03119]; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	51	48	50	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45664	10.1371/journal.pone.0045664	http://dx.doi.org/10.1371/journal.pone.0045664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029169	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800074
J	Bucharova, A; Munzbergova, Z				Bucharova, Anna; Muenzbergova, Zuzana			Gene Flow among Populations of Two Rare Co-Occurring Fern Species Differing in Ploidy Level	PLOS ONE			English	Article							ATHYRIUM-FILIX-FEMINA; REPRODUCTIVE-BIOLOGY; NATURAL-POPULATIONS; PLANT CONSERVATION; MATING SYSTEM; DIVERSITY; DEPRESSION; HISTORY; RATES; LIFE	Differences in ploidy levels among different fern species have a vast influence on their mating system, their colonization ability and on the gene flow among populations. Differences in the colonization abilities of species with different ploidy levels are well known: tetraploids, in contrast to diploids, are able to undergo intra-gametophytic selfing. Because fertilization is a post-dispersal process in ferns, selfing results in better colonization abilities in tetraploids because of single spore colonization. Considerably less is known about the gene flow among populations of different ploidy levels. The present study examines two rare fern species that differ in ploidy. While it has already been confirmed that tetraploid species are better at colonizing, the present study focuses on the gene flow among existing populations. We analyzed the genetic structure of a set of populations in a 10x10 km study region using isoenzymes. Genetic variation in tetraploid species is distributed mainly among populations; the genetic distance between populations is correlated with the geographical distance, and larger populations host more genetic diversity than smaller populations. In the diploid species, most variability is partitioned within populations; the genetic distance is not related to geographic distance, and the genetic diversity of populations is not related to the population size. This suggests that in tetraploid species, which undergo selfing, gene flow is limited. In contrast, in the diploid species, which experience outcrossing, gene flow is extensive and the whole system behaves as one large population. Our results suggest that in ferns, the ability to colonize new habitats and the gene flow among existing populations are affected by the mating system.	[Bucharova, Anna; Muenzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Bucharova, Anna; Muenzbergova, Zuzana] Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Bucharova, Anna] Univ Tubingen, Inst Evolut & Ecol, Dept Plant Ecol, Tubingen, Germany	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen	Bucharova, A (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	bucharka@email.cz	Bucharova, Anna Lampei/U-5784-2017; Münzbergová, Zuzana/F-6321-2013	Bucharova, Anna Lampei/0000-0002-5468-5426; Münzbergová, Zuzana/0000-0002-4026-6220	MSMT [2B06178]; FRVS [348/2004]; GAUK [176/2006]; GACR [526/09/0549]; RVO [67985939]; institutional resources of MSMT	MSMT(Ministry of Education, Youth & Sports - Czech Republic); FRVS; GAUK; GACR(Grant Agency of the Czech Republic); RVO; institutional resources of MSMT	This work was supported by MSMT [2B06178], FRVS [348/2004], GAUK [176/2006] and GACR [526/09/0549] and partly by RVO 67985939 and institutional resources of MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dias PMB, 2008, CROP BREED APPL BIOT, V8, P202, DOI 10.12702/1984-7033.v08n03a04; Bucharova A, 2010, AM J BOT, V97, P1260, DOI 10.3732/ajb.0900351; Dong YH, 2010, ANN BOT FENN, V47, P34, DOI 10.5735/085.047.0104; Duminil J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-177; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; GOVINDARAJU DR, 1988, HEREDITY, V61, P401, DOI 10.1038/hdy.1988.130; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HEJNY S, 1980, FLORA CZECH REPUBLIC; Hood G.M., 2010, POPTOOLS VERSION 3 2; Hooper EA, 1997, AM J BOT, V84, P1664, DOI 10.2307/2446464; Hunt HV, 2009, MOL ECOL, V18, P4940, DOI 10.1111/j.1365-294X.2009.04402.x; Kang M, 2008, DIVERS DISTRIB, V14, P799, DOI 10.1111/j.1472-4642.2008.00484.x; Landergott U, 2001, HEREDITY, V87, P344, DOI 10.1046/j.1365-2540.2001.00912.x; LLOYD RM, 1974, ANN MO BOT GARD, V61, P318, DOI 10.2307/2395060; Lott MS, 2003, AM J BOT, V90, P1144, DOI 10.3732/ajb.90.8.1144; LOVIS JD, 1955, P BOT SOC BR ISLE, V1, P2; Maki M, 1998, HEREDITY, V80, P604; MASUYAMA S, 1990, Plant Species Biology, V5, P13, DOI 10.1111/j.1442-1984.1990.tb00188.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; PECK JH, 1990, AM FERN J, V80, P126, DOI 10.2307/1547200; Pryor KV, 2001, MOL ECOL, V10, P1881, DOI 10.1046/j.1365-294X.2001.01343.x; R Core Team, 2020, R LANG ENV STAT COMP; Ranker TA, 1992, GENETIC DIVERSITY MA; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Schneller J, 2007, AM J BOT, V94, P965, DOI 10.3732/ajb.94.6.965; Schneller JJ, 1996, J VEG SCI, V7, P113, DOI 10.2307/3236423; Schneller JJ, 1996, BIOL J LINN SOC, V59, P281; Schneller JJ, 1997, INT J PLANT SCI, V158, P79, DOI 10.1086/297416; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Soltis D.E., 1989, ISOZYMES PLANT BIOL, P241; SOLTIS DE, 1992, AM J BOT, V79, P97, DOI 10.2307/2445202; SOLTIS PS, 1988, AM J BOT, V75, P248, DOI 10.2307/2443891; Suter M, 2000, INT J PLANT SCI, V161, P233, DOI 10.1086/314258; Tajek P, 2003, THESIS; Tajek P, 2011, ACTA OECOL, V37, P495, DOI 10.1016/j.actao.2011.06.009; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Tutin TG, 1993, FLORA EUROPAEA; Vogel JC, 1999, BIOL J LINN SOC, V66, P23, DOI 10.1111/j.1095-8312.1999.tb01915.x; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Yeh F., 1997, BELG J BOT, V129, P1	45	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45855	10.1371/journal.pone.0045855	http://dx.doi.org/10.1371/journal.pone.0045855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029277	gold, Green Published			2022-12-27	WOS:000309388900107
J	Fan, WW; Sun, DD; Liu, JT; Liang, D; Wang, YB; Narsinh, KH; Li, Y; Qin, X; Liang, JM; Tian, J; Cao, F				Fan, Weiwei; Sun, Dongdong; Liu, Junting; Liang, Dong; Wang, Yabin; Narsinh, Kazim H.; Li, Yong; Qin, Xing; Liang, Jimin; Tian, Jie; Cao, Feng			Adipose Stromal Cells Amplify Angiogenic Signaling via the VEGF/mTOR/Akt Pathway in a Murine Hindlimb Ischemia Model: A 3D Multimodality Imaging Study	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; STEM-CELLS; IN-VIVO; BONE-MARROW; REGENERATIVE MEDICINE; CLINICAL TRANSLATION; ENDOTHELIAL-CELLS; TISSUE; SURVIVAL; THERAPY	Although adipose-derived stromal cell (ADSC) transplantation has been demonstrated as a promising therapeutic strategy for peripheral arterial disease (PAD), the mechanism of action behind the observed therapeutic efficacy of ADSCs remains unclear. This study was designed to investigate the long-term outcome and therapeutic behavior of engrafted ADSCs in a murine hindlimb ischemia model using multimodality molecular imaging approaches. ADSCs (1.0x10(7)) were isolated from Tg(Fluc-egfp) mice which constitutively express dual-reporter firefly luciferase and enhanced green fluorescent protein (Fluc(+)-eGFP(+), mADSCs(Fluc+GFP+)), then intramuscularly injected into the hindlimb of BALB/c-nu mice after unilateral femoral artery ligation and excision. Abbreviated survival (similar to 5 weeks) of post-transplant mADSCs within the ischemic hindlimb was longitudinally monitored using noninvasive bioluminescence imaging (BLI), fluorescence imaging (FRI), and bioluminescence tomography with micro-computed tomography (BLT/micro-CT). Use of the BLT/micro-CT system enabled quantitative 3-dimensional (3D) imaging of the cells' distribution and kinetics in vivo. Engrafted mADSCs improved blood perfusion recovery, ambulatory performance and prognosis of the ischemic hindlimb, probably by inducing angiogenesis and formation of collateral vessels, which could be visualized using laser Doppler perfusion imaging (LDPI), micro-CT angiography, vascular-cast imaging, and immunofluorescence. mADSCs augmented activation of the pro-angiogenic VEGF/mTOR/Akt pathway in vivo, even though the cells failed to incorporate into the host microvasculature as functional components. Downregulation of VEGF/mTOR/Akt signaling using small molecule inhibitors counteracted mADSC-induced angiogenesis and perfusion restoration. This study demonstrates for the first time the spatiotemporal kinetics and functional survival of transplanted mADSCs in a PAD model using in vivo 3D multimodality imaging. Our study indicates that mADSCs potentiate pro-angiogenic signal amplification via a VEGF/mTOR/Akt-dependent pathway, and thereby promote recovery from hindlimb ischemia.	[Liu, Junting; Liang, Jimin; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Fan, Weiwei; Sun, Dongdong; Liang, Dong; Wang, Yabin; Qin, Xing; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Mol Imaging Program, Xian 710032, Shaanxi, Peoples R China; [Fan, Weiwei; Sun, Dongdong; Liang, Dong; Wang, Yabin; Qin, Xing; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Narsinh, Kazim H.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Narsinh, Kazim H.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Li, Yong] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Stanford University; Stanford University; Air Force Military Medical University	Tian, J (corresponding author), Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	tian@ieee.org; wind8828@gmail.com	Liu, Junting/F-3550-2010; Liu, Junting/D-7175-2012; Liang, Jimin/B-5394-2014; Tian, Jie/H-1190-2011; Frank, Viki/GXZ-9902-2022	Liu, Junting/0000-0002-2099-0190; Liang, Jimin/0000-0003-1428-5804; Tian, Jie/0000-0003-0498-0432; 	National Basic Research Program of China [2012CB518101]; National Natural Science Foundation of China [30970845, 81090274, 81090270, 81100579]; China Department of Education [2010CXTD01]; China's Ministry of Science and Technology 863 Program [2012AA02A603]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; China's Ministry of Science and Technology 863 Program	This work was supported by National Basic Research Program of China (2012CB518101); National Natural Science Foundation of China (No. 30970845, No. 81090274, No. 81090270, and No. 81100579); Innovation Team Development Grant by China Department of Education (2010CXTD01); China's Ministry of Science and Technology 863 Program (2012AA02A603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CIRCULATION, V124, P2020; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Falcon BL, 2011, CANCER RES, V71, P1573, DOI 10.1158/0008-5472.CAN-10-3126; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Lawall H, 2011, J VASC SURG, V53, P445, DOI 10.1016/j.jvs.2010.08.060; Liu JT, 2010, IEEE T BIO-MED ENG, V57, P2579, DOI 10.1109/TBME.2010.2056370; Liu JT, 2010, OPT EXPRESS, V18, P13102, DOI 10.1364/OE.18.013102; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sheikh AY, 2012, ARTERIOSCL THROM VAS, V32, P92, DOI 10.1161/ATVBAHA.111.238618; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Trinh XB, 2009, BRIT J CANCER, V100, P971, DOI 10.1038/sj.bjc.6604921; van der Bogt KEA, 2012, JACC-CARDIOVASC IMAG, V5, P46, DOI 10.1016/j.jcmg.2011.07.011; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45621	10.1371/journal.pone.0045621	http://dx.doi.org/10.1371/journal.pone.0045621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029141	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900082
J	Nawrocki, RA; Shaalan, M; Shaheen, SE; Lorenzon, NM				Nawrocki, Robert A.; Shaalan, Majid; Shaheen, Sean E.; Lorenzon, Nancy M.			Monitoring Performance Degradation of Cerebellar Functions Using Computational Neuroscience Methods: Implications on Neurological Diseases	PLOS ONE			English	Article							MODELS; SIMULATION; CORTEX; DEATH	Neurodegeneration is a major cause of human disease. Within the cerebellum, neuronal degeneration and/or dysfunction has been associated with many diseases, including several forms of cerebellar ataxia, since normal cerebellar function is paramount for proper motor coordination, balance, and motor learning. The cerebellum represents a well-established neural circuit. Determining the effects of neuronal loss is of great importance for understanding the fundamental workings of the cerebellum and disease-associated dysfunctions. This paper presents computational modeling of cerebellar function in relation to neurodegeneration either affecting a specific cerebellar cell type, such as granule cells or Purkinje cells, or more generally affecting cerebellar cells and the implications on effects in relation to performance degradation throughout the progression of cell death. The results of the models show that the overall number of cells, as a percentage of the total cell number in the model, of a particular type and, primarily, their proximity to the circuit output, and not the neuronal convergence due to the relative number of cells of a particular type, is the main indicator of the gravity of the functional deficit caused by the degradation of that cell type. Specifically, the greater the percentage loss of neurons of a specific type and the closer proximity of those cells to the deep cerebellar neurons, the greater the deficit caused by the neuronal cell loss. These findings contribute to the understanding of the functional consequences of neurodegeneration and the functional importance of specific connectivity within a neuronal circuit.	[Lorenzon, Nancy M.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Nawrocki, Robert A.] Univ Denver, Dept Comp Engn, Denver, CO 80208 USA; [Shaalan, Majid] Univ Colorado, Dept Comp Sci & Engn, Denver, CO 80202 USA; [Shaheen, Sean E.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA	University of Denver; University of Denver; University of Colorado System; University of Colorado Denver; University of Denver	Lorenzon, NM (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	nancy.lorenzon@du.edu	Nawrocki, Robert/AAU-9047-2020; Nawrocki, Robert/I-9928-2014; Shaheen, Sean E/M-7893-2013	Nawrocki, Robert/0000-0003-0695-3868; Nawrocki, Robert/0000-0003-0695-3868; 				Aisa B, 2008, NEURAL NETWORKS, V21, P1146, DOI 10.1016/j.neunet.2008.06.016; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; [Anonymous], 1996, WHAT SIZE NEURAL NET; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Devlin JT, 1998, J COGNITIVE NEUROSCI, V10, P77, DOI 10.1162/089892998563798; Ferrer I, 2002, Cerebellum, V1, P213, DOI 10.1080/14734220260418448; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Haykin S, 1999, P842; Howell FW, 2000, NEUROCOMPUTING, V32, P1041, DOI 10.1016/S0925-2312(00)00277-0; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Kandel E., 2000, PRINCIPLES NEURAL SC; Lamb S. M., 1999, PATHWAYS BRAIN NEURO; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; Lipo W, 2005, OPTIMAL SIZE FEEDFOR, P69; Luger GF, 2002, ARTIFICIAL INTELLIGE; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Mingus B, 2009, EMERGENT TUTORIAL RE; O'reilly R.C., 2000, COMPUTATIONAL EXPLOR; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Ramskov C.B., 2010, PSYCHOL NOTES; Rossant Cyrille, 2010, Front Neuroinform, V4, P2, DOI 10.3389/neuro.11.002.2010; Rubinov M, 2009, AM J GERIAT PSYCHIAT, V17, P210, DOI 10.1097/JGP.0b013e318187137a; Russell S. J., 2004, ARTIFICIAL INTELLIGE; Viscomi MT, 2009, CEREBELLUM, V8, P184, DOI 10.1007/s12311-009-0107-7; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065	29	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45581	10.1371/journal.pone.0045581	http://dx.doi.org/10.1371/journal.pone.0045581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029114	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900078
J	Yasgar, A; Furdas, SD; Maloney, DJ; Jadhav, A; Jung, M; Simeonov, A				Yasgar, Adam; Furdas, Silviya D.; Maloney, David J.; Jadhav, Ajit; Jung, Manfred; Simeonov, Anton			High-Throughput 1,536-Well Fluorescence Polarization Assays for alpha(1)-Acid Glycoprotein and Human Serum Albumin Binding	PLOS ONE			English	Article							PLASMA-PROTEIN BINDING; ALPHA-1-ACID GLYCOPROTEIN; DRUG-METABOLISM; LIGAND-BINDING; HIGH-AFFINITY; PRAZOSIN; SITES	Two major plasma proteins in humans are primarily responsible for drug binding, the alpha(1)-acid-glycoprotein (AGP) and human serum albumin (HSA). The availability of at least a semiquantitative high-throughput assay for assessment of protein binding is expected to aid in bridging the current gap between high-throughput screening and early lead discovery, where cell-based and biochemical assays are deployed routinely to test up to several million compounds rapidly, as opposed to the late-stage candidate drug profiling methods which test at most dozens of compounds at a time. Here, we describe the miniaturization of a pair of assays based on the binding-and displacement-induced changes in fluorescence polarization (FP) of fluorescent small molecule probes known to specifically target the drug-binding sites of these two proteins. A robust and reproducible assay performance was achieved in <= 4 mu L assay volume in 1,536-well format. The assays were tested against a validation set of 10 known protein binders, and the results compared favorably with data obtained using protein-coated beads with high-performance liquid chromatography analysis. The miniaturized assays were taken to a high-throughput level in a screen of the LOPAC(1280) collection of 1,280 pharmacologically active compounds. The adaptation of the AGP and HSA FP assays to a 1,536-well format should allow their use in early-stage profiling of large-size compound sets.	[Yasgar, Adam; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton] NIH, Chem Genom Ctr, Natl Ctr Advancing Translat Sci, Bethesda, MD 20892 USA; [Furdas, Silviya D.; Jung, Manfred] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Freiburg	Simeonov, A (corresponding author), NIH, Chem Genom Ctr, Natl Ctr Advancing Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	asimeono@mail.nih.gov	Jung, Manfred/Q-8029-2016	Jung, Manfred/0000-0002-6361-7716; Jadhav, Ajit/0000-0001-7955-1451; Yasgar, Adam/0000-0001-7350-1402	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; Intramural Research Program of the NHGRI, NIH	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and the Intramural Research Program of the NHGRI, NIH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FREQ ASK QUEST; Auld D. S, 2004, RECEPTOR BINDING ASS; Bass Alan S., 2009, Journal of Pharmacological and Toxicological Methods, V60, P69, DOI 10.1016/j.vascn.2009.04.194; Bradley Ronald H, 2003, Am J Ther, V10, P318, DOI 10.1097/00045391-200309000-00003; BRUNNER F, 1987, J PHARM PHARMACOL, V39, P986, DOI 10.1111/j.2042-7158.1987.tb03145.x; Campbell RM, 2004, DATA STANDARDIZATION; Carlson TJ, 2008, COMB CHEM HIGH T SCR, V11, P258, DOI 10.2174/138620708783877717; DALE O, 1984, BIOCHEM PHARMACOL, V33, P1719, DOI 10.1016/0006-2952(84)90339-3; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; GRIMALDI B, 1992, CR ACAD SCI III-VIE, V315, P93; Howard ML, 2010, COMB CHEM HIGH T SCR, V13, P170, DOI 10.2174/138620710790596745; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Israili ZH, 2001, DRUG METAB REV, V33, P161, DOI 10.1081/DMR-100104402; Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korfmacher WA, 2009, MINI-REV MED CHEM, V9, P703, DOI 10.2174/138955709788452694; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1985, BIOCHEM J, V225, P629, DOI 10.1042/bj2250629; Kratochwil NA, 2004, CURR OPIN DRUG DISC, V7, P507; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Lockhart A, 2003, NUCL MED BIOL, V30, P199, DOI 10.1016/S0969-8051(02)00410-9; Longhi R, 2011, DRUG METAB DISPOS, V39, P312, DOI 10.1124/dmd.110.036095; Mathias U, 2007, ANAL BIOANAL CHEM, V388, P1147, DOI 10.1007/s00216-007-1351-7; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Nassar AF, 2009, DRUG METABOLISM HDB; Netzer R, 2003, CURR OPIN DRUG DI DE, V6, P462; Roberts SA, 2001, XENOBIOTICA, V31, P557, DOI 10.1080/00498250110060978; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rusnak DW, 2004, BIOORG MED CHEM LETT, V14, P2309, DOI 10.1016/j.bmcl.2004.01.103; SAGER G, 1989, BRIT J CLIN PHARMACO, V27, P229, DOI 10.1111/j.1365-2125.1989.tb05355.x; SAGER G, 1989, PHARMACOL TOXICOL, V64, P365, DOI 10.1111/j.1600-0773.1989.tb00666.x; Schuhmacher J, 2004, J PHARM SCI-US, V93, P816, DOI 10.1002/jps.10588; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Titus SA, 2009, ANAL BIOCHEM, V394, P30, DOI 10.1016/j.ab.2009.07.003; Tsaioun K, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S1; Vogel GH, 2006, DRUG DISCOVERY EVALU, P473; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10	40	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45594	10.1371/journal.pone.0045594	http://dx.doi.org/10.1371/journal.pone.0045594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029124	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900081
J	Johnson, MO; Rose, CD; Dilworth, SE; Neilands, TB				Johnson, Mallory O.; Rose, Carol Dawson; Dilworth, Samantha E.; Neilands, Torsten B.			Advances in the Conceptualization and Measurement of Health Care Empowerment: Development and Validation of the Health Care Empowerment Inventory	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TREATMENT ADHERENCE; DECISION-MAKING; HIV-INFECTION; PREVENTION; BEHAVIOR	The Health Care Empowerment Model offers direction for the investigation of patient-controlled engagement and involvement in health care. At the core of the model is the construct of Health Care Empowerment (HCE), for which there exist no validated measures. A set of 27 candidate self-report survey items was constructed to capture five hypothesized inter-related facets of HCE (informed, engaged, committed, collaborative, and tolerant of uncertainty). The full item set was administered to 644 HIV-infected persons enrolled in three ongoing research studies. Exploratory and confirmatory factor analyses resulted in a two factor solution comprising four items each on two subscales: (1) HCE: Informed, Committed, Collaborative, and Engaged HCE ICCE) and (2) HCE Tolerance of Uncertainty (HCE TU). Subscale scores were evaluated for relationships with relevant constructs measured in the three studies, including depression, provider relationships, medication adherence, and HIV-1 viral load. Findings suggest the utility of this 8-item Health Care Empowerment Inventory (HCEI) in efforts to measure, understand, and track changes in the ways in which individuals engage in health care.	[Johnson, Mallory O.; Rose, Carol Dawson; Dilworth, Samantha E.; Neilands, Torsten B.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Johnson, MO (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mallory.johnson@ucsf.edu			National Institutes of Health (NIH) [R01MH0790700, K24MH087220, R01NR011087, RC1DA028224, UL1RR024131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087220, R01MH079700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028224] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This publication was supported by National Institutes of Health (NIH) grant numbers R01MH0790700, K24MH087220, R01NR011087, RC1DA028224 and UL1RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach MC, 2007, J GEN INTERN MED, V22, P1119, DOI 10.1007/s11606-007-0241-1; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chesney MA, 1997, ADHERENCE COMBINATIO; DHHS Panel-Office of AIDS Research Advisory Council (OARAC), 2011, GUID US ANT AG HIV I; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Ewart CK, 2004, HA CL HE PS, V3, P249; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gerbing DW, 1996, STRUCT EQU MODELING, V3, P62, DOI 10.1080/10705519609540030; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Harvey RM, 1999, RES NURS HEALTH, V22, P39, DOI 10.1002/(SICI)1098-240X(199902)22:1<39::AID-NUR5>3.0.CO;2-J; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Johnson MO, 2012, PATIENT PREFER ADHER, V6, P395, DOI 10.2147/PPA.S30040; Johnson MO, 2011, AM J PUBLIC HEALTH, V101, P265, DOI 10.2105/AJPH.2009.189829; Johnson MO, 2003, AIDS PATIENT CARE ST, V17, P645, DOI 10.1089/108729103771928708; Kalichman SC, 2000, INT J STD AIDS, V11, P579, DOI 10.1258/0956462001916551; Lazarus R.S., 1984, EMOTION ADAPTATION; McDonald RP., 1985, FACTOR ANAL RELATED; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raykov T., 2011, INTRO PSYCHOMETRIC T; Sevelius JM, 2010, J ASSOC NURSE AIDS C, V21, P256, DOI 10.1016/j.jana.2010.01.005; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Walsh JC, 2002, J ACQ IMMUN DEF SYND, V30, P278, DOI [10.1097/01.QAI.0000018000.56638.43, 10.1097/00126334-200207010-00003]; Yu C.Y., 2002, EVALUATING CUTOFF CR	28	28	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45692	10.1371/journal.pone.0045692	http://dx.doi.org/10.1371/journal.pone.0045692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23029184	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400120
J	Liu, TC; Jin, X; Zhang, XM; Yuan, HJ; Cheng, J; Lee, J; Zhang, BQ; Zhang, MN; Wu, J; Wang, LJ; Tian, G; Wang, WF				Liu, Tiecheng; Jin, Xin; Zhang, Xuemin; Yuan, Huijun; Cheng, Jing; Lee, Janet; Zhang, Baoquan; Zhang, Maonian; Wu, Jing; Wang, Lijuan; Tian, Geng; Wang, Weifeng			A Novel Missense SNRNP200 Mutation Associated with Autosomal Dominant Retinitis Pigmentosa in a Chinese Family	PLOS ONE			English	Article							PROTEIN; GENE; PRPF31	The SNRNP200 gene encodes hBrr2, a helicase essential for pre-mRNA splicing. Six mutations in SNRNP200 have recently been discovered to be associated with autosomal dominant retinitis pigmentosa (adRP). In this work, we analyzed a Chinese family with adRP and identified a novel missense mutation in SNRNP200. To identify the genetic defect in this family, exome of the proband was captured and sequencing analysis was performed to exclude known genetic defects and find possible pathogenic mutations. Subsequently, candidate mutations were validated in affected family members using Sanger sequencing. A novel missense mutation, c.2653C>G transition (p.Q885E), in exon 20 of SNRNP200 was identified. The mutation co-segregated with the disease phenotype over four generations and was absent in 100 normal unaffected individuals. This mutation occurs at highly conserved position in hBrr2 and is predicted to have a functional impact, suggesting that hBrr2-dependent small nuclear riboproteins (snRNPs) unwinding and spliceosome activation is important in the pathogenesis of some variants of RP.	[Liu, Tiecheng; Jin, Xin; Zhang, Xuemin; Zhang, Baoquan; Zhang, Maonian] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Liu, Tiecheng] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Ophthalmol, Sanya, Peoples R China; [Yuan, Huijun; Cheng, Jing] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Lee, Janet] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Lee, Janet] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Wu, Jing; Tian, Geng] BGI Tianjin, Dept Sci & Technol, Tianjin, Peoples R China; [Wang, Lijuan] BGI Shenzhen, Dept Reprod Hlth, Shenzhen, Peoples R China; [Wang, Weifeng] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Gastroenterol & Hepatol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Chinese People's Liberation Army General Hospital	Liu, TC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China.	ltc301@yahoo.com.cn; tiang@genomics.cn						Alvarez BV, 2007, INVEST OPHTH VIS SCI, V48, P3459, DOI 10.1167/iovs.06-1515; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chizzolini M, 2011, CURR GENOMICS, V12, P260, DOI 10.2174/138920211795860071; Dauber SL, 2008, J GLAUCOMA, V17, P248, DOI 10.1097/IJG.0b013e31816c4d9f; Guo HK, 2010, J HUM GENET, V55, P571, DOI 10.1038/jhg.2010.68; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kershaw CJ, 2009, RNA, V15, P1292, DOI 10.1261/rna.1347409; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Li ND, 2010, INVEST OPHTH VIS SCI, V51, P1036, DOI 10.1167/iovs.09-3725; Lim KP, 2009, ARCH OPHTHALMOL-CHIC, V127, P784, DOI 10.1001/archophthalmol.2009.112; Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006; Oyama T, 2011, BMC STRUCT BIOL, V9, P2; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Stephen PD, 2007, ARCH OPHTHALMOL-CHIC, V125, P158; Wang LJ, 2003, AM J MED GENET A, V121A, P235, DOI 10.1002/ajmg.a.20224; Wang M, 2011, CHINESE MED J-PEKING, V124, P1270, DOI 10.3760/cma.j.issn.0366-6999.2011.08.029; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	26	20	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45464	10.1371/journal.pone.0045464	http://dx.doi.org/10.1371/journal.pone.0045464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029027	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400089
J	Chung, JS; Katayama, H; Dircksen, H				Chung, J. Sook; Katayama, Hidekazu; Dircksen, Heinrich			New Functions of Arthropod Bursicon: Inducing Deposition and Thickening of New Cuticle and Hemocyte Granulation in the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							CRUSTACEAN CARDIOACTIVE PEPTIDE; MOLT-INHIBITING HORMONE; GREEN SHORE CRAB; CARCINUS-MAENAS; DEVELOPMENTAL EXPRESSION; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; HYPERGLYCEMIC HORMONE; HARDENING HORMONE; CELL-DEATH	Arthropod growth requires molt-associated changes in softness and stiffness of the cuticle that protects from desiccation, infection and injury. Cuticle hardening in insects depends on the blood-borne hormone, bursicon (Burs), although it has never been determined in hemolymph. Whilst also having Burs, decapod crustaceans reiterate molting many more times during their longer life span and are encased in a calcified exoskeleton, which after molting undergoes similar initial cuticle hardening processes as in insects. We investigated the role of homologous crustacean Burs in cuticular changes and growth in the blue crab, Callinectes sapidus. We found dramatic increases in size and number of Burs cells during development in paired thoracic ganglion complex (TGC) neurons with pericardial organs (POs) as neurohemal release sites. A skewed expression of Burs beta/Burs alpha mRNA in TGC corresponds to protein contents of identified Burs beta homodimer and Burs heterodimer in POs. In hemolymph, Burs is consistently present at similar to 21 pM throughout the molt cycle, showing a peak of similar to 89 pM at ecdysis. Since initial cuticle hardness determines the degree of molt-associated somatic increment (MSI), we applied recombinant Burs in vitro to cuticle explants of late premolt or early ecdysis. Burs stimulates cuticle thickening and granulation of hemocytes. These findings demonstrate novel cuticle-associated functions of Burs during molting, while the unambiguous and constant presence of Burs in cells and hemolymph throughout the molt cycle and life stages may implicate further functions of its homo-and heterodimer hormone isoforms in immunoprotective defense systems of arthropods.	[Chung, J. Sook; Katayama, Hidekazu] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Dircksen, Heinrich] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Stockholm University	Chung, JS (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	chung@umces.edu	Chung, J.Sook/D-3832-2012; Dircksen, Heinrich/C-7704-2013	Chung, J.Sook/0000-0002-9318-304X; Dircksen, Heinrich/0000-0001-7815-4868; Katayama, Hidekazu/0000-0003-3367-9147	NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office [NA17FU2841]; Japan Society for Promotion of Science	NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by a program grant (NA17FU2841) from NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office to the Blue Crab Advanced Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the blue crab hatchery staff at the Institute of Marine and Environmental Technology (Baltimore, MD, USA) for juvenile crabs, and to Ms. S. Tylor at Cooperative Oxford Laboratory, Center for Coastal Environmental Health & Biomolecular Research at Charleston (CCEHBR) (Oxford, MD, USA) for semi-thin sectioning. Dr. H. Katayama was sponsored by a fellowship from the Japan Society for Promotion of Science. This article is contribution No. 4674 of the University of Maryland Center for Environmental Science and contribution No. 12-236 of the Institute of Marine and Environmental Science.	Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; Bai H, 2010, DEV BIOL, V344, P248, DOI 10.1016/j.ydbio.2010.05.003; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 2004, DEVELOPMENT, V131, P4751, DOI 10.1242/dev.01312; Chung JS, 1996, EUR J BIOCHEM, V240, P358, DOI 10.1111/j.1432-1033.1996.0358h.x; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Churchill EP, 1919, B US BUR FISH, V36, P95; Dai L, 2008, J COMP NEUROL, V506, P759, DOI 10.1002/cne.21575; DALL W, 1978, J EXP MAR BIOL ECOL, V35, P165, DOI 10.1016/0022-0981(78)90074-6; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; DAVIS NT, 1993, J COMP NEUROL, V338, P612, DOI 10.1002/cne.903380410; DENNELL R, 1947, PROC R SOC SER B-BIO, V134, P485, DOI 10.1098/rspb.1947.0027; Dillaman R, 2005, J MORPHOL, V263, P356, DOI 10.1002/jmor.10311; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; DIRCKSEN H, 1991, CELL TISSUE RES, V263, P439, DOI 10.1007/BF00327278; Dircksen H, 1998, CONSERVED CRUSTACEAN; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Drexler AL, 2007, CELL TISSUE RES, V329, P391, DOI 10.1007/s00441-007-0391-9; Foyle TP, 1989, FIELD TESTING SHELL; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; FRAENKEL G., 1965, J INSECT PHYSIOL, V11, P513, DOI 10.1016/0022-1910(65)90137-X; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; HOSE JE, 1992, BIOL BULL-US, V183, P185, DOI 10.2307/1542206; Keller R, 1970, DEV GENES EVOL, V164, P209; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kostron B, 1996, J EXP BIOL, V199, P367; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; MYKLES DL, 1980, J EXP BIOL, V84, P89; Natzle JE, 2008, GENETICS, V180, P885, DOI 10.1534/genetics.108.092908; Ohira T, 1999, BIOSCI BIOTECH BIOCH, V63, P1576, DOI 10.1271/bbb.63.1576; Phillips JE, 1998, LOCUST ION TRANSPORT; Phlippen MK, 2000, J EXP BIOL, V203, P521; Reynolds S.E., 1980, Advances in Insect Physiology, V15, P475, DOI 10.1016/S0065-2806(08)60144-7; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; ROBERTSON JD, 1960, COMP BIOCHEM PHYSIOL, V1, P183, DOI 10.1016/0010-406X(60)90023-2; Sharp JH, 2010, GEN COMP ENDOCR, V169, P65, DOI 10.1016/j.ygcen.2010.07.006; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Suderman RJ, 2006, INSECT BIOCHEM MOLEC, V36, P353, DOI 10.1016/j.ibmb.2006.01.012; TRAVIS DF, 1955, BIOL BULL, V108, P88, DOI 10.2307/1538400; TRUBE A, 1994, J COMP NEUROL, V348, P80, DOI 10.1002/cne.903480104; Truman JW, 2005, VITAM HORM, V73, P1, DOI 10.1016/S0083-6729(05)73001-6; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; WEBSTER SG, 1986, GEN COMP ENDOCR, V61, P237, DOI 10.1016/0016-6480(86)90201-7; Wilcockson DC, 2008, GEN COMP ENDOCR, V156, P113, DOI 10.1016/j.ygcen.2007.12.003; Woodruff EA, 2008, PEPTIDES, V29, P2276, DOI 10.1016/j.peptides.2008.08.023; Yatsu J, 2009, INSECT BIOCHEM MOLEC, V39, P254, DOI 10.1016/j.ibmb.2008.12.005; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X; Zmora N, 2007, BIOL REPROD, V77, P138, DOI 10.1095/biolreprod.106.055483; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012	56	35	38	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46299	10.1371/journal.pone.0046299	http://dx.doi.org/10.1371/journal.pone.0046299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029467	Green Published, gold			2022-12-27	WOS:000309973900126
J	Davis, E; Tamayo, A; Fernandez, A				Davis, Elizabeth; Tamayo, Aracely; Fernandez, Alicia			"Because Somebody Cared about Me. That's How It Changed Things": Homeless, Chronically Ill Patients' Perspectives on Case Management	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; EMERGENCY-DEPARTMENT; ALCOHOL-PROBLEMS; FREQUENT USERS; SOCIAL SUPPORT; URBAN HOMELESS; COSTS; HOSPITALIZATION; POPULATION; LONELINESS	Background: Case management programs for chronically ill, homeless people improve health and resource utilization by linking patients with case managers focused on improving management of medical and psychosocial problems. Little is known about participants' perspectives on case management interventions. Methods: This qualitative study used in-depth, one-on-one interviews to understand the impact of a case management program from the perspective of participants. A standardized interview guide with open-ended questions explored experiences with the case management program and feelings about readiness to leave the program. Results: Four recurrent themes emerged: (1) Participants described profound social isolation prior to case management program enrollment; (2) Participants perceived that caring personal relationships with case managers were key to the program; (3) Participants valued assistance with navigating medical and social systems; and (4) Participants perceived that their health improved through both the interpersonal and the practical aspects of case management. Conclusions: Chronically ill, homeless people enrolled in a case management program perceived that social support from case managers resulted in improved health. Programs for this population should consider explicitly including comprehensive social support interventions. Further research on case management should explore the impact of different types of social support on outcomes for homeless chronically ill patients.	[Davis, Elizabeth; Fernandez, Alicia] Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Tamayo, Aracely] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Davis, E (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.	elizabeth.davis@ucsf.edu			National Institute of Health Career Development Award [K23-RR018324-01]; Arnold P. Gold Professorship award; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR018324] Funding Source: NIH RePORTER	National Institute of Health Career Development Award; Arnold P. Gold Professorship award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr. Alicia Fernandez was supported by an National Institute of Health Career Development Award (K23-RR018324-01) and by an Arnold P. Gold Professorship award. http://grants.nih.gov/training/careerdevelopmentawards.htm. http://www.humanism-in-medicine.org/index.php/programs_grants/gold_foundation_programs/gold_professorships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Berry-Millett Rachel, 2009, Synth Proj Res Synth Rep, DOI 52372; BF Crabtree, 1999, DOING QUALITATIVE RE, P33; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; Buchanan D, 2006, AM J PUBLIC HEALTH, V96, P1278, DOI 10.2105/AJPH.2005.067850; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Craig C, 2011, IHI INNOVATION SERIE; D'Amore J, 2001, ACAD EMERG MED, V8, P1051, DOI 10.1111/j.1553-2712.2001.tb01114.x; Gelberg L., 1996, CHANGING US HLTH CAR, P273; Glaser B.G., 1968, DISCOV GROUNDED THEO; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kim TW, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-19; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; MARTELL JV, 1992, ANN INTERN MED, V116, P299, DOI 10.7326/0003-4819-116-4-299; Martinez TE, 2006, PSYCHIAT SERV, V57, P992, DOI 10.1176/appi.ps.57.7.992; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moore G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-320; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Murphy BM, 2008, EUR J CARDIOV PREV R, V15, P210, DOI 10.1097/HJR.0b013e3282f2dc4e; National Coalition for the Homeless, 2009, HLTH CAR HOM; O'Connell J., 2005, PREMATURE MORTALITY; O'Connell J., 1999, UTILIZATION COSTS ME; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Rich E., 2012, COORDINATING CARE AD; ROBERTSON MJ, 1986, AM J PUBLIC HEALTH, V76, P561, DOI 10.2105/AJPH.76.5.561; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Salit SA, 1998, NEW ENGL J MED, V338, P1734, DOI 10.1056/NEJM199806113382406; Schneidermann M, 2007, MED MANAGEMENT VULNE, P151; Sorkin D, 2002, ANN BEHAV MED, V24, P290, DOI 10.1207/S15324796ABM2404_05; Thornquist L, 2002, ACAD EMERG MED, V9, P300, DOI 10.1111/j.1553-2712.2002.tb01323.x; Tovbin D, 2001, NEPHRON, V89, P26, DOI 10.1159/000046039; Turnbull J, 2007, CAN MED ASSOC J, V177, P1065, DOI 10.1503/cmaj.071294; Wright NMJ, 2006, BRIT J GEN PRACT, V56, P286	44	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45980	10.1371/journal.pone.0045980	http://dx.doi.org/10.1371/journal.pone.0045980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029350	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900069
J	Rosario, R; Araki, H; Print, CG; Shelling, AN				Rosario, Roseanne; Araki, Hiromitsu; Print, Cristin G.; Shelling, Andrew N.			The Transcriptional Targets of Mutant FOXL2 in Granulosa Cell Tumours	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; POTENTIAL TARGETS; EXPRESSION; MUTATION; OVARY; ADULT; MOUSE; LINE; IDENTIFICATION; ELEMENT	Background: Despite their distinct biology, granulosa cell tumours (GCTs) are treated the same as other ovarian tumours. Intriguingly, a recurring somatic mutation in the transcription factor Forkhead Box L2 (FOXL2) 402C>G has been found in nearly all GCTs examined. This investigation aims to identify the pathogenicity of mutant FOXL2 by studying its altered transcriptional targets. Methods: The expression of mutant FOXL2 was reduced in the GCT cell line KGN, and wildtype and mutant FOXL2 were overexpressed in the GCT cell line COV434. Total RNA was hybridised to Affymetrix U133 Plus 2 microarrays. Comparisons were made between the transcriptomes of control cells and cells altered by FOXL2 knockdown and overexpression, to detect potential transcriptional targets of mutant FOXL2. Results: The overexpression of wildtype and mutant FOXL2 in COV434, and the silencing of mutant FOXL2 expression in KGN, has shown that mutant FOXL2 is able to differentially regulate the expression of many genes, including two well known FOXL2 targets, StAR and CYP19A. We have shown that many of the genes regulated by mutant FOXL2 are clustered into functional annotations of cell death, proliferation, and tumourigenesis. Furthermore, TGF-beta signalling was found to be enriched when using the gene annotation tools GATHER and GeneSetDB. This enrichment was still significant after performing a robust permutation analysis. Conclusion: Given that many of the transcriptional targets of mutant FOXL2 are known TGF-beta signalling genes, we suggest that deregulation of this key antiproliferative pathway is one way mutant FOXL2 contributes to the pathogenesis of adult-type GCTs. We believe this pathway should be a target for future therapeutic interventions, if outcomes for women with GCTs are to improve.	[Rosario, Roseanne; Shelling, Andrew N.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand; [Araki, Hiromitsu; Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Bioinformat Inst New Zealand, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Rosario, R (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	r.rosario@auckland.ac.nz		Shelling, Andrew/0000-0002-5300-1934; Print, Cristin/0000-0001-8345-7812	Sladjana M. Crosley Fund for GCT Research; Granulosa Cell Tumour Foundation; University of Auckland; Cancer Society of New Zealand Training Scholarship in Cancer Research	Sladjana M. Crosley Fund for GCT Research; Granulosa Cell Tumour Foundation; University of Auckland; Cancer Society of New Zealand Training Scholarship in Cancer Research	This work is funded by the Sladjana M. Crosley Fund for GCT Research and the Granulosa Cell Tumour Foundation. Roseanne Rosario is supported by a University of Auckland Doctoral Scholarship and the Cancer Society of New Zealand Training Scholarship in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2012, FEBS OPEN BIO, V2, P76, DOI 10.1016/j.fob.2012.04.003; Arcellana-Panlilio MY, 2002, GENE CHROMOSOME CANC, V35, P176, DOI 10.1002/gcc.10108; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colombo N, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1005; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'Angelo E, 2011, MODERN PATHOL, V24, P1360, DOI 10.1038/modpathol.2011.95; East N, 2005, J OBSTET GYNAECOL CA, V27, P363, DOI 10.1016/S1701-2163(16)30464-9; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Fuller PJ, 2004, TRENDS ENDOCRIN MET, V15, P122, DOI 10.1016/j.tem.2004.02.005; Fuller PJ, 2002, MOL CELL ENDOCRINOL, V191, P89, DOI 10.1016/S0303-7207(02)00059-X; Gittleman AM, 2003, CLIN IMAG, V27, P221, DOI 10.1016/S0899-7071(02)00586-7; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Hes O, 2011, APPL IMMUNOHISTO M M, V19, P347, DOI 10.1097/PAI.0b013e3182039ef2; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kobel M, 2009, CANCER RES, V69, P9160, DOI 10.1158/0008-5472.CAN-09-2669; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Parman C, 2006, AFFYQCREPORTS PACKAG; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veitia RA, 2010, BIOESSAYS, V32, P375, DOI 10.1002/bies.200900193; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	51	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46270	10.1371/journal.pone.0046270	http://dx.doi.org/10.1371/journal.pone.0046270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029457	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900121
J	Busch, S; Ryden, L; Stal, O; Jirstrom, K; Landberg, G				Busch, Susann; Ryden, Lisa; Stal, Olle; Jirstrom, Karin; Landberg, Goran			Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIAL GROWTH-FACTOR; TUMOR MICROENVIRONMENT; KNOCKOUT MICE; LUNG-CANCER; EXPRESSION; SIGNATURE; ESTROGEN; CELLS; PATHWAY	Purpose: The aim of this study was to evaluate ERK phosphorylation as a stromal biomarker for breast cancer prognosis and tamoxifen treatment prediction within a randomized tamoxifen trial. Patients and Methods: Tissue microarrays of two breast cancer cohorts including in total 743 invasive breast cancer samples were analyzed for ERK phosphorylation (pERK) and smooth muscle actin-alpha expression (SMA alpha) in cancer-associated fibroblasts (CAFs) and links to clinico-pathological data and treatment-predictive values were delineated. Results: By analyzing a unique randomized tamoxifen trial including breast cancer patients receiving no adjuvant treatment we show for the first time that patients low in ERK phosphorylation in CAFs did not respond to tamoxifen treatment despite having estrogen-receptor alpha (ER alpha-positive tumors compared to patients with high pERK levels in CAFs (P = 0.015, multivariate Cox regression interaction analysis). In both clinical materials we further show a significant association between pERK and SMA alpha, a characteristic marker for activated fibroblasts. SMA alpha expression however was not linked to treatment-predictive information but instead had prognostic qualities. Conclusion: The data suggests that the presence of a subpopulation of CAFs, defined by minimal activated ERK signaling, is linked to an impaired tamoxifen response. Thus, this report illustrates the importance of the stroma for monitoring treatment effects in pre-menopausal breast cancer.	[Busch, Susann; Landberg, Goran] Univ Manchester, Breakthrough Breast Canc Res Unit, Sch Canc Enabling Sci & Technol,Christie NHS Fdn, Manchester Acad Hlth Sci Ctr,Paterson Inst Canc R, Manchester, Lancs, England; [Ryden, Lisa] Univ Lund Hosp, Dept Surg, Inst Clin Sci, S-22185 Lund, Sweden; [Stal, Olle] Linkoping Univ, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden; [Jirstrom, Karin; Landberg, Goran] Lund Univ, Skane Univ Hosp Malmo, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden; [Landberg, Goran] Gothenburg Univ, Sahlgrenska Canc Ctr, Gothenburg, Sweden	Christie NHS Foundation Trust; University of Manchester; Lund University; Skane University Hospital; Linkoping University; Lund University; Skane University Hospital; University of Gothenburg	Landberg, G (corresponding author), Univ Manchester, Breakthrough Breast Canc Res Unit, Sch Canc Enabling Sci & Technol,Christie NHS Fdn, Manchester Acad Hlth Sci Ctr,Paterson Inst Canc R, Manchester, Lancs, England.	glandberg@picr.man.ac.uk			Swedish Cancer Society and Breakthrough Breast Cancer UK; Breast Cancer Now [MAN-Q1] Funding Source: researchfish	Swedish Cancer Society and Breakthrough Breast Cancer UK; Breast Cancer Now	This study was supported by the Swedish Cancer Society and Breakthrough Breast Cancer UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Arendt LM, 2009, SEMIN CELL DEV BIOL; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Bogin L, 2002, CANCER RES, V62, P1948; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Garvin S, 2003, CANCER RES, V63, P8742; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Han SW, 2005, INT J CANCER, V113, P109, DOI 10.1002/ijc.20550; Hattar R, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2220; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Ihn H, 2000, J IMMUNOL, V165, P2149, DOI 10.4049/jimmunol.165.4.2149; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pages Gilles, 2004, Methods Mol Biol, V250, P155; Petricoin EF, 2004, TRENDS MOL MED, V10, P59, DOI 10.1016/j.molmed.2003.12.006; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Rajski M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-1; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rudnick JA, 2012, CLIN EXP METASTASIS; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wennmalm K, 2009, NAT MED, V15, P237, DOI 10.1038/nm0309-237; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	46	21	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45669	10.1371/journal.pone.0045669	http://dx.doi.org/10.1371/journal.pone.0045669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029174	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700056
J	Guo, L; Wu, WJ; Liu, LD; Wang, LC; Zhang, Y; Wu, LQ; Guan, Y; Li, QH				Guo, Lei; Wu, Wen-juan; Liu, Long-ding; Wang, Li-chun; Zhang, Ying; Wu, Lian-qiu; Guan, Ying; Li, Qi-han			Herpes Simplex Virus 1 ICP22 Inhibits the Transcription of Viral Gene Promoters by Binding to and Blocking the Recruitment of P-TEFb	PLOS ONE			English	Article							RNA-POLYMERASE-II; EARLY PROTEIN ICP22; CARBOXYL-TERMINAL DOMAIN; INFECTED-CELL PROTEIN; ELONGATION; TYPE-1; ACTIVATION; EXPRESSION; PHOSPHORYLATION; KINASE	ICP22 is a multifunctional herpes simplex virus 1 (HSV-1) immediate early protein that functions as a general repressor of a subset of cellular and viral promoters in transient expression systems. Although the exact mechanism of repression remains unclear, this protein induces a decrease in RNA polymerase II Serine 2 (RNAPII Ser-2) phosphorylation, which is critical for transcription elongation. To characterize the mechanism of transcriptional repression by ICP22, we established an in vivo transient expression reporter system. We found that ICP22 inhibits transcription of the HSV-1 alpha, beta and gamma gene promoters. The viral tegument protein VP16, which plays vital roles in initiation of viral gene expression and viral proliferation, can overcome the inhibitory effect of ICP22 on alpha-gene transcription. Further immunoprecipitation studies indicated that both ICP22 and VP16 bind to positive transcription elongation factor b (P-TEFb) and form a complex with it in vivo. We extended this to show that P-TEFb regulates transcription of the viral alpha-gene promoters and affects transcriptional regulation of ICP22 and VP16 on the alpha-genes. Additionally, ChIP assays demonstrated that ICP22 blocks the recruitment of P-TEFb to the viral promoters, while VP16 reverses this blocking effect by recruiting P-TEFb to the viral alpha-gene promoters through recognition of the TAATGARAT motif. Taken together, our results suggest that ICP22 interacts with and blocks the recruitment of P-TEFb to viral promoter regions, which inhibits transcription of the viral gene promoters. The transactivator VP16 binds to and induces the recruitment of P-TEFb to viral alpha-gene promoters, which counteracts the transcriptional repression of ICP22 on alpha-genes by recruiting p-TEFb to the promoter region.	[Guo, Lei; Wu, Wen-juan; Liu, Long-ding; Wang, Li-chun; Zhang, Ying; Guan, Ying; Li, Qi-han] Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China; [Wu, Wen-juan] Affiliated Hosp 1, Kunming Med Coll, Kunming, Peoples R China; [Wu, Lian-qiu] Chinese Acad Med Sci, Inst Mat Med, Peking Union Med Coll, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China.	imbcams.lq@gmail.com	Guo, Lei/AEU-0178-2022; Wu, wenjuan/GPX-6968-2022	Guo, Lei/0000-0003-1733-1802	National Basic Research Program [2012CB518901, 2011CB504903]; National Natural Sciences Foundation of China [31100127]	National Basic Research Program(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by funding from National Basic Research Program, 2012CB518901 and 2011CB504903 (http://www.973.gov.cn/) and National Natural Sciences Foundation of China, grant number 31100127 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Baringer JR, 1976, SURV OPHTHALMOL, V21, P71; Bowman JJ, 2009, J VIROL, V83, P8733, DOI 10.1128/JVI.00810-09; Bruni R, 1998, J VIROL, V72, P8525, DOI 10.1128/JVI.72.11.8525-8531.1998; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Cun W, 2006, J BIOCHEM, V140, P67, DOI 10.1093/jb/mvj135; Cun W, 2009, SCI CHINA SER C, V52, P344, DOI 10.1007/s11427-009-0051-2; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; GAFFNEY DF, 1985, NUCLEIC ACIDS RES, V13, P7847, DOI 10.1093/nar/13.21.7847; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; GODOWSKI PJ, 1986, P NATL ACAD SCI USA, V83, P256, DOI 10.1073/pnas.83.2.256; Hartzog GA, 2007, GENE DEV, V21, P3209, DOI 10.1101/gad.1628707; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Kalamvoki M, 2011, J VIROL, V85, P9472, DOI 10.1128/JVI.00876-11; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; Li WJ, 2009, POPUL SPACE PLACE, V15, P1, DOI 10.1002/psp.505; Lin Fu-sen, 2010, Virologica Sinica, V25, P1, DOI 10.1007/s12250-010-3080-x; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Markovitz NS, 2000, J VIROL, V74, P523, DOI 10.1128/JVI.74.1.523-528.2000; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Napolitano G, 2002, INT J ONCOL, V21, P171, DOI 10.3892/ijo.21.1.171; Ogle WO, 1999, J VIROL, V73, P4305, DOI 10.1128/JVI.73.5.4305-4315.1999; OHARE P, 1993, SEMIN VIROL, V4, P145, DOI 10.1006/smvy.1993.1010; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; ProdHon C, 1996, VIROLOGY, V226, P393, DOI 10.1006/viro.1996.0667; PURVES FC, 1993, P NATL ACAD SCI USA, V90, P6701, DOI 10.1073/pnas.90.14.6701; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rajcani J, 2000, FOLIA MICROBIOL, V45, P7, DOI 10.1007/BF02817445; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Roizman B, 2007, FIELDS VIROLOGY, P3238; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Spencer CA, 1997, J VIROL, V71, P2031, DOI 10.1128/JVI.71.3.2031-2040.1997; Weir JP, 2001, GENE, V271, P117, DOI 10.1016/S0378-1119(01)00512-1; Whitley Richard J, 2002, Semin Pediatr Infect Dis, V13, P6, DOI 10.1053/spid.2002.29752; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	58	30	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45749	10.1371/journal.pone.0045749	http://dx.doi.org/10.1371/journal.pone.0045749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029222	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700065
J	Kumar, A; Kantele, A; Jarvinen, T; Chen, TT; Kavola, H; Sadeghi, M; Hedman, K; Franssila, R				Kumar, Arun; Kantele, Anu; Jarvinen, Tommi; Chen, Tingting; Kavola, Heli; Sadeghi, Mohammadreza; Hedman, Klaus; Franssila, Rauli			Trichodysplasia spinulosa-Associated Polyomavirus (TSV) and Merkel Cell Polyomavirus: Correlation between Humoral and Cellular Immunity Stronger with TSV	PLOS ONE			English	Article							CD4(+) T-CELLS; IFN-GAMMA; RESPONSES; CARCINOMA; INTERLEUKIN-13; INFECTION; CYTOKINE; CD8(+); GROWTH; IL-13	Merkel Cell Polyomavirus (MCV) is a common infectious agent likely to be involved in the pathogenesis of most Merkel cell carcinomas (MCC). Trichodysplasia spinulosa-associated polyomavirus (TSV), which exhibit high seroprevalence in general population, has been detected in trichodysplasia spinulosa (TS) skin lesions suggesting an etiological role for this disease. Previous studies have shown strong MCV-specific T-cell responses, while no data exist on T-cell immunity against TSV. In order to characterize Th-cell immunity against TSV, and to allow comparisons with the MCV-specific Th-cell immunity, we studied TSV-specific proliferation, IFN-gamma, IL-10 and IL-13, and MCV-specific IFN-gamma and IL-10 responses in 51 healthy volunteers, and in one MCC patient. Recombinant TSV and MCV VP1 virus-like particles (VLPs) were used as antigens. A significant correlation was found between virus-specific Th-cell and antibody responses with TSV; with MCV it proved weaker. Despite significant homology in amino acid sequences, Th-cell crossreactivity was not evident between these viruses. Some subjects seronegative to both TSV and MCV exhibited Th-cell responses to both viruses. The agent initially priming these Th-cells remains an enigma. As CD8(+) cells specific to MCV T-Ag oncoprotein clearly provide an important defense against established MCC, the MCV VP1-specific Th-cells may, by suppressing MCV replication with antiviral cytokines such as IFN-gamma, significantly contribute to preventing the full process of oncogenesis.	[Kumar, Arun; Jarvinen, Tommi; Chen, Tingting; Sadeghi, Mohammadreza; Hedman, Klaus; Franssila, Rauli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Dept Med, Inst Clin Med, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Div Infect Dis, Cent Hosp, Helsinki, Finland; [Kavola, Heli] Helsinki Univ Hosp, Dept Plast Surg, Helsinki, Finland; [Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Kumar, A (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	arun.kumar@helsinki.fi	Chen, Tingting/I-8274-2019; Kantele, Anu/AAS-4131-2021; Hedman, Klaus/D-5379-2009; Kumar, Arun/C-9466-2013	Chen, Tingting/0000-0002-2227-3208; Kantele, Anu/0000-0002-0004-1000; Kumar, Arun/0000-0003-4483-7585; Hedman, Klaus/0000-0003-1779-7960; sadeghi, mohammad reza/0000-0002-2725-6407	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation; Medical Society of Finland; Academy of Finland [1122539]; Clinical Chemistry Research Foundation Grant; Orion-Farmos Research Foundation Grant; University of Helsinki Funds Grant	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Academy of Finland(Academy of Finland); Clinical Chemistry Research Foundation Grant; Orion-Farmos Research Foundation Grant; University of Helsinki Funds Grant	This study was supported by the Helsinki University Central Hospital Research and Education Fund, the Sigrid Juselius Foundation, the Medical Society of Finland, the Academy of Finland (project 1122539), the Clinical Chemistry Research Foundation Grant (A. Kumar), the Orion-Farmos Research Foundation Grant (A. Kumar), and the University of Helsinki Funds Grant (A. Kumar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty GL, 2001, IMMUNOL RES, V24, P201, DOI 10.1385/IR:24:2:201; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2008, EMERG INFECT DIS, V14, P1491, DOI 10.3201/eid1409.080651; Franssila R, 2001, J INFECT DIS, V183, P805, DOI 10.1086/318819; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Haycox CL, 1999, J INVEST DERM SYMP P, V4, P268, DOI 10.1038/sj.jidsp.5640227; Hemmer B, 1998, J IMMUNOL, V160, P3631; Iyer JG, 2011, CLIN CANCER RES, V17, P6671, DOI 10.1158/1078-0432.CCR-11-1513; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jung HS, 2011, HISTOL HISTOPATHOL, V26, P1231, DOI 10.14670/HH-26.1231; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kornacker M, 2006, INT J CANCER, V119, P1377, DOI 10.1002/ijc.21994; Kumar A, 2011, SCAND J IMMUNOL, V73, P135, DOI 10.1111/j.1365-3083.2010.02483.x; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Ma HL, 2004, INT IMMUNOL, V16, P1009, DOI 10.1093/intimm/dxh105; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Matthews MR, 2011, J CUTAN PATHOL, V38, P420, DOI 10.1111/j.1600-0560.2010.01664.x; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Moens Ugo, 2011, Patholog Res Int, V2011, P123491, DOI 10.4061/2011/123491; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; Nikiforow S, 2001, J VIROL, V75, P3740, DOI 10.1128/JVI.75.8.3740-3752.2001; Paolini F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-103; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Sadeghi M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-251; Salkowitz JR, 2004, J INFECT DIS, V189, P971, DOI 10.1086/382032; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sester M, 2002, J INFECT DIS, V185, P1379, DOI 10.1086/340502; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Sihto H, 2009, JNCI-J NATL CANCER I, V101, P938, DOI 10.1093/jnci/djp139; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tan BH, 2011, ADV ANAT PATHOL, V18, P450, DOI 10.1097/PAP.0b013e318234aad2; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; van der Meijden E, 2011, EMERG INFECT DIS, V17, P1355, DOI 10.3201/eid1708.110114; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Willmes C, 2012, CANCER RES, V72, P2120, DOI 10.1158/0008-5472.CAN-11-2651; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wyatt AJ, 2005, AM J SURG PATHOL, V29, P241, DOI 10.1097/01.pas.0000149691.83086.dc; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45773	10.1371/journal.pone.0045773	http://dx.doi.org/10.1371/journal.pone.0045773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029236	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700071
J	Wijayalath, W; Cheesman, S; Tanabe, K; Handunnetti, S; Carter, R; Pathirana, S				Wijayalath, Wathsala; Cheesman, Sandra; Tanabe, Kazuyuki; Handunnetti, Shiroma; Carter, Richard; Pathirana, Sisira			Strain-Specific Protective Effect of the Immunity Induced by Live Malarial Sporozoites under Chloroquine Cover	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GENETIC DIVERSITY; VIVAX MALARIA; PARASITES; VACCINE; STAGE; IMMUNIZATION; POLYMORPHISM; CYNOMOLGI; INVITRO	The efficacy of a whole-sporozoite malaria vaccine would partly be determined by the strain-specificity of the protective responses against malarial sporozoites and liver-stage parasites. Evidence from previous reports were inconsistent, where some studies have shown that the protective immunity induced by irradiated or live sporozoites in rodents or humans were cross-protective and in others strain-specific. In the present work, we have studied the strain-specificity of live sporozoite-induced immunity using two genetically and immunologically different strains of Plasmodium cynomolgi, Pc746 and PcCeylon, in toque monkeys. Two groups of monkeys were immunized against live sporozoites of either the Pc746 (n = 5), or the PcCeylon (n = 4) strain, by the bites of 2-4 sporozoite-infected Anopheles tessellates mosquitoes per monkey under concurrent treatments with chloroquine and primaquine to abrogate detectable blood infections. Subsequently, a group of non-immunized monkeys (n = 4), and the two groups of immunized monkeys were challenged with a mixture of sporozoites of the two strains by the bites of 2-5 infective mosquitoes from each strain per monkey. In order to determine the strain-specificity of the protective immunity, the proportions of parasites of the two strains in the challenge infections were quantified using an allele quantification assay, Pyrosequencing (TM), based on a single nucleotide polymorphism (SNP) in the parasites' circumsporozoite protein gene. The Pyrosequencing (TM) data showed that a significant reduction of parasites of the immunizing strain in each group of strain-specifically immunized monkeys had occurred, indicating a stronger killing effect on parasites of the immunizing strain. Thus, the protective immunity developed following a single, live sporozoite/chloroquine immunization, acted specifically against the immunizing strain and was, therefore, strain-specific. As our experiment does not allow us to determine the parasite stage at which the strain-specific protective immunity is directed, it is possible that the target of this immunity could be either the pre-erythrocytic stage, or the blood-stage, or both.	[Wijayalath, Wathsala; Pathirana, Sisira] Univ Colombo, Malaria Res Unit, Dept Parasitol, Fac Med, Colombo, Sri Lanka; [Cheesman, Sandra; Carter, Richard] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Handunnetti, Shiroma] Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo, Sri Lanka	University of Colombo; University of Edinburgh; Osaka University; University of Colombo	Pathirana, S (corresponding author), Univ Colombo, Malaria Res Unit, Dept Parasitol, Fac Med, Colombo, Sri Lanka.	sisira@med.cmb.ac.lk			National Science Foundation, Sri Lanka [RG/2005/HS/14/, NSF/Sch/2004/08]; National Research Council, Sri Lanka [05-66]; Wellcome Trust Programme [544RCX R37984]	National Science Foundation, Sri Lanka(National Science Foundation (NSF)); National Research Council, Sri Lanka; Wellcome Trust Programme(Wellcome Trust)	This investigation received financial support from the National Science Foundation, Sri Lanka (RG/2005/HS/14/) and the National Research Council, Sri Lanka (Research grant-05-66) granted to SP. WW was supported by a post-graduate research scholarship (NSF/Sch/2004/08) granted by the National Science Foundation of Sri Lanka. SC was supported under the Wellcome Trust Programme Grant No. 544RCX R37984, to RC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywickreme W, 1995, THESIS LIVERPOOL SCH; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Cheesman S, 2007, MOL BIOCHEM PARASIT, V152, P213, DOI 10.1016/j.molbiopara.2006.12.008; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; Culleton RL, 2011, PARASITE IMMUNOL, V33, P73, DOI 10.1111/j.1365-3024.2010.01251.x; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Farooq U, 2009, J VECTOR DIS, V46, P109; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Leclerc MC, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-40; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; MILLET P, 1989, PARASITE IMMUNOL, V11, P223, DOI 10.1111/j.1365-3024.1989.tb00661.x; Peters W., 1974, Advances Parasit, V12, P69, DOI 10.1016/S0065-308X(08)60387-5; Renia L, 2008, PARASITE, V15, P379, DOI 10.1051/parasite/2008153379; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wijayalath WAWK, 2008, PARASITE IMMUNOL, V30, P630, DOI 10.1111/j.1365-3024.2008.01065.x; Wijayalath WAWK, 2010, THESIS U COLOMBO; YAYON A, 1983, J PROTOZOOL, V30, P642, DOI 10.1111/j.1550-7408.1983.tb05336.x	25	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45861	10.1371/journal.pone.0045861	http://dx.doi.org/10.1371/journal.pone.0045861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029282	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700079
J	Calvet, X; Ruiz, MA; Dosal, A; Moreno, L; Lopez, M; Figuerola, A; Suarez, D; Miquel, M; Villoria, A; Gene, E				Calvet, Xavier; Angel Ruiz, Miquel; Dosal, Angelina; Moreno, Laura; Lopez, Maria; Figuerola, Ariadna; Suarez, David; Miquel, Mireia; Villoria, Albert; Gene, Emili			Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; OPEN-LABEL; IBD PATIENTS; ANEMIA; SAFETY; MANAGEMENT; EFFICACY; TOLERABILITY; TRIAL	Objective: Intravenous iron is widely used to treat iron deficiency in day-care units. Ferric carboxymaltose (FCM) allows administration of larger iron doses than iron sucrose (IS) in each infusion (1000 mg vs. 200 mg). As FCM reduces the number of infusions required but is more expensive, we performed a cost-minimization analysis to compare the cost impact of the two drugs. Materials and Methods: The number of infusions and the iron dose of 111 consecutive patients who received intravenous iron at a gastrointestinal diseases day-care unit from 8/2007 to 7/2008 were retrospectively obtained. Costs of intravenous iron drugs were obtained from the Spanish regulatory agencies. The accounting department of the Hospital determined hospital direct and indirect costs for outpatient iron infusion. Non-hospital direct costs were calculated on the basis of patient interviews. In the pharmacoeconomic model, base case mean costs per patient were calculated for administering 1000 mg of iron per infusion using FCM or 200 mg using IS. Sensitivity analysis and Monte Carlo simulation were performed. Results: Under baseline assumptions, the estimated cost of iron infusion per patient and year was (SIC)304 for IS and (SIC)274 for FCM, a difference of (SIC)30 in favour of FCM. Adding non-hospital direct costs to the model increased the difference to (SIC)67 ((SIC)354 for IS vs. (SIC)287 for FCM). A Monte Carlo simulation taking into account non-hospital direct costs favoured the use of FCM in 97% of simulations. Conclusion: In this pharmacoeconomic analysis, FCM infusion reduced the costs of iron infusion at a gastrointestinal day-care unit.	[Calvet, Xavier; Dosal, Angelina; Moreno, Laura; Lopez, Maria; Figuerola, Ariadna; Miquel, Mireia; Villoria, Albert] Univ Autonoma Barcelona, Inst Univ Parc Tauli, Hosp Sabadell, Serv Aparell Digestiu, Sabadell, Spain; [Calvet, Xavier; Figuerola, Ariadna; Miquel, Mireia; Villoria, Albert; Gene, Emili] Inst Salud Carlos III, CIBERehd, Barcelona, Spain; [Angel Ruiz, Miquel] Hosp Sabadell, Dept Comptabilitat Analit, Sabadell, Spain; [Suarez, David] Fundacio Parc Tauli, Unitat Epidemiol & Avaluacio, Sabadell, Spain; [Gene, Emili] Univ Autonoma Barcelona, Inst Univ Parc Tauli, Hosp Sabadell, Serv Urgencies, Sabadell, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Calvet, X (corresponding author), Univ Autonoma Barcelona, Inst Univ Parc Tauli, Hosp Sabadell, Serv Aparell Digestiu, Sabadell, Spain.	xcalvet@tauli.cat	Lopez-Arellano, Ma Eugenia/GWV-5056-2022; Calvet, Xavier/H-3288-2019	Calvet, Xavier/0000-0002-6278-9663; Calvet, Xavier/0000-0002-4413-4209; Gene Tous, Emili/0000-0001-8916-2919	Vifor Uriach Pharma S. L.	Vifor Uriach Pharma S. L.	This study was supported in part by a research agreement with Vifor Uriach Pharma S. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; [Anonymous], LIST COUNTRIES EUROP; Bager P, 2010, J CROHNS COLITIS, V4, P427, DOI 10.1016/j.crohns.2010.01.007; Bailie GR, 2010, ARZNEIMITTELFORSCH, V60, P386, DOI 10.1055/s-0031-1296303; Bailie GR, 2010, HEMODIAL INT, V14, P47, DOI 10.1111/j.1542-4758.2009.00409.x; Covic A, 2010, NEPHROL DIAL TRANSPL, V25, P2722, DOI 10.1093/ndt/gfq069; Dosal A, 2010, GASTROENT HEPAT-BARC, V33, P479, DOI 10.1016/j.gastrohep.2010.02.011; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1299, DOI 10.1111/j.1572-0241.2008.01846.x; Grimmelt AC, 2009, CLIN NEPHROL, V71, P125; Hayat A, 2008, CLIN MED RES, V6, P93, DOI 10.3121/cmr.2008.811; Johnson DW, 2001, NEPHROL DIAL TRANSPL, V16, P1879, DOI 10.1093/ndt/16.9.1879; Kim YH, 2009, ACTA HAEMATOL-BASEL, V121, P37, DOI 10.1159/000210062; Kociol Robb D, 2010, Ann Intern Med, V152, pJC4, DOI 10.7326/0003-4819-152-8-201004200-02005; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Lindgren S, 2009, SCAND J GASTROENTERO, V44, P838, DOI 10.1080/00365520902839667; Littlewood TJ, 2008, BRIT J HAEMATOL, V141, P751, DOI 10.1111/j.1365-2141.2008.07118.x; Lyseng-Williamson KA, 2009, DRUGS, V69, P739, DOI 10.2165/00003495-200969060-00007; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4666, DOI 10.3748/wjg.15.4666; Qunibi WY, 2010, ARZNEIMITTELFORSCH, V60, P399, DOI 10.1055/s-0031-1296304; Rubio C, 2010, PHARMACOECONOMICS SP, P109; Schroder O, 2005, AM J GASTROENTEROL, V100, P2503, DOI 10.1111/j.1572-0241.2005.00250.x; Seid MH, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.046; Seril DN, 2006, J CLIN GASTROENTEROL, V40, P391, DOI 10.1097/00004836-200605000-00006	24	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45604	10.1371/journal.pone.0045604	http://dx.doi.org/10.1371/journal.pone.0045604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029129	Green Published, gold			2022-12-27	WOS:000309392800065
J	Ossa, G; Kramer-Schadt, S; Peel, AJ; Scharf, AK; Voigt, CC				Ossa, Gonzalo; Kramer-Schadt, Stephanie; Peel, Alison J.; Scharf, Anne K.; Voigt, Christian C.			The Movement Ecology of the Straw-Colored Fruit Bat, Eidolon helvum, in Sub-Saharan Africa Assessed by Stable Isotope Ratios	PLOS ONE			English	Article							NITROGEN-BALANCE; HYDROGEN; CHIROPTERA; DELTA-N-15; PTEROPODIDAE; YOURE; EAT	Flying foxes (Pteropodidae) are key seed dispersers on the African continent, yet their migratory behavior is largely unknown. Here, we studied the movement ecology of the straw-colored fruit bat, Eidolon helvum, and other fruit bats by analyzing stable isotope ratios in fur collected from museum specimens. In a triple-isotope approach based on samples of two ecologically similar non-migratory pteropodids, we first confirmed that a stable isotope approach is capable of delineating between geographically distinct locations in Sub-Saharan Africa. A discriminant function analysis assigned 84% of individuals correctly to their capture site. Further, we assessed how well hydrogen stable isotope ratios (delta H-2) of fur keratin collected from non-migratory species (n = 191 individuals) records variation in delta H-2 of precipitation water in sub-Saharan Africa. Overall, we found positive, negative and no correlations within the six studied species. We then developed a reduced major axis regression equation based on individual data of non-migratory species to predict where potentially migratory E. helvum (n = 88) would come from based on their keratin delta H-2. Across non-migratory species, delta H-2 of keratin and local water correlated positively. Based on the isoscape origin model, 22% of E. helvum were migratory, i.e. individuals had migrated over at least 250 km prior to their capture. Migratory individuals came from locations at a median distance of about 860 km from the collection site, four even from distances of at least 2,000 km. Ground-truthing of our isoscape origin model based on keratin delta H-2 of extant E. helvum (n = 76) supported a high predictive power of assigning the provenance of African flying foxes. Our study highlights that stable isotope ratios can be used to explain the migratory behavior of flying foxes, even on the isotopically relatively homogenous African continent, and with material collected by museums many decades or more than a century ago.	[Ossa, Gonzalo; Kramer-Schadt, Stephanie; Scharf, Anne K.; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Peel, Alison J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Peel, Alison J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Voigt, Christian C.] Free Univ Berlin, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Cambridge; Zoological Society of London; Free University of Berlin	Voigt, CC (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	voigt@izw-berlin.de	Scharf, Anne K./P-6348-2019; Peel, Alison J/I-3202-2012; Kramer-Schadt, Stephanie/A-8778-2013	Scharf, Anne K./0000-0002-3357-8533; Peel, Alison J/0000-0003-3538-3550; Kramer-Schadt, Stephanie/0000-0002-9269-4446	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT); Region Ile de France; IZW	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Region Ile de France(Region Ile-de-France); IZW	Gonzalo Ossa was supported by a grant from the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), and by a grant from the Region Ile de France. Sample analysis was financed via institutional grants from the IZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1992, Mammalian Species, P1, DOI 10.2307/3504083; African Chiroptera Report, 2011, AFRICAN CHIROPTERA P; AYENSU ES, 1974, ANN MO BOT GARD, V61, P702, DOI 10.2307/2395025; Bairlein F, 2012, BIOL LETT, DOI [10.1098/ rsbl.2011.12231744-957X, DOI 10.1098/RSBL.2011.1223.1744-957X]; BAKER GH, 1963, SCIENCE, V139, P877, DOI 10.1126/science.139.3558.877; Bowen G.J., 2012, GRIDDED MAPS ISOTOPI; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Cosson Jean-Francois, 1996, Journal of African Zoology, V110, P369; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; DEFREES S L, 1988, Mammalian Species, P1, DOI 10.2307/3504095; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Erzberger A, 2011, ACTA CHIROPTEROL, V13, P431, DOI 10.3161/150811011X624910; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Ghanem SJ, 2012, ADV STUD BEHAV, V44, P279, DOI 10.1016/B978-0-12-394288-3.00007-1; Google Inc, 2012, GOOGL EARTH VERS 6 1; Harris B. J., 1959, Nigerian Field, V24, P151; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Henry M, 2004, J TROP ECOL, V20, P21, DOI 10.1017/S0266467404006145; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2009, ISOSCAPES UNDERSTAND, P299; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; JACOBSEN NHG, 1976, S AFR J SCI, V72, P270; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Kunz TH, 2011, ANN NEW YORK ACAD SC; Kwiecinski Gary G., 1999, Mammalian Species, V611, P1; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Legendre P., 2008, LMODEL2 MODEL 2 REGR; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Mickleburgh S, 2008, UICN 2011 UICN RED L; Mickleburgh S, 2008, IUCN 2011 IUCN RED L; Niamien CJM, 2010, SCI NATURE, V7, P21; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; R Development Core Team, 2012, R LANG ENV STAT COMP; Racey P., 2004, BATS, V22, P1; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; Smith CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014696; Taylor PJ, 2008, S AFR J WILDL RES, V38, P22, DOI 10.3957/0379-4369-38.1.22; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Voigt CC, 2012, BIOL CONSERV, V153, P80, DOI 10.1016/j.biocon.2012.04.027; Voigt CC, 2011, BIOTROPICA, V43, P108, DOI 10.1111/j.1744-7429.2010.00632.x; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; World Conservation Monitoring Centre, 1998, IUCN 2011 IUCN RED L	55	35	36	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45729	10.1371/journal.pone.0045729	http://dx.doi.org/10.1371/journal.pone.0045729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029206	Green Published, gold			2022-12-27	WOS:000309392800086
J	Amadi-Obi, A; Yu, CR; Dambuza, I; Kim, SH; Marrero, B; Egwuagu, CE				Amadi-Obi, Ahjoku; Yu, Cheng-Rong; Dambuza, Ivy; Kim, Sung-Hye; Marrero, Bernadette; Egwuagu, Charles E.			Interleukin 27 Induces the Expression of Complement Factor H (CFH) in the Retina	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MACULAR DEGENERATION; EPITHELIAL-CELLS; B-CELL; INFLAMMATION; UVEITIS; CYTOKINE; REGION; IRF8; PATHOGENESIS	Complement factor H (CFH) is a central regulator of the complement system and has been implicated in the etiology of age-related macular degeneration (AMD), a leading cause of blindness in the elderly. In view of previous studies showing that reduced expression of CFH in the retina is a risk factor for developing AMD, there is significant interest in understanding how CFH expression is regulated in the retina. In this study, we have shown that the anti-inflammatory cytokine, IL-27, induced CFH expression in mouse retinal cells and human retinal pigmented epithelial cells (RPE) through STAT1-mediated up-regulation of Interferon Regulatory Factor-1 (IRF-1) and IRF-8. We further show that cells in the ganglion and inner-nuclear layers of the retina constitutively express IRF-1 and IRF-8 and enhanced CFH expression in the retina during ocular inflammation correlated with significant increase in the expression of IRF-1, IRF-8 and IL-27 (IL-27p28 and Ebi3). Our data thus reveal a novel role of IL-27 in regulating complement activation through up-regulation of CFH and suggest that defects in IL-27 signaling or expression may contribute to the reduction of CFH expression in the retina of patients with AMD.	[Amadi-Obi, Ahjoku; Yu, Cheng-Rong; Dambuza, Ivy; Kim, Sung-Hye; Marrero, Bernadette; Egwuagu, Charles E.] NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Dambuza, Ivy/M-2484-2019	Yu, Cheng-Rong/0000-0001-7246-0362	National Eye Institute; National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000372, ZIAEY000262] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Intramural Research Programs of the National Eye Institute and National Institutes of Health provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Dick AD, 2003, J LEUKOCYTE BIOL, V74, P161, DOI 10.1189/jlb.1102535; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Fraczek LA, 2011, MOL IMMUNOL, V49, P201, DOI 10.1016/j.molimm.2011.08.013; Fraczek LA, 2010, MOL IMMUNOL, V48, P9, DOI 10.1016/j.molimm.2010.08.016; GASQUE P, 1992, J IMMUNOL, V149, P1381; Gery Igal, 2002, Int Rev Immunol, V21, P89, DOI 10.1080/08830180212061; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Li WM, 1999, INVEST OPHTH VIS SCI, V40, P976; Li WM, 1999, J BIOL CHEM, V274, P9686, DOI 10.1074/jbc.274.14.9686; Li WM, 1999, DEV BIOL, V210, P44, DOI 10.1006/dbio.1999.9267; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MUNOZCANOVES P, 1990, J BIOL CHEM, V265, P20065; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Taniguchi T, 1997, J CELL PHYSIOL, V173, P128, DOI 10.1002/(SICI)1097-4652(199711)173:2<128::AID-JCP8>3.0.CO;2-P; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Williams SA, 1997, SCAND J IMMUNOL, V45, P7, DOI 10.1046/j.1365-3083.1997.d01-364.x; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yu CR, 2011, INVEST OPHTH VIS SCI, V52, P6978, DOI 10.1167/iovs.11-7688; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	43	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45801	10.1371/journal.pone.0045801	http://dx.doi.org/10.1371/journal.pone.0045801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029250	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900101
J	D'Andrea, S; Berton, S; Segatto, I; Fabris, L; Canzonieri, V; Colombatti, A; Vecchione, A; Belletti, B; Baldassarre, G				D'Andrea, Sara; Berton, Stefania; Segatto, Ilenia; Fabris, Linda; Canzonieri, Vincenzo; Colombatti, Alfonso; Vecchione, Andrea; Belletti, Barbara; Baldassarre, Gustavo			Stathmin Is Dispensable for Tumor Onset in Mice	PLOS ONE			English	Article							MAJOR CYTOSOLIC TARGET; CELL-CYCLE; GENE-EXPRESSION; MICROTUBULE DYNAMICS; PROTEOMIC ANALYSIS; PROSTATE-CANCER; POOR-PROGNOSIS; PROTEIN-KINASE; MAMMARY-GLAND; P53	The microtubule-destabilizing protein stathmin is highly expressed in several types of tumor, thus deserving the name of oncoprotein 18. High levels of stathmin expression and/or activity favor the metastatic spreading and mark the most aggressive tumors, thus representing a realistic marker of poor prognosis. Stathmin is a downstream target of many signaling pathways, including Ras-MAPK, PI3K and p53, involved in both tumor onset and progression. We thus hypothesized that stathmin could also play a role during the early stages of tumorigenesis, an issue completely unexplored. In order to establish whether stathmin expression is necessary for tumor initiation, we challenged wild type (WT), stathmin heterozygous and stathmin knock-out (KO) mice with different carcinogens. Using well-defined mouse models of carcinogenesis of skin, bladder and muscle by the means of 7,12-dimethylbenz[alpha]antracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA), N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and 3-methylcholanthrylene (3MC) treatments, respectively, we demonstrated that knock-out of stathmin has no impact on the onset of cancer in mice. No significant difference was noticed either when the Ras oncogene was mutated (skin carcinogenesis model) or when the p53 pathway was inactivated (bladder carcinomas and fibrosarcomas). Finally, we concomitantly impinged on p53 and Ras pathways, by generating WT and stathmin KO mouse embryo fibroblasts transformed with papilloma virus large T antigen (LgTAg) plus the K-Ras(G12V) oncogene. In vivo growth of xenografts from these transformed fibroblasts did not highlight any significant difference depending on the presence or absence of stathmin. Overall, our work demonstrates that stathmin expression is dispensable for tumor onset, at least in mice, thus making stathmin a virtually exclusive marker of aggressive disease and a promising therapeutic target for advanced cancers.	[D'Andrea, Sara; Berton, Stefania; Segatto, Ilenia; Fabris, Linda; Colombatti, Alfonso; Belletti, Barbara; Baldassarre, Gustavo] Natl Canc Inst, CRO, Div Expt Oncol 2, Aviano, Italy; [Canzonieri, Vincenzo] Natl Canc Inst, CRO, Pathol Unit, Aviano, Italy; [Colombatti, Alfonso] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; [Colombatti, Alfonso] Univ Udine, MATI Ctr Excellence, I-33100 Udine, Italy; [Vecchione, Andrea] Univ Roma La Sapienza, Osped Santo Andrea, Div Pathol 2, Rome, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; University of Udine; Sapienza University Rome	Belletti, B (corresponding author), Natl Canc Inst, CRO, Div Expt Oncol 2, Aviano, Italy.	bbelletti@cro.it; gbaldassarre@cro.it	Belletti, Barbara/J-2028-2018; Baldassarre, Gustavo/K-1350-2016; Canzonieri, Vincenzo/Z-5933-2019; Segatto, Ilenia/AAX-5513-2020; D'Andrea, Sara/AAC-2148-2020; Canzonieri, Vincenzo/AAA-7951-2019	Belletti, Barbara/0000-0003-2249-0285; Baldassarre, Gustavo/0000-0002-9750-8825; Segatto, Ilenia/0000-0001-5282-1028; D'Andrea, Sara/0000-0001-5736-6431; Canzonieri, Vincenzo/0000-0001-6010-0976; colombatti, alfonso/0000-0002-3676-2379; Vecchione, Andrea/0000-0002-5497-6856	AIRC (Associazione Italiana Ricerca sul Cancro) [IG 8551, IG 10459]; "Friuli Exchange Program"; Outgoing AIRC/Marie Curie International Fellowship in Cancer Research	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); "Friuli Exchange Program"; Outgoing AIRC/Marie Curie International Fellowship in Cancer Research	This work is supported by grants from AIRC (Associazione Italiana Ricerca sul Cancro) to GB (IG 8551) and to BB (IG 10459) and from the "Friuli Exchange Program". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SB is the recipient of an Outgoing AIRC/Marie Curie International Fellowship in Cancer Research.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Ahn J, 1999, ONCOGENE, V18, P5954, DOI 10.1038/sj.onc.1202986; Alli E, 2007, ONCOGENE, V26, P1003, DOI 10.1038/sj.onc.1209864; Andersen J, 2010, DANCING TIMES, V100, P55; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Carney BK, 2010, CANCER BIOL THER, V9, P699, DOI 10.4161/cbt.9.9.11430; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Hasegawa A, 2007, EXP EYE RES, V85, P518, DOI 10.1016/j.exer.2007.07.003; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Karst AM, 2011, GYNECOL ONCOL, V123, P5, DOI 10.1016/j.ygyno.2011.05.021; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Lovric J, 1998, J BIOL CHEM, V273, P22848; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; MELHEM RF, 1991, J BIOL CHEM, V266, P17747; Misek DE, 2002, CANCER CELL, V2, P217, DOI 10.1016/S1535-6108(02)00124-1; Mistry SJ, 2005, MOL CANCER THER, V4, P1821, DOI 10.1158/1535-7163.MCT-05-0215; Mistry SJ, 2007, MOL CANCER RES, V5, P773, DOI 10.1158/1541-7786.MCR-06-0290; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Ng DCH, 2010, J BIOL CHEM, V285, P29001, DOI 10.1074/jbc.M110.128454; OKAZAKI T, 1993, FEBS LETT, V336, P8, DOI 10.1016/0014-5793(93)81598-T; Ozaki K, 1998, CANCER RES, V58, P3806; Papaconstantinou AD, 2006, INT J CANCER, V118, P17, DOI 10.1002/ijc.21247; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Puissant C, 1995, BIOL CELL, V85, P109, DOI 10.1016/0248-4900(96)85271-3; Rao DD, 2010, CANCER GENE THER, V17, P780, DOI 10.1038/cgt.2010.35; Rounbehler RJ, 2001, ONCOGENE, V20, P5341, DOI 10.1038/sj.onc.1204691; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; Shi XP, 2010, CANCER BIOL THER, V9, P640, DOI 10.4161/cbt.9.8.11269; Singer S, 2007, HEPATOLOGY, V46, P759, DOI 10.1002/hep.21736; SOBEL A, 1983, J BIOL CHEM, V258, P312; Tan HT, 2012, J PROTEOME RES, V11, P1433, DOI 10.1021/pr2010956; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; WEXLER H, 1979, J NATL CANCER I, V63, P1393; Xi W, 2009, J CANCER RES CLIN, V135, P837, DOI 10.1007/s00432-008-0520-1; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zhang Y, 2008, BMB REP, V41, P765, DOI 10.5483/BMBRep.2008.41.11.765	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45561	10.1371/journal.pone.0045561	http://dx.doi.org/10.1371/journal.pone.0045561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029098	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900072
J	Jurgens, CWD; Bell, KA; McQuiston, AR; Guido, W				Jurgens, Chris W. D.; Bell, Karen A.; McQuiston, A. Rory; Guido, William			Optogenetic Stimulation of the Corticothalamic Pathway Affects Relay Cells and GABAergic Neurons Differently in the Mouse Visual Thalamus	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; IN-VITRO; RETICULAR NUCLEUS; DYNAMIC PROPERTIES; FUNCTIONAL-ORGANIZATION; THALAMOCORTICAL NEURONS; POSTSYNAPTIC POTENTIALS; CORTICOFUGAL FEEDBACK; CORTICAL INTERNEURONS	The dorsal lateral geniculate nucleus (dLGN) serves as the primary conduit of retinal information to visual cortex. In addition to retinal input, dLGN receives a large feedback projection from layer VI of visual cortex. Such input modulates thalamic signal transmission in different ways that range from gain control to synchronizing network activity in a stimulus-specific manner. However, the mechanisms underlying such modulation have been difficult to study, in part because of the complex circuitry and diverse cell types this pathway innervates. To address this and overcome some of the technical limitations inherent in studying the corticothalamic (CT) pathway, we adopted a slice preparation in which we were able to stimulate CT terminal arbors in the visual thalamus of the mouse with blue light by using an adeno-associated virus to express the light-gated ion channel, ChIEF, in layer VI neurons. To examine the postsynaptic responses evoked by repetitive CT stimulation, we recorded from identified relay cells in dLGN, as well as GFP expressing GABAergic neurons in the thalamic reticular nucleus (TRN) and intrinsic interneurons of dLGN. Relay neurons exhibited large glutamatergic responses that continued to increase in amplitude with each successive stimulus pulse. While excitatory responses were apparent at postnatal day 10, the strong facilitation noted in adult was not observed until postnatal day 21. GABAergic neurons in TRN exhibited large initial excitatory responses that quickly plateaued during repetitive stimulation, indicating that the degree of facilitation was much larger for relay cells than for TRN neurons. The responses of intrinsic interneurons were smaller and took the form of a slow depolarization. These differences in the pattern of excitation for different thalamic cell types should help provide a framework for understanding how CT feedback alters the activity of visual thalamic circuitry during sensory processing as well as different behavioral or pathophysiological states.	[Jurgens, Chris W. D.; Bell, Karen A.; McQuiston, A. Rory; Guido, William] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Virginia Commonwealth University	Guido, W (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	william.guido@louisville.edu	McQuiston, Adam Rory/A-3072-2008		National Institutes of Health (NIH) [EY012716, MH094626, NS063059]; NIH-NINDS training grant [5T32NS07288-23]; NIH-NINDS Center Core grant [5P30NS047463]; NATIONAL EYE INSTITUTE [R01EY012716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463, T32NS007288, R21NS063059] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINDS training grant; NIH-NINDS Center Core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH), grant numbers EY012716 (W.G.), MH094626 (A.R.M.) and NS063059 (A.R.M.). C.W.J. was supported in part by NIH-NINDS training grant 5T32NS07288-23. Confocal reconstructions were performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility supported in part from NIH-NINDS Center Core grant (5P30NS047463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Alexander GM, 2006, NEUROSCIENCE, V141, P501, DOI 10.1016/j.neuroscience.2006.03.060; Alexander GM, 2006, NEUROSCIENCE, V137, P367, DOI 10.1016/j.neuroscience.2005.11.012; Alexander GM, 2005, J NEUROPHYSIOL, V94, P163, DOI 10.1152/jn.01198.2004; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Augustinaite S, 2011, J PHYSIOL-LONDON, V589, P2963, DOI 10.1113/jphysiol.2011.205542; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Bickford ME, 2010, J COMP NEUROL, V518, P622, DOI 10.1002/cne.22223; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Casale AE, 2011, J NEUROSCI, V31, P18289, DOI 10.1523/JNEUROSCI.4417-11.2011; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cox CL, 2003, J NEUROSCI, V23, P7642; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Crandall SR, 2012, J NEUROSCI, V32, P2513, DOI 10.1523/JNEUROSCI.4402-11.2012; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cudeiro J, 1996, J PHYSIOL-LONDON, V490, P481, DOI 10.1113/jphysiol.1996.sp021159; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erisir A, 1997, J COMP NEUROL, V377, P535; Errington AC, 2011, J NEUROSCI, V31, P8669, DOI 10.1523/JNEUROSCI.0317-11.2011; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Granseth B, 2004, J PHYSIOL-LONDON, V556, P135, DOI 10.1113/jphysiol.2003.052720; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; Granseth B, 2002, J PHYSIOL-LONDON, V544, P477, DOI 10.1113/jphysiol.2002.024703; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kielland A, 2006, J NEUROSCI, V26, P5786, DOI 10.1523/JNEUROSCI.4631-05.2006; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mohrmann R, 2003, NEUROSCIENCE, V117, P7, DOI 10.1016/S0306-4522(02)00835-7; MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; MONTERO VM, 1985, EXP BRAIN RES, V59, P151; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NORTON TT, 1992, PROG BRAIN RES, V90, P193; Parent M, 2008, J COMP NEUROL, V511, P678, DOI 10.1002/cne.21868; PARNAVELAS JG, 1977, J COMP NEUROL, V171, P481, DOI 10.1002/cne.901710405; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Schlesinger F, 2005, SYNAPSE, V55, P176, DOI 10.1002/syn.20110; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TSUMOTO T, 1978, EXP BRAIN RES, V32, P345; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; UHLRICH DJ, 1988, J NEUROSCI, V8, P4565; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; Wang ST, 2001, J COMP NEUROL, V440, P321, DOI 10.1002/cne.1389; WEBER AJ, 1989, J COMP NEUROL, V289, P156, DOI 10.1002/cne.902890113; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Yang YM, 2011, J PHYSIOL-LONDON, V589, P4209, DOI 10.1113/jphysiol.2011.208066; Zhu JJ, 1999, J NEUROSCI, V19, P5721, DOI 10.1523/JNEUROSCI.19-14-05721.1999	77	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45717	10.1371/journal.pone.0045717	http://dx.doi.org/10.1371/journal.pone.0045717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029198	gold, Green Published			2022-12-27	WOS:000309388900093
J	Matsueda, S; Wang, MJ; Weng, JS; Li, Y; Yin, BN; Zou, J; Li, QT; Zhao, W; Peng, WY; Legras, X; Loo, C; Wang, RF; Wang, HY				Matsueda, Satoko; Wang, Mingjun; Weng, Jinsheng; Li, Ying; Yin, Bingnan; Zou, Jia; Li, Qingtian; Zhao, Wei; Peng, Weiyi; Legras, Xavier; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.			Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8(+) T Cells for Cancer Immunotherapy	PLOS ONE			English	Article							MOLECULAR-CLONING; GENOME-WIDE; EXPRESSION; GENE; HOMOLOGY; PROSTEIN; EPITOPES; LINES; PSGR; RNA	Background: Prostate cancer is the most common cancer among elderly men in the US, and immunotherapy has been shown to be a promising strategy to treat patients with metastatic castration-resistant prostate cancer. Efforts to identify novel prostate specific tumor antigens will facilitate the development of effective cancer vaccines against prostate cancer. Prostate-specific G-protein coupled receptor (PSGR) is a novel antigen that has been shown to be specifically overexpressed in human prostate cancer tissues. In this study, we describe the identification of PSGR-derived peptide epitopes recognized by CD8(+) T cells in an HLA-A2 dependent manner. Methodology/Principal Findings: Twenty-one PSGR-derived peptides were predicted by an immuno-informatics approach based on the HLA-A2 binding motif. These peptides were examined for their ability to induce peptide-specific T cell responses in peripheral blood mononuclear cells (PBMCs) obtained from either HLA-A2(+) healthy donors or HLA-A2(+) prostate cancer patients. The recognition of HLA-A2 positive and PSGR expressing LNCaP cells was also tested. Among the 21 PSGR-derived peptides, three peptides, PSGR3, PSGR4 and PSGR14 frequently induced peptide-specific T cell responses in PBMCs from both healthy donors and prostate cancer patients. Importantly, these peptide-specific T cells recognized and killed LNCaP prostate cancer cells in an HLA class I-restricted manner. Conclusions/Significance: We have identified three novel HLA-A2-restricted PSGR-derived peptides recognized by CD8(+) T cells, which, in turn, recognize HLA-A2(+) and PSGR(+) tumor cells. The PSGR-derived peptides identified may be used as diagnostic markers as well as immune targets for development of anticancer vaccines.	[Matsueda, Satoko; Wang, Mingjun; Weng, Jinsheng; Li, Ying; Zou, Jia; Li, Qingtian; Zhao, Wei; Peng, Weiyi; Legras, Xavier; Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wang, Mingjun; Yin, Bingnan; Zou, Jia; Li, Qingtian; Zhao, Wei; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.] Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA; [Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Baylor College of Medicine	Wang, HY (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	ywang4@tmhs.org		WANG, MINGJUN/0000-0002-5848-0444	National Cancer Institute, National Institute of Health; Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA090327] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by grants from National Cancer Institute, National Institute of Health and Cancer Research Institute, and The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Carlsson B, 2007, PROSTATE, V67, P389, DOI 10.1002/pros.20498; Cormier JN, 1998, INT J CANCER, V75, P517, DOI 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.3.CO;2-M; Di Lorenzo G, 2011, NAT REV CLIN ONCOL, V8, P551, DOI 10.1038/nrclinonc.2011.72; Drake CG, 2012, CURRENT OPINION UROL; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Hammond AS, 2005, CLIN EXP IMMUNOL, V140, P109, DOI 10.1111/j.1365-2249.2005.02751.x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; ISRAELI RS, 1993, CANCER RES, V53, P227; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joniau S, 2012, EUR UROL, V61, P290, DOI 10.1016/j.eururo.2011.09.020; Kalos M, 2004, PROSTATE, V60, P246, DOI 10.1002/pros.20043; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawakami M, 1997, CANCER RES, V57, P2321; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; SOLIN T, 1990, BIOCHIM BIOPHYS ACTA, V1048, P72, DOI 10.1016/0167-4781(90)90024-V; SU SL, 1995, CANCER RES, V55, P1441; Tsavaler L, 2001, CANCER RES, V61, P3760; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Xu JC, 2001, CANCER RES, V61, P1563; Xu LL, 2000, CANCER RES, V60, P6568; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398	37	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45756	10.1371/journal.pone.0045756	http://dx.doi.org/10.1371/journal.pone.0045756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029225	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900097
J	Bravi, A; Green, G; Longtin, A; Seely, AJE				Bravi, Andrea; Green, Geoffrey; Longtin, Andre; Seely, Andrew J. E.			Monitoring and Identification of Sepsis Development through a Composite Measure of Heart Rate Variability	PLOS ONE			English	Article							SEPTIC SHOCK	Tracking the physiological conditions of a patient developing infection is of utmost importance to provide optimal care at an early stage. This work presents a procedure to integrate multiple measures of heart rate variability into a unique measure for the tracking of sepsis development. An early warning system is used to illustrate its potential clinical value. The study involved 17 adults (age median 51 (interquartile range 46-62)) who experienced a period of neutropenia following chemoradiotherapy and bone marrow transplant; 14 developed sepsis, and 3 did not. A comprehensive panel (N = 92) of variability measures was calculated for 5 min-windows throughout the period of monitoring (12 +/- 4 days). Variability measures underwent filtering and two steps of data reduction with the objective of enhancing the information related to the greatest degree of change. The proposed composite measure was capable of tracking the development of sepsis in 12 out of 14 patients. Simulating a real-time monitoring setting, the sum of the energy over the very low frequency range of the composite measure was used to classify the probability of developing sepsis. The composite revealed information about the onset of sepsis about 60 hours (median value) before of sepsis diagnosis. In a real monitoring setting this quicker detection time would be associated to increased efficacy in the treatment of sepsis, therefore highlighting the potential clinical utility of a composite measure of variability.	[Bravi, Andrea; Seely, Andrew J. E.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Green, Geoffrey; Seely, Andrew J. E.] Therapeut Monitoring Syst Inc, Ottawa, ON, Canada; [Longtin, Andre] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Dept Crit Care Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Bravi, A (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	a.bravi@uottawa.ca						Ahmad S, 2010, IEEE T INSTRUM MEAS, V59, P2575, DOI 10.1109/TIM.2010.2057571; Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; [Anonymous], CRIT CARE MED; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Brindley PG, 2006, CAN J ANAESTH, V53, P1157, DOI 10.1007/BF03022884; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Gunther A, ACTA NEUROLOGICA SCA; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Moorman JR, 2006, IEEE T BIO-MED ENG, V53, P126, DOI 10.1109/TBME.2005.859810; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1	14	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45666	10.1371/journal.pone.0045666	http://dx.doi.org/10.1371/journal.pone.0045666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029171	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400119
J	Head, JA; Kalveram, B; Ikegami, T				Head, Jennifer A.; Kalveram, Birte; Ikegami, Tetsuro			Functional Analysis of Rift Valley Fever Virus NSs Encoding a Partial Truncation	PLOS ONE			English	Article							RECENT COMMON ANCESTRY; IMMUNE-RESPONSES; INFECTED-CELLS; PROTECTS MICE; MOLECULAR EPIDEMIOLOGY; LETHAL INFECTION; GENETIC-EVIDENCE; RHESUS MACAQUES; DOWN-REGULATION; MESSENGER-RNA	Rift Valley fever virus (RVFV), belongs to genus Phlebovirus of the family Bunyaviridae, causes high rates of abortion and fetal malformation in infected ruminants as well as causing neurological disorders, blindness, or lethal hemorrhagic fever in humans. RVFV is classified as a category A priority pathogen and a select agent in the U. S., and currently there are no therapeutics available for RVF patients. NSs protein, a major virulence factor of RVFV, inhibits host transcription including interferon (IFN)-beta mRNA synthesis and promotes degradation of dsRNA-dependent protein kinase (PKR). NSs self-associates at the C-terminus 17 aa., while NSs at aa. 210-230 binds to Sin3A-associated protein (SAP30) to inhibit the activation of IFN-beta promoter. Thus, we hypothesize that NSs function(s) can be abolished by truncation of specific domains, and co-expression of nonfunctional NSs with intact NSs will result in the attenuation of NSs function by dominant-negative effect. Unexpectedly, we found that RVFV NSs truncated at aa. 6-30, 31-55, 56-80, 81-105, 106-130, 131-155, 156-180, 181-205, 206-230, 231-248 or 249-265 lack functions of IFN-b mRNA synthesis inhibition and degradation of PKR. Truncated NSs were less stable in infected cells, while nuclear localization was inhibited in NSs lacking either of aa. 81-105, 106-130, 131155, 156-180, 181-205, 206-230 or 231-248. Furthermore, none of truncated NSs had exhibited significant dominant-negative functions for NSs-mediated IFN-beta suppression or PKR degradation upon co-expression in cells infected with RVFV. We also found that any of truncated NSs except for intact NSs does not interact with RVFV NSs even in the presence of intact C-terminus self-association domain. Our results suggest that conformational integrity of NSs is important for the stability, cellular localization and biological functions of RVFV NSs, and the co-expression of truncated NSs does not exhibit dominant-negative phenotype.	[Kalveram, Birte; Ikegami, Tetsuro] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Head, Jennifer A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ikegami, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	teikegam@utmb.edu	Ikegami, Tetsuro/H-1329-2013	Ikegami, Tetsuro/0000-0001-8318-2783	Western Regional Center of Excellence [5 U54 AI057156]; National Institutes of Health [R01 AI08764301]; Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB); Institute for Human Infections and Immunity (IHII) at UTMB; James W. McLaughlin Fellowship Fund at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, R01AI087643] Funding Source: NIH RePORTER	Western Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB); Institute for Human Infections and Immunity (IHII) at UTMB; James W. McLaughlin Fellowship Fund at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by 5 U54 AI057156 through the Western Regional Center of Excellence, National Institutes of Health grant R01 AI08764301, and funding from Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB), and that from Institute for Human Infections and Immunity (IHII) at UTMB. BK was supported by the James W. McLaughlin Fellowship Fund at UTMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bird BH, 2011, J VIROL, V85, P12901, DOI 10.1128/JVI.06046-11; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Carroll SA, 2011, J VIROL, V85, P6162, DOI 10.1128/JVI.00335-11; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; de Boer SM, 2010, VACCINE, V28, P2330, DOI 10.1016/j.vaccine.2009.12.062; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Holman DH, 2009, CLIN VACCINE IMMUNOL, V16, P1624, DOI 10.1128/CVI.00182-09; HOUSE JA, 1992, ANN NY ACAD SCI, V653, P233, DOI 10.1111/j.1749-6632.1992.tb19652.x; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kawada S, 2008, J VIROL, V82, P4384, DOI 10.1128/JVI.01953-07; KENDE M, 1987, ANTIMICROB AGENTS CH, V31, P986, DOI 10.1128/AAC.31.7.986; KENDE M, 1985, ANTIMICROB AGENTS CH, V27, P903, DOI 10.1128/AAC.27.6.903; Kortekaas J, 2010, VACCINE, V28, P4394, DOI 10.1016/j.vaccine.2010.04.048; Kortekaas J, 2010, VACCINE, V28, P2271, DOI 10.1016/j.vaccine.2010.01.001; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lorenzo G, 2008, VACCINE, V26, P5255, DOI 10.1016/j.vaccine.2008.07.042; Mandell RB, 2010, HUM VACCIN, P6; Mandell RB, 2010, J VIROL METHODS, V169, P259, DOI 10.1016/j.jviromet.2010.07.015; Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Miller BR, 2002, EMERG INFECT DIS, V8, P1492, DOI 10.3201/eid0812.020194; MORRILL JC, 1989, RES VIROLOGY, V140, P139, DOI 10.1016/S0923-2516(89)80091-3; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; MORRILL JC, 1989, REV INFECT DIS, V11, pS815; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; Morrill JC, 2011, J INFECT DIS, V204, P229, DOI 10.1093/infdis/jir249; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Muller R, 1994, J GEN VIROL; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Naslund J, 2009, VIROLOGY, V385, P409, DOI 10.1016/j.virol.2008.12.012; Papin JF, 2011, P NATL ACAD SCI USA, V108, P14926, DOI 10.1073/pnas.1112149108; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters CJ, 1981, HDB SERIES ZOONOSE B, V1403-420; Pichlmair A, 2010, VECTOR-BORNE ZOONOT, V10, P701, DOI 10.1089/vbz.2009.0248; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Rusnak JM, 2011, VACCINE, V29, P3222, DOI 10.1016/j.vaccine.2011.02.037; Sanchez AB, 2005, J VIROL, V79, P7262, DOI 10.1128/JVI.79.11.7262-7268.2005; Scaglioni P, 1996, HEPATOLOGY, V24, P1010; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Soi RK, 2010, CLIN VACCINE IMMUNOL, V17, P1842, DOI 10.1128/CVI.00220-10; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; SWANEPOEL R, 1977, J GEN VIROL, V34, P557, DOI 10.1099/0022-1317-34-3-557; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; von Teichman B, 2011, VACCINE, V29, P5771, DOI 10.1016/j.vaccine.2011.05.055; Walker RC, 2010, J VIROL, V84, P5201, DOI 10.1128/JVI.02318-09; Wallace DB, 2006, VACCINE, V24, P7181, DOI 10.1016/j.vaccine.2006.06.041; WEBER PC, 1992, J GEN VIROL, V73, P2955, DOI 10.1099/0022-1317-73-11-2955; Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Zamoto-Niikura A, 2009, J VIROL, V83, P12779, DOI 10.1128/JVI.01310-09; 2005, FED REG, V70, P13241	80	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45730	10.1371/journal.pone.0045730	http://dx.doi.org/10.1371/journal.pone.0045730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029207	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400125
J	Liu, YQ; Qiu, F; Qiu, CY; Cai, Q; Zou, PC; Wu, HM; Hu, WP				Liu, Yu-Qiang; Qiu, Fang; Qiu, Chun-Yu; Cai, Qi; Zou, Pengcheng; Wu, Heming; Hu, Wang-Ping			Cannabinoids Inhibit Acid-Sensing Ion Channel Currents in Rat Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; NEUROPATHIC PAIN; CB1 RECEPTOR; SENSORY NEURONS; NOCICEPTORS; MODEL; IMMUNOREACTIVITY; LOCALIZATION; HYPERALGESIA; PHARMACOLOGY	Local acidosis has been found in various pain-generating conditions such as inflammation and tissue injury. Cannabinoids exert a powerful inhibitory control over pain initiation via peripheral cognate receptors. However, the peripheral molecular targets responsible for the antinociceptive effects of cannabinoids are still poorly understood. Here, we have found that WIN55,212-2, a cannabinoid receptor agonist, inhibits the activity of native acid-sensing ion channels (ASICs) in rat dorsal root ganglion (DRG) neurons. WIN55,212-2 dose-dependently inhibited proton-gated currents mediated by ASICs. WIN55,212-2 shifted the proton concentration-response curve downwards, with an decrease of 48.6 +/- 3.7% in the maximum current response but with no significant change in the EC50 value. The inhibition of proton-gated current induced by WIN55,212-2 was almost completely blocked by the selective CB1 receptor antagonist AM 281, but not by the CB2 receptor antagonist AM630. Pretreatment of forskolin, an AC activator, and the addition of cAMP also reversed the inhibition of WIN55,212-2. Moreover, WIN55,212-2 altered acid-evoked excitability of rat DRG neurons and decreased the number of action potentials induced by acid stimuli. Finally, WIN55,212-2 attenuated nociceptive responses to injection of acetic acid in rats. These results suggest that WIN55,212-2 inhibits the activity of ASICs via CB1 receptor and cAMP dependent pathway in rat primary sensory neurons. Thus, cannabinoids can exert their analgesic action by interaction with ASICs in the primary afferent neurons, which was novel analgesic mechanism of cannabinoids.	[Liu, Yu-Qiang; Qiu, Fang; Qiu, Chun-Yu; Cai, Qi; Hu, Wang-Ping] Hubei Univ Sci & Technol, Dept Pharmacol, Xianning, Hubei, Peoples R China; [Zou, Pengcheng; Wu, Heming] Hubei Furen Pharmaceut Corp Ltd, Tongcheng, Hubei, Peoples R China	Hubei University of Science & Technology	Hu, WP (corresponding author), Hubei Univ Sci & Technol, Dept Pharmacol, Xianning, Hubei, Peoples R China.	wangping_hu@yahoo.com	Hu, Wang-Ping/AAS-9314-2021	Liu, Yuqiang/0000-0002-0350-3071	National Natural Science Foundation of China [81171039, 30970944]; Program for New Century Excellent Talents in University (NCET); Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province [T201113]; Key Project of Chinese Ministry of Education [210142]; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province; Key Project of Chinese Ministry of Education(Ministry of Education, China); Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81171039 and No. 30970944) to W-PH, Program for New Century Excellent Talents in University (NCET to W-PH), Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province (T201113) to W-PH, Key Project of Chinese Ministry of Education (210142) to W-PH, and Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China to W-PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahluwalia J, 2000, NEUROSCIENCE, V100, P685, DOI 10.1016/S0306-4522(00)00389-4; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Childers SR, 1996, BIOCHEM PHARMACOL, V52, P819, DOI 10.1016/0006-2952(96)00419-4; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dube GR, 2009, CURR PHARM DESIGN, V15, P1750, DOI 10.2174/138161209788186263; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Guindon J, 2011, BRIT J PHARMACOL, V163, P1464, DOI 10.1111/j.1476-5381.2010.01192.x; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Mamet J, 2002, J NEUROSCI, V22, P10662; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Omori M, 2008, BRAIN RES, V1219, P26, DOI 10.1016/j.brainres.2008.03.040; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Smith ES, 2007, NEUROSCIENCE, V145, P686, DOI 10.1016/j.neuroscience.2006.12.024; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; STEEN KH, 1992, J NEUROSCI, V12, P86; Talwar R, 2011, CNS NEUROL DISORD-DR, V10, P536, DOI 10.2174/187152711796235005; Tsou K, 1996, NEUROSCIENCE, V70, P791, DOI 10.1016/S0306-4522(96)83015-6; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Walker JM, 2002, PHARMACOL THERAPEUT, V95, P127, DOI 10.1016/S0163-7258(02)00252-8; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yu XH, 2010, PAIN, V151, P337, DOI 10.1016/j.pain.2010.07.019; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	44	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45531	10.1371/journal.pone.0045531	http://dx.doi.org/10.1371/journal.pone.0045531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029075	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400099
J	Motbey, CP; Karanges, E; Li, KM; Wilkinson, S; Winstock, AR; Ramsay, J; Hicks, C; Kendig, MD; Wyatt, N; Callaghan, PD; McGregor, IS				Motbey, Craig P.; Karanges, Emily; Li, Kong M.; Wilkinson, Shane; Winstock, Adam R.; Ramsay, John; Hicks, Callum; Kendig, Michael D.; Wyatt, Naomi; Callaghan, Paul D.; McGregor, Iain S.			Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion	PLOS ONE			English	Article							MDMA ECSTASY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; BEHAVIORAL SENSITIZATION; 4-METHYLMETHCATHINONE MEPHEDRONE; INCREASED ANXIETY; ETHANOL EXPOSURE; ADULT RATS; METHAMPHETAMINE; NEUROTOXICITY; COMBINATION	Mephedrone (4-methylmethcathinone, MMC) is a popular recreational drug, yet its potential harms are yet to be fully established. The current study examined the impact of single or repeated MMC exposure on various neurochemical and behavioral measures in rats. In Experiment 1 male adolescent Wistar rats received single or repeated (once a day for 10 days) injections of MMC (30 mg/kg) or the comparator drug methamphetamine (METH, 2.5 mg/kg). Both MMC and METH caused robust hyperactivity in the 1 h following injection although this effect did not tend to sensitize with repeated treatment. Striatal dopamine (DA) levels were increased 1 h following either METH or MMC while striatal and hippocampal serotonin (5-HT) levels were decreased 1 h following MMC but not METH. MMC caused greater increases in 5-HT metabolism and greater reductions in DA metabolism in rats that had been previously exposed to MMC. Autoradiographic analysis showed no signs of neuroinflammation ([I-125]CLINDE ligand used as a marker for translocator protein (TSPO) expression) with repeated exposure to either MMC or METH. In Experiment 2, rats received repeated MMC (7.5, 15 or 30 mg/kg once a day for 10 days) and were examined for residual behavioral effects following treatment. Repeated high (30 mg/kg) dose MMC produced impaired novel object recognition 5 weeks after drug treatment. However, no residual changes in 5-HT or DA tissue levels were observed at 7 weeks post-treatment. Overall these results show that MMC causes acute but not lasting changes in DA and 5-HT tissue concentrations. MMC can also cause long-term memory impairment. Future studies of cognitive function in MMC users are clearly warranted.	[Motbey, Craig P.; Karanges, Emily; Hicks, Callum; Kendig, Michael D.; McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Li, Kong M.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; [Wilkinson, Shane] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Winstock, Adam R.] Univ London, Kings Coll, Inst Psychiat, London WC1E 7HU, England; [Ramsay, John] Univ London, St Georges Coll, TICTAC Commun Ltd, London WC1E 7HU, England; [Wyatt, Naomi; Callaghan, Paul D.] Australian Nucl Sci & Technol Org, Div Life Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of London; King's College London; University of London; Australian Nuclear Science & Technology Organisation	McGregor, IS (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	iain.mcgregor@sydney.edu.au	Li, Kong M./R-4655-2019; Kendig, Mike/K-3704-2019	Kendig, Mike/0000-0003-3337-6402; mcgregor, iain/0000-0002-9307-7159; Winstock, Adam/0000-0001-7854-8015; Wyatt, Naomi/0000-0002-5311-1623	Australian Research Council [DP0988609]; National Health and Medical Research Council (NHMRC) [1034649]; Australian Institute of Nuclear Science and Engineering	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Institute of Nuclear Science and Engineering	This work was supported by Australian Research Council (DP0988609) and National Health and Medical Research Council (NHMRC) (1034649) grants to IM and a Postgraduate Research Award from the Australian Institute of Nuclear Science and Engineering to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able JA, 2006, BIOL PSYCHIAT, V59, P1219, DOI 10.1016/j.biopsych.2005.09.006; Advisory Council on the Misuse of Drugs (AMCD), 2010, CONS CATH; Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; Arlicot N, 2008, EUR J NUCL MED MOL I, V35, P2203, DOI 10.1007/s00259-008-0834-x; Bajaj N, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.02.2010.2780; Ball KT, 2006, EUR J NEUROSCI, V24, P217, DOI 10.1111/j.1460-9568.2006.04885.x; Ball KT, 2011, BEHAV PHARMACOL, V22, P847, DOI 10.1097/FBP.0b013e32834d13b4; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Brunt TM, 2011, J PSYCHOPHARMACOL, V25, P1543, DOI 10.1177/0269881110378370; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cassel JC, 2005, NEUROPSYCHOPHARMACOL, V30, P1870, DOI 10.1038/sj.npp.1300714; Clemens KJ, 2007, DRUG ALCOHOL DEPEN, V86, P183, DOI 10.1016/j.drugalcdep.2006.06.004; Clemens KJ, 2005, NEUROPHARMACOLOGY, V49, P195, DOI 10.1016/j.neuropharm.2005.03.002; Clemens KJ, 2004, PSYCHOPHARMACOLOGY, V173, P318, DOI 10.1007/s00213-004-1786-x; Corkery J, 2012, PHARMACOLOGY, DOI DOI 10.5772/32935; Dargan PI, 2010, QJM-INT J MED, V103, P875, DOI 10.1093/qjmed/hcq134; Davidson C, 2002, EUR J PHARMACOL, V441, P75, DOI 10.1016/S0014-2999(02)01437-1; Dickson AJ, 2010, J ANAL TOXICOL, V34, P162, DOI 10.1093/jat/34.3.162; Drugs-Forum, 2011, EXP MEPH 4 METH 4 MM; Erowid, 2011, ER EXP VAULTS 4 METH; Fantegrossi WE, 2008, NEUROSCIENCE, V151, P533, DOI 10.1016/j.neuroscience.2007.11.007; Freeman TP, 2012, ADDICTION, V107, P792, DOI 10.1111/j.1360-0443.2011.03719.x; Garrett Gerard, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.04.2010.2925; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gustavsson David, 2009, Lakartidningen, V106, P2769; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; Halpern JH, 2011, ADDICTION, V106, P777, DOI 10.1111/j.1360-0443.2010.03252.x; Kalivas PW, 1998, NEUROPSYCHOPHARMACOL, V18, P469, DOI 10.1016/S0893-133X(97)00195-4; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Kelly JP, 2011, DRUG TEST ANAL, V3, P439, DOI 10.1002/dta.313; Klein C, 2011, PSYCHOPHARMACOLOGY, V218, P443, DOI 10.1007/s00213-011-2342-0; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; Malberg JE, 1998, J NEUROSCI, V18, P5086; Martinez-Clemente J, 2012, EUR NEUROPSYCHOPHARM, V22, P231, DOI 10.1016/j.euroneuro.2011.07.009; Maskell PD, 2011, J ANAL TOXICOL, V35, P188, DOI 10.1093/anatox/35.3.188; Mattner F, 2011, EUR J NUCL MED MOL I, V38, P1516, DOI 10.1007/s00259-011-1784-2; McGaw C., 2010, W LONDON MED J, V2, P9; McGregor IS, 2003, PSYCHOPHARMACOLOGY, V168, P465, DOI 10.1007/s00213-003-1452-8; McGregor IS, 2003, NEUROPSYCHOPHARMACOL, V28, P1472, DOI 10.1038/sj.npp.1300185; Meng H, 2012, TOXICOL LETT, V208, P62, DOI 10.1016/j.toxlet.2011.10.010; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Motbey CP, 2012, ADDICT BIOL, V17, P409, DOI 10.1111/j.1369-1600.2011.00384.x; Newcombe R., 2009, USE MEPHEDRONE M CAT; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Osorio-Olivares M, 2004, BIOORGAN MED CHEM, V12, P4055, DOI 10.1016/j.bmc.2004.05.033; Piper BJ, 2004, PHARMACOL BIOCHEM BE, V79, P723, DOI 10.1016/j.pbb.2004.10.001; Pubill D, 2003, N-S ARCH PHARMACOL, V367, P490, DOI 10.1007/s00210-003-0747-y; Schifano F, 2011, PSYCHOPHARMACOLOGY, V214, P593, DOI 10.1007/s00213-010-2070-x; SYAPIN PJ, 1988, EUR J PHARMACOL, V147, P101, DOI 10.1016/0014-2999(88)90638-3; Szumlinski KK, 2000, PSYCHOPHARMACOLOGY, V151, P234, DOI 10.1007/s002130000478; Torrance H, 2010, FORENSIC SCI INT, V202, pE62, DOI 10.1016/j.forsciint.2010.07.014; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; van Nieuwenhuijzen PS, 2009, NEUROPSYCHOBIOLOGY, V60, P195, DOI 10.1159/000253555; van Nieuwenhuijzen PS, 2010, PSYCHOPHARMACOLOGY, V212, P663, DOI 10.1007/s00213-010-1986-5; Wallace TL, 2001, SYNAPSE, V39, P1, DOI 10.1002/1098-2396(20010101)39:1<1::AID-SYN1>3.0.CO;2-7; Wiley JL, 2008, ADDICT BIOL, V13, P277, DOI 10.1111/j.1369-1600.2007.00077.x; Winstock A, 2011, ADDICTION, V106, P1991, DOI 10.1111/j.1360-0443.2011.03502.x; Winstock AR, 2010, DRUG ALCOHOL REV, V29, P82; Wood DM, 2011, EMERG MED J, V28, P280, DOI 10.1136/emj.2010.092288; Wood DM, 2010, CLIN TOXICOL, V48, P924, DOI 10.3109/15563650.2010.531021; Wood DM, 2010, J MED TOXICOL, V6, P327, DOI 10.1007/s13181-010-0018-5	63	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45473	10.1371/journal.pone.0045473	http://dx.doi.org/10.1371/journal.pone.0045473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029034	Green Published, gold			2022-12-27	WOS:000311313900142
J	Abdoul, H; Perrey, C; Amiel, P; Tubach, F; Gottot, S; Durand-Zaleski, I; Alberti, C				Abdoul, Hendy; Perrey, Christophe; Amiel, Philippe; Tubach, Florence; Gottot, Serge; Durand-Zaleski, Isabelle; Alberti, Corinne			Peer Review of Grant Applications: Criteria Used and Qualitative Study of Reviewer Practices	PLOS ONE			English	Review							EXTERNAL REVIEWERS; SCIENCE GRANT; AGREEMENT; OUTCOMES; PUBLICATION; RELIABILITY; ASSESSMENTS; PROPOSALS; TRIALS; PANEL	Background: Peer review of grant applications has been criticized as lacking reliability. Studies showing poor agreement among reviewers supported this possibility but usually focused on reviewers' scores and failed to investigate reasons for disagreement. Here, our goal was to determine how reviewers rate applications, by investigating reviewer practices and grant assessment criteria. Methods and Findings: We first collected and analyzed a convenience sample of French and international calls for proposals and assessment guidelines, from which we created an overall typology of assessment criteria comprising nine domains relevance to the call for proposals, usefulness, originality, innovativeness, methodology, feasibility, funding, ethical aspects, and writing of the grant application. We then performed a qualitative study of reviewer practices, particularly regarding the use of assessment criteria, among reviewers of the French Academic Hospital Research Grant Agencies (Programmes Hospitaliers de Recherche Clinique, PHRCs). Semi-structured interviews and observation sessions were conducted. Both the time spent assessing each grant application and the assessment methods varied across reviewers. The assessment criteria recommended by the PHRCs were listed by all reviewers as frequently evaluated and useful. However, use of the PHRC criteria was subjective and varied across reviewers. Some reviewers gave the same weight to each assessment criterion, whereas others considered originality to be the most important criterion (12/34), followed by methodology (10/34) and feasibility (4/34). Conceivably, this variability might adversely affect the reliability of the review process, and studies evaluating this hypothesis would be of interest. Conclusions: Variability across reviewers may result in mistrust among grant applicants about the review process. Consequently, ensuring transparency is of the utmost importance. Consistency in the review process could also be improved by providing common definitions for each assessment criterion and uniform requirements for grant application submissions. Further research is needed to assess the feasibility and acceptability of these measures.	[Abdoul, Hendy; Perrey, Christophe; Gottot, Serge; Alberti, Corinne] Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France; [Abdoul, Hendy; Tubach, Florence; Gottot, Serge; Alberti, Corinne] Univ Paris Diderot, Paris, France; [Abdoul, Hendy; Perrey, Christophe; Gottot, Serge; Alberti, Corinne] INSERM, CIE 5, Paris, France; [Perrey, Christophe; Amiel, Philippe] Inst Cancerol Gustave Roussy, Unite Rech Sci Humaines & Sociales, Villejuif, France; [Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France; [Durand-Zaleski, Isabelle] AP HP, Dept Rech Clin & Dev, Unite Rech Clin Econ Sante, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Abdoul, H (corresponding author), Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France.	hendy.abdoul@rdb.aphp.fr		AMIEL, Philippe/0000-0003-4557-9266	French Ministry of Heath; Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris [AOM 08 074]	French Ministry of Heath; Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris	This work was supported by a research grant from the French Ministry of Heath and sponsored by Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris (AOM 08 074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035247; Bornmann L, 2007, J INFORMETR, V1, P83, DOI 10.1016/j.joi.2006.09.005; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Callaham M, 2007, PLOS MED, V4, P774, DOI 10.1371/journal.pmed.0040166; Callaham ML, 2007, PLOS MED, V4, P32, DOI 10.1371/journal.pmed.0040040; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; Clark J., QUALITATIVE RES REV; de Sardan J-PO, POLITIQUE TERRAIN PR; Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2; Druss BG, 2005, AM J MED, V118, P658, DOI 10.1016/j.amjmed.2005.02.015; European Science Foundation, 2011, ESF SURV AN REP PEER, P144; Fogelholm M, 2012, J CLIN EPIDEMIOL, V65, P47, DOI 10.1016/j.jclinepi.2011.05.001; Ghiglione Rodolphe, 1998, ANAL AUTOMATIQUE CON; Glaser B.G., 1968, DISCOV GROUNDED THEO; Godlee F, 2002, JAMA-J AM MED ASSOC, V287, P2762, DOI 10.1001/jama.287.21.2762; GOLDMAN RL, 1994, EVAL HEALTH PROF, V17, P3, DOI 10.1177/016327879401700101; Gordon R, 2009, ACCOUNT RES, V16, P13, DOI 10.1080/08989620802689821; HODGSON C, 1995, CAN J CARDIOL, V11, P864; Hodgson C, 1997, J CLIN EPIDEMIOL, V50, P1189, DOI 10.1016/S0895-4356(97)00167-4; Holliday C, 2010, INT J GEN MED, V3, P225; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; Hutchinson TP, 2003, J CLIN NEUROSCI, V10, P213, DOI 10.1016/S0967-5868(02)00340-5; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Jefferson T., 2003, PEER REV HLTH SCI; Kelly J T, 1987, Qual Assur Util Rev, V2, P107; Kemper KJ, 1996, ARCH PEDIAT ADOL MED, V150, P380, DOI 10.1001/archpedi.1996.02170290046007; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; National Institute of Health, NIH GRANT REV PROC Y; Olbrecht M, 2010, RES EVALUAT, V19, P293, DOI 10.3152/095820210X12809191250762; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N; Porter R., 2005, J RES ADMIN, V36, P47; Regidor E, 2011, J EPIDEMIOL COMMUN H, V65, P1065, DOI 10.1136/jech.2009.094680; Rennie D, 2001, JAMA-J AM MED ASSOC, V285, P2006, DOI 10.1001/jama.285.15.2006; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Schroter S, 2004, BRIT MED J, V328, P673, DOI 10.1136/bmj.38023.700775.AE; Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62; Science and Technology Committee, 2011, PEER REV SCI PUBL; Shah S, 2001, AUST NZ J PUBL HEAL, V25, P556, DOI 10.1111/j.1467-842X.2001.tb00325.x; Stafinski T, 2010, PHARMACOECONOMICS, V28, P113, DOI 10.2165/11530820-000000000-00000; SUTHERLAND HJ, 1993, SOC SCI MED, V37, P1427, DOI 10.1016/0277-9536(93)90176-5; The International Committee of Medical Journal Editors, 2010, BIOMEDICAL UNPUB APR; Tite L, 2007, J EPIDEMIOL COMMUN H, V61, P9, DOI 10.1136/jech.2006.049817; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5; VENER KJ, 1993, FASEB J, V7, P1312, DOI 10.1096/fasebj.7.14.8224604; Wakefield D S, 1995, J Healthc Qual, V17, P11; Wakefield DS, 1995, J HEALTHC QUAL, V17, P15; Wakefield DS, 1995, J HEALTHC QUAL, V17, P51; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; Wu H, 2011, ALTERNATIVES PEER RE	51	29	30	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46054	10.1371/journal.pone.0046054	http://dx.doi.org/10.1371/journal.pone.0046054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029386	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900081
J	Mitra, A; Song, JZ				Mitra, Apratim; Song, Jiuzhou			WaveSeq: A Novel Data-Driven Method of Detecting Histone Modification Enrichments Using Wavelets	PLOS ONE			English	Article							CHIP-SEQ DATA; FACTOR-BINDING SITES; GENOME-WIDE ANALYSIS; LARGE GENE LISTS; IDENTIFICATION; LYMPHOCYTES; DOMAINS	Background: Chromatin immunoprecipitation followed by next-generation sequencing is a genome-wide analysis technique that can be used to detect various epigenetic phenomena such as, transcription factor binding sites and histone modifications. Histone modification profiles can be either punctate or diffuse which makes it difficult to distinguish regions of enrichment from background noise. With the discovery of histone marks having a wide variety of enrichment patterns, there is an urgent need for analysis methods that are robust to various data characteristics and capable of detecting a broad range of enrichment patterns. Results: To address these challenges we propose WaveSeq, a novel data-driven method of detecting regions of significant enrichment in ChIP-Seq data. Our approach utilizes the wavelet transform, is free of distributional assumptions and is robust to diverse data characteristics such as low signal-to-noise ratios and broad enrichment patterns. Using publicly available datasets we showed that WaveSeq compares favorably with other published methods, exhibiting high sensitivity and precision for both punctate and diffuse enrichment regions even in the absence of a control data set. The application of our algorithm to a complex histone modification data set helped make novel functional discoveries which further underlined its utility in such an experimental setup. Conclusions: WaveSeq is a highly sensitive method capable of accurate identification of enriched regions in a broad range of data sets. WaveSeq can detect both narrow and broad peaks with a high degree of accuracy even in low signal-to-noise ratio data sets. WaveSeq is also suited for application in complex experimental scenarios, helping make biologically relevant functional discoveries.	[Mitra, Apratim; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Song, JZ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020		National Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [USDA-NRI/NIFA 2008-35204-04660, USDA-NRI/NIFA 2010-65205-20588]	National Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture	This project was supported by National Research Initiative Competitive Grant no. USDA-NRI/NIFA 2008-35204-04660 and USDA-NRI/NIFA 2010-65205-20588 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; CALNEK BW, 1984, INT J CANCER, V33, P389, DOI 10.1002/ijc.2910330318; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng J, 2011, USING MACS IDENTIFY; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007978; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Team R. D. C., 2008, R LANG ENV STAT COMP; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45486	10.1371/journal.pone.0045486	http://dx.doi.org/10.1371/journal.pone.0045486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029045	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900043
J	Siedner, MJ; Lankowski, A; Musinga, D; Jackson, J; Muzoora, C; Hunt, PW; Martin, JN; Bangsberg, DR; Haberer, JE				Siedner, Mark J.; Lankowski, Alexander; Musinga, Derrick; Jackson, Jonathon; Muzoora, Conrad; Hunt, Peter W.; Martin, Jeffrey N.; Bangsberg, David R.; Haberer, Jessica E.			Optimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa	PLOS ONE			English	Article							CLUSTER-RANDOMIZED-TRIAL; DEVELOPING-COUNTRIES; DISEASE PREVENTION; BEHAVIOR-CHANGE; ADHERENCE; CARE; INTERVENTIONS; SERVICE; WORKERS; UGANDA	Background: Mobile health (mHealth) technologies hold incredible promise to improve healthcare delivery in resource-limited settings. Network reliability across large catchment areas can be a major challenge. We performed an analysis of network failure frequency as part of a study of real-time adherence monitoring in rural Uganda. We hypothesized that the addition of short messaging service (SMS+GPRS) to the standard cellular network modality (GPRS) would reduce network disruptions and improve transmission of data. Methods: Participants were enrolled in a study of real-time adherence monitoring in southwest Uganda. In June 2011, we began using Wisepill devices that transmit data each time the pill bottle is opened. We defined network failures as medication interruptions of >48 hours duration that were transmitted when network connectivity was re-established. During the course of the study, we upgraded devices from GPRS to GPRS+SMS compatibility. We compared network failure rates between GPRS and GPRS+SMS periods and created geospatial maps to graphically demonstrate patterns of connectivity. Results: One hundred fifty-seven participants met inclusion criteria of seven days of SMS and seven days of SMS+GPRS observation time. Seventy-three percent were female, median age was 40 years (IQR 33-46), 39% reported >1-hour travel time to clinic and 17% had home electricity. One hundred one had GPS coordinates recorded and were included in the geospatial maps. The median number of network failures per person-month for the GPRS and GPRS+SMS modalities were 1.5 (IQR 1.0-2.2) and 0.3 (IQR 0-0.9) respectively, (mean difference 1.2, 95% CI 1.0-1.3, p-value<0.0001). Improvements in network connectivity were notable throughout the region. Study costs increased by approximately $1USD per person-month. Conclusions: Addition of SMS to standard GPRS cellular network connectivity can significantly reduce network connection failures for mobile health applications in remote areas. Projects depending on mobile health data in resource-limited settings should consider this upgrade to optimize mHealth applications.	[Siedner, Mark J.; Lankowski, Alexander; Bangsberg, David R.; Haberer, Jessica E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Lankowski, Alexander; Musinga, Derrick; Muzoora, Conrad; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Jackson, Jonathon] Dimagi Inc, Boston, MA USA; [Hunt, Peter W.; Martin, Jeffrey N.; Bangsberg, David R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bangsberg, David R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Mbarara University of Science & Technology; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Siedner, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	msiedner@partners.org	Muzoora, Conrad/AAV-7023-2021; Haberer, Jessica/AAH-7976-2019; Lankowski, Alexander/AAE-6094-2020; Hunt, Peter W./P-2976-2017	Muzoora, Conrad/0000-0002-7866-5198; Haberer, Jessica/0000-0001-5845-3190; Lankowski, Alexander/0000-0002-4769-7242; Hunt, Peter W./0000-0002-4571-4870	National Institutes of Health [R01 MH054907, K23MH 087228, K24 MH87227, P30 AI027793]; Mark and Lisa Schwartz Family Foundation; Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; Doris Duke Charitable Foundation International Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, K23MH087228, R01MH054907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark and Lisa Schwartz Family Foundation; Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; Doris Duke Charitable Foundation International Clinical Research Fellowship at Harvard Medical School; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the National Institutes of Health (R01 MH054907, K23MH 087228, K24 MH87227, and P30 AI027793), and the Mark and Lisa Schwartz Family Foundation. MJS received additional support from the Harvard Institute for Global Health and from the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. AJL was supported by the Doris Duke Charitable Foundation International Clinical Research Fellowship at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Chib A, 2012, J HEALTH COMMUN, V17, P146, DOI 10.1080/10810730.2011.649104; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; Ghribi B, 2000, COMPUT NETW, V34, P763, DOI 10.1016/S1389-1286(00)00127-4; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Haberer JE, 2012, AIDS BEHAV, V16, P375, DOI 10.1007/s10461-011-9933-y; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Malkin RA, 2007, ANNU REV BIOMED ENG, V9, P567, DOI 10.1146/annurev.bioeng.9.060906.151913; Ofomata U, 2009, LEARNING LIVING LESS; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Short, 2009, USING MOBILE PHONES; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Whittaker R, 2012, J HEALTH COMMUN, V17, P11, DOI 10.1080/10810730.2011.649103; WHO, 2010, MED DEV MAN MISM OUT; World Health Organization, 2011, MHEALTHNEW HOR HLTH, V3; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	19	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45643	10.1371/journal.pone.0045643	http://dx.doi.org/10.1371/journal.pone.0045643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029155	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900048
J	Varchetta, S; Brunetta, E; Roberto, A; Mikulak, J; Hudspeth, KL; Mondelli, MU; Mavilio, D				Varchetta, Stefania; Brunetta, Enrico; Roberto, Alessandra; Mikulak, Joanna; Hudspeth, Kelly L.; Mondelli, Mario U.; Mavilio, Domenico			Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes	PLOS ONE			English	Article							KILLER-CELL RECEPTOR; SIALIC ACIDS; ERK PHOSPHORYLATION; INHIBITORY RECEPTOR; CYTOKINE PRODUCTION; IMMUNE-SYSTEM; RECOGNITION; IMMUNORECEPTOR; IDENTIFICATION; DECTIN-1	Sialic acid binding immunoglobulin-like lectin-7 (Siglec-7) is a trans-membrane receptor carrying immunoreceptor tyrosine based inhibitory motifs (ITIMs) and delivering inhibitory signals upon ligation with sialylated glycans. This inhibitory function can be also targeted by several pathogens that have evolved to express sialic acids on their surface to escape host immune responses. Here, we demonstrate that cross-linking of Siglec-7 by a specific monoclonal antibody (mAb) induces a remarkably high production of IL-6, IL-1 alpha, CCL4/MIP-1 beta, IL-8 and TNF-alpha. Among the three immune cell subsets known to constitutively express Siglec-7, the production of these pro-inflammatory cytokines and chemokines selectively occurs in monocytes and not in Natural Killer or T lymphocytes. This Siglec-7-mediated activating function is associated with the phosphorylation of the extracellular signal-regulated kinase (ERK) pathway. The present study also shows that sialic acid-free Zymosan yeast particles are able to bind Siglec-7 on monocytes and that this interaction mimics the ability of the anti Siglec-7 mAb to induce the production of pro-inflammatory mediators. Indeed, blocking or silencing Siglec-7 in primary monocytes greatly reduced the production of inflammatory cytokines and chemokines in response to Zymosan, thus confirming that Siglec-7 participates in generating a monocyte-mediated inflammatory outcome following pathogen recognition. The presence of an activating form of Siglec-7 in monocytes provides the host with a new and alternative mechanism to encounter pathogens not expressing sialylated glycans.	[Mavilio, Domenico] Ist Clin Humanitas, IRCCS, Lab Clin & Expt Immunol, Milan, Italy; [Varchetta, Stefania] Fdn San Matteo, IRCCS, Res Labs, Dept Infect Dis, Pavia, Italy; [Varchetta, Stefania] Univ Pavia, I-27100 Pavia, Italy; [Brunetta, Enrico; Roberto, Alessandra; Mikulak, Joanna; Hudspeth, Kelly L.; Mondelli, Mario U.] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy	IRCCS Humanitas Research Hospital; University of Pavia; University of Pavia	Mavilio, D (corresponding author), Ist Clin Humanitas, IRCCS, Lab Clin & Expt Immunol, Milan, Italy.	domenico.mavilio@humanitas.it	Mondelli, Mario U/J-5375-2016; mikulak, joanna/AAB-3070-2022; Varchetta, Stefania/C-9034-2018; Brunetta, Enrico/AAT-6524-2021; Mavilio, Domenico/E-5194-2017	Mondelli, Mario U/0000-0003-1811-3153; mikulak, joanna/0000-0001-8310-9543; Varchetta, Stefania/0000-0002-0289-2896; Roberto, Alessandra/0000-0001-6615-0026; Brunetta, Enrico/0000-0002-0676-1228; Mavilio, Domenico/0000-0001-6147-0952	Intramural Research program of Istituto Clinico Humanitas [20090917]; Italian Ministry of Health [RF-ICH-2009-1299677, RF-ICH-2009-1304134]	Intramural Research program of Istituto Clinico Humanitas; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Intramural Research program of Istituto Clinico Humanitas (Grant 20090917 to D.M.), and by the Italian Ministry of Health (Ricerca Finalizzata, Bando ISS, Grants RF-ICH-2009-1299677 to D.M. and RF-ICH-2009-1304134 and to J.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Chirathaworn C, 2002, J IMMUNOL, V168, P5530, DOI 10.4049/jimmunol.168.11.5530; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gupta S, 2010, BIOCHEM BIOPH RES CO, V402, P301, DOI 10.1016/j.bbrc.2010.10.020; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Jacobs T, 2010, EUR J CELL BIOL, V89, P113, DOI 10.1016/j.ejcb.2009.10.006; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; May LT, 2008, INT J BIOCHEM CELL B, V40, P2013, DOI 10.1016/j.biocel.2008.04.001; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Pillai S, 2011, ANN REV IMMUNOL; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Soares RMA, 2000, BBA-GEN SUBJECTS, V1474, P262, DOI 10.1016/S0304-4165(00)00003-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vitale C, 2001, P NATL ACAD SCI USA, V98, P5764, DOI 10.1073/pnas.091097198; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200	50	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45821	10.1371/journal.pone.0045821	http://dx.doi.org/10.1371/journal.pone.0045821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029261	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900055
J	Lee, Y; Kim, S; Lazar, P; Moon, JC; Hwang, S; Thangapandian, S; Shon, Y; Lee, KO; Lee, SY; Lee, KW				Lee, Yuno; Kim, Songmi; Lazar, Prettina; Moon, Jeong Chan; Hwang, Swan; Thangapandian, Sundarapandian; Shon, Youngsik; Lee, Kyun Oh; Lee, Sang Yeol; Lee, Keun Woo			Comparative Molecular Modeling Study of Arabidopsis NADPH-Dependent Thioredoxin Reductase and Its Hybrid Protein	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CHLOROPLAST; MECHANISM; PEROXIREDOXINS; GLUTAREDOXIN; DYNAMICS; CLONING; STRESS	2-Cys peroxiredoxins (Prxs) play important roles in the protection of chloroplast proteins from oxidative damage. Arabidopsis NADPH-dependent thioredoxin reductase isotype C (AtNTRC) was identified as efficient electron donor for chloroplastic 2-Cys Prx-A. There are three isotypes (A, B, and C) of thioredoxin reductase (TrxR) in Arabidopsis. AtNTRA contains only TrxR domain, but AtNTRC consists of N-terminal TrxR and C-terminal thioredoxin (Trx) domains. AtNTRC has various oligomer structures, and Trx domain is important for chaperone activity. Our previous experimental study has reported that the hybrid protein (AtNTRA-(Trx-D)), which was a fusion of AtNTRA and Trx domain from AtNTRC, has formed variety of structures and shown strong chaperone activity. But, electron transfer mechanism was not detected at all. To find out the reason of this problem with structural basis, we performed two different molecular dynamics (MD) simulations on AtNTRC and AtNTRA-(Trx-D) proteins with same cofactors such as NADPH and flavin adenine dinucleotide (FAD) for 50 ns. Structural difference has found from superimposition of two structures that were taken relatively close to average structure. The main reason that AtNTRA-(Trx-D) cannot transfer the electron from TrxR domain to Trx domain is due to the difference of key catalytic residues in active site. The long distance between TrxR C153 and disulfide bond of Trx C387-C390 has been observed in AtNTRA-(Trx-D) because of following reasons: i) unstable and unfavorable interaction of the linker region, ii) shifted Trx domain, and iii) different or weak interface interaction of Trx domains. This study is one of the good examples for understanding the relationship between structure formation and reaction activity in hybrid protein. In addition, this study would be helpful for further study on the mechanism of electron transfer reaction in NADPH-dependent thioredoxin reductase proteins.	[Lee, Yuno; Kim, Songmi; Lazar, Prettina; Moon, Jeong Chan; Hwang, Swan; Thangapandian, Sundarapandian; Shon, Youngsik; Lee, Kyun Oh; Lee, Sang Yeol; Lee, Keun Woo] Gyeongsang Natl Univ, Div Appl Life Sci Program BK21, Syst & Synthet Agrobiotech Ctr, Plant Mol Biol & Biotechnol Res Ctr,Res Inst Nat, Jinju, Gyeongsangnam D, South Korea	Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci Program BK21, Syst & Synthet Agrobiotech Ctr, Plant Mol Biol & Biotechnol Res Ctr,Res Inst Nat, Jinju, Gyeongsangnam D, South Korea.	kwlee@gnu.ac.kr			National Research Foundation of Korea (NRF); Korean Government (NRF-Fostering Core Leaders of the Future Basic Science Program); Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the NRF [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ008038]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (NRF-Fostering Core Leaders of the Future Basic Science Program)(National Research Foundation of Korea); Pioneer Research Center Program; Management of Climate Change Program through the NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2012-Fostering Core Leaders of the Future Basic Science Program). This research was supported by Pioneer Research Center Program (2009-0081539) and Management of Climate Change Program (2010-0029084) through the NRF funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lindahl E, 2006, DEP BIOPHYSICAL CHEM, V4, P9747; Lundqvist J, 2011, BIOCHEMISTRY-US; Perez-Ruiz JM, 2009, MOL PLANT, V2, P457, DOI 10.1093/mp/ssp011; Perez-Ruiz JM, 2009, FEBS LETT, V583, P1399, DOI 10.1016/j.febslet.2009.03.067; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Orozco M, 2003, CHEM SOC REV, V32, P350, DOI 10.1039/b207226m; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; Sali A, 1994, PROTEIN STRUCTURE DI, V64, pC86; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Van Wynsberghe AW, 2005, BIOPHYS J, V89, P2939, DOI 10.1529/biophysj.105.065664; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	38	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46279	10.1371/journal.pone.0046279	http://dx.doi.org/10.1371/journal.pone.0046279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029461	gold, Green Published			2022-12-27	WOS:000309517500082
J	Haglund, E; Sulkowska, JI; He, Z; Feng, GS; Jennings, PA; Onuchic, JN				Haglund, Ellinor; Sulkowska, Joanna I.; He, Zhao; Feng, Gen-Sheng; Jennings, Patricia A.; Onuchic, Jose N.			The Unique Cysteine Knot Regulates the Pleotropic Hormone Leptin	PLOS ONE			English	Article							INTRACHAIN DISULFIDE BOND; BODY-WEIGHT REGULATION; STRUCTURE-BASED MODELS; OBESE GENE-PRODUCT; OB PROTEIN; MISSENSE MUTATION; CRYSTAL-STRUCTURE; FOOD-INTAKE; DYNAMICS; INTERLEUKIN-1-BETA	Leptin plays a key role in regulating energy intake/expenditure, metabolism and hypertension. It folds into a four-helix bundle that binds to the extracellular receptor to initiate signaling. Our work on leptin revealed a hidden complexity in the formation of a previously un-described, cysteine-knotted topology in leptin. We hypothesized that this unique topology could offer new mechanisms in regulating the protein activity. A combination of in silico simulation and in vitro experiments was used to probe the role of the knotted topology introduced by the disulphide-bridge on leptin folding and function. Our results surprisingly show that the free energy landscape is conserved between knotted and unknotted protein, however the additional complexity added by the knot formation is structurally important. Native state analyses led to the discovery that the disulphide-bond plays an important role in receptor binding and thus mediate biological activity by local motions on distal receptor-binding sites, far removed from the disulphide-bridge. Thus, the disulphide-bridge appears to function as a point of tension that allows dissipation of stress at a distance in leptin.	[Haglund, Ellinor; Sulkowska, Joanna I.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haglund, Ellinor; Sulkowska, Joanna I.; Jennings, Patricia A.] Univ Calif San Diego, Ctr Theoret Biol Phys CTBP, La Jolla, CA 92093 USA; [He, Zhao; Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [He, Zhao; Feng, Gen-Sheng] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Onuchic, Jose N.] Rice Univ, Dept Phys & Astron Chem & Biochem & Cell Biol, Houston, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rice University; Rice University	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu; jonuchic@rice.edu	he, zhao/S-4989-2019		Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-0822283]; National Institutes of Health [GM54038]; Cancer Prevention and Research Institute of Texas;  [NSF- MCB-1051438]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054038, R29GM054038] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1212312] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF) (Grant PHY-0822283) and by NSF- MCB-1051438. National Institutes of Health GM54038 JNO is a CPRIT Scholar in Cancer Research sponsored by the Cancer Prevention and Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.T HRVaC, 1978, INTRO MATH STAT; Adamczyk M, 1999, RAPID COMMUN MASS SP, V13, P1813, DOI 10.1002/(SICI)1097-0231(19990930)13:18<1813::AID-RCM722>3.0.CO;2-1; Altmann SW, 1995, PROTEIN EXPRES PURIF, V6, P722, DOI 10.1006/prep.1995.0002; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andrews BT, 2008, P NATL ACAD SCI USA, V105, P12283, DOI 10.1073/pnas.0804039105; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Beldarrain A, 1999, BIOCHEMISTRY-US, V38, P7865, DOI 10.1021/bi990287g; Bishop B, 2001, J BIOL CHEM, V276, P33465, DOI 10.1074/jbc.M104494200; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Boute N, 2004, BIOCHIMIE, V86, P351, DOI 10.1016/j.biochi.2004.06.005; BREMS DN, 1990, J BIOL CHEM, V265, P5504; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Catalano S, 2004, J BIOL CHEM, V279, P19908, DOI 10.1074/jbc.M313191200; Cemazar M, 2008, ANTIOXID REDOX SIGN, V10, P103, DOI 10.1089/ars.2007.1849; CHOI SC, 1969, TECHNOMETRICS, V11, P683, DOI 10.2307/1266892; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Doshi U, 2012, P NATL ACAD SCI USA, V109, P5699, DOI 10.1073/pnas.1117060109; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fawzi AB, 1996, HORM METAB RES, V28, P694, DOI 10.1055/s-2007-979880; Feng YP, 1996, J MOL BIOL, V259, P524, DOI 10.1006/jmbi.1996.0337; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; Finke JM, 2000, BIOCHEMISTRY-US, V39, P575, DOI 10.1021/bi991518m; Finke JM, 2000, BIOCHEMISTRY-US, V39, P15633, DOI 10.1021/bi001307d; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Fiser Andras, 2006, NUCL ACIDS RES; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Giese K, 1996, MOL MED, V2, P50, DOI 10.1007/BF03402202; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Haglund E, 2012, J BIOL CHEM, V287, P2731, DOI 10.1074/jbc.M111.312447; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hamming OJ, 2011, J VIROL, V85, P8181, DOI 10.1128/JVI.00521-11; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Imagawa K, 1998, J BIOL CHEM, V273, P35245, DOI 10.1074/jbc.273.52.35245; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lo Verso F, 2007, J PHYS CHEM C, V111, P15803, DOI 10.1021/jp0737606; Marianayagam NJ, 2005, J R SOC INTERFACE, V2, P47, DOI 10.1098/rsif.2004.0025; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Niv-Spector L, 2005, BIOCHEM J, V390, P475, DOI 10.1042/BJ20050233; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Rees A. R., 1992, PROTEIN ENG PRACTICA; RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266; Rock FL, 1996, HORM METAB RES, V28, P649, DOI 10.1055/s-2007-979871; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.268103; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; TERRY RD, 1980, ANNU REV NEUROSCI, V3, P77, DOI 10.1146/annurev.ne.03.030180.000453; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yao SG, 2011, BIOCHEMISTRY-US, V50, P2464, DOI 10.1021/bi101810f; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zirah S, 2011, J AM SOC MASS SPECTR, V22, P467, DOI 10.1007/s13361-010-0028-1	96	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45654	10.1371/journal.pone.0045654	http://dx.doi.org/10.1371/journal.pone.0045654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029163	Green Published, gold			2022-12-27	WOS:000309554700055
J	Kim, H; Kang, HJ; Kim, HJ; Jang, MK; Kim, NH; Oh, Y; Han, BD; Choi, JY; Kim, CW; Lee, JW; Park, KD; Shin, HY; Ahn, HS				Kim, Hyery; Kang, Hyoung Jin; Kim, Hyo Jeong; Jang, Mi Kyung; Kim, Nam Hee; Oh, Yongtaek; Han, Byoung-Don; Choi, Ji-Yeob; Kim, Chul Woo; Lee, Ji Won; Park, Kyung Duk; Shin, Hee Young; Ahn, Hyo Seop			Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism	PLOS ONE			English	Article							INOSINE-TRIPHOSPHATE-PYROPHOSPHATASE; MULTIFACTOR DIMENSIONALITY REDUCTION; CHILDRENS CANCER GROUP; DETECTING GENE-GENE; MERCAPTOPURINE METABOLISM; TREATMENT RESPONSE; DRUG-THERAPY; RISK; GENOTYPE; INTENSIFICATION	Genetic polymorphisms are important factors in the effects and toxicity of chemotherapeutics. To analyze the pharmacogenetic and ethnic differences in chemotherapeutics, major genes implicated in the treatment of acute lymphoblastic leukemia (ALL) were analyzed. Eighteen loci of 16 genes in 100 patients with ALL were analyzed. The distribution of variant alleles were CYP3A4*1B (0%), CYP3A5*3 (0%), GSTM1 (21%), GSTP1 (21%), GSTT1 (16%), MDR1 exon 21 (77%), MDR1 exon 26 (61%), MTHFR 677 (63%), MTHFR 1298 (29%), NR3C1 1088 (0%), RFC1 80 (68%), TPMT combined genotype (7%), VDR intron 8 (11%), VDR FokI (83%), TYMS enhancer repeat (22%) and ITPA 94 (30%). The frequencies of single nucleotide polymorphisms (SNPs) of 10 loci were statistically different from those in Western Caucasians. Dose percents (actual/planned dose) or toxicity of mercaptopurine and methotrexate were not related to any SNPs. Event free survival (EFS) rate was lower in ITPA variants, and ITPA 94 AC/AA variant genotypes were the only independent risk factor for lower EFS in multivariate analysis, which was a different pharmacogenetic implication from Western studies. This study is the first pharmacogenetic study in Korean pediatric ALL. Our result suggests that there are other possible pharmacogenetic factors besides TPMT or ITPA polymorphisms which influence the metabolism of mercaptopurine in Asian populations.	[Kim, Hyery; Kang, Hyoung Jin; Kim, Hyo Jeong; Jang, Mi Kyung; Kim, Nam Hee; Lee, Ji Won; Park, Kyung Duk; Shin, Hee Young; Ahn, Hyo Seop] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Pediat, Seoul, South Korea; [Kim, Hyery] Seoul Natl Univ, Coll Med, Dept Pediat, SMG SNU Boramae Med Ctr, Seoul, South Korea; [Oh, Yongtaek; Han, Byoung-Don] YeBT Co LTD, Seoul, South Korea; [Choi, Ji-Yeob] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Chul Woo] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kang, HJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Pediat, Seoul, South Korea.	kanghj@snu.ac.kr	Kang, Hyoung Jin/J-2730-2012; Choi, Ji-Yeob/J-2796-2012; Shin, Hee Young/J-2766-2012		National R&D Program for Cancer Control, Ministry for Ministry for Health & Welfare, Republic of Korea [0520290]; Korea Health 21 R&D project, Ministry for Health & Welfare, Republic of Korea [A030001]	National R&D Program for Cancer Control, Ministry for Ministry for Health & Welfare, Republic of Korea; Korea Health 21 R&D project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Ministry for Health & Welfare, Republic of Korea (0520290) and by a grant of the Korea Health 21 R&D project, Ministry for Health & Welfare, Republic of Korea (A030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam de Beaumais T, 2012, EUR J CLIN PHARM; Aplenc R, 2005, CANCER RES, V65, P2482, DOI 10.1158/0008-5472.CAN-04-2606; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Broxson EH, 2005, PEDIATR BLOOD CANCER, V44, P226, DOI 10.1002/pbc.20202; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Cunningham L, 2007, EXPERT OPIN PHARMACO, V8, P2519, DOI 10.1517/14656566.8.15.2519; de Wildt SN, 2011, EXPERT OPIN DRUG MET, V7, P935, DOI 10.1517/17425255.2011.577739; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Dorababu P, 2012, EUR J CLIN PHARMACOL, V68, P379, DOI 10.1007/s00228-011-1133-1; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Felix CA, 1998, P NATL ACAD SCI USA, V95, P13176, DOI 10.1073/pnas.95.22.13176; Ganiere-Monteil C, 2004, EUR J CLIN PHARMACOL, V60, P89, DOI 10.1007/s00228-004-0732-5; Gao LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020157; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Huang MY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-50; Hutchinson RJ, 2003, J CLIN ONCOL, V21, P1790, DOI 10.1200/JCO.2003.03.009; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kang HJ, 2008, MOL CELL PROBE, V22, P193, DOI 10.1016/j.mcp.2008.02.001; Lange BJ, 2002, BLOOD, V99, P825, DOI 10.1182/blood.V99.3.825; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marsh S, 2009, CLIN PHARMACOL THER, V85, P139, DOI 10.1038/clpt.2008.219; Phillips EM, 2007, SOC FORCES, V86, P795, DOI 10.1093/sf/86.2.795; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Relling MV, 1999, BLOOD, V93, P2817; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Stocco G, 2010, EXPERT OPIN DRUG SAF, V9, P23, DOI 10.1517/14740330903426151; Tanaka Y, 2011, HUM MOL GENET, V20, P3507, DOI 10.1093/hmg/ddr249; Wang WG, 2001, CANCER RES, V61, P5505; Whitfield GK, 1999, J CELL BIOCHEM, P110; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Wu LM, 2007, J SURG ONCOL, V96, P62, DOI 10.1002/jso.20774; Xiang Q, 2010, J CLIN PHARMACOL, V50, P659, DOI 10.1177/0091270009347867	39	33	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45558	10.1371/journal.pone.0045558	http://dx.doi.org/10.1371/journal.pone.0045558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029095	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700046
J	Martelli, D; Luppi, M; Cerri, M; Tupone, D; Perez, E; Zamboni, G; Amici, R				Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto			Waking and Sleeping following Water Deprivation in the Rat	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; LOW AMBIENT-TEMPERATURE; EYE-MOVEMENT SLEEP; REM-SLEEP; COLD-EXPOSURE; DESYNCHRONIZED SLEEP; THERMOREGULATION; VASOPRESSIN; CALCIUM; PATTERN	Wake-sleep (W-S) states are affected by thermoregulation. In particular, REM sleep (REMS) is reduced in homeotherms under a thermal load, due to an impairment of hypothalamic regulation of body temperature. The aim of this work was to assess whether osmoregulation, which is regulated at a hypothalamic level, but, unlike thermoregulation, is maintained across the different W-S states, could influence W-S occurrence. Sprague-Dawley rats, kept at an ambient temperature of 24 degrees C and under a 12 h:12 h light-dark cycle, were exposed to a prolonged osmotic challenge of three days of water deprivation (WD) and two days of recovery in which free access to water was restored. Two sets of parameters were determined in order to assess: i) the maintenance of osmotic homeostasis (water and food consumption; changes in body weight and fluid composition); ii) the effects of the osmotic challenge on behavioral states (hypothalamic temperature (Thy), motor activity, and W-S states). The first set of parameters changed in WD as expected and control levels were restored on the second day of recovery, with the exception of urinary Ca++ that almost disappeared in WD, and increased to a high level in recovery. As far as the second set is concerned, WD was characterized by the maintenance of the daily oscillation of Thy and by a decrease in activity during the dark periods. Changes in W-S states were small and mainly confined to the dark period: i) REMS slightly decreased at the end of WD and increased in recovery; ii) non-REM sleep (NREMS) increased in both WD and recovery, but EEG delta power, a sign of NREMS intensity, decreased in WD and increased in recovery. Our data suggest that osmoregulation interferes with the regulation of W-S states to a much lesser extent than thermoregulation.	[Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto] Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Martelli, Davide] Univ Melbourne, Florey Neurosci Inst, Syst Neurophysiol Div, Melbourne, Vic, Australia; [Tupone, Domenico] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA	University of Bologna; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Oregon Health & Science University; Oregon National Primate Research Center	Zamboni, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	giovanni.zamboni@unibo.it	Luppi, Marco/AGH-3155-2022; Cerri, Matteo/F-5009-2017; Martelli, Davide/Q-7375-2016; Tupone, Domenico/M-8079-2016	Luppi, Marco/0000-0002-9462-5014; Cerri, Matteo/0000-0003-3556-305X; Tupone, Domenico/0000-0002-4238-1011; Martelli, Davide/0000-0001-6523-9598	University of Bologna	University of Bologna	This work has been funded by Research Funds for Fundamental and Applied Research (RFO Funds) from the University of Bologna (http://www.eng.unibo.it/PortaleEn/Research/Services+for+teachers+and+researchers/National+Regional+and+Local+Funding/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici R, 2004, BRAIN RES, V996, P9, DOI 10.1016/j.brainres.2003.09.026; Amici R, 2001, BEHAV BRAIN RES, V123, P155, DOI 10.1016/S0166-4328(01)00203-0; AMICI R, 1994, J SLEEP RES, V3, P250, DOI 10.1111/j.1365-2869.1994.tb00139.x; Amici R, 1998, BRAIN RES, V781, P252, DOI 10.1016/S0006-8993(97)01242-0; Amici R, 2008, SLEEP, V31, P708, DOI 10.1093/sleep/31.5.708; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ARNAULD E, 1989, AM J PHYSIOL, V256, pR674, DOI 10.1152/ajpregu.1989.256.3.R674; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; BORN J, 1992, AM J PHYSIOL, V262, pE295, DOI 10.1152/ajpendo.1992.262.3.E295; Caputa M, 1996, J THERM BIOL, V21, P21, DOI 10.1016/0306-4565(95)00016-X; Cerri M, 2005, SLEEP, V28, P694, DOI 10.1093/sleep/28.6.694; Chatelain D, 2003, REGUL PEPTIDES, V110, P249, DOI 10.1016/S0167-0115(02)00217-3; Endres DB, 1994, TIETZ TXB CLIN CHEM, P1887; FRANKEN P, 1993, PHYSIOL BEHAV, V54, P885, DOI 10.1016/0031-9384(93)90297-S; Heller C., 2005, PRINCIPLES PRACTICE, P292, DOI DOI 10.1016/B0-72-160797-7/50031-8; HOLM S, 1979, SCAND J STAT, V6, P65; KOULACK D, 1970, J NERV MENT DIS, V151, P143, DOI 10.1097/00005053-197008000-00008; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Kuznetsov IE, 2000, NEUROSCIENCE, V99, P363, DOI 10.1016/S0306-4522(00)00184-6; Luppi M, 2010, J SLEEP RES, V19, P394, DOI 10.1111/j.1365-2869.2009.00810.x; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Marenzana M, 2005, BONE, V37, P545, DOI 10.1016/j.bone.2005.04.036; McKinley M, 2008, CLIN EXP PHARMACOL P, V35, P701, DOI 10.1111/j.1440-1681.2007.04833.x; MCKINLEY MJ, 1983, AM J PHYSIOL, V245, pR287, DOI 10.1152/ajpregu.1983.245.2.R287; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mouret J R, 1971, Int J Neurosci, V2, P265, DOI 10.3109/00207457109147009; Parmeggiani P. L., 1994, PRINCIPLES PRACTICE, P194; PARMEGGIANI PL, 1980, ELECTROEN CLIN NEURO, V50, P293, DOI 10.1016/0013-4694(80)90157-1; Parmeggiani PL, 2003, FRONT BIOSCI, V8, pS557, DOI 10.2741/1054; Parmeggiani PL, 2005, PRINCIPLES PRACTICE, V4th, P185; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Simon E, 1999, JPN J PHYSIOL, V49, P297, DOI 10.2170/jjphysiol.49.297; Talmage D. W., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P108; Talmage RV, 2009, GEN COMP ENDOCR, V162, P245, DOI 10.1016/j.ygcen.2009.03.027; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Watts AG, 1999, PHYSIOL BEHAV, V65, P871; Waynforth H, 1980, EXPT SURGICAL TECHNI, P59; Wotus C, 2003, NEUROENDOCRINOLOGY, V78, P301, DOI 10.1159/000074883; Zamboni G, 2004, BRAIN RES, V1022, P62, DOI 10.1016/j.brainres.2004.07.002; Zamboni G, 2001, BEHAV BRAIN RES, V122, P25, DOI 10.1016/S0166-4328(01)00175-9	42	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46116	10.1371/journal.pone.0046116	http://dx.doi.org/10.1371/journal.pone.0046116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029406	Green Published, gold			2022-12-27	WOS:000309554700116
J	Saxena, N; Hartman, M; Yip, CH; Bhoo-Pathy, N; Khin, LW; Taib, NA; Looi, LM; Lim, SE; Lee, SC; Verkooijen, HM				Saxena, Nakul; Hartman, Mikael; Yip, Cheng-Har; Bhoo-Pathy, Nirmala; Khin, Lay Wai; Taib, Nur Aishah; Looi, Lai-Meng; Lim, Siew-Eng; Lee, Soo-Chin; Verkooijen, Helena M.			Does the Axillary Lymph Node Ratio Have Any Added Prognostic Value over pN Staging for South East Asian Breast Cancer Patients?	PLOS ONE			English	Article							DISSECTION; SURVIVAL; METASTASIS	Introduction: Lymph node ratio (LNR, i.e. the ratio of the number of positive nodes to the total number of nodes excised) is reported to be superior to the absolute number of nodes involved (pN stage) in classifying patients at high versus low risk of death following breast cancer. The added prognostic value of LNR over pN in addition to other prognostic factors has never been assessed. Methods: All patients diagnosed with lymph node positive, non-metastatic invasive breast cancer at the National University Hospital (Singapore) and University of Malaya Medical Center (Kuala Lumpur) between 1990-2007 were included (n = 1589). Overall survival of the patients was estimated by the Kaplan Meier method for LNR [categorized as low (>0 and <0.2), intermediate (0.2-0.65) and high (>0.65-1)] and pN staging [pN1, pN2 and pN3]. Adjusted overall relative mortality risks associated with LNR and pN were calculated by Cox regression. The added prognostic value of LNR over pN was evaluated by comparing the discriminating capacity (as indicated by the c statistic) of two multivariate models, one including pN and one including LNR. Results: LNR was superior to pN in categorizing mortality risks for women >= 60 years, those with ER negative or grade 3 tumors. In combination with other factors (i.e. age, treatment, grade, tumor size and receptor status), substituting pN by LNR did not result in better discrimination of women at high versus low risk of death, neither for the entire cohort (c statistic 0.72 [0.70-0.75] and 0.73 [0.71-0.76] respectively for pN versus LNR), nor for the subgroups mentioned above. Conclusion: In combination with other prognosticators, substitution of pN by LNR did not provide any added prognostic value for South East Asian breast cancer patients.	[Saxena, Nakul; Hartman, Mikael; Verkooijen, Helena M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Yip, Cheng-Har; Taib, Nur Aishah] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Hosp Kuala Lumpur, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Khin, Lay Wai] Natl Univ Singapore, Invest Med Unit, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Looi, Lai-Meng] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Lim, Siew-Eng; Lee, Soo-Chin] Natl Univ Hlth Syst, Dept Hematol Oncol, Natl Univ Canc Inst, Singapore, Singapore; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	National University of Singapore; National University of Singapore; Universiti Malaya; National University of Singapore; Universiti Malaya; National University of Singapore; Utrecht University; Utrecht University Medical Center	Hartman, M (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	mikael_hartman@nuhs.edu.sg	Lee, Soo Chin/S-9111-2016; Pathy, Nirmala Bhoo/C-1228-2010; LIM, SIEW ENG/AGO-6654-2022; Yip, Cheng-Har/B-1909-2010; Looi, Lai Meng/AAB-9403-2019; Looi, Lai Meng/A-3382-2009; Taib, Nur Aishah Mohd/B-2370-2010; Hartman, Mikael/B-4324-2011	Lee, Soo Chin/0000-0002-5835-6419; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Hartman, Mikael/0000-0001-5726-9965	HIR Grant Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/06]; European Union through a PhD fellowship grant (AsiaLink program) [MY/AsiaLink/044[128-713]]	HIR Grant Ministry of Higher Education, Malaysia; European Union through a PhD fellowship grant (AsiaLink program)	The Malaysian data was supported by an HIR Grant UM.C/HlR/MOHE/06 from the Ministry of Higher Education, Malaysia. Nirmala Bhoo-Pathy was funded by the European Union through a PhD fellowship grant (AsiaLink program MY/AsiaLink/044[128-713]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2011, BREAST CANCER RES TR, V130, P507, DOI 10.1007/s10549-011-1730-9; Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; AXELSSON CK, 1992, EUR J CANCER, V28A, P1415, DOI 10.1016/0959-8049(92)90534-9; Boughey JC, 2010, CANCER-AM CANCER SOC, V116, P3322, DOI 10.1002/cncr.25207; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Edge SB, 2010, AJCC CANC STAGING MA; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hatoum HA, 2009, ANN SURG ONCOL, V16, P3388, DOI 10.1245/s10434-009-0653-8; Keam B, 2009, BREAST CANCER RES TR, V116, P153, DOI 10.1007/s10549-008-0160-9; Lim SE, 2007, WORLD J SURG, V31, P1387, DOI 10.1007/s00268-007-9086-3; MATHIESEN O, 1990, ACTA ONCOL, V29, P721, DOI 10.3109/02841869009092990; Pathy NB, 2011, BREAST, V20, pS75, DOI 10.1016/j.breast.2011.01.015; RECHT A, 1995, CANCER, V76, P1491, DOI 10.1002/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8; SAEZ RA, 1989, SEMIN SURG ONCOL, V5, P102, DOI 10.1002/ssu.2980050206; Saxena N, 2011, EUR J CANCER, V47, P1186, DOI 10.1016/j.ejca.2010.12.009; Schaapveld M, 2004, J SURG ONCOL, V87, P4, DOI 10.1002/jso.20061; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tausch C, 2012, ANN SURG ONCOL, V19, P1808, DOI 10.1245/s10434-011-2189-y; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Vinh-Hung V, 2003, INT J ONCOL, V22, P697; Vinh-Hung V, 2009, FUTURE ONCOL, V5, P1585, DOI 10.2217/FON.09.129; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Woodward WA, 2006, J CLIN ONCOL, V24, P2910, DOI 10.1200/JCO.2005.03.1526; Yiangou C, 1999, BRIT J CANCER, V80, P1974, DOI 10.1038/sj.bjc.6690629	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45809	10.1371/journal.pone.0045809	http://dx.doi.org/10.1371/journal.pone.0045809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029254	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700074
J	de Jager, SCA; Bongaerts, BWC; Weber, M; Kraaijeveld, AO; Rousch, M; Dimmeler, S; van Dieijen-Visser, MP; Cleutjens, KBJM; Nelemans, PJ; van Berkel, TJC; Biessen, EAL				de Jager, Saskia C. A.; Bongaerts, Brenda W. C.; Weber, Michael; Kraaijeveld, Adriaan O.; Rousch, Mat; Dimmeler, Stefanie; van Dieijen-Visser, Marja P.; Cleutjens, Kitty B. J. M.; Nelemans, Patty J.; van Berkel, Theo J. C.; Biessen, Erik A. L.			Chemokines CCL3/MIP1 alpha, CCL5/RANTES and CCL18/PARC are Independent Risk Predictors of Short-Term Mortality in Patients with Acute Coronary Syndromes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; UNSTABLE ANGINA-PECTORIS; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; ARTERY-DISEASE; TROPONIN-T; EXPRESSION; CELLS	Cytokines play an important role in ischemic injury and repair. However, little is known about their prognostic value in cardiovascular disease. The aim of this study was to investigate the prognostic importance of chemokines CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC for the risk of future cardiovascular events in patients with acute coronary syndromes (ACS). Baseline levels of CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC were determined in ACS patients from the Bad Nauheim ACS II registry (n = 609). During the following 200 days, patients were monitored for the occurrence of fatal and non-fatal cardiovascular events. Patients with CCL3/MIP1 alpha, CCL5/RANTES and CCL18/PARC concentrations in the highest tertile were associated with an increased risk of a fatal event during follow-up (HR: 2.19, 95%CI: 1.04-4.61 for CCL3/MIP1 alpha, HR: 3.45, 95%CI: 1.54-7.72 for CCL5/RANTES and HR: 3.14, 95%CI: 1.33-7.46 for CCL18/PARC). This risk was highest for patients with all three biomarkers concentrations in the upper tertile (HR: 2.52, 95%CI: 1.11-5.65). Together with known risk predictors of cardiovascular events, CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC combined improved the c-statistics from 0.74 to 0.81 (p = 0.007). In conclusion, CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC are independently associated with the risk of short-term mortality in ACS patients. Combining all three biomarkers further increased their prognostic value.	[Bongaerts, Brenda W. C.; Rousch, Mat; Cleutjens, Kitty B. J. M.; Biessen, Erik A. L.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [de Jager, Saskia C. A.; van Berkel, Theo J. C.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Weber, Michael] Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany; [Kraaijeveld, Adriaan O.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [van Dieijen-Visser, Marja P.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Maastricht University; Leiden University; Leiden University - Excl LUMC; Kerckhoff Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Goethe University Frankfurt; Maastricht University; Maastricht University	Bongaerts, BWC (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands.	Brenda.Bongaerts@mumc.nl	de+Jager, Saskia/ABC-4264-2020; de+Jager, Saskia/AAE-1132-2022; Van Berkel, Theo/ABD-7677-2021	de Jager, Saskia/0000-0002-5233-0066; Dimmeler, Stefanie/0000-0002-1045-2436; Biessen, Erik/0000-0002-6454-8548	Netherlands Heart Foundation [M93.001]; Netherlands Scientific Organization, (Health Care Efficiency program grant) [170881003]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Scientific Organization, (Health Care Efficiency program grant)	This work was supported by the Netherlands Heart Foundation (grant M93.001, SCAdJ, AOK, TJCvB and EALB) and the Netherlands Scientific Organization, (Health Care Efficiency program grant 170881003 BWCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Butterfield LH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-173; Cavusoglu E, 2007, ARTERIOSCL THROM VAS, V27, P929, DOI 10.1161/01.ATV.0000258789.21585.76; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; de Jager SCA, 2008, J MOL CELL CARDIOL, V45, P446, DOI 10.1016/j.yjmcc.2008.06.003; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Frangogiannis NG, 2004, INFLAMM RES, V53, P585, DOI 10.1007/s00011-004-1298-5; Frangogiannis NG, 2004, CURR VASC PHARMACOL, V2, P163, DOI 10.2174/1570161043476375; Gonzalez-Quesada C, 2009, CURR ATHEROSCLER REP, V11, P131, DOI 10.1007/s11883-009-0021-y; Hagg Daniel A, 2009, Atherosclerosis, V204, pe15, DOI 10.1016/j.atherosclerosis.2008.10.010; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haumer M, 2005, J VASC SURG, V41, P610, DOI 10.1016/j.jvs.2005.01.013; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Kraaijeveld AO, 2007, CURR PHARM DESIGN, V13, P1039, DOI 10.2174/138161207780487584; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Simeoni E, 2004, EUR HEART J, V25, P1438, DOI 10.1016/j.ehj.2004.05.005; Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690; Tarzami ST, 2003, CIRCULATION, V108, P2387, DOI 10.1161/01.CIR.0000093192.72099.9A; Toor IS, 2008, J VASC SURG, V48, P1504, DOI 10.1016/j.jvs.2008.07.072; Vandervelde S, 2007, CARDIOVASC RES, V73, P783, DOI 10.1016/j.cardiores.2006.11.030; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vogiatzi K, 2009, THROMB RES, V124, P84, DOI 10.1016/j.thromres.2008.12.043; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	48	42	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45804	10.1371/journal.pone.0045804	http://dx.doi.org/10.1371/journal.pone.0045804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029252	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800101
J	Gao, YF; Chen, L; Cai, YD; Feng, KY; Huang, T; Jiang, Y				Gao, Yu-Fei; Chen, Lei; Cai, Yu-Dong; Feng, Kai-Yan; Huang, Tao; Jiang, Yang			Predicting Metabolic Pathways of Small Molecules and Enzymes Based on Interaction Information of Chemicals and Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; LOCALIZATION; SEQUENCES; STITCH	Metabolic pathway analysis, one of the most important fields in biochemistry, is pivotal to understanding the maintenance and modulation of the functions of an organism. Good comprehension of metabolic pathways is critical to understanding the mechanisms of some fundamental biological processes. Given a small molecule or an enzyme, how may one identify the metabolic pathways in which it may participate? Answering such a question is a first important step in understanding a metabolic pathway system. By utilizing the information provided by chemical-chemical interactions, chemical-protein interactions, and protein-protein interactions, a novel method was proposed by which to allocate small molecules and enzymes to 11 major classes of metabolic pathways. A benchmark dataset consisting of 3,348 small molecules and 654 enzymes of yeast was constructed to test the method. It was observed that the first order prediction accuracy evaluated by the jackknife test was 79.56% in identifying the small molecules and enzymes in a benchmark dataset. Our method may become a useful vehicle in predicting the metabolic pathways of small molecules and enzymes, providing a basis for some further analysis of the pathway systems.	[Gao, Yu-Fei; Jiang, Yang] Jilin Univ, Dept Surg, China Japan Union Hosp, Changchun 130023, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Feng, Kai-Yan] Shenzhen Beishan Ind Zone, Beijing Genom Inst, Shenzhen, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Jilin University; Shanghai Maritime University; Shanghai University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Jiang, Y (corresponding author), Jilin Univ, Dept Surg, China Japan Union Hosp, Changchun 130023, Peoples R China.	jy7555@163.com	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12YZ120, 12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ120, No. 12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2010, MED CHEM, V6, P388, DOI 10.2174/157340610793563983; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lu J, 2009, PROTEIN PEPTIDE LETT, V16, P969, DOI 10.2174/092986609788923374; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Mondal S, 2006, J THEOR BIOL, V243, P252, DOI 10.1016/j.jtbi.2006.06.014; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sun XD, 2006, AMINO ACIDS, V30, P469, DOI 10.1007/s00726-005-0239-0; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028	31	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45944	10.1371/journal.pone.0045944	http://dx.doi.org/10.1371/journal.pone.0045944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029334	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800125
J	Brattelid, T; Qvigstad, E; Moltzau, LR; Bekkevold, SVS; Sandnes, DL; Birkeland, JAK; Skomedal, T; Osnes, JB; Sjaastad, I; Levy, FO				Brattelid, Trond; Qvigstad, Eirik; Moltzau, Lise R.; Bekkevold, Silje V. S.; Sandnes, Dagny L.; Birkeland, Jon Arne K.; Skomedal, Tor; Osnes, Jan-Bjorn; Sjaastad, Ivar; Levy, Finn Olav			The Cardiac Ventricular 5-HT4 Receptor Is Functional in Late Foetal Development and Is Reactivated in Heart Failure	PLOS ONE			English	Article							POSITIVE INOTROPIC RESPONSE; MESSENGER-RNA; SPLICE VARIANTS; GENE-EXPRESSION; HUMAN ATRIUM; FAILING RAT; SEROTONIN; ANTAGONIST; BINDING; PROTEIN	A positive inotropic responsiveness to serotonin, mediated by 5-HT4 and 5-HT2A receptors, appears in the ventricle of rats with post-infarction congestive heart failure (HF) and pressure overload-induced hypertrophy. A hallmark of HF is a transition towards a foetal genotype which correlates with loss of cardiac functions. Thus, we wanted to investigate whether the foetal and neonatal cardiac ventricle displays serotonin responsiveness. Wistar rat hearts were collected day 3 and 1 before expected birth (days -3 and -1), as well as day 1, 3, 5 and 113 (age matched with Sham and HF) after birth. Hearts from post-infarction HF and sham-operated animals (Sham) were also collected. Heart tissue was examined for mRNA expression of 5-HT4, 5-HT2A and 5-HT2B serotonin receptors, 5-HT transporter, atrial natriuretic peptide (ANP) and myosin heavy chain (MHC)-alpha and MHC-beta (real-time quantitative RT-PCR) as well as 5-HT-receptor-mediated increase in contractile function ex vivo (electrical field stimulation of ventricular strips from foetal and neonatal rats and left ventricular papillary muscle from adult rats in organ bath). Both 5-HT4 mRNA expression and functional responses were highest at day -3 and decreased gradually to day 5, with a further decrease to adult levels. In HF, receptor mRNA levels and functional responses reappeared, but to lower levels than in the foetal ventricle. The 5-HT2A and 5-HT2B receptor mRNA levels increased to a maximum immediately after birth, but of these, only the 5-HT2A receptor mediated a positive inotropic response. We suggest that the 5-HT4 receptor is a representative of a foetal cardiac gene program, functional in late foetal development and reactivated in heart failure.	[Brattelid, Trond; Qvigstad, Eirik; Moltzau, Lise R.; Bekkevold, Silje V. S.; Sandnes, Dagny L.; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav] Univ Oslo, Dept Pharmacol, Fac Med, Oslo, Norway; [Brattelid, Trond; Qvigstad, Eirik; Moltzau, Lise R.; Bekkevold, Silje V. S.; Sandnes, Dagny L.; Birkeland, Jon Arne K.; Skomedal, Tor; Osnes, Jan-Bjorn; Sjaastad, Ivar; Levy, Finn Olav] Oslo Univ Hosp, Oslo, Norway; [Brattelid, Trond; Qvigstad, Eirik; Moltzau, Lise R.; Bekkevold, Silje V. S.; Birkeland, Jon Arne K.; Skomedal, Tor; Osnes, Jan-Bjorn; Sjaastad, Ivar; Levy, Finn Olav] Univ Oslo, Ctr Heart Failure Res, Fac Med, Oslo, Norway; [Brattelid, Trond] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Birkeland, Jon Arne K.; Sjaastad, Ivar] Univ Oslo, Expt Med Res Inst, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp Ullevaal, Dept Cardiol, Oslo, Norway; [Qvigstad, Eirik; Moltzau, Lise R.; Skomedal, Tor; Osnes, Jan-Bjorn; Sjaastad, Ivar; Levy, Finn Olav] KG Jebsen Cardiac Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Levy, FO (corresponding author), Univ Oslo, Dept Pharmacol, Fac Med, Oslo, Norway.	f.o.levy@medisin.uio.no		Moltzau, Lise Roman/0000-0002-8041-147X	The Norwegian Council on Cardiovascular Disease; The Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Foundation for the promotion of Science; The Novo Nordisk Foundation; The Simon Fougner Hartmann Family Foundation; The Family Blix Foundation	The Norwegian Council on Cardiovascular Disease; The Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Foundation for the promotion of Science; The Novo Nordisk Foundation(Novo Nordisk Foundation); The Simon Fougner Hartmann Family Foundation; The Family Blix Foundation	This work has been supported by The Norwegian Council on Cardiovascular Disease, The Research Council of Norway, Stiftelsen Kristian Gerhard Jebsen, Anders Jahre's Foundation for the promotion of Science, The Novo Nordisk Foundation, The Simon Fougner Hartmann Family Foundation and The Family Blix Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal F, 2008, BRIT J PHARMACOL, V155, P1005, DOI 10.1038/bjp.2008.339; Bach T, 2001, N-S ARCH PHARMACOL, V363, P146, DOI 10.1007/s002100000299; Bharti S, 2012, FEBS LETT, V586, P180, DOI 10.1016/j.febslet.2011.12.015; Birkeland JAK, 2007, BRIT J PHARMACOL, V150, P143, DOI 10.1038/sj.bjp.0706966; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Bonhaus DW, 1997, NEUROPHARMACOLOGY, V36, P621, DOI 10.1016/S0028-3908(97)00049-X; Brattelid T, 2004, N-S ARCH PHARMACOL, V370, P157, DOI 10.1007/s00210-004-0963-0; Brattelid T, 2007, J MOL CELL CARDIOL, V43, P767, DOI 10.1016/j.yjmcc.2007.08.019; Brattelid T, 2007, BASIC RES CARDIOL, V102, P198, DOI 10.1007/s00395-007-0648-1; Brattelid T, 2011, METHODS MOL BIOL, V746, P165, DOI 10.1007/978-1-61779-126-0_9; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Brudeli B, 2010, BIOORGAN MED CHEM, V18, P8600, DOI 10.1016/j.bmc.2010.10.011; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Florholmen G, 2004, ACTA PHYSIOL SCAND, V180, P133, DOI 10.1046/j.0001-6772.2003.01245.x; GUICHENEY P, 1981, BRIT J PHARMACOL, V73, P33, DOI 10.1111/j.1476-5381.1981.tb16768.x; Hara K, 2004, J LAB CLIN MED, V144, P31, DOI 10.1016/j.lab.2004.03.014; HEYMANN MA, 1981, ANNU REV PHYSIOL, V43, P371, DOI 10.1146/annurev.ph.43.030181.002103; Hirowatari Y, 2004, CLIN BIOCHEM, V37, P191, DOI 10.1016/j.clinbiochem.2003.11.009; Ikeda K, 2000, LIFE SCI, V67, P2991, DOI 10.1016/S0024-3205(00)00879-1; IYENGAR R, 1980, J BIOL CHEM, V255, P3558; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; JAHNEL U, 1992, N-S ARCH PHARMACOL, V346, P482; JUBERG EN, 1985, N-S ARCH PHARMACOL, V330, P193, DOI 10.1007/BF00572434; Kamel R, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-34; Kaumann AJ, 1996, N-S ARCH PHARMACOL, V353, P592; Kaumann AJ, 2006, PHARMACOL THERAPEUT, V111, P674, DOI 10.1016/j.pharmthera.2005.12.004; Kjekshus JK, 2009, EUR J HEART FAIL, V11, P771, DOI 10.1093/eurjhf/hfp087; KOJIMA M, 1990, BRIT J PHARMACOL, V99, P334, DOI 10.1111/j.1476-5381.1990.tb14704.x; KURSAR JD, 1994, MOL PHARMACOL, V46, P227; Laer S, 1998, BRIT J PHARMACOL, V123, P1182, DOI 10.1038/sj.bjp.0701702; Larsen KO, 2008, CARDIOVASC RES, V80, P47, DOI 10.1093/cvr/cvn180; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Medhurst AD, 2001, MOL BRAIN RES, V90, P125, DOI 10.1016/S0169-328X(01)00095-X; Muntasir HA, 2006, J PHARMACOL SCI, V102, P189, DOI 10.1254/jphs.FP0060610; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pindon A, 2002, MOL PHARMACOL, V61, P85, DOI 10.1124/mol.61.1.85; Qvigstad E, 2005, CIRC RES, V97, P268, DOI 10.1161/01.RES.0000176970.22603.8d; Qvigstad E, 2005, CARDIOVASC RES, V65, P869, DOI 10.1016/j.cardiores.2004.11.017; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sari Y, 2003, INT J DEV NEUROSCI, V21, P417, DOI 10.1016/j.ijdevneu.2003.10.002; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCHOEMAKER RG, 1993, EUR J PHARMACOL, V230, P103; Sjaastad I, 2003, ACTA PHYSIOL SCAND, V177, P449, DOI 10.1046/j.1365-201X.2003.01063.x; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; SKOMEDAL T, 1984, BIOCHEM PHARMACOL, V33, P1897, DOI 10.1016/0006-2952(84)90545-8; VANDENBERG EK, 1989, CIRCULATION, V79, P116, DOI 10.1161/01.CIR.79.1.116; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Waeber C, 1995, BEHAV BRAIN RES, V73, P259; WAELBROECK M, 1985, BIOCHEM J, V231, P469, DOI 10.1042/bj2310469; Wainscott DB, 1998, N-S ARCH PHARMACOL, V357, P17; Watts SW, 2005, CLIN SCI, V108, P399, DOI 10.1042/CS20040364; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088	59	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45489	10.1371/journal.pone.0045489	http://dx.doi.org/10.1371/journal.pone.0045489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029047	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900060
J	Huot, P; Johnston, TH; Gandy, MN; Reyes, MG; Fox, SH; Piggott, MJ; Brotchie, JM				Huot, Philippe; Johnston, Tom H.; Gandy, Michael N.; Reyes, M. Gabriela; Fox, Susan H.; Piggott, Matthew J.; Brotchie, Jonathan M.			The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; PSYCHOSIS-LIKE BEHAVIOR; L-DOPA; PARKINSONS-DISEASE; EXTRACELLULAR DOPAMINE; VISUAL HALLUCINATIONS; SYDNEY MULTICENTER; INDUCED DYSKINESIA; RECEPTOR AGONISTS; IN-VITRO	Background: The wearing-OFF phenomenon is a common motor complication of chronic L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for Parkinson's disease. We recently described the discovery of UWA-101, a dual serotonin (SERT) and dopamine (DAT) transporter inhibitor, which increases the duration of "good quality" ON-time provided by L-DOPA in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate. Here, we further characterise the effects of UWA-101 on this extension of ON-time in terms of L-DOPA-induced side-effects in the MPTP-lesioned common marmoset. Methods: Marmosets were rendered parkinsonian by MPTP injection and "primed" by repeated L-DOPA administration, to exhibit dyskinesia and psychosis-like behaviours. Animals were then administered acute challenges of L-DOPA in combination with UWA-101 (1, 3, 6 and 10 mg/kg) or vehicle. Results: In combination with L-DOPA, UWA-101 (3, 6 and 10 mg/kg) significantly increased duration of ON-time (by 28%, 28%, and 33%, respectively; all P<0.05). UWA-101 (10 mg/kg) significantly extended duration of ON-time without disabling dyskinesia (by 62%, P<0.01). UWA-101 did not exacerbate the severity of dyskinesia (P>0.05). However, at the highest doses (6 and 10 mg/kg), UWA-101 increased the severity of psychosis-like behaviours (P<0.05). Conclusions: Our results demonstrate that dual SERT/DAT inhibitors can effectively enhance L-DOPA anti-parkinsonian action, without exacerbating dyskinesia and, as such, represent a promising new therapeutic class for wearing-OFF. However, at higher doses, dual SERT/DAT inhibitors may exacerbate dopaminergic psychosis.	[Huot, Philippe; Johnston, Tom H.; Reyes, M. Gabriela; Fox, Susan H.; Brotchie, Jonathan M.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Huot, Philippe; Fox, Susan H.] Toronto Western Hosp, Div Neurol, Movement Disorder Clin, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; [Gandy, Michael N.; Piggott, Matthew J.] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Western Australia	Brotchie, JM (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	brotchie@uhnres.utoronto.ca	Piggott, Matthew J/A-3251-2008; Johnston, Tom H/D-2531-2018; Piggott, Matthew/K-6990-2019	Johnston, Tom H/0000-0002-1537-8175; Piggott, Matthew/0000-0002-5857-7051; Brotchie, Jonathan/0000-0003-2337-0816	Cure Parkinson's Trust; Krembil Neuroscience Fund; Edmond J Safra Philanthropic Foundation; Parkinson Society Canada; Canadian Institutes of Health Research; University of Western Australia Postgraduate Award; Merck; Merck Serono; Teva; Atuka Ltd; Atuka Inc.	Cure Parkinson's Trust; Krembil Neuroscience Fund; Edmond J Safra Philanthropic Foundation; Parkinson Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Australia Postgraduate Award; Merck(Merck & Company); Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Atuka Ltd; Atuka Inc.	This study was supported by The Cure Parkinson's Trust and Krembil Neuroscience Fund. PH was supported by Fellowships from the Edmond J Safra Philanthropic Foundation, the Parkinson Society Canada and the Canadian Institutes of Health Research. MNG was the recipient of an University of Western Australia Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. SHF has received consultancy fees from Merck, Merck Serono and Teva. JMB holds an equity position in Atuka Ltd. PH, THJ and JMB have received consultancy fees from Atuka Ltd and Atuka Inc. TH and JMB and hold equity positions in Atuka Inc. None of the above funds were used for this specific study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; ARAI R, 1995, NEUROSCI LETT, V195, P195, DOI 10.1016/0304-3940(95)11817-G; Ballanger B, 2010, ARCH NEUROL-CHICAGO, V67, P416, DOI 10.1001/archneurol.2010.35; Bara-Jimenez W, 2004, MOVEMENT DISORD, V19, P1183, DOI 10.1002/mds.20124; BERGER B, 1978, BRAIN RES, V147, P29, DOI 10.1016/0006-8993(78)90770-9; Berger B, 1978, Adv Biochem Psychopharmacol, V19, P405; Bhattacharyya S, 2006, P NATL ACAD SCI USA, V103, P15248, DOI 10.1073/pnas.0606578103; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Carta Manolo, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS154, DOI 10.1016/j.parkreldis.2008.04.021; Carta M, 2008, PROG BRAIN RES, V172, P465, DOI 10.1016/S0079-6123(08)00922-9; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Fox SH, 2002, MOVEMENT DISORD, V17, P1180, DOI 10.1002/mds.10289; Fox SH, 2006, ARCH NEUROL-CHICAGO, V63, P1343, DOI 10.1001/archneur.63.9.1343; Fox SH, 2010, CAN J NEUROL SCI, V37, P86, DOI 10.1017/S0317167100009707; Frackiewicz EJ, 2002, ANN PHARMACOTHER, V36, P225; Gallagher DA, 2011, BRAIN, V134, P3299, DOI 10.1093/brain/awr225; Gandy MN, 2010, MEDCHEMCOMM, V1, P287, DOI 10.1039/c0md00108b; Gomez-Ramirez J, 2006, MOVEMENT DISORD, V21, P839, DOI 10.1002/mds.20828; Gresch PJ, 2002, NEUROSCIENCE, V114, P707, DOI 10.1016/S0306-4522(02)00349-4; Hauser RA, 2007, MOVEMENT DISORD, V22, P359, DOI 10.1002/mds.21258; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; Hornykiewicz O, 1987, Adv Neurol, V45, P19; Huot P, 2011, J NEUROSCI, V31, P7190, DOI 10.1523/JNEUROSCI.1171-11.2011; Huot P, 2010, MOVEMENT DISORD, V25, P1399, DOI 10.1002/mds.23083; Johnston TH, 2012, FASEB J, V26, DOI [10.1096/fj.1011-195016, DOI 10.1096/FJ.1011-195016]; Kannari K, 2001, J NEUROCHEM, V76, P1346, DOI 10.1046/j.1471-4159.2001.00184.x; MELTZER HY, 1992, BRIT J PSYCHIAT, V160, P22, DOI 10.1192/S0007125000296876; Oz M, 2003, SYNAPSE, V50, P303, DOI 10.1002/syn.10273; Pearce RKB, 2002, MOVEMENT DISORD, V17, P877, DOI 10.1002/mds.10238; Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7; Rascol O, 2008, ARCH NEUROL-CHICAGO, V65, P577, DOI 10.1001/archneur.65.5.577; Rinne UK, 1998, NEUROLOGY, V51, P1309, DOI 10.1212/WNL.51.5.1309; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Visanji NP, 2006, MOVEMENT DISORD, V21, P1879, DOI 10.1002/mds.21073; Yamato H, 2001, NEUROREPORT, V12, P1123, DOI 10.1097/00001756-200105080-00015	39	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45587	10.1371/journal.pone.0045587	http://dx.doi.org/10.1371/journal.pone.0045587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029119	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900079
J	Kranjc, M; Bajd, F; Sersa, I; Woo, EJ; Miklavcic, D				Kranjc, Matej; Bajd, Franci; Sersa, Igor; Woo, Eung Je; Miklavcic, Damijan			Ex Vivo and In Silico Feasibility Study of Monitoring Electric Field Distribution in Tissue during Electroporation Based Treatments	PLOS ONE			English	Article							IMPEDANCE TOMOGRAPHY MREIT; IRREVERSIBLE ELECTROPORATION; ELECTROCHEMOTHERAPY; ELECTROTRANSFER; CONDUCTIVITY; METASTASES; PARAMETERS; ABLATION; CELLS; MODEL	Magnetic resonance electrical impedance tomography (MREIT) was recently proposed for determining electric field distribution during electroporation in which cell membrane permeability is temporary increased by application of an external high electric field. The method was already successfully applied for reconstruction of electric field distribution in agar phantoms. Before the next step towards in vivo experiments is taken, monitoring of electric field distribution during electroporation of ex vivo tissue ex vivo and feasibility for its use in electroporation based treatments needed to be evaluated. Sequences of high voltage pulses were applied to chicken liver tissue in order to expose it to electric field which was measured by means of MREIT. MREIT was also evaluated for its use in electroporation based treatments by calculating electric field distribution for two regions, the tumor and the tumor-liver region, in a numerical model based on data obtained from clinical study on electrochemotherapy treatment of deep-seated tumors. Electric field distribution inside tissue was successfully measured ex vivo using MREIT and significant changes of tissue electrical conductivity were observed in the region of the highest electric field. A good agreement was obtained between the electric field distribution obtained by MREIT and the actual electric field distribution in evaluated regions of a numerical model, suggesting that implementation of MREIT could thus enable efficient detection of areas with insufficient electric field coverage during electroporation based treatments, thus assuring the effectiveness of the treatment.	[Kranjc, Matej; Miklavcic, Damijan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia; [Bajd, Franci; Sersa, Igor] Jozef Stefan Inst, Ljubljana, Slovenia; [Woo, Eung Je] Kyung Hee Univ, Dept Biomed Engn, Seoul, South Korea	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Kyung Hee University	Miklavcic, D (corresponding author), Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia.	damijan.miklavcic@fe.uni-lj.si	Woo, Eung Je/ABH-6442-2020; Serša, Igor/AAN-5386-2021; Miklavčič, Damijan/A-9497-2008	Miklavčič, Damijan/0000-0003-3506-9449; Kranjc, Matej/0000-0002-7127-9673	Slovenian Research Agency (ARRS); Korean-Slovenian Scientific Cooperation	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Korean-Slovenian Scientific Cooperation	This study was supported by the Slovenian Research Agency (ARRS) and Korean-Slovenian Scientific Cooperation. Research was conducted in the scope of the Electroporation in Biology and Medicine European Associated Laboratory (LEA-EBAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corovic S, 2008, IEEE T PLASMA SCI, V36, P1665, DOI 10.1109/TPS.2008.2000996; Cukjati D, 2007, BIOELECTROCHEMISTRY, V70, P501, DOI 10.1016/j.bioelechem.2006.11.001; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Garcia PA, 2011, TECHNOL CANCER RES T, V10, P73, DOI 10.7785/tcrt.2012.500181; Granot Y, 2009, PHYS MED BIOL, V54, P4927, DOI 10.1088/0031-9155/54/16/006; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; Khang HS, 2002, IEEE T MED IMAGING, V21, P695, DOI 10.1109/TMI.2002.800604; Kim S, 2002, SIAM J MATH ANAL, V34, P511, DOI 10.1137/S0036141001391354; Kos B, 2010, J MEMBRANE BIOL, V236, P147, DOI 10.1007/s00232-010-9274-1; Kotnik T, 2010, J MEMBRANE BIOL, V236, P3, DOI 10.1007/s00232-010-9279-9; Kranjc M, 2011, IEEE T MED IMAGING, V30, P1771, DOI 10.1109/TMI.2011.2147328; Kwon O, 2002, IEEE T BIO-MED ENG, V49, P160, DOI 10.1109/10.979355; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Mezeme ME, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3700727; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Miklavcic D, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-10; Mir LM, 1999, ADV DRUG DELIVER REV, V35, P107, DOI 10.1016/S0169-409X(98)00066-0; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; Pavliha D, 2012, BIOELECTROCHEMISTRY, V87, P265, DOI 10.1016/j.bioelechem.2012.01.007; Pavlin M, 2005, BIOPHYS J, V88, P4378, DOI 10.1529/biophysj.104.048975; Pucihar G, 2011, IEEE T BIO-MED ENG, V58, P3279, DOI 10.1109/TBME.2011.2167232; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Sel D, 2005, IEEE T BIO-MED ENG, V52, P816, DOI 10.1109/TBME.2005.845212; Seo JK, 2011, SIAM REV, V53, P40, DOI 10.1137/080742932; SERSA G, 1995, CANCER RES, V55, P3450; Sersa G, 2008, JOVE; Sersa G, 2012, CANCER TREAT REV, V38, P379, DOI 10.1016/j.ctrv.2011.07.006; SERSA I, 1994, J MAGN RESON SER A, V111, P93, DOI 10.1006/jmra.1994.1230; Sersa I, 2008, J MAGN RESON, V190, P86, DOI 10.1016/j.jmr.2007.10.009; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Zhang Y, 2010, RADIOLOGY, V256, P424, DOI 10.1148/radiol.10091955; Zupanic A, 2012, PHYS MED BIOL, V57, P5425, DOI 10.1088/0031-9155/57/17/5425	36	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45737	10.1371/journal.pone.0045737	http://dx.doi.org/10.1371/journal.pone.0045737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029212	Green Published, gold			2022-12-27	WOS:000309388900096
J	Rohrer, S; Holsten, L; Weiss, E; Benghezal, M; Fischer, W; Haas, R				Rohrer, Stefanie; Holsten, Lea; Weiss, Evelyn; Benghezal, Mohammed; Fischer, Wolfgang; Haas, Rainer			Multiple Pathways of Plasmid DNA Transfer in Helicobacter pylori	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; TRANSFORMATION COMPETENCE; GENETIC-TRANSFORMATION; NATURAL COMPETENCE; MEMBRANE VESICLES; SYSTEM; RECOMBINATION; RELAXASE; COMPONENTS; EVOLUTION	Many Helicobacter pylori (Hp) strains carry cryptic plasmids of different size and gene content, the function of which is not well understood. A subgroup of these plasmids (e.g. pHel4, pHel12), contain a mobilisation region, but no cognate type IV secretion system (T4SS) for conjugative transfer. Instead, certain H. pylori strains (e. g. strain P12 carrying plasmid pHel12) can harbour up to four T4SSs in their genome (cag-T4SS, comB, tfs3, tfs4). Here, we show that such indigenous plasmids can be efficiently transferred between H. pylori strains, even in the presence of extracellular DNaseI eliminating natural transformation. Knockout of a plasmid-encoded mobA relaxase gene significantly reduced plasmid DNA transfer in the presence of DNaseI, suggesting a DNA conjugation or mobilisation process. To identify the T4SS involved in this conjugative DNA transfer, each individual T4SS was consecutively deleted from the bacterial chromosome. Using a marker-free counterselectable gene deletion procedure (rpsL counterselection method), a P12 mutant strain was finally obtained with no single T4SS (P12 Delta T4SS). Mating experiments using these mutants identified the comB T4SS in the recipient strain as the major mediator of plasmid DNA transfer between H. pylori strains, both in a DNaseI-sensitive (natural transformation) as well as a DNaseI-resistant manner (conjugative transfer). However, transfer of a pHel12::cat plasmid from a P12 Delta T4SS donor strain into a P12 Delta T4SS recipient strain provided evidence for the existence of a third, T4SS-independent mechanism of DNA transfer. This novel type of plasmid DNA transfer, designated as alternate DNaseI-Resistant (ADR) mechanism, is observed at a rather low frequency under in vitro conditions. Taken together, our study describes for the first time the existence of three distinct pathways of plasmid DNA transfer between H. pylori underscoring the importance of horizontal gene transfer for this species.	[Rohrer, Stefanie; Holsten, Lea; Weiss, Evelyn; Fischer, Wolfgang; Haas, Rainer] Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany; [Benghezal, Mohammed] Univ Western Australia, H Pylori Res Lab, Nedlands, WA 6009, Australia; [Benghezal, Mohammed] Ondek Pty Ltd, Nedlands, WA, Australia	University of Munich; University of Western Australia	Haas, R (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	haas@mvp.uni-muenchen.de		Benghezal, Mohammed/0000-0002-4207-0192	Deutsche Forschungsgemeinschaft [HA2697/10-1]; 30 ERA-NET PathoGenoMics 3 HELDIVPAT [0315905C]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 30 ERA-NET PathoGenoMics 3 HELDIVPAT	This work was supported by the Deutsche Forschungsgemeinschaft (HA2697/10-1) and by 30 ERA-NET PathoGenoMics 3 HELDIVPAT (0315905C) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Backert S, 2005, MICROBIOL-SGM, V151, P3493, DOI 10.1099/mic.0.28250-0; BOYD AC, 1989, MOL GEN GENET, V217, P488; Castillo AR, 2008, INFECT IMMUN, V76, P5632, DOI 10.1128/IAI.00627-08; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; De Ungria MCA, 1999, PLASMID, V41, P97, DOI 10.1006/plas.1998.1383; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hofler C, 2004, INT J MED MICROBIOL, V294, P141, DOI 10.1016/j.ijmm.2004.06.021; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; KLEANTHOUS H, 1991, MOL MICROBIOL, V5, P2377, DOI 10.1111/j.1365-2958.1991.tb02084.x; Kuipers EJ, 1998, J BACTERIOL, V180, P2901, DOI 10.1128/JB.180.11.2901-2905.1998; Lin EA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000337; NEDENSKOVSORENSEN P, 1990, J INFECT DIS, V161, P365, DOI 10.1093/infdis/161.2.365; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; PANSEGRAU W, 1994, J BIOL CHEM, V269, P2782; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; PENFOLD SS, 1988, J INFECT DIS, V157, P850, DOI 10.1093/infdis/157.4.850; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMITT W, 1995, MOL GEN GENET, V248, P563, DOI 10.1007/BF02423452; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; SEGAL ED, 1993, BIOTECHNIQUES, V14, P225; Song JY, 2003, PLASMID, V50, P236, DOI 10.1016/S0147-619X(03)00061-1; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x	40	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45623	10.1371/journal.pone.0045623	http://dx.doi.org/10.1371/journal.pone.0045623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029142	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900083
J	Chen, SJ; Yen, CH; Huang, YC; Lee, BJ; Hsia, S; Lin, PT				Chen, Shu-Ju; Yen, Chi-Hua; Huang, Yi-Chia; Lee, Bor-Jen; Hsia, Simon; Lin, Ping-Ting			Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; INTERLEUKIN-6; OBESITY; PREVALENCE; HYPERTENSION; ASSOCIATION; POPULATION; MARKERS	Metabolic syndrome (MS) represents a cluster of physiological and anthropometric abnormalities. The purpose of this study was to investigate the relationships between the levels of inflammation, adiponectin, and oxidative stress in subjects with MS. The inclusion criteria for MS, according to the Taiwan Bureau of Health Promotion, Department of Health, were applied to the case group (n = 72). The control group (n = 105) comprised healthy individuals with normal blood biochemical values. The levels of inflammatory markers [high sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6), adiponectin, an oxidative stress marker (malondialdehyde), and antioxidant enzymes activities [catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx)] were measured. Subjects with MS had significantly higher concentrations of inflammatory markers and lower adiponectin level, and lower antioxidant enzymes activities than the control subjects. The levels of inflammatory markers and adiponectin were significantly correlated with the components of MS. The level of hs-CRP was significantly correlated with the oxidative stress marker. The IL-6 level was significantly correlated with the SOD and GPx activities, and the adiponectin level was significantly correlated with the GPx activity. A higher level of hs-CRP (>= 1.00 mg/L), or IL-6 (>= 1.50 pg/mL) or a lower level of adiponectin (<7.90 mu g/mL) were associated with a significantly greater risk of MS. In conclusion, subjects suffering from MS may have a higher inflammation status and a higher level of oxidative stress. A higher inflammation status was significantly correlated with decreases in the levels of antioxidant enzymes and adiponectin and an increase in the risk of MS.	[Huang, Yi-Chia; Lee, Bor-Jen; Lin, Ping-Ting] Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan; [Chen, Shu-Ju] Chung Chou Univ Sci & Technol, Dept Hlth Food, Changhua, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ, Ctr Educ & Res Geriatr & Gerontol, Taichung, Taiwan; [Huang, Yi-Chia; Lin, Ping-Ting] Chung Shan Med Univ Hosp, Dept Nutr, Taichung, Taiwan; [Lee, Bor-Jen] Taichung Vet Gen Hosp, Intens Care Unit, Taichung, Taiwan; [Hsia, Simon] HungKuang Univ, Dept Nutr, Taichung, Taiwan; [Hsia, Simon] HungKuang Univ, Inst Biomed Nutr, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Hungkuang University; Hungkuang University	Lin, PT (corresponding author), Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan.	apt810@csmu.edu.tw	Huang, Yi-Chia/AAS-8877-2021; Stefanadis, Christodoulos/ABH-2232-2020	Huang, Yi-Chia/0000-0003-2234-4464; Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council of Taiwan [NSC 99-2320-B-040-011]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council (NSC 99-2320-B-040-011) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Antoniades C, 2003, HERZ, V28, P628, DOI 10.1007/s00059-003-2417-8; BATAILLE R, 1992, ARTHRITIS RHEUM-US, V35, P982, DOI 10.1002/art.1780350824; CERIELLO A, 1993, DIABETOLOGIA, V36, P265, DOI 10.1007/BF00399961; Choi KM, 2007, DIABETES RES CLIN PR, V75, P235, DOI 10.1016/j.diabres.2006.06.019; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Das UN, 2004, CURR HYPERTENS REP, V6, P66, DOI 10.1007/s11906-004-0014-8; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Giugliano D, 2000, NUTR METAB CARDIOVAS, V10, P38; GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Karaouzene N, 2011, NUTR METAB CARDIOVAS, V21, P792, DOI 10.1016/j.numecd.2010.02.007; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; Lapenna D, 2001, FREE RADICAL BIO MED, V31, P331, DOI 10.1016/S0891-5849(01)00584-6; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292	30	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45693	10.1371/journal.pone.0045693	http://dx.doi.org/10.1371/journal.pone.0045693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029185	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400121
J	Kang, XJ; Herron, TJ; Cate, AD; Yund, EW; Woods, DL				Kang, Xiaojian; Herron, Timothy J.; Cate, Anthony D.; Yund, E. William; Woods, David L.			Hemispherically-Unified Surface Maps of Human Cerebral Cortex: Reliability and Hemispheric Asymmetries	PLOS ONE			English	Article							CORTICAL THICKNESS; HUMAN BRAIN; SYSTEM; AREA; MORPHOMETRY; MRI; ORGANIZATION; ATLAS; GYRI	Understanding the anatomical and structural organization of the cerebral cortex is facilitated by surface-based analysis enabled by FreeSurfer, Caret, and related tools. Here, we examine the precision of FreeSurfer parcellation of the cortex and introduce a method to align FreeSurfer-registered left and right hemispheres onto a common template in order to characterize hemispheric asymmetries. The results are visualized using Mollweide projections, an area-preserving map. The regional distribution, inter-hemispheric asymmetries and intersubject variability in cortical curvature, sulcal depth, cortical thickness, and cortical surface area of 138 young, right handed subjects were analyzed on the Mollweide projection map of the common spherical space. The results show that gyral and sulcal structures are aligned with high but variable accuracy in different cortical regions and show consistent hemispheric asymmetries that are maximal in posterior temporal regions.	[Kang, Xiaojian; Herron, Timothy J.; Cate, Anthony D.; Yund, E. William; Woods, David L.] Dept Vet Affairs Med Ctr, VA Res Serv, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Kang, Xiaojian; Woods, David L.] Dept Neurol, Sacramento, CA USA; [Kang, Xiaojian; Woods, David L.] Ctr Neurosci, Sacramento, CA USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA USA	University of California System; University of California Davis	Kang, XJ (corresponding author), Dept Vet Affairs Med Ctr, VA Res Serv, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.	xkang@ucdavis.edu	Cate, Anthony/R-5104-2019	Cate, Anthony/0000-0003-0135-1622; Herron, Timothy/0000-0002-4297-014X; Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587	Research Service of the U.S. Department of Veterans Affairs	Research Service of the U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the Research Service of the U.S. Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2008, NEUROIMAGE, V41, P835, DOI 10.1016/j.neuroimage.2008.02.052; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Balasubramanian M, 2010, NEUROIMAGE, V51, P694, DOI 10.1016/j.neuroimage.2010.02.008; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Datta R, 2011, CEPHALALGIA, V31, P1452, DOI 10.1177/0333102411421025; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Devlin JT, 2003, J NEUROSCI, V23, P11516; Feeman TG, 2000, SIAM REV, V42, P109, DOI 10.1137/S0036144599358997; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Glasser M.F., 2011, CEREB CORTEX; Goldberg D.M., 2007, CARTOGRAPHICA INT J, V42, P297, DOI [https://doi.org/10.3138/carto.42.4.297, DOI 10.3138/CARTO.42.4.297]; Hagler D. J., 2006, NEUROIMAGE; Hamilton LS, 2007, NEUROREPORT, V18, P1427, DOI 10.1097/WNR.0b013e3282e9a5a2; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hurdal MK, 2004, NEUROIMAGE, V23, pS119, DOI 10.1016/j.neuroimage.2004.07.018; Huster RJ, 2007, NEUROIMAGE, V34, P888, DOI 10.1016/j.neuroimage.2006.10.023; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Janauskaite L, 2008, MED LITH, V44, P126, DOI 10.3390/medicina44020016; Jo HJ, 2007, NEUROIMAGE, V34, P550, DOI 10.1016/j.neuroimage.2006.09.047; Jouandet M L, 1989, J Cogn Neurosci, V1, P88, DOI 10.1162/jocn.1989.1.1.88; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Koo BB, 2010, INT J IMAG SYST TECH, V20, P117, DOI 10.1002/ima.20230; Luders E, 2006, CEREB CORTEX, V16, P1232, DOI 10.1093/cercor/bhj064; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; Lyttelton OC, 2009, NEUROIMAGE, V46, P895, DOI 10.1016/j.neuroimage.2009.03.063; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Makris N, 2006, NEUROIMAGE, V33, P139, DOI 10.1016/j.neuroimage.2006.04.220; Mangin JF, 2010, CURR OPIN NEUROL, V23, P359, DOI 10.1097/WCO.0b013e32833a0afc; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Meyer JR, 1996, AM J NEURORADIOL, V17, P1699; Mietchen Daniel, 2009, Front Neuroinform, V3, P25, DOI 10.3389/neuro.11.025.2009; Modha DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005693; Ono M, 1990, ATLAS CEREBRAL SULCI; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pereira JB, 2011, HUMAN BRAIN MAPPING; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanchez-Panchuelo RM, 2010, J NEUROPHYSIOL, V103, P2544, DOI 10.1152/jn.01017.2009; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Sultan F, 2010, MAGN RESON IMAGING, V28, P1159, DOI 10.1016/j.mri.2010.03.023; TBLER WR, 1973, J GEOPHYS RES, V78, P1753, DOI 10.1029/JB078i011p01753; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Woods DL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00042; Woods DL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00155; Woods DL, 2011, FRONT HUMAN IN PRESS; Yang Q., 2000, MAP PROJECTION TRANS	64	27	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45582	10.1371/journal.pone.0045582	http://dx.doi.org/10.1371/journal.pone.0045582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029115	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900160
J	Zhang, D; Cui, JG; Tang, YZ				Zhang, Dian; Cui, Jianguo; Tang, Yezhong			Plasticity of Peripheral Auditory Frequency Sensitivity in Emei Music Frog	PLOS ONE			English	Article							BRAIN-STEM RESPONSES; SONG CONTROL-SYSTEM; SEASONAL PLASTICITY; ADVERTISEMENT CALLS; GROUND-SQUIRRELS; LEOPARD FROG; MIDDLE-EAR; SONGBIRDS; ANDROGEN; NUCLEI	In anurans reproductive behavior is strongly seasonal. During the spring, frogs emerge from hibernation and males vocalize for mating or advertising territories. Female frogs have the ability to evaluate the quality of the males' resources on the basis of these vocalizations. Although studies revealed that central single torus semicircularis neurons in frogs exhibit season plasticity, the plasticity of peripheral auditory sensitivity in frog is unknown. In this study the seasonally plasticity of peripheral auditory sensitivity was test in the Emei music frog Babina daunchina, by comparing thresholds and latencies of auditory brainstem responses (ABRs) evoked by tone pips and clicks in the reproductive and non-reproductive seasons. The results show that both ABR thresholds and latency differ significantly between the reproductive and non-reproductive seasons. The thresholds of tone pip evoked ABRs in the non-reproductive season increased significantly about 10 dB than those in the reproductive season for frequencies from 1 KHz to 6 KHz. ABR latencies to waveform valley values for tone pips for the same frequencies using appropriate threshold stimulus levels are longer than those in the reproductive season for frequencies from 1.5 to 6 KHz range, although from 0.2 to 1.5 KHz range it is shorter in the non-reproductive season. These results demonstrated that peripheral auditory frequency sensitivity exhibits seasonal plasticity changes which may be adaptive to seasonal reproductive behavior in frogs.	[Zhang, Dian] Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Sichuan, Peoples R China; [Zhang, Dian; Cui, Jianguo; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Cui, JG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	cuijg@cib.ac.cn; Tangyz@cib.ac.cn			National Natural Science Foundation of China [30900141]; Chinese Academy of Sciences [KSCX2-EW-J-22]; Youth Innovation Promotion Association of Chinese Academy of Sciences [Y2C3011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (30900141), the Chinese Academy of Sciences (KSCX2-EW-J-22) and Youth Innovation Promotion Association of Chinese Academy of Sciences (Y2C3011) to Jianguo Cui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball GF, 1999, DESIGN OF ANIMAL COMMUNICATION, P213; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Brenowitz EA, 2004, ANN NY ACAD SCI, V1016, P560, DOI 10.1196/annals.1298.006; Brittan-Powell EF, 2010, J ACOUST SOC AM, V128, P787, DOI 10.1121/1.3458813; Buck CL, 2003, HORM BEHAV, V43, P318, DOI 10.1016/S0018-506X(02)00050-8; Chen Q, 2011, J HERPETOL, V45, P406; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; Chu J, 2002, NEUROENDOCRINOLOGY, V76, P18, DOI 10.1159/000063680; Cui JG, 2012, BIOL LETTERS, V8, P337, DOI 10.1098/rsbl.2011.1091; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Freeberg TM, 2007, INFORM CHICK A DEE C, P199; Goense JBM, 2005, J NEUROBIOL, V65, P22, DOI 10.1002/neu.20172; HAMILL NJ, 1989, J COMP PHYSIOL B, V159, P159, DOI 10.1007/BF00691736; Katbamna B, 2006, J COMP PHYSIOL A, V192, P381, DOI 10.1007/s00359-005-0076-3; Lucas JR, 2007, J COMP PHYSIOL A, V193, P201, DOI 10.1007/s00359-006-0180-z; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; RYAN MJ, 1995, SCIENCE, V269, P390, DOI 10.1126/science.269.5222.390; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Smith GT, 1997, J NEUROSCI, V17, P6001; Smith GT, 1996, BRAIN RES, V734, P79, DOI 10.1016/S0006-8993(96)00613-0; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Wilczynski W, 2003, J NEUROBIOL, V56, P54, DOI 10.1002/neu.10228; Wollerman L, 1999, ANIM BEHAV, V57, P529, DOI 10.1006/anbe.1998.1013	28	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45792	10.1371/journal.pone.0045792	http://dx.doi.org/10.1371/journal.pone.0045792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029243	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900169
J	Bshary, A; Bshary, R				Bshary, Andrea; Bshary, Redouan			Individual Differences in Foraging Strategies of Parasitic Sabre-Tooth Blennies	PLOS ONE			English	Article							VOLUNTEERS DILEMMA; BEHAVIORAL SYNDROMES; FLOWER CONSTANCY; NATIONAL-PARK; COOPERATION; PUNISHMENT; EVOLUTION; FREQUENCY; SPECIALIZATION; BENEFITS	Originally, evolutionary game theory typically predicted that optimal behaviour in a given situation is uniform or bimodal. However, the growing evidence that animals behave more variably while individuals may differ consistently in their behaviour, has led to the development of models that predict a distribution of strategies. Here we support the importance of such models in a study on a coral reef fish host-parasite system. Parasitic blennies (Plagiotremus sp.) regularly attack other fishes to bite off scales and mucus. Individuals of some victim species react to being bitten with punishing the parasite through aggressive chasing. Our field observations and laboratory experiments show that individual blennies differ markedly in how they incorporate being punished into their foraging decisions. We discuss how these differences may affect the payoff structure and hence the net effect of punishment on punishers and on the appearance of a public good for look-alikes.	[Bshary, Andrea; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Bshary, A (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	andrea.bshary@unine.ch		Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council fellowship [NER/A/S/2002/00898]; Swiss Science Foundation [3100A0-120552/1]; Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was financed by grant number NER/A/S/2002/00898 by the Natural Environment Research Council fellowship (http://www.nerc.ac.uk/) to Rufus Johnstone and R.B. and grant number 3100A0-120552/1 by the Swiss Science Foundation (http://www.snf.ch/E/Pages/default.aspx) to R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, J EVOLUTION BIOL, V22, P2192, DOI 10.1111/j.1420-9101.2009.01835.x; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2011, EVOLUTION, V65, P885, DOI 10.1111/j.1558-5646.2010.01176.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; AVISE JC, 1986, EVOLUTION, V40, P1051, DOI 10.1111/j.1558-5646.1986.tb00572.x; Bergmuller R, 2010, PHILOS T R SOC B, V365, P2751, DOI 10.1098/rstb.2010.0124; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Bshary A, 2010, ETHOLOGY, V116, P681, DOI 10.1111/j.1439-0310.2010.01781.x; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Cisarovsky G, 2012, ETHOLOGY, V118, P850, DOI 10.1111/j.1439-0310.2012.02075.x; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Darlington RB, 2008, SIGN TEST TABLE; Davies NB, 2012, INTRO BEHAV ECOLOGY; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gigerenzer G., 2002, BOUNDED RATIONALITY; Hamblin S, 2009, ANIM BEHAV, V78, P1343, DOI 10.1016/j.anbehav.2009.09.001; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; HOPPEDOMINIK B, 1984, MAMMALIA, V48, P477, DOI 10.1515/mamm.1984.48.4.477; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Ishii Y, 2010, POPUL ECOL, V52, P27, DOI 10.1007/s10144-009-0185-x; Johnson ML, 2006, MAR BIOL, V148, P889, DOI 10.1007/s00227-005-0118-y; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; Maynard Smith J., 1982, pi; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; NSHOMBO M, 1994, ENVIRON BIOL FISH, V39, P59, DOI 10.1007/BF00004757; OLLASON JG, 1980, THEOR POPUL BIOL, V18, P44, DOI 10.1016/0040-5809(80)90039-8; Preacher K.J., 2001, CALCULATION CHI SQUA; Raihani NJ, 2011, EVOLUTION, V65, P2725, DOI 10.1111/j.1558-5646.2011.01383.x; Rana JS, 2002, J ANIM ECOL, V71, P15, DOI 10.1046/j.0021-8790.2001.00574.x; Schindler DE, 1997, OECOLOGIA, V110, P592, DOI 10.1007/s004420050200; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; Sherratt TN, 2009, FRONT BIOSCI-LANDMRK, V14, P4557, DOI 10.2741/3548; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith-Vaniz W.F., 1976, MONOGRAPH ACAD NATUR, V19, p[i, 1]; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051	47	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45998	10.1371/journal.pone.0045998	http://dx.doi.org/10.1371/journal.pone.0045998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029356	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900071
J	Hwang, WS; Weirauch, C				Hwang, Wei Song; Weirauch, Christiane			Evolutionary History of Assassin Bugs (Insecta: Hemiptera: Reduviidae): Insights from Divergence Dating and Ancestral State Reconstruction	PLOS ONE			English	Article							COMPREHENSIVE PHYLOGENY; MOLECULAR CLOCK; DIVERSIFICATION; REVEALS; ORIGIN; HETEROPTERA; LINEAGES; AGE; BIOGEOGRAPHY; REDUVIOIDEA	Assassin bugs are one of the most successful clades of predatory animals based on their species numbers (similar to 6,800 spp.) and wide distribution in terrestrial ecosystems. Various novel prey capture strategies and remarkable prey specializations contribute to their appeal as a model to study evolutionary pathways involved in predation. Here, we reconstruct the most comprehensive reduviid phylogeny (178 taxa, 18 subfamilies) to date based on molecular data (5 markers). This phylogeny tests current hypotheses on reduviid relationships emphasizing the polyphyletic Reduviinae and the blood-feeding, disease-vectoring Triatominae, and allows us, for the first time in assassin bugs, to reconstruct ancestral states of prey associations and microhabitats. Using a fossil-calibrated molecular tree, we estimated divergence times for key events in the evolutionary history of Reduviidae. Our results indicate that the polyphyletic Reduviinae fall into 11-14 separate clades. Triatominae are paraphyletic with respect to the reduviine genus Opisthacidius in the maximum likelihood analyses; this result is in contrast to prior hypotheses that found Triatominae to be monophyletic or polyphyletic and may be due to the more comprehensive taxon and character sampling in this study. The evolution of blood-feeding may thus have occurred once or twice independently among predatory assassin bugs. All prey specialists evolved from generalist ancestors, with multiple evolutionary origins of termite and ant specializations. A bark-associated life style on tree trunks is ancestral for most of the lineages of Higher Reduviidae; living on foliage has evolved at least six times independently. Reduviidae originated in the Middle Jurassic (178 Ma), but significant lineage diversification only began in the Late Cretaceous (97 Ma). The integration of molecular phylogenetics with fossil and life history data as presented in this paper provides insights into the evolutionary history of reduviids and clears the way for in-depth evolutionary hypothesis testing in one of the most speciose clades of predators.	[Hwang, Wei Song; Weirauch, Christiane] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hwang, WS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	weisong.hwang@email.ucr.edu	Hwang, Wei Song/J-4679-2013	Hwang, Wei Song/0000-0003-3462-2142	National Science Foundation Reduviidae [PEET DEB-0933853]; University of California, Riverside (UCR); Department of Entomology; UCR Graduate Division Dissertation Year Program Award; American Museum of Natural History Collection Study Grant	National Science Foundation Reduviidae; University of California, Riverside (UCR); Department of Entomology; UCR Graduate Division Dissertation Year Program Award; American Museum of Natural History Collection Study Grant	The study was financially supported by National Science Foundation Reduviidae PEET DEB-0933853, University of California, Riverside (UCR) Department of Entomology, UCR Graduate Division Dissertation Year Program Award and American Museum of Natural History Collection Study Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Arillo Antonio, 2005, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V352, P1; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown RP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-271; Buckley TR, 2007, BIOL J LINN SOC, V91, P419, DOI 10.1111/j.1095-8312.2007.00807.x; CARAYON JACQUES, 1950, BULL MUS NATION HIST NAT [ PARIS], V22, P95; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; DAVIS NT, 1966, ANN ENTOMOL SOC AM, V59, P911, DOI 10.1093/aesa/59.5.911; DAVIS NT, 1969, ANN ENTOMOL SOC AM, V62, P74, DOI 10.1093/aesa/62.1.74; de Paula AS, 2005, MOL PHYLOGENET EVOL, V35, P712, DOI 10.1016/j.ympev.2005.03.003; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Distant W.L, 1904, FAUNA BRIT INDIA INC; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Forero D, 2011, J MORPHOL, V272, P204, DOI 10.1002/jmor.10907; Froeschner R.C., 1989, Entomography, V6, P1; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Graham A, 2011, AM J BOT, V98, P336, DOI 10.3732/ajb.1000353; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Jacobson E., 1911, TIJDSCHRIFT ENTOMOL, V54, P175; Jung S, 2012, SYST ENTOMOL, V37, P22, DOI 10.1111/j.1365-3113.2011.00596.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; LENT H., 1956, REV BRASIL BIOL, V16, P327; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032152; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; LOUIS D, 1974, AM MIDL NAT, V91, P68, DOI 10.2307/2424512; Maddison WP, 2011, MESQUITE MODULAR SYS; Maldonado-Capriles J., 1990, SYSTEMATIC CATALOGUE, P1; MCMAHAN EA, 1983, ANN ENTOMOL SOC AM, V76, P483, DOI 10.1093/aesa/76.3.483; Melo MC, 2007, INSECT SYST EVOL, V38, P51, DOI 10.1163/187631207788784021; MILLER N. C. E., 1953, TRANS ZOOL SOC LONDON, V27, P541; Miller N. C. E., 1959, Bulletin of the British Museum (Natural History) Entomology, V8, P49; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Patterson JS, 2010, MOL PHYLOGENET EVOL, V56, P608, DOI 10.1016/j.ympev.2010.04.038; Patterson JS, 2009, ACTA TROP, V110, P187, DOI 10.1016/j.actatropica.2008.09.008; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Putshkov VG, 1985, KATALOG RODOV KHISHC, P1; Readio P. A., 1927, Science Bulletin University of Kansas, V17, P1; Ryckman R. E., 1954, Bulletin of the Southern California Academy of Sciences, V53, P88; Scheffer SJ, 2000, MOL PHYLOGENET EVOL, V17, P244, DOI 10.1006/mpev.2000.0830; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Schofield C.J., 2000, CAD SAUDE PUBLICA, V16, pS89; Schofield CJ, 1994, TRIATOMINAEBIOLOGY C; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Scudder S.H., 1891, B US GEOLOGICAL SURV, V71, P1, DOI [10.5962/bhl.title.34455, DOI 10.5962/BHL.TITLE.34455]; Shcherbakov D. E., 2007, Russian Entomological Journal, V16, P401; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Smith VS, 2011, BIOL LETTERS, V7, P782, DOI 10.1098/rsbl.2011.0105; Soley FG, 2011, NEW ZEAL J ZOOL, V38, P297, DOI 10.1080/03014223.2011.604092; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stireman JO, 2005, J EVOLUTION BIOL, V18, P325, DOI 10.1111/j.1420-9101.2004.00850.x; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Urban JM, 2007, MOL PHYLOGENET EVOL, V42, P556, DOI 10.1016/j.ympev.2006.08.009; Urban JM, 2010, SYST ENTOMOL, V35, P678, DOI 10.1111/j.1365-3113.2010.00539.x; Usinger RL, 1967, MONOGRAPH CIMICIDAE, V7, P1; Usinger Robert L, 1943, ANN ENT SOC AMERICA, V36, P602; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Veevers JJ, 2004, EARTH-SCI REV, V68, P1, DOI 10.1016/j.earscirev.2004.05.002; Verard C, 2012, J GEODYN, V53, P43, DOI 10.1016/j.jog.2011.07.007; Weirauch C, 2008, SYST ENTOMOL, V33, P229, DOI 10.1111/j.1365-3113.2007.00417.x; Weirauch C, 2011, CLADISTICS, V27, P138, DOI 10.1111/j.1096-0031.2010.00325.x; Weirauch C, 2009, MOL PHYLOGENET EVOL, V53, P287, DOI 10.1016/j.ympev.2009.05.039; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wignall AE, 2011, P ROY SOC B-BIOL SCI, V278, P1427, DOI 10.1098/rspb.2010.2060; WYGODZINSKY PEDRO, 1964, AMER MUS NOVITATES, P1; Zhang GY, 2013, ACTA ZOOL-STOCKHOLM, V94, P1, DOI 10.1111/j.1463-6395.2011.00522.x	84	128	130	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45523	10.1371/journal.pone.0045523	http://dx.doi.org/10.1371/journal.pone.0045523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029072	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900044
J	Arvanitis, CD; Livingstone, MS; Vykhodtseva, N; McDannold, N				Arvanitis, Costas D.; Livingstone, Margaret S.; Vykhodtseva, Natalia; McDannold, Nathan			Controlled Ultrasound-Induced Blood-Brain Barrier Disruption Using Passive Acoustic Emissions Monitoring	PLOS ONE			English	Article							FOCUSED ULTRASOUND; CAVITATION THRESHOLD; CONTRAST AGENT; MICROBUBBLES; DELIVERY; SINGLE; PROPAGATION; FREQUENCY; COLLAPSE; EFFICACY	The ability of ultrasonically-induced oscillations of circulating microbubbles to permeabilize vascular barriers such as the blood-brain barrier (BBB) holds great promise for noninvasive targeted drug delivery. A major issue has been a lack of control over the procedure to ensure both safe and effective treatment. Here, we evaluated the use of passively-recorded acoustic emissions as a means to achieve this control. An acoustic emissions monitoring system was constructed and integrated into a clinical transcranial MRI-guided focused ultrasound system. Recordings were analyzed using a spectroscopic method that isolates the acoustic emissions caused by the microbubbles during sonication. This analysis characterized and quantified harmonic oscillations that occur when the BBB is disrupted, and broadband emissions that occur when tissue damage occurs. After validating the system's performance in pilot studies that explored a wide range of exposure levels, the measurements were used to control the ultrasound exposure level during transcranial sonications at 104 volumes over 22 weekly sessions in four macaques. We found that increasing the exposure level until a large harmonic emissions signal was observed was an effective means to ensure BBB disruption without broadband emissions. We had a success rate of 96% in inducing BBB disruption as measured by in contrast-enhanced MRI, and we detected broadband emissions in less than 0.2% of the applied bursts. The magnitude of the harmonic emissions signals was significantly (P < 0.001) larger for sonications where BBB disruption was detected, and it correlated with BBB permeabilization as indicated by the magnitude of the MRI signal enhancement after MRI contrast administration (R-2 = 0.78). Overall, the results indicate that harmonic emissions can be a used to control focused ultrasound-induced BBB disruption. These results are promising for clinical translation of this technology.	[Arvanitis, Costas D.; Vykhodtseva, Natalia; McDannold, Nathan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Livingstone, Margaret S.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Arvanitis, CD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA.	cda@bwh.harvard.edu	Arvanitis, Costas/AGW-2764-2022	Livingstone, Margaret/0000-0002-1950-0123	National Institutes of Health [R25 CA089017, RC2NS069413]; NATIONAL CANCER INSTITUTE [R25CA089017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health award numbers R25 CA089017 and RC2NS069413. The focused ultrasound system was supplied by InSightec. Additional support was provided by a gift from Betty Brudnick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhatov I, 2001, PHYS FLUIDS, V13, P2805, DOI 10.1063/1.1401810; Arvanitis CD, 2011, P IEEE ULTR IN PRESS; Arvanitis CD, 2011, ULTRASOUND MED BIOL, V37, P1838, DOI 10.1016/j.ultrasmedbio.2011.08.004; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Chen H, PHYS REV LETT, V106; Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301; de Boer AG, 2007, CLIN PHARMACOKINET, V46, P553, DOI 10.2165/00003088-200746070-00002; de Jong N, 2009, MED BIOL ENG COMPUT, V47, P861, DOI 10.1007/s11517-009-0497-1; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Flannigan DJ, 2005, NATURE, V434, P52, DOI 10.1038/nature03361; Gyongy M, 2010, IEEE T BIO-MED ENG, V57, P48, DOI 10.1109/TBME.2009.2026907; Hockham N, 2010, IEEE T ULTRASON FERR, V57, P2685, DOI 10.1109/TUFFC.2010.1742; HOLLAND CK, 1990, J ACOUST SOC AM, V88, P2059, DOI 10.1121/1.400102; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; ILYICHEV VI, 1989, ULTRASONICS, V27, P357, DOI 10.1016/0041-624X(89)90034-6; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Kodama T, 2000, APPL PHYS B-LASERS O, V70, P139, DOI 10.1007/s003400050022; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Leighton T., 1997, ACOUSTIC BUBBLE; Lele PP, 1987, EFFECTS ULTRASOUND S, P275; Logothetis NK, 2007, COMBINED MRI HISTOLO; MADANSHETTY SI, 1991, J ACOUST SOC AM, V90, P1515, DOI 10.1121/1.401891; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; McDannold N, 2010, IEEE T ULTRASON FERR, V57, P1967, DOI 10.1109/TUFFC.2010.1644; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; Miller DL, 2000, P NATL ACAD SCI USA, V97, P10179, DOI 10.1073/pnas.180294397; O'Reilly MA, 2010, IEEE ULTRASONICS S P, P892; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; OHL CD, 1995, ANN PHYS-LEIPZIG, V4, P26, DOI 10.1002/andp.19955070104; Pardridge WM, 2007, PHARM RES, V24, P1733, DOI 10.1007/s11095-007-9324-2; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pinton G, 2012, MED PHYS, V39, P455, DOI 10.1118/1.3670376; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Samuel S, 2009, ULTRASOUND MED BIOL, V35, P1574, DOI 10.1016/j.ultrasmedbio.2009.04.013; Sassaroli E, 2005, PHYS MED BIOL, V50, P5293, DOI 10.1088/0031-9155/50/22/006; Sassaroli E, 2007, ULTRASOUND MED BIOL, V33, P1651, DOI 10.1016/j.ultrasmedbio.2007.04.018; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Sheikov N, 2006, ULTRASOUND MED BIOL, V32, P1399, DOI 10.1016/j.ultrasmedbio.2006.05.015; Song JH, 2012, IEEE T BIO-MED ENG, V59, P435, DOI 10.1109/TBME.2011.2174057; Tang MX, 2006, IEEE T ULTRASON FERR, V53, P2406, DOI 10.1109/TUFFC.2006.189; Tho P, 2007, J FLUID MECH, V576, P191, DOI 10.1017/S0022112006004393; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Yin XT, 2005, PHYS MED BIOL, V50, P1821, DOI 10.1088/0031-9155/50/8/013	50	125	127	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45783	10.1371/journal.pone.0045783	http://dx.doi.org/10.1371/journal.pone.0045783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029240	Green Published, gold			2022-12-27	WOS:000309554700072
J	Takagi, M; Ishii, T; Inokuchi, M; Amano, N; Narumi, S; Asakura, Y; Muroya, K; Hasegawa, Y; Adachi, M; Hasegawa, T				Takagi, Masaki; Ishii, Tomohiro; Inokuchi, Mikako; Amano, Naoko; Narumi, Satoshi; Asakura, Yumi; Muroya, Koji; Hasegawa, Yukihiro; Adachi, Masanori; Hasegawa, Tomonobu			Gradual Loss of ACTH Due to a Novel Mutation in LHX4: Comprehensive Mutation Screening in Japanese Patients with Congenital Hypopituitarism	PLOS ONE			English	Article							PITUITARY-HORMONE DEFICIENCY; 2-BASE PAIR DELETION; GENE; CHILDREN; PROP1; POU1F1	Mutations in transcription factors genes, which are well regulated spatially and temporally in the pituitary gland, result in congenital hypopituitarism (CH) in humans. The prevalence of CH attributable to transcription factor mutations appears to be rare and varies among populations. This study aimed to define the prevalence of CH in terms of nine CH-associated genes among Japanese patients. We enrolled 91 Japanese CH patients for DNA sequencing of POU1F1, PROP1, HESX1, LHX3, LHX4, SOX2, SOX3, OTX2, and GLI2. Additionally, gene copy numbers for POU1F1, PROP1, HESX1, LHX3, and LHX4 were examined by multiplex ligation-dependent probe amplification. The gene regulatory properties of mutant LHX4 proteins were characterized in vitro. We identified two novel heterozygous LHX4 mutations, namely c.249-1G>A, p.V75I, and one common POU1F1 mutation, p.R271W. The patient harboring the c.249-1G>A mutation exhibited isolated growth hormone deficiency at diagnosis and a gradual loss of ACTH, whereas the patient with the p.V75I mutation exhibited multiple pituitary hormone deficiency. In vitro experiments showed that both LHX4 mutations were associated with an impairment of the transactivation capacities of POU1F1 and alpha GSU, without any dominant-negative effects. The total mutation prevalence in Japanese CH patients was 3.3%. This study is the first to describe, a gradual loss of ACTH in a patient carrying an LHX4 mutation. Careful monitoring of hypothalamic-pituitary -adrenal function is recommended for CH patients with LHX4 mutations.	[Takagi, Masaki; Ishii, Tomohiro; Inokuchi, Mikako; Amano, Naoko; Narumi, Satoshi; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Takagi, Masaki; Hasegawa, Yukihiro] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Asakura, Yumi; Muroya, Koji; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Kanagawa, Japan	Keio University; Tokyo Metropolitan Children's Medical Center	Hasegawa, T (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	thaseg@a6.keio.jp	Ishii, Tomohiro/B-8711-2019; Hasegawa, Tomonobu/L-3331-2013; Muroya, Koji/J-1304-2016	Ishii, Tomohiro/0000-0001-7360-2465; Muroya, Koji/0000-0002-1810-9894; ASAKURA, YUMI/0000-0001-7242-8354	Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan [014]; Foundation for Growth Science, Japan	Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan; Foundation for Growth Science, Japan	This work was supported by Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan - 014). This work was supported by a grant from the Foundation for Growth Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asteria C, 2000, EUR J ENDOCRINOL, V143, P347, DOI 10.1530/eje.0.1430347; Bonfig W, 2011, EUR J PEDIATR, V170, P1017, DOI 10.1007/s00431-011-1393-x; Castinetti F, 2008, J CLIN ENDOCR METAB, V93, P2790, DOI 10.1210/jc.2007-2389; Cogan JD, 1998, J CLIN ENDOCR METAB, V83, P3346, DOI 10.1210/jc.83.9.3346; Crofton PM, 2004, HORM RES, V61, P92, DOI 10.1159/000075339; Dateki S, 2010, J CLIN ENDOCR METAB, V95, P4043, DOI 10.1210/jc.2010-0150; de Graaff LCG, 2010, HORM RES PAEDIAT, V73, P363, DOI 10.1159/000308169; FUJIEDA K, 1996, CLIN ENDOCRINOL TOKY, V44, P1229; Ito J, 1993, J JPN PEDIAT SOC, V97, P1789; *JAP PUBL HLTH ASS, 1996, NORM BIOCH VAL JAP C; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Machinis K, 2005, J CLIN ENDOCR METAB, V90, P5456, DOI 10.1210/jc.2004-2332; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; McLennan K, 2003, CLIN ENDOCRINOL, V58, P785, DOI 10.1046/j.1365-2265.2003.01781.x; Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P942, DOI 10.1210/jc.84.3.942; Pernasetti F, 2000, J CLIN ENDOCR METAB, V85, P390, DOI 10.1210/jc.85.1.390; Pfaffle R, 2011, BEST PRACT RES CL EN, V25, P43, DOI 10.1016/j.beem.2010.10.014; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Rainbow LA, 2005, CLIN ENDOCRINOL, V62, P163, DOI 10.1111/j.1365-2265.2004.02189.x; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Romero CJ, 2009, TRENDS ENDOCRIN MET, V20, P506, DOI 10.1016/j.tem.2009.06.005; Tajima T, 2010, EXP CLIN ENDOCR DIAB, V118, P405, DOI 10.1055/s-0029-1225612; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46008	10.1371/journal.pone.0046008	http://dx.doi.org/10.1371/journal.pone.0046008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029363	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700105
J	Kim, KH; Choi, BK; Kim, JD; Kim, YH; Lee, SK; Suh, JH; Lee, SC; Kang, SW; Kwon, BS				Kim, Kwang H.; Choi, Beom K.; Kim, Jung D.; Kim, Young H.; Lee, Sun K.; Suh, Jae H.; Lee, Sang C.; Kang, Sang W.; Kwon, Byoung S.			4-1BB Signaling Breaks the Tolerance of Maternal CD8(+) T Cells That Are Reactive with Alloantigens	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; IN-VIVO; PREGNANCY; COMPLEMENT; IMMUNOTHERAPY; AMELIORATION; ACTIVATION; EXPRESSION	4-1BB (CD137, TNFRSF9), a member of the activation-induced tumor necrosis factor receptor family, is a powerful T-cell costimulatory molecule. It generally enhances CD8(+) T responses and even breaks the tolerance of CD8(+) T cells in an antigen-specific manner. In the present study we found that it was expressed in the placentas of pregnant mice and that its expression coincided with that of the immunesuppressive enzyme indoleamine 2,3-dioxygenase (IDO). Therefore, we investigated whether 4-1BB signaling is involved in fetal rejection using agonistic anti-4-1BB mAb and 4-1BB-deficient mice. Treatment with agonistic anti-4-1BB mAb markedly increased the rate of rejection of allogeneic but not syngeneic fetuses, and this was primarily dependent on CD8(+) T cells. Complement component 3 (C3) seemed to be the effector molecule because 4-1BB triggering resulting in accumulation of C3 in the placenta, and this accumulation was also reversed by anti-CD8 mAb treatment. These findings demonstrate that 4-1BB triggering breaks the tolerance of CD8(+) T cells to alloantigens in the placenta. Moreover, triggering 4-1BB protected the pregnant mice from Listeria monocytogenes (LM) infection, but led to rejection of semi-allogeneic fetuses. Therefore, given the cross-recognition of alloantigen by pathogen-reactive CD8(+) T cells, the true function of 4-1BB may be to reverse the hypo-responsiveness of pathogen-reactive CD8(+) T cells in the placenta in cases of infection, even if that risks losing the fetus.	[Kim, Kwang H.; Choi, Beom K.; Lee, Sang C.; Kwon, Byoung S.] Natl Canc Ctr, Div Canc Biol, Goyang, Kyeonggi Do, South Korea; [Kim, Jung D.] Yale Univ, Sch Med, Dept Obstet, New Haven, CT USA; [Kim, Jung D.] Yale Univ, Sch Med, Dept Gynecol, New Haven, CT USA; [Kim, Jung D.] Yale Univ, Sch Med, Dept Reprod Sci, New Haven, CT USA; [Kim, Young H.; Kwon, Byoung S.] Natl Canc Ctr, Program Immunotherapeut Res, Goyang, Kyeonggi Do, South Korea; [Lee, Sun K.; Kang, Sang W.] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Suh, Jae H.] Ulsan Univ Hosp, Dept Pathol, Ulsan, South Korea; [Kwon, Byoung S.] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA	National Cancer Center - Korea (NCC); Yale University; Yale University; Yale University; National Cancer Center - Korea (NCC); University of Ulsan; University of Ulsan; Ulsan University Hospital; Tulane University	Kwon, BS (corresponding author), Natl Canc Ctr, Div Canc Biol, Goyang, Kyeonggi Do, South Korea.	bskwon@ncc.re.kr		Kim, Jung Dae/0000-0002-4750-6856; Kim, Kwang H/0000-0002-6585-9524	National Cancer Center, Korea [NCC-1210370, NCC-1040830]; National Research Foundation of Korea; Korea government [2005-0093837, 2006-2004212]	National Cancer Center, Korea; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by grants from the National Cancer Center, Korea (NCC-1210370, NCC-1040830) and the National Research Foundation of Korea funded by the Korea government (2005-0093837, 2006-2004212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; Constantin CM, 2007, J IMMUNOL, V179, P4383, DOI 10.4049/jimmunol.179.7.4383; Eckstrum K, 2011, CELL TISSUE RES, V344, P567, DOI 10.1007/s00441-011-1171-0; Girardi G, 2003, AUTOIMMUNITY, V36, P19, DOI 10.1080/0891693031000067322; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; Hellstrom KE, 2003, J MOL MED, V81, P71, DOI 10.1007/s00109-002-0413-8; Joachim RA, 2001, AM J REPROD IMMUNOL, V45, P303, DOI 10.1111/j.8755-8920.2001.450506.x; Kim JD, 2011, MOL CELLS, V31, P141, DOI 10.1007/s10059-011-0018-6; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Larsen CP, 2006, AM J TRANSPLANT, V6, P876, DOI 10.1111/j.1600-6143.2006.01259.x; LUFT BJ, 1982, INFECT IMMUN, V38, P1164, DOI 10.1128/IAI.38.3.1164-1171.1982; Makhseed M, 2001, HUM REPROD, V16, P2219, DOI 10.1093/humrep/16.10.2219; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Myers L, 2003, P NATL ACAD SCI USA, V100, P5348, DOI 10.1073/pnas.0837611100; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; POLLOK KE, 1993, J IMMUNOL, V150, P771; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Raghupathy R, 2001, SEMIN IMMUNOL, V13, P219, DOI 10.1006/smim.2001.0316; SCHWARZ H, 2006, CD137 PATHWAY IMMUNO, P29; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shuford WW, 2007, J EXP MED, V26, P47; Sun YL, 2002, J IMMUNOL, V168, P1457, DOI 10.4049/jimmunol.168.3.1457; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vacchio MS, 2007, J EXP MED, V26, P19; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Wilcox RA, 2004, BLOOD, V103, P177, DOI 10.1182/blood-2003-06-2184; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yoshimatsu J, 2006, INT J GYNECOL OBSTET, V93, P240, DOI 10.1016/j.ijgo.2006.02.020	32	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45481	10.1371/journal.pone.0045481	http://dx.doi.org/10.1371/journal.pone.0045481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029041	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800053
J	Flores-Munoz, M; Godinho, BMDC; Almalik, A; Nicklin, SA				Flores-Munoz, Monica; Godinho, Bruno M. D. C.; Almalik, Abdulaziz; Nicklin, Stuart A.			Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor	PLOS ONE			English	Article							FUSION PROTEIN; RATS; MICE; EXPRESSION; HEART; VIVO	The counter-regulatory axis of the renin angiotensin system peptide angiotensin-(1-7) [Ang-(1-7)] has been identified as a potential therapeutic target in cardiac remodelling, acting via the mas receptor. Furthermore, we recently reported that an alternative peptide, Ang-(1-9) also counteracts cardiac remodelling via the angiotensin type 2 receptor (AT(2)R). Here, we have engineered adenoviral vectors expressing fusion proteins which release Ang-(1-7) [RAdAng-(1-7)] or Ang-(1-9) [RAdAng-(1-9)] and compared their effects on cardiomyocyte hypertrophy in rat H9c2 cardiomyocytes or primary adult rabbit cardiomyocytes, stimulated with angiotensin II, isoproterenol or arg-vasopressin. RAdAng-(1-7) and RAdAng-(1-9) efficiently transduced cardiomyocytes, expressed fusion proteins and secreted peptides, as demonstrated by western immunoblotting and conditioned media assays. Furthermore, secreted Ang-(1-7) and Ang-(1-9) inhibited cardiomyocyte hypertrophy (Control = 168.7 +/- 8.4 mu m; AngII = 232.1 +/- 10.7 mu m; AngII+RAdAng-(1-7) = 186 +/- 9.1 mu m, RAdAng-(19) = 180.5 +/- 9 mu m; P<0.05) and these effects were selectively reversed by inhibitors of their cognate receptors, the mas antagonist A779 for RAdAng-(1-7) and the AT(2)R antagonist PD123,319 for RAdAng-(1-9). Thus gene transfer of Ang-(1-7) and Ang-(1-9) produces receptor-specific effects equivalent to those observed with addition of exogenous peptides. These data highlight that Ang-(1-7) and Ang-(1-9) can be expressed via gene transfer and inhibit cardiomyocyte hypertrophy via their respective receptors. This supports applications for this approach for sustained peptide delivery to study molecular effects and potential gene therapeutic actions.	[Flores-Munoz, Monica; Godinho, Bruno M. D. C.; Almalik, Abdulaziz; Nicklin, Stuart A.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow	Nicklin, SA (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	stuart.nicklin@glasgow.ac.uk	Godinho, Bruno M. D. C./H-6511-2014	Godinho, Bruno M. D. C./0000-0001-6192-3333; Nicklin, Stuart/0000-0002-9691-6210	University of Glasgow Postgraduate Scholarship Scheme; Consejo Nacional de Ciencia y Tecnologia (CONACYT)	University of Glasgow Postgraduate Scholarship Scheme; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank University of Glasgow Postgraduate Scholarship Scheme and Consejo Nacional de Ciencia y Tecnologia (CONACYT) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Botelho-Santos GA, 2007, AM J PHYSIOL-HEART C, V292, pH2485, DOI 10.1152/ajpheart.01245.2006; Ferreira AJ, 2010, THER ADV CARDIOVASC; Ferreira AJ, 2006, REGUL PEPTIDES, V137, P128, DOI 10.1016/j.regpep.2006.06.005; Flores-Munoz M, 2011, J PHYSIOL-LONDON, V589, P939, DOI 10.1113/jphysiol.2010.203075; Flores-Munoz M, 2012, HYPERTENSION, V59, P300, DOI 10.1161/HYPERTENSIONAHA.111.177485; George SJ, 2011, CIRCULATION, V124, pS135, DOI 10.1161/CIRCULATIONAHA.110.012732; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Hiroyama M, 2007, EUR J PHARMACOL, V559, P89, DOI 10.1016/j.ejphar.2006.12.010; Lochard N, 2003, J BIOL CHEM, V278, P2184, DOI 10.1074/jbc.M209933200; Masson R, 2009, HYPERTENSION; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Methot D, 1997, J BIOL CHEM, V272, P12994, DOI 10.1074/jbc.272.20.12994; Nadu AP, 2008, J AM SOC HYPERTENS, V2, P341, DOI 10.1016/j.jash.2008.04.012; NICKLIN SA, 1999, METHODS MOL MED VASC, P271; Palomeque J, 2007, GENE THER, V14, P989, DOI 10.1038/sj.gt.3302895; Qi Y, 2011, EXP PHYSL; Santiago NM, 2010, HYPERTENSION, V55, P889, DOI 10.1161/HYPERTENSIONAHA.110.149815; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2004, PHYSIOL GENOMICS, V17, P292, DOI 10.1152/physiolgenomics.00227.2003; Takayanagi T, 2012, AM J HYPERTENS, V25, P280, DOI 10.1038/ajh.2011.221; van Kats JP, 2001, J BIOL CHEM, V276, P44012, DOI 10.1074/jbc.M106132200; Verma A, 2011, MOL THER; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	25	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45564	10.1371/journal.pone.0045564	http://dx.doi.org/10.1371/journal.pone.0045564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029101	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900075
J	Reichenbach, T; Hudspeth, AJ				Reichenbach, Tobias; Hudspeth, A. J.			Discrimination of Low-Frequency Tones Employs Temporal Fine Structure	PLOS ONE			English	Article							SOUND LOCALIZATION; MAMMALIAN COCHLEA; HEARING; SPEECH; VERTEBRATES; ABILITY	An auditory neuron can preserve the temporal fine structure of a low-frequency tone by phase-locking its response to the stimulus. Apart from sound localization, however, much about the role of this temporal information for signal processing in the brain remains unknown. Through psychoacoustic studies we provide direct evidence that humans employ temporal fine structure to discriminate between frequencies. To this end we construct tones that are based on a single frequency but in which, through the concatenation of wavelets, the phase changes randomly every few cycles. We then test the frequency discrimination of these phase-changing tones, of control tones without phase changes, and of short tones that consist of a single wavelet. For carrier frequencies below a few kilohertz we find that phase changes systematically worsen frequency discrimination. No such effect appears for higher carrier frequencies at which temporal information is not available in the central auditory system.	[Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	hudspaj@rockefeller.edu	Reichenbach, Tobias/G-7475-2011	Reichenbach, Tobias/0000-0003-3367-3511	National Institutes of Health [DC000241]; Burroughs Wellcome Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This research was supported by grant DC000241 from the National Institutes of Health. T. R. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund; A.J.H. is an Investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EDWARDS AL, 1976, INTRO LINEAR REGRESS, P33; Gilbert G, 2006, J ACOUST SOC AM, V119, P2438, DOI 10.1121/1.2173522; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hopkins K, 2008, J ACOUST SOC AM, V123, P1140, DOI 10.1121/1.2824018; Joris PX, 2008, NEUROSCIENCE, V154, P65, DOI 10.1016/j.neuroscience.2008.03.002; Koppl C, 2009, CURR BIOL, V19, pR635, DOI 10.1016/j.cub.2009.05.035; Loizou PC, 1998, IEEE SIGNAL PROC MAG, V15, P101, DOI 10.1109/79.708543; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; Pickles JO, 1996, INTRO PHYSL HEARING; Reichenbach T, 2012, FREQUENCY DECO UNPUB; Reichenbach T, 2010, P NATL ACAD SCI USA, V107, P4973, DOI 10.1073/pnas.0914345107; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rossing T., 2007, SPRINGER HDB ACOUSTI; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; Ulfendahl M, 1997, PROG NEUROBIOL, V53, P331, DOI 10.1016/S0301-0082(97)00040-3	16	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45579	10.1371/journal.pone.0045579	http://dx.doi.org/10.1371/journal.pone.0045579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029113	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400110
J	Cameron, MJ; Kelvin, AA; Leon, AJ; Cameron, CM; Ran, LS; Xu, LL; Chu, YK; Danesh, A; Fang, Y; Li, QJ; Anderson, A; Couch, RC; Paquette, SG; Fomukong, NG; Kistner, O; Lauchart, M; Rowe, T; Harrod, KS; Jonsson, CB; Kelvin, DJ				Cameron, Mark J.; Kelvin, Alyson A.; Leon, Alberto J.; Cameron, Cheryl M.; Ran, Longsi; Xu, Luoling; Chu, Yong-Kyu; Danesh, Ali; Fang, Yuan; Li, Qianjun; Anderson, Austin; Couch, Ronald C.; Paquette, Stephane G.; Fomukong, Ndingsa G.; Kistner, Otfried; Lauchart, Manfred; Rowe, Thomas; Harrod, Kevin S.; Jonsson, Colleen B.; Kelvin, David J.			Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; IMMUNE-RESPONSES; INFLUENZA-VIRUS; MICE; PATHOGENESIS; MECHANISMS; CYTOKINES; EVENTS; FAMILY; ISG15	In terms of its highly pathogenic nature, there remains a significant need to further define the immune pathology of SARS-coronavirus (SARS-CoV) infection, as well as identify correlates of immunity to help develop vaccines for severe coronaviral infections. Here we use a SARS-CoV infection-reinfection ferret model and a functional genomics approach to gain insight into SARS immunopathogenesis and to identify correlates of immune protection during SARS-CoV-challenge in ferrets previously infected with SARS-CoV or immunized with a SARS virus vaccine. We identified gene expression signatures in the lungs of ferrets associated with primary immune responses to SARS-CoV infection and in ferrets that received an identical second inoculum. Acute SARS-CoV infection prompted coordinated innate immune responses that were dominated by antiviral IFN response gene (IRG) expression. Reinfected ferrets, however, lacked the integrated expression of IRGs that was prevalent during acute infection. The expression of specific IRGs was also absent upon challenge in ferrets immunized with an inactivated, Al(OH)(3)-adjuvanted whole virus SARS vaccine candidate that protected them against SARS-CoV infection in the lungs. Lack of IFN-mediated immune enhancement in infected ferrets that were previously inoculated with, or vaccinated against, SARS-CoV revealed 9 IRG correlates of protective immunity. This data provides insight into the molecular pathogenesis of SARS-CoV and SARS-like-CoV infections and is an important resource for the development of CoV antiviral therapeutics and vaccines.	[Cameron, Mark J.; Leon, Alberto J.; Cameron, Cheryl M.; Ran, Longsi; Xu, Luoling; Danesh, Ali; Fang, Yuan; Paquette, Stephane G.; Rowe, Thomas; Kelvin, David J.] Toronto Gen Hosp, Div Expt Therapeut, Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Paquette, Stephane G.; Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Danesh, Ali; Fang, Yuan; Kelvin, David J.] Univ Toronto, Dept Immunol, Fac Med, Toronto, ON, Canada; [Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Int Inst Infect & Immun, Coll Med, Shantou, Guangdong, Peoples R China; [Chu, Yong-Kyu; Li, Qianjun; Anderson, Austin] So Res Inst, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Couch, Ronald C.; Fomukong, Ndingsa G.; Harrod, Kevin S.; Kelvin, David J.] Lovelace Resp Res Inst, Albuquerque, NM USA; [Jonsson, Colleen B.] Ctr Predict Med, Louisville, KY USA; [Kistner, Otfried; Lauchart, Manfred] Baxter Innovat GmbH, Vienna, Austria; [Kelvin, Alyson A.] Immune Diagnost & Res, Toronto, ON, Canada; [Kelvin, David J.] Univ Sassari, Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, I-07100 Sassari, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Shantou University; Lovelace Respiratory Research Institute; Baxter International Inc; Baxter Innovations GmbH; University of Sassari	Kelvin, DJ (corresponding author), Toronto Gen Hosp, Div Expt Therapeut, Res Inst, Univ Hlth Network, Toronto, ON, Canada.	dkelvin@uhnres.utoronto.ca	Jonsson, Colleen/GPC-4424-2022; Rowe, Thomas/AAW-4899-2020; Jonsson, Colleen/X-2360-2019; Cameron, Mark/O-6775-2019	Jonsson, Colleen/0000-0002-2640-7672; Cameron, Mark/0000-0003-4768-4094; Harrod, Kevin/0000-0003-0780-9470	Canadian Institutes of Health Research (CIHR); Baxter Innovations GmbH; National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID) [N01-AI-30063, 03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Baxter Innovations GmbH; National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Canadian Institutes of Health Research (CIHR), and Baxter Innovations GmbH and the National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID) through Contract No. N01-AI-30063 Task Order No. 03. The CIHR and NIH/NIAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Baxter supplied the SARS vaccine and were involved in the design of vaccination study.	Banner D, 2012, J INFECT DEV COUNTR, V6, P465; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Chan M C W, 2011, Hong Kong Med J, V17 Suppl 6, P31; Chu YK, 2008, VIROLOGY, V374, P151, DOI 10.1016/j.virol.2007.12.032; Czub M, 2005, VACCINE, V23, P2273, DOI 10.1016/j.vaccine.2005.01.033; Danesh A, 2011, VIROLOGY, V409, P102, DOI 10.1016/j.virol.2010.10.002; Darnell MER, 2007, J INFECT DIS, V196, P1329, DOI 10.1086/522431; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hogan RJ, 2004, J VIROL, V78, P11416, DOI 10.1128/JVI.78.20.11416-11421.2004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Kelvin AA, 2012, INTECH IMMUNOASSAYS; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kobinger GP, 2007, VACCINE, V25, P5220, DOI 10.1016/j.vaccine.2007.04.065; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006; Lu HC, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-3; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Peiris J. S. Malik, 2008, V454, P61, DOI 10.1007/978-1-59745-181-9_6; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005; Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09; Rowe T, 2010, J GEN VIROL, V91, P2898, DOI 10.1099/vir.0.024323-0; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; See RH, 2008, J GEN VIROL, V89, P2136, DOI 10.1099/vir.0.2008/001891-0; Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10; Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004; Vega VB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-32; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Weingartl H, 2004, J VIROL, V78, P12672, DOI 10.1128/JVI.78.22.12672-12676.2004; Wentworth DE, 2004, EMERG INFECT DIS, V10, P1293, DOI 10.3201/eid1007.031119; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	52	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45842	10.1371/journal.pone.0045842	http://dx.doi.org/10.1371/journal.pone.0045842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029269	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700077
J	Hashemi, H; Pouyanfard, S; Bandehpour, M; Noroozbabaei, Z; Kazemi, B; Saelens, X; Mokhtari-Azad, T				Hashemi, Hamidreza; Pouyanfard, Somayeh; Bandehpour, Mojgan; Noroozbabaei, Zahra; Kazemi, Bahram; Saelens, Xavier; Mokhtari-Azad, Talat			Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge	PLOS ONE			English	Article							ANTIGENIC PEPTIDE VACCINE; MATRIX PROTEIN-2; M2 PROTEIN; MONOCLONAL-ANTIBODY; PHAGE DISPLAY; EXTRACELLULAR DOMAIN; EFFICIENT INDUCTION; CAPSID SURFACE; BACTERIOPHAGE-T4; RESPONSES	Considering the emergence of highly pathogenic influenza viruses and threat of worldwide pandemics, there is an urgent need to develop broadly-protective influenza vaccines. In this study, we demonstrate the potential of T7 bacteriophage-based nanoparticles with genetically fused ectodomain of influenza A virus M2 protein (T7-M2e) as a candidate universal flu vaccine. Immunization of mice with non-adjuvanted T7-M2e elicited M2e-specific serum antibody responses that were similar in magnitude to those elicited by M2e peptide administered in Freund's adjuvant. Comparable IgG responses directed against T7 phage capsomers were induced following vaccination with wild type T7 or T7-M2e. T7-M2e immunization induced balanced amounts of IgG(1) and IgG(2a) antibodies and these antibodies specifically recognized native M2 on the surface of influenza A virus-infected mammalian cells. The frequency of IFN-gamma-secreting T cells induced by T7-M2e nanoparticles was comparable to those elicited by M2e peptide emulsified in Freund's adjuvant. Emulsification of T7-M2e nanoparticles in Freund's adjuvant, however, induced a significantly stronger T cell response. Furthermore, T7-M2e-immunized mice were protected against lethal challenge with an H1N1 or an H3N2 virus, implying the induction of heterosubtypic immunity in our mouse model. T7-M2e-immunized mice displayed considerable weight loss and had significantly reduced viral load in their lungs compared to controls. We conclude that display of M2e on the surface of T7 phage nanoparticles offers an efficient and economical opportunity to induce cross-protective M2e-based immunity against influenza A.	[Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran; [Pouyanfard, Somayeh] Tarbiat Modares Univ, Dept Virol, Tehran, Iran; [Hashemi, Hamidreza; Noroozbabaei, Zahra; Mokhtari-Azad, Talat] Univ Tehran Med Sci, Dept Virol, Tehran, Iran; [Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Dept Biotechnol, Sch Med, Tehran, Iran; [Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Shahid Beheshti University Medical Sciences; Tarbiat Modares University; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Flanders Institute for Biotechnology (VIB); Ghent University	Kazemi, B (corresponding author), Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran.	kazemi@sbmu.ac.ir; Mokhtari@Sina.tums.ac.ir	Kazemi, Bahram/F-2785-2016; bandehpour, mojgan/O-9744-2019; Saelens, Xavier/N-5728-2015; Kazemi, Bahram/GRR-9838-2022	Kazemi, Bahram/0000-0002-3072-8831; bandehpour, mojgan/0000-0002-5479-2846; , Xavier/0000-0002-3861-6965	Tehran University of Medical Sciences [15786]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was part of a Ph.D thesis supported by Tehran University of Medical Sciences, grant number 15786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballea S, 2007, VALUE HEALTH, V10, P98, DOI 10.1111/j.1524-4733.2006.00157.x; Adams MH, 1959, BACTERIOPHAGES; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Chackerian B, 1999, P NATL ACAD SCI USA, V96, P2373, DOI 10.1073/pnas.96.5.2373; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Couch R B, 1975, Dev Biol Stand, V28, P295; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; De Berardinis P, 2000, NAT BIOTECHNOL, V18, P873, DOI 10.1038/78490; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; DENKERS EY, 1985, J IMMUNOL, V135, P2183; Di Giovine M, 2001, VIROLOGY, V282, P102, DOI 10.1006/viro.2000.0809; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Fang JB, 2005, VACCINE, V23, P4860, DOI 10.1016/j.vaccine.2005.05.024; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Franke ED, 1997, J IMMUNOL, V159, P3424; Gamage LNA, 2009, VACCINE, V27, P6595, DOI 10.1016/j.vaccine.2009.08.019; GETHING MJ, 1980, NATURE, V287, P301, DOI 10.1038/287301a0; Gupta A, 2003, J MOL BIOL, V334, P241, DOI 10.1016/j.jmb.2003.09.033; Hayes S, 2010, VACCINE, V28, P6789, DOI 10.1016/j.vaccine.2010.07.047; Herrmann S, 2007, J VIROL METHODS, V141, P133, DOI 10.1016/j.jviromet.2006.11.041; HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; JACKSON DC, 1991, ARCH VIROL, V118, P199, DOI 10.1007/BF01314030; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Jiang J, 1997, INFECT IMMUN, V65, P4770, DOI 10.1128/IAI.65.11.4770-4777.1997; JOU WM, 1980, CELL, V19, P683, DOI 10.1016/S0092-8674(80)80045-6; Kouskoff V, 2000, SCIENCE, V287, P2501, DOI 10.1126/science.287.5462.2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LAMB RA, 1981, VIROLOGY, V112, P729, DOI 10.1016/0042-6822(81)90317-2; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Morrot A, 2006, INFECT IMMUN, V74, P2495, DOI 10.1128/IAI.74.4.2495-2497.2006; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park EK, 1998, J VIROL, V72, P2449, DOI 10.1128/JVI.72.3.2449-2455.1998; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Ren SX, 2009, ACTA PHARMACOL SIN, V30, P637, DOI 10.1038/aps.2009.44; Ren SX, 2011, VACCINE, V29, P5802, DOI 10.1016/j.vaccine.2011.03.051; Ren ZJ, 2008, VACCINE, V26, P1471, DOI 10.1016/j.vaccine.2007.12.053; Rosenberg AGK, 1996, NOVAGEN NEWSLETTER, P1; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Shivachandra SB, 2007, VACCINE, V25, P1225, DOI 10.1016/j.vaccine.2006.10.010; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Tan GH, 2005, J MED VIROL, V77, P475, DOI 10.1002/jmv.20479; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Towbin H, 1992, Biotechnology, V24, P145; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Ulivieri C, 2008, IMMUNOL LETT, V119, P62, DOI 10.1016/j.imlet.2008.04.004; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P6095, DOI 10.1016/j.vaccine.2008.11.037; Wu JM, 2007, J VIROL METHODS, V139, P50, DOI 10.1016/j.jviromet.2006.09.017; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9	75	64	67	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45765	10.1371/journal.pone.0045765	http://dx.doi.org/10.1371/journal.pone.0045765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029232	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700068
J	Lee, S; Jeong, J; Park, YU; Kwak, Y; Lee, SA; Lee, H; Son, H; Park, SK				Lee, Saebom; Jeong, Jaehoon; Park, Young-Un; Kwak, Yongdo; Lee, Seol Ae; Lee, Haeryun; Son, Hyeon; Park, Sang Ki			Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HISTONE DEACETYLASE; BIPOLAR DISORDER; LITHIUM; RECEPTOR; ACID; PHOSPHORYLATION; DEPRESSION; NEURONS; BINDING	Chromatin remodeling through histone modifications has emerged as a key mechanism in the pathophysiology of psychiatric disorders. Valproate (VPA), a first-line medication for bipolar disorder, is known to have histone deacetylase (HDAC) inhibitor activity, but the relationship between its efficacy as a mood stabilizer and HDAC inhibitory activity is unclear. Here we provide evidence that prostate apoptosis response-4 (Par-4), an intracellular binding partner of dopamine D2 receptors (DRD2), plays a role in mediating the effectiveness of VPA. We found that chronic VPA treatment enhanced the expression of Par-4 in cultured neurons and adult mouse brains. This Par-4 induction phenomenon occurred at the transcriptional level and was correlated with an increase in histone H3 and H4 acetylation of the Par-4 promoter regions. Furthermore, chronic VPA treatment potentiated the suppression of the cAMP signaling cascade upon dopamine stimulation, which was blocked by sulpiride treatment. These results indicate that VPA potentiates DRD2 activity by enhancing Par-4 expression via a chromatin remodeling mechanism.	[Lee, Saebom; Jeong, Jaehoon; Park, Young-Un; Kwak, Yongdo; Lee, Seol Ae; Park, Sang Ki] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Lee, Haeryun] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Son, Hyeon] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Son, Hyeon] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Hanyang University; Hanyang University	Park, SK (corresponding author), Pohang Univ Sci & Technol, Biotechnol Res Ctr, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	skpark@postech.ac.kr			Brain Research Center of the 21st Century Frontier Research Program [2012K001115]; Ministry of Education, Science and Technology, Republic of Korea [2012R1A2A2A01012923, 20090076351]	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Brain Research Center of the 21st Century Frontier Research Program Grant 2012K001115, and in part by the grants 2012R1A2A2A01012923 and 20090076351 funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry JM, 2009, PSYCHOPHARMACOLOGY, V205, P419, DOI 10.1007/s00213-009-1551-2; Basso AM, 2005, NEUROPSYCHOPHARMACOL, V30, P1257, DOI 10.1038/sj.npp.1300677; Bowden C, 1997, BRAIN RES, V769, P135, DOI 10.1016/S0006-8993(97)00692-6; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Glantz LA, 2010, SCHIZOPHR RES, V118, P292, DOI 10.1016/j.schres.2009.12.027; Goodwin FK, 1998, ARCH GEN PSYCHIAT, V55, P23, DOI 10.1001/archpsyc.55.1.23; Goodwin GM, 2003, J PSYCHOPHARMACOL, V17, P149, DOI 10.1177/0269881103017002003; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; NAU H, 1982, J PHARMACOL EXP THER, V220, P654; Omata N, 2008, BIPOLAR DISORD, V10, P360, DOI 10.1111/j.1399-5618.2007.00521.x; Panomvana Na Ayudhya D, 2006, AM J THER, V13, P211; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Qi YP, 1997, J NEUROSCI, V17, P1217; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Ryves WJ, 2005, BIPOLAR DISORD, V7, P260, DOI 10.1111/j.1399-5618.2005.00194.x; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tatebayashi Y, 2004, J CELL SCI, V117, P1653, DOI 10.1242/jcs.01018; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhu XZ, 2011, BEHAV BRAIN RES, V223, P329, DOI 10.1016/j.bbr.2011.04.052	37	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45618	10.1371/journal.pone.0045618	http://dx.doi.org/10.1371/journal.pone.0045618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029138	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700052
J	Lenart, N; Szegedi, V; Juhasz, G; Kasztner, A; Horvath, J; Bereczki, E; Toth, ME; Penke, B; Santha, M				Lenart, Nikolett; Szegedi, Viktor; Juhasz, Gabor; Kasztner, Aniko; Horvath, Janos; Bereczki, Erika; Toth, Melinda E.; Penke, Botond; Santha, Miklos			Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice	PLOS ONE			English	Article							GAMMA-MUTANT MICE; ALZHEIMERS-DISEASE; PKC-GAMMA; NEUROFIBRILLARY DEGENERATION; APOLIPOPROTEIN-B; NILE RED; A-BETA; PROTEIN; BRAIN; MOUSE	Aims: ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further characterize this transgenic strain in order to reveal a possible link between hypeprlipidemia and neurodegeneration. Methods and Results: We analyzed the serum and cerebral lipid profiles, tau phosphorylation patterns, amyloid plaque-formation, neuronal apoptosis and synaptic plasticity of young (3 month old), adult (6 month old) and aging (10-11 month old) transgenic mice. We show that ApoB-100 transgenic animals present i) elevated serum and cerebral levels of triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser(199), Ser(199/202), Ser(396) and Ser(404). Furthermore, we demonstrate, that tau hyperphosphorylation is accompanied by impaired presynaptic function, long-term potentiation and widespread hippocampal neuronal apoptosis. Conclusions: The results presented here indicate that elevated ApoB-100 level and the consequent chronic hypertriglyceridemia may lead to impaired neuronal function and neurodegeneration, possibly via hyperphosphorylation of tau protein. On account of their specific phenotype, ApoB-100 transgenic mice may be considered a versatile model of hyperlipidemia-induced age-related neurodegeneration.	[Lenart, Nikolett; Kasztner, Aniko; Bereczki, Erika; Toth, Melinda E.; Santha, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Szegedi, Viktor; Juhasz, Gabor; Penke, Botond] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary; [Horvath, Janos; Penke, Botond] Univ Szeged, Inst Med Chem, Fac Med, Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Santha, M (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	santha@brc.hu	Bereczki, Erika/GSD-4808-2022; Santha, Miklos/F-4772-2013	Bereczki, Erika/0000-0002-0373-7417; Lenart, Nikolett/0000-0002-7456-949X; Juhasz, Gabor/0000-0001-6912-5109; Szegedi, Viktor/0000-0003-4191-379X	National Office for Research and Technology [TAMOP-4.2.2-08/1-2008-0002, TAMOP 4.2.1B-1/9-KONV, GOP 1.1.1-11-2011-0003]; NKTH [TAMOP-4.2.2/B-10/1-2010-0012]	National Office for Research and Technology(National Office for Research and TechnologyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NKTH(National Office for Research and Technology)	This work was supported by the National Office for Research and Technology grants (TAMOP-4.2.2-08/1-2008-0002 to BP and MS, TAMOP 4.2.1B-1/9-KONV to BP and GOP 1.1.1-11-2011-0003 to MS). NL was a participant of the PhD Support Program for Talented Students at University of Szeged, supported by NKTH (TAMOP-4.2.2/B-10/1-2010-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Antonios N, 2008, EUR NEUROL, V60, P269, DOI 10.1159/000157880; Bjelik A, 2006, NEUROCHEM INT, V49, P393, DOI 10.1016/j.neuint.2006.01.026; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chan A, 2006, J ALZHEIMERS DIS, V9, P399; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cromwell William C, 2009, Curr Cardiol Rep, V11, P468; Csont T, 2007, CARDIOVASC RES, V76, P100, DOI 10.1016/j.cardiores.2007.06.006; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Panza F, 2006, BRAIN RES REV, V51, P275, DOI 10.1016/j.brainresrev.2005.11.007; Pei JJ, 2008, CURR OPIN PSYCHIATR, V21, P555, DOI 10.1097/YCO.0b013e328314b78b; Pelech Steven, 2003, Methods Mol Biol, V218, P99; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Sabbagh M, 2004, J ALZHEIMERS DIS, V6, P585; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; SPARKS DL, 1995, NEUROSCI LETT, V187, P142, DOI 10.1016/0304-3940(95)11357-6; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Sule Z, 2009, LIFE SCI, V84, P935, DOI 10.1016/j.lfs.2009.04.011; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Watanabe T, 2004, METABOLISM, V53, P476, DOI 10.1016/j.metabol.2003.11.020; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46007	10.1371/journal.pone.0046007	http://dx.doi.org/10.1371/journal.pone.0046007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029362	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309554700104
J	Mao, HY; Li, Q; Gao, SJ				Mao, Hongyan; Li, Qin; Gao, Shujun			Meta-Analysis of the Relationship between Common Type 2 Diabetes Risk Gene Variants with Gestational Diabetes Mellitus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; INSULIN-SECRETION; TCF7L2 GENE; GLUCOSE-TOLERANCE; KOREAN POPULATION; WOMEN; PREGNANCY; POLYMORPHISMS; SUSCEPTIBILITY	Background: A number of case-control studies were conducted to investigate the association of common type 2 diabetes (T2D) risk gene polymorphisms with gestational diabetes mellitus (GDM). However, these studies have yielded contradictory results. We therefore performed a meta-analysis to derive a more precise estimation of the association between these polymorphisms and GDM, hence achieve a better understanding to the relationship between T2D and GDM. Methods: PubMed, EMBASE, ISI web of science and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to examine the association between 9 polymorphisms from 8 genes and susceptibility to GDM. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity among articles and their publication bias were also tested. Results: We identified 22 eligible studies including a total of 10,336 GDM cases and 17,445 controls. We found 8 genetic polymorphisms were significantly associated with GDM in a random-effects meta-analysis. These polymorphisms were in or near the following genes: TCF7L2 (rs7903146), MTNR1B (rs10830963), IGF2BP2 (rs4402960), KCNJ11 (rs5219), CDKAL1 (rs7754840), KCNQ1 (rs2237892 and rs2237895) and GCK (rs4607517); while no association was found for PPARG with GDM risk. Similar results were also observed under dominant genetic model for these polymorphisms. Conclusions: This meta-analysis found 8 genetic variants associated with GDM. The relative contribution and relevance of the identified genes in the pathogenesis of GDM should be the focus of future studies.	[Gao, Shujun] Fudan Univ, Gynecol & Obstet Hosp, Shanghai 200433, Peoples R China	Fudan University	Gao, SJ (corresponding author), Fudan Univ, Gynecol & Obstet Hosp, Shanghai 200433, Peoples R China.	drshujungao@yahoo.cn		Gao, Shujun/0000-0002-3217-7519				Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; BUCHANAN TA, 1990, AM J OBSTET GYNECOL, V162, P1008, DOI 10.1016/0002-9378(90)91306-W; Cheng Yan, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P170; CHIU KC, 1994, DIABETOLOGIA, V37, P104; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Deng ZF, 2011, ZHONGHUA WEI CHAN YI, V14, P666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Hadden D R, 1985, Diabetes, V34 Suppl 2, P8; Heude B, 2011, J CLIN ENDOCR METAB, V96, pE1656, DOI 10.1210/jc.2011-0381; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Kwak SH, 2010, HORM RES PAEDIAT, V74, P333, DOI 10.1159/000313918; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; MARTIN AO, 1985, AM J OBSTET GYNECOL, V151, P471, DOI 10.1016/0002-9378(85)90272-8; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; METZGER BE, 1991, DIABETES, V40, P197, DOI 10.2337/diab.40.2.S197; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Papadopoulou A, 2011, DIABETIC MED, V28, P1018, DOI 10.1111/j.1464-5491.2011.03359.x; Pappa KI, 2011, GYNECOL ENDOCRINOL, V27, P267, DOI 10.3109/09513590.2010.490609; Pascoe L, 2008, DIABETOLOGIA, V51, P1989, DOI 10.1007/s00125-008-1124-7; RYAN EA, 1985, DIABETES, V34, P380, DOI 10.2337/diabetes.34.4.380; Santos ICR, 2010, CLIN CHIM ACTA, V411, P892, DOI 10.1016/j.cca.2010.03.011; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaat N, 2007, DIABETOLOGIA, V50, P972, DOI 10.1007/s00125-007-0623-2; Shaat N, 2006, DIABETOLOGIA, V49, P1545, DOI 10.1007/s00125-006-0258-8; Shaat N, 2005, DIABETOLOGIA, V48, P2544, DOI 10.1007/s00125-005-0035-0; Shaat N, 2004, DIABETOLOGIA, V47, P878, DOI 10.1007/s00125-004-1388-5; Shaat N, 2007, CURR MED CHEM, V14, P569, DOI 10.2174/092986707780059643; Shin HD, 2010, J CLIN ENDOCR METAB, V95, P445, DOI 10.1210/jc.2009-1393; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Tok EC, 2006, EUR J OBSTET GYN R B, V129, P25, DOI 10.1016/j.ejogrb.2006.03.016; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026953; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Williams MA, 2003, J REPROD MED, V48, P955; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Zhou Q, 2009, DIABETOLOGIA, V52, P2466, DOI 10.1007/s00125-009-1500-y; Zhu Y, 2009, SHI YONG YI XUE ZA Z, P1963	57	88	98	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45882	10.1371/journal.pone.0045882	http://dx.doi.org/10.1371/journal.pone.0045882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029294	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700085
J	Chang, YM; Chen, CKM; Chang, YC; Jeng, WY; Hou, MH; Wang, AHJ				Chang, Yu-Ming; Chen, Cammy K. -M.; Chang, Yuan-Chih; Jeng, Wen-Yih; Hou, Ming-Hon; Wang, Andrew H. -J.			Functional Studies of ssDNA Binding Ability of MarR Family Protein TcaR from Staphylococcus epidermidis	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; DNA-BINDING; BACTERIOPHAGE THERAPY; REGULATOR; REPRESSOR; MECHANISM; STABILITY; LIGAND; TRANSCRIPTION	The negative transcription regulator of the ica locus, TcaR, regulates proteins involved in the biosynthesis of poly-N-acetylglucosamine (PNAG). Absence of TcaR increases PNAG production and promotes biofilm formation in Staphylococci. Previously, the 3D structure of TcaR in its apo form and its complex structure with several antibiotics have been analyzed. However, the detailed mechanism of multiple antibiotic resistance regulator (MarR) family proteins such as TcaR is unclear and only restricted on the binding ability of double-strand DNA (dsDNA). Here we show by electrophoretic mobility shift assay (EMSA), electron microscopy (EM), circular dichroism (CD), and Biacore analysis that TcaR can interact strongly with single-stranded DNA (ssDNA), thereby identifying a new role in MarR family proteins. Moreover, we show that TcaR preferentially binds 33-mer ssDNA over double-stranded DNA and inhibits viral ssDNA replication. In contrast, such ssDNA binding properties were not observed for other MarR family protein and TetR family protein, suggesting that the results from our studies are not an artifact due to simple charge interactions between TcaR and ssDNA. Overall, these results suggest a novel role for TcaR in regulation of DNA replication. We anticipate that the results of this work will extend our understanding of MarR family protein and broaden the development of new therapeutic strategies for Staphylococci.	[Chang, Yu-Ming; Chen, Cammy K. -M.; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016	CHANG, Yuan-Chih/0000-0002-0289-3768; Hou, Ming-hon/0000-0003-4170-1527	Academia Sinica and National Science Council (Taiwan) [NSC96-3114-P-001-004, NSC97-3114-P-001-001, NSC99-3113-B-001-001]; Institute of Biological Chemistry at Academia Sinica and; National Research Program for Biopharmaceuticals	Academia Sinica and National Science Council (Taiwan); Institute of Biological Chemistry at Academia Sinica and; National Research Program for Biopharmaceuticals	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC96-3114-P-001-004, NSC97-3114-P-001-001, and NSC99-3113-B-001-001 (to AH-JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We, the authors, acknowledge the support of grants from the Institute of Biological Chemistry at Academia Sinica and National Research Program for Biopharmaceuticals. We are also grateful for the use of the Tecnai F20 in the Cryo-EM Core Facility, Scientific Instrument Center at Academia Sinica.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Anderson SD, 2008, ANN PHARMACOTHER, V42, P806, DOI 10.1345/aph.1L016; [Anonymous], 1983, LANCET, V2, P1287; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Chin KH, 2006, PROTEINS, V65, P239, DOI 10.1002/prot.21017; Christensen J, 2002, J VIROL, V76, P6518, DOI 10.1128/JVI.76.13.6518-6531.2002; Corbin-Lickfett KA, 2009, NUCLEIC ACIDS RES, V37, P7290, DOI 10.1093/nar/gkp793; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hou MH, 2008, BIOCHEMISTRY-US, V47, P5493, DOI 10.1021/bi701915f; Hou MH, 2009, BIOCHEMISTRY-US, V48, P4691, DOI 10.1021/bi900092w; Huang CY, 2009, PROTEIN SCI, V18, P2209, DOI 10.1002/pro.225; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Llull D, 2011, J BACTERIOL, V193, P1919, DOI 10.1128/JB.01109-10; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mattey M, 2008, CURR OPIN BIOTECH, V19, P608, DOI 10.1016/j.copbio.2008.09.001; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Palm GJ, 2012, NUCL ACIDS RES; Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Sitohy M, 2006, J AGR FOOD CHEM, V54, P3800, DOI 10.1021/jf0531757; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu JG, 2007, NUCLEIC ACIDS RES, V35, P2390, DOI 10.1093/nar/gkm149	52	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45665	10.1371/journal.pone.0045665	http://dx.doi.org/10.1371/journal.pone.0045665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029170	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800075
J	Di Milia, L; Rogers, NL; Akerstedt, T				Di Milia, Lee; Rogers, Naomi L.; Akerstedt, Torbjorn			Sleepiness, Long Distance Commuting and Night Work as Predictors of Driving Performance	PLOS ONE			English	Article							SHIFT-WORK; FATIGUE; ACCIDENTS; ALERTNESS; DISORDERS; SLEEPY; HEALTH; RISK	Few studies have examined the effect of working night shift and long distance commuting. We examined the association between several sleep related and demographic variables, commuting distance, night work and use of mobile phones on driving performance. We used a prospective design to recruit participants and conducted a telephone survey (n = 649). The survey collected demographic and journey details, work and sleep history and driving performance concerning the day the participant was recruited. Participants also completed the Karolinska Sleepiness Scale and the Epworth Sleepiness Scale. Night workers reported significantly more sleepiness, shorter sleep duration and commuting longer distances. Seven variables were significant predictors of lane crossing. The strongest predictor was acute sleepiness (OR = 5.25, CI, 1.42-19.49, p < 0.01) followed by driving >= 150 kms (OR = 3.61, CI, 1.66-7.81, p < 0.001), obtaining less than 10 hours sleep in the previous 48 hours (OR = 2.58, CI, 1.03-6.46, p < 0.05), driving after night shift (OR = 2.19, CI, 1.24-3.88, p < 0.001), being <43 years old (OR = 1.95, CI, 1.11-3.41, p < 0.05) and using mobile phones during the journey (OR = 1.90, CI, 1.10-3.27, p < 0.05). Sleep related variables, long-distance commuting and night work have a major impact on lane crossing. Several interventions should be considered to reduce the level of sleepiness in night workers.	[Di Milia, Lee] Cent Queensland Univ, Sch Management, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Rogers, Naomi L.] Cent Queensland Univ, Chronobiol & Sleep Unit, Rockhampton, Qld 4702, Australia; [Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Central Queensland University; Central Queensland University; Stockholm University	Di Milia, L (corresponding author), Cent Queensland Univ, Sch Management, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia.	v.dimilia@cqu.edu.au	Di Milia, Lee/A-6810-2008; Rogers, Naomi/G-3538-2013	Di Milia, Lee/0000-0001-7681-5589; Rogers, Naomi/0000-0002-0536-9814; Akerstedt, Torbjorn/0000-0001-8049-8504	Department of Transport and Main Roads, QLD, Australia	Department of Transport and Main Roads, QLD, Australia	The study was funded by the Department of Transport and Main Roads, QLD, Australia. The funders had no role in study design, data collection and analysis, decision to submit or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Basner M, 2012, SLEEP, V35, P193, DOI 10.5665/sleep.1620; Bjorvatn B, 2006, SLEEP, V29, P821, DOI 10.1093/sleep/29.6.821; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Cummings P, 2001, Inj Prev, V7, P194, DOI 10.1136/ip.7.3.194; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Czeisler CA, 2009, MAYO CLIN PROC, V84, P958, DOI 10.1016/S0025-6196(11)60666-6; Dawson D, 2005, SLEEP MED REV, V9, P365, DOI 10.1016/j.smrv.2005.03.002; Di Milia L, 2006, TRANSPORT RES F-TRAF, V9, P278, DOI 10.1016/j.trf.2006.01.006; GOLD DR, 1992, AM J PUBLIC HEALTH, V82, P1011, DOI 10.2105/AJPH.82.7.1011; Horne J, 1999, BRIT MED J, V310, P565; Jermakian JS, 2011, ACCIDENT ANAL PREV, V43, P732, DOI 10.1016/j.aap.2010.10.020; Lowden A, 2012, CHRONOBIOL INT, V29, P641, DOI 10.3109/07420528.2012.675850; Muller R, 2008, ANN OCCUP HYG, V52, P63, DOI 10.1093/annhyg/mem058; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; National Sleep Foundation, 2011, 2011 SLEEP AM POLL C; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P577, DOI 10.1016/S0022-3999(02)00438-5; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Pilcher JJ, 2000, SLEEP, V23, P155; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Richardson G S, 1989, Alcohol Drugs Driving, V5-6, P265; Rogers A, 2001, J Hum Ergol (Tokyo), V30, P131; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; ROSA RR, 1991, WORK STRESS, V5, P107, DOI 10.1080/02678379108257008; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Siskind V, 2011, ACCIDENT ANAL PREV, V43, P1082, DOI 10.1016/j.aap.2010.12.016; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Ting PH, 2008, PHYSIOL BEHAV, V94, P448, DOI 10.1016/j.physbeh.2008.02.015; Tziotis N, 2005, APR27305; Waage S, 2012, SLEEP MED, V13, P64, DOI 10.1016/j.sleep.2011.04.009; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45856	10.1371/journal.pone.0045856	http://dx.doi.org/10.1371/journal.pone.0045856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029278	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800106
J	Li, J; Mo, ML; Chen, Z; Chen, Z; Sheng, Q; Mu, H; Zhang, F; Zhang, Y; Zhi, XY; Li, H; He, BA; Zhou, HM				Li, Jie; Mo, Minli; Chen, Zhao; Chen, Zhe; Sheng, Qing; Mu, Hang; Zhang, Fang; Zhang, Yi; Zhi, Xiu-Yi; Li, Hui; He, Biao; Zhou, Hai-Meng			Adenoviral Delivery of the EMX2 Gene Suppresses Growth in Human Gastric Cancer	PLOS ONE			English	Article							ONCOLYTIC ADENOVIRUS; FUNCTION LEADS; VIRAL VECTORS; EXPRESSION; THERAPY; SURGERY; CELLS; P53; ADENOCARCINOMA; PROLIFERATION	Background: EMX2 is a human orthologue of the Drosophila empty spiracles homeobox gene that has been implicated in embryogenesis. Recent studies suggest possible involvement of EMX2 in human cancers; however, the role of EMX2 in carcinogenesis needs further exploration. Results: In this study, we reported that down-regulation of EMX2 expression was significantly correlated with EMX2 promoter hypermethylation in gastric cancer. Restoring EMX2 expression using an adenovirus delivery system in gastric cancer cell lines lacking endogenous EMX2 expression led to inhibition of cell proliferation and Wnt signaling pathway both in vitro and in a gastric cancer xenograft model in vivo. In addition, we observed that animals treated with the adenoviral EMX2 expression vector had significantly better survival than those treated with empty adenoviral vector. Conclusion: Our study suggests that EMX2 is a putative tumor suppressor in human gastric cancer. The adenoviral-EMX2 may have potential as a novel gene therapy for the treatment of patients with gastric cancer.	[Li, Hui; He, Biao] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Li, Jie; Mo, Minli; Chen, Zhao; Chen, Zhe; Mu, Hang; Zhou, Hai-Meng] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Sheng, Qing] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Mu, Hang; Zhang, Fang; Zhou, Hai-Meng] Tsinghua Univ, Yangtze Delta Reg Inst, Zhejiang Prov Key Lab Appl Enzymol, Jiaxing, Zhejiang, Peoples R China; [Zhang, Yi; Zhi, Xiu-Yi] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tsinghua University; Zhejiang Sci-Tech University; Tsinghua University; Capital Medical University	He, BA (corresponding author), Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	biao.he@ucsfmedctr.org; zhm-dbs@tsinghua.edu.cn	Chen, Zhe/E-4278-2015; Chen, Zhe/H-1417-2016	Chen, Zhe/0000-0002-8209-0999; 	National Key Basic Research and Development (973) Program of China [2011CB910800, 2012CB917304]; National Natural Science Foundation of China [31170732]; Natural Science Foundation of Zhejiang Province [Y2101329]; Postdoctoral Science Foundation of Zhejiang Province [2010-BSH-031]	National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Postdoctoral Science Foundation of Zhejiang Province(China Postdoctoral Science Foundation)	This work was supported by funds from the National Key Basic Research and Development (973) Program of China (2011CB910800 and 2012CB917304), the National Natural Science Foundation of China (31170732), the Natural Science Foundation of Zhejiang Province (Y2101329), and the Postdoctoral Science Foundation of Zhejiang Province (2010-BSH-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Appledorn DM, 2008, CONTRIB NEPHROL, V159, P47, DOI 10.1159/000125581; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Galli R, 2002, DEVELOPMENT, V129, P1633; Galm Oliver, 2005, V113, P279, DOI 10.1385/1-59259-916-8:279; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Idogawa M, 2009, CLIN CANCER RES, V15, P3725, DOI 10.1158/1078-0432.CCR-08-2396; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Makower D, 2003, CLIN CANCER RES, V9, P693; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Nishimura S, 2001, CANCER RES, V61, P7009; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Okamoto J, 2011, CLIN LUNG CANCER, V12, P237, DOI 10.1016/j.cllc.2011.03.025; Park CY, 2008, INVEST OPHTH VIS SCI, V49, P399, DOI 10.1167/iovs.07-0619; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Roukos D, 2009, ANN SURG ONCOL, V16, P795, DOI 10.1245/s10434-009-0317-8; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Taylor HS, 2005, MOL ENDOCRINOL, V19, P2839, DOI 10.1210/me.2005-0130; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wu KC, 2009, J GASTROEN HEPATOL, V24, P37, DOI 10.1111/j.1440-1746.2008.05753.x; Yoshida M, 1997, DEVELOPMENT, V124, P101	43	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45970	10.1371/journal.pone.0045970	http://dx.doi.org/10.1371/journal.pone.0045970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029345	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800126
J	Bailey, K; West, R; Mullaney, KM				Bailey, Kira; West, Robert; Mullaney, Kellie M.			Neural Correlates of Processing Negative and Sexually Arousing Pictures	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PARTIAL LEAST-SQUARES; ELECTROCORTICAL RESPONSE; EMOTIONAL PERCEPTION; ATTENTION; BRAIN; TASK; BIAS; REPETITION	Recent work has questioned whether the negativity bias is a distinct component of affective picture processing. The current study was designed to determine whether there are different neural correlates of processing positive and negative pictures using event-related brain potentials. The early posterior negativity and late positive potential were greatest in amplitude for erotic pictures. Partial Least Squares analysis revealed one latent variable that distinguished erotic pictures from neutral and positive pictures and another that differentiated negative pictures from neutral and positive pictures. The effects of orienting task on the neural correlates of processing negative and erotic pictures indicate that affective picture processing is sensitive to both stimulus-driven, and attentional or decision processes. The current data, together with other recent findings from our laboratory, lead to the suggestion that there are distinct neural correlates of processing negative and positive stimuli during affective picture processing.	[Bailey, Kira] Univ Missouri Columbia, Dept Psychol Sci, Columbia, MO 65211 USA; [West, Robert; Mullaney, Kellie M.] Iowa State Univ, Dept Psychol, Ames, IA USA	University of Missouri System; University of Missouri Columbia; Iowa State University	Bailey, K (corresponding author), Univ Missouri Columbia, Dept Psychol Sci, Columbia, MO 65211 USA.	baileyki@missouri.edu	West, Robert L/D-8533-2011	West, Robert/0000-0002-1835-8874				Bailey K, 2011, COGN AFFECT BEHAV NE, V11, P259, DOI 10.3758/s13415-011-0029-y; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dien J., 2005, EVENT RELATED POTENT; Dunning JP, 2009, PSYCHOPHYSIOLOGY, V46, P28, DOI 10.1111/j.1469-8986.2008.00723.x; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Fox E, 2007, EMOTION, V7, P691, DOI 10.1037/1528-3542.7.4.691; Gorsuch R., 1983, FACTOR ANAL; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Ito TA, 2005, COGNITION EMOTION, V19, P1, DOI 10.1080/02699930441000120; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; Kisley MA, 2007, PSYCHOL SCI, V18, P838, DOI 10.1111/j.1467-9280.2007.01988.x; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Luck S.J., 2005, INTRO EVENT RELATED; MacNamara A, 2011, COGN AFFECT BEHAV NE, V11, P321, DOI 10.3758/s13415-011-0036-z; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	35	9	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45522	10.1371/journal.pone.0045522	http://dx.doi.org/10.1371/journal.pone.0045522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PT	23029071	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900069
J	Schellingerhout, D; LeRoux, LG; Hobbs, BP; Bredow, S				Schellingerhout, Dawid; LeRoux, Lucia G.; Hobbs, Brian P.; Bredow, Sebastian			Impairment of Retrograde Neuronal Transport in Oxaliplatin-Induced Neuropathy Demonstrated by Molecular Imaging	PLOS ONE			English	Article							SPINAL-CORD PLASTICITY; ROOT GANGLION NEURONS; NERVE GROWTH-FACTOR; TETANUS TOXIN; AXONAL-TRANSPORT; C-FRAGMENT; ESCHERICHIA-COLI; BINDING-SITE; CISPLATIN; NEUROTOXICITY	Background and Purpose: The purpose of our study was to utilize a molecular imaging technology based on the retrograde axonal transport mechanism (neurography), to determine if oxaliplatin-induced neurotoxicity affects retrograde axonal transport in an animal model. Materials and Methods: Mice (n = 8/group) were injected with a cumulative dose of 30 mg/kg oxaliplatin (sufficient to induce neurotoxicity) or dextrose control injections. Intramuscular injections of Tetanus Toxin C-fragment (TTc) labeled with Alexa 790 fluorescent dye were done (15 ug/20 uL) in the left calf muscles, and in vivo fluorescent imaging performed (0-60 min) at baseline, and then weekly for 5 weeks, followed by 2-weekly imaging out to 9 weeks. Tissues were harvested for immunohistochemical analysis. Results: With sham treatment, TTc transport causes fluorescent signal intensity over the thoracic spine to increase from 0 to 60 minutes after injection. On average, fluorescence signal increased 722%+/-117% (Mean+/-SD) from 0 to 60 minutes. Oxaliplatin treated animals had comparable transport at baseline (787%+/-140%), but transport rapidly decreased through the course of the study, falling to 363%+/-88%, 269%+/-96%, 191%+/-58%, 121%+/-39%, 75%+/-21% with each successive week and stabilizing around 57% (+/-15%) at 7 weeks. Statistically significant divergence occurred at approximately 3 weeks (p <= 0.05, linear mixed-effects regression model). Quantitative immuno-fluorescence histology with a constant cutoff threshold showed reduced TTc in the spinal cord at 7 weeks for treated animals versus controls (5.2 Arbitrary Units +/-0.52 vs 7.1 AU +/-1.38, p<0.0004, T-test). There was no significant difference in neural cell mass between the two groups as shown with NeuN staining (10.2+/-1.21 vs 10.5 AU +/-1.53, p>0.56, T-test). Conclusion: We show-for the first time to our knowledge-that neurographic in vivo molecular imaging can demonstrate imaging changes in a model of oxaliplatin-induced neuropathy. Impaired retrograde neural transport is suggested to be an important part of the pathophysiology of oxaliplatin-induced neuropathy.	[Schellingerhout, Dawid] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Schellingerhout, Dawid; LeRoux, Lucia G.; Bredow, Sebastian] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Hobbs, Brian P.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schellingerhout, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA.	Dawid.schellingerhout@mdanderson.org		Le Roux, Lucia/0000-0002-6053-2194	Mike Hogg Fund; MD Anderson Cancer Center Institutional Research Grant; John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging; National Institute of Neurologic Disorders and Stroke [R01NS070742]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070742] Funding Source: NIH RePORTER	Mike Hogg Fund; MD Anderson Cancer Center Institutional Research Grant; John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging; National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The support of the Mike Hogg Fund, MD Anderson Cancer Center Institutional Research Grant, John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging and Award Number R01NS070742 National Institute of Neurologic Disorders and Stroke are gratefully acknowledged. The content of this paper is the sole responsibility of the authors, and does not necessarily reflect the official views of our funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; BIZZINI B, 1980, BRAIN RES, V193, P221, DOI 10.1016/0006-8993(80)90959-2; BIZZINI B, 1977, J NEUROCHEM, V28, P529, DOI 10.1111/j.1471-4159.1977.tb10423.x; BIZZINI B, 1981, BRAIN RES, V210, P291, DOI 10.1016/0006-8993(81)90902-1; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; CAVALETTI G, 1992, CANCER-AM CANCER SOC, V69, P203, DOI 10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1; CAVALETTI G, 1991, INT J TISSUE REACT, V13, P151; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Cersosimo RJ, 2005, ANN PHARMACOTHER, V39, P128, DOI 10.1345/aph.1E319; Chen XY, 2002, J NEUROPHYSIOL, V87, P645, DOI 10.1152/jn.00391.2001; Egashira N, 2010, J PHARMACOL SCI, V112, P473, DOI 10.1254/jphs.10012SC; EISEL U, 1986, EMBO J, V5, P2495, DOI 10.1002/j.1460-2075.1986.tb04527.x; FAIRWEATHER NF, 1986, J BACTERIOL, V165, P21, DOI 10.1128/jb.165.1.21-27.1986; FAIRWEATHER NF, 1986, NUCLEIC ACIDS RES, V14, P7809, DOI 10.1093/nar/14.19.7809; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; FISHMAN PS, 1987, BRAIN RES, V406, P275, DOI 10.1016/0006-8993(87)90792-X; Grafstein B, 1999, BRAIN RES BULL, V50, P311, DOI 10.1016/S0361-9230(99)00157-4; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Konya D, 2008, REGEN MED, V3, P309, DOI 10.2217/17460751.3.3.309; Kottschade LA, 2010, SUPPORT CAR IN PRESS; Kurniali PC, 2010, ONCOLOGY-NY, V24, P289; Louch HA, 2002, BIOCHEMISTRY-US, V41, P13644, DOI 10.1021/bi020291j; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Park SB, 2008, CURR MED CHEM, V15, P3081, DOI 10.2174/092986708786848569; Parker AR, 2010, MOL CANCER THER, V9, P2558, DOI 10.1158/1535-7163.MCT-10-0300; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Raynaud M, 1967, Prog Immunobiol Stand, V3, P244; Saif M Wasif, 2005, Ther Clin Risk Manag, V1, P249; Schellingerhout D, 2009, MOL IMAGING, V8, P319, DOI 10.2310/7290.2009.00029; SCHMIDT Y, 1995, EXP NEUROL, V132, P16, DOI 10.1016/0014-4886(95)90054-3; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Sinha K, 2000, MOL MICROBIOL, V37, P1041, DOI 10.1046/j.1365-2958.2000.02091.x; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Stockel K, 1975, EXPT BRAIN RES S, V23; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wolpaw JR, 2006, PROG NEUROBIOL, V78, P233, DOI 10.1016/j.pneurobio.2006.03.001; Wolpaw JR, 2006, LEARN MEMORY, V13, P208, DOI 10.1101/lm.92706; Wu SN, 2009, NEUROTOXICOLOGY, V30, P677, DOI 10.1016/j.neuro.2009.04.010; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Xu YD, 2012, J NUCL MED, V53, P312, DOI 10.2967/jnumed.111.094623; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45776	10.1371/journal.pone.0045776	http://dx.doi.org/10.1371/journal.pone.0045776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029238	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900098
J	Teixeira, PJPL; Thomazella, DPT; Vidal, RO; do Prado, PFV; Reis, O; Baroni, RM; Franco, SF; Mieczkowski, P; Pereira, GAG; Mondego, JMC				Teixeira, Paulo J. P. L.; Thomazella, Daniela P. T.; Vidal, Ramon O.; do Prado, Paula F. V.; Reis, Osvaldo; Baroni, Renata M.; Franco, Sulamita F.; Mieczkowski, Piotr; Pereira, Goncalo A. G.; Mondego, Jorge M. C.			The Fungal Pathogen Moniliophthora perniciosa Has Genes Similar to Plant PR-1 That Are Highly Expressed during Its Interaction with Cacao	PLOS ONE			English	Article							RICH SECRETORY PROTEIN; WITCHES-BROOM DISEASE; VENOM ALLERGEN; CRINIPELLIS-PERNICIOSA; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; THEOBROMA-CACAO; CAUSAL AGENT; MELOIDOGYNE-INCOGNITA; BIOTROPHIC-LIKE	The widespread SCP/TAPS superfamily (SCP/Tpx-1/Ag5/PR-1/Sc7) has multiple biological functions, including roles in the immune response of plants and animals, development of male reproductive tract in mammals, venom activity in insects and reptiles and host invasion by parasitic worms. Plant Pathogenesis Related 1 (PR-1) proteins belong to this superfamily and have been characterized as markers of induced defense against pathogens. This work presents the characterization of eleven genes homologous to plant PR-1 genes, designated as MpPR-1, which were identified in the genome of Moniliophthora perniciosa, a basidiomycete fungus responsible for causing the devastating witches' broom disease in cacao. We describe gene structure, protein alignment and modeling analyses of the MpPR-1 family. Additionally, the expression profiles of MpPR-1 genes were assessed by qPCR in different stages throughout the fungal life cycle. A specific expression pattern was verified for each member of the MpPR-1 family in the conditions analyzed. Interestingly, some of them were highly and specifically expressed during the interaction of the fungus with cacao, suggesting a role for the MpPR-1 proteins in the infective process of this pathogen. Hypothetical functions assigned to members of the MpPR-1 family include neutralization of plant defenses, antimicrobial activity to avoid competitors and fruiting body physiology. This study provides strong evidence on the importance of PR-1-like genes for fungal virulence on plants.	[Teixeira, Paulo J. P. L.; Thomazella, Daniela P. T.; Vidal, Ramon O.; do Prado, Paula F. V.; Reis, Osvaldo; Baroni, Renata M.; Franco, Sulamita F.; Pereira, Goncalo A. G.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vidal, Ramon O.] Lab Nacl Biociencias, Sao Paulo, Brazil; [Baroni, Renata M.; Mondego, Jorge M. C.] Inst Agron Campinas, Ctr Pesquisa & Desenvolvimento Recursos Genet Veg, Sao Paulo, Brazil; [Mieczkowski, Piotr] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pereira, GAG (corresponding author), Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	goncalo@unicamp.br	Thomazella, Daniela Paula de Toledo/D-2750-2012; Teixeira, Paulo/C-1546-2013; Pereira, Gonçalo A. G./B-7944-2012	Teixeira, Paulo/0000-0002-0776-5044; Mieczkowski, Piotr/0000-0003-2418-0096; Favoretti Vital do Prado, Paula/0000-0002-3427-2229	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/53553-3, 2007/50262-0, 2009/51018-1, 2009/50119-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2006/53553-3, 2007/50262-0, 2009/51018-1 and 2009/50119-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Braun BR, 2000, GENETICS, V156, P31; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031164; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding X, 2000, INT J PARASITOL, V30, P77, DOI 10.1016/S0020-7519(99)00165-4; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; FRIAS GA, 1995, PLANT DIS, V79, P787, DOI 10.1094/PD-79-0787; Gao B, 2001, INT J PARASITOL, V31, P1617, DOI 10.1016/S0020-7519(01)00300-9; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kiba A, 2007, PLANT BIOTECHNOL-NAR, V24, P247, DOI 10.5511/plantbiotechnology.24.247; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lozano J, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P28, DOI 10.1079/9781845936877.0028; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; LU G, 1993, J IMMUNOL, V150, P2823; Meinhardt LW, 2006, CURR MICROBIOL, V52, P191, DOI 10.1007/s00284-005-0182-z; Meinhardt LW, 2008, MOL PLANT PATHOL, V9, P577, DOI 10.1111/J.1364-3703.2008.00496.X; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MIZUKI N, 1992, MAMM GENOME, V3, P274, DOI 10.1007/BF00292155; MOCHCAMORALES J, 1990, TOXICON, V28, P299, DOI 10.1016/0041-0101(90)90065-F; Mondego JMC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-548; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Oeser B, 2009, MOL PLANT PATHOL, V10, P665, DOI [10.1111/j.1364-3703.2009.00560.x, 10.1111/J.1364-3703.2009.00560.X]; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Pires ABL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-158; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573; Rauscher M, 1999, PLANT J, V19, P625, DOI 10.1046/j.1365-313x.1999.00545.x; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; REALINI C, 1995, J BIOL CHEM, V270, P29664; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rincones J, 2008, MOL PLANT MICROBE IN, V21, P891, DOI 10.1094/MPMI-21-7-0891; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Scarpari LM, 2005, J EXP BOT, V56, P865, DOI 10.1093/jxb/eri079; SCHUREN FHJ, 1993, J GEN MICROBIOL, V139, P2083, DOI 10.1099/00221287-139-9-2083; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; Thomazella DPT, 2012, NEW PHYTOL, V194, P1025, DOI 10.1111/j.1469-8137.2012.04119.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Wang X, 2007, EXP PARASITOL, V117, P133, DOI 10.1016/j.exppara.2007.03.017; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu F, 2012, BIOTECHNOL LETT; Zuniga S, 1999, GENE, V233, P141, DOI 10.1016/S0378-1119(99)00145-6	62	23	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45929	10.1371/journal.pone.0045929	http://dx.doi.org/10.1371/journal.pone.0045929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029323	Green Published, gold			2022-12-27	WOS:000309388900113
J	Ajay, AK; Saikumar, J; Bijol, V; Vaidya, VS				Ajay, Amrendra Kumar; Saikumar, Janani; Bijol, Vanesa; Vaidya, Vishal S.			Heterozygosity for Fibrinogen Results in Efficient Resolution of Kidney Ischemia Reperfusion Injury	PLOS ONE			English	Article							LEUKOCYTE-ENDOTHELIUM INTERACTION; DEFICIENT MICE; MYOCARDIAL-INFARCTION; PLASMA-FIBRINOGEN; ADHESION; DISEASE; ACTIVATION; FIBROSIS; RECOGNITION; EXPRESSION	Fibrinogen (Fg) has been recognized to play a central role in coagulation, inflammation and tissue regeneration. Several studies have used Fg deficient mice (Fg(-/-)) in comparison with heterozygous mice (Fg(+/-)) to point the proinflammatory role of Fg in diverse pathological conditions and disease states. Although Fg(+/-) mice are considered 'ormal', plasma Fg is reduced to similar to 75% of the normal circulating levels present in wild type mice (Fg(+/+)). We report that this reduction in Fg protein production in the Fg(+/-) mice is enough to protect them from kidney ischemia reperfusion injury (IRI) as assessed by tubular injury, kidney dysfunction, necrosis, apoptosis and inflammatory immune cell infiltration. Mechanistically, we observed binding of Fg to ICAM-1 in kidney tissues of Fg(+/+) mice at 24 h following IRI as compared to a complete absence of binding observed in the Fg(+/-) and Fg(-/-) mice. Raf-1 and ERK were highly activated as evident by significantly higher phosphorylation in the Fg(+/+) kidneys at 24 h following IRI as compared to Fg(+/-) and Fg(-/-) mice kidneys. On the other hand Cyclin D1 and pRb, indicating higher cell proliferation, were significantly increased in the Fg(+/-) and Fg(-/-) as compared to Fg(+/+) kidneys. These data suggest that Fg heterozygosity allows maintenance of a critical balance of Fg that enables regression of initial injury and promotes faster resolution of kidney damage.	[Ajay, Amrendra Kumar; Saikumar, Janani; Vaidya, Vishal S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA; [Bijol, Vanesa] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Vaidya, VS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA.	vvaidya@partners.org	Saikumar, Janani/AAE-9461-2021; Ajay, Amrendra K/D-7431-2016	Ajay, Amrendra K/0000-0003-2790-5726; Saikumar, Janani/0000-0002-8930-2472	National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award [ES017543]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017543] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work in Vaidya laboratory was supported by National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award (ES017543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Cruz-Topete D, 2006, J PATHOL, V210, P325, DOI 10.1002/path.2060; Degen JL, 2001, ANN NY ACAD SCI, V936, P276; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Drew AF, 2001, AM J PHYSIOL-RENAL, V281, pF1157, DOI 10.1152/ajprenal.0002.2001; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; Iacoviello L, 2001, HYPERTENSION, V38, P1199, DOI 10.1161/hy1101.099478; Iwaki T, 2006, BLOOD, V107, P3883, DOI 10.1182/blood-2005-09-3780; Jeong HJ, 1998, TRANSPLANT P, V30, P2953, DOI 10.1016/S0041-1345(98)00884-7; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Krishnamoorthy A, 2010, TOXICOL SCI, V118, P298, DOI 10.1093/toxsci/kfq240; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Peyvandi F, 2006, J THROMB HAEMOST, V4, P1634, DOI 10.1111/j.1538-7836.2006.02014.x; Reinhart WH, 2003, VASC MED, V8, P211, DOI 10.1191/1358863x03vm494ra; SCARABIN PY, 1993, ARTERIOSCLER THROMB, V13, P886, DOI 10.1161/01.ATV.13.6.886; Sorensen I, 2011, KIDNEY INT, V80, P1035, DOI 10.1038/ki.2011.214; Sorensen I, 2011, J AM SOC NEPHROL, V22, P1887, DOI 10.1681/ASN.2011010031; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Wilberding JA, 2001, ANN NY ACAD SCI, V936, P542	30	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45628	10.1371/journal.pone.0045628	http://dx.doi.org/10.1371/journal.pone.0045628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029147	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400115
J	Rungroj, N; Sudtachat, N; Nettuwakul, C; Sawasdee, N; Praditsap, O; Jungtrakoon, P; Sritippayawan, S; Chuawattana, D; Borvornpadungkitti, S; Predanon, C; Susaengrat, W; Yenchitsomanus, P				Rungroj, Nanyawan; Sudtachat, Nirinya; Nettuwakul, Choochai; Sawasdee, Nunghathai; Praditsap, Oranud; Jungtrakoon, Prapaporn; Sritippayawan, Suchai; Chuawattana, Duangporn; Borvornpadungkitti, Sombat; Predanon, Chagkrapan; Susaengrat, Wattanachai; Yenchitsomanus, Pathai			Association between Human Prothrombin Variant (T165M) and Kidney Stone Disease	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALLIZATION; F1 ACTIVATION PEPTIDE; HUMAN URINE; GENE; AGGREGATION; FRAGMENT-1; INHIBITOR; PROTEINS; SEQUENCE; BLOOD	We previously reported the association between prothrombin (F2), encoding a stone inhibitor protein - urinary prothrombin fragment 1 (UPTF1), and the risk of kidney stone disease in Northeastern Thai patients. To identify specific F2 variation responsible for the kidney stone risk, we conducted sequencing analysis of this gene in a group of the patients with kidney stone disease. Five intronic SNPs (rs2070850, rs2070852, rs1799867, rs2282687, and rs3136516) and one exonic non-synonymous single nucleotide polymorphism (nsSNP; rs5896) were found. The five intronic SNPs have no functional change as predicted by computer programs while the nsSNP rs5896 (c.494 C>T) located in exon 6 results in a substitution of threonine (T) by methionine (M) at the position 165 (T165M). The nsSNP rs5896 was subsequently genotyped in 209 patients and 216 control subjects. Genotypic and allelic frequencies of this nsSNP were analyzed for their association with kidney stone disease. The frequency of CC genotype of rs5896 was significantly lower in the patient group (13.4%) than that in the control group (22.2%) (P = 0.017, OR 0.54, 95% CI 0.32-0.90), and the frequency of C allele was significantly lower in the patient group (36.1%) than that in the control group (45.6%) (P = 0.005, OR 0.68, 95% CI 0.51-0.89). The significant differences of genotype and allele frequencies were maintained only in the female group (P = 0.033 and 0.003, respectively). The effect of amino-acid change on UPTF1 structure was also examined by homologous modeling and in silico mutagenesis. T165 is conserved and T165M substitution will affect hydrogen bond formation with E180. In conclusion, our results indicate that prothrombin variant (T165M) is associated with kidney stone risk in the Northeastern Thai female patients.	[Rungroj, Nanyawan; Sudtachat, Nirinya; Nettuwakul, Choochai; Sawasdee, Nunghathai; Praditsap, Oranud; Jungtrakoon, Prapaporn; Yenchitsomanus, Pathai] Mahidol Univ, Siriraj Hosp, Fac Med, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand; [Rungroj, Nanyawan; Praditsap, Oranud] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Genet,Dept Res & Dev, Bangkok 10700, Thailand; [Sudtachat, Nirinya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Med Biotechnol Unit, Bangkok, Thailand; [Sritippayawan, Suchai; Chuawattana, Duangporn] Mahidol Univ, Fac Med, Siriraj Hosp, Div Nephrol,Dept Med, Bangkok 10700, Thailand; [Borvornpadungkitti, Sombat; Predanon, Chagkrapan; Susaengrat, Wattanachai] Khon Kaen Hosp, Khon Kaen, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Yenchitsomanus, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand.	grpye@mahidol.ac.th	Rungroj, Nanyawan/O-4481-2015; Rungroj, Nanyawan/GYR-2610-2022; Rungroj, Nanyawan/AAU-3374-2020	Rungroj, Nanyawan/0000-0002-2379-9658; Jungtrakoon Thamtarana, Prapaporn/0000-0002-2637-6618	Thailand Research Fund (TRF) [RTA5080009]; Siriraj Research Development Fund, Mahidol University [RO15532006]; Faculty of Medicine Siriraj Hospital, Mahidol University	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Siriraj Research Development Fund, Mahidol University; Faculty of Medicine Siriraj Hospital, Mahidol University	This work was financially supported by the grants from Thailand Research Fund (TRF) (RTA5080009) and Siriraj Research Development Fund, Mahidol University (RO15532006). NR and PY are supported by Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University. PY is a TRF Senior Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegukkatajit Siripong, 1994, Journal of the Medical Association of Thailand, V77, P484; ATKINSON RA, 1990, J MOL BIOL, V212, P541, DOI 10.1016/0022-2836(90)90330-O; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DOYLE IR, 1991, CLIN CHEM, V37, P1589; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Grover PK, 2006, J PATHOL, V210, P273, DOI 10.1002/path.2061; Grover PK, 1998, EUR J BIOCHEM, V253, P637, DOI 10.1046/j.1432-1327.1998.2530637.x; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Howard J E, 1959, Trans Am Clin Climatol Assoc, V70, P94; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Liu JH, 2006, UROLOGY, V67, P201, DOI 10.1016/j.urology.2005.07.058; Liu JH, 2005, J UROLOGY, V173, P113, DOI 10.1097/01.ju.0000146847.24571.c8; Mann K G, 1976, Methods Enzymol, V45, P123; MCMULLEN BA, 1985, J BIOL CHEM, V260, P5328; NILWARANGKUR S, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P437; PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; Ramegowda D., 2007, EAU EBU UPDATE SER, V5, P126, DOI [10.1016/j.eeus.2007.03.002, DOI 10.1016/J.EEUS.2007.03.002]; ROYLE NJ, 1987, SOMAT CELL MOLEC GEN, V13, P285, DOI 10.1007/BF01535211; Rungroj N, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.07.494; Ryall RL, 1997, WORLD J UROL, V15, P155, DOI 10.1007/BF02201852; RYALL RL, 1995, CLIN SCI, V89, P533, DOI 10.1042/cs0890533; SRIBOONLUE P, 1991, NEPHRON, V59, P591, DOI 10.1159/000186649; Sritippayawan S, 2009, UROL RES, V37, P141, DOI 10.1007/s00240-009-0189-1; STAPLETON AMF, 1995, BRIT J UROL, V75, P712, DOI 10.1111/j.1464-410X.1995.tb07377.x; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Tore S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001281; Urabe Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002541; Vezzoli G, 2011, KIDNEY INT, V80, P587, DOI 10.1038/ki.2010.430; Webber D, 2007, UROL RES, V35, P277, DOI 10.1007/s00240-007-0119-z; Webber D, 2006, FEBS J, V273, P3024, DOI 10.1111/j.1742-4658.2006.05314.x; Yanagawa M, 1997, Int J Urol, V4, P537, DOI 10.1111/j.1442-2042.1997.tb00304.x	31	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45533	10.1371/journal.pone.0045533	http://dx.doi.org/10.1371/journal.pone.0045533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029076	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400100
J	Adair-Kirk, TL; Griffin, GL; Meyer, MJ; Kelley, DG; Miner, JH; Keene, DR; Marinkovich, MP; Ruppert, JM; Uitto, J; Senior, RM				Adair-Kirk, Tracy L.; Griffin, Gail L.; Meyer, Michelle J.; Kelley, Diane G.; Miner, Jeffrey H.; Keene, Douglas R.; Marinkovich, M. Peter; Ruppert, J. Michael; Uitto, Jouni; Senior, Robert M.			Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice	PLOS ONE			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; EPITHELIAL BASEMENT-MEMBRANES; HOMOZYGOUS NONSENSE MUTATION; CHAIN GENE; TRANSGENIC MICE; HUMAN TISSUES; HERLITZ; DIFFERENTIATION; HEMIDESMOSOMES; ABNORMALITIES	Laminin-332 is a heterotrimeric basement membrane component comprised of the alpha 3, beta 3, and gamma 2 laminin chains. Laminin-332 modulates epithelial cell processes, such as adhesion, migration, and differentiation and is prominent in many embryonic and adult tissues. In skin, laminin-332 is secreted by keratinocytes and is a key component of hemidesmosomes connecting the keratinocytes to the underlying dermis. In mice, lack of expression of any of the three Laminin-332 chains result in impaired anchorage and detachment of the epidermis, similar to that seen in human junctional epidermolysis bullosa, and death occurs within a few days after birth. To bypass the early lethality of laminin-332 deficiency caused by the knockout of the mouse laminin gamma 2 chain, we expressed a dox-controllable human laminin gamma 2 transgene under a keratinocyte-specific promoter on the laminin gamma 2 (Lamc2) knockout background. These mice appear similar to their wild-type littermates, do not develop skin blisters, are fertile, and survive >1.5 years. Immunofluorescence analyses of the skin showed that human laminin gamma 2 colocalized with mouse laminin alpha 3 and beta 3 in the basement membrane zone underlying the epidermis. Furthermore, the presence of "humanized'' laminin-332 in the epidermal basement membrane zone rescued the alterations in the deposition of hemidesmosomal components, such as plectin, collagen type XVII/BP180, and integrin alpha 6 and beta 4 chains, seen in conventional Lamc2 knockout mice, leading to restored formation of hemidesmosomes. These mice will be a valuable tool for studies of organs deficient in laminin-332 and the role of laminin-332 in skin, including wound healing.	[Adair-Kirk, Tracy L.; Griffin, Gail L.; Meyer, Michelle J.; Kelley, Diane G.; Senior, Robert M.] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO 63110 USA; [Miner, Jeffrey H.; Senior, Robert M.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Keene, Douglas R.] Shriners Hosp Children, Dept Mol & Med Genet, Portland, OR 97201 USA; [Marinkovich, M. Peter] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Ruppert, J. Michael] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Uitto, Jouni] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Stanford University; West Virginia University; Jefferson University	Adair-Kirk, TL (corresponding author), Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA.	tkirk@dom.wustl.edu			National Institutes of Health [P01HL029594]; Alan A. and Edith L. Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alan A. and Edith L. Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (P01HL029594) and Alan A. and Edith L. Charitable Trust/Barnes-Jewish Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; Airenne T, 1996, GENOMICS, V32, P54, DOI 10.1006/geno.1996.0076; Airenne T, 2000, CELL TISSUE RES, V300, P129, DOI 10.1007/s004410050054; Bauer J, 2002, EUR J PEDIATR, V161, P672, DOI 10.1007/s00431-001-0851-2; Bubier JA, 2010, J INVEST DERMATOL, V130, P1819, DOI 10.1038/jid.2010.46; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Elizur A, 2007, AM J PHYSIOL-LUNG C, V293, pL383, DOI 10.1152/ajplung.00024.2007; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; Kariya Y, 2008, J MOL HISTOL, V39, P435, DOI 10.1007/s10735-008-9183-0; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Kuster JE, 1997, MAMM GENOME, V8, P673, DOI 10.1007/s003359900535; Laimer M, 2010, DERMATOL CLIN, V28, P55, DOI 10.1016/j.det.2009.10.006; Lu W, 2001, HISTOCHEM J, V33, P629, DOI 10.1023/A:1016350316926; Maatta M, 2001, J HISTOCHEM CYTOCHEM, V49, P711; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; Nguyen NM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-28; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; STAGGERS WR, 1995, GENE, V153, P297, DOI 10.1016/0378-1119(94)00731-7; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; Xie W, 1998, CELL GROWTH DIFFER, V9, P313; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Yancey KB, 2010, DERMATOL CLIN, V28, P67, DOI 10.1016/j.det.2009.10.008	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45546	10.1371/journal.pone.0045546	http://dx.doi.org/10.1371/journal.pone.0045546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029085	gold, Green Published			2022-12-27	WOS:000311313900155
J	Finlayson, C; Brown, K; Blasco, R; Rosell, J; Negro, JJ; Bortolotti, GR; Finlayson, G; Marco, AS; Pacheco, FG; Vidal, JR; Carrion, JS; Fa, DA; Llanes, JMR				Finlayson, Clive; Brown, Kimberly; Blasco, Ruth; Rosell, Jordi; Jose Negro, Juan; Bortolotti, Gary R.; Finlayson, Geraldine; Sanchez Marco, Antonio; Giles Pacheco, Francisco; Rodriguez Vidal, Joaquin; Carrion, Jose S.; Fa, Darren A.; Llanes, Jose M. Rodriguez			Birds of a Feather: Neanderthal Exploitation of Raptors and Corvids	PLOS ONE			English	Article							SOUTH-AFRICA; SMALL-GAME; EVOLUTION	The hypothesis that Neanderthals exploited birds for the use of their feathers or claws as personal ornaments in symbolic behaviour is revolutionary as it assigns unprecedented cognitive abilities to these hominins. This inference, however, is based on modest faunal samples and thus may not represent a regular or systematic behaviour. Here we address this issue by looking for evidence of such behaviour across a large temporal and geographical framework. Our analyses try to answer four main questions: 1) does a Neanderthal to raptor-corvid connection exist at a large scale, thus avoiding associations that might be regarded as local in space or time?; 2) did Middle (associated with Neanderthals) and Upper Palaeolithic (associated with modern humans) sites contain a greater range of these species than Late Pleistocene paleontological sites?; 3) is there a taphonomic association between Neanderthals and corvids-raptors at Middle Palaeolithic sites on Gibraltar, specifically Gorham's, Vanguard and Ibex Caves? and; 4) was the extraction of wing feathers a local phenomenon exclusive to the Neanderthals at these sites or was it a geographically wider phenomenon?. We compiled a database of 1699 Pleistocene Palearctic sites based on fossil bird sites. We also compiled a taphonomical database from the Middle Palaeolithic assemblages of Gibraltar. We establish a clear, previously unknown and widespread, association between Neanderthals, raptors and corvids. We show that the association involved the direct intervention of Neanderthals on the bones of these birds, which we interpret as evidence of extraction of large flight feathers. The large number of bones, the variety of species processed and the different temporal periods when the behaviour is observed, indicate that this was a systematic, geographically and temporally broad, activity that the Neanderthals undertook. Our results, providing clear evidence that Neanderthal cognitive capacities were comparable to those of Modern Humans, constitute a major advance in the study of human evolution.	[Blasco, Ruth; Rosell, Jordi] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Finlayson, Clive] Univ Toronto, Dept Social Sci, Toronto, ON, Canada; [Blasco, Ruth; Rosell, Jordi] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Jose Negro, Juan] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Sanchez Marco, Antonio] Inst Catala Paleontol, Area Neogene & Quaternary Faunas, Cerdanyola Del Valles, Spain; [Rodriguez Vidal, Joaquin] Univ Huelva, Fac Ciencias Expt, Depto Geodinam & Paleontol, Huelva, Spain; [Carrion, Jose S.] Univ Murcia, Dept Plant Biol, Murcia, Spain; [Llanes, Jose M. Rodriguez] Univ Catholique Louvain 30, CRED, Inst Hlth & Soc, Brussels, Belgium	Universitat Rovira i Virgili; University of Toronto; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Saskatchewan; Institut Catala de Paleontologia Miquel Crusafont (ICP); Universidad de Huelva; University of Murcia	Blasco, R (corresponding author), Univ Rovira & Virgili, Area Prehist, Tarragona, Spain.	rblascolopez@gmail.com	Negro, Juan Jose/I-2653-2015; Fa, Darren A./F-1863-2015; Rosell, Jordi/G-8705-2015; Rodriguez-Llanes, Jose Manuel/L-4537-2019; Carrion, Jose S/A-8983-2015; Blasco, Ruth/AAG-8200-2019; Marco, Antonio Sánchez/F-9837-2010; Fa, Darren/Z-4376-2019	Negro, Juan Jose/0000-0002-8697-5647; Fa, Darren A./0000-0002-5900-9814; Rosell, Jordi/0000-0002-6758-6291; Rodriguez-Llanes, Jose Manuel/0000-0003-3736-736X; Carrion, Jose S/0000-0002-6949-4382; Blasco, Ruth/0000-0001-9804-739X; Marco, Antonio Sánchez/0000-0003-0654-1935; Fa, Darren/0000-0002-5900-9814; Rodriguez-Vidal, Joaquin/0000-0002-9475-3307	Government of Gibraltar; European Community - Program Interreg [IIIB: 2002-02-4, 1-U-048 -]; Generalitat de Catalunya [2009 SGR 188]; Spanish Goverment [CGL2009-12703-C03-02, CGL2011-28681]	Government of Gibraltar; European Community - Program Interreg; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Goverment(Spanish Government)	The excavations and scientific research associated with Gorham's Cave have been funded by the Government of Gibraltar and, additionally between 2002-04, by the European Community - Program Interreg IIIB: 2002-02-4, 1-U-048 -. R. Blasco and J. Rosell are part of the following projects: 2009 SGR 188 of Generalitat de Catalunya and CGL2009-12703-C03-02 of the Spanish Goverment. A. Sanchez Marco belongs to the CGL2011-28681 project of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biebuyk DP, 1984, POWER HEADDRESSES CR; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bovy KM, 2002, J ARCHAEOL SCI, V29, P965, DOI 10.1006/jasc.2001.0795; Bovy KM, 2012, J ARCHAEOL SCI, V39, P2049, DOI 10.1016/j.jas.2012.02.028; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; Ferraro-Dorta S, 2000, PLUMARIA INDIGENA BR; Finlayson C., 2011, AVIAN SURVIVORS HIST; Finlayson C., 2004, NEANDERTHALS MODERN; Grande JM, 2004, ARDEOLA, V51, P375; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guthrie R. D., 2005, NATURE PALEOLITHIC A; Hiroa TR, 1944, J POLYNESIAN SOC, V53, P1; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Klein RG, 2001, J ANTHROPOL RES, V57, P1; Klein RG, 2008, P NATL ACAD SCI USA, V105, pE115, DOI 10.1073/pnas.0809985106; Levi-Strauss C., 1963, TOTEMISM; Livingston SD, 1988, THESIS U WASHINGTON; Lyman RL, 2003, REPORTS ARCHAEOLOGY, P235; Mails TE, 1972, MYSTIC WARRIORS PLAI; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2007, RETHINKING HUMAN REV, P133; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Mundy P., 1992, VULTURES AFRICA; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Renfrew C., 2007, PREHISTORY MAKING HU; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; SCHAFER W, 1972, ECOLOGY PALEOECOLOGY; Serjeantson D., 2009, BIRDS CAMBRIDGE MANU; Soressi M., 2008, SOCIETE PREHISTORIQU, P95; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Tattersall I, 2011, HUMAN BRAIN EVOLUTIO, P1; Tyrberg T., 1998, PUBLICATIONS NUTTALL, V27; Tyrberg T, 2008, ONLINE SUPPLEMENT PL; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	43	154	156	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45927	10.1371/journal.pone.0045927	http://dx.doi.org/10.1371/journal.pone.0045927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23029321	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800066
J	Alasaari, JS; Lagus, M; Ollila, HM; Toivola, A; Kivimaki, M; Vahtera, J; Kronholm, E; Harma, M; Puttonen, S; Paunio, T				Alasaari, Jukka S.; Lagus, Markus; Ollila, Hanna M.; Toivola, Auli; Kivimaki, Mika; Vahtera, Jussi; Kronholm, Erkki; Harma, Mikko; Puttonen, Sampsa; Paunio, Tiina			Environmental Stress Affects DNA Methylation of a CpG Rich Promoter Region of Serotonin Transporter Gene in a Nurse Cohort	PLOS ONE			English	Article							EPIGENETIC REGULATION; SLC6A4 METHYLATION; DEPRESSION; EXPRESSION; BEHAVIOR; RISK; POLYMORPHISM; METAANALYSIS; ASSOCIATION; DISEASE	Background: Shift-working nurses are exposed to a stressful work environment, which puts them at an increased risk for burnout and depression. We explored the effect of environmental stress on serotonin transporter gene (SLC6A4) promoter methylation among nurses from high and low work stress environments. Methodology: Using bisulfite sequencing, we investigated the methylation status of five CpG residues of a CpG-rich region in the promoter of SLC6A4 by comparing female shift working nurses from a high work stress environment (n = 24) to low work stress environment (n = 25). We also analyzed the association of 5-HTTLPR polymorphism at 59 end of SLC6A4. Work stress was assessed by the Karasek's Model and possible signs of burnout or depression were measured by the Maslach Burnout Index General Survey and Beck Depression Index. Methylation levels were assessed by bisulfite sequencing of DNA extracted from peripheral blood leucocytes. Restriction enzyme treatment followed by standard PCR was used to identify 5-HTTLPR genotypes. Principal Findings: We found that nurses in the high stress environment had significantly lower promoter methylation levels at all five CpG residues compared to nurses in the low stress environment (p < 0.01). There was no significant interaction of 5-HTTLPR genotype and work stress with methylation (p = 0.58). In unadjusted (bivariate) analysis, burnout was not significantly associated to methylation levels. However, when mutually adjusted for both, burnout and work stress were significant contributors (p = 0.038 and p < 0.0001 respectively) to methylation levels. Conclusions: Our findings show that environmental stress is concurrent with decreased methylation of the SLC6A4 promoter. This may lead to increased transcriptional activity of the gene, increased reuptake of serotonin from synaptic clefts, and termination of the activity of serotonin. This could present a possible coping mechanism for environmental stress in humans that could eventually increase risk for disturbed functional capability and experience of depressed mood in long-term stress.	[Alasaari, Jukka S.; Lagus, Markus; Ollila, Hanna M.; Toivola, Auli; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Kivimaki, Mika; Vahtera, Jussi; Harma, Mikko; Puttonen, Sampsa] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kivimaki, Mika; Vahtera, Jussi] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kronholm, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Turku, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, Cent Hosp, SF-00180 Helsinki, Finland	Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; University of London; University College London; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Paunio, T (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland.	tiina.paunio@thl.fi	Kivimaki, Mika/B-3607-2012; Ollila, Hanna M/I-8552-2017; Vahtera, Jussi/J-3271-2013; Ollila, Hanna M/GQA-6308-2022	Kivimaki, Mika/0000-0002-4699-5627; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [124404]; Helsinki University Central Hospital [TYH2010306]; Sigrid and Arne Juselius Foundation; Academy of Finland; Finnish Work Environment Fund; European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme; United States National Institutes of Health [AG034454, HL036310]; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G8802774, G0902037] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Sigrid and Arne Juselius Foundation; Academy of Finland(Academy of Finland); Finnish Work Environment Fund; European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was financially supported by the Academy of Finland (WORK grant number 124404), Helsinki University Central Hospital (TYH2010306) and Sigrid and Arne Juselius Foundation (to TP). MK is supported by the Academy of Finland, the Finnish Work Environment Fund, the European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme, and the United States National Institutes of Health (AG034454 & HL036310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach SRH, 2011, PSYCHOSOM MED, V73, P83, DOI 10.1097/PSY.0b013e3181fdd074; Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534; Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gorwood Philip, 2004, Am J Pharmacogenomics, V4, P9, DOI 10.2165/00129785-200404010-00002; Haenisch B, 2010, PHARMACOL THERAPEUT, V129, P352, DOI DOI 10.1016/J.PHARMTHERA.2010.12.002; Han WG, 2006, ANAL BIOCHEM, V355, P50, DOI 10.1016/j.ab.2006.05.010; Hu XZ, 2004, BIOL PSYCHIAT, V55, p191S; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Karasek R.A., 1998, ENCY OCCUPATIONAL HL, p34.36; Kinnally EL, 2010, GENES BRAIN BEHAV, V9, P575, DOI 10.1111/j.1601-183X.2010.00588.x; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd ed., P19; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	44	70	73	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45813	10.1371/journal.pone.0045813	http://dx.doi.org/10.1371/journal.pone.0045813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029256	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900054
J	Garcia-Gonzalez, MA; Nicolas-Perez, D; Lanas, A; Bujanda, L; Carrera, P; Benito, R; Strunk, M; Sopena, F; Santolaria, S; Piazuelo, E; Jimenez, P; Campo, R; Espinel, J; Manzano, M; Geijo, F; Pellise, M; Gonzalez-Huix, F; Espinos, J; Zaballa, M; Tito, L; Barranco, L; Pazo, R; Quintero, E				Asuncion Garcia-Gonzalez, Maria; Nicolas-Perez, David; Lanas, Angel; Bujanda, Luis; Carrera, Patricia; Benito, Rafael; Strunk, Mark; Sopena, Federico; Santolaria, Santos; Piazuelo, Elena; Jimenez, Pilar; Campo, Rafael; Espinel, Jesus; Manzano, Marisa; Geijo, Fernando; Pellise, Maria; Gonzalez-Huix, Ferran; Espinos, Jorge; Zaballa, Manuel; Tito, Llucia; Barranco, Luis; Pazo, Roberto; Quintero, Enrique			Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; PEPTIC-ULCER DISEASE; CELL LUNG-CANCER; COLORECTAL-CANCER; GASTROESOPHAGEAL CANCER; POOR-PROGNOSIS; BREAST-CANCER; POLYMORPHISMS; CARCINOMA	Background: Genetic factors influencing the prognosis of gastric adenocarcinoma (GAC) are not well known. Given the relevance of cytokines and other pro-inflammatory mediators in cancer progression and invasiveness, we aimed to assess the prognostic role of several functional cytokine and cyclooxygenase gene polymorphisms in patients with GAC. Methodology: Genomic DNA from 380 Spanish Caucasian patients with primary GAC was genotyped for 23 polymorphisms in pro-inflammatory (IL1B, TNFA, LTA, IL6, IL12p40), anti-inflammatory (IL4, IL1RN, IL10, TGFB1) cytokine, and cyclooxygenase (PTGS1 and PTGS2) genes by PCR, RFLP and TaqMan assays. Clinical and histological information was collected prospectively. Survival curves were estimated by the Kaplan-Meier method and compared using the log rank test. Outcome was determined by analysis of Cox proportional hazards, adjusting for confounding factors. Results: The median follow-up period and median overall survival (OS) time were 9.9 months (range 0.4-120.3) and 10.9 months (95% CI: 8.9-14.1), respectively. Multivariate analysis identified tumor stages III (HR, 3.23; 95% CI: 2-5.22) and IV (HR, 5.5; 95% CI: 3.51-8.63) as independent factors associated with a significantly reduced OS, whereas surgical treatment (HR: 0.44; 95% CI: 0.3-0.6) was related to a better prognosis of the disease. Concerning genetic factors, none of the 23 polymorphisms evaluated in the current study did influence survival. Moreover, no gene-environment interactions on GAC prognosis were observed. Conclusions: Our results show that, in our population, the panel of selected pro-and anti-inflammatory cytokine, and cyclooxygenase gene polymorphisms are not relevant in determining the prognosis of gastric adenocarcinoma.	[Asuncion Garcia-Gonzalez, Maria; Lanas, Angel; Strunk, Mark; Sopena, Federico; Piazuelo, Elena] IIS Aragon, Zaragoza, Spain; [Asuncion Garcia-Gonzalez, Maria; Lanas, Angel; Bujanda, Luis; Carrera, Patricia; Benito, Rafael; Strunk, Mark; Sopena, Federico; Piazuelo, Elena; Jimenez, Pilar] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Nicolas-Perez, David; Quintero, Enrique] Hosp Univ Canarias, Dept Gastroenterol, Tenerife, Spain; [Lanas, Angel; Benito, Rafael] Univ Zaragoza, Fac Med, Zaragoza, Spain; [Lanas, Angel; Sopena, Federico] Hosp Clin Univ, Dept Gastroenterol, Zaragoza, Spain; [Bujanda, Luis] Univ Basque Country, Fac Med, Hosp Donostia, Dept Gastroenterol, San Sebastian, Spain; [Benito, Rafael] Hosp Clin Univ Lozano Blesa, Dept Microbiol, Zaragoza, Spain; [Santolaria, Santos] Hosp San Jorge, Dept Gastroenterol, Huesca, Spain; [Campo, Rafael] Hosp Parc Tauli, Dept Gastroenterol, Sabadell, Spain; [Espinel, Jesus] Complejo Hosp Leon, Dept Gastroenterol, Leon, Spain; [Manzano, Marisa] Hosp 12 Octubre, Dept Gastroenterol, E-28041 Madrid, Spain; [Geijo, Fernando] Hosp Clin Univ, Dept Gastroenterol, Salamanca, Spain; [Pellise, Maria] Hosp Clin Barcelona, Dept Gastroenterol, Barcelona, Spain; [Gonzalez-Huix, Ferran] Hosp Josep Trueta, Dept Gastroenterol, Girona, Spain; [Espinos, Jorge] Hosp Mutua Terrassa, Dept Gastroenterol, Terrassa, Spain; [Zaballa, Manuel] Hosp Cruces, Dept Gastroenterol, Baracaldo, Spain; [Tito, Llucia] Hosp Mataro, Dept Gastroenterol, Mataro, Spain; [Barranco, Luis] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [Pazo, Roberto] Hosp Miguel Servet, Dept Oncol, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de la Laguna; University of Zaragoza; Universidad de la Laguna; University Hospital Donostia; University of Basque Country; Lozano Blesa University Clinical Hospital; Hospital Universidad San Jorge; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Universidad de Leon; Hospital de Leon; Hospital Universitario 12 de Octubre; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Universitario Mutua Terrassa; Hospital Universitario Cruces; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Miguel Servet University Hospital	Garcia-Gonzalez, MA (corresponding author), IIS Aragon, Zaragoza, Spain.	asgarcia@unizar.es	CARRERA-LASFUENTES, PATRICIA/ABG-6300-2020; Barranco Priego, Luis/AFV-2437-2022; Pellise, Maria/ABC-3246-2021; Strunk, Mark/I-2423-2017; Quintero, Enrique/C-3841-2017; Bujanda, Luis/AAB-2485-2021; ESPINEL, JESUS/GVT-4480-2022; Benito, Rafael/AAH-9885-2019; García-González, María Asunción/D-9821-2018; Strunk, Mark HP/K-3597-2014	CARRERA-LASFUENTES, PATRICIA/0000-0002-8848-709X; Barranco Priego, Luis/0000-0002-7352-7415; Strunk, Mark/0000-0002-8619-3979; Quintero, Enrique/0000-0002-7244-8125; Bujanda, Luis/0000-0002-4353-9968; García-González, María Asunción/0000-0002-8906-2683; Strunk, Mark HP/0000-0002-8619-3979; Pellise, Maria/0000-0001-9739-4998; Piazuelo, Elena/0000-0001-5813-3445; Santolaria, Santos/0000-0003-4414-2361	Spanish "Fondo de Investigaciones Sanitarias" [PI05/0405, PS09/00213]; Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas)	Spanish "Fondo de Investigaciones Sanitarias"; Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas)(Instituto de Salud Carlos III)	This study was supported by the Spanish "Fondo de Investigaciones Sanitarias" (grants PI05/0405 and PS09/00213), and Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Canzian F, 2008, EUR J CANCER PREV, V17, P178, DOI 10.1097/CEJ.0b013e3282b6fd88; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chulada PC, 2000, CANCER RES, V60, P4705; Church RD, 2004, BRIT J CANCER, V91, P1015, DOI 10.1038/sj.bjc.6602119; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Coghill AE, 2011, CLIN CANCER RES, V17, P7139, DOI 10.1158/1078-0432.CCR-11-1134; Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Deans C, 2007, ANN SURG ONCOL, V14, P329, DOI 10.1245/s10434-006-9122-9; Degiuli M, 2004, BRIT J CANCER, V90, P1727, DOI 10.1038/sj.bjc.6601761; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fujimura T, 2006, WORLD J GASTROENTERO, V12, P1336, DOI 10.3748/wjg.v12.i9.1336; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Gawron AJ, 2011, SCAND J GASTROENTERO, V46, P333, DOI 10.3109/00365521.2010.537679; Gonzalez-Conejero R, 2005, STROKE, V36, P276, DOI 10.1161/01.STR.0000151362.65339.f9; Graziano F, 2005, J CLIN ONCOL, V23, P2339, DOI 10.1200/JCO.2005.02.345; Guan XX, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-94; Gupta RA, 2003, CANCER RES, V63, P906; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Hobsley M, 2007, GASTROENTEROLOGY, V132, P2076, DOI 10.1053/j.gastro.2007.03.088; Hou L, 2007, ANTICANCER RES, V27, P4243; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huang XE, 2000, NUTR CANCER, V38, P30, DOI 10.1207/S15327914NC381_5; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Iglesias D, 2009, CANCER CAUSE CONTROL, V20, P1421, DOI 10.1007/s10552-009-9368-1; Inui A, 2002, CA-CANCER J CLIN, V52, P72, DOI 10.3322/canjclin.52.2.72; KABIR S, 1995, CANCER LETT, V95, P207, DOI 10.1016/0304-3835(95)03895-4; Kawaguchi T, 2010, J THORAC ONCOL, V5, P1001, DOI 10.1097/JTO.0b013e3181e2f607; Kooby DA, 2003, ANN SURG, V237, P828, DOI 10.1097/00000658-200306000-00011; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu JL, 2010, WORLD J GASTROENTERO, V16, P5510, DOI 10.3748/wjg.v16.i43.5510; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Maehara Y, 1999, J CLIN ONCOL, V17, P607, DOI 10.1200/JCO.1999.17.2.607; MALEFYT RD, 1991, J EXP MED, V174, P915; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Marrelli D, 2009, CANCER, V115, P2071, DOI 10.1002/cncr.24253; Meimarakis G, 2006, LANCET ONCOL, V7, P211, DOI 10.1016/S1470-2045(06)70586-1; MORISAKI T, 1994, CANCER RES, V54, P1113; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; Qiu HB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-374; Rad R, 2006, LANCET ONCOL, V7, P364, DOI 10.1016/S1470-2045(06)70672-6; RASHID SA, 1982, BRIT J CANCER, V45, P390, DOI 10.1038/bjc.1982.66; Ristimaki A, 1997, CANCER RES, V57, P1276; Santolaria S, 2001, MED CLIN-BARCELONA, V116, P641, DOI 10.1016/S0025-7753(01)71935-5; Saxena A, 2008, WORLD J GASTROENTERO, V14, P1498, DOI 10.3748/wjg.14.1498; Shibata M, 2002, J CLIN GASTROENTEROL, V34, P416, DOI 10.1097/00004836-200204000-00006; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2005, ALCOHOL, V35, P259, DOI 10.1016/j.alcohol.2005.04.007; Shiraishi N, 2007, J SURG ONCOL, V96, P14, DOI 10.1002/jso.20631; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; SIEWERT JR, 1987, CHIRURG, V58, P25; Soria JC, 2003, CLIN CANCER RES, V9, P1785; Tahara T, 2011, CLIN EXP MED, V11, P211, DOI 10.1007/s10238-010-0129-y; Takeda H, 2003, CANCER RES, V63, P4872; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; von Rahden BHA, 2005, CANCER RES, V65, P5038, DOI 10.1158/0008-5472.CAN-04-1107; Wang KS, 2006, ACTA BIOCH BIOPH SIN, V38, P179, DOI 10.1111/j.1745-7270.2006.00151.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Zhang XM, 2011, MOL CARCINOGEN, V50, P876, DOI 10.1002/mc.20784	67	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46179	10.1371/journal.pone.0046179	http://dx.doi.org/10.1371/journal.pone.0046179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029430	Green Published, gold			2022-12-27	WOS:000309973900103
J	Eberle, D; Kurth, T; Santos-Ferreira, T; Wilson, J; Corbeil, D; Ader, M				Eberle, Dominic; Kurth, Thomas; Santos-Ferreira, Tiago; Wilson, John; Corbeil, Denis; Ader, Marius			Outer Segment Formation of Transplanted Photoreceptor Precursor Cells	PLOS ONE			English	Article							RETINAL STEM-CELLS; RED FLUORESCENT PROTEIN; MOUSE RETINA; RCS RATS; GENERATION; MICE; DIFFERENTIATE; EXPRESSION; EPITHELIUM; RHODOPSIN	Transplantation of photoreceptor precursor cells (PPCs) into the retina represents a promising treatment for cell replacement in blinding diseases characterized by photoreceptor loss. In preclinical studies, we and others demonstrated that grafted PPCs integrate into the host outer nuclear layer (ONL) and develop into mature photoreceptors. However, a key feature of light detecting photoreceptors, the outer segment (OS) with natively aligned disc membrane staples, has not been studied in detail following transplantation. Therefore, we used as donor cells PPCs isolated from neonatal double transgenic reporter mice in which OSs are selectively labeled by green fluorescent protein while cell bodies are highlighted by red fluorescent protein. PPCs were enriched using CD73-based magnetic associated cell sorting and subsequently transplanted into either adult wild-type or a model of autosomal-dominant retinal degeneration mice. Three weeks post-transplantation, donor photoreceptors were identified based on fluorescent-reporter expression and OS formation was monitored at light and electron microscopy levels. Donor cells that properly integrated into the host wild-type retina developed OSs with the formation of a connecting cilium and well-aligned disc membrane staples similar to the surrounding native cells of the host. Surprisingly, the majority of not-integrated PPCs that remained in the sub-retinal space also generated native-like OSs in wild-type mice and those affected by retinal degeneration. Moreover, they showed an improved photoreceptor maturation and OS formation by comparison to donor cells located on the vitreous side suggesting that environmental cues influence the PPC differentiation and maturation. We conclude that transplanted PPCs, whether integrated or not into the host ONL, are able to generate the cellular structure for effective light detection, a phenomenon observed in wild-type as well as in degenerated retinas. Given that patients suffering from retinitis pigmentosa lose almost all photoreceptors, our findings are of utmost importance for the development of cell-based therapies.	[Eberle, Dominic; Kurth, Thomas; Santos-Ferreira, Tiago; Corbeil, Denis; Ader, Marius] Cluster Excellence TU Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [Corbeil, Denis] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Wilson, John] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Technische Universitat Dresden; Technische Universitat Dresden; Baylor College of Medicine	Ader, M (corresponding author), Cluster Excellence TU Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany.	marius.ader@crt-dresden.de	Ader, Marius/E-7535-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/A-6519-2010; Corbeil, Denis/L-2340-2019	Ader, Marius/0000-0001-9467-7677; Corbeil, Denis/0000-0003-1181-3659; Eberle, Dominic/0000-0003-0369-6042; Ferreira, Tiago/0000-0002-2065-6440; Kurth, Thomas/0000-0001-5624-1717	Deutsche Forschungsgemeinschaft; CRTD [043_264030]; Fundacao Para a Ciencia e Tecnologia [SFRH/BD/60787/2009]; charity ProRetina E.V. stipend [060_3229];  [SFB 655]; NATIONAL EYE INSTITUTE [R01EY011731] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CRTD; Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); charity ProRetina E.V. stipend; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de), CRTD seed grant #043_264030 (http://www.crt-dresden.de), SFB 655 (http://www.sfb655.de), Fundacao Para a Ciencia e Tecnologia #SFRH/BD/60787/2009 (http://www.fct.pt), and the charity ProRetina E.V. stipend #060_3229 (http://www.pro-retina-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Barber AC, 2011, ARVO M, V52, P4019; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Comyn O, 2010, CURR OPIN NEUROL, V23, P4, DOI 10.1097/WCO.0b013e3283352f96; Eberle D, 2011, INVEST OPHTH VIS SCI, V52, P6462, DOI 10.1167/iovs.11-7399; Fabig G, 2012, METHOD CELL BIOL, V111, P75, DOI 10.1016/B978-0-12-416026-2.00005-4; GAUR VP, 1992, EXP EYE RES, V54, P645, DOI 10.1016/0014-4835(92)90020-S; GOURAS P, 1992, INVEST OPHTH VIS SCI, V33, P2579; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; GOURAS P, 1991, INVEST OPHTH VIS SCI, V32, P3167; GOURAS P, 1991, INVEST OPHTH VIS SCI, V32, P1704; GOURAS P, 1991, Journal of Neural Transplantation and Plasticity, V2, P91; Hippert C, 2012, ARVO M, V53, P2010; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Lin N, 1996, CURR EYE RES, V15, P1069, DOI 10.3109/02713689609017657; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Merhi-Soussi F, 2006, STEM CELLS, V24, P2060, DOI 10.1634/stemcells.2005-0311; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pearson RA, 2012, NATURE; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Schwarz H, 2009, HDB CRYOPREPARATION, P537; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Sheedlo HJ, 1998, DEV BRAIN RES, V107, P57, DOI 10.1016/S0165-3806(97)00219-8; STIEMKE MM, 1994, DEV BIOL, V162, P169, DOI 10.1006/dbio.1994.1076; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Vicidomini G, 2008, TRAFFIC, V9, P1828, DOI 10.1111/j.1600-0854.2008.00815.x; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	36	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46305	10.1371/journal.pone.0046305	http://dx.doi.org/10.1371/journal.pone.0046305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029471	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900129
J	Hamadah, A; Schreiber, Y; Toye, B; McDiarmid, S; Huebsch, L; Bredeson, C; Tay, J				Hamadah, Aziz; Schreiber, Yoko; Toye, Baldwin; McDiarmid, Sheryl; Huebsch, Lothar; Bredeson, Christopher; Tay, Jason			The Use of Intravenous Antibiotics at the Onset of Neutropenia in Patients Receiving Outpatient-Based Hematopoietic Stem Cell Transplants	PLOS ONE			English	Article							HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; HEART-RATE-VARIABILITY; INFECTIOUS COMPLICATIONS; ANTIBACTERIAL PROPHYLAXIS; RECIPIENTS; LEVOFLOXACIN; METAANALYSIS; RESISTANCE; MORTALITY	Empirical antibiotics at the onset of febrile neutropenia are one of several strategies for management of bacterial infections in patients undergoing Hematopoietic Stem Cell Transplant (HSCT) (empiric strategy). Our HSCT program aims to perform HSCT in an outpatient setting, where an empiric antibiotic strategy was employed. HSCT recipients began receiving intravenous antibiotics at the onset of neutropenia in the absence of fever as part of our institutional policy from 01 Jan 2009; intravenous Prophylactic strategy. A prospective study was conducted to compare two consecutive cohorts [Year 2008 (Empiric strategy) vs. Year 2009 (Prophylactic strategy)] of patients receiving HSCT. There were 238 HSCTs performed between 01 Jan 2008 and 31 Dec 2009 with 127 and 111 in the earlier and later cohorts respectively. Infection-related mortality pre-engraftment was similar with a prophylactic compared to an empiric strategy (3.6% vs. 7.1%; p = 0.24), but reduced among recipients of autologous HSCT (0% vs. 6.8%; p = 0.03). Microbiologically documented, blood stream infections and clinically documented infections pre-engraftment were reduced in those receiving a prophylactic compared to an empiric strategy, (11.7% vs. 28.3%; p = 0.001), (9.9% vs. 24.4%; p = 0.003) and (18.2% vs. 33.9% p = 0.007) respectively. The prophylactic use of intravenous once-daily ceftriaxone in patients receiving outpatient based HSCT is safe and may be particularly effective in patients receiving autologous HSCT. Further studies are warranted to study the impact of this Prophylactic strategy in an outpatient based HSCT program.	[Hamadah, Aziz; McDiarmid, Sheryl; Huebsch, Lothar; Bredeson, Christopher; Tay, Jason] Ottawa Hosp, Blood & Marrow Programme, Ottawa, ON, Canada; [Schreiber, Yoko; Toye, Baldwin] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Tay, J (corresponding author), Ottawa Hosp, Blood & Marrow Programme, Ottawa, ON, Canada.	jtay@ottawahospital.on.ca	Tay, Jason/J-5061-2019	Tay, Jason/0000-0002-5969-9755; Schreiber, Yoko/0000-0003-4981-3486				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; AVRIL M, 1994, PEDIATR HEMAT ONCOL, V11, P63; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Bow EJ, 2011, CURR OPIN INFECT DIS, V24, P545, DOI 10.1097/QCO.0b013e32834cf054; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Craig M, 2007, BONE MARROW TRANSPL, V39, P477, DOI 10.1038/sj.bmt.1705591; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dekker A, 2006, J CLIN ONCOL, V24, P5207, DOI 10.1200/JCO.2006.06.1663; Engels EA, 1999, CLIN INFECT DIS, V28, P256, DOI 10.1086/515103; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gafter-Gvili A, 2007, J ANTIMICROB CHEMOTH, V59, P5, DOI 10.1093/jac/dkl425; Gluck S, 1997, BONE MARROW TRANSPL, V20, P431, DOI 10.1038/sj.bmt.1700901; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Guthrie KA, 2010, BONE MARROW TRANSPL, V45, P675, DOI 10.1038/bmt.2009.216; Jagannath S, 1997, BONE MARROW TRANSPL, V20, P445, DOI 10.1038/sj.bmt.1700900; Kimura SI, 2010, BIOL BLOOD MARROW TR, V16, P1355, DOI 10.1016/j.bbmt.2010.04.012; Liu CY, 2011, BONE MARROW TRANSPL, V46, P1231, DOI 10.1038/bmt.2010.286; McDiarmid S, 2010, BONE MARROW TRANSPL, V45, P1220, DOI 10.1038/bmt.2009.330; Meisenberg BR, 1997, J CLIN ONCOL, V15, P11, DOI 10.1200/JCO.1997.15.1.11; Meisenberg BR, 1998, BONE MARROW TRANSPL, V21, P927, DOI 10.1038/sj.bmt.1701191; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Park SH, 2006, J KOREAN MED SCI, V21, P199, DOI 10.3346/jkms.2006.21.2.199; Pasquini M, 2011, CURRENT USE OUTCOME; PETERSEN F, 1988, INFECTION, V16, P199, DOI 10.1007/BF01650752; Roberts AW, 1993, AUSTR NZ J MED, V141; Slavin MA, 2007, BONE MARROW TRANSPL, V40, P157, DOI 10.1038/sj.bmt.1705686; Slavin MA, 2011, INTERN MED J, V41, P102, DOI 10.1111/j.1445-5994.2010.02341.x; Spellman S, 2008, BIOL BLOOD MARROW TR, V14, P37, DOI 10.1016/j.bbmt.2008.05.001; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Therriault BL, 2010, MAYO CLIN PROC, V85, P711, DOI 10.4065/mcp.2010.0006; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Woolfrey A, 2010, BIOL BLOOD MARROW TR, V16, P1382, DOI 10.1016/j.bbmt.2010.03.024	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46220	10.1371/journal.pone.0046220	http://dx.doi.org/10.1371/journal.pone.0046220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029441	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900111
J	Mortillaro, JM; Rigal, F; Rybarczyk, H; Bernardes, M; Abril, G; Meziane, T				Mortillaro, Jean-Michel; Rigal, Francois; Rybarczyk, Herve; Bernardes, Marcelo; Abril, Gwenael; Meziane, Tarik			Particulate Organic Matter Distribution along the Lower Amazon River: Addressing Aquatic Ecology Concepts Using Fatty Acids	PLOS ONE			English	Article							FLOODPLAIN LAKE; CARBON-DIOXIDE; SPATIAL PROCESSES; LIPID BIOMARKERS; ENERGY-SOURCES; LAGO GRANDE; VEGETATION; DYNAMICS; ESTUARY; PHYTOPLANKTON	One of the greatest challenges in understanding the Amazon basin functioning is to ascertain the role played by floodplains in the organic matter (OM) cycle, crucial for a large spectrum of ecological mechanisms. Fatty acids (FAs) were combined with environmental descriptors and analyzed through multivariate and spatial tools (asymmetric eigenvector maps, AEM and principal coordinates of neighbor matrices, PCNM). This challenge allowed investigating the distribution of suspended particulate organic matter (SPOM), in order to trace its seasonal origin and quality, along a 800 km section of the Amazon river-floodplain system. Statistical analysis confirmed that large amounts of saturated FAs (15: 0, 18: 0, 24: 0, 25: 0 and 26: 0), an indication of refractory OM, were concomitantly recorded with high pCO(2) in rivers, during the high water season (HW). Contrastingly, FAs marker which may be attributed in this ecosystem to aquatic plants (18:2 omega 6 and 18:3 omega 3) and cyanobacteria (16:1 omega 7), were correlated with higher O-2, chlorophyll a and pheopigments in floodplains, due to a high primary production during low waters (LW). Decreasing concentrations of unsaturated FAs, that characterize labile OM, were recorded during HW, from upstream to downstream. Furthermore, using PCNM and AEM spatial methods, FAs compositions of SPOM displayed an upstream-downstream gradient during HW, which was attributed to OM retention and the extent of flooded forest in floodplains. Discrimination of OM quality between the Amazon River and floodplains corroborate higher autotrophic production in the latter and transfer of OM to rivers at LW season. Together, these gradients demonstrate the validity of FAs as predictors of spatial and temporal changes in OM quality. These spatial and temporal trends are explained by 1) downstream change in landscape morphology as predicted by the River Continuum Concept; 2) enhanced primary production during LW when the water level decreased and its residence time increased as predicted by the Flood Pulse Concept.	[Mortillaro, Jean-Michel; Rigal, Francois; Rybarczyk, Herve; Meziane, Tarik] MNHN, Dept Milieux & Peuplements Aquat, BOREA, UMR CNRS IRD UPMC 7208, Paris, France; [Rigal, Francois] Univ Acores, Azorean Biodivers Grp, Angra Do Heroismo, Terceira, Portugal; [Bernardes, Marcelo] Univ Fed Fluminense, Inst Quim, Programa Geoquim, Rio De Janeiro, Brazil; [Abril, Gwenael] Univ Bordeaux 1, EPOC, UMR CNRS 5805, F-33405 Talence, France; [Abril, Gwenael] Univ Fed Amazonas, IRD, GET, Lab Potamol Amazon, Manaus, Amazonas, Brazil	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universidade dos Acores; Universidade Federal Fluminense; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; Universidade Federal de Amazonas	Mortillaro, JM (corresponding author), MNHN, Dept Milieux & Peuplements Aquat, BOREA, UMR CNRS IRD UPMC 7208, CP 53, Paris, France.	mortillaro@mnhn.fr	Abril, Gwenaël/C-7835-2011; mortillaro, Jean-Michel/A-2496-2012; Bernardes, Marcelo C/H-7869-2012; Meziane, Tarik/A-5465-2009; Meziane, Tarik/AAF-7906-2020	Abril, Gwenaël/0000-0002-4914-086X; mortillaro, Jean-Michel/0000-0003-1911-9338; Bernardes, Marcelo C/0000-0002-4338-4353; Meziane, Tarik/0000-0003-2142-6441; Meziane, Tarik/0000-0003-2142-6441; Rigal, Francois/0000-0001-6882-1591	French National Agency for Research (ANR)	French National Agency for Research (ANR)(French National Research Agency (ANR))	This research is a contribution to the CARBAMA project, supported by the French National Agency for Research (ANR), and conducted within an international cooperation agreement between the National Council for Scientific and Technological Development - Brazil (CNPq) and the Institute for Research and Development - France (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2006, SCI TOTAL ENVIRON, V354, P246, DOI 10.1016/j.scitotenv.2004.12.051; Abril G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019714; AGUSTI S, 1992, LIMNOL OCEANOGR, V37, P434, DOI 10.4319/lo.1992.37.2.0434; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Arts M.T., 1999, LIPIDS FRESHWATER EC; Aufdenkampe AK, 2007, ORG GEOCHEM, V38, P337, DOI 10.1016/j.orggeochem.2006.06.003; Battin TJ, 2009, NAT GEOSCI, V2, P595, DOI 10.1038/ngeo602; Bechtel A, 2009, ORG GEOCHEM, V40, P441, DOI 10.1016/j.orggeochem.2009.01.011; Bernardes MC, 2004, ECOL APPL, V14, pS263; Bianchi TS, 2009, P NATL ACAD SCI USA, V106, P8085, DOI 10.1073/pnas.0812878106; Blanchet F., 2010, AEM TOOLS CONSTRUCT; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnet MP, 2008, J HYDROL, V349, P18, DOI 10.1016/j.jhydrol.2007.10.055; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Canuel EA, 2001, ORG GEOCHEM, V32, P563, DOI 10.1016/S0146-6380(00)00195-9; Caraco N, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P301; Dray S, 2009, PACKFOR FORWARD SELE, P46; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; FORSBERG BR, 1988, LIMNOL OCEANOGR, V33, P41, DOI 10.4319/lo.1988.33.1.0041; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; FURCH K, 1993, ARCH HYDROBIOL, V128, P277; Goulding M, 2003, SMITHSONIAN ATLAS AM; HAMILTON SK, 1987, LIMNOL OCEANOGR, V32, P1277, DOI 10.4319/lo.1987.32.6.1277; Hawkes H.A., 1975, RIVER ECOLOGY; Hedges JI, 2000, LIMNOL OCEANOGR, V45, P1449, DOI 10.4319/lo.2000.45.7.1449; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743, DOI 10.4319/lo.1994.39.4.0743; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Hess LL, 2003, REMOTE SENS ENVIRON, V87, P404, DOI 10.1016/j.rse.2003.04.001; Hu JF, 2006, ESTUAR COAST SHELF S, V66, P346, DOI 10.1016/j.ecss.2005.09.009; HUMPHRIES SE, 1988, LIMNOL OCEANOGR, V33, P79, DOI 10.4319/lo.1988.33.1.0079; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W. J., 1997, CENTRAL AMAZON FLOOD; Junk W.J., 1984, AMAZON LIMNOLOGY LAN, P269, DOI [10.1007/978-94-009-6542-3_10, DOI 10.1007/978-94-009-6542-3, DOI 10.1007/978-94-009-6542-3_10]; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2010, RDATEST CANONICAL RE; Legendre P., 2012, NUMERICAL ECOLOGY; Leite RG, 2002, ECOL FRESHW FISH, V11, P56, DOI 10.1034/j.1600-0633.2002.110106.x; Martinez JM, 2007, REMOTE SENS ENVIRON, V108, P209, DOI 10.1016/j.rse.2006.11.012; Maurice Bourgoin L, 2007, J HYDROL, V335, P140, DOI 10.1016/j.jhydrol.2006.11.023; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; Melack J.M., 2010, AMAZONIAN FLOODPLAIN, P43, DOI DOI 10.1007/978-90-481-8725-6_3; MERTES LAK, 1995, GEOMORPHOLOGY, V13, P215, DOI 10.1016/0169-555X(95)00038-7; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; MEYERS PA, 1993, ORG GEOCHEM, V20, P47, DOI 10.1016/0146-6380(93)90080-U; Meziane T, 2007, MAR BIOL, V150, P1103, DOI 10.1007/s00227-006-0424-z; Moreira-Turcq P, 2004, PALAEOGEOGR PALAEOCL, V214, P27, DOI 10.1016/j.palaeo.2004.06.013; Moreira-Turcq P, 2003, HYDROL PROCESS, V17, P1329, DOI 10.1002/hyp.1287; Moreira-Turcq PF, 2003, HYDROL PROCESS, V17, P1393, DOI 10.1002/hyp.1291; Mortillaro JM, 2011, ORG GEOCHEM, V42, P1159, DOI 10.1016/j.orggeochem.2011.08.011; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Nesterov VN, 2009, RUSS J PLANT PHYSL+, V56, P85, DOI 10.1134/S1021443709010130; Oksanen J, 2010, VEGAN COMUNITY ECOLO; Oliveira ACB, 2006, AQUAT SCI, V68, P229, DOI 10.1007/s00027-006-0808-7; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Phlips EJ, 2008, FUND APPL LIMNOL, V172, P99, DOI 10.1127/1863-9135/2008/0172-0099; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Richey JE, 1989, GLOBAL BIOGEOCHEM CY, V3, P191, DOI 10.1029/GB003i003p00191; Rozentsvet OA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P351, DOI 10.1023/A:1014892601961; Saliot A, 2001, BIOGEOCHEMISTRY, V53, P79, DOI 10.1023/A:1010754022594; SEDELL J R, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P49; SETARO FV, 1984, LIMNOL OCEANOGR, V29, P972, DOI 10.4319/lo.1984.29.5.0972; Sioli H, 1984, AMAZON LIMNOLOGY LAN, DOI 10.1007/978-94-009-6542-3; Thorp JH, 1998, OECOLOGIA, V117, P551, DOI 10.1007/s004420050692; THORP JH, 1994, OIKOS, V70, P305, DOI 10.2307/3545642; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waichman AV, 1996, HYDROBIOLOGIA, V341, P27, DOI 10.1007/BF00012300; Wakeham SG, 1995, DEEP-SEA RES PT I, V42, P1749, DOI 10.1016/0967-0637(95)00074-G; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Xu Y, 2007, MAR ENVIRON RES, V64, P666, DOI 10.1016/j.marenvres.2007.07.004	79	17	17	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46141	10.1371/journal.pone.0046141	http://dx.doi.org/10.1371/journal.pone.0046141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029412	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900094
J	Sharma, R; Florea, M; Nau, WM; Swaminathan, K				Sharma, Reetu; Florea, Mara; Nau, Werner M.; Swaminathan, Kunchithapadam			Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate alpha-Decarboxylase Using Nuclear Magnetic Resonance (H-1 NMR)	PLOS ONE			English	Article							TANDEM ENZYME ASSAYS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MASS-SPECTROMETRY; BETA-ALANINE; BIOSYNTHESIS; PURIFICATION; SPECTROSCOPY; PANTOTHENATE; BINDING	The catalytic activity of L-aspartate alpha-decarboxylase (ADC) is essential for the growth of several micro-organisms, including Mycobacterium tuberculosis (Mtb), and has triggered efforts for the development of pharmaceutically active compounds against tuberculosis. The present study is a continuation of our recent chemoinformatics-based design approach for identifying potential drug-like inhibitors against MtbADC. We report an NMR-based protocol that allows label-free and direct monitoring of enzymatic conversion, which we have combined with a systematic testing of reported and newly identified potential inhibitors against MtbADC. Quantification of enzymatic conversion in the absence and presence of inhibitors allowed for a relative measure of the inhibitory effect (k(rel)). Among the newly identified compounds, D-tartrate, L-tartrate, and 2,4-dihydroxypyrimidine-5-carboxylate were found to inhibit the enzyme with k(rel) values of 0.36, 0.38, and 0.54, respectively. In addition to the identification of potential building blocks for the development of therapeutic agents, the current study highlights the importance of electrostatic interactions governing enzyme-inhibitor binding.	[Florea, Mara; Nau, Werner M.] Jacobs Univ, Sch Sci & Engn, Bremen, Germany; [Sharma, Reetu; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Jacobs University; National University of Singapore	Nau, WM (corresponding author), Jacobs Univ, Sch Sci & Engn, Bremen, Germany.	w.nau@jacobs-university.de; dbsks@nus.edu.sg	mo, qin/O-7877-2014; Nau, Werner/E-6686-2011	Nau, Werner/0000-0002-7654-6232; Sharma, Reetu/0000-0002-3300-9832	Ministry of Education [R154-000-439-112, R154-000-491-112]; Biomedical Research Council of Singapore [R154-000-424-305]; National University of Singapore; Fonds der Chemischen Industrie; Jacobs University Bremen	Ministry of Education; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Jacobs University Bremen	KS acknowledges the funding support of the Ministry of Education (Grants R154-000-439-112 and R154-000-491-112) and the Biomedical Research Council (Grant R154-000-424-305) of Singapore. The graduate research scholarship for RS is provided by National University of Singapore. MF and WMN acknowledge the support from the Fonds der Chemischen Industrie (doctoral stipend for MF) and Jacobs University Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL LM, 1988, BIOCHEMISTRY-US, V27, P5933, DOI 10.1021/bi00416a017; Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Belliveau KA, 2010, NAT PROD RES, V24, P24, DOI 10.1080/14786410802278285; Chopra S, 2002, PROTEIN EXPRES PURIF, V25, P533, DOI 10.1016/S1046-5928(02)00039-6; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; de Villiers J, 2010, CHEM-EUR J, V16, P10030, DOI 10.1002/chem.201000622; Dsouza RN, 2012, CHEM-EUR J, V18, P3444, DOI 10.1002/chem.201103364; Ghale G, 2011, J AM CHEM SOC, V133, P7528, DOI 10.1021/ja2013467; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gopalan G, 2006, PROTEINS, V65, P796, DOI 10.1002/prot.21126; Lee B, 2004, J MOL BIOL, V340, P1, DOI 10.1016/j.jmb.2004.04.049; MAAS WK, 1950, J BACTERIOL, V60, P733, DOI 10.1128/JB.60.6.733-745.1950; Ramjee MK, 1997, BIOCHEM J, V323, P661, DOI 10.1042/bj3230661; RAVEL JM, 1946, J BIOL CHEM, V166, P407; Sahoo H, 2007, J AM CHEM SOC, V129, P15927, DOI 10.1021/ja074975w; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033521; SHIVE W, 1946, J BIOL CHEM, V162, P451; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; VANDENBERG JI, 1986, ANAL BIOCHEM, V155, P38, DOI 10.1016/0003-2697(86)90221-6; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Webb ME, 2003, CHEM COMMUN, P2416, DOI 10.1039/b308182f; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074	24	8	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45947	10.1371/journal.pone.0045947	http://dx.doi.org/10.1371/journal.pone.0045947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029336	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900066
J	Baco, AR; Cairns, SD				Baco, Amy R.; Cairns, Stephen D.			Comparing Molecular Variation to Morphological Species Designations in the Deep-Sea Coral Narella Reveals New Insights into Seamount Coral Ranges	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; OCTOCORALLIA CNIDARIA; COMMUNITY STRUCTURE; SEQUENCE EVOLUTION; WATER CORALS; ANTHOZOA; ENDEMISM; HABITAT; GROWTH; DEPTH	Recent studies have countered the paradigm of seamount isolation, confounding conservation efforts at a critical time. Efforts to study deep-sea corals, one of the dominant taxa on seamounts, to understand seamount connectivity, are hampered by a lack of taxonomic keys. A prerequisite for connectivity is species overlap. Attempts to better understand species overlap using DNA barcoding methods suggest coral species are widely distributed on seamounts and nearby features. However, no baseline has been established for variation in these genetic markers relative to morphological species designations for deep-sea octocoral families. Here we assess levels of genetic variation in potential octocoral mitochondrial barcode markers relative to thoroughly examined morphological species in the genus Narella. The combination of six markers used here, approximately 3350 bp of the mitochondrial genome, resolved 83% of the morphological species. Our results show that two of the markers, ND2 and NCR1, are not sufficient to resolve genera within Primnoidae, let alone species. Re-evaluation of previous studies of seamount octocorals based on these results suggest that those studies were looking at distributions at a level higher than species, possibly even genus or subfamily. Results for Narella show that using more markers provides haplotypes with relatively narrow depth ranges on the seamounts studied. Given the lack of 100% resolution of species with such a large portion of the mitochondrial genome, we argue that previous genetic studies have not resolved the degree of species overlap on seamounts and that we may not have the power to even test the hypothesis of seamount isolation using mitochondrial markers, let alone refute it. Thus a precautionary approach is advocated in seamount conservation and management, and the potential for depth structuring should be considered.	[Baco, Amy R.] Woods Hole, Woods Hole, MA USA; [Cairns, Stephen D.] Smithsonian Inst, Dept Invertebrate Zool, Washington, DC 20560 USA	Woods Hole Oceanographic Institution; Smithsonian Institution; Smithsonian National Museum of Natural History	Baco, AR (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	abacotaylor@fsu.edu			Hawaii Undersea Research Laboratory; Hawaii Sea Grant; National Oceanographic and Atmospheric Administration's (NOAA) Office of Ocean Exploration Award [NA0OAR4600108, NA03OAR4600110, NA04OAR4600071]; NOAA West Coast and Polar Programs National Undersea Research Program Award [UAF-040118]; NOAA Office of Ocean Exploration grant [NA07OAR4600292];  [NA04OAR4600051]	Hawaii Undersea Research Laboratory; Hawaii Sea Grant; National Oceanographic and Atmospheric Administration's (NOAA) Office of Ocean Exploration Award; NOAA West Coast and Polar Programs National Undersea Research Program Award; NOAA Office of Ocean Exploration grant; 	Remaining specimens were collected by ARB with grants in Hawaii funded by the Hawaii Undersea Research Laboratory, Hawaii Sea Grant, and the National Oceanographic and Atmospheric Administration's (NOAA) Office of Ocean Exploration Award Nos. NA0OAR4600108, NA03OAR4600110, and NA04OAR4600071; collections on the Gulf of Alaska seamounts funded by Award No. NA04OAR4600051; and collections on Derickson Seamount funded by NOAA West Coast and Polar Programs National Undersea Research Program Award No. UAF-040118. NOAA Office of Ocean Exploration grant No. NA07OAR4600292 to ARB funded the laboratory analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, MOL PHYLOGENET EVOL, V43, P774, DOI 10.1016/j.ympev.2006.11.005; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Andrews AH, 2005, ERLANGEN EARTH C SER, P1021, DOI 10.1007/3-540-27673-4_51; Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Auster PJ, 2005, ERLANGEN EARTH C SER, P761, DOI 10.1007/3-540-27673-4_40; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cairns SD, 2007, SYST BIODIVERS, V5, P391, DOI 10.1017/S1477200007002472; Cairns SD, 2008, PAC SCI, V62, P83, DOI 10.2984/1534-6188(2008)62[83:AROTOC]2.0.CO;2; Cairns Stephen D., 2011, Smithsonian Contributions to Zoology, P1; Cairns SD, 2009, PAC SCI, V63, P413, DOI 10.2984/049.063.0309; Cairns Stephen D., 2009, Smithsonian Contributions to Zoology, P1; CenSeam, 2006, SEAM DEEP SEA COR FI; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 2011, FAUNA COBALT RICH FE; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MOL MARINE BIOL BIOT; France SC, 2007, B MAR SCI, V81, P323; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; GENIN A, 1992, DEEP-SEA RES, V39, P293, DOI 10.1016/0198-0149(92)90110-F; GRIGG RW, 1988, MAR ECOL PROG SER, V45, P121, DOI 10.3354/meps045121; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Herrera S, 2010, MOL PHYLOGENET EVOL, V55, P123, DOI 10.1016/j.ympev.2009.12.007; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Howell KL, 2010, MAR ECOL-EVOL PERSP, V31, P52, DOI 10.1111/j.1439-0485.2010.00368.x; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Krieger KJ, 2001, P 1 INT S DEEP SEA C, P106; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Morgan LE, 2006, STATUS DEEP SEA CORA; Muzik KM, 1980, SYSTEMATIC REVISION; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Parin NV, 1997, ADV MAR BIOL, V32, P145; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; Parrish FA, 2007, STATE DEEP CORAL ECO; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Probert P. Keith, 1997, Aquatic Conservation, V7, P27, DOI 10.1002/(SICI)1099-0755(199703)7:1<27::AID-AQC214>3.3.CO;2-0; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Sanchez J. A., 2004, Zoologische Mededelingen (Leiden), V78, P265; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith PJ, 2004, MAR BIOL, V144, P253, DOI 10.1007/s00227-003-1206-5; Stocks K, 2004, SEAMOUNTS BIODIVERSI; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; van der Ham JL, 2009, MAR GENOM, V2, P183, DOI 10.1016/j.margen.2009.10.002; Wilson RR, 1987, GEOPHYS MONOGR SER, P355, DOI DOI 10.1029/GM043P0355; Wirshing HH, 2005, MAR BIOL, V147, P497, DOI 10.1007/s00227-005-1592-y; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	77	37	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45555	10.1371/journal.pone.0045555	http://dx.doi.org/10.1371/journal.pone.0045555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029093	gold, Green Published			2022-12-27	WOS:000309517500034
J	Downing, AS; van Nes, EH; Mooij, WM; Scheffer, M				Downing, Andrea S.; van Nes, Egbert H.; Mooij, Wolf M.; Scheffer, Marten			The Resilience and Resistance of an Ecosystem to a Collapse of Diversity	PLOS ONE			English	Article							LAKE VICTORIA; STABLE STATES; EAST-AFRICA; CORAL-REEFS; NILE PERCH; FOOD-WEB; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; POPULATIONS	Diversity is expected to increase the resilience of ecosystems. Nevertheless, highly diverse ecosystems have collapsed, as did Lake Victoria's ecosystem of cichlids or Caribbean coral reefs. We try to gain insight to this paradox, by analyzing a simple model of a diverse community where each competing species inflicts a small mortality pressure on an introduced predator. High diversity strengthens this feedback and prevents invasion of the introduced predator. After a gradual loss of native species, the introduced predator can escape control and the system collapses into a contrasting, invaded, low-diversity state. Importantly, we find that a diverse system that has high complementarity gains in resilience, whereas a diverse system with high functional redundancy gains in resistance. Loss of resilience can display early-warning signals of a collapse, but loss of resistance not. Our results emphasize the need for multiple approaches to studying the functioning of ecosystems, as managing an ecosystem requires understanding not only the threats it is vulnerable to but also pressures it appears resistant to.	[Downing, Andrea S.; van Nes, Egbert H.; Mooij, Wolf M.; Scheffer, Marten] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Downing, AS (corresponding author), Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands.	andrea.downing@wur.nl	downing, andrea s./H-4465-2012; Mooij, Wolf M/C-2677-2008; van Nes, Egbert H/F-2681-2011; Scheffer, Marten/C-1852-2012; KNAW, NIOO-KNAW/A-4320-2012	downing, andrea s./0000-0002-5206-9355; Mooij, Wolf M/0000-0001-5586-8200; KNAW, NIOO-KNAW/0000-0002-3835-159X; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization for Scientific Research (NWO/WOTRO) [W01.65.304.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the integrated project "Exploitation or eutrophication as threats for fisheries? Disentangling social and ecological drivers of ecosystem changes in Lake Victoria (SEDEC)", supported by the Netherlands Organization for Scientific Research (NWO/WOTRO) grant number W01.65.304.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Downing AS, 2012, ECOL APPL, V22, P229, DOI 10.1890/11-0941.1; DRAKE JA, 1990, TRENDS ECOL EVOL, V5, P159, DOI 10.1016/0169-5347(90)90223-Z; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Elton C. S., 1958, ECOLOGY INVASIONS AN; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Goudswaard KPC, 2008, ENVIRON BIOL FISH, V81, P127, DOI 10.1007/s10641-006-9180-7; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kitchell JF, 1997, ECOL APPL, V7, P653; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Schroder A, 2009, P NATL ACAD SCI USA, V106, P2671, DOI 10.1073/pnas.0808279106; Schroder A, 2012, OIKOS, V121, P417, DOI 10.1111/j.1600-0706.2011.19764.x; Steneck RS, 2011, CONSERV BIOL, V25, P904, DOI 10.1111/j.1523-1739.2011.01717.x; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van de Wolfshaar K, 2006, POPULATION PERSISTEN; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Whiteside JH, 2011, GEOLOGY, V39, P99, DOI 10.1130/G31401.1; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	43	54	54	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46135	10.1371/journal.pone.0046135	http://dx.doi.org/10.1371/journal.pone.0046135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029410	Green Published, gold			2022-12-27	WOS:000309517500063
J	Mandalos, N; Saridaki, M; Harper, JL; Kotsoni, A; Yang, P; Economides, AN; Remboutsika, E				Mandalos, Nikolaos; Saridaki, Marannia; Harper, Jessica Lea; Kotsoni, Anastasia; Yang, Peter; Economides, Aris N.; Remboutsika, Eumorphia			Application of a Novel Strategy of Engineering Conditional Alleles to a Single Exon Gene, Sox2	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIAL EXPRESSION; REGULATORY REGION; INTRONLESS GENES; MESSENGER-RNAS; MOUSE GENOME; IN-VITRO; DNA; SEQUENCE; NEUROGENESIS	Background: The Conditional by Inversion (COIN) method for engineering conditional alleles relies on an invertible optimized gene trap-like element, the COIN module, for imparting conditionality. The COIN module contains an optimized 3' splice site-polyadenylation signal pair, but is inserted antisense to the target gene and therefore does not alter transcription, until it is inverted by Cre recombinase. In order to make COIN applicable to all protein-coding genes, the COIN module has been engineered within an artificial intron, enabling insertion into an exon. Methodology/Principal Findings: Therefore, theoretically, the COIN method should be applicable to single exon genes, and to test this idea we engineered a COIN allele of Sox2. This single exon gene presents additional design challenges, in that its proximal promoter and coding region are entirely contained within a CpG island, and are also spanned by an overlapping transcript, Sox2Ot, which contains mmu-miR1897. Here, we show that despite disruption of the CpG island by the COIN module intron, the COIN allele of Sox2 (Sox2(COIN)) is phenotypically wild type, and also does not interfere with expression of Sox2Ot and miR1897. Furthermore, the inverted COIN allele of Sox2, Sox2(INV) is functionally null, as homozygotes recapitulate the phenotype of Sox2(beta geo/beta geo) mice, a well-characterized Sox2 null. Lastly, the benefit of the eGFP marker embedded in the COIN allele is demonstrated as it mirrors the expression pattern of Sox2. Conclusions/Significance: Our results demonstrate the applicability of the COIN technology as a method of choice for targeting single exon genes.	[Harper, Jessica Lea; Yang, Peter; Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Mandalos, Nikolaos; Saridaki, Marannia; Harper, Jessica Lea; Kotsoni, Anastasia; Remboutsika, Eumorphia] Biomed Sci Res Ctr Alexander Fleming, Stem Cell Biol Lab, Inst Mol Biol & Genet, Vari, Greece	Regeneron; Alexander Fleming Biomedical Sciences Research Center	Economides, AN (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	aris.economides@regeneron.com; remboutsika@gmail.com	Remboutsika, Eumorphia/L-2718-2019	Remboutsika, Eumorphia/0000-0002-1243-9569; Economides, Aris/0000-0002-6508-8942	General Secretariat of Research and Technology [NON-EU82]; REGENERON Pharmaceuticals Inc., New York, USA	General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); REGENERON Pharmaceuticals Inc., New York, USA	This work was financially supported by BILATERAL COOPERATION GRANT (NON-EU82) from the General Secretariat of Research and Technology and it was performed under the auspices of a collaboration agreement with REGENERON Pharmaceuticals Inc., New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Three authors (Jessica Lea Harper, Peter Yang and Aris N. Economides) have the affiliation to the commercial funders of this research REGENERON Pharmaceuticals Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Alonso MM, PLOS ONE, V6; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barrand S, BIOCH BIOPHYS RES CO, V391, P762; Barrand S, 2010, BIOCHEM BIOPH RES CO, V401, P611, DOI 10.1016/j.bbrc.2010.09.116; Behbahaninia M, 2011, NEUROSURGERY, V69, pN19, DOI 10.1227/01.neu.0000405596.78460.20; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Economides AN, 2012, CONDITIONALS BY INVE; Ekonomou A, 2005, PLOS BIOL, V3, P1111, DOI 10.1371/journal.pbio.0030186; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Funabashi H, 2010, BIOCHEM BIOPH RES CO, V400, P554, DOI 10.1016/j.bbrc.2010.08.098; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hill AE, 2006, FEBS LETT, V580, P4303, DOI 10.1016/j.febslet.2006.06.051; Huang YQ, 1997, P NATL ACAD SCI USA, V94, P10104, DOI 10.1073/pnas.94.19.10104; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Kamachi Y, 2009, P JPN ACAD B-PHYS, V85, P55, DOI 10.2183/pjab.85.55; Kirby PJ, 2002, CYTOGENET GENOME RES, V98, P96, DOI 10.1159/000068539; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Remboutsika E, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00016; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Sakharkar KR, 2006, FEBS LETT, V580, P1472, DOI 10.1016/j.febslet.2006.01.070; Sakharkar Meena Kishore, 2005, In Silico Biology, V5, P221; SCHILHAM MW, 1993, NUCLEIC ACIDS RES, V21, P2009, DOI 10.1093/nar/21.8.2009; Seoighe C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S16; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Swinburne IA, 2008, DEV CELL, V14, P324, DOI 10.1016/j.devcel.2008.02.002; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45768	10.1371/journal.pone.0045768	http://dx.doi.org/10.1371/journal.pone.0045768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029233	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500043
J	Yan, L; Gao, Y; Zhang, Y; Tildesley, M; Liu, LQ; Zhang, Y; Wen, LY; Wang, W; Li, XD; Hu, Y; Bai, T; Wang, M; Zeng, YH; Wang, DM; Wang, XJ; Lan, Y; Wang, SW; Shu, YL				Yan, Lei; Gao, Yan; Zhang, Yong; Tildesley, Michael; Liu, Liqi; Zhang, Ye; Wen, Leying; Wang, Wei; Li, Xiaodan; Hu, Ying; Bai, Tian; Wang, Min; Zeng, Yuhong; Wang, Dingming; Wang, Xianjun; Lan, Yu; Wang, Shiwen; Shu, Yuelong			Epidemiological and Virological Characteristics of Pandemic Influenza A (H1N1) School Outbreaks in China in 2009	PLOS ONE			English	Article							INFECTION; VIRUS; CALIFORNIA; ENGLAND; ADULT; DEATH	Background: During the 2009 pandemic influenza H1N1 (2009) virus (pH1N1) outbreak, school students were at an increased risk of infection by the pH1N1 virus. However, the estimation of the attack rate showed significant variability. Methods: Two school outbreaks were investigated in this study. A questionnaire was designed to collect information by interview. Throat samples were collected from all the subjects in this study 6 times and sero samples 3 times to confirm the infection and to determine viral shedding. Data analysis was performed using the software STATA 9.0. Findings: The attack rate of the pH1N1 outbreak was 58.3% for the primary school, and 52.9% for the middle school. The asymptomatic infection rates of the two schools were 35.8% and 37.6% respectively. Peak virus shedding occurred on the day of ARI symptoms onset, followed by a steady decrease over subsequent days (p = 0.026). No difference was found either in viral shedding or HI titer between the symptomatic and the asymptomatic infectious groups. Conclusions: School children were found to be at a high risk of infection by the novel virus. This may be because of a heightened risk of transmission owing to increased mixing at boarding school, or a lack of immunity owing to socioeconomic status. We conclude that asymptomatically infectious cases may play an important role in transmission of the pH1N1 virus.	[Yan, Lei; Gao, Yan; Liu, Liqi; Zhang, Ye; Wen, Leying; Wang, Wei; Li, Xiaodan; Hu, Ying; Bai, Tian; Wang, Min; Zeng, Yuhong; Lan, Yu; Wang, Shiwen; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Tildesley, Michael] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Tildesley, Michael] US Natl Inst Hlth, Fogarty Int Ctr, Bethesda, MD USA; [Wang, Dingming] Ctr Dis Control & Prevent Guizhou Prov, Guiyang, Peoples R China; [Wang, Xianjun] Ctr Dis Control & Prevent Shandong Prov, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Beijing Normal University; University of Warwick; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wang, SW (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wangshiwencdc@163.com; yshu@cnic.org.cn		Tildesley, Michael/0000-0002-6875-7232	National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases [2008ZX10004-012]; NIH/NIAID [5-U54-AI-057157-08]; Wellcome Trust; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases (Grant No. 2008ZX10004-012), and NIH/NIAID Grant 5-U54-AI-057157-08 (Epidemiology and Molecular Mechanism of Highly Pathogenic Avian Influenza H5N1 and Pandemic Influenza H1N1). MT is supported by the Wellcome Trust, the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, LANCET, V374, P2032, DOI 10.1016/S0140-6736(09)61916-4; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chan M., 2009, WORLD NOW START 2009; Chan M, 2010, H1N1 POSTPANDEMIC PE; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Huai Y, 2010, INFLUENZA OTHER RESP, V4, P259, DOI 10.1111/j.1750-2659.2010.00150.x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kendal AP, 1982, WHO COLLABORATING CT, pB17; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; ROSS T, 2010, PLOS CURR INFLUENZA; San Diego County Health and Human Svcs Imperial County Public Health Dept California Dept of Public Health Dallas County Health and Human Svcs Texas Dept of State Health Svcs, 2009, MMWR-MORBID MORTAL W, V58, P435; Wang Wei, 2009, Chinese Journal of Virology, V25, P4; WHO, 2005, REC LAB TESTS ID AV; WHO CDC, WHO CDC PROT REAL TI; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization (WHO), WHO MAN AN INFL DIAG; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; [张欣 ZHANG Xin], 2011, [中华传染病杂志, Chinese Journal of Infections Diseases], V29, P154; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	29	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45898	10.1371/journal.pone.0045898	http://dx.doi.org/10.1371/journal.pone.0045898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029300	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500045
J	Bories, C; Guitton, MJ; Julien, C; Tremblay, C; Vandal, M; Msaid, M; De Koninck, Y; Calon, F				Bories, Cyril; Guitton, Matthieu J.; Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; De Koninck, Yves; Calon, Frederic			Sex-Dependent Alterations in Social Behaviour and Cortical Synaptic Activity Coincide at Different Ages in a Model of Alzheimer's Disease	PLOS ONE			English	Article							DEVELOPMENTAL-GENETIC ANALYSIS; MEDIAL PREFRONTAL CORTEX; MILD COGNITIVE IMPAIRMENT; APPSWE/PS1 BIGENIC MODEL; TRANSGENIC MOUSE MODEL; A-BETA; AGGRESSIVE-BEHAVIOR; NEUROPSYCHIATRIC SYMPTOMS; MICE; APATHY	Besides memory deficits, Alzheimer's disease (AD) patients suffer from neuropsychiatric symptoms, including alterations in social interactions, which are subject of a growing number of investigations in transgenic models of AD. Yet the biological mechanisms underlying these behavioural alterations are poorly understood. Here, a social interaction paradigm was used to assess social dysfunction in the triple-transgenic mouse model of AD (3xTg-AD). We observed that transgenic mice displayed dimorphic behavioural abnormalities at different ages. Social disinhibition was observed in 18 months old 3xTg-AD males compared to age and sex-matched control mice. In 3xTg-AD females, social disinhibition was present at 12 months followed by reduced social interactions at 18 months. These dimorphic behavioural alterations were not associated with alterations in AD neuropathological markers such as A beta or tau levels in the frontal cortex. However, patch-clamp recordings revealed that enhanced social interactions coincided temporally with an increase in both excitatory and inhibitory basal synaptic inputs to layer 2-3 pyramidal neurons in the prefrontal cortex. These findings uncover a novel pattern of occurrence of psychiatric-like symptoms between sexes in an AD model. Our results also reveal that functional alterations in synapse activity appear as a potentially significant substrate underlying behavioural correlates of AD.	[Guitton, Matthieu J.; Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Bories, Cyril; Guitton, Matthieu J.; De Koninck, Yves] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; Calon, Frederic] CHU Laval, Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Bories, Cyril; Guitton, Matthieu J.; De Koninck, Yves] Quebec Mental Hlth Inst, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Calon, F (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	frederic.calon@crchul.ulaval.ca	Calon, Frederic/AAF-4390-2020; Bories, Cyril/O-9869-2019; Julien, Carl/AAU-5309-2021; De Koninck, Yves/C-2659-2008	De Koninck, Yves/0000-0002-5779-9330; Bories, Cyril/0000-0003-0811-5219; Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [MOP74443]; Alzheimer Society Canada [ASC 0516, 0823]; Canada Foundation for Innovation [10307]; "Fonds de la Recherche en Sante du Quebec" (FRSQ); FRSQ; Laval University "Fonds d'Enseignement et de Recherche"; Clinical Research Initiative; CIHR Institute of Aging [CAN-76833]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); "Fonds de la Recherche en Sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Laval University "Fonds d'Enseignement et de Recherche"; Clinical Research Initiative; CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR))	Grants to FC from the Canadian Institutes of Health Research (CIHR) (MOP74443), the Alzheimer Society Canada (ASC 0516 and 0823) and the Canada Foundation for Innovation (10307) supported this work. MJG and YDK are supported by Career Awards from the "Fonds de la Recherche en Sante du Quebec" (FRSQ). CJ held studentships from the Alzheimer Society Canada, the FRSQ, and Laval University "Fonds d'Enseignement et de Recherche". FC was supported by a New Investigator Award from the Clinical Research Initiative and the CIHR Institute of Aging(CAN-76833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; CAIRNS RB, 1983, J COMP PSYCHOL, V97, P69, DOI 10.1037/0735-7036.97.1.69; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; Cooke BM, 2005, J NEUROSCI, V25, P10759, DOI 10.1523/JNEUROSCI.2919-05.2005; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Filali M, 2011, PHYSIOL BEHAV, V104, P880, DOI 10.1016/j.physbeh.2011.05.023; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GARIEPY JL, 1988, J COMP PSYCHOL, V102, P392, DOI 10.1037/0735-7036.102.4.392; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Guitton MJ, 2008, BEHAV BRAIN RES, V191, P148, DOI 10.1016/j.bbr.2008.03.022; Guitton MJ, 2009, J PSYCHOSOM RES, V67, P273, DOI 10.1016/j.jpsychores.2008.10.017; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; HOOD KE, 1988, BEHAV GENET, V18, P605, DOI 10.1007/BF01082312; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; JULIEN C, 2008, NEUROBIOL AGING; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lechowski L, 2009, INT J GERIATR PSYCH, V24, P341, DOI 10.1002/gps.2125; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lueken U, 2007, AM J GERIAT PSYCHIAT, V15, P376, DOI 10.1097/JGP.0b013e3180437db3; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Mizrahi R, 2007, DRUG AGING, V24, P547, DOI 10.2165/00002512-200724070-00003; Mizuno K, 2010, TRENDS NEUROSCI, V33, P285, DOI 10.1016/j.tins.2010.03.001; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pietropaolo S, 2011, NEUROBIOL AGING; Pietropaolo S, 2009, BEHAV NEUROSCI, V123, P181, DOI 10.1037/a0013607; Preuss UW, 2010, AM J GERIAT PSYCHIAT, V18, P821, DOI 10.1097/JGP.0b013e3181ca3a13; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Stack A, 2010, NEUROPSYCHOPHARMACOL, V35, P570, DOI 10.1038/npp.2009.163; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Teng E, 2007, DEMENT GERIATR COGN, V24, P253, DOI 10.1159/000107100; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tremblay C, 2007, J ALZHEIMERS DIS, V12, P377; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wu LJ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-9; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zahs KR, 2010, TRENDS NEUROSCI	64	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46111	10.1371/journal.pone.0046111	http://dx.doi.org/10.1371/journal.pone.0046111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029404	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700115
J	Yuan, K; Qin, W; Liu, P; Zhao, L; Yu, DH; Zhao, LM; Dong, MH; Liu, JX; Yang, XJ; von Deneen, KM; Liang, FR; Tian, J				Yuan, Kai; Qin, Wei; Liu, Peng; Zhao, Ling; Yu, Dahua; Zhao, Limei; Dong, Minghao; Liu, Jixin; Yang, Xuejuan; von Deneen, Karen M.; Liang, Fanrong; Tian, Jie			Reduced Fractional Anisotropy of Corpus Callosum Modulates Inter-Hemispheric Resting State Functional Connectivity in Migraine Patients without Aura	PLOS ONE			English	Article							BRAIN-STEM ACTIVATION; HUMAN ORBITOFRONTAL CORTEX; GRAY-MATTER; STRUCTURAL CONNECTIVITY; VOXELWISE ANALYSIS; PAIN; ARCHITECTURE; TRACT; ABNORMALITIES; FREQUENCY	Background: Diffusion tensor imaging (DTI) study revealed reduced fractional anisotropy (FA) values in the corpus callosum (CC) in migraine patients without aura. Abnormalities in white matter integrity, particularly in the CC, may affect interhemispheric resting state functional connectivity (RSFC). Unfortunately, relatively little is known about the alterations in functional interactions between the cerebral hemispheres during resting state in migraine patients without aura, and even less about how the inter-hemispheric RSFC are affected by the abnormalities of the CC. Methods and findings: Twenty-one migraine patients without aura and 21 healthy controls participated in this study, age-, sex-, and education-matched. Tract-based spatial statistics (TBSS) was employed to investigate the white matter alterations of the CC. Meanwhile, voxel-mirrored homotopic connectivity (VMHC) was used to compare the inter-hemispheric RSFC differences between the patients and controls. TBSS analysis revealed reduced FA values in the genu and the splenium of CC in patient group. VMHC analysis showed decreased inter-hemispheric RSFC of anterior cingulate cortex (ACC) in migraine patients without aura relative to that of the controls. Furthermore, in migraine patients without aura, the reduced FA values of the genu of CC correlated with the decreased inter-hemispheric RSFC of the ACC. Conclusions: Our findings demonstrated that the migraine patients without aura showed reduced FA values of the genu of CC and decreased inter-hemispheric RSFC of the ACC. The correlation between the above structural and functional changes suggested that the reduced fractional anisotropy (FA) of CC modulates inter-hemispheric VMHC in migraine patients without aura. Our results demonstrated that the VMHC alterations of ACC can reflect the FA changes of the genu of CC in migraine patients without aura.	[Yuan, Kai; Qin, Wei; Liu, Peng; Yu, Dahua; Zhao, Limei; Dong, Minghao; Liu, Jixin; Yang, Xuejuan; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016; Dong, Minghao/A-6425-2014; Yuan, Kai/M-9403-2013; Yuan, Kai/I-4150-2016; tian, jie/M-6336-2013; Life, PAM/M-9552-2013; Tian, Jie/H-1190-2011	Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406; Dong, Minghao/0000-0002-0190-6985; Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; Liang, Fanrong/0000-0003-2210-2027	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837, 61179019]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Inner Mongolia [2012MS0908]; Innovation Fund Project of Inner Mongolia University of Science and Technology [2010NC030, 2010NC037]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Inner Mongolia; Innovation Fund Project of Inner Mongolia University of Science and Technology	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702, 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837, 61179019, the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia under Grant Nos. 2012MS0908 and the Innovation Fund Project of Inner Mongolia University of Science and Technology Nos. 2010NC030, 2010NC037.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Andersson J, 2007, FMRIB ANALYSIS GROUP; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Drabant EM, 2011, NEUROIMAGE, V55, P401, DOI 10.1016/j.neuroimage.2010.11.040; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HOPTMAN MJ, 1994, PSYCHOL BULL, V116, P195, DOI 10.1037/0033-2909.116.2.195; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Li XL, 2010, HEADACHE J HEAD FACE, V51, P237; Li ZH, 2009, BRAIN RES, V1295, P149, DOI 10.1016/j.brainres.2009.08.004; May Arne, 2006, J Headache Pain, V7, P174, DOI 10.1007/s10194-006-0307-1; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; May A, 2009, BRAIN, V132, P1419, DOI 10.1093/brain/awp116; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rocca MA, 2006, J NEUROL NEUROSUR PS, V77, P686, DOI 10.1136/jnnp.2005.080002; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent M, 2003, CEPHALALGIA, V23, P860, DOI 10.1046/j.1468-2982.2003.00609.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	64	78	86	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45476	10.1371/journal.pone.0045476	http://dx.doi.org/10.1371/journal.pone.0045476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029036	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700042
J	Balada, E; Castro-Marrero, J; Felip, L; Ordi-Ros, J; Vilardell-Tarres, M				Balada, Eva; Castro-Marrero, Jesus; Felip, Lledo; Ordi-Ros, Josep; Vilardell-Tarres, Miquel			Associations between the Expression of Epigenetically Regulated Genes and the Expression of DNMTs and MBDs in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CD4(+) T-CELLS; ABNORMAL DNA METHYLATION; NATURAL-KILLER-CELLS; SOLUBLE CD40 LIGAND; ELEMENTS CONTRIBUTES; SYNGENEIC MICE; OVEREXPRESSION; DEMETHYLATION; METHYLTRANSFERASE; HYPOMETHYLATION	Objectives: We determined the expression of ITGAL, PRF1, KIR2DL4, CD70, and CD40LG in patients with SLE and performed correlations with the global DNA methylation status and the levels of three DNA methylation enzymes and two methyl CpG-binding domain (MBD) proteins. Patients and Methods: CD4(+) T cells were isolated from 35 SLE patients and 30 healthy controls. DNA deoxymethylcytosine content was measured by an enzyme-linked immunosorbent assay (ELISA). Transcript levels of ITGAL, PRF1, KIR2DL4, CD70, CD40LG, DNMT1, DNMT3A, DNMT3B, MBD2, and MBD4 were quantified by real-time reverse-transcription polymerase chain reaction (RT-PCR). Results: SLE patients had significantly elevated transcript levels of ITGAL (18.61+/-22.17 vs. 7.33+/-9.17, p = 0.042), PRF1 (21.67+/-26.34 vs. 10.67+/-11.65, p = 0.039), and CD70 (1.45+/-1.63 vs. 0.67+/-0.28, p = 0.011). A positive correlation was observed between transcript levels of CD40LG and ITGAL (r = 0.477, p = 0.004) as well as between CD40LG and PRF1 (r = 0.557, p = 0.001). Transcript levels of KIR2DL4 were higher than controls' but it did not reach statistical significance (1.36+/-3.52 vs. 0.22+/-0.79, p = 0.560). A tight relationship with global DNA hypomethylation as well as with the expression of most of the DNA methylation-related genes was observed, especially for ITGAL, PRF1, and CD40LG. Conclusions: ITGAL, PRF1, and CD70 are overexpressed in SLE CD4(+) T cells. The tight association of CD40LG with ITGAL and PRF1 leads us to infer that it probably contributes to the pathogenesis of the disease. The apparent simultaneous regulation between their expression and the global DNA hypomethylation as well as with the transcription of many DNA methylation-related enzymes, reinforces the idea that epigenetic mechanisms are responsible for the deregulation of ITGAL, PRF1, and CD40LG.	[Balada, Eva; Castro-Marrero, Jesus; Felip, Lledo; Ordi-Ros, Josep; Vilardell-Tarres, Miquel] Univ Autonoma Barcelona, Hosp Vall dHebron, Vall dHebron Res Inst, Res Unit Syst Autoimmune Dis, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Balada, E (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Vall dHebron Res Inst, Res Unit Syst Autoimmune Dis, E-08193 Barcelona, Spain.	eva.balada@vhir.org		Castro-Marrero, Jesus/0000-0002-2481-3052				Balada E, 2008, IMMUNOLOGY, V124, P339, DOI 10.1111/j.1365-2567.2007.02771.x; Balada E, 2007, J LEUKOCYTE BIOL, V81, P1609, DOI 10.1189/jlb.0107064; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Basu D, 2009, J IMMUNOL, V183, P3481, DOI 10.4049/jimmunol.0900034; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Kaplan MJ, 2004, J IMMUNOL, V172, P3652, DOI 10.4049/jimmunol.172.6.3652; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kozlowska A, 2010, J RHEUMATOL, V37, P53, DOI 10.3899/jrheum.090424; Lei W, 2009, SCAND J RHEUMATOL, V38, P369, DOI 10.1080/03009740902758875; Li GJ, 2008, J LEUKOCYTE BIOL, V84, P824, DOI 10.1189/jlb.0807583; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Lu Q, 2007, J IMMUNOL, V179, P6352, DOI 10.4049/jimmunol.179.9.6352; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Luo Y, 2008, BRIT J DERMATOL, V159, P827, DOI 10.1111/j.1365-2133.2008.08758.x; Luo Y, 2010, CLIN EXP DERMATOL, V35, P425, DOI 10.1111/j.1365-2230.2009.03611.x; Mizugaki M, 1997, CLIN EXP IMMUNOL, V110, P265; Oelke K, 2004, ARTHRITIS RHEUM-US, V50, P1850, DOI 10.1002/art.20255; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Perez OD, 2004, BLOOD, V104, P1083, DOI 10.1182/blood-2003-08-2652; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; RICHARDSON B, 1994, ARTHRITIS RHEUM, V37, P1363, DOI 10.1002/art.1780370915; RICHARDSON BC, 1992, ARTHRITIS RHEUM, V35, P647, DOI 10.1002/art.1780350608; Shi WM, 2009, J DERMATOL SCI, V53, P236, DOI 10.1016/j.jdermsci.2008.09.007; Shoshan Y, 2001, J IMMUNOL, V167, P5963, DOI 10.4049/jimmunol.167.10.5963; Urquizu-Padilla M, 2009, J RHEUMATOL, V36, P953, DOI 10.3899/jrheum.080978; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yung R, 1996, J CLIN INVEST, V97, P2866, DOI 10.1172/JCI118743; Zhao M, 2010, J AUTOIMMUN, V35, P58, DOI 10.1016/j.jaut.2010.02.002; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196; Zhou Y, 2011, LUPUS; Zhou Y, 2009, CLIN IMMUNOL, V132, P362, DOI 10.1016/j.clim.2009.05.011; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157; Zhu XH, 2011, INT J DERMATOL, V50, P697, DOI 10.1111/j.1365-4632.2010.04804.x	43	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45897	10.1371/journal.pone.0045897	http://dx.doi.org/10.1371/journal.pone.0045897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029299	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800114
J	Baysinger, AN; Kent, BA; Brown, TH				Baysinger, Amber N.; Kent, Brianne A.; Brown, Thomas H.			Muscarinic Receptors in Amygdala Control Trace Fear Conditioning	PLOS ONE			English	Article							GRADED PERSISTENT ACTIVITY; LONG-TERM POTENTIATION; ENTORHINAL CORTEX; MEMORY CONSOLIDATION; FUNCTIONAL NEUROANATOMY; CHOLINERGIC MODULATION; PARAHIPPOCAMPAL REGION; VENTRAL HIPPOCAMPUS; CELLULAR MECHANISM; PERIRHINAL CORTEX	Intelligent behavior requires transient memory, which entails the ability to retain information over short time periods. A newly-emerging hypothesis posits that endogenous persistent firing (EPF) is the neurophysiological foundation for aspects or types of transient memory. EPF is enabled by the activation of muscarinic acetylcholine receptors (mAChRs) and is triggered by suprathreshold stimulation. EPF occurs in several brain regions, including the lateral amygdala (LA). The present study examined the role of amygdalar mAChRs in trace fear conditioning, a paradigm that requires transient memory. If mAChR-dependent EPF selectively supports transient memory, then blocking amygdalar mAChRs should impair trace conditioning, while sparing delay and context conditioning, which presumably do not rely upon transient memory. To test the EPF hypothesis, LA was bilaterally infused, prior to trace or delay conditioning, with either a mAChR antagonist (scopolamine) or saline. Computerized video analysis quantified the amount of freezing elicited by the cue and by the training context. Scopolamine infusion profoundly reduced freezing in the trace conditioning group but had no significant effect on delay or context conditioning. This pattern of results was uniquely anticipated by the EPF hypothesis. The present findings are discussed in terms of a systems-level theory of how EPF in LA and several other brain regions might help support trace fear conditioning.	[Baysinger, Amber N.; Kent, Brianne A.; Brown, Thomas H.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Brown, Thomas H.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	Brown, TH (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	thomas.brown@yale.edu		Kent, Brianne/0000-0003-0074-028X	National Science and Engineering Research Council Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0644492]; Yale University;  [MH58405]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058405] Funding Source: NIH RePORTER	National Science and Engineering Research Council Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Yale University; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by MH58405 to THB, National Science and Engineering Research Council Fellowship to BAK, National Science Foundation Graduate Research Fellowship Grant DGE-0644492 to ANB, and Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALONSO JR, 1995, J COMP NEUROL, V355, P135, DOI 10.1002/cne.903550202; Bang SJ, 2009, J NEUROSCI, V29, P4346, DOI 10.1523/JNEUROSCI.0069-09.2009; Barnet RC, 2005, LEARN BEHAV, V33, P437, DOI 10.3758/BF03193182; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BROWN TH, 2004, CELLULAR MOL NEUROSC, P499; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Edeline JM, 2002, NEUROBIOL LEARN MEM, V78, P100, DOI 10.1006/nlme.2001.4035; Egorov AV, 2006, EUR J NEUROSCI, V24, P3183, DOI 10.1111/j.1460-9568.2006.05200.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Goosens KA, 2000, BEHAV BRAIN RES, V114, P145, DOI 10.1016/S0166-4328(00)00224-2; Guimarais M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00089; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2006, TRENDS COGN SCI, V10, P487, DOI 10.1016/j.tics.2006.09.005; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; HEBB D. O., 1949; Huang CH, 2010, BRAIN RES, V1326, P143, DOI 10.1016/j.brainres.2010.02.033; Ivkovich D, 2001, NEUROBIOL LEARN MEM, V76, P426, DOI 10.1006/nlme.2001.4027; Ivkovich D, 2000, DEV PSYCHOBIOL, V36, P148, DOI 10.1002/(SICI)1098-2302(200003)36:2<148::AID-DEV6>3.0.CO;2-L; Jochems A, 2012, FENS ABSTR; KELSO SR, 1986, SCIENCE, V232, P85, DOI 10.1126/science.3952501; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; Kent BA, 2012, HIPPOCAMPUS, V22, P2068, DOI 10.1002/hipo.22058; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Knauer B, 2012, FENS ABSTR; Kwapis JL, 2011, LEARN MEMORY, V18, P728, DOI 10.1101/lm.023945.111; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Majchrzak M, 2006, HIPPOCAMPUS, V16, P114, DOI 10.1002/hipo.20138; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Moyer JR, 2006, BEHAV NEUROSCI, V120, P612, DOI 10.1037/0735-7044.120.3.612; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; Pang MH, 2010, NEUROBIOL LEARN MEM, V94, P206, DOI 10.1016/j.nlm.2010.05.008; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Reboreda A, 2007, J NEUROPHYSIOL, V97, P3937, DOI 10.1152/jn.01233.2006; Reboreda A, 2011, ADV EXP MED BIOL, V704, P595, DOI 10.1007/978-94-007-0265-3_32; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Schafe GE, 2000, J NEUROSCI, V20, P8177; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006; Yoshida M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00010; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zaborszky L, 2002, PROG BRAIN RES, V136, P359; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043	78	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45720	10.1371/journal.pone.0045720	http://dx.doi.org/10.1371/journal.pone.0045720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029199	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800082
J	Liu, LW; Sun, XF; Yan, PF; Wang, LM; Chen, HG				Liu, Liangwei; Sun, Xiaofeng; Yan, Pengfei; Wang, Linmin; Chen, Hongge			Non-Structured Amino-Acid Impact on GH11 Differs from GH10 Xylanase	PLOS ONE			English	Article							TRICHODERMA-REESEI ENDO-1,4-BETA-XYLANASE-II; DISULFIDE BRIDGE; ENZYMATIC-ACTIVITY; THERMAL-STABILITY; SUBSTRATE-BINDING; THERMOSTABILITY; COMBINATION; DELETION; DOMAINS; REGION	The Aspergillus niger xylanase (Xyn) was used as a model to investigate impacts of un-structured residues on GH11 family enzyme, because the beta-jelly roll structure has five residues (Ser1Ala2Gly3Ile4Asn5) at N-terminus and two residues (Ser183Ser184) at C-terminus that do not form to helix or strand. The N- or/and C-terminal residues were respectively deleted to construct three mutants. The optimal temperatures of Xyn Delta N, Xyn Delta C, and Xyn Delta NC were 46, 50, and 46 degrees C, and the thermostabilities were 15.7, 73.9, 15.5 min at 50 degrees C, respectively, compared to 48 degrees C and 33.9 min for the Xyn. After kinetic analysis, the substrate-binding affinities for birch-wood xylan decreased in the order Xyn Delta C>Xyn>Xyn Delta NC>Xyn Delta N, while the K-cat values increased in the order Xyn Delta C<Xyn Delta NC<Xyn<Xyn Delta N. The C-terminal deletion increased the GH11 xylanase thermostability and T-opt, while the N- and NC-terminal deletions decreased its thermostability and optimal temperature. The C-terminal residues created more impact on enzyme thermal property, while the N-terminal residues created more impact on its catalytic efficiency and substrate-binding affinity. The impact of non-structured residues on GH11 xylanase was different from that of similar residues on GH10 xylanase, and the difference is attributed to structural difference between GH11 jelly-roll and GH10 (beta/alpha)(8).	[Liu, Liangwei; Sun, Xiaofeng; Yan, Pengfei; Wang, Linmin; Chen, Hongge] Henan Agr Univ, Life Sci Coll, Zhengzhou, Henan, Peoples R China; [Wang, Linmin; Chen, Hongge] Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, LW (corresponding author), Henan Agr Univ, Life Sci Coll, Zhengzhou, Henan, Peoples R China.	LLW321@yahoo.com.cn		liu, liangwei/0000-0002-1896-8437	Natural Science Foundation of China [30972123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (30972123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HG, 2006, J MICROBIOL BIOTECHN, V16, P1132; Fenel F, 2004, J BIOTECHNOL, V108, P137, DOI 10.1016/j.jbiotec.2003.11.002; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Hamana H, 1999, J BIOCHEM-TOKYO, V125, P109, DOI 10.1093/oxfordjournals.jbchem.a022246; Huang BH, 1996, BIOCHEMISTRY-US, V35, P12164, DOI 10.1021/bi960234o; Jeong MY, 2007, J BIOTECHNOL, V127, P300, DOI 10.1016/j.jbiotec.2006.07.005; KAUFMANN E, 1984, FEBS LETT, V170, P81, DOI 10.1016/0014-5793(84)81373-3; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Krengel U, 1996, ACTA CRYSTALLOGR D, V52, P571, DOI 10.1107/S0907444995014740; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu LW, 2011, PROCESS BIOCHEM, V46, P395, DOI 10.1016/j.procbio.2010.07.026; Liu LW, 2008, J BIOTECHNOL, V136, pS201, DOI 10.1016/j.jbiotec.2008.07.423; Lo Leggio L, 1999, PROTEINS, V36, P295; Ma YF, 2000, BIOCHEMISTRY-US, V39, P13350, DOI 10.1021/bi000688s; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Niu D, 2010, BIOTECHNOL LETT, V32, P963, DOI 10.1007/s10529-010-0241-9; Phannachet K, 2010, CURR MICROBIOL, V61, P549, DOI 10.1007/s00284-010-9651-0; Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; Wang Q, 2008, APPL BIOCHEM BIOTECH, V144, P273, DOI 10.1007/s12010-007-8016-z; Wang S, 2009, PLOS ONE, V4, P1; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Wassenberg D, 1997, PROTEIN SCI, V6, P1718, DOI 10.1002/pro.5560060812; Wen TN, 2005, BIOCHEMISTRY-US, V44, P9197, DOI 10.1021/bi0500630; Xiong HR, 2004, EXTREMOPHILES, V8, P393, DOI 10.1007/s00792-004-0400-9; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159	26	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45762	10.1371/journal.pone.0045762	http://dx.doi.org/10.1371/journal.pone.0045762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029229	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800093
J	Wei, Y; Zhao, LQ; Qi, BZ; Xiao, X; He, L; Zhou, GQ; Chen, SW; Li, HL; Ruan, L; Zhang, CT; Liu, SW				Wei, Yong; Zhao, Li-qun; Qi, Bao-zhen; Xiao, Xing; He, Li; Zhou, Gen-qing; Chen, Song-wen; Li, Hong-li; Ruan, Lei; Zhang, Cun-tai; Liu, Shao-wen			Lysophosphatidic Acid Increases the Electrophysiological Instability of Adult Rabbit Ventricular Myocardium by Augmenting L-Type Calcium Current	PLOS ONE			English	Article							LONG-QT SYNDROME; CARDIAC MYOCYTES; ARRHYTHMIC RISK; LPA RECEPTORS; IDENTIFICATION; HYPERTROPHY; MODULATION; ACTIVATION; MECHANISMS; CELLS	Lysophosphatidic acid (LPA) has diverse actions on the cardiovascular system and is widely reported to modulate multiple ion currents in some cell types. However, little is known about its electrophysiological effects on cardiac myocytes. This study investigated whether LPA has electrophysiological effects on isolated rabbit myocardial preparations. The results indicate that LPA prolongs action potential duration at 90% repolarization (APD(90)) in a concentration- and frequency-dependent manner in isolated rabbit ventricular myocytes. The application of extracellular LPA significantly increases the coefficient of APD(90) variability. LPA increased L-type calcium current (I-Ca,I-L) density without altering its activation or deactivation properties. In contrast, LPA has no effect on two other ventricular repolarizing currents, the transient outward potassium current (I-to) and the delayed rectifier potassium current (I-K). In arterially perfused rabbit left ventricular wedge preparations, the monophasic action potential duration, QT interval, and Tpeak-end are prolonged by LPA. LPA treatment also significantly increases the incidence of ventricular tachycardia induced by S1S2 stimulation. Notably, the effects of LPA on action potentials and I-Ca,I-L are PTX-sensitive, suggesting LPA action requires a G(i)-type G protein. In conclusion, LPA prolongs APD and increases electrophysiological instability in isolated rabbit myocardial preparations by increasing I-Ca,I-L in a G(i) protein-dependent manner.	[Wei, Yong; Zhao, Li-qun; Qi, Bao-zhen; Zhou, Gen-qing; Chen, Song-wen; Li, Hong-li; Liu, Shao-wen] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Wei, Yong] Shanghai Songjiang Ctr Hosp, Dept Cardiol, Shanghai, Peoples R China; [Xiao, Xing; He, Li; Ruan, Lei; Zhang, Cun-tai] Huazhong Univ Sci & Technol, Dept Geratol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Shanghai Jiao Tong University; Huazhong University of Science & Technology	Liu, SW (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	shaowen.liu@hotmail.com	Chen, Songwen/AAI-4389-2020; Liu, Shaowen/AAJ-4121-2020	Chen, Songwen/0000-0002-6492-5702; Zhou, Genqing/0000-0003-4506-7658	Shanghai Jiao Tong University School of Medicine [BXJ201135]	Shanghai Jiao Tong University School of Medicine	This research was supported by the Doctoral Students' Innovation Fund of Shanghai Jiao Tong University School of Medicine (grant number: BXJ201135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA T, 1994, CIRCULATION, V90, P469, DOI 10.1161/01.CIR.90.1.469; Chang YJ, 2007, PROSTAG OTH LIPID M, V83, P268, DOI 10.1016/j.prostaglandins.2007.01.014; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Chen JH, 2008, J CELL BIOCHEM, V103, P1718, DOI 10.1002/jcb.21564; Chen X, 2003, SCAND J CLIN LAB INV, V63, P497, DOI 10.1080/00365510310003265; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Cremers B, 2003, J MOL CELL CARDIOL, V35, P71, DOI 10.1016/S0022-2828(02)00279-1; de Jong JSSG, 2011, J MOL CELL CARDIOL, V51, P347, DOI 10.1016/j.yjmcc.2011.05.016; Fukushima N, 2001, PROSTAG OTH LIPID M, V64, P21, DOI 10.1016/S0090-6980(01)00105-8; Hilal-Dandan R, 2004, J MOL CELL CARDIOL, V36, P481, DOI 10.1016/j.yjmcc.2003.12.010; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; Kaufman ES, 2011, J ELECTROCARDIOL, V44, P645, DOI 10.1016/j.jelectrocard.2011.07.023; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohata H, 2011, EXP PHYSIOL, V96, P468, DOI 10.1113/expphysiol.2011.056416; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Parrill AL, 2004, SEMIN CELL DEV BIOL, V15, P467, DOI 10.1016/j.semcdb.2004.05.006; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Shimizu W, 2004, J AM COLL CARDIOL, V44, P117, DOI 10.1016/j.jacc.2004.03.043; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Spector AA, 2003, CIRCULATION, V108, P641, DOI 10.1161/01.CIR.0000082307.85449.1D; Swarthout JT, 2000, CELL MOL LIFE SCI, V57, P1978, DOI 10.1007/PL00000678; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; Tomar A, 2009, J BIOL CHEM, V284, P35278, DOI 10.1074/jbc.C109.060830; Wang J, 2002, INVEST OPHTH VIS SCI, V43, P3202; Wei L, 2004, J MOL CELL CARDIOL, V36, P465, DOI 10.1016/j.yjmcc.2004.02.006; Xu Yan-Jun, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P109, DOI 10.1177/107424840200700207; Xu YJ, 2005, CELL CALCIUM, V38, P569, DOI 10.1016/j.ceca.2005.08.001; Yan GX, 2001, CIRCULATION, V103, P2851; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45862	10.1371/journal.pone.0045862	http://dx.doi.org/10.1371/journal.pone.0045862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029283	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800109
J	Avella, MA; Place, A; Du, SJ; Williams, E; Silvi, S; Zohar, Y; Carnevali, O				Avella, Matteo A.; Place, Allen; Du, Shao-Jun; Williams, Ernest; Silvi, Stefania; Zohar, Yonathan; Carnevali, Oliana			Lactobacillus rhamnosus Accelerates Zebrafish Backbone Calcification and Gonadal Differentiation through Effects on the GnRH and IGF Systems	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ACTIVATED RECEPTOR-BETA/DELTA; VITAMIN-D-RECEPTOR; RETINOIC ACID; DANIO-RERIO; PROBIOTIC STRAINS; IMMUNE-RESPONSES; BINDING-PROTEINS; PPAR-BETA; GROWTH	Endogenous microbiota play essential roles in the host's immune system, physiology, reproduction and nutrient metabolism. We hypothesized that a continuous administration of an exogenous probiotic might also influence the host's development. Thus, we treated zebrafish from birth to sexual maturation (2-months treatment) with Lactobacillus rhamnosus, a probiotic species intended for human use. We monitored for the presence of L. rhamnosus during the entire treatment. Zebrafish at 6 days post fertilization (dpf) exhibited elevated gene expression levels for Insulin-like growth factors -I and -II, Peroxisome proliferator activated receptors -alpha and -beta, VDR-alpha and RAR-gamma when compared to untreated-10 days old zebrafish. Using a gonadotropin-releasing hormone 3 GFP transgenic zebrafish (GnRH3-GFP), higher GnRH3 expression was found at 6, 8 and 10 dpf upon L. rhamnosus treatment. The same larvae exhibited earlier backbone calcification and gonad maturation. Noteworthy in the gonad development was the presence of first testes differentiation at 3 weeks post fertilization in the treated zebrafish population -which normally occurs at 8 weeks-and a dramatic sex ratio modulation (93% females, 7% males in control vs. 55% females, 45% males in the treated group). We infer that administration of L. rhamnosus stimulated the IGF system, leading to a faster backbone calcification. Moreover we hypothesize a role for administration of L. rhamnosus on GnRH3 modulation during early larval development, which in turn affects gonadal development and sex differentiation. These findings suggest a significant role of the microbiota composition on the host organism development profile and open new perspectives in the study of probiotics usage and application.	[Place, Allen; Williams, Ernest] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [Avella, Matteo A.; Carnevali, Oliana] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Du, Shao-Jun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Silvi, Stefania] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy; [Zohar, Yonathan] Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA; [Zohar, Yonathan] Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Marche Polytechnic University; University System of Maryland; University of Maryland Baltimore; University of Camerino; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Place, A (corresponding author), Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA.	place@umces.edu; zohar@umbc.edu; o.carnevali@univpm.it	Avella, Matteo/M-6857-2019; Place, Allen R/F-9267-2013; Carnevali, Oliana/P-2751-2015	Carnevali, Oliana/0000-0001-5994-0572; Williams, Ernest/0000-0001-8727-4968	Fondi di Ateneo	Fondi di Ateneo	This research was supported by "Fondi di Ateneo 2008-2009" to Oliana Carnevali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; Abraham E, 2009, GEN COMP ENDOCR, V164, P151, DOI 10.1016/j.ygcen.2009.01.012; Avella MA, 2010, AM J PHYSIOL-REG I, V298, pR359, DOI 10.1152/ajpregu.00300.2009; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bedu E, 2007, BIOCHEM BIOPH RES CO, V357, P877, DOI 10.1016/j.bbrc.2007.04.003; Bedu E, 2005, EXPERT OPIN THER TAR, V9, P861, DOI 10.1517/14728222.9.4.861; Bertotto D, 2011, GEN COMP ENDOCR, V174, P44, DOI 10.1016/j.ygcen.2011.08.003; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Carnevali O, 2006, AQUACULTURE, V258, P430, DOI 10.1016/j.aquaculture.2006.04.025; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CIGUERE V, 1994, ENDOCR REV, V15, P61; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Du S, 2004, BIOMINERALIZATION PR; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Gaudel C, 2007, PPAR RES, V2007, DOI 10.1155/2007/86394; Gill HS, 2001, BRIT J NUTR, V86, P285, DOI 10.1079/BJN2001402; Gioacchini G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094243; Gioacchini G, 2010, REPRODUCTION, V140, P953, DOI 10.1530/REP-10-0145; Grimaldi PA, 2007, BBA-MOL CELL BIOL L, V1771, P983, DOI 10.1016/j.bbalip.2007.02.006; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kajimura S, 2003, J ENDOCRINOL, V178, P91, DOI 10.1677/joe.0.1780091; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Keller JM, 2008, COMP BIOCHEM PHYS A, V150, P307, DOI 10.1016/j.cbpa.2008.03.021; Kuisma J, 2003, ALIMENT PHARM THER, V17, P509, DOI 10.1046/j.1365-2036.2003.01465.x; Kullberg MC, 2008, NATURE, V453, P602, DOI 10.1038/453602a; Kuo MW, 2005, J BIOMED SCI, V12, P629, DOI 10.1007/s11373-005-7457-z; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Matsuzaki T, 2000, IMMUNOL CELL BIOL, V78, P67, DOI 10.1046/j.1440-1711.2000.00887.x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MENDELSOHN C, 1994, MECH DEVELOP, V45, P227, DOI 10.1016/0925-4773(94)90010-8; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MENDELSOHN C, 1994, DEV BIOL, V166, P246, DOI 10.1006/dbio.1994.1311; Narva M, 2004, LIFE SCI, V75, P1727, DOI 10.1016/j.lfs.2004.04.011; Okubo K, 2008, ACTA PHYSIOL, V193, P3, DOI 10.1111/j.1748-1716.2008.01832.x; Patruno M, 2006, COMP BIOCHEM PHYS B, V144, P137, DOI 10.1016/j.cbpb.2006.02.003; Pelegri F, 1999, METHOD CELL BIOL, V60, P1; Peterson BC, 2004, DOMEST ANIM ENDOCRIN, V26, P231, DOI 10.1016/j.domaniend.2003.10.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saggese G, 2002, BEST PRACT RES CL EN, V16, P53, DOI 10.1053/beem.2001.0180; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Teusink B, 2006, NAT REV MICROBIOL, V4, P46, DOI 10.1038/nrmicro1319; Uchida D, 2002, J EXP BIOL, V205, P711; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Verdenelli MC, 2011, LETT APPL MICROBIOL, V52, P596, DOI 10.1111/j.1472-765X.2011.03042.x; Vijayan MM, 2003, GEN COMP ENDOCR, V132, P256, DOI 10.1016/S0016-6480(03)00092-3; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	67	87	98	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45572	10.1371/journal.pone.0045572	http://dx.doi.org/10.1371/journal.pone.0045572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029107	Green Published, gold			2022-12-27	WOS:000309388900077
J	Deguines, N; Julliard, R; de Flores, M; Fontaine, C				Deguines, Nicolas; Julliard, Romain; de Flores, Mathieu; Fontaine, Colin			The Whereabouts of Flower Visitors: Contrasting Land-Use Preferences Revealed by a Country-Wide Survey Based on Citizen Science	PLOS ONE			English	Article							GLOBAL BIODIVERSITY INDICATORS; POLLINATOR DECLINES; PLANTS; CONSERVATION; DIVERSITY; URBANIZATION; ENVIRONMENTS; COMMUNITIES; BUTTERFLIES; EXTINCTION	Background: In the past decade, accumulating evidence of pollinator decline has raised concerns regarding the functioning of terrestrial ecosystems and the sustainability of crop production. Although land-use changes have been advanced as the major causes, the affinities of most wild pollinators with the main land-use types remain unknown. Filling this gap in our knowledge is a prerequisite to improving conservation and management programmes. Methodology/Principal Findings: We estimated the affinity of flower visitors with urban, agricultural and natural land-uses using data from a country-wide scale monitoring scheme based on citizen science (Spipoll). We tested whether the affinities differed among insect orders and according to insect frequency (frequent or infrequent). Our results indicate that the affinities with the three land-use types differed among insect orders. Apart from Hymenopterans, which appeared tolerant to the different land-uses, all flower visitors presented a negative affinity with urban areas and a positive affinity with agricultural and natural areas. Additionally, infrequent taxa displayed a lower affinity with urban areas and a higher affinity with natural areas than did frequent taxa. Within frequent taxa, Hymenoptera and Coleoptera included specialists of the three land-use types whereas Diptera and Lepidoptera contained specialists of all but urban areas. Conclusions/Significance: Our approach allowed the first standardised evaluation of the affinity of flower visitors with the main land-use types across a broad taxonomical range and a wide geographic scope. Our results suggest that the most detrimental land-use change for flower visitor communities is urbanisation. Moreover, our findings highlight the fact that agricultural areas have the potential to host highly diverse pollinator communities. We suggest that policy makers should, therefore, focus on the implementation of pollinator-friendly practices in agricultural lands. This may be a win-win strategy, as both biodiversity and crop production may benefit from healthier communities of flower visitors in these areas.	[Deguines, Nicolas; Julliard, Romain; Fontaine, Colin] Museum Natl Hist Nat, MNHN CNRS UPMC, UMR CERSP 7204, F-75231 Paris, France; [de Flores, Mathieu] Off Insectes & Environm, Guyancourt, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Deguines, N (corresponding author), Museum Natl Hist Nat, MNHN CNRS UPMC, UMR CERSP 7204, F-75231 Paris, France.	deguines@mnhn.fr	Deguines, Nicolas/N-7818-2018; Fontaine, Colin/N-6469-2015	Deguines, Nicolas/0000-0001-6930-916X; Fontaine, Colin/0000-0001-5367-5675	l'Agence Nationale de la Recherche [ANR-09-RPDOC-020-01]	l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was funded by l'Agence Nationale de la Recherche (Grant number ANR-09-RPDOC-020-01; URL http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; [Anonymous], 2009, NATURE, V457, P8, DOI 10.1038/457008a; Barfod AS, 2011, ANN BOT-LONDON, V108, P1503, DOI 10.1093/aob/mcr192; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bellmann H., 1999, GUIDE ABEILLES BOURD; Bergerot B, 2011, LANDSCAPE ECOL, V26, P83, DOI 10.1007/s10980-010-9537-3; Bergerot B, 2010, LANDSCAPE URBAN PLAN, V96, P98, DOI 10.1016/j.landurbplan.2010.02.007; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bossard M, 2006, CORINE LAND COVER; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cane James H., 2005, P109; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Canty A., FUNCTIONS, V1; Carvalheiro LG, 2008, J APPL ECOL, V45, P1419, DOI 10.1111/j.1365-2664.2008.01518.x; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Crawley M.J., 2007, R BOOK; DALLWITZ MJ, 1980, TAXON, V29, P41, DOI 10.2307/1219595; Dallwitz MJ, 1999, USERS GUIDE DELTA ED; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Dias B, 1999, REC WORKSH CONS SUST, DOI DOI 10.1093/SYSBI0/33.1.69; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dupont YL, 2009, J ANIM ECOL, V78, P346, DOI 10.1111/j.1365-2656.2008.01501.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fattorini S, 2011, BIOL CONSERV, V144, P370, DOI 10.1016/j.biocon.2010.09.014; Ferreira LB, 2005, BIODIVERS CONSERV, V14, P1809, DOI 10.1007/s10531-004-0701-4; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Goujon P, 2010, SYSTEME IDENTIFICATI; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jonason D, 2011, J APPL ECOL, V48, P543, DOI 10.1111/j.1365-2664.2011.01989.x; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Mayer C., 2011, Journal of Pollination Ecology, V3, P8; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Mulieri PR, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.9101; National Research Council, 2007, STAT POLL N AM; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Palmieri A., 2011, LAND QUALITY LAND US, P59; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; SOeS, 2010, ENV FRANC ED 2010; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; UNEP/COP/CBD, 2011, 10 M C PART CONV BIO; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042	68	81	83	2	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45822	10.1371/journal.pone.0045822	http://dx.doi.org/10.1371/journal.pone.0045822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029262	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400134
J	Li, H; Liu, HY; Song, F; Shi, AM; Zhou, XG; Cai, WZ				Li, Hu; Liu, Haiyu; Song, Fan; Shi, Aimin; Zhou, Xuguo; Cai, Wanzhi			Comparative Mitogenomic Analysis of Damsel Bugs Representing Three Tribes in the Family Nabidae (Insecta: Hemiptera)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; TRANSFER-RNA GENES; A+T-RICH REGION; PHYLOGENETIC ANALYSIS; WEB SERVER; EVOLUTION; DNA; SEQUENCE; ORGANIZATION; LEPIDOPTERA	Background: Nabidae, a family of predatory heteropterans, includes two subfamilies and five tribes. We previously reported the complete mitogenome of Alloeorhynchus bakeri, a representative of the tribe Prostemmatini in the subfamily Prostemmatinae. To gain a better understanding of architecture and evolution of mitogenome in Nabidae, mitogenomes of five species representing two tribes (Gorpini and Nabini) in the subfamily Nabinae were sequenced, and a comparative mitogenomic analysis of three nabid tribes in two subfamilies was carried out. Methodology/Principal Findings: Nabid mitogenomes share a similar nucleotide composition and base bias, except for the control region, where differences are observed at the subfamily level. In addition, the pattern of codon usage is influenced by the GC content and consistent with the standard invertebrate mitochondrial genetic code and the preference for A+T-rich codons. The comparison among orthologous protein-coding genes shows that different genes have been subject to different rates of molecular evolution correlated with the GC content. The stems and anticodon loops of tRNAs are extremely conserved, and the nucleotide substitutions are largely restricted to T psi C and DHU loops and extra arms, with insertion-deletion polymorphisms. Comparative analysis shows similar rates of substitution between the two rRNAs. Long non-coding regions are observed in most Gorpini and Nabini mtDNAs in-between trnI-trnQ and/or trnS2-nad1. The lone exception, Nabis apicalis, however, has lost three tRNAs. Overall, phylogenetic analysis using mitogenomic data is consistent with phylogenies constructed mainly form morphological traits. Conclusions/Significance: This comparative mitogenomic analysis sheds light on the architecture and evolution of mitogenomes in the family Nabidae. Nucleotide diversity and mitogenomic traits are phylogenetically informative at subfamily level. Furthermore, inclusion of a broader range of samples representing various taxonomic levels is critical for the understanding of mitogenomic evolution in damsel bugs.	[Li, Hu; Liu, Haiyu; Song, Fan; Shi, Aimin; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; University of Kentucky	Cai, WZ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xuguozhou@uky.edu; caiwz@cau.edu.cn	SHI, AIMIN/L-7480-2019; li, hu/N-7159-2013	SHI, AIMIN/0000-0001-8275-3185; 	National Natural Science Foundation of China [30825006, 30970394, 31061160186, 31111140015]; Special Fund for Agroscientific Research in the Public Interest [201103012, 201103022]; Natural Science Foundation of Beijing [6112013]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; College of Agriculture, University of Kentucky	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agroscientific Research in the Public Interest; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; College of Agriculture, University of Kentucky	This research is supported by grants from the National Natural Science Foundation of China (Nos. 30825006, 30970394, 31061160186, 31111140015), the Special Fund for Agroscientific Research in the Public Interest (Nos. 201103012, 201103022), the Natural Science Foundation of Beijing (No. 6112013), the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105), and College of Agriculture, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Duenas JCR, 2006, GENOME, V49, P931, DOI 10.1139/G06-053; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hu J, 2010, MOL BIOL REP, V37, P3431, DOI 10.1007/s11033-009-9934-3; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATTIN JD, 1989, ANNU REV ENTOMOL, V34, P383, DOI 10.1146/annurev.en.34.010189.002123; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x; MORTON BR, 1993, J MOL EVOL, V37, P273, DOI 10.1007/BF00175504; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nokkala C, 2007, EUR J ENTOMOL, V104, P661, DOI 10.14411/eje.2007.083; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt TR, 2001, MOL BIOL EVOL, V18, P563, DOI 10.1093/oxfordjournals.molbev.a003836; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Schuh RT, 1995, TURE BUGS WORLD HEMI; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vila M, 2004, J MOL EVOL, V58, P280, DOI 10.1007/s00239-003-2550-2; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	53	58	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45925	10.1371/journal.pone.0045925	http://dx.doi.org/10.1371/journal.pone.0045925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029320	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900065
J	Patnaik, SK; Yendamuri, S; Kannisto, E; Kucharczuk, JC; Singhal, S; Vachani, A				Patnaik, Santosh K.; Yendamuri, Sai; Kannisto, Eric; Kucharczuk, John C.; Singhal, Sunil; Vachani, Anil			MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; PERIPHERAL-BLOOD; CIRCULATING MICRORNAS; MICROARRAY DATA; CANCER-PATIENTS; BIOMARKERS; SIGNATURES; SERUM; MIRNA; RNA	The association of lung cancer with changes in microRNAs in plasma shown in multiple studies suggests a utility for circulating microRNA biomarkers in non-invasive detection of the disease. We examined if presence of lung cancer is reflected in whole blood microRNA expression as well, possibly because of a systemic response. Locked nucleic acid microarrays were used to quantify the global expression of microRNAs in whole blood of 22 patients with lung adenocarcinoma and 23 controls, ten of whom had a radiographically detected non-cancerous lung nodule and the other 13 were at high risk for developing lung cancer because of a smoking history of >20 pack-years. Cases and controls differed significantly for age with a mean difference of 10.7 years, but not for gender, race, smoking history, blood hemoglobin, platelet count, or white blood cell count. Of 1282 quantified human microRNAs, 395 (31%) were identified as expressed in the study's subjects, with 96 (24%) differentially expressed between cases and controls. Classification analyses of microRNA expression data were performed using linear kernel support vector machines (SVM) and top-scoring pairs (TSP) methods, and classifiers to identify presence of lung adenocarcinoma were internally cross-validated. In leave-one-out cross-validation, the TSP classifiers had sensitivity and specificity of 91% and 100%, respectively. The values with SVM were both 91%. In a Monte Carlo cross-validation, average sensitivity and specificity values were 86% and 97%, respectively, with TSP, and 88% and 89%, respectively, with SVM. MicroRNAs miR-190b, miR-630, miR-942, and miR-1284 were the most frequent constituents of the classifiers generated during the analyses. These results suggest that whole blood microRNA expression profiles can be used to distinguish lung cancer cases from clinically relevant controls. Further studies are needed to validate this observation, including in non-adenocarcinomatous lung cancers, and to clarify upon the confounding effect of age.	[Vachani, Anil] Univ Penn, Abramson Res Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Patnaik, Santosh K.; Yendamuri, Sai; Kannisto, Eric] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Kucharczuk, John C.; Singhal, Sunil] Univ Penn, Div Thorac Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Roswell Park Cancer Institute; University of Pennsylvania	Vachani, A (corresponding author), Univ Penn, Abramson Res Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	avachani@mail.med.upenn.edu		Yendamuri, Sai/0000-0001-6654-3487	National Cancer Institute [1R21CA156087-01A1]; NCI [K07CA111952]; Thoracic Surgery Foundation for Research and Education; State University of New York at Buffalo; NATIONAL CANCER INSTITUTE [K07CA111952, R21CA156087, P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Thoracic Surgery Foundation for Research and Education; State University of New York at Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Cancer Institute research grant 1R21CA156087-01A1 and Career Development Award K07CA111952 from the NCI (http://www.nci.gov) to Anil Vachani, and a research award from the Thoracic Surgery Foundation for Research and Education (http://www.tsfre.org), and Buswell Fellowship award from the State University of New York at Buffalo to Sai Yendamuri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bauer AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034151; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dudoit S, 2003, INTERDISC STAT, P93; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Hamilton AJ, 2010, BIOCHEM SOC T, V38, P229, DOI 10.1042/BST0380229; Hammerle-Fickinger A, 2010, BIOTECHNOL LETT, V32, P35, DOI 10.1007/s10529-009-0130-2; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jeong HC, 2011, MOL MED REP, V4, P383, DOI 10.3892/mmr.2011.430; Kagedal B, 2005, CLIN CHEM LAB MED, V43, P1190, DOI 10.1515/CCLM.2005.206; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Leek JT, 2009, BIOINFORMATICS, V25, P1203, DOI 10.1093/bioinformatics/btp126; Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Maertzdorf J, 2012, P NATL ACAD SCI US; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morandi E, 2009, RADIAT RES, V172, P500, DOI 10.1667/RR1545.1; Muller MC, 2002, LEUKEMIA, V16, P2395, DOI 10.1038/sj.leu.2402734; Orlova IA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-195; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; Patnaik SK, 2010, ANAL BIOCHEM, V407, P147, DOI 10.1016/j.ab.2010.08.004; Pirker Robert, 2003, Clin Lung Cancer, V5, P90, DOI 10.3816/CLC.2003.n.022; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Rykova EY, 2006, ANN NY ACAD SCI, V1075, P328, DOI 10.1196/annals.1368.044; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; SHOENFELD Y, 1986, J CANCER RES CLIN, V111, P54, DOI 10.1007/BF00402777; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tomita M, 2010, ANTICANCER RES, V30, P3099; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	71	83	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46045	10.1371/journal.pone.0046045	http://dx.doi.org/10.1371/journal.pone.0046045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029380	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900079
J	Okamoto, Y; Vricella, LA; Moss, WJ; Griffin, DE				Okamoto, Yukari; Vricella, Luca A.; Moss, William J.; Griffin, Diane E.			Immature CD4(+)CD8(+) Thymocytes Are Preferentially Infected by Measles Virus in Human Thymic Organ Cultures	PLOS ONE			English	Article							LYMPHOCYTIC ACTIVATION MOLECULE; WILD-TYPE MEASLES; BLOOD MONONUCLEAR-CELLS; LYMPHOID-TISSUES; CELLULAR RECEPTOR; GAMMA-INTERFERON; DENDRITIC CELLS; TERMINAL DIFFERENTIATION; IMMUNE-RESPONSES; EPITHELIAL-CELLS	Cells of the human immune system are important target cells for measles virus (MeV) infection and infection of these cells may contribute to the immunologic abnormalities and immune suppression that characterize measles. The thymus is the site for production of naive T lymphocytes and is infected during measles. To determine which populations of thymocytes are susceptible to MeV infection and whether strains of MeV differ in their ability to infect thymocytes, we used ex vivo human thymus organ cultures to assess the relative susceptibility of different subpopulations of thymocytes to infection with wild type and vaccine strains of MeV. Thymocytes were susceptible to MeV infection with the most replication in immature CD4(+)CD8(+) double positive cells. Susceptibility correlated with the level of expression of the MeV receptor CD150. Wild type strains of MeV infected thymocytes more efficiently than the Edmonston vaccine strain. Thymus cultures from children >= 3 years of age were less susceptible to MeV infection than cultures from children 5 to 15 months of age. Resistance in one 7 year-old child was associated with production of interferon-gamma suggesting that vaccination may result in MeV-specific memory T cells in the thymus. We conclude that immature thymocytes are susceptible to MeV infection and thymocyte infection may contribute to the immunologic abnormalities associated with measles.	[Okamoto, Yukari; Moss, William J.; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Vricella, Luca A.] Johns Hopkins Univ, Sch Med, Dept Cardiac Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Griffin, DE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.	dgriffin@jhsph.edu			National Institutes of Health [R01 AI23047]; Bill and Melinda Gates Foundation [RG3522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health R01 AI23047; The Bill and Melinda Gates Foundation RG3522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akramuzzaman SM, 2000, AM J EPIDEMIOL, V151, P723, DOI 10.1093/oxfordjournals.aje.a010267; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; Auwaerter PG, 1999, J INFECT DIS, V180, P950, DOI 10.1086/314993; Auwaerter PG, 1996, J VIROL, V70, P3734, DOI 10.1128/JVI.70.6.3734-3740.1996; Aversa G, 1997, J IMMUNOL, V158, P4036; Bartz R, 1998, J GEN VIROL, V79, P1015, DOI 10.1099/0022-1317-79-5-1015; BECKFORD AP, 1985, S AFR MED J, V68, P858; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Condack C, 2007, J INFECT DIS, V196, P541, DOI 10.1086/519689; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; FINKE D, 1995, J VIROL, V69, P5469, DOI 10.1128/JVI.69.9.5469-5474.1995; Gagneur A, 2008, CLIN VACCINE IMMUNOL, V15, P1845, DOI 10.1128/CVI.00229-08; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Hahm B, 2003, J VIROL, V77, P3505, DOI 10.1128/JVI.77.6.3505-3515.2003; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; ILONEN J, 1988, J GEN VIROL, V69, P247, DOI 10.1099/0022-1317-69-1-247; JOHNSON RT, 1984, NEW ENGL J MED, V310, P137, DOI 10.1056/NEJM198401193100301; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Kruse M, 2001, J IMMUNOL, V167, P1989, DOI 10.4049/jimmunol.167.4.1989; LEOPARDI R, 1992, APMIS, V100, P125, DOI 10.1111/j.1699-0463.1992.tb00850.x; LISZEWSKI MK, 1992, CURR TOP MICROBIOL, V178, P45; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; McQuaid S, 2002, LAB INVEST, V82, P403, DOI 10.1038/labinvest.3780434; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; Mrkic B, 2000, J VIROL, V74, P1364, DOI 10.1128/JVI.74.3.1364-1372.2000; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; NOZAWA Y, 1994, PATHOL INT, V44, P442, DOI 10.1111/j.1440-1827.1994.tb01708.x; Obojes K, 2005, J VIROL, V79, P7768, DOI 10.1128/JVI.79.12.7768-7776.2005; Ohgimoto K, 2007, VIRUS RES, V123, P1, DOI 10.1016/j.virusres.2006.07.006; Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002; Permar SR, 2003, J VIROL, V77, P7872, DOI 10.1128/JVI.77.14.7872-7879.2003; Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Ryon JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P994, DOI 10.1128/CDLI.9.5.994-1003.2002; SAKAGUCHI M, 1986, MICROBIOL IMMUNOL, V30, P1067, DOI 10.1111/j.1348-0421.1986.tb03036.x; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; SMARON MF, 1991, J VIROL METHODS, V33, P223, DOI 10.1016/0166-0934(91)90022-R; Sprent J, 2009, IMMUNOL CELL BIOL, V87, P46, DOI 10.1038/icb.2008.88; STARR S, 1964, NEW ENGL J MED, V270, P386, DOI 10.1056/NEJM196402202700802; Takeuchi K, 2005, J VIROL, V79, P7838, DOI 10.1128/JVI.79.12.7838-7844.2005; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Valentin H, 1999, J VIROL, V73, P2212, DOI 10.1128/JVI.73.3.2212-2221.1999; Vidalain PO, 2002, J VIROL, V76, P6415, DOI 10.1128/JVI.76.13.6415-6424.2002; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; WARD BJ, 1991, CLIN IMMUNOL IMMUNOP, V61, P236, DOI 10.1016/S0090-1229(05)80027-3; Watanabe A, 2010, J VIROL, V84, P4183, DOI 10.1128/JVI.02168-09; Welstead GG, 2005, P NATL ACAD SCI USA, V102, P16415, DOI 10.1073/pnas.0505945102; WHITE RG, 1973, CLIN EXP IMMUNOL, V13, P343; YAMANOUC.K, 1973, J INFECT DIS, V128, P795, DOI 10.1093/infdis/128.6.795	64	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45999	10.1371/journal.pone.0045999	http://dx.doi.org/10.1371/journal.pone.0045999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029357	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700103
J	Kateete, DP; Katabazi, FA; Okeng, A; Okee, M; Musinguzi, C; Asiimwe, BB; Kyobe, S; Asiimwe, J; Boom, WH; Joloba, ML				Kateete, David Patrick; Katabazi, Fred Ashaba; Okeng, Alfred; Okee, Moses; Musinguzi, Conrad; Asiimwe, Benon Byamugisha; Kyobe, Samuel; Asiimwe, Jeniffer; Boom, W. Henry; Joloba, Moses Lutaakome			Rhomboids of Mycobacteria: Characterization Using an aarA Mutant of Providencia stuartii and Gene Deletion in Mycobacterium smegmatis	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; FAMILY; IDENTIFICATION; MECHANISM; PROTEINS; GENOME; BCG	Background: Rhomboids are ubiquitous proteins with unknown roles in mycobacteria. However, bioinformatics suggested putative roles in DNA replication pathways and metabolite transport. Here, mycobacterial rhomboid-encoding genes were characterized; first, using the Providencia stuartii null-rhomboid mutant and then deleted from Mycobacterium smegmatis for additional insight in mycobacteria. Methodology/Principal Findings: Using in silico analysis we identified in M. tuberculosis genome the genes encoding two putative rhomboid proteins; Rv0110 (referred to as "rhomboid protease 1") and Rv1337 ("rhomboid protease 2"). Genes encoding orthologs of these proteins are widely represented in all mycobacterial species. When transformed into P. stuartii null-rhomboid mutant (Delta aarA), genes encoding mycobacterial orthologs of "rhomboid protease 2" fully restored AarA activity (AarA is the rhomboid protein of P. stuartii). However, most genes encoding mycobacterial "rhomboid protease 1" orthologs did not. Furthermore, upon gene deletion in M. smegmatis, the Delta MSMEG_4904 single mutant (which lost the gene encoding MSMEG_4904, orthologous to Rv1337, "rhomboid protease 2") formed the least biofilms and was also more susceptible to ciprofloxacin and novobiocin, antimicrobials that inhibit DNA gyrase. However, the Delta MSMEG_5036 single mutant (which lost the gene encoding MSMEG_5036, orthologous to Rv0110, "rhomboid protease 1") was not as susceptible. Surprisingly, the double rhomboid mutant Delta MSMEG_4904-Delta MSMEG_5036 (which lost genes encoding both homologs) was also not as susceptible suggesting compensatory effects following deletion of both rhomboid-encoding genes. Indeed, transforming the double mutant with a plasmid encoding MSMEG_5036 produced phenotypes of the Delta MSMEG_4904 single mutant (i.e. susceptibility to ciprofloxacin and novobiocin). Conclusions/Significance: Mycobacterial rhomboid-encoding genes exhibit differences in complementing aarA whereby it's only genes encoding "rhomboid protease 2" orthologs that fully restore AarA activity. Additionally, gene deletion data suggests inhibition of DNA gyrase by MSMEG_4904; however, the ameliorated effect in the double mutant suggests occurrence of compensatory mechanisms following deletion of genes encoding both rhomboids.	[Kateete, David Patrick; Katabazi, Fred Ashaba; Okeng, Alfred; Okee, Moses; Musinguzi, Conrad; Asiimwe, Benon Byamugisha; Kyobe, Samuel; Asiimwe, Jeniffer; Joloba, Moses Lutaakome] Makerere Univ, Coll Hlth Sci MakCHS, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Asiimwe, Jeniffer] Makerere Univ, Coll Vet Med Anim Resources & Biosecur CoVAB, Kampala, Uganda; [Boom, W. Henry; Joloba, Moses Lutaakome] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Makerere University; Makerere University; Case Western Reserve University	Joloba, ML (corresponding author), Makerere Univ, Coll Hlth Sci MakCHS, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.	mlj10@case.edu	Kateete, David Patrick/HCH-5603-2022	Joloba, Moses/0000-0002-0334-9983; Kateete, David Patrick/0000-0001-8075-3069	National Institutes of Health [R03 AI062849, R01 AI075637]; Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases; United States National Institutes of Health and Human Services [NO1-AI-95383, HHSN266200700022C/NO1-AI-70022]; Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala [U2RTW006879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI062849, R01AI075637, N01AI095383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by the National Institutes of Health (Grants # R03 AI062849 and R01 AI075637); the Tuberculosis Research Unit (TBRU), established with Federal funds from the United States National Institutes of Allergy and Infectious Diseases and the United States National Institutes of Health and Human Services, under Contract Nos. NO1-AI-95383 and HHSN266200700022C/NO1-AI-70022; and with training support to DPK from the Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala (award # U2RTW006879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bischoff E, 2000, MOL MICROBIOL, V35, P1005, DOI 10.1046/j.1365-2958.2000.01788.x; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Clemmer KM, 2006, J BACTERIOL, V188, P3415, DOI 10.1128/JB.188.9.3415-3419.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cook GM, 2009, ADV MICROB PHYSL, V55, P318; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Garcia MJ, 2008, BIOINFORMATICS TROPI; Harth G, 2005, MOL MICROBIOL, V58, P1157, DOI 10.1111/j.1365-2958.2005.04899.x; Hill RB, 2010, SEMIN CELL DEV BIOL, V21, P582, DOI 10.1016/j.semcdb.2009.12.011; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Kana BD, 2004, TUBERCULOSIS, V84, P63, DOI 10.1016/j.tube.2003.08.006; Kateete DP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-272; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Okuni JB, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-99; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Sambrook J., 2001, MOL CLONING LAB MANU; Sander P, 2001, Methods Mol Med, V54, P93, DOI 10.1385/1-59259-147-7:093; Song HH, 2007, GENE, V399, P112, DOI 10.1016/j.gene.2007.05.005; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Stephan J, 2004, GENE, V343, P181, DOI 10.1016/j.gene.2004.08.028; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45741	10.1371/journal.pone.0045741	http://dx.doi.org/10.1371/journal.pone.0045741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029216	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800089
J	Sniegula, S; Nilsson-Ortman, V; Johansson, F				Sniegula, Szymon; Nilsson-Ortman, Viktor; Johansson, Frank			Growth Pattern Responses to Photoperiod across Latitudes in a Northern Damselfly	PLOS ONE			English	Article							LIFE-HISTORY PLASTICITY; BODY-SIZE; TIME CONSTRAINTS; EVOLUTIONARY SIGNIFICANCE; SEASONAL ENVIRONMENT; DEVELOPMENTAL RATE; SPERM COMPETITION; REACTION NORMS; CLIMATE-CHANGE; TEMPERATURE	Background: Latitudinal clines in temperature and seasonality impose strong seasonal constraints on ectotherms. Studies of population differentiation in phenotypic plasticity of life history traits along latitudinal gradients are important for understanding how organisms have adapted to seasonal environments and predict how they respond to climate changes. Such studies have been scarce for species with a northern distribution. Methodology/Principle Finding: Larvae of the northern damselfly Coenagrion johanssoni originating from semivoltine central, partivoltine northern, and partivoltine northernmost Swedish populations were reared in the laboratory. To investigate whether larvae use photoperiodic cues to induce compensatory growth along this latitudinal gradient, larvae were reared under two different photoperiods corresponding to a northern and southern latitude. In addition, field adult size was assessed to test the strength of possible compensatory growth mechanisms under natural conditions and hatchling size was measured to test for maternal effects. We hypothesized that populations originating from lower latitudes would be more time constrained than high-latitude populations because they have a shorter life cycle. The results showed that low-latitude populations had higher growth rates in summer/fall. In general northern photoperiods induced higher growth rates, but this plastic response to photoperiod was strongest in the southernmost populations and negligible in the northernmost population. During spring, central populations grew faster under the southern rather than the northern photoperiod. On the other hand, northern and northernmost populations did not differ between each other and grew faster in the northern rather than in the southern photoperiod. Field sampled adults did not differ in size across the studied regions. Conclusion/Significance: We found a significant differentiation in growth rate across latitudes and latitudinal difference in growth rate response to photoperiod. Importantly, growth responses measured at a single larval developmental stage in one season may not always generalize to other developmental stages or seasons.	[Sniegula, Szymon] Polish Acad Sci, Inst Nat Conservat, Dept Ecosyst Conservat, Krakow, Poland; [Nilsson-Ortman, Viktor; Johansson, Frank] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Johansson, Frank] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Polish Academy of Sciences; Umea University; Uppsala University	Sniegula, S (corresponding author), Polish Acad Sci, Inst Nat Conservat, Dept Ecosyst Conservat, Krakow, Poland.	szymon.sniegula@gmail.com	Sniegula, Szymon/E-9588-2015; /AAG-2132-2019	Sniegula, Szymon/0000-0003-1459-3751; /0000-0003-1459-3751	Polish State Committee for Scientific Research grant [N N304 294237]; Swedish Research Council; Swedish Research Council FORMAS	Polish State Committee for Scientific Research grant(Polish State Committee for Scientific Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	We wish to thank Maria Golab for her great help with the laboratory work and Elzbieta Sniegula for her help in the field collection. We are very grateful to Prof. Gordon Pritchard and Kamila Zloty and two anonymous reviewers for helpful comments on the earlier version of the manuscript. SS is funded by a Polish State Committee for Scientific Research grant (Project No. N N304 294237).; Funding was provided by the Polish State Committee for Scientific Research grant (Project No. N N304 294237), Swedish Research Council, and Swedish Research Council FORMAS. SS is funded by a Polish State Committee for Scientific Research grant (Project No. N N304 294237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Addo-Bediako A, 2002, FUNCT ECOL, V16, P332, DOI 10.1046/j.1365-2435.2002.00634.x; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; CANNINGS SG, 1997, INSECTS YUKON, P169; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Cooper G, 1996, P ROY SOC B-BIOL SCI, V263, P1343, DOI 10.1098/rspb.1996.0197; Corbet P.S., 1972, Acta Arctica, V18, P1; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2003, Journal of the Entomological Society of British Columbia, V100, P3; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; CORBET PS, 1969, SCIENCE, V166, P865, DOI 10.1126/science.166.3907.865; Danks HV, 1987, INSECT DORMANCY ECOL; De Block M, 2003, J EVOLUTION BIOL, V16, P986, DOI 10.1046/j.1420-9101.2003.00581.x; De Block M, 2008, ECOGRAPHY, V31, P115, DOI 10.1111/j.2007.0906-7590.05313.x; Dijkstra K.-D.B., 2006, FIELD GUIDE DRAGONFL; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; FINCKE OM, 1984, BEHAV ECOL SOCIOBIOL, V14, P235, DOI 10.1007/BF00299623; Fox J., 2019, R COMPANION APPL REG, V.; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gotthard K, 2001, EXPTL BIOL REV, P287; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Johansson F., 1994, Odonatologica, V23, P355; Johansson F, 1999, ECOLOGY, V80, P1242, DOI 10.2307/177071; Johansson F, 2010, ODONATOLOGICA, V39, P97; Johansson F, 2001, ECOLOGY, V82, P1857, DOI 10.1890/0012-9658(2001)082[1857:LHPIAD]2.0.CO;2; Kidokoro T, 1978, JPN J ECOL, V29, P291; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Lowe CD, 2009, ECOLOGY, V90, P2202, DOI 10.1890/08-1780.1; LUTZ PE, 1964, BIOL BULL, V127, P304, DOI 10.2307/1539228; Nicieza A, 2009, OECOLOGIA, V159, P27, DOI 10.1007/s00442-008-1194-8; Nilsson-Ortman V, 2012, ECOLOGY, V93, P1340; Norling U., 1984, Advances in Odonatology, V2, P127; NORLING U, 1984, Odonatologica, V13, P429; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pritchard G, 1996, BIOL J LINN SOC, V58, P221, DOI 10.1111/j.1095-8312.1996.tb01432.x; Pritchard G., 1982, Advances in Odonatology, V1, P227; PROCTER DLC, 1973, CAN J ZOOL, V51, P1165, DOI 10.1139/z73-169; R Development Core Team, 2008, R LANG ENG STAT COMP; Ragland GJ, 2007, J EVOLUTION BIOL, V20, P2144, DOI 10.1111/j.1420-9101.2007.01428.x; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Roff Derek, 2002, pi; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Shama LNS, 2011, MOL ECOL, V20, P2929, DOI 10.1111/j.1365-294X.2011.05156.x; Sniegula S, 2012, OIKOS, V121, P1073, DOI 10.1111/j.1600-0706.2011.20015.x; Sniegula S, 2010, ECOL ENTOMOL, V35, P149, DOI 10.1111/j.1365-2311.2009.01164.x; Sokolovska N, 2000, ECOL ENTOMOL, V25, P239, DOI 10.1046/j.1365-2311.2000.00251.x; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Stoks R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016935; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Thompson DJ, 2011, ECOL LETT, V14, P905, DOI 10.1111/j.1461-0248.2011.01655.x; Thompson DJ, 2002, ECOL ENTOMOL, V27, P378, DOI 10.1046/j.1365-2311.2002.00419.x; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Van Doorslaer W, 2005, OIKOS, V111, P599, DOI 10.1111/j.1600-0706.2005.14335.x; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	65	25	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46024	10.1371/journal.pone.0046024	http://dx.doi.org/10.1371/journal.pone.0046024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029371	Green Published, gold			2022-12-27	WOS:000309392800131
J	Correa, RFT; Ardisson-Araujo, DMP; Monnerat, RG; Ribeiro, BM				Teixeira Correa, Roberto Franco; Pereira Ardisson-Araujo, Daniel Mendes; Monnerat, Rose Gomes; Ribeiro, Bergmann Morais			Cytotoxicity Analysis of Three Bacillus thuringiensis Subsp israelensis delta-Endotoxins towards Insect and Mammalian Cells	PLOS ONE			English	Article							MOSQUITO-LARVICIDAL ACTIVITY; CRYSTAL PROTEINS; CYTOLYTIC TOXIN; GENE; TOXICITY; CRY11A; IDENTIFICATION; ESTABLISHMENT; ORGANIZATION; PARASPORIN	Three members of the delta-endotoxin group of toxins expressed by Bacillus thuringiensis subsp. israelensis, Cyt2Ba, Cry4Aa and Cry11A, were individually expressed in recombinant acrystalliferous B. thuringiensis strains for in vitro evaluation of their toxic activities against insect and mammalian cell lines. Both Cry4Aa and Cry11A toxins, activated with either trypsin or Spodoptera frugiperda gastric juice (GJ), resulted in different cleavage patterns for the activated toxins as seen by SDS-PAGE. The GJ-processed proteins were not cytotoxic to insect cell cultures. On the other hand, the combination of the trypsinactivated Cry4Aa and Cry11A toxins yielded the highest levels of cytotoxicity to all insect cells tested. The combination of activated Cyt2Ba and Cry11A also showed higher toxic activity than that of toxins activated individually. When activated Cry4Aa, Cry11A and Cyt2Ba were used simultaneously in the same assay a decrease in toxic activity was observed in all insect cells tested. No toxic effect was observed for the trypsin-activated Cry toxins in mammalian cells, but activated Cyt2Ba was toxic to human breast cancer cells (MCF-7) when tested at 20 mu g/mL.	[Teixeira Correa, Roberto Franco; Pereira Ardisson-Araujo, Daniel Mendes; Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Monnerat, Rose Gomes] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ribeiro, BM (corresponding author), Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil.	bergmann@unb.br	Ribeiro, Bergmann Morais/C-7114-2015; Ardisson-Araújo, Daniel Mendes Pereira/AAM-6320-2020	Ribeiro, Bergmann Morais/0000-0002-1061-196X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Fundacao de Apoio a Pesquisa do Distrito	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (www.cnpq.br) and Fundacao de Apoio a Pesquisa do Distrito Federal-FAPDF (www.fap.df.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSUTHANASOMBAT C, 1992, FEMS MICROBIOL LETT, V94, P63, DOI 10.1111/j.1574-6968.1992.tb05290.x; Angsuthanasombat C, 2004, J BIOCHEM MOL BIOL, V37, P304; BENDOV E, 1995, J BACTERIOL, V177, P2851, DOI 10.1128/jb.177.10.2851-2857.1995; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Bravo A, 2001, METODOLOGIAS UTILIZA; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Butko P, 2003, APPL ENVIRON MICROB, V69, P2415, DOI 10.1128/AEM.69.5.2415-2422.2003; Carmona D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019952; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Cheong HS, 1997, APPL ENVIRON MICROB, V63, P3254, DOI 10.1128/AEM.63.8.3254-3260.1997; CHILCOTT CN, 1988, J GEN MICROBIOL, V134, P2551; CHRISTELLER JT, 1990, INSECT BIOCHEM, V20, P157, DOI 10.1016/0020-1790(90)90008-I; COOK RJ, 1993, ANNU REV PHYTOPATHOL, V31, P53, DOI 10.1146/annurev.py.31.090193.000413; Crickmore N, 2006, J APPL MICROBIOL, V101, P616, DOI 10.1111/j.1365-2672.2006.02936.x; CRICKMORE N, 1990, BIOCHEM J, V270, P133, DOI 10.1042/bj2700133; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Estruch JJ, 1997, NAT BIOTECHNOL, V15, P137, DOI 10.1038/nbt0297-137; Finney D.J., 1971, PROBIT ANAL; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Gringorten JL, 1999, IN VITRO CELL DEV-AN, V35, P299, DOI 10.1007/s11626-999-0075-8; Guerchicoff A, 1997, APPL ENVIRON MICROB, V63, P2716, DOI 10.1128/AEM.63.7.2716-2721.1997; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hughes PA, 2005, J INVERTEBR PATHOL, V88, P34, DOI 10.1016/j.jip.2004.10.004; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KNOWLES BH, 1992, P ROY SOC B-BIOL SCI, V248, P1, DOI 10.1098/rspb.1992.0035; Li J, 1996, J MOL BIOL, V257, P129, DOI 10.1006/jmbi.1996.0152; MCCLINTOCK JT, 1986, J VIROL, V57, P197, DOI 10.1128/JVI.57.1.197-204.1986; Mizuki E, 1999, J APPL MICROBIOL, V86, P477, DOI 10.1046/j.1365-2672.1999.00692.x; Mizuki E, 2000, CLIN DIAGN LAB IMMUN, V7, P625, DOI 10.1128/CDLI.7.4.625-634.2000; Moreira Beltrao HDB, 2007, FEMS MICROBIOL LETT, V266, P163, DOI 10.1111/j.1574-6968.2006.00527.x; Ohba M, 2009, ANTICANCER RES, V29, P427; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; PONCET S, 1995, J INVERTEBR PATHOL, V66, P131, DOI 10.1006/jipa.1995.1075; Pootanakit K, 2003, J BIOCHEM MOL BIOL, V36, P508; Promdonkoy B, 2003, CURR MICROBIOL, V46, P94, DOI 10.1007/s00284-002-3823-5; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sauka DH, 2007, J INVERTEBR PATHOL, V94, P125, DOI 10.1016/j.jip.2006.09.002; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; THOMAS WE, 1983, J CELL SCI, V60, P181; Uawithya P, 1998, BIOCHEM MOL BIOL INT, V44, P825; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Vilchez S, 2004, APPL ENVIRON MICROB, V70, P6587, DOI 10.1128/AEM.70.11.6587-6594.2004; WARD ES, 1987, NUCLEIC ACIDS RES, V15, P7195, DOI 10.1093/nar/15.17.7195; WHO, 1996, WORLD HLTH REP 1996, P46; Wirth MC, 1997, P NATL ACAD SCI USA, V94, P10536, DOI 10.1073/pnas.94.20.10536; Wirth MC, 2005, APPL ENVIRON MICROB, V71, P185, DOI 10.1128/AEM.71.1.185-189.2005; Xu Y, 2001, APPL ENVIRON MICROB, V67, P3010, DOI 10.1128/AEM.67.7.3010-3015.2001; Yamagiwa M, 2004, BIOSCI BIOTECH BIOCH, V68, P523, DOI 10.1271/bbb.68.523; Yousten A A, 1984, Adv Biotechnol Processes, V3, P315	56	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46121	10.1371/journal.pone.0046121	http://dx.doi.org/10.1371/journal.pone.0046121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029407	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800134
J	Weng, MZ; Zhang, Y; Zhou, D; Yang, Y; Tang, ZH; Zhao, MN; Quan, ZW; Gong, W				Weng, Mingzhe; Zhang, Yong; Zhou, Di; Yang, Yong; Tang, Zhaohui; Zhao, Mingning; Quan, Zhiwei; Gong, Wei			Radiofrequency Ablation versus Resection for Colorectal Cancer Liver Metastases: A Meta-Analysis	PLOS ONE			English	Article							LONG-TERM SURVIVAL; HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; INJECTION THERAPY; RANDOMIZED-TRIAL; NATURAL-HISTORY; RECURRENCE; OUTCOMES; TUMORS; HEPATECTOMY	Background: No randomized controlled trial (RCT) has yet been performed to provide the evidence to clarify the therapeutic debate on liver resection (LR) and radiofrequency ablation (RFA) in treating colorectal liver metastases (CLM). The meta-analysis was performed to summarize the evidence mostly from retrospective clinical trials and to investigate the effect of LR and RFA. Methodology/Principal Findings: Systematic literature search of clinical studies was carried out to compare RFA and LR for CLM in Pubmed, Embase and the Cochrane Library Central databases. The meta-analysis was performed using risk ratio (RR) and random effect model, in which 95% confidence intervals (95% CI) for RR were calculated. Primary outcomes were the overall survival (OS) and disease-free survival (DFS) at 3 and 5 years plus mortality and morbidity. 1 prospective study and 12 retrospective studies were finally eligible for meta-analysis. LR was significantly superior to RFA in 3-year OS (RR 1.377, 95% CI: 1.246-1.522); 5-year OS (RR: 1.474, 95% CI: 1.284-1.692); 3-year DFS (RR 1.735, 95% CI: 1.483-2.029) and 5-year DFS (RR 2.227, 95% CI: 1.823-2.720). The postoperative morbidity was higher in LR (RR: 2.495, 95% CI: 1.881-3.308), but no significant difference was found in mortality between LR and RFA. The data from the 3 subgroups (tumor<3 cm; solitary tumor; open surgery or laparoscopic approach) showed significantly better OS and DFS in patients who received surgical resection. Conclusions/Significances: Although multiple confounders exist in the clinical trials especially the bias in patient selection, LR was significantly superior to RFA in the treatment of CLM, even when conditions limited to tumor<3 cm, solitary tumor and open surgery or laparoscopic (lap) approach. Therefore, caution should be taken when treating CLM with RFA before more supportive evidences for RFA from RCTs are obtained.	[Weng, Mingzhe; Zhang, Yong; Zhou, Di; Yang, Yong; Tang, Zhaohui; Zhao, Mingning; Quan, Zhiwei; Gong, Wei] Shanghai Jiao Tong Univ, Dept Gen Surg, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Quan, ZW (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	zhiwquan@yahoo.com.cn; gongweius@hotmail.com		Weng, Mingzhe/0000-0002-4856-7925; Gong, Wei/0000-0002-9949-6207	China Natural Science Project [30972919]; Shanghai Scientific Bureau International Cooperation Project [10410700100]; Shanghai Municipal Health Bureau funding [2009064]	China Natural Science Project; Shanghai Scientific Bureau International Cooperation Project; Shanghai Municipal Health Bureau funding	Funding agencies: China Natural Science Project to ZWQ (30972919); Shanghai Scientific Bureau International Cooperation Project to WG (10410700100); and Shanghai Municipal Health Bureau funding to WG (2009064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2006, ANN SURG ONCOL, V13, P1271, DOI 10.1245/s10434-006-9045-5; Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; American Cancer Society, 2002, CANC FACTS FIG; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENGTSSON G, 1981, AM J SURG, V141, P586, DOI 10.1016/0002-9610(81)90057-X; Berber E, 2004, SURG ENDOSC, V18, P390, DOI 10.1007/s00464-003-8911-5; Berber E, 2008, J GASTROINTEST SURG, V12, P1967, DOI 10.1007/s11605-008-0622-8; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Danila M, 2009, J GASTROINTEST LIVER, V18, P317; Elias D, 2004, HEPATO-GASTROENTEROL, V51, P1788; Elias D, 2002, BRIT J SURG, V89, P752, DOI 10.1046/j.1365-2168.2002.02081.x; Evrard S, 2004, EJSO, V30, P399, DOI 10.1016/j.ejso.2004.01.019; Gillams AR, 2005, ABDOM IMAGING, V30, P419, DOI 10.1007/s00261-004-0256-6; Gleisner AL, 2008, ARCH SURG-CHICAGO, V143, P1204, DOI 10.1001/archsurg.143.12.1204; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Hildebrand P, 2006, EJSO, V32, P430, DOI 10.1016/j.ejso.2006.01.006; Huo TI, 2006, J CLIN GASTROENTEROL, V40, P639, DOI 10.1097/00004836-200608000-00017; Hur H, 2009, AM J SURG, V197, P728, DOI 10.1016/j.amjsurg.2008.04.013; Kannerup Anne-Sofie, 2008, Ugeskr Laeger, V170, P1338; Kawamoto C, 2005, CANCER-AM CANCER SOC, V103, P985, DOI 10.1002/cncr.20880; Kim KH, 2011, J KOREAN SURG SOC, V81, P25, DOI 10.4174/jkss.2011.81.1.25; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Leblanc F, 2008, EJSO-EUR J SURG ONC, V34, P185, DOI 10.1016/j.ejso.2007.09.028; Lee KH, 2011, KOREAN J GASTROENTER, V59, P218; Lee WS, 2008, J CLIN GASTROENTEROL, V42, P945, DOI 10.1097/MCG.0b013e318064e752; Lencioni Riccardo, 2004, Liver Transpl, V10, pS91, DOI 10.1002/lt.20043; Livraghi T, 2003, CANCER, V97, P3027, DOI 10.1002/cncr.11426; Lu Ming-de, 2006, Zhonghua Yi Xue Za Zhi, V86, P801; McKay A, 2009, HPB SURG, P1; Mulier S, 2005, ANN SURG, V242, P158, DOI 10.1097/01.sla.0000171032.99149.fe; Mulier S, 2008, ANN SURG ONCOL, V15, P144, DOI 10.1245/s10434-007-9478-5; Mulier S, 2008, DIGEST SURG, V25, P445, DOI 10.1159/000184736; Oshowo A, 2003, BRIT J SURG, V90, P1240, DOI 10.1002/bjs.4264; Otto G, 2010, ANN SURG, V251, P796, DOI 10.1097/SLA.0b013e3181bc9fae; PELLETIER G, 1990, J HEPATOL, V11, P181, DOI 10.1016/0168-8278(90)90110-D; Reuter NP, 2009, J GASTROINTEST SURG, V13, P486, DOI 10.1007/s11605-008-0727-0; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; Shibata T, 2002, RADIOLOGY, V223, P331, DOI 10.1148/radiol.2232010775; SILEN W, 1989, ARCH SURG-CHICAGO, V124, P1021; Solbiati L, 2001, RADIOLOGY, V221, P625; Sorensen SM, 2007, ACTA RADIOL, V48, P253, DOI 10.1080/02841850601161539; Vauthey JN, 2004, ANN SURG, V239, P722, DOI 10.1097/01.sla.0000124385.83887.d5; WAGNER JS, 1984, ANN SURG, V199, P502, DOI 10.1097/00000658-198405000-00002; White RR, 2007, J GASTROINTEST SURG, V11, P256, DOI 10.1007/s11605-007-0100-8; Wood TF, 2000, ANN SURG ONCOL, V7, P593, DOI 10.1007/BF02725339; Wu YZ, 2011, WORLD J GASTROENTERO, V17, P4143, DOI 10.3748/wjg.v17.i36.4143; Zhou XD, 1998, SEMIN SURG ONCOL, V14, P171, DOI 10.1002/(SICI)1098-2388(199803)14:2<171::AID-SSU9>3.0.CO;2-2	48	58	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45493	10.1371/journal.pone.0045493	http://dx.doi.org/10.1371/journal.pone.0045493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029051	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800054
J	Chan, WP; Yuan, HW; Huang, CY; Wang, CH; Lin, SD; Lo, YC; Huang, BW; Hatch, KA; Shiu, HJ; You, CF; Chang, YM; Shen, SF				Chan, Wei-Ping; Yuan, Hsiao-Wei; Huang, Cho-Ying; Wang, Chung-Ho; Lin, Shou-De; Lo, Yi-Chen; Huang, Bo-Wen; Hatch, Kent A.; Shiu, Hau-Jie; You, Cheng-Feng; Chang, Yuan-Mou; Shen, Sheng-Feng			Regional Scale High Resolution delta O-18 Prediction in Precipitation Using MODIS EVI	PLOS ONE			English	Article							CIRCULATION MODEL; STABLE-ISOTOPES; OXYGEN ISOTOPES; HYDROGEN; WATER; CYCLE	The natural variation in stable water isotope ratio data, also known as water isoscape, is a spatiotemporal fingerprint and a powerful natural tracer that has been widely applied in disciplines as diverse as hydrology, paleoclimatology, ecology and forensic investigation. Although much effort has been devoted to developing a predictive water isoscape model, it remains a central challenge for scientists to generate high accuracy, fine scale spatiotemporal water isoscape prediction. Here we develop a novel approach of using the MODIS-EVI (the Moderate Resolution Imagining Spectroradiometer-Enhanced Vegetation Index), to predict delta O-18 in precipitation at the regional scale. Using a structural equation model, we show that the EVI and precipitated delta O-18 are highly correlated and thus the EVI is a good predictor of precipitated delta O-18. We then test the predictability of our EVI-delta O-18 model and demonstrate that our approach can provide high accuracy with fine spatial (250x250 m) and temporal (16 days) scale delta O-18 predictions (annual and monthly predictabilities [r] are 0.96 and 0.80, respectively). We conclude the merging of the EVI and delta O-18 in precipitation can greatly extend the spatial and temporal data availability and thus enhance the applicability for both the EVI and water isoscape.	[Shiu, Hau-Jie; Chang, Yuan-Mou] Natl Univ Tainan, Dept Ecosci & Ecotechnol, Tainan, Taiwan; [You, Cheng-Feng] Natl Cheng Kung Univ, Dept Earth Sci, Tainan 70101, Taiwan; [Chan, Wei-Ping; Shen, Sheng-Feng] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chan, Wei-Ping; Yuan, Hsiao-Wei] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Huang, Cho-Ying] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Wang, Chung-Ho] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Lin, Shou-De; Lo, Yi-Chen] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Huang, Bo-Wen] Taiwan AF Weather Wing, Taipei, Taiwan; [Hatch, Kent A.] Long Isl Univ, Dept Biol, Brookville, NY USA	National University Tainan; National Cheng Kung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Chang, YM (corresponding author), Natl Univ Tainan, Dept Ecosci & Ecotechnol, Tainan, Taiwan.	changyuanmou@gmail.com; shensf@gate.sinica.edu.tw	Shen, Sheng-Feng/R-1177-2019; Huang, Cho-ying/E-6573-2012; Hatch, Kent/AAF-9886-2020	Shen, Sheng-Feng/0000-0002-0631-6343; Huang, Cho-ying/0000-0002-9174-7542; Hatch, Kent/0000-0001-9486-2207; Wang, Chung-Ho/0000-0003-2014-6747; YUAN, HSIAO-WEI/0000-0002-1540-9584; LIN, SHOU-DE/0000-0001-9970-1250	National Science Council of Taiwan [NSC98-2119-M024-001, NSC96-2621-B024-001]; Taroko National Park of Taiwan; Academia Sinica [AS-BRC-PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taroko National Park of Taiwan; Academia Sinica(Academia Sinica - Taiwan)	Funding provided by National Science Council of Taiwan, Grant Number: NSC98-2119-M024-001 & NSC96-2621-B024-001 (http://web1.nsc.gov.tw/), Taroko National Park of Taiwan, http://www.taroko.gov.tw/, and Academia Sinica, Grant Number: AS-BRC-PI quota (http://www.sinica.edu.tw/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson S, 2006, FORENSIC SCI INT, V157, P1, DOI 10.1016/j.forsciint.2005.03.012; Bowen GJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P139, DOI 10.1007/978-90-481-3354-3_7; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; CRAIG H, 1966, SCIENCE, V154, P1544, DOI 10.1126/science.154.3756.1544; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Frankenberg C, 2009, SCIENCE, V325, P1374, DOI 10.1126/science.1173791; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gonfiantini R, 2001, CHEM GEOL, V181, P147, DOI 10.1016/S0009-2541(01)00279-0; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; JOUSSAUME S, 1984, NATURE, V311, P24, DOI 10.1038/311024a0; Mendez-Barroso LA, 2009, J HYDROL, V377, P59, DOI 10.1016/j.jhydrol.2009.08.009; Noone D, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P195, DOI 10.1007/978-90-481-3354-3_10; Peng TR, 2007, ENVIRON GEOL, V52, P1617, DOI 10.1007/s00254-006-0607-4; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Sturm K, 2005, HYDROL PROCESS, V19, P3425, DOI 10.1002/hyp.5979; Treydte KS, 2006, NATURE, V440, P1179, DOI 10.1038/nature04743; Wang C.H., 2001, W PACIFIC EARTH SCI, V1, P429; Wolfram S, 1999, MATH BOOK, P1; Worden J, 2007, NATURE, V445, P528, DOI 10.1038/nature05508; Yoshimura K, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003477; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	30	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45496	10.1371/journal.pone.0045496	http://dx.doi.org/10.1371/journal.pone.0045496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029053	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400094
J	Baiden, F; Owusu-Agyei, S; Okyere, E; Tivura, M; Adjei, G; Chandramohan, D; Webster, J				Baiden, Frank; Owusu-Agyei, Seth; Okyere, Eunice; Tivura, Mathilda; Adjei, George; Chandramohan, Daniel; Webster, Jayne			Acceptability of Rapid Diagnostic Test-Based Management of Malaria among Caregivers of Under-Five Children in Rural Ghana	PLOS ONE			English	Article							HEALTH-WORKERS; PRESUMPTIVE TREATMENT; IMPLEMENTATION; TRIAL; TRANSMISSION; FEASIBILITY; MOTIVATION; ACCURACY; TANZANIA; AREA	Introduction: WHO now recommends test-based management of malaria (TBMM) across all age-groups. This implies artemisinin-based combination treatment (ACT) should be restricted to rapid diagnostic test (RDT)-positive cases. This is a departure from what caregivers in rural communities have been used to for many years. Methods: We conducted a survey among caregivers living close to 32 health centres in six districts in rural Ghana and used logistic regression to explore factors likely to influence caregiver acceptability of RDT based case management and concern about the denial of ACT on account of negative RDT results. Focus group discussions were conducted to explain the quantitative findings and to elicit further factors. Results: A total of 3047 caregivers were interviewed. Nearly all (98%) reported a preference for TBMM over presumptive treatment. Caregivers who preferred TBMM were less likely to be concerned about the denial of ACT to their test-negative children (O.R. 0.57, 95%C.I. 0.33-0.98). Compared with caregivers who had never secured national health insurance cover, caregivers who had valid (adjusted O.R. 1.30, 95% CI 1.07-1.61) or expired (adjusted O.R. 1.38, 95% CI 1.12-1.73) insurance cover were more likely to be concerned about the denial of ACT to their RDT-negative children. Major factors that promote TBMM acceptability include the perception that a blood test at health centre level represents improvement in the quality of care, leads to improvement in treatment outcomes, and offers opportunity for better communication between health workers and caregivers. Acceptability is also enhanced by engaging caregivers in the procedures of the test. Apprehensions about negative health worker attitude could however undermine acceptance. Conclusion: Test (RDT)-based management of malaria in under-five children is likely to be acceptable to caregivers in rural Ghana. The quality of caregiver-health worker interaction needs to be improved if acceptability is to be sustained.	[Baiden, Frank; Owusu-Agyei, Seth; Tivura, Mathilda] Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana; [Okyere, Eunice] Kintampo Hlth Res Ctr, Social Sci Grp, Kintampo, Ghana; [Adjei, George] Kintampo Hlth Res Ctr, Stat Unit, Kintampo, Ghana; [Chandramohan, Daniel; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	Kintampo Health Research Centre; Kintampo Health Research Centre; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine	Baiden, F (corresponding author), Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana.	baidenf@yahoo.co.uk	Baiden, Frank/Q-2018-2019; Baiden, Frank/AAF-7309-2020	Baiden, Frank/0000-0003-0141-6561; Webster, Jayne/0000-0002-0498-8883; Okyere, Eunice/0000-0003-3566-7561; Owusu-Agyei, Seth/0000-0002-0807-1781	ACT Consortium through Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Robert S. McNamara Fellowship Program at the World Bank	This research was funded by the ACT Consortium (www.actconsortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. Frank Baiden is supported by a grant from the Robert S. McNamara Fellowship Program at the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Asiimwe C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-5; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Chandler CIR, 2011, SOC SCI MED, V72, P937, DOI 10.1016/j.socscimed.2011.01.009; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Ghana Health Service, 2009, NATL MAL CONTR PROGR; Ghana Health Service Regional Health Directorate, 2005, PERF REV REP; Ghana Statistical Service and ICF Macro, 2009, GHAN DEM HLTH SURV 2; Ghana. Statistical Service/Macro International. MEASURE/DHS+ (Programme), 2008, GHAN DEM HLTH SURV 2; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Masanja MI, 2010, AM J TROP MED HYG, V83, P1238, DOI 10.4269/ajtmh.2010.10-0194; Mbonye AK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-367; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Mukanga D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-203; Mwanziva C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-232; Newton S, 2009, T ROY SOC TROP MED H, V103, P497, DOI 10.1016/j.trstmh.2008.11.030; Pagnoni F, 2009, LANCET, V374, P288, DOI 10.1016/S0140-6736(09)61358-1; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Sargent T.J., 1987, NEW PALGRAVE DICT EC, V4, P76; Sheffrin S. M., 1996, RATIONAL EXPECTATION, P97; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Ukwaja KN, 2011, J INFECT DEV COUNTR, V5, P199, DOI 10.3855/jidc.945; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2011, WORLD HLTH STAT ANN; WHO, 2010, GUID TREATM MAL, V2nd; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization Department of Child Adolescent Health World Health Organization and UNICEF, 2005, HDB IMCI INT MAN CHI	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45556	10.1371/journal.pone.0045556	http://dx.doi.org/10.1371/journal.pone.0045556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23029094	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311313900157
J	Cardoso, S; Lau, W; Dias, JE; Fevereiro, P; Maniatis, N				Cardoso, Silvana; Lau, Winston; Dias, Jose Eiras; Fevereiro, Pedro; Maniatis, Nikolas			A Candidate-Gene Association Study for Berry Colour and Anthocyanin Content in Vitis vinifera L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; PROANTHOCYANIDIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; POPULATION-STRUCTURE; GRAPE BERRIES; MIXED-MODEL; EXPRESSION; PATHWAY; DISEASE; FRUIT	Anthocyanin content is a trait of major interest in Vitis vinifera L. These compounds affect grape and wine quality, and have beneficial effects on human health. A candidate-gene approach was used to identify genetic variants associated with anthocyanin content in grape berries. A total of 445 polymorphisms were identified in 5 genes encoding transcription factors and 10 genes involved in either the biosynthetic pathway or transport of anthocyanins. A total of 124 SNPs were selected to examine association with a wide range of phenotypes based on RP-HPLC analysis and visual characterization. The phenotypes were total skin anthocyanin (TSA) concentration but also specific types of anthocyanins and relative abundance. The visual assessment was based on OIV (Organisation Internationale de la Vigne et du Vin) descriptors for berry and skin colour. The genes encoding the transcription factors MYB11, MYBCC and MYCB were significantly associated with TSA concentration. UFGT and MRP were associated with several different types of anthocyanins. Skin and pulp colour were associated with nine genes (MYB11, MYBCC, MYCB, UFGT, MRP, DFR, LDOX, CHI and GST). Pulp colour was associated with a similar group of 11 genes (MYB11, MYBCC, MYCB, MYCA, UFGT, MRP, GST, DFR, LDOX, CHI and CHSA). Statistical interactions were observed between SNPs within the transcription factors MYB11, MYBCC and MYCB. SNPs within LDOX interacted with MYB11 and MYCB, while SNPs within CHI interacted with MYB11 only. Together, these findings suggest the involvement of these genes in anthocyanin content and on the regulation of anthocyanin biosynthesis. This work forms a benchmark for replication and functional studies.	[Cardoso, Silvana; Fevereiro, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Plant Cell Biotechnol, Oeiras, Portugal; [Cardoso, Silvana; Lau, Winston; Maniatis, Nikolas] UCL, Dept Genet Evolut & Environm, London, England; [Dias, Jose Eiras] Inst Nacl Recursos Biol, Inst Nacl Invest Agr, Dois Portos, Portugal	Universidade Nova de Lisboa; University of London; University College London	Cardoso, S (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Plant Cell Biotechnol, Oeiras, Portugal.	silvana@itqb.unl.pt	Fevereiro, Pedro/A-2447-2010; Eiras-Dias, José J.E./B-5382-2016	Fevereiro, Pedro/0000-0003-1311-8406; Eiras-Dias, José J.E./0000-0001-7997-8199; Maniatis, Nikolas/0000-0002-6567-5936; Lau, Winston/0000-0001-5501-4619	Fundacao para a Ciencia e a Tecnolgia [SFRH/BD/29379/2006]; European Commission 6th Framework Programme for research [ERA-PG 074B GRASP GRAPE WINE]	Fundacao para a Ciencia e a Tecnolgia; European Commission 6th Framework Programme for research	This work was supported by the Fundacao para a Ciencia e a Tecnolgia (grant number SFRH/BD/29379/2006) and by the European Commission 6th Framework Programme for research (grant number ERA-PG 074B GRASP GRAPE WINE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageorges A, 2006, PLANT SCI, V170, P372, DOI 10.1016/j.plantsci.2005.09.007; Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; [Anonymous], 1998, BUSINESS MEDIA, DOI DOI 10.1007/978-94-009-5570-7; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Brouillard R., 1982, ANTHOCYANINS FOOD CO, P1, DOI [10.1016/b978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.X5001-X]; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cortell JM, 2006, J AGR FOOD CHEM, V54, P8510, DOI 10.1021/jf0616560; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Doligez A, 2006, MOL BREEDING, V18, P109, DOI 10.1007/s11032-006-9016-3; Doligez A, 2002, THEOR APPL GENET, V105, P780, DOI 10.1007/s00122-002-0951-z; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Eder A, 2000, FOOD ANAL HPLC, P845; Evanno G RS, 2005, MOL ECOL, V14, P10; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gollop R, 2002, J EXP BOT, V53, P1397, DOI 10.1093/jexbot/53.373.1397; Gollop R, 2001, PLANT SCI, V161, P579, DOI 10.1016/S0168-9452(01)00445-9; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; MANTEL N, 1967, CANCER RES, V27, P209; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; OIV, 2009, REC METH INT AN VINS; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Ribereau-Gayon P., 1982, ANTHOCYANINS FOOD CO, P209; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito K, 2002, NEW PHYTOL, V155, P9, DOI 10.1046/j.1469-8137.2002.00440.x; Salmaso M, 2008, THEOR APPL GENET, V116, P1129, DOI 10.1007/s00122-008-0741-3; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Stuber CW, 1999, CROP SCI, V39, P1571, DOI 10.2135/cropsci1999.3961571x; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	57	29	31	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46021	10.1371/journal.pone.0046021	http://dx.doi.org/10.1371/journal.pone.0046021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029369	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900073
J	Castro, OW; Santos, VR; Pun, RYK; McKlveen, JM; Batie, M; Holland, KD; Gardner, M; Garcia-Cairasco, N; Herman, JP; Danzer, SC				Castro, Olagide W.; Santos, Victor R.; Pun, Raymund Y. K.; McKlveen, Jessica M.; Batie, Matthew; Holland, Katherine D.; Gardner, Margaret; Garcia-Cairasco, Norberto; Herman, James P.; Danzer, Steve C.			Impact of Corticosterone Treatment on Spontaneous Seizure Frequency and Epileptiform Activity in Mice with Chronic Epilepsy	PLOS ONE			English	Article							SPONTANEOUS RECURRENT SEIZURES; LOW-DOSE CORTICOSTERONE; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; CHRONIC STRESS; MINERALOCORTICOID RECEPTORS; KINDLING EPILEPTOGENESIS; GLUCOCORTICOID-RECEPTORS; STRUCTURAL PLASTICITY	Stress is the most commonly reported precipitating factor for seizures in patients with epilepsy. Despite compelling anecdotal evidence for stress-induced seizures, animal models of the phenomena are sparse and possible mechanisms are unclear. Here, we tested the hypothesis that increased levels of the stress-associated hormone corticosterone ( CORT) would increase epileptiform activity and spontaneous seizure frequency in mice rendered epileptic following pilocarpine-induced status epilepticus. We monitored video-EEG activity in pilocarpine-treated mice 24/7 for a period of four or more weeks, during which animals were serially treated with CORT or vehicle. CORT increased the frequency and duration of epileptiform events within the first 24 hours of treatment, and this effect persisted for up to two weeks following termination of CORT injections. Interestingly, vehicle injection produced a transient spike in CORT levels - presumably due to the stress of injection - and a modest but significant increase in epileptiform activity. Neither CORT nor vehicle treatment significantly altered seizure frequency; although a small subset of animals did appear responsive. Taken together, our findings indicate that treatment of epileptic animals with exogenous CORT designed to mimic chronic stress can induce a persistent increase in interictal epileptiform activity.	[McKlveen, Jessica M.; Herman, James P.; Danzer, Steve C.] Univ Cincinnati, Program Neurosci, Cincinnati, OH 45221 USA; [Castro, Olagide W.; Santos, Victor R.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Batie, Matthew] Cincinnati Childrens Hosp, Med Ctr, Div Clin Engn, Cincinnati, OH USA; [Holland, Katherine D.] Cincinnati Childrens Hosp, Med Ctr, Div Neurol, Cincinnati, OH USA; [Pun, Raymund Y. K.; Danzer, Steve C.] Cincinnati Childrens Hosp, Med Ctr, Dept Anesthesia, Cincinnati, OH USA; [Gardner, Margaret; Danzer, Steve C.] Univ Cincinnati, Mol & Dev Biol Program, Cincinnati, OH USA; [McKlveen, Jessica M.; Herman, James P.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Anesthesia, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Universidade de Sao Paulo; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Danzer, SC (corresponding author), Univ Cincinnati, Program Neurosci, Cincinnati, OH 45221 USA.	Steve.Danzer@cchmc.org	Santos, Victor R/Y-3257-2018; Herman, James P/D-4960-2015; Castro, Olagide/C-6781-2015; Cairasco, Norberto Garcia/E-3250-2015	Santos, Victor R/0000-0003-4979-3120; Herman, James P/0000-0003-3571-2406; Castro, Olagide/0000-0002-1874-509X; Cairasco, Norberto Garcia/0000-0001-8857-3775	Charles L. Shor Foundation for Epilepsy Research; National Institute of Neurological Disorders and Stroke [R01NS065020, R01NS062806]; Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062806, R01NS065020] Funding Source: NIH RePORTER	Charles L. Shor Foundation for Epilepsy Research; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Charles L. Shor Foundation for Epilepsy Research, the National Institute of Neurological Disorders and Stroke (SCD, Award Numbers R01NS065020 and R01NS062806) and the Brazilian foundations Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Bajorat R, 2011, EPILEPSIA, V52, pE118, DOI 10.1111/j.1528-1167.2011.03200.x; Benkovic SA, 2009, NEUROTOXICOLOGY, V30, P965, DOI 10.1016/j.neuro.2009.07.005; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; Chang PS, 2011, J NEUROSCI METH, V201, P106, DOI 10.1016/j.jneumeth.2011.07.018; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Danzer SC, 2010, HIPPOCAMPUS, V20, P113, DOI 10.1002/hipo.20589; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; EHLERS CL, 1979, ELECTROEN CLIN NEURO, V47, P404, DOI 10.1016/0013-4694(79)90156-1; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Erbayat-Altay E, 2007, EPILEPSIA, V48, P1470, DOI 10.1111/j.1528-1167.2007.01110.x; Evanson NK, 2010, J NEUROENDOCRINOL, V22, P846, DOI 10.1111/j.1365-2826.2010.02000.x; FUXE K, 1985, ENDOCRINOLOGY, V117, P1803, DOI 10.1210/endo-117-5-1803; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Goosens K.A., 2007, SOURCEBRAIN AGING MO; Hall CB, 2009, EPILEPSY BEHAV, V14, P472, DOI 10.1016/j.yebeh.2008.12.011; Haut SR, 2007, NEUROLOGY, V69, P1905, DOI 10.1212/01.wnl.0000278112.48285.84; Haut SR, 2012, EPILEPSY BEHAV, V23, P415, DOI 10.1016/j.yebeh.2012.02.007; Haut SR, 2009, NEUROL CLIN, V27, P925, DOI 10.1016/j.ncl.2009.06.002; Haut SR, 2003, EPILEPSY BEHAV, V4, P511, DOI 10.1016/S1525-5050(03)00182-3; Heinrichs SC, 2010, PROG NEURO-PSYCHOPH, V34, P808, DOI 10.1016/j.pnpbp.2009.11.002; HERMAN JP, 1993, CELL MOL NEUROBIOL, V13, P349, DOI 10.1007/BF00711577; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; HERMAN JP, 1989, MOL ENDOCRINOL, V3, P1886, DOI 10.1210/mend-3-11-1886; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; Longordo F, 2011, SLEEP, V34, P679, DOI 10.1093/sleep/34.5.679; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; MEANEY MJ, 1985, BRAIN RES, V328, P176, DOI 10.1016/0006-8993(85)91340-X; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003; Pavlides C, 1996, BRAIN RES, V738, P229, DOI 10.1016/S0006-8993(96)00776-7; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pineda E, 2010, EPILEPSIA, V51, P110, DOI 10.1111/j.1528-1167.2010.02623.x; PRITCHARD PB, 1991, EPILEPSIA, V32, pS46; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAO ML, 1989, NEUROENDOCRINOLOGY, V49, P33, DOI 10.1159/000125088; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Roberts AJ, 1995, PSYCHONEUROENDOCRINO, V20, P891, DOI 10.1016/0306-4530(95)00016-X; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sawyer NT, 2010, J CLIN NEUROPHYSIOL, V27, P445, DOI 10.1097/WNP.0b013e3181fe0573; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schridde U, 2004, PHARMACOL BIOCHEM BE, V78, P369, DOI 10.1016/j.pbb.2004.04.012; Selassie GRH, 2010, EPILEPSY BEHAV, V18, P267, DOI 10.1016/j.yebeh.2010.04.015; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; Taher TR, 2005, NEUROPSYCHOPHARMACOL, V30, P1610, DOI 10.1038/sj.npp.1300709; Talmi M, 1995, BRAIN RES, V704, P97, DOI 10.1016/0006-8993(95)01123-4; TEMKIN NR, 1984, EPILEPSIA, V25, P450, DOI 10.1111/j.1528-1157.1984.tb03442.x; Tolmacheva EA, 2012, HORM BEHAV, V61, P706, DOI 10.1016/j.yhbeh.2012.03.004; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WEISS GK, 1993, NEUROSCI LETT, V157, P91, DOI 10.1016/0304-3940(93)90650-A; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Williams P, 2006, J NEUROSCI METH, V155, P39, DOI 10.1016/j.jneumeth.2005.12.035; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wolff M, 2005, EPILEPSIA, V46, P1661, DOI 10.1111/j.1528-1167.2005.00255.x; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	75	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46044	10.1371/journal.pone.0046044	http://dx.doi.org/10.1371/journal.pone.0046044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029379	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900078
J	Luo, YL; Ye, P; Zhang, QH; Hu, TT; Luo, MH; Li, MQ; Chen, Q				Luo, Ya Li; Ye, Ping; Zhang, Qiong Hua; Hu, Ting Ting; Luo, Min Hong; Li, Mei Qing; Chen, Qing			Methylenetetrahydrofolate Reductase C677T Polymorphism and Susceptibility to Cervical Cancer and Cervical Intraepithelial Neoplasia: A Meta-Analysis	PLOS ONE			English	Article							MTHFR POLYMORPHISMS; UTERINE CERVIX; A1298C POLYMORPHISMS; INDIAN POPULATION; COMMON MUTATION; PLASMA FOLATE; RISK-FACTOR; ASSOCIATION; DYSPLASIA; GENE	Background: A number of studies have explored the association between methyl enetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia (CIN). However, results remained controversial. To address this gap, we decided to conduct a meta-analysis of all available published studies. Methods: Electronic literature searches of the PubMed, EmBase and Medline databases were performed up to April 30, 2012. Fixed-effects or random-effects model was used to calculate the pooled ORs for different genetic models. Results: A total of 12 case-control studies were ultimately identified. No statistical correlation was found between C677T variants and cervical cancer for the overall population. However, subgroup analyses on the White women pointed to a significant protective effect for individuals heterozygous or homozygous for the T-allele (for CT vs. CC: OR = 0.72, 95% CI 0.59-0.88; for TT vs. CC: OR = 0.69, 95% CI = 0.49-0.97; for CT+TT vs. CC: OR = 0.71, 95% CI 0.59-0.86). C677T variants were associated with neither combined nor stratified CIN among the overall population. Conclusions: This meta-analysis suggests that White women with mutant C677T genotypes might have a lower risk of cervical cancer, yet lacking enough statistical robustness. Further investigations are needed to get more insight into the role of this polymorphism in cervical carcinogenesis.	[Luo, Ya Li; Ye, Ping; Zhang, Qiong Hua; Hu, Ting Ting; Luo, Min Hong; Li, Mei Qing; Chen, Qing] So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Chen, Q (corresponding author), So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	Qingchen_smu@163.com						American Cancer Society, 2011, CANC FACTS FIG 2011, P22; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boccia S, 2009, CANCER LETT, V273, P55, DOI 10.1016/j.canlet.2008.07.026; BRINTON LA, 1992, EPIDEMIOLOGY CERVICA, P3; Cerqueira EMM, 1998, ACTA CYTOL, V42, P639, DOI 10.1159/000331820; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Delgado-Enciso I, 2006, REV INVEST CLIN, V58, P462; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goodman MT, 2001, CANCER EPIDEM BIOMAR, V10, P1275; Goodman MT, 2000, CANCER-AM CANCER SOC, V89, P376, DOI 10.1002/1097-0142(20000715)89:2&lt;376::AID-CNCR24&gt;3.0.CO;2-O; HERRERO R, 1990, CANCER-AM CANCER SOC, V65, P380, DOI 10.1002/1097-0142(19900115)65:2<380::AID-CNCR2820650234>3.0.CO;2-9; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; Kohaar I, 2010, BIOMARKERS, V15, P61, DOI 10.3109/13547500903295881; Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4; LUTHRA UK, 1987, ACTA CYTOL, V31, P226; MANTEL N, 1959, J NATL CANCER I, V22, P719; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Mostowska A, 2011, CLIN BIOCHEM, V44, P596, DOI 10.1016/j.clinbiochem.2011.02.007; Office of Management and Budget, 2003, REV STAND CLASS FED; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piyathilake CJ, 2007, NUTRITION, V23, P203, DOI 10.1016/j.nut.2006.12.002; Piyathilake CJ, 2009, CANCER PREV RES, V2, P658, DOI 10.1158/1940-6207.CAPR-08-0175; Piyathilake CJ, 2000, ANTICANCER RES, V20, P1751; Prasad VVTS, 2011, ONKOLOGIE, V34, P422, DOI 10.1159/000331131; Qi XW, 2010, BREAST CANCER RES TR, V123, P499, DOI 10.1007/s10549-010-0773-7; ROMNEY SL, 1987, ANN NY ACAD SCI, V498, P132, DOI 10.1111/j.1749-6632.1987.tb23757.x; SADEGHI SB, 1988, CANCER-AM CANCER SOC, V61, P2359, DOI 10.1002/1097-0142(19880601)61:11<2359::AID-CNCR2820611135>3.0.CO;2-7; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; Shaw GM, 2002, AM J MED GENET, V108, P1, DOI 10.1002/ajmg.10195; Shekari M, 2008, ARCH GYNECOL OBSTET, V278, P517, DOI 10.1007/s00404-008-0623-6; Sheng X, 2012, MOL BIOL REP; Shin HR, 2008, INT J CANCER, V122, P393, DOI 10.1002/ijc.23015; Sull JW, 2004, GYNECOL ONCOL, V95, P557, DOI 10.1016/j.ygyno.2004.08.008; Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANEENWYK J, 1992, CANCER EPIDEM BIOMAR, V1, P119; Yan JR, 2012, PEDIATR BLOOD CANCER, V58, P513, DOI 10.1002/pbc.23137; Zacho J, 2011, INT J CANCER, V128, P644, DOI 10.1002/ijc.25375; Zhang Y, 2012, MOL BIOL REP, V39, P6203, DOI 10.1007/s11033-011-1439-1; Zoodsma M, 2005, HUM GENET, V116, P247, DOI 10.1007/s00439-004-1233-4	49	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46272	10.1371/journal.pone.0046272	http://dx.doi.org/10.1371/journal.pone.0046272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029458	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900122
J	Valenza, F; Pizzocri, M; Salice, V; Chevallard, G; Fossali, T; Coppola, S; Froio, S; Polli, F; Gatti, S; Fortunato, F; Comi, GP; Gattinoni, L				Valenza, Franco; Pizzocri, Marta; Salice, Valentina; Chevallard, Giorgio; Fossali, Tommaso; Coppola, Silvia; Froio, Sara; Polli, Federico; Gatti, Stefano; Fortunato, Francesco; Comi, Giacomo P.; Gattinoni, Luciano			Sodium Bicarbonate Treatment during Transient or Sustained Lactic Acidemia in Normoxic and Normotensive Rats	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD LACTATE LEVELS; METABOLIC-ACIDOSIS; SEPTIC SHOCK; PH; HEMODYNAMICS; HYPERLACTATEMIA; SUBSTRATE; VARIABLES; INCREASE	Introduction: Lactic acidosis is a frequent cause of poor outcome in the intensive care settings. We set up an experimental model of lactic acid infusion in normoxic and normotensive rats to investigate the systemic effects of lactic acidemia per se without the confounding factor of an underlying organic cause of acidosis. Methodology: Sprague Dawley rats underwent a primed endovenous infusion of L(+) lactic acid during general anesthesia. Normoxic and normotensive animals were then randomized to the following study groups (n = 8 per group): S) sustained infusion of lactic acid, S+B) sustained infusion+sodium bicarbonate, T) transient infusion, T+B transient infusion+sodium bicarbonate. Hemodynamic, respiratory and acid-base parameters were measured over time. Lactate pharmacokinetics and muscle phosphofructokinase enzyme's activity were also measured. Principal Findings: Following lactic acid infusion blood lactate rose (P<0.05), pH (P<0.05) and strong ion difference (P<0.05) drop. Some rats developed hemodynamic instability during the primed infusion of lactic acid. In the normoxic and normotensive animals bicarbonate treatment normalized pH during sustained infusion of lactic acid (from 7.22 +/- 0.02 to 7.36 +/- 0.04, P<0.05) while overshoot to alkalemic values when the infusion was transient (from 7.24 +/- 0.01 to 7.53 +/- 0.03, P<0.05). When acid load was interrupted bicarbonate infusion affected lactate wash-out kinetics (P<0.05) so that blood lactate was higher (2.9 +/- 1 mmol/l vs. 1.0 +/- 0.2, P<0.05, group T vs. T+B respectively). The activity of phosphofructokinase enzyme was correlated with blood pH (R2 = 0.475, P<0.05). Conclusions: pH decreased with acid infusion and rose with bicarbonate administration but the effects of bicarbonate infusion on pH differed under a persistent or transient acid load. Alkalization affected the rate of lactate disposal during the transient acid load.	[Valenza, Franco; Pizzocri, Marta; Salice, Valentina; Chevallard, Giorgio; Fossali, Tommaso; Coppola, Silvia; Froio, Sara; Polli, Federico; Gattinoni, Luciano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Anestesia Rianimaz Intens & Subinten, Milan, Italy; [Gatti, Stefano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Ric Chirurg Preclin, Milan, Italy; [Fortunato, Francesco; Comi, Giacomo P.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Sci Neurol, Ctr Dino Ferrari, Milan, Italy; [Valenza, Franco; Gatti, Stefano; Comi, Giacomo P.; Gattinoni, Luciano] Univ Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Valenza, F (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Anestesia Rianimaz Intens & Subinten, Milan, Italy.	franco.valenza@unimi.it	Polli, Federico/AAB-9868-2022; Comi, Giacomo P/K-5702-2016; Fossali, Tommaso/HGD-3325-2022; Gatti, Stefano/AAE-3281-2022; Pizzocri, Marta/AAB-5888-2021; Gatti, Stefano/M-1780-2015	Comi, Giacomo P/0000-0002-1383-5248; Gatti, Stefano/0000-0003-2209-4338; Pizzocri, Marta/0000-0002-9058-5457; Gatti, Stefano/0000-0003-2209-4338; Valenza, Franco/0000-0003-0634-2282; Gattinoni, Luciano/0000-0001-5380-2494; Coppola, Silvia/0000-0001-9290-5090	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy	The study was funded by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUROMEH S, 1986, AM J PHYSIOL, V250, pF702, DOI 10.1152/ajprenal.1986.250.4.F702; ARIEFF AI, 1982, AM J PHYSIOL, V242, pF586, DOI 10.1152/ajprenal.1982.242.6.F586; Arieff AI, 1996, CURR ANAES CRIT CARE, V7, P182; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; BARON PG, 1978, CLIN SCI MOL MED, V55, P175, DOI 10.1042/cs0550175; BENJAMIN E, 1994, CRIT CARE MED, V22, P1616; Boyd JH, 2008, CURR OPIN CRIT CARE, V14, P379, DOI 10.1097/MCC.0b013e3283069d5c; BRODER G, 1964, SCIENCE, V143, P1457, DOI 10.1126/science.143.3613.1457; Cady L D Jr, 1973, Crit Care Med, V1, P75, DOI 10.1097/00003246-197303000-00003; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; Chrusch C, 2002, J CRIT CARE, V17, P188, DOI 10.1053/jcrc.2002.35816; Chrusch C, 2000, AM J RESP CRIT CARE, V161, P517, DOI 10.1164/ajrccm.161.2.9902403; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; DRUML W, 1991, CRIT CARE MED, V19, P1120, DOI 10.1097/00003246-199109000-00005; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gattinoni L, 2006, MINERVA ANESTESIOL, V72, P551; GRAF H, 1985, AM J PHYSIOL, V249, pF630, DOI 10.1152/ajprenal.1985.249.5.F630; GRAF H, 1985, SCIENCE, V227, P754, DOI 10.1126/science.3969564; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; Hood VL, 1998, NEW ENGL J MED, V339, P819, DOI 10.1056/NEJM199809173391207; HOOD VL, 1983, MINER ELECTROL METAB, V9, P317; Jansen TC, 2008, CRIT CARE, V12, DOI 10.1186/cc7159; Khosravani H, 2009, CRIT CARE, V13, DOI 10.1186/cc7918; Kitano T, 2002, LIFE SCI, V72, P557, DOI 10.1016/S0024-3205(02)02251-8; Kraut Jeffrey A, 2006, Clin Exp Nephrol, V10, P111, DOI 10.1007/s10157-006-0408-9; Leverve X M, 1999, Curr Opin Clin Nutr Metab Care, V2, P165, DOI 10.1097/00075197-199903000-00013; Leverve XM, 2001, CURR OPIN CLIN NUTR, V4, P137, DOI 10.1097/00075197-200103000-00010; Levraut J, 2000, INTENS CARE MED, V26, P558, DOI 10.1007/s001340051204; Ling K H, 2010, METHOD ENZYMOL, P306; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Miller BF, 2002, J PHYSIOL-LONDON, V544, P963, DOI 10.1113/jphysiol.2002.027128; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; OKAMOTO H, 1995, ACTA ANAESTH SCAND, V39, P79, DOI 10.1111/j.1399-6576.1995.tb05596.x; PAGLIASSOTTI MJ, 1990, AM J PHYSIOL, V258, pR903, DOI 10.1152/ajpregu.1990.258.4.R903; PARK R, 1982, J CLIN INVEST, V70, P853, DOI 10.1172/JCI110682; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; RHEE KH, 1993, CHEST, V104, P913, DOI 10.1378/chest.104.3.913; ROTH DA, 1990, ARCH BIOCHEM BIOPHYS, V279, P386, DOI 10.1016/0003-9861(90)90506-T; SESTOFT L, 1986, CLIN SCI, V70, P19, DOI 10.1042/cs0700019; Tanaka M, 1996, BRIT J ANAESTH, V77, P408, DOI 10.1093/bja/77.3.408; Tanaka M, 1997, ANAESTH INTENS CARE, V25, P615, DOI 10.1177/0310057X9702500603; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; VITEK V, 1971, ANN SURG, V173, P308, DOI 10.1097/00000658-197102000-00021; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989	50	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46035	10.1371/journal.pone.0046035	http://dx.doi.org/10.1371/journal.pone.0046035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029373	Green Published, gold			2022-12-27	WOS:000309973900074
J	Waidmann, O; Koberle, V; Brunner, F; Zeuzem, S; Piiper, A; Kronenberger, B				Waidmann, Oliver; Koeberle, Verena; Brunner, Friederike; Zeuzem, Stefan; Piiper, Albrecht; Kronenberger, Bernd			Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CHRONIC HEPATITIS; VARICEAL HEMORRHAGE; VIRUS-INFECTION; CANCER; BIOMARKERS; MIR-122; DISEASE; INJURY; MODEL	Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers. In particular, the serum level of the liver-specific miR-122 might be a clinically useful new parameter in patients with acute or chronic liver disease. Aim: Here we investigated if the serum level of miR-122 might be a prognostic parameter in patients with liver cirrhosis. Methods: 107 patients with liver cirrhosis in the test cohort and 143 patients in the validation cohort were prospectively enrolled into the present study. RNA was extracted from the sera obtained at the time of study enrollment and the level of miR-122 was assessed. Serum miR-122 levels were assessed by quantitative reverse-transcription PCR (RT-PCR) and were compared to overall survival time and to different complications of liver cirrhosis. Results: Serum miR-122 levels were reduced in patients with hepatic decompensation in comparison to patients with compensated liver disease. Patients with ascites, spontaneous bacterial peritonitis and hepatorenal syndrome had significantly lower miR-122 levels than patients without these complications. Multivariate Cox regression analysis revealed that the miR-122 serum levels were associated with survival independently from the MELD score, sex and age. Conclusions: Serum miR-122 is a new independent marker for prediction of survival of patients with liver cirrhosis.	[Waidmann, Oliver; Koeberle, Verena; Brunner, Friederike; Zeuzem, Stefan; Piiper, Albrecht; Kronenberger, Bernd] Klinikum Goethe Univ, Dept Med 1, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Waidmann, O (corresponding author), Klinikum Goethe Univ, Dept Med 1, Frankfurt, Germany.	waidmann@biochem2.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019		Dr. Paul und Ursula Klein Foundation; Marie Christine Held and Erika Hecker foundation; Medical Faculty, Goethe University Frankfurt; Deutsche Forschungsgemeinschaft [WA 2924/2-1, GRK 1172]; Schaufler foundation; Else-Kroner-Fresenius foundation; Scolari foundation to Bernd Kronenberger	Dr. Paul und Ursula Klein Foundation; Marie Christine Held and Erika Hecker foundation; Medical Faculty, Goethe University Frankfurt; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schaufler foundation; Else-Kroner-Fresenius foundation; Scolari foundation to Bernd Kronenberger	The work was supported by grants from the Dr. Paul und Ursula Klein Foundation, the Marie Christine Held and Erika Hecker foundation and in parts by the Nachwuchsforscherprogramm 2010 of the Medical Faculty, Goethe University Frankfurt and the Deutsche Forschungsgemeinschaft (WA 2924/2-1) to Oliver Waidmann, the Schaufler foundation, the Else-Kroner-Fresenius foundation and the Deutsche Forschungsgemeinschaft (GRK 1172) to Albrecht Piiper and the Scolari foundation to Bernd Kronenberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandria C, 2005, HEPATOLOGY, V41, P1282, DOI 10.1002/hep.20687; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bambha K, 2008, GUT, V57, P814, DOI 10.1136/gut.2007.137489; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Cardenas A, 2011, GUT, V60, P412, DOI 10.1136/gut.2009.179937; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farid WRR, 2012, LIVER TRANSPLANT, V18, P290, DOI 10.1002/lt.22438; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; JALAN R, 1995, ALIMENT PHARM THER, V9, P263; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wiesner RH, 2005, NAT CLIN PRACT GASTR, V2, P24, DOI 10.1038/ncpgasthep0070; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	29	64	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45652	10.1371/journal.pone.0045652	http://dx.doi.org/10.1371/journal.pone.0045652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029162	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900051
J	Sheng, XW; Reppel, M; Nguemo, F; Mohammad, FI; Kuzmenkin, A; Hescheler, J; Pfannkuche, K				Sheng, Xiaowu; Reppel, Michael; Nguemo, Filomain; Mohammad, Farooq Ibrahem; Kuzmenkin, Alexey; Hescheler, Juergen; Pfannkuche, Kurt			Human Pluripotent Stem Cell-Derived Cardiomyocytes: Response to TTX and Lidocain Reveals Strong Cell to Cell Variability	PLOS ONE			English	Article							CARDIAC MYOCYTES; HUMAN FIBROBLASTS; SODIUM CURRENT; NA+ CURRENT; GENERATION; MOUSE; INDUCTION; DIFFERENTIATION; TRANSPLANTATION; INTEGRATION	Stem cell derived cardiomyocytes generated either from human embryonic stem cells (hESC-CMs) or human induced pluripotent stem cells (hiPSC-CMs) hold great promise for the investigation of early developmental processes in human cardiomyogenesis and future cell replacement strategies. We have analyzed electrophysiological properties of hESC-CMs (HES2) and hiPSC-CMs, derived from reprogrammed adult foreskin fibroblasts that have previously been found to be highly similar in terms of gene expression. In contrast to the similarity found in the expression profile we found substantial differences in action potentials (APs) and sodium currents at late stage (day 60) of in vitro differentiation with higher sodium currents in hiPSC-CMs. Sensitivity to lidocain was considerably reduced in hESC-CMs as compared to hiPSC-CMs, and the effect could not be explained by differences in beating frequency. In contrast, sensitivity to tetrodotoxin (TTX) was higher in hESC-CMs suggesting different contributions of TTX-sensitive and TTX-resistant sodium channels to AP generation. These data point to physiological differences that are not necessarily detected by genomics. We conclude that novel pharmacological screening-assays using hiPSC-CMs need to be applied with some caution.	[Sheng, Xiaowu; Nguemo, Filomain; Mohammad, Farooq Ibrahem; Kuzmenkin, Alexey; Hescheler, Juergen; Pfannkuche, Kurt] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Sheng, Xiaowu] Huazhong Univ Sci & Technol, Coll Med, Dept Physiol, Wuhan 430074, Peoples R China; [Sheng, Xiaowu] Huazhong Univ Sci & Technol, Coll Med, German Chinese Stem Cell Ctr, Wuhan 430074, Peoples R China; [Reppel, Michael] Univ Lubeck, Med Clin 2, Lubeck, Germany; [Mohammad, Farooq Ibrahem] Al Nahrain Univ, Biotechnol Res Ctr, Baghdad, Iraq; [Pfannkuche, Kurt] Univ Cologne, Clin & Polyclin Paedriatr Cardiol, D-50931 Cologne, Germany	University of Cologne; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Lubeck; Al-Nahrain University; University of Cologne	Pfannkuche, K (corresponding author), Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany.	kurt.pfannkuche@uni-koeln.de		Pfannkuche, Kurt Paul/0000-0002-4284-774X; Nguemo, Filomain/0000-0002-2236-6797	North Rhine Westphalian Stem Cell Network [314-40001110]; Maria Pesch Foundation	North Rhine Westphalian Stem Cell Network; Maria Pesch Foundation	This project was supported by a grant from The North Rhine Westphalian Stem Cell Network (Grant No. 314-40001110) to Kurt Pfannkuche and a grant from the Maria Pesch Foundation to Alexei Kuzmenkin and by Koln Fortune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JL, 2000, J MOL CELL CARDIOL, V32, P1169, DOI 10.1006/jmcc.2000.1155; BKAILY G, 1991, J MOL CELL CARDIOL, V23, P25, DOI 10.1016/0022-2828(91)90036-L; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Jonsson M.K., 2012, J MOL CELL CARDIOL; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lin XM, 2011, HEART RHYTHM, V8, P1923, DOI 10.1016/j.hrthm.2011.07.016; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maltsev VA, 1998, CIRCULATION, V98, P2545, DOI 10.1161/01.CIR.98.23.2545; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	48	46	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45963	10.1371/journal.pone.0045963	http://dx.doi.org/10.1371/journal.pone.0045963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029342	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500049
J	Yilmaz, A; Zhang, XY; Chung, JT; Tan, SL; Holzer, H; Ao, A				Yilmaz, Ahmet; Zhang, Xiao Yun; Chung, Jin-Tae; Tan, Seang Lin; Holzer, Hananel; Ao, Asangla			Chromosome Segregation Analysis in Human Embryos Obtained from Couples Involving Male Carriers of Reciprocal or Robertsonian Translocation	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; IN-SITU HYBRIDIZATION; MEIOTIC SEGREGATION; MALE-INFERTILITY; CLEAVAGE DIVISIONS; SPERM; ABNORMALITIES; CYCLES; FISH; MOSAICISM	The objective of this study was to investigate the frequency and type of chromosome segregation patterns in cleavage stage embryos obtained from male carriers of Robertsonian (ROB) and reciprocal (REC) translocations undergoing preimplantation genetic diagnosis (PGD) at our reproductive center. We used FISH to analyze chromosome segregation in 308 day 3 cleavage stage embryos obtained from 26 patients. The percentage of embryos consistent with normal or balanced segregation (55.1% vs. 27.1%) and clinical pregnancy (62.5% vs. 19.2%) rates were higher in ROB than the REC translocation carriers. Involvement of non-acrocentric chromosome(s) or terminal breakpoint(s) in reciprocal translocations was associated with an increase in the percent of embryos consistent with adjacent 1 but with a decrease in 3: 1 segregation. Similar results were obtained in the analysis of nontransferred embryos donated for research. 3:1 segregation was the most frequent segregation type in both day 3 (31%) and spare (35%) embryos obtained from carriers of t(11;22)(q23;q11), the only non-random REC with the same breakpoint reported in a large number of unrelated families mainly identified by the birth of a child with derivative chromosome 22. These results suggest that chromosome segregation patterns in day 3 and nontransferred embryos obtained from male translocation carriers vary with the type of translocation and involvement of acrocentric chromosome(s) or terminal breakpoint(s). These results should be helpful in estimating reproductive success in translocation carriers undergoing PGD.	[Ao, Asangla] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Yilmaz, Ahmet; Zhang, Xiao Yun; Chung, Jin-Tae; Tan, Seang Lin; Holzer, Hananel] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Ao, A (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	asangla.ao@muhc.mcgill.ca	ao, asangla/Q-5454-2019; Holzer, Hananel/AAJ-1059-2020	Holzer, Hananel/0000-0001-8565-6145; Yilmaz, Ahmet/0000-0002-4010-8599				Alves C, 2002, PRENATAL DIAG, V22, P1153, DOI 10.1002/pd.503; Armstrong SJ, 2000, AM J HUM GENET, V67, P601, DOI 10.1086/303052; Benet J, 2005, CYTOGENET GENOME RES, V111, P281, DOI 10.1159/000086901; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Bielanska M, 2005, FERTIL STERIL, V84, P336, DOI 10.1016/j.fertnstert.2005.03.031; Bint SM, 2011, HUM REPROD, V26, P1575, DOI 10.1093/humrep/der080; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Colls P, 2012, REPROD BIOMED ONLINE, V24, P621, DOI 10.1016/j.rbmo.2012.02.006; Conn CM, 1998, HUM GENET, V102, P117, DOI 10.1007/s004390050663; Coonen E, 2000, MOL HUM REPROD, V6, P199, DOI 10.1093/molehr/6.3.199; Delhanty JDA, 1995, HUM REPROD UPDATE, V1, P201, DOI 10.1093/humupd/1.3.201; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Escudero T, 2003, FERTIL STERIL, V79, P1528, DOI 10.1016/S0015-0282(03)00252-8; Escudero T, 2000, PRENATAL DIAG, V20, P599, DOI 10.1002/1097-0223(200007)20:7<599::AID-PD883>3.3.CO;2-H; Estop AM, 1999, HUM GENET, V104, P412, DOI 10.1007/s004390050977; Frydman N, 2001, HUM REPROD, V16, P2274, DOI 10.1093/humrep/16.11.2274; Gardner RJM, 2004, CHROMOSOME ABNORMALI, P388; Harper JC, 2010, HUM REPROD, V25, P2685, DOI 10.1093/humrep/deq228; Huang J, 2009, PRENATAL DIAG, V29, P1167, DOI 10.1002/pd.2376; Irvine DS, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.suppl_1.33; Iwarsson E, 2000, PRENATAL DIAG, V20, P1038, DOI 10.1002/1097-0223(200012)20:13<1038::AID-PD976>3.3.CO;2-#; Jin H, 2010, FERTIL STERIL, V93, P1061, DOI 10.1016/j.fertnstert.2008.11.020; Ko DS, 2010, AM J MED GENET A, V152A, P1428, DOI 10.1002/ajmg.a.33368; Kovaleva NV, 2003, AM J MED GENET A, V121A, P180, DOI 10.1002/ajmg.a.20156; Lim CK, 2008, FERTIL STERIL, V90, P2144, DOI 10.1016/j.fertnstert.2007.10.035; Lledo B, 2010, HUM REPROD, V25, P1843, DOI 10.1093/humrep/deq111; Morel F, 2004, INT J ANDROL, V27, P200, DOI 10.1111/j.1365-2605.2004.00490.x; Munne S, 1997, HUM REPROD, V12, P780, DOI 10.1093/humrep/12.4.780; Munne S, 2005, CYTOGENET GENOME RES, V111, P305, DOI 10.1159/000086904; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Munne Santiago, 2002, Reprod Biomed Online, V4, P183; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Ogilvie CM, 2002, EUR J HUM GENET, V10, P801, DOI 10.1038/sj.ejhg.5200895; Poongothai J, 2009, SINGAP MED J, V50, P336; Raghavan M, 2005, CANCER RES, V65, P375; Roux C, 2005, CYTOGENET GENOME RES, V111, P291, DOI 10.1159/000086902; Scriven PN, 1998, PRENATAL DIAG, V18, P1437, DOI 10.1002/(SICI)1097-0223(199812)18:13<1437::AID-PD497>3.3.CO;2-G; Scriven PN, 2001, HUM REPROD, V16, P2267, DOI 10.1093/humrep/16.11.2267; Shi QH, 2001, REPRODUCTION, V121, P655, DOI 10.1530/rep.0.1210655; Tease C, 1998, CHROMOSOMA, V107, P549, DOI 10.1007/s004120050341; Traversa MV, 2010, MOL HUM REPROD, V16, P329, DOI 10.1093/molehr/gaq013; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Van Assche E, 1999, MOL HUM REPROD, V5, P682, DOI 10.1093/molehr/5.7.682; Ye YH, 2012, REPROD BIOMED ONLINE, V24, P83, DOI 10.1016/j.rbmo.2011.08.012; Zhang XY, 2010, REPROD BIOMED ONLINE, V21, P552, DOI 10.1016/j.rbmo.2010.05.002	46	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46046	10.1371/journal.pone.0046046	http://dx.doi.org/10.1371/journal.pone.0046046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029381	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500057
J	Cheung, H; Xiao, W; Lai, CM				Cheung, Him; Xiao, Wen; Lai, Ching Man			Twelve-Month-Olds' Understanding of Intention Transfer through Communication	PLOS ONE			English	Article							SOCIAL COGNITION; INFANT ATTENTION; FALSE BELIEFS; OTHERS; GOAL; MIND; EXPERIENCE; GESTURES; OBJECTS; SIGNALS	Do infants understand that intention can be transferred through communication? We answered this question by examining 12-month-olds' looking times in a violation-of-expectation paradigm with two human agents. In familiarization, the non-acting agent spoke, clapped her hands, read aloud a book, or remained silent before the acting agent grasped one (the target) of two objects. During test only the non-actor remained, grasping either the target or distractor. The infants looked longer in the distractor than target condition, suggesting violation of expectation, only if the non-actor had spoken or clapped in familiarization. Because the non-actor never had grasped any of the objects in familiarization, the infants' expectation on her behavior could have developed from the understanding that her intention was transferred to the actor, who executed it by grasping the target in familiarization, via speaking and clapping as acts of communication (but not reading aloud and remaining silent).	[Cheung, Him; Xiao, Wen; Lai, Ching Man] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Cheung, H (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	hcheung@psy.cuhk.edu.hk	Cogde, Lab/M-5885-2016	Eva, Lai/0000-0001-8204-6608; Cheung, Him/0000-0002-1553-2339	Research Grants Council, Hong Kong Government [441809]	Research Grants Council, Hong Kong Government(Hong Kong Research Grants Council)	This research is supported by a General Research Fund granted to the first author by the Research Grants Council, Hong Kong Government (project number 441809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschersleben G, 2008, DEVELOPMENTAL SCI, V11, P862, DOI 10.1111/j.1467-7687.2008.00736.x; Aureli T, 2009, COGNITIVE DEV, V24, P1, DOI 10.1016/j.cogdev.2008.07.003; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Buresh JS, 2007, COGNITION, V104, P287, DOI 10.1016/j.cognition.2006.07.001; Buttelmann D, 2009, COGNITION, V112, P337, DOI 10.1016/j.cognition.2009.05.006; Camaioni L, 2004, INFANCY, V5, P291, DOI 10.1207/s15327078in0503_3; Caron AJ, 2009, DEV REV, V29, P69, DOI 10.1016/j.dr.2009.04.002; CSIBRA G, 2010, MIND LANG, V25, P141, DOI DOI 10.1111/J.1468-0017.2009.01384.X; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Grafenhain M, 2009, COGNITIVE DEV, V24, P23, DOI 10.1016/j.cogdev.2008.10.001; Grossmann T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00201; Legerstee M, 2003, COGNITIVE DEV, V18, P91, DOI 10.1016/S0885-2014(02)00165-X; Luo Y, 2007, COGNITION, V105, P489, DOI 10.1016/j.cognition.2006.10.007; Luo YY, 2009, DEVELOPMENTAL SCI, V12, P142, DOI 10.1111/j.1467-7687.2008.00741.x; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; Martin A, 2012, COGNITION, V123, P50, DOI 10.1016/j.cognition.2011.12.003; Meltzoff AN, 2008, DEV PSYCHOL, V44, P1257, DOI 10.1037/a0012888; Moll H, 2006, J COGN DEV, V7, P411, DOI 10.1207/s15327647jcd0703_9; Moll H, 2007, DEVELOPMENTAL SCI, V10, P826, DOI 10.1111/j.1467-7687.2007.00615.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Senju A, 2008, COGNITION, V108, P303, DOI 10.1016/j.cognition.2008.02.009; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Sommerville JA, 2009, DEVELOPMENTAL SCI, V12, P314, DOI 10.1111/j.1467-7687.2008.00787.x; Song HJ, 2008, DEV PSYCHOL, V44, P1789, DOI 10.1037/a0013774; Southgate V, 2010, DEVELOPMENTAL SCI, V13, P907, DOI 10.1111/j.1467-7687.2009.00946.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Wellman HA, 2008, DEV PSYCHOL, V44, P618, DOI 10.1037/0012-1649.44.2.618; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 2000, PSYCHOL SCI, V11, P73, DOI 10.1111/1467-9280.00218; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Yamaguchi M, 2009, DEVELOPMENTAL SCI, V12, P746, DOI 10.1111/j.1467-7687.2008.00813.x	31	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46168	10.1371/journal.pone.0046168	http://dx.doi.org/10.1371/journal.pone.0046168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029427	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700119
J	Juss, JK; Hayhoe, RP; Owen, CE; Bruce, I; Walmsley, SR; Cowburn, AS; Kulkarni, S; Boyle, KB; Stephens, L; Hawkins, PT; Chilvers, ER; Condliffe, AM				Juss, Jatinder K.; Hayhoe, Richard P.; Owen, Charles E.; Bruce, Ian; Walmsley, Sarah R.; Cowburn, Andrew S.; Kulkarni, Suhasini; Boyle, Keith B.; Stephens, Len; Hawkins, Phillip T.; Chilvers, Edwin R.; Condliffe, Alison M.			Functional Redundancy of Class I Phosphoinositide 3-Kinase (PI3K) Isoforms in Signaling Growth Factor-Mediated Human Neutrophil Survival	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RESPIRATORY-DISTRESS-SYNDROME; PHOSPHATIDYLINOSITOL 3-KINASE; KINASE INHIBITORS; DISTINCT ROLES; CELL-SURVIVAL; APOPTOSIS; PI3K-GAMMA; ACTIVATION; GAMMA	We have investigated the contribution of individual phosphoinositide 3-kinase (PI3K) Class I isoforms to the regulation of neutrophil survival using (i) a panel of commercially available small molecule isoform-selective PI3K Class I inhibitors, (ii) novel inhibitors, which target single or multiple Class I isoforms (PI3K alpha, PI3K beta, PI3K delta, and PI3K gamma), and (iii) transgenic mice lacking functional PI3K isoforms (p110 delta(KO)gamma(KO) or p110 gamma(KO)). Our data suggest that there is considerable functional redundancy amongst Class I PI3Ks (both Class IA and Class IB) with regard to GM-CSF-mediated suppression of neutrophil apoptosis. Hence pharmacological inhibition of any 3 or more PI3K isoforms was required to block the GM-CSF survival response in human neutrophils, with inhibition of individual or any two isoforms having little or no effect. Likewise, isolated blood neutrophils derived from double knockout PI3K p110 delta(KO)gamma(KO) mice underwent normal time-dependent constitutive apoptosis and displayed identical GM-CSF mediated survival to wild type cells, but were sensitized to pharmacological inhibition of the remaining PI3K isoforms. Surprisingly, the pro-survival neutrophil phenotype observed in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) was resilient to inactivation of the PI3K pathway.	[Juss, Jatinder K.; Hayhoe, Richard P.; Cowburn, Andrew S.; Chilvers, Edwin R.; Condliffe, Alison M.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Juss, Jatinder K.; Hayhoe, Richard P.; Cowburn, Andrew S.; Chilvers, Edwin R.; Condliffe, Alison M.] Papworth Hosp, Cambridge CB3 8RE, England; [Juss, Jatinder K.; Kulkarni, Suhasini; Boyle, Keith B.; Stephens, Len; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Owen, Charles E.; Bruce, Ian] Novartis, Horsham Res Ctr, Horsham, W Sussex, England; [Walmsley, Sarah R.] Univ Sheffield, Sch Med, Acad Unit Resp Med, Sheffield, S Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Novartis; University of Sheffield	Condliffe, AM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England.	amc46@medschl.cam.ac.uk		Walmsley, Sarah/0000-0001-9584-174X; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Hayhoe, Richard/0000-0002-7335-2715; Cowburn, Andrew/0000-0001-9145-4275; condliffe, alison/0000-0002-6697-8648; Chilvers, Edwin/0000-0002-4230-9677	NIHR Cambridge Biomedical Research Centre; Biotechnogy and Biological Science Research Council (BBSRC); Papworth Hospital RD Department; BBSRC [BBS/E/B/000C0411, BBS/E/B/0000H111, BBS/E/B/0000M211] Funding Source: UKRI; MRC [G0600840] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H111, BBS/E/B/000C0411, BBS/E/B/0000M211] Funding Source: researchfish; Medical Research Council [G0600840] Funding Source: researchfish	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnogy and Biological Science Research Council (BBSRC); Papworth Hospital RD Department; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in this manuscript was funded by the NIHR Cambridge Biomedical Research Centre (fellowship for Dr Jatinder Juss), the Biotechnogy and Biological Science Research Council (BBSRC) and Papworth Hospital R&D Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Ameriks MK, 2009, CURR TOP MED CHEM, V9, P738, DOI 10.2174/156802609789044434; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; Cowburn AS, 2011, AM J RESP CELL MOL, V44, P879, DOI 10.1165/rcmb.2010-0101OC; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; de Frias M, 2010, BRIT J HAEMATOL, V150, P108, DOI 10.1111/j.1365-2141.2010.08151.x; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; HASLETT C, 1989, CURR OPIN IMMUNOL, V2, P10, DOI 10.1016/0952-7915(89)90091-5; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Johnson C, 2007, ONCOGENE, V26, P7049, DOI 10.1038/sj.onc.1210504; King AG, 2001, BLOOD, V97, P1534, DOI 10.1182/blood.V97.6.1534; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Matute-Bello G, 2000, CRIT CARE MED, V28, P1, DOI 10.1097/00003246-200001000-00001; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Yang KY, 2003, CELL SIGNAL, V15, P225, DOI 10.1016/S0898-6568(02)00063-3	43	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45933	10.1371/journal.pone.0045933	http://dx.doi.org/10.1371/journal.pone.0045933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029326	Green Published, Green Accepted, gold			2022-12-27	WOS:000309554700090
J	Marcilla, A; Trelis, M; Cortes, A; Sotillo, J; Cantalapiedra, F; Minguez, MT; Valero, ML; del Pino, MMS; Munoz-Antoli, C; Toledo, R; Bernal, D				Marcilla, Antonio; Trelis, Maria; Cortes, Alba; Sotillo, Javier; Cantalapiedra, Fernando; Teresa Minguez, Maria; Luz Valero, Maria; Sanchez del Pino, Manuel Mateo; Munoz-Antoli, Carla; Toledo, Rafael; Bernal, Dolores			Extracellular Vesicles from Parasitic Helminths Contain Specific Excretory/Secretory Proteins and Are Internalized in Intestinal Host Cells	PLOS ONE			English	Article							ECHINOSTOMA-FRIEDI TREMATODA; FASCIOLA-HEPATICA; LEUCINE AMINOPEPTIDASE; SECRETORY PRODUCTS; MOLECULAR-CLONING; EXOSOMES; IDENTIFICATION; INFECTIONS; CAPRONI; ENOLASE	The study of host-parasite interactions has increased considerably in the last decades, with many studies focusing on the identification of parasite molecules (i.e. surface or excretory/secretory proteins (ESP)) as potential targets for new specific treatments and/or diagnostic tools. In parallel, in the last few years there have been significant advances in the field of extracellular vesicles research. Among these vesicles, exosomes of endocytic origin, with a characteristic size ranging from 30-100 nm, carry several atypical secreted proteins in different organisms, including parasitic protozoa. Here, we present experimental evidence for the existence of exosome-like vesicles in parasitic helminths, specifically the trematodes Echinostoma caproni and Fasciola hepatica. These microvesicles are actively released by the parasites and are taken up by host cells. Trematode extracellular vesicles contain most of the proteins previously identified as components of ESP, as confirmed by proteomic, immunogold labeling and electron microscopy studies. In addition to parasitic proteins, we also identify host proteins in these structures. The existence of extracellular vesicles explains the secretion of atypical proteins in trematodes, and the demonstration of their uptake by host cells suggests an important role for these structures in host-parasite communication, as described for other infectious agents.	[Marcilla, Antonio; Trelis, Maria; Cortes, Alba; Sotillo, Javier; Cantalapiedra, Fernando; Munoz-Antoli, Carla; Toledo, Rafael] Univ Valencia, Area Parasitol, Dept Biol Celular & Parasitol, Valencia, Spain; [Teresa Minguez, Maria; Luz Valero, Maria] Univ Valencia, Serv Cent Soporte Invest Expt SCSIE, Valencia, Spain; [Luz Valero, Maria] Ctr Invest Principe Felipe, Serv Prote, Valencia, Spain; [Sanchez del Pino, Manuel Mateo; Bernal, Dolores] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	University of Valencia; University of Valencia; Prince Felipe Research Center; University of Valencia	Marcilla, A (corresponding author), Univ Valencia, Area Parasitol, Dept Biol Celular & Parasitol, Valencia, Spain.	antonio.marcilla@uv.es	Muñoz-Antoli, Carla/ABF-6047-2020; Toledo, Rafael/AAA-5052-2020; del Pino, Manuel M. Sánchez/I-3977-2015; Villanueva, María MTV Trelis/K-6021-2014; marcilla, antonio/F-9996-2010; Toledo, Rafael/G-6741-2016; Bernal, Dolores/K-7769-2014; Sotillo, Javier/B-7354-2014	del Pino, Manuel M. Sánchez/0000-0001-9696-7600; Villanueva, María MTV Trelis/0000-0002-5977-3337; marcilla, antonio/0000-0003-0004-0531; Toledo, Rafael/0000-0003-2651-9794; Bernal, Dolores/0000-0003-4627-8393; Sotillo, Javier/0000-0002-1443-7233; Cortes Carbonell, Alba/0000-0002-9027-8780; Cantalapiedra, Fernando/0000-0003-3021-3296	Spanish Ministry of Science and Innovation [FIS09/02355, SAF2010-16236]; FEDER; Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain) [PROMETEO/2009/081]; Universitat de Valencia (Valencia, Spain) [UV-AE-10-23739]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain); Universitat de Valencia (Valencia, Spain)	Funding was provided by FIS09/02355 and SAF2010-16236 from the Spanish Ministry of Science and Innovation and FEDER; PROMETEO/2009/081 from Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain), and UV-AE-10-23739 from the Universitat de Valencia (Valencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; ANDRESEN K, 1989, INT J PARASITOL, V19, P111, DOI 10.1016/0020-7519(89)90028-3; Bernal D, 2006, PROTEOMICS, V6, P2835, DOI 10.1002/pmic.200500571; Bernal D, 2004, FEBS LETT, V563, P203, DOI 10.1016/S0014-5793(04)00306-0; Bobrie A, 2011, TRAFFIC; Clayton C, 2010, ADV EXP MED BIOL, V702, P39, DOI 10.1007/978-1-4419-7841-7_4; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Gehrmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021480; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Giuliani A, 2010, METHODS MOL BIOL, V618, P137, DOI 10.1007/978-1-60761-594-1_10; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Izquierdo-Useros N, 2011, CELL MICROBIOL, V13, P10, DOI 10.1111/j.1462-5822.2010.01542.x; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Liu F, 2009, MOL CELL PROTEOMICS, V8, P1236, DOI 10.1074/mcp.M800538-MCP200; Marcilla A, 2008, CLIN VACCINE IMMUNOL, V15, P95, DOI 10.1128/CVI.00338-07; Marcilla A, 2007, EXP PARASITOL, V117, P57, DOI 10.1016/j.exppara.2007.03.011; Marcilla A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001513; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morphew RM, 2007, MOL CELL PROTEOMICS, V6, P963, DOI 10.1074/mcp.M600375-MCP200; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Robinson MW, 2010, TRENDS PARASITOL, V26, P371, DOI 10.1016/j.pt.2010.05.004; Robinson MW, 2009, PHILOS T R SOC B, V364, P2763, DOI 10.1098/rstb.2009.0089; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Rodrigues ML, 2011, MYCOPATHOLOGIA; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sotillo J, 2008, PARASITE IMMUNOL, V30, P271, DOI 10.1111/j.1365-3024.2007.01019.x; Sotillo J, 2010, PARASITOL RES, V107, P691, DOI 10.1007/s00436-010-1923-x; Stack C, 2011, ADV EXP MED BIOL, V712, P116, DOI 10.1007/978-1-4419-8414-2_8; Thery C, 2011, SCIENTIST, V25, P36; THREADGOLD LT, 1963, Q J MICROSC SCI, V104, P505; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; Toledo R, 2005, TRENDS PARASITOL, V21, P251, DOI 10.1016/j.pt.2005.04.006; Toledo R, 2003, PARASITOLOGY, V126, P433, DOI 10.1017/S0031182003213068; Toledo R, 2012, EUR J CLIN MICROBIOL; Toledo R, 2011, J PROTEOMICS, V74, P1485, DOI 10.1016/j.jprot.2011.03.029; Wang XY, 2011, MOL BIOCHEM PARASIT, V177, P135, DOI 10.1016/j.molbiopara.2011.02.011; Wilson RA, 2011, INT J PARASITOL, V41, P1347, DOI 10.1016/j.ijpara.2011.08.003	52	229	241	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45974	10.1371/journal.pone.0045974	http://dx.doi.org/10.1371/journal.pone.0045974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029346	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309554700099
J	Chang, S; Ross, EM				Chang, Seungwoo; Ross, Elliott M.			Activation Biosensor for G Protein-Coupled Receptors: A FRET-Based m1 Muscarinic Activation Sensor That Regulates G(q)	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CHOLINERGIC-RECEPTOR; RHODOPSIN; BINDING; CRYSTALLOGRAPHY; ENVIRONMENT; MOVEMENT; AGONISTS	We describe the design, construction and validation of a fluorescence sensor to measure activation by agonist of the m1 muscarinic cholinergic receptor, a prototypical class I G(q)-coupled receptor. The sensor uses an established general design in which Forster resonance energy transfer (FRET) from a circularly permuted CFP mutant to FlAsH, a selectively reactive fluorescein, is decreased 15-20% upon binding of a full agonist. Notably, the sensor displays essentially wild-type capacity to catalyze activation of G alpha(q), and the purified and reconstituted sensor displays appropriate regulation of affinity for agonists by G(q). We describe the strategies used to increase the agonist-driven change in FRET while simultaneously maintaining regulatory interactions with G alpha(q), in the context of the known structures of Class I G protein-coupled receptors. The approach should be generally applicable to other Class I receptors which include numerous important drug targets.	[Chang, Seungwoo; Ross, Elliott M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Green Ctr Syst Biol, Dallas, TX 75390 USA.	ross@utsw.swmed.edu			National Institutes of Health [R01GM030355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from National Institutes of Health R01GM030355, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams S, 2002, FORBES, V169, P124; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ambrosio M, 2012, MOL PHARMACOL, V81, P770, DOI 10.1124/mol.112.077693; ARDEN JR, 1992, BIOCHEM BIOPH RES CO, V188, P1111, DOI 10.1016/0006-291X(92)91346-R; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Granier S, 2009, METHODS MOL BIOL, V552, P253, DOI 10.1007/978-1-60327-317-6_18; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Harikumar KG, 2002, J BIOL CHEM, V277, P18552, DOI 10.1074/jbc.M201164200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; HOGGER P, 1995, J BIOL CHEM, V270, P7405; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Inglese J, 1998, BIOCHEMISTRY-US, V37, P2372, DOI 10.1021/bi972161u; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; JOU WM, 1980, CELL, V19, P683, DOI 10.1016/S0092-8674(80)80045-6; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Martikkala E, 2009, ANAL BIOCHEM, V392, P103, DOI 10.1016/j.ab.2009.05.022; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; Middleton RJ, 2005, CURR OPIN CHEM BIOL, V9, P517, DOI 10.1016/j.cbpa.2005.08.016; MINTA A, 1989, J BIOL CHEM, V264, P8171; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARKER EM, 1991, J BIOL CHEM, V266, P519; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Weiss JM, 1996, J THEOR BIOL, V178, P169, DOI 10.1006/jtbi.1996.0015; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45651	10.1371/journal.pone.0045651	http://dx.doi.org/10.1371/journal.pone.0045651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029161	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900085
J	Zhou, L; Cai, JG; Liu, G; Wei, Y; Tang, H				Zhou, Liang; Cai, Jianguang; Liu, Gang; Wei, Yuan; Tang, Hui			Associations between Interleukin-1 Gene Polymorphisms and Coronary Heart Disease Risk: A Meta-Analysis	PLOS ONE			English	Article							RECEPTOR ANTAGONIST GENE; MESSENGER-RNA LEVELS; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; ISCHEMIC-STROKE; CLUSTER POLYMORPHISMS; TURKISH POPULATION; IN-VITRO; ATHEROSCLEROSIS; PERIODONTITIS	Objective: A great number of studies regarding the associations between IL-1B-511, IL-1B+3954 and IL-1RN VNTR polymorphisms within the IL-1gene cluster and coronary heart disease (CHD) have been published. However, results have been inconsistent. In this study, a meta-analysis was performed to investigate the associations. Methods: Published literature from PubMed and Embase databases were searched for eligible publications. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-or fixed-effect model. Results: Thirteen studies (3,219 cases/2,445 controls) for IL-1B-511 polymorphism, nine studies (1,828 cases/1,818 controls) for IL-1B+3954 polymorphism and twelve studies (2,987 cases/2,208 controls) for IL-1RN VNTR polymorphism were included in this meta analysis. The results indicated that both IL-1B-511 and IL-1B+3954 polymorphisms were not associated with CHD risk (IL-1B-511 T vs. C: OR = 0.98, 95% CI 0.87-1.09; IL-1B+3954 T vs. C: OR = 1.06, 95% CI 0.95-1.19). Similarly, there was no association between IL-1RN VNTR polymorphism and CHD risk (*2 vs. L: OR = 1.00, 95% CI 0.85-1.17). Conclusions: This meta-analysis suggested that there were no associations between IL-1 gene cluster polymorphisms and CHD.	[Zhou, Liang; Cai, Jianguang; Liu, Gang; Tang, Hui] Hunan Univ Sci & Technol, Dept Sports Physiol, Xiangtan, Hunan, Peoples R China; [Wei, Yuan] Guangzhou Sports Univ, Dept Sports Physiol, Guangzhou, Guangdong, Peoples R China	Hunan University of Science & Technology; Guangzhou Sport University	Zhou, L (corresponding author), Hunan Univ Sci & Technol, Dept Sports Physiol, Xiangtan, Hunan, Peoples R China.	liangzhou0731@163.com			Key Project of Chinese Ministry of Education [2010148]; Natural Science Foundation of China [30971413]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project of Chinese Ministry of Education (2010148) and Natural Science Foundation of China (30971413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti F, 2002, HEART, V87, P107, DOI 10.1136/heart.87.2.107; Arman A, 2008, ARQ BRAS CARDIOL, V91, P268; Auer J, 2002, CLIN INFECT DIS, V34, P1536, DOI 10.1086/340531; Banerjee I, 2009, J THROMB THROMBOLYS, V27, P88, DOI 10.1007/s11239-007-0184-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brown BD, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-5; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Chen Fan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1635; Coker A, 2011, INT J IMMUNOGENET, V38, P201, DOI 10.1111/j.1744-313X.2010.00988.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Francis SE, 1999, CIRCULATION, V99, P861, DOI 10.1161/01.CIR.99.7.861; Geismar K, 2008, J PERIODONTOL, V79, P2322, DOI [10.1902/jop.2008.070454, 10.1902/jop.2008.070454 ]; Goracy J, 2011, ARCH MED RES, V42, P426, DOI 10.1016/j.arcmed.2011.08.002; Hackett TL, 2011, INT J CHRONIC OBSTR, V6, P277, DOI 10.2147/COPD.S18279; Hurme M, 1998, EUR J IMMUNOL, V28, P2598, DOI 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.3.CO;2-B; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Iacoviello L, 2000, CIRCULATION, V101, pE193; Kariz S, 2007, COLLEGIUM ANTROPOL, V31, P503; Keavney B, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-6; Kim HJ, 2010, CELL MOL LIFE SCI, V67, P2119, DOI 10.1007/s00018-010-0328-4; Kornman KS, 1999, J PERIODONTAL RES, V34, P353, DOI 10.1111/j.1600-0765.1999.tb02265.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Licastro F, 2004, MECH AGEING DEV, V125, P575, DOI 10.1016/j.mad.2004.06.008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Fragoso JM, 2010, IMMUNOL LETT, V133, P106, DOI 10.1016/j.imlet.2010.08.003; Marculescu R, 2002, DIABETES, V51, P3582, DOI 10.2337/diabetes.51.12.3582; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V274, pE210, DOI 10.1152/ajpendo.1998.274.2.E210; Momiyama Y, 2005, ARTERIOSCL THROM VAS, V25, pE36, DOI 10.1161/01.ATV.0000159700.18731.d2; Momiyama Y, 2001, J AM COLL CARDIOL, V38, P712, DOI 10.1016/S0735-1097(01)01438-3; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Rios DLS, 2010, CYTOKINE, V50, P292, DOI 10.1016/j.cyto.2010.02.012; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Soylu O, 2008, EUR CYTOKINE NETW, V19, P42, DOI 10.1684/ecn.2008.0119; Stein JM, 2009, J PERIODONTOL, V80, P1095, DOI 10.1902/jop.2009.080639; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Vamvakopoulos JE, 2002, EUR J IMMUNOGENET, V29, P337, DOI 10.1046/j.1365-2370.2002.00319.x; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Vohnout B, 2003, HAEMATOLOGICA, V88, P54; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; World Health Organization, GLOB ATL CARD DIS PR; World Health Organization. Department of Health Statistics and Infromatics, CAUS DEATH 2008 DAT; Yang L, 2012, INFLAMMATION, DOI [10.1016/j.gene.2012.02.026, DOI 10.1016/J.GENE.2012.02.026]; Ye F, 2012, GENE, V499, P61, DOI 10.1016/j.gene.2012.02.026; Zee RYL, 2008, ATHEROSCLEROSIS, V201, P124, DOI 10.1016/j.atherosclerosis.2008.01.004; Zee RYL, 2001, THROMB HAEMOSTASIS, V86, P1141; Zeybek U, 2011, MOL BIOL REP, V38, P5453, DOI 10.1007/s11033-011-0701-x; Zhang Yuan-ming, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P86; Zhu Yin-Hua, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P73	55	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45641	10.1371/journal.pone.0045641	http://dx.doi.org/10.1371/journal.pone.0045641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029154	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400116
J	Belotti, E; Puvirajesinghe, TM; Audebert, S; Baudelet, E; Camoin, L; Pierres, M; Lasvaux, L; Ferracci, G; Montcouquiol, M; Borg, JP				Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Pierres, Michel; Lasvaux, Lea; Ferracci, Geraldine; Montcouquiol, Mireille; Borg, Jean-Paul			Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes	PLOS ONE			English	Article							PLANAR CELL-POLARITY; NEURAL-TUBE DEFECTS; LOOP-TAIL; TISSUE POLARITY; VANGL2; MOUSE; GENE; STRABISMUS; IDENTIFICATION; DROSOPHILA	Background: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. Methodology and Main Findings: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. Conclusion: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues.	[Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] INSERM, U1068, CRCM, F-13258 Marseille, France; [Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] CNRS UMR7258, CRCM, Marseille, France; [Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, CRN2M UMR7286, Marseille, France; [Pierres, Michel] CNRS, Ctr Immunol Marseille Luminy, UMR INSERM 6102, Marseille, France; [Lasvaux, Lea; Montcouquiol, Mireille] Bordeaux Univ, Neuroctr Magendie, Planar Polar & Plast Grp, INSERM,U862, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Borg, JP (corresponding author), INSERM, U1068, CRCM, F-13258 Marseille, France.	jean-paul.borg@inserm.fr	Puvirajesinghe, Tania/AAD-9137-2020; Camoin, Luc/AAB-3856-2019; montcouquiol, mireille/L-6199-2017; Borg, Jean-Paul/AAX-8096-2020	Camoin, Luc/0000-0002-1230-4787; montcouquiol, mireille/0000-0001-8739-6519; Borg, Jean-Paul/0000-0001-8418-3382; Puvirajesinghe, Tania/0000-0002-8304-9824; Belotti, Edwige/0000-0002-0496-2309; Audebert, Stephane/0000-0002-9409-2588	Foundation of Medical Research (FRM, France); Association pour la Recherche contre le Cancer (ARC); La Ligue Contre le Cancer (Label Ligue JPB); EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)); INCa (L'Institut National du Cancer); IBiSA (Infrastructures Biologie Sante et Agronomie) [ANR-08-MNPS-040-01]; Region Regional Aquitaine	Foundation of Medical Research (FRM, France); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Ligue Contre le Cancer (Label Ligue JPB); EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)); INCa (L'Institut National du Cancer); IBiSA (Infrastructures Biologie Sante et Agronomie); Region Regional Aquitaine	This work was supported by grants from the Foundation of Medical Research (FRM, France), Association pour la Recherche contre le Cancer (ARC) and La Ligue Contre le Cancer (Label Ligue JPB), EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)), INCa (L'Institut National du Cancer) and IBiSA (Infrastructures Biologie Sante et Agronomie), ANR-08-MNPS-040-01(MM), Region Regional Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gravel M, 2010, BIOCHEMISTRY-US, V49, P3445, DOI 10.1021/bi902180m; Iliescu A, 2011, BIOCHEMISTRY-US, V50, P2274, DOI 10.1021/bi101767a; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Jessen JR, 2004, GENE EXPR PATTERNS, V4, P339, DOI 10.1016/j.modgep.2003.09.012; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Lake BB, 2009, J CELL BIOL, V185, P59, DOI 10.1083/jcb.200807073; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Taylor J, 1998, GENETICS, V150, P199; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988	30	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46213	10.1371/journal.pone.0046213	http://dx.doi.org/10.1371/journal.pone.0046213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029439	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900109
J	Wang, XG; Huang, XT; Jackson, T; Chen, RJ				Wang, Xiaogang; Huang, Xiting; Jackson, Todd; Chen, Ruijun			Components of Implicit Stigma against Mental Illness among Chinese Students	PLOS ONE			English	Article							EXPLICIT ATTITUDES; ASSOCIATION TEST; PEOPLE; SCHIZOPHRENIA; SHAME	Although some research has examined negative automatic aspects of attitudes toward mental illness via relatively indirect measures among Western samples, it is unclear whether negative attitudes can be automatically activated in individuals from non-Western countries. This study attempted to validate results from Western samples with Chinese college students. We first examined the three-component model of implicit stigma (negative cognition, negative affect, and discriminatory tendencies) toward mental illness with the Single Category Implicit Association Test (SC-IAT). We also explored the relationship between explicit and implicit stigma among 56 Chinese university college students. In the three separate SC-IATs and the combined SC-IAT, automatic associations between mental illness and negative descriptors were stronger relative to those with positive descriptors and the implicit effect of cognitive and affective SC-IATs were significant. Explicit and implicit measures of stigma toward mental illness were unrelated. In our sample, women's overall attitudes toward mental illness were more negative than men's were, but no gender differences were found for explicit measures. These findings suggested that implicit stigma toward mental illness exists in Chinese students, and provide some support for the three-component model of implicit stigma toward mental illness. Future studies that focus on automatic components of stigmatization and stigma-reduction in China are warranted.	[Wang, Xiaogang; Huang, Xiting; Jackson, Todd] Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Wang, Xiaogang; Huang, Xiting; Jackson, Todd] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Wang, Xiaogang] Sichuan Judicial & Police Officers Profess Coll, Deyang, Peoples R China; [Chen, Ruijun] Southwest Univ, Sch Culture & Social Dev Studies, Chongqing, Peoples R China; [Chen, Ruijun] Zhengzhou Normal Univ, Coll Educ Sci, Zhengzhou, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China; Zhengzhou Normal University	Huang, XT (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xthuang@swu.edu.cn			Fundamental Research Funds for the Central Universities [SWU1209480]; Key Discipline Fund of the National 211 Project, China [NSKD11001]; Study for Well-being Index of a City [2010CQZDW07]; Ministry of Education of the People's Republic of China [05JZD00031]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of the National 211 Project, China; Study for Well-being Index of a City; Ministry of Education of the People's Republic of China(Ministry of Education, China)	This research was supported by the Fundamental Research Funds for the Central Universities (SWU1209480) to the first author, the Key Discipline Fund of the National 211 Project, China (NSKD11001), The Study for Well-being Index of a City (2010CQZDW07), and a Philosophy and Social Science grant (05JZD00031) from the Ministry of Education of the People's Republic of China to the corresponding author and research fellow. Study design and data collection were supported by The Fundamental Research Funds for the Central Universities (SWU1209480) and The Study for Well-being Index of a City (2010CQZDW07). Data analysis was supported by a Philosophy and Social Science grant (05JZD00031) from the Ministry of Education of the People's Republic of China; SWU1209480 and the Key Discipline Fund of the National 211 Project, China. (NSKD11001) have roles in preparation of the manuscript and, decision to publish.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Bennett K, 1996, QUALITY LIFE PHARMAC, P259; Chang HC., 1991, COMMUN Q, V39, P251, DOI [10.1080/01463379109369802, DOI 10.1080/01463379109369802]; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; [戴晓阳 Dai Xiaoyang], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P171; De Houwer J, 2003, EXP PSYCHOL, V50, P77, DOI 10.1026//1618-3169.50.2.77; Farina A., 1981, CLIN PSYCHOL REV, V1, P223, DOI DOI 10.1016/0272-7358(81)90005-2; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Hanzawa S, 2010, ASIA-PAC PSYCHIAT, V2, P105, DOI 10.1111/j.1758-5872.2010.00065.x; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Lai Y. M., 2001, SMJ Singapore Medical Journal, V42, P111; Lee S, 2005, BRIT J PSYCHIAT, V186, P153, DOI 10.1192/bjp.186.2.153; Lincoln TM, 2008, SCHIZOPHRENIA BULL, V34, P984, DOI 10.1093/schbul/sbm131; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; OLSON JM, 1993, ANNU REV PSYCHOL, V44, P117, DOI 10.1146/annurev.psych.44.1.117; Peris TS, 2008, J NERV MENT DIS, V196, P752, DOI 10.1097/NMD.0b013e3181879dfd; Phillips MR, 2002, BRIT J PSYCHIAT, V181, P488, DOI 10.1192/bjp.181.6.488; Rusch N, 2007, AM J PSYCHIAT, V164, P500, DOI 10.1176/appi.ajp.164.3.500; Rusch N, 2011, PSYCHIAT RES, V186, P34, DOI 10.1016/j.psychres.2010.08.024; Rusch N, 2010, PSYCHIAT RES, V179, P328, DOI 10.1016/j.psychres.2009.09.010; Rusch N, 2010, J NERV MENT DIS, V198, P150, DOI 10.1097/NMD.0b013e3181cc43b5; Rusch N, 2010, J BEHAV THER EXP PSY, V41, P60, DOI 10.1016/j.jbtep.2009.10.002; Rusch N, 2009, SCHIZOPHR RES, V112, P119, DOI 10.1016/j.schres.2009.04.011; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Stier A, 2007, AUST PSYCHOL, V42, P106, DOI 10.1080/00050060701280599; Teachman BA, 2006, J SOC CLIN PSYCHOL, V25, P75, DOI 10.1521/jscp.2006.25.1.75; Tsang HWH, 2003, J COMMUNITY PSYCHOL, V31, P383, DOI 10.1002/jcop.10055; [王晓刚 Wang Xiaogang], 2012, [心理科学进展, Advances in Psychological Science], V20, P384; Xu Y, 2009, PSYCHOL EXPLOR, V29, P33; Yang L. H., 2007, SMJ Singapore Medical Journal, V48, P977	35	5	7	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46016	10.1371/journal.pone.0046016	http://dx.doi.org/10.1371/journal.pone.0046016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029366	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900072
J	Chen, J; Cai, QP; Shen, PJ; Yan, RL; Wang, CM; Yang, DJ; Fu, HB; Chen, XY				Chen, Ji; Cai, Qing-ping; Shen, Pi-jie; Yan, Rong-lin; Wang, Chang-ming; Yang, De-jun; Fu, Hong-bing; Chen, Xue-yun			Netrin-1 Protects against L-Arginine-Induced Acute Pancreatitis in Mice	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SURVIVAL; INFLAMMATION; EXPRESSION; SEVERITY; RECEPTORS; MIGRATION; INHIBITION; MECHANISMS; CYTOKINES	Acute pancreatitis (AP) is a common inflammatory disease mediated by damage to acinar cells and subsequent pancreatic inflammation with infiltration of leukocytes. The neuronal guidance protein, netrin-1, has been shown to control leukocyte trafficking and modulate inflammatory responses in several inflammation-based diseases. The present study was aimed toward investigating the effects of netrin-1 in an in vivo model of AP in mice. AP was induced in C57BL/6 mice by administration of two intraperitoneal injections of L-Arginine (4 g/kg). Mice were treated with recombinant mouse netrin-1 at a dose of 1 mu g/mouse or vehicle (0.1% BSA) intravenously through the tail vein immediately after the second injection of L-Arginine, and every 24 h thereafter. Mice were sacrificed at several time intervals from 0 to 96 h after the induction of pancreatitis. Blood and tissue samples of pancreas and lung were collected and processed to determine the severity of pancreatitis biochemically and histologically. Immunohistochemical staining demonstrated that netrin-1 was mainly expressed in the islet cells of the normal pancreas and the AP model pancreas, and the pancreatic expression of netrin-1 was down-regulated at both the mRNA and protein levels during the course of AP. Exogenous netrin-1 administration significantly reduced plasma amylase levels, myeloperoxidase activity, pro-inflammatory cytokine production, and pancreas and lung tissue damages. Furthermore, netrin-1 administration did not cause significant inhibition of nuclear factor-kappa B activation in the pancreas of L-Arginine-induced AP. In conclusion, our novel data suggest that netrin-1 is capable of improving damage of pancreas and lung, and exerting anti-inflammatory effects in mice with severe acute pancreatitis. Thus, our results indicate that netrin-1 may constitute a novel target in the management of AP.	[Chen, Ji; Cai, Qing-ping; Shen, Pi-jie; Yan, Rong-lin; Wang, Chang-ming; Yang, De-jun; Fu, Hong-bing; Chen, Xue-yun] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China	Naval Medical University	Yan, RL (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China.	yanronglin@163.com			Shanghai Municipal Science and Technology commission [10JC1412700]; Natural Science Foundation of China [30901770, 81150110493]	Shanghai Municipal Science and Technology commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by Shanghai Municipal Science and Technology commission (no. 10JC1412700) and the Natural Science Foundation of China (no. 30901770 and no. 81150110493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, GUT, V10, P1136; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Bhatia M, 1998, INT J PANCREATOL, V24, P77; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; De Breuck S, 2003, DIABETOLOGIA, V46, P926, DOI 10.1007/s00125-003-1125-5; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Gravante G, 2009, PANCREATOLOGY, V9, P601, DOI 10.1159/000212097; Hughes CB, 1996, AM J SURG, V171, P274, DOI 10.1016/S0002-9610(97)89568-2; INOUE S, 1995, ARCH SURG-CHICAGO, V130, P93; JAVIER P, 2004, ANN SURG, V240, P108; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Link BC, 2007, ANN SURG ONCOL, V14, P2591, DOI 10.1245/s10434-007-9469-6; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Pezzilli R, 2009, EXPERT OPIN PHARMACO, V10, P2999, DOI 10.1517/14656560903382630; Rakonczay Z, 2003, FREE RADICAL BIO MED, V34, P696, DOI 10.1016/S0891-5849(02)01373-4; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sandoval D, 1996, GASTROENTEROLOGY, V111, P1081, DOI 10.1016/S0016-5085(96)70077-X; Satoh A, 1999, GUT, V44, P253, DOI 10.1136/gut.44.2.253; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Steinle AU, 1999, GASTROENTEROLOGY, V116, P420, DOI 10.1016/S0016-5085(99)70140-X; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; Vonlaufen A, 2008, J GASTROEN HEPATOL, V23, P1339, DOI 10.1111/j.1440-1746.2008.05520.x; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PHYSIOL-RENAL, V296, pF723, DOI 10.1152/ajprenal.90686.2008; Werner J, 1998, ANN SURG, V227, P86, DOI 10.1097/00000658-199801000-00013; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Yang YHC, 2011, DIABETOLOGIA, V54, P828, DOI 10.1007/s00125-010-2012-5; Zhou XL, 2009, PANCREAS, V38, P752, DOI 10.1097/MPA.0b013e3181a86b74	45	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46201	10.1371/journal.pone.0046201	http://dx.doi.org/10.1371/journal.pone.0046201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029434	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500071
J	Huang, SX; Zhu, XM; Liu, YF; Tao, YX; Feng, GY; He, L; Guo, XZ; Ma, G				Huang, Sixia; Zhu, Xuming; Liu, Yanfang; Tao, Yixin; Feng, Guoyin; He, Lin; Guo, Xizhi; Ma, Gang			Wls Is Expressed in the Epidermis and Regulates Embryonic Hair Follicle Induction in Mice	PLOS ONE			English	Article							SONIC HEDGEHOG; WNT LIGANDS; MORPHOGENESIS; SECRETION; WNTLESS; PROTEIN; DIFFERENTIATION; INITIATION; AXIS	Wnt proteins are secreted molecules that play multiple roles during hair follicle development and postnatal hair cycling. Wntless (Wls) is a cargo protein required for the secretion of various Wnt ligands. However, its role during hair follicle development and hair cycling remains unclear. Here, we examined the expression of Wls during hair follicle induction and postnatal hair cycling. We also conditionally deleted Wls with K14-cre to investigate its role in hair follicle induction. K14-cre;Wls(c/c) mice exhibited abnormal hair follicle development, which is possibly caused by impaired canonical Wnt signaling. Meanwhile, Wnt5a is also expressed in embryonic epidermis, but Wnt5a null mice showed no significant defect in embryonic hair follicle morphogenesis. Therefore, Wls may regulate hair follicle induction by mediating the Wnt/beta-catenin pathway.	[Huang, Sixia; Zhu, Xuming; Liu, Yanfang; Tao, Yixin; Feng, Guoyin; He, Lin; Guo, Xizhi; Ma, Gang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xzguo2005@gmail.com; magang2004@gmail.com	Zhu, Xuming/ABC-6380-2021; liu, yan/HCI-5542-2022	Zhu, Xuming/0000-0003-1148-4162; Huang, Sixia/0000-0003-3591-1085; Guo, Xizhi/0000-0001-8047-6049	973 Program [2011CBA00803, 2010CB529600, 2012CB966900]; National Key Technology Research and Development Program [2012BAI01B09]; National Nature Science Foundation of China [81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The study was supported by the 973 Program (2011CBA00803, 2010CB529600,2012CB966900), the National Key Technology Research and Development Program (2012BAI01B09), the National Nature Science Foundation of China (81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim H, 2009, MOL CELL BIOL, V29, P2118, DOI 10.1128/MCB.01503-08; Lindner G, 1997, AM J PATHOL, V151, P1601; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	24	30	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45904	10.1371/journal.pone.0045904	http://dx.doi.org/10.1371/journal.pone.0045904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029304	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700087
J	Niu, HJ; Wang, JH; Zhao, TD; Shu, N; He, Y				Niu, Haijing; Wang, Jinhui; Zhao, Tengda; Shu, Ni; He, Yong			Revealing Topological Organization of Human Brain Functional Networks with Resting-State Functional near Infrared Spectroscopy	PLOS ONE			English	Article							SMALL-WORLD; MODULAR ORGANIZATION; CORTICAL NETWORKS; LARGE-SCALE; CONNECTIVITY; LANGUAGE; INFANTS; CORTEX; ARCHITECTURE; BEHAVIOR	Background: The human brain is a highly complex system that can be represented as a structurally interconnected and functionally synchronized network, which assures both the segregation and integration of information processing. Recent studies have demonstrated that a variety of neuroimaging and neurophysiological techniques such as functional magnetic resonance imaging (MRI), diffusion MRI and electroencephalography/magnetoencephalography can be employed to explore the topological organization of human brain networks. However, little is known about whether functional near infrared spectroscopy (fNIRS), a relatively new optical imaging technology, can be used to map functional connectome of the human brain and reveal meaningful and reproducible topological characteristics. Results: We utilized resting-state fNIRS (R-fNIRS) to investigate the topological organization of human brain functional networks in 15 healthy adults. Brain networks were constructed by thresholding the temporal correlation matrices of 46 channels and analyzed using graph-theory approaches. We found that the functional brain network derived from R-fNIRS data had efficient small-world properties, significant hierarchical modular structure and highly connected hubs. These results were highly reproducible both across participants and over time and were consistent with previous findings based on other functional imaging techniques. Conclusions: Our results confirmed the feasibility and validity of using graph-theory approaches in conjunction with optical imaging techniques to explore the topological organization of human brain networks. These results may expand a methodological framework for utilizing fNIRS to study functional network changes that occur in association with development, aging and neurological and psychiatric disorders.	[Niu, Haijing; Wang, Jinhui; Zhao, Tengda; Shu, Ni; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Wang, jinhui/AAF-8668-2019	He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81030028, 81201122]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant numbers 81030028 and 81201122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Duan L, 2012, NEUROIMAGE, V60, P2008, DOI 10.1016/j.neuroimage.2012.02.014; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; Nakano T, 2009, CEREB CORTEX, V19, P455, DOI 10.1093/cercor/bhn096; Niu HJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3561687; Niu HJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462986; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2011, NEUROIMAGE IN PRESS; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White BR, 2012, NEUROIMAGE, V59, P2529, DOI 10.1016/j.neuroimage.2011.08.094; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Xia M, 2011, BRAIN CONNE IN PRESS; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhang H, 2010, NEUROIMAGE, V51, P1150, DOI 10.1016/j.neuroimage.2010.02.080; Zhang YJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462973; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	64	64	65	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45771	10.1371/journal.pone.0045771	http://dx.doi.org/10.1371/journal.pone.0045771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029235	Green Published, gold			2022-12-27	WOS:000309554700070
J	Saito, S; Furuno, A; Sakurai, J; Park, HR; Shin-ya, K; Tomida, A				Saito, Sakae; Furuno, Aki; Sakurai, Junko; Park, Hae-Ryong; Shin-ya, Kazuo; Tomida, Akihiro			Compound C Prevents the Unfolded Protein Response during Glucose Deprivation through a Mechanism Independent of AMPK and BMP Signaling	PLOS ONE			English	Article							KINASE INHIBITORS; CHEMICAL GENOMICS; CELL-SURVIVAL; MESSENGER-RNA; ATF6; STRESS; PROLIFERATION; PROTEOLYSIS; ACTIVATION; RESISTANCE	Inhibiting the unfolded protein response (UPR) can be a therapeutic approach, especially for targeting the tumor microenvironment. Here, we show that compound C (also known as dorsomorphin), a small-molecule inhibitor of AMP-activated protein kinase (AMPK) and bone morphogenetic protein (BMP) signaling, inhibit the UPR-induced transcription program depending on the glucose deprivation conditions. We found that compound C prevented UPR marker glucose-regulated protein 78 (GRP78) accumulation and exerted enhanced cytotoxicity during glucose deprivation. Gene expression profiling, together with biochemical analysis, revealed that compound C had a unique mode of action to suppress the transcriptional activation of UPR-targeted genes, as compared with the classic UPR inhibitors versipelostatin and biguanides. Surprisingly, the UPR-inhibiting activity of compound C was not associated with either AMPK or BMP signaling inhibition. We further found that combination treatments of compound C and the classic UPR inhibitors resulted in synergistic cell death with UPR suppression during glucose deprivation. Our findings demonstrate that compound C could be a unique tool for developing a UPR-targeted antitumor therapy.	[Saito, Sakae; Furuno, Aki; Sakurai, Junko; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan; [Park, Hae-Ryong] Kyungnam Univ, Dept Food Sci & Biotechnol, Masan, South Korea; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Kyungnam University; National Institute of Advanced Industrial Science & Technology (AIST)	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan.	akihiro.tomida@jfcr.or.jp	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661	Ministry of Education, Culture, Sports, Science and Technology of Japan [22300342, 23701067]; National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare [21-3-1]; Kobayashi Foundation for Cancer Research; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [24650626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research (B) (22300342; AT) and a Grant-in-Aid for Young Scientists (B) (23701067; SS), from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the National Cancer Center Research and Development Fund (21-3-1) (AT) from the Ministry of Health, Labour and Welfare; a grant from Kobayashi Foundation for Cancer Research (AT); and from the Vehicle Racing Commemorative Foundation (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dan S, 2002, CANCER RES, V62, P1139; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DILMAN VM, 1979, CANCER LETT, V7, P357, DOI 10.1016/S0304-3835(79)80066-X; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Haga N, 2010, CANCER SCI, V101, P1125, DOI 10.1111/j.1349-7006.2010.01525.x; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Matsuo J, 2009, CANCER SCI, V100, P327, DOI 10.1111/j.1349-7006.2008.01036.x; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogiso Y, 2000, CANCER RES, V60, P2429; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45845	10.1371/journal.pone.0045845	http://dx.doi.org/10.1371/journal.pone.0045845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029271	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700078
J	Wang, XP; Deng, XL; Zhang, XC				Wang, Xinping; Deng, Xuliang; Zhang, Xichen			Identification of a Novel Splicing Form of Amelogenin Gene in a Reptile, Ctenosaura similis	PLOS ONE			English	Article							PRIMARY RNA TRANSCRIPT; MESSENGER-RNAS; DNA-SEQUENCE; RAT INCISOR; CDNA SEQUENCE; IN-VIVO; PROTEIN; ENAMEL; CLONING; EXPRESSION	Amelogenin, the major enamel matrix protein in tooth development, has been demonstrated to play a significant role in tooth enamel formation. Previous studies have identified the alternative splicing of amelogenin in many mammalian vertebrates as one mechanism for amelogenin heterogeneous expression in teeth. While amelogenin and its splicing forms in mammalian vertebrates have been cloned and sequenced, the amelogenin gene, especially its splicing forms in non-mammalian species, remains largely unknown. To better understand the mechanism underlying amelogenin evolution, we previously cloned and characterized an amelogenin gene sequence from a squamate, the green iguana. In this study, we employed RT-PCR to amplify the amelogenin gene from the black spiny-tailed iguana Ctenosaura similis teeth, and discovered a novel splicing form of the amelogenin gene. The transcript of the newly identified iguana amelogenin gene (named C. Similis-T2L) is 873 nucleotides long encoding an expected polypeptide of 206 amino acids. The C. Similis-T2L contains a unique exon denominated exon X, which is located between exon 5 and exon 6. The C. Similis-T2L contains 7 exons including exon 1, 2, 3, 5, X, 6, and 7. Analysis of the secondary and tertiary structures of T2L amelogenin protein demonstrated that exon X has a dramatic effect on the amelogenin structures. This is the first report to provide definitive evidence for the amelogenin alternative splicing in non-mammalian vertebrates, revealing a unique exon X and the splicing form of the amelogenin gene transcript in Ctenosaura similis.	[Wang, Xinping; Zhang, Xichen] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China; [Deng, Xuliang] Beijing Univ, Sch Stomatol, Beijing 100871, Peoples R China	Jilin University; Peking University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Jilin University [4305050102Q6, 4305050102O1]; National Basic Research Program of China [2012CB933904]; National Natural Science Foundation of China [81171000]	Jilin University(Jilin University); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Jilin University (4305050102Q6 and 4305050102O1) to Xinping Wang; the National Basic Research Program of China (2012CB933904), the National Natural Science Foundation of China (No. 81171000) to Xuliang Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOBA T, 1989, J DENT RES, V68, P1331, DOI 10.1177/00220345890680090901; Baba O, 2002, J HISTOCHEM CYTOCHEM, V50, P1229, DOI 10.1177/002215540205000910; BONASS WA, 1994, BIOCHEM BIOPH RES CO, V198, P755, DOI 10.1006/bbrc.1994.1109; BONASS WA, 1994, BBA-GENE STRUCT EXPR, V1219, P690, DOI 10.1016/0167-4781(94)90228-3; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; DENBESTEN PK, 1992, ARCH ORAL BIOL, V37, P1097, DOI 10.1016/0003-9969(92)90043-8; DIEKWISCH T, 1993, DEVELOPMENT, V117, P471; GIBSON C, 1991, BIOCHEMISTRY-US, V30, P1075, DOI 10.1021/bi00218a028; Hu CC, 1996, J DENT RES, V75, P1728, DOI 10.1177/00220345960750100401; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Hu CC, 1997, J DENT RES, V76, P641, DOI 10.1177/00220345970760020401; Ishiyama M, 1998, ARCH HISTOL CYTOL, V61, P467, DOI 10.1679/aohc.61.467; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; Li R, 1995, J DENT RES, V74, P1880, DOI 10.1177/00220345950740121101; Li W, 1998, ARCH ORAL BIOL, V43, P497, DOI 10.1016/S0003-9969(98)00013-2; Lyaruu DM, 1998, EUR J ORAL SCI, V106, P299, DOI 10.1111/j.1600-0722.1998.tb02190.x; LYNGSTADAAS SP, 1995, EMBO J, V14, P5224, DOI 10.1002/j.1460-2075.1995.tb00207.x; Mathur Ajay Kishore, 2000, Journal of Mammalian Evolution, V7, P23, DOI 10.1023/A:1009413632741; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Shimokawa H, 1987, Adv Dent Res, V1, P293; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Wang XP, 2006, J EXP ZOOL PART B, V306B, P393, DOI 10.1002/jez.b.21096; Wang XP, 2005, J EXP ZOOL PART B, V304B, P177, DOI 10.1002/jez.b.21035; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324; Zhang X, 2011, PLOS ONE, V6, P1	32	6	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45871	10.1371/journal.pone.0045871	http://dx.doi.org/10.1371/journal.pone.0045871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029286	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700080
J	Ofran, Y; Paltiel, O; Pelleg, D; Rowe, JM; Yom-Tov, E				Ofran, Yishai; Paltiel, Ora; Pelleg, Dan; Rowe, Jacob M.; Yom-Tov, Elad			Patterns of Information-Seeking for Cancer on the Internet: An Analysis of Real World Data	PLOS ONE			English	Article							HEALTH INFORMATION; INTERVENTION; PROGNOSIS	Although traditionally the primary information sources for cancer patients have been the treating medical team, patients and their relatives increasingly turn to the Internet, though this source may be misleading and confusing. We assess Internet searching patterns to understand the information needs of cancer patients and their acquaintances, as well as to discern their underlying psychological states. We screened 232,681 anonymous users who initiated cancer-specific queries on the Yahoo Web search engine over three months, and selected for study users with high levels of interest in this topic. Searches were partitioned by expected survival for the disease being searched. We compared the search patterns of anonymous users and their contacts. Users seeking information on aggressive malignancies exhibited shorter search periods, focusing on disease-and treatment-related information. Users seeking knowledge regarding more indolent tumors searched for longer periods, alternated between different subjects, and demonstrated a high interest in topics such as support groups. Acquaintances searched for longer periods than the proband user when seeking information on aggressive (compared to indolent) cancers. Information needs can be modeled as transitioning between five discrete states, each with a unique signature representing the type of information of interest to the user. Thus, early phases of information-seeking for cancer follow a specific dynamic pattern. Areas of interest are disease dependent and vary between probands and their contacts. These patterns can be used by physicians and medical Web site authors to tailor information to the needs of patients and family members.	[Ofran, Yishai] Rambam Med Ctr, Dept Hematol & Bone Marrow Transplantat, Haifa, Israel; [Ofran, Yishai] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Paltiel, Ora] Hadassah Univ Hosp, Dept Hematol, IL-91120 Jerusalem, Israel; [Paltiel, Ora] Hadassah Univ Hosp, Sch Publ Hlth, IL-91120 Jerusalem, Israel; [Pelleg, Dan] Yahoo Res, Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Jerusalem, Israel; [Yom-Tov, Elad] Yahoo Res, New York, NY USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Yom-Tov, E (corresponding author), Microsoft Res, New York, NY USA.	eladyt@microsoft.com		Yom-Tov, Elad/0000-0002-2380-4584; Ofran, Yishai/0000-0002-5521-1337				Breyer BN, 2010, EPIDEMIOLOGY, V21, P584, DOI 10.1097/EDE.0b013e3181e080cd; Butow PN, 1997, ANN ONCOL, V8, P857, DOI 10.1023/A:1008284006045; Bylund CL, 2009, PSYCHO-ONCOLOGY, V18, P1139, DOI 10.1002/pon.1511; Castleton K, 2011, SUPPORT CARE CANCER, V19, P1183, DOI 10.1007/s00520-010-0935-5; Chou WYS, 2011, J CANCER SURVIV, V5, P263, DOI 10.1007/s11764-011-0179-5; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Gage EA, 2011, SOCIOL HLTH ILLN, V2011; Gencer D, 2011, ONKOLOGIE, V34, P435, DOI 10.1159/000330940; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Howlader N, 2011, SEER CANC STAT REV 1; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Imes RS, 2008, HEALTH COMMUN, V23, P538, DOI 10.1080/10410230802460580; INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604; James N, 2007, CLIN ONCOL-UK, V19, P356, DOI 10.1016/j.clon.2007.02.005; Kubler-Ross E., 1973, DEATH DYING; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P389, DOI 10.1016/S1083-8791(03)00103-4; Lopez-Gomez M, 2011, ANN ONCOL, V2011; Nagler RH, 2010, PATIENT EDUC COUNS, V81, pS54, DOI 10.1016/j.pec.2010.09.010; Partin MR, 2003, J CLIN EPIDEMIOL, V56, P867, DOI 10.1016/S0895-4356(03)00061-1; Paul MJ, 2011, ICWSM 2011; Quin J, 2010, J SURG RES, V160, P35, DOI 10.1016/j.jss.2008.10.004; Russ H, 2011, ISR MED ASSOC J, V13, P220; Shiffman S, 2009, HEALTH PSYCHOL, V28, P519, DOI 10.1037/a0015197; Smith-McLallen A, 2011, J HLTH COMM, V1, P1; Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751; Sogaard AJ, 2004, INT J EQUITY HLTH, V3; Stehl ML, 2009, J PEDIATR PSYCHOL, V34, P803, DOI 10.1093/jpepsy/jsn130; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WEISMAN AD, 1976, INT J PSYCHIAT MED, V7, P1, DOI 10.2190/UQ2G-UGV1-3PPC-6387; White R. W., 2009, P CIKM; White RW, 2009, ACM T INFORM SYST, P271; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; YANG H, 2010, P ACM SIGIR, P459; Yom-Tov E, 2011, SIGIR, P385	37	46	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45921	10.1371/journal.pone.0045921	http://dx.doi.org/10.1371/journal.pone.0045921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029317	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800121
J	Xie, WB; Yang, Y; Gu, XP; Zheng, YG; Sun, YE; Liang, Y; Bo, JH; Ma, ZL				Xie, Weibin; Yang, Yan; Gu, Xiaoping; Zheng, Yaguo; Sun, Yu-e; Liang, Ying; Bo, Jinhua; Ma, Zhengliang			Senegenin Attenuates Hepatic Ischemia-Reperfusion Induced Cognitive Dysfunction by Increasing Hippocampal NR2B Expression in Rats	PLOS ONE			English	Article							POLYGALA-TENUIFOLIA ROOT; LONG-TERM POTENTIATION; GENETIC ENHANCEMENT; NMDA RECEPTORS; MEMORY; TENUIGENIN; EXTRACT; DECLINE; MICE; SECRETION	Background: The root of Polygala tenuifolia, a traditional Chinese medicine, has been used to improve memory and intelligence, while the underlying mechanisms remain largely unknown. In this study, we investigated the protective effects of senegenin, an component of Polygala tenuifolia root extracts, on cognitive dysfunction induced by hepatic ischemia-reperfusion. Methodology/Principal Findings: Initially, we constructed a rat model of hepatic ischemia-reperfusion (HIR) and found that the memory retention ability of rats in the step-down and Y maze test was impaired after HIR, paralleled by a decrease of N-methyl-D-aspartate (NMDA) receptor NR2B subunit mRNA and protein expressions in hippocampus. Furthermore, we found that administration of senegenin by gavage attenuated HIR-induced cognitive impairment in a dose and time dependent manner, and its mechanisms might partly due to the increasing expression of NR2B in rat hippocampus. Conclusions/Significance: Cognitive dysfunction induced by HIR is associated with reduction of NR2B expression. Senegenin plays a neuroprotective role in HIR via increasing NR2B expression in rat hippocampus. These findings suggest that senegenin might be a potential agent for prevention and treatment of postoperative cognitive dysfunction (POCD) or other neurodegenerative diseases.	[Yang, Yan; Gu, Xiaoping; Zheng, Yaguo; Sun, Yu-e; Liang, Ying; Bo, Jinhua; Ma, Zhengliang] Nanjing Univ, Coll Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China; [Xie, Weibin] Nanjing Univ Chinese Med, Drum Tower Clin Coll Chinese & Western Integrat M, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine	Ma, ZL (corresponding author), Nanjing Univ, Coll Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China.	mazhengliang1964@yahoo.com.cn			National Natural Foundation of China [81070892, 81171047]; Jiangsu Province of China [BK2009030, BK2010105, RC2007012, RC2011006, 2009044, XK201140]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province of China	This research was supported by grants from the National Natural Foundation of China(Research Grant 81070892 and 81171047), and funds from Jiangsu Province of China (BK2009030, BK2010105, RC2007012, RC2011006, 2009044 and XK201140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Chen Qin, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1336; Chen YL, 2004, J ETHNOPHARMACOL, V95, P47, DOI 10.1016/j.jep.2004.06.015; Chen YJ, 2010, EUR J PHARMACOL, V645, P1, DOI 10.1016/j.ejphar.2010.06.034; Chung IW, 2002, PHARMACOL BIOCHEM BE, V71, P191, DOI 10.1016/S0091-3057(01)00648-7; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clayton DA, 2002, J NEUROSCI, V22, P3628; Colletti LM, 1996, HEPATOLOGY, V23, P506; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Ikeya Y, 2004, BIOL PHARM BULL, V27, P1081, DOI 10.1248/bpb.27.1081; Jia HX, 2004, NEUROSCI LETT, V367, P123, DOI 10.1016/j.neulet.2004.05.093; Kawashima K, 2004, BIOL PHARM BULL, V27, P1317, DOI 10.1248/bpb.27.1317; Kim B. G., 2003, J ORIENTAL NEUROPSYC, V14, P43; Kim HM, 1998, J ETHNOPHARMACOL, V61, P201, DOI 10.1016/S0378-8741(98)00040-3; KOO A, 1992, HEPATOLOGY, V15, P507, DOI 10.1002/hep.1840150325; Lee JY, 2009, NEUROSCI LETT, V454, P111, DOI 10.1016/j.neulet.2009.03.024; Liang ZG, 2011, NEUROSCI LETT, V497, P104, DOI 10.1016/j.neulet.2011.04.041; Lv J, 2009, ACTA PHYSIOL, V196, P419, DOI 10.1111/j.1748-1716.2009.01961.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niu QA, 2007, NEUROTOX RES, V12, P163, DOI 10.1007/BF03033913; Park CH, 2002, J NEUROSCI RES, V70, P484, DOI 10.1002/jnr.10429; Park HJ, 2008, PHYTOTHER RES, V22, P1324, DOI 10.1002/ptr.2488; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; RIEDEL G, 1994, NEUROREPORT, V5, P2061; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Shi F, 2011, NEURAL REGEN RES, V6, P171, DOI 10.3969/j.issn.1673-5374.2011.03.002; Shin KY, 2009, NEUROSCI LETT, V465, P157, DOI 10.1016/j.neulet.2009.08.033; Steinman L, 2010, P NATL ACAD SCI USA, V107, P20595, DOI 10.1073/pnas.1015282107; Sun Gui-bo, 2007, Zhong Yao Cai, V30, P991; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099	41	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45575	10.1371/journal.pone.0045575	http://dx.doi.org/10.1371/journal.pone.0045575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029109	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800060
J	Turney, K				Turney, Kristin			Prevalence and Correlates of Stability and Change in Maternal Depression: Evidence from the Fragile Families and Child Wellbeing Study	PLOS ONE			English	Article							UNITED-STATES; SYMPTOMS; COMORBIDITY; MOTHERS; DISORDERS; SAMPLE; EPIDEMIOLOGY; MARRIAGE; EARNINGS	Children of depressed mothers have impaired cognitive, behavioral, and health outcomes from infancy through adulthood, and are especially at risk when maternal depression persists over multiple years. But there are several important limitations to our current descriptive knowledge about maternal depression, especially depression among unmarried mothers. Data from the Fragile Families and Child Wellbeing Study, a recent cohort of children born in urban areas to mostly unmarried parents (N = 4,366), was used to examine the prevalence and correlates of maternal depression when children were about 1, 3, 5, and 9 years old. Results show that, at any given survey wave, between 16% and 21% of mothers reported depression. Nearly two-fifths (38%) of mothers reported depression at least once during the eight-year period, and 7% reported persistent depression (depression at three or four of the four survey waves). Employment status, relationship status, and fathers' depression were among the sociodemographic characteristics most robustly associated with both stability and change in maternal depression. Given the important social consequences of maternal depression, not least of which is impaired wellbeing among children of depressed mothers, prevention and treatment of maternal depression should be an imperative for researchers, clinicians, and policymakers alike.	Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Turney, K (corresponding author), Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA.	kristin.turney@uci.edu			Robert Wood Johnson Foundation Health & Society Scholars Program; NICHD [R01HD36916, R01HD39135, R01HD40421]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036916] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040421, R01HD039135] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Health & Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Turney's work on this project was supported by the Robert Wood Johnson Foundation Health & Society Scholars Program. Funding for the Fragile Families and Child Wellbeing Study was provided by the NICHD through grants R01HD36916, R01HD39135, and R01HD40421, as well as a consortium of private foundations (see http://www.fragilefamilies.princeton.edu/funders.asp for the complete list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato PR, 2007, J POLICY ANAL MANAG, V26, P952, DOI 10.1002/pam.20294; Augustine JM, 2010, J HEALTH SOC BEHAV, V51, P274, DOI 10.1177/0022146510377757; Beeghly Marjorie, 2003, Matern Child Health J, V7, P157, DOI 10.1023/A:1025132320321; Bendheim-Thoman Center for Research on Child Wellbeing, 2011, DAT US GUID 9 YEAR F; Bendheim-Thomas Center for Research on Child Wellbeing, 2008, INTR FRAG FAM PUBL U; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Carlson M, 2011, SOCIAL CLASS CHANGIN; Chisholm D., 2006, DOLLARS DALYS DECISI; Civic D, 2000, Matern Child Health J, V4, P215, DOI 10.1023/A:1026667720478; DeKlyen M, 2006, AM J PUBLIC HEALTH, V96, P1836, DOI 10.2105/AJPH.2004.049296; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Gibson-Davis CM, 2005, J MARRIAGE FAM, V67, P1301, DOI 10.1111/j.1741-3737.2005.00218.x; Goodman S.H., 2002, CHILDREN DEPRESSED P; HALL LA, 1990, PUBLIC HEALTH NURS, V7, P71, DOI 10.1111/j.1525-1446.1990.tb00615.x; Hamilton Brady E, 2010, Natl Vital Stat Rep, V59, P1; Hayes DK, 2010, MATERN CHILD HLTH J, V14, P765, DOI 10.1007/s10995-009-0504-z; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Lanzi RG, 1999, ARCH PEDIAT ADOL MED, V153, P801, DOI 10.1001/archpedi.153.8.801; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Marcotte DE, 2001, SOC SCI MED, V53, P21, DOI 10.1016/S0277-9536(00)00312-9; McLanahan S, 2009, ANN AM ACAD POLIT SS, V621, P111, DOI 10.1177/0002716208324862; McLennan JD, 2001, J AM ACAD CHILD PSY, V40, P1316, DOI 10.1097/00004583-200111000-00012; MCLEOD JD, 1993, J MARRIAGE FAM, V55, P733, DOI 10.2307/353353; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Mirowsky J, 2002, J HEALTH SOC BEHAV, V43, P152, DOI 10.2307/3090194; Mulvaney C, 2005, SOC PSYCH PSYCH EPID, V40, P202, DOI 10.1007/s00127-005-0859-4; ORR ST, 1984, AM J PUBLIC HEALTH, V74, P363, DOI 10.2105/AJPH.74.4.363; ORR ST, 1989, AM J PUBLIC HEALTH, V79, P1295, DOI 10.2105/AJPH.79.9.1295; Pascoe John M, 2006, J Pediatr Health Care, V20, P261, DOI 10.1016/j.pedhc.2006.01.006; Patten S B, 2000, Chronic Dis Can, V21, P68; Petterson SM, 2001, CHILD DEV, V72, P1794, DOI 10.1111/1467-8624.00379; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Radke-Yarrow M., 2002, CHILDREN DEPRESSED P, P155, DOI DOI 10.1037/10449-006; Reichman NE, 2001, CHILD YOUTH SERV REV, V23, P303, DOI 10.1016/S0190-7409(01)00141-4; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; SAMEROFF AJ, 1983, INFANT MENT HEALTH J, V4, P236; Sigle-Rushton W., 2004, FUTURE FAMILY, P116; StataCorp, 2011, STAT STAT SOFTW REL, P173; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; WEISSMAN MM, 1987, AM J PUBLIC HEALTH, V77, P445, DOI 10.2105/AJPH.77.4.445	45	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45709	10.1371/journal.pone.0045709	http://dx.doi.org/10.1371/journal.pone.0045709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PT	23029194	Green Published, gold			2022-12-27	WOS:000309388900091
J	Qian, J; Yao, DM; Lin, J; Qian, W; Wang, CZ; Chai, HY; Yang, J; Li, Y; Deng, ZQ; Ma, JC; Chen, XX				Qian, Jun; Yao, Dong-ming; Lin, Jiang; Qian, Wei; Wang, Cui-zhu; Chai, Hai-yan; Yang, Jing; Li, Yun; Deng, Zhao-qun; Ma, Ji-chun; Chen, Xing-xing			U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome	PLOS ONE			English	Article							MECHANISMS; MACHINERY; PATHWAY; DISEASE; IMPACT; CYCLE	Somatic mutations of U2AF1 gene have recently been identified in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this study, we analyzed the frequency and clinical impact of U2AF1 mutations in a cohort of 452 Chinese patients with myeloid neoplasms. Mutations in U2AF1 were found in 2.5% (7/275) of AML and 6.3% (6/96) of MDS patients, but in none of 81 CML. All mutations were heterozygous missense mutations affecting codon S34 or Q157. There was no significant association of U2AF1 mutation with blood parameters, FAB subtypes, karyotypes and other gene mutations in AML. The overall survival (OS) of AML patients with U2AF1 mutation (median 3 months) was shorter than those without mutation (median 7 months) (P = 0.035). No difference in the OS was observed between MDS patients with and without U2AF1 mutations. Our data show that U2AF1 mutation is a recurrent event at a low frequency in AML and MDS.	[Qian, Jun; Lin, Jiang; Wang, Cui-zhu; Chai, Hai-yan; Yang, Jing; Li, Yun; Ma, Ji-chun; Chen, Xing-xing] Jiangsu Univ, Affiliated Peoples Hosp, Dept Haematol, Zhenjiang, Jiangsu, Peoples R China; [Lin, Jiang; Qian, Wei; Deng, Zhao-qun] Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China; [Yao, Dong-ming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Lin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Haematol, Zhenjiang, Jiangsu, Peoples R China.	linjiangmail@sina.com; dwqian@yahoo.com			Science and Technology Special Project in Clinical Medicine of Jiangsu Province [BL2012056]; National Natural Science foundation of China [81172592]; 333 Project of Jiangsu Province [BRA2011085]; Natural Science foundation of Jiangsu Province [BK2009206]	Science and Technology Special Project in Clinical Medicine of Jiangsu Province; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), National Natural Science foundation of China (81172592), 333 Project of Jiangsu Province (BRA2011085) and Natural Science foundation of Jiangsu Province (BK2009206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ding WQ, 2002, CANCER RES, V62, P947; Dohner H, 2011, HEMATOL-AM SOC HEMAT, P36, DOI 10.1182/asheducation-2011.1.36; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lin J, 2012, ANN HEMATOL, V91, P519, DOI 10.1007/s00277-011-1352-7; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Qian J, 2010, CLIN CHIM ACTA, V411, P2097, DOI 10.1016/j.cca.2010.08.020; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Swerdlow SH, 2008, WHO CLASSIFICATION T; Szankasi P, 2008, J MOL DIAGN, V10, P236, DOI 10.2353/jmoldx.2008.070167; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x	25	68	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45760	10.1371/journal.pone.0045760	http://dx.doi.org/10.1371/journal.pone.0045760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029227	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400129
J	Ruiz, OE; Nikolova, LS; Metzstein, MM				Ruiz, Oscar E.; Nikolova, Linda S.; Metzstein, Mark M.			Drosophila Zpr1 (Zinc Finger Protein 1) Is Required Downstream of Both EGFR And FGFR Signaling in Tracheal Subcellular Lumen Formation	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; CELL-MIGRATION; BRANCHING MORPHOGENESIS; ECTOPIC EXPRESSION; RECEPTOR HOMOLOG; GENE ENCODES; SMN PROTEIN; SYSTEM; MELANOGASTER; PATTERN	The cellular and molecular cues involved in creating branched tubular networks that transport liquids or gases throughout an organism are not well understood. To identify factors required in branching and lumen formation of Drosophila tracheal terminal cells, a model for branched tubular networks, we performed a forward genetic-mosaic screen to isolate mutations affecting these processes. From this screen, we have identified the first Drosophila mutation in the gene Zpr1 (Zinc finger protein 1) by the inability of Zpr1-mutant terminal cells to form functional, gas-filled lumens. We show that Zpr1 defective cells initiate lumen formation, but are blocked from completing the maturation required for gas filling. Zpr1 is an evolutionarily conserved protein first identified in mammalian cells as a factor that binds the intracellular domain of the unactivated epidermal growth factor receptor (EGFR). We show that down-regulation of EGFR in terminal cells phenocopies Zpr1 mutations and that Zpr1 is epistatic to ectopic lumen formation driven by EGFR overexpression. However, while Zpr1 mutants are fully penetrant, defects observed when reducing EGFR activity are only partially penetrant. These results suggest that a distinct pathway operating in parallel to the EGFR pathway contributes to lumen formation, and this pathway is also dependent on Zpr1. We provide evidence that this alternative pathway may involve fibroblast growth factor receptor (FGFR) signaling. We suggest a model in which Zpr1 mediates both EGFR and FGFR signal transduction cascades required for lumen formation in terminal cells. To our knowledge, this is the first genetic evidence placing Zpr1 downstream of EGFR signaling, and the first time Zpr1 has been implicated in FGFR signaling. Finally, we show that down-regulation of Smn, a protein known to interact with Zpr1 in mammalian cells, shows defects similar to Zpr1 mutants.	[Ruiz, Oscar E.; Nikolova, Linda S.; Metzstein, Mark M.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Metzstein, MM (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	markm@genetics.utah.edu		Ruiz, Oscar/0000-0002-5426-260X	Kirschstein-NRSA predoctoral institutional training grant at the University of Utah [NIH 5T32GM007464-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM084947] Funding Source: NIH RePORTER	Kirschstein-NRSA predoctoral institutional training grant at the University of Utah; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	OER was supported by a Kirschstein-NRSA predoctoral institutional training grant at the University of Utah (NIH 5T32GM007464-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Ahmad S, 2012, HUM MOL GENET, V21, P2745, DOI 10.1093/hmg/dds102; Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; CHOU TB, 1992, GENETICS, V131, P643; CLIFFORD RJ, 1989, GENETICS, V123, P771; Doran B, 2006, P NATL ACAD SCI USA, V103, P7471, DOI 10.1073/pnas.0602057103; Egginton S, 2011, ACTA PHYSIOL, V202, P225, DOI 10.1111/j.1748-1716.2010.02194.x; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Galcheva-Gargova Z, 1998, MOL BIOL CELL, V9, P2963, DOI 10.1091/mbc.9.10.2963; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Gangwani L, 2005, MOL CELL BIOL, V25, P2744, DOI 10.1128/MCB.25.7.2744-2756.2005; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Gangwani L, 2006, J BIOL CHEM, V281, P40330, DOI 10.1074/jbc.M608165200; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guillemin K, 1996, DEVELOPMENT, V122, P1353; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jeon M, 2009, DEVELOPMENT, V136, P3121, DOI 10.1242/dev.033597; JONES T, 2011, AGENDA, V45, P153, DOI DOI 10.1534/GENETICS.111.130351; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Llimargas M, 1999, DEV GENES EVOL, V209, P174, DOI 10.1007/s004270050241; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Mishra AK, 2007, P NATL ACAD SCI USA, V104, P13930, DOI 10.1073/pnas.0704915104; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rozen S, 2000, Methods Mol Biol, V132, P365; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schottenfeld-Roames J, 2012, NAT CELL BIOL, V14, P386, DOI 10.1038/ncb2454; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Shim K, 2001, DEVELOPMENT, V128, P4923; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wilk R, 2000, DEV BIOL, V219, P183, DOI 10.1006/dbio.2000.9619; XU T, 1993, DEVELOPMENT, V117, P1223	55	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45649	10.1371/journal.pone.0045649	http://dx.doi.org/10.1371/journal.pone.0045649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029159	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900165
J	Sengupta, A; Sarkar, DK				Sengupta, Amitabha; Sarkar, Dipak K.			Roles of Dopamine 2 Receptor Isoforms and G Proteins in Ethanol Regulated Prolactin Synthesis and Lactotropic Cell Proliferation	PLOS ONE			English	Article							ANTERIOR-PITUITARY; D2 RECEPTOR; GROWTH-FACTOR; MICE LACKING; ESTROGEN; ALCOHOL; EXPRESSION; HYPERPROLACTINEMIA; RELEASE; BROMOCRIPTINE	Alcohol consumption has been shown to increase prolactin (PRL) production and cell proliferation of pituitary lactotropes. It also causes a reduction in the lactotrope's response to dopaminergic agents and a differential expression of dopamine 2 receptor short (D2S) and long (D2L) isoforms in the pituitary. However, the role of each of these D2 receptor isoforms and its coupled G protein in mediation of ethanol actions on lactotropes is not known. We have addressed this issue by comparing ethanol effects on the level of PRL production gene transcription rate cellular protein, G proteins and cell proliferation in enriched lactotropes and lactotrope-derived PR1 cells containing various D2 receptor isoforms. Additionally, we determined the effects of G protein blockade on ethanol-induced PRL production and cell proliferation in these cells. We show here that the D2 receptor, primarily the D2S isoform, is critically involved in the regulation of ethanol actions on PRL production and cell proliferation in lactotropes. We also present data to elucidate that the presence of the pertussis toxin (PTX)-sensitive D2S receptor is critical to mediate the ethanol stimulatory action on Gs and the ethanol's inhibitory action on Gi3 protein in lactotropes. Additionally, we provide evidence for the existence of an inhibitory action of Gi3 on Gs that is under the control of the D2S receptor and is inhibited by ethanol. These results suggest that ethanol via the inhibitory action on D2S receptor activity suppresses Gi3 repression of Gs expression resulting in stimulation of PRL synthesis and cell proliferation in lactotropes.	[Sengupta, Amitabha; Sarkar, Dipak K.] Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA.	sarkar@aesop.rutgers.edu	Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871	NIH (National Institute of Health)/NIAAA (National Institute on Alcohol Abuse and Alcoholism) [R01 AA11591]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011591] Funding Source: NIH RePORTER	NIH (National Institute of Health)/NIAAA (National Institute on Alcohol Abuse and Alcoholism); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by a grant from NIH (National Institute of Health)/NIAAA (National Institute on Alcohol Abuse and Alcoholism) R01 AA11591. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAERTSCHI AJ, 1992, MOL ENDOCRINOL, V6, P2257, DOI 10.1210/me.6.12.2257; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; BLUM K, 1991, ALCOHOL, V8, P409, DOI 10.1016/0741-8329(91)90693-Q; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; CACCAVELLI L, 1994, NEUROENDOCRINOLOGY, V60, P314, DOI 10.1159/000126764; Caporali S, 2003, MOL BIOL CELL, V14, P5051, DOI 10.1091/mbc.E03-05-0303; Chaturvedi K, 2008, ALCOHOL CLIN EXP RES, V32, P806, DOI 10.1111/j.1530-0277.2008.00638.x; Chun TY, 1998, P NATL ACAD SCI USA, V95, P2325, DOI 10.1073/pnas.95.5.2325; CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; De A, 2002, ALCOHOL CLIN EXP RES, V26, P1420, DOI 10.1097/01.ALC.0000030621.35354.E0; DE A, 1995, INT J ONCOL, V7, P643; DELAESCALERA GM, 1988, NEUROENDOCRINOLOGY, V47, P38, DOI 10.1159/000124888; ENJALBERT A, 1983, MOL PHARMACOL, V23, P576; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Ghahremani MH, 1999, J BIOL CHEM, V274, P9238, DOI 10.1074/jbc.274.14.9238; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; Hentges S, 2000, ENDOCRINOLOGY, V141, P859, DOI 10.1210/en.141.3.859; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; LACCARINO C, 2002, P SOC NAT ACAD SCI U, V99, P14530, DOI DOI 10.1073/PNAS.222319599; MARCHESI C, 1992, ALCOHOL ALCOHOLISM, V27, P531; MAURER RA, 1989, J BIOL CHEM, V264, P6870; MELLO NK, 1993, RES MONOGRAPH, V23, P139; MENDELSON JH, 1988, J PHARMACOL EXP THER, V245, P407; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONTMAYEUR JP, 1991, FEBS LETT, V278, P239, DOI 10.1016/0014-5793(91)80125-M; Oomizu S, 2003, ALCOHOL CLIN EXP RES, V27, P975, DOI 10.1097/01.ALC.0000071743.57855.BE; PASTORCIC M, 1995, CANCER RES, V55, P4892; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; SANCHIS R, 1985, PHARMACOL BIOCHEM BE, V23, P221, DOI 10.1016/0091-3057(85)90560-X; Sarkar DK, 2005, ENDOCRINOLOGY, V146, P4179, DOI 10.1210/en.2005-0430; SEKI M, 1991, Japanese Journal of Alcohol Studies and Drug Dependence, V26, P49; Sengupta A, 2012, J ENDOCRINOL, V214, P67, DOI 10.1530/JOE-12-0125; TEOH SK, 1992, J STUD ALCOHOL, V53, P176, DOI 10.15288/jsa.1992.53.176; Tupala E, 2001, MOL PSYCHIATR, V6, P261, DOI 10.1038/sj.mp.4000859; VALIMAKI M, 1990, EUR J CLIN INVEST, V20, P177, DOI 10.1111/j.1365-2362.1990.tb02266.x; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Wiens BL, 1998, MOL PHARMACOL, V54, P435, DOI 10.1124/mol.54.2.435; Xu R, 2002, BRAIN RES, V939, P95, DOI 10.1016/S0006-8993(02)02559-3	42	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45593	10.1371/journal.pone.0045593	http://dx.doi.org/10.1371/journal.pone.0045593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029123	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900161
J	Scala, C; Tian, XJ; Mehdiabadi, NJ; Smith, MH; Saxer, G; Stephens, K; Buzombo, P; Strassmann, JE; Queller, DC				Scala, Clea; Tian, Xiangjun; Mehdiabadi, Natasha J.; Smith, Margaret H.; Saxer, Gerda; Stephens, Katie; Buzombo, Prince; Strassmann, Joan E.; Queller, David C.			Amino Acid Repeats Cause Extraordinary Coding Sequence Variation in the Social Amoeba Dictyostelium discoideum	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; TRINUCLEOTIDE REPEATS; SELF-INCOMPATIBILITY; COMPARATIVE GENOMICS; MICROSATELLITES; EVOLUTION; SELECTION; DNA; GENES; RECOMBINATION	Protein sequences are normally the most conserved elements of genomes owing to purifying selection to maintain their functions. We document an extraordinary amount of within-species protein sequence variation in the model eukaryote Dictyostelium discoideum stemming from triplet DNA repeats coding for long strings of single amino acids. D. discoideum has a very large number of such strings, many of which are polyglutamine repeats, the same sequence that causes various human neurological disorders in humans, like Huntington's disease. We show here that D. discoideum coding repeat loci are highly variable among individuals, making D. discoideum a candidate for the most variable proteome. The coding repeat loci are not significantly less variable than similar non-coding triplet repeats. This pattern is consistent with these amino-acid repeats being largely non-functional sequences evolving primarily by mutation and drift.	[Tian, Xiangjun; Strassmann, Joan E.; Queller, David C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Scala, Clea; Mehdiabadi, Natasha J.; Smith, Margaret H.; Stephens, Katie; Buzombo, Prince] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Saxer, Gerda] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Washington University (WUSTL); Rice University; Rice University	Queller, DC (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	queller@wustl.edu		Strassmann, Joan/0000-0003-0638-8440; Smith, Margaret/0000-0002-3523-0979	National Science Foundation [DEB-0918931]; Division Of Environmental Biology [0949689] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under Grant No. DEB-0918931 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Awadalla P, 1999, GENETICS, V152, P413; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Clark AG, 1993, EVOLUTIONARY INFEREN; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Guillaudeux T, 1998, P NATL ACAD SCI USA, V95, P9494, DOI 10.1073/pnas.95.16.9494; Haerty W, 2010, GENOME RES, V20, P755, DOI 10.1101/gr.101246.109; Hancock JM, 1996, BIOESSAYS, V18, P421, DOI 10.1002/bies.950180512; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1964, GENETICS, V49, P725; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lewis PO, 2001, GENETIC DATA ANAL GD; Li W. H, 1997, MOL EVOLUTION; LI WH, 1991, FUNDAMENTALS MOL EVO; LITT M, 1989, AM J HUM GENET, V44, P397; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Metzgar D, 2000, GENOME RES, V10, P72; Michalakis Y, 1996, GENETICS, V143, P1713; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Nei M, 1979, P NATL ACAD SCI USA, V76, P362; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Richman AD, 2000, PLANT MOL BIOL, V42, P169, DOI 10.1023/A:1006336206637; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SPUDICH JA, 1982, METHOD CELL BIOL, V25, P359, DOI 10.1016/S0091-679X(08)61433-8; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Tian XJ, 2011, MOL BIOL EVOL, V28, P899, DOI 10.1093/molbev/msq266; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Wierdl M, 1997, GENETICS, V146, P769	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46150	10.1371/journal.pone.0046150	http://dx.doi.org/10.1371/journal.pone.0046150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029418	Green Published, gold			2022-12-27	WOS:000309973900098
J	Wang, H; Yang, L; Zou, LN; Huang, DS; Guo, Y; Pan, MG; Tan, YG; Zhong, HB; Ji, WD; Ran, PX; Zhong, NS; Lu, JC				Wang, Hui; Yang, Lei; Zou, Linnan; Huang, Dongsheng; Guo, Yuan; Pan, Mingan; Tan, Yigang; Zhong, Haibo; Ji, Weidong; Ran, Pixin; Zhong, Nanshan; Lu, Jiachun			Association between Chronic Obstructive Pulmonary Disease and Lung Cancer: A Case-Control Study in Southern Chinese and a Meta-Analysis	PLOS ONE			English	Article							FORCED EXPIRATORY VOLUME; AIR-FLOW OBSTRUCTION; RISK-FACTORS; NONSMOKING WOMEN; GENETIC-VARIANTS; ONE 2ND; EMPHYSEMA; INFLAMMATION; POPULATION; COPD	Background: Lung cancer and chronic obstructive pulmonary disease (COPD) share a common risk factor in cigarette smoking and a large portion of patients with lung cancer suffer from COPD synchronously. We therefore hypothesized that COPD is an independent risk factor for lung cancer. Our aim was to investigate the intrinsic linkage of COPD (or emphysema, chronic bronchitis and asthma) and lung cancer. Methods: The present hospital-based case-control study included 1,069 patients with newly diagnosed lung cancer and 1,132 age frequency matched cancer-free controls. The odds ratios (ORs) for the associations between each previous pulmonary disease and lung cancer were estimated with logistic regression models, adjusting for age, sex, family history of cancer, BMI and pack year smoking. In meta-analysis, the pooled effects of previous pulmonary diseases were analyzed with random effects models; and stratification analyses were conducted on smoking status and ethnicity. Results: In the case-control study, previous COPD was associated with the odds for increased risk of lung cancer (OR = 1.29, 95% confidence interval [CI] = 1.00 similar to 1.68); so were emphysema (OR = 1.55, 95% CI = 1.03 similar to 2.32) and chronic bronchitis (OR = 1.22, 95% CI = 0.99 similar to 1.67); while asthma was associated with odds for decreased risk of lung cancer (OR = 0.29, 95% CI = 0.16 similar to 0.53). These associations were more pronounced in smokers (P<.05 for all strata), but not in non-smokers. In meta-analysis, 35 studies (22,010 cases and 44,438 controls) were identified. COPD was significantly associated with the odds for increased risk of lung cancer (pooled OR = 2.76; 95% CI = 1.85-4.11), so were emphysema (OR = 3.02; 95% CI = 2.41-3.79) and chronic bronchitis (OR = 1.88; 95% CI = 1.49-2.36); and these associations were more pronounced in smokers than in non-smokers (P<.001 respectively). No significant association was observed for asthma. Conclusion: Previous COPD could increase the risk of lung cancer, especially in smokers.	[Wang, Hui; Yang, Lei; Zou, Linnan; Huang, Dongsheng; Ji, Weidong; Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ran, Pixin; Zhong, Nanshan] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Huang, Dongsheng; Tan, Yigang] Guangzhou Chest Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Guo, Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Pan, Mingan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Haibo] Guangzhou Red Cross Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Sun Yat Sen University	Lu, JC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	jcLu@gzhmc.edu.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366, 81273149, 81170043, 30872142]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University Grant [IRT0961]; Guangdong Natural Science Foundation [10351012003000000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Scientific Foundation of China Grants 30671813, 30872178, 81072366, 81273149 (Dr. J. Lu), and partly by 81170043 (Dr. P. Ran), 30872142 (Dr. W. Ji); Guangdong Provincial High Level Experts Grants 2010-79 (Dr. J. Lu); Changjiang Scholars and Innovative Research Team in University Grant IRT0961 and Guangdong Natural Science Foundation Team Grant 10351012003000000 (Prof. N. Zhong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; ALAVANJA MCR, 1992, AM J EPIDEMIOL, V136, P623, DOI 10.1093/oxfordjournals.aje.a116542; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Ardies C Murray, 2003, Integr Cancer Ther, V2, P238, DOI 10.1177/1534735403256332; Borczuk Alain C, 2007, Proc Am Thorac Soc, V4, P127, DOI 10.1513/pats.200607-143JG; Brenner AV, 2001, INT J EPIDEMIOL, V30, P118, DOI 10.1093/ije/30.1.118; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Brownson RC, 2000, CANCER CAUSE CONTROL, V11, P853, DOI 10.1023/A:1008999202040; Caramori G, 2011, INT J BIOCHEM CELL B, V43, P1030, DOI 10.1016/j.biocel.2010.08.022; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Galeone C, 2008, EUR J CANCER PREV, V17, P473, DOI 10.1097/CEJ.0b013e328305a0b9; Gonzalez-Perez A, 2006, PHARMACOEPIDEM DR S, V15, P131, DOI 10.1002/pds.1163; [韩勇 Han Yong], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P146; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia-chun L, 2003, CHINA J CANC PREV TR, V10, P673; Kishi K, 2002, EUR RESPIR J, V19, P1093, DOI 10.1183/09031936.02.00264202; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Kreuzer M, 2002, INT J CANCER, V100, P706, DOI 10.1002/ijc.10549; Liang HY, 2009, J WOMENS HEALTH, V18, P1989, DOI 10.1089/jwh.2008.1355; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Littman AJ, 2004, CANCER CAUSE CONTROL, V15, P819, DOI 10.1023/B:CACO.0000043432.71626.45; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Maldonado F, 2010, CHEST, V138, P1295, DOI 10.1378/chest.09-2567; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayne ST, 1999, AM J EPIDEMIOL, V149, P13; Miao Z, 2009, CHINESE J COAL IND M, V12, P125; Mizuno S, 2009, RESPIROLOGY, V14, P377, DOI 10.1111/j.1440-1843.2008.01477.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molfino NA, 2007, CURR OPIN PULM MED, V13, P107, DOI 10.1097/MCP.0b013e328013e97d; Neuberger JS, 2006, CANCER DETECT PREV, V30, P158, DOI 10.1016/j.cdp.2006.03.001; Osann KE, 2000, LUNG CANCER, V28, P1, DOI 10.1016/S0169-5002(99)00106-3; Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Purdue MP, 2007, THORAX, V62, P51, DOI 10.1136/thx.2006.064196; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rong GX, 2010, TUMOR, V30, P502; Rutgers SR, 2000, THORAX, V55, P12, DOI 10.1136/thorax.55.1.12; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Schabath MB, 2006, AM J EPIDEMIOL, V163, DOI 10.1093/aje/kwj065; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schwartz AG, 2006, AM J RESP CRIT CARE, V173, P16, DOI 10.1164/rccm.200502-235PP; Schwartz AG, 2007, CARCINOGENESIS, V28, P507, DOI 10.1093/carcin/bgl253; Schwartz AG, 2009, J THORAC ONCOL, V4, P291, DOI 10.1097/JTO.0b013e3181951cd1; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; Van Dyke AL, 2009, CANCER EPIDEM BIOMAR, V18, P1829, DOI 10.1158/1055-9965.EPI-08-0962; Wang SY, 1996, LUNG CANCER-J IASLC, V14, pS99, DOI 10.1016/S0169-5002(96)90215-9; Wang XR, 2009, CANCER CAUSE CONTROL, V20, P757, DOI 10.1007/s10552-008-9289-4; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; WU AH, 1988, CANCER RES, V48, P7279; Yang L, 2011, CARCINOGENESIS, V33, P338; Yang P, 2008, ARCH INTERN MED, V168, P1097, DOI 10.1001/archinte.168.10.1097; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Young RP, 2009, POSTGRAD MED J, V85, P515, DOI 10.1136/pgmj.2008.077107; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Young RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016476; Zeki AA, 2010, J AUTOIMMUN, V34, pJ327, DOI 10.1016/j.jaut.2009.11.004; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	71	24	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46144	10.1371/journal.pone.0046144	http://dx.doi.org/10.1371/journal.pone.0046144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029414	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900095
J	de Celles, MD; Salomon, J; Marinier, A; Lawrence, C; Gaillard, JL; Herrmann, JL; Guillemot, D				de Celles, Matthieu Domenech; Salomon, Jerome; Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis; Guillemot, Didier			Identifying More Epidemic Clones during a Hospital Outbreak of Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							HEALTH-CARE WORKERS; STAPHYLOCOCCUS-AUREUS; TRANSMISSION; STRAINS; ROUTES	Infections caused by multidrug-resistant bacteria are a major concern in hospitals. Current infection-control practices legitimately focus on hygiene and appropriate use of antibiotics. However, little is known about the intrinsic abilities of some bacterial strains to cause outbreaks. They can be measured at a population level by the pathogen's transmission rate, i.e. the rate at which the pathogen is transmitted from colonized hosts to susceptible hosts, or its reproduction number, counting the number of secondary cases per infected/colonized host. We collected data covering a 20-month surveillance period for carriage of multidrug-resistant Acinetobacter baumannii (MDRAB) in a surgery ward. All isolates were subjected to molecular fingerprinting, and a cluster analysis of profiles was performed to identify clonal groups. We then applied stochastic transmission models to infer transmission rates of MDRAB and each MDRAB clone. Molecular fingerprinting indicated that 3 clonal complexes spread in the ward. A first model, not accounting for different clones, quantified the level of in-ward cross-transmission, with an estimated transmission rate of 0.03/day (95% credible interval [0.012-0.049]) and a single-admission reproduction number of 0.61 [0.30-1.02]. The second model, accounting for different clones, suggested an enhanced transmissibility of clone 3 (transmission rate 0.047/day [0.018-0.091], with a single-admission reproduction number of 0.81 [0.30-1.56]). Clones 1 and 2 had comparable transmission rates (respectively, 0.016 [0.001-0.045], 0.014 [0.001-0.045]). The method used is broadly applicable to other nosocomial pathogens, as long as surveillance data and genotyping information are available. Building on these results, more epidemic clones could be identified, and could lead to follow-up studies dissecting the functional basis for variation in transmissibility of MDRAB lineages.	[de Celles, Matthieu Domenech; Salomon, Jerome; Guillemot, Didier] Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France; [de Celles, Matthieu Domenech; Salomon, Jerome; Guillemot, Didier] Inst Natl Sante & Rech Med, U657, Paris, France; [de Celles, Matthieu Domenech] Univ Paris 06, Cellule Pasteur UPMC, Paris, France; [Salomon, Jerome] Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Securite San, Paris, France; [Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis] Hop Raymond Poincare, AP HP, Lab Microbiol, Garches, France; [Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis] Univ Versailles St Quentin En Yvelines, EA 3647, Versailles, France; [de Celles, Matthieu Domenech; Guillemot, Didier] Univ Versailles St Quentin En Yvelines, EA 4499, Versailles, France; [Guillemot, Didier] Hop Raymond Poincare, AP HP, Unite Fonct Sante Publ, Garches, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	de Celles, MD (corresponding author), Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France.	domenech@pasteur.fr	Guillemot, Didier/AAN-3051-2020; SALOMON, JEROME/AGY-7338-2022	Herrmann, Jean-Louis/0000-0003-2347-6418; Domenech de Celles, Matthieu/0000-0002-9302-4858; Guillemot, Didier/0000-0002-8497-1765				ANDERSON R M, 1991; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Charbonneau P, 2006, CLIN INFECT DIS, V42, P778, DOI 10.1086/500319; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2008, AM J EPIDEMIOL, V168, P548, DOI 10.1093/aje/kwn176; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79; Forrester ML, 2007, BIOSTATISTICS, V8, P383, DOI 10.1093/biostatistics/kxl017; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaki R, 2011, J ANTIMICROB CHEMOTH, V66, P1223, DOI 10.1093/jac/dkr137; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kretzschmar M, 2010, TRENDS MICROBIOL, V18, P406, DOI 10.1016/j.tim.2010.06.008; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Saeed S, 2006, INFECT CONT HOSP EP, V27, P981, DOI 10.1086/507286; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Tenorio AR, 2001, CLIN INFECT DIS, V32, P826, DOI 10.1086/319214; Trampuz A, 2004, MAYO CLIN PROC, V79, P109, DOI 10.4065/79.1.109; Villalon P, 2011, J CLIN MICROBIOL, V49, P875, DOI 10.1128/JCM.01026-10; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016	37	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45758	10.1371/journal.pone.0045758	http://dx.doi.org/10.1371/journal.pone.0045758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029226	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500042
J	Navarro, G; Chokpaiboon, S; De Muylder, G; Bray, WM; Nisam, SC; McKerrow, JH; Pudhom, K; Linington, RG				Navarro, Gabriel; Chokpaiboon, Supchar; De Muylder, Geraldine; Bray, Walter M.; Nisam, Sean C.; McKerrow, James H.; Pudhom, Khanitha; Linington, Roger G.			Hit-to-Lead Development of the Chamigrane Endoperoxide Merulin A for the Treatment of African Sleeping Sickness	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; NORSESQUITERPENE PEROXIDES; PLASMODIUM-FALCIPARUM; ARTEMISININ; FUNGUS; DERIVATIVES; DISCOVERY; DRUGS	Background: Human African trypanosomiasis (HAT) is an infectious disease with a large global health burden occurring primarily in Central and Eastern Africa. Most current treatments have poor blood brain barrier (BBB) penetration, which prevent them from targeting the most lethal stage of the infection. In addition, current therapeutics suffer from a variety of limitations ranging from serious side effects to difficulties with treatment administration. Therefore it is of crucial importance to find new treatments that are safe, affordable, and effective against both sub-species of Trypanosoma brucei. Methods: Semi-synthetic derivatization of the fungally-derived natural product merulin A (1) has led to the discovery of new development candidates for the protozoan parasite T. brucei, the causative agent of HAT. Creation of an initial SAR library based around the merulin scaffold revealed several key features required for activity, including the endoperoxide bridge, as well as one position suitable for further derivatization. Subsequent synthesis of a 20-membered analogue library, guided by the addition of acyl groups that improve the drug-like properties of the merulin A core, resulted in the development of compound 12 with an IC50 of 60 nM against T. brucei, and a selectivity index greater than 300-fold against HeLa and immortalized glial cells. Significance: We report the semi-synthetic optimization of the merulin class of endoperoxide natural products as development candidates against T. brucei. We have identified compounds with low nM antiparasitic activities and high selectivity indices against HeLa cells. These compounds can be produced economically in large quantities via a one step derivatization from the microbial fermentation broth isolate, making them encouraging lead candidates for further development.	[Navarro, Gabriel; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Chokpaiboon, Supchar; Pudhom, Khanitha] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [De Muylder, Geraldine; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94143 USA; [Bray, Walter M.; Nisam, Sean C.] Univ Calif Santa Cruz, Chem Screening Ctr, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Chulalongkorn University; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Linington, RG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu	Linington, Roger/ABD-5582-2021	Linington, Roger/0000-0003-1818-4971	Sandler Center for Drug Discovery; Sandler Foundation; NIAID [R56 AI085177-01A1, U01AI075641]; Belgian American Education Foundation; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085177, U01AI075641] Funding Source: NIH RePORTER	Sandler Center for Drug Discovery; Sandler Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Belgian American Education Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funding from the Sandler Center for Drug Discovery, funded by the Sandler Foundation (RGL and JHM), NIAID grant R56 AI085177-01A1 (RGL), the Belgian American Education Foundation (GDM) NIAID grant U01AI075641 (JHM), and from a National Science Foundation Predoctoral Fellowship (GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM MH, 1994, J PHARM SCI-US, V83, P1257, DOI 10.1002/jps.2600830915; Alexander MD, 2006, CHEMBIOCHEM, V7, P409, DOI 10.1002/cbic.200500466; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Chokpaiboon S, 2011, J NAT PROD, V74, P2290, DOI 10.1021/np200491g; Chokpaiboon S, 2010, J NAT PROD, V73, P1005, DOI 10.1021/np100103j; Crespo MD, 2008, ANTIMICROB AGENTS CH, V52, P98, DOI 10.1128/AAC.00609-07; Diamond JM, 1969, P ROY SOC LOND B BIO, V171, P273; Feng YJ, 2010, J NAT PROD, V73, P716, DOI 10.1021/np900535z; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Holla H, 2011, BIOORG MED CHEM LETT, V21, P4793, DOI 10.1016/j.bmcl.2011.06.059; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; KARARLI TT, 1989, CRIT REV THER DRUG, V6, P39; Kumar S, 2004, IND CROP PROD, V19, P77, DOI 10.1016/j.indcrop.2003.07.003; Li HX, 2011, J NAT PROD, V74, P1230, DOI 10.1021/np200164k; Liu DZ, 2010, TETRAHEDRON LETT, V51, P3152, DOI 10.1016/j.tetlet.2010.04.048; Mackey ZB, 2006, CHEM BIOL DRUG DES, V67, P355, DOI 10.1111/j.1747-0285.2006.00389.x; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Oguri H, 2011, J AM CHEM SOC, V133, P7096, DOI 10.1021/ja200374q; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Rubio BK, 2009, J NAT PROD, V72, P218, DOI 10.1021/np800711a; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Torreele E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000923; WILS P, 1994, J PHARMACOL EXP THER, V269, P654; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	27	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46172	10.1371/journal.pone.0046172	http://dx.doi.org/10.1371/journal.pone.0046172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029428	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500070
J	Guo, WJ; Liu, W; Hong, SC; Liu, HL; Qian, C; Shen, Y; Wu, XF; Sun, Y; Xu, Q				Guo, Wenjie; Liu, Wen; Hong, Shaocheng; Liu, Hailiang; Qian, Cheng; Shen, Yan; Wu, Xuefeng; Sun, Yang; Xu, Qiang			Mitochondria-Dependent Apoptosis of Con A-Activated T Lymphocytes Induced by Asiatic Acid for Preventing Murine Fulminant Hepatitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELL-CYCLE ARREST; CONCANAVALIN-A; LIVER-INJURY; DEATH; MICE; MECHANISMS; MODEL; PROLIFERATION; PATHWAYS	Selectively facilitating apoptosis of activated T cells is essential for the clearance of pathogenic injurious cells and subsequent efficient resolution of inflammation. However, few chemicals have been reported to trigger apoptosis of activated T cells for the treatment of hepatitis without affecting quiescent T cells. In the present study, we found that asiatic acid, a natural triterpenoid, selectively triggered apoptosis of concanavalin A (Con A)-activated T cells in a mitochondria-dependent manner indicated by the disruption of the mitochondrial transmembrane potential, release of cytochrome c from mitochondria to cytosol, caspases activation, and cleavage of PARP. In addition, asiatic acid also induced the cleavage of caspase 8 and Bid and augmented Fas expression in Con A-activated T cells. However, following activation of T cells from MRLlpr/lpr mice with mutation of Fas demonstrated a similar susceptibility to asiatic acid-induced apoptosis compared with normal T cells, suggesting that Fas-mediated death-receptor apoptotic pathway does not mainly contribute to asiatic acid-induced cell death. Furthermore, asiatic acid significantly alleviated Con A-induced T cell-dependent fulminant hepatitis in mice, as assessed by reduced serum transaminases, pro-inflammatory cytokines, and pathologic parameters. Consistent with the in vitro results, asiatic acid also induced apoptosis of activated CD4(+) T cells in vivo. Taken together, our results demonstrated that the ability of asiatic acid to induce apoptosis of activated T cells and its potential use in the treatment of T-cell-mediated inflammatory diseases.	[Guo, Wenjie; Liu, Wen; Hong, Shaocheng; Liu, Hailiang; Qian, Cheng; Shen, Yan; Wu, Xuefeng; Sun, Yang; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Sun, Y (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	sunyangnju@163.com; molpharm@163.com	Qian, Cheng/ACI-6931-2022; Guo, Wenjie/AAQ-7553-2020	Qian, Cheng/0000-0001-7573-3717; 	Science Fund for Creative Research Groups of NSFC [81121062]; National Natural Science Foundation of China [30973920, 81173070, 90913023]; National Science & Technology Major Project [2012ZX09304-001]; National Fundamental Fund of Personnel Training in Biology [J1103512]	Science Fund for Creative Research Groups of NSFC(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project; National Fundamental Fund of Personnel Training in Biology	This work was supported by Science Fund for Creative Research Groups of NSFC (No. 81121062), National Natural Science Foundation of China (Nos. 30973920, 81173070 and 90913023), National Science & Technology Major Project (No. 2012ZX09304-001) and National Fundamental Fund of Personnel Training in Biology (No. J1103512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gao J, 2004, J PHARM PHARMACOL, V56, P1449, DOI 10.1211/0022357044733; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gerspach J, 2011, RECENT PAT ANTI-CANC, V6, P294, DOI 10.2174/157489211796957739; Gong FY, 2008, EXP BIOL MED, V233, P1124, DOI 10.3181/0801-RM-15; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Kanuri G, 2011, J NUTR BIOCHEM, V22, P527, DOI 10.1016/j.jnutbio.2010.04.007; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Kuzuhara H, 2000, EUR J PHARMACOL, V391, P175, DOI 10.1016/S0014-2999(99)00931-0; Lee MK, 2009, NAT PROD COMMUN, V4, P765; Lee MK, 2000, RES COMMUN MOL PATH, V108, P75; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Luo QO, 2011, TOXICOL APPL PHARM, V251, P130, DOI 10.1016/j.taap.2010.12.011; Ma K, 2000, EUR J PHARMACOL, V603, P98; Santucci L, 2000, HEPATOLOGY, V31, P399, DOI 10.1002/hep.510310220; Sturm A, 2008, CURR DRUG TARGETS, V9, P381, DOI 10.2174/138945008784221198; Sun Y, 2010, BIOCHEM PHARMACOL, V79, P229, DOI 10.1016/j.bcp.2009.08.014; Sun Y, 2009, BIOCHEM PHARMACOL, V77, P1717, DOI 10.1016/j.bcp.2009.03.002; Sun Y, 2009, INT IMMUNOPHARMACOL, V9, P978, DOI 10.1016/j.intimp.2009.04.006; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Urayama S, 2001, J LAB CLIN MED, V138, P11, DOI 10.1067/mlc.2001.115938; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Xiong YY, 2009, NEUROCHEM RES, V34, P746, DOI 10.1007/s11064-008-9844-0; Zhang XN, 2012, EUR J PHARMACOL, V679, P51, DOI 10.1016/j.ejphar.2012.01.006	31	22	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46018	10.1371/journal.pone.0046018	http://dx.doi.org/10.1371/journal.pone.0046018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029367	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700107
J	Loot, AE; Moneke, I; Keseru, B; Oelze, M; Syzonenko, T; Daiber, A; Fleming, I				Loot, Annemarieke E.; Moneke, Isabelle; Keserue, Benjamin; Oelze, Matthias; Syzonenko, Tetyana; Daiber, Andreas; Fleming, Ingrid			11,12-EET Stimulates the Association of BK Channel alpha and beta(1) Subunits in Mitochondria to Induce Pulmonary Vasoconstriction	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SOLUBLE EPOXIDE HYDROLASE; VASCULAR SMOOTH-MUSCLE; EPOXYEICOSATRIENOIC ACIDS; LARGE-CONDUCTANCE; HYPERPOLARIZING FACTOR; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; BETA-1 SUBUNIT; HYPOXIA	In the systemic circulation, 11,12-epoxyeicosatrienoic acid (11,12-EET) elicits nitric oxide (NO)- and prostacyclin-independent vascular relaxation, partially through the activation of large conductance Ca2+-activated potassium (BK) channels. However, in the lung 11,12-EET contributes to hypoxia-induced pulmonary vasoconstriction. Since pulmonary artery smooth muscle cells also express BK channels, we assessed the consequences of BK beta(1) subunit deletion on pulmonary responsiveness to 11,12-EET as well as to acute hypoxia. In buffer-perfused mouse lungs, hypoxia increased pulmonary artery pressure and this was significantly enhanced in the presence of NO synthase (NOS) and cyclooxygenase (COX) inhibitors. Under these conditions the elevation of tissue EET levels using an inhibitor of the soluble epoxide hydrolase (sEH-I), further increased the hypoxic contraction. Direct administration of 11,12-EET also increased pulmonary artery pressure, and both the sEH-I and 11,12-EET effects were prevented by iberiotoxin and absent in BK beta(-/-)(1) mice. In pulmonary artery smooth muscle cells treated with NOS and COX inhibitors and loaded with the potentiometric dye, di-8-ANEPPS, 11,12-EET induced depolarization while the BK channel opener NS1619 elicited hyperpolarization indicating there was no effect of the EET on classical plasma membrane BK channels. In pulmonary artery smooth muscle cells a subpopulation of BK channels is localized in mitochondria. In these cells, 11,12-EET elicited an iberiotoxin-sensitive loss of mitochondrial membrane potential (JC-1 fluorescence) leading to plasma membrane depolarization, an effect not observed in BK beta(-/-)(1) cells. Mechanistically, stimulation with 11,12-EET time-dependently induced the association of the BK alpha and beta(1) subunits. Our data indicate that in the absence of NO and prostacyclin 11,12-EET contributes to pulmonary vasoconstriction by stimulating the association of the alpha and beta(1) subunits of mitochondrial BK channels. The 11,12-EET-induced activation of BK channels results in loss of the mitochondrial membrane potential and depolarization of the pulmonary artery smooth muscle cells.	[Loot, Annemarieke E.; Moneke, Isabelle; Keserue, Benjamin; Syzonenko, Tetyana; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany; [Oelze, Matthias; Daiber, Andreas] Johannes Gutenberg Univ Mainz, Dept Cardiol, Med Clin 2, Mainz, Germany	Goethe University Frankfurt; Johannes Gutenberg University of Mainz	Fleming, I (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/L-1225-2014; Fleming, Ingrid/AAB-6123-2022	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635	Deutsche Forschungsgemeinschaft [Exzellenzcluster 147 "Cardio-Pulmonary Systems"] [GRK 757]; European Vascular Genomics Network, a Network of Excellence; European Community [LSHM-CT-2003-503254]	Deutsche Forschungsgemeinschaft [Exzellenzcluster 147 "Cardio-Pulmonary Systems"](German Research Foundation (DFG)); European Vascular Genomics Network, a Network of Excellence; European Community(European Commission)	This study was supported by the Deutsche Forschungsgemeinschaft [GRK 757, Exzellenzcluster 147 "Cardio-Pulmonary Systems"] and by the European Vascular Genomics Network, a Network of Excellence supported by the European Community's sixth Framework Program [Contract No LSHM-CT-2003-503254]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YT, 2012, AM J PHYSIOL-LUNG C, V302, pL352, DOI 10.1152/ajplung.00302.2011; Bauersachs J, 1996, CIRCULATION, V94, P3341, DOI 10.1161/01.CIR.94.12.3341; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fike CD, 2005, J APPL PHYSIOL, V98, P1111, DOI 10.1152/japplphysiol.00810.2004; FLEMING I, 1994, CIRC RES, V74, P1220, DOI 10.1161/01.RES.74.6.1220; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Fukao M, 2001, MOL PHARMACOL, V59, P16, DOI 10.1124/mol.59.1.16; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Keseru B, 2010, CARDIOVASC RES, V85, P232, DOI 10.1093/cvr/cvp281; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kiss L, 2008, ANAL BIOANAL CHEM, V390, P697, DOI 10.1007/s00216-007-1718-9; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Loot AE, 2011, J CARDIOVASC PHARM, V57, P140, DOI 10.1097/FJC.0b013e3181ed088d; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Michelakis EV, 2004, J MOL CELL CARDIOL, V37, P1119, DOI 10.1016/j.yjmcc.2004.09.007; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Roth M, 2009, AM J RESP CRIT CARE, V180, P353, DOI 10.1164/rccm.200806-848OC; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sommer N, 2008, EUR RESPIR J, V32, P1639, DOI 10.1183/09031936.00013908; SPEAR RK, 1978, ANAL BIOCHEM, V90, P211, DOI 10.1016/0003-2697(78)90025-8; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Weir EK, 2006, CARDIOVASC RES, V71, P630, DOI 10.1016/j.cardiores.2006.04.014; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Weissmann N, 2006, CARDIOVASC RES, V71, P620, DOI 10.1016/j.cardiores.2006.04.009; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001	45	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46065	10.1371/journal.pone.0046065	http://dx.doi.org/10.1371/journal.pone.0046065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029390	Green Published, gold			2022-12-27	WOS:000309554700112
J	Al-Salih, G; Al-Attar, N; Delbosc, S; Louedec, L; Corvazier, E; Loyau, S; Michel, JB; Pidard, D; Duval, X; Meilhac, O				Al-Salih, Ghada; Al-Attar, Nawwar; Delbosc, Sandrine; Louedec, Liliane; Corvazier, Elisabeth; Loyau, Stephane; Michel, Jean-Baptiste; Pidard, Dominique; Duval, Xavier; Meilhac, Olivier			Role of Vegetation-Associated Protease Activity in Valve Destruction in Human Infective Endocarditis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIPLATELET THERAPY; EMBOLIC EVENTS; MURAL THROMBUS; INVOLVEMENT; ACTIVATION; PATHOGENS; APOPTOSIS; PLASMIN; COAGULATION	Aims: Infective endocarditis (IE) is characterized by septic thrombi (vegetations) attached on heart valves, consisting of microbial colonization of the valvular endocardium, that may eventually lead to congestive heart failure or stroke subsequent to systemic embolism. We hypothesized that host defense activation may be directly involved in tissue proteolytic aggression, in addition to pathogenic effects of bacterial colonization. Methods and Results: IE valve samples collected during surgery (n = 39) were dissected macroscopically by separating vegetations (VG) and the surrounding damaged part of the valve from the adjacent, apparently normal (N) valvular tissue. Corresponding conditioned media were prepared separately by incubation in culture medium. Histological analysis showed an accumulation of platelets and polymorphonuclear neutrophils (PMNs) at the interface between the VG and the underlying tissue. Apoptotic cells (PMNs and valvular cells) were abundantly detected in this area. Plasminogen activators (PA), including urokinase (uPA) and tissue (tPA) types were also associated with the VG. Secreted matrix metalloproteinase (MMP) 9 was also increased in VG, as was leukocyte elastase and myeloperoxidase (MPO). The presence of neutrophil extracellular traps (NETs) associating MPO and externalized nucleosomes, was shown by immunostaining in the VG. Both MPO and cell-free DNA were released in larger amounts by VG than N samples, suggesting bacterial activation of PMNs within the vegetation. Finally, evidence of proteolytic tissue damage was obtained by the release of fragments of extracellular matrix components such as fibrinogen and fibronectin, as well as protease-sensitive receptors such as the uPA receptor. Conclusion: Our data obtained using human IE valves suggest that septic vegetations represent an important source of proteases originating from massive leukocyte recruitment and activation of the host plasminergic system. The latter forms a potential therapeutic target to minimize valvular tissue degradation independently from that induced by bacterial proteases.	[Al-Salih, Ghada; Delbosc, Sandrine; Louedec, Liliane; Corvazier, Elisabeth; Loyau, Stephane; Michel, Jean-Baptiste; Pidard, Dominique; Meilhac, Olivier] INSERM, U698, Paris, France; [Al-Attar, Nawwar] Hop Xavier Bichat, AP HP, Dept Cardiovasc Surg, Paris, France; [Al-Attar, Nawwar; Michel, Jean-Baptiste; Meilhac, Olivier] Univ Paris Diderot, Paris, France; [Pidard, Dominique] CNRS, Inst Natl Sci Vivant, Paris, France; [Duval, Xavier] INSERM, CIC 007, Paris, France; [Meilhac, Olivier] AP HP, Bichat Stroke Ctr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Meilhac, O (corresponding author), INSERM, U698, Paris, France.	olivier.meilhac@inserm.fr	Meilhac, Olivier/N-4385-2017; DELBOSC, Sandrine/ABB-4618-2021; Michel, Jean-Baptiste/AAH-9336-2020	Meilhac, Olivier/0000-0002-3740-7539; Loyau, stephane/0000-0001-8748-501X; Pidard, Dominique/0000-0002-5732-3279; Delbosc, Sandrine/0000-0001-8076-6927				Anavekar NS, 2007, CLIN INFECT DIS, V44, P1180, DOI 10.1086/513197; Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUITING AGM, 1989, THROMB HAEMOSTASIS, V62, P1029; Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5; DELAHAYE F, 1995, EUR HEART J, V16, P394, DOI 10.1093/oxfordjournals.eurheartj.a060923; Delbosc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018679; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Hippenstiel S, 2003, THROMB HAEMOSTASIS, V89, P18; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Kochtebane N, 2010, J PATHOL, V221, P37, DOI 10.1002/path.2681; Kupferwasser LI, 1999, CIRCULATION, V99, P2791, DOI 10.1161/01.CIR.99.21.2791; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McKittrick IB, 2011, AM J PHYSIOL-RENAL, V301, pF1326, DOI 10.1152/ajprenal.00267.2011; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mtairag EM, 2002, ARTERIOSCL THROM VAS, V22, P1824, DOI 10.1161/01.ATV.0000037102.31086.F4; Neumann FJ, 1999, J AM COLL CARDIOL, V34, P1420, DOI 10.1016/S0735-1097(99)00350-2; Ovechkin AV, 2005, J APPL PHYSIOL, V99, P2398, DOI 10.1152/japplphysiol.00442.2005; Pepin J, 2009, CLIN MICROBIOL INFEC, V15, P193, DOI 10.1111/j.1469-0691.2008.02665.x; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45695	10.1371/journal.pone.0045695	http://dx.doi.org/10.1371/journal.pone.0045695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029186	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900090
J	Liere, H; Jackson, D; Vandermeer, J				Liere, Heidi; Jackson, Doug; Vandermeer, John			Ecological Complexity in a Coffee Agroecosystem: Spatial Heterogeneity, Population Persistence and Biological Control	PLOS ONE			English	Article							SELF-ORGANIZATION; PHORID FLIES; HOST; MUTUALISM; PREY; DYNAMICS; ANTS; AGGREGATION; STABILITY; SYSTEMS	Background: Spatial heterogeneity is essential for the persistence of many inherently unstable systems such as predatorprey and parasitoid-host interactions. Since biological interactions themselves can create heterogeneity in space, the heterogeneity necessary for the persistence of an unstable system could be the result of local interactions involving elements of the unstable system itself. Methodology/Principal Findings: Here we report on a predatory ladybird beetle whose natural history suggests that the beetle requires the patchy distribution of the mutualism between its prey, the green coffee scale, and the arboreal ant, Azteca instabilis. Based on known ecological interactions and the natural history of the system, we constructed a spatially-explicit model and showed that the clustered spatial pattern of ant nests facilitates the persistence of the beetle populations. Furthermore, we show that the dynamics of the beetle consuming the scale insects can cause the clustered distribution of the mutualistic ants in the first place. Conclusions/Significance: From a theoretical point of view, our model represents a novel situation in which a predator indirectly causes a spatial pattern of an organism other than its prey, and in doing so facilitates its own persistence. From a practical point of view, it is noteworthy that one of the elements in the system is a persistent pest of coffee, an important world commodity. This pest, we argue, is kept within limits of control through a complex web of ecological interactions that involves the emergent spatial pattern.	[Liere, Heidi] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Jackson, Doug; Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Liere, H (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	liere@wisc.edu			U.S. National Science Foundation [DEB 0349388]; Graham Environmental Sustainability Institute fellowship, University of Michigan; Helen Olsen Brower Fellowship, Department of Ecology and Evolutionary Biology, University of Michigan	U.S. National Science Foundation(National Science Foundation (NSF)); Graham Environmental Sustainability Institute fellowship, University of Michigan; Helen Olsen Brower Fellowship, Department of Ecology and Evolutionary Biology, University of Michigan	U.S. National Science Foundation, DEB 0349388 to JV and Ivette Perfecto; Graham Environmental Sustainability Institute fellowship, University of Michigan, to HL and DJ; and Helen Olsen Brower Fellowship, Department of Ecology and Evolutionary Biology, University of Michigan, to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Brown BV, 2012, PSYCHE-J ENTOMOL, V2012, DOI DOI 10.1155/2012/351232; COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Dov Y, 1997, SOFT SCALE INSECTS T; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goreaud F, 1999, J VEG SCI, V10, P433, DOI 10.2307/3237072; Gurney WSC, 2000, B MATH BIOL, V62, P61, DOI 10.1006/bulm.1999.0130; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; HANKS LM, 1990, BIOTROPICA, V22, P210, DOI 10.2307/2388415; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hodek I., 1996, ECOLOGY COCCINELLIDA; Hodek I, 2009, BIOL CONTROL, V51, P232, DOI 10.1016/j.biocontrol.2009.05.018; Hsieh HY, 2012, ECOL EVOL, V2, P2181, DOI 10.1002/ece3.322; Jackson D., 2009, Open Ecology Journal, V2, P62, DOI 10.2174/1874213000902010062; Jha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043510; Liere H, 2008, ENVIRON ENTOMOL, V37, P143, DOI 10.1603/0046-225X(2008)37[143:COAMIB]2.0.CO;2; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Murdoch WW, 1996, ECOLOGY, V77, P2001, DOI 10.2307/2265696; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; MYERS JH, 1978, ENVIRON ENTOMOL, V7, P619, DOI 10.1093/ee/7.5.619; MYERS JH, 1976, OECOLOGIA, V23, P255, DOI 10.1007/BF00345956; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Philpott SM, 2005, ENVIRON ENTOMOL, V34, P1089, DOI 10.1603/0046-225X(2005)034[1089:TEOPPF]2.0.CO;2; Philpott SM, 2004, OIKOS, V105, P141, DOI 10.1111/j.0030-1299.2004.12889.x; Reimer N, 1993, ENVIRON ENTOMOL, V22, P383; ROHANI P, 1994, AM NAT, V144, P491, DOI 10.1086/285688; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; ROHANI P, 1995, P ROY SOC B-BIOL SCI, V260, P335, DOI 10.1098/rspb.1995.0101; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354	39	20	20	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45508	10.1371/journal.pone.0045508	http://dx.doi.org/10.1371/journal.pone.0045508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029061	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900066
J	Waterman, RS; Henkle, SL; Betancourt, AM				Waterman, Ruth S.; Henkle, Sarah L.; Betancourt, Aline M.			Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis	PLOS ONE			English	Article							MACROPHAGE DIFFERENTIATION; IMMUNE SUPPRESSION; STROMAL CELLS; MOUSE MODEL; MAST-CELLS; CANCER; POLARIZATION; PROGRESSION; MIGRATION; ENHANCE	Background: Currently, there are many promising clinical trials using mesenchymal stem cells (MSCs) in cell-based therapies of numerous diseases. Increasingly, however, there is a concern over the use of MSCs because they home to tumors and can support tumor growth and metastasis. For instance, we established that MSCs in the ovarian tumor microenvironment promoted tumor growth and favored angiogenesis. In parallel studies, we also developed a new approach to induce the conventional mixed pool of MSCs into two uniform but distinct phenotypes we termed MSC1 and MSC2. Methodology/Principal Findings: Here we tested the in vitro and in vivo stability of MSC1 and MSC2 phenotypes as well as their effects on tumor growth and spread. In vitro co-culture of MSC1 with various cancer cells diminished growth in colony forming units and tumor spheroid assays, while conventional MSCs or MSC2 co-culture had the opposite effect in these assays. Co-culture of MSC1 and cancer cells also distinctly affected their migration and invasion potential when compared to MSCs or MSC2 treated samples. The expression of bioactive molecules also differed dramatically among these samples. MSC1-based treatment of established tumors in an immune competent model attenuated tumor growth and metastasis in contrast to MSCs- and MSC2-treated animals in which tumor growth and spread was increased. Also, in contrast to these groups, MSC1-therapy led to less ascites accumulation, increased CD45+leukocytes, decreased collagen deposition, and mast cell degranulation. Conclusion/Significance: These observations indicate that the MSC1 and MSC2 phenotypes may be convenient tools for the discovery of critical components of the tumor stroma. The continued investigation of these cells may help ensure that cell based-therapy is used safely and effectively in human disease.	[Henkle, Sarah L.; Betancourt, Aline M.] Tulane Univ, Sch Med, Tulane Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA; [Waterman, Ruth S.] Ochsner Clin Fdn, Dept Anesthesiol, New Orleans, LA USA; [Betancourt, Aline M.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA	Tulane University; Ochsner Health System; Tulane University	Betancourt, AM (corresponding author), Tulane Univ, Sch Med, Tulane Ctr Stem Cell Res & Regenerat Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	alibscan@tulane.edu			National Institutes of Health [1P20RR20152-01]; Department of Defense [OC073102]; Tulane Cancer Center; Center for Stem Cell Research and Regenerative Medicine; Foundation for Anesthesiology Education and Research (FAER); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Tulane Cancer Center; Center for Stem Cell Research and Regenerative Medicine; Foundation for Anesthesiology Education and Research (FAER); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided to AMB by the National Institutes of Health 1P20RR20152-01, Department of Defense OC073102 Concept Award and research support from the Tulane Cancer Center and the Center for Stem Cell Research and Regenerative Medicine. Funding was provided to RSW by the Foundation for Anesthesiology Education and Research (FAER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Bianchi G, 2011, HISTOL HISTOPATHOL, V26, P941, DOI 10.14670/HH-26.941; Brown JM, 2011, CLIN EXP ALLERGY, V41, P526, DOI 10.1111/j.1365-2222.2010.03685.x; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cubillos-Ruiz JR, 2010, CELL CYCLE, V9, P260, DOI 10.4161/cc.9.2.10430; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517; Klopp AH, 2010, STEM CELLS; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Liu Y, 2008, CLIN IMMUNOL, V129, P471, DOI 10.1016/j.clim.2008.07.030; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Navi D, 2007, CLIN REV ALLERG IMMU, V33, P144, DOI 10.1007/s12016-007-0029-4; Nesbeth Y, 2009, CANCER RES, V69, P6331, DOI 10.1158/0008-5472.CAN-08-4329; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Prockop DJ, 2011, MOL THER; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Ribatti D, 2011, PATHOL INT, V61, P442, DOI 10.1111/j.1440-1827.2011.02680.x; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Strausberg RL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-211; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; von Bahr L, 2012, STEM CELLS; Waterman RS, 2012, ROLE MESENCHYMAL STE; Waterman RS, 2012, STEM CELL TRANSL MED, V1, P557, DOI 10.5966/sctm.2012-0025; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Yang RC, 2006, CANCER RES, V66, P6807, DOI 10.1158/0008-5472.CAN-05-3755; Zwezdaryk KJ, 2007, EXP HEMATOL, V35, P640, DOI 10.1016/j.exphem.2007.01.044	49	133	140	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45590	10.1371/journal.pone.0045590	http://dx.doi.org/10.1371/journal.pone.0045590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029122	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900080
J	Lin, CH; Su, CH; Tseng, DY; Ding, FC; Hwang, PP				Lin, Chia-Hao; Su, Che-Hsien; Tseng, Deng-Yu; Ding, Feng-Chun; Hwang, Pung-Pung			Action of Vitamin D and the Receptor, VDRa, in Calcium Handling in Zebrafish (Danio rerio)	PLOS ONE			English	Article							1,25-DIHYDROXYVITAMIN D-3; PARATHYROID-HORMONE; NUCLEAR RECEPTOR; ION REGULATION; RAINBOW-TROUT; EXPRESSION; FISH; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; 25-HYDROXYCHOLECALCIFEROL; PUFFERFISH	The purpose of the present study was to use zebrafish as a model to investigate how vitamin D and its receptors interact to control Ca2+ uptake function. Low-Ca2+ fresh water stimulated Ca2+ influx and expressions of epithelial calcium channel (ecac), vitamin D-25-hydroxylase (cyp2r1), vitamin D receptor a (vdra), and vdrb in zebrafish. Exogenous vitamin D increased Ca2+ influx and expressions of ecac and 25-hydroxyvitamin D3-24-hydroxylase (cyp24a1), but downregulated 1 alpha-OHase (cyp27b1) with no effects on other Ca2+ transporters. Morpholino oligonucleotide knockdown of VDRa, but not VDRb, was found as a consequence of calcium uptake inhibition by knockdown of ecac, and ossification of vertebrae is impaired. Taken together, vitamin D-VDRa signaling may stimulate Ca2+ uptake by upregulating ECaC in zebrafish, thereby clarifying the Ca2+-handling function of only a VDR in teleosts. Zebrafish may be useful as a model to explore the function of vitamin D-VDR signaling in Ca2+ homeostasis and the related physiological processes in vertebrates.	[Lin, Chia-Hao; Su, Che-Hsien; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Su, Che-Hsien; Ding, Feng-Chun; Hwang, Pung-Pung] Natl Taiwan Univ, Inst Fishery Sci, Taipei 10764, Taiwan; [Tseng, Deng-Yu] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National University Tainan	Hwang, PP (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AAH-1538-2022; Lin, Chia-Hao/AHC-6514-2022		National Science Council, Taiwan, R.O.C.	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was financially supported by the grant to P.P.H. from the National Science Council, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink W, 2007, J ENDOCRINOL, V193, P473, DOI 10.1677/JOE-06-0164; Barletta F, 2004, AM J PHYSIOL-ENDOC M, V286, pE598, DOI 10.1152/ajpendo.00214.2003; Chen YY, 2003, J EXP ZOOL PART A, V295A, P127, DOI 10.1002/jez.a.10195; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Chou MY, 2011, CELL MOL LIFE SCI, V68, P2797, DOI 10.1007/s00018-010-0593-2; Craig TA, 2008, J BONE MINER RES, V23, P1486, DOI 10.1359/jbmr.080403; DUBOIS MB, 1988, GEN COMP ENDOCR, V71, P1, DOI 10.1016/0016-6480(88)90288-2; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; HAYES ME, 1986, GEN COMP ENDOCR, V64, P143, DOI 10.1016/0016-6480(86)90040-7; Henry H. L., 1997, Vitamin D., P57; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Krasowski MD, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-5; Lafont AG, 2011, J BONE MINER RES, V26, P1072, DOI 10.1002/jbmr.301; Lechner D, 2007, MOL CELL ENDOCRINOL, V263, P55, DOI 10.1016/j.mce.2006.08.009; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023689; Lock EJ, 2007, J ENDOCRINOL, V193, P459, DOI 10.1677/JOE-06-0198; Lynch M, 2000, GENETICS, V154, P459; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Murayama A, 1999, ENDOCRINOLOGY, V140, P2224, DOI 10.1210/en.140.5.2224; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Qiu AD, 2004, GENE, V342, P113, DOI 10.1016/j.gene.2004.07.041; Qiu A, 2007, AQUAT TOXICOL, V84, P142, DOI 10.1016/j.aquatox.2007.02.020; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; SUNDELL K, 1993, GEN COMP ENDOCR, V91, P344, DOI 10.1006/gcen.1993.1135; SWARUP K, 1991, COMP BIOCHEM PHYS A, V100, P445, DOI 10.1016/0300-9629(91)90497-Z; TAKEUCHI A, 1991, LIFE SCI, V48, P275, DOI 10.1016/0024-3205(91)90355-F; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Vanoevelen J, 2011, FASEB J, V25, P3197, DOI 10.1096/fj.11-183145; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Whitfield GK, 2003, ENDOCRINOLOGY, V144, P2704, DOI 10.1210/en.2002-221101; Zierold C, 2003, J CELL BIOCHEM, V88, P234, DOI 10.1002/jcb.10341	44	44	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45650	10.1371/journal.pone.0045650	http://dx.doi.org/10.1371/journal.pone.0045650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029160	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400117
J	Salem, SD; Saif-Ali, R; Ismail, IS; Al-Hamodi, Z; Poh, R; Muniandy, S				Salem, Sameer D.; Saif-Ali, Riyadh; Ismail, Ikram S.; Al-Hamodi, Zaid; Poh, Rozaida; Muniandy, Sekaran			IGF2BP2 Alternative Variants Associated with Glutamic Acid Decarboxylase Antibodies Negative Diabetes in Malaysian Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; CHINESE POPULATION; GENETIC-VARIANTS; INSULIN-RELEASE; TYPE-2; CDKN2A/B; SLC30A8; CDKAL1; HHEX	Background: The association of Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) common variants (rs4402960 and rs1470579) with type 2 diabetes (T2D) has been performed in different populations. The aim of this study was to evaluate the association of alternative variants of IGF2BP2; rs6777038, rs16860234 and rs7651090 with glutamic acid decarboxylase antibodies (GADA) negative diabetes in Malaysian Subjects. Methods/Principal Findings: IGF2BP2; rs6777038, rs16860234 and rs7651090 single nucleotide polymorphisms (SNPs) were genotyped in 1107 GADA negative diabetic patients and 620 control subjects of Asian from Malaysia. The additive genetic model adjusted for age, race, gender and BMI showed that alternative variants; rs6777038, rs16860234 and rs7651090 of IGF2BP2 associated with GADA negative diabetes (OR = 1.21; 1.36; 1.35, P = 0.03; 0.0004; 0.0002, respectively). In addition, the CCG haplotype and diplotype CCG-TCG increased the risk of diabetes (OR = 1.51, P = 0.01; OR = 2.36, P = 0.009, respectively). Conclusions/Significance: IGF2BP2 alternative variants were associated with GADA negative diabetes. The IGF2BP2 haplotypes and diplotypes increased the risk of diabetes in Malaysian subject.	[Salem, Sameer D.; Saif-Ali, Riyadh; Al-Hamodi, Zaid; Poh, Rozaida; Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Saif-Ali, Riyadh] Sanaa Univ, Fac Med, Dept Biochem, Sanaa, Yemen; [Ismail, Ikram S.] Univ Malaya, Med Ctr, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Salem, SD (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	sameersalem@yahoo.com; sekaran@um.edu.my	ISMAIL, IKRAM SHAH/B-8651-2010; Ismail, Ikram Shah/A-6329-2009; MUNIANDY, SEKARAN/B-5345-2010; POH, ROZAIDA Yuen Ying/B-9625-2010	ISMAIL, IKRAM SHAH/0000-0001-8796-1936; MUNIANDY, SEKARAN/0000-0003-1310-3634; POH, ROZAIDA Yuen Ying/0000-0002-7893-9929; Salem, Sameer/0000-0002-8269-9382; Saif-Ali, Riyadh/0000-0002-0246-3856	University of Malaya; UMRG [RG350/11HTM]; FRGS [PS251/2010B];  [PV029/2012A];  [UM-MOHE/MED/11]	University of Malaya(Universiti Malaya); UMRG; FRGS; ; 	This work was supported by University of Malaya grant; UMRG (RG350/11HTM), (PV029/2012A), FRGS (PS251/2010B) and UM-MOHE/MED/11 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; GROOP LC, 1986, DIABETES, V35, P237, DOI 10.2337/diabetes.35.2.237; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Hinohara K, 2009, J HUM GENET, V54, P248, DOI 10.1038/jhg.2009.22; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; International Diabetes Federation, 2011, DIABETES ATLAS, V5th; Jia HX, 2011, ARCH MED RES, V42, P361, DOI 10.1016/j.arcmed.2011.08.001; Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090; Le HTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033140; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; Monge L, 2004, DIABETIC MED, V21, P456, DOI 10.1111/j.1464-5491.2004.01177.x; Moonesinghe R, 2012, EUR J HUM GENET, DOI [10.1038/ejhg.2012.1015., DOI 10.1038/EJHG.2012.1015]; Nemr R, 2012, DIABETES RES CLIN PR, DOI [10.1016/j.dia-bres.2011.1012.1026., DOI 10.1016/J.DIABRES.2011.1012.1026]; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Rodriguez S, 2010, GROWTH HORM IGF RES, V20, P310, DOI 10.1016/j.ghir.2010.04.002; Roh M-O, 2010, ACTA DIABETOL, P1; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stenstrom G, 2005, DIABETES, V54, pS68, DOI 10.2337/diabetes.54.suppl_2.S68; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45573	10.1371/journal.pone.0045573	http://dx.doi.org/10.1371/journal.pone.0045573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029108	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388400107
J	Banning, A; Ockenga, W; Finger, F; Siebrasse, P; Tikkanen, R				Banning, Antje; Ockenga, Wymke; Finger, Fabian; Siebrasse, Philipp; Tikkanen, Ritva			Transcriptional Regulation of Flotillins by the Extracellularly Regulated Kinases and Retinoid X Receptor Complexes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SERUM RESPONSE ELEMENT; TERNARY COMPLEX; MAP KINASE; IN-VIVO; CARCINOMA-CELLS; BREAST-CANCER; UP-REGULATION; TARGET GENES; EXPRESSION	Flotillin-1 and flotillin-2 are important regulators of signal transduction pathways such as growth factor signaling. Flotillin expression is increased under pathological conditions such as neurodegenerative disorders and cancer. Despite their importance for signal transduction, very little is known about the transcriptional regulation of flotillins. Here, we analyzed the expression of flotillins at transcriptional level and identified flotillins as downstream targets of the mitogen activated kinases ERK1/2. The promoter activity of flotillins was increased upon growth factor stimulation in a MAPK dependent manner. Overexpression of serum response factor or early growth response gene 1 resulted in increased flotillin mRNA and protein expression. Furthermore, both promoter activity and expression of endogenous flotillins were increased upon treatment with retinoic acid or by overexpression of the retinoid X receptor and its binding partners RAR alpha and PPAR gamma. Our data indicate that the expression of flotillins, which can be detected in all cultured cells, is fine-tuned in response to various external stimuli. This regulation may be critical for the outcome of signaling cascades in which flotillins are known to be involved.	[Banning, Antje; Ockenga, Wymke; Finger, Fabian; Siebrasse, Philipp; Tikkanen, Ritva] Univ Giessen, Fac Med, Inst Biochem, Giessen, Germany	Justus Liebig University Giessen	Tikkanen, R (corresponding author), Univ Giessen, Fac Med, Inst Biochem, Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de		Tikkanen, Ritva/0000-0002-8393-1825; Finger, Fabian/0000-0002-0763-6250	Deutsche Forschungsgemeinschaft [DFG: Ti291/6-1, Ti291/6-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG: Ti291/6-1, Ti291/6-2 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaddii M, 2012, J BIOL CHEM; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; CAO XM, 1993, J BIOL CHEM, V268, P16949; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Flicker SH, 1997, CANCER LETT, V115, P63, DOI 10.1016/S0304-3835(97)04715-0; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Hazarika P, 1999, J CELL BIOCHEM, V75, P147, DOI 10.1002/(SICI)1097-4644(19991001)75:1<147::AID-JCB15>3.0.CO;2-D; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; Iida S, 2005, J LEUKOCYTE BIOL, V78, P481, DOI 10.1189/jlb.0904515; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Katanaev VL, 2008, EMBO J, V27, P509, DOI 10.1038/sj.emboj.7601981; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kokubo H, 2000, NEUROSCI LETT, V290, P93, DOI 10.1016/S0304-3940(00)01334-3; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lim JH, 2008, J CELL BIOCHEM, V105, P1117, DOI 10.1002/jcb.21914; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Lopez-Casas PP, 2003, FEBS LETT, V555, P223, DOI 10.1016/S0014-5793(03)01239-0; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Maegawa M, 2009, ANTICANCER RES, V29, P1111; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Raimondo F, 2008, OPEN PROTEOMICS J, V1, P87, DOI DOI 10.2174/1875039700801010087; RAO VN, 1994, ONCOGENE, V9, P1855; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Sasaki Y, 2008, MOL CANC RES; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schulte T, 1997, DEVELOPMENT, V124, P577; SETH A, 1991, J BIOL CHEM, V266, P23521; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Swanwick CC, 2010, DEV NEUROBIOL, V70, P875, DOI 10.1002/dneu.20828; Swanwick CC, 2010, MOL CELL NEUROSCI, V45, P213, DOI 10.1016/j.mcn.2010.06.012; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tikkanen R, 2010, CELL BIO RES PROG, P1; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; von Philipsborn AC, 2005, J COMP NEUROL, V482, P257, DOI 10.1002/cne.20423; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yang XY, 2005, CELL ONCOL, V27, P215; Yen A, 2004, IN VITRO CELL DEV-AN, V40, P216, DOI 10.1290/1543-706X(2004)40<216:RABATM>2.0.CO;2; Yen A, 1998, CANCER RES, V58, P3163; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	82	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45514	10.1371/journal.pone.0045514	http://dx.doi.org/10.1371/journal.pone.0045514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029064	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900150
J	Giffin, MM; Raab, RW; Morganstern, M; Sohaskey, CD				Giffin, Michelle M.; Raab, Ronald W.; Morganstern, Melissa; Sohaskey, Charles D.			Mutational Analysis of the Respiratory Nitrate Transporter NarK2 of Mycobacterium tuberculosis	PLOS ONE			English	Article							PARACOCCUS-DENITRIFICANS; NITRITE TRANSPORT; BOVIS BCG; IN-VITRO; OXYGEN; INHIBITION; REDUCTASE; PROTEIN; MECHANISM; PERSISTENCE	Mycobacterium tuberculosis induces nitrate reductase activity in response to decreasing oxygen levels. This is due to regulation of both the transcription and the activity of the nitrate transporter NarK2. A model of NarK2 structure is proposed containing 12 membrane spanning regions consistent with other members of the major facilitator superfamily. The role of the proton gradient was determined by exposing M. tuberculosis to uncouplers. Nitrite production decreased indicating that the importation of nitrate involved an H+/nitrate symporter. The addition of nitrite before nitrate had no effect, suggesting no role for a nitrate/nitrite antiporter. In addition the NarK2 knockout mutant showed no defect in nitrite export. NarK2 is proposed to be a Type I H+/nitrate symporter. Site directed mutagenesis was performed changing 23 amino acids of NarK2. This allowed the identification of important regions and amino acids of this transporter. Five of these mutants were inactive for nitrate transport, seven produced reduced activity and eleven mutants retained wild type activity. NarK2 is inactivated in the presence of oxygen by an unknown mechanism. However none of the mutants, including those with mutated cysteines, were altered in their response to oxygen levels. The assimilatory nitrate transporter NasA of Bacillus subtilis was expressed in the M. tuberculosis NarK2 mutant. It remained active during aerobic incubation showing that the point of oxygen control is NarK2.	[Giffin, Michelle M.; Sohaskey, Charles D.] Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA; [Raab, Ronald W.; Morganstern, Melissa] James Madison Univ, ISAT Dept, Harrisonburg, VA 22807 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; James Madison University	Sohaskey, CD (corresponding author), Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA.	Chuck@Sohaskey.com			Medical Research Services of the U.S. Department of Veterans Affairs	Medical Research Services of the U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Medical Research Services of the U.S. Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEFOUNDER PR, 1981, FEMS MICROBIOL LETT, V12, P321; ALEFOUNDER PR, 1983, BIOCHIM BIOPHYS ACTA, V724, P20, DOI 10.1016/0005-2728(83)90022-1; ALEFOUNDER PR, 1980, BIOCHEM J, V192, P231, DOI 10.1042/bj1920231; Bald D, 2010, FEMS MICROBIOL LETT, V308, P1, DOI 10.1111/j.1574-6968.2010.01959.x; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; BOOGERD FC, 1983, BIOCHIM BIOPHYS ACTA, V723, P415, DOI 10.1016/0005-2728(83)90049-X; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Goddard AD, 2008, MOL MICROBIOL, V70, P667, DOI 10.1111/j.1365-2958.2008.06436.x; HERNANDEZ D, 1988, J BIOL CHEM, V263, P7937; Hirai T, 2004, BIOPHYS J, V87, P3600, DOI 10.1529/biophysj.104.049320; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Jia W, 2009, BIOCH J; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; KIM CH, 1982, BIOCHEM BIOPH RES CO, V108, P1126, DOI 10.1016/0006-291X(82)92117-9; Kinghorn JR, 2005, GENETICS, V169, P1369, DOI 10.1534/genetics.104.036590; Kucera I, 2003, ARCH BIOCHEM BIOPHYS, V409, P327, DOI 10.1016/S0003-9861(02)00550-7; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; NOJI S, 1989, FEBS LETT, V252, P139, DOI 10.1016/0014-5793(89)80906-8; NOJI S, 1987, J BIOL CHEM, V262, P9441; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Ramirez S, 2000, J BACTERIOL, V182, P2179, DOI 10.1128/JB.182.8.2179-2183.2000; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Sohaskey CD, 2005, MICROBIOL-SGM, V151, P3803, DOI 10.1099/mic.0.28263-0; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Sohaskey CD, 2009, FEMS MICROBIOL LETT, V290, P129, DOI 10.1111/j.1574-6968.2008.01424.x; Song HH, 2012, J BACTERIOL, V194, P956, DOI 10.1128/JB.06132-11; Tan W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012924, 10.1371/journal.pone.0013356]; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Unkles SE, 2005, BIOCHEMISTRY-US, V44, P5471, DOI 10.1021/bi047732e; Unkles SE, 2004, P NATL ACAD SCI USA, V101, P17549, DOI 10.1073/pnas.0405054101; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45459	10.1371/journal.pone.0045459	http://dx.doi.org/10.1371/journal.pone.0045459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029022	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900138
J	Po, C; Kalthoff, D; Kim, YB; Nelles, M; Hoehn, M				Po, Chrystelle; Kalthoff, Daniel; Kim, Young Beom; Nelles, Melanie; Hoehn, Mathias			White Matter Reorganization and Functional Response after Focal Cerebral Ischemia in the Rat	PLOS ONE			English	Article							EXPERIMENTAL STROKE; NERVOUS-SYSTEM; DIFFUSION; MRI; RECOVERY; CONNECTIVITY; TISSUE; FMRI	After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite severe cerebral damage. This phenomenon is poorly understood. To address this issue, focal transient ischemia was induced by 60 min middle cerebral artery occlusion in Wistar rats. The evolution of stroke was followed using two magnetic resonance imaging modalities: diffusion spectrum imaging (acquired before, one and four weeks after stroke) and functional magnetic resonance imaging (acquired before and five weeks after stroke). To confirm the imaging observations, immunohistochemical staining for myelin, astrocytes and macrophages/microglia was added. At four weeks after stroke, a focal alteration of the diffusion anisotropy was observed between the ipsilesional ventricle and the lesion area. Using tractography this perturbation was identified as reorganization of the ipsilesional internal capsule. Functional imaging at five weeks after ischemia demonstrated activation of the primary sensorimotor cortex in both hemispheres in all rats except one animal lacking a functional response in the ipsilesional cortex. Furthermore, fiber tracking showed a transhemispheric fiber connection through the corpus callosum, which-in the rat without functional recovery-was lost. Our study shows the influence of the internal capsule reorganization, combined with inter-hemispheric connections though the corpus callosum, on the functional activation of the brain from stroke. In conclusion, tractography opens a new door to non-invasively investigate the structural correlates of lack of functional recovery after stroke.	[Po, Chrystelle; Kalthoff, Daniel; Kim, Young Beom; Nelles, Melanie; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany	Max Planck Society	Hoehn, M (corresponding author), Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany.	mathias@nf.mpg.de		Po, Chrystelle/0000-0001-9785-9572	EU [HEALTH-F5-2008-201842 (ENCITE)]; German Federal Ministry of Education and Research [BMBF-0314104]	EU(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded by the EU project HEALTH-F5-2008-201842 (ENCITE) and by a grant from the German Federal Ministry of Education and Research BMBF-0314104 (Biomarkers of Brain Ageing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; CHEN CN, 1993, MAGNET RESON MED, V29, P386, DOI 10.1002/mrm.1910290316; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Farr TD, 2011, NMR BIOMED, V24, P35, DOI 10.1002/nbm.1553; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Kim YB, 2012, NMR BIOMED, V25, P943, DOI 10.1002/nbm.1815; Kleiser R, 2010, NEURORADIOLOGY, V52, P37, DOI 10.1007/s00234-009-0539-2; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Koizumi JYY, 1986, JPN J STROKE, V8, P1, DOI [DOI 10.3995/JSTROKE.8.1, DOI 10.3995/jstroke.8.1]; Kreisel SH, 2007, CEREBROVASC DIS, V23, P243, DOI 10.1159/000098323; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Norris DG, 2001, J MAGN RESON IMAGING, V13, P486, DOI 10.1002/jmri.1072; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ramos-Cabrer P, 2005, NMR BIOMED, V18, P440, DOI 10.1002/nbm.978; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tang PF, 2010, AM J NEURORADIOL, V31, P1023, DOI 10.3174/ajnr.A1981; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Ween JE, 2008, J NEUROIMAGING, V18, P227, DOI 10.1111/j.1552-6569.2007.00180.x; Wegener S, 2006, J CEREBR BLOOD F MET, V26, P38, DOI 10.1038/sj.jcbfm.9600166; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087	35	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45629	10.1371/journal.pone.0045629	http://dx.doi.org/10.1371/journal.pone.0045629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029148	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900164
J	Wu, ZQ; Sun, HB; Zeng, WX; He, JC; Mao, XM				Wu, Ziqing; Sun, Huabin; Zeng, Weixia; He, Jincan; Mao, Xiangming			Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TUMOR SUPPRESSION; BIOCHEMICAL RECURRENCE; FACTOR FKHR; EXPRESSION; INHIBITION; APOPTOSIS; GENE; PHOSPHORYLATION; ACTIVATION	Forkhead box protein O1 (FOXO1), a key member of the FOXO family of transcription factors, acts as a tumor suppressor and has been associated with various key cellular functions, including cell growth, differentiation, apoptosis and angiogenesis. Therefore, it is puzzling why FOXO protein expression is downregulated in cancer cells. MicroRNAs, non-coding 20 similar to 22 nucleotide single-stranded RNAs, result in translational repression or degradation and gene silencing of their target genes, and significantly contribute to the regulation of gene expression. In the current study, we report that miR-370 expression was significantly upregulated in five prostate cancer cell lines, compared to normal prostatic epithelial (PrEC) cells. Ectopic expression of miR-370 induced proliferation and increased the anchorage-independent growth and colony formation ability of DU145 and LNCaP prostate cancer cells, while inhibition of miR-370 reduced proliferation, anchorage-independent growth and colony formation ability. Furthermore, upregulation of miR-370 promoted the entry of DU145 and LNCaP prostate cancer cells into the G1/S cell cycle transition, which was associated with downregulation of the cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) and p21(Cip1), and upregulation of the cell-cycle regulator cyclin D1 mRNA. Additionally, we demonstrated that miR-370 can downregulate expression of FOXO1 by directly targeting the FOXO1 3'-untranslated region. Taken together, our results suggest that miR-370 plays an important role in the proliferation of human prostate cancer cells, by directly suppressing the tumor suppressor FOXO1.	[He, Jincan; Mao, Xiangming] So Med Univ, Dept Urol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Ziqing] So Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Ziqing] So Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Sun, Huabin] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 5, Zhuhai, Guangdong, Peoples R China; [Zeng, Weixia] Laura Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University	Mao, XM (corresponding author), So Med Univ, Dept Urol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	xmmao2012@sina.cn						Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Huang HJ, 2004, J BIOL CHEM, V279, P13866, DOI 10.1074/jbc.M314143200; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; ISAACS WB, 1995, CANCER SURV, V23, P19; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Lu HR, 2011, NEOPLASIA, V13, P854, DOI 10.1593/neo.11594; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Roehrborn CG, 2011, BJU INT, V108, P806, DOI 10.1111/j.1464-410X.2011.10365.x; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang HT, 2010, PROSTATE, V70, P1265, DOI 10.1002/pros.21162	55	74	81	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45825	10.1371/journal.pone.0045825	http://dx.doi.org/10.1371/journal.pone.0045825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029264	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900170
J	Jono, CMA; Pavoine, S				Jono, Clementine M. A.; Pavoine, Sandrine			Threat Diversity Will Erode Mammalian Phylogenetic Diversity in the Near Future	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION PRIORITIZATION; AUSTRALIAN MARSUPIALS; BIODIVERSITY; IMPACT; PROBABILITIES; SELECTIVITY; HISTORY; DECLINE; BATS	To reduce the accelerating rate of phylogenetic diversity loss, many studies have searched for mechanisms that could explain why certain species are at risk, whereas others are not. In particular, it has been demonstrated that species might be affected by both extrinsic threat factors as well as intrinsic biological traits that could render a species more sensitive to extinction; here, we focus on extrinsic factors. Recently, the International Union for Conservation of Nature developed a new classification of threat types, including climate change, urbanization, pollution, agriculture and aquaculture, and harvesting/hunting. We have used this new classification to analyze two main factors that could explain the expected future loss of mammalian phylogenetic diversity: 1. differences in the type of threats that affect mammals and 2. differences in the number of major threats that accumulate for a single species. Our results showed that Cetartiodactyla, Diprotodontia, Monotremata, Perissodactyla, Primates, and Proboscidea could lose a high proportion of their current phylogenetic diversity in the coming decades. In contrast, Chiroptera, Didelphimorphia, and Rodentia could lose less phylogenetic diversity than expected if extinctions were random. Some mammalian clades, including Marsupiala, Chiroptera, and a subclade of Primates, are affected by particular threat types, most likely due solely to their geographic locations and associations with particular habitats. However, regardless of the geography, habitat, and taxon considered, it is not the threat type, but the threat diversity that determines the extinction risk for species and clades. Thus, some mammals might be randomly located in areas subjected to a large diversity of threats; they might also accumulate detrimental traits that render them sensitive to different threats, which is a characteristic that could be associated with large body size. Any action reducing threat diversity is expected to have a significant impact on future mammalian phylogeny.	[Jono, Clementine M. A.; Pavoine, Sandrine] UMR CNRS UPMC 7204, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, Paris, France; [Pavoine, Sandrine] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Jono, CMA (corresponding author), UMR CNRS UPMC 7204, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, Paris, France.	clementine.jono@gmail.com						Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Baillie J. E., 2004, GLOBAL SPECIES ASSES; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Elliott W.R., 2004, ENCY CAVES, P428; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Greenacre Michael, 1984, THEORY APPL CORRES A; Gros G, 1982, BIOMETR PRAX, V22, P117; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hayward MW, 2009, CONSERV BIOL, V23, P1568, DOI 10.1111/j.1523-1739.2009.01260.x; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15, DOI DOI 10.2305/IUCN.CH.2009.17.EN; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; Johnson CN, 2002, ANIM CONSERV, V5, P135, DOI 10.1017/S1367943002002196; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; KRAJEWSKI C, 1991, SCIENCE, V254, P918, DOI 10.1126/science.254.5034.918-a; Lapointe FJ, 2001, J CLASSIF, V18, P109, DOI 10.1007/s00357-001-0007-0; MACE GM, 2000, FUTURE PRIORITIES CO, P27; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Meijaard E, 2008, BIOTROPICA, V40, P76, DOI 10.1111/j.1744-7429.2007.00340.x; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rodriguez JP, 2000, NATURE, V403, P241, DOI 10.1038/35002183; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sodhi N. S., 2009, PRINCET GUIDE ECOL, P514, DOI DOI 10.1515/9781400833023.514; Vie J-C, 2009, WILDLIFE CHANGING WO; Wilson D. E., 2005, MAMMAL SPECIES WORLD	61	20	20	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46235	10.1371/journal.pone.0046235	http://dx.doi.org/10.1371/journal.pone.0046235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029443	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900113
J	Loyola, RD; Lemes, P; Faleiro, FV; Trindade, J; Machado, RB				Loyola, Rafael D.; Lemes, Priscila; Faleiro, Frederico V.; Trindade-Filho, Joaquim; Machado, Ricardo B.			Severe Loss of Suitable Climatic Conditions for Marsupial Species in Brazil: Challenges and Opportunities for Conservation	PLOS ONE			English	Article							MODELS; IMPACTS	A wide range of evidences indicate climate change as one the greatest threats to biodiversity in the 21st century. The impacts of these changes, which may have already resulted in several recent species extinction, are species-specific and produce shifts in species phenology, ecological interactions, and geographical distributions. Here we used cutting-edge methods of species distribution models combining thousands of model projections to generate a complete and comprehensive ensemble of forecasts that shows the likely impacts of climate change in the distribution of all 55 marsupial species that occur in Brazil. Consensus projections forecasted range shifts that culminate with high species richness in the southeast of Brazil, both for the current time and for 2050. Most species had a significant range contraction and lost climate space. Turnover rates were relatively high, but vary across the country. We also mapped sites retaining climatic suitability. They can be found in all Brazilian biomes, especially in the pampas region, in the southern part of the Brazilian Atlantic Forest, in the north of the Cerrado and Caatinga, and in the northwest of the Amazon. Our results provide a general overview on the likely effects of global climate change on the distribution of marsupials in the country as well as in the patterns of species richness and turnover found in regional marsupial assemblages.	[Loyola, Rafael D.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Lemes, Priscila; Faleiro, Frederico V.; Trindade-Filho, Joaquim] Univ Fed Goias, Grad Program Ecol & Evolut, Goiania, Go, Brazil; [Machado, Ricardo B.] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Brasilia	Loyola, RD (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Machado, Ricardo/GXM-8198-2022; Machado, Ricardo Bomfim/J-5894-2012; Faleiro, Frederico V/B-8250-2016; Loyola, Rafael/A-4425-2008; Loyola, Rafael/S-3978-2019; Lemes, Priscila/I-5877-2013; Filho, Joaquim Trindade/AAP-1545-2021	Machado, Ricardo Bomfim/0000-0002-6508-9005; Faleiro, Frederico V/0000-0002-4183-6897; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Lemes, Priscila/0000-0002-0918-5158; TRINDADE FILHO, JOAQUIM/0000-0001-5429-3193	CNPq [304703/2011-7]; CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	R.D.L. received a research productivity scholarship from the CNPq (grant #304703/2011-7). P. L. received a PhD scholarship from CNPq. F. V. F. and J.T.-F. received PhD scholarships from CAPES. Conservation Biogeography Lab research has been continuously supported by the CNPq, CAPES, Conservation International Brazil, and MCT-Rede CLIMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caceres N.C., 2006, MARSUPIAIS BRASIL BI, V1; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eastman JR, 2009, IDRISI KILIMANJARO G; Diniz JAF, 2009, NAT CONSERVACAO, V7, P100; Fernandez Fernando A.S., 2006, P191; Franklin J, 2009, MAPPING SPECIES DIST; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Gardner A.L., 2008, MAMMALS S AM MARSUPI, V1; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie T., 1986, STAT SCI, V1, P297; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Loyola RD, 2012, MAMIFEROS B IN PRESS; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Parry ML, 2007, CLIMATE CHANGE 2007; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pimm SL, 2010, NAT CONSERVACAO, V8, P71, DOI 10.4322/natcon.00801011; Prevedello JA, 2011, J ZOOL, V284, P53, DOI 10.1111/j.1469-7998.2010.00783.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Puettker Thomas, 2008, BMC Ecology, V8, P9, DOI 10.1186/1472-6785-8-9; Rossi R. V., 2006, MAMIFEROS BRASIL, P27; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x	36	42	42	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46257	10.1371/journal.pone.0046257	http://dx.doi.org/10.1371/journal.pone.0046257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029452	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900118
J	Tobudic, S; Plunger, V; Sunder-Plassmann, G; Riegersperger, M; Burgmann, H				Tobudic, Selma; Plunger, Veronika; Sunder-Plassmann, Gere; Riegersperger, Markus; Burgmann, Heinz			Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients	PLOS ONE			English	Article							FUNCTIONAL ANTIBODY-ACTIVITY; COMPLEX CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; STREPTOCOCCUS-PNEUMONIAE; OLDER-ADULTS; CAPSULAR POLYSACCHARIDE; PROTEIN-CONJUGATE; IMMUNE-RESPONSE; IMMUNOGENICITY; REVACCINATION	Renal transplant recipients are at increased risk of developing invasive pneumococcal diseases but may have poor response to the 23-valent pneumococcal polysaccharide vaccine (PPV). It may be possible to enhance immunogenicity by priming with 7-valent pneumococcal conjugate vaccine (7vPnC) and boosting with PPV 1 year later. In a randomized single-blind, controlled study, adult recipients of renal transplants received either 7nPVC or PPV followed by PPV 1 year later. The vaccine response was defined as 2-fold increase in antibody concentration from baseline and an absolute post-vaccination values >= 1 mu g/ml. The primary endpoint was vaccine response of the primed group (7vPnC/PPV) compared with single PPV vaccination. Antibody concentrations for 10 serotypes were measured at baseline, 8 weeks after first vaccination, before second vaccination, and 8 weeks after second vaccination. Of 320 screened patients, 80 patients were randomized and 62 completed the study. Revaccination with PPV achieved no significant increase of immune response in the 7vPnC/PPV group compared with the single PPV recipients A response to at least 1 serotype was seen in 77.1% of patients who received 7vPnC and 93.1% of patients who received PPV (P = 0.046). After second vaccination response to at least 1 serotype was seen in 87.5% patients of 7vPnC/PPV group and 87.1% patients of PPV group (non significant p). The median number of serotypes eliciting a response was 3.5 (95% CI 2.5-4.5) in the 7vPnC/PPV group versus 5 (95% CI 3.9-6.1) in the PPV group (non-significant p). Immunogenicity of pneumococcal vaccination was not enhanced by the prime-boost strategy compared with vaccination with PPV alone. Administration of a single dose of PPV should continue to be the standard of care for adult recipients of renal transplants.	[Tobudic, Selma; Plunger, Veronika; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria; [Sunder-Plassmann, Gere; Riegersperger, Markus] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Burgmann, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Burgmann, Heinz/N-2409-2013	Sunder-Plassmann, Gere/0000-0002-9253-9921; Riegersperger, Markus/0000-0002-1151-9049; Burgmann, Heinz/0000-0002-2114-0999	Jubilaumsfonds der Osterreichischen Nationalbank [13092]	Jubilaumsfonds der Osterreichischen Nationalbank	The study was funded by the Jubilaumsfonds der Osterreichischen Nationalbank, grant number 13092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman H, 1996, PEDIATR INFECT DIS J, V15, P134, DOI 10.1097/00006454-199602000-00009; Artz AS, 2003, CLIN MICROBIOL REV, V16, P308, DOI 10.1128/CMR.16.2.308-318.2003; Baxendale HE, 2000, EUR J IMMUNOL, V30, P1214, DOI 10.1002/(SICI)1521-4141(200004)30:4<1214::AID-IMMU1214>3.0.CO;2-D; Blum MD, 2000, VACCINE, V18, P2359, DOI 10.1016/S0264-410X(00)00021-9; Blumberg EA, 2001, CLIN INFECT DIS, V32, P307, DOI 10.1086/318482; Chan CY, 1996, J INFECT DIS, V173, P256, DOI 10.1093/infdis/173.1.256; Danzinger-Isakov L, 2009, AM J TRANSPLANT, V9, pS258, DOI 10.1111/j.1600-6143.2009.02917.x; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; Dransfield MT, 2009, AM J RESP CRIT CARE, V180, P499, DOI 10.1164/rccm.200903-0488OC; Edwards KM, 2003, NEW ENGL J MED, V349, P1312, DOI 10.1056/NEJMp038102; Fedson DS, 1999, DRUG AGING, V15, P21, DOI 10.2165/00002512-199915001-00003; Gattringer R, 2011, TRANSPL INFECT DIS; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Goldblatt D, 2009, CLIN INFECT DIS, V49, P1318, DOI 10.1086/606046; Hjuler T, 2008, PEDIATRICS, V122, pE26, DOI 10.1542/peds.2007-1510; Jackson L, 1999, JAMA-J AM MED ASSOC, V281, P243, DOI 10.1001/jama.281.3.243; Jackson LA, 2007, VACCINE, V25, P4029, DOI 10.1016/j.vaccine.2007.02.062; Johnson SE, 1999, J INFECT DIS, V180, P133, DOI 10.1086/314845; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Kumar D, 2007, AM J TRANSPLANT, V7, P1209, DOI 10.1111/j.1600-6143.2006.01705.x; Kumar D, 2007, AM J TRANSPLANT, V7, P633, DOI 10.1111/j.1600-6143.2007.01668.x; Kumar D, 2003, J INFECT DIS, V187, P1639, DOI 10.1086/374784; Kumar D, 2008, CLIN INFECT DIS, V47, P885, DOI 10.1086/591537; Landgren O, 2004, J INTERN MED, V255, P664, DOI 10.1111/j.1365-2796.2004.01312.x; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; LINNEMANN CC, 1981, ARCH INTERN MED, V141, P1637, DOI 10.1001/archinte.141.12.1637; LINNEMANN CC, 1986, ARCH INTERN MED, V146, P1554, DOI 10.1001/archinte.146.8.1554; LINNEMANN CC, 1979, JAMA-J AM MED ASSOC, V241, P2619, DOI 10.1001/jama.241.24.2619; Manoff SB, 2010, J INFECT DIS, V201, P525, DOI 10.1086/651131; McCashland TM, 2000, J INFECT DIS, V181, P757, DOI 10.1086/315245; Metersky ML, 2010, CHEST, V138, P486, DOI 10.1378/chest.10-0738; Miernyk KM, 2000, CLIN INFECT DIS, V31, P34, DOI 10.1086/313907; Molrine DC, 2001, INFECT DIS CLIN N AM, V15, P273, DOI 10.1016/S0891-5520(05)70279-8; Musher DM, 2010, J INFECT DIS, V201, P516, DOI 10.1086/649839; O'Brien KL, 2007, J INFECT DIS, V196, P104, DOI 10.1086/518438; Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Sarmiento E, 2006, Int Immunopharmacol, V6, P2027, DOI 10.1016/j.intimp.2006.09.011; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P788, DOI 10.1111/j.1365-2141.2005.05918.x; Zangwill KM, 2003, VACCINE, V21, P1894, DOI 10.1016/S0264-410X(03)00013-6	41	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46133	10.1371/journal.pone.0046133	http://dx.doi.org/10.1371/journal.pone.0046133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029408	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900093
J	Geng, QR; Xu, DZ; He, LJ; Lu, JB; Zhou, ZW; Zhan, YQ; Lu, Y				Geng, Qi-Rong; Xu, Da-Zhi; He, Long-Jun; Lu, Jia-Bing; Zhou, Zhi-Wei; Zhan, You-Qing; Lu, Yue			Beclin-1 Expression Is a Significant Predictor of Survival in Patients with Lymph Node-Positive Gastric Cancer	PLOS ONE			English	Article							AUTOPHAGY; STATISTICS	Background: Beclin 1 is a main actor of autophagy. The expression of Beclin 1 and its prognostic role in gastric cancer is largely unexplored. The purpose of the present study is to investigate the expression of beclin 1 in gastric cancer cells, tissues and its relationship with prognosis. Methods: The expression of Beclin 1 was detected in 271 specimens of lymph-node positive gastric cancer patients by immunohistochemistry. The correlation of Beclin 1 expression to clinicopathologic features and survival of gastric cancer was studied. Beclin-1 expression in gastric cancer cell lines and clinical specimens is also detected using reverse transcription-PCR and Western blotting. Results: Beclin 1 is up-regulated at both mRNA and protein levels in six gastric cancer cell lines compared with those in normal gastric mucosa cell line (GES-1). The expression of Beclin-1 in gastric clinical specimens is also higher than those in the adjacent noncancerous tissues. Of the 271 patients, 229 (84.5%) were Beclin 1 high expression tumors by immunohistochemistry. Beclin 1 expression is closely associated with intravascular embolus. Kaplan-Meier analysis showed high beclin 1 expression was associated with longer overall survival. Both univariate analysis and multivariate analysis revealed that Beclin 1 expression were independent prognostic factors in the patients with node-positive gastric cancer. Conclusions: Our findings strongly suggest that Beclin 1 has a potential role in tumorigenesis of gastric cancer and could be a promising biomarker for predicting the prognosis of patients with lymph node-positive gastric cancer. It might also serve as a novel therapeutic target for gastric cancer treatment.	[Geng, Qi-Rong; Xu, Da-Zhi; He, Long-Jun; Lu, Jia-Bing; Zhou, Zhi-Wei; Zhan, You-Qing; Lu, Yue] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Geng, Qi-Rong; Lu, Yue] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Da-Zhi; Zhou, Zhi-Wei; Zhan, You-Qing] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [He, Long-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Jia-Bing] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, DZ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xudzh@sysucc.org.cn; lvyue@sysucc.org.cn			Medical Science Foundation of Guangdong Province [2010B031600071]	Medical Science Foundation of Guangdong Province	This work was supported by the Medical Science Foundation of Guangdong Province (No. 2010B031600071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Bang YJ, 2010, LANCET, V376, P1302; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Cui MH, 2010, MED ONCOL, V27, P632, DOI 10.1007/s12032-009-9260-6; Daniel F, 2007, CANCER INVEST, V25, P226, DOI 10.1080/07357900701206323; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Galizia G, 2006, J SURG ONCOL, V93, P241, DOI 10.1002/jso.20402; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Holden J, 2011, LANCET ONCOL, V12, P16, DOI 10.1016/S1470-2045(10)70276-X; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang XH, 2001, CANCER RES, V61, P3443; Lordick F, 2011, FUTURE ONCOL, V7, P187, DOI 10.2217/FON.10.178; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Sobin LH., 2010, TNM CLASSIFICATION M; Sutter AP, 2004, ONKOLOGIE, V27, P17, DOI 10.1159/000075600; TAGLIABUE E, 1991, INT J CANCER, V47, P933, DOI 10.1002/ijc.2910470625; Wan XM, 2011, INT J CANCER, V129, P1087, DOI 10.1002/ijc.25771; Wang ZH, 2007, GYNECOL ONCOL, V107, P107, DOI 10.1016/j.ygyno.2007.05.034; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Xu DZ, 2004, WORLD J GASTROENTERO, V10, P2727, DOI 10.3748/wjg.v10.i18.2727; Xu DZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-536; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yamaguchi T, 2001, JPN J CLIN ONCOL, V31, P153, DOI 10.1093/jjco/hye035	34	28	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45968	10.1371/journal.pone.0045968	http://dx.doi.org/10.1371/journal.pone.0045968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029344	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500050
J	Green, JA; Gu, C; Mykytyn, K				Green, Jill A.; Gu, Chen; Mykytyn, Kirk			Heteromerization of Ciliary G Protein-Coupled Receptors in the Mouse Brain	PLOS ONE			English	Article							NEURONAL CILIA; ADENYLYL-CYCLASE; SIGNALING CENTER; LEPTIN ACTION; DOPAMINE D1; MICE LEADS; SOMATOSTATIN; LOCALIZATION; DISEASE; MEMORY	Nearly every cell type in the mammalian body projects from its cell surface a primary cilium that provides important sensory and signaling functions. Defects in the formation or function of primary cilia have been implicated in the pathogenesis of many human developmental disorders and diseases, collectively termed ciliopathies. Most neurons in the brain possess cilia that are enriched for signaling proteins such as G protein-coupled receptors and adenylyl cyclase type 3, suggesting neuronal cilia sense neuromodulators in the brain and contribute to non-synaptic signaling. Indeed, disruption of neuronal cilia or loss of neuronal ciliary signaling proteins is associated with obesity and learning and memory deficits. As the functions of primary cilia are defined by the signaling proteins that localize to the ciliary compartment, identifying the complement of signaling proteins in cilia can provide important insights into their physiological roles. Here we report for the first time that different GPCRs can colocalize within the same cilium. Specifically, we found the ciliary GPCRs, melanin-concentrating hormone receptor 1 (Mchr1) and somatostatin receptor 3 (Sstr3) colocalizing within cilia in multiple mouse brain regions. In addition, we have evidence suggesting Mchr1 and Sstr3 form heteromers. As GPCR heteromerization can affect ligand binding properties as well as downstream signaling, our findings add an additional layer of complexity to neuronal ciliary signaling.	[Green, Jill A.; Mykytyn, Kirk] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA; [Gu, Chen] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mykytyn, K (corresponding author), Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA.	mykytyn.1@osu.edu	Mykytyn, Kirk/E-3723-2011	Mykytyn, Kirk/0000-0002-0158-4592	National Institutes of Health/National Institute of General Medical Sciences [R01 GM083120]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS062720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 GM083120 from the National Institutes of Health/National Institute of General Medical Sciences (K.M.) and R01 NS062720 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (C.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Chung SJ, 2011, J MOL NEUROSCI, V43, P115, DOI 10.1007/s12031-010-9411-4; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Domire JS, 2009, METHOD CELL BIOL, V91, P111, DOI 10.1016/S0091-679X(08)91006-2; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Kokkotou EG, 2001, ENDOCRINOLOGY, V142, P680, DOI 10.1210/en.142.2.680; Kolakowski LF, 1996, FEBS LETT, V398, P253, DOI 10.1016/S0014-5793(96)01160-X; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Marcellino D, 2008, J BIOL CHEM, V283, P26016, DOI 10.1074/jbc.M710349200; Monzon ME, 1999, PEPTIDES, V20, P1517, DOI 10.1016/S0196-9781(99)00164-3; Pachoud B, 2010, J NEUROPHYSIOL, V104, P1417, DOI 10.1152/jn.01052.2009; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Stanic D, 2009, BRAIN RES, V1249, P101, DOI 10.1016/j.brainres.2008.10.024; Stengel A, 2010, J PHYSIOL PHARMACOL, V61, P399; Stepanyan Z, 2007, J NEUROCHEM, V100, P468, DOI 10.1111/j.1471-4159.2006.04219.x; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010	35	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46304	10.1371/journal.pone.0046304	http://dx.doi.org/10.1371/journal.pone.0046304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029470	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500086
J	Laakkonen, JP; Engler, T; Romero, IA; Weksler, B; Couraud, PO; Kreppel, F; Kochanek, S				Laakkonen, Johanna P.; Engler, Tatjana; Romero, Ignacio A.; Weksler, Babette; Couraud, Pierre-Olivier; Kreppel, Florian; Kochanek, Stefan			Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro	PLOS ONE			English	Article							TRANSGENE EXPRESSION; DRUG TRANSPORT; ADULT BRAIN; BARRIER; GENE; TRANSCYTOSIS; RECEPTOR; MODEL; TRAFFICKING	In central nervous system (CNS)-directed gene therapy, efficient targeting of brain parenchyma through the vascular route is prevented by the endothelium and the epithelium of the blood-brain and the blood-cerebrospinal fluid barriers, respectively. In this study, we evaluated the feasibility of the combined genetic and chemical adenovirus capsid modification technology to enable transcellular delivery of targeted adenovirus (Ad) vectors across the blood-brain barrier (BBB) in vitro models. As a proof-of-principle ligand, maleimide-activated full-length human transferrin (hTf) was covalently attached to cysteine-modified Ad serotype 5 vectors either to its fiber or hexon protein. In transcytosis experiments, hTf-coupled vectors were shown to be redirected across the BBB models, the transcytosis activity of the vectors being dependent on the location of the capsid modification and the in vitro model used. The transduction efficiency of hTf-targeted vectors decreased significantly in confluent, polarized cells, indicating that the intracellular route of the vectors differed between unpolarized and polarized cells. After transcellular delivery the majority of the hTf-modified vectors remained intact and partly capable of gene transfer. Altogether, our results demonstrate that i) covalent attachment of a ligand to Ad capsid can mediate transcellular targeting across the cerebral endothelium in vitro, ii) the attachment site of the ligand influences its transcytosis efficiency and iii) combined genetic/chemical modification of Ad vector can be used as a versatile platform for the development of Ad vectors for transcellular targeting.	[Laakkonen, Johanna P.; Engler, Tatjana; Kreppel, Florian; Kochanek, Stefan] Univ Ulm, Dept Gene Therapy, Ulm, Germany; [Romero, Ignacio A.; Weksler, Babette; Couraud, Pierre-Olivier] Cochin Inst, INSERM, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kochanek, S (corresponding author), Univ Ulm, Dept Gene Therapy, Ulm, Germany.	stefan.kochanek@uni-ulm.de		Romero, Ignacio/0000-0002-0322-9180; Laakkonen, Johanna/0000-0002-8556-9727	Academy of Finland [130242]; Finnish Cultural Foundation [00107022]; EU (NoE Clinigene) [LSHB-CT-2006-018933]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); EU (NoE Clinigene)	This work was supported by Academy of Finland (130242), Finnish Cultural Foundation (00107022) and the EU (NoE Clinigene - LSHB-CT-2006-018933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Batista L, 2010, NEUROBIOL DIS, V37, P656, DOI 10.1016/j.nbd.2009.12.001; Campos SK, 2006, VIROLOGY, V349, P453, DOI 10.1016/j.virol.2006.01.032; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Corjon S, 2008, MOL THER, V16, P1813, DOI 10.1038/mt.2008.174; Cudkowicz A, 1984, Prog Clin Biol Res, V165, P509; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Espenlaub S, 2010, HUM GENE THER, V21, P1155, DOI 10.1089/hum.2009.171; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Georgieva JV, 2011, MOL THER, V19, P318, DOI 10.1038/mt.2010.236; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Goldsmith ME, 2003, CLIN CANCER RES, V9, P5394; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544, 10.1111/j.1471-4159.2009.06544.x]; Lindemann D, 2009, THROMB HAEMOSTASIS, V102, P1135, DOI 10.1160/TH09-10-0724; Manfredsson FP, 2010, DISCOV MED, V9, P204; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Nitz T, 2003, BRAIN RES, V981, P30, DOI 10.1016/S0006-8993(03)02834-8; Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725; Pardridge WM, 1998, J NEUROCHEM, V70, P1781; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Prill JM, 2011, MOL THER, V19, P83, DOI 10.1038/mt.2010.229; Pulzova L, 2009, FEMS IMMUNOL MED MIC, V57, P203, DOI 10.1111/j.1574-695X.2009.00594.x; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Thomas CE, 2002, J VIROL, V76, P3452, DOI 10.1128/JVI.76.7.3452-3460.2002; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xia HB, 2000, J VIROL, V74, P11359, DOI 10.1128/JVI.74.23.11359-11366.2000	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45977	10.1371/journal.pone.0045977	http://dx.doi.org/10.1371/journal.pone.0045977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029348	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500051
J	Chen, GW; Tsao, KC; Huang, CG; Gong, YN; Chang, SC; Liu, YC; Wu, HH; Yang, SL; Lin, TY; Huang, YC; Shih, SR				Chen, Guang-Wu; Tsao, Kuo-Chien; Huang, Chung-Guei; Gong, Yu-Nong; Chang, Shih-Cheng; Liu, Yi-Chun; Wu, Hsiao-Han; Yang, Shu-Li; Lin, Tzou-Yien; Huang, Yhu-Chering; Shih, Shin-Ru			Amino Acids Transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011	PLOS ONE			English	Article							INFLUENZA-A; NEURAMINIDASE INHIBITORS; OSELTAMIVIR RESISTANCE; VIRUS; SURVEILLANCE; MUTATIONS; EMERGENCE; SELECTION; WORLDWIDE; DRUG	A swine-origin influenza A was detected in April 2009 and soon became the 2009 H1N1 pandemic strain (H1N1pdm). The current study revealed the genetic diversity of H1N1pdm, based on 77 and 70 isolates which we collected, respectively, during the 2009/2010 and 2010/2011 influenza seasons in Taiwan. We focused on tracking the amino acid transitioning of hemagglutinin (HA) and neuraminidase (NA) genes in the early diversification of the virus and compared them with H1N1pdm strains reported worldwide. We identified newly emerged mutation markers based on A/California/04/2009, described how these markers shifted from the first H1N1pdm season to the one that immediately followed, and discussed how these observations may relate to antigenicity, receptor-binding, and drug susceptibility. It was found that the amino acid mutation rates of H1N1pdm were elevated, from 9.29 x 10(-3) substitutions per site in the first season to 1.46 x 10(-2) in the second season in HA, and from 5.23 x 10(-3) to 1.10 x 10(-2) in NA. Many mutation markers were newly detected in the second season, including 11 in HA and 8 in NA, and some were found having statistical correlation to disease severity. There were five noticeable HA mutations made to antigenic sites. No significant titer changes, however, were detected based on hemagglutination inhibition tests. Only one isolate with H275Y mutation known to reduce susceptibility to NA inhibitors was detected. As limited Taiwanese H1N1pdm viruses were isolated after our sampling period, we gathered 8,876 HA and 6,017 NA H1N1pdm sequences up to April 2012 from NCBI to follow up the dynamics of mentioned HA mutations. While some mutations described in this study seemed to either settle in or die out in the 2011-2012 season, a number of them still showed signs of transitioning, prompting the importance of continuous monitoring of this virus for more seasons to come.	[Chen, Guang-Wu; Tsao, Kuo-Chien; Huang, Chung-Guei; Chang, Shih-Cheng; Lin, Tzou-Yien; Shih, Shin-Ru] Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Chen, Guang-Wu] Chang Gung Univ, Dept Comp Sci & Informat Engn, Tao Yuan, Taiwan; [Tsao, Kuo-Chien; Huang, Chung-Guei; Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Gong, Yu-Nong] Chang Gung Univ, Grad Inst Elect Engn, Tao Yuan, Taiwan; [Tsao, Kuo-Chien; Huang, Chung-Guei; Liu, Yi-Chun; Wu, Hsiao-Han; Yang, Shu-Li; Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsao, KC (corresponding author), Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan.	kctsao@adm.cgmh.org.tw	Chen, Guang-Wu/M-6768-2016; liu, yi/GXE-9662-2022; Shih, Shin-Ru/M-9711-2016	Chen, Guang-Wu/0000-0002-5322-4839; Gong, Yu-Nong/0000-0002-6799-1561; Shih, Shin-Ru/0000-0003-4874-401X	Chang Gung Memorial Hospital [CMRPG390601, CMRPG390602, CMRPG320018, CMRPD180213]; National Science Council, Taiwan [NSC97-2221-E-182-034-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Grants from Chang Gung Memorial Hospital: CMRPG390601, CMRPG390602, CMRPG320018, CMRPD180213. http://www.cgmh.org.tw. Grants from National Science Council, Taiwan: NSC97-2221-E-182-034-MY3. http://www.nsc.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hurt A, 2011, EURO SURVEILL, V16; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyicheva T, 2011, INFECT GENET EVOL, V11, P2107, DOI 10.1016/j.meegid.2011.05.002; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Renaud C, 2011, J CLIN VIROL, V52, P70, DOI 10.1016/j.jcv.2011.05.019; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Ujike M, 2011, EMERG INFECT DIS, V17, P470, DOI 10.3201/eid1703.101188; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028288	24	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45946	10.1371/journal.pone.0045946	http://dx.doi.org/10.1371/journal.pone.0045946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029335	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700094
J	Chino, K; Akagi, R; Dohi, M; Fukashiro, S; Takahashi, H				Chino, Kentaro; Akagi, Ryota; Dohi, Michiko; Fukashiro, Senshi; Takahashi, Hideyuki			Reliability and Validity of Quantifying Absolute Muscle Hardness Using Ultrasound Elastography	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; ACOUSTIC STRAIN WAVES; MR ELASTOGRAPHY; CONTRACTION; VISUALIZATION; FEASIBILITY; EXERCISE	Muscle hardness is a mechanical property that represents transverse muscle stiffness. A quantitative method that uses ultrasound elastography for quantifying absolute human muscle hardness has been previously devised; however, its reliability and validity have not been completely verified. This study aimed to verify the reliability and validity of this quantitative method. The Young's moduli of seven tissue-mimicking materials (in vitro; Young's modulus range, 20-80 kPa; increments of 10 kPa) and the human medial gastrocnemius muscle (in vivo) were quantified using ultrasound elastography. On the basis of the strain/Young's modulus ratio of two reference materials, one hard and one soft (Young's moduli of 7 and 30 kPa, respectively), the Young's moduli of the tissue-mimicking materials and medial gastrocnemius muscle were calculated. The intra-and inter-investigator reliability of the method was confirmed on the basis of acceptably low coefficient of variations (<= 6.9%) and substantially high intraclass correlation coefficients (>= 0.77) obtained from all measurements. The correlation coefficient between the Young's moduli of the tissue-mimicking materials obtained using a mechanical method and ultrasound elastography was 0.996, which was equivalent to values previously obtained using magnetic resonance elastography. The Young's moduli of the medial gastrocnemius muscle obtained using ultrasound elastography were within the range of values previously obtained using magnetic resonance elastography. The reliability and validity of the quantitative method for measuring absolute muscle hardness using ultrasound elastography were thus verified.	[Chino, Kentaro; Fukashiro, Senshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Sports Sci, Meguro Ku, Tokyo, Japan; [Akagi, Ryota; Takahashi, Hideyuki] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo, Japan; [Dohi, Michiko] Japan Inst Sports Sci, Dept Sports Med, Kita Ku, Tokyo, Japan	University of Tokyo	Chino, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Sports Sci, Meguro Ku, Tokyo, Japan.	chinokentaro@idaten.c.u-tokyo.ac.jp		ANWAR, ZAWAR/0000-0003-1140-664X	Sports Medicine/Science Research Program (Conditioning Research Project) at Japan Institute of Sports Sciences; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Sports Medicine/Science Research Program (Conditioning Research Project) at Japan Institute of Sports Sciences; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Sports Medicine/Science Research Program (Conditioning Research Project) at Japan Institute of Sports Sciences and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2012, ACTA RADIOL, V53, P307, DOI 10.1258/ar.2011.110481; Ariji Y, 2009, J ORAL REHABIL, V36, P627, DOI 10.1111/j.1365-2842.2009.01977.x; Ashina M, 1998, CEPHALALGIA, V18, P106, DOI 10.1046/j.1468-2982.1998.1802106.x; Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; CHILIBECK P, 1994, CAN ASSOC RADIOL J, V45, P297; Chino K, 2009, J APPL BIOMECH, V25, P111, DOI 10.1123/jab.25.2.111; Drakonaki EE, 2010, SKELETAL RADIOL, V39, P391, DOI 10.1007/s00256-009-0861-0; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013; Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095; Jenkyn TR, 2003, J BIOMECH, V36, P1917, DOI 10.1016/S0021-9290(03)00005-8; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Muthupillai R, 1996, MAGN RESON MED, V36, P266, DOI 10.1002/mrm.1910360214; Niitsu M, 2011, ACTA RADIOL, V52, P99, DOI 10.1258/ar.2010.100190; Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194; Shiina T, 2007, J MED ULTRASON, V29, P119; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Suga M, 2001, STUD HEALTH TECHNOL, V84, P933; Suga M, 2003, STUD HLTH TECHNOL IN, V84, P933; Uffmann K, 2004, NMR BIOMED, V17, P181, DOI 10.1002/nbm.887; Yamakawa M, 2003, JPN J APPL PHYS 1, V42, P3265, DOI 10.1143/JJAP.42.3265; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012	27	79	85	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45764	10.1371/journal.pone.0045764	http://dx.doi.org/10.1371/journal.pone.0045764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029231	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800094
J	Shin, IS; Lee, MY; Lim, HS; Ha, H; Seo, CS; Kim, JC; Shin, HK				Shin, In Sik; Lee, Mee Young; Lim, Hye Sun; Ha, Hyekyung; Seo, Chang Seob; Kim, Jong-Choon; Shin, Hyeun Kyoo			An Extract of Crataegus pinnatifida Fruit Attenuates Airway Inflammation by Modulation of Matrix Metalloproteinase-9 in Ovalbumin Induced Asthma	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; MURINE MODEL; TOLUENE DIISOCYANATE; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; IN-VITRO; EXPRESSION; MIGRATION; EOSINOPHILS; MECHANISMS	Background: Crataegus pinnatifida (Chinese hawthorn) has long been used as a herbal medicine in Asia and Europe. It has been used for the treatment of various cardiovascular diseases such as myocardial weakness, tachycardia, hypertension and arteriosclerosis. In this study, we investigated the anti-inflammatory effects of Crataegus pinnatifida ethanolic extracts (CPEE) on Th2-type cytokines, eosinophil infiltration, expression of matrix metalloproteinase (MMP)-9, and other factors, using an ovalbumin (OVA)-induced murine asthma model. Methods/Principal Finding: Airways of OVA-sensitized mice exposed to OVA challenge developed eosinophilia, mucus hypersecretion and increased cytokine levels. CPEE was applied 1 h prior to OVA challenge. Mice were administered CPEE orally at doses of 100 and 200 mg/kg once daily on days 18-23. Bronchoalveolar lavage fluid (BALF) was collected 48 h after the final OVA challenge. Levels of interleukin (IL)-4 and IL-5 in BALF were measured using enzyme-linked immunosorbent (ELISA) assays. Lung tissue sections 4 mm in thickness were stained with Mayer's hematoxylin and eosin for assessment of cell infiltration and mucus production with PAS staining, in conjunction with ELISA, and Western blot analyses for the expression of MMP-9, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 protein expression. CPEE significantly decreased the Th2 cytokines including IL-4 and IL-5 levels, reduced the number of inflammatory cells in BALF and airway hyperresponsiveness, suppressed the infiltration of eosinophil-rich inflammatory cells and mucus hypersecretion and reduced the expression of ICAM-1, VCAM-1 and MMP-9 and the activity of MMP-9 in lung tissue of OVA-challenged mice. Conclusions: These results showed that CPEE can protect against allergic airway inflammation and can act as an MMP-9 modulator to induce a reduction in ICAM-1 and VCAM-1 expression. In conclusion, we strongly suggest the feasibility of CPEE as a therapeutic drug for allergic asthma.	[Shin, In Sik; Lee, Mee Young; Lim, Hye Sun; Ha, Hyekyung; Seo, Chang Seob; Shin, Hyeun Kyoo] Korea Inst Oriental Med, Basic Herbal Med Res Grp, Taejon, South Korea; [Shin, In Sik; Kim, Jong-Choon] Chonnam Natl Univ, Coll Vet Med, Kwangju, South Korea	Korea Institute of Oriental Medicine (KIOM); Chonnam National University	Shin, HK (corresponding author), Korea Inst Oriental Med, Basic Herbal Med Res Grp, Taejon, South Korea.	toxkim@chonnam.ac.kr; hkshin@kiom.re.kr			Korea Research Council of Fundamental Science and Technology of the Republic of Korea	Korea Research Council of Fundamental Science and Technology of the Republic of Korea	This research was supported by grants from the Korea Research Council of Fundamental Science and Technology of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2008, J IMMUNOL, V180, P3543, DOI 10.4049/jimmunol.180.5.3543; BOSCHETTO P, 1987, J ALLERGY CLIN IMMUN, V80, P261, DOI 10.1016/0091-6749(87)90028-5; BurkeGaffney A, 1996, BRIT J PHARMACOL, V119, P1149, DOI 10.1111/j.1476-5381.1996.tb16017.x; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Di Girolamo N, 2006, J IMMUNOL, V177, P2638, DOI 10.4049/jimmunol.177.4.2638; Gueders MM, 2008, BIOCHEM PHARMACOL, V75, P514, DOI 10.1016/j.bcp.2007.09.012; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V104, P356, DOI 10.1016/S0091-6749(99)70379-9; Kao ES, 2005, J AGR FOOD CHEM, V53, P430, DOI 10.1021/jf040231f; Kim CH, 2004, AM J PHYSIOL-LUNG C, V288, P307; Kong Ying-Jun, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P129; Korenblat PE, 2001, ANN ALLERG ASTHMA IM, V86, P31, DOI 10.1016/S1081-1206(10)62309-5; Kumagai K, 1999, J IMMUNOL, V162, P4212; Lee KS, 2003, J ALLERGY CLIN IMMUN, V111, P1278, DOI 10.1067/mai.2003.1501; Lee MY, 2010, INT IMMUNOPHARMACOL, V10, P474, DOI 10.1016/j.intimp.2010.01.008; Lee YC, 2001, J ALLERGY CLIN IMMUN, V108, P1021, DOI 10.1067/mai.2001.120132; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; Liu ZY, 2005, BIOMED PHARMACOTHER, V59, P481, DOI 10.1016/j.biopha.2005.06.009; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Lynch KR, 1999, NATURE, V399, P789; MAPP CE, 1987, B EUR PHYSIOPATH RES, V23, P583; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; Niu CS, 2011, HORM METAB RES, V43, P625, DOI 10.1055/s-0031-1283147; OHKAWARA Y, 1995, AM J RESP CELL MOL, V12, P4, DOI 10.1165/ajrcmb.12.1.7529029; Okada S, 1997, AM J RESP CELL MOL, V17, P519, DOI 10.1165/ajrcmb.17.4.2877; Punithavathi VR, 2010, CARDIOVASC TOXICOL, V10, P181, DOI 10.1007/s12012-010-9077-8; Rosseau S, 2000, J IMMUNOL, V164, P427, DOI 10.4049/jimmunol.164.1.427; Scholz D, 1996, CELL TISSUE RES, V284, P415, DOI 10.1007/s004410050602; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Shan G, 2007, J SEP SCI, V30, P717; Soberon JR, 2010, J ETHNOPHARMACOL, V130, P329, DOI 10.1016/j.jep.2010.05.015; Tadic VM, 2008, J AGR FOOD CHEM, V56, P7700, DOI 10.1021/jf801668c; Wagner JG, 2000, PHARMACOL REV, V52, P349; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wang T, 2011, J AGR FOOD CHEM, V59, P4987, DOI 10.1021/jf1049062; Wills-Karp M, 2004, SCIENCE, V305, P1726, DOI 10.1126/science.1104134	36	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45734	10.1371/journal.pone.0045734	http://dx.doi.org/10.1371/journal.pone.0045734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029210	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800087
J	Waldeck-Weiermair, M; Alam, MR; Khan, MJ; Deak, AT; Vishnu, N; Karsten, F; Imamura, H; Graier, WF; Malli, R				Waldeck-Weiermair, Markus; Alam, Muhammad Rizwan; Khan, Muhammad Jadoon; Deak, Andras T.; Vishnu, Neelanjan; Karsten, Felix; Imamura, Hiromi; Graier, Wolfgang F.; Malli, Roland			Spatiotemporal Correlations between Cytosolic and Mitochondrial Ca2+ Signals Using a Novel Red-Shifted Mitochondrial Targeted Cameleon	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEINS; INSULIN-SECRETION; CALCIUM DYNAMICS; CELL PHYSIOLOGY; ATP SYNTHESIS; FRET; INDICATORS; METABOLISM; MEMBRANE; MOTILITY	The transfer of Ca2+ from the cytosol into the lumen of mitochondria is a crucial process that impacts cell signaling in multiple ways. Cytosolic Ca2+ ([Ca2+](cyto)) can be excellently quantified with the ratiometric Ca2+ probe fura-2, while genetically encoded Forster resonance energy transfer (FRET)-based fluorescent Ca2+ sensors, the cameleons, are efficiently used to specifically measure Ca2+ within organelles. However, because of a significant overlap of the fura-2 emission with the spectra of the cyan and yellow fluorescent protein of most of the existing cameleons, the measurement of fura-2 and cameleons within one given cell is a complex task. In this study, we introduce a novel approach to simultaneously assess [Ca2+](cyto) and mitochondrial Ca2+ ([Ca2+](mito)) signals at the single cell level. In order to eliminate the spectral overlap we developed a novel red-shifted cameleon, D1GO-Cam, in which the green and orange fluorescent proteins were used as the FRET pair. This ratiometric Ca2+ probe could be successfully targeted to mitochondria and was suitable to be used simultaneously with fura-2 to correlate [Ca2+](cyto) and [Ca2+](mito) within same individual cells. Our data indicate that depending on the kinetics of [Ca2+](cyto) rises there is a significant lag between onset of [Ca2+](cyto) and [Ca2+](mito) signals, pointing to a certain threshold of [Ca2+](cyto) necessary to activate mitochondrial Ca2+ uptake. The temporal correlation between [Ca2+](mito) and [Ca2+](cyto) as well as the efficiency of the transfer of Ca2+ from the cytosol into mitochondria varies between different cell types. Moreover, slow mitochondrial Ca2+ extrusion and a desensitization of mitochondrial Ca2+ uptake cause a clear difference in patterns of mitochondrial and cytosolic Ca2+ oscillations of pancreatic beta-cells in response to D-glucose.	[Waldeck-Weiermair, Markus; Alam, Muhammad Rizwan; Khan, Muhammad Jadoon; Deak, Andras T.; Vishnu, Neelanjan; Karsten, Felix; Graier, Wolfgang F.; Malli, Roland] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Imamura, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci, Tokyo, Japan	Medical University of Graz; Japan Science & Technology Agency (JST)	Malli, R (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria.	roland.malli@medunigraz.at	Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020; Alam, Muhammad Rizwan/AAE-2266-2019; Graier, Wolfgang F./B-7052-2008; Imamura, Hiromi/AAD-5109-2019	Waldeck-Weiermair, Markus/0000-0002-5792-6766; Alam, Muhammad Rizwan/0000-0002-1578-5723; Graier, Wolfgang F./0000-0003-1871-3298; Imamura, Hiromi/0000-0002-1896-0443; Vishnu, Neelanjan/0000-0001-6395-4686; Malli, Roland/0000-0001-6327-8729	Austrian Science Funds, FWF [P21857-B18, P22553-B18]; FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz; FWF within the DKplus Metabolic and Cardiovascular Disease [W1226-B18]; Austrian Science Fund (FWF) [P 21857, P 22553] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz; FWF within the DKplus Metabolic and Cardiovascular Disease; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Austrian Science Funds (http://www.fwf.ac.at/, FWF, P21857-B18 and P22553-B18). M.J.K., M. R. A. and A. T. D. are funded by the FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz. N.V. is supported by the FWF within the DKplus Metabolic and Cardiovascular Disease (W1226-B18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Adamikova L, 2004, MOL BIOL CELL, V15, P1969, DOI 10.1091/mbc.E03-09-0675; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Davidson SM, 2012, METHODS MOL BIOL, V810, P219, DOI 10.1007/978-1-61779-382-0_14; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Khan MJ, 2012, J BIOL CHEM; Knot HJ, 2005, MOL INTERV, V5, P112, DOI 10.1124/mi.5.2.8; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Moreau B, 2008, CURR BIOL, V18, P855, DOI 10.1016/j.cub.2008.05.026; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; PAPACONSTANTINOU J, 1961, J BIOL CHEM, V236, P285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Tarasov AI, 2012, CELL CALCIUM; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; WARBURG O, 1956, SCIENCE, V124, P269; Wei AC, 2012, J GEN PHYSIOL, V139, P465, DOI 10.1085/jgp.201210784; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Yang XF, 2005, BIOCHEM BIOPH RES CO, V330, P914, DOI 10.1016/j.bbrc.2005.03.054; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zecchini Erika, 2007, Ital J Biochem, V56, P235	67	36	36	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45917	10.1371/journal.pone.0045917	http://dx.doi.org/10.1371/journal.pone.0045917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029314	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800119
J	Wang, JY; Zhang, XL; Liu, YL; Pan, XJ; Liu, PL; Chen, ZZ; Huang, TQ; Xiong, ZQ				Wang, Jinyang; Zhang, Xiaolin; Liu, Yinglie; Pan, Xiaojian; Liu, Pingli; Chen, Zhaozhi; Huang, Taiqing; Xiong, Zhengqin			Modeling Impacts of Alternative Practices on Net Global Warming Potential and Greenhouse Gas Intensity from Rice-Wheat Annual Rotation in China	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; SOIL CARBON SEQUESTRATION; METHANE EMISSION; ORGANIC-CARBON; PADDY FIELDS; CROPPING SYSTEMS; N2O EMISSIONS; DNDC MODEL; STRAW INCORPORATION; WATER REGIME	Background: Evaluating the net exchange of greenhouse gas (GHG) emissions in conjunction with soil carbon sequestration may give a comprehensive insight on the role of agricultural production in global warming. Materials and Methods: Measured data of methane (CH4) and nitrous oxide (N2O) were utilized to test the applicability of the Denitrification and Decomposition (DNDC) model to a winter wheat - single rice rotation system in southern China. Six alternative scenarios were simulated against the baseline scenario to evaluate their long-term (45-year) impacts on net global warming potential (GWP) and greenhouse gas intensity (GHGI). Principal Results: The simulated cumulative CH4 emissions fell within the statistical deviation ranges of the field data, with the exception of N2O emissions during rice-growing season and both gases from the control treatment. Sensitivity tests showed that both CH4 and N2O emissions were significantly affected by changes in both environmental factors and management practices. Compared with the baseline scenario, the long-term simulation had the following results: (1) high straw return and manure amendment scenarios greatly increased CH4 emissions, while other scenarios had similar CH4 emissions, (2) high inorganic N fertilizer increased N2O emissions while manure amendment and reduced inorganic N fertilizer scenarios decreased N2O emissions, (3) the mean annual soil organic carbon sequestration rates (SOCSR) under manure amendment, high straw return, and no-tillage scenarios averaged 0.20 t C ha(-1) yr(-1), being greater than other scenarios, and (4) the reduced inorganic N fertilizer scenario produced the least N loss from the system, while all the scenarios produced comparable grain yields. Conclusions: In terms of net GWP and GHGI for the comprehensive assessment of climate change and crop production, reduced inorganic N fertilizer scenario followed by no-tillage scenario would be advocated for this specified cropping system.	[Wang, Jinyang; Zhang, Xiaolin; Liu, Yinglie; Pan, Xiaojian; Liu, Pingli; Chen, Zhaozhi; Huang, Taiqing; Xiong, Zhengqin] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Low Carbon Agr & GHGs Mitigat, Nanjing, Jiangsu, Peoples R China; [Liu, Pingli] Hebi Acad Agr Sci, Hebi, Henan, Peoples R China	Nanjing Agricultural University	Xiong, ZQ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Low Carbon Agr & GHGs Mitigat, Nanjing, Jiangsu, Peoples R China.	zqxiong@njau.edu.cn	Wang, Jinyang/E-7780-2011; xiong, zhengqin/B-2808-2010	Wang, Jinyang/0000-0003-0668-336X; 	National Science Foundation of China [41171238, 40971139]; National Basic Research Program of China [2009CB118603]; Nonprofit Research Foundation for Agriculture [200903003]; Program for New Century Excellent Talent in Universities [NCET-10-0475]; Doctoral Program of Higher Education of China [20110097110001]; Fundamental Research Funds for the Central Universities [KYZ201110]; PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Nonprofit Research Foundation for Agriculture; Program for New Century Excellent Talent in Universities(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions)	This research was jointly supported by the National Science Foundation of China (41171238 and 40971139), the National Basic Research Program of China (2009CB118603), the Nonprofit Research Foundation for Agriculture (200903003), the Program for New Century Excellent Talent in Universities (NCET-10-0475), the Doctoral Program of Higher Education of China (20110097110001), the Fundamental Research Funds for the Central Universities (KYZ201110) and the PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2009, GEODERMA, V151, P327, DOI 10.1016/j.geoderma.2009.04.021; Babu YJ, 2006, NUTR CYCL AGROECOSYS, V74, P157, DOI 10.1007/s10705-005-6111-5; Beheydt D, 2007, ATMOS ENVIRON, V41, P6196, DOI 10.1016/j.atmosenv.2007.04.003; Cai ZC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002046; Cai ZC, 2003, GLOBAL CHANGE BIOL, V9, P37, DOI 10.1046/j.1365-2486.2003.00562.x; Cai ZC, 1997, PLANT SOIL, V196, P7, DOI 10.1023/A:1004263405020; Cai ZC, 2007, SOIL SCI PLANT NUTR, V53, P353, DOI 10.1111/j.1747-0765.2007.00153.x; Fornara DA, 2011, GLOBAL CHANGE BIOL, V17, P1925, DOI 10.1111/j.1365-2486.2010.02328.x; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Fumoto T, 2008, GLOBAL CHANGE BIOL, V14, P382, DOI 10.1111/j.1365-2486.2007.01475.x; Huang Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004401; Jia JX, 2012, AGR ECOSYST ENVIRON, V150, P27, DOI 10.1016/j.agee.2012.01.011; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kang XM, 2011, J SOIL SEDIMENT, V11, P562, DOI 10.1007/s11368-011-0339-2; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Li CS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002341; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 1996, GLOBAL BIOGEOCHEM CY, V10, P297, DOI 10.1029/96GB00470; Li CS, 2003, ECOL APPL, V13, P327, DOI 10.1890/1051-0761(2003)013[0327:MSOCCI]2.0.CO;2; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Li DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026176; Li H, 2010, AGR ECOSYST ENVIRON, V135, P24, DOI 10.1016/j.agee.2009.08.003; Liu SW, 2010, SCI TOTAL ENVIRON, V408, P906, DOI 10.1016/j.scitotenv.2009.11.002; Ludwig B, 2011, SOIL TILL RES, V112, P114, DOI 10.1016/j.still.2010.12.005; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Pathak H, 2005, BIOGEOSCIENCES, V2, P113, DOI 10.5194/bg-2-113-2005; RGCST Sesearch Group on Chinese Soil Taxonomy Institute of Soil Scence Chinese Academy of Sciences, 2001, CHINESE SOIL TAXONOM, P1; Robertson GP, 2004, SCOPE SER, V62, P493; Rochette P, 2008, SOIL TILL RES, V101, P97, DOI 10.1016/j.still.2008.07.011; Rui WY, 2010, AGR ECOSYST ENVIRON, V135, P199, DOI 10.1016/j.agee.2009.09.010; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Smith P, 2001, NUTR CYCL AGROECOSYS, V60, P237, DOI 10.1023/A:1012617517839; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Solomon S., 2007, PHYS SCI BASIS WORKI; Tang HJ, 2006, GEODERMA, V134, P200, DOI 10.1016/j.geoderma.2005.10.005; USEPA, 2006, GLOB ANTHR NONC GREE; Wang J, 2012, PLANT SOIL, DOI [10.1007/s11104-012-12503, DOI 10.1007/S11104-012-12503]; Wang JY, 2011, AGR ECOSYST ENVIRON, V141, P437, DOI 10.1016/j.agee.2011.04.009; Wang JY, 2012, NUTR CYCL AGROECOSYS, V93, P103, DOI 10.1007/s10705-012-9503-3; Wang LG, 2008, GEODERMA, V147, P47, DOI 10.1016/j.geoderma.2008.07.009; Xu Z, 1992, PADDY SOILS CHINA, P108; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Yan XY, 2003, GLOBAL CHANGE BIOL, V9, P237, DOI 10.1046/j.1365-2486.2003.00564.x; Zhang LM, 2009, ATMOS ENVIRON, V43, P2737, DOI 10.1016/j.atmosenv.2009.02.051; Zhang WJ, 2012, J SOIL SEDIMENT, V12, P457, DOI 10.1007/s11368-011-0467-8; Zhang Y, 2011, BIOGEOSCIENCES, V8, P1225, DOI 10.5194/bg-8-1225-2011; Zheng X.H., 2004, GLOBAL BIOGEOCHEM CY, V18, P1, DOI DOI 10.1029/2003GB002167; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x	54	12	14	5	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45668	10.1371/journal.pone.0045668	http://dx.doi.org/10.1371/journal.pone.0045668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029173	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800076
J	Ruiz-Gonzalez, C; Gali, M; Sintes, E; Herndl, GJ; Gasol, JM; Simo, R				Ruiz-Gonzalez, Clara; Gali, Marti; Sintes, Eva; Herndl, Gerhard J.; Gasol, Josep M.; Simo, Rafel			Sunlight Effects on the Osmotrophic Uptake of DMSP-Sulfur and Leucine by Polar Phytoplankton	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ULTRAVIOLET-RADIATION; SUBSTRATE UPTAKE; SOLAR-RADIATION; AMINO-ACIDS; MARINE; BACTERIA; GLUCOSE; LIGHT; DIMETHYLSULFONIOPROPIONATE	Even though the uptake and assimilation of organic compounds by phytoplankton has been long recognized, very little is still known about its potential ecological role in natural marine communities and whether it varies depending on the light regimes the algae experience. We combined measurements of size-fractionated assimilation of trace additions of H-3-leucine and S-35-dimethylsulfoniopropionate (DMSP) with microautoradiography to assess the extent and relevance of osmoheterotrophy in summer phytoplankton assemblages from Arctic and Antarctic waters, and the role of solar radiation on it was further investigated by exposing samples to different radiation spectra. Significant assimilation of both substrates occurred in the size fraction containing most phytoplankton (>5 mu m), sunlight exposure generally increasing S-35-DMSP-sulfur assimilation and decreasing H-3-leucine assimilation. Microautoradiography revealed that the capacity to take up both organic substrates seemed widespread among different polar algal phyla, particularly in pennate and centric diatoms, and photosynthetic dinoflagellates. Image analysis of the microautoradiograms showed for the first time interspecific variability in the uptakes of S-35-DMSP and H-3-leucine by phytoplankton depending on the solar spectrum. Overall, these results suggest that the role of polar phytoplankton in the utilization of labile dissolved organic matter may be significant under certain conditions and further confirm the relevance of solar radiation in regulating heterotrophy in the pelagic ocean.	[Ruiz-Gonzalez, Clara; Gali, Marti; Gasol, Josep M.; Simo, Rafel] CSIC, Dept Marine Biol, Inst Ciencies Mar, Barcelona, Spain; [Sintes, Eva; Herndl, Gerhard J.] Univ Vienna, Fac Ctr Ecol, Dept Marine Biol, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Vienna	Ruiz-Gonzalez, C (corresponding author), CSIC, Dept Marine Biol, Inst Ciencies Mar, Barcelona, Spain.	clararg@icm.csic.es	Ruiz-González, Clara/K-7782-2017; Herndl, Gerhard J./B-1513-2013; Gasol, Josep M M/B-1709-2008; Galí, Martí/L-1541-2013; Sintes, Eva/H-8494-2015; Herndl, Gerhard J./S-3011-2019	Herndl, Gerhard J./0000-0002-2223-2852; Gasol, Josep M M/0000-0001-5238-2387; Galí, Martí/0000-0002-5587-1271; Sintes, Eva/0000-0002-7408-5647; Herndl, Gerhard J./0000-0002-2223-2852; Ruiz Gonzalez, Clara/0000-0003-3568-4943; Simo, Rafel/0000-0003-3276-7663	Spanish Ministry of Science and Innovation [POL2006-00550/CTM, CTM2005-04795/MAR, CTM2008-03309/MAR]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the Spanish Ministry of Science and Innovation through a PhD studentship to Clara Ruiz-Gonzalez and through the projects ATOS (POL2006-00550/CTM), MODIVUS (CTM2005-04795/MAR) and SUMMER (CTM2008-03309/MAR). The funders only provided funding after recommendation by a peer review panel. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas P, 1996, AQUAT MICROB ECOL, V11, P229, DOI 10.3354/ame011229; AMBLARD C, 1991, ANN BIOL-PARIS, V30, P6; ANTIA N J, 1970, Phycologia, V9, P179, DOI 10.2216/i0031-8884-9-2-179.1; Archer SD, 2010, LIMNOL OCEANOGR, V55, P1579, DOI 10.4319/lo.2010.55.4.1579; AZAM F, 1977, LIMNOL OCEANOGR, V22, P492, DOI 10.4319/lo.1977.22.3.0492; Azam F., 1987, Symposium of the Society for General Microbiology, V41, P261; BIRD DF, 1989, LIMNOL OCEANOGR, V34, P155, DOI 10.4319/lo.1989.34.1.0155; Bouarab L, 2004, WATER RES, V38, P2706, DOI 10.1016/j.watres.2004.03.021; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Droop MR, 1974, ALGAL PHYSL BIOCH, P530; FAUST MA, 1977, MAR BIOL, V41, P293, DOI 10.1007/BF00389096; FLYNN KJ, 1986, MAR ECOL PROG SER, V34, P281, DOI 10.3354/meps034281; Gali M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048051; Gali M, 2010, MAR CHEM, V122, P105, DOI 10.1016/j.marchem.2010.07.003; HELLEBUS.JA, 1971, J PHYCOL, V7, P345; Hellebust JA, 1970, I MARINE SCI OCCASIO, P225; Herndl GJ, 1997, PLANT ECOL, V128, P42; JONES RI, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P87; Kamjunke N, 2008, LIMNOLOGICA, V38, P360, DOI 10.1016/j.limno.2008.05.002; Kamjunke N, 2008, J PHYCOL, V44, P616, DOI 10.1111/j.1529-8817.2008.00520.x; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, AQUAT MICROB ECOL, V17, P311, DOI 10.3354/ame017311; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kirchman DL, 2001, DEEP-SEA RES PT II, V48, P4179, DOI 10.1016/S0967-0645(01)00085-6; Lasternas S, 2010, POLAR BIOL, V33, P1709, DOI 10.1007/s00300-010-0877-x; Legrand C, 1998, AQUAT MICROB ECOL, V15, P65, DOI 10.3354/ame015065; LEWIN J, 1976, MAR BIOL, V36, P313, DOI 10.1007/BF00389192; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; NEILSON A H, 1974, Phycologia, V13, P227, DOI 10.2216/i0031-8884-13-3-227.1; Nilsson C, 1996, HYDROBIOLOGIA, V332, P119, DOI 10.1007/BF00016691; PAERL HW, 1993, LIMNOL OCEANOGR, V38, P1150, DOI 10.4319/lo.1993.38.6.1150; PAERL HW, 1991, APPL ENVIRON MICROB, V57, P473, DOI 10.1128/AEM.57.2.473-479.1991; PALMER EG, 1971, J PROTOZOOL, V18, P640, DOI 10.1111/j.1550-7408.1971.tb03389.x; PALMISANO AC, 1982, J PHYCOL, V18, P489; PARKER BC, 1961, SCIENCE, V133, P761, DOI 10.1126/science.133.3455.761; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Rich J, 1997, DEEP-SEA RES PT II, V44, P1645, DOI 10.1016/S0967-0645(97)00058-1; RIVKIN RB, 1987, J PHYCOL, V23, P442, DOI 10.1111/j.1529-8817.1987.tb02530.x; Rothrock DA, 1999, GEOPHYS RES LETT, V26, P3469, DOI 10.1029/1999GL010863; Ruiz-Gonzalez C, 2012, BIOGEOCHEMISTRY, V110, P57, DOI 10.1007/s10533-012-9699-y; Ruiz-Gonzalez C, 2012, ISME J, V6, P650, DOI 10.1038/ismej.2011.118; Sakka A, 1997, MAR ECOL PROG SER, V149, P227, DOI 10.3354/meps149227; Salo V, 2009, ENVIRON MICROBIOL, V11, P3063, DOI 10.1111/j.1462-2920.2009.02011.x; SCHELL DM, 1974, LIMNOL OCEANOGR, V19, P260, DOI 10.4319/lo.1974.19.2.0260; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 1999, GLOBAL BIOGEOCHEM CY, V13, P1173, DOI 10.1029/1999GB900081; Sintes E, 2006, APPL ENVIRON MICROB, V72, P7022, DOI 10.1128/AEM.00763-06; SMAYDA TJ, 1974, MAR BIOL, V25, P195, DOI 10.1007/BF00394965; Sommaruga R, 1996, APPL ENVIRON MICROB, V62, P4395, DOI 10.1128/AEM.62.12.4395-4400.1996; Spielmeyer A, 2011, CHEMBIOCHEM, V12, P2276, DOI 10.1002/cbic.201100416; STAMNES K, 1990, GEOPHYS RES LETT, V17, P2181, DOI 10.1029/GL017i012p02181; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Thingstad T. F, 2003, AQUATIC ECOSYSTEMS I, P383; Toole DA, 2006, DEEP-SEA RES PT I, V53, P136, DOI 10.1016/j.dsr.2005.09.003; Toole DA, 2004, GEOPHYS RES LETT, V31; Tuchman NC, 2006, HYDROBIOLOGIA, V561, P167, DOI 10.1007/s10750-005-1612-4; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Waibel AE, 1999, SCIENCE, V283, P2064, DOI 10.1126/science.283.5410.2064; WRIGHT RICHARD T., 1965, LIMNOL OCEANOGR, V10, P22; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Znachor P, 2010, J PLANKTON RES, V32, P367, DOI 10.1093/plankt/fbp129	62	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45545	10.1371/journal.pone.0045545	http://dx.doi.org/10.1371/journal.pone.0045545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029084	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400102
J	Fu, M; Gao, Y; Pan, YF; Li, W; Liao, WJ; Wang, G; Li, CY; Li, CX; Gao, TW; Liu, YF				Fu, Meng; Gao, Yang; Pan, Yuefei; Li, Wei; Liao, Wenjun; Wang, Gang; Li, Chunying; Li, Chengxin; Gao, Tianwen; Liu, Yufeng			Recovered Patients with Stevens-Johson Syndrome and Toxic Epidermal Necrolysis Maintain Long-Lived IFN-gamma and sFasL Memory Response	PLOS ONE			English	Article							SOLUBLE FAS LIGAND; DRUG HYPERSENSITIVITY REACTIONS; CYTOTOXIC T-CELLS; JOHNSON-SYNDROME; RELEASE TEST; PERIPHERAL-BLOOD; DIAGNOSTIC ROLE; LYMPHOCYTES; PROTECTION; INFECTION	There is evidence that drug-specific T cells are involved in inducing keratinocyte apoptosis in acute stage of Steven-Johson syndrome (SJS) and Toxic epidermal necrolysis (TEN). However, there are few studies that have attempted to examine T cell memory responses over time. We sought to determine the duration of IFN-gamma and sFasL memory response to causal drugs in patients with SJS and TEN after remission. Eight patients with previous SJS and TEN were enrolled. Memory T cells were measured by 10-day cultured IFN-gamma enzyme-linked immunosorbent spot-forming cell (ELISpot) assay. Effector T-cell responses were measured by ex vivo IFN-gamma ELISpot assay and sFasL ELISA. The sFasL-mediated toxicities of drug-stimulated PBMC supernatants against keratinocyte line were further investigated by MTT proliferation assay and Annexin-V staining. We observed significant cultured and ex vivo IFN-gamma ELISpot responses against causal drugs in all 8 patients. In addition, the sFasL levels were specifically increased in the supernatant of PBMCs cultured with causal drugs from 6 of 8 patients. Drug-stimulated PBMC supernatants were cytotoxic against keratinocyte line, which was inhibited by anti-FasL mAb in a dose-dependent manner. Our findings confirmed that drug-specific IFN-gamma and sFasL memory response against causal drugs could be sustained over several years and further suggest that patients should avoid causal drug re-exposure after the recovery of TEN and SJS.	[Fu, Meng; Pan, Yuefei; Li, Wei; Liao, Wenjun; Wang, Gang; Li, Chunying; Li, Chengxin; Gao, Tianwen; Liu, Yufeng] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Gao, Yang] Fourth Mil Med Univ, Sch Mil Prevent Med, Dept Hlth Sci, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, YF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	liuyf@fmmu.edu.cn	Wang, Gang/H-6710-2019; fu, meng/GZG-3120-2022	fu, meng/0000-0002-8867-0951; Wang, Gang/0000-0002-5842-8080	Key Science and Technology Program of Shaanxi Province, China [2011K12-03-07]; Program for Young Talents in Fourth Military Medical University	Key Science and Technology Program of Shaanxi Province, China; Program for Young Talents in Fourth Military Medical University	This study was supported by the Key Science and Technology Program of Shaanxi Province, China (2011K12-03-07) and by Program for Young Talents in Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Abe R, 2008, J DERMATOL SCI, V52, P151, DOI 10.1016/j.jdermsci.2008.06.003; Arnold R, 1999, J IMMUNOL, V162, P7140; Beeler A, 2006, J ALLERGY CLIN IMMUN, V117, P455, DOI 10.1016/j.jaci.2005.10.030; Chang HY, 2004, ARCH DERMATOL, V140, P242, DOI 10.1001/archderm.140.2.242; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Cush SS, 2007, J IMMUNOL, V179, P141, DOI 10.4049/jimmunol.179.1.141; Gerber BO, 2004, CURR OPIN IMMUNOL, V16, P732, DOI 10.1016/j.coi.2004.09.016; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Halevy S, 2005, J AM ACAD DERMATOL, V52, P254, DOI 10.1016/j.jaad.2004.05.006; Halevy S, 2004, ISRAEL MED ASSOC J, V6, P59; Halevy S, 2000, CLIN EXP DERMATOL, V25, P652, DOI 10.1046/j.1365-2230.2000.00729.x; Halevy S, 1999, INT J DERMATOL, V38, P835, DOI 10.1046/j.1365-4362.1999.00792.x; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Murata J, 2008, J ALLERGY CLIN IMMUN, V122, P992, DOI 10.1016/j.jaci.2008.06.013; Nassif A, 2004, J ALLERGY CLIN IMMUN, V114, P1209, DOI 10.1016/j.jaci.2004.07.047; Nassif A, 2002, J INVEST DERMATOL, V118, P728, DOI 10.1046/j.1523-1747.2002.01622.x; Neuman M, 2007, TRANSL RES, V149, P254, DOI 10.1016/j.trsl.2006.12.005; Neuman MG, 2007, TRANSL RES, V149, P243, DOI 10.1016/j.trsl.2006.12.001; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; Posadas SJ, 2002, J ALLERGY CLIN IMMUN, V109, P155, DOI 10.1067/mai.2002.120563; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Schnyder B, 1998, ALLERGY, V53, P817; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Zawodniak A, 2010, ALLERGY, V65, P376, DOI 10.1111/j.1398-9995.2009.02180.x	27	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45516	10.1371/journal.pone.0045516	http://dx.doi.org/10.1371/journal.pone.0045516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029066	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900151
J	Modan-Moses, D; Yaroslavsky, A; Kochavi, B; Toledano, A; Segev, S; Balawi, F; Mitrany, E; Stein, D				Modan-Moses, Dalit; Yaroslavsky, Amit; Kochavi, Brigitte; Toledano, Anat; Segev, Sharon; Balawi, Fadel; Mitrany, Edith; Stein, Daniel			Linear Growth and Final Height Characteristics in Adolescent Females with Anorexia Nervosa	PLOS ONE			English	Article							CATCH-UP GROWTH; CONSTITUTIONAL DELAY; EATING-DISORDERS; ADULT HEIGHT; IGF-I; PUBERTY; WEIGHT; ONSET; GIRLS; RETARDATION	Objective: Growth retardation is an established complication of anorexia nervosa (AN). However, findings concerning final height of AN patients are inconsistent. The aim of this study was to assess these phenomena in female adolescent inpatients with AN. Methods: We retrospectively studied all 211 female adolescent AN patients hospitalized in an inpatient eating disorders department from 1/1/1987 to 31/12/99. Height and weight were assessed at admission and thereafter routinely during hospitalization and follow-up. Final height was measured in 69 patients 2-10 years after discharge. Pre-morbid height data was available in 29 patients. Results: Patients' height standard deviation scores (SDS) on admission (-0.285 +/- 1.0) and discharge (-0.271 +/- 1.02) were significantly (p<0.001) lower than expected in normal adolescents. Patients admitted at age <= 13 years, or less than 1 year after menarche, were more severely growth-impaired than patients admitted at an older age, (p=0.03). Final height SDS, available for 69 patients, was -0.258 +/- 1.04, significantly lower than expected in a normal population (p=0.04), and was more severely compromised in patients who were admitted less than 1 year from their menarche. In a subgroup of 29 patients with complete growth data (pre-morbid, admission, discharge, and final adult height), the pre-morbid height SDS was not significantly different from the expected (-0.11 +/- 1.1), whereas heights at the other time points were significantly (p=0.001) lower (-0.56 +/- 1.2, -0.52 +/- 1.2, and -0.6 +/- 1.2, respectively). Conclusions: Our findings suggest that whereas the premorbid height of female adolescent AN patients is normal, linear growth retardation is a prominent feature of their illness. Weight restoration is associated with catch-up growth, but complete catch-up is often not achieved.	[Modan-Moses, Dalit] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Endocrinol & Diabet Unit, Ramat Gan, Israel; [Yaroslavsky, Amit; Kochavi, Brigitte; Toledano, Anat; Segev, Sharon; Balawi, Fadel; Mitrany, Edith; Stein, Daniel] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Psychosomat Dept, Ramat Gan, Israel; [Modan-Moses, Dalit; Stein, Daniel] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Modan-Moses, D (corresponding author), Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Endocrinol & Diabet Unit, Ramat Gan, Israel.	dmodan@sheba.health.gov.il	Stein, Dan/A-1752-2008; Iron-Segev, Sharon/GQI-1364-2022	Stein, Dan/0000-0001-7218-7810; Iron-Segev, Sharon/0000-0002-7034-9385				ACHESON ROY M., 1960, SYMPOSIA SOC STUDY HUMAN BIOL, V3, P73; ALBANESE A, 1995, J PEDIATR-US, V126, P545, DOI 10.1016/S0022-3476(95)70347-0; American Psychiatric Association, 1994, DIAGN STAT MAN DIAGN; [Anonymous], 1994, DIAGNOSIS TREATMENT; Chui HT, 2008, PEDIATRICS, V122, pE426, DOI 10.1542/peds.2008-0170; CROWNE EC, 1991, EUR J PEDIATR, V150, P708, DOI 10.1007/BF01958760; DANZIGER Y, 1994, ISRAEL J MED SCI, V30, P581; DAVIS DR, 1978, BRIT MED J, V1, P539, DOI 10.1136/bmj.1.6112.539; Favaro A, 2007, INT J EAT DISORDER, V40, P549, DOI 10.1002/eat.20409; Gafni RI, 2000, PEDIATR NEPHROL, V14, P616, DOI 10.1007/s004670000338; Gat-Yablonski G, 2004, ENDOCRINOLOGY, V145, P343, DOI 10.1210/en.2003-0910; Golden Neville H, 2003, J Adolesc Health, V33, P496, DOI 10.1016/j.jadohealth.2003.08.004; GOLDEN NH, 1994, J PEDIATR-US, V125, P655, DOI 10.1016/S0022-3476(94)70030-3; Goldstein A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e108; Hartman D, 2000, INT J EAT DISORDER, V28, P107, DOI 10.1002/(SICI)1098-108X(200007)28:1&lt;107::AID-EAT13&gt;3.0.CO;2-M; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Kerem Nogah C, 2003, Adolesc Med, V14, P109; KIRSCHNER BS, 1981, GASTROENTEROLOGY, V80, P10; KLEIN DF, 1996, CURRENT PSYCHOTHERAP; LAFRANCHI S, 1991, PEDIATRICS, V87, P82; Lanes R, 2004, J PEDIATR-US, V145, P128, DOI 10.1016/j.jpeds.2004.03.053; Lantzouni E, 2002, J ADOLESCENT HEALTH, V31, P162, DOI 10.1016/S1054-139X(02)00342-7; Mackenzie R, 1996, ADOLESCENT HLTH CARE, P564; Micali N, 2007, BRIT J PSYCHIAT, V190, P255, DOI 10.1192/bjp.bp.106.020768; Miller KK, 2011, J CLIN ENDOCR METAB, V96, P2939, DOI 10.1210/jc.2011-1222; Modan-Moses D, 2003, PEDIATRICS, V111, P270, DOI 10.1542/peds.111.2.270; Modan-Moses D, 2007, J CLIN ENDOCR METAB, V92, P1843, DOI 10.1210/jc.2006-1683; NIELSEN S, 1985, J PSYCHIAT RES, V19, P227, DOI 10.1016/0022-3956(85)90022-6; PFEIFFER RJ, 1986, CLIN PEDIATR, V25, P7, DOI 10.1177/000992288602500101; Prabhakaran R, 2008, PEDIATRICS, V121, pE1517, DOI 10.1542/peds.2007-2820; PRADER A, 1963, J PEDIATR-US, V62, P646, DOI 10.1016/S0022-3476(63)80035-9; PUGLIESE MT, 1983, NEW ENGL J MED, V309, P513, DOI 10.1056/NEJM198309013090901; Rensonnet C, 1999, HORM RES, V51, P223, DOI 10.1159/000023375; ROOT AW, 1983, J ADOLESCENT HEALTH, V4, P25, DOI 10.1016/S0197-0070(83)80224-1; SIEGEL JH, 1995, J ADOLESCENT HEALTH, V16, P448, DOI 10.1016/1054-139X(94)00003-W; Stein D, 2005, EUR NEUROPSYCHOPHARM, V15, P647, DOI 10.1016/j.euroneuro.2005.05.001; Stoving RK, 1999, J CLIN ENDOCR METAB, V84, P1346, DOI 10.1210/jc.84.4.1346; Strober M., 1987, EATING DISORDERS FAM; Swenne I, 2005, INT J EAT DISORDER, V38, P340, DOI 10.1002/eat.20182; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; UNDERWOOD LE, 1994, HORM RES, V42, P145, DOI 10.1159/000184187; Warren MP, 1995, PRINCIPLES PRACTICE, P1169	42	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45504	10.1371/journal.pone.0045504	http://dx.doi.org/10.1371/journal.pone.0045504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029058	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900149
J	Chiappini, E; Della Bella, C; Bonsignori, F; Sollai, S; Amedei, A; Galli, L; Niccolai, E; Del Prete, G; Singh, M; D'Elios, MM; de Martino, M				Chiappini, Elena; Della Bella, Chiara; Bonsignori, Francesca; Sollai, Sara; Amedei, Amedeo; Galli, Luisa; Niccolai, Elena; Del Prete, Gianfranco; Singh, Mahavir; D'Elios, Mario M.; de Martino, Maurizio			Potential Role of M. tuberculosis Specific IFN-gamma and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis	PLOS ONE			English	Article							RELEASE ASSAYS; INFECTION; DIAGNOSIS; RESPONSES	Background: Although currently available IGRA have been reported to be promising markers for TB infection, they cannot distinguish active tuberculosis (TB) from latent infection (LTBI). Objective: Children with LTBI, active TB disease or uninfected were prospectively evaluated by an in-house ELISPOT assay in order to investigate possible immunological markers for a differential diagnosis between LTBI and active TB. Methods: Children at risk for TB infection prospectively enrolled in our infectious disease unit were evaluated by in-house IFN-gamma and IL-2 based ELISPOT assays using a panel of Mycobacterium tuberculosis antigens. Results: Twenty-nine children were classified as uninfected, 21 as LTBI and 25 as active TB cases (including 5 definite and 20 probable cases). Significantly higher IFN-gamma ELISPOT responses were observed in infected vs. uninfected children for ESAT-6 (p<0.0001), CFP-10 (p<0.0001), TB 10.3 (p = 0.003), and AlaDH (p = 0.001), while differences were not significant considering Ag85B (p = 0.063), PstS1 (p = 0.512), and HspX (16 kDa) (p = 0.139). IL-2 ELISPOT assay responses were different for ESAT-6 (p<0.0001), CFP-10 (p<0.0001), TB 10.3 (p<0.0001), HspX (16 kDa) (p<0.0001), PstS1 (p<0.0001) and AlaDH (p = 0.001); but not for Ag85B (p = 0.063). Comparing results between children with LTBI and those with TB disease differences were significant for IFN-gamma ELISPOT only for AlaDH antigen (p = 0.021) and for IL-2 ELISPOT assay for AlaDH (p<0.0001) and TB 10.3 antigen (p = 0.043). ROC analyses demonstrated sensitivity of 100% and specificity of 81% of AlaDH-IL-2 ELISPOT assay in discriminating between latent and active TB using a cut off of 12.5 SCF per million PBMCs. Conclusion: Our data suggest that IL-2 based ELISPOT with AlaDH antigen may be of help in discriminating children with active from those with latent TB.	[Chiappini, Elena; Bonsignori, Francesca; Sollai, Sara; Galli, Luisa; de Martino, Maurizio] Univ Florence, Anna Meyer Univ Hosp, Dept Sci Woman & Child Hlth, Florence, Italy; [Della Bella, Chiara; Amedei, Amedeo; Niccolai, Elena; Del Prete, Gianfranco; D'Elios, Mario M.] Univ Florence, Dept Internal Med, Florence, Italy; [Singh, Mahavir] Lionex GmbH, Braunschweig, Germany	University of Florence; University of Florence	Chiappini, E (corresponding author), Univ Florence, Anna Meyer Univ Hosp, Dept Sci Woman & Child Hlth, Florence, Italy.	echiappini@unifi.it	DELLA BELLA, CHIARA/K-1432-2018; D'Elios, Mario Milco/Y-9573-2019; chiappini, elena/AAC-3121-2020; niccolai, elena/K-6091-2016; Chiappini, Elena/D-1118-2012; Amedei, Amedeo/G-5378-2011	DELLA BELLA, CHIARA/0000-0002-2565-6220; D'Elios, Mario Milco/0000-0001-9160-0930; niccolai, elena/0000-0002-9205-8079; Chiappini, Elena/0000-0002-1476-4752; Amedei, Amedeo/0000-0002-6797-9343; Sollai, Sara/0000-0001-5003-993X	Italian Health Ministry; European Union	Italian Health Ministry(Ministry of Health, Italy); European Union(European Commission)	Financial support was given in part by Italian Health Ministry, Young Research Prize, 2007, and by European Union FP7 NOPERSIST research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J MOL BIOL, V377, P1161, DOI 10.1016/j.jmb.2008.01.091; Amanatidou V, 2012, EUR J CLIN MICROBIOL, V31, P1285, DOI 10.1007/s10096-011-1524-3; [Anonymous], 2009, RED BOOK 2009 REPORT, P680; Benagiano M, 2012, P NATL ACAD SCI USA, V109, P1222, DOI 10.1073/pnas.1111833109; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Chiappini E, 2012, CLIN THER; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Hogarth PJ, 2006, VACCINE, V24, P95, DOI 10.1016/j.vaccine.2005.07.115; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Krummel B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011670; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Mori T, 2009, J INFECT CHEMOTHER, V15, P143, DOI 10.1007/s10156-009-0686-8; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Sun L, 2011, FEMS IMMUNOL MED MIC, V63, P165, DOI 10.1111/j.1574-695X.2011.00838.x; Takamura S, 2005, J IMMUNOL, V175, P2541, DOI 10.4049/jimmunol.175.4.2541; Vilaplana C, 2008, SCAND J IMMUNOL, V67, P610, DOI 10.1111/j.1365-3083.2008.02103.x	20	49	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46041	10.1371/journal.pone.0046041	http://dx.doi.org/10.1371/journal.pone.0046041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029377	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900076
J	Liu, Y; Zhou, YJ; Zhu, KQ				Liu, Yu; Zhou, Yijiang; Zhu, Keqing			Inhibition of Glioma Cell Lysosome Exocytosis Inhibits Glioma Invasion	PLOS ONE			English	Article							CATHEPSIN-B; SECRETORY LYSOSOMES; TUMOR-GROWTH; EXPRESSION; EFFECTORS; RAB27; ANGIOGENESIS; RELEASE; GENE; RNA	Cancer cells invade by secreting enzymes that degrade the extracellular matrix and these are sequestered in lysosomal vesicles. In this study, the effects of the selective lysosome lysing drug GPN and the lysosome exocytosis inhibitor vacuolin-1 on lysosome exocytosis were studied to determine their effect on glioma cell migration and invasion. Both GPN and vacuolin-1 evidently inhibited migration and invasion in transwell experiments and scratch experiments. There are more lysosomes located on the cell membrane of glioma cells than of astrocytes. GPN decreased the lysosome number on the cell membrane. We found that rab27A was expressed in glioma cells, and colocalized with cathepsin D in lysosome. RNAi-Rab27A inhibited lysosome cathepsin D exocytosis and glioma cell invasion in an in vitro assay. Inhibition of cathepsin D inhibited glioma cell migration. The data suggest that the inhibition of lysosome exocytosis from glioma cells plays an important modulatory role in their migration and invasion.	[Liu, Yu; Zhou, Yijiang; Zhu, Keqing] Zhejiang Univ, Sch Med, Dept Neurobiol, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, KQ (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	zhukeqing@zju.edu.cn			Zhejiang Provincial National Science Foundation of China [Y2080213]; National Natural Science Foundation of China [30770677]	Zhejiang Provincial National Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Zhejiang Provincial National Science Foundation of China (Y2080213) and by the National Natural Science Foundation of China (30770677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Fukuda ME, 2005, CANCER RES, V65, P5190, DOI 10.1158/0008-5472.CAN-04-4134; Goishi K, 2004, BIOCHEM BIOPH RES CO, V324, P294, DOI 10.1016/j.bbrc.2004.09.050; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Levicar N, 2002, J NEURO-ONCOL, V58, P21, DOI 10.1023/A:1015892911420; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mohanam S, 2001, ONCOGENE, V20, P3665, DOI 10.1038/sj.onc.1204480; Shaik GM, 2009, CELL SIGNAL, V21, P1337, DOI 10.1016/j.cellsig.2009.04.001; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	22	44	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45910	10.1371/journal.pone.0045910	http://dx.doi.org/10.1371/journal.pone.0045910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029308	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900063
J	Thakur, D; Saxena, R; Singh, V; Haq, W; Katti, SB; Singh, BN; Tripathi, RK				Thakur, Dharamsheela; Saxena, Reshu; Singh, Vandana; Haq, Wahajul; Katti, S. B.; Singh, Bhupendra Narain; Tripathi, Raj Kamal			Human Beta Casein Fragment (54-59) Modulates M. bovis BCG Survival and Basic Transcription Factor 3 (BTF3) Expression in THP-1 Cell Line	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VIRULENT MYCOBACTERIUM-TUBERCULOSIS; TOXIN-1 AND/OR LIPOPOLYSACCHARIDES; ALVEOLAR MACROPHAGES; PHAGOCYTE OXIDASE; ADJUVANT ACTIVITY; APOPTOSIS; IDENTIFICATION; INFECTION; STRAINS	Immunostimulatory peptides potentiate the immune system of the host and are being used as a viable adjunct to established therapeutic modalities in treatment of cancer and microbial infections. Several peptides derived from milk protein have been reported to induce immunostimulatory activity. Human beta-casein fragment (54-59), natural sequence peptide (NS) carrying the Val-Glu-Pro-Ile-Pro-Tyr amino acid residues, was reported to activate the macrophages and impart potent immunostimulatory activity. In present study, we found that this peptide increases the clearance of M. bovis BCG from THP-1 cell line in vitro. The key biomolecules, involved in the clearance of BCG from macrophage like, nitric oxide, pro-inflammatory cytokines and chemokines, were not found to be significantly altered after peptide treatment in comparison to the untreated control. Using proteomic approach we found that BTF3a, an isoform of the Basic Transcription Factor, BTF3, was down regulated in THP-1 cell line after peptide treatment. This was reconfirmed by real time RT-PCR and western blotting. We report the BTF3a as a novel target of this hexapeptide. Based on the earlier findings and the results from the present studies, we suggest that the down regulation of BTF3a following the peptide treatment may augment the M. bovis BCG mediated apoptosis resulting in enhanced clearance of M. bovis BCG from THP-1 cell line.	[Singh, Vandana; Singh, Bhupendra Narain] Cent Drug Res Inst, Div Microbiol, Lucknow 226001, Uttar Pradesh, India; [Thakur, Dharamsheela; Saxena, Reshu; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Lucknow 226001, Uttar Pradesh, India; [Haq, Wahajul; Katti, S. B.] Cent Drug Res Inst, Div Med & Proc Chem, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, BN (corresponding author), Cent Drug Res Inst, Div Microbiol, Lucknow 226001, Uttar Pradesh, India.	bnsingh@cdri.res.in; rk_tripathi@cdri.res.in	Saxena, Reshu/AAU-3178-2021	Singh, Bhupendra Narain/0000-0002-8197-5381	Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI); Alternative Animal Model project [NWP0034]	Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI); Alternative Animal Model project	We are thankful to the "Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI)" for providing the institutional funding and Alternative Animal Model project (NWP0034) for providing the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1974, BIOCHEM BIOPH RES CO, V56, P561, DOI 10.1016/0006-291X(74)90640-8; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Bringans S, 2008, RAPID COMMUN MASS SP, V22, P3450, DOI 10.1002/rcm.3752; Brockstedt E, 1999, J PROTEIN CHEM, V18, P225, DOI 10.1023/A:1020636308270; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; DING AH, 1988, J IMMUNOL, V141, P2407; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Harrison LM, 2005, INFECT IMMUN, V73, P403, DOI 10.1128/IAI.73.1.403-412.2005; KANNO M, 1992, GENE, V117, P219, DOI 10.1016/0378-1119(92)90732-5; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Li Rong, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P323; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; LOWY I, 1977, CELL IMMUNOL, V29, P195, DOI 10.1016/0008-8749(77)90288-X; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; PARKER F, 1984, EUR J BIOCHEM, V145, P677, DOI 10.1111/j.1432-1033.1984.tb08609.x; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Rysz J, 2000, Acta Pol Pharm, V57 Suppl, P11; Sharma P, 2004, PEPTIDES, V25, P1873, DOI 10.1016/j.peptides.2004.06.011; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; SUGIMURA K, 1979, CELL IMMUNOL, V43, P137, DOI 10.1016/0008-8749(79)90157-6; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	35	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45905	10.1371/journal.pone.0045905	http://dx.doi.org/10.1371/journal.pone.0045905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029305	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900061
J	Wang, HG; Chen, YH; Zhu, HJ; Wang, S; Zhang, XW; Xu, DJ; Cao, KJ; Zou, JG				Wang, Hegui; Chen, Yanhong; Zhu, Hongjun; Wang, Sen; Zhang, Xiwen; Xu, Dongjie; Cao, Kejiang; Zou, Jiangang			Increased Response to beta(2)-Adrenoreceptor Stimulation Augments Inhibition of I-Kr in Heart Failure Ventricular Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-A; RECTIFIER POTASSIUM CURRENT; GUINEA-PIG HEART; RAPID COMPONENT; BETA(2)-ADRENERGIC STIMULATION; DEPENDENT PATHWAYS; ION-CHANNEL; ACTIVATION; CURRENTS; CANINE	Background: Increasing evidence indicates that the rapid component of delayed rectifier potassium current (I-Kr) is modulated by alpha- and beta-adrenergic stimulation. However, the role and mechanism regulating I-Kr through beta(2)-adrenoreceptor (beta-AR) stimulation in heart failure (HF) are unclear. Methodology/Principal Findings: In the present study, we investigated the effects of fenoterol, a highly selective beta(2)-AR agonist, on I-Kr in left ventricular myocytes obtained from control and guinea pigs with HF induced by descending aortic banding. I-Kr was measured by using whole cell patch clamp technique. In control myocytes, superfusion of fenoterol (10 mu M) caused a 17% decrease in I-Kr. In HF myocytes, the same concentration of fenoterol produced a significantly greater decrease (33%) in I-Kr. These effects were not modified by the incubation of myocytes with CGP-20712A, a beta(1)-AR antagonist, but were abolished by pretreatment of myocytes with ICI-118551, a beta(2)-AR antagonist. An inhibitory cAMP analog, Rp-cAMPS and PKA inhibitor significantly attenuated fenoterol-induced inhibition of I-Kr in HF myocytes. Moreover, fenoterol markedly prolonged action potential durations at 90% (APD(90)) repolarization in HF ventricular myocytes. Conclusions: The results indicate that inhibition of I-Kr induced by beta(2)-AR stimulation is increased in HF. The inhibitory effect is likely to be mediated through a cAMP/PKA pathway in HF ventricular myocytes.	[Chen, Yanhong; Zhu, Hongjun; Wang, Sen; Zhang, Xiwen; Xu, Dongjie; Cao, Kejiang; Zou, Jiangang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Hegui] Wannan Med Coll, Yijishan Hosp, Dept Cardiol, Wuhu, Peoples R China	Nanjing Medical University; Wannan Medical College	Zou, JG (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	jgzou@njmu.edu.cn			National Nature Science Foundation of China [81170162]; University Nature Science Foundation of Jiangsu Province [09KJB320008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Nature Science Foundation of Jiangsu Province	This work was supported by the National Nature Science Foundation of China (81170162) http://www.nsfc.gov.cn/Portal0/default166.htm) and University Nature Science Foundation of Jiangsu Province (09KJB320008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULD RA, 1995, CIRCULATION, V92, P1612, DOI 10.1161/01.CIR.92.6.1612; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Duan DY, 2009, J PHYSIOL-LONDON, V587, P2163, DOI 10.1113/jphysiol.2008.165860; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Harmati G, 2011, BRIT J PHARMACOL, V162, P890, DOI 10.1111/j.1476-5381.2010.01092.x; James AF, 1996, CIRC RES, V79, P201, DOI 10.1161/01.RES.79.2.201; Karle CA, 2002, CARDIOVASC RES, V53, P355, DOI 10.1016/S0008-6363(01)00509-0; KIUCHI K, 1993, J CLIN INVEST, V91, P907, DOI 10.1172/JCI116312; Li Y, 2008, J MEMBRANE BIOL, V223, P107, DOI 10.1007/s00232-008-9118-4; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Pelzer S, 1997, AM J PHYSIOL-HEART C, V273, pH2539, DOI 10.1152/ajpheart.1997.273.6.H2539; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomas D, 2006, CURR PHARM DESIGN, V12, P2271, DOI 10.2174/138161206777585102; Thomas D, 2004, BASIC RES CARDIOL, V99, P279, DOI 10.1007/s00395-004-0474-7; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Vittorio TJ, 2008, J CARDIOVASC PHARM T, V13, P51, DOI 10.1177/1074248407312629; VOSS HP, 1994, J PHARMACOL EXP THER, V271, P386; Wang S, 2009, EUR J PHARMACOL, V608, P1, DOI 10.1016/j.ejphar.2009.02.017; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Zankov DP, 2009, HEART RHYTHM, V6, P1038, DOI 10.1016/j.hrthm.2009.02.045; Zhang ZS, 2001, J PHARMACOL EXP THER, V298, P188; Zicha S, 2003, AM J PHYSIOL-HEART C, V285, pH1641, DOI 10.1152/ajpheart.00346.2003	32	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46186	10.1371/journal.pone.0046186	http://dx.doi.org/10.1371/journal.pone.0046186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029432	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900105
J	Testoni, S; Bartolone, E; Rossi, M; Patrignani, A; Bruggmann, R; Lichtner, P; Tetens, J; Gentile, A; Drogemuller, C				Testoni, Stefania; Bartolone, Elena; Rossi, Marco; Patrignani, Andrea; Bruggmann, Remy; Lichtner, Peter; Tetens, Jens; Gentile, Arcangelo; Droegemueller, Cord			KDM2B Is Implicated in Bovine Lethal Multi-Organic Developmental Dysplasia	PLOS ONE			English	Article							HISTONE DEMETHYLATION; GENE; ASSOCIATION	In the last decade breeders of Romagnola cattle observed an outbreak of a new congenital anomaly. This lethal multi-organ developmental dysplasia is mainly characterized by facial deformities, ascites and hepatic fibrosis. Affected stillborn calves were inbred to a single founder sire suggesting autosomal monogenic recessive inheritance. We localized the causative mutation to a 1.2 Mb interval on BTA 17 by genome-wide association and identical by descent mapping. A solution-based method for targeted DNA capture combined with massively parallel sequencing was used to analyze the entire critical region containing 24 genes. Homozygosity for two non-synonymous coding sequence variants affecting the RNF34 and KDM2B genes was detected by evaluating one affected calf. Here we show that the disease phenotype is associated with a KDM2B missense mutation (c.2503G>A) leading to an amino acid exchange (p.D835N) in an evolutionary strongly conserved domain. In addition, the genetic makeup of three inbred cattle strongly supports the causality of the KDM2B mutation. This report of a naturally-occurring spontaneous mutation of a JmjC domain containing histone demethylase gene provides evidence for their important role in the endo-and mesodermal organ development.	[Bartolone, Elena; Rossi, Marco; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Testoni, Stefania] Univ Padua, Dept Vet Clin Sci, Padua, Italy; [Bartolone, Elena; Rossi, Marco; Gentile, Arcangelo] Univ Bologna, Vet Clin Dept, Bologna, Italy; [Patrignani, Andrea; Bruggmann, Remy] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Bruggmann, Remy] Univ Bern, Dept Biol, Bern, Switzerland; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; University of Padua; University of Bologna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch		Partigiani, Andrea/0000-0001-8019-3911; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X; Bruggmann, Remy/0000-0001-5629-6363	region of Emilia Romagna (Italy)	region of Emilia Romagna (Italy)(Regione Emilia Romagna)	The authors thank the region of Emilia Romagna (Italy) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HOMEPAGE BOS TAURUS; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Testoni S, 2009, VET REC, V164, P693, DOI 10.1136/vr.164.22.693; Thompson PN, 2006, J ANIM SCI, V84, P2629, DOI 10.2527/jas.2005-774; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Verrier L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001390; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	20	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45634	10.1371/journal.pone.0045634	http://dx.doi.org/10.1371/journal.pone.0045634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029151	Green Published, gold, Green Accepted			2022-12-27	WOS:000309517500036
J	Tewari-Singh, N; Jain, AK; Inturi, S; Agarwal, C; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Chapla; White, Carl W.; Agarwal, Rajesh			Silibinin Attenuates Sulfur Mustard Analog-Induced Skin Injury by Targeting Multiple Pathways Connecting Oxidative Stress and Inflammation	PLOS ONE			English	Article							SULFIDE-INDUCED SKIN; SKH-1 HAIRLESS MICE; MOUSE SKIN; MOLECULAR-MECHANISMS; INDUCED TOXICITY; DNA-DAMAGE; CELLS; EFFICACY; CYTOKINE; CANCER	Chemical warfare agent sulfur mustard (HD) inflicts delayed blistering and incapacitating skin injuries. To identify effective countermeasures against HD-induced skin injuries, efficacy studies were carried out employing HD analog 2-chloroethyl ethyl sulfide (CEES)-induced injury biomarkers in skin cells and SKH-1 hairless mouse skin. The data demonstrate strong therapeutic efficacy of silibinin, a natural flavanone, in attenuating CEES-induced skin injury and oxidative stress. In skin cells, silibinin (10 mu M) treatment 30 min after 0.35/0.5 mM CEES exposure caused a significant (p<0.05) reversal in CEES-induced decrease in cell viability, apoptotic and necrotic cell death, DNA damage, and an increase in oxidative stress. Silibinin (1 mg) applied topically to mouse skin 30 min post-CEES exposure (2 mg), was effective in reversing CEES-induced increases in skin bi-fold (62%) and epidermal thickness (85%), apoptotic cell death (70%), myeloperoxidase activity (complete reversal), induction of iNOS, COX-2, and MMP-9 protein levels (>90%), and activation of transcription factors NF-kappa B and AP-1 (complete reversal). Similarly, silibinin treatment was also effective in attenuating CEES-induced oxidative stress measured by 4-hydroxynonenal and 5,5-dimethyl-2-(8-octanoic acid)-1-pyrolline N-oxide protein adduct formation, and 8-oxo-2-deoxyguanosine levels. Since our previous studies implicated oxidative stress, in part, in CEES-induced toxic responses, the reversal of CEES-induced oxidative stress and other toxic effects by silibinin in this study indicate its pleiotropic therapeutic efficacy. Together, these findings support further optimization of silibinin in HD skin toxicity model to develop a novel effective therapy for skin injuries by vesicants.	[Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Chapla; Agarwal, Rajesh] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [White, Carl W.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Rajesh.Agarwal@ucdenver.edu			CounterACT Program, Office of the Director, National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES-015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	CounterACT Program, Office of the Director, National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the CounterACT Program, Office of the Director, National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), Grant Number [U54 ES-015678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo CM, 2003, PHARMACOL TOXICOL, V92, P204, DOI 10.1034/j.1600-0773.2003.920503.x; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; Black AT, 2010, TOXICOL APPL PHARM, V245, P352, DOI 10.1016/j.taap.2010.04.001; Chittezhath M, 2008, MOL CANCER THER, V7, P1817, DOI 10.1158/1535-7163.MCT-08-0256; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P99, DOI 10.1093/carcin/bgg188; Dhanalakshmi S, 2005, J BIOL CHEM, V280, P20375, DOI 10.1074/jbc.M414640200; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Gould NS, 2009, J PHARMACOL EXP THER, V328, P732, DOI 10.1124/jpet.108.145037; Graham John S, 2005, J Burns Wounds, V4, pe1; Graham JS, 2009, TOXICOLOGY, V263, P47, DOI 10.1016/j.tox.2008.07.067; Gu M, 2005, CARCINOGENESIS, V26, P1404, DOI 10.1093/carcin/bgi096; Gu M, 2005, CANCER EPIDEM BIOMAR, V14, P1344, DOI 10.1158/1055-9965.EPI-04-0664; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Gu M, 2010, MOL CARCINOGEN, V49, P1, DOI 10.1002/mc.20560; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Henemyre-Harris Claudia L, 2008, Eplasty, V8, pe16; Inturi S, 2011, FREE RADIC BIOL MED; Jain AK, 2011, TOXICOL LETT, V205, P293, DOI 10.1016/j.toxlet.2011.06.019; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Jowsey PA, 2009, TOXICOLOGY, V257, P105, DOI 10.1016/j.tox.2008.12.001; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P12, DOI 10.1016/j.tox.2009.01.019; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Kehe Kai, 2008, Eplasty, V8, pe32; Laskin JD, 2010, ANN NY ACAD SCI, V1203, P92, DOI 10.1111/j.1749-6632.2010.05605.x; LINDSAY CD, 1995, HUM EXP TOXICOL, V14, P580, DOI 10.1177/096032719501400705; Mallikarjuna G, 2004, CANCER RES, V64, P6349, DOI 10.1158/0008-5472.CAN-04-1632; Matijasevic Z, 2001, CARCINOGENESIS, V22, P661, DOI 10.1093/carcin/22.4.661; Pal A, 2009, FREE RADICAL BIO MED, V47, P1640, DOI 10.1016/j.freeradbiomed.2009.09.011; Paromov V, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/109516; Paromov Victor, 2007, J Burns Wounds, V7, pe7; Ray R, 2000, J APPL TOXICOL, V21, pS87; Rowell M, 2009, TOXICOLOGY, V263, P9, DOI 10.1016/j.tox.2009.05.015; Sabourin CLK, 2002, J BIOCHEM MOL TOXIC, V16, P263, DOI 10.1002/jbt.10050; Sabourin CLK, 2000, J BIOCHEM MOL TOXIC, V14, P291, DOI 10.1002/1099-0461(2000)14:6<291::AID-JBT1>3.0.CO;2-B; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Singh RP, 2009, CLIN DERMATOL, V27, P479, DOI 10.1016/j.clindermatol.2009.05.012; Singh RP, 2005, EUR J CANCER, V41, P1969, DOI 10.1016/j.ejca.2005.03.033; Smith WJ, 2009, TOXICOLOGY, V263, P70, DOI 10.1016/j.tox.2008.09.012; Tewari-Singh N, 2011, J PHARMACOL EXP THER, V336, P450, DOI 10.1124/jpet.110.173708; Tewari-Singh N, 2010, CHEM RES TOXICOL, V23, P1034, DOI 10.1021/tx100038b; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Tyagi A, 2011, MOL CARCINOG; VOGT RF, 1984, FUND APPL TOXICOL, V4, pS71, DOI 10.1016/0272-0590(84)90139-8	47	55	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46149	10.1371/journal.pone.0046149	http://dx.doi.org/10.1371/journal.pone.0046149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029417	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500066
J	de Oliveira, GAP; Pereira, EG; Dias, CV; Souza, TLF; Ferretti, GDS; Cordeiro, Y; Camillo, LR; Cascardo, J; Almeida, FC; Valente, AP; Silva, JL				de Oliveira, Guilherme A. P.; Pereira, Elen G.; Dias, Cristiano V.; Souza, Theo L. F.; Ferretti, Giulia D. S.; Cordeiro, Yraima; Camillo, Luciana R.; Cascardo, Julio; Almeida, Fabio C.; Valente, Ana Paula; Silva, Jerson L.			Moniliophthora perniciosa Necrosis- and Ethylene-Inducing Protein 2 (MpNep2) as a Metastable Dimer in Solution: Structural and Functional Implications	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; WITCHES-BROOM; NEP1-LIKE PROTEINS; CAUSAL AGENT; CRINIPELLIS-PERNICIOSA; IDENTIFICATION; EXPRESSION; CAROTOVORA; DEFENSE; DISEASE	Understanding how Nep-like proteins (NLPs) behave during the cell cycle and disease progression of plant pathogenic oomycetes, fungi and bacteria is crucial in light of compelling evidence that these proteins play a role in Witches Broom Disease (WBD) of Theobroma cacao, one of the most important phytopathological problems to afflict the Southern Hemisphere. The crystal structure of MpNep2, a member of the NLP family and the causal agent of WBD, revealed the key elements for its activity. This protein has the ability to refold after heating and was believed to act as a monomer in solution, in contrast to the related homologs MpNep1 and NPP from the oomyceteous fungus Phytophthora parasitica. Here, we identify and characterize a metastable MpNep2 dimer upon over-expression in Escherichia coli using different biochemical and structural approaches. We found using ultra-fast liquid chromatography that the MpNep2 dimer can be dissociated by heating but not by dilution, oxidation or high ionic strength. Small-angle X-ray scattering revealed a possible tail-to-tail interaction between monomers, and nuclear magnetic resonance measurements identified perturbed residues involved in the putative interface of interaction. We also explored the ability of the MpNep2 monomer to refold after heating or chemical denaturation. We observed that MpNep2 has a low stability and cooperative fold that could be an explanation for its structure and activity recovery after stress. These results can provide new insights into the mechanism for MpNep2's action in dicot plants during the progression of WBD and may open new avenues for the involvement of NLP-oligomeric species in phytopathological disorders.	[de Oliveira, Guilherme A. P.; Pereira, Elen G.; Ferretti, Giulia D. S.; Almeida, Fabio C.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil; [Dias, Cristiano V.; Camillo, Luciana R.; Cascardo, Julio] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Lab Proteom, Ilheus, BA, Brazil; [Dias, Cristiano V.] Mars Ctr Cocoa Sci, Itajuipe, BA, Brazil; [Souza, Theo L. F.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual de Santa Cruz; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Valente, Ana Paula/J-3010-2017; de Oliveira, Guilherme A. P./O-1192-2013; SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014; Pereira, Elen/H-9585-2013; de Souza, Theo LF/E-1705-2017; Cordeiro, Yraima/J-7619-2012; Almeida, Fabio/O-4989-2018	Valente, Ana Paula/0000-0001-7219-1123; de Oliveira, Guilherme A. P./0000-0002-0063-5888; SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; Pereira, Elen/0000-0001-8073-7931; de Souza, Theo LF/0000-0002-0109-0357; Cordeiro, Yraima/0000-0003-4278-212X; Almeida, Fabio/0000-0001-6046-7006; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian Synchrotron Light Laboratory (LNLS) [SAXS1-10895, SAXS1-11698]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Synchrotron Light Laboratory (LNLS); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to J.L.S. This research was also supported by the Brazilian Synchrotron Light Laboratory (LNLS) under proposals SAXS1-10895 and SAXS1-11698. G.A.P.O. is the recipient of a graduate fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; Bae H, 2006, PLANT PHYSIOL, V141, P1056, DOI 10.1104/pp.106.076869; Bae HH, 2005, MYCOL RES, V109, P1373, DOI 10.1017/S0953756205003941; Bailey BA, 1997, CAN J MICROBIOL, V43, P45, DOI 10.1139/m97-007; Bailey Bryan A., 1995, Phytopathology, V85, P1250, DOI 10.1094/Phyto-85-1250; Cechin AL, 2008, PLANT SIGNAL BEHAV, V3, P906, DOI 10.4161/psb.3.10.6643; EVANS HC, 1980, T BRIT MYCOL SOC, V74, P515, DOI 10.1016/S0007-1536(80)80051-9; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; FRIAS GA, 1991, PLANT DIS, V75, P552, DOI 10.1094/PD-75-0552; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Jennings JC, 2000, WEED SCI, V48, P7, DOI 10.1614/0043-1745(2000)048[0007:IOEBAN]2.0.CO;2; Keates SE, 2003, PLANT PHYSIOL, V132, P1610, DOI 10.1104/pp.102.019836; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kufner I, 2009, PLANT SIGNAL BEHAV, V4, P977, DOI 10.4161/psb.4.10.9669; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Mattinen L, 2004, MOL PLANT MICROBE IN, V17, P1366, DOI 10.1094/MPMI.2004.17.12.1366; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Pace C N, 1986, Methods Enzymol, V131, P266; Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343; Pemberton CL, 2004, MOL PLANT PATHOL, V5, P353, DOI 10.1111/j.1364-3703.2004.00235.x; Penman D, 2000, MYCOL RES, V104, P671, DOI 10.1017/S0953756299001689; Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974; Schouten A, 2008, NEW PHYTOL, V177, P493, DOI 10.1111/j.1469-8137.2007.02274.x; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber G, 1992, PROTEIN INTERACTIONS; Zaparoli G, 2011, BIOCHEMISTRY-US, V50, P9901, DOI 10.1021/bi201253b	36	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45620	10.1371/journal.pone.0045620	http://dx.doi.org/10.1371/journal.pone.0045620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029140	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700053
J	Harris, JA; Koyama, A; Maeda, S; Ho, K; Devidze, N; Dubal, DB; Yu, GQ; Masliah, E; Mucke, L				Harris, Julie A.; Koyama, Akihiko; Maeda, Sumihiro; Ho, Kaitlyn; Devidze, Nino; Dubal, Dena B.; Yu, Gui-Qiu; Masliah, Eliezer; Mucke, Lennart			Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MOUSE; MUTANT-TAU; P301L TAU; MEMORY; MODEL; MICE; PROTEIN; TANGLE; PARAHIPPOCAMPAL	Accumulation of hyperphosphorylated tau in the entorhinal cortex (EC) is one of the earliest pathological hallmarks in patients with Alzheimer's disease (AD). It can occur before significant A beta deposition and appears to "spread" into anatomically connected brain regions. To determine whether this early-stage pathology is sufficient to cause disease progression and cognitive decline in experimental models, we overexpressed mutant human tau (hTauP301L) predominantly in layer II/III neurons of the mouse EC. Cognitive functions remained normal in mice at 4, 8, 12 and 16 months of age, despite early and extensive tau accumulation in the EC. Perforant path (PP) axon terminals within the dentate gyrus (DG) contained abnormal conformations of tau even in young EC-hTau mice, and phosphorylated tau increased with age in both the EC and PP. In old mice, ultrastructural alterations in presynaptic terminals were observed at PP-to-granule cell synapses. Phosphorylated tau was more abundant in presynaptic than postsynaptic elements. Human and pathological tau was also detected within hippocampal neurons of this mouse model. Thus, hTauP301L accumulation predominantly in the EC and related presynaptic pathology in hippocampal circuits was not sufficient to cause robust cognitive deficits within the age range analyzed here.	[Harris, Julie A.; Koyama, Akihiko; Maeda, Sumihiro; Ho, Kaitlyn; Devidze, Nino; Dubal, Dena B.; Yu, Gui-Qiu; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Harris, Julie A.; Maeda, Sumihiro; Dubal, Dena B.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu	Maeda, Sumihiro/W-9146-2019; Dubal, Dena/AAL-2091-2021		National Institutes of Health (NIH) [AG011385, AG022074, AG023501, NS065780, AG18440, AG5131, NS044233]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R01AG011385, R37AG018440, P01AG022074, P50AG023501, R01AG018440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants AG011385, AG022074, AG023501 and NS065780 to L.M. and AG18440, AG5131 and NS044233 to E.M., and by a gift from the S.D. Bechtel, Jr. Foundation to L.M. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; Dr. Mucke is a member of the scientific advisory boards of AgeneBio, iPierian, ProBiodrug and Neuropore Therapies. He has received research funding for other projects and consulting fees from Bristol-Myers Squibb. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P35; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; CALLAHAN LM, 1994, NEUROBIOL AGING, V15, P381, DOI 10.1016/0197-4580(94)90041-8; Chin J, 2004, NEUROBIOL AGING, V25, pS18, DOI 10.1016/S0197-4580(04)80058-7; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dayton RD, 2012, EXP NEUROL, V233, P807, DOI 10.1016/j.expneurol.2011.12.002; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Lee SJ, 2011, NEUROSCI RES, V70, P339, DOI 10.1016/j.neures.2011.05.008; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murakami T, 2006, AM J PATHOL, V169, P1365, DOI 10.2353/ajpath.2006.051250; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reed LA, 2001, NEUROBIOL AGING, V22, P89, DOI 10.1016/S0197-4580(00)00202-5; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004	66	86	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45881	10.1371/journal.pone.0045881	http://dx.doi.org/10.1371/journal.pone.0045881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029293	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700084
J	Spencer-Smith, R; Varkey, EM; Fielder, MD; Snyder, LAS				Spencer-Smith, Russell; Varkey, Eldho M.; Fielder, Mark D.; Snyder, Lori A. S.			Sequence Features Contributing to Chromosomal Rearrangements in Neisseria gonorrhoeae	PLOS ONE			English	Article							REPEAT-ENCLOSED ELEMENTS; GENOME; MENINGITIDIS; STRAIN; DNA; PHASE; VISUALIZATION; PROPHAGE; FAMILY	Through whole genome sequence alignments, breakpoints in chromosomal synteny can be identified and the sequence features associated with these determined. Alignments of the genome sequences of Neisseria gonorrhoeae strain FA1090, N. gonorrhoeae strain NCCP11945, and N. gonorrhoeae strain TCDC-NG08107 reveal chromosomal rearrangements that have occurred. Based on these alignments and dot plot pair-wise comparisons, the overall chromosomal arrangement of strain NCCP11945 and TCDC-NG08107 are very similar, with no large inversions or translocations. The insertion of the Gonococcal Genetic Island in strain NCCP11945 is the most prominent distinguishing feature differentiating these strains. When strain NCCP11945 is compared to strain FA1090, however, 14 breakpoints in chromosomal synteny are identified between these gonococcal strains. The majority of these, 11 of 14, are associated with a prophage, IS elements, or IS-like repeat enclosed elements which appear to have played a role in the rearrangements observed. Additional rearrangements of small regions of the genome are associated with pilin genes. Evidence presented here suggests that the rearrangements of blocks of sequence are mediated by activation of prophage and associated IS elements and reintegration elsewhere in the genome or by homologous recombination between IS-like elements that have generated inversions.	[Spencer-Smith, Russell; Varkey, Eldho M.; Fielder, Mark D.; Snyder, Lori A. S.] Kingston Univ, Sch Life Sci, Kingston Upon Thames, Surrey, England	Kingston University	Snyder, LAS (corresponding author), Kingston Univ, Sch Life Sci, Kingston Upon Thames, Surrey, England.	l.snyder@kingston.ac.uk		Spencer-Smith, Russell/0000-0002-8865-0520; Snyder, Lori/0000-0003-3172-3984	Kingston University	Kingston University	RS-S and this work were supported by a Kingston University award to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Chen CC, 2011, J BACTERIOL, V193, P1788, DOI 10.1128/JB.00007-11; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Gibbs CP, 1996, FEMS MICROBIOL LETT, V145, P173, DOI 10.1016/S0378-1097(96)00404-1; Jordan P, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-23; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kawai M, 2006, GENE, V383, P52, DOI 10.1016/j.gene.2006.07.013; Klee SR, 2000, INFECT IMMUN, V68, P2082, DOI 10.1128/IAI.68.4.2082-2095.2000; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Liu SV, 2002, J BACTERIOL, V184, P6163, DOI 10.1128/JB.184.22.6163-6173.2002; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Masignani V, 2001, INFECT IMMUN, V69, P2580, DOI 10.1128/IAI.69.4.2580-2588.2001; Mazzone M, 2001, GENE, V278, P211, DOI 10.1016/S0378-1119(01)00725-9; MEYER TF, 1982, CELL, V30, P45, DOI 10.1016/0092-8674(82)90010-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; NACHAMKIN I, 1981, INFECT IMMUN, V32, P641, DOI 10.1128/IAI.32.2.641-648.1981; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; SEGAL E, 1985, CELL, V40, P293, DOI 10.1016/0092-8674(85)90143-6; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Skaar EP, 2005, J BACTERIOL, V187, P1276, DOI 10.1128/JB.187.4.1276-1286.2005; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; STERN A, 1987, MOL MICROBIOL, V1, P5, DOI 10.1111/j.1365-2958.1987.tb00520.x; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46023	10.1371/journal.pone.0046023	http://dx.doi.org/10.1371/journal.pone.0046023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029370	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309554700108
J	Xie, J; Xiang, DB; Wang, H; Zhao, C; Chen, J; Xiong, F; Li, TY; Wang, XL				Xie, Jiang; Xiang, De-Bing; Wang, Hong; Zhao, Cong; Chen, Jie; Xiong, Feng; Li, Ting-Yu; Wang, Xiao-Lei			Inhibition of Tcf-4 Induces Apoptosis and Enhances Chemosensitivity of Colon Cancer Cells	PLOS ONE			English	Article							CATENIN SIGNALING PATHWAY; NUCLEAR BETA-CATENIN; DOWN-REGULATION; CYCLIN D1; IN-VITRO; GENE; GROWTH; TARGET; APC; EXPRESSION	Aberrant activation of beta-catenin/Tcf-4 signaling has been implicated in human carcinogenesis, including colorectal cancer. In this study, we compared the effects of Tcf-4 knockdown with beta-catenin knockdown on cell proliferation, apoptosis, and chemosensitivity in SW480 and HCT116 colon cancer cells using adenoviral vector-mediated short hairpin RNA (shRNA). Our results show that, compared to beta-catenin knockdown, Tcf-4 knockdown more effectively inhibited colony formation, induced apoptosis, and increased 5-FU and oxaliplatin-mediated cytotoxicity in colon cancer cells. We further investigated the mechanisms involved in the different efficacies observed with beta-catenin and Tcf-4 knockdown in colon cancer cells. FOXO4 is a member of the subfamily of mammalian FOXO forkhead transcription factors and plays a major role in controlling cellular proliferation, apoptosis, and DNA repair. Our data showed that the protein level of FOXO4 did not change after treatment with both beta-catenin and Tcf-4 shRNA. However, beta-catenin shRNA was found to increase the accumulation of phosphorylated FOXO4 S193 and decrease the expression of FOXO target genes p27Kip1 and MnSOD, whereas Tcf-4 shRNA showed the opposite effect. Therefore, compared to beta-catenin knockdown, Tcf-4 knockdown shows better efficacy for inhibiting proliferation and inducing apoptosis of colorectal cancer cells, which may be related to increased FOXO4 transcriptional activity. These results suggest that Tcf-4 is an attractive potential therapeutic target for colorectal cancer therapy.	[Xie, Jiang; Chen, Jie; Xiong, Feng; Li, Ting-Yu] Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China; [Xie, Jiang; Zhao, Cong; Wang, Xiao-Lei] Third Peoples Hosp Chengdu, Chengdu, Sichuan, Peoples R China; [Xiang, De-Bing] Jiangjin Cent Hosp, Ctr Canc, Chongqing, Peoples R China; [Wang, Hong] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xie, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China.	jiangxie_cd@hotmail.com; wxl3721@163.com	Xiang, Debing/AAZ-7727-2020		National Natural Science Foundation of China [30700978]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants from the National Natural Science Foundation of China (No. 30700978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Boon EMJ, 2004, BRIT J CANCER, V90, P224, DOI 10.1038/sj.bjc.6601505; Bright-Thomas RM, 2003, EUR J SURG ONCOL, V29, P107, DOI 10.1053/ejso.2002.1331; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Dihlmann S, 2001, ONCOGENE, V20, P645, DOI 10.1038/sj.onc.1204123; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang WS, 2007, WORLD J GASTROENTERO, V13, P6581, DOI 10.3748/wjg.13.6581; Katoh M, 2004, INT J ONCOL, V25, P1495; Kaur M, 2010, NEOPLASIA, V12, P415, DOI 10.1593/neo.10188; Kwon IK, 2010, ONCOGENE, V29, P3423, DOI 10.1038/onc.2010.91; Lupertz R, 2008, CARCINOGENESIS, V29, P2045, DOI 10.1093/carcin/bgn184; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sparks AB, 1998, CANCER RES, V58, P1130; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Xiang DB, 2006, ANTI-CANCER DRUG, V17, P753, DOI 10.1097/01.cad.0000224441.01082.bb; Xu WL, 2010, CANCER BIOTHER RADIO, V25, P529, DOI 10.1089/cbr.2010.0768; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034	39	22	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45617	10.1371/journal.pone.0045617	http://dx.doi.org/10.1371/journal.pone.0045617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029137	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700051
J	Jia, ZQ; Zhu, YJ; Liu, LY				Jia, Zhiqing; Zhu, Yajuan; Liu, Liying			Different Water Use Strategies of Juvenile and Adult Caragana intermedia Plantations in the Gonghe Basin, Tibet Plateau	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; COLORADO PLATEAU; STABLE-ISOTOPES; DESERT PLANTS; CHINA; SHRUBS; POPULATION; COMMUNITY; ECOSYSTEM; SUMMER	Background: In a semi-arid ecosystem, water is one of the most important factors that affect vegetation dynamics, such as shrub plantation. A water use strategy, including the main water source that a plant species utilizes and water use efficiency (WUE), plays an important role in plant survival and growth. The water use strategy of a shrub is one of the key factors in the evaluation of stability and sustainability of a plantation. Methodology/Principal Findings: Caragana intermedia is a dominant shrub of sand-binding plantations on sand dunes in the Gonghe Basin in northeastern Tibet Plateau. Understanding the water use strategy of a shrub plantation can be used to evaluate its sustainability and long-term stability. We hypothesized that C. intermedia uses mainly deep soil water and its WUE increases with plantation age. Stable isotopes of hydrogen and oxygen were used to determine the main water source and leaf carbon isotope discrimination was used to estimate long-term WUE. The root system was investigated to determine the depth of the main distribution. The results showed that a 5-year-old C. intermedia plantation used soil water mainly at a depth of 0-30 cm, which was coincident with the distribution of its fine roots. However, 9- or 25-year-old C. intermedia plantations used mainly 0-50 cm soil depth water and the fine root system was distributed primarily at soil depths of 0-50 cm and 0-60 cm, respectively. These sources of soil water are recharged directly by rainfall. Moreover, the long-term WUE of adult plantations was greater than that of juvenile plantations. Conclusions: The C. intermedia plantation can change its water use strategy over time as an adaptation to a semi-arid environment, including increasing the depth of soil water used for root growth, and increasing long-term WUE.	[Jia, Zhiqing; Zhu, Yajuan; Liu, Liying] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Jia, Zhiqing; Zhu, Yajuan] Qinghai Gonghe Desert Ecosyst Res Stn, Gonghe Cty, Qinghai Provinc, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Zhu, YJ (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.	zhuyajuan80@gmail.com			Forestry Public Benefit Scientific Research Special Project of P.R. China [201204203]; Research Institute of Forestry, Chinese Academy of Forestry [ZD200908]	Forestry Public Benefit Scientific Research Special Project of P.R. China; Research Institute of Forestry, Chinese Academy of Forestry	This research was supported by the Forestry Public Benefit Scientific Research Special Project of P.R. China (201204203) and the Key Project of the Research Institute of Forestry, Chinese Academy of Forestry (ZD200908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casper BB, 2005, OECOLOGIA, V145, P541, DOI 10.1007/s00442-005-0162-9; Cheng XR, 2009, PLANT SOIL, V315, P149, DOI 10.1007/s11104-008-9739-5; Cheng XL, 2006, PLANT ECOL, V184, P1, DOI 10.1007/s11258-005-9047-6; Chimner RA, 2004, PLANT SOIL, V260, P225, DOI 10.1023/B:PLSO.0000030190.70085.e9; Darrouzet-Nardi A, 2006, PLANT SOIL, V285, P31, DOI 10.1007/s11104-005-4453-z; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; DONOVAN LA, 1994, OECOLOGIA, V100, P347, DOI 10.1007/BF00316964; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Fu K, 1992, FLORA REPUBLICAE POP, P47; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; Li G, 2007, J HYDROL, V333, P109; Li S, 2001, DESERTIFICATION SUST, P253; Ohte N, 2003, ECOL APPL, V13, P337, DOI 10.1890/1051-0761(2003)013[0337:WUONAP]2.0.CO;2; Schwinning S, 2005, J ARID ENVIRON, V60, P547, DOI 10.1016/j.jaridenv.2004.07.003; Schwinning S, 2003, OECOLOGIA, V136, P252, DOI 10.1007/s00442-003-1255-y; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Yang H, 2010, PLANT SOIL, V340, P141; Zhao LJ, 2006, ENVIRON GEOL, V50, P285, DOI 10.1007/s00254-006-0209-1; Zhu Y.J., 2011, ACTA ECOL SIN, V31, P341, DOI [10.1016/j.chnaes.2011.09.004, DOI 10.1016/J.CHNAES.2011.09.004]; Zhu YJ, 2011, J FOOD AGRIC ENVIRON, V9, P832; Zhu YaJuan, 2010, Scientia Silvae Sinicae, V46, P15	23	25	47	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45902	10.1371/journal.pone.0045902	http://dx.doi.org/10.1371/journal.pone.0045902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029303	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800116
J	Schurman, SH; Dunn, CA; Greaves, R; Yu, BB; Ferrucci, L; Croteau, DL; Seidman, MM; Bohr, VA				Schurman, Shepherd H.; Dunn, Christopher A.; Greaves, Rebecca; Yu, Binbing; Ferrucci, Luigi; Croteau, Deborah L.; Seidman, Michael M.; Bohr, Vilhelm A.			Age-Related Disease Association of Endogenous gamma-H2AX Foci in Mononuclear Cells Derived from Leukapheresis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; OBSTRUCTIVE SLEEP-APNEA; OXIDATIVE DNA-DAMAGE; MOLECULAR MARKER; HISTONE H2AX; VITAMIN-D; REPAIR; HYPERTENSION; LYMPHOCYTES; CANCER	The phosphorylated form of histone H2AX (gamma-H2AX) forms immunohistochemically detectable foci at DNA double strand breaks. In peripheral blood mononuclear cells (PBMCs) derived from leukapheresis from patients enrolled in the Baltimore Longitudinal Study of Aging, gamma-H2AX foci increased in a linear fashion with regards to age, peaking at similar to 57 years. The relationship between the frequency of gamma-H2AX foci and age-related pathologies was assessed. We found a statistically significant (p = 0.023) 50% increase in foci in PBMCs derived from patients with a known history of vitamin D deficiency. In addition, there were trends toward increased gamma-H2AX foci in patients with cataracts (34% increase, p<0.10) and in sleep apnea patients (44%, p<0.10). Among patients >= 57 y/o, we found a significant (p = 0.037) 36% increase in the number of gamma-H2AX foci/cell for patients with hypertension compared to non-hypertensive patients. Our results support a role for increased DNA damage in the morbidity of age-related diseases. gamma-H2AX may be a biomarker for human morbidity in age-related diseases.	[Schurman, Shepherd H.; Dunn, Christopher A.; Greaves, Rebecca; Croteau, Deborah L.; Seidman, Michael M.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Yu, Binbing] NIA, Lab Epidemiol Demog & Biometry, NIH, Baltimore, MD 21224 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Croteau, Deb/AAP-5933-2020; Schurman, Shepherd/ABF-8125-2021; Bohr, Vilhelm/AAP-5931-2020	Schurman, Shepherd/0000-0002-9133-7906; Dunn, Christopher/0000-0001-7899-0110; Croteau, Deborah/0000-0002-6094-4084	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the Intramural Progam of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Chatterjee M, 2001, MUTAT RES-FUND MOL M, V475, P69, DOI 10.1016/S0027-5107(01)00080-X; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; DEWITZ TS, 1979, BLOOD CELLS, V5, P499; Dielis AWJH, 2005, HYPERTENSION, V46, P1236, DOI 10.1161/01.HYP.0000193538.20705.23; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kontogianni K, 2007, ENVIRON MOL MUTAGEN, V48, P722, DOI 10.1002/em.20351; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; Love CC, 2005, THERIOGENOLOGY, V63, P1584, DOI 10.1016/j.theriogenology.2004.05.030; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Prasad K, 2011, J MED SYST; R Development Core Team, 2012, R LANG ENV STAT COMP; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shock N.W., 1984, NORMAL HUMAN AGING B; Sobol RW, 2003, DNA REPAIR, V2, P609, DOI 10.1016/S1568-7864(03)00026-0; Subash P, 2010, J HUM HYPERTENS, V24, P475, DOI 10.1038/jhh.2009.100; Tremezaygues L, 2009, DERM-ENDOCRINOL, V1, P239, DOI 10.4161/derm.1.4.9705; Tremezaygues L, 2010, J STEROID BIOCHEM, V121, P324, DOI 10.1016/j.jsbmb.2010.03.007; Yamauchi M, 2005, CHEST, V127, P1674, DOI 10.1378/chest.127.5.1674; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Yildiz A, 2008, TURK KARDIYOL DERN A, V36, P231; Zwicker F, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-62	36	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45728	10.1371/journal.pone.0045728	http://dx.doi.org/10.1371/journal.pone.0045728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029205	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800085
J	Munoz-Martinez, F; Garcia-Fontana, C; Rico-Jimenez, M; Alfonso, C; Krell, T				Munoz-Martinez, Francisco; Garcia-Fontana, Cristina; Rico-Jimenez, Miriam; Alfonso, Carlos; Krell, Tino			Genes Encoding Cher-TPR Fusion Proteins Are Predominantly Found in Gene Clusters Encoding Chemosensory Pathways with Alternative Cellular Functions	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MYXOCOCCUS-XANTHUS; PSEUDOMONAS-AERUGINOSA; BACTERIAL CHEMOTAXIS; SELF-ASSOCIATION; TETRATRICOPEPTIDE REPEAT; AZOSPIRILLUM-BRASILENSE; METHYLTRANSFERASE CHER; ENVIRONMENTAL SIGNALS; TWITCHING MOTILITY	Chemosensory pathways correspond to major signal transduction mechanisms and can be classified into the functional families flagellum-mediated taxis, type four pili-mediated taxis or pathways with alternative cellular functions (ACF). CheR methyltransferases are core enzymes in all of these families. CheR proteins fused to tetratricopeptide repeat (TPR) domains have been reported and we present an analysis of this uncharacterized family. We show that CheR-TPRs are widely distributed in GRAM-negative but almost absent from GRAM-positive bacteria. Most strains contain a single CheR-TPR and its abundance does not correlate with the number of chemoreceptors. The TPR domain fused to CheR is comparatively short and frequently composed of 2 repeats. The majority of CheR-TPR genes were found in gene clusters that harbor multidomain response regulators in which the REC domain is fused to different output domains like HK, GGDEF, EAL, HPT, AAA, PAS, GAF, additional REC, HTH, phosphatase or combinations thereof. The response regulator architectures coincide with those reported for the ACF family of pathways. Since the presence of multidomain response regulators is a distinctive feature of this pathway family, we conclude that CheR-TPR proteins form part of ACF type pathways. The diversity of response regulator output domains suggests that the ACF pathways form a superfamily which regroups many different regulatory mechanisms, in which all CheR-TPR proteins appear to participate. In the second part we characterize WspC of Pseudomonas putida, a representative example of CheR-TPR. The affinities of WspC-Pp for S-adenosylmethionine and S-adenosylhomocysteine were comparable to those of prototypal CheR, indicating that WspC-Pp activity is in analogy to prototypal CheRs controlled by product feed-back inhibition. The removal of the TPR domain did not impact significantly on the binding constants and consequently not on the product feed-back inhibition. WspC-Pp was found to be monomeric, which rules out a role of the TPR domain in self-association.	[Munoz-Martinez, Francisco; Garcia-Fontana, Cristina; Rico-Jimenez, Miriam; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, Granada, Spain; [Alfonso, Carlos] Ctr Invest Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, Granada, Spain.	tino.krell@eez.csic.es	Fontana, Cristina Garcia/AAJ-4536-2021; Krell, Tino/G-7296-2015; Alfonso, Carlos/K-1316-2014; Fontana, Cristina Garcia/L-8184-2014	Fontana, Cristina Garcia/0000-0002-9328-6022; Krell, Tino/0000-0002-9040-3166; Alfonso, Carlos/0000-0001-7165-4800; Fontana, Cristina Garcia/0000-0002-9328-6022; Rico Jimenez, Miriam/0000-0002-0126-1478; Munoz-Martinez, Francisco/0000-0001-8416-0092	Andalusian regional government Junta de Andalucia [P09-RNM-4509, CVI-7335]; Spanish Ministry for Economy and Competitiveness [Bio2010-16937]; BBVA Foundation [BIOCON08 185/09]	Andalusian regional government Junta de Andalucia(Junta de Andalucia); Spanish Ministry for Economy and Competitiveness(Spanish Government); BBVA Foundation(BBVA Foundation)	This work has been funded by research projects from the Andalusian regional government Junta de Andalucia (grants P09-RNM-4509 and CVI-7335 to T. K.), the Spanish Ministry for Economy and Competitiveness (grant Bio2010-16937 to T. K.) and from the BBVA Foundation (grant BIOCON08 185/09 to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As part of its activities, the BBVA Foundation funds research projects in the area of environmental protection. Tino Krell has been granted the research project entitled "Biodegradation: challenging the constrains" (please see for further information http://www.fbbva.es/TLFU/tlfu/ing/areas/medioamb/investigacion/fichainves/index.jsp?codigo = 351). This project contains basic research to increase the efficiency of biodegradation. A major strategy in increasing the efficiency of biodegradation is to optimize chemotaxis of different Pseudomonas strains towards environmental contaminants. In this context CheR methyltransferases are of importance. This project covers expenses for hiring a post-doctoral researcher during 2 years, expenses for traveling and general expenses for running a research laboratory. Apart from this research project there is no other interaction between Tino Krell and the BBVA Foundation such as consultancy. This project will finish by the end of June and no patents will be deposited that are the result of this project. There are no products on the market or will be developed. In summary, the interaction between T. K. and the BBVA Foundation is purely scientific. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexandre G, 2004, FEMS MICROBIOL REV, V28, P113, DOI 10.1016/j.femsre.2003.10.003; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Berleman JE, 2005, MOL MICROBIOL, V56, P1457, DOI 10.1111/j.1365-2958.2005.04646.x; Bible AN, 2008, J BACTERIOL, V190, P6365, DOI 10.1128/JB.00734-08; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Cole JL, 2004, METHOD ENZYMOL, V384, P212; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Harighi B, 2009, MICROBIOL RES, V164, P634, DOI 10.1016/j.micres.2008.11.001; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Kanungpean D, 2011, MICROBIOL-SGM, V157, P1279, DOI 10.1099/mic.0.047399-0; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Luciano J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002268; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MCCLEARY WR, 1990, J BACTERIOL, V172, P4877, DOI 10.1128/jb.172.9.4877-4887.1990; Nan B, 2011, ANNU REV GENET, V45, P21, DOI 10.1146/annurev-genet-110410-132547; Nan BY, 2010, MOL MICROBIOL, V76, P1539, DOI 10.1111/j.1365-2958.2010.07184.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Perez E, 2007, MOL MICROBIOL, V63, P363, DOI 10.1111/j.1365-2958.2006.05518.x; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; RodriguezSoto JP, 1997, J BACTERIOL, V179, P4361, DOI 10.1128/jb.179.13.4361-4371.1997; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott AE, 2008, MOL MICROBIOL, V69, P724, DOI 10.1111/j.1365-2958.2008.06323.x; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; Stephens BB, 2006, J BACTERIOL, V188, P4759, DOI 10.1128/JB.00267-06; STOCK JB, 1981, CELL, V27, P37, DOI 10.1016/0092-8674(81)90358-5; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yi X, 2002, BBA-PROTEIN STRUCT M, V1596, P28, DOI 10.1016/S0167-4838(01)00314-4; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, P480; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	62	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45810	10.1371/journal.pone.0045810	http://dx.doi.org/10.1371/journal.pone.0045810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029255	Green Published, gold			2022-12-27	WOS:000309388900103
J	Soliman, T; Mourits, MCM; van der Werf, W; Hengeveld, GM; Robinet, C; Lansink, AGJMO				Soliman, Tarek; Mourits, Monique C. M.; van der Werf, Wopke; Hengeveld, Geerten M.; Robinet, Christelle; lansink, Alfons G. J. M. Oude			Framework for Modelling Economic Impacts of Invasive Species, Applied to Pine Wood Nematode in Europe	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; WILT DISEASE; COSTS; DISPERSAL; SPREAD	Background: Economic impact assessment of invasive species requires integration of information on pest entry, establishment and spread, valuation of assets at risk and market consequences at large spatial scales. Here we develop such a framework and demonstrate its application to the pinewood nematode, Bursaphelenchus xylophilus, which threatens the European forestry industry. The effect of spatial resolution on the assessment result is analysed. Methodology/Principal Findings: Direct economic impacts resulting from wood loss are computed using partial budgeting at regional scale, while impacts on social welfare are computed by a partial equilibrium analysis of the round wood market at EU scale. Substantial impacts in terms of infested stock are expected in Portugal, Spain, Southern France, and North West Italy but not elsewhere in EU in the near future. The cumulative value of lost forestry stock over a period of 22 years (2008-2030), assuming no regulatory control measures, is estimated at (sic)22 billion. The greatest yearly loss of stock is expected to occur in the period 2014-2019, with a peak of three billion euros in 2016, but stabilizing afterwards at 300-800 million euros/year. The reduction in social welfare follows the loss of stock with considerable delay because the yearly harvest from the forest is only 1.8%. The reduction in social welfare for the downstream round wood market is estimated at (sic)218 million in 2030, whereby consumers incur a welfare loss of (sic)357 million, while producers experience a (sic)139 million increase, due to higher wood prices. The societal impact is expected to extend to well beyond the time horizon of the analysis, and long after the invasion has stopped. Conclusions/Significance: Pinewood nematode has large economic consequences for the conifer forestry industry in the EU. A change in spatial resolution affected the calculated directed losses by 24%, but did not critically affect conclusions.	[Soliman, Tarek; Mourits, Monique C. M.; van der Werf, Wopke; lansink, Alfons G. J. M. Oude] Wageningen Univ, Crop & Weed Ecol Grp, Ctr Crop Syst Anal, Wageningen, Netherlands; [Hengeveld, Geerten M.] Alterra, Wageningen UR, Wageningen, Netherlands; [Robinet, Christelle] INRA, UR Zool Forestiere 633, Orleans, France	Wageningen University & Research; Wageningen University & Research; INRAE	Mourits, MCM (corresponding author), Wageningen Univ, Crop & Weed Ecol Grp, Ctr Crop Syst Anal, Wageningen, Netherlands.	Monique.Mourits@wur.nl	Oude Lansink, Alfons GJM/H-8840-2012; Van Der Werf, Wopke/A-2557-2009; Hengeveld, Geerten/O-8943-2019	Oude Lansink, Alfons GJM/0000-0002-9273-6044; Van Der Werf, Wopke/0000-0002-5506-4699; Hengeveld, Geerten/0000-0002-9592-3080; Mourits, Monique/0000-0001-5213-2927; Robinet, Christelle/0000-0002-4933-4656	EU [PRATIQUE KBBE-2007-212459, 226544, 226299, FP7 KBBE-2009-1-2-08, FP7 KBBE-2010-265483]	EU(European Commission)	The authors greatly acknowledge support for this work from the EU projects PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques; https://secure.fera.defra.gov.uk/pratique/), MOTIVE (Models for adaptive forest management, grant No. 226544), BACCARA (Biodiversity And Climate Change, A Risk Analysis, grant 226299), ISEFOR (FP7 KBBE-2009-1-2-08, Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change) and REPHRAME (FP7 KBBE-2010-265483, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophylus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EUROPEAN FOREST SECT; [Anonymous], 2010, M STAND COMM PLANT H; [Anonymous], 2008, ANAL SOCIOECONOMIC E; [Anonymous], 2007, QLK5CT200200672; BAIN J, 1988, New Zealand Forestry, V32, P19; Baker R, 2005, ANN APPL BIOL, V146, P177, DOI 10.1111/j.1744-7348.2005.040071.x; Braasch H, 2004, NEMATOL MONOGR PERSP, V1, P77; Carrasco LR, 2010, ANN APPL BIOL, V156, P63, DOI 10.1111/j.1744-7348.2009.00363.x; Carrasco LR, 2008, EURECO GFOE EUR EC F; Chai XM, 2003, OCCURRENCE CONTROL P, P70; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; EPPO, 1986, B OEPP EPPO B, V16, P55; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; FAO, 2004, FAO PUBL; Haight RG, 2011, ENVIRON MANAGE, V47, P506, DOI 10.1007/s00267-011-9624-5; HEESTERBEEK JAP, 1987, CROP PROT, V6, P211, DOI 10.1016/0261-2194(87)90041-X; Heikkila J, 2004, AGR ECON-BLACKWELL, V31, P343, DOI 10.1016/j.agecon.2004.09.019; Higgins SI, 2000, ECOL APPL, V10, P1833, DOI 10.1890/1051-0761(2000)010[1833:UADLMF]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodda M, 2009, PHYTOPATHOLOGY, V99, P1387, DOI 10.1094/PHYTO-99-12-1387; Janssen MA, 2006, HANDB ECON, V13, P1465; Kangas K, 2003, MODELLING PROJECTING; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Margarey R, 2010, 4 INT PEST RISK MOD; Mas-Colell A., 1995, MICROECONOMIC THEORY; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nabuurs GJ, 2007, EUR J FOREST RES, V126, P391, DOI 10.1007/s10342-006-0158-y; NICKLE WR, 1981, J NEMATOL, V13, P385; PEDIGO L P, 1992, American Entomologist, V38, P12; PEDIGO LP, 1986, ANNU REV ENTOMOL, V31, P341, DOI 10.1146/annurev.en.31.010186.002013; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Rodrigues JM, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P5, DOI 10.1007/978-1-4020-8455-3_1; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Sathyapala S., 2004, PEST RISK ANAL BIOSE; Soliman T, 2010, CROP PROT, V29, P517, DOI 10.1016/j.cropro.2009.12.014; Steiner G, 1934, J AGRIC RES, V48, P0949; STERN VERNON M., 1959, HILGARDIA, V29, P81; Surkov IV, 2009, EUR REV AGRIC ECON, V36, P295, DOI 10.1093/erae/jbp030; Sutherland JR, 1991, SCAND J FOREST RES, V6, P209, DOI 10.1080/02827589109382662; UNECE/FAO, 2009, FOR PROD STAT; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; WINGFIELD MJ, 1984, J FOREST, V82, P232; Wittwer G, 2005, AUST J AGR RESOUR EC, V49, P75, DOI 10.1111/j.1467-8489.2005.00276.x; Yemshanov D, 2011, J ENVIRON MANAGE, V92, P205, DOI 10.1016/j.jenvman.2010.09.002; Zhu TD, 1998, GFPOSWP01 FOR POL PL; [No title captured]	50	75	80	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45505	10.1371/journal.pone.0045505	http://dx.doi.org/10.1371/journal.pone.0045505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029059	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900064
J	Zhang, WD; Savelieva, KV; Tran, DT; Pogorelov, VM; Cullinan, EB; Baker, KB; Platt, KA; Hu, S; Rajan, I; Xu, NH; Lanthorn, TH				Zhang, Wandong; Savelieva, Katerina V.; Tran, David T.; Pogorelov, Vladimir M.; Cullinan, Emily B.; Baker, Kevin B.; Platt, Kenneth A.; Hu, Sean; Rajan, Indrani; Xu, Nianhua; Lanthorn, Thomas H.			Characterization of PTPRG in Knockdown and Phosphatase-Inactive Mutant Mice and Substrate Trapping Analysis of PTPRG in Mammalian Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; NEURITE OUTGROWTH; NERVOUS-SYSTEM; AXON GUIDANCE; BINDING-SITE; RPTP-BETA; IN-VIVO; RECEPTOR	Receptor tyrosine phosphatase gamma (PTPRG, or RPTP gamma) is a mammalian receptor-like tyrosine phosphatase which is highly expressed in the nervous system as well as other tissues. Its function and biochemical characteristics remain largely unknown. We created a knockdown (KD) line of this gene in mouse by retroviral insertion that led to 98-99% reduction of RPTP gamma gene expression. The knockdown mice displayed antidepressive-like behaviors in the tail-suspension test, confirming observations by Lamprianou et al. 2006. We investigated this phenotype in detail using multiple behavioral assays. To see if the antidepressive-like phenotype was due to the loss of phosphatase activity, we made a knock-in (KI) mouse in which a mutant, RPTP gamma C1060S, replaced the wild type. We showed that human wild type RPTP gamma protein, expressed and purified, demonstrated tyrosine phosphatase activity, and that the RPTP gamma C1060S mutant was completely inactive. Phenotypic analysis showed that the KI mice also displayed some antidepressive-like phenotype. These results lead to a hypothesis that an RPTPc inhibitor could be a potential treatment for human depressive disorders. In an effort to identify a natural substrate of RPTPc for use in an assay for identifying inhibitors, "substrate trapping" mutants (C1060S, or D1028A) were studied in binding assays. Expressed in HEK293 cells, these mutant RPTP gamma s retained a phosphorylated tyrosine residue, whereas similarly expressed wild type RPTP gamma did not. This suggested that wild type RPTP gamma might auto-dephosphorylate which was confirmed by an in vitro dephosphorylation experiment. Using truncation and mutagenesis studies, we mapped the auto-dephosphorylation to the Y1307 residue in the D2 domain. This novel discovery provides a potential natural substrate peptide for drug screening assays, and also reveals a potential functional regulatory site for RPTP gamma. Additional investigation of RPTP gamma activity and regulation may lead to a better understanding of the biochemical underpinnings of human depression.	[Zhang, Wandong; Savelieva, Katerina V.; Tran, David T.; Pogorelov, Vladimir M.; Cullinan, Emily B.; Baker, Kevin B.; Platt, Kenneth A.; Hu, Sean; Rajan, Indrani; Xu, Nianhua; Lanthorn, Thomas H.] Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA	Lexicon Pharmaceuticals	Zhang, WD (corresponding author), Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA.	zhangw96@gmail.com			Lexicon Pharmaceuticals, Inc.	Lexicon Pharmaceuticals, Inc.	The source of funding is Lexicon Pharmaceuticals, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Appiah KK, 2011, J BIOMOL SCREEN, V16, P476, DOI 10.1177/1087057111399336; AUTERO M, 1994, MOL CELL BIOL, V14, P1308, DOI 10.1128/MCB.14.2.1308; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Bugga L, 2009, MOL CELL BIOL, V29, P3390, DOI 10.1128/MCB.01764-08; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chagnon MJ, 2010, CELL SIGNAL, V22, P1626, DOI 10.1016/j.cellsig.2010.06.001; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Della Peruta M, 2010, CANCER RES, V70, P8896, DOI 10.1158/0008-5472.CAN-10-0258; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; DRUGAN RC, 1989, PHARMACOL BIOCHEM BE, V33, P649, DOI 10.1016/0091-3057(89)90403-6; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Lamprianou S, 2006, MOL CELL BIOL, V26, P5106, DOI 10.1128/MCB.00101-06; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; POGORELOV VM, 2008, EXPT ANIMAL MODELS N, P17; Powell DR, 2005, PEDIATR NEPHROL, V20, P432, DOI 10.1007/s00467-004-1696-5; Prakash S, 2009, DEV BIOL, V336, P10, DOI 10.1016/j.ydbio.2009.09.016; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; SAP J, 1994, MOL CELL BIOL, V14, P1; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sheriff S, 2011, J MED CHEM, V54, P6548, DOI 10.1021/jm2003766; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Shu ST, 2010, ANTICANCER RES, V30, P1937; STOVER DR, 1991, P NATL ACAD SCI USA, V88, P7704, DOI 10.1073/pnas.88.17.7704; SU J, 1994, J BIOL CHEM, V269, P18731; Toychiev AH, 2009, AM J PHYSIOL-CELL PH, V297, pC990, DOI 10.1152/ajpcell.00131.2009; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zheng J, 2000, ANTICANCER RES, V20, P11	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45500	10.1371/journal.pone.0045500	http://dx.doi.org/10.1371/journal.pone.0045500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029056	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900062
J	Cadotte, DW; Bosma, R; Mikulis, D; Nugaeva, N; Smith, K; Pokrupa, R; Islam, O; Stroman, PW; Fehlings, MG				Cadotte, David W.; Bosma, Rachael; Mikulis, David; Nugaeva, Natalia; Smith, Karen; Pokrupa, Ronald; Islam, Omar; Stroman, Patrick W.; Fehlings, Michael G.			Plasticity of the Injured Human Spinal Cord: Insights Revealed by Spinal Cord Functional MRI	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY IN-1; VASCULAR MECHANISMS; NEURITE OUTGROWTH; FMRI	Introduction: While numerous studies have documented evidence for plasticity of the human brain there is little evidence that the human spinal cord can change after injury. Here, we employ a novel spinal fMRI design where we stimulate normal and abnormal sensory dermatomes in persons with traumatic spinal cord injury and perform a connectivity analysis to understand how spinal networks process information. Methods: Spinal fMRI data was collected at 3 Tesla at two institutions from 38 individuals using the standard SEEP functional MR imaging techniques. Thermal stimulation was applied to four dermatomes in an interleaved timing pattern during each fMRI acquisition. SCI patients were stimulated in dermatomes both above (normal sensation) and below the level of their injury. Sub-group analysis was performed on healthy controls (n = 20), complete SCI (n = 3), incomplete SCI (n = 9) and SCI patients who recovered full function (n = 6). Results: Patients with chronic incomplete SCI, when stimulated in a dermatome of normal sensation, showed an increased number of active voxels relative to controls (p = 0.025). There was an inverse relationship between the degree of sensory impairment and the number of active voxels in the region of the spinal cord corresponding to that dermatome of abnormal sensation (R-2 = 0.93, p<0.001). Lastly, a connectivity analysis demonstrated a significantly increased number of intraspinal connections in incomplete SCI patients relative to controls suggesting altered processing of afferent sensory signals. Conclusions: In this work we demonstrate the use of spinal fMRI to investigate changes in spinal processing of somatosensory information in the human spinal cord. We provide evidence for plasticity of the human spinal cord after traumatic injury based on an increase in the average number of active voxels in dermatomes of normal sensation in chronic SCI patients and an increased number of intraspinal connections in incomplete SCI patients relative to healthy controls.	[Cadotte, David W.; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Cadotte, David W.; Fehlings, Michael G.] Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Cadotte, David W.; Nugaeva, Natalia; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON, Canada; [Bosma, Rachael; Stroman, Patrick W.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Mikulis, David] Univ Toronto, Toronto Western Hosp, Div Neuroradiol, Dept Radiol, Toronto, ON M5T 2S8, Canada; [Smith, Karen] Providence Hlth Care, Spinal Rehabil Unit, Kingston, ON, Canada; [Pokrupa, Ronald] Queens Univ, Kingston Gen Hosp, Div Neurosurg, Kingston, ON, Canada; [Islam, Omar] Queens Univ, Kingston Gen Hosp, Div Neuroradiol & Head & Neck Imaging, Dept Radiol, Kingston, ON, Canada; [Islam, Omar] Queens Univ, Hotel Dieu Hosp, Div Neuroradiol & Head & Neck Imaging, Dept Radiol, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Diagnost Radiol, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	Michael.Fehlings@uhn.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Fehlings, Michael/0000-0002-5722-6364	Ontario Neurotrauma Foundation; Rick Hansen Institute; Congress of Neurological Surgeons; American Association of Neurological Surgeons (Codman Neurotrauma Award); Cervical Spine Research Society; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration at the University of Toronto	Ontario Neurotrauma Foundation; Rick Hansen Institute; Congress of Neurological Surgeons; American Association of Neurological Surgeons (Codman Neurotrauma Award); Cervical Spine Research Society; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration at the University of Toronto	The authors are grateful to their funding sources that include the Ontario Neurotrauma Foundation, Rick Hansen Institute, Congress of Neurological Surgeons, American Association of Neurological Surgeons (Codman Neurotrauma Award), Cervical Spine Research Society and the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Endo T, 2008, EXP NEUROL, V209, P155, DOI 10.1016/j.expneurol.2007.09.017; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, PLOS ONE, V7; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Figley CR, 2009, NEUROIMAGE, V44, P421, DOI 10.1016/j.neuroimage.2008.08.040; Figley CR, 2012, MAGN RESON IMAGING; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Furlan JC, J NEUROTRAUMA, V28, P1371; Gesierich B, CEREB CORTEX; HANDWERKER HO, 1975, PAIN, V1, P147, DOI 10.1016/0304-3959(75)90099-8; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kornelsen J, 2007, SPINAL CORD, V45, P485, DOI 10.1038/sj.sc.3102019; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lang J, 1982, Gegenbaurs Morphol Jahrb, V128, P417; Leitch JK, 2010, MAGN RESON IMAGING, V28, P1225, DOI 10.1016/j.mri.2010.03.032; Maieron M, 2007, J NEUROSCI, V27, P4182, DOI 10.1523/JNEUROSCI.3910-06.2007; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spillmann AA, 1997, EUR J NEUROSCI, V9, P549, DOI 10.1111/j.1460-9568.1997.tb01631.x; Stroman PW, 2008, MAGN RESON MED, V59, P700, DOI 10.1002/mrm.21534; Stroman PW, 2002, NEUROIMAGE, V17, P1854, DOI 10.1006/nimg.2002.1305; Stroman PW, 2002, MAGN RESON IMAGING, V20, P1, DOI 10.1016/S0730-725X(02)00468-X; Stroman PW, MAGN RESON MED; Stroman PW, 2011, MAGN RESON MED; Summers PE, 2010, NEUROIMAGE, V50, P1408, DOI 10.1016/j.neuroimage.2010.01.043; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xuan Y, PLOS ONE, V7, pe30570	36	41	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45560	10.1371/journal.pone.0045560	http://dx.doi.org/10.1371/journal.pone.0045560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029097	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400105
J	Qiu, MH; Liu, W; Qu, WM; Urade, Y; Lu, J; Huang, ZL				Qiu, Mei-Hong; Liu, Wei; Qu, Wei-Min; Urade, Yoshihiro; Lu, Jun; Huang, Zhi-Li			The Role of Nucleus Accumbens Core/Shell in Sleep-Wake Regulation and their Involvement in Modafinil-Induced Arousal	PLOS ONE			English	Article							SHELL; RECEPTORS; WAKEFULNESS; BEHAVIOR; CORE; DOPAMINE; LESIONS; HYPOTHALAMUS; NEUROBIOLOGY; DISSOCIATION	Background: We have previously shown that modafinil promotes wakefulness via dopamine receptor D-1 and D-2 receptors; however, the locus where dopamine acts has not been identified. We proposed that the nucleus accumbens (NAc) that receives the ventral tegmental area dopamine inputs play an important role not only in reward and addiction but also in sleep-wake cycle and in mediating modafinil-induced arousal. Methodology/Principal Findings: In the present study, we further explored the role of NAc in sleep-wake cycle and sleep homeostasis by ablating the NAc core and shell, respectively, and examined arousal response following modafinil administration. We found that discrete NAc core and shell lesions produced 26.5% and 17.4% increase in total wakefulness per day, respectively, with sleep fragmentation and a reduced sleep rebound after a 6-hr sleep deprivation compared to control. Finally, NAc core but not shell lesions eliminated arousal effects of modafinil. Conclusions/Significance: These results indicate that the NAc regulates sleep-wake behavior and mediates arousal effects of the midbrain dopamine system and stimulant modafinil.	[Qiu, Mei-Hong; Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Liu, Wei; Qu, Wei-Min; Lu, Jun; Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, Dept Pharmacol, Shanghai 200433, Peoples R China; [Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan; [Lu, Jun] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Lu, Jun] Harvard Univ, Sch Med, Boston, MA USA	Fudan University; Fudan University; Fudan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Qiu, MH (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	mhqiu@shmu.edu.cn; huangzljp@yahoo.com.cn	Qiu, Mei-Hong/AAX-4362-2021	Huang, Zhi-Li/0000-0001-9359-1150	National Natural Science Foundation of China [30970955, 30901797, 31171049, 31171010, 31121061]; Shanghai Committee of Science and Technology [11ZR1401800, 10441901600]; National Basic Research Program of China [2009CB5220004, 2011CB711004]; Shanghai Leading Academic Discipline Project [B119]; China National Science and Technology Major Project for Drug Discovery [2009ZX09303-006]; Japan China Medical Association	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); China National Science and Technology Major Project for Drug Discovery; Japan China Medical Association	This study was supported in part by grants-in-aid for scientific research from the National Natural Science Foundation of China (30970955, 30901797, 31171049, 31171010, 31121061), the Shanghai Committee of Science and Technology (11ZR1401800, 10441901600), National Basic Research Program of China grants (2009CB5220004, 2011CB711004), Shanghai Leading Academic Discipline Project (B119), China National Science and Technology Major Project for Drug Discovery (2009ZX09303-006) and Japan China Medical Association-Chinese Research support funding(2010). The funders had no role in study desigh, data collection and analysis, decision to publish, or preprartion of the manuscript.	Betancur C, 1997, MOL BRAIN RES, V44, P334, DOI 10.1016/S0169-328X(96)00289-6; CHANG JY, 1994, J NEUROSCI, V14, P1224, DOI 10.1523/JNEUROSCI.14-03-01224.1994; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Deroche-Gamonet V, 2002, PSYCHOPHARMACOLOGY, V161, P387, DOI 10.1007/s00213-002-1080-8; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Ferre S, 2007, PROG NEUROBIOL, V83, P332, DOI 10.1016/j.pneurobio.2007.04.002; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Huang ZL, 2011, CURR TOP MED CHEM, V11, P1047, DOI 10.2174/156802611795347654; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Jasinski DR, 2000, J PSYCHOPHARMACOL, V14, P53, DOI 10.1177/026988110001400107; JONGENRELO AL, 1994, EUR J NEUROSCI, V6, P1255, DOI 10.1111/j.1460-9568.1994.tb00315.x; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; Lazarus M, 2012, TRENDS NEUR IN PRESS; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parmentier R, 2007, BIOCHEM PHARMACOL, V73, P1157, DOI 10.1016/j.bcp.2007.01.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; Qiu MH, 2010, EUR J NEUROSCI, V31, P499, DOI 10.1111/j.1460-9568.2009.07062.x; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Ross S, 2009, CLIN NEUROPHARMACOL, V32, P269, DOI 10.1097/WNF.0b013e3181a9163c; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Stratford TR, 1997, J NEUROSCI, V17, P4434; Willie JT, 2005, NEUROSCIENCE, V130, P983, DOI 10.1016/j.neuroscience.2004.10.005; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zeitzer JM, 2006, TRENDS PHARMACOL SCI, V27, P368, DOI 10.1016/j.tips.2006.05.006; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	37	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45471	10.1371/journal.pone.0045471	http://dx.doi.org/10.1371/journal.pone.0045471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029032	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400090
J	Wardhaugh, CW; Stork, NE; Edwards, W; Grimbacher, PS				Wardhaugh, Carl W.; Stork, Nigel E.; Edwards, Will; Grimbacher, Peter S.			The Overlooked Biodiversity of Flower-Visiting Invertebrates	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; PLANT-POLLINATOR INTERACTIONS; INSECT HERBIVORES; TROPICAL FORESTS; SPECIES RICHNESS; PHYTOPHAGOUS BEETLES; INORDINATE FONDNESS; HOST-SPECIFICITY; GUILD STRUCTURE; TREES	Estimates suggest that perhaps 40% of all invertebrate species are found in tropical rainforest canopies. Extrapolations of total diversity and food web analyses have been based almost exclusively on species inhabiting the foliage, under the assumption that foliage samples are representative of the entire canopy. We examined the validity of this assumption by comparing the density of invertebrates and the species richness of beetles across three canopy microhabitats (mature leaves, new leaves and flowers) on a one hectare plot in an Australian tropical rainforest. Specifically, we tested two hypotheses: 1) canopy invertebrate density and species richness are directly proportional to the amount of resource available; and 2) canopy microhabitats represent discrete resources that are utilised by their own specialised invertebrate communities. We show that flowers in the canopy support invertebrate densities that are ten to ten thousand times greater than on the nearby foliage when expressed on a per-unit resource biomass basis. Furthermore, species-level analyses of the beetle fauna revealed that flowers support a unique and remarkably rich fauna compared to foliage, with very little species overlap between microhabitats. We reject the hypothesis that the insect fauna on mature foliage is representative of the greater canopy community even though mature foliage comprises a very large proportion of canopy plant biomass. Although the significance of the evolutionary relationship between flowers and insects is well known with respect to plant reproduction, less is known about the importance of flowers as resources for tropical insects. Consequently, we suggest that this constitutes a more important piece of the 'diversity jigsaw puzzle' than has been previously recognised and could alter our understanding of the evolution of plant-herbivore interactions and food web dynamics, and provide a better foundation for accurately estimating global species richness.	[Wardhaugh, Carl W.; Edwards, Will] James Cook Univ, Sch Marine & Trop Biol, Smithfield, Qld, Australia; [Stork, Nigel E.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Grimbacher, Peter S.] Univ Melbourne, Dept Resource Management & Geog, Richmond, Vic, Australia	James Cook University; Griffith University; University of Melbourne	Wardhaugh, CW (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Smithfield, Qld, Australia.	carl.wardhaugh@my.jcu.edu.au	Edwards, Will/M-6652-2015; Wardhaugh, Carl W/K-6474-2015; Edwards, Will/GRS-5509-2022	Edwards, Will/0000-0001-8981-7479; Wardhaugh, Carl W/0000-0002-1628-8163; Stork, Nigel/0000-0001-7812-2452	MTSRF grant; Skyrail Rainforest Foundation; Australian Postgraduate Award	MTSRF grant; Skyrail Rainforest Foundation; Australian Postgraduate Award(Australian Government)	Financial support for fieldwork was provided by a MTSRF grant. CWW was supported by a grant from the Skyrail Rainforest Foundation and an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Armbruster WS, 1997, ECOLOGY, V78, P1661; BASSET Y, 1991, OECOLOGIA, V87, P388, DOI 10.1007/BF00634596; BASSET Y, 1992, ECOL ENTOMOL, V17, P310, DOI 10.1111/j.1365-2311.1992.tb01063.x; Basset Y, 2001, OECOLOGIA, V129, P253, DOI 10.1007/s004420100724; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; Carisey N, 1997, ENTOMOL EXP APPL, V85, P17, DOI 10.1023/A:1003097429242; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Colwell RK, 2013, ESTIMATES STAT ESTIM; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Ellwood MDF, 2004, NATURE, V429, P549, DOI 10.1038/nature02560; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Feinstein J, 2007, BIOTROPICA, V39, P549, DOI 10.1111/j.1744-7429.2007.00279.x; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Frame D, 2003, TAXON, V52, P681, DOI 10.2307/3647343; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P189, DOI 10.1007/BF00936405; Gribel R, 1999, J TROP ECOL, V15, P247, DOI 10.1017/S0266467499000796; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grove SJ, 2000, INVERTEBR TAXON, V14, P733, DOI 10.1071/IT00023; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hammond Peter M., 1996, Ecotropica, V2, P99; Hopkins MS, 1996, J BIOGEOGR, V23, P737, DOI 10.1111/j.1365-2699.1996.tb00035.x; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Kitching RL, 2006, SCIENCE, V313, P1055, DOI 10.1126/science.1131117; Laidlaw M, 2007, AUSTRAL ECOL, V32, P10, DOI 10.1111/j.1442-9993.2007.01739.x; Lawrence JF., 2000, BEETLES WORLD; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; LOWMAN MD, 1992, ECOLOGY, V73, P129, DOI 10.2307/1938726; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Morais HC, 2009, BIOTROPICA, V41, P401, DOI 10.1111/j.1744-7429.2009.00534.x; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, ECOL LETT, V7, P1090, DOI 10.1111/j.1461-0248.2004.00666.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Odegaard F, 2004, ECOL ENTOMOL, V29, P76, DOI 10.1111/j.0307-6946.2004.00580.x; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Pratt PD, 2005, ECOL ENTOMOL, V30, P316, DOI 10.1111/j.0307-6946.2005.00691.x; REGAL PJ, 1977, SCIENCE, V196, P622, DOI 10.1126/science.196.4290.622; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; SIMPSON BB, 1981, ANN MO BOT GARD, V68, P301, DOI 10.2307/2398800; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; STORK NE, 1987, ECOL ENTOMOL, V12, P69, DOI 10.1111/j.1365-2311.1987.tb00986.x; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Stork NE, 2007, AUSTRAL ECOL, V32, P4, DOI 10.1111/j.1442-9993.2007.01740.x; Strauss SY, 1999, EVOLUTION, V53, P1105, DOI [10.2307/2640815, 10.1111/j.1558-5646.1999.tb04525.x]; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; Teichert H, 2011, PLANT SYST EVOL, V291, P25, DOI 10.1007/s00606-010-0367-1; THOMAS CD, 1990, ECOLOGY, V71, P610, DOI 10.2307/1940314; Tracey JG, 1982, VEGETATION HUMID TRO; van Dulmen A, 2001, PLANT ECOL, V153, P73, DOI 10.1023/A:1017577305193; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Walter DE, 1998, AUST J ECOL, V23, P501, DOI 10.1111/j.1442-9993.1998.tb00760.x; Wardhaugh CW, 2012, J ANIM ECOL, V81, P1086, DOI 10.1111/j.1365-2656.2012.01988.x; Wardhaugh CW, 2012, INSECT CONS IN PRESS	69	30	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45796	10.1371/journal.pone.0045796	http://dx.doi.org/10.1371/journal.pone.0045796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029246	gold, Green Accepted, Green Published			2022-12-27	WOS:000309388400131
J	Wolfe, AP; Csank, AZ; Reyes, AV; McKellar, RC; Tappert, R; Muehlenbachs, K				Wolfe, Alexander P.; Csank, Adam Z.; Reyes, Alberto V.; McKellar, Ryan C.; Tappert, Ralf; Muehlenbachs, Karlis			Pristine Early Eocene Wood Buried Deeply in Kimberlite from Northern Canada	PLOS ONE			English	Article							TREE-RING CELLULOSE; OXYGEN-ISOTOPE RATIOS; NORTHWEST-TERRITORIES; INFRARED-SPECTROSCOPY; THERMAL MAXIMUM; STABLE-ISOTOPES; EKATI PROPERTY; SLAVE CRATON; FOSSIL; HYDROGEN	We report exceptional preservation of fossil wood buried deeply in a kimberlite pipe that intruded northwestern Canada's Slave Province 53.3 +/- 0.6 million years ago (Ma), revealed during excavation of diamond source rock. The wood originated from forest surrounding the eruption zone and collapsed into the diatreme before resettling in volcaniclastic kimberlite to depths >300 m, where it was mummified in a sterile environment. Anatomy of the unpermineralized wood permits conclusive identification to the genus Metasequoia (Cupressaceae). The wood yields genuine cellulose and occluded amber, both of which have been characterized spectroscopically and isotopically. From cellulose delta O-18 and delta H-2 measurements, we infer that Early Eocene paleoclimates in the western Canadian subarctic were 12-17 degrees C warmer and four times wetter than present. Canadian kimberlites offer Lagerstatte-quality preservation of wood from a region with limited alternate sources of paleobotanical information.	[Wolfe, Alexander P.; McKellar, Ryan C.; Muehlenbachs, Karlis] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Csank, Adam Z.] Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK USA; [Reyes, Alberto V.] Univ Wisconsin, Dept Geosci, Madison, WI USA; [Tappert, Ralf] Univ Innsbruck, Inst Mineral & Petrog, A-6020 Innsbruck, Austria	University of Alberta; University of Alaska System; University of Alaska Anchorage; University of Wisconsin System; University of Wisconsin Madison; University of Innsbruck	Wolfe, AP (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada.	awolfe@ualberta.ca		Reyes, Alberto/0000-0002-7838-4214; Csank, Adam/0000-0002-7001-4470	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KB, 2006, GEOCHEM T, V7, P1, DOI 10.1186/1467-4866-7-2; Anderson WT, 2002, CHEM GEOL, V182, P121, DOI 10.1016/S0009-2541(01)00285-6; Ault AK, 2009, EARTH PLANET SC LETT, V284, P1, DOI 10.1016/j.epsl.2009.02.035; Birks SJ, 2003, CANADIAN NETWORK ISO; Byrne MC, 2005, THESIS MIT CAMBRIDGE; Chikaraishi Y, 2004, PHYTOCHEMISTRY, V65, P323, DOI 10.1016/j.phytochem.2003.12.003; Cookenboo HO, 1998, GEOLOGY, V26, P391, DOI 10.1130/0091-7613(1998)026<0391:ROPCOT>2.3.CO;2; Creaser RA, 2004, LITHOS, V76, P399, DOI 10.1016/j.lithos.2004.03.039; Doria G, 2011, AM J SCI, V311, P63, DOI 10.2475/01.2011.03; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; Edwards B, 1966, ECON GEOL, V61, P537; Environment Canada, 2009, NAT CLIM DAT INF ARC; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Gaudinski JB, 2005, ANAL CHEM, V77, P7212, DOI 10.1021/ac050548u; Gonzalez G, 2012, GEOPH RES ABSTR, V14; Greguss P., 1955, IDENTIFICATION LIVIN; Hudgins JW, 2003, NEW PHYTOL, V159, P677, DOI 10.1046/j.1469-8137.2003.00839.x; Jahren A.H., 2002, GEOLOGICAL SOC AM TO, V12, P4, DOI DOI 10.1130/1052-5173(2002)012%3C0004:EMWPRI%3E2.0.CO;2; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Kavanagh JL, 2009, EARTH PLANET SC LETT, V286, P404, DOI 10.1016/j.epsl.2009.07.011; KRAUSEL R., 1949, PALAEONTOGRAPHICA, V89B, P83; LEPAGE BA, 2005, TOPICS GEOBIOLOGY, V22; LIPP J, 1991, TELLUS B, V43, P322, DOI 10.1034/j.1600-0889.1991.t01-2-00005.x; McKellar RC, 2008, CAN J EARTH SCI, V45, P1061, DOI 10.1139/E08-049; Meijer JJF, 2000, REV PALAEOBOT PALYNO, V112, P297, DOI 10.1016/S0034-6667(00)00007-5; Nassichuk WW, 1995, NW TERRITORIES GEOLO, P109; Nowicki T, 2004, LITHOS, V76, P1, DOI 10.1016/j.lithos.2004.03.020; Otto A, 2007, BOT J LINN SOC, V154, P129, DOI 10.1111/j.1095-8339.2007.00638.x; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; RHOADS CA, 1987, INT J COAL GEOL, V8, P69, DOI 10.1016/0166-5162(87)90023-1; Richter SL, 2008, GEOCHIM COSMOCHIM AC, V72, P2744, DOI 10.1016/j.gca.2008.01.031; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; SMITH RMH, 1986, SEDIMENTOLOGY, V33, P369, DOI 10.1111/j.1365-3091.1986.tb00542.x; Stasiuk LD, 1999, INT J COAL GEOL, V40, P1, DOI 10.1016/S0166-5162(98)00053-6; Sternberg L.D.S.L., 1989, MODERN METHODS PLANT, P89, DOI 10.1007/978-3%2D642-83349-6%5F5; Sunderlin D, 2011, PALAIOS, V26, P335, DOI 10.2110/palo.2010.p10-077r; Tappert R, 2011, INT J PLANT SCI, V172, P120, DOI 10.1086/657277; Terinte N., 2011, LENZINGER BERICHTE, V89, P118, DOI DOI 10.1163/156856198X00740; Visscher GE, 2003, IAWA J, V24, P439, DOI 10.1163/22941932-90000348; West JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002447; Wilson L, 2007, NATURE, V447, P53, DOI 10.1038/nature05692; Wolfe AP, 2009, AM J BOT, V96, P487, DOI 10.3732/ajb.0800307; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	45	35	35	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45537	10.1371/journal.pone.0045537	http://dx.doi.org/10.1371/journal.pone.0045537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029080	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400101
J	Jallow, M; Casals-Pascual, C; Ackerman, H; Walther, B; Walther, M; Pinder, M; Sisay-Joof, F; Usen, S; Jallow, M; Abubakar, I; Olaosebikan, R; Jobarteh, A; Conway, DJ; Bojang, K; Kwiatkowski, D				Jallow, Muminatou; Casals-Pascual, Climent; Ackerman, Hans; Walther, Brigitte; Walther, Michael; Pinder, Margaret; Sisay-Joof, Fatou; Usen, Stanley; Jallow, Mariatou; Abubakar, Ismaela; Olaosebikan, Rasaq; Jobarteh, Aminata; Conway, David J.; Bojang, Kalifa; Kwiatkowski, Dominic			Clinical Features of Severe Malaria Associated with Death: A 13-Year Observational Study in The Gambia	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; AFRICAN CHILDREN; CEREBRAL MALARIA; TRANSMISSION; INDICATORS; MORBIDITY	Background: Severe malaria (SM) is a major cause of death in sub-Saharan Africa. Identification of both specific and sensitive clinical features to predict death is needed to improve clinical management. Methods: A 13-year observational study was conducted from 1997 through 2009 of 2,901 children with SM enrolled at the Royal Victoria Teaching Hospital in The Gambia to identify sensitive and specific predictors of poor outcome in Gambian children with severe malaria between the ages 4 months to 14 years. We have measured the sensitivity and specificity of clinical features that predict death or development of neurological sequelae. Findings: Impaired consciousness (odds ratio {OR} 4.4 [95% confidence interval {CI}, 2.7-7.3]), respiratory distress (OR 2.4 [95% CI, 1.7-3.2]), hypoglycemia (OR 1.7 [95%CI, 1.2-2.3]), jaundice (OR 1.9 [95%CI, 1.2-2.9]) and renal failure (OR 11.1 [95%CI, 3.3-36.5]) were independently associated with death in children with SM. The clinical features that showed the highest sensitivity and specificity to predict death were respiratory distress (area under the curve 0.63 [95% CI, 0.60-0.65]) and impaired consciousness (AUC 0.61[95% CI, 0.59-0.63]), which were comparable to the ability of hyperlactatemia (blood lactate>5 mM) to predict death (AUC 0.64 [95% CI, 0.55-0.72]). A Blantyre coma score (BCS) of 2 or less had a sensitivity of 74% and specificity of 67% to predict death (AUC 0.70 [95% C.I. 0.68-0.72]), and sensitivity and specificity of 74% and 69%, respectively to predict development of neurological sequelae (AUC 0.72 [95% CI, 0.67-0.76]). The specificity of this BCS threshold to identify children at risk of dying improved in children less than 3 years of age (AUC 0.74, [95% C.I 0.71-0.76]). Conclusion: The BCS is a quantitative predictor of death. A BCS of 2 or less is the most sensitive and specific clinical feature to predict death or development of neurological sequelae in children with SM.	[Casals-Pascual, Climent; Kwiatkowski, Dominic] Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Walther, Brigitte; Pinder, Margaret; Sisay-Joof, Fatou; Usen, Stanley; Abubakar, Ismaela; Olaosebikan, Rasaq; Jobarteh, Aminata; Bojang, Kalifa] MRC Labs, Malaria Programme, Banjul, Gambia; [Ackerman, Hans; Walther, Michael] NIAID, Lab Malaria & Vector Res, Rockville, MD USA; [Conway, David J.] London Sch Hyg & Trop Med, London WC1, England; [Jallow, Muminatou; Jallow, Mariatou] Royal Victoria Teaching Hosp, Banjul, Gambia	University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Casals-Pascual, C (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	ccasals@well.ox.ac.uk	Casals-Pascual, Climent/N-7692-2018; Ackerman, Hans/U-9621-2019	Casals-Pascual, Climent/0000-0002-0867-8954; Ackerman, Hans/0000-0003-4940-3305; Olaosebikan, Rasaq/0000-0002-3244-2212; Kwiatkowski, Dominic/0000-0002-5023-0176; Conway, David/0000-0002-8711-3037	Wellcome Trust [077383/Z/05/Z, 075491/Z/04]; Bill & Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health initiative [566]; Medical Research Council [G0701885]; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001150] Funding Source: NIH RePORTER; Medical Research Council [G19/9, MC_UP_A900_1118, MC_U190081993, G0600230, G0600718] Funding Source: researchfish; MRC [MC_UP_A900_1118, G19/9, G0600718, G0600230, G0701885, MC_U190081993] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Bill & Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust [grant number 077383/Z/05/Z] [grant number 075491/Z/04] and by the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (grant number 566) as part of the Grand Challenges in Global Health initiative. CC-P is supported by the Medical Research Council (Clinician Scientist Fellowship: G0701885). HA is supported by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newton CRJC, 2005, CLIN INFECT DIS, V41, P948, DOI 10.1086/432941; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, WHO CHILD GROWTH STA	22	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45645	10.1371/journal.pone.0045645	http://dx.doi.org/10.1371/journal.pone.0045645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029157	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000309973900049
J	Sangwan, N; Lata, P; Dwivedi, V; Singh, A; Niharika, N; Kaur, J; Anand, S; Malhotra, J; Jindal, S; Nigam, A; Lal, D; Dua, A; Saxena, A; Garg, N; Verma, M; Kaur, J; Mukherjee, U; Gilbert, JA; Dowd, SE; Raman, R; Khurana, P; Khurana, JP; Lal, R				Sangwan, Naseer; Lata, Pushp; Dwivedi, Vatsala; Singh, Amit; Niharika, Neha; Kaur, Jasvinder; Anand, Shailly; Malhotra, Jaya; Jindal, Swati; Nigam, Aeshna; Lal, Devi; Dua, Ankita; Saxena, Anjali; Garg, Nidhi; Verma, Mansi; Kaur, Jaspreet; Mukherjee, Udita; Gilbert, Jack A.; Dowd, Scot E.; Raman, Rajagopal; Khurana, Paramjit; Khurana, Jitendra P.; Lal, Rup			Comparative Metagenomic Analysis of Soil Microbial Communities across Three Hexachlorocyclohexane Contamination Levels	PLOS ONE			English	Article							GAMMA-HEXACHLOROCYCLOHEXANE; SPHINGOMONAS-PAUCIMOBILIS; LIN GENES; REDUCTIVE DECHLORINATION; BACTERIAL DIVERSITY; RAST SERVER; SP NOV.; DEGRADATION; HCH; SEQUENCE	This paper presents the characterization of the microbial community responsible for the in-situ bioremediation of hexachlorocyclohexane (HCH). Microbial community structure and function was analyzed using 16S rRNA amplicon and shotgun metagenomic sequencing methods for three sets of soil samples. The three samples were collected from a HCH-dumpsite (450 mg HCH/g soil) and comprised of a HCH/soil ratio of 0.45, 0.0007, and 0.00003, respectively. Certain bacterial; (Chromohalobacter, Marinimicrobium, Idiomarina, Salinosphaera, Halomonas, Sphingopyxis, Novosphingobium, Sphingomonas and Pseudomonas), archaeal; (Halobacterium, Haloarcula and Halorhabdus) and fungal (Fusarium) genera were found to be more abundant in the soil sample from the HCH-dumpsite. Consistent with the phylogenetic shift, the dumpsite also exhibited a relatively higher abundance of genes coding for chemotaxis/motility, chloroaromatic and HCH degradation (lin genes). Reassembly of a draft pangenome of Chromohalobacter salaxigenes sp. (similar to 8X coverage) and 3 plasmids (pISP3, pISP4 and pLB1; 13X coverage) containing lin genes/clusters also provides an evidence for the horizontal transfer of HCH catabolism genes.	[Sangwan, Naseer; Lata, Pushp; Dwivedi, Vatsala; Singh, Amit; Niharika, Neha; Kaur, Jasvinder; Anand, Shailly; Malhotra, Jaya; Jindal, Swati; Nigam, Aeshna; Lal, Devi; Dua, Ankita; Saxena, Anjali; Garg, Nidhi; Verma, Mansi; Kaur, Jaspreet; Mukherjee, Udita; Raman, Rajagopal; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Dowd, Scot E.] Mol Res LP, MR DNA, Shallowater, TX USA; [Khurana, Paramjit; Khurana, Jitendra P.] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi, India; [Khurana, Paramjit; Khurana, Jitendra P.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Delhi; United States Department of Energy (DOE); Argonne National Laboratory; University of Delhi; University of Delhi; University of Chicago	Lal, R (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	ruplal@gmail.com	Lal, Devi/GXN-0410-2022; Lal, Rup/AFP-1009-2022; Gilbert, Jack/AAF-3270-2019; Dowd, Scot E/M-5386-2017; Kaur, Jasvinder/ABQ-2529-2022	Dowd, Scot E/0000-0002-6296-1427; Kaur, Jasvinder/0000-0003-1163-5039; Kumar Singh, Amit/0000-0002-9517-7786; Lal, Devi/0000-0002-6480-4249; verma, mansi/0000-0003-3170-9576; Sangwan, Naseer/0000-0002-2407-769X	University of Delhi/Department of Science and Technology PURSE Program; Department of Biotechnology, Government of India [BT/PR3301/BCE/8/875/2011]; Application of microorganisms and allied sector [AMAAS/2006-07/NBAIM/CIR]; United States Department of Energy [DE-AC02-06CH11357]	University of Delhi/Department of Science and Technology PURSE Program; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Application of microorganisms and allied sector; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by grants under University of Delhi/Department of Science and Technology PURSE Program and grants from Department of Biotechnology, Government of India under project BT/PR3301/BCE/8/875/2011 and Application of microorganisms and allied sector F. No.AMAAS/2006-07/NBAIM/CIR. This work was also supported in part by the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barker MS, 2010, EVOL BIOINFORM, V6, P143, DOI 10.4137/EBO.S5861; Barker MS, 2009, BIOINFORMATICS, V25, P535, DOI 10.1093/bioinformatics/btp011; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Boltner D, 2005, ENVIRON MICROBIOL, V7, P1329, DOI 10.1111/j.1462-5822.2005.00820.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Canovas D, 1996, J BACTERIOL, V178, P7221, DOI 10.1128/jb.178.24.7221-7226.1996; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Ceremonie H, 2006, FEMS MICROBIOL LETT, V257, P243, DOI 10.1111/j.1574-6968.2006.00188.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cui ZJ, 2012, J BIOSCI BIOENG, V113, P765, DOI 10.1016/j.jbiosc.2012.01.006; Dadhwal M, 2009, J APPL MICROBIOL, V106, P381, DOI 10.1111/j.1365-2672.2008.03982.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dogra C, 2004, J BACTERIOL, V186, P2225, DOI 10.1128/JB.186.8.2225-2235.2004; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Endo R, 2007, J BACTERIOL, V189, P3712, DOI 10.1128/JB.01883-06; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jit S, 2011, ENVIRON SCI POLLUT R, V18, P586, DOI 10.1007/s11356-010-0401-4; Kalantzi OI, 2004, CARCINOGENESIS, V25, P613, DOI 10.1093/carcin/bgh048; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Kumari R, 2002, APPL ENVIRON MICROB, V68, P6021, DOI 10.1128/AEM.68.12.6021-6028.2002; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; Le Borgne S, 2008, J MOL MICROB BIOTECH, V15, P74, DOI 10.1159/000121323; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MACRAE IC, 1969, NATURE, V221, P859, DOI 10.1038/221859a0; Malhotra Shweta, 2007, Indian Journal of Microbiology, V47, P271, DOI 10.1007/s12088-007-0050-6; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Middeldorp PJM, 2005, BIODEGRADATION, V16, P283, DOI 10.1007/s10532-004-1573-8; Miyauchi K, 2002, APPL ENVIRON MICROB, V68, P1803, DOI 10.1128/AEM.68.4.1803-1807.2002; Miyazaki R, 2006, APPL ENVIRON MICROB, V72, P6923, DOI 10.1128/AEM.01531-06; Mohn WW, 2006, ENVIRON MICROBIOL, V8, P60, DOI 10.1111/j.1462-2920.2005.00865.x; Mwangi K, 2010, AFR J MICROBIOL RES, V4, P185; Nagata Y, 2006, FEMS MICROBIOL LETT, V256, P112, DOI 10.1111/j.1574-6968.2005.00096.x; Nagata Y, 2011, ENZYME MICROB TECH, V49, P499, DOI 10.1016/j.enzmictec.2011.10.005; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Phillips TM, 2005, BIODEGRADATION, V16, P363, DOI 10.1007/s10532-004-2413-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raina V, 2008, BIODEGRADATION, V19, P27, DOI 10.1007/s10532-007-9112-z; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Sagar V, 2011, WORLD J MICROB BIOT, V27, P1747, DOI 10.1007/s11274-010-0628-8; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Siddique T, 2003, J ENVIRON QUAL, V32, P47, DOI 10.2134/jeq2003.0047; Suar M, 2005, APPL ENVIRON MICROB, V71, P8514, DOI 10.1128/AEM.71.12.8514-8518.2005; Tabata M, 2011, BIOSCI BIOTECH BIOCH, V75, P466, DOI 10.1271/bbb.100652; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Doesburg W, 2005, FEMS MICROBIOL ECOL, V54, P87, DOI 10.1016/j.femsec.2005.03.003; Vega FA, 2007, J ENVIRON QUAL, V36, P272, DOI 10.2134/jeq2006.0053; Vijgen J., 2006, LEGACY LINDANE HCH I; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Walker A, 2001, ENVIRON POLLUT, V111, P407, DOI 10.1016/S0269-7491(00)00092-0; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	75	66	69	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46219	10.1371/journal.pone.0046219	http://dx.doi.org/10.1371/journal.pone.0046219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029440	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900110
J	Mi, T; Rajasekaran, S; Merlin, JC; Gryk, M; Schiller, MR				Mi, Tian; Rajasekaran, Sanguthevar; Merlin, Jerlin Camilus; Gryk, Michael; Schiller, Martin R.			Achieving High Accuracy Prediction of Minimotifs	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LINEAR MOTIF RESOURCE; SEQUENCE MOTIFS; WIDE PREDICTION; TOOL; PROTEINS; DATABASE; SEARCH; SITES; MINER	The low complexity of minimotif patterns results in a high false-positive prediction rate, hampering protein function prediction. A multi-filter algorithm, trained and tested on a linear regression model, support vector machine model, and neural network model, using a large dataset of verified minimotifs, vastly improves minimotif prediction accuracy while generating few false positives. An optimal threshold for the best accuracy reaches an overall accuracy above 90%, while a stringent threshold for the best specificity generates less than 1% false positives or even no false positives and still produces more than 90% true positives for the linear regression and neural network models. The minimotif multi-filter with its excellent accuracy represents the state-of-the-art in minimotif prediction and is expected to be very useful to biologists investigating protein function and how missense mutations cause disease.	[Mi, Tian; Rajasekaran, Sanguthevar; Merlin, Jerlin Camilus] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Gryk, Michael] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Connecticut; University of Connecticut; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Rajasekaran, S (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	rajasek@engr.uconn.edu; martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, LM010101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health [GM079689 to M. R. S., LM010101 to S. R.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; BARTON GJ, 1994, TRENDS BIOCHEM SCI, V19, P554, DOI 10.1016/0968-0004(94)90060-4; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Davey NE, 2010, FRONT BIOSCI-LANDMRK, V15, P801, DOI 10.2741/3647; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Kamath U, 2012, IEEE ACM T IN PRESS; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mukherjee D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/498031; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Vapnik N, 1963, AUTOMAT REM CONTR, V24, P774; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Wang X, 2012, PROTEIN PEPTIDE LETT, V19, P559, DOI 10.2174/092986612800191017; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhao XW, 2012, INT J MOL SCI, V13, P2196, DOI 10.3390/ijms13022196	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45589	10.1371/journal.pone.0045589	http://dx.doi.org/10.1371/journal.pone.0045589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029121	Green Published, gold			2022-12-27	WOS:000309517500035
J	Le Guillou, S; Sdassi, N; Laubier, J; Passet, B; Vilotte, M; Castille, J; Laloe, D; Polyte, J; Bouet, S; Jaffrezic, F; Cribiu, EP; Vilotte, JL; Le Provost, F				Le Guillou, Sandrine; Sdassi, Nezha; Laubier, Johann; Passet, Bruno; Vilotte, Marthe; Castille, Johan; Laloe, Denis; Polyte, Jacqueline; Bouet, Stephan; Jaffrezic, Florence; Cribiu, Edmond-Paul; Vilotte, Jean-Luc; Le Provost, Fabienne			Overexpression of miR-30b in the Developing Mouse Mammary Gland Causes a Lactation Defect and Delays Involution	PLOS ONE			English	Article							STEM-CELL ANTIGEN-1; DOWN-REGULATION; MESSENGER-RNA; CANCER-CELLS; MESENCHYMAL TRANSITION; TRANSGENIC MICE; FAMILY-MEMBERS; KNOCKOUT MICE; EXPRESSION; MICRORNAS	Background: MicroRNA (miRNA) are negative regulators of gene expression, capable of exerting pronounced influences upon the translation and stability of mRNA. They are potential regulators of normal mammary gland development and of the maintenance of mammary epithelial progenitor cells. This study was undertaken to determine the role of miR-30b on the establishment of a functional mouse mammary gland. miR-30b is a member of the miR-30 family, composed of 6 miRNA that are highly conserved in vertebrates. It has been suggested to play a role in the differentiation of several cell types. Methodology/Principal Findings: The expression of miR-30b was found to be regulated during mammary gland development. Transgenic mice overexpressing miR-30b in mammary epithelial cells were used to investigate its role. During lactation, mammary histological analysis of the transgenic mice showed a reduction in the size of alveolar lumen, a defect of the lipid droplets and a growth defect of pups fed by transgenic females. Moreover some mammary epithelial differentiated structures persisted during involution, suggesting a delay in the process. The genes whose expression was affected by the overexpression of miR-30b were characterized by microarray analysis. Conclusion/ Significance: Our data suggests that miR-30b is important for the biology of the mammary gland and demonstrates that the deregulation of only one miRNA could affect lactation and involution.	[Le Guillou, Sandrine; Sdassi, Nezha; Laubier, Johann; Passet, Bruno; Vilotte, Marthe; Castille, Johan; Laloe, Denis; Polyte, Jacqueline; Bouet, Stephan; Jaffrezic, Florence; Cribiu, Edmond-Paul; Vilotte, Jean-Luc; Le Provost, Fabienne] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Le Provost, F (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	Fabienne.LeProvost@jouy.inra.fr	Vilotte, Jean-Luc/AAF-4688-2019; Laloe, Denis/O-7045-2019	Laloe, Denis/0000-0001-8359-0760				Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batts TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027841; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bockmeyer CL, 2011, METHODS MOL BIOL, V755, P85, DOI 10.1007/978-1-61779-163-5_7; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kho Y, 2008, BIOSCI BIOTECH BIOCH, V72, P70, DOI 10.1271/bbb.70374; Lambert AW, 2012, ONCOL; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Lu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006159; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond K, 2012, SEMIN CELL DEV BIOL; Saidi S, 2007, GENE, V401, P97, DOI 10.1016/j.gene.2007.06.023; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VALIVULLAH HM, 1986, INT J BIOCHEM, V18, P799, DOI 10.1016/0020-711X(86)90056-X; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	64	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45727	10.1371/journal.pone.0045727	http://dx.doi.org/10.1371/journal.pone.0045727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029204	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700062
J	Logge, W; Cheng, D; Chesworth, R; Bhatia, S; Garner, B; Kim, WS; Karl, T				Logge, Warren; Cheng, David; Chesworth, Rose; Bhatia, Surabhi; Garner, Brett; Kim, Woojin Scott; Karl, Tim			Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases	PLOS ONE			English	Article							CASSETTE TRANSPORTER A7; NEUREGULIN-1 MUTANT MICE; HIGH-DENSITY-LIPOPROTEIN; OBJECT RECOGNITION; ALZHEIMERS-DISEASE; CELLULAR CHOLESTEROL; PREPULSE INHIBITION; AMYLOID DEPOSITION; KNOCKOUT MICE; MEMORY	ATP-binding cassette transporters of the subfamily A (ABCA) are responsible for the translocation of lipids including cholesterol, which is crucial for neurological function. Recent studies suggest that the ABC transporter ABCA7 may play a role in the development of brain disorders such as schizophrenia and Alzheimer's disease. However, Abca7's role in cognition and other behaviours has not been investigated. Therefore, we characterised homozygous Abca7 knockout mice in a battery of tests for baseline behaviours (i.e. physical exam, baseline locomotion and anxiety) and behaviours relevant to schizophrenia (i.e. prepulse inhibition and locomotor response to psychotropic drugs) and Alzheimer's disease (i.e. cognitive domains). Knockout mice had normal motor functions and sensory abilities and performed the same as wild type-like animals in anxiety tasks. Short-term spatial memory and fear-associated learning was also intact in Abca7 knockout mice. However, male knockout mice exhibited significantly impaired novel object recognition memory. Task acquisition was unaffected in the cheeseboard task. Female mice exhibited impaired spatial reference memory. This phenomenon was more pronounced in female Abca7 null mice. Acoustic startle response, sensorimotor gating and baseline locomotion was unaltered in Abca7 knockout mice. Female knockouts showed a moderately increased motor response to MK-801 than control mice. In conclusion, Abca7 appears to play only a minor role in behavioural domains with a subtle sex-specific impact on particular cognitive domains.	[Logge, Warren; Cheng, David; Chesworth, Rose; Bhatia, Surabhi; Garner, Brett; Kim, Woojin Scott; Karl, Tim] Neurosci Res Australia, Randwick, NSW, Australia; [Cheng, David; Bhatia, Surabhi; Kim, Woojin Scott; Karl, Tim] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Logge, Warren; Chesworth, Rose; Karl, Tim] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Karl, Tim] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Wollongong; University of Wollongong; University of New South Wales Sydney	Karl, T (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	t.karl@neura.edu.au	Karl, Tim/E-2088-2011	Karl, Tim/0000-0001-9904-8482; Chesworth, Rose/0000-0002-3758-9598; Logge, Warren/0000-0003-0777-3033	National Health and Medical Research Council (NHMRC) [510148]; Schizophrenia Research Institute (SRI); New South Wales Health; National Health and Medical Research Council Career Development Award [568752]; National Alliance for Research on Schizophrenia and Depression (Young Investigator Award); Motor Neuron Disease Research Institute of Australia; Australian Research Council [FT0991986]; National Health and Medical Research Council [1003886, 630445]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health; National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); National Alliance for Research on Schizophrenia and Depression (Young Investigator Award)(NARSAD); Motor Neuron Disease Research Institute of Australia; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a project grant to BG from the National Health and Medical Research Council (NHMRC: 510148) and the Schizophrenia Research Institute (SRI) utilizing infrastructure funding from New South Wales Health. TK is supported by a National Health and Medical Research Council Career Development Award (568752), by the National Alliance for Research on Schizophrenia and Depression (Young Investigator Award), and the Motor Neuron Disease Research Institute of Australia. BG is supported by a Fellowship from the Australian Research Council (FT0991986) and is an honorary National Health and Medical Research Council Senior Research Fellow (630445). BG and TK are also supported by a National Health and Medical Research Council project grant (1003886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Bimonte HA, 2000, PHYSIOL BEHAV, V70, P311, DOI 10.1016/S0031-9384(00)00259-6; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Bryan KJ, 2009, FRONT NEUROSCI, P1; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chen XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006875; Chesworth R, 2012, BEHAV BRAIN RES, V226, P218, DOI 10.1016/j.bbr.2011.09.019; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; D'Souza DN, 2002, J APPL PHYSIOL, V92, P493, DOI 10.1152/japplphysiol.00565.2001; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Frick KM, 2000, NEUROSCIENCE, V95, P293; Geyer MA, 2003, CURR PROTOC NEUROSCI; Ghi P, 1999, PHARMACOL BIOCHEM BE, V64, P761, DOI 10.1016/S0091-3057(99)00143-4; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Harburger LL, 2008, BEHAV BRAIN RES, V194, P174, DOI 10.1016/j.bbr.2008.07.014; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V273, P532, DOI 10.1006/bbrc.2000.2954; Karasinska JM, 2009, J NEUROSCI, V29, P3579, DOI 10.1523/JNEUROSCI.4741-08.2009; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karl T, 2012, BEHAV BRAIN RES, V228, P392, DOI 10.1016/j.bbr.2011.12.021; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; Kim WS, 2008, J NEUROCHEM, V104, P1145, DOI 10.1111/j.1471-4159.2007.05099.x; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Lopez LL, 2010, BEHAV BRAIN RES, V209, P85, DOI 10.1016/j.bbr.2010.01.020; Nie T, 2001, BEHAV NEUROSCI, V115, P951, DOI 10.1037//0735-7044.115.4.951; Parkinson PF, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-5; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274, DOI 10.5551/jat.6726; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200	54	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45959	10.1371/journal.pone.0045959	http://dx.doi.org/10.1371/journal.pone.0045959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029339	gold, Green Published			2022-12-27	WOS:000309554700096
J	Oliveira, JM; Segurado, P; Santos, JM; Teixeira, A; Ferreira, MT; Cortes, RV				Oliveira, Joao M.; Segurado, Pedro; Santos, Jose M.; Teixeira, Amilcar; Ferreira, Maria T.; Cortes, Rui V.			Modelling Stream-Fish Functional Traits in Reference Conditions: Regional and Local Environmental Correlates	PLOS ONE			English	Article							FRESH-WATER FISH; TROUT SALMO-TRUTTA; SEINE RIVER-BASIN; ASSEMBLAGE STRUCTURE; SPECIES RICHNESS; LAND-USE; TERRESTRIAL INVERTEBRATES; LONGITUDINAL PATTERNS; RELATIVE INFLUENCES; COMMUNITY STRUCTURE	Identifying the environmental gradients that control the functional structure of biological assemblages in reference conditions is fundamental to help river management and predict the consequences of anthropogenic stressors. Fish metrics (density of ecological guilds, and species richness) from 117 least disturbed stream reaches in several western Iberia river basins were modelled with generalized linear models in order to investigate the importance of regional-and local-scale abiotic gradients to variation in functional structure of fish assemblages. Functional patterns were primarily associated with regional features, such as catchment elevation and slope, rainfall, and drainage area. Spatial variations of fish guilds were thus associated with broad geographic gradients, showing (1) pronounced latitudinal patterns, affected mainly by climatic factors and topography, or (2) at the basin level, strong upstream-downstream patterns related to stream position in the longitudinal gradient. Maximum native species richness was observed in midsize streams in accordance with the river continuum concept. The findings of our study emphasized the need to use a multi-scale approach in order to fully assess the factors that govern the functional organization of biotic assemblages in 'natural' streams, as well as to improve biomonitoring and restoration of fluvial ecosystems.	[Oliveira, Joao M.; Cortes, Rui V.] Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal; [Oliveira, Joao M.; Segurado, Pedro; Santos, Jose M.; Ferreira, Maria T.] Univ Tecn Lisboa, CEF, P-1100 Lisbon, Portugal; [Teixeira, Amilcar] Inst Politecn Braganca, Ctr Invest Montanha CIMO, Escola Super Agr, Braganca, Portugal	University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Instituto Politecnico de Braganca	Oliveira, JM (corresponding author), Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal.	jmoliveira@utad.pt	Ferreira, Teresa/C-9785-2012; Oliveira, João M./ADT-6348-2022; Segurado, Pedro/A-1145-2011; Oliveira, João M./K-3130-2013; Santos, José Maria/F-9022-2010; Cortes, Rui Manuel Vitor/K-1896-2013	Ferreira, Teresa/0000-0002-3900-1460; Oliveira, João M./0000-0002-7048-5096; Segurado, Pedro/0000-0002-5917-7893; Oliveira, João M./0000-0002-7048-5096; Santos, José Maria/0000-0003-1232-2560; Cortes, Rui Manuel Vitor/0000-0002-8602-7663; Teiga Teixeira, Amilcar Antonio/0000-0001-5336-1174	National Forest Authority (AFN) under project AQUARIPORT; Foundation for Science and Technology (FCT) [SFRH/BPD/44624/2008, SFRH/BPD/39067/2007]	National Forest Authority (AFN) under project AQUARIPORT; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financially supported by the National Forest Authority (AFN) (http://www.afn.min-agricultura.pt) under project AQUARIPORT, and post-doctoral grants from the Foundation for Science and Technology (FCT) (http://www.fct.pt) (JMO - SFRH/BPD/44624/2008; PS - SFRH/BPD/39067/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts BGW, 2003, HYDROBIOLOGIA, V500, P157, DOI 10.1023/A:1024638726162; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Allan JD, 2003, CAN J FISH AQUAT SCI, V60, P309, DOI 10.1139/F03-019; [Anonymous], 2010, R LANG ENV STAT COMP; BALON EK, 1986, ENVIRON BIOL FISH, V15, P243; Belliard J, 1997, ENVIRON BIOL FISH, V50, P133, DOI 10.1023/A:1007353527126; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carmona JA, 1999, ENVIRON BIOL FISH, V54, P371, DOI 10.1023/A:1007535200837; CEN (Comite Europeen de Normalisation), 2003, 140112003E CEN EN; Chappaz R, 1996, HYDROBIOLOGIA, V331, P63, DOI 10.1007/BF00025408; Clavero M, 2005, AQUAT CONSERV, V15, P415, DOI 10.1002/aqc.679; Coelho M.M., 1997, Fisheries Management and Ecology, V4, P83, DOI 10.1046/j.1365-2400.1997.d01-165.x; Doadrio I., 2002, ATLAS LIBRO ROJO PEC; ELLIOTT JM, 1975, J ANIM ECOL, V44, P823, DOI 10.2307/3721; Esselman PC, 2010, ECOL FRESHW FISH, V19, P439, DOI 10.1111/j.1600-0633.2010.00430.x; Fame Consortium, 2005, MAN APPL EUR FISH IN; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Ferreira MT, 2007, ECOL FRESHW FISH, V16, P504, DOI 10.1111/j.1600-0633.2007.00241.x; Ferreira T, 2007, FISHERIES MANAG ECOL, V14, P519, DOI 10.1111/j.1365-2400.2007.00581.x; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gehrke PC, 2000, MAR FRESHWATER RES, V51, P165, DOI 10.1071/MF99061; Gido KB, 2006, AM FISH S S, V48, P265; Godinho FN, 1998, ENVIRON BIOL FISH, V51, P41, DOI 10.1023/A:1007412714605; Goldstein RM, 2005, N AM J FISH MANAGE, V25, P180, DOI 10.1577/M04-042.1; Goldstein RM, 2004, T AM FISH SOC, V133, P971, DOI 10.1577/T03-080.1; Grant EHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034170; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; Grubaugh JW, 1996, CAN J FISH AQUAT SCI, V53, P896, DOI 10.1139/cjfas-53-4-896; Higgins CL, 2009, AQUAT ECOL, V43, P1133, DOI 10.1007/s10452-009-9233-z; Hoeinghaus DJ, 2007, J BIOGEOGR, V34, P324, DOI 10.1111/j.1365-2699.2006.01587.x; HORWITZ RJ, 1978, ECOL MONOGR, V48, P307, DOI 10.2307/2937233; Huet M., 1949, Schweizerische Zeitschrift fuer Hydrologie Basle, V11, P332, DOI 10.1007/BF02503356; Hynes H., 1975, INT VER THEOR ANGEW, V19, P1, DOI DOI 10.1080/03680770.1974.11896033; Ibanez C, 2009, ECOGRAPHY, V32, P658, DOI 10.1111/j.1600-0587.2008.05591.x; INAG, 2008, MAN AV BIOL QUAL AG; JACKSON DA, 1989, ECOLOGY, V70, P1472, DOI 10.2307/1938206; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Lasne E, 2007, RIVER RES APPL, V23, P877, DOI 10.1002/rra.1030; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Logez M, 2010, J N AM BENTHOL SOC, V29, P1310, DOI 10.1899/09-125.1; MAGALHAES MF, 1993, OECOLOGIA, V96, P253, DOI 10.1007/BF00317739; Magalhaes MF, 2002, FRESHWATER BIOL, V47, P1015, DOI 10.1046/j.1365-2427.2002.00830.x; Marsh-Matthews E, 2000, ECOL FRESHW FISH, V9, P9, DOI 10.1034/j.1600-0633.2000.90103.x; MASON CF, 1982, FRESHWATER BIOL, V12, P305, DOI 10.1111/j.1365-2427.1982.tb00624.x; Matthews W. J., 1998, PATTERNS FRESHWATER; McCullagh P, 1989, GEN LINEAR MODELS; McGarvey DJ, 2008, FRESHWATER BIOL, V53, P2206, DOI 10.1111/j.1365-2427.2008.02046.x; McGarvey DJ, 2008, COPEIA, P311, DOI 10.1643/CE-07-020; MCNEELY DL, 1986, SOUTHWEST NAT, V31, P375, DOI 10.2307/3671842; Melcher A, 2007, FISHERIES MANAG ECOL, V14, P453, DOI 10.1111/j.1365-2400.2007.00583.x; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Noble RAA, 2007, FISHERIES MANAG ECOL, V14, P381, DOI 10.1111/j.1365-2400.2007.00575.x; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; OBERDORFF T, 1993, HYDROBIOLOGIA, V259, P157, DOI 10.1007/BF00006595; Oliveira JM, 2009, N AM J FISH MANAGE, V29, P1466, DOI 10.1577/M08-175.1; Pires AM, 1999, J FISH BIOL, V54, P235; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Pont D, 2007, FISHERIES MANAG ECOL, V14, P427, DOI 10.1111/j.1365-2400.2007.00577.x; Pont D, 2006, J APPL ECOL, V43, P70, DOI 10.1111/j.1365-2664.2005.01126.x; Pont D, 2005, CAN J FISH AQUAT SCI, V62, P163, DOI 10.1139/F04-183; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Pouilly M, 2006, J FISH BIOL, V68, P137, DOI 10.1111/j.0022-1112.2006.00883.x; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Pusey BJ, 1996, MAR FRESHWATER RES, V47, P563, DOI 10.1071/MF9960563; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quist MC, 2004, CAN J ZOOL, V82, P1554, DOI [10.1139/z04-134, 10.1139/Z04-134]; Ribeiro F, 2009, FISHERIES MANAG ECOL, V16, P255, DOI 10.1111/j.1365-2400.2009.00659.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rivas-Martinez S., 2004, BIOBLIMATIC MAP EURO; RIVAS-MARTINEZ S., 1996, FOLIA BOT MATRITENSI, V16, P1; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Roset N, 2007, FISHERIES MANAG ECOL, V14, P393, DOI 10.1111/j.1365-2400.2007.00589.x; Sandin L, 2009, FUND APPL LIMNOL, V174, P75, DOI 10.1127/1863-9135/2009/0174-0075; Santos JM, 2011, AQUAT SCI, V73, P233, DOI 10.1007/s00027-010-0172-5; Schlosser I.J., 1987, P17; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Smith K. G., 2006, STATUS DISTRIBUTION; Stanford JA, 1996, REGUL RIVER, V12, P391, DOI 10.1002/(SICI)1099-1646(199607)12:4/5&lt;391::AID-RRR436&gt;3.0.CO;2-4; Tomanova S, 2007, FUND APPL LIMNOL, V170, P233, DOI 10.1127/1863-9135/2007/0170-0233; Vadas RL, 2001, T AM FISH SOC, V130, P217, DOI 10.1577/1548-8659(2001)130<0217:FOHSMF>2.0.CO;2; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters DM, 2003, FRESHWATER BIOL, V48, P1950, DOI 10.1046/j.1365-2427.2003.01137.x; Wang LZ, 2003, CAN J FISH AQUAT SCI, V60, P491, DOI 10.1139/F03-043; Wang LZ, 2002, J AM WATER RESOUR AS, V38, P663, DOI 10.1111/j.1752-1688.2002.tb00988.x; Warren C.E., 1971, BIOL WATER POLLUTION; [No title captured]; [No title captured]	91	30	30	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45787	10.1371/journal.pone.0045787	http://dx.doi.org/10.1371/journal.pone.0045787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029242	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700073
J	Svistounov, D; Warren, A; McNerney, GP; Owen, DM; Zencak, D; Zykova, SN; Crane, H; Huser, T; Quinn, RJ; Smedsrod, B; Le Couteur, DG; Cogger, VC				Svistounov, Dmitri; Warren, Alessandra; McNerney, Gregory P.; Owen, Dylan M.; Zencak, Dusan; Zykova, Svetlana N.; Crane, Harry; Huser, Thomas; Quinn, Ronald J.; Smedsrod, Bard; Le Couteur, David G.; Cogger, Victoria C.			The Relationship between Fenestrations, Sieve Plates and Rafts in Liver Sinusoidal Endothelial Cells	PLOS ONE			English	Article							ACTIN MICROFILAMENTS; MEMBRANE RAFTS; GROWTH-FACTOR; LINE TENSION; LIPID RAFTS; RAT-LIVER; CYTOSKELETON; CAVEOLIN-1; AGE; PERMEABILITY	Fenestrations are transcellular pores in endothelial cells that facilitate transfer of substrates between blood and the extravascular compartment. In order to understand the regulation and formation of fenestrations, the relationship between membrane rafts and fenestrations was investigated in liver sinusoidal endothelial cells where fenestrations are grouped into sieve plates. Three dimensional structured illumination microscopy, scanning electron microscopy, internal reflectance fluorescence microscopy and two-photon fluorescence microscopy were used to study liver sinusoidal endothelial cells isolated from mice. There was an inverse distribution between sieve plates and membrane rafts visualized by structured illumination microscopy and the fluorescent raft stain, Bodipy FL C5 ganglioside GM1. 7-ketocholesterol and/or cytochalasin D increased both fenestrations and lipid-disordered membrane, while Triton X-100 decreased both fenestrations and lipid-disordered membrane. The effects of cytochalasin D on fenestrations were abrogated by co-administration of Triton X-100, suggesting that actin disruption increases fenestrations by its effects on membrane rafts. Vascular endothelial growth factor (VEGF) depleted lipid-ordered membrane and increased fenestrations. The results are consistent with a sieve-raft interaction, where fenestrations form in non-raft lipid-disordered regions of endothelial cells once the membrane-stabilizing effects of actin cytoskeleton and membrane rafts are diminished.	[Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; [Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, ANZAC Med Res Inst, Sydney, NSW 2006, Australia; [Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Concord Hosp, Sydney, NSW, Australia; [McNerney, Gregory P.; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Owen, Dylan M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Zencak, Dusan; Quinn, Ronald J.] Griffith Univ, Eskitis Inst, Brisbane, Qld 4111, Australia; [Smedsrod, Bard] Univ Tromso, Dept Med Biol, Tromso, Norway	University of Sydney; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; National Science Foundation (NSF); University of California System; University of California Davis; University of New South Wales Sydney; Griffith University; UiT The Arctic University of Tromso	Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.	david.lecouteur@sydney.edu.au	Huser, Thomas/K-7291-2019; Quinn, Ronald J/A-7931-2008; Research Institute, ANZAC/CAE-9030-2022; Zencak, Dusan/K-8383-2012	Huser, Thomas/0000-0003-2348-7416; Quinn, Ronald J/0000-0002-4022-2623; Le Couteur, David/0000-0002-4227-5817; Crane, Harry/0000-0001-5001-3123	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney); National Health and Medical Research Foundation of Australia [570937]; Tromso, Research Foundation	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney); National Health and Medical Research Foundation of Australia(National Health and Medical Research Council (NHMRC) of Australia); Tromso, Research Foundation	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney http://www.cera.usyd.edu.au/news_aarf.html), National Health and Medical Research Foundation of Australia (nhmrc.gov.au grant number 570937) and the Tromso, Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicout DJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.060101; Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635; Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387; Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008; Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; Funyu J, 2001, BIOCHEM BIOPH RES CO, V280, P481, DOI 10.1006/bbrc.2000.4148; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937; Kahn E, 2011, CYTOM PART A, V79A, P293, DOI 10.1002/cyto.a.21017; Kahn E, 2010, INT J NANOMED, V5, P185; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004; Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553; Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loison C, 2004, J CHEM PHYS, V121, P1890, DOI 10.1063/1.1752884; Mrowczynska L, 2011, CELL BIOL INT, V35, P991, DOI 10.1042/CBI20100786; O'Reilly JN, 2010, J ELECTRON MICROSC, V59, P65, DOI 10.1093/jmicro/dfp039; Owen DM, 2010, IMMUNOLOGY, V131, P1, DOI 10.1111/j.1365-2567.2010.03319.x; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rubtsova SN, 1998, FEBS LETT, V430, P353, DOI 10.1016/S0014-5793(98)00692-9; STEFFAN AM, 1987, HEPATOLOGY, V7, P1230, DOI 10.1002/hep.1840070610; Vind-Kezunovic D, 2008, BBA-BIOMEMBRANES, V1778, P2480, DOI 10.1016/j.bbamem.2008.05.015; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Warren A, 2010, MICROCIRCULATION, V17, P32, DOI 10.1111/j.1549-8719.2009.00004.x; Yokomori H, 2004, LAB INVEST, V84, P857, DOI 10.1038/labinvest.3700114; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x; Yokomori H, 2001, LIVER, V21, P198, DOI 10.1034/j.1600-0676.2001.021003198.x	36	55	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46134	10.1371/journal.pone.0046134	http://dx.doi.org/10.1371/journal.pone.0046134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029409	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700117
J	Boddy, LM; Thomas, NE; Fairclough, SJ; Tolfrey, K; Brophy, S; Rees, A; Knox, G; Baker, JS; Stratton, G				Boddy, Lynne M.; Thomas, Non E.; Fairclough, Stuart J.; Tolfrey, Keith; Brophy, Sinead; Rees, Anwen; Knox, Gareth; Baker, Julien S.; Stratton, Gareth			ROC Generated Thresholds for Field-Assessed Aerobic Fitness Related to Body Size and Cardiometabolic Risk in Schoolchildren	PLOS ONE			English	Article							METABOLIC RISK; CHILDREN; FATNESS; OBESITY; ADOLESCENTS; CHILDHOOD; WORLDWIDE	Objectives: 1. to investigate whether 20 m multi-stage shuttle run performance (20mSRT), an indirect measure of aerobic fitness, could discriminate between healthy and overweight status in 9-10.9 yr old schoolchildren using Receiver Operating Characteristic (ROC) analysis; 2. Investigate if cardiometabolic risk differed by aerobic fitness group by applying the ROC cut point to a second, cross-sectional cohort. Design: Analysis of cross-sectional data. Participants: 16,619 9-10.9 year old participants from SportsLinx project and 300 11-13.9 year old participants from the Welsh Schools Health and Fitness Study. Outcome Measures: SportsLinx; 20mSRT, body mass index (BMI), waist circumference, subscapular and superilliac skinfold thicknesses. Welsh Schools Health and Fitness Study; 20mSRT performance, waist circumference, and clustered cardiometabolic risk. Analyses: Three ROC curve analyses were completed, each using 20mSRT performance with ROC curve 1 related to BMI, curve 2 was related to waist circumference and 3 was related to skinfolds (estimated % body fat). These were repeated for both girls and boys. The mean of the three aerobic fitness thresholds was retained for analysis. The thresholds were subsequently applied to clustered cardiometabolic risk data from the Welsh Schools study to assess whether risk differed by aerobic fitness group. Results: The diagnostic accuracy of the ROC generated thresholds was higher than would be expected by chance (all models AUC>0.7). The mean thresholds were 33 and 25 shuttles for boys and girls respectively. Participants classified as 'fit' had significantly lower cardiometabolic risk scores in comparison to those classed as unfit (p<0.001). Conclusion: The use of the ROC generated cut points by health professionals, teachers and coaches may provide the opportunity to apply population level 'risk identification and stratification' processes and plan for "at-risk" children to be referred onto intervention services.	[Boddy, Lynne M.; Fairclough, Stuart J.; Stratton, Gareth] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Thomas, Non E.; Brophy, Sinead] Swansea Univ, Coll Human & Hlth Sci, Ctr Children & Young Peoples Well Being, Swansea, W Glam, Wales; [Tolfrey, Keith] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Leicester, Leics, England; [Rees, Anwen; Knox, Gareth] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff, S Glam, Wales; [Knox, Gareth] Univ W England, Hartpury Coll, Dept Business & Appl Sport Sci, Gloucester, England; [Stratton, Gareth] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Stratton, Gareth] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA 6009, Australia	Liverpool John Moores University; Swansea University; Loughborough University; Cardiff Metropolitan University; University of West England; Swansea University; University of Western Australia	Boddy, LM (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England.	L.M.Boddy@ljmu.ac.uk	Fairclough, Stuart/AAE-8512-2020; Fairclough, Stuart/F-8900-2015; stratton, Gareth/Z-5471-2019	Fairclough, Stuart/0000-0001-8358-1979; Fairclough, Stuart/0000-0001-8358-1979; stratton, Gareth/0000-0001-5618-0803; Brophy, Sinead/0000-0001-7417-2858; Tolfrey, Keith/0000-0001-6269-1538; Boddy, Lynne/0000-0002-7477-4389	Liverpool John Moores University; Liverpool City Council; Liverpool Primary Care Trust; National Institute for Social Care and Health Research within the Welsh Assembly Government.; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI	Liverpool John Moores University; Liverpool City Council; Liverpool Primary Care Trust; National Institute for Social Care and Health Research within the Welsh Assembly Government.; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The SportsLinx study was funded by Liverpool John Moores University, Liverpool City Council, and Liverpool Primary Care Trust. The Welsh Schools Health and Fitness study was funded by the National Institute for Social Care and Health Research within the Welsh Assembly Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 1998, EUROFIT EUROPEAN TES; Adegboye ARA, 2011, BRIT J SPORT MED, V45, P722, DOI 10.1136/bjsm.2009.068346; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; Berthoin S., 2010, CHILDREN EXERCISE 25, P213; Boddy LM, 2010, J HUM NUTR DIET, V23, P254, DOI 10.1111/j.1365-277X.2009.01025.x; Boddy LM, 2012, MED SCI SPORT EXER, V44, P481, DOI 10.1249/MSS.0b013e3182300267; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Department of Health, 2011, START ACT STAY ACT R; Department of Health, 2009, ANN REP CHIEF MED OF; Eisenmann JC, 2007, INT J PEDIATR OBES, P1; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Rees A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-86; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; TAYLOR S, 2004, ED HLTH, V22, P3; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358	22	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45755	10.1371/journal.pone.0045755	http://dx.doi.org/10.1371/journal.pone.0045755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029224	gold, Green Published			2022-12-27	WOS:000309392800092
J	Duarte, A; Poderoso, C; Cooke, M; Soria, G; Maciel, FC; Gottifredi, V; Podesta, EJ				Duarte, Alejandra; Poderoso, Cecilia; Cooke, Mariana; Soria, Gaston; Maciel, Fabiana Cornejo; Gottifredi, Vanesa; Podesta, Ernesto J.			Mitochondrial Fusion Is Essential for Steroid Biosynthesis	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACYL-COA SYNTHETASE-4; RAT ADRENAL-GLAND; ARACHIDONIC-ACID; STAR PROTEIN; STIMULATED STEROIDOGENESIS; LH/CHORIONIC GONADOTROPIN; CHOLESTEROL TRANSPORT; REGULATORY PROTEIN; CELLS	Although the contribution of mitochondrial dynamics (a balance in fusion/fission events and changes in mitochondria subcellular distribution) to key biological process has been reported, the contribution of changes in mitochondrial fusion to achieve efficient steroid production has never been explored. The mitochondria are central during steroid synthesis and different enzymes are localized between the mitochondria and the endoplasmic reticulum to produce the final steroid hormone, thus suggesting that mitochondrial fusion might be relevant for this process. In the present study, we showed that the hormonal stimulation triggers mitochondrial fusion into tubular-shaped structures and we demonstrated that mitochondrial fusion does not only correlate-with but also is an essential step of steroid production, being both events depend on PKA activity. We also demonstrated that the hormone-stimulated relocalization of ERK1/2 in the mitochondrion, a critical step during steroidogenesis, depends on mitochondrial fusion. Additionally, we showed that the SHP2 phosphatase, which is required for full steroidogenesis, simultaneously modulates mitochondrial fusion and ERK1/2 localization in the mitochondrion. Strikingly, we found that mitofusin 2 (Mfn2) expression, a central protein for mitochondrial fusion, is upregulated immediately after hormone stimulation. Moreover, Mfn2 knockdown is sufficient to impair steroid biosynthesis. Together, our findings unveil an essential role for mitochondrial fusion during steroidogenesis. These discoveries highlight the importance of organelles' reorganization in specialized cells, prompting the exploration of the impact that organelle dynamics has on biological processes that include, but are not limited to, steroid synthesis.	[Duarte, Alejandra; Poderoso, Cecilia; Cooke, Mariana; Maciel, Fabiana Cornejo; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Biomed INBIOMED,CONICET, Buenos Aires, DF, Argentina; [Soria, Gaston; Gottifredi, Vanesa] Univ Buenos Aires, Fdn Inst Leloir, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Podesta, EJ (corresponding author), Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Biomed INBIOMED,CONICET, Buenos Aires, DF, Argentina.	biohrdc@fmed.uba.ar	Cooke, Mariana/ABD-5051-2021; Gottifredi, Vanesa/AAI-1788-2019; Cooke, Mariana/V-1375-2019	Gottifredi, Vanesa/0000-0001-9656-5951; CORNEJO MACIEL, MARIA FABIANA/0000-0003-0685-9038; Cooke, Mariana/0000-0001-9300-8447	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) to E.J.P., V.G. and C.P.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to E.J.P.; and Universidad de Buenos Aires (UBA) to E.J.P., F.C.M. and C.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; CHAN YL, 1987, J BIOL CHEM, V262, P1111; Cooke M, 2011, MOL CELL ENDOCRINOL, V336, P63, DOI 10.1016/j.mce.2010.11.030; CRIVELLO JF, 1980, J BIOL CHEM, V255, P8144; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Garren L D, 1971, Recent Prog Horm Res, V27, P433; Hall PF, 1997, MICROSC RES TECHNIQ, V36, P463, DOI 10.1002/(SICI)1097-0029(19970315)36:6<463::AID-JEMT4>3.0.CO;2-J; Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; King SR, 1999, J STEROID BIOCHEM, V69, P143, DOI 10.1016/S0960-0760(98)00152-6; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Maciel FC, 2005, J MOL ENDOCRINOL, V34, P655, DOI 10.1677/jme.1.01691; Maciel FC, 2001, J ENDOCRINOL, V170, P403, DOI 10.1677/joe.0.1700403; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Manes S, 1999, MOL CELL BIOL, V19, P3125; Martin SJ, 2011, DEV CELL, V20, P142, DOI 10.1016/j.devcel.2011.01.016; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mikkola R, 1999, EUR J BIOCHEM, V263, P112, DOI 10.1046/j.1432-1327.1999.00476.x; Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838; Paz C, 2002, J ENDOCRINOL, V175, P793, DOI 10.1677/joe.0.1750793; Paz C, 1999, EUR J BIOCHEM, V265, P911, DOI 10.1046/j.1432-1327.1999.00759.x; Poderoso C, 2002, ENDOCR RES, V28, P413, DOI 10.1081/ERC-120016816; Poderoso C, 2009, MOL CELL ENDOCRINOL, V300, P37, DOI 10.1016/j.mce.2008.10.009; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; RAE PA, 1979, P NATL ACAD SCI USA, V76, P1896, DOI 10.1073/pnas.76.4.1896; Rocchi S, 2000, BIOCHEM J, V352, P483, DOI 10.1042/0264-6021:3520483; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Schimmer B P, 1979, Methods Enzymol, V58, P570; Schimmer B P, 1980, Adv Cyclic Nucleotide Res, V13, P181; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Wang XJ, 2003, J STEROID BIOCHEM, V85, P159, DOI 10.1016/S0960-0760(03)00189-4; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	51	79	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45829	10.1371/journal.pone.0045829	http://dx.doi.org/10.1371/journal.pone.0045829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029265	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800102
J	Ottenhoff, THM; Dass, RH; Yang, NH; Zhang, MZM; Wong, HEE; Sahiratmadja, E; Khor, CC; Alisjahbana, B; van Crevel, R; Marzuki, S; Seielstad, M; van de Vosse, E; Hibberd, ML				Ottenhoff, Tom H. M.; Dass, Ranjeeta Hari; Yang, Ninghan; Zhang, Mingzi M.; Wong, Hazel E. E.; Sahiratmadja, Edhyana; Khor, Chiea Chuen; Alisjahbana, Bachti; van Crevel, Reinout; Marzuki, Sangkot; Seielstad, Mark; van de Vosse, Esther; Hibberd, Martin L.			Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INFECTION; DISEASE; CELLS; PATTERNS; GENES; ISG15	Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), remains the leading cause of mortality from a single infectious agent. Each year around 9 million individuals newly develop active TB disease, and over 2 billion individuals are latently infected with M.tb worldwide, thus being at risk of developing TB reactivation disease later in life. The underlying mechanisms and pathways of protection against TB in humans, as well as the dynamics of the host response to M.tb infection, are incompletely understood. We carried out whole-genome expression profiling on a cohort of TB patients longitudinally sampled along 3 time-points: during active infection, during treatment, and after completion of curative treatment. We identified molecular signatures involving the upregulation of type-1 interferon (alpha/beta\) mediated signaling and chronic inflammation during active TB disease in an Indonesian population, in line with results from two recent studies in ethnically and epidemiologically different populations in Europe and South Africa. Expression profiles were captured in neutrophil-depleted blood samples, indicating a major contribution of lymphocytes and myeloid cells. Expression of type-1 interferon (alpha/beta) genes mediated was also upregulated in the lungs of M.tb infected mice and in infected human macrophages. In patients, the regulated gene expression-signature normalized during treatment, including the type-1 interferon mediated signaling and a concurrent opposite regulation of interferon-gamma. Further analysis revealed IL15RA, UBE2L6 and GBP4 as molecules involved in the type-I interferon response in all three experimental models. Our data is highly suggestive that the innate immune type-I interferon signaling cascade could be used as a quantitative tool for monitoring active TB disease, and provide evidence that components of the patient's blood gene expression signature bear similarities to the pulmonary and macrophage response to mycobacterial infection.	[Ottenhoff, Tom H. M.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Dass, Ranjeeta Hari; Yang, Ninghan; Zhang, Mingzi M.; Wong, Hazel E. E.; Khor, Chiea Chuen; Seielstad, Mark; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Marzuki, Sangkot] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Sahiratmadja, Edhyana; Alisjahbana, Bachti] Padjadjaran State Univ, Hlth Res Unit, Hasan Sadikin Hosp, Fac Med, Bandung, Indonesia; [van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Eijkman Institute; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	t.h.m.ottenhoff@lumc.nl; hibberdml@gis.a-star.edu.sg	van Crevel, reinout/A-6636-2010; Hibberd, Martin L/D-5050-2009; van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009; Seielstad, Mark/T-7841-2019	van Crevel, reinout/0000-0002-6233-6410; van de Vosse, Esther/0000-0001-5199-3426; Hibberd, Martin/0000-0001-8587-1849; Zhang, Mingzi/0000-0002-1213-3340; Khor, Chiea Chuen/0000-0002-1128-4729; Seielstad, Mark/0000-0001-5783-1401; Sahiratmadja, Edhyana/0000-0001-9092-5848	Netherlands' Organization of Scientific Research (NWO); Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP [GC6 74]; Bill and Melinda Gates Foundation Grand Challenges in Global Health; Netherlands Leprosy Relief Foundation; Q.M. Gastmann Wichers Foundation; European Union's Seventh Framework Programme [FP7] for project NEWTBVAC; European Union's Seventh Framework Programme [FP7] for project IDEA; European Union's Seventh Framework Programme [FP7] for project ADITEC [280873]	Netherlands' Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP; Bill and Melinda Gates Foundation Grand Challenges in Global Health(Bill & Melinda Gates Foundation); Netherlands Leprosy Relief Foundation; Q.M. Gastmann Wichers Foundation; European Union's Seventh Framework Programme [FP7] for project NEWTBVAC; European Union's Seventh Framework Programme [FP7] for project IDEA; European Union's Seventh Framework Programme [FP7] for project ADITEC	The authors gratefully acknowledge the support of the following organizations: the Netherlands' Organization of Scientific Research (NWO); the Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP; the Bill and Melinda Gates Foundation Grand Challenges in Global Health (grant GC6#74); the Netherlands Leprosy Relief Foundation; the Q.M. Gastmann Wichers Foundation. The research also received funding from the European Union's Seventh Framework Programme [FP7/2007-2013] for projects NEWTBVAC; IDEA; and ADITEC (No: 280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; de Jong R, 1998, SCIENCE, V280, P1435; de Paus RA, 2012, INHIBITION TYP UNPUB; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jeon YJ, 2009, EMBO REP, V10, P374, DOI 10.1038/embor.2009.23; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kuchtey J, 2006, IMMUNOLOGY, V118, P39, DOI 10.1111/j.1365-2567.2006.02337.x; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Levin M, 2000, MICROBES INFECT, V2, P1549, DOI 10.1016/S1286-4579(00)01310-1; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; Ottenhoff THM, 2012, TRENDS MICROBIOL, V2012; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; van de Wetering D, 2011, CLIN IMMUNOL, V138, P282, DOI 10.1016/j.clim.2010.12.005; Wong RL, 2011, PROTEIN ENG DES SEL, V24, P373, DOI 10.1093/protein/gzq116; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101	39	165	168	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45839	10.1371/journal.pone.0045839	http://dx.doi.org/10.1371/journal.pone.0045839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029268	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309392800104
J	Wang, Y; Guo, TT; Zhao, SY; Li, ZX; Mao, YQ; Li, H; Wang, X; Wang, R; Xu, W; Song, RJ; Jin, L; Li, XL; Irwin, DM; Niu, G; Tan, HR				Wang, Yi; Guo, Tingting; Zhao, Shuyong; Li, Zhixin; Mao, Yiqing; Li, Hui; Wang, Xi; Wang, Rong; Xu, Wei; Song, Rongjing; Jin, Ling; Li, Xiuli; Irwin, David M.; Niu, Gang; Tan, Huanran			Expression of the Human Glucokinase Gene: Important Roles of the 5 ' Flanking and Intron 1 Sequences	PLOS ONE			English	Article							I-HYPERSENSITIVE SITES; ELEMENT-BINDING PROTEIN-1C; GENOMIC DNA-SEQUENCES; MAMMALIAN GLUCOKINASE; PRIMARY HEPATOCYTES; LIVER; INSULIN; IDENTIFICATION; TRANSCRIPTION; INDUCTION	Background: Glucokinase plays important tissue-specific roles in human physiology, where it acts as a sensor of blood glucose levels in the pancreas, and a few other cells of the gut and brain, and as the rate-limiting step in glucose metabolism in the liver. Liver-specific expression is driven by one of the two tissue-specific promoters, and has an absolute requirement for insulin. The sequences that mediate regulation by insulin are incompletely understood. Methodology/Principal Findings: To better understand the liver-specific expression of the human glucokinase gene we compared the structures of this gene from diverse mammals. Much of the sequence located between the 5' pancreatic beta-cell-specific and downstream liver-specific promoters of the glucokinase genes is composed of repetitive DNA elements that were inserted in parallel on different mammalian lineages. The transcriptional activity of the liver-specific promoter 5' flanking sequences were tested with and without downstream intronic sequences in two human liver cells lines, HepG2 and L-02. While glucokinase liver-specific 5' flanking sequences support expression in liver cell lines, a sequence located about 2000 bases 3' to the liver-specific mRNA start site represses gene expression. Enhanced reporter gene expression was observed in both cell lines when cells were treated with fetal calf serum, but only in the L-02 cells was expression enhanced by insulin. Conclusions/Significance: Our results suggest that the normal liver L-02 cell line may be a better model to understand the regulation of the liver-specific expression of the human glucokinase gene. Our results also suggest that sequences downstream of the liver-specific mRNA start site have important roles in the regulation of liver-specific glucokinase gene expression.	[Wang, Yi; Guo, Tingting; Zhao, Shuyong; Li, Zhixin; Mao, Yiqing; Li, Hui; Wang, Xi; Wang, Rong; Xu, Wei; Song, Rongjing; Jin, Ling; Irwin, David M.; Tan, Huanran] Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China; [Li, Xiuli] Chifeng Coll, Dept Pharmacol, Chifeng, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Niu, Gang] Beijing N&N Genetech Co, Beijing, Peoples R China	Peking University; Chifeng University; University of Toronto	Irwin, DM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China.	david.irwin@utoronto.ca; tanlab@bjmu.edu.cn		Irwin, David/0000-0001-6131-4933; Jin, Ling/0000-0002-0687-9234	National Natural Science Foundation of China (NSFC) [30772603]; National Key Technologies RD Program [2006BAF07B01, 2009BAK61B01, 2009BAK61B04]; National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative [81061120525, CCI-109605]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the National Natural Science Foundation of China (NSFC) Grant Number 30772603, National Key Technologies R&D Program (Grant Numbers 2006BAF07B01, 2009BAK61B01, and 2009BAK61B04), and a grant from the National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative (Grant Numbers 81061120525 and CCI-109605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Berrougui H, 2012, REJUV RES, V12, P117; BOSSARD P, 1993, EUR J BIOCHEM, V215, P883, DOI 10.1111/j.1432-1033.1993.tb18106.x; Cha JY, 2001, EXP MOL MED, V33, P59, DOI 10.1038/emm.2001.11; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Gregori C, 2006, FEBS LETT, V580, P410, DOI 10.1016/j.febslet.2005.12.032; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Iynedjian PB, 1996, J BIOL CHEM, V271, P29113, DOI 10.1074/jbc.271.46.29113; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lannoy VJ, 2002, DIABETOLOGIA, V45, P1136, DOI 10.1007/s00125-002-0856-z; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Parsa R, 1996, EUR J BIOCHEM, V236, P214, DOI 10.1111/j.1432-1033.1996.00214.x; POSTIC C, 1995, GENOMICS, V29, P740, DOI 10.1006/geno.1995.9943; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Poupeau A, 2011, BBA-MOL BASIS DIS, V1812, P995, DOI 10.1016/j.bbadis.2011.03.015; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SHELTON KD, 1992, MOL CELL BIOL, V12, P4578, DOI 10.1128/MCB.12.10.4578; Smit A, 1996, REPEATMASKER OPEN 30; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; TANIZAWA Y, 1992, MOL ENDOCRINOL, V6, P1070, DOI 10.1210/me.6.7.1070; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; URETA T, 1981, COMP BIOCHEM PHYS B, V70, P225, DOI 10.1016/0305-0491(81)90038-9; YEH HJ, 1980, ACTA BIOL EXP SINICA, V13, P361; Zhu LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1210, DOI 10.1152/ajpendo.00633.2009	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45824	10.1371/journal.pone.0045824	http://dx.doi.org/10.1371/journal.pone.0045824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029263	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900105
J	Cheng, W; Chen, LZ; Yang, SS; Han, J; Zhai, DX; Ni, J; Yu, CQ; Cai, ZL				Cheng, Wen; Chen, Lizao; Yang, Shengsheng; Han, Jie; Zhai, Dongxia; Ni, Jian; Yu, Chaoqin; Cai, Zailong			Puerarin Suppresses Proliferation of Endometriotic Stromal Cells Partly via the MAPK Signaling Pathway Induced by 17 beta-estradiol-BSA	PLOS ONE			English	Article							BREAST-CANCER CELLS; NON-GENOMIC PATHWAY; ESTROGEN-RECEPTOR; INTRACELLULAR CALCIUM; INDUCED ACTIVATION; UP-REGULATION; PROTEIN; ESTRADIOL; EXPRESSION; CULTURE	Background: Puerarin is a major isoflavonoid compound extracted from Radix puerariae. It has a weak estrogenic action by binding to estrogen receptors (ERs). In our early clinical practice to treat endometriosis, a better therapeutic effect was achieved if the formula of traditional Chinese medicine included Radix puerariae. The genomic and non-genomic effects of puerarin were studied in our Lab. This study aims to investigate the ability of puerarin to bind competitively to ERs in human endometriotic stromal cells (ESCs), determine whether and how puerarin may influence phosphorylation of the non-genomic signaling pathway induced by 17 beta-estradiol conjugated to BSA (E-2-BSA). Methodology: ESCs were successfully established. Binding of puerarin to ERs was assessed by a radioactive competitive binding assay in ESCs. Activation of the signaling pathway was screened by human phospho-kinase array, and was further confirmed by western blot. Cell proliferation was analyzed according to the protocol of CCK-8. The mRNA and protein levels of cyclin D1, Cox-2 and Cyp19 were determined by real-time PCR and western blotting. Inhibitor of MEK1/2 or ER antagonist was used to confirm the involved signal pathway. Principal Findings: Our data demonstrated that the total binding ability of puerarin to ERs on viable cells is around 1/3 that of 17 beta-estradiol (E-2). E-2-BSA was able to trigger a rapid, non-genomic, membrane-mediated activation of ERK1/2 in ESCs and this phenomenon was associated with an increased proliferation of ESCs. Treating ESCs with puerarin abrogated the phosphorylation of ERK and significantly decreased cell proliferation, as well as related gene expression levels enhanced by E-2-BSA. Conclusions/Significance: Puerarin suppresses proliferation of ESCs induced by E-2-BSA partly via impeding a rapid, non-genomic, membrane-initiated ERK pathway, and down-regulation of Cyclin D1, Cox-2 and Cyp19 are involved in the process. Our data further show that puerarin may be a new candidate to treat endometriosis.	[Cheng, Wen; Chen, Lizao; Yang, Shengsheng; Han, Jie; Zhai, Dongxia; Yu, Chaoqin; Cai, Zailong] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Cheng, Wen; Chen, Lizao; Yang, Shengsheng; Han, Jie; Zhai, Dongxia; Yu, Chaoqin; Cai, Zailong] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Ni, Jian] Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Yu, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	chqyu81@gmail.com; czl8003@hotmail.com		Yu, Chaoqin/0000-0003-1614-2655	National Natural Science Foundation of China [30672742, 30873353, 30930113]; 973 project [2010CB933902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	This work was supported by a grant from the National Natural Science Foundation of China (Project No. 30672742, 30873353, 30930113) and 973 project (2010CB933902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Attar E, 2006, FERTIL STERIL, V85, P1307, DOI 10.1016/j.fertnstert.2005.09.064; Bergqvist A, 2000, GYNECOL ENDOCRINOL, V14, P425, DOI 10.3109/09513590009167714; Bo J, 2005, NEUROSCI RES, V53, P183, DOI 10.1016/j.neures.2005.06.014; Bulun SE, 2000, J MOL ENDOCRINOL, V25, P35, DOI 10.1677/jme.0.0250035; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen S, 2010, J HEPATOL, V52, P864, DOI 10.1016/j.jhep.2009.12.040; Chen Y, 2011, REPROD SCI, V18, P886, DOI 10.1177/1933719111398500; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; DOLD KM, 1990, ANAL BIOCHEM, V184, P67, DOI 10.1016/0003-2697(90)90013-Y; Fu XD, 2007, GYNECOL ENDOCRINOL, V23, P131, DOI 10.1080/09513590601181457; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; Jacobson TZ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001300.pub2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Kwintkiewicz J, 2007, MOL ENDOCRINOL, V21, P933, DOI 10.1210/me.2006-0446; LeMellay V, 1997, J BIOL CHEM, V272, P11902, DOI 10.1074/jbc.272.18.11902; Lessey BA, 2000, FERTIL STERIL, V73, P1089, DOI 10.1016/S0015-0282(00)00519-7; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Rice VM, 2002, ANN NY ACAD SCI, V955, P343, DOI 10.1111/j.1749-6632.2002.tb02795.x; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Suzuki T, 2008, CYTOKINE, V42, P32, DOI 10.1016/j.cyto.2008.02.002; Thin TH, 2003, J BIOL CHEM, V278, P7699, DOI 10.1074/jbc.M206172200; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Valle RF, 2003, ANN NY ACAD SCI, V997, P229, DOI 10.1196/annals.1290.026; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025011; Wong R, 2007, OSTEOARTHR CARTILAGE, V15, P894, DOI 10.1016/j.joca.2007.02.009; Yamakawa K, 2004, J STEROID BIOCHEM, V88, P123, DOI 10.1016/j.jsbmb.2003.11.003; Yeung DKY, 2006, EUR J PHARMACOL, V552, P105, DOI 10.1016/j.ejphar.2006.08.078; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zhai BB, 2010, J BIOL CHEM, V285, P23568, DOI 10.1074/jbc.M110.107623; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhang SH, 2006, J NUTR BIOCHEM, V17, P485, DOI 10.1016/j.jnutbio.2005.09.002	38	30	31	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45529	10.1371/journal.pone.0045529	http://dx.doi.org/10.1371/journal.pone.0045529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029074	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400098
J	Sopel, MJ; Rosin, NL; Falkenham, AG; Bezuhly, M; Esmon, CT; Lee, TDG; Liwski, RS; Legare, JF				Sopel, Mryanda J.; Rosin, Nicole L.; Falkenham, Alec G.; Bezuhly, Michael; Esmon, Charles T.; Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois			Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice	PLOS ONE			English	Article							SEVERE SEPSIS; CIRCULATING FIBROCYTES; ISCHEMIA-REPERFUSION; CELLULAR MECHANISMS; PERIPHERAL-BLOOD; MEDIATE FIBROSIS; TRIAL ENHANCE; RECEPTOR; EXPRESSION; SURVIVAL	Aims: Myocardial fibrosis contributes to the development of heart failure. Activated Protein C (aPC) is a circulating anticoagulant with anti-inflammatory and cytoprotective properties. Using a model of myocardial fibrosis second to Angiotensin II (AngII) infusion, we investigated the novel therapeutic function aPC in the development of fibrosis. Methods and Results: C57Bl/6 and Tie2-EPCR mice were infused with AngII (2.0 mu g/kg/min), AngII and aPC (0.4 mu g/kg/min) or saline for 3d. Hearts were harvested and processed for analysis or used for cellular isolation. Basic histology and collagen deposition were assessed using histologic stains. Transcript levels of molecular mediators were analyzed by quantitative RTPCR. Mice infused with AngII exhibited multifocal areas of myocardial cellular infiltration associated with significant collagen deposition compared to saline control animals (p<0.01). AngII-aPC infusion inhibited this cellular infiltration and the corresponding collagen deposition. AngII-aPC infusion also inhibited significant expression of the pro-fibrotic cytokines TGF-beta 1, CTGF and PDGF found in AngII only infused animals (p<0.05). aPC signals through its receptor, EPCR. Using Tie2-EPCR animals, where endothelial cells over-express EPCR and exhibit enhanced aPC-EPCR signaling, no significant reduction in cellular infiltration or fibrosis was evident with AngII infusion suggesting aPC-mediate protection is endothelial cell independent. Isolated infiltrating cells expressed significant EPCR transcripts suggesting a direct effect on infiltrating cells. Conclusions: This data indicates that aPC treatment abrogates the fibrogenic response to AngII. aPC does not appear to confer protection by stimulating the endothelium but by acting directly on the infiltrating cells, potentially inhibiting migration or activation.	[Sopel, Mryanda J.; Rosin, Nicole L.; Falkenham, Alec G.; Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Bezuhly, Michael; Lee, Timothy D. G.; Legare, Jean-Francois] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada; [Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA; [Esmon, Charles T.] Cardiovasc Biol Res Program, Oklahoma City, OK USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Dalhousie University; Dalhousie University; Dalhousie University; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Liwski, RS (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	rliwski@dal.ca; jean.legare@cdha.nshealth.ca		Bezuhly, Michael/0000-0002-7356-5147	Nova Scotia Health Research Foundation [42311]; Canadian Institute of Health Research [44122]; Astellas [43742]	Nova Scotia Health Research Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Astellas(Astellas Pharmaceuticals)	This work was supported by a grant from the Nova Scotia Health Research Foundation (#42311 to J.F.L. http://www.nshrf.ca/); the Canadian Institute of Health Research (#44122 to J.F.L. http://www.cihr-irsc.gc.ca/e/193.html); and an investigator initiated research grant from Astellas (#43742 to R.S.L. http://www.astellas.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bezuhly M, 2009, PLAST RECONSTR SURG, V123, P502, DOI 10.1097/PRS.0b013e318196b87f; Bezuhly M, 2009, BLOOD, V113, P3371, DOI 10.1182/blood-2008-05-159434; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Chesney J, 1998, J IMMUNOL, V160, P419; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; Dillon JP, 2005, J ORTHOP RES, V23, P1454, DOI 10.1016/j.orthres.2005.04.009; Ding JW, 2010, J KOREAN MED SCI, V25, P1609, DOI 10.3346/jkms.2010.25.11.1609; Doughty RN, 1997, EUR HEART J, V18, P560; Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35; Fabris B, 2007, J HYPERTENS, V25, P1481, DOI 10.1097/HJH.0b013e328121aae7; Galligan L, 2001, BRIT J HAEMATOL, V115, P408, DOI 10.1046/j.1365-2141.2001.03187.x; Gillibert-Duplantier J, 2010, WORLD J GASTROENTERO, V16, P210, DOI 10.3748/wjg.v16.i2.210; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Ireland H, 1997, CIRCULATION, V96, P15; Kelly DJ, 2004, HYPERTENSION, V44, P195, DOI 10.1161/01.HYP.0000132883.20764.12; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kim S, 2000, PHARMACOL REV, V52, P11; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198; Marian AJ, 2009, J CARDIOVASC TRANSL, V2, P483, DOI 10.1007/s12265-009-9132-7; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Mizutani A, 2000, BLOOD, V95, P3781; Neyrinck AP, 2009, BRIT J PHARMACOL, V158, P1034, DOI 10.1111/j.1476-5381.2009.00251.x; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; SAMANI NJ, 1994, LANCET, V344, P1709, DOI 10.1016/S0140-6736(94)90495-2; Sopel M, 2012, INT J EXP PATHOL, V93, P115, DOI 10.1111/j.1365-2613.2011.00797.x; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; van Sluis GL, 2011, CANCER LETT, V306, P106, DOI 10.1016/j.canlet.2011.02.038; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Xue ML, 2007, ANN RHEUM DIS, V66, P1574, DOI 10.1136/ard.2006.068239; Yasui H, 2001, AM J RESP CRIT CARE, V163, P1660, DOI 10.1164/ajrccm.163.7.9911068	39	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45663	10.1371/journal.pone.0045663	http://dx.doi.org/10.1371/journal.pone.0045663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029168	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400118
J	Stefanoff, P; Rosinska, M; Samuels, S; White, DJ; Morse, DL; Randolph, SE				Stefanoff, Pawel; Rosinska, Magdalena; Samuels, Steven; White, Dennis J.; Morse, Dale L.; Randolph, Sarah E.			A National Case-Control Study Identifies Human Socio-Economic Status and Activities as Risk Factors for Tick-Borne Encephalitis in Poland	PLOS ONE			English	Article							VIRUS; VACCINATION; RESPONSES; SURVIVAL; UPSURGE; VECTOR; EUROPE; HEALTH; CRISES	Background: Tick-borne encephalitis (TBE) is endemic to Europe and medically highly significant. This study, focused on Poland, investigated individual risk factors for TBE symptomatic infection. Methods and Findings: In a nation-wide population-based case-control study, of the 351 TBE cases reported to local health departments in Poland in 2009, 178 were included in the analysis. For controls, of 2704 subjects (matched to cases by age, sex, district of residence) selected at random from the national population register, two were interviewed for each case and a total of 327 were suitable for the analysis. Questionnaires yielded information on potential exposure to ticks during the six weeks (maximum incubation period) preceding disease onset in each case. Independent associations between disease and socio-economic factors and occupational or recreational exposure were assessed by conditional logistic regression, stratified according to residence in known endemic and non-endemic areas. Adjusted population attributable fractions (PAF) were computed for significant variables. In endemic areas, highest TBE risk was associated with spending >= 10 hours/week in mixed forests and harvesting forest foods (adjusted odds ratio 19.19 [95% CI: 1.72-214.32]; PAF 0.127 [0.064-0.193]), being unemployed (11.51 [2.84-46.59]; 0.109 [0.046-0.174]), or employed as a forester (8.96 [1.58-50.77]; 0.053 [0.011-0.100]) or non-specialized worker (5.39 [2.21-13.16]; 0.202 [0.090-0.282]). Other activities (swimming, camping and travel to non-endemic regions) reduced risk. Outside TBE endemic areas, risk was greater for those who spent >= 10 hours/week on recreation in mixed forests (7.18 [1.90-27.08]; 0.191 [0.065-0.304]) and visited known TBE endemic areas (4.65 [0.59-36.50]; 0.058 [20.007-0.144]), while travel to other non-endemic areas reduced risk. Conclusions: These socio-economic factors and associated human activities identified as risk factors for symptomatic TBE in Poland are consistent with results from previous correlational studies across eastern Europe, and allow public health interventions to be targeted at particularly vulnerable sections of the population.	[Randolph, Sarah E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Stefanoff, Pawel; Rosinska, Magdalena] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, PL-00791 Warsaw, Poland; [Samuels, Steven; White, Dennis J.] SUNY Albany, Sch Publ Hlth, Rensselaer, NY USA; [White, Dennis J.] New York State Dept Hlth, Albany, NY USA; [Morse, Dale L.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	University of Oxford; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Centers for Disease Control & Prevention - USA	Randolph, SE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sarah.randolph@zoo.ox.ac.uk	Rosińska, Magdalena/Q-2068-2018; Stefanoff, Paweł/E-5506-2013; Rosińska, Magdalena/K-5857-2019; Randolph, Sarah/AAR-9346-2021	Rosińska, Magdalena/0000-0002-6256-7809; Stefanoff, Paweł/0000-0003-0087-0906; Rosińska, Magdalena/0000-0002-6256-7809; 	National Institutes of Health/Fogarty International Center [5R01-TW007248]; Baxter; GlaxoSmithKline; Novartis; FOGARTY INTERNATIONAL CENTER [R01TW007248] Funding Source: NIH RePORTER	National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Baxter; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by National Institutes of Health/Fogarty International Center grant 5R01-TW007248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PS has received travel grants from Baxter and unrestricted research grants from GlaxoSmithKline, Baxter and Novartis. SER is a member of the International Scientific Working Group on TBE, funded by Baxter. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and material. The other authors have declared no competing interests.	Arinaminpathy N, 2010, J R SOC INTERFACE, V7, P1559, DOI 10.1098/rsif.2010.0072; Barszcz A, 2006, ELECT J POLISH AGR U, V9; Barszcz A., 2006, ELECT J POLISH AGR U, V9, P21; Brinkley C, 2008, INT J MED MICROBIOL, V298, P73, DOI 10.1016/j.ijmm.2007.12.005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Burri C, 2011, J MED ENTOMOL, V48, P615, DOI 10.1603/ME10180; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Csango PA, 2004, EMERG INFECT DIS, V10, P533, DOI 10.3201/eid1003.020734; Czupryna P, 2011, EUR J NEUROL, V18, P673, DOI 10.1111/j.1468-1331.2010.03278.x; Daniel M, 2009, EPIDEMIOL MIKROBI IM, V58, P179; Daniel M, 1998, EXP APPL ACAROL, V22, P417, DOI 10.1023/A:1006030827216; Daniel M, 2008, INT J MED MICROBIOL, V298, P81, DOI 10.1016/j.ijmm.2008.02.006; Danielova V, 2010, VECTOR-BORNE ZOONOT, V10, P223, DOI 10.1089/vbz.2009.0020; Donoso Mantke O, 2011, EUROSURVEIL, V16; Godfrey ER, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-35; Grgic-Vitek M, 2011, VACCINE, V29, P5178, DOI 10.1016/j.vaccine.2011.05.033; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Holzmann H, 2009, EMERG INFECT DIS, V15, P1671, DOI 10.3201/eid1510.090743; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kriz B, 2004, INT J MED MICROBIOL, V293, P63, DOI 10.1016/S1433-1128(04)80010-X; KUNZE U, 2006, VACCINE, V24, P1236; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; Lerman Z, 2008, J PEASANT STUD, V35, P60, DOI 10.1080/03066150801983378; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lukan M, 2010, EMERG INFECT DIS, V16, P524, DOI 10.3201/eid1603.081364; Lundkvist A, 2011, EUROSURVEIL, V16; *MARK PUBL OP RES, 2001, INV FACT HIND IMM PO; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2007, ECOL CONT VECTOR-BOR, V1, P187; Randolph SE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-44; Randolph SE, 2010, EUROSURVEIL, V15; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Semenza JC, 2010, EUROSURVEIL, V15; Smith G, 2001, PUBLIC HEALTH REP, V116, P146, DOI 10.1093/phr/116.S1.146; Stefanoff P, 2011, SURVEILLANCE, V16; Stefanoff P, 2011, VACCINE, V29, P1283, DOI 10.1016/j.vaccine.2010.11.077; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Sumilo D, 2009, CLIN MICROBIOL INFEC, V15, P75, DOI 10.1111/j.1469-0691.2008.02121.x; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Zeman P, 2010, TICKS TICK-BORNE DIS, V1, P129, DOI 10.1016/j.ttbdis.2010.05.003	50	31	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45511	10.1371/journal.pone.0045511	http://dx.doi.org/10.1371/journal.pone.0045511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029063	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400095
J	Swan, DJ; Kirby, JA; Ali, S				Swan, David J.; Kirby, John A.; Ali, Simi			Post-Transplant Immunosuppression: Regulation of the Efflux of Allospecific Effector T Cells from Lymphoid Tissues	PLOS ONE			English	Article							HEART TRANSPLANTATION MODEL; RANDOMIZED CONTROLLED-TRIAL; NOVO RENAL-TRANSPLANTATION; ACTIVATION ANTIGEN CD69; ALLOGRAFT-REJECTION; MEMBRANE-PROTEIN; FTY720; RECEPTOR-1; EGRESS; S1P(1)	A functional sphingosine-1-phosphate (S1P) receptor antagonist specifically inhibited the egress of activated allospecific T cells from draining popliteal lymph nodes in alloantigen-sensitised mice. The level of S1P receptor 1 (S1PR1) mRNA was similarly reduced 1 and 3 days after mitogenic activation of T cells. However, the response of these cells to the S1PR1-specific agonist SEW2871 was only reduced on the first day after T cell activation with normal receptor-mediated Akt-phosphorylation restored by day 3. Longitudinal analysis of CD69 expression showed that almost all T cells expressed this antigen on days 1 and 3 after activation. However, the absolute level of cell-surface expression of CD69 peaked on undivided T cells and was then halved by each of the first 3 cycles of mitosis. CD69-specific small interfering RNA (siRNA) reduced the maximal level of CD69 expression by undivided, mitogen-stimulated T cells. These cells retained their capacity to phosphorylate Akt in response to stimulation with SEW2871. These data show that S1P receptors are involved in controlling the egress of activated T cells from lymph nodes, and that S1PR1 function is regulated by the level of T cell surface CD69. They suggest a potential for augmentation of this process to deplete alloreactive effector cells after organ transplantation.	[Swan, David J.; Kirby, John A.; Ali, Simi] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Appl Immunobiol & Transplantat Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Ali, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Appl Immunobiol & Transplantat Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Simi.Ali@newcastle.ac.uk		Swan, David/0000-0002-6480-9621; Kirby, John/0000-0003-2543-4131	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was funded by a British Heart Foundation Studentship to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Habicht A, 2006, J IMMUNOL, V176, P36, DOI 10.4049/jimmunol.176.1.36; HAMANN J, 1993, J IMMUNOL, V150, P4920; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hofmann M, 2006, INT IMMUNOPHARMACOL, V6, P1902, DOI 10.1016/j.intimp.2006.07.030; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nakashima D, 2008, J INVEST DERMATOL, V128, P2833, DOI 10.1038/jid.2008.174; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pan SF, 2006, CHEM BIOL, V13, P1227, DOI 10.1016/j.chembiol.2006.09.017; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Suzuki C, 2006, J HEART LUNG TRANSPL, V25, P302, DOI 10.1016/j.healun.2005.09.021; Tedesco-Silva H, 2006, TRANSPLANTATION, V82, P1689, DOI 10.1097/01.tp.0000251718.95622.b3; TESTI R, 1989, J IMMUNOL, V142, P1854; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45548	10.1371/journal.pone.0045548	http://dx.doi.org/10.1371/journal.pone.0045548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029087	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900156
J	Gaidet, N; El Mamy, ABO; Cappelle, J; Caron, A; Cumming, GS; Grosbois, V; Gil, P; Hammoumi, S; de Almeida, RS; Fereidouni, SR; Cattoli, G; Abolnik, C; Mundava, J; Fofana, B; Ndlovu, M; Diawara, Y; Hurtado, R; Newman, SH; Dodman, T; Balanca, G				Gaidet, Nicolas; El Mamy, Ahmed B. Ould; Cappelle, Julien; Caron, Alexandre; Cumming, Graeme S.; Grosbois, Vladimir; Gil, Patricia; Hammoumi, Saliha; de Almeida, Renata Servan; Fereidouni, Sasan R.; Cattoli, Giovanni; Abolnik, Celia; Mundava, Josphine; Fofana, Bouba; Ndlovu, Mduduzi; Diawara, Yelli; Hurtado, Renata; Newman, Scott H.; Dodman, Tim; Balanca, Gilles			Investigating Avian Influenza Infection Hotspots in Old-World Shorebirds	PLOS ONE			English	Article							WILD AQUATIC BIRDS; A VIRUSES; SURVEILLANCE; DYNAMICS; PATTERNS; GENE; TRANSMISSION; STRATEGIES; MIGRATION; WATERFOWL	Heterogeneity in the transmission rates of pathogens across hosts or environments may produce disease hotspots, which are defined as specific sites, times or species associations in which the infection rate is consistently elevated. Hotspots for avian influenza virus (AIV) in wild birds are largely unstudied and poorly understood. A striking feature is the existence of a unique but consistent AIV hotspot in shorebirds (Charadriiformes) associated with a single species at a specific location and time (ruddy turnstone Arenaria interpres at Delaware Bay, USA, in May). This unique case, though a valuable reference, limits our capacity to explore and understand the general properties of AIV hotspots in shorebirds. Unfortunately, relatively few shorebirds have been sampled outside Delaware Bay and they belong to only a few shorebird families; there also has been a lack of consistent oropharyngeal sampling as a complement to cloacal sampling. In this study we looked for AIV hotspots associated with other shorebird species and/or with some of the larger congregation sites of shorebirds in the old world. We assembled and analysed a regionally extensive dataset of AIV prevalence from 69 shorebird species sampled in 25 countries across Africa and Western Eurasia. Despite this diverse and extensive coverage we did not detect any new shorebird AIV hotspots. Neither large shorebird congregation sites nor the ruddy turnstone were consistently associated with AIV hotspots. We did, however, find a low but widespread circulation of AIV in shorebirds that contrast with the absence of AIV previously reported in shorebirds in Europe. A very high AIV antibody prevalence coupled to a low infection rate was found in both first-year and adult birds of two migratory sandpiper species, suggesting the potential existence of an AIV hotspot along their migratory flyway that is yet to be discovered.	[Gaidet, Nicolas; Cappelle, Julien; Caron, Alexandre; Grosbois, Vladimir; Balanca, Gilles] UPR AGIRS, CIRAD ES, Montpellier, France; [El Mamy, Ahmed B. Ould] Ctr Natl Elevage & Rech Vet, Nouakchott, Mauritania; [Gil, Patricia; Hammoumi, Saliha; de Almeida, Renata Servan] INRA CMAEE, UMR CIRAD, CIRAD BIOS, Montpellier, France; [Cumming, Graeme S.; Ndlovu, Mduduzi] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7925 Cape Town, South Africa; [Fereidouni, Sasan R.] Friedrich Loeffler Inst, Insel Riems, Germany; [Cattoli, Giovanni] Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, Italy; [Abolnik, Celia] Univ Pretoria, Fac Vet Sci, ARC Onderstepoort Vet Inst, ZA-0110 Onderstepoort, South Africa; [Abolnik, Celia] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, ZA-0110 Onderstepoort, South Africa; [Mundava, Josphine] Natl Univ Sci & Technol, Bulawayo, Zimbabwe; [Fofana, Bouba] Direct Natl Eaux & Forets Mali, Bamako, Mali; [Hurtado, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Hurtado, Renata] Univ Sao Paulo, Fac Vet Med, Dept Prevent Med & Anim Hlth, Sao Paulo, Brazil; [Newman, Scott H.] EMPRES Anim Hlth, Wildlife Hlth & Ecol Unit, Food & Agr Org United Nat, Rome, Italy; [Dodman, Tim] Wetlands Int, Wageningen, Netherlands	CIRAD; CIRAD; INRAE; National Research Foundation - South Africa; University of Cape Town; Friedrich Loeffler Institute; IZS delle Venezie; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; National University of Science & Technology - Zimbabwe; Universidade de Sao Paulo; Universidade de Sao Paulo; Food & Agriculture Organization of the United Nations (FAO)	Gaidet, N (corresponding author), UPR AGIRS, CIRAD ES, Montpellier, France.	nicolas.gaidet@cirad.fr	Caron, Alexandre/F-8969-2010; Gaidet, Niccolas/H-8122-2013; Ndlovu, Mduduzi/B-1300-2019; Abolnik, Celia/N-9324-2014; Dodman, Tim/AAM-9817-2021; Cumming, Graeme S./B-6551-2008	Caron, Alexandre/0000-0002-5213-3273; Ndlovu, Mduduzi/0000-0002-2997-9430; Cumming, Graeme S./0000-0002-3678-1326; Mundava, Josephine/0000-0003-2062-3216; Fereidouni, Sasan/0000-0002-3508-991X; Cappelle, Julien/0000-0001-7668-1971; Abolnik, Celia/0000-0003-3044-465X	French Ministry of Foreign Affairs; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of France; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of Sweden; USAID - and Wildlife Conservation Society; EU	French Ministry of Foreign Affairs; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of France; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of Sweden; USAID - and Wildlife Conservation Society(United States Agency for International Development (USAID)); EU(European Commission)	This survey was conducted under four international programmes including the GRIPAVI project sponsored by grants from the French Ministry of Foreign Affairs, the Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through additional financial resources from the government of France and Sweden, the USAID - and Wildlife Conservation Society - sponsored Global Avian Influenza Network for Surveillance (GAINS), and the EU-funded New Flubird project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; BARBOSA A, 1995, J AVIAN BIOL, V26, P182, DOI 10.2307/3677317; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown LH, 1982, BIRDS AFRICA, VI; Caron A, 2011, ECOHEALTH, V8, P109, DOI 10.1007/s10393-010-0356-4; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; CLARK KE, 1993, CONDOR, V95, P694, DOI 10.2307/1369612; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Cramp S., 1983, BIRDS W PALEARCTIC, VIII; Cumming GS, 2011, ECOHEALTH, V8, P4, DOI 10.1007/s10393-011-0684-z; Delany S., 2009, ATLAS WADER POPULATI; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gaidet N, 2007, J WILDLIFE DIS, V43, pS22; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gillings S, 2007, J ANIM ECOL, V76, P503, DOI 10.1111/j.1365-2656.2007.01229.x; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hlinak A, 2006, J VET MED B, V53, P105, DOI 10.1111/j.1439-0450.2006.00935.x; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jindal N, 2010, AVIAN DIS, V54, P115, DOI 10.1637/9032-082109-Reg.1; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Maxted AM, 2012, J WILDLIFE DIS, V48, P322, DOI 10.7589/0090-3558-48.2.322; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Sivay Mariya V., 2011, Chinese Birds, V2, P140; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; ZWARTS L, 1990, ARDEA, V78, P39	44	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46049	10.1371/journal.pone.0046049	http://dx.doi.org/10.1371/journal.pone.0046049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029383	Green Published, Green Accepted, gold			2022-12-27	WOS:000309973900080
J	Blanco, F; Matute, H; Vadillo, MA				Blanco, Fernando; Matute, Helena; Vadillo, Miguel A.			Mediating Role of Activity Level in the Depressive Realism Effect	PLOS ONE			English	Article							CONTINGENCY JUDGMENTS; INTERTRIAL INTERVAL; COLLEGE-STUDENTS; ILLUSION; WISER; REINFORCEMENT; HELPLESSNESS; INFORMATION; SYMPTOMS; INTERNET	Several classic studies have concluded that the accuracy of identifying uncontrollable situations depends heavily on depressive mood. Nondepressed participants tend to exhibit an optimistic illusion of control, whereas depressed participants tend to better detect a lack of control. Recently, we suggested that the different activity levels (measured as the probability of responding during a contingency learning task) exhibited by depressed and nondepressed individuals is partly responsible for this effect. The two studies presented in this paper provide further support for this mediational hypothesis, in which mood is the distal cause of the illusion of control operating through activity level, the proximal cause. In Study 1, the probability of responding, P(R), was found to be a mediator variable between the depressive symptoms and the judgments of control. In Study 2, we intervened directly on the mediator variable: The P(R) for both depressed and nondepressed participants was manipulated through instructions. Our results confirm that P(R) manipulation produced differences in the participants' perceptions of uncontrollability. Importantly, the intervention on the mediator variable cancelled the effect of the distal cause; the participants' judgments of control were no longer mood dependent when the P(R) was manipulated. This result supports the hypothesis that the so-called depressive realism effect is actually mediated by the probability of responding.	[Blanco, Fernando; Matute, Helena; Vadillo, Miguel A.] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Blanco, F (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fblanco81@gmail.com	Vadillo, Miguel A./A-8702-2011; Blanco, Fernando/E-8941-2010; Matute, Helena/A-8256-2011	Vadillo, Miguel A./0000-0001-8421-816X; Blanco, Fernando/0000-0003-1283-8313; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion of the Basque Government [PI2012-56]	Direccion General de Investigacion of the Spanish Government; Departamento de Educacion, Universidades e Investigacion of the Basque Government	Support for this research was provided by the Direccion General de Investigacion of the Spanish Government (Grant PSI2011-26965) and the Departamento de Educacion, Universidades e Investigacion of the Basque Government (Grant PI2012-56). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN R, 1991, CLIN PSYCHOL REV, V11, P565, DOI 10.1016/0272-7358(91)90004-E; Aeschleman SR, 2003, BEHAV PROCESS, V61, P37, DOI 10.1016/S0376-6357(02)00158-4; Allan LG, 2007, Q J EXP PSYCHOL, V60, P482, DOI 10.1080/17470210601002686; Alloy L. B., 1988, COGNITIVE PROCESS; ALLOY LB, 1992, J ABNORM PSYCHOL, V101, P234, DOI 10.1037/0021-843X.101.2.234; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BENASSI VA, 1985, J PERS SOC PSYCHOL, V49, P1323, DOI 10.1037/0022-3514.49.5.1323; Birnbaum MH, 2005, HANDBOOK OF HUMAN FACTORS IN WEB DESIGN, P471; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2009, PSYCHOL REC, V59, P551, DOI 10.1007/BF03395681; COHEN J, 1968, PSYCHOL BULL, V70, P426, DOI 10.1037/h0026714; Conde V, 1976, REV PSICOLOGIA GEN A, V31, P496; Consejo General de Colegios Oficiales de Psicologos, 2010, COD DEONT; DOBSON K, 1989, Canadian Journal of Behavioural Science, V21, P419, DOI 10.1037/h0079839; FRANKEL MS, 1999, WORKSH CONV AM ASS A; Hannah SD, 2009, CAN J EXP PSYCHOL, V63, P59, DOI 10.1037/a0013403; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; Kraut R, 2003, PSYCHOL RES ONLINE O; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; LEWINSOHN PM, 1980, PSYCHOTHER-THEOR RES, V17, P322, DOI 10.1037/h0085929; Lewinsohn PM, 1974, PSYCHOL DEPRESSION C, P176; MATUTE H, 1995, Q J EXP PSYCHOL-B, V48, P142; MATUTE H, 1994, LEARN MOTIV, V25, P216, DOI 10.1006/lmot.1994.1012; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; MATUTE H, 2007, P EUR COGN SCI C, P341; Matute H, 2007, CYBERPSYCHOL BEHAV, V10, P176, DOI 10.1089/cpb.2006.9971; MISCHEL W, 1979, AM PSYCHOL, V34, P740, DOI 10.1037/0003-066X.34.9.740; Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004; Msetfi RM, 2007, Q J EXP PSYCHOL, V60, P461, DOI 10.1080/17470210601002595; Msetfi RM, 2005, J EXP PSYCHOL GEN, V134, P10, DOI 10.1037/0096-3445.134.1.10; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Presson PK, 2003, SOC BEHAV PERSONAL, V31, P483, DOI 10.2224/sbp.2003.31.5.483; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rudski JM, 1999, PSYCHOL REC, V49, P245, DOI 10.1007/BF03395319; Sloman S., 2005, CAUSAL MODELS PEOPLE; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Taylor SE, 1988, PSYCHOL BULL, V103, P192, DOI [10.1037/0033-2909.103.2.193, DOI 10.1037/0033-2909.103.2.193]; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Wasserman EA, 1996, PSYCHOL LEARN MOTIV, V34, P207, DOI 10.1016/S0079-7421(08)60562-9; White PA, 2002, EUR J SOC PSYCHOL, V32, P667, DOI 10.1002/ejsp.115	45	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46203	10.1371/journal.pone.0046203	http://dx.doi.org/10.1371/journal.pone.0046203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23029435	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500072
J	Berguer, PM; Alzogaray, VA; Rossi, AH; Mundinano, J; Piazzon, I; Goldbaum, FA				Berguer, Paula M.; Alzogaray, Vanina A.; Hugo Rossi, Andres; Mundinano, Juliana; Piazzon, Isabel; Goldbaum, Fernando A.			A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants	PLOS ONE			English	Article							T-CELL RESPONSES; SPP. LUMAZINE SYNTHASE; CROSS-PRESENTATION; IN-VIVO; ENDOPLASMIC-RETICULUM; SELECTIVE EXPRESSION; ANTIGEN PRESENTATION; CYTOPLASMIC PROTEIN; PROTECTIVE IMMUNITY; BACTERIAL PROTEIN	Lumazine synthase from Brucella spp. (BLS) is a highly immunogenic decameric protein. It is possible to insert foreign peptides or proteins at its ten-amino acid termini. These chimeras elicit systemic and oral immunity without adjuvants, which are commonly needed in the formulation of subunit-based vaccines. Here, we show that BLS induces the cross presentation of a covalently attached peptide OVA(257-264) and a specific cytotoxic response to this peptide in the absence of adjuvants. Unlike other subunit-based vaccines, this chimera induces rapid activation of CTLs and a specific cytotoxic response, making this polymeric protein an ideal antigen carrier for vaccine development. Adoptive transfer of transgenic OT-I T cells revealed efficient cross presentation of BLS-OVA(257-264) in vivo. BLS-OVA(257-264) immunization induced the proliferation of OVA(257-264)-specific CD8+ lymphocytes and also increased the percentage of OVA(257-264)-specific CD8+ cells expressing the early activation marker CD69; after 5 days, the percentage of OVA(257-264)-specific CD8+ cells expressing high levels of CD44 increased. This cell subpopulation showed decreased expression of IL-7R alpha, indicating that BLS-OVA(257-264) induced the generation of CD8+ effector cells. BLS-OVA(257-264) was cross presented in vitro independently of the presence of a functional TLR4 in the DCs. Finally, we show that immunization of wild type mice with the chimera BLS-OVA(257-264) without adjuvants induced a strong OVA(257-264)-specific effector cytotoxic response. This cytotoxicity is dependent on TLR4 as is not induced in mice lacking a functional receptor. These data show that TLR4 signaling is necesary for the induction of a cytotoxic response but not for antigen cross presentation.	[Berguer, Paula M.; Alzogaray, Vanina A.; Hugo Rossi, Andres; Goldbaum, Fernando A.] Consejo Nacl Invest Cient & Tecn CONICET, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Mundinano, Juliana; Piazzon, Isabel] Acad Nacl Med Buenos Aires, Lab Med Expt, IMEX CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental	Berguer, PM (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina.	pau_berguer@yahoo.com	Berguer, Paula/AAI-6353-2020	Goldbaum, Fernando/0000-0001-6235-3002	Howard Hughes Medical Institute; Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT(ANPCyT)	This work was supported in part by grants from the Howard Hughes Medical Institute to F.A.G. (http://www.hhmi.org/grants) and from the Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT (http://www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baldi PC, 1996, CLIN DIAGN LAB IMMUN, V3, P472, DOI 10.1128/CDLI.3.4.472-476.1996; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Bellido D, 2009, VACCINE, V27, P136, DOI 10.1016/j.vaccine.2008.10.018; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; Fierer J, 2000, J INFECT DIS, V181, P681, DOI 10.1086/315256; Freigang S, 2007, P NATL ACAD SCI USA, V104, P13426, DOI 10.1073/pnas.0704423104; Goldbaum FA, 1999, J MED MICROBIOL, V48, P833, DOI 10.1099/00222615-48-9-833; GOLDBAUM FA, 1993, J CLIN MICROBIOL, V31, P2141, DOI 10.1128/JCM.31.8.2141-2145.1993; HAVRAN WL, 1988, J IMMUNOL, V140, P1034; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heit A, 2005, J IMMUNOL, V174, P4373, DOI 10.4049/jimmunol.174.7.4373; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Koniaras C, 1997, INT IMMUNOL, V9, P1601, DOI 10.1093/intimm/9.10.1601; Laplagne DA, 2004, PROTEINS, V57, P820, DOI 10.1002/prot.20248; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MERUELO D, 1982, P NATL ACAD SCI-BIOL, V79, P7460, DOI 10.1073/pnas.79.23.7460; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Oh JZ, 2010, J IMMUNOL, V185, P4602, DOI 10.4049/jimmunol.1001892; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Schirmbeck R, 2003, J IMMUNOL, V171, P5198, DOI 10.4049/jimmunol.171.10.5198; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sciutto E, 2005, VACCINE, V23, P2784, DOI 10.1016/j.vaccine.2004.11.043; Shaw CA, 2008, INFECT IMMUN, V76, P1214, DOI 10.1128/IAI.01208-07; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Velikovsky CA, 2000, J IMMUNOL METHODS, V244, P1, DOI 10.1016/S0022-1759(00)00244-1; Velikovsky CA, 2003, INFECT IMMUN, V71, P5750, DOI 10.1128/IAI.71.10.5750-5755.2003; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Weck MM, 2007, BLOOD, V109, P3890, DOI 10.1182/blood-2006-04-015719; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	59	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45705	10.1371/journal.pone.0045705	http://dx.doi.org/10.1371/journal.pone.0045705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029192	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700060
J	Gil-Humanes, J; Piston, F; Gimenez, MJ; Martin, A; Barro, F				Gil-Humanes, Javier; Piston, Fernando; Gimenez, Maria J.; Martin, Antonio; Barro, Francisco			The Introgression of RNAi Silencing of gamma-Gliadins into Commercial Lines of Bread Wheat Changes the Mixing and Technological Properties of the Dough	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNIT; SDS-SEDIMENTATION TEST; MAKING QUALITY; FUNCTIONAL-PROPERTIES; ALLELIC VARIATION; GEL-ELECTROPHORESIS; TRANSGENIC LINES; OMEGA-GLIADINS; PROTEINS; GENES	In the present work the effects on dough quality by the down-regulation of gamma-gliadins in different genetic backgrounds of bread wheat were investigated. RNAi-mediated silencing of gamma-gliadins was introgressed by conventional crossing into three commercial bread wheat lines (namely 'Gazul', 'Podenco' and 'Arpain'), and along with the transgenic line A1152 (cv. Bobwhite) compared with their respective wild types. The protein fractions were quantified by RP-HPLC, whereas the technological and mixing properties were assessed by SDSS test and by the Mixograph instrument. Principal component analysis (PCA) was carried out for both the wild types and the transgenic lines, showing differences in the factors affecting the technological and mixing properties of the dough as a consequence of the reduction of the gamma-gliadins. In transgenic lines, the alpha- and omega-gliadins, and total gliadins negatively affected the dough strength and tolerance to over-mixing, whereas the L/H ratio showed the opposite effect, positively influencing the dough quality. The increase of the SDSS volume in the transgenic lines of 'Gazul', 'Podenco' and 'Arpain' indicates increased gluten strength and quality respect to the wild types. SDSS volume was found to be positively influenced by the amount of glutenins, which were also increased in the transgenic lines. In addition, a positive effect was observed in the MT, PR1 and RBD in some of the transgenic lines of 'Podenco' and 'Arpain'. In conclusion, the down-regulation of gamma-gliadins resulted in stronger doughs and a better tolerance to over-mixing in some transgenic lines. Although the reduction of gamma-gliadins seems not to have a direct effect on the mixing and bread-making properties, the compensatory effect on the synthesis of the other prolamins may result in stronger doughs with improved over-mixing resistance.	[Gil-Humanes, Javier; Piston, Fernando; Gimenez, Maria J.; Martin, Antonio; Barro, Francisco] Inst Sustainable Agr CSIC, Dept Plant Breeding, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Gil-Humanes, J (corresponding author), Inst Sustainable Agr CSIC, Dept Plant Breeding, Cordoba, Spain.	javigil@ias.csic.es	Piston, Fernando/AAD-6975-2020; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/E-8572-2017; Barro, Francisco/J-3254-2014; Martin, Antonio/K-6547-2017	Barro, Francisco/0000-0002-7652-229X; Martin, Antonio/0000-0002-9755-9278; Piston, Fernando/0000-0002-5496-0205; Gimenez, Maria Jose/0000-0003-3854-5746; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Ministerio de Economia y Competitividad [AGL2010-19643-C02-02, TRA2009_0047]; European Regional Development Fund (FEDER); Junta de Andalucia [P09-AGR-4783]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministerio de Economia y Competitividad (AGL2010-19643-C02-02 and TRA2009_0047), the European Regional Development Fund (FEDER) and Junta de Andalucia (Project P09-AGR-4783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1999, 5440A AACC, P1; Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Becker D, 2006, SILENCING ALPHA GLIA, P86; BRANLARD G, 1985, J CEREAL SCI, V3, P329, DOI 10.1016/S0733-5210(85)80006-0; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; ECKERT B, 1993, Z LEBENSM UNTERS FOR, V196, P122, DOI 10.1007/BF01185570; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Gil-Humanes J, 2012, J CEREAL SCI; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; GUPTA RB, 1994, J CEREAL SCI, V19, P19, DOI 10.1006/jcrs.1994.1004; Hamer RJ, 2009, WHEAT CHEM TECHNOLOG; HOSENEY RC, 1969, CEREAL CHEM, V46, P117; Hsia CC, 2001, THEOR APPL GENET, V103, P37, DOI 10.1007/s00122-001-0552-2; ICC, 1994, 1052 ICC INT ASS CER; ICC, 1994, 1231 ICC INT ASS CER; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; KASARDA DD, 1983, BIOCHIM BIOPHYS ACTA, V747, P138, DOI 10.1016/0167-4838(83)90132-2; KHAN K, 1985, CEREAL CHEM, V62, P310; KHAN K, 1989, CEREAL CHEM, V66, P391; Khatkar BS, 2002, J CEREAL SCI, V35, P299, DOI 10.1006/jcrs.2001.0429; KOLSTER P, 1993, CEREAL FOOD WORLD, V38, P76; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; Masci S, 2003, MOL BREEDING, V12, P209, DOI 10.1023/A:1026346823301; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1984, THEOR APPL GENET, V67, P235, DOI 10.1007/BF00317044; PAYNE PI, 1987, J CEREAL SCI, V6, P103, DOI 10.1016/S0733-5210(87)80047-4; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; Piston F, 2011, PLOS ONE, V6; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Rakszegi M, 2005, J CEREAL SCI, V42, P15, DOI 10.1016/j.jcs.2005.02.006; Shewry P R, 1995, Methods Mol Biol, V49, P399; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; SHEWRY PR, 1989, OXFORD SURV PLANT MO, V6, P163; Sissons MJ, 1998, CEREAL CHEM, V75, P30, DOI 10.1094/CCHEM.1998.75.1.30; Tosi P, 2005, MOL BREEDING, V16, P113, DOI 10.1007/s11032-005-5912-1; Uthayakumaran S, 2001, CEREAL CHEM, V78, P138, DOI 10.1094/CCHEM.2001.78.2.138; Uthayakumaran S, 2000, CEREAL CHEM, V77, P737, DOI 10.1094/CCHEM.2000.77.6.737; WEEGELS PL, 1994, J CEREAL SCI, V20, P253, DOI 10.1006/jcrs.1994.1065; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 2006, CHARACTERIZATION WHE, P13; Williams R, 1988, 4 ICARDA; Yue SJ, 2008, J CEREAL SCI, V47, P153, DOI 10.1016/j.jcs.2007.03.006	50	38	41	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45937	10.1371/journal.pone.0045937	http://dx.doi.org/10.1371/journal.pone.0045937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029328	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700091
J	Jusufovic, E; Rijavec, M; Keser, D; Korosec, P; Sodja, E; Iljazovic, E; Radojevic, Z; Kosnik, M				Jusufovic, Edin; Rijavec, Matija; Keser, Dragan; Korosec, Peter; Sodja, Eva; Iljazovic, Ermina; Radojevic, Zorica; Kosnik, Mitja			let-7b and miR-126 Are Down-Regulated in Tumor Tissue and Correlate with Microvessel Density and Survival Outcomes in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ACTIVATED MICRORNA; ANGIOGENESIS; GROWTH; EXPRESSION; CLUSTER; MYC; METASTASIS; MIR-17-92; TARGETS	Angiogenesis is a critical event in the development, progression, and spread of various human cancers, including lung cancer. Molecular mechanisms that underlie the complex regulation of angiogenic processes are poorly understood. However, an increasing body of evidence indicates miRNAs as important regulators of tumor angiogenesis. Forceps biopsies were collected from tumor tissue, surrounding tissue, and non-tumor tissue from 50 NSCLC patients. Lung tissue samples from individuals with no clinical evidence of a cancerous disease served as controls. Immunohistochemical staining for Factor VIII was used to evaluate microvessel density (MVD). TaqMan (R) primer-probe sets were used in quantitative real-time RT-PCR reactions to determine expression levels of let-7b, miR-126, miR-9, and miR-19a. We demonstrated significantly higher MVD and decreased expression levels of let-7b and miR-126 in tumor tissue and surrounding tissue in comparison to corresponding non-tumor tissue or lung tissue from the control group. In addition, no differences in MVD and expression levels of both miRNAs between tumor tissue and surrounding tissue from NSCLC patients were observed. Low expression of both miRNAs correlated with high MVD and worse progression-free survival and overall survival. These observations strongly suggest similar molecular alternations within tumor tissue and surrounding tissue that comprise a specific microenvironment. Low expression of let-7b and miR-126 seems to have a possible anti-angiogenic role in lung tumor tissue and significantly correlates with worse survival outcomes for lung cancer patients. Moreover, the regulation of let-7b and miR-126 expression could have therapeutic potential because it could reduce tumor angiogenesis and therefore suppress tumor growth in lung cancer patients.	[Jusufovic, Edin; Keser, Dragan; Iljazovic, Ermina; Kosnik, Mitja] Univ Tuzla, Fac Med, Tuzla, Bosnia & Herceg; [Jusufovic, Edin; Keser, Dragan] Med Ctr Tuzla, Polyclin Pulm Dis, Tuzla, Bosnia & Herceg; [Rijavec, Matija; Korosec, Peter; Sodja, Eva; Kosnik, Mitja] Univ Clin Golnik, Golnik, Slovenia; [Radojevic, Zorica] Gen Hosp Uzice, Uzice, Serbia	University of Tuzla; University Clinic Golnik	Kosnik, M (corresponding author), Univ Tuzla, Fac Med, Tuzla, Bosnia & Herceg.	mitja.kosnik@klinika-golnik.si	Košnik, Mitja/AAI-2295-2019	Košnik, Mitja/0000-0002-4701-7374; Korosec, Peter/0000-0002-0835-1599; Rijavec, Matija/0000-0002-2596-4952				Arora H, 2011, EXP MOL MED, V43, P298, DOI 10.3858/emm.2011.43.5.031; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mathonnet M, 2006, WORLD J GASTROENTERO, V12, P830, DOI 10.3748/wjg.v12.i5.830; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pavet V, 2011, ONCOGENE, V30, P1, DOI 10.1038/onc.2010.460; Peng CW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-101; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsunoda S, 2009, AM J PATHOL, V174, P671, DOI 10.2353/ajpath.2009.080471; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yu DC, 2010, INT J MOL SCI, V11, P2901, DOI 10.3390/ijms11082901; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	41	86	94	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45577	10.1371/journal.pone.0045577	http://dx.doi.org/10.1371/journal.pone.0045577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029111	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700047
J	Tandon, R; Giret, MTM; SenGupta, D; York, VA; Wiznia, AA; Rosenberg, MG; Kallas, EG; Ndhlovu, LC; Nixon, DF				Tandon, Ravi; Giret, Maria T. M.; SenGupta, Devi; York, Vanessa A.; Wiznia, Andrew A.; Rosenberg, Michael G.; Kallas, Esper G.; Ndhlovu, Lishomwa C.; Nixon, Douglas F.			Age-Related Expansion of Tim-3 Expressing T Cells in Vertically HIV-1 Infected Children	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; DISEASE PROGRESSION; REPLICATIVE SENESCENCE; CD38 EXPRESSION; VIRUS-INFECTION; UNITED-KINGDOM; RNA LEVELS; CD4(+)	As perinatally HIV-1-infected children grow into adolescents and young adults, they are increasingly burdened with the long-term consequences of chronic HIV-1 infection, with long-term morbidity due to inadequate immunity. In progressive HIV-1 infection in horizontally infected adults, inflammation, T cell activation, and perturbed T cell differentiation lead to an "immune exhaustion'', with decline in T cell effector functions. T effector cells develop an increased expression of CD57 and loss of CD28, with an increase in co-inhibitory receptors such as PD-1 and Tim-3. Very little is known about HIV-1 induced T cell dysfunction in vertical infection. In two perinatally antiretroviral drug treated HIV-1-infected groups with median ages of 11.2 yr and 18.5 yr, matched for viral load, we found no difference in the proportion of senescent CD28(-)CD57(+)CD8(+) T cells between the groups. However, the frequency of Tim-3(+)CD8(+) and Tim-3(+)CD4(+) exhausted T cells, but not PD-1(+) T cells, was significantly increased in the adolescents with longer duration of infection compared to the children with shorter duration of HIV-1 infection. PD-1(+)CD8(+) T cells were directly associated with T cell immune activation in children. The frequency of Tim-3(+)CD8(+) T cells positively correlated with HIV-1 plasma viral load in the adolescents but not in the children. These data suggest that Tim-3 upregulation was driven by both HIV-1 viral replication and increased age, whereas PD-1 expression is associated with immune activation. These findings also suggest that the Tim-3 immune exhaustion phenotype rather than PD-1 or senescent cells plays an important role in age-related T cell dysfunction in perinatal HIV-1 infection. Targeting Tim-3 may serve as a novel therapeutic approach to improve immune control of virus replication and mitigate age related T cell exhaustion.	[Tandon, Ravi; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Honolulu, HI 96822 USA; [SenGupta, Devi; York, Vanessa A.; Nixon, Douglas F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Giret, Maria T. M.; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Wiznia, Andrew A.; Rosenberg, Michael G.] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Hawaii System; University of California System; University of California San Francisco; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine	Tandon, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Honolulu, HI 96822 USA.	rtandon@hawaii.edu	n, l/AAX-3992-2020; Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Ndhlovu, Lishomwa/0000-0001-5427-4187; Kallas, Esper/0000-0003-2026-6925	National Institute of Allergy and Infectious Diseases [R56AI083112]; National Institutes of Health grant [AI60397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083112, R21AI060397, P30AI027763] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Award Number R56AI083112 from the National Institute of Allergy and Infectious Diseases supported this work (http://www.niaid.nih.gov/Pages/default.aspx). The project was also supported by National Institutes of Health grant (AI60397)(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Agarwal A, 2007, J CLIN VIROL, V40, P301, DOI 10.1016/j.jcv.2007.08.020; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Amaya RA, 2002, PEDIATR INFECT DIS J, V21, P405, DOI 10.1097/00006454-200205000-00011; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Baitsch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030852; Banerjee P, 2007, J VIROL, V81, P9707, DOI 10.1128/JVI.00887-07; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brugnoni D, 1997, CLIN EXP IMMUNOL, V109, P412, DOI 10.1046/j.1365-2249.1997.4871386.x; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gibb DM, 2003, BMJ-BRIT MED J, V327, P1019, DOI 10.1136/bmj.327.7422.1019; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Goulder PJR, 2011, ADV EXP MED BIOL, V719, P25, DOI 10.1007/978-1-4614-0204-6_3; Harrison L, 2012, AIDS BEHAV; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kahana SY, 2012, AIDS BEHAV; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kassu A, 2011, AIDS RES HUM RETROV, V27, P1, DOI 10.1089/aid.2010.0156; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Legrand FA, 2005, AIDS, V19, P1575, DOI 10.1097/01.aids.0000186816.99993.8e; Leonard EG, 2003, PEDIATR INFECT DIS J, V22, P77, DOI 10.1097/00006454-200301000-00018; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; McElhaney JE, 2009, EXPERT REV VACCINES, V8, P593, DOI 10.1586/ERV.09.12; Mekmullica J, 2009, CLIN INFECT DIS, V48, P338, DOI 10.1086/595885; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Merino J, 1998, CLIN EXP IMMUNOL, V112, P48; MJ O, 1994, VERTICALLY ACQUIRED; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nociari MM, 1999, J IMMUNOL, V162, P3327; Paul ME, 2005, J ALLERGY CLIN IMMUN, V115, P848, DOI 10.1016/j.jaci.2004.11.054; Prendergast A, 2011, AIDS RES HUMAN RETRO; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Resino S, 2004, CLIN INFECT DIS, V38, P412, DOI 10.1086/380793; Romeiro Juliana Ribeiro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P164, DOI 10.1177/1545109711421642; Sabin CA, 2008, AIDS, V22, P1463; SADATSOWTI B, 1991, EUR J IMMUNOL, V21, P737, DOI 10.1002/eji.1830210329; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Shimada Y, 2009, EXP GERONTOL, V44, P517, DOI 10.1016/j.exger.2009.05.003; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	65	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45733	10.1371/journal.pone.0045733	http://dx.doi.org/10.1371/journal.pone.0045733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029209	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700063
J	Bueno, CR; Pantaleao, LC; Voltarelli, VA; Bozi, LHM; Brum, PC; Zatz, M				Bueno Junior, Carlos R.; Pantaleao, Lucas C.; Voltarelli, Vanessa A.; Bozi, Luiz Henrique M.; Brum, Patricia Chakur; Zatz, Mayana			Combined Effect of AMPK/PPAR Agonists and Exercise Training in mdx Mice Functional Performance	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; CREATINE-KINASE; HEART-FAILURE; ANIMAL-MODELS; MOUSE; EXPRESSION; IMPROVES; DISEASES	The present investigation was undertaken to test whether exercise training (ET) associated with AMPK/PPAR agonists (EM) would improve skeletal muscle function in mdx mice. These drugs have the potential to improve oxidative metabolism. This is of particular interest because oxidative muscle fibers are less affected in the course of the disease than glycolitic counterparts. Therefore, a cohort of 34 male congenic C57Bl/10J mdx mice included in this study was randomly assigned into four groups: vehicle solution (V), EM [AICAR (AMPK agonist, 50 mg/Kg-1.day-1, ip) and GW 1516 (PPAR delta agonist, 2.5 mg/Kg-1.day-1, gavage)], ET (voluntary running on activity wheel) and EM+ET. Functional performance (grip meter and rotarod), aerobic capacity (running test), muscle histopathology, serum creatine kinase (CK), levels of ubiquitined proteins, oxidative metabolism protein expression (AMPK, PPAR, myoglobin and SCD) and intracellular calcium handling (DHPR, SERCA and NCX) protein expression were analyzed. Treatments started when the animals were two months old and were maintained for one month. A significant functional improvement (p<0.05) was observed in animals submitted to the combination of ET and EM. CK levels were decreased and the expression of proteins related to oxidative metabolism was increased in this group. There were no differences among the groups in the intracellular calcium handling protein expression. To our knowledge, this is the first study that tested the association of ET with EM in an experimental model of muscular dystrophy. Our results suggest that the association of ET and EM should be further tested as a potential therapeutic approach in muscular dystrophies.	[Bueno Junior, Carlos R.; Zatz, Mayana] Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil; [Pantaleao, Lucas C.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Voltarelli, Vanessa A.; Bozi, Luiz Henrique M.; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zatz, M (corresponding author), Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil.	mayazatz@usp.br	Bozi, Luiz H M/K-5259-2012; Zatz, Mayana/M-5338-2015; Junior, Carlos Bueno/K-3440-2016; Cetgen, Inct/I-2412-2013; Voltarelli, Vanessa Azevedo/J-3419-2015; Bozi, Luiz/AAT-6126-2020; Voltarelli, Vanessa Azevedo/AAB-8897-2021; humano, Cepid Genoma/I-4067-2013; Brum, Patricia C/E-6605-2011	Bozi, Luiz H M/0000-0002-5698-1181; Zatz, Mayana/0000-0003-3970-8025; Junior, Carlos Bueno/0000-0002-2228-0758; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Brum, Patricia C/0000-0002-4750-6506	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - CEPID 98/14254-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - CEPID 98/14254-2), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Instituto Nacional de Ciencia e Tecnologia (INCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, EXP NEUROL, V190, P184, DOI 10.1016/j.expneurol.2004.06.029; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Baltgalvis KA, 2012, MED SCI SPO IN PRESS; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Carter GT, 2002, AM J PHYS MED REHAB, V81, pS151, DOI 10.1097/00002060-200211001-00016; CARTER GT, 1995, NEUROMUSCULAR DISORD, V5, P323, DOI 10.1016/0960-8966(94)00063-F; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Garrood P, 2008, NEUROMUSCULAR DISORD, V18, P71, DOI 10.1016/j.nmd.2007.07.006; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; Hayes A, 1998, AM J PHYSIOL-CELL PH, V274, pC1138, DOI 10.1152/ajpcell.1998.274.4.C1138; Kreuz S, 2009, DIABETES-METAB RES, V25, P577, DOI 10.1002/dmrr.997; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Li ZF, 2008, J NEUROL SCI, V264, P77, DOI 10.1016/j.jns.2007.07.027; Markert CD, 2011, MUSCLE NERVE, V43, P464, DOI 10.1002/mus.21987; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I; ZATZ M, 1976, J GENET HUM, V24, P153	42	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45699	10.1371/journal.pone.0045699	http://dx.doi.org/10.1371/journal.pone.0045699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029189	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800081
J	Kiiski, H; Reilly, RB; Lonergan, R; Kelly, S; O'Brien, MC; Kinsella, K; Bramham, J; Burke, T; Donnchadha, SO; Nolan, H; Hutchinson, M; Tubridy, N; Whelan, R				Kiiski, Hanni; Reilly, Richard B.; Lonergan, Roisin; Kelly, Siobhan; O'Brien, Marie Claire; Kinsella, Katie; Bramham, Jessica; Burke, Teresa; Donnchadha, Sean O.; Nolan, Hugh; Hutchinson, Michael; Tubridy, Niall; Whelan, Robert			Only Low Frequency Event-Related EEG Activity Is Compromised in Multiple Sclerosis: Insights from an Independent Component Clustering Analysis	PLOS ONE			English	Article							SERIAL-ADDITION TASK; HIGH-RESOLUTION EEG; COGNITIVE IMPAIRMENT; THETA-OSCILLATIONS; BLIND SEPARATION; ERP; POTENTIALS; DYNAMICS; AMPLITUDE; RESPONSES	Cognitive impairment (CI), often examined with neuropsychological tests such as the Paced Auditory Serial Addition Test (PASAT), affects approximately 65% of multiple sclerosis (MS) patients. The P3b event-related potential (ERP), evoked when an infrequent target stimulus is presented, indexes cognitive function and is typically compared across subjects' scalp electroencephalography (EEG) data. However, the clustering of independent components (ICs) is superior to scalp-based EEG methods because it can accommodate the spatiotemporal overlap inherent in scalp EEG data. Event-related spectral perturbations (ERSPs; event-related mean power spectral changes) and inter-trial coherence (ITCs; event-related consistency of spectral phase) reveal a more comprehensive overview of EEG activity. Ninety-five subjects (56 MS patients, 39 controls) completed visual and auditory two-stimulus P3b event-related potential tasks and the PASAT. MS patients were also divided into CI and non-CI groups (n = 18 in each) based on PASAT scores. Data were recorded from 128-scalp EEG channels and 4 IC clusters in the visual, and 5 IC clusters in the auditory, modality were identified. In general, MS patients had significantly reduced ERSP theta power versus controls, and a similar pattern was observed for CI vs. non-CI MS patients. The ITC measures were also significantly different in the theta band for some clusters. The finding that MS patients had reduced P3b task-related theta power in both modalities is a reflection of compromised connectivity, likely due to demyelination, that may have disrupted early processes essential to P3b generation, such as orientating and signal detection. However, for posterior sources, MS patients had a greater decrease in alpha power, normally associated with enhanced cognitive function, which may reflect a compensatory mechanism in response to the compromised early cognitive processing.	[Kiiski, Hanni; Reilly, Richard B.; Nolan, Hugh; Whelan, Robert] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Lonergan, Roisin; Kelly, Siobhan; Kinsella, Katie; Hutchinson, Michael; Tubridy, Niall] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [O'Brien, Marie Claire; Bramham, Jessica; Burke, Teresa; Donnchadha, Sean O.] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland; [Whelan, Robert] Univ Vermont, Dept Psychiat, Burlington, VT USA	Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University of Vermont	Whelan, R (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.	whelanrob@gmail.com	Whelan, Robert/E-5365-2010; Kiiski, Hanni/O-2827-2014; Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011; hutchinson, michael/H-3508-2019	Whelan, Robert/0000-0002-2790-7281; Kiiski, Hanni/0000-0002-2884-2352; Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Burke, Teresa/0000-0001-8093-9912; Bramham, Jessica/0000-0002-6696-7500; O Donnchadha, Sean/0000-0002-7861-426X; hutchinson, michael/0000-0002-8675-1723	Enterprise Ireland grant; Science Foundation Ireland grant; Irish Research Council for Science, Engineering Technology	Enterprise Ireland grant; Science Foundation Ireland grant(Science Foundation Ireland); Irish Research Council for Science, Engineering Technology(Irish Research Council for Science, Engineering and Technology)	This study was partly funded by an Enterprise Ireland grant to R.B. Reilly (eBiomed: eHealthCare based on Biomedical Signal Processing and ICT for Integrated Diagnosis and Treatment of Disease, http://www.enterprise-ireland.com/en/), by a Science Foundation Ireland grant to R.B. Reilly (Research Frontiers Program, http://www.sfi.ie), and by an Irish Research Council for Science, Engineering & Technology (www.ircset.ie) grant to H. Kiiski. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Barker-Collo SL, 2005, ARCH CLIN NEUROPSYCH, V20, P145, DOI 10.1016/j.acn.2004.03.007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benjamini Y, 2001, ANN STAT, V29, P1165; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2006, ENCYCL MED DEVICES I, DOI [10.1002/0471732877.emd318, DOI 10.1002/0471732877.EMD318]; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Ellger T, 2002, J NEUROL SCI, V205, P35, DOI 10.1016/S0022-510X(02)00278-2; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Gerschlager W, 2000, EUR NEUROL, V44, P205, DOI 10.1159/000008237; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GIL R, 1993, ELECTROEN CLIN NEURO, V88, P182, DOI 10.1016/0168-5597(93)90003-8; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Groppe D. M., 2008, COGNITIVE SCI ONLINE, V6.1, P1; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hoffmann S, 2007, CURR OPIN NEUROL, V20, P275, DOI 10.1097/WCO.0b013e32810c8e87; Kalmar JH, 2008, NEUROPSYCHOLOGY, V22, P442, DOI 10.1037/0894-4105.22.4.442; Kiiski H, 2011, J NEUROL SCI, V305, P45, DOI 10.1016/j.jns.2011.03.018; Kiiski H, 2010, EUROPEAN J NEUROLOGY; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Lazeron RHC, 2005, MULT SCLER J, V11, P524, DOI 10.1191/1352458505ms1201oa; Leocani L, 2000, J NEUROL NEUROSUR PS, V69, P192, DOI 10.1136/jnnp.69.2.192; Leocani L, 2010, NEUROL SCI, V31, P249, DOI 10.1007/s10072-010-0398-y; Magnano I, 2006, J NEUROL SCI, V245, P117, DOI 10.1016/j.jns.2005.08.027; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; POLICH J, 1992, INT J PSYCHOPHYSIOL, V12, P155, DOI 10.1016/0167-8760(92)90006-W; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Sailer M, 2001, J NEUROL, V248, P1049, DOI 10.1007/s004150170024; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Vazquez-Marrufo M, 2008, INT J NEUROSCI, V118, P27, DOI 10.1080/00207450601041906; Vazquez-Marrufo M, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-44; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Whelan R, 2010, CLIN NEUROPHYSIOL, V121, P1420, DOI 10.1016/j.clinph.2010.03.019; Whelan R, 2010, J NEUROL SCI, V293, P45, DOI 10.1016/j.jns.2010.03.010; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079	70	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45536	10.1371/journal.pone.0045536	http://dx.doi.org/10.1371/journal.pone.0045536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029079	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800057
J	Murray, JE; Judge, M; Chen, Y				Murray, Janice E.; Judge, Madeline; Chen, Yan			Ignored Faces Produce Figural Face Aftereffects	PLOS ONE			English	Article							SPATIAL ATTENTION; ADAPTATION; RACE; COMPETITION; DISTINCT; GENDER; INFORMATION	Following adaptation to faces with contracted (or expanded) internal features, faces previously perceived as normal appear distorted in the opposite direction. This figural face aftereffect suggests face-coding mechanisms adapt to changes in the spatial relations of features and/or the global structure of faces. Here, we investigated whether the figural aftereffect requires spatial attention. Participants ignored a distorted adapting face and performed a highly demanding letter-count task. Before and after adaptation, participants rated the normality of morphed distorted faces ranging from 50% contracted through undistorted to 50% expanded. A robust aftereffect was observed. These results suggest that the figural face aftereffect can occur in the absence of spatial attention, even when the attentional demands of the relevant task are high.	[Murray, Janice E.; Judge, Madeline; Chen, Yan] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Murray, JE (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	jmur@psy.otago.ac.nz	Judge, Madeline/AAI-1572-2021; Chen, Yan/L-2855-2015; Chen, Yan/X-3108-2018	Judge, Madeline/0000-0001-5215-9353; Chen, Yan/0000-0002-1665-9294; Chen, Yan/0000-0002-1665-9294	Department of Psychology, University of Otago	Department of Psychology, University of Otago	Supported by the Department of Psychology, University of Otago. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Beselmeyer PEG, 2008, COGNITION, V107, P353; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; Fox E, 2012, EMOTION, V12, P236, DOI 10.1037/a0025321; Hsu SM, 2004, VIS COGN, V11, P871, DOI 10.1080/13506280444000030; Jacques C, 2004, NEUROREPORT, V15, P2417, DOI 10.1097/00001756-200410250-00023; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jaquet E, 2008, VIS COGN, V16, P734, DOI 10.1080/13506280701350647; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Jaquet E, 2007, Q J EXP PSYCHOL, V60, P1457, DOI 10.1080/17470210701467870; Jeffery L, 2006, PSYCHOL SCI, V17, P501, DOI 10.1111/j.1467-9280.2006.01735.x; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; Jenkins R, 2002, COGNITION, V86, pB43, DOI 10.1016/S0010-0277(02)00172-5; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Murray JE, 2011, PSYCHOL RES-PSYCH FO, V75, P324, DOI 10.1007/s00426-010-0310-7; Pegna AJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00088; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; Schneider W., 2002, E PRIME USERS GUIDE; Shin K, 2009, ATTEN PERCEPT PSYCHO, V71, P1507, DOI 10.3758/APP.71.7.1507; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Susilo T, 2010, J VISION, V10, DOI 10.1167/10.13.1; Suzuki S., 2005, FITTING MIND WORLD A, V2, P135, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0006; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24; Yates A, 2010, EMOTION, V10, P822, DOI 10.1037/a0020325; Zhao L, 2001, VISION RES, V41, P2979, DOI 10.1016/S0042-6989(01)00202-4	41	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45928	10.1371/journal.pone.0045928	http://dx.doi.org/10.1371/journal.pone.0045928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029322	Green Published, gold			2022-12-27	WOS:000309392800122
J	Qin, WS; Xu, ZX; Lu, YZ; Zeng, CH; Zheng, CX; Wang, SY; Liu, ZH				Qin, Weisong; Xu, Zhongxiu; Lu, Yizhou; Zeng, Caihong; Zheng, Chunxia; Wang, Shengyu; Liu, Zhihong			Mixed Organic Solvents Induce Renal Injury in Rats	PLOS ONE			English	Article							CHRONIC GLOMERULONEPHRITIS; HYDROCARBON EXPOSURE; OXIDATIVE STRESS; NEPHROTOXICITY; TRICHLOROETHYLENE; DISEASE; TOLUENE; CELL; NEPHROPATHY; MECHANISMS	To investigate the injury effects of organic solvents on kidney, an animal model of Sprague-Dawley (SD) rats treated with mixed organic solvents via inhalation was generated and characterized. The mixed organic solvents consisted of gasoline, dimethylbenzene and formaldehyde (GDF) in the ratio of 2: 2: 1, and were used at 12,000 PPM to treat the rats twice a day, each for 3 hours. Proteinuria appeared in the rats after exposure for 5-6 weeks. The incidences of proteinuria in male and female rats after exposure for 12 weeks were 43.8% (7/16) and 25% (4/16), respectively. Urinary N-Acetyl-beta-(D)-Glucosaminidase (NAG) activity was increased significantly after exposure for 4 weeks. Histological examination revealed remarkable injuries in the proximal renal tubules, including tubular epithelial cell detachment, cloud swelling and vacuole formation in the proximal tubular cells, as well as proliferation of parietal epithelium and tubular reflux in glomeruli. Ultrastructural examination found that brush border and cytoplasm of tubular epithelial cell were dropped, that tubular epithelial cells were partially disintegrated, and that the mitochondria of tubular epithelial cells were degenerated and lost. In addition to tubular lesions, glomerular damages were also observed, including segmental foot process fusion and loss of foot process covering on glomerular basement membrane (GBM). Immunofluorescence staining indicated that the expression of nephrin and podocin were both decreased after exposure of GDF. In contrast, increased expression of desmin, a marker of podocyte injury, was found in some areas of a glomerulus. TUNEL staining showed that GDF induced apoptosis in tubular cells and glomerular cells. These studies demonstrate that GDF can induce both severe proximal tubular damage and podocyte injury in rats, and the tubular lesions appear earlier than that of glomeruli.	[Qin, Weisong; Xu, Zhongxiu; Zeng, Caihong; Zheng, Chunxia; Wang, Shengyu; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Lu, Yizhou] Cent Hosp Zhabei Dist, Dept Nephrol, Shanghai, Peoples R China	Nanjing University	Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	zhihong-liu@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726	National Basic Research Program of China 973 program [2012CB517600, 2012CB517605]; National Natural Science Foundation of China [81270811]	National Basic Research Program of China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517605) and National Natural Science Foundation of China (no. 81270811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi SS, 2004, DRUG CHEM TOXICOL, V27, P425, DOI 10.1081/DCT-200039782; Al-Ghamdi SS, 2003, TOXICOL IN VITRO, V17, P335, DOI 10.1016/S0887-2333(03)00021-3; Bemis JC, 2000, NEUROTOXICOLOGY, V21, P1123; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; Chu I, 2005, J APPL TOXICOL, V25, P193, DOI 10.1002/jat.1051; COMMANDEUR JNM, 1990, CHEM RES TOXICOL, V3, P171, DOI 10.1021/tx00015a001; DANIELL WE, 1988, JAMA-J AM MED ASSOC, V259, P2280; Endou H, 1998, TOXICOL LETT, V103, P29, DOI 10.1016/S0378-4274(98)00275-6; FLOEGE J, 1992, LAB INVEST, V67, P486; Gonzalez-Yebra AL, 2006, INT ARCH OCC ENV HEA, V79, P259, DOI 10.1007/s00420-005-0001-7; Gradden CW, 2001, QJM-MON J ASSOC PHYS, V94, P79, DOI 10.1093/qjmed/94.2.79; HARMAN JW, 1971, J PATHOL, V104, P119, DOI 10.1002/path.1711040206; INOUE O, 1988, INT ARCH OCC ENV HEA, V60, P15, DOI 10.1007/BF00409373; Jakab MG, 2010, MUTAT RES-GEN TOX EN, V698, P11, DOI 10.1016/j.mrgentox.2010.02.015; KLEINKNECHT D, 1980, ARCH INTERN MED, V140, P230, DOI 10.1001/archinte.140.2.230; Kum C, 2007, TOXICOL IND HEALTH, V23, P115, DOI 10.1177/0748233707078218; LOW LK, 1989, TOXICOL IND HEALTH, V5, P85, DOI 10.1177/074823378900500108; McDermott C, 2008, TOXICOL SCI, V101, P263, DOI 10.1093/toxsci/kfm274; Mensing T, 2002, TOXICOL LETT, V128, P243, DOI 10.1016/S0378-4274(01)00545-8; Mutti A, 1999, RENAL FAILURE, V21, P369, DOI 10.3109/08860229909085101; NAKAJIMA H, 1982, Osaka City Medical Journal, V28, P59; Nanez A, 2005, AM J PHYSIOL-RENAL, V289, pF1291, DOI 10.1152/ajprenal.00107.2005; NELSON NA, 1990, AM J NEPHROL, V10, P10, DOI 10.1159/000168048; NUYTS GD, 1995, LANCET, V346, P7, DOI 10.1016/S0140-6736(95)92648-8; PORRO A, 1992, BRIT J IND MED, V49, P738; Radican L, 2006, J OCCUP ENVIRON MED, V48, P1, DOI 10.1097/01.jom.0000190300.51629.e0; Rankin GO, 2008, TOXICOLOGY, V245, P123, DOI 10.1016/j.tox.2007.12.014; RAVNSKOV U, 1979, ACTA MED SCAND, V205, P575; Ravnskov U, 2000, AM J IND MED, V37, P599, DOI 10.1002/(SICI)1097-0274(200006)37:6<599::AID-AJIM4>3.0.CO;2-X; Ravnskov Uffe, 2005, BMC Nephrol, V6, P15, DOI 10.1186/1471-2369-6-15; Skowron J, 2001, Int J Occup Saf Ergon, V7, P35; STACEY NH, 1989, TOXICOL IND HEALTH, V5, P441, DOI 10.1177/074823378900500305; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; STENGEL B, 1995, INT J EPIDEMIOL, V24, P427, DOI 10.1093/ije/24.2.427; Thier R, 2003, INT J HYG ENVIR HEAL, V206, P149, DOI 10.1078/1438-4639-00209; YAQOOB M, 1993, Q J MED, V86, P165; ZIMMERMAN SW, 1975, LANCET, V2, P199	37	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45873	10.1371/journal.pone.0045873	http://dx.doi.org/10.1371/journal.pone.0045873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029287	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800112
J	Dwyer, J; Hebda, JK; Le Guelte, A; Galan-Moya, EM; Smith, SS; Azzi, S; Bidere, N; Gavard, J				Dwyer, Julie; Hebda, Jagoda K.; Le Guelte, Armelle; Galan-Moya, Eva-Maria; Smith, Sherri S.; Azzi, Sandy; Bidere, Nicolas; Gavard, Julie			Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; GROWTH-FACTOR; INDUCED ANGIOGENESIS; VE-CADHERIN; TUMOR-GROWTH; CANCER; INDUCTION; PATHWAY; ACTIVATION; INHIBITION	Glioblastoma constitutes the most aggressive and deadly of brain tumors. As yet, both conventional and molecular-based therapies have met with limited success in treatment of this cancer. Among other explanations, the heterogeneity of glioblastoma and the associated microenvironment contribute to its development, as well as resistance and recurrence in response to treatments. Increased vascularity suggests that tumor angiogenesis plays an important role in glioblastoma progression. However, the molecular crosstalk between endothelial and glioblastoma cells requires further investigation. To examine the effects of glioblastoma-derived signals on endothelial homeostasis, glioblastoma cell secretions were collected and used to treat brain endothelial cells. Here, we present evidence that the glioblastoma secretome provides pro-angiogenic signals sufficient to disrupt VE-cadherin-mediated cell-cell junctions and promote endothelial permeability in brain microvascular endothelial cells. An unbiased angiogenesis-specific antibody array screen identified the chemokine, interleukin-8, which was further demonstrated to function as a key factor involved in glioblastoma-induced permeability, mediated through its receptor CXCR2 on brain endothelia. This underappreciated interface between glioblastoma cells and associated endothelium may inspire the development of novel therapeutic strategies to induce tumor regression by preventing vascular permeability and inhibiting angiogenesis.	[Dwyer, Julie; Hebda, Jagoda K.; Le Guelte, Armelle; Galan-Moya, Eva-Maria; Smith, Sherri S.; Azzi, Sandy; Gavard, Julie] CNRS, UMR8104, Paris, France; [Dwyer, Julie; Hebda, Jagoda K.; Le Guelte, Armelle; Galan-Moya, Eva-Maria; Smith, Sherri S.; Azzi, Sandy; Gavard, Julie] INSERM, U1016, Paris, France; [Dwyer, Julie; Hebda, Jagoda K.; Le Guelte, Armelle; Galan-Moya, Eva-Maria; Smith, Sherri S.; Azzi, Sandy; Gavard, Julie] Univ Paris 05, Paris, France; [Bidere, Nicolas] INSERM, U1014, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gavard, J (corresponding author), CNRS, UMR8104, Paris, France.	julie.gavard@inserm.fr	Galan-Moya, Eva M/I-2912-2015; Gavard, Julie/I-5487-2012; Bidère, Nicolas/K-8887-2015; Gavard, Julie/I-5487-2012	Galan-Moya, Eva M/0000-0001-5758-7592; Gavard, Julie/0000-0002-7985-9007; Bidère, Nicolas/0000-0001-9177-0008; Le Guelte, Armelle/0000-0001-8674-3064; Gavard, Julie/0000-0003-3107-2026	Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer (ARC); Association des Neuro Oncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM); Agence Nationale pour la Recherche (ANR JCJC); Marie Curie International Reintegration grant; Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS); Canceropole Ile-de-France; Universite Paris Descartes	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association des Neuro Oncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche (ANR JCJC)(French National Research Agency (ANR)); Marie Curie International Reintegration grant(European Commission); Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Universite Paris Descartes	This research was supported by Ligue Nationale contre le Cancer, Association pour la Recherche sur le Cancer (ARC), Association des Neuro Oncologues d'Expression Francaise (ANOCEF), Fondation pour la Recherche Medicale (FRM), Agence Nationale pour la Recherche (ANR JCJC) and by a Marie Curie International Reintegration grant. JD is supported by Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS), EMGM and SA by Association pour la Recherche sur le Cancer (ARC), SSS by Canceropole Ile-de-France, ALG and JH by Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia MS, 2010, J ONCOL, V2010, DOI 10.1155/2010/689018; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bonavia R, 2011, ONCOGENE IN PRESS; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caunt M, 2006, CANCER RES, V66, P4125, DOI 10.1158/0008-5472.CAN-05-2570; Desbaillets I, 1997, J EXP MED, V186, P1201, DOI 10.1084/jem.186.8.1201; Dwyer J, 2011, ONCOGENE, V30, P190, DOI 10.1038/onc.2010.411; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hong TM, 2009, J NEURO-ONCOL, V93, P289, DOI 10.1007/s11060-008-9786-z; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jensen RL, 2006, J NEURO-ONCOL, V78, P233, DOI 10.1007/s11060-005-9103-z; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lai Y, 2011, INT J BIOL SCI, V7, P782, DOI 10.7150/ijbs.7.782; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63; Zhang HT, 2011, INT J MOL SCI, V12, P1505, DOI 10.3390/ijms12031505	45	68	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45562	10.1371/journal.pone.0045562	http://dx.doi.org/10.1371/journal.pone.0045562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029099	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900073
J	Manktelow, BN; Seaton, SE				Manktelow, Bradley N.; Seaton, Sarah E.			Specifying the Probability Characteristics of Funnel Plot Control Limits: An Investigation of Three Approaches	PLOS ONE			English	Article							STATISTICAL PROCESS-CONTROL; HOSPITAL MORTALITY; CARE	Background: Emphasis is increasingly being placed on the monitoring and comparison of clinical outcomes between healthcare providers. Funnel plots have become a standard graphical methodology to identify outliers and comprise plotting an outcome summary statistic from each provider against a specified 'target' together with upper and lower control limits. With discrete probability distributions it is not possible to specify the exact probability that an observation from an 'in-control' provider will fall outside the control limits. However, general probability characteristics can be set and specified using interpolation methods. Guidelines recommend that providers falling outside such control limits should be investigated, potentially with significant consequences, so it is important that the properties of the limits are understood. Methods: Control limits for funnel plots for the Standardised Mortality Ratio (SMR) based on the Poisson distribution were calculated using three proposed interpolation methods and the probability calculated of an 'in-control' provider falling outside of the limits. Examples using published data were shown to demonstrate the potential differences in the identification of outliers. Results: The first interpolation method ensured that the probability of an observation of an 'in control' provider falling outside either limit was always less than a specified nominal probability (p). The second method resulted in such an observation falling outside either limit with a probability that could be either greater or less than p, depending on the expected number of events. The third method led to a probability that was always greater than, or equal to, p. Conclusion: The use of different interpolation methods can lead to differences in the identification of outliers. This is particularly important when the expected number of events is small. We recommend that users of these methods be aware of the differences, and specify which interpolation method is to be used prior to any analysis.	[Manktelow, Bradley N.; Seaton, Sarah E.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester	Manktelow, BN (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	brad.manktelow@le.ac.uk	Manktelow, Bradley N/G-2794-2011; Seaton, Sarah/S-6875-2019	Manktelow, Bradley N/0000-0002-3264-0323; Seaton, Sarah/0000-0001-8711-4817	National Institute for Health Research; National Institute for Health Research [MET-08-05-101] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Sarah Seaton is funded by a Research Methods Fellowship award from the National Institute for Health Research. This report is independent research arising from a Research Methods Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Association of Public Health Observatories, 2009, STAT PROC CONTR METH; Aziz O, 2011, ANN ROY COLL SURG, V93, P193, DOI 10.1308/003588411X563411; Berry G, 1995, STATISTICIAN, V44, P417, DOI 10.2307/2348891; Black N, 2010, BMJ-BRIT MED J, V340, P933; Field D, 2010, NEONATAL SURVEY REPO; Forni S, 2009, FUNNEL PLOT I COMP F; Hart Marilyn K, 2007, Qual Manag Health Care, V16, P123; Healthcare Commission, 2009, INV MID STAFF NHS FD; Henderson GR, 2008, QUAL SAF HEALTH CARE, V17, P301, DOI 10.1136/qshc.2006.020784; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jones HE, 2008, J CLIN EPIDEMIOL, V61, P232, DOI 10.1016/j.jclinepi.2007.04.017; Kirkham JJ, 2008, J TRAUMA, V65, P1494, DOI 10.1097/TA.0b013e31815ebabf; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Mayer EK, 2009, ANN SURG, V249, P376, DOI 10.1097/SLA.0b013e31819a47b1; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; National Clinical Audit Advisory Group, 2011, DET MAN OUTL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NHS, 2012, NHS SUMM HOSP LEV MO; NHS, 2010, REV PAED CARD SERV O; NHS Department of Health, 2010, NHS OUTC FARM 2011 1; Penfold Robert B, 2008, Healthc Pap, V8, P8; Scott IA, 2011, MED J AUSTRALIA, V194, P645, DOI 10.5694/j.1326-5377.2011.tb03150.x; Seaton SE, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-98; Shojania KG, 2008, CAN MED ASSOC J, V179, P153, DOI 10.1503/cmaj.080010; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45723	10.1371/journal.pone.0045723	http://dx.doi.org/10.1371/journal.pone.0045723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029202	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900094
J	Ning, DL; Wang, H				Ning, Daliang; Wang, Hui			Involvement of Cytochrome P450 in Pentachlorophenol Transformation in a White Rot Fungus Phanerochaete chrysosporium	PLOS ONE			English	Article							ORGANOCHLORINE PESTICIDES; P450 MONOOXYGENASES; PHLEBIA-RADIATA; DEGRADATION; BIODEGRADATION; PCP; BINDING; SOIL; PENTACHLOROANISOLE; DECHLORINATION	The occurrence of cytochrome P450 and P450-mediated pentachlorophenol oxidation in a white rot fungus Phanerochaete chrysosporium was demonstrated in this study. The carbon monoxide difference spectra indicated induction of P450 (103 +/- 13 pmol P450 per mg protein in the microsomal fraction) by pentachlorophenol. The pentachlorophenol oxidation by the microsomal P450 was NADPH-dependent at a rate of 19.0 +/- 1.2 pmol min(-1) (mg protein)(-1), which led to formation of tetrachlorohydroquinone and was significantly inhibited by piperonyl butoxide (a P450 inhibitor). Tetrachlorohydroquinone was also found in the cultures, while the extracellular ligninases which were reported to be involved in tetrachlorohydroquinone formation were undetectable. The formation of tetrachlorohydroquinone was not detectable in the cultures added with either piperonyl butoxide or cycloheximide (an inhibitor of de novo protein synthesis). These results revealed the pentachlorophenol oxidation by induced P450 in the fungus, and it should be the first time that P450-mediated pentachlorophenol oxidation was demonstrated in a microorganism. Furthermore, the addition of the P450 inhibitor to the cultures led to obvious increase of pentachlorophenol, suggesting that the relationship between P450 and pentachlorophenol methylation is worthy of further research.	[Ning, Daliang; Wang, Hui] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China	Tsinghua University	Wang, H (corresponding author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.	wanghui@tsinghua.edu.cn	Ning, Daliang/AAT-2601-2021; Wang, Hui/G-8744-2012		National Nature Science Foundation of China [31000066, 30970098, 20737001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (Admission No. 31000066, 30970098 and 20737001. http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken BS, 1996, BIODEGRADATION, V7, P175, DOI 10.1007/BF00058177; Barakat AO, 2002, MAR POLLUT BULL, V44, P1426, DOI 10.1016/S0025-326X(02)00313-2; Barque JP, 2002, BIOCHEM BIOPH RES CO, V298, P277, DOI 10.1016/S0006-291X(02)02439-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campoy S, 2009, ENVIRON MICROBIOL, V11, P99, DOI 10.1111/j.1462-2920.2008.01744.x; Chigu NL, 2010, APPL MICROBIOL BIOT, V87, P1907, DOI 10.1007/s00253-010-2616-1; Da-Liang N, 2007, CHEM J CHINESE U, V28, P1469; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; Dubois M, 1997, BIOMARKERS, V2, P17, DOI 10.1080/135475097231922; Fisher B., 1991, J PESTICIDE REFORM, V11, P2; GILBERT FI, 1990, ARCH ENVIRON CON TOX, V19, P603, DOI 10.1007/BF01059082; Goswami M, 2007, ENVIRON MICROBIOL, V9, P2512, DOI 10.1111/j.1462-2920.2007.01370.x; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Ichinose H, 2012, ARCH BIOCHEM BIOPHYS, V518, P8, DOI 10.1016/j.abb.2011.12.010; Jiang X, 2000, CHEMOSPHERE, V41, P901, DOI 10.1016/S0045-6535(99)00435-X; Kamada F, 2002, MICROBIOL-SGM, V148, P1939, DOI 10.1099/00221287-148-6-1939; Laugero C, 1997, CAN J MICROBIOL, V43, P378, DOI 10.1139/m97-052; Livingstone DR, 1998, COMP BIOCHEM PHYS A, V120, P43, DOI 10.1016/S1095-6433(98)10008-9; Luykx DMAM, 2003, BIOCHEM BIOPH RES CO, V312, P373, DOI 10.1016/j.bbrc.2003.10.128; Machado KMG, 2005, WORLD J MICROB BIOT, V21, P297, DOI 10.1007/s11274-004-3693-z; Mahmood S, 2005, ENVIRON MICROBIOL, V7, P1349, DOI 10.1111/j.1462-2920.2005.00822.x; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Masaphy S, 1996, FEMS MICROBIOL LETT, V135, P51; McLellan L, 2007, J ENVIRON MONITOR, V9, P1055, DOI 10.1039/b701436h; Mehmood Z, 1996, CHEMOSPHERE, V33, P759, DOI 10.1016/0045-6535(96)00212-3; Miller GP, 1999, FASEB J, V13, pA1346; MURRAY M, 1990, PHARMACOL REV, V42, P85; NEILSON AH, 1988, APPL ENVIRON MICROB, V54, P524, DOI 10.1128/AEM.54.2.524-530.1988; NIKUPAAVOLA ML, 1988, BIOCHEM J, V254, P877, DOI 10.1042/bj2540877; Ning Da-liang, 2009, China Environmental Science, V29, P407; Ning Da-liang, 2009, Huanjing Kexue, V30, P2485; Ning DL, 2010, BIODEGRADATION, V21, P889, DOI 10.1007/s10532-010-9349-9; Ning DL, 2010, BIODEGRADATION, V21; Omura T, 1999, BIOCHEM BIOPH RES CO, V266, P690, DOI 10.1006/bbrc.1999.1887; OMURA T, 1964, J BIOL CHEM, V239, P2370; PALM H, 1991, CHEMOSPHERE, V23, P263, DOI 10.1016/0045-6535(91)90182-D; PASZCZYNSKI A, 1988, METHOD ENZYMOL, V161, P264; Pedroza AM, 2007, CHEMOSPHERE, V67, P793, DOI 10.1016/j.chemosphere.2006.10.015; Peng Dan, 2008, Huanjing Kexue, V29, P3568; Reddy GVB, 2000, MICROBIOL-UK, V146, P405, DOI 10.1099/00221287-146-2-405; Reddy GVB, 1998, J BACTERIOL, V180, P5159, DOI 10.1128/JB.180.19.5159-5164.1998; Rubilar O, 2011, BIODEGRADATION, V22, P31, DOI 10.1007/s10532-010-9373-9; Sei K, 2008, J ENVIRON SCI HEAL A, V43, P53, DOI 10.1080/10934520701750397; Subramanian V, 2009, APPL ENVIRON MICROB, V75, P5570, DOI 10.1128/AEM.02942-08; Suwanchaichinda C, 2001, PESTIC BIOCHEM PHYS, V70, P63, DOI 10.1006/pest.2001.2544; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Szewczyk R, 2009, INT BIODETER BIODEGR, V63, P123, DOI 10.1016/j.ibiod.2008.08.001; Teramoto H, 2004, APPL MICROBIOL BIOT, V66, P312, DOI 10.1007/s00253-004-1637-z; TIEN M, 1988, METHOD ENZYMOL, V161, P238; Uotila J S, 1991, Biodegradation, V2, P25, DOI 10.1007/BF00122422; Walter M, 2004, J ENVIRON MANAGE, V71, P361, DOI 10.1016/j.jenvman.2004.04.002; WITTLINGER R, 1990, FRESEN J ANAL CHEM, V336, P193, DOI 10.1007/BF00332252; XUN LY, 1991, J BACTERIOL, V173, P4447, DOI 10.1128/JB.173.14.4447-4453.1991; Yu Z, 2011, PROCESS BIOCHEM, V46, P1285, DOI 10.1016/j.procbio.2011.02.018; YUAN JH, 1993, XENOBIOTICA, V23, P427, DOI 10.3109/00498259309057031; Zhang JB, 2007, INT BIODETER BIODEGR, V59, P307, DOI 10.1016/j.ibiod.2006.09.003; Zhou Wen-Min, 1990, ENV MONITORING CHINA, V6, p1 ~ 3	58	23	24	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45887	10.1371/journal.pone.0045887	http://dx.doi.org/10.1371/journal.pone.0045887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029295	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900108
J	Tang, RB; Chai, WM; Yang, GY; Xie, HL; Chen, KM				Tang, Rongbiao; Chai, Wei-Min; Yang, Guo-Yuan; Xie, Honglan; Chen, Ke-Min			X-ray Phase Contrast Imaging of Cell Isolation with Super-Paramagnetic Microbeads	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; MICROBUBBLES; ANGIOGENESIS; AGENT	Super-paramagnetic microbeads are widely used for cell isolation. Evaluation of the binding affinity of microbeads to cells using optical microscopy has been limited by its small scope. Here, magnetic property of microbeads was first investigated by using synchrotron radiation (SR) in-line x-ray phase contrast imaging (PCI). The cell line mouse LLC (Lewis lung carcinoma) was selected for cell adhesion studies. Targeted microbeads were prepared by attaching anti-VEGFR2 (vascular endothelial growth factor receptor-2) antibody to the shell of the microbeads. The bound microbeads were found to better adhere to LLC cells than unbound ones. PCI dynamically and clearly showed the magnetization and demagnetization of microbeads in PE-50 tube. The cells incubated with different types of microbeads were imaged by PCI, which provided clear and real-time visualization of the cell isolation. Therefore, PCI might be considered as a novel and efficient tool for further cell isolation studies.	[Tang, Rongbiao; Chai, Wei-Min; Chen, Ke-Min] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Ctr, Shanghai 200030, Peoples R China; [Xie, Honglan] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Chen, KM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	keminchenrj1@yahoo.com.cn	Tang, Rui/I-6391-2015; Tang, Rui/AAR-8048-2020	Tang, Rui/0000-0002-9313-0802; 	Nation Basic Research Program of China (973 Program) [2010CB834305]; Shanghai Leading Academic Discipline Project; Jiao Tong University Med-Science Cross Research Foundation [YG2010MS20]	Nation Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Jiao Tong University Med-Science Cross Research Foundation	This work was financially supported by grants from the Nation Basic Research Program of China (973 Program 2010CB834305), Shanghai Leading Academic Discipline Project, and Jiao Tong University Med-Science Cross Research Foundation (YG2010MS20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen J., 2005, IMMUNODIAGNOSTIC, V29, P22; Brzeska M, 2004, J BIOTECHNOL, V112, P25, DOI 10.1016/j.jbiotec.2004.04.018; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Kim KJ, 1993, INHIBITION VASCULAR; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Lien KY, 2010, LAB CHIP, V10, P2875, DOI 10.1039/c005178k; Lien KY, 2010, PROC IEEE MICR ELECT, P100, DOI 10.1109/MEMSYS.2010.5442557; Lin PN, 1998, CELL GROWTH DIFFER, V9, P49; Liu P, 2008, J SYNCHROTRON RADIAT, V15, P36, DOI 10.1107/S0909049507045761; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Tang RBA, 2012, PHYS MED BIOL, V57, P3051, DOI 10.1088/0031-9155/57/10/3051; Tang RB, 2011, PHYS MED BIOL, V56, P3503, DOI 10.1088/0031-9155/56/12/004; Wen J, 2005, MOL VIS, V11, P256; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Xi Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3607292	19	31	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45597	10.1371/journal.pone.0045597	http://dx.doi.org/10.1371/journal.pone.0045597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029126	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700048
J	Tang, R; Zhang, JP; Zhang, ZN				Tang, Rui; Zhang, Jin Ping; Zhang, Zhong Ning			Electrophysiological and Behavioral Responses of Male Fall Webworm Moths (Hyphantria cunea) to Herbivory-Induced Mulberry (Morus alba) Leaf Volatiles	PLOS ONE			English	Article							(E)-BETA-OCIMENE SYNTHASE; PLANT VOLATILES; SEX-PHEROMONE; BOLL-WEEVIL; EMISSIONS; IDENTIFICATION; LEPIDOPTERA; FEMALES	Volatile organic compounds (VOCs) were collected from damaged and intact mulberry leaves (Morus alba L., Moraceae) and from Hyphantria cunea larvae by headspace absorption with Super Q columns. We identified their constituents using gas chromatography-mass spectrometry, and evaluated the responses of male H. cunea antennae to the compounds using gas chromatography-flame ionization detection coupled with electroantennographic detection. Eleven VOC constituents were found to stimulate antennae of male H. cunea moths: beta-ocimene, hexanal, cis-3-hexenal, limonene, trans-2-hexenal, cyclohexanone, cis-2-penten-1-ol, 6-methyl-5-hepten-2-one, 4-hydroxy-4-methyl-2-pentanone, trans-3-hexen-1-ol, and 2,4-dimethyl-3-pentanol. Nine of these chemicals were released by intact, mechanically-damaged, and herbivore-damaged leaves, while cis-2-penten-1-ol was released only by intact and mechanically-damaged leaves and beta-ocimene was released only by herbivore-damaged leaves. Results from wind tunnel experiments conducted with volatile components indicated that male moths were significantly more attracted to herbivory-induced volatiles than the solvent control. Furthermore, male moths' attraction to a sex pheromone lure was increased by herbivory-induced compounds and beta-ocimene, but reduced by cis-2-penten-1-ol. A proof long-range field trapping experiment showed that the efficiency of sex pheromone lures in trapping male moths was increased by beta-ocimene and reduced by cis-2-penten-1-ol.	[Tang, Rui; Zhang, Jin Ping; Zhang, Zhong Ning] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Tang, R (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangzn@ioz.ac.cn	Tang, Rui/I-6391-2015; Tang, Rui/AAR-8048-2020	Tang, Rui/0000-0002-9313-0802; 				Angerosa F, 2000, FOOD CHEM, V68, P283, DOI 10.1016/S0308-8146(99)00189-2; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Cao MQ, 2010, TERRITORY NATURAL RE, P86; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Chen MZ, 2011, J FOOD SCI, V76, pC1032, DOI 10.1111/j.1750-3841.2011.02328.x; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; DICKENS JC, 1984, J CHEM ECOL, V10, P1759, DOI 10.1007/BF00987360; DICKENS JC, 1993, J INSECT PHYSIOL, V39, P503, DOI 10.1016/0022-1910(93)90083-4; DICKENS JC, 1989, ENTOMOL EXP APPL, V52, P191, DOI 10.1007/BF00414044; Dickens Joseph C., 1993, Chemoecology, V4, P175, DOI 10.1007/BF01256553; Hartvigsen K, 2000, J AGR FOOD CHEM, V48, P4858, DOI 10.1021/jf991385b; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; ITO Y, 1968, Researches on Population Ecology (Tokyo), V10, P177, DOI 10.1007/BF02510872; JAENIKE J, 1980, ENTOMOL EXP APPL, V27, P31, DOI 10.1007/BF00377237; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; Li JieHong, 2007, Chemistry and Industry of Forest Products, V27, P107; [李卫国 LI Wei-Guo], 2009, [蚕业科学, Acta Sericologica Sinica], V35, P355; Lu Yu-Jie, 2003, Acta Ecologica Sinica, V23, P308; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Navia-Gine WG, 2009, PLANT PHYSIOL BIOCH, V47, P416, DOI 10.1016/j.plaphy.2009.01.008; Noe SM, 2006, ATMOS ENVIRON, V40, P4649, DOI 10.1016/j.atmosenv.2006.04.049; Ruther J, 2002, ECOL ENTOMOL, V27, P76, DOI 10.1046/j.1365-2311.2002.0373a.x; SAAD AD, 1981, ENTOMOL EXP APPL, V30, P123, DOI 10.1007/BF00300876; Stelinski LL, 2003, J INSECT PHYSIOL, V49, P845, DOI 10.1016/S0022-1910(03)00136-7; Su MW, 2008, CHINESE SCI BULL, V53, P555, DOI 10.1007/s11434-008-0124-9; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tang R, 2012, CHINESE SCI IN PRESS, V57; Tasin M, 2006, CHEMOECOLOGY, V16, P87, DOI 10.1007/s00049-005-0332-6; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; Travis HJ, 2005, AM MIDL NAT, V153, P270, DOI 10.1674/0003-0031(2005)153[0270:TEOETC]2.0.CO;2; WILLIAMS KS, 1984, OECOLOGIA, V63, P166, DOI 10.1007/BF00379873; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z	35	31	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49256	10.1371/journal.pone.0049256	http://dx.doi.org/10.1371/journal.pone.0049256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23029126	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900111
J	Yan, P; Zhu, XZ; Li, HM; Shrubsole, MJ; Shi, HM; Zhang, MZ; Harris, RC; Hao, CM; Dai, Q				Yan, Ping; Zhu, Xiangzhu; Li, Haiming; Shrubsole, Martha J.; Shi, Haiming; Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming; Dai, Qi			Association of High Blood Pressure with Renal Insufficiency: Role of Albuminuria, from NHANES, 1999-2006	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; POSITION STATEMENT; HYPERTENSION; PROGRESSION; PROTEINURIA; PREVALENCE; MORTALITY	Background: The relationship between hypertension and kidney disease is complicated. Clinical trials found intense blood pressure control was not associated with alterations in glomerular filtration rate (GFR) in all patients but did slow the rate of GFR decline among those with a higher baseline proteinuria. However, the underlying mechanism has been unclear. Methods: We tested the hypothesis that the association between high blood pressure and renal function is modified by albuminuria status by conducting analyses in a cross-sectional study with 12,440 adult participants without known kidney diseases, diabetes or cardiovascular diseases, participating in the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Results: 1226 out of 12440 were found to have unknown high blood pressure and 4494 were found to have reduced renal function. Overall, a moderate association was found between high blood pressure and renal function insufficiency in all participants analyzed. However, among participants with albuminuria, the prevalence of moderate-severe renal insufficiency substantially and progressively increased from normal subjects to prehypertensive and undiagnosed hypertensive subjects (1.43%, 3.44%, 10.96%, respectively, P for trend <0.0001); on the other hand, the prevalence of undiagnosed hypertension was also significantly higher among subjects with moderate-severe renal insufficiency than those with mild renal insufficiency (35.54% Vs 19.09%, P value <0.05), supporting an association between hypertension and renal function damage. In contrast, no association between hypertension and renal insufficiency was observed among those without albuminuria in this population. Similar findings were observed when the CKD-EPI equation was used. Conclusions: The association between high blood pressure and reduced renal function could be dependent upon the albuminuria status. This finding may provide a possible explanation for results observed in clinical trials of intensive blood pressure control. Further studies are warranted to confirm our findings.	[Yan, Ping; Shi, Haiming] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Haiming; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Yan, Ping; Zhu, Xiangzhu; Shrubsole, Martha J.; Dai, Qi] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA	Fudan University; Fudan University; Vanderbilt University; Vanderbilt University	Yan, P (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	qi.dai@vanderbilt.edu	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021; Zhu, Xiao-Shan/B-2179-2015	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815; Zhu, Xiao-Shan/0000-0003-1223-1415	International Society of Nephrology; Vanderbilt Epidemiology Center	International Society of Nephrology; Vanderbilt Epidemiology Center	This work is partially supported by the International Fellowship Program of the International Society of Nephrology (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Drs. Qi Dai and Xiangzhu Zhu's effort was supported by the Vanderbilt Epidemiology Center's development fund. No additional external funding received for this study.	[Anonymous], 2004, AM J KIDNEY DIS, V43, pS14, DOI 10.1053/j/ajkd.2004.03.004; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Bidani AK, 2011, NAT REV NEPHROL, V7, P128, DOI 10.1038/nrneph.2010.168; CHAVERS BM, 1984, KIDNEY INT, V25, P576, DOI 10.1038/ki.1984.57; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Hamm LL, 2010, AM J MED SCI, V340, P30, DOI 10.1097/MAJ.0b013e3181e590f0; Islam TM, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-17; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kalaitzidis RG, 2010, KIDNEY INT, V77, P194, DOI 10.1038/ki.2009.439; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Center for Health Statistics. Centers for Disease Control and Prevention, CTR DIS CONTR PREV N; National Health and Nutrition Examination Survey, 2003, PHYS EX PROC MAN; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Population Division US Census Bureau, 2007, NCEST200601 US BUR C; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Sabanayagam C, 2011, ASIA-PAC J PUBLIC HE, V23, P936, DOI 10.1177/1010539510361637; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Segura J, 2011, ADV CHRONIC KIDNEY D, V18, P23, DOI 10.1053/j.ackd.2010.11.001; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	46	81	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e37837	10.1371/journal.pone.0037837	http://dx.doi.org/10.1371/journal.pone.0037837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	23029464	gold, Green Published, Green Submitted			2022-12-27	WOS:000306186900001
J	Sim, SC; Durstewitz, G; Plieske, J; Wieseke, R; Ganal, MW; Van Deynze, A; Hamilton, JP; Buell, CR; Causse, M; Wijeratne, S; Francis, DM				Sim, Sung-Chur; Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.; Van Deynze, Allen; Hamilton, John P.; Buell, C. Robin; Causse, Mathilde; Wijeratne, Saranga; Francis, David M.			Development of a Large SNP Genotyping Array and Generation of High-Density Genetic Maps in Tomato	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LYCOPERSICON-PENNELLII; DISEASE RESISTANCE; CULTIVATED TOMATO; GENOMIC SELECTION; LINKAGE MAPS; DISCOVERY; MARKERS; POLYMORPHISM; LOCI	The concurrent development of high-throughput genotyping platforms and next generation sequencing (NGS) has increased the number and density of genetic markers, the efficiency of constructing detailed linkage maps, and our ability to overlay recombination and physical maps of the genome. We developed an array for tomato with 8,784 Single Nucleotide Polymorphisms (SNPs) mainly discovered based on NGS-derived transcriptome sequences. Of the SNPs, 7,720 (88%) passed manufacturing quality control and could be scored in tomato germplasm. The array was used to generate high-density linkage maps for three interspecific F-2 populations: EXPEN 2000 (Solanum lycopersicum LA0925 x S. pennellii LA0716, 79 individuals), EXPEN 2012 (S. lycopersicum Moneymaker x S. pennellii LA0716, 160 individuals), and EXPIM 2012 (S. lycopersicum Moneymaker x S. pimpinellifolium LA0121, 183 individuals). The EXPEN 2000-SNP and EXPEN 2012 maps consisted of 3,503 and 3,687 markers representing 1,076 and 1,229 unique map positions (genetic bins), respectively. The EXPEN 2000-SNP map had an average marker bin interval of 1.6 cM, while the EXPEN 2012 map had an average bin interval of 0.9 cM. The EXPIM 2012 map was constructed with 4,491 markers (1,358 bins) and an average bin interval of 0.8 cM. All three linkage maps revealed an uneven distribution of markers across the genome. The dense EXPEN 2012 and EXPIM 2012 maps showed high levels of colinearity across all 12 chromosomes, and also revealed evidence of small inversions between LA0716 and LA0121. Physical positions of 7,666 SNPs were identified relative to the tomato genome sequence. The genetic and physical positions were mostly consistent. Exceptions were observed for chromosomes 3, 10 and 12. Comparing genetic positions relative to physical positions revealed that genomic regions with high recombination rates were consistent with the known distribution of euchromatin across the 12 chromosomes, while very low recombination rates were observed in the heterochromatic regions.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Causse, Mathilde] INRA, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France; [Wijeratne, Saranga] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol Cellular & Imagining Ctr, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; INRAE; University System of Ohio; Ohio State University	Sim, SC (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]; Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA)(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. INRA SNPs were obtained from the INRA AIP Bioresources and from the ARCAD sub-project "Comparative population genomics''. ARCAD (Agropolis Resource Center for Crop Conservation, Adaptation and Diversity) is funded (2009-2013) by the Agropolis Fondation, the French foundation for Agricultural Sciences and Sustainable Development (www.arcad-project.org and www.agropolis-fondation.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2010, CYTOGENET GENOME RES, V129, P24, DOI 10.1159/000313850; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Frary A, 1996, MOL GEN GENET, V250, P295, DOI 10.1007/BF02174387; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Meuwissen THE, 2001, GENETICS, V157, P1819; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHERMAN JD, 1992, GENOME, V35, P354, DOI 10.1139/g92-054; Shirasawa K, 2010, DNA RES, V17, P381, DOI 10.1093/dnares/dsq024; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TANKSLEY SD, 1992, GENETICS, V132, P1141; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; van der Knaap E, 2004, GENETICS, V168, P2127, DOI 10.1534/genetics.104.031013; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y	48	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40563	10.1371/journal.pone.0040563	http://dx.doi.org/10.1371/journal.pone.0040563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802968	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500057
J	Sim, SC; Van Deynze, A; Stoffel, K; Douches, DS; Zarka, D; Ganal, MW; Chetelat, RT; Hutton, SF; Scott, JW; Gardner, RG; Panthee, DR; Mutschler, M; Myers, JR; Francis, DM				Sim, Sung-Chur; Van Deynze, Allen; Stoffel, Kevin; Douches, David S.; Zarka, Daniel; Ganal, Martin W.; Chetelat, Roger T.; Hutton, Samuel F.; Scott, John W.; Gardner, Randolph G.; Panthee, Dilip R.; Mutschler, Martha; Myers, James R.; Francis, David M.			High-Density SNP Genotyping of Tomato (Solanum lycopersicum L.) Reveals Patterns of Genetic Variation Due to Breeding	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM ANALYSIS; LATE BLIGHT RESISTANCE; SELF-PRUNING GENE; MAP-BASED CLONING; DISEASE RESISTANCE; CULTIVATED TOMATO; PHYTOPHTHORA-INFESTANS; BACTERIAL SPOT; COMPLEX TRAITS	The effects of selection on genome variation were investigated and visualized in tomato using a high-density single nucleotide polymorphism (SNP) array. 7,720 SNPs were genotyped on a collection of 426 tomato accessions (410 inbreds and 16 hybrids) and over 97% of the markers were polymorphic in the entire collection. Principal component analysis (PCA) and pairwise estimates of F-st supported that the inbred accessions represented seven sub-populations including processing, large-fruited fresh market, large-fruited vintage, cultivated cherry, landrace, wild cherry, and S. pimpinellifolium. Further divisions were found within both the contemporary processing and fresh market sub-populations. These sub-populations showed higher levels of genetic diversity relative to the vintage sub-population. The array provided a large number of polymorphic SNP markers across each sub-population, ranging from 3,159 in the vintage accessions to 6,234 in the cultivated cherry accessions. Visualization of minor allele frequency revealed regions of the genome that distinguished three representative sub-populations of cultivated tomato (processing, fresh market, and vintage), particularly on chromosomes 2, 4, 5, 6, and 11. The PCA loadings and F-st outlier analysis between these three sub-populations identified a large number of candidate loci under positive selection on chromosomes 4, 5, and 11. The extent of linkage disequilibrium (LD) was examined within each chromosome for these sub-populations. LD decay varied between chromosomes and sub-populations, with large differences reflective of breeding history. For example, on chromosome 11, decay occurred over 0.8 cM for processing accessions and over 19.7 cM for fresh market accessions. The observed SNP variation and LD decay suggest that different patterns of genetic variation in cultivated tomato are due to introgression from wild species and selection for market specialization.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Van Deynze, Allen; Stoffel, Kevin] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Douches, David S.; Zarka, Daniel] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; [Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Chetelat, Roger T.] Univ Calif Davis, CM Rick Tomato Genet Resource Ctr, Davis, CA 95616 USA; [Hutton, Samuel F.; Scott, John W.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Gardner, Randolph G.; Panthee, Dilip R.] N Carolina State Univ, Mt Hort Crops Res & Extens Ctr, Dept Hort Sci, Mills River, NC USA; [Mutschler, Martha] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; University of California System; University of California Davis; State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Cornell University; Oregon State University	Francis, DM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]	United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LJ, 1934, OHIO AGR EXP STA B, V539; [Anonymous], MICROSATELLITE ANAL; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; Bates D., 1988, NONLINEAR REGRESSION; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BERRY SZ, 1991, HORTSCIENCE, V26, P1093, DOI 10.21273/HORTSCI.26.8.1093; BOHN G. W., 1939, SCIENCE, V89, P603, DOI 10.1126/science.89.2322.603; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Budiman MA, 2004, THEOR APPL GENET, V108, P190, DOI 10.1007/s00122-003-1429-3; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ESHED Y, 1995, GENETICS, V141, P1147; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GARDNER RG, 1992, HORTSCIENCE, V27, P1233, DOI 10.21273/HORTSCI.27.11.1233; George WL, 1983, TOMATO PRODUCTION PR, P48; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham E. B., 2004, REP TOMATO GENET COO, V54, P22; Graham TO, 1959, TOM GEN COOP REP, V9, P37; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hemming MN, 2004, THEOR APPL GENET, V109, P409, DOI 10.1007/s00122-004-1646-4; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Jones CM, 2007, AM J BOT, V94, P935, DOI 10.3732/ajb.94.6.935; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MJ, 2005, J AM SOC HORTIC SCI, V130, P877, DOI 10.21273/JASHS.130.6.877; Labate JA, 2005, MOL BREEDING, V16, P343, DOI 10.1007/s11032-005-1911-5; Labate JA, 2010, HORTSCIENCE, V45, pS145; Labate JA, 2009, THEOR APPL GENET, V118, P1005, DOI 10.1007/s00122-008-0957-2; Lanfermeijer FC, 2003, PLANT MOL BIOL, V52, P1037, DOI 10.1023/A:1025434519282; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Merk HL, 2012, J AM SOC HORTIC SCI, V137, P427, DOI 10.21273/JASHS.137.6.427; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; NEI M, 1974, GENETICS, V76, P379; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Park YH, 2004, GENOME, V47, P510, DOI 10.1139/G04-004; Pei CC, 2012, THEOR APPL GENET, V124, P533, DOI 10.1007/s00122-011-1726-1; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; RASMUSSEN W. D., 1968, Technology Cult., Chicago., V9, P531, DOI 10.2307/3101894; RAY J, 1992, PLANT MOL BIOL, V19, P401, DOI 10.1007/BF00023387; Rick C. M., 1976, Evolution of crop plants., P268; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Robbins MD, 2010, HORTSCIENCE, V45, P1424, DOI 10.21273/HORTSCI.45.10.1424; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scott JW, 2008, HORTSCIENCE, V43, P2228, DOI 10.21273/HORTSCI.43.7.2228; Scott JW, 2004, J AM SOC HORTIC SCI, V129, P394, DOI 10.21273/JASHS.129.3.0394; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2011, DOWNSTREAM ANAL SNPS; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Spassova MI, 2001, MOL BREEDING, V7, P151, DOI 10.1023/A:1011363119763; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stevens MA., 1986, TOMATO CROP SCI BASI, P35; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; United States Department of Agriculture States Relations Service Office of Experiment Stations, 1919, EXP STAT REC, V39; van Berloo R, 2008, THEOR APPL GENET, V117, P89, DOI 10.1007/s00122-008-0755-x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; WATTS VM, 1947, P AM SOC HORTIC SCI, V49, P233; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS CE, 1993, GENOME, V36, P619, DOI 10.1139/g93-083; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang WC, 2005, PHYTOPATHOLOGY, V95, P519, DOI 10.1094/PHYTO-95-0519; Yang WC, 2004, MOL BREEDING, V14, P21, DOI 10.1023/B:MOLB.0000037992.03731.a5; Yuan DJ, 2008, SCI HORTIC-AMSTERDAM, V118, P20, DOI 10.1016/j.scienta.2008.05.011; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	102	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45520	10.1371/journal.pone.0045520	http://dx.doi.org/10.1371/journal.pone.0045520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	22802968	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900068
J	Lan, GY; Getzin, S; Wiegand, T; Hu, YH; Xie, GS; Zhu, H; Cao, M				Lan, Guoyu; Getzin, Stephan; Wiegand, Thorsten; Hu, Yuehua; Xie, Guishui; Zhu, Hua; Cao, Min			Spatial Distribution and Interspecific Associations of Tree Species in a Tropical Seasonal Rain Forest of China	PLOS ONE			English	Article							DENSITY-DEPENDENCE; DISTRIBUTION PATTERNS; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; XISHUANGBANNA; DIVERSITY; VEGETATION; RECRUITMENT; MAINTENANCE; POPULATIONS	Studying the spatial pattern and interspecific associations of plant species may provide valuable insights into processes and mechanisms that maintain species coexistence. Point pattern analysis was used to analyze the spatial distribution patterns of twenty dominant tree species, their interspecific spatial associations and changes across life stages in a 20-ha permanent plot of seasonal tropical rainforest in Xishuangbanna, China, to test mechanisms maintaining species coexistence. Torus-translation tests were used to quantify positive or negative associations of the species to topographic habitats. The results showed: (1) fourteen of the twenty tree species were negatively (or positively) associated with one or two of the topographic variables, which evidences that the niche contributes to the spatial pattern of these species. (2) Most saplings of the study species showed a significantly clumped distribution at small scales (0-10 m) which was lost at larger scales (10-30 m). (3) The degree of spatial clumping deceases from saplings, to poles, to adults indicates that density-dependent mortality of the offspring is ubiquitous in species. (4) It is notable that a high number of positive small-scale interactions were found among the twenty species. For saplings, 42.6% of all combinations of species pairs showed positive associations at neighborhood scales up to five meters, but only 38.4% were negative. For poles and adults, positive associations at these distances still made up 45.5% and 29.5%, respectively. In conclusion, there is considerable evidence for the presence of positive interactions among the tree species, which suggests that species herd protection may occur in our plot. In addition, niche assembly and limited dispersal (likely) contribute to the spatial patterns of tree species in the tropical seasonal rain forest in Xishuangbanna, China.	[Lan, Guoyu; Hu, Yuehua; Zhu, Hua; Cao, Min] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Lan, Guoyu; Xie, Guishui] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou City, Hainan Province, Peoples R China; [Getzin, Stephan; Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Tropical Agricultural Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Cao, M (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	caom@xtbg.ac.cn	Wiegand, Thorsten/AAP-9709-2021; Hua, Zhu/AFO-6233-2022; Wiegand, Thorsten/H-5877-2016	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248	National Science Foundation of China [31061160188-03]; National Science & Technology Pillar Program of China [2008BAC39B02]; Environmental Research Center [233066]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China; Environmental Research Center	This project was supported by a grant from the National Science Foundation of China (31061160188-03) and a grant from the National Science & Technology Pillar Program of China (2008BAC39B02). SG was supported by the Environmental Research Center Advanced Grant "SpatioDiversity" (grant number 233066) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunyavejchewin S, 2003, FOREST ECOL MANAG, V175, P87, DOI 10.1016/S0378-1127(02)00126-3; Cao M, 1997, BIODIVERS CONSERV, V6, P995, DOI 10.1023/A:1018367630923; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS, P17; CONNELL J H, 1971, P298; Donnelly K, 1978, SIMULATION STUDIES A, P91; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Getzin S, 2011, J TROP ECOL, V27, P93, DOI 10.1017/S0266467410000453; Grubb PJ, 1977, BIOL REV CAMBRIDGE; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hua Z., 2006, FOR STUD CHINA, V8, P1, DOI [10.1007/s11632-006-0014-7, DOI 10.1007/S11632-006-0014-7]; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; King DA, 2006, FOREST ECOL MANAG, V223, P152, DOI 10.1016/j.foreco.2005.10.066; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Lan GY, 2011, FOREST ECOL MANAG, V262, P1507, DOI 10.1016/j.foreco.2011.06.052; Lan GY, 2009, ECOL RES, V24, P1117, DOI 10.1007/s11284-009-0590-9; Lan GY, 2012, J FOR RES; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Liu JX, 2008, THESIS QUPU NORMAL U, P1; Liu Y, 2002, J PLANT ECOL, V26, P427; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, PLANT ECOL, V192, P193, DOI 10.1007/s11258-007-9328-3; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Stoyan D., 1994, FRACTALS RANDOM SHAP; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WILLS C, 1995, IMMUNOL REV, V143, P263, DOI 10.1111/j.1600-065X.1995.tb00679.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang Xiao-Fei, 2010, Acta Botanica Yunnanica, V32, P367, DOI 10.3724/SP.J.1143.2010.10064; YIN SH, 1990, ACTA BOT YUNNANICA, V12, P415; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	49	42	67	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46074	10.1371/journal.pone.0046074	http://dx.doi.org/10.1371/journal.pone.0046074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	29294477	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900085
J	Dakos, V; Carpenter, SR; Brock, WA; Ellison, AM; Guttal, V; Ives, AR; Kefi, S; Livina, V; Seekell, DA; van Nes, EH; Scheffer, M				Dakos, Vasilis; Carpenter, Stephen R.; Brock, William A.; Ellison, Aaron M.; Guttal, Vishwesha; Ives, Anthony R.; Kefi, Sonia; Livina, Valerie; Seekell, David A.; van Nes, Egbert H.; Scheffer, Marten			Methods for Detecting Early Warnings of Critical Transitions in Time Series Illustrated Using Simulated Ecological Data	PLOS ONE			English	Article							CRITICAL SLOWING-DOWN; REGIME SHIFTS; CATASTROPHIC SHIFTS; LEADING INDICATOR; STATES; DESERTIFICATION; ECOSYSTEMS; ESTIMATORS; VEGETATION; STABILITY	Many dynamical systems, including lakes, organisms, ocean circulation patterns, or financial markets, are now thought to have tipping points where critical transitions to a contrasting state can happen. Because critical transitions can occur unexpectedly and are difficult to manage, there is a need for methods that can be used to identify when a critical transition is approaching. Recent theory shows that we can identify the proximity of a system to a critical transition using a variety of so-called 'early warning signals', and successful empirical examples suggest a potential for practical applicability. However, while the range of proposed methods for predicting critical transitions is rapidly expanding, opinions on their practical use differ widely, and there is no comparative study that tests the limitations of the different methods to identify approaching critical transitions using time-series data. Here, we summarize a range of currently available early warning methods and apply them to two simulated time series that are typical of systems undergoing a critical transition. In addition to a methodological guide, our work offers a practical toolbox that may be used in a wide range of fields to help detect early warning signals of critical transitions in time series data.	[Dakos, Vasilis; van Nes, Egbert H.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Dakos, Vasilis] Estn Biol Donana, Integrat Ecol Grp, Seville, Spain; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Guttal, Vishwesha] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Kefi, Sonia] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Livina, Valerie] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Seekell, David A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Indian Institute of Science (IISC) - Bangalore; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of East Anglia; University of Virginia	Dakos, V (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands.	vasilis.dakos@gmail.com	van Nes, Egbert H/F-2681-2011; Scheffer, Marten/C-1852-2012; Leite-Moreira, Adelino F./A-1463-2018; Guttal, Vishwesha/A-3007-2008; Livina, Valerie N/C-7636-2011; Carpenter, Stephen/AAQ-6404-2020; Ives, Anthony/A-5698-2008	Leite-Moreira, Adelino F./0000-0001-7808-3596; Guttal, Vishwesha/0000-0002-2677-857X; Livina, Valerie N/0000-0003-3759-9013; Ives, Anthony/0000-0001-9375-9523; Dakos, Vasilis/0000-0001-8862-718X; van Nes, Egbert/0000-0002-6345-104X; Kefi, Sonia/0000-0002-9678-7770; Ellison, Aaron/0000-0003-4151-6081	Spinoza Award; European Research Council; Vilas Trust; Center for Robust Decision Making in Climate and Energy Policy; National Science Foundation (NSF) through the Decision Making Under Uncertainty Program; NSF; Hilldale Fund of UW-Madison; Natural Environment Research Council [NE/F005474/1]; AXA Research Fund; US National Science Foundation (GRFP); US National Science Foundation through its LTER program [DEB 06-20443]; Santa Fe Institute; Arizona State University; NERC [NE/F005474/1] Funding Source: UKRI	Spinoza Award; European Research Council(European Research Council (ERC)European Commission); Vilas Trust; Center for Robust Decision Making in Climate and Energy Policy; National Science Foundation (NSF) through the Decision Making Under Uncertainty Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Hilldale Fund of UW-Madison; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); AXA Research Fund(AXA Research Fund); US National Science Foundation (GRFP)(National Science Foundation (NSF)); US National Science Foundation through its LTER program; Santa Fe Institute; Arizona State University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	VD, EHvN and MS are supported by a Spinoza Award and a European Research Council Advanced Grant both awarded to MS. WAB is grateful for financial and scientific support from the Vilas Trust and the Center for Robust Decision Making in Climate and Energy Policy funded by the National Science Foundation (NSF) through the Decision Making Under Uncertainty Program. SRC's work is supported by the NSF and the Hilldale Fund of UW-Madison. VNL was supported by the Natural Environment Research Council project 'Detecting and classifying bifurcations in the climate system' (NE/F005474/1) and by the AXA Research Fund through a postdoctoral fellowship. VNL's research was carried out on the High Performance Computing Cluster at the University of East Anglia. DS is supported by the US National Science Foundation (GRFP). AME's work on critical transitions is supported by the US National Science Foundation through its LTER program (DEB 06-20443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was based on the workshop 'Practical Methods for Analysis of Early Warnings for Regime Shifts' organized by VD, SRC and MS in the Santa Fe Institute, in Santa Fe, New Mexico, USA, from 10 to 12 of October 2011. We are grateful to the Santa Fe Institute and the Arizona State University for the financial support, and in particular to Sander van der Leeuw for the invitation to organize the workshop as part of the Complex Adaptive Systems Initiative. We are also grateful to Marty Anderies serving as our critical observer during the workshop. We thank Tim Cline for writing the R code for the Conditional Heteroskedasticity.	[Anonymous], 1991, FRACTALS CHAOS POWER; Bandi FM, 2003, J ECONOMETRICS, V116, P293, DOI 10.1016/S0304-4076(03)00110-6; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Broock W.A., 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2002, REGIME SHIFTS LAKE E; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, ECOLOGY, V93, P264, DOI 10.1890/11-0889.1; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; ENGLE RF, 1985, CAN J ECON, V18, P66, DOI 10.2307/135114; ENGLE RF, 1982, J ECONOMETRICS, V20, P83, DOI 10.1016/0304-4076(82)90104-X; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Halley JM, 2011, CLIMATIC CHANGE, V109, P549, DOI 10.1007/s10584-011-0053-5; Hardle W., 1990, APPL NONPARAMETRIC R; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Horsthemke W, 2006, NOISE INDUCED TRANSI; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Ives AR, ECOSPHERE IN PRESS; Johannes M, 2004, J FINANC, V59, P227, DOI 10.1111/j.1540-6321.2004.00632.x; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; KRAMER J, 1985, J CHEM PHYS, V83, P6234, DOI 10.1063/1.449571; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Lenton TM, 2012, PHILOS T R SOC A, V370, P1185, DOI 10.1098/rsta.2011.0304; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; Livina VN, 2012, PHYSICA A, V391, P485, DOI 10.1016/j.physa.2011.08.025; Livina VN, 2011, CLIM DYNAM, V37, P2437, DOI 10.1007/s00382-010-0980-2; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Maestre FT, 2009, ECOLOGY, V90, P1729, DOI 10.1890/08-2096.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Oborny B, 2005, OIKOS, V109, P291; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2011, AM NAT, V178, P442, DOI 10.1086/661898; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson JMT, 2011, INT J BIFURCAT CHAOS, V21, P399, DOI 10.1142/S0218127411028519; Tredicce JR, 2004, AM J PHYS, V72, P799, DOI 10.1119/1.1688783; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	63	473	489	13	321	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41010	10.1371/journal.pone.0041010	http://dx.doi.org/10.1371/journal.pone.0041010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815897	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000306507000052
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900115
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500028
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600039
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
